Citrus Sinensis ID: 044996
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 678 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGU0 | 662 | Probable LRR receptor-lik | yes | no | 0.899 | 0.921 | 0.511 | 0.0 | |
| Q9LPT1 | 686 | Probably inactive leucine | no | no | 0.884 | 0.874 | 0.411 | 1e-120 | |
| C0LGR9 | 676 | Probable LRR receptor-lik | no | no | 0.873 | 0.875 | 0.376 | 1e-117 | |
| Q3E991 | 659 | Probable inactive leucine | no | no | 0.887 | 0.913 | 0.334 | 1e-101 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.882 | 0.892 | 0.373 | 2e-92 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.877 | 0.904 | 0.362 | 3e-92 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.883 | 0.925 | 0.353 | 5e-92 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.895 | 0.926 | 0.348 | 4e-89 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.859 | 0.929 | 0.343 | 6e-86 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.858 | 0.889 | 0.349 | 1e-83 |
| >sp|C0LGU0|RLK_ARATH Probable LRR receptor-like serine/threonine-protein kinase RLK OS=Arabidopsis thaliana GN=RLK PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 653 bits (1684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/690 (51%), Positives = 461/690 (66%), Gaps = 80/690 (11%)
Query: 1 LTDSQTLLTLKQSL--SNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQ 58
L+DS+ +L K+SL ALA+W+ ++PPC W+GVLC+ G +W L++E++ L
Sbjct: 32 LSDSEAILKFKESLVVGQENALASWNAKSPPCT-----WSGVLCNGGSVWRLQMENLELS 86
Query: 59 GNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDG 118
G+IDI L L +RTLS M N EGP PD ++L AL+S+YLSNN+F G+IP DAF+G
Sbjct: 87 GSIDIEALSGLTSLRTLSFMNNKFEGPFPDFKKLA--ALKSLYLSNNQFGGDIPGDAFEG 144
Query: 119 MTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNAL 178
M L+K+ LA N+F G IP S+ +L +L+ELRL+GN+F G+IP+F+ + L N+SNNAL
Sbjct: 145 MGWLKKVHLAQNKFTGQIPSSVAKLPKLLELRLDGNQFTGEIPEFEHQ-LHLLNLSNNAL 203
Query: 179 FGSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNH 238
G I +L DP F GN+ L G+PL + C +P H
Sbjct: 204 TGPIPESLSMTDPKVFEGNKGLYGKPLETECDSP----------------------YIEH 241
Query: 239 PPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFV 298
PP P +SS P LVI + V+ + I ++ IF+
Sbjct: 242 PPQS----EARPKSSSRGP------------------LVITA--IVAALTILIILGVIFL 277
Query: 299 IERKRKRER-GVSIENPPPLPPPSSNLQKTSGIRESGQC------------SPSSTEAVV 345
+ R K ++ +++E P S+LQK +GIRE+ Q S ++
Sbjct: 278 LNRSYKNKKPRLAVETGP------SSLQKKTGIREADQSRRDRKKADHRKGSGTTKRMGA 331
Query: 346 GGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMN 405
KLSF+R+D E+FDL DLL+ASAEILGSGCFG+SYKA LS+G MMVVKRFKQMN
Sbjct: 332 AAGVENTKLSFLREDREKFDLQDLLKASAEILGSGCFGASYKAVLSSGQMMVVKRFKQMN 391
Query: 406 NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQP 465
N GR+EFQEHM+RLGRL H NLL +VAYYYRKEEKLLV +F + SLA+NLH +Q+LG+P
Sbjct: 392 NAGRDEFQEHMKRLGRLMHHNLLSIVAYYYRKEEKLLVCDFAERGSLAINLHSNQSLGKP 451
Query: 466 SLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525
SLDWP+RLKIVKGVAKGL YL+++LPSL+APHGH+KSSNVLL ++ EP+L DYGLIP++N
Sbjct: 452 SLDWPTRLKIVKGVAKGLFYLHQDLPSLMAPHGHLKSSNVLLTKTFEPLLTDYGLIPLIN 511
Query: 526 QESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLAS 585
QE AQ M AY+SPE+LQ RITKKTDVW LG+LILEI+TGKFPANF Q ++ DLAS
Sbjct: 512 QEKAQMHMAAYRSPEYLQHRRITKKTDVWGLGILILEILTGKFPANFSQSSEE---DLAS 568
Query: 586 WVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645
WVNS +G +FDK M + EG+++KLL IGL CCE +VEKRLD+ +AVEKIEE
Sbjct: 569 WVNSGF-HGVWAPSLFDKGMGKTSHCEGQILKLLTIGLNCCEPDVEKRLDIGQAVEKIEE 627
Query: 646 VKERDG-DEDFYSSYASEADLRSPRGKSDE 674
+KER+G D+DFYS+Y SE D RS +G+S E
Sbjct: 628 LKEREGDDDDFYSTYVSETDGRSSKGESCE 657
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LPT1|Y1061_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At1g50610 OS=Arabidopsis thaliana GN=At1g50610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1116), Expect = e-120, Method: Compositional matrix adjust.
Identities = 276/670 (41%), Positives = 390/670 (58%), Gaps = 70/670 (10%)
Query: 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNI 61
+D+ LL K +L+N + +WD + PC N ANW GVLC +WGL+LE MGL G +
Sbjct: 46 SDADCLLRFKDTLANGSEFRSWDPLSSPCQGNTANWFGVLC-SNYVWGLQLEGMGLTGKL 104
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
++ L ++ +RT+S M NN GPMP +++ TS
Sbjct: 105 NLDPLVPMKNLRTISFMNNNFNGPMPQVKRF---------------------------TS 137
Query: 122 LRKLLLADNQFNGPIP-ESLTRLSRLVELRLEGNKFEGQIPDFQQK--DLVSFNVSNNAL 178
L+ L L++N+F+G IP ++ + L ++ L N F G IP L+ ++ N
Sbjct: 138 LKSLYLSNNRFSGEIPADAFLGMPLLKKILLANNAFRGTIPSSLASLPMLLELRLNGNQF 197
Query: 179 FGSI-SPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPN 237
G I S ++L +SF N DL G P P + PG + P +
Sbjct: 198 QGQIPSFQQKDLKLASFENN-DLDG-----PIPESLRNMDPGSFAGNKGLCDAPLSPCSS 251
Query: 238 HPPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIF 297
P P S SPP +G + + + + I ++A +F
Sbjct: 252 SSPGVPVVPVSPVDPKSTSPP----------TGKKAGSFYTLAIILIVIGIILVIIALVF 301
Query: 298 VIERKRKRERGVSIENPPPLPPPSSNLQK--TSGIRESGQCSPSSTEAVVGGKK-----P 350
+ R+R N P S+ ++ + +S + E+V ++ P
Sbjct: 302 CFVQSRRR-------NFLSAYPSSAGKERIESYNYHQSTNKNNKPAESVNHTRRGSMPDP 354
Query: 351 EIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGRE 410
+L FVRDD++RFDL DLLRASAE+LGSG FG+SYKA++S+G +VVKR+K MNNVGR+
Sbjct: 355 GGRLLFVRDDIQRFDLQDLLRASAEVLGSGTFGASYKAAISSGQTLVVKRYKHMNNVGRD 414
Query: 411 EFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWP 470
EF EHMRRLGRL HPN+LPLVAYYYR+EEKLLV EF+P SLA +LH + + G LDW
Sbjct: 415 EFHEHMRRLGRLNHPNILPLVAYYYRREEKLLVTEFMPNSSLASHLHANNSAG---LDWI 471
Query: 471 SRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ 530
+RLKI+KGVAKGL YL+ ELP+L PHGH+KSSN++L++S EP+L DY L P+M+ E A
Sbjct: 472 TRLKIIKGVAKGLSYLFDELPTLTIPHGHMKSSNIVLDDSFEPLLTDYALRPMMSSEHAH 531
Query: 531 ELMIAYKSPEFL-QLGR-ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVN 588
M AYKSPE+ G+ ITKKTDVW GVLILE++TG+FP N+L QG ++ L +WVN
Sbjct: 532 NFMTAYKSPEYRPSKGQIITKKTDVWCFGVLILEVLTGRFPENYLTQGYDSNMSLVTWVN 591
Query: 589 SVLANGDNRT-EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647
++ + +T +VFDKEM ++N + EM+ LLKIGL CCEEE E+R+D++E VE +E ++
Sbjct: 592 DMVK--EKKTGDVFDKEMKGKKNCKAEMINLLKIGLRCCEEEEERRMDMREVVEMVEMLR 649
Query: 648 ERDGDEDFYS 657
E + ++DF S
Sbjct: 650 EGESEDDFGS 659
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGR9|Y4312_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g31250 OS=Arabidopsis thaliana GN=At4g31250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1090), Expect = e-117, Method: Compositional matrix adjust.
Identities = 275/730 (37%), Positives = 385/730 (52%), Gaps = 138/730 (18%)
Query: 3 DSQTLLTLKQSLSNPTALANWDDRTPPCN-ENGAN--WNGVLCHRGKIWGLKLEDMGLQG 59
D+ LL K SL N ++L WD PPC+ + G++ W GV+C
Sbjct: 29 DADALLKFKSSLVNASSLGGWDSGEPPCSGDKGSDSKWKGVMC----------------- 71
Query: 60 NIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGM 119
NG++ ++ L N SGE+ A +
Sbjct: 72 ---------------------------------SNGSVFALRLENMSLSGELDVQALGSI 98
Query: 120 TSLRKLLLADNQFNGPIPESLTRLSRLVELRL---------EGNKFEGQIPDFQQKDLVS 170
L+ + N F G IP + L L L L +G+ F G K L+
Sbjct: 99 RGLKSISFMRNHFEGKIPRGIDGLVSLAHLYLAHNQFTGEIDGDLFSGM------KALLK 152
Query: 171 FNVSNNALFGSI------SPALREL--DPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSP 222
++ N G I P L EL + + F+G P + +
Sbjct: 153 VHLEGNRFSGEIPESLGKLPKLTELNLEDNMFTGK---------IPAFKQKNLVTVNVAN 203
Query: 223 ESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAP-----PPGNDSAGSGSSNSTLV 277
P+ L L N I S + +P P PP T+
Sbjct: 204 NQLEGRIPLTLGLMN-----ITFFSGNKGLCG-APLLPCRYTRPP----------FFTVF 247
Query: 278 IASATTVSVVAIAAVVAAIFVIERKRKR------ERGV-----SIENPPPLPPPSSNLQK 326
+ + T ++VV + V ++ ++ R++ + GV + P S +
Sbjct: 248 LLALTILAVVVLITVFLSVCILSRRQGKGQDQIQNHGVGHFHGQVYGQPEQQQHSEKSSQ 307
Query: 327 TSGI-----RESGQCSPSSTEAV--VGGKKP-------EIKLSFVRDDVERFDLHDLLRA 372
S + E+ Q ++T VGG P + KL FVR+D ERF L D+LRA
Sbjct: 308 DSKVYRKLANETVQRDSTATSGAISVGGLSPDEDKRGDQRKLHFVRNDQERFTLQDMLRA 367
Query: 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
SAE+LGSG FGSSYKA+LS+G +VVKRF+ M+N+GREEF +HM+++GRL HPNLLPL+A
Sbjct: 368 SAEVLGSGGFGSSYKAALSSGRAVVVKRFRFMSNIGREEFYDHMKKIGRLSHPNLLPLIA 427
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+YYRKEEKLLV ++ SLA LH ++ GQ LDWP RLKIV+GV +GL YLYR P
Sbjct: 428 FYYRKEEKLLVTNYISNGSLANLLHANRTPGQVVLDWPIRLKIVRGVTRGLAYLYRVFPD 487
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSPEFLQLGRITKKTD 552
L PHGH+KSSNVLL+ + EP+L DY L+PV+N++ +Q+ M+AYK+PEF Q R ++++D
Sbjct: 488 LNLPHGHLKSSNVLLDPNFEPLLTDYALVPVVNRDQSQQFMVAYKAPEFTQQDRTSRRSD 547
Query: 553 VWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSE 612
VWSLG+LILEI+TGKFPAN+L+QGK AD +LA+WV SV A + +VFDKEM + E
Sbjct: 548 VWSLGILILEILTGKFPANYLRQGKGADDELAAWVESV-ARTEWTADVFDKEMKAGKEHE 606
Query: 613 GEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD---GDEDFYSSY--ASEADLRS 667
+M+KLLKIGL CC+ ++EKR++L EAV++IEEV +RD G E SSY AS+ D RS
Sbjct: 607 AQMLKLLKIGLRCCDWDIEKRIELHEAVDRIEEV-DRDAGGGQESVRSSYVTASDGDHRS 665
Query: 668 PRGKSDEFTF 677
R ++EF+
Sbjct: 666 SRAMTEEFSL 675
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E991|Y5269_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At5g20690 OS=Arabidopsis thaliana GN=At5g20690 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-101, Method: Compositional matrix adjust.
Identities = 226/676 (33%), Positives = 360/676 (53%), Gaps = 74/676 (10%)
Query: 1 LTDSQTLLTLKQSLSNPTA-LANWDDRTPPCNENGANWNGVLCHRG-KIWGLKLEDMGLQ 58
+++S+ L+ K S+ L +W + T PC+ W G+ C +G + G+ + +GL
Sbjct: 28 VSESEPLVRFKNSVKITKGDLNSWREGTDPCS---GKWFGIYCQKGLTVSGIHVTRLGLS 84
Query: 59 GNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDG 118
G I + LK+L ++T+ L N L GP+P +L L+S+ LSNN FSGEI D F
Sbjct: 85 GTITVDDLKDLPNLKTIRLDNNLLSGPLPHFFKLR--GLKSLMLSNNSFSGEIRDDFFKD 142
Query: 119 MTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIP-DF-QQKDLVSFNVSNN 176
M+ L++L L N+F G IP S+T+L +L EL ++ N G+IP +F K+L ++S N
Sbjct: 143 MSKLKRLFLDHNKFEGSIPSSITQLPQLEELHMQSNNLTGEIPPEFGSMKNLKVLDLSTN 202
Query: 177 ALFGSI--SPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLP 234
+L G + S A ++ + + N LCG + C I L
Sbjct: 203 SLDGIVPQSIADKKNLAVNLTENEYLCGPVVDVGCEN-------------------IEL- 242
Query: 235 LPNHPPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVA 294
+DP +++ + N+ +V ++S++ + ++
Sbjct: 243 -------------NDPQEGQPPSKPSSSVPETSNKAAINAIMV-----SISLLLLFFIIV 284
Query: 295 AIFVIERKRK----------RERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAV 344
+ K+K RE V ++ S + G ST+
Sbjct: 285 GVIKRRNKKKNPDFRMLANNRENDVVEVRISESSSTTAKRSTDSSRKRGGHSDDGSTKKG 344
Query: 345 VGG-------------KKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLS 391
V + V D F L DL++A+AE+LG+G GS+YKA ++
Sbjct: 345 VSNIGKGGNGGGGGALGGGMGDIIMVNTDKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMT 404
Query: 392 TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451
TG +VVKR + MN + RE F MRR G+LRHPN+L +AY+YR+EEKL+V E++PK S
Sbjct: 405 TGLSVVVKRIRDMNQLAREPFDVEMRRFGKLRHPNILTPLAYHYRREEKLVVSEYMPKSS 464
Query: 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL 511
L LHG + + L W +RLKI++GVA G+++L+ E S PHG++KSSNVLL+E+
Sbjct: 465 LLYVLHGDRGIYHSELTWATRLKIIQGVAHGMKFLHEEFASYDLPHGNLKSSNVLLSETY 524
Query: 512 EPVLADYGLIPVMNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571
EP+++DY +P++ +A + + A+K+PEF Q +++ K+DV+ LG++ILEI+TGKFP+
Sbjct: 525 EPLISDYAFLPLLQPSNASQALFAFKTPEFAQTQQVSHKSDVYCLGIIILEILTGKFPSQ 584
Query: 572 FLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVE 631
+L GK D+ WV S +A E+ D E+ + S +MV+LL++G AC +
Sbjct: 585 YLNNGKGGT-DIVQWVQSSVAE-QKEEELIDPEIVNNTESMRQMVELLRVGAACIASNPD 642
Query: 632 KRLDLKEAVEKIEEVK 647
+RLD++EAV +IE+VK
Sbjct: 643 ERLDMREAVRRIEQVK 658
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (872), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 245/656 (37%), Positives = 355/656 (54%), Gaps = 58/656 (8%)
Query: 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNI 61
TDS+TLL K + + L +W+ T PC W GV C+R ++ L LED+ L G+I
Sbjct: 30 TDSETLLNFKLTADSTGKLNSWNTTTNPCQ-----WTGVSCNRNRVTRLVLEDINLTGSI 84
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
L +R LSL NNL GP+P+L L AL+ ++LSNN+FSG PT + +T
Sbjct: 85 SSL--TSLTSLRVLSLKHNNLSGPIPNLSNLT--ALKLLFLSNNQFSGNFPT-SITSLTR 139
Query: 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGS 181
L +L L+ N F+G IP LT L+ L+ LRLE N+F GQIP+ DL FNVS N G
Sbjct: 140 LYRLDLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQ 199
Query: 182 ISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPS-PGPSPESSPTPSPIPLPLPNHPP 240
I +L + S F+ N LCG PL C S P+ PG E+ +P P +P+ P
Sbjct: 200 IPNSLSQFPESVFTQNPSLCGAPL-LKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSP- 257
Query: 241 NPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIE 300
S H G SN+T I++ + ++++ ++ + +
Sbjct: 258 -----------TSIH------------GGDKSNNTSRISTISLIAIILGDFIILSFVSLL 294
Query: 301 RKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAV------VGGKKPEIKL 354
R ++ S + + I S P+ST+ VG K K+
Sbjct: 295 LYYCFWRQYAVNKKK-----HSKILEGEKIVYSSNPYPTSTQNNNNQNQQVGDKG---KM 346
Query: 355 SFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNV-GREEFQ 413
F + RF+L DLLRASAE+LG G FG++YKA L G + VKR K V G++EF+
Sbjct: 347 VFF-EGTRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFE 405
Query: 414 EHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRL 473
+ M LGRLRH NL+ L AYY+ +EEKLLV++++P SL LHG++ G+ LDW +RL
Sbjct: 406 QQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRL 465
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL-IPVMNQESAQEL 532
KI G A+GL +++ +L HG IKS+NVLL+ S ++D+GL I +Q A+
Sbjct: 466 KIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVAKS- 524
Query: 533 MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADG-DLASWVNSVL 591
Y++PE + + T+K+DV+S GVL+LEI+TGK P N ++ G DL WV SV+
Sbjct: 525 -NGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCP-NMVETGHSGGAVDLPRWVQSVV 582
Query: 592 ANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647
+ EVFD E+ ++ E EMV LL+I +AC + R + V+ IE+++
Sbjct: 583 RE-EWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIR 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 238/657 (36%), Positives = 345/657 (52%), Gaps = 62/657 (9%)
Query: 3 DSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCH--RGKIWGLKLEDMGLQGN 60
+ Q LLT Q + + L W++ CN W GV C+ + I L+L GL G
Sbjct: 28 EKQALLTFLQQIPHENRL-QWNESDSACN-----WVGVECNSNQSSIHSLRLPGTGLVGQ 81
Query: 61 IDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGM 119
I L L E+R LSL N L G +P D L + LRS+YL +N FSGE PT +F +
Sbjct: 82 IPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTH--LRSLYLQHNEFSGEFPT-SFTQL 138
Query: 120 TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALF 179
+L +L ++ N F G IP S+ L+ L L L N F G +P LV FNVSNN L
Sbjct: 139 NNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL-GLVDFNVSNNNLN 197
Query: 180 GSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP 239
GSI +L SF+GN DLCG PL PC + SPSP +PS I
Sbjct: 198 GSIPSSLSRFSAESFTGNVDLCGGPL-KPCKSFFVSPSP--------SPSLIN------- 241
Query: 240 PNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVI 299
P S+ + ++A ++VA+ + +F+
Sbjct: 242 ---------------------PSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLC 280
Query: 300 ERKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRD 359
RKR+ + P P + N+ G S + + T + +GG+ KL F
Sbjct: 281 LRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKE-EVTGTSSGMGGETERNKLVFTEG 339
Query: 360 DVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRL 419
V FDL DLLRASAE+LG G G+SYKA L G +VVKR K + ++EF+ M +
Sbjct: 340 GVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVM-ASKKEFETQMEVV 398
Query: 420 GRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGV 479
G+++HPN++PL AYYY K+EKLLV +F+P SL+ LHG + G+ LDW +R++I
Sbjct: 399 GKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITA 458
Query: 480 AKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSP 539
A+GL +L+ S HG+IK+SN+LL+ + + ++DYGL + + S + Y +P
Sbjct: 459 ARGLAHLH---VSAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAP 515
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGKFP--ANFLQQGKKADGDLASWVNSVLANGDNR 597
E L+ ++T K+DV+S GVL+LE++TGK P A+ ++G DL WV SV+ +
Sbjct: 516 EVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGI----DLPRWVLSVVRE-EWT 570
Query: 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDED 654
EVFD E+ N E EMV+LL+I +AC ++R ++E + IE+V + +D
Sbjct: 571 AEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRSETTDD 627
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 339 bits (869), Expect = 5e-92, Method: Compositional matrix adjust.
Identities = 234/662 (35%), Positives = 347/662 (52%), Gaps = 63/662 (9%)
Query: 3 DSQTLLTLKQSLSNPTALANWD-DRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNI 61
D LL+ + ++ T L WD +T PCN W GVLC G++ L+L L G+I
Sbjct: 34 DKSALLSFRSAVGGRTLL--WDVKQTSPCN-----WTGVLCDGGRVTALRLPGETLSGHI 86
Query: 62 DITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMT 120
I L ++RTLSL N L G +P DL + LR +YL NRFSGEIP F ++
Sbjct: 87 PEGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSD--LRRLYLQGNRFSGEIPEVLFS-LS 143
Query: 121 SLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG 180
+L +L LA+N+F+G I L+RL L LE NK L FNVSNN L G
Sbjct: 144 NLVRLNLAENEFSGEISSGFKNLTRLKTLYLENNKLS-GSLLDLDLSLDQFNVSNNLLNG 202
Query: 181 SISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPP 240
SI +L++ D SF G LCG+PL C PS P+ + N
Sbjct: 203 SIPKSLQKFDSDSFVGT-SLCGKPL-VVCSNEGTVPSQ-------------PISVGN--- 244
Query: 241 NPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIE 300
P G++ S IA VV ++ +V + V+
Sbjct: 245 ----------------IPGTVEGSEEKKKRKKLSGGAIAGIVIGCVVGLSLIVMILMVLF 288
Query: 301 RKRKRERGVSIE------NPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKL 354
RK+ ER +I+ + +P + ++ + SPS+ +AV KL
Sbjct: 289 RKKGNERTRAIDLATIKHHEVEIPGEKAAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKL 348
Query: 355 SFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQE 414
F + + FDL DLLRASAE+LG G FG++YKA L ++ VKR K + RE F+E
Sbjct: 349 VFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMADRE-FKE 407
Query: 415 HMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK 474
+ +G + H NL+PL AYYY +EKLLV++F+P SL+ LHG++ G+P L+W R
Sbjct: 408 KIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSG 467
Query: 475 IVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ-ELM 533
I G A+GL YL+ + P ++ HG++KSSN+LL S + ++D+GL +++ S
Sbjct: 468 IALGAARGLDYLHSQDP--LSSHGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNRA 525
Query: 534 IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593
Y++PE R+++K DV+S GV++LE++TGK P+N + + DLA WV+SV A
Sbjct: 526 TGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGM--DLARWVHSV-AR 582
Query: 594 GDNRTEVFDKEMADER---NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650
+ R EVFD E+ + E EM ++L++G+ C E+ +KR + E V +I+E+++
Sbjct: 583 EEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELRQSG 642
Query: 651 GD 652
D
Sbjct: 643 AD 644
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 235/675 (34%), Positives = 346/675 (51%), Gaps = 68/675 (10%)
Query: 3 DSQTLLTLKQSLSNPTALANWD-DRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNI 61
D LL+L+ ++ T W+ +T PCN W GV C ++ L+L + L G+I
Sbjct: 36 DRTALLSLRSAVGGRTF--RWNIKQTSPCN-----WAGVKCESNRVTALRLPGVALSGDI 88
Query: 62 DITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMT 120
I L ++RTLSL N L G +P DL N LR +YL NRFSGEIP F ++
Sbjct: 89 PEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSN--LRHLYLQGNRFSGEIPEVLFS-LS 145
Query: 121 SLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG 180
L +L LA N F G I T L++L L LE N+ G IPD LV FNVSNN+L G
Sbjct: 146 HLVRLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLP-LVQFNVSNNSLNG 204
Query: 181 SISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPP 240
SI L+ + SF LCG+PL CP PS
Sbjct: 205 SIPKNLQRFESDSFL-QTSLCGKPL-KLCPDEETVPS----------------------- 239
Query: 241 NPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIE 300
P + + P G++ + S IA VV A +V + V+
Sbjct: 240 --------QPTSGGNRTPPSVEGSEEKKKKNKLSGGAIAGIVIGCVVGFALIVLILMVLC 291
Query: 301 RKR--KRERGVSI----ENPPPLPPPSSNLQKTSGIRESGQCSPSST---EAVVGGKKPE 351
RK+ KR R V I + P +P + + S + + T +A G
Sbjct: 292 RKKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPAT 351
Query: 352 IKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREE 411
KL F + + FDL DLLRASAE+LG G FG++YKA L ++ VKR K + + +E
Sbjct: 352 KKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVM-MADKE 410
Query: 412 FQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPS 471
F+E + +G + H NL+PL AYY+ ++EKLLV++F+P SL+ LHG++ G+ L+W
Sbjct: 411 FKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDV 470
Query: 472 RLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ- 530
R +I G A+GL YL+ + S HG+IKSSN+LL +S + ++D+GL ++ +
Sbjct: 471 RSRIAIGAARGLDYLHSQGTS--TSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNP 528
Query: 531 ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSV 590
Y++PE R+++K DV+S GV++LE++TGK P+N + + DL WV SV
Sbjct: 529 NRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGV--DLPRWVKSV 586
Query: 591 LANGDNRTEVFDKEMADERNSEGEMV-KLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649
A + R EVFD E+ E EM+ +++++GL C + ++R ++ E V K+E ++
Sbjct: 587 -ARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLRPY 645
Query: 650 DGDEDFYSSYASEAD 664
G S +EAD
Sbjct: 646 SG-----SDQVNEAD 655
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (816), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 227/660 (34%), Positives = 338/660 (51%), Gaps = 77/660 (11%)
Query: 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNI 61
+D + LL ++ S+ L N +P NW+GV C G++ L+L GL G++
Sbjct: 28 SDRRALLAVRNSVRGRPLLWNMSASSP------CNWHGVHCDAGRVTALRLPGSGLFGSL 81
Query: 62 DITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMT 120
I + L +++TLSL N+L GP+P D L LR +YL N FSGEIP+ F +
Sbjct: 82 PIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLV--LLRYLYLQGNAFSGEIPSLLFT-LP 138
Query: 121 SLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG 180
S+ ++ L +N+F+G IP+++ +RLV L LE N+ G IP+ L FNVS+N L G
Sbjct: 139 SIIRINLGENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPEITLP-LQQFNVSSNQLNG 197
Query: 181 SISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPP 240
SI +L ++F GN LCG+PL + C SP+
Sbjct: 198 SIPSSLSSWPRTAFEGN-TLCGKPLDT-CEAESPN------------------------- 230
Query: 241 NPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIE 300
+ P PP DS S I VV + ++ +F +
Sbjct: 231 ----------GGDAGGPNTPPEKKDS----DKLSAGAIVGIVIGCVVGLLLLLLILFCLC 276
Query: 301 RKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVV------GGKKPEIK- 353
RKRK+E V PS N++ S P T VV G + +
Sbjct: 277 RKRKKEENV----------PSRNVEAPVAAATSSAAIPKETVVVVPPAKATGSESGAVNK 326
Query: 354 -LSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEF 412
L+F FDL LL+ASAE+LG G GSSYKAS G ++ VKR + + V +EF
Sbjct: 327 DLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLRDVV-VPEKEF 385
Query: 413 QEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSR 472
+E + LG + H NL+ L+AYY+ ++EKLLV E++ K SL+ LHG++ G+ L+W +R
Sbjct: 386 RERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGNGRTPLNWETR 445
Query: 473 LKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532
I G A+ + YL+ + HG+IKSSN+LL++S E ++DYGL P+++ SA
Sbjct: 446 AGIALGAARAISYLHSRDGT--TSHGNIKSSNILLSDSYEAKVSDYGLAPIISSTSAPNR 503
Query: 533 MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA 592
+ Y++PE +I++K DV+S GVLILE++TGK P + QQ + DL WV SV
Sbjct: 504 IDGYRAPEITDARKISQKADVYSFGVLILELLTGKSPTH--QQLNEEGVDLPRWVQSVTE 561
Query: 593 NGDNRTEVFDKEMADERNSEGE-MVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651
++V D E+ + E +++LLKIG++C + + R + E IEEV G
Sbjct: 562 Q-QTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIEEVSHSSG 620
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (797), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 230/658 (34%), Positives = 337/658 (51%), Gaps = 76/658 (11%)
Query: 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHR--GKIWGLKLEDMGLQG 59
+D Q LL S+ + L NW+ C +W GV C + L+L +GL G
Sbjct: 47 SDRQALLAFAASVPHLRRL-NWNSTNHICK----SWVGVTCTSDGTSVHALRLPGIGLLG 101
Query: 60 NIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDG 118
I L +L +R LSL N L G +P D+ L +L +YL +N FSGE+P+
Sbjct: 102 PIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLP--SLDYIYLQHNNFSGEVPSFV--- 156
Query: 119 MTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNAL 178
L L L+ N F G IP + L +L L L+ NK G +P+ L N+SNN L
Sbjct: 157 SRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLRRLNLSNNHL 216
Query: 179 FGSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNH 238
GSI AL SSFSGN LCG PL PC T SP PS
Sbjct: 217 NGSIPSALGGFPSSSFSGNTLLCGLPL-QPCATSSPPPS--------------------- 254
Query: 239 PPNPIPSPSHDPHASSHSPPAPP-PGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIF 297
PH S+ PP PP P + + ST++ +A +++ + V+
Sbjct: 255 ---------LTPHIST--PPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCC 303
Query: 298 VIERKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEI-KLSF 356
I++K KRE ++ K + E + E G ++PE KL F
Sbjct: 304 CIKKKDKRE---------------DSIVKVKTLTEKAK-----QEFGSGVQEPEKNKLVF 343
Query: 357 VRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHM 416
FDL DLLRASAE+LG G +G++YKA L +VVKR K++ G+ EF++ M
Sbjct: 344 FNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVA-AGKREFEQQM 402
Query: 417 RRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKI 475
+ R+ HP+++PL AYYY K+EKL+V ++ P +L+ LHG++ + LDW SR+KI
Sbjct: 403 EIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKI 462
Query: 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA 535
AKG+ +L+ + HG+IKSSNV++ + + ++D+GL P+M A
Sbjct: 463 TLSAAKGIAHLHAAGGPKFS-HGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMRGAG 521
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADG-DLASWVNSVLANG 594
Y++PE ++ + T K+DV+S GVLILE++TGK P +Q + D DL WV SV+
Sbjct: 522 YRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSP---VQSPSRDDMVDLPRWVQSVVRE- 577
Query: 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652
+ +EVFD E+ +N E EMV++L+I +AC + E R + + V IEE++ D +
Sbjct: 578 EWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIRVSDSE 635
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 678 | ||||||
| 224118616 | 671 | predicted protein [Populus trichocarpa] | 0.915 | 0.925 | 0.578 | 0.0 | |
| 224090562 | 612 | predicted protein [Populus trichocarpa] | 0.883 | 0.978 | 0.570 | 0.0 | |
| 449439569 | 655 | PREDICTED: probable LRR receptor-like se | 0.902 | 0.934 | 0.553 | 0.0 | |
| 449518733 | 655 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.902 | 0.934 | 0.551 | 0.0 | |
| 359484945 | 633 | PREDICTED: probable LRR receptor-like se | 0.889 | 0.952 | 0.513 | 0.0 | |
| 334188021 | 662 | leucine-rich repeat protein kinase-like | 0.899 | 0.921 | 0.511 | 0.0 | |
| 3047095 | 690 | similar to eukaryotic protein kinase dom | 0.898 | 0.882 | 0.509 | 0.0 | |
| 147866686 | 633 | hypothetical protein VITISV_017867 [Viti | 0.889 | 0.952 | 0.513 | 0.0 | |
| 356511425 | 632 | PREDICTED: probable LRR receptor-like se | 0.874 | 0.938 | 0.527 | 0.0 | |
| 356527710 | 632 | PREDICTED: probable LRR receptor-like se | 0.873 | 0.936 | 0.522 | 1e-179 |
| >gi|224118616|ref|XP_002331406.1| predicted protein [Populus trichocarpa] gi|222873620|gb|EEF10751.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/686 (57%), Positives = 493/686 (71%), Gaps = 65/686 (9%)
Query: 1 LTDSQTLLTLKQSLSNPTALANWDDRTPPCNENGA-NWNGVLCHRGKIWGLKLEDMGLQG 59
LTDS+ LL K SL+N + L++W D+T PC +N A NW GV+C G +WGL+LE+MGL G
Sbjct: 43 LTDSEILLKFKGSLTNASVLSDWSDKTTPCTKNNATNWVGVICVEGSLWGLQLENMGLAG 102
Query: 60 NIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGM 119
ID+ ILK L +++T S+M NN +GPMP+ +++ LRS+YLSNN FSG IP DAFDG+
Sbjct: 103 KIDVEILKSLPDLKTFSIMNNNFDGPMPEFKKMV--TLRSIYLSNNHFSGVIPPDAFDGI 160
Query: 120 TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALF 179
L+K+ LA N+F G IP SL L +L+ LRLEGN+F G++PDF +L SF+VSNNAL
Sbjct: 161 LKLKKVYLAQNEFTGAIPSSLVALPKLLVLRLEGNQFTGKLPDFTH-NLQSFSVSNNALE 219
Query: 180 GSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP 239
G I L ++D SSFSGN+ LCG PL + C T + + G +S TP
Sbjct: 220 GPIPTGLSKMDLSSFSGNKGLCGPPL-NECNT---TDNDGHDSDSKKTPV---------- 265
Query: 240 PNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVI 299
L++ A V ++ I A+VAA F+
Sbjct: 266 -----------------------------------LLIVILAAAVGLL-IGAIVAA-FLF 288
Query: 300 ERKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEI-KLSFVR 358
R+R+R+ SIE PPP P SNL+K +G +E Q SS + VG +K E KLSFVR
Sbjct: 289 LRRRQRQASGSIEAPPP--PIPSNLKKKTGFKEENQSPSSSPDHSVGSRKGEGPKLSFVR 346
Query: 359 DDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRR 418
DD E+FDL DLL+ASAEILGSGCFGSSYKA+LS+G MMVVKRFKQMNNVG+EEFQEHMRR
Sbjct: 347 DDREKFDLPDLLKASAEILGSGCFGSSYKAALSSGTMMVVKRFKQMNNVGKEEFQEHMRR 406
Query: 419 LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG 478
LGRL+H NLLPLVAYYYRKEEKLL+ +FV K SLA +LHGHQALGQPSL WPSRLKIVKG
Sbjct: 407 LGRLKHSNLLPLVAYYYRKEEKLLITDFVEKGSLAAHLHGHQALGQPSLGWPSRLKIVKG 466
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKS 538
VA+GL YLY++LP++IA HGH+KSSNVLL +S EP+L DYGL+PV+NQE+AQELM+AYKS
Sbjct: 467 VARGLAYLYKDLPNIIAAHGHLKSSNVLLTQSNEPMLTDYGLVPVINQENAQELMVAYKS 526
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKAD-GDLASWVNSVLANGDNR 597
PE+L GRITKKTDVWSLG+LI+EI+TGK PANF+ QGK ++ DLASWVNSV +
Sbjct: 527 PEYLHHGRITKKTDVWSLGILIVEILTGKLPANFVPQGKGSEQQDLASWVNSV-PYEEWI 585
Query: 598 TEVFDKEMADERN-----SEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652
V DK+M + E E++KLLKIGL+CCE +VEKRLDLKEAVE+IEE+KE+D D
Sbjct: 586 NVVLDKDMTNVSTKPNGGGESEVMKLLKIGLSCCEADVEKRLDLKEAVERIEEIKEKDSD 645
Query: 653 EDFYSSYASEADLRSPRGKSDEFTFS 678
+DF+SSYASE D++S RGKSDEFTFS
Sbjct: 646 DDFFSSYASEGDMKSSRGKSDEFTFS 671
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224090562|ref|XP_002309026.1| predicted protein [Populus trichocarpa] gi|222855002|gb|EEE92549.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/666 (57%), Positives = 474/666 (71%), Gaps = 67/666 (10%)
Query: 1 LTDSQTLLTLKQSLSNPTALANWDDRTPPCNENGA-NWNGVLCHRGKIWGLKLEDMGLQG 59
LTDS+ LL K SLSN +AL++W D+T PC +N A NW GV+C G +WGL+LE+MGL G
Sbjct: 6 LTDSEILLKFKGSLSNASALSDWSDKTTPCTKNNATNWAGVICVDGILWGLQLENMGLAG 65
Query: 60 NIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGM 119
ID+ L+ L +++TLS+M NN +GPMP+ +++ +LR++YLSNN FSG IP DAFDGM
Sbjct: 66 KIDMETLQALPDLKTLSIMNNNFDGPMPEFKKIV--SLRALYLSNNHFSGVIPLDAFDGM 123
Query: 120 TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALF 179
L+K+ LA N+F G IP SL L +L++LRLEGN+F GQ+PD Q +L+SF+VSNNAL
Sbjct: 124 LKLKKVYLAQNEFTGAIPSSLIALPKLLDLRLEGNQFTGQLPDLTQ-NLLSFSVSNNALE 182
Query: 180 GSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP 239
G I L ++D SSFSGN+ LCG PL C T
Sbjct: 183 GPIPAGLSKMDSSSFSGNKGLCGPPL-KECNT---------------------------- 213
Query: 240 PNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVI 299
+S+S PP L+I V + + A+VAA +
Sbjct: 214 ------------INSNSDSKKPP------------VLLIVIIAAVVGLLLGAIVAAFLFL 249
Query: 300 ERKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEI-KLSFVR 358
R+ +R+ SIE PPP P SNL+K +G +E Q SS + VG KK E KLSFVR
Sbjct: 250 RRQSQRQPLASIEAPPP--PIPSNLKKKTGFKEENQSPSSSPDHSVGSKKGEPPKLSFVR 307
Query: 359 DDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRR 418
DD E+FDL DLL+ASAEILGSGCFGSSYKA+L++G MMVVKRFKQMNNVGREEFQEHMRR
Sbjct: 308 DDREKFDLPDLLKASAEILGSGCFGSSYKAALNSGTMMVVKRFKQMNNVGREEFQEHMRR 367
Query: 419 LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG 478
LGRL+H NLLPLVAYYYRKEEKLL+ +FV K SLAV+LHGHQALGQPSLDWPSRLKIVKG
Sbjct: 368 LGRLKHSNLLPLVAYYYRKEEKLLITDFVEKGSLAVHLHGHQALGQPSLDWPSRLKIVKG 427
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKS 538
V +GL YLY++LP++IA HGH+KSSNVLL +S EP+L DYGL+PV+NQE+AQELM+AYKS
Sbjct: 428 VVRGLAYLYKDLPNIIAAHGHLKSSNVLLTQSNEPLLTDYGLVPVINQENAQELMVAYKS 487
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKA-DGDLASWVNSVLANGDNR 597
PE+L GRITKKTDVWSLG+LILEI++ K PANF+ QGK + + DLA+WVNSV + +
Sbjct: 488 PEYLHHGRITKKTDVWSLGILILEILSAKLPANFVPQGKGSEEEDLANWVNSV-PHEEWT 546
Query: 598 TEVFDKEMAD-----ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652
V DK+M + E E++KLLKIGL+CCE +VEKR+DLKEAVE+IEE+KERD D
Sbjct: 547 NVVIDKDMTNGPTKQNGGGESEVIKLLKIGLSCCEADVEKRIDLKEAVERIEEIKERDSD 606
Query: 653 EDFYSS 658
+DF+SS
Sbjct: 607 DDFFSS 612
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439569|ref|XP_004137558.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RLK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1785), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/687 (55%), Positives = 470/687 (68%), Gaps = 75/687 (10%)
Query: 2 TDSQTLLTLKQSL---SNPTALANWDDRTPPCNE---NGANWNGVLCHRGKIWGLKLEDM 55
TD+ LL K SL SN AL NW + N ANW G+LC +G +WGLKLE M
Sbjct: 33 TDADALLKFKSSLDISSNNDALGNWGSGGSSSSPCSGNKANWVGILCEKGNVWGLKLESM 92
Query: 56 GLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDA 115
GL+GNIDI L+ + +RTLSLM N EG +PD+++LG AL+S+YLS N FSG IP
Sbjct: 93 GLKGNIDIESLEGVPHLRTLSLMNNEFEGSLPDIKRLG--ALKSLYLSRNHFSGNIPGYF 150
Query: 116 FDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSN 175
F M SL+K+ LA+N+ G IP SL L RL+ELRLEGNKF GQIP+FQQ + +FN+SN
Sbjct: 151 FSNMLSLKKVHLANNELEGQIPWSLVELHRLLELRLEGNKFSGQIPNFQQNTIKAFNLSN 210
Query: 176 N-ALFGSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLP 234
N L G I PAL LDPSSFSG LCG PL PC S +P
Sbjct: 211 NDQLHGQIPPALSRLDPSSFSGIEGLCGAPLNKPC-----------------NASKVP-- 251
Query: 235 LPNHPPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVA 294
S S ++++ A T++++AI A +
Sbjct: 252 ------------------------------------SIGSIIMVSIAVTLALLAIGAGIV 275
Query: 295 AIFVIERKRKRERGVSIENPPPLPPPSSNLQ-KTSGIRESGQCSPSSTEAVVGGKKPE-I 352
+ R + + E+P PS+N Q + +G++ + SS +V G + +
Sbjct: 276 IL-----SRCNQSSSNNEDPAHGKSPSANEQDQGAGVKSPDR--GSSNGSVTGKRSADSA 328
Query: 353 KLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEF 412
KLSFVR+D ERFDL DLL+ASAEILGSGCFGSSYKA+L+ G +MVVKRFKQMNNV REEF
Sbjct: 329 KLSFVREDSERFDLSDLLKASAEILGSGCFGSSYKAALTNGPVMVVKRFKQMNNVDREEF 388
Query: 413 QEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSR 472
QEHMRR+GRL+H NLLPLVAYYY+KEEKLL+ +++ K SLAV+LHGH+A+GQP+LDWP+R
Sbjct: 389 QEHMRRIGRLKHTNLLPLVAYYYKKEEKLLITDYIEKGSLAVHLHGHKAVGQPALDWPAR 448
Query: 473 LKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532
LKIVKGV KGL+YLY ELPSLI PHGH+KSSNVL+ + EP+L+DYGLIPV+NQE A EL
Sbjct: 449 LKIVKGVGKGLRYLYSELPSLITPHGHLKSSNVLIKANYEPLLSDYGLIPVVNQEHAHEL 508
Query: 533 MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKA-DGDLASWVNSVL 591
M+AYKSPE+ Q GRITKKTDVWS G+LILEI++G+FPANFL Q K + DLASWV S+
Sbjct: 509 MVAYKSPEYSQQGRITKKTDVWSFGLLILEILSGQFPANFLHQNKSGEEEDLASWVKSIP 568
Query: 592 ANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651
N T VFDKEM ++SEGEM+KLL+I +ACCE + EKRLDL+EAVEKI+EVKE+DG
Sbjct: 569 EKEWN-TRVFDKEMGPNKSSEGEMMKLLRIAMACCESDFEKRLDLREAVEKIDEVKEKDG 627
Query: 652 DEDFYSSYASEADLRSPRGKSDEFTFS 678
DEDFYSSYASEAD+RS RG SDE F+
Sbjct: 628 DEDFYSSYASEADIRSSRGLSDELNFT 654
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449518733|ref|XP_004166390.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase RLK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/687 (55%), Positives = 469/687 (68%), Gaps = 75/687 (10%)
Query: 2 TDSQTLLTLKQSL---SNPTALANWDDRTPPCNE---NGANWNGVLCHRGKIWGLKLEDM 55
TD+ LL K SL SN AL NW + N ANW G+LC +G +WGLKLE M
Sbjct: 33 TDADALLKFKSSLDISSNNDALGNWGSGGSSSSPCSGNKANWVGILCEKGNVWGLKLESM 92
Query: 56 GLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDA 115
GL+GNIDI L+ + +RTLSLM N EG +PD+++LG AL+S+YLS N FSG IP
Sbjct: 93 GLKGNIDIESLEGVPHLRTLSLMNNEFEGSLPDIKRLG--ALKSLYLSRNHFSGNIPGYF 150
Query: 116 FDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSN 175
F M SL+K+ LA+N+ G IP SL L RL+ELRLEGNKF GQIP+FQQ + +FN+SN
Sbjct: 151 FSNMLSLKKVHLANNELEGQIPWSLVELHRLLELRLEGNKFSGQIPNFQQNTIKAFNLSN 210
Query: 176 N-ALFGSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLP 234
N L G I PAL LDPSSFSG LCG PL PC S +P
Sbjct: 211 NDQLHGQIPPALSRLDPSSFSGIEGLCGAPLNKPC-----------------NASKVP-- 251
Query: 235 LPNHPPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVA 294
S S ++++ A T++++AI A +
Sbjct: 252 ------------------------------------SIGSIIMVSIAVTLALLAIGAGIV 275
Query: 295 AIFVIERKRKRERGVSIENPPPLPPPSSNLQ-KTSGIRESGQCSPSSTEAVVGGKKPE-I 352
+ R + + E+P PS+N Q + +G++ + SS +V G + +
Sbjct: 276 IL-----SRCNQSSSNNEDPAHGKSPSANEQDQGAGVKSPDR--GSSNGSVTGKRSADSA 328
Query: 353 KLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEF 412
KLSFVR+D ERFDL DLL+ASAEILGSGCFGSSYKA+L+ G +MVVKRFKQMNNV REEF
Sbjct: 329 KLSFVREDSERFDLSDLLKASAEILGSGCFGSSYKAALTNGPVMVVKRFKQMNNVDREEF 388
Query: 413 QEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSR 472
QEHMRR+GRL+H NLLPLVAYYY+KEEKLL+ +++ K SLAV+LHGH+A+GQP+LDWP+R
Sbjct: 389 QEHMRRIGRLKHTNLLPLVAYYYKKEEKLLITDYIEKGSLAVHLHGHKAVGQPALDWPAR 448
Query: 473 LKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532
LKIVKGV KGL+YLY ELPSLI PHGH+KSSNVL+ + EP+L+DYGLIPV+NQE A EL
Sbjct: 449 LKIVKGVGKGLRYLYSELPSLITPHGHLKSSNVLIKANYEPLLSDYGLIPVVNQEHAHEL 508
Query: 533 MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKA-DGDLASWVNSVL 591
M+AYKSPE+ Q GRITKKTDVWS G+LILEI++G+FPANFL Q K + DLASWV S+
Sbjct: 509 MVAYKSPEYSQQGRITKKTDVWSFGLLILEILSGQFPANFLHQNKSGEEEDLASWVKSIP 568
Query: 592 ANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651
N T VFDKEM ++SEGEM+KLL+I +ACCE + EKRLDL+EAVEKI+EVK +DG
Sbjct: 569 EKEWN-TRVFDKEMGPNKSSEGEMMKLLRIAMACCESDFEKRLDLREAVEKIDEVKXKDG 627
Query: 652 DEDFYSSYASEADLRSPRGKSDEFTFS 678
DEDFYSSYASEAD+RS RG SDE F+
Sbjct: 628 DEDFYSSYASEADIRSSRGLSDELNFT 654
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484945|ref|XP_002266187.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RLK-like [Vitis vinifera] gi|297736026|emb|CBI24064.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/678 (51%), Positives = 450/678 (66%), Gaps = 75/678 (11%)
Query: 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNI 61
+ S+ LL K SL N TAL +W+ T PC + W GV+C G +WGL+LE MGL G I
Sbjct: 30 SQSEILLEFKNSLRNVTALGSWNTSTTPCGGSPGGWVGVICINGDVWGLQLEGMGLMGTI 89
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
D+ L +L +R +S M N+ +G +P +++L AL+SV+LSNN+FSGEI DAF GM S
Sbjct: 90 DMDTLAKLPHLRGISFMNNHFDGAIPKIKKLS--ALKSVFLSNNQFSGEIEDDAFSGMVS 147
Query: 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGS 181
L+K+ LA N+F+G +PESL L R++ELRLEGN F+GQIP+F+ L SFN+SNN L G
Sbjct: 148 LKKVHLAHNKFSGGVPESLALLPRILELRLEGNHFKGQIPEFRATQLQSFNISNNNLEGP 207
Query: 182 ISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPN 241
I +LR+++ +SFSGN++LC G+P + P P P
Sbjct: 208 IPESLRKMELTSFSGNKNLC----GAPLGS---------------------CPRPKKP-- 240
Query: 242 PIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIER 301
+TL++ V +A++A++ A ++
Sbjct: 241 --------------------------------TTLMMVVVGIVVALALSAIIVAFILLRC 268
Query: 302 KRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDV 361
+ + V +E PP + T + + S+TE+ G K + KL ++R+D
Sbjct: 269 SKCQTTLVQVETPPS--------KVTCRELDKVKLQESNTES--GKKVEQGKLYYLRNDE 318
Query: 362 ERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGR 421
+ DL DLL+ASAEILGSG FGSSYKA L G+ +VVKRF+ MNNVG+EEFQEHMRRLGR
Sbjct: 319 NKCDLKDLLKASAEILGSGYFGSSYKAVLVNGSSVVVKRFRHMNNVGKEEFQEHMRRLGR 378
Query: 422 LRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAK 481
L HPNLLP VAYYYR+EEKLLV +F+ SLA++LHG+ A QP LDW +RLKI+KG+AK
Sbjct: 379 LNHPNLLPFVAYYYREEEKLLVTDFIDNGSLAIHLHGNHARDQPRLDWATRLKIIKGIAK 438
Query: 482 GLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSPEF 541
GL YLY ELP+LIAPH H+KSSNVLL++S P+L DYGL+P++NQE AQ LM+AYKSPE+
Sbjct: 439 GLAYLYTELPTLIAPHSHLKSSNVLLSKSFTPLLTDYGLVPLINQEIAQALMVAYKSPEY 498
Query: 542 LQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601
Q GRITKKTDVWS G LILEI+TGKFP LQQG+ +D DLASWVNSV + + EVF
Sbjct: 499 KQHGRITKKTDVWSFGTLILEILTGKFPTQNLQQGQASDTDLASWVNSV-SQEEWEDEVF 557
Query: 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFYSSYAS 661
DKEM NS+ EMVKLLKIGLACCE +V KR D+KEAVEKIEE+KE+D ++DFYSSYAS
Sbjct: 558 DKEMGGTTNSKWEMVKLLKIGLACCEGDVGKRWDMKEAVEKIEELKEKDSEDDFYSSYAS 617
Query: 662 EADLRSP-RGKSDEFTFS 678
E + SP R SDE +FS
Sbjct: 618 E--MESPSRQLSDEPSFS 633
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334188021|ref|NP_198389.2| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|263505488|sp|C0LGU0.1|RLK_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase RLK; Flags: Precursor gi|224589687|gb|ACN59375.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332006579|gb|AED93962.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/690 (51%), Positives = 461/690 (66%), Gaps = 80/690 (11%)
Query: 1 LTDSQTLLTLKQSL--SNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQ 58
L+DS+ +L K+SL ALA+W+ ++PPC W+GVLC+ G +W L++E++ L
Sbjct: 32 LSDSEAILKFKESLVVGQENALASWNAKSPPCT-----WSGVLCNGGSVWRLQMENLELS 86
Query: 59 GNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDG 118
G+IDI L L +RTLS M N EGP PD ++L AL+S+YLSNN+F G+IP DAF+G
Sbjct: 87 GSIDIEALSGLTSLRTLSFMNNKFEGPFPDFKKLA--ALKSLYLSNNQFGGDIPGDAFEG 144
Query: 119 MTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNAL 178
M L+K+ LA N+F G IP S+ +L +L+ELRL+GN+F G+IP+F+ + L N+SNNAL
Sbjct: 145 MGWLKKVHLAQNKFTGQIPSSVAKLPKLLELRLDGNQFTGEIPEFEHQ-LHLLNLSNNAL 203
Query: 179 FGSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNH 238
G I +L DP F GN+ L G+PL + C +P H
Sbjct: 204 TGPIPESLSMTDPKVFEGNKGLYGKPLETECDSP----------------------YIEH 241
Query: 239 PPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFV 298
PP P +SS P LVI + V+ + I ++ IF+
Sbjct: 242 PPQS----EARPKSSSRGP------------------LVITA--IVAALTILIILGVIFL 277
Query: 299 IERKRKRER-GVSIENPPPLPPPSSNLQKTSGIRESGQC------------SPSSTEAVV 345
+ R K ++ +++E P S+LQK +GIRE+ Q S ++
Sbjct: 278 LNRSYKNKKPRLAVETGP------SSLQKKTGIREADQSRRDRKKADHRKGSGTTKRMGA 331
Query: 346 GGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMN 405
KLSF+R+D E+FDL DLL+ASAEILGSGCFG+SYKA LS+G MMVVKRFKQMN
Sbjct: 332 AAGVENTKLSFLREDREKFDLQDLLKASAEILGSGCFGASYKAVLSSGQMMVVKRFKQMN 391
Query: 406 NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQP 465
N GR+EFQEHM+RLGRL H NLL +VAYYYRKEEKLLV +F + SLA+NLH +Q+LG+P
Sbjct: 392 NAGRDEFQEHMKRLGRLMHHNLLSIVAYYYRKEEKLLVCDFAERGSLAINLHSNQSLGKP 451
Query: 466 SLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525
SLDWP+RLKIVKGVAKGL YL+++LPSL+APHGH+KSSNVLL ++ EP+L DYGLIP++N
Sbjct: 452 SLDWPTRLKIVKGVAKGLFYLHQDLPSLMAPHGHLKSSNVLLTKTFEPLLTDYGLIPLIN 511
Query: 526 QESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLAS 585
QE AQ M AY+SPE+LQ RITKKTDVW LG+LILEI+TGKFPANF Q ++ DLAS
Sbjct: 512 QEKAQMHMAAYRSPEYLQHRRITKKTDVWGLGILILEILTGKFPANFSQSSEE---DLAS 568
Query: 586 WVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645
WVNS +G +FDK M + EG+++KLL IGL CCE +VEKRLD+ +AVEKIEE
Sbjct: 569 WVNSGF-HGVWAPSLFDKGMGKTSHCEGQILKLLTIGLNCCEPDVEKRLDIGQAVEKIEE 627
Query: 646 VKERDG-DEDFYSSYASEADLRSPRGKSDE 674
+KER+G D+DFYS+Y SE D RS +G+S E
Sbjct: 628 LKEREGDDDDFYSTYVSETDGRSSKGESCE 657
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|3047095|gb|AAC13607.1| similar to eukaryotic protein kinase domains (Pfam: pkinase.hmm, score: 72.39) [Arabidopsis thaliana] gi|10178102|dbj|BAB11489.1| receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1683), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/689 (50%), Positives = 458/689 (66%), Gaps = 80/689 (11%)
Query: 2 TDSQTLLTLKQSL--SNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQG 59
T+S+ +L K+SL ALA+W+ ++PPC W+GVLC+ G +W L++E++ L G
Sbjct: 61 TNSEAILKFKESLVVGQENALASWNAKSPPCT-----WSGVLCNGGSVWRLQMENLELSG 115
Query: 60 NIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGM 119
+IDI L L +RTLS M N EGP PD ++L AL+S+YLSNN+F G+IP DAF+GM
Sbjct: 116 SIDIEALSGLTSLRTLSFMNNKFEGPFPDFKKLA--ALKSLYLSNNQFGGDIPGDAFEGM 173
Query: 120 TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALF 179
L+K+ LA N+F G IP S+ +L +L+ELRL+GN+F G+IP+F+ + L N+SNNAL
Sbjct: 174 GWLKKVHLAQNKFTGQIPSSVAKLPKLLELRLDGNQFTGEIPEFEHQ-LHLLNLSNNALT 232
Query: 180 GSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP 239
G I +L DP F GN+ L G+PL + C +P HP
Sbjct: 233 GPIPESLSMTDPKVFEGNKGLYGKPLETECDSP----------------------YIEHP 270
Query: 240 PNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVI 299
P P SS LVI + V+ + I ++ IF++
Sbjct: 271 PQSEARPK----------------------SSSRGPLVITA--IVAALTILIILGVIFLL 306
Query: 300 ERKRKRER-GVSIENPPPLPPPSSNLQKTSGIRESGQC------------SPSSTEAVVG 346
R K ++ +++E P S+LQK +GIRE+ Q S ++
Sbjct: 307 NRSYKNKKPRLAVETGP------SSLQKKTGIREADQSRRDRKKADHRKGSGTTKRMGAA 360
Query: 347 GKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNN 406
KLSF+R+D E+FDL DLL+ASAEILGSGCFG+SYKA LS+G MMVVKRFKQMNN
Sbjct: 361 AGVENTKLSFLREDREKFDLQDLLKASAEILGSGCFGASYKAVLSSGQMMVVKRFKQMNN 420
Query: 407 VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPS 466
GR+EFQEHM+RLGRL H NLL +VAYYYRKEEKLLV +F + SLA+NLH +Q+LG+PS
Sbjct: 421 AGRDEFQEHMKRLGRLMHHNLLSIVAYYYRKEEKLLVCDFAERGSLAINLHSNQSLGKPS 480
Query: 467 LDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526
LDWP+RLKIVKGVAKGL YL+++LPSL+APHGH+KSSNVLL ++ EP+L DYGLIP++NQ
Sbjct: 481 LDWPTRLKIVKGVAKGLFYLHQDLPSLMAPHGHLKSSNVLLTKTFEPLLTDYGLIPLINQ 540
Query: 527 ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASW 586
E AQ M AY+SPE+LQ RITKKTDVW LG+LILEI+TGKFPANF Q ++ DLASW
Sbjct: 541 EKAQMHMAAYRSPEYLQHRRITKKTDVWGLGILILEILTGKFPANFSQSSEE---DLASW 597
Query: 587 VNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646
VNS +G +FDK M + EG+++KLL IGL CCE +VEKRLD+ +AVEKIEE+
Sbjct: 598 VNSGF-HGVWAPSLFDKGMGKTSHCEGQILKLLTIGLNCCEPDVEKRLDIGQAVEKIEEL 656
Query: 647 KERDG-DEDFYSSYASEADLRSPRGKSDE 674
KER+G D+DFYS+Y SE D RS +G+S E
Sbjct: 657 KEREGDDDDFYSTYVSETDGRSSKGESCE 685
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147866686|emb|CAN83670.1| hypothetical protein VITISV_017867 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1678), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/678 (51%), Positives = 448/678 (66%), Gaps = 75/678 (11%)
Query: 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNI 61
+ S+ LL K SL N TAL +W+ T PC + W GV+C G +WGL+LE MGL G I
Sbjct: 30 SQSEILLEFKNSLRNVTALGSWNTSTTPCGGSPGGWVGVICINGDVWGLQLEGMGLMGTI 89
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
D+ L +L +R +S M N+ +G +P +++L AL+SV+LSNN+FSGEI DAF GM S
Sbjct: 90 DMDTLAKLPHLRGISFMNNHFDGAIPKIKKLS--ALKSVFLSNNQFSGEIEDDAFSGMVS 147
Query: 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGS 181
L+K+ LA N+F+G +PESL L R++ELRLEGN F+GQIP+F+ L SFN+SNN L G
Sbjct: 148 LKKVHLAHNKFSGGVPESLALLPRILELRLEGNHFKGQIPEFRATQLQSFNISNNNLEGP 207
Query: 182 ISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPN 241
I +LR+++ +SFSGN++LC G+P + P P P
Sbjct: 208 IPESLRKMELTSFSGNKNLC----GAPLGS---------------------CPRPKKP-- 240
Query: 242 PIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIER 301
+TL++ V +A++A++ A ++
Sbjct: 241 --------------------------------TTLMMVVVGIVVALALSAIIVAFILLRC 268
Query: 302 KRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDV 361
+ + V +E PP + T + + S+TE+ G K + KL ++R+D
Sbjct: 269 SKCQTTLVQVETPPS--------KVTCRELDKVKLQESNTES--GKKVEQGKLYYLRNDE 318
Query: 362 ERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGR 421
+ DL DLL+ASAEILGSG FGSSYKA L G+ +VVKRF+ MNNVG+EEFQEHMRRLGR
Sbjct: 319 NKCDLKDLLKASAEILGSGYFGSSYKAVLVNGSSVVVKRFRHMNNVGKEEFQEHMRRLGR 378
Query: 422 LRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAK 481
L HPNLLP VAYYYR+EEKLLV +F+ SLA++LHG+ A QP LDW +RLKI+KG+AK
Sbjct: 379 LNHPNLLPFVAYYYREEEKLLVTDFIDNGSLAIHLHGNHARDQPRLDWATRLKIIKGIAK 438
Query: 482 GLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSPEF 541
GL YLY ELP+LIAPH H+KSSNVLL+ S P+L DYGL+P++NQE AQ LM+AYKSPE+
Sbjct: 439 GLAYLYTELPTLIAPHSHLKSSNVLLSXSFTPLLTDYGLVPLINQEIAQALMVAYKSPEY 498
Query: 542 LQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601
Q GRITKKTDVWS G LILEI+TGKFP LQQG+ +D DLASWVNSV + + EVF
Sbjct: 499 KQHGRITKKTDVWSFGTLILEILTGKFPTQNLQQGQASDTDLASWVNSV-SQEEWEDEVF 557
Query: 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFYSSYAS 661
DKEM NS+ EMVKLLKIGLACCE +V KR D+KEAVEKIEE+KE D ++DFYSSYAS
Sbjct: 558 DKEMGGTTNSKWEMVKLLKIGLACCEGDVGKRWDMKEAVEKIEELKEXDSEDDFYSSYAS 617
Query: 662 EADLRSP-RGKSDEFTFS 678
E + SP R SDE +FS
Sbjct: 618 E--MESPSRQLSDEPSFS 633
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511425|ref|XP_003524427.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RLK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/675 (52%), Positives = 452/675 (66%), Gaps = 82/675 (12%)
Query: 2 TDSQTLLTLKQSL-SNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGN 60
+DS+ LL +K++L ++ L++W+ PPC+ +NW GVLCH GK+WG+KLE+MGL+G
Sbjct: 29 SDSELLLQVKENLQTHNDELSSWNASIPPCSGARSNWRGVLCHEGKVWGVKLENMGLKGV 88
Query: 61 IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMT 120
ID+ LK L +RTLS M N+ EG P++ L L+S+YLSNN+FSGEIP F+G+
Sbjct: 89 IDVDSLKGLPYLRTLSFMNNDFEGAWPEIDHLI--GLKSIYLSNNKFSGEIPFRTFEGLK 146
Query: 121 SLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKD-LVSFNVSNNALF 179
L+K+ L++N F G +P SL L RL+ELRLEGNKF G IP F + + L SF+V+
Sbjct: 147 WLKKVHLSNNHFTGAVPTSLVLLPRLIELRLEGNKFNGPIPRFTRHNKLKSFSVA----- 201
Query: 180 GSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP 239
N +L GE IP L P
Sbjct: 202 -----------------NNELSGE---------------------------IPASLRRMP 217
Query: 240 PNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSV---VAIAAVVAAI 296
SS S G S STL I A V + IAAVV +
Sbjct: 218 ------------VSSFSGNERLCGGPLGACNSKPSTLSIVVAVVVVCVAVIMIAAVV--L 263
Query: 297 FVIERKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGG---KKPEIK 353
F++ R+R + S+ENPP S K +RE G S ST ++ + K
Sbjct: 264 FILHRRRNQGSATSVENPP------SGCNKGR-LREVGSESMRSTRSISSNHSRRGDHTK 316
Query: 354 LSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQ 413
LSF+RDD +RFDLH+LLRASAEILGSGCF SSYKA+L G +VVKRFKQMNNVG+EEFQ
Sbjct: 317 LSFLRDDRQRFDLHELLRASAEILGSGCFSSSYKAALLNGPTIVVKRFKQMNNVGKEEFQ 376
Query: 414 EHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRL 473
EHMRRLGRL HPNLLP +AYYYRKEEKL+V ++V SLAV LHGHQ++G+PSLDWP RL
Sbjct: 377 EHMRRLGRLSHPNLLPPLAYYYRKEEKLVVTDYVQNGSLAVRLHGHQSIGEPSLDWPIRL 436
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM 533
KIVKG+AKGL+YLY+++PSLIAPHG++KSSNVLL ES EP+L DYGL+PV+NQ+ AQ++M
Sbjct: 437 KIVKGIAKGLEYLYKDMPSLIAPHGNLKSSNVLLTESFEPLLTDYGLVPVINQDLAQDIM 496
Query: 534 IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593
+ YKSPE+LQ GRITKKTDVW LG+LILEI+TGKFPANFLQQGK ++ LASW++SV+
Sbjct: 497 VIYKSPEYLQQGRITKKTDVWCLGILILEILTGKFPANFLQQGKGSEVSLASWIHSVVPE 556
Query: 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD- 652
+ + VFD+EM +NSEGEM KLLKI L CCE +V+KR DLKEAVEKI+EVK+RD D
Sbjct: 557 -EWTSAVFDQEMGATKNSEGEMGKLLKIALNCCEGDVDKRWDLKEAVEKIQEVKQRDHDQ 615
Query: 653 EDFYSSYASEADLRS 667
E+F++SYASEAD++S
Sbjct: 616 ENFFTSYASEADMKS 630
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356527710|ref|XP_003532451.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RLK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1639), Expect = e-179, Method: Compositional matrix adjust.
Identities = 353/676 (52%), Positives = 451/676 (66%), Gaps = 84/676 (12%)
Query: 2 TDSQTLLTLKQSL-SNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGN 60
+DS+ LL +KQ+L +N L++W+ PPC+ +NW GVLC+ GK+WG+KLE+MGL+G
Sbjct: 29 SDSELLLNVKQNLQTNNQQLSSWNASVPPCSGGHSNWRGVLCYEGKVWGIKLENMGLKGL 88
Query: 61 IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMT 120
ID+ LK L +RTLS M N+ EG P+++ L L+S+YLSNN+FSGEIP+ F+G+
Sbjct: 89 IDVDSLKGLPYLRTLSFMNNDFEGAWPEIQHLI--GLKSIYLSNNKFSGEIPSRTFEGLQ 146
Query: 121 SLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKD-LVSFNVSNNALF 179
L+K+ L++N F G +P SL L RL+ELRLEGNKF G IP F + L SF+V+
Sbjct: 147 WLKKVHLSNNHFTGAVPTSLVLLPRLIELRLEGNKFNGPIPYFSSHNKLKSFSVA----- 201
Query: 180 GSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP 239
N +L G+ IP L P
Sbjct: 202 -----------------NNELSGQ---------------------------IPASLGAMP 217
Query: 240 PNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSV---VAIAAVVAAI 296
SS S G S +STL I A V + IAAVV +
Sbjct: 218 ------------VSSFSGNERLCGGPLGACNSKSSTLSIVVALVVVCVAVIMIAAVV--L 263
Query: 297 FVIERKRKRERGVSIENPPPLPPPSSNLQKTSG-IRESGQCSPSSTEAVVGG---KKPEI 352
F + R+RK + VS+ENP +S G +RE G S ST ++ + ++
Sbjct: 264 FSLHRRRKNQ--VSVENP------ASGFGGNKGRVRELGSESMRSTRSISSNHSRRGDQM 315
Query: 353 KLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEF 412
KLSF+RDD +RFD+ +LLRASAEILGSGCF SSYKA+L G +VVKRFKQMNNVG+EEF
Sbjct: 316 KLSFLRDDRQRFDMQELLRASAEILGSGCFSSSYKAALLNGPTIVVKRFKQMNNVGKEEF 375
Query: 413 QEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSR 472
QEHMRR+GRL HPNLLP VAYYYRKEEKL+V ++V SLAV LHGHQ++G+PSLDWP R
Sbjct: 376 QEHMRRIGRLTHPNLLPPVAYYYRKEEKLVVTDYVQNGSLAVRLHGHQSIGEPSLDWPIR 435
Query: 473 LKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532
LKIVKG+AKGL+ LY+++PSLIAPHG++KSSNVLL ES EP+L DYGL+PV+NQ+ AQ++
Sbjct: 436 LKIVKGIAKGLENLYKDMPSLIAPHGNLKSSNVLLTESFEPLLTDYGLVPVINQDLAQDI 495
Query: 533 MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA 592
M+ YKSPE+LQ GRITKKTDVW LG+LILEI+TGKFPANFLQ+GK ++ LASWV+SV+
Sbjct: 496 MVIYKSPEYLQQGRITKKTDVWCLGILILEILTGKFPANFLQKGKGSEVSLASWVHSVVP 555
Query: 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652
+VFD+EM NSEGEM KLLKI L C E +V+KR DLKEAVEKI E+K+RD D
Sbjct: 556 E-QWTNDVFDQEMGATMNSEGEMGKLLKIALNCVEGDVDKRWDLKEAVEKILEIKQRDND 614
Query: 653 -EDFYSSYASEADLRS 667
EDF++SYASEAD++S
Sbjct: 615 QEDFFTSYASEADMKS 630
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 678 | ||||||
| TAIR|locus:2063621 | 647 | PRK2A "AT2G07040" [Arabidopsis | 0.514 | 0.539 | 0.598 | 1.7e-154 | |
| TAIR|locus:2087595 | 679 | PRK4 "pollen receptor like kin | 0.458 | 0.458 | 0.582 | 2.2e-152 | |
| TAIR|locus:2008061 | 686 | PRK5 "pollen receptor like kin | 0.446 | 0.441 | 0.581 | 5.4e-145 | |
| TAIR|locus:2128156 | 676 | AT4G31250 [Arabidopsis thalian | 0.505 | 0.507 | 0.552 | 1e-139 | |
| TAIR|locus:2193942 | 644 | AT1G72460 [Arabidopsis thalian | 0.511 | 0.538 | 0.353 | 9.7e-99 | |
| TAIR|locus:2180409 | 659 | PRK6 "pollen receptor like kin | 0.448 | 0.461 | 0.428 | 2.9e-97 | |
| TAIR|locus:2078546 | 633 | PRK3 "AT3G42880" [Arabidopsis | 0.410 | 0.439 | 0.442 | 6e-97 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.407 | 0.411 | 0.443 | 6.3e-89 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.429 | 0.449 | 0.418 | 1.3e-86 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.424 | 0.437 | 0.423 | 5.7e-86 |
| TAIR|locus:2063621 PRK2A "AT2G07040" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1069 (381.4 bits), Expect = 1.7e-154, Sum P(2) = 1.7e-154
Identities = 212/354 (59%), Positives = 263/354 (74%)
Query: 325 QKTSGIRES--GQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCF 382
Q +GI+ES GQ S S KLSF+RDD +F+L DLL+ASAEILGSGCF
Sbjct: 290 QMRAGIQESERGQGSYHSQNRAAKKMIHTTKLSFLRDDKGKFELQDLLKASAEILGSGCF 349
Query: 383 GSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLL 442
G+SYK LS G++MVVKRFK MN+ G +EFQEHM+RLGRL H NLLP+VAYYY+KEEKL
Sbjct: 350 GASYKTLLSNGSVMVVKRFKHMNSAGIDEFQEHMKRLGRLNHENLLPIVAYYYKKEEKLF 409
Query: 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKS 502
V +FV SLA +LHGH++LGQPSLDWP+R IVKGV +GL YL++ LPSL+APHGH+KS
Sbjct: 410 VSDFVANGSLAAHLHGHKSLGQPSLDWPTRFNIVKGVGRGLLYLHKNLPSLMAPHGHLKS 469
Query: 503 SNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILE 562
SNVLL+E EP+L DYGLIP++N+ESAQELM+AYKSPE+++ R+TKKTDVW LGVLILE
Sbjct: 470 SNVLLSEKFEPLLMDYGLIPMINEESAQELMVAYKSPEYVKQSRVTKKTDVWGLGVLILE 529
Query: 563 IMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIG 622
I+TGK +F Q K+++ DLASWV S G+ E+FD+EM N E ++ L++IG
Sbjct: 530 ILTGKLLESFSQVDKESEEDLASWVRSSF-KGEWTQELFDQEMGKTSNCEAHILNLMRIG 588
Query: 623 LACCEEEVEKRLDLXXXXXXXXXXXXR--DGDEDFYSSYASEADLRSPRGKSDE 674
L+CCE +VEKRLD+ GD+DFYS+YASEAD RS RG S E
Sbjct: 589 LSCCEVDVEKRLDIREAVEKMEDLMKEREQGDDDFYSTYASEADGRSSRGLSSE 642
|
|
| TAIR|locus:2087595 PRK4 "pollen receptor like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 2.2e-152, Sum P(2) = 2.2e-152
Identities = 183/314 (58%), Positives = 242/314 (77%)
Query: 346 GGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMN 405
G + KL F++DD++RFDL DLLRASAE+LGSG FGSSYK +++G M+VVKR+K MN
Sbjct: 347 GAVPDQNKLLFLQDDIQRFDLQDLLRASAEVLGSGSFGSSYKTGINSGQMLVVKRYKHMN 406
Query: 406 NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQP 465
NVGR+EF EHMRRLGRL+HPNLLP+VAYYYR+EEKLL+ EF+P RSLA +LH + ++ QP
Sbjct: 407 NVGRDEFHEHMRRLGRLKHPNLLPIVAYYYRREEKLLIAEFMPNRSLASHLHANHSVDQP 466
Query: 466 SLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525
LDWP+RLKI++GVAKGL YL+ EL +L PHGH+KSSNV+L+ES EP+L DY L PVMN
Sbjct: 467 GLDWPTRLKIIQGVAKGLGYLFNELTTLTIPHGHLKSSNVVLDESFEPLLTDYALRPVMN 526
Query: 526 QESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLAS 585
E + LMI+YKSPE+ G +TKKTDVW LGVLILE++TG+FP N+L QG A+ L +
Sbjct: 527 SEQSHNLMISYKSPEYSLKGHLTKKTDVWCLGVLILELLTGRFPENYLSQGYDANMSLVT 586
Query: 586 WVNSVLANGDNRT-EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLXXXXXXXX 644
WV++++ + +T +VFDKEM ++N + EM+ LLKIGL+CCEE+ E+R+++
Sbjct: 587 WVSNMVK--EKKTGDVFDKEMTGKKNCKAEMLNLLKIGLSCCEEDEERRMEMRDAVEKIE 644
Query: 645 XXXXRDGDEDFYSS 658
+ D DF S+
Sbjct: 645 RLKEGEFDNDFAST 658
|
|
| TAIR|locus:2008061 PRK5 "pollen receptor like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 5.4e-145, Sum P(2) = 5.4e-145
Identities = 181/311 (58%), Positives = 234/311 (75%)
Query: 350 PEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGR 409
P +L FVRDD++RFDL DLLRASAE+LGSG FG+SYKA++S+G +VVKR+K MNNVGR
Sbjct: 354 PGGRLLFVRDDIQRFDLQDLLRASAEVLGSGTFGASYKAAISSGQTLVVKRYKHMNNVGR 413
Query: 410 EEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDW 469
+EF EHMRRLGRL HPN+LPLVAYYYR+EEKLLV EF+P SLA +LH + + G LDW
Sbjct: 414 DEFHEHMRRLGRLNHPNILPLVAYYYRREEKLLVTEFMPNSSLASHLHANNSAG---LDW 470
Query: 470 PSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529
+RLKI+KGVAKGL YL+ ELP+L PHGH+KSSN++L++S EP+L DY L P+M+ E A
Sbjct: 471 ITRLKIIKGVAKGLSYLFDELPTLTIPHGHMKSSNIVLDDSFEPLLTDYALRPMMSSEHA 530
Query: 530 QELMIAYKSPEFL-QLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWV 587
M AYKSPE+ G+I TKKTDVW GVLILE++TG+FP N+L QG ++ L +WV
Sbjct: 531 HNFMTAYKSPEYRPSKGQIITKKTDVWCFGVLILEVLTGRFPENYLTQGYDSNMSLVTWV 590
Query: 588 NSVLANGDNRT-EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLXXXXXXXXXX 646
N ++ + +T +VFDKEM ++N + EM+ LLKIGL CCEEE E+R+D+
Sbjct: 591 NDMVK--EKKTGDVFDKEMKGKKNCKAEMINLLKIGLRCCEEEEERRMDMREVVEMVEML 648
Query: 647 XXRDGDEDFYS 657
+ ++DF S
Sbjct: 649 REGESEDDFGS 659
|
|
| TAIR|locus:2128156 AT4G31250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 1.0e-139, Sum P(2) = 1.0e-139
Identities = 196/355 (55%), Positives = 256/355 (72%)
Query: 327 TSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSY 386
TSG G SP + G ++ KL FVR+D ERF L D+LRASAE+LGSG FGSSY
Sbjct: 327 TSGAISVGGLSPDEDKR--GDQR---KLHFVRNDQERFTLQDMLRASAEVLGSGGFGSSY 381
Query: 387 KASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446
KA+LS+G +VVKRF+ M+N+GREEF +HM+++GRL HPNLLPL+A+YYRKEEKLLV +
Sbjct: 382 KAALSSGRAVVVKRFRFMSNIGREEFYDHMKKIGRLSHPNLLPLIAFYYRKEEKLLVTNY 441
Query: 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVL 506
+ SLA LH ++ GQ LDWP RLKIV+GV +GL YLYR P L PHGH+KSSNVL
Sbjct: 442 ISNGSLANLLHANRTPGQVVLDWPIRLKIVRGVTRGLAYLYRVFPDLNLPHGHLKSSNVL 501
Query: 507 LNESLEPVLADYGLIPVMNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTG 566
L+ + EP+L DY L+PV+N++ +Q+ M+AYK+PEF Q R ++++DVWSLG+LILEI+TG
Sbjct: 502 LDPNFEPLLTDYALVPVVNRDQSQQFMVAYKAPEFTQQDRTSRRSDVWSLGILILEILTG 561
Query: 567 KFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACC 626
KFPAN+L+QGK AD +LA+WV SV A + +VFDKEM + E +M+KLLKIGL CC
Sbjct: 562 KFPANYLRQGKGADDELAAWVESV-ARTEWTADVFDKEMKAGKEHEAQMLKLLKIGLRCC 620
Query: 627 EEEVEKRLDLXXXXXXXXXXXXRD---GDEDFYSSY--ASEADLRSPRGKSDEFT 676
+ ++EKR++L RD G E SSY AS+ D RS R ++EF+
Sbjct: 621 DWDIEKRIELHEAVDRIEEVD-RDAGGGQESVRSSYVTASDGDHRSSRAMTEEFS 674
|
|
| TAIR|locus:2193942 AT1G72460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 9.7e-99, Sum P(2) = 9.7e-99
Identities = 131/371 (35%), Positives = 209/371 (56%)
Query: 300 ERKRKRERGVSIEXXXXXXXXXXXXQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRD 359
+R+RK+ R S + + ++ R+S V G L V
Sbjct: 278 KRRRKKARRTSEQDNSDDQQIQVTVEGSNSSRQSRSSRSGELNKGVAGTSD---LVMVNK 334
Query: 360 DVERFDLHDLLRASAEILG-----------SGCFGSSYKASLSTGAMMVVKRFKQMNNVG 408
+ F L DL++A+A +LG SG GS+YKA LS G +VVKR MN V
Sbjct: 335 EKGVFRLSDLMKAAAHVLGNPGGGSNRPRSSGGVGSAYKAVLSNGVTVVVKRVTVMNQVS 394
Query: 409 REEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHG-HQALGQPSL 467
+ F + +R+LG L+H N+L +AY++R++EKLLV EFVP +L LHG H+ L
Sbjct: 395 VDVFDKEIRKLGSLQHKNVLTPLAYHFRQDEKLLVFEFVPNLNLLHRLHGDHEEF---QL 451
Query: 468 DWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527
DWPSRLKI++G+A+G+ YL+REL L PHG++KSSN+ L E EP+++++GL ++N +
Sbjct: 452 DWPSRLKIIQGIARGMWYLHRELGFLNLPHGNLKSSNIFLAEDGEPLISEFGLQKLINPD 511
Query: 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWV 587
+ + ++A+KSPE + G ++ K+DV+S GV++LEI+TGKFP+ + + +L W+
Sbjct: 512 AQSQSLVAFKSPEADRDGTVSAKSDVFSFGVVVLEILTGKFPSQYAGLNRAGGANLVEWL 571
Query: 588 NSVLANG---DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLXXXXXXXX 644
S L G D + A+++ E E+ +L+IG+ C E+ ++R ++
Sbjct: 572 GSALEQGGWMDLLHPMVVTAAAEDKIMEEEIENVLRIGVRCTREDPDQRPNMTEVVDELT 631
Query: 645 XXXXRDGDEDF 655
D ++DF
Sbjct: 632 I---EDSNDDF 639
|
|
| TAIR|locus:2180409 PRK6 "pollen receptor like kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 2.9e-97, Sum P(2) = 2.9e-97
Identities = 132/308 (42%), Positives = 202/308 (65%)
Query: 329 GIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA 388
G+ G+ +GG +I + V D F L DL++A+AE+LG+G GS+YKA
Sbjct: 344 GVSNIGKGGNGGGGGALGGGMGDIIM--VNTDKGSFGLPDLMKAAAEVLGNGSLGSAYKA 401
Query: 389 SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448
++TG +VVKR + MN + RE F MRR G+LRHPN+L +AY+YR+EEKL+V E++P
Sbjct: 402 VMTTGLSVVVKRIRDMNQLAREPFDVEMRRFGKLRHPNILTPLAYHYRREEKLVVSEYMP 461
Query: 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN 508
K SL LHG + + L W +RLKI++GVA G+++L+ E S PHG++KSSNVLL+
Sbjct: 462 KSSLLYVLHGDRGIYHSELTWATRLKIIQGVAHGMKFLHEEFASYDLPHGNLKSSNVLLS 521
Query: 509 ESLEPVLADYGLIPVMNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKF 568
E+ EP+++DY +P++ +A + + A+K+PEF Q +++ K+DV+ LG++ILEI+TGKF
Sbjct: 522 ETYEPLISDYAFLPLLQPSNASQALFAFKTPEFAQTQQVSHKSDVYCLGIIILEILTGKF 581
Query: 569 PANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEE 628
P+ +L GK D+ WV S +A E+ D E+ + S +MV+LL++G AC
Sbjct: 582 PSQYLNNGKGGT-DIVQWVQSSVAE-QKEEELIDPEIVNNTESMRQMVELLRVGAACIAS 639
Query: 629 EVEKRLDL 636
++RLD+
Sbjct: 640 NPDERLDM 647
|
|
| TAIR|locus:2078546 PRK3 "AT3G42880" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 667 (239.9 bits), Expect = 6.0e-97, Sum P(2) = 6.0e-97
Identities = 124/280 (44%), Positives = 191/280 (68%)
Query: 357 VRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHM 416
V + F L DL++A+AE+LG+G GS+YKA ++ G +VVKR + MN + RE F M
Sbjct: 344 VNSEKGSFGLPDLMKAAAEVLGNGSLGSAYKAVMANGLSVVVKRIRDMNKLAREAFDTEM 403
Query: 417 RRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIV 476
+R G+LRHPN+L +AY+YR+EEKL+V E++PK SL LHG + + L W +RLKI+
Sbjct: 404 QRFGKLRHPNVLTPLAYHYRREEKLVVSEYMPKSSLLYVLHGDRGVYHSELTWATRLKII 463
Query: 477 KGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAY 536
+GVA+G+ +L+ E S PHG++KSSNVLL+E+ EP+++DY +P++ +A + + A+
Sbjct: 464 QGVARGMDFLHEEFASYDLPHGNLKSSNVLLSETYEPLISDYAFLPLLQPNNASQALFAF 523
Query: 537 KSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596
KSPEF+Q +++ K+DV+ LG+++LE+MTGKFP+ +L GK D+ WV S +A
Sbjct: 524 KSPEFVQNQQVSPKSDVYCLGIIVLEVMTGKFPSQYLNTGKGGT-DIVEWVQSSIAQ-HK 581
Query: 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636
E+ D E+A +S +MV+LL+IG AC +R ++
Sbjct: 582 EEELIDPEIASNTDSIKQMVELLRIGAACIASNPNERQNM 621
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 6.3e-89, Sum P(2) = 6.3e-89
Identities = 126/284 (44%), Positives = 179/284 (63%)
Query: 353 KLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNV-GREE 411
K+ F + RF+L DLLRASAE+LG G FG++YKA L G + VKR K V G++E
Sbjct: 345 KMVFF-EGTRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKE 403
Query: 412 FQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPS 471
F++ M LGRLRH NL+ L AYY+ +EEKLLV++++P SL LHG++ G+ LDW +
Sbjct: 404 FEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTT 463
Query: 472 RLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL-IPVMNQESAQ 530
RLKI G A+GL +++ +L HG IKS+NVLL+ S ++D+GL I +Q A+
Sbjct: 464 RLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVAK 523
Query: 531 ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADG-DLASWVNS 589
Y++PE + + T+K+DV+S GVL+LEI+TGK P N ++ G DL WV S
Sbjct: 524 SN--GYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCP-NMVETGHSGGAVDLPRWVQS 580
Query: 590 VLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKR 633
V+ + EVFD E+ ++ E EMV LL+I +AC + R
Sbjct: 581 VVRE-EWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHR 623
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 1.3e-86, Sum P(2) = 1.3e-86
Identities = 126/301 (41%), Positives = 189/301 (62%)
Query: 337 SPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMM 396
SPS+ +AV KL F + + FDL DLLRASAE+LG G FG++YKA L ++
Sbjct: 331 SPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLV 390
Query: 397 VVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNL 456
VKR K + RE F+E + +G + H NL+PL AYYY +EKLLV++F+P SL+ L
Sbjct: 391 AVKRLKDVTMADRE-FKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALL 449
Query: 457 HGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLA 516
HG++ G+P L+W R I G A+GL YL+ + P ++ HG++KSSN+LL S + ++
Sbjct: 450 HGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDP--LSSHGNVKSSNILLTNSHDARVS 507
Query: 517 DYGLIPVMNQESAQ-ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQ 575
D+GL +++ S Y++PE R+++K DV+S GV++LE++TGK P+N +
Sbjct: 508 DFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMN 567
Query: 576 GKKADGDLASWVNSVLANGDNRTEVFDKE-MADER--NSEGEMVKLLKIGLACCEEEVEK 632
+ D LA WV+SV A + R EVFD E M+ E + E EM ++L++G+ C E+ +K
Sbjct: 568 EEGMD--LARWVHSV-AREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDK 624
Query: 633 R 633
R
Sbjct: 625 R 625
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 575 (207.5 bits), Expect = 5.7e-86, Sum P(2) = 5.7e-86
Identities = 125/295 (42%), Positives = 185/295 (62%)
Query: 339 SSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVV 398
+ T + +GG+ KL F V FDL DLLRASAE+LG G G+SYKA L G +VV
Sbjct: 319 TGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVV 378
Query: 399 KRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHG 458
KR K + ++EF+ M +G+++HPN++PL AYYY K+EKLLV +F+P SL+ LHG
Sbjct: 379 KRLKDVM-ASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHG 437
Query: 459 HQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADY 518
+ G+ LDW +R++I A+GL +L+ L+ HG+IK+SN+LL+ + + ++DY
Sbjct: 438 SRGSGRTPLDWDNRMRIAITAARGLAHLHVSA-KLV--HGNIKASNILLHPNQDTCVSDY 494
Query: 519 GLIPVMNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKK 578
GL + + S + Y +PE L+ ++T K+DV+S GVL+LE++TGK P N G++
Sbjct: 495 GLNQLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSP-NQASLGEE 553
Query: 579 ADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKR 633
DL WV SV+ + EVFD E+ N E EMV+LL+I +AC ++R
Sbjct: 554 GI-DLPRWVLSVVRE-EWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQR 606
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGU0 | RLK_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5115 | 0.8997 | 0.9214 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_164000054 | hypothetical protein (671 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 678 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-28 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-23 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-21 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-13 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-07 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 8e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-06 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-06 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-06 | |
| pfam05887 | 145 | pfam05887, Trypan_PARP, Procyclic acidic repetitiv | 5e-06 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 5e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 1e-05 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-05 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 3e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-05 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 5e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-05 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 8e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-05 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-04 | |
| pfam05887 | 145 | pfam05887, Trypan_PARP, Procyclic acidic repetitiv | 3e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-04 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 5e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-04 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 6e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 7e-04 | |
| pfam04625 | 407 | pfam04625, DEC-1_N, DEC-1 protein, N-terminal regi | 8e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-04 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 8e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 0.001 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.001 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.001 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.001 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.001 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.001 | |
| pfam05616 | 502 | pfam05616, Neisseria_TspB, Neisseria meningitidis | 0.001 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.001 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 0.001 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.001 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.001 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 0.001 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 0.002 | |
| pfam05616 | 502 | pfam05616, Neisseria_TspB, Neisseria meningitidis | 0.002 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 0.002 | |
| PRK09752 | 1250 | PRK09752, PRK09752, adhesin; Provisional | 0.002 | |
| pfam04731 | 135 | pfam04731, Caudal_act, Caudal like protein activat | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.002 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.002 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.002 | |
| pfam09606 | 768 | pfam09606, Med15, ARC105 or Med15 subunit of Media | 0.002 | |
| PRK09752 | 1250 | PRK09752, PRK09752, adhesin; Provisional | 0.003 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.003 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.003 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 0.003 | |
| PRK05641 | 153 | PRK05641, PRK05641, putative acetyl-CoA carboxylas | 0.003 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 | |
| pfam08693 | 40 | pfam08693, SKG6, Transmembrane alpha-helix domain | 0.003 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 0.004 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 0.004 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.004 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.004 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.004 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.004 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.004 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.004 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.004 | |
| PHA01929 | 306 | PHA01929, PHA01929, putative scaffolding protein | 0.004 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.004 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.004 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLP 429
LGSG FG+ YKA TG ++ VK K+ + + + + RR L RL HPN++
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE--KSKKDQTARREIRILRRLSHPNIVR 62
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L+ + K+ LV E+ L L L KI + +GL+YL+
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEYLHSN 117
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGL--IPVMNQESAQELM--IAYKSPEFLQLG 545
+I H +K N+LL+E+ +AD+GL + + S + Y +PE L G
Sbjct: 118 --GII--HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 546 R-ITKKTDVWSLGVLILEIMTGKFP 569
K DVWSLGV++ E++TGK P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 5e-28
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRF-KQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
LG G FG+ Y A TG + +K K+ ++ EE + L +L HPN++ L +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+ LV E+ SL +L + L L+I+ + +GL+YL+ +I
Sbjct: 61 EDENHLYLVMEYCEGGSLK-DLLKEN---EGKLSEDEILRILLQILEGLEYLHSN--GII 114
Query: 495 APHGHIKSSNVLLNE-SLEPVLADYGL---IPVMNQESAQELM-IAYKSPE-FLQLGRIT 548
H +K N+LL+ + + LAD+GL + + AY +PE L G +
Sbjct: 115 --HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 549 KKTDVWSLGVLILEI 563
+K+D+WSLGV++ E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 375 EILGSGCFGSSYKASLSTGAMMV----VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLP 429
+ LG G FG YK L VK K+ + R++F + R + +L HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 430 LVAYYYRKEEKLLVHEFVPKRSL----AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
L+ +E LV E++ L + + + +L L +AKG++Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE------SAQELMIAYKSP 539
L + + H + + N L+ E L ++D+GL + + + +L I + +P
Sbjct: 121 LASK--KFV--HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
E L+ G T K+DVWS GVL+ EI T G P
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 375 EILGSGCFGSSYKASL----STGAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLL 428
+ LG G FG YK +L V VK K+ + REEF E + +L HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L+ + E +V E++P L L H L L++ +AKG++YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG----EKLTLKDLLQMALQIAKGMEYL-- 118
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGL-IPVMNQE---SAQELMIAYK--SPEFL 542
E + + H + + N L+ E+L ++D+GL + + + K +PE L
Sbjct: 119 ESKNFV--HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 543 QLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ G+ T K+DVWS GVL+ EI T G+ P
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 32/209 (15%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLP 429
E LG G FG Y A TG ++ +K + ++ +E + R L +L+HPN++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKV---IKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L + +++ LV E+ L L L S D ++ + L+YL
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL---SEDE--ARFYLRQILSALEYL--- 113
Query: 490 LPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI---AYKSPE 540
H +K N+LL+E LAD+GL ++ + Y +PE
Sbjct: 114 -------HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166
Query: 541 FLQLGRITKKTDVWSLGVLILEIMTGKFP 569
L K D+WSLGV++ E++TGK P
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 2e-21
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 375 EILGSGCFGSSYKASLSTGAMMV-----VKRFKQM-NNVGREEFQEHMRRLGRLRHPNLL 428
+ LG G FG YK L VK K+ + EEF R + +L HPN++
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L+ +E +V E++ L L ++ P L L +A+G++YL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR----PKLSLSDLLSFALQIARGMEYLES 120
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMNQESAQELMIAYK--SPEFLQ 543
+ + I H + + N L+ E+L ++D+GL + + + + + +PE L+
Sbjct: 121 K--NFI--HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 544 LGRITKKTDVWSLGVLILEIMT-GKFP 569
G+ T K+DVWS GVL+ EI T G+ P
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVK--RFKQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
E+LG G FGS Y A TG +M VK + E + +R L L+HPN+ V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI---V 62
Query: 432 AYYY--RKEEK---LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
YY R EEK + E+V SL+ L L +P + R K + + +GL YL
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI----R-KYTRQILEGLAYL 117
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM------IAYKSPE 540
+ ++ H IK +N+L++ LAD+G + E + +PE
Sbjct: 118 HSN--GIV--HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 541 FLQLGRITKKTDVWSLGVLILEIMTGKFP 569
++ + D+WSLG ++E+ TGK P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LGSG FG ++ + +K K + + +++FQ+ ++ L RLRH +L+ L A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQP---SLDWPSRLKIVKGVAKGLQYLYRELPSL 493
E ++ E + K SL L P L S + + VA+G+ YL E +
Sbjct: 74 GEPVYIITELMEKGSL------LAFLRSPEGQVLPVASLIDMACQVAEGMAYL--EEQNS 125
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--SAQELMIAYK--SPEFLQLGRITK 549
I H + + N+L+ E L +AD+GL ++ ++ + + I YK +PE G +
Sbjct: 126 I--HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 550 KTDVWSLGVLILEIMT-GKFP 569
K+DVWS G+L+ E+ T G+ P
Sbjct: 184 KSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 7e-20
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 375 EILGSGCFGSSYKASLSTGAMMV-----VKRFKQM-NNVGREEFQEHMRRLGRLRHPNLL 428
+ LG G FG YK +L VK K+ + EEF R + +L HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPS---LDWPSRLKIVKGVAKGLQY 485
L+ +E ++V E++P L L + L L +A+G++Y
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDL------LDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMNQESAQELMIAYK--SPE 540
L + + I H + + N L+ E+L ++D+GL + + + + + +PE
Sbjct: 119 LESK--NFI--HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
L+ G+ T K+DVWS GVL+ EI T G+ P
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR---HPNLLPL 430
E +G G FG YKA TG + +K + +E+ ++ + + L+ HPN++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKV---IKLESKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 431 VAYYYRKEEKLLVHEFVPKRSL--AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
Y +K+E +V EF SL + +L + K + KGL+YL+
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ------TLTESQIAYVCKELLKGLEYLHS 116
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI---AYKSPEFLQLG 545
+I H IK++N+LL E L D+GL ++ A+ M+ + +PE +
Sbjct: 117 N--GII--HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 546 RITKKTDVWSLGVLILEIMTGKFP 569
K D+WSLG+ +E+ GK P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGRE--EFQEHMRRLGRLRHPNLLPLV 431
+++G G FG YK +L TG + +K+ + + L L+HPN++ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
+ ++ E+ SL + + + V V +GL YL+ +
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----AVYVYQVLQGLAYLHEQ-- 118
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQLGRI 547
+I H IK++N+L + LAD+G+ +N S + + + +PE +++
Sbjct: 119 GVI--HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 548 TKKTDVWSLGVLILEIMTGKFP 569
+ +D+WSLG ++E++TG P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 377 LGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLPLV 431
LG G G YK TG + +K+ + G EEF++ + R L P ++
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
+Y++ E +V E++ SLA L + +P L I + + KGL YL+ +
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKR- 119
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL----MIAYKSPEFLQLGRI 547
+I H IK SN+L+N E +AD+G+ V+ Q + Y SPE +Q
Sbjct: 120 HII--HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177
Query: 548 TKKTDVWSLGVLILEIMTGKFPANFLQQGKKAD 580
+ D+WSLG+ +LE GKFP Q +
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-18
Identities = 67/287 (23%), Positives = 140/287 (48%), Gaps = 22/287 (7%)
Query: 364 FDLHDLLRASAE--ILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLG 420
++D+L + E ++ G G+SYK S+ G VVK +N++ E + +G
Sbjct: 683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MG 738
Query: 421 RLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVA 480
+L+HPN++ L+ ++ L+HE++ ++L+ L L W R KI G+A
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIA 790
Query: 481 KGLQYLY-RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSP 539
K L++L+ R P+++ G++ ++++ EP L L ++ ++ + AY +P
Sbjct: 791 KALRFLHCRCSPAVVV--GNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAP 847
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599
E + IT+K+D++ G++++E++TGK PA+ G + W ++
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV---HGSIVEWARYCYSDCHLDMW 904
Query: 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646
+ D ++ E+V+++ + L C + R + ++ +E
Sbjct: 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LG+G FG + + + VK K + + F E + L+H L+ L A +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAP 496
+E ++ E++ K SL ++ G+ L P + +A+G+ Y+ R+ + I
Sbjct: 73 EEPIYIITEYMAKGSL-LDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK--NYI-- 125
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVM--NQESAQE---LMIAYKSPEFLQLGRITKKT 551
H ++++NVL++ESL +AD+GL V+ N+ +A+E I + +PE + G T K+
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 552 DVWSLGVLILEIMT-GKFP 569
DVWS G+L+ EI+T GK P
Sbjct: 186 DVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LG+G FG ++ + + VK K + ++F + + +LRHP L+ L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAP 496
+E +V E + SL L G +L P + + VA G+ YL E + I
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYL--EAQNYI-- 125
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQE--SAQE---LMIAYKSPEFLQLGRITKKT 551
H + + NVL+ E+ +AD+GL V+ ++ A+E I + +PE R + K+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 552 DVWSLGVLILEIMT-GKFP 569
DVWS G+L+ EI+T G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LG+G FG + + + + VK K + E F + + + +LRH L+ L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 437 KEEKLLVHEFVPKRSLAVNLH--GHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+E +V E++ K SL L + L P L + + +A+G+ YL + I
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-----VDMAAQIAEGMAYLESR--NYI 125
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVM--NQESAQE---LMIAYKSPEFLQLGRITK 549
H + + N+L+ E+L +AD+GL ++ ++ +A+E I + +PE GR T
Sbjct: 126 --HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 550 KTDVWSLGVLILEIMT-GKFP 569
K+DVWS G+L+ EI+T G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LG GCFG + + + + +K K + E F + + + +LRH L+ L A
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 71
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAP 496
+E +V E++ K SL L G L P + + +A G+ Y+ R +
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVER----MNYV 124
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVM--NQESAQE---LMIAYKSPEFLQLGRITKKT 551
H ++++N+L+ E+L +AD+GL ++ N+ +A++ I + +PE GR T K+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 552 DVWSLGVLILEIMT-GKFP 569
DVWS G+L+ E+ T G+ P
Sbjct: 185 DVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 59/199 (29%), Positives = 105/199 (52%), Gaps = 15/199 (7%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LG GCFG + + + + +K K + E F + + + +LRH L+PL A
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAP 496
+E +V EF+ K SL L + G+ L P + + +A G+ Y+ R +
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLK--EGDGK-YLKLPQLVDMAAQIADGMAYIER----MNYI 124
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVM--NQESAQE---LMIAYKSPEFLQLGRITKKT 551
H ++++N+L+ ++L +AD+GL ++ N+ +A++ I + +PE GR T K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 552 DVWSLGVLILEIMT-GKFP 569
DVWS G+L+ E++T G+ P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 37/276 (13%)
Query: 377 LGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY- 434
LG+G G K TG +M VK + + ++ +R L L N +V +Y
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRL--EINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 435 --YRKEEKLLVHEFVPKRSLAVNL-HGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
Y + + E++ SL L + + L KI V KGL YL+ +
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKH- 120
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--IAYKSPEFLQLGRITK 549
+I H +K SN+L+N + L D+G+ + A+ + +Y +PE +Q +
Sbjct: 121 KII--HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 550 KTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT---EVFDKEMA 606
K+D+WSLG+ ++E+ TG+FP +L ++ N F +
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI----VNEPPPRLPSGKFSPDFQ 234
Query: 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642
D V L C ++ +R KE +E
Sbjct: 235 D-------FVNL------CLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-15
Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 13/180 (7%)
Query: 7 LLTLKQSLSNPTA-LANWDDRTPPCNENGANWNGVLCHR-GKIWGLKLEDMGLQGNIDIT 64
LL+ K S+++P L+NW+ C W G+ C+ ++ + L + G I
Sbjct: 34 LLSFKSSINDPLKYLSNWNSSADVCL-----WQGITCNNSSRVVSIDLSGKNISGKISSA 88
Query: 65 ILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124
I + L ++T++L N L GP+PD + +LR + LSNN F+G IP + + +L
Sbjct: 89 IFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLD- 146
Query: 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQK--DLVSFNVSNNALFGSI 182
L++N +G IP + S L L L GN G+IP+ L +++N L G I
Sbjct: 147 --LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204
|
Length = 968 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGR-------LRHPN 426
E+LGSG FGS Y+ +L G VK ++ QE +++L + L+HPN
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTG--QEAVKQLEQEIALLSKLQHPN 63
Query: 427 LLPLVAYY--YRKEEKLLVH-EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGL 483
+ V Y R+E+ L + E VP SLA L + + +P + +R + GL
Sbjct: 64 I---VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGL 115
Query: 484 QYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYK------ 537
+YL+ H IK +N+L++ + LAD+G+ Q ++K
Sbjct: 116 EYLH----DRNTVHRDIKGANILVDTNGVVKLADFGM---AKQVVEFSFAKSFKGSPYWM 168
Query: 538 SPEFL-QLGRITKKTDVWSLGVLILEIMTGKFP 569
+PE + Q G D+WSLG +LE+ TGK P
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LG+G FG + + + + VK K + E F E + + +LRH L+ L A
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAP 496
E +V E++ K SL L + +L P+ + + VA G+ Y+ R +
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIER----MNYI 124
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVM--NQESAQE---LMIAYKSPEFLQLGRITKKT 551
H ++S+N+L+ + L +AD+GL ++ N+ +A++ I + +PE GR T K+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 552 DVWSLGVLILEIMT-GKFP 569
DVWS G+L+ E++T G+ P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-15
Identities = 66/195 (33%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 7 LLTLKQSLSNPTALA-NWDDRTPPCNENGANWNGVLCHRGKI---W---GLKLEDMGLQG 59
L TLK SL P N D PC W+G C W GL L++ GL+G
Sbjct: 377 LQTLKSSLGLPLRFGWNGD----PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRG 432
Query: 60 NIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGM 119
I I LR L +S+ LS N G IP + +
Sbjct: 433 FIPNDI---------------------SKLRHL-----QSINLSGNSIRGNIPP-SLGSI 465
Query: 120 TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLV---SFNVSNN 176
TSL L L+ N FNG IPESL +L+ L L L GN G++P L+ SFN ++N
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
Query: 177 ALFGSISPALRELDP 191
A I P LR P
Sbjct: 526 AGLCGI-PGLRACGP 539
|
Length = 623 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 54/213 (25%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGR------EEFQEHMRRLGRLRHPNL 427
+ LG+G F S Y+A + TG +M VK+ + N E ++ +R + RL HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
+ ++ L E++ S++ L + A + + + + + +GL YL+
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLH 120
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPV-LADYGLIPVMNQE--SAQELM------IAYKS 538
+I H +K +N+L++ + + + +AD+G + + A E IA+ +
Sbjct: 121 EN--QII--HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571
PE L+ + + DVWS+G +I+E+ T K P N
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 375 EILGSGCFGSSYKASLSTGAMM------VVKRFKQMNNVG-REEFQEHMRRLGRLRHPNL 427
E LG G FG YK L+ +K K+ ++EF++ + L+HPN+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 428 LPLVAYYYRKEEKLLV---------HEFVPKRS--LAVNLHGHQALGQPSLDWPSRLKIV 476
+ L+ +++ ++ HEF+ + S V + SLD L I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 477 KGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM------NQESAQ 530
+A G++YL S H + + N L+ E L ++D+GL + +S
Sbjct: 131 IQIAAGMEYL----SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 531 ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEI 563
L + + PE + G+ T ++D+WS GV++ EI
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 34/216 (15%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLP 429
+G G +G YKA + TG ++ +K+ + M N +E F R L +LRHPN++
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR-MEN-EKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 430 LVAYYYRKEEK--LLVHEFVPK--RSLAVNLHGHQALGQPSLDWPSRLK-IVKGVAKGLQ 484
L K + +V E++ L + Q +K +K + +GLQ
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ--------IKCYMKQLLEGLQ 114
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL---MIA--YKSP 539
YL+ ++ H IK SN+L+N LAD+GL + ++ + +I Y+ P
Sbjct: 115 YLHSN--GIL--HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 540 EFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
E L LG R + D+WS+G ++ E+ GK F +
Sbjct: 171 ELL-LGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 57/144 (39%), Positives = 76/144 (52%), Gaps = 10/144 (6%)
Query: 45 GKIWGLKLEDMG---LQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGN-GALRSV 100
G LK+ D+G L G I ++ L + L+L N L G +P R+LG +L+ +
Sbjct: 161 GSFSSLKVLDLGGNVLVGKIPNSLTN-LTSLEFLTLASNQLVGQIP--RELGQMKSLKWI 217
Query: 101 YLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQI 160
YL N SGEIP + G+TSL L L N GPIP SL L L L L NK G I
Sbjct: 218 YLGYNNLSGEIPYE-IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 161 PD--FQQKDLVSFNVSNNALFGSI 182
P F + L+S ++S+N+L G I
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEI 300
|
Length = 968 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E +G G FG YK L + VK + + + +F + L + HPN++ L+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
+K+ +V E VP SL L + L L++ A G++YL E +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYL--ESKNC 114
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA----------QELMIAYKSPEFLQ 543
I H + + N L+ E+ ++D+G M++E +++ I + +PE L
Sbjct: 115 I--HRDLAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 544 LGRITKKTDVWSLGVLILEIMTG 566
GR T ++DVWS G+L+ E +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-14
Identities = 53/148 (35%), Positives = 81/148 (54%), Gaps = 14/148 (9%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSG 109
++L+D G + K L + L + NNL+G + + R+ +L+ + L+ N+F G
Sbjct: 409 VRLQDNSFSGELPSEFTK-LPLVYFLDISNNNLQGRI-NSRKWDMPSLQMLSLARNKFFG 466
Query: 110 EIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKD 167
+P D+F G L L L+ NQF+G +P L LS L++L+L NK G+IPD K
Sbjct: 467 GLP-DSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524
Query: 168 LVSFNVSNNALFGSISPALRELDPSSFS 195
LVS ++S+N L G I P+SFS
Sbjct: 525 LVSLDLSHNQLSGQI--------PASFS 544
|
Length = 968 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 23/204 (11%)
Query: 377 LGSGCFGSSYKASL-----STGAMMVVKRFK-QMNNVGREEFQEHMRRLGRLRHPNLLPL 430
LG G FG +TG + VK R +F+ + L L H N++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 431 --VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
V L+ E++P SL L H+ ++ L + KG+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYL-- 125
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-------SAQELMIAYKSPEF 541
I H + + N+L+ ++D+GL V+ ++ E I + +PE
Sbjct: 126 GSQRYI--HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 542 LQLGRITKKTDVWSLGVLILEIMT 565
L+ + + +DVWS GV + E+ T
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LG+G FG + + + +K KQ ++ E F + +L+HP L+ L A
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVV-T 71
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAP 496
+E ++ E++ SL L + + L + + +A+G+ ++ E + I
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFI--ERKNYI-- 124
Query: 497 HGHIKSSNVLLNESLEPVLADYGL--IPVMNQESAQE---LMIAYKSPEFLQLGRITKKT 551
H ++++N+L++E+L +AD+GL + N+ +A+E I + +PE + G T K+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 552 DVWSLGVLILEIMT-GKFP 569
DVWS G+L+ EI+T G+ P
Sbjct: 185 DVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E LG G +GS YKA TG ++ +K +E + + L + P + V Y
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYI---VKY 63
Query: 434 Y--YRKEEKL-LVHEFVPKRSL--AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
Y Y K L +V E+ S+ + + +L I+ KGL+YL+
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKIT------NKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ-ELMIA---YKSPEFLQL 544
I H IK+ N+LLNE + LAD+G+ + A+ +I + +PE +Q
Sbjct: 118 N--KKI--HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 545 GRITKKTDVWSLGVLILEIMTGKFP 569
K D+WSLG+ +E+ GK P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 71.7 bits (174), Expect = 3e-13
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 22/211 (10%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHP-NLLPLVA 432
LG G FG Y A A+ V+ + + + E F ++ L L HP N++ L
Sbjct: 6 RKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
++ + LV E+V SL L + L L I+ + L+YL+ +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGR--KGPLSESEALFILAQILSALEYLHSKG-- 121
Query: 493 LIAPHGHIKSSNVLLNESL-EPVLADYGLI----------PVMNQESAQELMIAYKSPEF 541
H IK N+LL+ L D+GL + S Y +PE
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 542 LQ---LGRITKKTDVWSLGVLILEIMTGKFP 569
L L + +D+WSLG+ + E++TG P
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LG+G FG + A+ + + VK K ++ E F + L+H L+ L A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAP 496
E ++ EF+ K SL L + QP P + +A+G+ ++ E + I
Sbjct: 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQP---LPKLIDFSAQIAEGMAFI--EQRNYI-- 124
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVM--NQESAQE---LMIAYKSPEFLQLGRITKKT 551
H ++++N+L++ SL +AD+GL V+ N+ +A+E I + +PE + G T K+
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 552 DVWSLGVLILEIMT-GKFP 569
DVWS G+L++EI+T G+ P
Sbjct: 185 DVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (171), Expect = 4e-13
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 40/214 (18%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKR--FKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+G G FG Y S G + V+K M+ RE+ ++ L +L HPN+ + Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---IKY 64
Query: 434 YYRKEEK---LLVHEFVPKRSLAVNLHGHQALGQP-----SLDWPSRLKIVKGVAKGLQY 485
Y EEK +V E+ L+ + + G+P LDW +L L+Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKY 118
Query: 486 LYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQ-ELMI---A 535
L H IK N+ L + L D+G+ V++ + ++
Sbjct: 119 L----------HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY 168
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y SPE Q K+D+WSLG ++ E+ T K P
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 376 ILGSGCFGSSYKA---SLSTGAMMVVKRFKQMNNVGREEFQEHMRR---LGRLRHPNLLP 429
+LGSG FG+ YK + V + +E + + + HP+++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQA-LG-QPSLDWPSRLKIVKGVAKGLQYLY 487
L+ + L+ + +P L + H+ +G Q L+W + +AKG+ YL
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL- 125
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ------ELMIAYKSPEF 541
E L+ H + + NVL+ + D+GL +++ + + ++ I + + E
Sbjct: 126 -EEKRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 542 LQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ T K+DVWS GV + E+MT G P
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
+G G FG G + VK K ++ + F + LRHPNL+ L+
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+ +V E++ K SL L ++ G+ + +L V +G++YL E + +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYL--EEKNFV 124
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLI--PVMNQESAQELMIAYKSPEFLQLGRITKKTD 552
H + + NVL++E L ++D+GL Q+S + L + + +PE L+ + + K+D
Sbjct: 125 --HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK-LPVKWTAPEALREKKFSTKSD 181
Query: 553 VWSLGVLILEIMT-GKFP 569
VWS G+L+ EI + G+ P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 44/209 (21%), Positives = 94/209 (44%), Gaps = 33/209 (15%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVG----REEFQEHMRR--------LGRL 422
+++G G FG + L K+ +V + + R +G+
Sbjct: 10 KVIGGGEFGEVCRGRLK-------LPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 423 RHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG 482
HPN++ L + +++ E++ SL L + G+ + +++G+A G
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND--GK--FTVGQLVGMLRGIASG 118
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM-NQESAQELM-----IAY 536
++YL E+ + H + + N+L+N +L ++D+GL + + E+ I +
Sbjct: 119 MKYL-SEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174
Query: 537 KSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+PE + + T +DVWS G+++ E+M+
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 36/247 (14%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKR--FKQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
E +G G FG+ K S G ++V K + M +++ + L L+HPN+ V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI---V 62
Query: 432 AYYYR---KEEKLL--VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
YY R + + L V E+ LA + + + ++ +I+ + L
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK-YIEEEFIWRILTQLLLALYEC 121
Query: 487 -YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA--------YK 537
R P H +K +N+ L+ + L D+GL ++ +S A Y
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS----SFAKTYVGTPYYM 177
Query: 538 SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP---ANFLQ-QGKKADGDLASW------- 586
SPE L +K+D+WSLG LI E+ P N LQ K +G
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237
Query: 587 VNSVLAN 593
+N V+ +
Sbjct: 238 LNEVIKS 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 41/114 (35%), Positives = 56/114 (49%), Gaps = 5/114 (4%)
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM 533
KI V +GL YLY + H IK SN+L+N + L D+G+ + A +
Sbjct: 107 KIAVAVVEGLTYLYNVHRIM---HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163
Query: 534 --IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLAS 585
Y SPE +Q G+ T K+DVWSLG+ I+E+ GKFP F D
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKR--FKQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+G G FG +K + + +K+ +MN REE + R L +L ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQP---SLDWPSRLKIVKGVAKGLQYLYR 488
+ K + +V E+ L L + G+P W + + GL +L+
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVW----RFFIQILLGLAHLHS 119
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--AQELMIA--YKSPEFLQL 544
+ ++ H IKS N+ L+ + D G+ +++ + A ++ Y SPE +
Sbjct: 120 K--KIL--HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175
Query: 545 GRITKKTDVWSLGVLILEIMTGKFPANFLQQG 576
+K+DVW+LGV++ E TGK P + QG
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
+GSG FG + + +K ++ + E+F E + + +L HP L+ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAP 496
+ LV EF+ L+ L + + L + V +G+ YL E ++I
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYL--ESSNVI-- 122
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVM-----NQESAQELMIAYKSPEFLQLGRITKKT 551
H + + N L+ E+ ++D+G+ + + + + + SPE + + K+
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 552 DVWSLGVLILEIMT-GKFP 569
DVWS GVL+ E+ + GK P
Sbjct: 183 DVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 30/233 (12%)
Query: 348 KKPEIKLSFVRDDVERF--DLHDLLRASAEILGSGCFGSSYKASLS-TGAMMVVKRF--- 401
K PEI F +DD E LH++ G G FG+ Y A+ S T ++ VK+
Sbjct: 6 KDPEIADLFYKDDPEEIFVGLHEI--------GHGSFGAVYFATNSHTNEVVAVKKMSYS 57
Query: 402 -KQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF-VPKRSLAVNLHGH 459
KQ N ++ +E ++ L +L+HPN + Y ++ LV E+ + S + +H
Sbjct: 58 GKQTNEKWQDIIKE-VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH-- 114
Query: 460 QALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519
+ L I G +GL YL+ ++I H IK+ N+LL E + LAD+G
Sbjct: 115 ----KKPLQEVEIAAITHGALQGLAYLHSH--NMI--HRDIKAGNILLTEPGQVKLADFG 166
Query: 520 LIPVMNQESAQELMIAYKSPEF---LQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ ++ + +PE + G+ K DVWSLG+ +E+ K P
Sbjct: 167 SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
EI+G G FG+ + TG + VK K +V + F E + +L H NL+ L+
Sbjct: 12 EIIGEGEFGAVLQGEY-TGQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+V E + K +L L + G+ + L+ VA+G++YL E L+
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYL--ESKKLV 122
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-SAQELMIAYKSPEFLQLGRITKKTDV 553
H + + N+L++E ++D+GL V + +L + + +PE L+ + + K+DV
Sbjct: 123 --HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDV 180
Query: 554 WSLGVLILEIMT-GKFP 569
WS GVL+ E+ + G+ P
Sbjct: 181 WSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 54/222 (24%), Positives = 87/222 (39%), Gaps = 35/222 (15%)
Query: 375 EILGSGCFGSSYKASLSTG------AMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNL 427
LG G FG + ++ VK K+ +N R++F+ L +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNL--HGHQA---LGQPS----LDWPSRLKIVKG 478
+ + ++V E++ L L HG A S L L+I
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ----------ES 528
+A G+ YL S H + + N L+ L + D+G M++
Sbjct: 131 IASGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFG----MSRDVYTTDYYRVGG 182
Query: 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
L I + PE + + T ++DVWS GV++ EI T GK P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 28/232 (12%)
Query: 348 KKPEIKLSFVRDDVERF--DLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQM 404
K PEI F ++D E+ DL ++ G G FG+ Y A + T ++ +K+
Sbjct: 10 KDPEIAELFFKEDPEKLFTDLREI--------GHGSFGAVYFARDVRTNEVVAIKKMSYS 61
Query: 405 NNVGREEFQE---HMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF-VPKRSLAVNLHGHQ 460
E++Q+ ++ L R++HPN + Y R+ LV E+ + S + +H
Sbjct: 62 GKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH--- 118
Query: 461 ALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL 520
+ L I G +GL YL+ ++I H IK+ N+LL E + LAD+G
Sbjct: 119 ---KKPLQEVEIAAITHGALQGLAYLHSH--NMI--HRDIKAGNILLTEPGQVKLADFGS 171
Query: 521 IPVMNQESAQELMIAYKSPEF---LQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ + ++ + +PE + G+ K DVWSLG+ +E+ K P
Sbjct: 172 ASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLV 431
++G G +G K + +TG ++ +K+FK+ + ++ ++ L +LRH N++ L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
+ RK LV E+V + L L + + + + + Y +
Sbjct: 67 EAFRRKGRLYLVFEYVER-----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--IA---YKSPEFLQLGR 546
++I H IK N+L++ES L D+G + A L +A Y++PE L +G
Sbjct: 120 NII--HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL-VGD 176
Query: 547 IT--KKTDVWSLGVLILEIMTGK--FP 569
K DVW++G ++ E++ G+ FP
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFP 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 375 EILGSGCFGSSYKA-----SLSTGAMMVVKRFKQMNNVGREEFQE---HMRRLGRLRHPN 426
++LGSG FG+ +K S + +K + + GR+ FQE HM +G L H
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 427 LLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPS--LDWPSRLKIVKGVAKGLQ 484
++ L+ +L V + P SL ++ H+ P L+W + +AKG+
Sbjct: 71 IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMY 123
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSP----- 539
YL E ++ H ++ + N+LL +AD+G+ ++ + + +K+P
Sbjct: 124 YL--EEHRMV--HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 540 -EFLQLGRITKKTDVWSLGVLILEIMT 565
E + GR T ++DVWS GV + E+M+
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 377 LGSGCFGSSYKASLST-GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYY 435
LG G +G Y+ + VK K+ + + EEF + + ++HPNL+ L+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 436 RKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIA 495
R+ ++ EF+ +L L + + ++ L + ++ ++YL E + I
Sbjct: 73 REPPFYIITEFMTYGNL---LDYLRECNRQEVNAVVLLYMATQISSAMEYL--EKKNFI- 126
Query: 496 PHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-----SAQELMIAYKSPEFLQLGRITKK 550
H + + N L+ E+ +AD+GL +M + + + I + +PE L + + K
Sbjct: 127 -HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 551 TDVWSLGVLILEIMT---GKFPANFLQQ 575
+DVW+ GVL+ EI T +P L Q
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVK--RFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+G G FG Y A +L TG +M VK R + + +E + M+ L L+HPNL V Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL---VKY 64
Query: 434 Y---YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
Y +E+ + E+ +L L + L + + + +GL YL+
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR-----VYTLQLLEGLAYLHSHG 119
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYG--LIPVMNQESAQELMI------AYKSPEFL 542
H IK +N+ L+ + L D+G + N + E + AY +PE +
Sbjct: 120 IV----HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 543 QLGRITKK---TDVWSLGVLILEIMTGKFPANFLQQ 575
G+ D+WSLG ++LE+ TGK P + L
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 38/212 (17%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY- 434
+GSG +G YKA ++TG ++ +K K E Q+ + L RHPN+ VAY+
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI---VAYFG 67
Query: 435 -YRKEEKL-LVHEFVPKRSLAVNLH-GHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
Y + +KL +V E+ SL L + + + R KGL YL+
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLH---- 118
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ--ELMIAYKS---------PE 540
H IK +N+LL E + LAD+G+ SAQ + KS PE
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGV-------SAQLTATIAKRKSFIGTPYWMAPE 171
Query: 541 FLQL---GRITKKTDVWSLGVLILEIMTGKFP 569
+ G K D+W+LG+ +E+ + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 375 EILGSGCFGSSYKASLSTGAM-----MVVKRFKQMNNVGR-EEFQEHMRRLGRLRHPNLL 428
E LG FG YK L M + +K K +NN + EFQ+ + L HPN++
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNL---HGHQALG---------QPSLDWPSRLKIV 476
L+ +++ ++ E++ + L L H +G + SLD L I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 477 KGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ------ESAQ 530
+A G++YL S H + + N+L+ E L ++D GL + +
Sbjct: 131 IQIAAGMEYL----SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 531 ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
L I + PE + G+ + +D+WS GV++ EI +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LGSG FG + + +K + + E+F E + + +L HP L+ L +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAP 496
++ +V EF+ L L Q G+ S D L + + V +G++YL R S I
Sbjct: 71 QKPLYIVTEFMENGCLLNYLR--QRQGKLSKD--MLLSMCQDVCEGMEYLERN--SFI-- 122
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIP-VMNQE----SAQELMIAYKSPEFLQLGRITKKT 551
H + + N L++ + ++D+G+ V++ E S + + + PE + + K+
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 552 DVWSLGVLILEIMT-GKFP 569
DVWS GVL+ E+ T GK P
Sbjct: 183 DVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 24/228 (10%)
Query: 350 PEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG 408
P++ F +DD E+ L + +G G FG+ Y A + ++ +K+
Sbjct: 2 PDVAELFFKDDPEK------LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55
Query: 409 REEFQE---HMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF-VPKRSLAVNLHGHQALGQ 464
E++Q+ +R L +LRHPN + Y R+ LV E+ + S + +H +
Sbjct: 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH------K 109
Query: 465 PSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524
L + G +GL YL+ ++I H +K+ N+LL+E L D+G +M
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLHSH--NMI--HRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 525 NQESAQELMIAYKSPEF---LQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ + +PE + G+ K DVWSLG+ +E+ K P
Sbjct: 166 APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-10
Identities = 48/127 (37%), Positives = 67/127 (52%), Gaps = 12/127 (9%)
Query: 66 LKELREMRTLSLMRNNLEGPMP----DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
L L+ ++ L L +N L GP+P L++L S+ LS+N SGEIP + + +
Sbjct: 256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKL-----ISLDLSDNSLSGEIP-ELVIQLQN 309
Query: 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDLVSFNVSNNALF 179
L L L N F G IP +LT L RL L+L NKF G+IP + +L ++S N L
Sbjct: 310 LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369
Query: 180 GSISPAL 186
G I L
Sbjct: 370 GEIPEGL 376
|
Length = 968 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E+LG G FG +K +L + VK K+ + + +F R L + HPN++ L+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
+++ +V E VP L + L +K A G+ YL E +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYL--ESKNC 114
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIP-----VMNQESAQELMIAYKSPEFLQLGRIT 548
I H + + N L+ E+ ++D+G+ + + +++ I + +PE L GR +
Sbjct: 115 I--HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 549 KKTDVWSLGVLILEIMT 565
++DVWS G+L+ E +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 375 EILGSGCFGSSYKASLSTGA------MMVVKRFKQMNNVG-REEFQEHMRRLGRLRHPNL 427
E LG FG YK L A + +K K REEF+ RL+HPN+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 428 LPLVAYYYRKEEKLLV---------HEFVPKRSLAVNLHGHQALG--------QPSLDWP 470
+ L+ +++ ++ HEF+ RS H +G + +L+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRS------PHSDVGSTDDDKTVKSTLEPA 124
Query: 471 SRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ 530
+ IV +A G+++L S H + + NVL+ + L ++D GL +
Sbjct: 125 DFVHIVTQIAAGMEFL----SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180
Query: 531 ELM------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+LM I + SPE + G+ + +D+WS GV++ E+ +
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 52/158 (32%), Positives = 75/158 (47%), Gaps = 31/158 (19%)
Query: 66 LKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124
L L E+ L L N L G +PD L L S+ LS+N+ SG+IP +F M L +
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKK--LVSLDLSHNQLSGQIP-ASFSEMPVLSQ 551
Query: 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISP 184
L L+ NQ +G IP++L + LV++ N+S+N L GS+
Sbjct: 552 LDLSQNQLSGEIPKNLGNVESLVQV----------------------NISHNHLHGSLPS 589
Query: 185 --ALRELDPSSFSGNRDLCGEPLGS---PCPTPSPSPS 217
A ++ S+ +GN DLCG S PC +PS
Sbjct: 590 TGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPS 627
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 51/146 (34%), Positives = 74/146 (50%), Gaps = 20/146 (13%)
Query: 66 LKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS--- 121
L L ++ L L N G +P +L + N L + LS N +GEIP +G+ S
Sbjct: 328 LTSLPRLQVLQLWSNKFSGEIPKNLGKHNN--LTVLDLSTNNLTGEIP----EGLCSSGN 381
Query: 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIP-DFQQKDLVSF-NVSNNALF 179
L KL+L N G IP+SL L +RL+ N F G++P +F + LV F ++SNN L
Sbjct: 382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ 441
Query: 180 GSIS------PALRELDPS--SFSGN 197
G I+ P+L+ L + F G
Sbjct: 442 GRINSRKWDMPSLQMLSLARNKFFGG 467
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 375 EILGSGCFGSSYKASLS----TGAMMVVKRFKQMNNVGR--EEFQEHMRRLGRLRHPNLL 428
+ILG G FGS + LS + + VK K + EEF + HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 429 PLVAYYYRKEEK------LLVHEFVPKRSLAVNLHGHQALGQP-SLDWPSRLKIVKGVAK 481
L+ + +++ F+ L L + G P L + LK + +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 482 GLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM------NQESAQELMIA 535
G++YL + I H + + N +L E + +AD+GL + Q ++ +
Sbjct: 125 GMEYLSNR--NFI--HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+ + E L T K+DVW+ GV + EI T
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 376 ILGSGCFGSSYKA-SLSTGAMMVVKRFK----QMNNVGR-----EEFQEHMRRLGRLRHP 425
++GSG FGS Y + S+G +M VK+ + ++ R + + L L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 426 NLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
N++ + + + E+VP S+A L+ + A + + V+ + KGL Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKGLNY 121
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG---------LIPVMN-QESAQELMIA 535
L+ +I H IK +N+L++ ++D+G L N + + +
Sbjct: 122 LHNR--GII--HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ +PE ++ T+K D+WSLG L++E++TGK P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 377 LGSGCFGSSYKASLST------GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPL 430
LG G FG + A ++ VK K+ + R++FQ L L+H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGH------------QALGQPSLDWPSRLKIVKG 478
L+V E++ L L H A GQ +L L I
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL--GQMLAIASQ 130
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQE------L 532
+A G+ YL SL H + + N L+ + L + D+G+ + L
Sbjct: 131 IASGMVYL----ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 533 MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
I + PE + + T ++D+WS GV++ EI T GK P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 44/203 (21%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 375 EILGSGCFGSSYKASLSTG----AMMVVKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLP 429
+++G+G FG ++ L + +K K R++F +G+ H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L + + +++ E++ +L L H + +++G+A G++YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY----QLVGMLRGIAAGMKYL--- 123
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-------SAQELMIAYKSPEFL 542
+ H + + N+L+N +LE ++D+GL V+ + S ++ I + +PE +
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 543 QLGRITKKTDVWSLGVLILEIMT 565
+ T +DVWS G+++ E+M+
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
+ +G G FG G + VK K N+ + F + +LRH NL+ L+
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 435 YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
++ L +V E++ K SL L ++ G+ L LK V + ++YL E +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL--EANNF 123
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIP-VMNQESAQELMIAYKSPEFLQLGRITKKTD 552
+ H + + NVL++E ++D+GL + + +L + + +PE L+ + + K+D
Sbjct: 124 V--HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 553 VWSLGVLILEIMT-GKFP 569
VWS G+L+ EI + G+ P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 41/183 (22%), Positives = 84/183 (45%), Gaps = 18/183 (9%)
Query: 397 VVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKL----LVHEFVPK 449
+++ FK+ + V + + ++ L R+ N+L + + + L L+ E+ +
Sbjct: 47 IIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTR 106
Query: 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE 509
L L + L + ++L + KGL LY+ P+ ++ S + L+ E
Sbjct: 107 GYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYK---YTNKPYKNLTSVSFLVTE 158
Query: 510 SLEPVLADYGLIPVMNQESAQEL-MIAYKSPEFLQ--LGRITKKTDVWSLGVLILEIMTG 566
+ + + +GL +++ + + + Y S + L T K D++SLGV++ EI TG
Sbjct: 159 NYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218
Query: 567 KFP 569
K P
Sbjct: 219 KIP 221
|
Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 83/303 (27%), Positives = 126/303 (41%), Gaps = 67/303 (22%)
Query: 301 RKRKR--------ERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEI 352
R R+R +R S+ P PLPPPSS+ S SS+ + G P
Sbjct: 23 RPRRRPDLTLPLPQRDPSLAVPLPLPPPSSS-------------SSSSSSSSASGSAPSA 69
Query: 353 KLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKR-FKQMNNVGRE 410
S ++ER + +GSG G+ YK TG + +K + + R
Sbjct: 70 AKSL--SELERVN----------RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR 117
Query: 411 EFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWP 470
+ + L + HPN++ + E ++ EF+ SL G + L
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLADV 173
Query: 471 SRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527
+R +I+ G+A YL+R H IK SN+L+N + +AD+G+ ++ Q
Sbjct: 174 AR-QILSGIA----YLHRRH----IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224
Query: 528 -SAQELMIAYKSPEFLQLGRITKKT----------DVWSLGVLILEIMTGKFPANFLQQG 576
++ IAY SPE RI D+WSLGV ILE G+FP +QG
Sbjct: 225 CNSSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG 279
Query: 577 KKA 579
A
Sbjct: 280 DWA 282
|
Length = 353 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 68/238 (28%), Positives = 106/238 (44%), Gaps = 44/238 (18%)
Query: 350 PEIKLSFVRDDVERF--DLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNV 407
PEI F +DD E+ DL ++ G G FG+ Y A +V K+M+
Sbjct: 2 PEIAELFSKDDPEKLFTDLREI--------GHGSFGAVYFARDVRTNEVVA--IKKMSYS 51
Query: 408 GR---EEFQE---HMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF-VPKRSLAVNLHGHQ 460
G+ E++Q+ +R L +LRHPN + Y R+ LV E+ + S + +H
Sbjct: 52 GKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVH--- 108
Query: 461 ALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL 520
+ L I G +GL YL+ S H IK+ N+LL E LAD+G
Sbjct: 109 ---KKPLQEVEIAAICHGALQGLAYLH----SHERIHRDIKAGNILLTEPGTVKLADFGS 161
Query: 521 IPVMNQES---------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+++ + A E+++A + G+ K DVWSLG+ +E+ K P
Sbjct: 162 ASLVSPANSFVGTPYWMAPEVILA------MDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 76/293 (25%), Positives = 118/293 (40%), Gaps = 53/293 (18%)
Query: 377 LGSGCFG-----SSYKASLSTGAMMV-VKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPL 430
LG G FG Y S + M+V VK K R++FQ L L+H +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 431 VAYYYRKEEKLLVHEFVPKRSLA--VNLHGHQAL----GQP-----SLDWPSRLKIVKGV 479
+ ++V E++ L + HG A+ GQP L L I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 480 AKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQE------LM 533
A G+ YL S H + + N L+ +L + D+G+ + L
Sbjct: 133 ASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 534 IAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLA 592
I + PE + + T ++DVWS GV++ EI T GK P + Q + V +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLSN-------TEVIECIT 239
Query: 593 NGD--NRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643
G R V KE+ D I L C + E ++RL++KE + KI
Sbjct: 240 QGRVLERPRVCPKEVYD-------------IMLGCWQREPQQRLNIKE-IYKI 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 35/210 (16%)
Query: 377 LGSGCFGSSYKAS-LSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLL 428
LG G FG TG AM V+K+ K + + + EH L R+ HP ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK----IIKRKEVEHTLTERNILSRINHPFIV 56
Query: 429 PLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
L Y ++ EEKL LV E+ P L +L + +R + + L+YL+
Sbjct: 57 KLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER----ARFYAAE-IVLALEYLH 110
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA--------YKSP 539
+I + +K N+LL+ L D+GL +E + E Y +P
Sbjct: 111 SL--GII--YRDLKPENILLDADGHIKLTDFGL----AKELSSEGSRTNTFCGTPEYLAP 162
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
E L K D WSLGVL+ E++TGK P
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 377 LGSGCFGSSYKASL-----STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPL- 430
LG G FGS +TG ++ VK+ + +F+ + L L+H N++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 431 -VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
V Y + LV E++P SL L H+ LD L + KG++YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYL--- 124
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ-------ELMIAYKSPEFL 542
S H + + N+L+ + D+GL V+ Q+ E I + +PE L
Sbjct: 125 -GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 543 QLGRITKKTDVWSLGVLILEIMT-----GKFPANFLQQ-GKKADGDLAS 585
+ + +DVWS GV++ E+ T PA F++ G G +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 40/164 (24%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 409 REEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLD 468
R +F +G+ HPN++ L + + ++V E++ SL L H GQ ++
Sbjct: 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD--GQFTV- 105
Query: 469 WPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527
+ +++G+A G++YL + H + + N+L+N +L ++D+GL V+ +
Sbjct: 106 -IQLVGMLRGIASGMKYL----SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160
Query: 528 ------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
++ I + +PE + + T +DVWS G+++ E+M+
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 20/190 (10%)
Query: 384 SSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLV 443
S + VV + ++ F E + +L H +L+ L R +E ++V
Sbjct: 20 SDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78
Query: 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSS 503
E+V L V L H+ SL W +L + K +A L YL E L+ HG++
Sbjct: 79 EEYVKFGPLDVFL--HREKNNVSLHW--KLDVAKQLASALHYL--EDKKLV--HGNVCGK 130
Query: 504 NVLL-----NESLEPV--LADYGL-IPVMNQESAQELMIAYKSPEFLQLGR--ITKKTDV 553
N+L+ NE P L+D G+ I V+++E E I + +PE ++ G+ +T D
Sbjct: 131 NILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-RIPWIAPECIRNGQASLTIAADK 189
Query: 554 WSLGVLILEI 563
WS G +LEI
Sbjct: 190 WSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 377 LGSGCFG----SSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
LGSG FG ++ + M+ R M+ ++F E + + +L HPNL+ L
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI--REGAMS---EDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
++ +V E++ L L + L + V + ++YL E
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW----LLDMCSDVCEAMEYL--ESNG 120
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIP-VMNQE--SAQ--ELMIAYKSPEFLQLGRI 547
I H + + N L+ E ++D+GL V++ + S+Q + + + PE R
Sbjct: 121 FI--HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRF 178
Query: 548 TKKTDVWSLGVLILEIMT-GKFP 569
+ K+DVWS GVL+ E+ + GK P
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 376 ILGSGCFGSSYKASL------STGAMMV-VKRFKQMNNVGREEFQEHMRR---LGRLRHP 425
LGSG FG Y+ + +G + V VK ++ +E +E ++ + HP
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK--GATDQEKKEFLKEAHLMSNFNHP 59
Query: 426 NLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQA--LGQPSLDWPSRLKIVKGVAKGL 483
N++ L+ E + ++ E + L L + G P L L I VAKG
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 484 QYLYRELPSLIAPHGHIKSSNVLLNESLEPV-----LADYGLIPVM------NQESAQEL 532
YL E I H + + N L++E + D+GL + +E L
Sbjct: 120 VYL--EQMHFI--HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 533 MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+ + +PE L G+ T ++DVWS GVL+ EI+T
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 46/205 (22%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 375 EILGSGCFGSSYKASLSTGA----MMVVKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLP 429
E++G+G FG + L + +K K R +F +G+ HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L + +++ EF+ +L L Q GQ ++ + +++G+A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLR--QNDGQFTV--IQLVGMLRGIAAGMKYL--- 122
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ---------ELMIAYKSPE 540
+ H + + N+L+N +L ++D+GL + +++ ++ I + +PE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT 565
+ + T +DVWS G+++ E+M+
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 38/102 (37%), Positives = 56/102 (54%), Gaps = 13/102 (12%)
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG----LIPVMNQESA 529
KI V +GL YL RE ++ H +K SN+L+N E L D+G LI M A
Sbjct: 103 KISIAVLRGLTYL-REKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----A 155
Query: 530 QELM--IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ +Y SPE LQ T ++D+WSLG+ ++E+ G++P
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFK-QMNNVGREE-----FQEHMRRLGRLRHPNLL 428
E+LG G +G+ Y + G ++ VK+ + +NV E QE + L L+H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
+ + EFVP S++ L+ L +P K K + G+ YL+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHN 120
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYG----LIPVMNQESAQELMIA------YKS 538
H IK +NV+L + L D+G L V + ++ + + +
Sbjct: 121 N----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
PE + +K+D+WS+G + E+ TGK P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 48/205 (23%), Positives = 80/205 (39%), Gaps = 24/205 (11%)
Query: 375 EILGSGCFGSSYKASLSTG-------AMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL 427
+ LG G FG + ST A+ +K K + + ++F + + L H NL
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLDHENL 58
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
+ L + V E P SL L + +A G++YL
Sbjct: 59 IRLYGVVLTHPLMM-VTELAPLGSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYL- 113
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-------IAYKSPE 540
E I H + + N+LL + + D+GL+ + Q +M A+ +PE
Sbjct: 114 -ESKRFI--HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT 565
L+ + +DVW GV + E+ T
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
LG+G FG + +K K+ ++ +EF E + + +L H L+ L +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAP 496
+ +V E++ L L H QPS L++ K V +G+ YL E I
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGMAYL--ESKQFI-- 122
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIP-VMNQE----SAQELMIAYKSPEFLQLGRITKKT 551
H + + N L+++ ++D+GL V++ E + + + PE L + + K+
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 552 DVWSLGVLILEIMT-GKFP 569
DVW+ GVL+ E+ + GK P
Sbjct: 183 DVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 25/214 (11%)
Query: 377 LGSGCFGSSYKASL------STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPL 430
LG G FG + A ++ VK K ++ R++F L L+H +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGH------QALGQP--SLDWPSRLKIVKGVAKG 482
+ ++V E++ L L H A G L L I + +A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQE------LMIAY 536
+ YL S H + + N L+ E+L + D+G+ + L I +
Sbjct: 133 MVYL----ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 537 KSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
PE + + T ++DVWSLGV++ EI T GK P
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 376 ILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQ----EHMRRLGRLRHPNLLPL 430
+G G +G YKA TG ++ +K+ + N +E F ++ L +L H N++ L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNL 71
Query: 431 ----------VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVA 480
+ + K LV E++ +L G G +K +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDH-----DLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 481 KGLQYLYRE--LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQE-----LM 533
+GL Y +++ L H IK SN+LLN + LAD+GL + N E ++ +
Sbjct: 127 EGLNYCHKKNFL------HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 534 IAYKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
+ Y+ PE L LG R DVWS G ++ E+ T K F AN
Sbjct: 181 LWYRPPELL-LGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 59/223 (26%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR-------LGRLRHPNLL 428
+G G +G YKA TG ++ +K+ K R E + + L L HPN++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKL-----RFESEGIPKTALREIKLLKELNHPNII 61
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGL----- 483
L+ + K + LV EF+ L K++K +GL
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-----------DTDL----------YKLIKDRQRGLPESLI 100
Query: 484 -QYLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--- 533
YLY+ L L H H +K N+L+N LAD+GL S
Sbjct: 101 KSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFG--SPVRPYTHY 158
Query: 534 IA---YKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FP 569
+ Y++PE L LG + D+WS+G + E+++ + FP
Sbjct: 159 VVTRWYRAPELL-LGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 78/310 (25%), Positives = 121/310 (39%), Gaps = 96/310 (30%)
Query: 376 ILGSGCFG----SSYKASLSTGAMMVVKRFKQMNNVGREEFQEHM--RRL----GRLRHP 425
+LG G FG + YK TG + +K K+ + + R+E + M +R+ RHP
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 426 NLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
L+ L A + ++ V E+ L +++H P + V GLQY
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV------FSEPRAVFYAACVVLGLQY 116
Query: 486 L------YRELP---SLIAPHGHIKSSNVLLNESLEPVLADYGL----IPVMNQES---- 528
L YR+L L+ G +K +AD+GL + ++ S
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVK-------------IADFGLCKEGMGFGDRTSTFCG 163
Query: 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGK--FPANFLQQGKKADGDLASW 586
E + +PE L T+ D W LGVLI E++ G+ FP
Sbjct: 164 TPEFL----APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP----------------- 202
Query: 587 VNSVLANGDNRTEVFDKEMADE--------RNSEGEMVKLLKIGLACCEEEVEKRLDLKE 638
GD+ EVFD + DE R + M +LL+ E+RL E
Sbjct: 203 -------GDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR-------RNPERRLGSGE 248
Query: 639 AVEKIEEVKE 648
+ E+VK+
Sbjct: 249 --KDAEDVKK 256
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 64/235 (27%), Positives = 95/235 (40%), Gaps = 46/235 (19%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVK-RFKQMNNVGREEFQEHMRRLGRL----RHPNLLP 429
++G G FG Y +L + K +N + E E + G + HPN+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-------VAKG 482
L+ E LV L HG L + + VK VAKG
Sbjct: 61 LLGICLPSEGSPLV-------VLPYMKHGD--LRN-FIRSETHNPTVKDLIGFGLQVAKG 110
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI---------PVMNQESAQELM 533
++YL S H + + N +L+ES +AD+GL V N A+ L
Sbjct: 111 MEYL----ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK-LP 165
Query: 534 IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP----------ANFLQQGKK 578
+ + + E LQ + T K+DVWS GVL+ E+MT P +L QG++
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR 220
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 2e-08
Identities = 24/60 (40%), Positives = 33/60 (55%), Gaps = 1/60 (1%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
L+S+ LSNNR + IP AF G+ +L+ L L+ N PE+ + L L L L GN
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 54/232 (23%)
Query: 375 EILGSGCFGSSYKASL-STGAMMVVKRF--------KQMNNVGREEFQEHMRRLGRLRHP 425
+I+G G F + A T +K K++ V E +E + RL HP
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE--KEVLTRLN--GHP 62
Query: 426 NLLPLVAYY-YRKEEKL-LVHEFVPKRSLA--VNLHGHQALGQPSLDWPSRLKIVKGVAK 481
++ L YY ++ EE L V E+ P L + +G SLD +
Sbjct: 63 GIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYG-------SLDEKCTRFYAAEILL 113
Query: 482 GLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG--------LIPVMNQESAQELM 533
L+YL+ + +I H +K N+LL++ + + D+G P N+ A +
Sbjct: 114 ALEYLHSK--GII--HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 534 IA----------------YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y SPE L K +D+W+LG +I +++TGK P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 23/217 (10%)
Query: 363 RFDLHDLLRASAEILGSGCFGSSYKAS-LSTGAMMVVKRFK--QMNNVGREEFQEHMRRL 419
F + L G G +GS YK LS +K M+ RE+ +R L
Sbjct: 1 DFKVLKKL-------GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRIL 53
Query: 420 GRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQP---SLDWPSRLKIV 476
+ HPN++ + + +V E+ P L+ + + + W +I
Sbjct: 54 ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIF 109
Query: 477 KGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA--QELMI 534
+ +GLQ L+ H +KS+N+LL + + D G+ V+ + A Q
Sbjct: 110 IQLLRGLQALH----EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP 165
Query: 535 AYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571
Y +PE + + K+D+WSLG L+ E+ T P
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 50/206 (24%), Positives = 79/206 (38%), Gaps = 21/206 (10%)
Query: 377 LGSGCFGSSYKASLSTG---AMMVVKRFKQMNNVGRE-EFQEHMRRLGRLRHPNLLPLVA 432
+G+G FG G A +VVK + + F + ++ L HPN+L +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
LLV EF P L L ++ + ++ VA GL +L++
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---- 118
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQE------LMIAYKSPEF----- 541
H + N L L + DYGL E + + + +PE
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 542 --LQLGRITKKTDVWSLGVLILEIMT 565
L TKK+++WSLGV + E+ T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 375 EILGSGCFGSSYKASLS------TGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNL 427
+++G G FG +A + A+ ++K F N+ +F + L +L HPN+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND--HRDFAGELEVLCKLGHHPNI 65
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQAL----------GQPS-LDWPSRLKIV 476
+ L+ + + E+ P +L L + L G S L L+
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 477 KGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI---PVMNQESAQELM 533
VA G+QYL + I H + + NVL+ E+L +AD+GL V +++ L
Sbjct: 126 SDVATGMQYLSEK--QFI--HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 534 IAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+ + + E L T K+DVWS GVL+ EI++
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 22/106 (20%)
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM 533
KI + V KGL YL+ +I H IK SN+LL + L D+G+ + EL+
Sbjct: 109 KIAESVLKGLSYLHSR--KII--HRDIKPSNILLTRKGQVKLCDFGV--------SGELV 156
Query: 534 IA----------YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ Y +PE +Q + +DVWSLG+ +LE+ +FP
Sbjct: 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYY 435
LG G FG YKA + TGA+ K + + E++ + L HP ++ L+ +Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 436 RKEEKLLVHEFVPKRSL-AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+ ++ EF P ++ A+ L + L +P + I + + + LQYL+ S+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VICRQMLEALQYLH----SMK 130
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ--ELMIA---YKSPEFLQLGRITK 549
H +K+ NVLL + LAD+G + N ++ Q + I + +PE + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFG-VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 550 -----KTDVWSLGVLILEI 563
K D+WSLG+ ++E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 35/215 (16%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRF------KQMNNVGREEFQEHMRRLGRLRHPNL 427
++G G +G K TG ++ +K+F K + + E +R L +LRH NL
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMRE----IRMLKQLRHENL 62
Query: 428 LPLVAYYYRKEEKLLVHEFVPKR---SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ 484
+ L+ + RK+ LV EFV L +G LD K + + +G++
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--------LDESRVRKYLFQILRGIE 114
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN--QESAQELMIA--YKSPE 540
+ + ++I H IK N+L+++S L D+G + E + + Y++PE
Sbjct: 115 FCHSH--NII--HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170
Query: 541 FLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
L +G + + D+W++G L+ E++TG+ FP +
Sbjct: 171 LL-VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E +G G G+ Y A ++TG + +K+ +E + + +HPN++ +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
Y +E +V E++ SL + + +D + + + L++L+ S
Sbjct: 85 YLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLH----SN 134
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-SAQELMIA---YKSPEFLQLGRITK 549
H IKS N+LL L D+G + E S + M+ + +PE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 550 KTDVWSLGVLILEIMTGKFP 569
K D+WSLG++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 37/220 (16%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQMNNVGREEFQ------EHMRRLGRL 422
+ LG G FG KA V VK K + ++ E M+ +G+
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGK- 74
Query: 423 RHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQ---PSLDWPSRLKIVK-- 477
H N++ L+ ++ +V E+ +L L + G+ P P + +
Sbjct: 75 -HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 478 ------GVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL------IPVMN 525
VA+G+++L S H + + NVL+ E +AD+GL I
Sbjct: 134 LVSFAYQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 526 QESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+ + L + + +PE L T ++DVWS GVL+ EI T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK---QMNNVGREEFQEHMRRLGRLRHPNLLPL 430
E +G G +G YKA + TG ++ +K+ + + V +E + L L HPN++ L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE-ISLLKELNHPNIVKL 64
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ + + + LV EF+ + L + G P L ++K YL++ L
Sbjct: 65 LDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIP-------LPLIK------SYLFQLL 110
Query: 491 PSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMIAYKSP 539
L H H +K N+L+N LAD+GL +PV + + + + Y++P
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAP 169
Query: 540 EFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
E L LG + D+WSLG + E++T + FP +
Sbjct: 170 EIL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 32/108 (29%), Positives = 49/108 (45%), Gaps = 27/108 (25%)
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPV-LADYGLIPVMNQ 526
KI++ + + L L H H IK NVL + + + + L DYGL ++
Sbjct: 113 KIIRQLVEALNDL----------HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162
Query: 527 ESAQELMIAYKSPEFLQLGRITKKT-----DVWSLGVLILEIMTGKFP 569
S + + Y SPE +I D W++GVL E++TGK P
Sbjct: 163 PSCYDGTLDYFSPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGRE----EFQEHMRRLGRL-RHPNLLP 429
+++G G FG KA + + + K+M + +F + L +L HPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKG 478
L+ + L E+ P +L L + L +L L
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI---PVMNQESAQELMIA 535
VA+G+ YL ++ I H + + N+L+ E+ +AD+GL V +++ L +
Sbjct: 121 VARGMDYLSQK--QFI--HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+ + E L T +DVWS GVL+ EI++
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 9e-08
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 40/213 (18%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRF----KQMNNVGREEFQEHMRRLGRLRHPNLLP 429
E +G G G YKA +TG + +K+ + + E + + +HPN+
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINE-----ILIMKDCKHPNI-- 77
Query: 430 LVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK------IVKGVA 480
V YY Y ++L +V E++ SL + + R+ + + V
Sbjct: 78 -VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN----------FVRMNEPQIAYVCREVL 126
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI----AY 536
+GL+YL+ S H IKS N+LL++ LAD+G + +E ++ + +
Sbjct: 127 QGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYW 182
Query: 537 KSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+PE ++ K D+WSLG++ +E+ G+ P
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKR--FKQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+ +G G FG Y A + S V+K +M +E ++ + L +++HPN++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNL---HGHQALGQPSLDWPSRLKIVKGVAKGLQYLY- 487
A + +V E+ L + G L W + ++ GL++++
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLKHIHD 119
Query: 488 RELPSLIAPHGHIKSSNVLLNES-LEPVLADYGLIPVMNQ--ESAQELMIA--YKSPEFL 542
R++ H IKS N+ L+++ + L D+G+ +N E A + Y SPE
Sbjct: 120 RKIL-----HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174
Query: 543 QLGRITKKTDVWSLGVLILEIMTGKFP--ANFLQQ 575
Q KTD+WSLG ++ E+ T K P N L Q
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 16/209 (7%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGRE--EFQEHMRRLGRLRHPNLLPLVA 432
E +G G FG +K + +V + + E + Q+ + L + P +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
Y + + ++ E++ S A++L L LD I++ + KGL YL+ E
Sbjct: 70 SYLKDTKLWIIMEYLGGGS-ALDL-----LEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQLGRIT 548
H IK++NVLL+E E LAD+G+ + + + +PE ++
Sbjct: 124 ----HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 549 KKTDVWSLGVLILEIMTGKFPANFLQQGK 577
K D+WSLG+ +E+ G+ P + L K
Sbjct: 180 SKADIWSLGITAIELAKGEPPHSELHPMK 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 34/210 (16%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG------REEFQEHMRRLGRLRHPNL 427
E LG G + + YK + +TG ++ +K G RE + + L+H N+
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIRE-----ISLMKELKHENI 60
Query: 428 LPLVAYYYRKEEKLLVHEFVPKR-SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY- 485
+ L + + + +LV E++ K ++ HG + P+ +++KG+A +
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 486 -LYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMIAYKSP 539
L+R+L K N+L+N+ E LAD+GL IPV N S + + + Y++P
Sbjct: 121 VLHRDL----------KPQNLLINKRGELKLADFGLARAFGIPV-NTFSNEVVTLWYRAP 169
Query: 540 EFLQLGRITKKT--DVWSLGVLILEIMTGK 567
+ L LG T T D+WS+G ++ E++TG+
Sbjct: 170 DVL-LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 36/103 (34%), Positives = 58/103 (56%), Gaps = 10/103 (9%)
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM 533
KI + K L+YL+ +L S+I H +K SNVL+N + + L D+G+ + A+ +
Sbjct: 107 KIAVSIVKALEYLHSKL-SVI--HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID 163
Query: 534 IA---YKSPEFLQLGRITK----KTDVWSLGVLILEIMTGKFP 569
Y +PE + K K+DVWSLG+ ++E+ TG+FP
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREE----FQEHMRRLGRL-RHPNLLP 429
+++G G FG KA + + + K+M ++ F + L +L HPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQAL-GQPSLDWPSR----------LKIVKG 478
L+ + L E+ P +L L + L P+ + L
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI---PVMNQESAQELMIA 535
VA+G+ YL ++ I H + + N+L+ E+ +AD+GL V +++ L +
Sbjct: 133 VARGMDYLSQK--QFI--HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 188
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+ + E L T +DVWS GVL+ EI++
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 46/207 (22%), Positives = 77/207 (37%), Gaps = 30/207 (14%)
Query: 377 LGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLPLV 431
LG G FG + S +K K+ ++ QEH+ L HP ++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK-RHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL----- 486
+ K+ ++ E+ L L ++ +R + V +YL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFD----EYTARF-YIACVVLAFEYLHNRGI 114
Query: 487 -YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---YKSPEFL 542
YR+L K N+LL+ + L D+G + Y +PE +
Sbjct: 115 IYRDL----------KPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII 164
Query: 543 QLGRITKKTDVWSLGVLILEIMTGKFP 569
D WSLG+L+ E++TG+ P
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 40/220 (18%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEF----QEHMRRLGRLRHPNLLPLV 431
LG G FG YKA + TG ++ +K+ + + ++ F ++ L +L+HPN++PL+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 432 AYYYRKEEKLLVHEFVPKRSLAV------NLHGHQALGQPSLDW-PSRLK-IVKGVAKGL 483
+ +K + V +L G L PS+ S++K + + +G+
Sbjct: 74 DMAVERPDK---SKRKRGSVYMVTPYMDHDLSG--LLENPSVKLTESQIKCYMLQLLEGI 128
Query: 484 QYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI-------------PVMNQESAQ 530
YL+ + I H IK++N+L++ +AD+GL
Sbjct: 129 NYLHE---NHIL-HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 531 ELMIA--YKSPEF-LQLGRITKKTDVWSLGVLILEIMTGK 567
L++ Y+ PE L R T D+W +G + E+ T +
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 40/185 (21%), Positives = 82/185 (44%), Gaps = 18/185 (9%)
Query: 395 MMVVKRFK-QMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453
++ VK + + R +F + ++ + RL++PN++ L+ + ++ E++ L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 454 VNLHGHQALGQ-------PSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVL 506
L + PS+ + L + +A G++YL SL H + + N L
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL----ASLNFVHRDLATRNCL 161
Query: 507 LNESLEPVLADYGLIPVMNQ------ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLI 560
+ +AD+G+ + + L I + + E + LG+ T +DVW+ GV +
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 561 LEIMT 565
E+ T
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 61/231 (26%), Positives = 94/231 (40%), Gaps = 52/231 (22%)
Query: 365 DLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR 423
DL DL +G G FG+ K +G +M VKR + +E+ + M +R
Sbjct: 5 DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMR 58
Query: 424 HPNLLPLVAYY--YRKE--------------EKL--LVHEFVPKRSLAVNLHGHQALGQP 465
+ +V +Y +E +K V+E V K + + G A+
Sbjct: 59 SSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVA-- 115
Query: 466 SLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525
K L YL EL +I H +K SN+LL+ + L D+G I
Sbjct: 116 -------------TVKALNYLKEEL-KII--HRDVKPSNILLDRNGNIKLCDFG-ISGQL 158
Query: 526 QESAQELMIA----YKSPEFLQLGRITK---KTDVWSLGVLILEIMTGKFP 569
+S + A Y +PE + ++DVWSLG+ + E+ TGKFP
Sbjct: 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG-REEFQEHMRRLGRLRHPNLLPLVA 432
EILG G G+ YKA L T ++ VK V +++ + L + P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
++ + + EF+ SL V ++ + + L +I V KGL YL+ S
Sbjct: 67 AFFVENRISICTEFMDGGSLDV----YRKIPEHVLG-----RIAVAVVKGLTYLW----S 113
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--IAYKSPEFLQLGRITKK 550
L H +K SN+L+N + L D+G+ + A+ + AY +PE + +
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 551 TDVWSLGVLILEIMTGKFP 569
+DVWSLG+ +E+ G+FP
Sbjct: 174 SDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 44/200 (22%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E +G G G+ + A ++TG + +K+ +E + + L++PN++ +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
+ +E +V E++ SL + + +D + + + L++L+
Sbjct: 85 FLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQIAAVCRECLQALEFLHANQ--- 135
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIP-VMNQESAQELMIA---YKSPEFLQLGRITK 549
H IKS NVLL L D+G + ++S + M+ + +PE +
Sbjct: 136 -VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 550 KTDVWSLGVLILEIMTGKFP 569
K D+WSLG++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 375 EILGSGCFGSSYKASLSTGAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
E +G G FG + L V VK ++ + + +F + R L + HPN++ L+
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+K+ +V E V L P L +++V+ A G++YL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYL----ES 112
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA----------QELMIAYKSPEFL 542
H + + N L+ E ++D+G M++E +++ + + +PE L
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFG----MSREEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 543 QLGRITKKTDVWSLGVLILE 562
GR + ++DVWS G+L+ E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 66/241 (27%), Positives = 94/241 (39%), Gaps = 70/241 (29%)
Query: 364 FDLHDLLRASAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRL 422
DL+DL +GSG G YK TG +M VK QM G +E E+ R L L
Sbjct: 12 ADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVK---QMRRTGNKE--ENKRILMDL 64
Query: 423 R-----H--PNLLPLVAYYYRKE-------------EKLL--VHEFVPKRSLAVNLHGHQ 460
H P ++ Y+ +KLL + +P+ L
Sbjct: 65 DVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG------- 117
Query: 461 ALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL 520
K+ + K L YL +E +I H +K SN+LL+ S L D+G+
Sbjct: 118 -------------KMTVAIVKALHYL-KEKHGVI--HRDVKPSNILLDASGNVKLCDFGI 161
Query: 521 IPVMNQESA---QELMIAYKSPEFLQLGRITKKT---------DVWSLGVLILEIMTGKF 568
+ A AY +PE RI DVWSLG+ ++E+ TG+F
Sbjct: 162 SGRLVDSKAKTRSAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQF 216
Query: 569 P 569
P
Sbjct: 217 P 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (126), Expect = 3e-07
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 51/223 (22%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQ-MNNVG------REEFQEHMRRLGRLRHPN 426
E LG G +G YKA TG ++ +K+ + G RE + L L+HPN
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE-----ISLLKELKHPN 59
Query: 427 LLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-IVKGVAKGLQ 484
++ L+ + E KL LV E+ +L + L P+ +K I+ + +GL
Sbjct: 60 IVKLLDVIH-TERKLYLVFEYCDM-----DLKKYLDKRPGPLS-PNLIKSIMYQLLRGLA 112
Query: 485 YLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELM 533
Y H H +K N+L+N LAD+GL IP+ + E++
Sbjct: 113 YC----------HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYTHEVV 160
Query: 534 -IAYKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
+ Y++PE L LG + D+WS+G + E++TGK FP +
Sbjct: 161 TLWYRAPEIL-LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 375 EILGSGCFGSSY---KAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPN 426
++LG+G +G + K + TG + +K ++ V + + EH R L +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 427 LLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VAKGLQ 484
L + Y ++ E KL L+ ++V + +L+ + ++ G + L+
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE------DEVRFYSGEIILALE 119
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-----IAYKSP 539
+L++ L + IK N+LL+ VL D+GL E + I Y +P
Sbjct: 120 HLHK----LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 540 EFLQ-LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKK 578
E ++ G K D WSLG+LI E++TG P F +G++
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASP--FTLEGER 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLP 429
E++G G Y A L + +KR ++ + + +R+ + + HPN++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
+ +E LV ++ SL + + + LD ++K V KGL+YL+
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMK--SSYPRGGLDEAIIATVLKEVLKGLEYLHS- 120
Query: 490 LPSLIAPHGHI----KSSNVLLNESLEPVLADYG-----LIPVMNQESAQELMIA---YK 537
+G I K+ N+LL E +AD+G ++ + +
Sbjct: 121 -------NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 538 SPEFLQLGR-ITKKTDVWSLGVLILEIMTGKFP 569
+PE ++ K D+WS G+ +E+ TG P
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 50/204 (24%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 376 ILGSGCFGSS--YKASLSTGAMMVVKR--FKQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+LG G FG + Y+ + +++V K +++ R + + L L+HPN+ +
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI---I 62
Query: 432 AYY--YRKEEKLLVH-EFVPKRSLAVNL-HGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
AYY + + LL+ E+ +L + L + + +IV V+ Y++
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS----YIH 118
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-SAQELMIA---YKSPEFLQ 543
+ ++ H IK+ N+ L ++ L D+G+ ++ E S E ++ Y SPE Q
Sbjct: 119 KA--GIL--HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ 174
Query: 544 LGRITKKTDVWSLGVLILEIMTGK 567
+ K+D+W+LG ++ E++T K
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 377 LGSGCFGS-SYKASLSTGAMMVVKRFK---QMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+GSG +G+ TGA + +K+ Q + ++E +R L ++H N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRE-LRLLKHMKHENVIGLLD 81
Query: 433 YYYRKEEKLLVHEF---VPKRSLAV-NLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
+ H+F +P + L H+ L + + + +V + KGL+Y++
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-----LVYQMLKGLKYIHA 136
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-YKSPE-FLQLGR 546
+I H +K N+ +NE E + D+GL + E ++ Y++PE L
Sbjct: 137 --AGII--HRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMH 192
Query: 547 ITKKTDVWSLGVLILEIMTGK 567
T+ D+WS+G ++ E++TGK
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 17/195 (8%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYY 435
+GSG +G YKA +++TG + +K K Q+ + + +H N++ Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 436 RKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIA 495
R+++ + EF SL H L + + + SR + +GL YL+ +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGKM--- 128
Query: 496 PHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQLGR---IT 548
H IK +N+LL ++ LAD+G+ + A+ + +PE + R
Sbjct: 129 -HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 549 KKTDVWSLGVLILEI 563
+ D+W++G+ +E+
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 36/209 (17%)
Query: 377 LGSGCFGSSYKASL----STGAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPL 430
+G G FG KA L G V+K +M+ REE ++ + L ++HPN +
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN---I 61
Query: 431 VAYYYRKEEK---LLVHEFVPKRSLAVNLHGHQALGQPS---LDWPSRLKIVKGVAKGLQ 484
V Y EE +V ++ L ++ + + P LDW ++ + +
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA------YKS 538
L+R+ IKS N+ L + L D+G+ V+N S EL Y S
Sbjct: 122 ILHRD----------IKSQNIFLTKDGTIKLGDFGIARVLN--STVELARTCIGTPYYLS 169
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGK 567
PE + K+D+W+LG ++ E+ T K
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 375 EILGSGCFGSSYKA----SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPL 430
E +G G FG +K + A+ ++ + + + E+ Q+ + L + P +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYVTKY 67
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
Y + + ++ E++ S A++L L D ++K + KGL YL+ E
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGS-ALDL-----LRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGLI-PVMNQESAQELMIA---YKSPEFLQLGR 546
H IK++NVLL+E + LAD+G+ + + + + + + +PE +Q
Sbjct: 122 KI----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 547 ITKKTDVWSLGVLILEIMTGKFP 569
K D+WSLG+ +E+ G+ P
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 408 GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQA------ 461
RE+F + ++ L RL PN+ L+ ++ E++ L L H A
Sbjct: 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 462 LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521
SL + + L + +A G++YL SL H + + N L+ ++ +AD+G
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYL----ESLNFVHRDLATRNCLVGKNYTIKIADFG-- 175
Query: 522 PVMNQ----------ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
M++ + L I + + E + LG+ T K+DVW+ GV + EI+T
Sbjct: 176 --MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 376 ILGSGCFGSSYKASL----STGAMMVVKRFKQMNNVGR--EEFQEHMRRLGRLRHPNLLP 429
+LG G FGS +A L + + VK K EEF + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGH-------QALGQPSLDWPSR--LKIVKGVA 480
L+ R K + +P L HG +G+ P + ++ + +A
Sbjct: 66 LIGVSLRSRAKGRLP--IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM------NQESAQELMI 534
G++YL + + I H + + N +LNE++ +AD+GL + Q A +L +
Sbjct: 124 SGMEYLSSK--NFI--HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 535 AYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ + E L T +DVW+ GV + EIMT G+ P
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-07
Identities = 30/149 (20%), Positives = 46/149 (30%), Gaps = 6/149 (4%)
Query: 180 GSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP 239
G+ +PA ++S + P PTP SP P P + P SP P P P+
Sbjct: 76 GTEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLS 135
Query: 240 PNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVI 299
P S P ++ P A A +S+ + ++ + A
Sbjct: 136 EMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPP 195
Query: 300 ERKRK------RERGVSIENPPPLPPPSS 322
R I P P+
Sbjct: 196 STPPAAASPRPPRRSSPISASASSPAPAP 224
|
Length = 1352 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 27/109 (24%), Positives = 38/109 (34%)
Query: 212 PSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGS 271
P+ S + P P P P PP P P P P PP PPP + +
Sbjct: 2887 ARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPT 2946
Query: 272 SNSTLVIASATTVSVVAIAAVVAAIFVIERKRKRERGVSIENPPPLPPP 320
++ + V + A+V + R R + S E P PP
Sbjct: 2947 TDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQPAPSREAPASSTPP 2995
|
Length = 3151 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 40/173 (23%), Positives = 81/173 (46%), Gaps = 16/173 (9%)
Query: 405 NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQ 464
N R +F + ++ + RL+ PN++ L+A + ++ E++ L L H+
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118
Query: 465 P------SLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADY 518
++ + + + + +A G++YL SL H + + N L+ ++ +AD+
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYL----SSLNFVHRDLATRNCLVGKNYTIKIADF 174
Query: 519 GLIPVMNQ------ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
G+ + + L I + S E + LG+ T +DVW+ GV + EI+T
Sbjct: 175 GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 39/121 (32%), Positives = 63/121 (52%), Gaps = 12/121 (9%)
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM 533
K+ V KGL YL RE ++ H +K SN+L+N E L D+G+ + A +
Sbjct: 107 KVSIAVIKGLTYL-REKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163
Query: 534 --IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP-----ANFLQQ--GKKADGDLA 584
+Y SPE LQ + ++D+WS+G+ ++E+ G++P A L+ G +GD A
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPA 223
Query: 585 S 585
Sbjct: 224 E 224
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 59/240 (24%), Positives = 97/240 (40%), Gaps = 52/240 (21%)
Query: 358 RDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVG--REEFQEH 415
D F+L E++G G +G YKA +V K M+ + EE +E
Sbjct: 2 PDPTGIFEL-------VEVIGEGTYGKVYKARHKKTGQLVA--IKIMDIIEDEEEEIKEE 52
Query: 416 MRRLGRL-RHPNLLPLVAYYYRK-----EEKL-LVHEFVPKRSLAVNLHGHQALGQPSLD 468
L + HPN+ + +K +++L LV E S +L +
Sbjct: 53 YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS-VTDL------VKGLRK 105
Query: 469 WPSRLK------IVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522
RLK I++ +GL YL+ +I H IK N+LL ++ E L D+G+
Sbjct: 106 KGKRLKEEWIAYILRETLRGLAYLHENK--VI--HRDIKGQNILLTKNAEVKLVDFGVSA 161
Query: 523 VMNQES-------------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
++ A E++ + P+ ++DVWSLG+ +E+ GK P
Sbjct: 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDA----SYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E +G G G+ Y A ++TG + +K+ +E + + ++PN++ +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
Y +E +V E++ SL + + +D + + + L +L+ S
Sbjct: 85 YLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALDFLH----SN 134
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIP-VMNQESAQELMIA---YKSPEFLQLGRITK 549
H IKS N+LL L D+G + ++S + M+ + +PE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 550 KTDVWSLGVLILEIMTGKFP 569
K D+WSLG++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 59/239 (24%), Positives = 107/239 (44%), Gaps = 40/239 (16%)
Query: 372 ASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNV--GREEFQEHMRR---LGRLRHPN 426
A + LG G FGS + L+ ++ K M R E ++ + + HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 427 LLPLVAYYYRKEEKLLVHEFVPKRSLAV------NLHG---HQALGQPSLDWPSRL--KI 475
++ L+ + E E P + + +LH + LG P+++ K
Sbjct: 62 VMRLIGVCLQTVES----EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP-VMNQESAQELMI 534
+ +A G++YL + S I H + + N +LNE++ +AD+GL + N + ++ I
Sbjct: 118 MTDIASGMEYLSSK--SFI--HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173
Query: 535 AYKSPEFLQLGRI-----TKKTDVWSLGVLILEIMT-GKFP---------ANFLQQGKK 578
A +++ + + T K+DVWS GV + EI T G+ P ++L+QG +
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR 232
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGRE--EFQEHMRRLGRLRHPNLLPLVA 432
E +G G FG YK + +V + + E + Q+ + L + P +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
Y + + ++ E++ S A++L L L+ I++ + KGL YL+ E
Sbjct: 70 SYLKGTKLWIIMEYLGGGS-ALDL-----LKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQLGRIT 548
H IK++NVLL+E + LAD+G+ + + + +PE ++
Sbjct: 124 ----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 549 KKTDVWSLGVLILEIMTGKFP 569
K D+WSLG+ +E+ G+ P
Sbjct: 180 FKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVK-RFKQMNNV----GREEFQEHMRRLGRLRHPNLL 428
++LGSG FG+ YK + G + + K +N EF + + + HP+L+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQ-ALG-QPSLDWPSRLKIVKGVAKGLQYL 486
L+ +L V + +P L +H H+ +G Q L+W + +AKG+ YL
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ------ELMIAYKSPE 540
E L+ H + + NVL+ + D+GL ++ + + ++ I + + E
Sbjct: 126 --EERRLV--HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT 565
+ + T ++DVWS GV I E+MT
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 37/152 (24%), Positives = 73/152 (48%), Gaps = 13/152 (8%)
Query: 419 LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG 478
LG+ H N++ L R ++V E++ +L L H+ GQ L + ++ G
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE--GQ--LVAGQLMGMLPG 115
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM----- 533
+A G++YL E+ + H + + VL+N L ++ + + E+ M
Sbjct: 116 LASGMKYL-SEMGYV---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP 171
Query: 534 IAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+ + +PE +Q + +DVWS G+++ E+M+
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 49/202 (24%), Positives = 95/202 (47%), Gaps = 25/202 (12%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVA 432
+G G +G +K + TG ++ +K+F + + + +E +R L +L+HPNL+ L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE-IRMLKQLKHPNLVNLIE 67
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+ RK + LV E+ ++ L + G P KI+ + + + ++ +
Sbjct: 68 VFRRKRKLHLVFEYC-DHTVLNELEKNPR-GVPEH---LIKKIIWQTLQAVNFCHKH--N 120
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN-QESAQELMIA---YKSPEFL----QL 544
I H +K N+L+ + + L D+G ++ +A Y++PE L Q
Sbjct: 121 CI--HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 545 GRITKKTDVWSLGVLILEIMTG 566
G DVW++G + E++TG
Sbjct: 179 G---PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 45/199 (22%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 376 ILGSGCFGSSYKA-SLSTGAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
++G G FG + + ++++K+ +QM R Q + L L HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+ + ++V E+ P +LA + Q LD + L + L +++ +L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 493 LIAPHGHIKSSNVLLNESLEPV-LADYGLIPVMNQESAQELMIA---YKSPEFLQLGRIT 548
H +K+ N+LL++ V + D+G+ +++ +S ++ Y SPE +
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 549 KKTDVWSLGVLILEIMTGK 567
+K+D+W+LG ++ E+ + K
Sbjct: 180 QKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 44/200 (22%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E +G G G+ Y A ++TG + +++ +E + + ++PN++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
Y +E +V E++ SL + + +D + + + L++L+ S
Sbjct: 86 YLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLH----SN 135
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIP-VMNQESAQELMIA---YKSPEFLQLGRITK 549
H IKS N+LL L D+G + ++S + M+ + +PE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 550 KTDVWSLGVLILEIMTGKFP 569
K D+WSLG++ +E++ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 49/211 (23%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 376 ILGSGCFGSSYKASLS------TGAMMVVKRF-KQMNNVGREEFQEHMRRLGRLRHPNLL 428
LG G FG + A +++VK K + + EF+ + +L H N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 429 PLVAYYYRKEEKLLVHEFVP----KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ 484
L+ E ++ E+ K+ L + L P L ++ + +A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI-PVMNQES---AQELM-IAYKSP 539
+L H + + N L++ E ++ L V N E L+ + + +P
Sbjct: 132 HLSN----ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
E +Q + K+DVWS GVL+ E+ T G+ P
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 41/214 (19%)
Query: 373 SAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNN-------VGREEFQEHMRRLGRLRH 424
AEI G G +G+ YKA L+TG + +K+ + + RE +++L H
Sbjct: 4 LAEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEH 60
Query: 425 PNLLPL--VAYYYRKEEKL---LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-IVKG 478
PN++ L V + R + +L LV E V + LA L G P P +K +++
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLP----PETIKDLMRQ 115
Query: 479 VAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532
+ +G+ +L H H +K N+L+ + +AD+GL + + E A
Sbjct: 116 LLRGVDFL----------HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS 165
Query: 533 MIA---YKSPEFLQLGRITKKTDVWSLGVLILEI 563
++ Y++PE L D+WS+G + E+
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM 533
K+ V +GL YL RE ++ H +K SN+L+N E L D+G+ + A +
Sbjct: 107 KVSIAVLRGLAYL-REKHQIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163
Query: 534 --IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+Y SPE LQ + ++D+WS+G+ ++E+ G++P
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 42/221 (19%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR--------------L 419
E++G G +G Y A +++TG MM VK+ + + H R L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVE----LPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 420 GRLRHPNLLPLVAY--YYRKEEKLLVH-EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIV 476
L H N+ V Y + EE L + E+VP S+ L + + + + +
Sbjct: 63 KDLDHLNI---VQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE---- 115
Query: 477 KGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL------IPVMNQESAQ 530
V +GL YL+ + ++ H +K+ N+L++ ++D+G+ I +Q +
Sbjct: 116 -QVLEGLAYLHSK--GIL--HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 531 ELMIAYKSPEFLQLGR--ITKKTDVWSLGVLILEIMTGKFP 569
+ + + +PE + + K D+WSLG ++LE+ G+ P
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 375 EILGSGCFGSSY---KAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPN 426
++LG+G +G + K S +G + +K K+ V + + EH R L +R
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 427 LLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VAKGLQ 484
L + Y ++ + KL L+ +++ L +L + + ++I G + L+
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE------QEVQIYSGEIVLALE 119
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL-----MIAYKSP 539
+L++ L + IK N+LL+ + VL D+GL +++ + I Y +P
Sbjct: 120 HLHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 540 EFLQLGRI--TKKTDVWSLGVLILEIMTGKFP 569
+ ++ G K D WS+GVL+ E++TG P
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 22/106 (20%)
Query: 475 IVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI 534
I++ V GL+YL+ E I H IK++N+LL+E + LAD+G+ S Q
Sbjct: 103 ILREVLLGLEYLHEE--GKI--HRDIKAANILLSEEGDVKLADFGV-------SGQLTST 151
Query: 535 AYK-----------SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
K +PE ++ +K D+WSLG+ +E+ G+ P
Sbjct: 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|114603 pfam05887, Trypan_PARP, Procyclic acidic repetitive protein (PARP) | Back alignment and domain information |
|---|
Score = 46.5 bits (109), Expect = 5e-06
Identities = 19/83 (22%), Positives = 24/83 (28%)
Query: 203 EPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPP 262
+ P P PE P P P P P +P P P P
Sbjct: 61 DDEPEEEEEPEPEEEGEEEPEPEEEGEEEPEPEETGEEEPEPEPEPEPEPEPEPEPEPEP 120
Query: 263 GNDSAGSGSSNSTLVIASATTVS 285
+A S IA+A V+
Sbjct: 121 EPGAATLKSVALPFAIAAAALVA 143
|
This family consists of several Trypanosoma brucei procyclic acidic repetitive protein (PARP) like sequences. The procyclic acidic repetitive protein (parp) genes of Trypanosoma brucei encode a small family of abundant surface proteins whose expression is restricted to the procyclic form of the parasite. They are found at two unlinked loci, parpA and parpB; transcription of both loci is developmentally regulated. Length = 145 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 33/132 (25%), Positives = 50/132 (37%), Gaps = 15/132 (11%)
Query: 202 GEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPP 261
P +P T SP +P PS +SP + IP P P P A P P
Sbjct: 206 ATPRPTPRTTASPETTPTPSTTTSPPSTTIPAPSTTIAA---PQAGTTPEAEGTPAPPTP 262
Query: 262 PGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFV----------IER--KRKRERGV 309
G ++ + ++ + TV+ + A+ A+I + R +R+R R
Sbjct: 263 GGGEAPPANATPAPEASRYELTVTQIIQIAIPASIIACVFLGSCACCLHRRCRRRRRRPA 322
Query: 310 SIENPPPLPPPS 321
I PP PS
Sbjct: 323 RIYRPPSPVAPS 334
|
Length = 401 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEF-----QEHMRRLGRLRHPNLL 428
E++G G +G+ Y+ + TG ++ +K + N+ + Q + L +LR
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALK----IINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 429 PLVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPS-LDWPSRLKIVKGVAKGLQ 484
+ YY Y K +L ++ E+ S+ + L + + I++ V L+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSV-------RTLMKAGPIAEKYISVIIREVLVALK 115
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPE 540
Y+++ +I H IK++N+L+ + L D+G+ ++NQ S++ + +PE
Sbjct: 116 YIHKV--GVI--HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE 171
Query: 541 FLQLGRI-TKKTDVWSLGVLILEIMTGKFP 569
+ G+ K D+WSLG+ I E+ TG P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 6e-06
Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 14/88 (15%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGL---IPVMNQESAQELM---IA---YKSPEFLQLG-- 545
H +K SN+LLN LAD+GL + + + ++ +A Y++PE L LG
Sbjct: 130 HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL-LGST 188
Query: 546 RITKKTDVWSLGVLILEIMTGK--FPAN 571
R TK D+WS+G ++ E++ GK FP
Sbjct: 189 RYTKGVDMWSVGCILGEMLLGKPLFPGT 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 43/219 (19%)
Query: 376 ILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG--------REEFQEHMRRLGRLRHPN 426
+G G +G Y+A ++G ++ +K+ + M+N RE + L LRHPN
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLRE-----ITLLLNLRHPN 67
Query: 427 LLPL--VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVA---- 480
++ L V + LV E+ ++ LA L P VK +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPT--------PFSESQVKCLMLQLL 118
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI----PVMNQESAQELMIAY 536
+GLQYL+ +I H +K SN+LL + +AD+GL + + + + Y
Sbjct: 119 RGLQYLHENF--II--HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWY 174
Query: 537 KSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
++PE L LG T D+W++G ++ E++ K P
Sbjct: 175 RAPELL-LGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 42/223 (18%)
Query: 377 LGSGCFGSSYKA------SLSTGAMMVVKRFK-----QMNNVGREEFQEHMRRLGRLRHP 425
+G G FG ++A M+ VK K M +FQ + HP
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA----DFQREAALMAEFDHP 68
Query: 426 NLLPLVAYYYRKEEKLLVHEFV-------------PKRSLAVNLHGHQA----LGQPSLD 468
N++ L+ + L+ E++ P+ +++ A L L
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 469 WPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMN 525
+L I K VA G+ YL + H + + N L+ E++ +AD+GL I +
Sbjct: 129 CTEQLCIAKQVAAGMAYLSER--KFV--HRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 526 QESAQE---LMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
A E + I + PE + R T ++DVW+ GV++ EI +
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPL 430
E +G G +G YK + TG ++ +K+ + + V +E + L L+HPN++ L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIRE-ISLLKELQHPNIVCL 64
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
++ L+ EF+ S+ + + +D +K YLY+ L
Sbjct: 65 QDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMD-AELVK---------SYLYQIL 111
Query: 491 PSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMIAYKSP 539
++ H +K N+L++ LAD+GL IPV + + + + Y++P
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAP 170
Query: 540 EFLQLG--RITKKTDVWSLGVLILEIMTGK 567
E L LG R + D+WS+G + E+ T K
Sbjct: 171 EVL-LGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKR--FKQMNNVGREEFQE---HMRRLGRLRHPNLL 428
++LG G FG Y + TG + VK+ F + ++E ++ L L+H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI- 66
Query: 429 PLVAYY--YRKEEKLLVH-EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
V YY R +E L + E++P S+ L + AL + +R K + + +G++Y
Sbjct: 67 --VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALT----ETVTR-KYTRQILEGVEY 119
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG----LIPVMNQESAQELMIA---YKS 538
L+ ++I H IK +N+L + + L D+G L + + + + + + S
Sbjct: 120 LHS---NMIV-HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFP-ANF 572
PE + +K DVWS+G ++E++T K P A F
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 39/217 (17%)
Query: 376 ILGSGCFGSSY---KAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNL 427
+LG+G +G + K G + +K K+ V + + EH R L +R
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 428 LPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VAKGLQY 485
L + Y ++ + KL L+ ++V L +L+ + + S +++ + L +
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE------SEVRVYIAEIVLALDH 120
Query: 486 L------YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM---NQESAQEL--MI 534
L YR+ IK N+LL+ VL D+GL +E A I
Sbjct: 121 LHQLGIIYRD----------IKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI 170
Query: 535 AYKSPEFLQLGRI--TKKTDVWSLGVLILEIMTGKFP 569
Y +PE ++ G K D WSLGVL E++TG P
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 24/85 (28%), Positives = 34/85 (40%), Gaps = 7/85 (8%)
Query: 206 GSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPN-PIPSPSHDPHASSHSPPAPPPGN 264
P TP+ +P+P PSP +SP P P + S S P G+
Sbjct: 85 APPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTSVPSSGS 144
Query: 265 DSAGSGSSNSTLVIASATTVSVVAI 289
D+A STLV+ S ++ I
Sbjct: 145 DAA------STLVVGSERETTIEEI 163
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 23/69 (33%), Positives = 30/69 (43%), Gaps = 4/69 (5%)
Query: 203 EPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSH---SPPA 259
P P T + +P+P +P P P+ P P P+ P P P DP+A P A
Sbjct: 42 APPPPPPSTAAAAPAP-AAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNA 100
Query: 260 PPPGNDSAG 268
PPP G
Sbjct: 101 PPPPAPEPG 109
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 31/83 (37%), Positives = 44/83 (53%), Gaps = 10/83 (12%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-----YKSPEFLQ-----LGR 546
H IK NVLL+ + LAD+G MNQ+ + +A Y SPE LQ +G+
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK 184
Query: 547 ITKKTDVWSLGVLILEIMTGKFP 569
+ D WSLGV + E++ G+ P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 41/176 (23%), Positives = 81/176 (46%), Gaps = 24/176 (13%)
Query: 409 REEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQ---- 464
R +F + ++ L RL+ PN++ L+ ++ ++ E++ L L H +
Sbjct: 63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 465 ----------PSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPV 514
P++ + S L + +A G++YL SL H + + N L+ E+L
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYL----SSLNFVHRDLATRNCLVGENLTIK 178
Query: 515 LADYGLIPVMNQ------ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIM 564
+AD+G+ + + L I + + E + +G+ T +DVW+ GV + EI+
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 32/210 (15%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYY 435
LG G FG YKA TG K + + E+F + L +HPN++ L Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 436 RKEEKLLVHEFVPKRSL-AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+ + ++ EF +L ++ L L + L P + + + + L +L+ +I
Sbjct: 73 YENKLWILIEFCDGGALDSIML----ELERG-LTEPQIRYVCRQMLEALNFLHSHK--VI 125
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-------------AQELMI--AYKSP 539
H +K+ N+LL + LAD+G+ A E++ +K
Sbjct: 126 --HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ K D+WSLG+ ++E+ + P
Sbjct: 184 PY------DYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 42/212 (19%)
Query: 377 LGSGCFGSSYKA---------SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL 427
+G+G FG + +L A+ V R KQ +V E+ R L + HP +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK-----RVLKEVSHPFI 63
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQAL-GQPSLDWPSRLKIVKGVAKGLQYL 486
+ L + + ++ E+VP L L L + S + + +
Sbjct: 64 IRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV 123
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM---------IAYK 537
YR+L K N+LL++ L D+G A++L Y
Sbjct: 124 YRDL----------KPENILLDKEGHIKLTDFGF--------AKKLRDRTWTLCGTPEYL 165
Query: 538 SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+PE +Q K D W+LG+LI E++ G P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 13/195 (6%)
Query: 377 LGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+G G F YKA L G A+ V+ F+ M+ R++ + + L +L HPN++ +A
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+ E +V E L+ + H + + + K + L++++ S
Sbjct: 70 SFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----S 124
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--AQELMIA--YKSPEFLQLGRIT 548
H IK +NV + + L D GL + ++ A L+ Y SPE +
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 549 KKTDVWSLGVLILEI 563
K+D+WSLG L+ E+
Sbjct: 185 FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 375 EILGSGCFGS----SYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPL 430
+++G G FG +K+S AM ++ +F+ + F E + P ++ L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ + +V E++P L VNL + D P K K + +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDL-VNL-------MSNYDVPE--KWAKFYTAEVVLALDAI 158
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-----YKSPEFLQL- 544
S+ H +K N+LL++ LAD+G M++ A Y SPE L+
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 545 ---GRITKKTDVWSLGVLILEIMTGKFP 569
G ++ D WS+GV + E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 47/195 (24%), Positives = 86/195 (44%), Gaps = 17/195 (8%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYY 435
+GSG +G YKA +L TG + VK K Q+ + + +H N++ Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 436 RKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIA 495
+E+ + E+ SL H L + + + R + +GL YL+ S
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH----SKGK 127
Query: 496 PHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQL---GRIT 548
H IK +N+LL ++ + LAD+G+ + A+ + +PE + G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 549 KKTDVWSLGVLILEI 563
+ D+W++G+ +E+
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 30/203 (14%)
Query: 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRR---LGRLRHPNLLPLV-A 432
LG G FG YKA ++ K ++ EE +++M L HPN++ L+ A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAA--KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 433 YYYRKEEKLLVHEFVPKRSL-AVNLHGHQALGQPSLDWPSRLKIV-KGVAKGLQYLYREL 490
+YY +L+ EF ++ AV L + L +P ++++V K + L YL+
Sbjct: 71 FYYENNLWILI-EFCAGGAVDAVMLELERPLTEP------QIRVVCKQTLEALNYLHEN- 122
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSPEFLQ----LGR 546
+I H +K+ N+L + LAD+G + N + Q +P ++ +
Sbjct: 123 -KII--HRDLKAGNILFTLDGDIKLADFG-VSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 547 ITK------KTDVWSLGVLILEI 563
+K K DVWSLG+ ++E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-05
Identities = 13/43 (30%), Positives = 19/43 (44%), Gaps = 6/43 (13%)
Query: 2 TDSQTLLTLKQSLSNP--TALANWDDRTPPCNENGANWNGVLC 42
D LL K SL+ AL++W+ + +W GV C
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSSSDPC----SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 35/218 (16%)
Query: 377 LGSGCFGSSY------------KASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRH 424
LG GCFG K +++ M+ + + E M+ +G+ H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 425 PNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALG-----------QPSLDWPSRL 473
N++ L+ + ++ E+ K +L L + G + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL------IPVMNQE 527
VA+G++YL S H + + NVL+ E+ +AD+GL I +
Sbjct: 141 SCTYQVARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+ L + + +PE L T ++DVWS GVL+ EI T
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 54/223 (24%)
Query: 377 LGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQ--EHMRR-------LGRLRHPN 426
+GSG +G A + TG + +K+ FQ H +R L + H N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL-------SRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 427 LLPLVAYYYRKEEK------LLVHEFVPKRSLAVNLHG---HQALGQPSLDWPSRLKIVK 477
++ L+ + LV + +L+ Q L + + +V
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLM-----GADLNNIVKCQKLSDDHIQF-----LVY 125
Query: 478 GVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-- 535
+ +GL+Y++ S H +K SN+ +NE E + D+GL + M
Sbjct: 126 QILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGL-----ARHTDDEMTGYV 176
Query: 536 ----YKSPE-FLQLGRITKKTDVWSLGVLILEIMTGK--FPAN 571
Y++PE L + D+WS+G ++ E++TGK FP +
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 47/217 (21%), Positives = 89/217 (41%), Gaps = 28/217 (12%)
Query: 377 LGSGCFGSSYKASL-STGAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
LG G FG + +TG M K+ K++ E+ + +++ + +AY
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 434 YYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL------ 486
+ ++ L LV + L +++ G+P + + GL++L
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMNQESAQELMIAYKSPEFLQ 543
YR+L K NVLL++ ++D GL + + + Y +PE LQ
Sbjct: 118 YRDL----------KPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167
Query: 544 LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKAD 580
D ++LG + E++ G+ P F Q+ +K +
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSP--FRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 44/218 (20%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK---QMNNVGREEFQEHMRRLGRLRHPNLLPL 430
E +G G +G YKA TG ++ +K+ + + V +E + L L HPN++ L
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE-ISLLKELNHPNIVRL 63
Query: 431 VAYYYRKEEKL-LVHEFVP---KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
+ + E KL LV EF+ K+ + + L P ++K YL
Sbjct: 64 LDVVH-SENKLYLVFEFLDLDLKKYM--DSSPLTGLDPP---------LIKS------YL 105
Query: 487 YRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMIA 535
Y+ L + H H +K N+L++ LAD+GL +PV + + + +
Sbjct: 106 YQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHEVVTLW 164
Query: 536 YKSPEFLQLGRITKKT--DVWSLGVLILEIMTGK--FP 569
Y++PE L LG T D+WS+G + E++ + FP
Sbjct: 165 YRAPEIL-LGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 375 EILGSGCFGSSYKA--SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLG-----------R 421
E LGSG FG YK + ++ +K N ++ +E + +G +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 422 LRHPNLLPLVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRL-KIVK 477
LRHPN+ V YY + + ++L +V + + L + + + Q + R+ I
Sbjct: 66 LRHPNI---VRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFV 120
Query: 478 GVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM---I 534
+ L+YL++E + H + +N++L E + + D+GL ES + I
Sbjct: 121 QMVLALRYLHKEKRIV---HRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 535 AYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
Y PE ++ +K DVW+ G ++ ++ T
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 39/220 (17%)
Query: 377 LGSGCFGSSYKAS-----------LSTGAMMVVK---RFKQMNNVGREEFQEHMRRLGRL 422
LG GCFG +A T A+ ++K K + ++ E E M+ +G+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE--MELMKLIGK- 76
Query: 423 RHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALG-----------QPSLDWPS 471
H N++ L+ ++ ++ E+ K +L L + G + L +
Sbjct: 77 -HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 472 RLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL------IPVMN 525
+ VA+G++YL S H + + NVL+ E +AD+GL I
Sbjct: 136 LVSCAYQVARGMEYL----ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 526 QESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+ S L + + +PE L T ++DVWS G+L+ EI T
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 48/219 (21%), Positives = 91/219 (41%), Gaps = 29/219 (13%)
Query: 370 LRASAE------ILGSGCFGS----SYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRL 419
LR AE ++G G FG +K++ AM ++ +F+ + F E +
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 420 GRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGV 479
P ++ L + +V E++P L + + + + + + + +
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 157
Query: 480 AKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---- 535
+ +++R+ +K N+LL++S LAD+G MN+E A
Sbjct: 158 IHSMGFIHRD----------VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207
Query: 536 -YKSPEFLQL----GRITKKTDVWSLGVLILEIMTGKFP 569
Y SPE L+ G ++ D WS+GV + E++ G P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 60/216 (27%), Positives = 87/216 (40%), Gaps = 28/216 (12%)
Query: 369 LLRASAEILGSGCFGSSYKASLSTGAMMVVK---RFKQMNNVGREEFQEH--MRRL--GR 421
LLRA LG G FG Y+ V+ K + E+ + M L +
Sbjct: 10 LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 422 LRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNL-HGHQALGQPS-LDWPSRLKIVKGV 479
H N++ L+ + + + ++ E + L L +PS L L + V
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 480 AKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEP----VLADYGLIPVMNQESAQE---- 531
AKG +YL E I H I + N LL P +AD+G+ + + S
Sbjct: 126 AKGCKYL--EENHFI--HRDIAARNCLLT-CKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 532 --LMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
L I + PE G T KTDVWS GVL+ EI +
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 376 ILGSGCFGSSYKAS---------LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN 426
LG G FG KA+ +T A+ ++K + ++ + L ++ HP+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK--ENASSSELRDLLSEFNLLKQVNHPH 64
Query: 427 LLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALG-----------QPSLDWPSRLKI 475
++ L + LL+ E+ SL L + +G LD P +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 476 VKG--------VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527
G +++G+QYL E+ L+ H + + NVL+ E + ++D+GL + +E
Sbjct: 125 TMGDLISFAWQISRGMQYL-AEM-KLV--HRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 528 ------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
S + + + + E L T ++DVWS GVL+ EI+T
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 19/54 (35%), Positives = 23/54 (42%), Gaps = 4/54 (7%)
Query: 210 PTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPG 263
P P P P + +P P P P P PP P P P+A+ PPA P
Sbjct: 41 PAPPPPPPSTAAAAPAPAA-PPPPPPPAAPPAPQPDD---PNAAPPPPPADPNA 90
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 14/201 (6%)
Query: 376 ILGSGCFGSSYKASL-STGAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+LG G FG + +TG M KR K++ E + +++ + + +A
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 433 YYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
Y Y ++ L LV + L +++ +G P + L + GL+ L+RE
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMNQESAQELMIAYKSPEFLQLGRIT 548
+ +K N+LL++ ++D GL IP + + Y +PE L R T
Sbjct: 122 --NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 549 KKTDVWSLGVLILEIMTGKFP 569
D W LG LI E++ G+ P
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 22/201 (10%)
Query: 380 GCFGSSYKA-SLSTGAMMVVKRFK--------QMNNVGREEFQEHMRRLGRLRHPNLLPL 430
G FGS Y A STG +K K Q+ NV E ++ P + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES----PYVAKL 62
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ K+ LV E++ A + + LG DW + + V G++ L++
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLHQR- 116
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSPEFLQLGRITKK 550
+I H IK N+L++++ L D+GL + Y +PE + K
Sbjct: 117 -GII--HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKM 173
Query: 551 TDVWSLGVLILEIMTGKFPAN 571
+D WSLG +I E + G P +
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 375 EILGSGCFGSSYKA---SLSTGAMMV-VKRFK-QMNNVGREEFQEHMRRLGRLRHPNLLP 429
+G G FG Y+ S + V VK K + RE+F + + + HP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L+ + +V E P L L ++ SLD S + ++ L YL
Sbjct: 72 LIGVI-TENPVWIVMELAPLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLE-- 124
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPV-LADYGLIPVMNQE-----SAQELMIAYKSPEFLQ 543
S H I + NVL++ S + V L D+GL + E S +L I + +PE +
Sbjct: 125 --SKRFVHRDIAARNVLVS-SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 544 LGRITKKTDVWSLGVLILEI-MTGKFP 569
R T +DVW GV + EI M G P
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 65/273 (23%), Positives = 103/273 (37%), Gaps = 74/273 (27%)
Query: 376 ILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHM--RRLGRL--RHPNLLPL 430
+LG G FG A L T + VK K+ + ++ + M +R+ L +HP L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VAKGLQYL--- 486
+ + K+ V E+V L ++ +P R + + GLQ+L
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP------RARFYAAEIVLGLQFLHER 115
Query: 487 ---YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-------- 535
YR+L K NVLL+ +AD+G+ +E ++
Sbjct: 116 GIIYRDL----------KLDNVLLDSEGHIKIADFGM--------CKEGILGGVTTSTFC 157
Query: 536 ----YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL 591
Y +PE L D W+LGVL+ E++ G+ P F
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP--F------------------- 196
Query: 592 ANGDNRTEVFDKEMADE----RNSEGEMVKLLK 620
GD+ E+F + DE R E +LK
Sbjct: 197 -EGDDEDELFQSILEDEVRYPRWLSKEAKSILK 228
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 27/210 (12%)
Query: 376 ILGSGCFGS-SYKASLSTGAMMVVKRFKQMNNVGREE--FQEHMRRLGRLRHPNLLPLVA 432
++G G +G S + G V+K+ N RE ++ + L +L+HPN +VA
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVA 63
Query: 433 Y--YYRKEEKLL--VHEFVPKRSLAVNL---HGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
Y + E+ LL V F L L G ++W + +A LQY
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQY 117
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM-NQESAQELMIA---YKSPEF 541
L+ + H +K+ NV L + + D G+ V+ NQ +I Y SPE
Sbjct: 118 LHEKH----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 542 LQLGRITKKTDVWSLGVLILEIMTGKFPAN 571
K+DVW+LG + E+ T K N
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 6e-05
Identities = 70/300 (23%), Positives = 119/300 (39%), Gaps = 72/300 (24%)
Query: 377 LGSGCFGSSYKA-SLSTG---AMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLV 431
+ G +G + A STG A+ V+K+ + N + E L + + P ++ L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI-LSQAQSPYVVKLY 59
Query: 432 AYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
Y ++ ++ L LV E++P LA L +G SLD + + L+YL+
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLE---NVG--SLDEDVARIYIAEIVLALEYLHS-- 111
Query: 491 PSLIAPHG--H--IKSSNVLLNESLEPVLADYGL--------IPVMNQESAQELMIA--- 535
+G H +K N+L++ + L D+GL +N + ++ I
Sbjct: 112 ------NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 536 -YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594
Y +PE + +K D WSLG ++ E + G P F +G
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP--F--------------------HG 203
Query: 595 DNRTEVFDK------EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648
+ E+F E ++ E + L+ L + EKRL K IEE+K
Sbjct: 204 ETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLL---VPDPEKRLGAK----SIEEIKN 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 377 LGSGCFGSSYKASLSTG---AMMVVKRFKQMNNVGRE-EFQEHMRRLGRLRHPNLLPLVA 432
+G+G FG +++G A +VVK + +V + +F E + L+H NLL +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
LLV EF P L L + + D + ++ +A GL +L++ +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--N 120
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----SAQELMIAYK--SPEF----- 541
I H + N LL L + DYGL +E + +L + + +PE
Sbjct: 121 FI--HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 542 --LQLGRITKKTDVWSLGVLILEI 563
L + TK+++VWSLGV I E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 52/246 (21%)
Query: 351 EIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGR 409
+I LS +RD F+L E++G+G +G YK + TG + +K + +V
Sbjct: 5 DIDLSALRDPAGIFEL-------VEVVGNGTYGQVYKGRHVKTGQLAAIK----VMDVTE 53
Query: 410 EEFQEHMRRLGRLR----HPNLLPLVAYYYRK------EEKLLVHEFVPKRS---LAVNL 456
+E +E + L+ H N+ + +K ++ LV EF S L N
Sbjct: 54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT 113
Query: 457 HGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLA 516
G+ AL + DW + I + + +GL +L+ +I H IK NVLL E+ E L
Sbjct: 114 KGN-ALKE---DWIAY--ICREILRGLAHLHAH--KVI--HRDIKGQNVLLTENAEVKLV 163
Query: 517 DYGLIPVMNQE-------------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEI 563
D+G+ +++ A E++ ++P+ ++D+WSLG+ +E+
Sbjct: 164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD----ATYDYRSDIWSLGITAIEM 219
Query: 564 MTGKFP 569
G P
Sbjct: 220 AEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 12/118 (10%)
Query: 473 LKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG--LIPV---MNQE 527
L I + V + +QYL+ +I H IK+ N+ +N + L D+G PV N+
Sbjct: 185 LAIERSVLRAIQYLHEN--RII--HRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240
Query: 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLAS 585
IA +PE L D+WS G+++ E+ T + L + DGD S
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKDGLDGDCDS 295
|
Length = 391 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 56/235 (23%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 375 EILGSGCFGSSYKASLSTGAMMV-----VKRFKQMNN-VGREEFQEHMRRLGRLRHPNLL 428
++LGSG FG+ YK V +K ++ + +E + + + +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLA--VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
L+ +L + + +P L V H Q L+W + +AKG+ YL
Sbjct: 73 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL 125
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ------ELMIAYKSPE 540
E L+ H + + NVL+ + D+GL ++ + + ++ I + + E
Sbjct: 126 --EERRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 541 FLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD 595
+ T ++DVWS GV + E+MT F + K DG AS ++S+L G+
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMT--FGS------KPYDGIPASEISSILEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 25/64 (39%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 210 PTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPGN-DSAG 268
P P P P P P P P PN P P DP+A PPAP PG D+A
Sbjct: 58 AAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPPPPVDPNAP--PPPAPEPGRIDNAV 115
Query: 269 SGSS 272
G S
Sbjct: 116 GGFS 119
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 377 LGSGCFG--SSYKASLSTGAMMVVKRFKQMNN--VGREEFQEHMRRLGRLRHPNLLPLVA 432
+G G FG S + L+ + + K K + + + ++E ++ L LRH N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-LKLLKHLRHENIISLSD 76
Query: 433 YYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
+ E + V E L +LH + L L+ + + +GL+Y++
Sbjct: 77 IFISPLEDIYFVTEL-----LGTDLH--RLLTSRPLEKQFIQYFLYQILRGLKYVH---- 125
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---YKSPE-FLQLGRI 547
S H +K SN+L+NE+ + + D+GL + Q+ ++ Y++PE L +
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 548 TKKTDVWSLGVLILEIMTGK--FP 569
+ D+WS G + E++ GK FP
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFP 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 376 ILGSGCFGSSYKASL-STGAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+LG G FG + +TG M K+ K++ E + +++ + + +A
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 433 YYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
Y Y ++ L LV + L +++ +G+ + + + GL+ L++E
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIY---HMGEAGFEEGRAVFYAAEICCGLEDLHQER- 122
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMNQESAQELMIAYKSPEFLQLGRIT 548
+ +K N+LL++ ++D GL +P + + Y +PE ++ R T
Sbjct: 123 ---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179
Query: 549 KKTDVWSLGVLILEIMTGKFPANFLQQGKK 578
D W+LG L+ E++ G+ P F Q+ KK
Sbjct: 180 FSPDWWALGCLLYEMIAGQSP--FQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 37/162 (22%), Positives = 53/162 (32%), Gaps = 7/162 (4%)
Query: 183 SPALRELDPSSFSGNRDLCGEPLG-SPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPN 241
A SS S + P P P P+P P E+S P P P +
Sbjct: 230 DDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSS 289
Query: 242 PIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIER 301
S P SS P ++ S SS+ +S ++ S + A V+
Sbjct: 290 SPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVS------P 343
Query: 302 KRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEA 343
R S PPP PSS ++ R + S+
Sbjct: 344 GPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRP 385
|
Length = 1352 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 33/210 (15%)
Query: 375 EILGSGCFGSSYKASL--------STGAMMVVKRFKQMNNVGREE-FQEHMRRLGRLRHP 425
+LG G FG K SL TG M+ VK K+ +++ + L L H
Sbjct: 10 RVLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 426 NLLPLVAYYYRKEEK--LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGL 483
N++ + K L+ E+VP SL L H L+ L + + +G+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGM 120
Query: 484 QYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMNQ-----ESAQELMIA 535
YL+ S H + + NVLL+ + D+GL +P ++ E +
Sbjct: 121 AYLH----SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
Y + E L+ + + +DVWS GV + E++T
Sbjct: 177 Y-AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 376 ILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
+LG G +G Y A LST + +K + ++ + E + L+H N++ +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 435 YRKEEKLLVHEFVPKRSLAVNLH---GHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
+ E VP SL+ L G + ++ + + K + +GL+YL+
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT-----KQILEGLKYLH---- 125
Query: 492 SLIAPHGHIKSSNVLLNESLEPV-LADYG----LIPVMNQESAQELMIAYKSPEFLQLGR 546
H IK NVL+N V ++D+G L + + Y +PE + G
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185
Query: 547 --ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKA 579
D+WSLG I+E+ TGK P L + + A
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA 220
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 1e-04
Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 11/90 (12%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-------YKSPE-FLQLGRIT 548
H +K SN+L+N + + + D+GL ++ + ++ + Y++PE L R T
Sbjct: 126 HRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYT 185
Query: 549 KKTDVWSLGVLILEIMTGK--FPA-NFLQQ 575
K D+WS+G + E++T K FP +++ Q
Sbjct: 186 KAIDIWSVGCIFAELLTRKPLFPGRDYIDQ 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 19/204 (9%)
Query: 377 LGSGCFGSSYKASL----STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+G G F Y+A+ A+ V+ F+ M+ R++ + + L +L HPN++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 433 YYYRKEEKLLVHEFVPKRSLA---VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
+ E +V E L+ + L W +++ V
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV--------EH 121
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--AQELMIA--YKSPEFLQLG 545
+ S H IK +NV + + L D GL + ++ A L+ Y SPE +
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 546 RITKKTDVWSLGVLILEIMTGKFP 569
K+D+WSLG L+ E+ + P
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 51/219 (23%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHM--RRLGRLR----HPNLLP 429
LG G FGS Y A + TG ++ +K+ K+ ++E M R + LR HPN++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKK----FYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-IVKGVAKGLQYLYR 488
L + +E V E++ NL+ + S ++ I+ + +GL ++++
Sbjct: 63 LKEVFRENDELYFVFEYMEG-----NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 489 ELPSLIAPHG--H--IKSSNVLLNESLEPVLADYGLIPVMNQESAQEL--------MIA- 535
HG H +K N+L++ +AD+GL A+E+ ++
Sbjct: 118 --------HGFFHRDLKPENLLVSGPEVVKIADFGL--------AREIRSRPPYTDYVST 161
Query: 536 --YKSPE-FLQLGRITKKTDVWSLGVLILEIMTGK--FP 569
Y++PE L+ + D+W+LG ++ E+ T + FP
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 375 EILGSGCFGSSYKASLSTG-------AMMVVKRFKQMNNVGREEFQEHMRR--LGRLRHP 425
++LG G FG + TG AM V+K K V R+ + M R L + HP
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLK--KATLKV-RDRVRTKMERDILAEVNHP 58
Query: 426 NLLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLD-WPSRLKIVKGVAKGL 483
++ L Y ++ E KL L+ +F+ L L + + + + L + L
Sbjct: 59 FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 484 QYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI--PVMNQESAQEL--MIAYKSP 539
+YR+L K N+LL+E L D+GL + +++ A + Y +P
Sbjct: 118 GIIYRDL----------KPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGK 577
E + T+ D WS GVL+ E++TG P QGK
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPF----QGK 201
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 18/64 (28%), Positives = 23/64 (35%), Gaps = 3/64 (4%)
Query: 204 PLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPG 263
P G P+ P P P P P+P+P P P P+PS PP P
Sbjct: 399 PGGDDQTRPAA-PVPASVPT--PAPTPVPASAPPPPATPLPSAEPGSDDGPAPPPERQPP 455
Query: 264 NDSA 267
+
Sbjct: 456 APAT 459
|
Length = 3151 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 32/224 (14%)
Query: 377 LGSGCFGSSYKASLSTGAMMVV----KRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLV 431
LG G FGS K + V K KQ + G++EF + +L HP ++ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
+ E +LV E P L L + + L ++ VA G+ YL E
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYL--ESK 114
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN-------QESAQELMIAYKSPEFLQL 544
+ H + + NVLL + ++D+G+ + +A + + +PE +
Sbjct: 115 HFV--HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 545 GRITKKTDVWSLGVLILEI----------MTGKFPANFLQQGKK 578
G+ + K+DVWS GV + E M G L+ G++
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 419 LGRLRHPNLLPLVAYYYRKEEKLLVHE---FVPKRSLAVNLHGHQALGQPSLDWPSR--L 473
LGRL H N+L K E++L E ++ + +L+ + DW R L
Sbjct: 217 LGRLNHENIL--------KIEEILRSEANTYMITQKYDFDLYSFMYDE--AFDWKDRPLL 266
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG-LIPVMNQESAQEL 532
K + + K L + H IK N+ LN + VL D+G +P + A +
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 533 ----MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKF 568
+A SPE L + TD+WS G+++L++++ F
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 40/182 (21%), Positives = 82/182 (45%), Gaps = 14/182 (7%)
Query: 392 TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451
TG + VK+ RE + + H N++ + Y +E +V EF+ +
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL 511
L ++ H + + + + V + L YL+ + +I H IKS ++LL
Sbjct: 106 LT-DIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQ--GVI--HRDIKSDSILLTSDG 155
Query: 512 EPVLADYGLIPVMNQESAQELMIA----YKSPEFLQLGRITKKTDVWSLGVLILEIMTGK 567
L+D+G +++E + + + +PE + + D+WSLG++++E++ G+
Sbjct: 156 RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
Query: 568 FP 569
P
Sbjct: 216 PP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 10/83 (12%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-----YKSPEFLQ-----LGR 546
H IK NVLL+++ LAD+G + + + +A Y SPE LQ GR
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 547 ITKKTDVWSLGVLILEIMTGKFP 569
+ D WSLGV + E++ G+ P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 34/212 (16%)
Query: 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHM--RRLGRL--RHPNLLP 429
++LG G FG A L T + +K K+ + ++ M +R+ L +HP L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L + K+ V E+V L + + +P SR + V L +L+R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPR----SRFYAAE-VTLALMFLHR- 114
Query: 490 LPSLIAPHGHI----KSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA--------YK 537
HG I K N+LL+ LAD+G M +E + Y
Sbjct: 115 -------HGVIYRDLKLDNILLDAEGHCKLADFG----MCKEGILNGVTTTTFCGTPDYI 163
Query: 538 SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+PE LQ D W+LGVL+ E+M G+ P
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 44/198 (22%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 377 LGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYY 435
+G G G A++ S+G ++ VK+ RE + + +H N++ + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 436 RKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIA 495
+E +V EF+ +L ++ H + + + + V K L L+ + +I
Sbjct: 88 VGDELWVVMEFLEGGALT-DIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQ--GVI- 138
Query: 496 PHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQLGRITKKT 551
H IKS ++LL L+D+G +++E + + + +PE + +
Sbjct: 139 -HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 552 DVWSLGVLILEIMTGKFP 569
D+WSLG++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 48/219 (21%)
Query: 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHM--RRLGRL--RHPNLLP 429
++LG G FG + A L T +K K+ + ++ + M +R+ L HP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHG-HQALGQPSLDWPSRLKIVKGVAKGLQYL-- 486
L + KE V E++ L ++ H+ D P + GLQ+L
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK------FDLPRATFYAAEIICGLQFLHS 114
Query: 487 ----YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA------- 535
YR+L K N+LL+ +AD+G+ +E M+
Sbjct: 115 KGIVYRDL----------KLDNILLDTDGHIKIADFGM--------CKENMLGDAKTCTF 156
Query: 536 -----YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y +PE L + D WS GVL+ E++ G+ P
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 51/222 (22%), Positives = 92/222 (41%), Gaps = 33/222 (14%)
Query: 368 DLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQE-----HMRRLGRL 422
+LL + K T ++ VK+ +++ +E+ + R +L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSR--QL 56
Query: 423 RHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG 482
+HPN+LP V + E +V + S L H G P L + I+K V
Sbjct: 57 QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL---AIAFILKDVLNA 113
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADY-GLIPVMNQ------------ESA 529
L Y++ + I H +K+S++LL+ + VL+ + ++ S
Sbjct: 114 LDYIHSK--GFI--HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169
Query: 530 QELMIAYKSPEFLQ--LGRITKKTDVWSLGVLILEIMTGKFP 569
+ L + SPE LQ L +K+D++S+G+ E+ G P
Sbjct: 170 KNL--PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 19/72 (26%), Positives = 28/72 (38%)
Query: 195 SGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASS 254
G D P P+P+P+P P+ P +P+P P P P P P A +
Sbjct: 399 PGGDDQTRPAAPVPASVPTPAPTPVPASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPA 458
Query: 255 HSPPAPPPGNDS 266
P P + +
Sbjct: 459 TEPAPDDPDDAT 470
|
Length = 3151 |
| >gnl|CDD|114603 pfam05887, Trypan_PARP, Procyclic acidic repetitive protein (PARP) | Back alignment and domain information |
|---|
Score = 41.5 bits (96), Expect = 3e-04
Identities = 19/88 (21%), Positives = 26/88 (29%), Gaps = 3/88 (3%)
Query: 208 PCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPGNDSA 267
P P P P E P P P +P P P P +
Sbjct: 60 PDDEPEEEEEPEPEEEGEEEPEPEEEGEEEPEPEETGEEEPEPEPEPEPEPEPEPEPEPE 119
Query: 268 GSGSSNSTLVIASATTVSVVAIAAVVAA 295
+ + + S +A AA+VAA
Sbjct: 120 PEPGAAT---LKSVALPFAIAAAALVAA 144
|
This family consists of several Trypanosoma brucei procyclic acidic repetitive protein (PARP) like sequences. The procyclic acidic repetitive protein (parp) genes of Trypanosoma brucei encode a small family of abundant surface proteins whose expression is restricted to the procyclic form of the parasite. They are found at two unlinked loci, parpA and parpB; transcription of both loci is developmentally regulated. Length = 145 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQ--EHMRRLGRLRHPNLLPLVA 432
E LG G + + YK +V + ++ F L L+H N++ L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKI-VKGVAKGLQYLYRELP 491
+ KE LV E+V L + H P P +K+ + + +GL Y+++
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYMDKH-----PGGLHPENVKLFLFQLLRGLSYIHQRY- 123
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLI---PVMNQESAQELMIAYKSPEFLQLGRIT 548
H +K N+L++++ E LAD+GL V + + E++ + P + LG
Sbjct: 124 ---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 549 KKT--DVWSLGVLILEIMTG--KFPA 570
T D+W +G + +E++ G FP
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 36/211 (17%)
Query: 374 AEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHM-----------RRLGR 421
AEI G G +G +KA L G RF + V + +E M R L
Sbjct: 7 AEI-GEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 422 LRHPNLLPL-----VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-I 475
HPN++ L V+ R+ + LV E V + L L G P +K +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVP----TETIKDM 115
Query: 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA 535
+ + +GL +L+ S H +K N+L+ S + LAD+GL + + + A ++
Sbjct: 116 MFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 171
Query: 536 ---YKSPEFLQLGRITKKTDVWSLGVLILEI 563
Y++PE L D+WS+G + E+
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 376 ILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHM-----RRLGRLRHPNLLP 429
+LG G FG + +TG M K+ ++ R+ E M + L ++ ++
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALNEKQILEKVNSRFVVS 64
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L Y K+ LV + L +++ +G P D + + GL+ L+RE
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMNQESAQELMIAYKSPEFLQLGR 546
+ +K N+LL++ ++D GL IP + + Y +PE ++ R
Sbjct: 122 R----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER 177
Query: 547 ITKKTDVWSLGVLILEIMTGKFPANFLQQGKK 578
T D W LG LI E++ GK P F Q+ +K
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSP--FRQRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 30/124 (24%), Positives = 36/124 (29%), Gaps = 10/124 (8%)
Query: 183 SPALRELDPSSFSGNRDLC----GEPLGSPCPTPSPSPSPGPSPESSP-----TPSPIPL 233
P L E D + + GE +PS PS P S P SP
Sbjct: 151 GPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDS 210
Query: 234 PLPNHPPNPIPSPSHDPHASSHSPPAPP-PGNDSAGSGSSNSTLVIASATTVSVVAIAAV 292
LP P + S +P PP P L A T S A A
Sbjct: 211 SLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAP 270
Query: 293 VAAI 296
+ I
Sbjct: 271 IGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 49/228 (21%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKR----FKQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+GSG +GS A + VK+ F+ + + R ++E +R L ++H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH-ARRTYRE-LRLLKHMKHENVIGLL 80
Query: 432 AYYYRKEEKLLVHEFVPKRS--------LAVNLHGH--------QALGQPSLDWPSRLKI 475
F P S L NL G Q L + + +
Sbjct: 81 DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-----L 123
Query: 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA 535
+ + +GL+Y++ S H +K SNV +NE E + D+GL + E +
Sbjct: 124 IYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR 179
Query: 536 -YKSPE-FLQLGRITKKTDVWSLGVLILEIMTGK--FPAN-FLQQGKK 578
Y++PE L + D+WS+G ++ E++ GK FP N ++ Q K+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR 227
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 20/98 (20%), Positives = 31/98 (31%)
Query: 190 DPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHD 249
DP+S S + P P+P PS P PS P P +PS
Sbjct: 178 DPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPP 237
Query: 250 PHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVV 287
P ++ PP + + + + A +
Sbjct: 238 PGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGGIT 275
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRR-----LGRLRHPNLL 428
+++G G FG A G VK ++ + R+E Q+H+ L ++HP L+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLV 59
Query: 429 PLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
L Y ++ EKL V +FV L +L ++ +P +R + +A L YL+
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR----ARFYAAE-IASALGYLH 113
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGL----IPVMNQESAQELMIAYKSPEFLQ 543
S+ + +K N+LL+ VL D+GL I + + Y +PE ++
Sbjct: 114 ----SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 544 LGRITKKTDVWSLGVLILEIMTGKFP 569
D W LG ++ E++ G P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 14/201 (6%)
Query: 376 ILGSGCFGSSYKASL-STGAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+LG G FG + +TG M K+ K++ E + +R+ + + +A
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 433 YYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
Y Y ++ L LV + L +++ +G P D + + GL+ L RE
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQRER- 122
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMNQESAQELMIAYKSPEFLQLGRIT 548
+ +K N+LL++ ++D GL IP + + Y +PE + + T
Sbjct: 123 ---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179
Query: 549 KKTDVWSLGVLILEIMTGKFP 569
D W LG LI E++ G+ P
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 375 EILGSGCFGSSYKA----SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPL 430
E +G G +G YKA + T A+ ++ ++ V +E + L ++H N++ L
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIRE-ISLLKEMQHGNIVRL 66
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ ++ LV E+ L ++L H S D+ +++K YLY+ L
Sbjct: 67 QDVVHSEKRLYLVFEY-----LDLDLKKHM---DSSPDFAKNPRLIK------TYLYQIL 112
Query: 491 PSLIAPHGH------IKSSNVLLNESLEPV-LADYGL-----IPVMNQESAQELMIAYKS 538
+ H H +K N+L++ + LAD+GL IPV + + + + Y++
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTFTHEVVTLWYRA 171
Query: 539 PEFLQLGRITKKT--DVWSLGVLILEIMTGK--FPAN 571
PE L LG T D+WS+G + E++ K FP +
Sbjct: 172 PEIL-LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 374 AEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQE------HMRRLGRLRHPN 426
++LG G FG Y + TG + K+ Q + E +E ++ L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQV-QFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 427 LLPLVAYYYRKEEKLLV--HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ 484
++ + EK L E++P S+ L + AL + K + + +G+
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-----KYTRQILEGMS 120
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-------YK 537
YL+ S + H IK +N+L + + L D+G + I +
Sbjct: 121 YLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 538 SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
SPE + +K DVWSLG ++E++T K P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 19/59 (32%), Positives = 25/59 (42%), Gaps = 1/59 (1%)
Query: 204 PLGSPCPTPSPSPSPG-PSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPP 261
P +P P+ +PG P+P+ P P P P P P P P P + P A P
Sbjct: 757 PAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPTPQPPPQAGPTSMQLMPRAAP 815
|
Length = 991 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 48/219 (21%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKR----FKQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+GSG +GS A TG + VK+ F+ + + R ++E +R L ++H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRE-LRLLKHMKHENVIGLL 82
Query: 432 AYYYRKEEKLLVHEFVPKRSLA----VNLHGH------------QALGQPSLDWPSRLKI 475
F P RSL V L H Q L + + +
Sbjct: 83 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----L 125
Query: 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA 535
+ + +GL+Y++ S H +K SN+ +NE E + D+GL + E +
Sbjct: 126 IYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
Query: 536 -YKSPE-FLQLGRITKKTDVWSLGVLILEIMTGK--FPA 570
Y++PE L + D+WS+G ++ E++TG+ FP
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 55/216 (25%), Positives = 84/216 (38%), Gaps = 42/216 (19%)
Query: 375 EILGSGCFGSSYKASL-STGAMMVVKRFK-----QMNNVGREEFQEHMRRLGRLRHPNLL 428
+LG G FG A L +G + VK K Q ++V ++ + L R HP L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLT 59
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQP-----SLDWPSRLKIV--KGVAK 481
L + + V EFV L ++ + + + + S L + KG+
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI-- 117
Query: 482 GLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA------ 535
+YR+L K NVLL+ LAD+G M +E
Sbjct: 118 ----IYRDL----------KLDNVLLDHEGHCKLADFG----MCKEGIFNGKTTSTFCGT 159
Query: 536 --YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y +PE LQ D W++GVL+ E++ G P
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 35/174 (20%), Positives = 54/174 (31%), Gaps = 17/174 (9%)
Query: 182 ISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPS------PESSPTPSPIPLPL 235
+S LR + + S + E++ PS P
Sbjct: 134 LSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEP 193
Query: 236 PNHPPNPIPSPS----HDPHASSHSPPAPPPG---NDSAGSGSSNSTLVIASATTVSVVA 288
P P SP P ++S S PAP PG D AG+ SS+S+ +S
Sbjct: 194 PPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPEN 253
Query: 289 IAAVVAAIFVIERKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTE 342
+ + + P P P+S+ +S RE S+
Sbjct: 254 ECPLPRPAPIT-LPTRIWEASGWNGPSSRPGPASS---SSSPRERSPSPSPSSP 303
|
Length = 1352 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 16/73 (21%), Positives = 22/73 (30%)
Query: 205 LGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPGN 264
+G P+ S P P P P P+ P + + PA
Sbjct: 200 IGDANAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPV 259
Query: 265 DSAGSGSSNSTLV 277
S SG + LV
Sbjct: 260 SSGDSGPYVTPLV 272
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 18/108 (16%)
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-----IA 535
+GL+Y++ S H +K SN+L+NE E + D+G+ ++ + +A
Sbjct: 118 RGLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 536 ---YKSPEFL-QLGRITKKTDVWSLGVLILEIMTGK---FP-ANFLQQ 575
Y++PE L L T D+WS+G + E M G+ FP N++ Q
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAE-MLGRRQLFPGKNYVHQ 220
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 376 ILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQE----HMRRLGRLRHPNLLPL 430
++G G +G K T ++ +K+FK ++ EE +E ++ L L+ N++ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-IVKGVAKGLQYLYRE 489
+ R+ + LV E+V K L + L P+ P +++ + + K + + ++
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLEL-LEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--IA---YKSPEFLQL 544
++ H IK N+L++ + L D+G +++ S +A Y+SPE L
Sbjct: 120 --DIV--HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 545 GRITKKTDVWSLGVLILEIMTGK--FPA 570
K D+WS+G ++ E+ G+ FP
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR----HPNLLP 429
E++G+G +G YK + TG + +K M+ G EE +E + + L+ H N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEE-EEIKQEINMLKKYSHHRNIAT 67
Query: 430 LVAYYYRK------EEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGL 483
+ +K ++ LV EF S+ +L + +W + I + + +GL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 484 QYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSP 539
+L++ H IK NVLL E+ E L D+G+ +++ + + +P
Sbjct: 125 SHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
Query: 540 EFLQLGRITK-----KTDVWSLGVLILEIMTGKFP 569
E + K+D+WSLG+ +E+ G P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 12/94 (12%)
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL------IPVMNQESAQEL 532
VA+G++YL S H + + NVL+ E +AD+GL I + + L
Sbjct: 149 VARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 204
Query: 533 MIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMT 565
+ + +PE L RI T ++DVWS GVL+ EI T
Sbjct: 205 PVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 60/234 (25%), Positives = 95/234 (40%), Gaps = 62/234 (26%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFK-------QMNNVGREEFQEHMRRLGRLRHPNLL 428
+G G F KA S TG +K K Q+NN+ E Q +RRL HPN+L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQA-LRRLSP--HPNIL 61
Query: 429 PLVAYYYRKEEKLL----------VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG 478
L+ + ++ L ++E + R + L + +
Sbjct: 62 RLIEVLFDRKTGRLALVFELMDMNLYELIKGR--------KRPLPEKRVKS--------- 104
Query: 479 VAKGLQYLYRELPSLIAPHGH------IKSSNVLLN-ESLEPVLADYGLIPVMNQESAQE 531
Y+Y+ L SL H + IK N+L+ + L+ LAD+G + +
Sbjct: 105 ------YMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILK--LADFGSCRGIYSKPPYT 156
Query: 532 LMIA---YKSPE-FLQLGRITKKTDVWSLGVLILEIMTGK--FP-ANFLQQGKK 578
I+ Y++PE L G K D+W++G + EI++ FP N L Q K
Sbjct: 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 49/210 (23%), Positives = 83/210 (39%), Gaps = 31/210 (14%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHM---RRLGRLRHPNLLPL 430
++LG G FG ++G +K K+ + ++E + R L RHP L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VAKGLQYL--- 486
+ K+ V E+V L +L + + R + + L YL
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSE------DRTRFYGAEIVSALDYLHSG 114
Query: 487 ---YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSP 539
YR+L K N++L++ + D+GL ++A Y +P
Sbjct: 115 KIVYRDL----------KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAP 164
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
E L+ + D W LGV++ E+M G+ P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 377 LGSGCFGSSYKASLS-TGAMMVVKRFK-QMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
LG G +GS YK TG M +K + +++ + + L + P ++ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+ + + E++ SL G A + +I V KGL++L E ++I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATE--GIPEDVLRRITYAVVKGLKFLKEEH-NII 125
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--IAYKSPEFL------QLGR 546
H +K +NVL+N + + L D+G+ + A+ + +Y +PE + Q
Sbjct: 126 --HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPT 183
Query: 547 ITKKTDVWSLGVLILEIMTGKFP 569
T ++DVWSLG+ ILE+ G++P
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 15/104 (14%)
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMIA 535
+GL Y +R H +K N+L+NE E LAD+GL IP S + + +
Sbjct: 115 RGLNYCHRRK----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVVTLW 169
Query: 536 YKSPEFLQLGRITKKT--DVWSLGVLILEIMTGK--FPANFLQQ 575
Y+ P+ L LG T D+W +G + E+ TG+ FP + +++
Sbjct: 170 YRPPDIL-LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 7e-04
Identities = 31/144 (21%), Positives = 53/144 (36%), Gaps = 16/144 (11%)
Query: 181 SISPALREL-----DPSSFSGNRDLCGEPLGSPCPTPSP--SPSPGPSPESSPTPSPIPL 233
S+ P+ RE S+ + + P +P P+P +P
Sbjct: 24 SVDPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAP 83
Query: 234 PLPNHPPNPIPSPSHDPHASSHSPPAPPPGNDS-------AGSGSSN--STLVIASATTV 284
P P +P+ P A++ + PA D A + + N ++L + +AT+V
Sbjct: 84 PKPAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEVTPLRGAAAAVAKNMDASLEVPTATSV 143
Query: 285 SVVAIAAVVAAIFVIERKRKRERG 308
V ++ VI KR RG
Sbjct: 144 RAVPAKLLIDNRIVINNHLKRTRG 167
|
Length = 1228 |
| >gnl|CDD|113398 pfam04625, DEC-1_N, DEC-1 protein, N-terminal region | Back alignment and domain information |
|---|
Score = 42.1 bits (98), Expect = 8e-04
Identities = 9/34 (26%), Positives = 16/34 (47%)
Query: 206 GSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP 239
+P P P+P+P+ P +P P+P+
Sbjct: 106 AAPVPAPAPAPAAAPPAAPAPAADTPAAPIPDAV 139
|
The defective chorion-1 gene (dec-1) in Drosophila encodes follicle cell proteins necessary for proper eggshell assembly. Multiple products of the dec-1 gene are formed by alternative RNA splicing and proteolytic processing. Cleavage products include S80 (80 kDa) which is incorporated into the eggshell, and further proteolysis of S80 gives S60 (60 kDa). Length = 407 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 8e-04
Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 1/94 (1%)
Query: 202 GEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPP 261
+ P+ + + + P+P P P P+ + P + PAPP
Sbjct: 384 RLGVAGGAGAPAAAAPSAAAAAPAAAPAP-AAAAPAAAAAPAPAAAPQPAPAPAPAPAPP 442
Query: 262 PGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAA 295
+A +G + S A+ + A AA
Sbjct: 443 SPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEP 476
|
Length = 824 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 16/105 (15%)
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----- 535
+GL+Y++ S H +K SN+LLN + + + D+GL + + M
Sbjct: 119 RGLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--EKGDFMTEYVVTR 172
Query: 536 -YKSPE-FLQLGRITKKTDVWSLGVLILEIMTGK--FPA-NFLQQ 575
Y++PE L T DVWS+G + E++ K FP +++ Q
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ 217
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL------IPVMNQESAQEL 532
VA+G++YL S H + + NVL+ E +AD+GL I + + L
Sbjct: 143 VARGMEYL----ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL 198
Query: 533 MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+ + +PE L T ++DVWS GVL+ EI T
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 19/117 (16%), Positives = 43/117 (36%)
Query: 206 GSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPGND 265
+ +P+ P+ + P+ P+ P P +P+ A + P A PP
Sbjct: 367 AAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPV 426
Query: 266 SAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIERKRKRERGVSIENPPPLPPPSS 322
+A + ++ + A+ V++ AA + + ++ + P P +
Sbjct: 427 AAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAP 483
|
Length = 618 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRR-----LGRLRHPNLLP 429
+++G G FG A + + Q + +++ Q H+ L L+HP L+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 430 LVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L Y ++ EKL V ++V L +L + +P +R + VA + YL+
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR----ARFYAAE-VASAIGYLH- 113
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV-MNQESAQELMIA---YKSPEFLQL 544
SL + +K N+LL+ VL D+GL + E Y +PE L+
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK 170
Query: 545 GRITKKTDVWSLGVLILEIMTGKFP 569
+ D W LG ++ E++ G P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 34/149 (22%), Positives = 43/149 (28%), Gaps = 8/149 (5%)
Query: 180 GSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSP-----TPSPIPLP 234
G P+ R SS S R+ P S + SP S SS + S
Sbjct: 274 GWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSS 333
Query: 235 LPNHPPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVA 294
+ P PS S PP P S S + A + A
Sbjct: 334 ESSRGAAVSPGPSPSRSPSPSRPPPPADP-SSPRKRPRPSRAPSSPAASAGRPTRRRARA 392
Query: 295 AIFVIERKRKRERGVSIENPPPLPPPSSN 323
A V R R+R+ P P P
Sbjct: 393 A--VAGRARRRDATGRFPAGRPRPSPLDA 419
|
Length = 1352 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 25/86 (29%), Positives = 29/86 (33%), Gaps = 1/86 (1%)
Query: 203 EPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPP 262
E P P P P P P P P P P P P P P P P+ S + P P
Sbjct: 2906 ERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSG-AVPQPWL 2964
Query: 263 GNDSAGSGSSNSTLVIASATTVSVVA 288
G G + V A + A
Sbjct: 2965 GALVPGRVAVPRFRVPQPAPSREAPA 2990
|
Length = 3151 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 375 EILGSGCFGSSYK-ASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVA 432
E +G G +G YK + G++ VK +++V EE + L L HPN++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYG 86
Query: 433 YYYRKEEKL-----LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
+Y+ ++ + LV E S+ + G GQ LD I+ G GLQ+L+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYGALLGLQHLH 145
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL-------MIAYKSPE 540
+I H +K +N+LL L D+G V Q ++ L + +PE
Sbjct: 146 NN--RII--HRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 541 FLQLGR-----ITKKTDVWSLGVLILEIMTGKFP 569
+ + + DVWSLG+ +E+ G P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 13/201 (6%)
Query: 377 LGSGCFGSSYKAS-LSTGAMMVVKR---FKQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+G G F Y+A+ L G + +K+ F M+ R + + + L +L HPN++ A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+ E +V E L+ + H + + + K + L++++ S
Sbjct: 70 SFIEDNELNIVLELADAGDLS-RMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----S 124
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQLGRIT 548
H IK +NV + + L D GL + ++ + Y SPE +
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 549 KKTDVWSLGVLILEIMTGKFP 569
K+D+WSLG L+ E+ + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 16/107 (14%)
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIPVMNQESAQELMIA---- 535
+GL+Y++ S H +K +NV +N E L + D+GL +++ + + ++
Sbjct: 125 RGLKYIH----SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 536 ---YKSPEF-LQLGRITKKTDVWSLGVLILEIMTGK--FP-ANFLQQ 575
Y+SP L TK D+W+ G + E++TGK F A+ L+Q
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 374 AEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNN-------VGREEFQEHMRRLGRLRHP 425
AEI G G +G+ YKA +G + +K + N RE ++RL HP
Sbjct: 6 AEI-GVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE--VALLKRLEAFDHP 62
Query: 426 NLLPLV-----AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVA 480
N++ L+ + R+ + LV E V + L L + P L + +++
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQFL 118
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---YK 537
+GL +L+ H +K N+L+ + LAD+GL + + + A ++ Y+
Sbjct: 119 RGLDFLHANC----IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYR 174
Query: 538 SPEFLQLGRITKKTDVWSLGVLILEIMTGK 567
+PE L D+WS+G + E+ K
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|218658 pfam05616, Neisseria_TspB, Neisseria meningitidis TspB protein | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 19/55 (34%), Positives = 24/55 (43%)
Query: 212 PSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPGNDS 266
P P P SP +P +P P P PNP P P +P A+ + P DS
Sbjct: 327 PEAQPLPEVSPAENPANNPNPRENPGTRPNPEPDPDLNPDANPDTDGQPGTRPDS 381
|
This family consists of several Neisseria meningitidis TspB virulence factor proteins. Length = 502 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 15/136 (11%)
Query: 441 LLVHEFVPKRSLAVNLHGH--QALGQPSLDWPSRLKIVK---GVAKGLQYLYRELPSLIA 495
L+V E + K L L +A P L P+ K ++ +A G+ YL +
Sbjct: 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL----AAKKF 140
Query: 496 PHGHIKSSNVLLNESLEPVLADYGLIPVMNQ-----ESAQELM-IAYKSPEFLQLGRITK 549
H + + N ++ E L + D+G+ + + + + L+ + + +PE L+ G T
Sbjct: 141 VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT 200
Query: 550 KTDVWSLGVLILEIMT 565
K+DVWS GV++ E+ T
Sbjct: 201 KSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 41/183 (22%), Positives = 83/183 (45%), Gaps = 14/183 (7%)
Query: 391 STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450
STG + VK+ RE + + +HPN++ + + Y +E +V EF+
Sbjct: 42 STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101
Query: 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES 510
+L + ++ + V K L +L+ + +I H IKS ++LL
Sbjct: 102 ALT------DIVTHTRMNEEQIATVCLAVLKALSFLHAQ--GVI--HRDIKSDSILLTSD 151
Query: 511 LEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQLGRITKKTDVWSLGVLILEIMTG 566
L+D+G +++E + + + +PE + + D+WSLG++++E++ G
Sbjct: 152 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
Query: 567 KFP 569
+ P
Sbjct: 212 EPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 17/103 (16%)
Query: 484 QY-LYRELPSLIAPHG----H--IKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA- 535
QY LY+ L L H H +K SN+LLN + + + D+GL + + E +
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 536 ------YKSPE-FLQLGRITKKTDVWSLGVLILEIMTGK--FP 569
Y++PE L TK D+WS+G ++ E+++ + FP
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 34/151 (22%), Positives = 72/151 (47%), Gaps = 14/151 (9%)
Query: 423 RHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG 482
+H N++ + Y EE ++ EF+ +L + Q L+ + + V +
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQA 129
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKS 538
L YL+ + +I H IKS ++LL L+D+G ++++ + + + +
Sbjct: 130 LCYLHSQ--GVI--HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
PE + + D+WSLG++++E++ G+ P
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 31/175 (17%), Positives = 50/175 (28%), Gaps = 16/175 (9%)
Query: 180 GSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP 239
SPA L + + R G P +P P P+ +P+ P P P+
Sbjct: 424 ARRSPAPEALAAARQASARGPGGAP--APAPAPAAAPAAAARP---AAAGPRPVAAAAAA 478
Query: 240 PNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVI 299
+P+ P + PPP + +S + +A V A
Sbjct: 479 APARAAPAAAPAP---ADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPAT---- 531
Query: 300 ERKRKRERGVSIENPP--PLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEI 352
P P P ++ + R S S + G P +
Sbjct: 532 -ADPDDAFETLAPAPAAAPAPRAAAATEPVVAPRPPRA-SASGLPDMFDGDWPAL 584
|
Length = 700 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 23/78 (29%), Positives = 30/78 (38%), Gaps = 7/78 (8%)
Query: 204 PLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPP-- 261
P + P P S PTP+P P+P PP P PS +P S P PP
Sbjct: 394 PFARGPGGDDQTRPAAPVPASVPTPAPTPVPASAPPPPATPLPSAEP-GSDDGPAPPPER 452
Query: 262 ----PGNDSAGSGSSNST 275
P + A ++T
Sbjct: 453 QPPAPATEPAPDDPDDAT 470
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 20/65 (30%), Positives = 29/65 (44%)
Query: 204 PLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPG 263
P G+ +PSP P +P + P P+P P P P P P + P A+ +P AP
Sbjct: 444 PAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAP 503
Query: 264 NDSAG 268
+
Sbjct: 504 AGADD 508
|
Length = 824 |
| >gnl|CDD|218658 pfam05616, Neisseria_TspB, Neisseria meningitidis TspB protein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 16/53 (30%), Positives = 24/53 (45%)
Query: 208 PCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAP 260
P +P+ +P+ P+P +P P P P P+ P+ P P SP P
Sbjct: 333 PEVSPAENPANNPNPRENPGTRPNPEPDPDLNPDANPDTDGQPGTRPDSPAVP 385
|
This family consists of several Neisseria meningitidis TspB virulence factor proteins. Length = 502 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 22/92 (23%), Positives = 28/92 (30%), Gaps = 15/92 (16%)
Query: 204 PLGSPCPTPS-----PSPSPGPSPESSPTPSP-------IPLPLPNHPPNPIPSPSHDPH 251
P PT P P P +P IPLP HPP+ +PS
Sbjct: 356 SSQLPPPTKRRLRLLPVPPPKVQALPLTALAPLVRHSPSIPLP---HPPSALPSHVGASS 412
Query: 252 ASSHSPPAPPPGNDSAGSGSSNSTLVIASATT 283
+ H P S S + +L T
Sbjct: 413 SKHHRLPPSVLPGPRLSSPSPSPSLPTRRPGT 444
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|182059 PRK09752, PRK09752, adhesin; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 16/40 (40%), Positives = 22/40 (55%), Gaps = 6/40 (15%)
Query: 211 TPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDP 250
TP P P P+P+ PTP P P P+P P+P++ P
Sbjct: 919 TPPSPPDPDPTPDPDPTPDPDP------TPDPEPTPAYQP 952
|
Length = 1250 |
| >gnl|CDD|218232 pfam04731, Caudal_act, Caudal like protein activation region | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 16/71 (22%), Positives = 20/71 (28%), Gaps = 10/71 (14%)
Query: 204 PLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPN----HPPNPIPSPSHDPHASSHSP-- 257
G + + SPG S P SP+ P P P + P A SP
Sbjct: 63 GPGPGPSATAATGSPGQMAYSPPDYSPVHPPGPGPGLLQPADSGSVEQLSPSAQRRSPYE 122
Query: 258 ----PAPPPGN 264
P
Sbjct: 123 WMRKTVQPTST 133
|
This family consists of the amino termini of proteins belonging to the caudal-related homeobox protein family. This region is thought to mediate transcription activation. The level of activation caused by mouse Cdx2 is affected by phosphorylation at serine 60 via the mitogen-activated protein kinase pathway. Caudal family proteins are involved in the transcriptional regulation of multiple genes expressed in the intestinal epithelium, and are important in differentiation and maintenance of the intestinal epithelial lining. Caudal proteins always have a homeobox DNA binding domain (pfam00046). Length = 135 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 10/83 (12%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-----YKSPEFLQL-----GR 546
H IK N+L++ + LAD+G + ++ + +A Y SPE LQ G+
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184
Query: 547 ITKKTDVWSLGVLILEIMTGKFP 569
+ D WSLGV + E++ G+ P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 25/206 (12%)
Query: 376 ILGSGCFG-----SSYKASLSTGAMMV-VKRFKQMNNVGREEFQEHMRRLGRL----RHP 425
LG+G FG ++Y S S M V VK K + E + M L + H
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHE 99
Query: 426 NLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
N++ L+ L++ E+ L L + + L L VAKG+ +
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAF 156
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI-PVMNQES-----AQELMIAYKSP 539
L S H + + NVLL + D+GL +MN + L + + +P
Sbjct: 157 L----ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMT 565
E + T ++DVWS G+L+ EI +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 20/180 (11%)
Query: 410 EEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDW 469
E F E + +L H +L+ +E ++V E+V SL L ++ L S W
Sbjct: 44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS--W 101
Query: 470 PSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL-----NESLEP---VLADYGL- 520
+L++ K +A L +L E L HG++ + NVLL ++ P L+D G+
Sbjct: 102 --KLEVAKQLAWALHFL--EDKGL--THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
Query: 521 IPVMNQESAQELMIAYKSPEFLQLGR-ITKKTDVWSLGVLILEIMTG-KFPANFLQQGKK 578
I V+ +E E I + PE ++ + ++ D WS G + EI +G P + L KK
Sbjct: 156 ITVLPKEILLE-RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 21/113 (18%), Positives = 32/113 (28%), Gaps = 19/113 (16%)
Query: 198 RDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSP 257
P+PS + S T P PP +P
Sbjct: 263 LTWADAAAQPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPP--------------PNP 308
Query: 258 PAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIERKRKRERGVS 310
PA PP + S A V V+A AA V + + + ++ +
Sbjct: 309 PATPPEPPARRGRGSA-----ALWFVVVVLACAAAVGGYALNRKVDRLDQELV 356
|
Length = 656 |
| >gnl|CDD|220309 pfam09606, Med15, ARC105 or Med15 subunit of Mediator complex non-fungal | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 21/81 (25%), Positives = 26/81 (32%), Gaps = 11/81 (13%)
Query: 205 LGSPCPTPSPSPS----PGPSPESSPTPS-PIPLPLPNHPPNPIPSP-----SHDPHASS 254
+ SP P P + P P S P+P P P + IPSP S P S
Sbjct: 411 MSSPSPVPQVQTNQSMPQPPQP-SVPSPGGPGSQPPQSVSGGMIPSPPALMPSPSPQMSQ 469
Query: 255 HSPPAPPPGNDSAGSGSSNST 275
D G +T
Sbjct: 470 SPASQRTIQQDMVSPGGPLNT 490
|
The approx. 70 residue Med15 domain of the ARC-Mediator co-activator is a three-helix bundle with marked similarity to the KIX domain. The sterol regulatory element binding protein (SREBP) family of transcription activators use the ARC105 subunit to activate target genes in the regulation of cholesterol and fatty acid homeostasis. In addition, Med15 is a critical transducer of gene activation signals that control early metazoan development. Length = 768 |
| >gnl|CDD|182059 PRK09752, PRK09752, adhesin; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 25/71 (35%), Positives = 32/71 (45%), Gaps = 6/71 (8%)
Query: 175 NNALF---GSISPALRELDPSSFSGNRD--LCGEPLGSPCPTPSPSPSPGPSPESSPTPS 229
NNA F GS + D + N D L + + P P P P P+P P P P P+
Sbjct: 883 NNAQFSLAGSGYVNMGAYDYTLVEDNNDWYLRSQEVTPPSP-PDPDPTPDPDPTPDPDPT 941
Query: 230 PIPLPLPNHPP 240
P P P P + P
Sbjct: 942 PDPEPTPAYQP 952
|
Length = 1250 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 14/100 (14%)
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----- 535
+GL+YL+ S H IK N+L+N + + D+GL V + ++ M
Sbjct: 114 RGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVVTQ 168
Query: 536 -YKSPEFLQLGR-ITKKTDVWSLGVLILEIMTGK--FPAN 571
Y++PE L R T D+WS+G + E++ + F A
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 33/149 (22%), Positives = 66/149 (44%), Gaps = 12/149 (8%)
Query: 419 LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG 478
L + HP+++ + +V +P S +L+ + L L I K
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMV---LPHYS--SDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL--IPVMNQES-AQELMIA 535
+ +GL+YL+ + +I H +K+ N+ +N+ + + D G PV+ +
Sbjct: 166 ILEGLRYLHAQ--RII--HRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
+PE L + K D+WS G+++ E++
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 20/98 (20%)
Query: 482 GLQYL------YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV-MNQESAQELMI 534
GLQ+L YR+L K NVLL++ +AD+G+ MN E
Sbjct: 108 GLQFLHKKGIIYRDL----------KLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157
Query: 535 A---YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y +PE L+ + + D WS GVL+ E++ G+ P
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 25/205 (12%)
Query: 377 LGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR---LGRLRHPNLLPLVA 432
+G G FG + T + +K ++ + V R E + L ++ P ++PL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLD----WPSRLKIVKGVAKGLQYLYR 488
+ E+ LV F+ L H Q G+ L + + L +YR
Sbjct: 61 SFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV-MNQESAQELMIA---YKSPEFLQL 544
+L K N+LL+ L D+GL + M + Y +PE L
Sbjct: 118 DL----------KPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG 167
Query: 545 GRITKKTDVWSLGVLILEIMTGKFP 569
TK D W+LGVL+ E++TG P
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.003
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 62/221 (28%)
Query: 375 EILGSGCFGS----SYKASLSTGAMMVVK-----RFKQMNNVGREEFQEHMRRLGRLRHP 425
+ LG+G FG +K S A+ ++ + KQ+ +V E+ R L +RHP
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEK-----RILQSIRHP 61
Query: 426 NLLPLVAYYYRKEEKLL--VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGL 483
L+ L + +++ L V E+VP L + G+ +R + V L
Sbjct: 62 FLVNLYGSF--QDDSNLYLVMEYVPGGEL---FSHLRKSGRFPEPV-ARFYAAQ-VVLAL 114
Query: 484 QYL------YREL-PS--LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL-- 532
+YL YR+L P L+ G+IK + D+G A+ +
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIK-------------ITDFGF--------AKRVKG 153
Query: 533 ---MIA----YKSPEFLQLGRITKKTDVWSLGVLILEIMTG 566
+ Y +PE + K D W+LG+LI E++ G
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|235540 PRK05641, PRK05641, putative acetyl-CoA carboxylase biotin carboxyl carrier protein subunit; Validated | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 16/57 (28%), Positives = 23/57 (40%), Gaps = 9/57 (15%)
Query: 207 SPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPG 263
S P+P+P P+P P+P+ P P P+ A + AP PG
Sbjct: 46 SAVQEQVPTPAPAPAPAVPSAPTPVAPA----APAPAPAS-----AGENVVTAPMPG 93
|
Length = 153 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 26/82 (31%), Positives = 39/82 (47%), Gaps = 9/82 (10%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-----YKSPEFLQL----GRI 547
H +K N+LL++S LAD+G M+ A Y SPE L+ G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224
Query: 548 TKKTDVWSLGVLILEIMTGKFP 569
++ D WS+GV + E++ G P
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|149674 pfam08693, SKG6, Transmembrane alpha-helix domain | Back alignment and domain information |
|---|
Score = 35.4 bits (82), Expect = 0.003
Identities = 15/38 (39%), Positives = 20/38 (52%), Gaps = 1/38 (2%)
Query: 269 SGSSNSTLV-IASATTVSVVAIAAVVAAIFVIERKRKR 305
S S N T V IA + V IAAV+ A + +RK+
Sbjct: 3 SDSDNKTTVAIAVGVVIPVGVIAAVLLAFLFLWYRRKK 40
|
SKG6/Axl2 are membrane proteins that show polarised intracellular localisation. SKG6_Tmem is the highly conserved transmembrane alpha-helical domain of SKG6 and Axl2 proteins. The full-length fungal protein has a negative regulatory function in cytokinesis. Length = 40 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 14/68 (20%), Positives = 20/68 (29%), Gaps = 3/68 (4%)
Query: 202 GEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPP 261
G+ +P S P P P P P P+P A + +P A
Sbjct: 201 GDANAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAP---APAKTAAPAAAA 257
Query: 262 PGNDSAGS 269
P +
Sbjct: 258 PVSSGDSG 265
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.004
Identities = 19/63 (30%), Positives = 29/63 (46%)
Query: 207 SPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPGNDS 266
PSP P+ PS + +P P+ P P P P +P+ ++ + PA P G D
Sbjct: 449 PAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADD 508
Query: 267 AGS 269
A +
Sbjct: 509 AAT 511
|
Length = 824 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 20/205 (9%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHM---RRLGRLRHPNLLPL 430
++LG G FG +TG +K K+ V ++E + R L RHP L L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 431 VAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VAKGLQYLYR 488
Y ++ ++L V E+ L +L + + R + + L YL+
Sbjct: 61 -KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE------DRARFYGAEIVSALDYLHS 113
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQL 544
E + + +K N++L++ + D+GL ++ A Y +PE L+
Sbjct: 114 EKNVV---YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 170
Query: 545 GRITKKTDVWSLGVLILEIMTGKFP 569
+ D W LGV++ E+M G+ P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPL 430
E +G G +G+ +KA + T ++ +KR + ++ V +E + L L+H N++ L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE-ICLLKELKHKNIVRL 64
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ ++ LV E+ + +L + +D + + KGL + +
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-----DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMIAYKSPEFLQLG 545
H +K N+L+N++ E LAD+GL IPV SA+ + + Y+ P+ L G
Sbjct: 120 ----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVL-FG 173
Query: 546 RITKKT--DVWSLGVLILEIMTGK---FPAN 571
T D+WS G + E+ FP N
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGN 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 56/221 (25%)
Query: 376 ILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
I+G+G FG Y+A + T + +K+ Q E + + L H N++ L YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE----LLIMKNLNHINIIFLKDYY 128
Query: 435 Y----RKEEKLL----VHEFVPKRSLAVNLHG---HQALGQPSLDWPSRLKIVK----GV 479
Y +K EK + V EF+P+ +H H A +L L +VK +
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-----TVHKYMKHYARNNHALP----LFLVKLYSYQL 179
Query: 480 AKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPV-LADYGLIPVMNQESAQELMIA--- 535
+ L Y++ S H +K N+L++ + + L D+G SA+ L+
Sbjct: 180 CRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDFG--------SAKNLLAGQRS 227
Query: 536 --------YKSPEFLQLG--RITKKTDVWSLGVLILEIMTG 566
Y++PE L LG T D+WSLG +I E++ G
Sbjct: 228 VSYICSRFYRAPE-LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 45/193 (23%), Positives = 76/193 (39%), Gaps = 56/193 (29%)
Query: 422 LRHPNLL------------PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDW 469
L H N+L P V Y Y L F+ + L + QAL L
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNL--KLFLQQCRLG-EANNPQALSTQQL-- 119
Query: 470 PSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529
+ + +A G+ YL++ +I H I + N +++E L+ + D L +
Sbjct: 120 ---VHMAIQIACGMSYLHKR--GVI--HKDIAARNCVIDEELQVKITDNAL--------S 164
Query: 530 QELM--------------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP----- 569
++L + + + E L + +DVWS GVL+ E+MT G+ P
Sbjct: 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224
Query: 570 ----ANFLQQGKK 578
A +L+ G +
Sbjct: 225 PFEMAAYLKDGYR 237
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 30/214 (14%)
Query: 374 AEILGSGCFGSSYKA-SLSTGAMMVVKRF-----KQMNNVGREEFQEHMRRLGRLRHPNL 427
++LG G FG Y TG + VK+ Q + + ++ L LRH +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 428 LPLVAYYY----RKEEKLLVH-EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG 482
V YY +E+KL + E++P S+ L + AL + + + + +G
Sbjct: 67 ---VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-----RYTRQILQG 118
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA------- 535
+ YL+ S + H IK +N+L + + L D+G + I
Sbjct: 119 VSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ SPE + +K DVWS+ ++E++T K P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 26/78 (33%), Positives = 36/78 (46%), Gaps = 12/78 (15%)
Query: 500 IKSSNVLLNESLEPVLADYGLIPVMNQESAQEL--------MIAYKSPEFLQLGRITKKT 551
+K N+LL+ L D+GL +ES E I Y +PE L K
Sbjct: 126 LKPENILLDAQGHVKLTDFGLC----KESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAV 181
Query: 552 DVWSLGVLILEIMTGKFP 569
D WSLG L+ +++TG P
Sbjct: 182 DWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-YKSP 539
GL+Y++ +I H +K N+ +NE E + D+GL + E ++ Y++P
Sbjct: 128 CGLKYIHSA--GII--HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAP 183
Query: 540 E-FLQLGRITKKTDVWSLGVLILEIMTGK 567
E L + D+WS+G ++ E++TGK
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|177328 PHA01929, PHA01929, putative scaffolding protein | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 17/66 (25%), Positives = 26/66 (39%)
Query: 197 NRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHS 256
P +P P P+P P + +P L +P P P+P+ + PH +
Sbjct: 14 GLVANVPPAAAPTPQPNPVIQPQAPVQPGQPGAPQQLAIPTQQPQPVPTSAMTPHVVQQA 73
Query: 257 PPAPPP 262
P P P
Sbjct: 74 PAQPAP 79
|
Length = 306 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 30/210 (14%)
Query: 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHM--RRLGRL--RHPNLLP 429
++LG G FG A L G VK K+ + ++ + M +R+ L +P L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL--- 486
L + KE V EF+ L ++ Q G+ D + GLQ+L
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHI---QDKGR--FDLYRATFYAAEIVCGLQFLHSK 115
Query: 487 ---YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP--VMNQESAQEL--MIAYKSP 539
YR+L K NV+L+ +AD+G+ V A Y +P
Sbjct: 116 GIIYRDL----------KLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
E LQ + T D WS GVL+ E++ G+ P
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 31/122 (25%), Positives = 53/122 (43%), Gaps = 12/122 (9%)
Query: 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE 509
RSL + + PSL +++ +A G+ YL H + + N ++ E
Sbjct: 101 RSLRPEMENNPVQAPPSLK--KMIQMAGEIADGMAYLNANK----FVHRDLAARNCMVAE 154
Query: 510 SLEPVLADYGLIPVMNQESAQE------LMIAYKSPEFLQLGRITKKTDVWSLGVLILEI 563
+ D+G+ + + L + + SPE L+ G T +DVWS GV++ EI
Sbjct: 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
Query: 564 MT 565
T
Sbjct: 215 AT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.004
Identities = 26/84 (30%), Positives = 42/84 (50%), Gaps = 15/84 (17%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGL-------IPVMNQESAQELMIAYKSPEFLQLG--RI 547
H +K+SN+LLN + D+GL + Q + + Y++PE L LG
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV---VTLWYRAPELL-LGAKEY 184
Query: 548 TKKTDVWSLGVLILEIMTGK--FP 569
+ D+WS+G + E++T K FP
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFP 208
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 678 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.17 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.17 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.04 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.04 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.03 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.83 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.82 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.79 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.7 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.68 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.62 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.59 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.58 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.56 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.55 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.51 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.42 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.35 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.26 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.24 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.08 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.06 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.03 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.02 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.01 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.01 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.0 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.93 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.9 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.87 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-61 Score=577.67 Aligned_cols=519 Identities=24% Similarity=0.409 Sum_probs=341.2
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCccccee
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l 125 (678)
.+..|+|++|.+.|.++. .+..+++|+.|+|++|++.|.+|..... .+|+.|+|++|+++|.+|.. |.++++|+.|
T Consensus 429 ~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~n~~~~~~p~~~~~--~~L~~L~ls~n~l~~~~~~~-~~~l~~L~~L 504 (968)
T PLN00113 429 LVYFLDISNNNLQGRINS-RKWDMPSLQMLSLARNKFFGGLPDSFGS--KRLENLDLSRNQFSGAVPRK-LGSLSELMQL 504 (968)
T ss_pred CCCEEECcCCcccCccCh-hhccCCCCcEEECcCceeeeecCccccc--ccceEEECcCCccCCccChh-hhhhhccCEE
Confidence 567788888888887775 3667888888888888888888864433 56777777777777777755 6777777777
Q ss_pred eccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhcCC---CCCCCCCCCC
Q 044996 126 LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRELD---PSSFSGNRDL 200 (678)
Q Consensus 126 ~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~l~---~~~~~gn~~l 200 (678)
+|++|+++|.+|..+.++++|++|+|++|.++|.+|.. .+++|+.|+|++|+++|.+|..+..+. ...+.+|...
T Consensus 505 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~ 584 (968)
T PLN00113 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH 584 (968)
T ss_pred ECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcce
Confidence 77777777777777777777777777777777777763 456777777777777777777655433 3345555433
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCceeeee
Q 044996 201 CGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIAS 280 (678)
Q Consensus 201 c~~~~~~~c~~~~~~~~~~~~~~ss~~~s~~~~~~p~~~~~~~p~p~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~i~~ 280 (678)
+.-|....- ..-..++....+.-+ .+.+.. ..++. . .. .+...+.+++
T Consensus 585 ~~~p~~~~~---------~~~~~~~~~~n~~lc---------~~~~~~------~~~~c---~----~~-~~~~~~~~~~ 632 (968)
T PLN00113 585 GSLPSTGAF---------LAINASAVAGNIDLC---------GGDTTS------GLPPC---K----RV-RKTPSWWFYI 632 (968)
T ss_pred eeCCCcchh---------cccChhhhcCCcccc---------CCcccc------CCCCC---c----cc-cccceeeeeh
Confidence 211100000 000000000000000 000000 00000 0 00 0111122222
Q ss_pred hHHHHHHHHHHHHHhheeeeeccccccCCCCCCCCCCCCCCCccccccCccCcCCCCCCCcccccCCCCCceeeeeec-C
Q 044996 281 ATTVSVVAIAAVVAAIFVIERKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVR-D 359 (678)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~r~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 359 (678)
++++++++++++++++++++|+|++......+.. .+ . ....++. .
T Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~-----~----------------~~~~~~~~~ 678 (968)
T PLN00113 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENE-------------DG-----T----------------WELQFFDSK 678 (968)
T ss_pred hHHHHHHHHHHHHHHHHHHHHhhhcccccccccc-------------cc-----c----------------ccccccccc
Confidence 2222222222222222232232221111000000 00 0 0000000 0
Q ss_pred cccccchHHHHHHh--ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe
Q 044996 360 DVERFDLHDLLRAS--AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436 (678)
Q Consensus 360 ~~~~~~~~~~~~~~--~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 436 (678)
....+++.++.... .++||+|+||.||+|.. .++..||||+++..... ...|++.+++++|||||+++|+|.+
T Consensus 679 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 679 VSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred cchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence 01223444443332 45799999999999986 57889999998754322 2346889999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEe
Q 044996 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLA 516 (678)
Q Consensus 437 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 516 (678)
.+..|+|||||++|+|.++++ .++|.++.+|+.|||+||+|||+.+ +.+|+||||||+||+++.++.+++.
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~~~~~~~~~~ 825 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLR 825 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCC-CCCeecCCCCHHhEEECCCCceEEE
Confidence 999999999999999999995 3899999999999999999999664 3479999999999999999998876
Q ss_pred ecCCccccCccccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 517 DYGLIPVMNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 517 DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
||............++..|||||++.+..++.|+|||||||++|||+||+.||+.. ......+.+|++.......
T Consensus 826 -~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~- 900 (968)
T PLN00113 826 -LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE---FGVHGSIVEWARYCYSDCH- 900 (968)
T ss_pred -eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc---cCCCCcHHHHHHHhcCccc-
Confidence 77665544444445678999999999999999999999999999999999998632 2234578889876654433
Q ss_pred cccccchhhhcc-cCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 597 RTEVFDKEMADE-RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 597 ~~~~~d~~l~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
....+|+.+... ....+++.++.+++.+||+.||++||||+||++.|+++.....+
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence 335667666432 23456778899999999999999999999999999998775543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-56 Score=466.42 Aligned_cols=283 Identities=34% Similarity=0.631 Sum_probs=245.3
Q ss_pred cccccchHHHHHHh-----ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEE
Q 044996 360 DVERFDLHDLLRAS-----AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434 (678)
Q Consensus 360 ~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~ 434 (678)
....|++.++..|+ .++||+|+||.||+|.+.++..||||++........++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 35578999999987 3689999999999999999999999988765433145699999999999999999999999
Q ss_pred EeCC-ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCce
Q 044996 435 YRKE-EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEP 513 (678)
Q Consensus 435 ~~~~-~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~ 513 (678)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.+ .|||||||++|||||+++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~-~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPP-PIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCC-CEecCCCCHHHeeECCCCCE
Confidence 9988 499999999999999999976532 689999999999999999999998755 59999999999999999999
Q ss_pred EEeecCCccccCc-cccc----cccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHH
Q 044996 514 VLADYGLIPVMNQ-ESAQ----ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVN 588 (678)
Q Consensus 514 kl~DfGla~~~~~-~~~~----~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~ 588 (678)
||+|||+|+.... .... .+|.+|+|||++..+..|+|+|||||||+|+||+||+.|.+... ......+++|+.
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAK 294 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHH
Confidence 9999999977654 3221 68899999999999999999999999999999999998887432 123456999999
Q ss_pred HHHhcCCccccccchhhhcccCC-HHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 589 SVLANGDNRTEVFDKEMADERNS-EGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~-~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
..+.++ ...+++|+.+....+. .+++.++.++|++|++.+|.+||+|.||+++|+.+...
T Consensus 295 ~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999888 4459999999743344 36899999999999999999999999999999776654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=404.53 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=207.4
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC-ceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE-EKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||+|.++....||||++.... ....++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 45699999999999999765569999998643 222669999999999999999999999999877 799999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCC-CcccCCCCCCEEecCCC-ceEEeecCCccccCcc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI-APHGHIKSSNVLLNESL-EPVLADYGLIPVMNQE- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~- 527 (678)
+|.++++... ...++|..+++|+.|||+||.|||++ + |||||||++|||++.++ ++||+|||+++.....
T Consensus 126 sL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 126 SLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred cHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999998741 23699999999999999999999976 5 99999999999999997 9999999999876532
Q ss_pred ---ccccccceeeCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 528 ---SAQELMIAYKSPEFLQ--LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~--~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
....||..|||||++. ...|+.|+|||||||+||||+||+.||... ...+-+......+... .+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~--------~~~~~~~~v~~~~~Rp-~~-- 267 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL--------APVQVASAVVVGGLRP-PI-- 267 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhcCCCC-CC--
Confidence 2246789999999999 568999999999999999999999999732 2222222233222211 11
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
+..+...+..++.+||+.||..||++.|++..|+.+......
T Consensus 268 --------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 268 --------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred --------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 112445677788899999999999999999999988665444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=399.71 Aligned_cols=251 Identities=26% Similarity=0.443 Sum_probs=212.3
Q ss_pred HhccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 372 ASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 372 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
...+.||+|.||.||.|.+.....|++|.++.. ....++|.+|+++|++|+|+|||+++|+|..++.+|||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 346779999999999999988889999999875 3455789999999999999999999999999889999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.++|+.... ..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+||...++.
T Consensus 288 Ll~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 288 LLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred HHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999987322 3688999999999999999999966 79999999999999999999999999999655432
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++.|.|||.+..++++.|||||||||+||||+| |+.||.. ....+-+ ..+..|-.+
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--------msn~ev~-~~le~GyRl-------- 423 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--------MSNEEVL-ELLERGYRL-------- 423 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC--------CCHHHHH-HHHhccCcC--------
Confidence 2234688999999999999999999999999999999 9999862 3333333 333333222
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
..+..++..+.+++..||+.+|++|||++.+...|+++....
T Consensus 424 ---p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 424 ---PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ---CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 123346778999999999999999999999999999886543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=415.66 Aligned_cols=264 Identities=25% Similarity=0.408 Sum_probs=217.9
Q ss_pred ccchHHHHHHhccccCccCceeEEEEEec------CCceEEEEEecccChh-hHHHHHHHHHHHhccCCCCccceeEEEE
Q 044996 363 RFDLHDLLRASAEILGSGCFGSSYKASLS------TGAMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLVAYYY 435 (678)
Q Consensus 363 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~ 435 (678)
+|+..++. ..+.||+|+||+||+|+.. +...||||.++..... .+.+|++|+++|..++|||||+|+|+|.
T Consensus 482 ~i~r~~i~--~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIV--FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred Eechhhee--ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 34444443 2467999999999999752 3568999999976655 7899999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHhhccCCCC---------CCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEE
Q 044996 436 RKEEKLLVHEFVPKRSLAVNLHGHQALG---------QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVL 506 (678)
Q Consensus 436 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NIL 506 (678)
.++..|||+|||..|||.+||+.+.... .++|+-.+.+.||.|||.||+||-++ .+|||||..+|+|
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNCL 635 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNCL 635 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhce
Confidence 9999999999999999999998643211 33589999999999999999999866 6999999999999
Q ss_pred ecCCCceEEeecCCccccCcc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCC
Q 044996 507 LNESLEPVLADYGLIPVMNQE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKA 579 (678)
Q Consensus 507 l~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~ 579 (678)
|.++..+||+|||++|.+-.. .....+++||+||.+..++||++||||||||||||++| |+.||....
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS----- 710 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS----- 710 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-----
Confidence 999999999999999754322 22334689999999999999999999999999999999 999987322
Q ss_pred CCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 580 DGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 580 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
.+-|-..+..+..+ ..++.++.++..|++.||+.+|++||+++||-..|+......+-
T Consensus 711 ----n~EVIe~i~~g~lL-----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 711 ----NQEVIECIRAGQLL-----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred ----hHHHHHHHHcCCcc-----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 22233333443222 23456788999999999999999999999999999988776554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=369.19 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=214.0
Q ss_pred ccchHHHHHHhccccCccCceeEEEEEec-CCceEEEEEecc-cChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC-c
Q 044996 363 RFDLHDLLRASAEILGSGCFGSSYKASLS-TGAMMVVKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE-E 439 (678)
Q Consensus 363 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~ 439 (678)
.++.+|+.. .+.||+|..|+|||++++ ++..+|+|.+.. .+...++++.+|++++++++||+||++||.|+..+ .
T Consensus 75 ~i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 455666643 467999999999999875 678899999854 34566788999999999999999999999999998 4
Q ss_pred eEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecC
Q 044996 440 KLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519 (678)
Q Consensus 440 ~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 519 (678)
..++||||.+|||++++...+ .+++...-+|+.+|++||.|||+. .+||||||||+|||++..|++||||||
T Consensus 153 isI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~---~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEE---RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhc---cCeeeccCCHHHeeeccCCCEEecccc
Confidence 999999999999999998653 488899999999999999999974 279999999999999999999999999
Q ss_pred CccccCcc--ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 520 LIPVMNQE--SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 520 la~~~~~~--~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
.++.+... ....||..|||||.+.+..|+.++||||||++++|+.+|+.||-.. .....++.+.+..+..+..
T Consensus 225 VS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~pp-- 299 (364)
T KOG0581|consen 225 VSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEPP-- 299 (364)
T ss_pred ccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCCC--
Confidence 99887655 3456889999999999999999999999999999999999998732 1112344444444443221
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhccCCC
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKERDGD 652 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~~~~~ 652 (678)
|.+... ....++..++..|++.||.+||+++|+++ .+++....+-+
T Consensus 300 -----P~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd 347 (364)
T KOG0581|consen 300 -----PRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD 347 (364)
T ss_pred -----CCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence 222221 13445777888999999999999999988 35554443333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=359.01 Aligned_cols=188 Identities=24% Similarity=0.386 Sum_probs=170.9
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.||+|+||+||+|+++ ++..||||.+... .....+-+..|+.+|+.++|||||+++++++.++..|||||||.+||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 34999999999999874 5789999999765 56667788999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC------CceEEeecCCccccC
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES------LEPVLADYGLIPVMN 525 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~------~~~kl~DfGla~~~~ 525 (678)
|.+||+.++ .+++.....++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|+.+.
T Consensus 96 Ls~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 96 LSDYIRRRG-----RLPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999999875 489999999999999999999977 79999999999999864 468999999999998
Q ss_pred cccc---ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 526 QESA---QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 526 ~~~~---~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.... -.|++-|||||++...+|+.|+|+||.|+||||+++|+.||+
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 6633 346788999999999999999999999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=388.59 Aligned_cols=251 Identities=21% Similarity=0.412 Sum_probs=213.0
Q ss_pred hccccCccCceeEEEEEec----CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 373 SAEILGSGCFGSSYKASLS----TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
+.++||.|.||.||+|+++ ....||||.++.. .+..+.+|+.|+.||.+++||||++|.|+.......+||+|||
T Consensus 633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 4688999999999999874 3468999999964 4567789999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
+||+|+.||+.+.. .+++.+...++++||.||.||-+. ++|||||.++|||++.+..+||+|||++|.++++
T Consensus 713 ENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhc----CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999998753 599999999999999999999854 8999999999999999999999999999988665
Q ss_pred ccc-------cccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 528 SAQ-------ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 528 ~~~-------~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
... ..+++|.|||.+..+++|.+||||||||||||.++ |..||=++. .+-|-+.++++-.+
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---------NQdVIkaIe~gyRL-- 853 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---------NQDVIKAIEQGYRL-- 853 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---------hHHHHHHHHhccCC--
Confidence 421 23578999999999999999999999999999998 999985322 12222333332111
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
+.+-+++..+.+|++.||++|-.+||.+.+++..|+++.....
T Consensus 854 ---------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 854 ---------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ---------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 1234677889999999999999999999999999999865433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.59 Aligned_cols=239 Identities=22% Similarity=0.344 Sum_probs=201.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecc---cChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQ---MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+|+.||.++. .+|+.||+|++.+ .+...++...+||++.++|+|||||+++++|++.++.|||+|+|++
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~ 102 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR 102 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence 46799999999999987 8899999999975 2456678899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.++++.++ ++++.++..+++||+.||.|||+. +|+|||||..|++|++++++||+|||||..+....
T Consensus 103 ~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 103 GSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred ccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999998543 699999999999999999999976 89999999999999999999999999998887442
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
.-.||+.|+|||++....++..+||||+|||||-|++|+.||+. ..+.+-...+....-.+
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet--------k~vkety~~Ik~~~Y~~-------- 237 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET--------KTVKETYNKIKLNEYSM-------- 237 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc--------chHHHHHHHHHhcCccc--------
Confidence 33478899999999988999999999999999999999999971 22333332222221111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+........+++.++|+.||.+|||+++|+..
T Consensus 238 -----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 -----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222345667779999999999999999873
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=395.18 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=213.5
Q ss_pred hccccCccCceeEEEEEecC--C----ceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASLST--G----AMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
..+.||+|+||.||+|.+.+ + ..||||.++.. +.....+|.+|..+|++++|||||+++|+|.+....+|++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 35689999999999997643 3 34899999875 45667899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccCC--CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 446 FVPKRSLAVNLHGHQA--LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
||++|||..||++.+. .+...|+..+.+.++.|||+|+.||++. ++|||||.++|+||++...+||+|||+|+.
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 9999999999987632 1234689999999999999999999976 799999999999999999999999999994
Q ss_pred cCcc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 524 MNQE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 524 ~~~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
+... .....++.|||||.+..+.+|.|+|||||||+|||++| |..||.... -.+-+...+..++
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--------n~~v~~~~~~ggR- 922 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--------NFEVLLDVLEGGR- 922 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--------hHHHHHHHHhCCc-
Confidence 3222 11234588999999999999999999999999999999 999986221 1122222333331
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCcccc
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFYS 657 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~~~~ 657 (678)
| ..+..+...+.+++..||+.+|++||++..+++++..+........+..
T Consensus 923 --------L---~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~ 972 (1025)
T KOG1095|consen 923 --------L---DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGP 972 (1025)
T ss_pred --------c---CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccc
Confidence 1 1234567789999999999999999999999999998877665554433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=338.76 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=204.6
Q ss_pred hccccCccCceeEEEEE-ecCCceEEEEEecc--cChhhHHHHHHHHHHHhccCCCCccceeE-EEEeCCc-eEEEEecc
Q 044996 373 SAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQ--MNNVGREEFQEHMRRLGRLRHPNLLPLVA-YYYRKEE-KLLVHEFV 447 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~lv~Ey~ 447 (678)
+.++||+|.||.|||+. ..+|..+|.|.++- .+...+++...|+.+|++|+|||||++++ -+.++.+ ++||||||
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence 45779999999999995 57899999998873 45566788999999999999999999998 4444555 88999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
..|+|...++..+.. ...+++..+++++.|+++||..+|...+...|+||||||.||+|+.+|.+||+|||+++.+...
T Consensus 103 ~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~ 181 (375)
T KOG0591|consen 103 DAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK 181 (375)
T ss_pred cccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence 999999999765442 3369999999999999999999998544334899999999999999999999999999988765
Q ss_pred ----ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 528 ----SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 528 ----~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
....||+.||+||.+....|+.||||||+||++|||+.-+.||. +.++-+..+.+-+. +. +
T Consensus 182 ~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~--------g~n~~~L~~KI~qg-d~------~ 246 (375)
T KOG0591|consen 182 TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY--------GDNLLSLCKKIEQG-DY------P 246 (375)
T ss_pred hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc--------cccHHHHHHHHHcC-CC------C
Confidence 34468999999999999999999999999999999999999997 23444444333322 11 1
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
.+ .++.....+.+|+..|+..||+.||+.-..+..+..
T Consensus 247 ~~----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 PL----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CC----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 113456678889999999999999986555554443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=359.81 Aligned_cols=254 Identities=21% Similarity=0.353 Sum_probs=208.0
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccCh-hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.++||+|.||.|..+....+..||||+++.... ..+.+|.+|+++|.+|+|||||+++|+|..++.+++|+|||++|+
T Consensus 542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 4688999999999999998889999999997544 456899999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|..|+..+... .+.-..-++|+.|||.||+||.+ .++|||||.++|||+|.++++||+|||+++.+-...
T Consensus 622 LnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes----~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 622 LNQFLSAHELP---TAETAPGVSICTQIASGMAYLES----LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHh----hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999887542 24555667899999999999984 489999999999999999999999999998543322
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh--CCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT--GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t--g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
....+++|||+|.+.-+++|+++|||+|||+|||+++ ...||+...+ ..+++-...++...... ++=
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~~~~~~~~--~~l- 766 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEFFRDQGRQ--VVL- 766 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhhcCCCCcc--eec-
Confidence 2234689999999999999999999999999999987 8899985432 23333333333322211 110
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
..+..+...+.+++++||..|-++||+++++...|.+.
T Consensus 767 -----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 -----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11234567789999999999999999999999988764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=351.36 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=193.1
Q ss_pred hccccCccCceeEEEEE-ecCCceEEEEEecccCh-------hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEE
Q 044996 373 SAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNN-------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 444 (678)
+.+.||+|+||.|-+|. .++|+.||||.+.+... ......++|+++|++|+|||||+++++|...+..||||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 35679999999999995 56899999999975321 12334679999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC---CceEEeecCCc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES---LEPVLADYGLI 521 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla 521 (678)
|||++|+|.+.+-.+. .+.+..-..+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+|
T Consensus 256 E~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999998765 366667788999999999999976 89999999999999765 88999999999
Q ss_pred cccCcc---ccccccceeeCccccccCCC---CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC
Q 044996 522 PVMNQE---SAQELMIAYKSPEFLQLGRI---TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD 595 (678)
Q Consensus 522 ~~~~~~---~~~~~~~~y~aPE~~~~~~~---t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 595 (678)
+..... ....||+.|.|||++.+..+ ..|+|+||+|||||-+++|..||+... ....+.+ + +..+.
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~----~~~sl~e---Q-I~~G~ 398 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY----TDPSLKE---Q-ILKGR 398 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc----CCccHHH---H-HhcCc
Confidence 988644 23457899999999976543 458899999999999999999998321 1111111 1 11111
Q ss_pred ccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 596 NRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. .+-|. ...+...+.+.++.++|..||++|||+.|+++
T Consensus 399 y---~f~p~-----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 399 Y---AFGPL-----QWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred c---cccCh-----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1 11111 12234556777888999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=357.31 Aligned_cols=252 Identities=22% Similarity=0.371 Sum_probs=203.1
Q ss_pred HhccccCccCceeEEEEEecCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 372 ASAEILGSGCFGSSYKASLSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 372 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
...+.||+|.||+||+|+|. ..||||+++.. +....+.|++|+..+++-||.||+-+.|||..+.. .||+.+|++
T Consensus 395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 35788999999999999984 35899999854 34567889999999999999999999999998776 999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
-+|+.+||..+. .++..+...||+|||+||.|||.+ +|||||||+.||++.+++++||+|||++......
T Consensus 472 sSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 472 SSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred chhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999997653 699999999999999999999977 8999999999999999999999999998654322
Q ss_pred ----ccccccceeeCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 ----SAQELMIAYKSPEFLQL---GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ----~~~~~~~~y~aPE~~~~---~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
....+.+.|||||+++. .+|+..+||||||||+|||+||..||. .... +-.-| ..++.. -.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~-----dqIif-----mVGrG~-l~ 611 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNR-----DQIIF-----MVGRGY-LM 611 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCCh-----hheEE-----Eecccc-cC
Confidence 22345688999999864 578999999999999999999999997 2111 00011 111111 01
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.|.. . ....+.+++.+|+..||..++++||.+.+|+..|+++....
T Consensus 612 pd~s--~--~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 612 PDLS--K--IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ccch--h--hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 1111 1 11245667888888999999999999999999999887754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=366.66 Aligned_cols=254 Identities=27% Similarity=0.375 Sum_probs=208.5
Q ss_pred ccccCccCceeEEEEEecCC----ce-EEEEEecc---cChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLSTG----AM-MVVKRFKQ---MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~----~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
.++||+|+||.||+|++... .. ||||..+. .......+|.+|+++|++++|||||++||++......|+|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 47899999999999987532 23 89998884 446677899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
+|.+|+|.++|+.... .++..++++++.++|.||+|||.. +++||||.++|||++.++.+||+|||+++.-.
T Consensus 242 l~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred ecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999987653 599999999999999999999976 79999999999999999999999999987654
Q ss_pred ccc----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 526 QES----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 526 ~~~----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
... ....++.|+|||.+..+.|+.++|||||||++||+++ |..||.. ....+-...+...+... .
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g--------~~~~~v~~kI~~~~~r~-~- 383 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG--------MKNYEVKAKIVKNGYRM-P- 383 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC--------CCHHHHHHHHHhcCccC-C-
Confidence 221 2245689999999999999999999999999999999 8889872 22222222232222111 0
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCc
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDED 654 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 654 (678)
.+...+..+..++.+||..+|++||+|.+|.+.|+.+.......+
T Consensus 384 ---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~~ 428 (474)
T KOG0194|consen 384 ---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAFD 428 (474)
T ss_pred ---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccccc
Confidence 011234456666779999999999999999999999988777643
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=359.50 Aligned_cols=250 Identities=20% Similarity=0.362 Sum_probs=201.4
Q ss_pred cccchHHHHHHhccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceE
Q 044996 362 ERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKL 441 (678)
Q Consensus 362 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 441 (678)
.++-|+++.+ .+-||+|+.|.||+|+++ ++.||||+++..++ .+|+-|++|+|+||+.|.|+|.....+|
T Consensus 119 WeiPFe~IsE--LeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 119 WEIPFEEISE--LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred ccCCHHHhhh--hhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeE
Confidence 3444555432 356999999999999985 56799998876433 4577899999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCc
Q 044996 442 LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521 (678)
Q Consensus 442 lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 521 (678)
||||||..|-|..+|+..+ .++-...+.+..+||.||.|||.+ .|||||||+-||||..+..+||+|||.+
T Consensus 189 IiMEfCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred EeeeccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999998764 477777889999999999999987 6999999999999999999999999999
Q ss_pred cccCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 522 PVMNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 522 ~~~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
+...... ...+|+.|||||++.....++|+||||||||||||+||..||.+.+.. ..-| .-+.+..
T Consensus 260 ~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------AIIw-----GVGsNsL 328 (904)
T KOG4721|consen 260 KELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------AIIW-----GVGSNSL 328 (904)
T ss_pred HhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh------eeEE-----eccCCcc
Confidence 8776553 235789999999999999999999999999999999999999743221 0111 0011110
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
. ...+..++.-+.-++.+||+..|..||++++++..|+-...+
T Consensus 329 ~--------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 329 H--------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred c--------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 1 112334555566777799999999999999999999865443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=350.27 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=205.9
Q ss_pred ccccchHHHHHHhccccCccCceeEEEEEecCCceEEEEEecccChhh---HHHHHHHHHHHhccCCCCccceeEEEEe-
Q 044996 361 VERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVG---REEFQEHMRRLGRLRHPNLLPLVAYYYR- 436 (678)
Q Consensus 361 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~~~~~~- 436 (678)
.+.++..++.......||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|.+++|||||+++|++.+
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 334455555444446799999999999988 68899999987543222 4678899999999999999999999977
Q ss_pred ---CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCce
Q 044996 437 ---KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEP 513 (678)
Q Consensus 437 ---~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~ 513 (678)
....++||||+++|+|.++++... .++|...++++.+++.||.|||... +++||||||+|||+++++.+
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcE
Confidence 346889999999999999997643 5889999999999999999999742 57799999999999999999
Q ss_pred EEeecCCccccCcc-ccccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHH
Q 044996 514 VLADYGLIPVMNQE-SAQELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSV 590 (678)
Q Consensus 514 kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~ 590 (678)
||+|||+++..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.. ....++....
T Consensus 163 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~--------~~~~~~~~~i 234 (283)
T PHA02988 163 KIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN--------LTTKEIYDLI 234 (283)
T ss_pred EEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC--------CCHHHHHHHH
Confidence 99999998865433 23346788999999975 6899999999999999999999999972 2233333333
Q ss_pred HhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 591 LANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
...+... .+ +......+.+++.+||+.||++||||.|+++.|+...
T Consensus 235 ~~~~~~~------~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 235 INKNNSL------KL-----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HhcCCCC------CC-----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 3222111 01 1122345778888999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=356.06 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=197.6
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCC-ceEEE
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKE-EKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-~~~lv 443 (678)
..++||+|+||.||+|.. .++..||||+++... ....+.+.+|++++.++ +||||++++++|...+ ..++|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence 457899999999999964 234679999987533 23456789999999999 8999999999987644 58899
Q ss_pred EeccCCCCHHHHhhccCCC---------------------------------------------------------CCCC
Q 044996 444 HEFVPKRSLAVNLHGHQAL---------------------------------------------------------GQPS 466 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~ 466 (678)
|||+++|+|.+++...... ....
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 9999999999999753210 0124
Q ss_pred CChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc------cccccceeeCcc
Q 044996 467 LDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES------AQELMIAYKSPE 540 (678)
Q Consensus 467 l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE 540 (678)
+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...++..|+|||
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 88899999999999999999976 89999999999999999999999999997653221 122346799999
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHH
Q 044996 541 FLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLL 619 (678)
Q Consensus 541 ~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 619 (678)
++.+..++.++|||||||++|||++ |+.||.... ....+...+..+... . . .......+.
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~--------~~~~~~~~~~~~~~~-~-----~-----~~~~~~~l~ 307 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ--------INEEFCQRLKDGTRM-R-----A-----PENATPEIY 307 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC--------ccHHHHHHHhcCCCC-C-----C-----CCCCCHHHH
Confidence 9998899999999999999999997 999986211 111112222222111 0 0 112234578
Q ss_pred HHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 620 KIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 620 ~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
+++.+||+.||++||||.|+++.|+++...
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=335.70 Aligned_cols=233 Identities=21% Similarity=0.298 Sum_probs=193.8
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
..++||+|+||+||.++. .+++.+|+|++++.. ....+...+|..+|.+++||.||+++-.|++.+.+|||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 357899999999999975 568899999998643 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
||.|..+|.+.. .+++..+.-++.+|+.||.|||+. +||||||||+|||||++|+++|+|||+++.....
T Consensus 109 GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 109 GGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred CccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999998654 478888888999999999999976 8999999999999999999999999999865433
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....||+.|||||++....|+..+|.||+||++|||++|..||. ..+...+.+.+.......
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~--------~~~~~~~~~~I~~~k~~~------- 244 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY--------AEDVKKMYDKILKGKLPL------- 244 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc--------CccHHHHHHHHhcCcCCC-------
Confidence 22357899999999999999999999999999999999999997 356667777666554111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCC
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRL 634 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP 634 (678)
.......+ ..+++...++.||++|-
T Consensus 245 --~p~~ls~~---ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 --PPGYLSEE---ARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCccCCHH---HHHHHHHHhccCHHHhc
Confidence 01112223 34455588899999995
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=341.22 Aligned_cols=246 Identities=27% Similarity=0.395 Sum_probs=196.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC--ceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE--EKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||++... +|...|||.....+....+.+.+|+.+|.+++|||||+++|...... .+++.|||+++|
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 567999999999999765 48999999987654444677899999999999999999999865554 588999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCccccCc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIPVMNQ--- 526 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~--- 526 (678)
+|.+++.+.+. .|++..+.++++||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 102 sL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 102 SLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999987642 499999999999999999999966 8999999999999999 79999999999886652
Q ss_pred ----cccccccceeeCccccccCC-CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 527 ----ESAQELMIAYKSPEFLQLGR-ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 527 ----~~~~~~~~~y~aPE~~~~~~-~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
.....+|+.|||||++..+. ...++|||||||++.||+||+.||... ....+++....... ..
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~-~~---- 241 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGRED-SL---- 241 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccC-CC----
Confidence 12345788999999998643 345999999999999999999999721 22333433333222 11
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
|.+. ........+++.+|++.||++|||+.|+++.---
T Consensus 242 -P~ip-----~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 242 -PEIP-----DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred -CCCC-----cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2221 1123345666779999999999999999986543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=348.44 Aligned_cols=239 Identities=25% Similarity=0.354 Sum_probs=200.2
Q ss_pred cccCccCceeEEEEE-ecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
+.||+|+.|.||.|. ..+++.||||++.......++-+.+|+.+|+..+|+|||.++..|...+++|+|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 569999999999995 5678899999998877777778899999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----cc
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----SA 529 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 529 (678)
+.+... .+++.++..|++++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+... ..
T Consensus 359 DvVt~~------~~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 359 DVVTKT------RMTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred hhhhcc------cccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 998754 489999999999999999999976 8999999999999999999999999999877654 34
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..||+.|||||++....|++|+||||||++++||+-|+.||-. .+...-+..+...+.. .+.
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln--------E~PlrAlyLIa~ng~P-------~lk--- 490 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN--------ENPLRALYLIATNGTP-------KLK--- 490 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC--------CChHHHHHHHhhcCCC-------CcC---
Confidence 4678999999999999999999999999999999999999862 1111112222222221 111
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..+.....+.++..+||..|+++||++.|+++
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11223344666777999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=338.43 Aligned_cols=189 Identities=27% Similarity=0.409 Sum_probs=166.2
Q ss_pred ccccCccCceeEEEEE-ecCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~Ey~~ 448 (678)
.++||+|.||.||||+ ..+|+.||+|++.... ........+||.+|++|+||||++|.+..... ..+|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 4679999999999996 5689999999998644 34455678999999999999999999998876 68999999997
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+ ||.-++..... .++..++..++.|++.||+|+|.. +|+|||||.+|||||.+|.+||+|||||+++....
T Consensus 202 h-DL~GLl~~p~v----kft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 202 H-DLSGLLSSPGV----KFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred c-hhhhhhcCCCc----ccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 6 89888875433 699999999999999999999966 89999999999999999999999999999876553
Q ss_pred c-----ccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 529 A-----QELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 529 ~-----~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
. ...|..|+|||.+.+ ..|+.++|+||.||||.||++|+..|.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 2 345789999999876 479999999999999999999998876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=322.56 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=191.3
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.++|+|+||.|||++.+ +|+.||||++.... ..-.+-..+|+++|++++|+|+|.++.+|......+||+|||+.--
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 46999999999999864 69999999998643 3345567899999999999999999999999999999999997744
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc-cc--
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ-ES-- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~-~~-- 528 (678)
| +-|..... -++...+.+++.|+++|+.|+|++ ++|||||||+||||+.++.+||||||+|+.+.. ..
T Consensus 88 L-~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 88 L-HELERYPN----GVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred H-HHHHhccC----CCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 4 44444322 378888999999999999999977 799999999999999999999999999998873 32
Q ss_pred -cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHH--H-----------HHHHhc
Q 044996 529 -AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASW--V-----------NSVLAN 593 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~--~-----------~~~~~~ 593 (678)
.+..|..|+|||.+.+ .+|...+||||.||++.||++|..-|-. ..++.+. + ..++..
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG-------~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG-------RSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC-------cchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 2345788999999987 6899999999999999999999987752 1222221 1 222222
Q ss_pred CCccccccchhhh-----cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 594 GDNRTEVFDKEMA-----DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 594 ~~~~~~~~d~~l~-----~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.=|... ...++ ....-+++++..|++.||++|++-.+++.
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 2111111111111 11111 12335788999999999999999998875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=345.86 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=211.1
Q ss_pred HhccccCccCceeEEEEEecC-CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 372 ASAEILGSGCFGSSYKASLST-GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 372 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+..+||-|.||.||.|.|+. .-.||||.++.. ....++|+.|..+|+.++|||+|+|+|+|..+...|||+|||.+|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 346789999999999999865 457899999875 345789999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA- 529 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 529 (678)
+|.+||++.... .++--..+.++.||+.||+||... ++|||||..+|+|+.++..+||+|||+++++..+..
T Consensus 349 NLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 349 NLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999976542 456566789999999999999976 799999999999999999999999999999875532
Q ss_pred ----ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 530 ----QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 530 ----~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....+.|.|||.+..+.++.|+|||+|||+||||.| |-.||- +.++. -|...++++-.+ |
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP--------GidlS-qVY~LLEkgyRM----~-- 486 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP--------GIDLS-QVYGLLEKGYRM----D-- 486 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC--------CccHH-HHHHHHhccccc----c--
Confidence 234688999999999999999999999999999999 999986 23333 345555554222 1
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.++.++..+.++++.||+++|.+||++.|+-+.+|.+-..
T Consensus 487 -----~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 487 -----GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred -----CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 1345677899999999999999999999999999876443
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=338.17 Aligned_cols=243 Identities=31% Similarity=0.506 Sum_probs=191.2
Q ss_pred ccccCccCceeEEEEEec-----CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-----TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++.+++++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 357999999999999886 35689999996533 345788999999999999999999999999888899999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.++|+.... ..+++.++++|+.||++||.|||+. +++|+||+++|||+++++.+||+|||+++.....
T Consensus 84 ~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 84 PGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---ccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccc
Confidence 99999999987622 2699999999999999999999976 7999999999999999999999999998776221
Q ss_pred ------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 ------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
........|+|||.+....++.++||||||+++|||+| |+.||.. ....++.... .++... .
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~--------~~~~~~~~~~-~~~~~~-~- 225 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD--------YDNEEIIEKL-KQGQRL-P- 225 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT--------SCHHHHHHHH-HTTEET-T-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccc-cccccc-e-
Confidence 22234578999999988889999999999999999999 7888862 2333444333 222111 0
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHH
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L 643 (678)
........+.+++.+||+.+|++||+|+++++.|
T Consensus 226 ---------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111234577888899999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=329.79 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=197.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh-hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||.|..++||+|+. ..+..||||++.-... ...+.+++|+..|+.++||||++++..|..+..+|+||.||.+||
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS 110 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGS 110 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCc
Confidence 45799999999999974 5789999999985433 346889999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
+.++++..-.. -+++..+..|.+++++||.|||++ |.||||||+.|||||.+|.+||+|||....+...
T Consensus 111 ~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 111 LLDIIKTYYPD---GLEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred HHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 99999876443 388999999999999999999987 8999999999999999999999999986544322
Q ss_pred ----ccccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc--c
Q 044996 528 ----SAQELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT--E 599 (678)
Q Consensus 528 ----~~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~--~ 599 (678)
....++++|||||++.. ..|+.|+|||||||+.+||.+|..||..+.+ .+.+-..++...... .
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--------mkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--------MKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--------HHHHHHHhcCCCCCcccc
Confidence 22356789999999643 4699999999999999999999999984322 222222333322110 1
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..|... .......+.+++..|++.||.+|||+.++++
T Consensus 256 ~~~~d~-----~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDE-----DKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHH-----hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111 1112346888899999999999999999886
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=338.81 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=196.0
Q ss_pred ccccCccCceeEEEEEecC-----------------CceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEE
Q 044996 374 AEILGSGCFGSSYKASLST-----------------GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYY 435 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 435 (678)
.+.||+|+||.||+|.+.+ +..||+|.+.... .....+|.+|++++.+++||||+++++++.
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 4679999999999997532 3368999887542 344568999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHhhccCCC--------------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCC
Q 044996 436 RKEEKLLVHEFVPKRSLAVNLHGHQAL--------------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIK 501 (678)
Q Consensus 436 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk 501 (678)
..+..++||||+++|+|.+++...... ....++|.++++++.||+.||.|||+. +|+|||||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~ivH~dlk 165 (304)
T cd05096 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NFVHRDLA 165 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----CccccCcc
Confidence 999999999999999999998653211 113578899999999999999999976 79999999
Q ss_pred CCCEEecCCCceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh--CCCCcccc
Q 044996 502 SSNVLLNESLEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT--GKFPANFL 573 (678)
Q Consensus 502 ~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t--g~~P~~~~ 573 (678)
|+|||+++++.+||+|||+++.+.... ...++..|+|||++..+.++.++|||||||++|||++ +..||...
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 999999999999999999987653321 1223567999999988899999999999999999987 56677522
Q ss_pred ccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 574 QQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 574 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
. ...+..++...+.......... ........+.+++.+||+.||++||||.||++.|++
T Consensus 246 ~-----~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 246 T-----DEQVIENAGEFFRDQGRQVYLF--------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred C-----HHHHHHHHHHHhhhcccccccc--------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 1 1122233322222111100000 011233467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=336.43 Aligned_cols=256 Identities=19% Similarity=0.251 Sum_probs=194.6
Q ss_pred hccccCccCceeEEEEE-ecCCceEEEEEecccChh-hHHHHHHHHHHHhccC-CCCccceeEEEEeCC-ceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNV-GREEFQEHMRRLGRLR-HPNLLPLVAYYYRKE-EKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~lv~Ey~~ 448 (678)
+.+.||.|.||.||+|+ ..++..||||+++..-.. ..-.-.+|++.|++|. |||||++..++.+.+ .+++|||||+
T Consensus 14 ~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md 93 (538)
T KOG0661|consen 14 VIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD 93 (538)
T ss_pred HHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh
Confidence 45679999999999996 467899999999864322 2222468999999998 999999999999888 8999999995
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
.+|.++++.++. .+++..+..|+.||++||+|+|++ |+.||||||+|||+..+..+||+|||+||.+....
T Consensus 94 -~NLYqLmK~R~r----~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 94 -CNLYQLMKDRNR----LFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred -hhHHHHHhhcCC----cCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEecccccccccccCC
Confidence 599999987743 699999999999999999999987 89999999999999999999999999999886553
Q ss_pred ---cccccceeeCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc-------
Q 044996 529 ---AQELMIAYKSPEFLQ-LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR------- 597 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~-~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~------- 597 (678)
.+..|..|+|||++. .+-|+.+.||||+|||++|+.+-+.-|-. .. +.+-.--+..++......
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG----~s-E~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG----AS-EIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC----Cc-HHHHHHHHHHHhCCCccccchhHHH
Confidence 345678899999874 57899999999999999999998877751 11 111111111122111000
Q ss_pred -ccccc---hhhhccc---CCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 598 -TEVFD---KEMADER---NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 598 -~~~~d---~~l~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
...+. |...+.. .......+.++++.+|+++||.+|||+.|+++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00000 1111100 011245667888889999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=306.56 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=195.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChh--hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNV--GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.++||+|.||.||+|+. .+|+.||||+++..... -.....+||+.|+.++|+||+.++++|-..+..-||+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 46799999999999964 67999999999864322 234578999999999999999999999999999999999965
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|+..++.... .++-.++..++.++++|++|||.+ .|+||||||.|+||+.++.+||+|||+|+.+....
T Consensus 86 dLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 86 DLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred cHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 99999987654 689999999999999999999977 69999999999999999999999999999886442
Q ss_pred --cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc-------c
Q 044996 529 --AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR-------T 598 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~-------~ 598 (678)
....|..|+|||.+.+ +.|+..+||||.|||+.||+-|..-|. ++.++.+...-+-.-|... .
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-------G~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-------GDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-------CCchHHHHHHHHHHcCCCCcccCcccc
Confidence 2246788999998876 579999999999999999998875543 1223333322221111110 0
Q ss_pred cccc---hh----hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 599 EVFD---KE----MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 599 ~~~d---~~----l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
++-| -. .........+..+.++++..++..||.+|+|+.|+++.
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0100 00 00000112234556889999999999999999999874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=329.01 Aligned_cols=246 Identities=20% Similarity=0.346 Sum_probs=197.0
Q ss_pred hccccCccCceeEEEEEec----CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 373 SAEILGSGCFGSSYKASLS----TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
..++||+|+||.||+|.+. .+..|++|.++... ....+.|.+|+..+.+++||||+++++++...+..++||||+
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeC
Confidence 3567999999999999753 35689999987643 334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .++|.+++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+......
T Consensus 89 ~~~~L~~~l~~~~~----~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 89 SNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred CCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999976432 589999999999999999999976 7999999999999999999999999987554322
Q ss_pred c-----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 528 S-----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 528 ~-----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
. ....+..|+|||++.+..++.++|||||||++||+++ |+.||... ...+.+.. +.++...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~--------~~~~~~~~-~~~~~~~---- 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM--------SGQDVIKA-VEDGFRL---- 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC--------CHHHHHHH-HHCCCCC----
Confidence 1 1123467999999998999999999999999999875 99998621 11222222 2221111
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.........+.+++.+||+.+|.+||++.++.+.|+++
T Consensus 228 -------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112345678888899999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=345.55 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=196.1
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
..+.||+|+||.||+|.. .++..||||+++... ....+.+.+|++++..+ +|||||+++++|...+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 357899999999999963 245689999987532 33456788999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHhhccCCC--------------------------------------------------------------
Q 044996 445 EFVPKRSLAVNLHGHQAL-------------------------------------------------------------- 462 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~-------------------------------------------------------------- 462 (678)
||+++|+|.++++.....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 999999999999753210
Q ss_pred --------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-----
Q 044996 463 --------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA----- 529 (678)
Q Consensus 463 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~----- 529 (678)
....++|..+.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 012478999999999999999999975 799999999999999999999999999876543221
Q ss_pred -ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 530 -QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 530 -~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
..++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...+.. .+..+... ..+
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~----~~~~~~----~~~~~~~~---~~~---- 339 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV----DSKFYK----MIKEGYRM---LSP---- 339 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc----hHHHHH----HHHhCccC---CCC----
Confidence 123457999999998899999999999999999998 8889862210 011111 12221110 000
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.....++.+++.+||+.||++||+|.||++.|++.
T Consensus 340 ----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01123577888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=324.90 Aligned_cols=262 Identities=27% Similarity=0.415 Sum_probs=200.5
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHh--ccCCCCccceeEEEEeCC----ceEEEEeccC
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLG--RLRHPNLLPLVAYYYRKE----EKLLVHEFVP 448 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~~~~~~~~----~~~lv~Ey~~ 448 (678)
++||+|+||.||||.+. ++.||||++.. .....|++|-++.+ .++|+||++++++-.... +++||+||.+
T Consensus 216 eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 56999999999999985 48999999974 45677888887765 468999999999977655 7899999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCC-----CCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP-----SLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-----~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
+|+|.+||..+ .++|....+|+..+++||+|||+..+ .+.|+|||||++||||..|+++-|+|||+|..
T Consensus 292 kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 292 KGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999876 69999999999999999999998653 35799999999999999999999999999987
Q ss_pred cCcc------ccccccceeeCccccccCC-CC-----CcchHHHHHHHHHHHHhCCCCccc--------cccCCCCC-CC
Q 044996 524 MNQE------SAQELMIAYKSPEFLQLGR-IT-----KKTDVWSLGVLILEIMTGKFPANF--------LQQGKKAD-GD 582 (678)
Q Consensus 524 ~~~~------~~~~~~~~y~aPE~~~~~~-~t-----~ksDvwS~Gvvl~el~tg~~P~~~--------~~~~~~~~-~~ 582 (678)
+... ....||.+|||||++.+.. +. .+.||||+|.|||||+++-.-++. .+....+. -.
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 7543 2346899999999997642 12 369999999999999986533320 00001111 12
Q ss_pred hHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 583 LASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 583 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
+.+ ++..+-..+.+..+-|.-.. ...+..+.+.+-.||+.||+.|-|+.=|.+++.++....++
T Consensus 446 ~e~-mq~~VV~kK~RP~~p~~W~~-----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 446 LEE-MQELVVRKKQRPKIPDAWRK-----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHH-HHHHHHhhccCCCChhhhhc-----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 222 22222222222133222221 13566788888899999999999999999999998877765
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.01 Aligned_cols=241 Identities=23% Similarity=0.393 Sum_probs=195.9
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||++.+.++..+++|.+... ....++|.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 4569999999999999888888999987643 334567899999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
++++.... .++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 88 NYLRQRQG----KLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred HHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99975432 489999999999999999999976 79999999999999999999999999987653221
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....+..|+|||++.+..++.++||||||+++|||++ |+.||.. ....+.+........ ...+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~--------~~~~~~~~~i~~~~~----~~~~~--- 224 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK--------KSNYEVVEMISRGFR----LYRPK--- 224 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHHHCCCC----CCCCC---
Confidence 1123467999999988889999999999999999999 9999862 122222222222111 11111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L 643 (678)
.....+.+++.+||+.+|++||+|.|+++.|
T Consensus 225 -----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 -----LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1223578899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=333.48 Aligned_cols=239 Identities=19% Similarity=0.271 Sum_probs=193.3
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
++.||+|+|++||+|+. .+++.+|||++.+. .+...+....|-++|.+| .||.||+|+-.|++...+|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 56799999999999964 57899999998752 233345577888999999 89999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.++|++.+ .+++.....++.+|+.||+|||.. +||||||||+|||||+||++||+|||.|+.+...
T Consensus 158 nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 158 NGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred CCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999998764 488888999999999999999965 8999999999999999999999999999887532
Q ss_pred ----------------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHH
Q 044996 528 ----------------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL 591 (678)
Q Consensus 528 ----------------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~ 591 (678)
....||..|++||++..+..+..+|+|+||||||+|+.|+.||... +----++.++
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~--------NeyliFqkI~ 300 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA--------NEYLIFQKIQ 300 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc--------cHHHHHHHHH
Confidence 1134678899999999999999999999999999999999999721 1111112222
Q ss_pred hcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 592 ANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+-... +++.-...+.+|+.+-|..||.+|+|.+++-+.
T Consensus 301 ----------~l~y~---fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 ----------ALDYE---FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----------Hhccc---CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11111 111122345666678899999999999877653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.24 Aligned_cols=237 Identities=21% Similarity=0.342 Sum_probs=199.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||||+. .+.+.||+|.+.+.. +.+.+.+.+|++++++++|||||.++++|+...++|+|+||+.+
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 35699999999999965 467899999987643 34566789999999999999999999999999999999999966
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|..+|.... .+.+..+..|+.++..||.|||++ +|+|||+||.|||++..+.+|+||||+|+.+....
T Consensus 86 ~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 86 DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 9999998654 589999999999999999999976 89999999999999999999999999999876543
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...||+.|||||.+.+..|+..+|+||+|||+||+++|+.||. ...+.+.++.++.+.-..
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~--------a~si~~Lv~~I~~d~v~~--------- 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY--------ARSITQLVKSILKDPVKP--------- 219 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch--------HHHHHHHHHHHhcCCCCC---------
Confidence 2357889999999999999999999999999999999999996 235556666665443221
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+......+..+..--+..||.+|.|-.+++.
T Consensus 220 ----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 ----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1122334555666888999999999998875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=344.12 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=196.1
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
..+.||+|+||.||+|.. .++..||+|+++... ....+.+.+|+++++.+ +|+|||+++++|...+..++||
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence 457899999999999864 233579999997543 33456788999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHhhccCC---------------------------------------------------------------
Q 044996 445 EFVPKRSLAVNLHGHQA--------------------------------------------------------------- 461 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~--------------------------------------------------------------- 461 (678)
||+++|+|.++++....
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 99999999999864321
Q ss_pred --CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc------cccc
Q 044996 462 --LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA------QELM 533 (678)
Q Consensus 462 --~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~------~~~~ 533 (678)
.....+++.++++|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+..... ..++
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 0012478899999999999999999975 899999999999999999999999999876543221 1234
Q ss_pred ceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCH
Q 044996 534 IAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSE 612 (678)
Q Consensus 534 ~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 612 (678)
..|||||++....++.++|||||||++|||++ |+.||..... ..-.......+... ..+ .
T Consensus 278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~--------~~~~~~~~~~~~~~---~~~--------~ 338 (374)
T cd05106 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV--------NSKFYKMVKRGYQM---SRP--------D 338 (374)
T ss_pred cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--------cHHHHHHHHcccCc---cCC--------C
Confidence 57999999988899999999999999999998 9999863211 01111111111100 000 0
Q ss_pred HHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 613 GEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 613 ~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
.....+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11245778888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.53 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=211.5
Q ss_pred ccchHHHHHHhccccCccCceeEEEEEecC---C--ceEEEEEecc-cChhhHHHHHHHHHHHhccCCCCccceeEEEEe
Q 044996 363 RFDLHDLLRASAEILGSGCFGSSYKASLST---G--AMMVVKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436 (678)
Q Consensus 363 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 436 (678)
.+.+..-+....++||.|-||.||+|.+.+ | -.||||..+. ......+.|..|.-+|++++|||||+++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 344444334457789999999999997632 2 3688999987 345567889999999999999999999999974
Q ss_pred CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEe
Q 044996 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLA 516 (678)
Q Consensus 437 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 516 (678)
...|+|||.++.|.|+.||+.++. .|+......++.||+.||+|||+. .+|||||..+|||+....-+||+
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred -cceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhheeecCcceeeec
Confidence 679999999999999999987654 588889999999999999999965 89999999999999999999999
Q ss_pred ecCCccccCccccc-----cccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHH
Q 044996 517 DYGLIPVMNQESAQ-----ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSV 590 (678)
Q Consensus 517 DfGla~~~~~~~~~-----~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~ 590 (678)
|||+++.+.....+ ..++.|||||.+..+++|.++|||-|||.+||+++ |..||...... + |-..
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-----D----VI~~ 604 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-----D----VIGH 604 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-----c----eEEE
Confidence 99999998766433 23578999999999999999999999999999998 99999732111 0 0001
Q ss_pred HhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 591 LANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
+++|+.. +.++.++..+..++.+||+.||.+||.+.|+...|+++....
T Consensus 605 iEnGeRl-----------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 605 IENGERL-----------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred ecCCCCC-----------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 1122111 124467778999999999999999999999999999987743
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.52 Aligned_cols=249 Identities=23% Similarity=0.402 Sum_probs=197.4
Q ss_pred ccccCccCceeEEEEEecC------CceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLST------GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|.... ...+++|.++... .....+|.+|++++.+++||||+++++++...+..+++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 4679999999999997633 2578999887533 33456799999999999999999999999988899999999
Q ss_pred cCCCCHHHHhhccCCCCC-----------CCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEE
Q 044996 447 VPKRSLAVNLHGHQALGQ-----------PSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVL 515 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 515 (678)
+++|+|.+++........ ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcCCCcEEE
Confidence 999999999976432111 3588999999999999999999976 7999999999999999999999
Q ss_pred eecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHH
Q 044996 516 ADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVN 588 (678)
Q Consensus 516 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~ 588 (678)
+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~--------~~~~~~~ 237 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF--------SNQEVIE 237 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHH
Confidence 9999987543221 1223567999999988899999999999999999998 99998621 1122221
Q ss_pred HHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 589 SVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
. +..+... . ........+.+++.+||+.||.+||++.||++.|+++
T Consensus 238 ~-i~~~~~~-~----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 M-IRSRQLL-P----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H-HHcCCcC-C----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 1111111 0 1122345688888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.55 Aligned_cols=244 Identities=21% Similarity=0.291 Sum_probs=196.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc----Ch-hhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM----NN-VGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|.||+||.|.. .++..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 45799999999999965 56899999976653 11 23456778999999999 99999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC-CceEEeecCCccccC
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES-LEPVLADYGLIPVMN 525 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~ 525 (678)
+.+|+|.+++.... .+.+.+..++++|++.|++|+|.. +|+||||||+|||+|.+ +++||+|||++....
T Consensus 102 ~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 102 CSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred cCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999998732 588899999999999999999976 89999999999999999 999999999998873
Q ss_pred -cc---ccccccceeeCccccccCC-CC-CcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 526 -QE---SAQELMIAYKSPEFLQLGR-IT-KKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 526 -~~---~~~~~~~~y~aPE~~~~~~-~t-~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
.. ....|+..|+|||++.+.. |+ .++||||+||+||.|++|+.||++ .++....+.+....-....
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--------~~~~~l~~ki~~~~~~~p~ 244 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--------SNVPNLYRKIRKGEFKIPS 244 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--------ccHHHHHHHHhcCCccCCC
Confidence 22 3456789999999999877 85 789999999999999999999983 3333333332222111111
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
.++ ...+..++.+|+..||.+|+++.||+ .-.-++
T Consensus 245 ~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 245 YLL------------SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred CcC------------CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 110 33467777799999999999999999 433333
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.96 Aligned_cols=237 Identities=21% Similarity=0.254 Sum_probs=191.2
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
++||+|+||.||+++. .+++.+|+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3599999999999976 468899999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 9999987543 589999999999999999999976 8999999999999999999999999998753221
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+.............. +
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~--------~~~~~~~~~~~~~~~~--------~- 214 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHEKLFELILMEEIR--------F- 214 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC--------CCHHHHHHHHHcCCCC--------C-
Confidence 223467899999999988999999999999999999999999962 1222222222211111 1
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+||+.||++|| ++.++++
T Consensus 215 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 111223466777899999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.14 Aligned_cols=249 Identities=20% Similarity=0.353 Sum_probs=198.1
Q ss_pred ccccCccCceeEEEEEec-CCc----eEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGA----MMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|.+. ++. .||+|.++... ....++|.+|+.+++.++||||++++|+|... ..++|+||+
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~ 90 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 90 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence 467999999999999763 333 38899887543 34567899999999999999999999999764 578999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.++++.... .+++..+++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 91 ~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 91 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred CCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999986532 588999999999999999999965 7999999999999999999999999999876532
Q ss_pred cc------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 SA------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~~------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
.. ...+..|+|||++....++.++|||||||++|||++ |+.||+. ....++ ...+..+...
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~--------~~~~~~-~~~~~~~~~~--- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------IPASEI-SSILEKGERL--- 230 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CCHHHH-HHHHhCCCCC---
Confidence 21 123467999999998899999999999999999998 9999862 122222 2222222111
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
.. ...+...+.+++.+||+.+|.+||++.+++..|..+.....
T Consensus 231 ~~--------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 231 PQ--------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred CC--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 00 01123457888999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.19 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=197.8
Q ss_pred hccccCccCceeEEEEEec------CCceEEEEEecccC-hhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEE
Q 044996 373 SAEILGSGCFGSSYKASLS------TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 444 (678)
+.++||+|+||.||+|... .+..||||+++... ....+.|.+|+++++++. |||||+++++|...+..||||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 4567999999999999752 23469999997533 334567999999999996 999999999999999999999
Q ss_pred eccCCCCHHHHhhccCCC--------------------------------------------------------------
Q 044996 445 EFVPKRSLAVNLHGHQAL-------------------------------------------------------------- 462 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~-------------------------------------------------------------- 462 (678)
|||++|+|.++|+.....
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999999999998753210
Q ss_pred -----------------------------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCce
Q 044996 463 -----------------------------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEP 513 (678)
Q Consensus 463 -----------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~ 513 (678)
....+++.++++++.||+.||+|||+. +|+||||||+|||+++++.+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHhEEEeCCCEE
Confidence 012478899999999999999999976 79999999999999999999
Q ss_pred EEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHH
Q 044996 514 VLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASW 586 (678)
Q Consensus 514 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~ 586 (678)
||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |+.||.... ....
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~--------~~~~ 348 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI--------VDST 348 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc--------hhHH
Confidence 999999987654321 1123467999999988899999999999999999997 999986211 1111
Q ss_pred HHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 587 VNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
+......+... . ........+.+++.+||+.||++||++.+|++.|+++.+
T Consensus 349 ~~~~~~~~~~~-~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FYNKIKSGYRM-A----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHhcCCCC-C----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11122221111 0 011234567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=321.00 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=202.8
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
..++||+|+||.||+|....+..+++|.+.........++.+|+.+++.++|+||+++++++...+..++||||+++|+|
T Consensus 10 ~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (261)
T cd05148 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL 89 (261)
T ss_pred HhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCH
Confidence 45679999999999999888899999999876655677899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.++++.... ..+++.++.+++.|++.||.|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 90 ~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 90 LAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred HHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 999976432 2589999999999999999999976 79999999999999999999999999987654321
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....+..|+|||++....++.++||||||+++|||++ |+.||... ...+......... ..
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~--------~~~~~~~~~~~~~-~~---------- 223 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM--------NNHEVYDQITAGY-RM---------- 223 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC--------CHHHHHHHHHhCC-cC----------
Confidence 1224567999999988889999999999999999998 89998621 1122222222110 00
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.........+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 -PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00112334578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.16 Aligned_cols=235 Identities=20% Similarity=0.256 Sum_probs=190.2
Q ss_pred cCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 377 LGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
||+|+||.||+|+.. ++..+|+|.++.. .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999864 5788999998743 233456788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 99997542 489999999999999999999965 8999999999999999999999999998754322 1
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. .................
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~--------~~~~~~~~~~~~~~~~~----------- 212 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD--------ENVNEMYRKILQEPLRF----------- 212 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC--------CCHHHHHHHHHcCCCCC-----------
Confidence 23467889999999988999999999999999999999999962 23334444433322111
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCC---HHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLD---LKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~ev~~ 641 (678)
.......+.+++.+||+.||.+||+ +.|+++
T Consensus 213 --~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 213 --PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 0111234667788999999999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=325.57 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=201.3
Q ss_pred ccccCccCceeEEEEEe------cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASL------STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||++.. .++..+++|.+........+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 89 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 46799999999999974 234568899887766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCC--------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecC
Q 044996 448 PKRSLAVNLHGHQA--------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519 (678)
Q Consensus 448 ~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 519 (678)
++++|.+++..... .....+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEeccCC
Confidence 99999999975431 1122489999999999999999999976 79999999999999999999999999
Q ss_pred CccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHh
Q 044996 520 LIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLA 592 (678)
Q Consensus 520 la~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~ 592 (678)
+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~--------~~~~~~~~i~- 236 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--------SNNEVIECIT- 236 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHH-
Confidence 987553221 1123567999999998889999999999999999999 99998621 1122222222
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.+... . . .......+.+++.+||+.+|.+|||+.||++.|+++...
T Consensus 237 ~~~~~-~-----~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 QGRVL-Q-----R-----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred cCCcC-C-----C-----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111 0 0 011234578899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=337.60 Aligned_cols=239 Identities=21% Similarity=0.292 Sum_probs=200.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++.||.|+-|.|-.|++ .+|+.+|||.+.... ......+.+|+-+|+-+.||||+++|+++++..++|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 45699999999999975 689999999997642 23345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|-|.++|..++ .+.+.+..++++||+.|+.|+|+. +|+||||||+|+|||..+++||+|||+|.+-..+.
T Consensus 97 GELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 97 GELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred chhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999998764 589999999999999999999976 79999999999999999999999999997755442
Q ss_pred --cccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 --AQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...|.+.|.|||++.+.+| +.++||||.|||||-|+||+.||+ ++++.....++-...-.+ |
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--------DdNir~LLlKV~~G~f~M-----P-- 232 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--------DDNIRVLLLKVQRGVFEM-----P-- 232 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--------CccHHHHHHHHHcCcccC-----C--
Confidence 3456788999999999998 679999999999999999999998 456665554443322111 1
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.....+...++.+|+..||+.|.|++||++.
T Consensus 233 ------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 233 ------SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1122335566669999999999999999984
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.58 Aligned_cols=244 Identities=21% Similarity=0.276 Sum_probs=191.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|++++.+++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 36799999999999976 578999999886432 22334678999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 85 g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 85 GDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999988864322 2589999999999999999999965 8999999999999999999999999998765432
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... .....-+.........
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~---------- 222 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE-----RVKREEVDRRVKEDQE---------- 222 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc-----chhHHHHHHHhhcccc----------
Confidence 223467899999999989999999999999999999999999973211 0111111111111000
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
.........+.+++.+||+.||.+||+ +.|+++
T Consensus 223 --~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 --EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 001112235677888999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=325.02 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=201.6
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|... ++..+++|.++.......+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 457999999999999742 34568888887665566678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEe
Q 044996 448 PKRSLAVNLHGHQA-----------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLA 516 (678)
Q Consensus 448 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 516 (678)
++++|.+++..... .....++|..+++++.||+.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEEC
Confidence 99999999975431 1122489999999999999999999976 79999999999999999999999
Q ss_pred ecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHH
Q 044996 517 DYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNS 589 (678)
Q Consensus 517 DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~ 589 (678)
|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... .....+..
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--------~~~~~~~~ 237 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL--------SNTEVIEC 237 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH
Confidence 999987553321 1223567999999998899999999999999999999 99998621 11222221
Q ss_pred HHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 590 VLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
. ..+... +. .......+.+++.+||+.+|++||+|++|++.|+++...
T Consensus 238 ~-~~~~~~-~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 I-TQGRVL-ER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H-hCCCCC-CC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 111111 00 011234578899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=321.57 Aligned_cols=246 Identities=26% Similarity=0.435 Sum_probs=198.8
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
..++||+|+||.||+|...++..+++|.+... ....+.+.+|+.++++++|+||+++++++...+..++||||+++|+|
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05072 10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88 (261)
T ss_pred EeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence 34679999999999999888888999987653 23467899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.++++.... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 89 LDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 999976432 2588999999999999999999975 79999999999999999999999999997764322
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||++....++.++|||||||++|||+| |+.||... ...+... .+..+... +.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--------~~~~~~~-~~~~~~~~-----~~-- 225 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM--------SNSDVMS-ALQRGYRM-----PR-- 225 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC--------CHHHHHH-HHHcCCCC-----CC--
Confidence 1123567999999988889999999999999999999 99998621 1111111 11221111 00
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.......+.+++.+|++.+|++||+|+++.+.|+++
T Consensus 226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 ----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011234577888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=323.58 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=197.7
Q ss_pred ccccCccCceeEEEEEecC------CceEEEEEecccChh-hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLST------GAMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|.... +..+++|.++..... ..+.|.+|++++++++|+||+++++++......++||||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 89 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEY 89 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEec
Confidence 4679999999999997633 478999998765433 467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCC---------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEee
Q 044996 447 VPKRSLAVNLHGHQA---------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLAD 517 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 517 (678)
+++|+|.++++.... .....+++.++..++.|++.||+|||.. +++||||||+||+++.++.+||+|
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCCeEEECC
Confidence 999999999976431 1223588999999999999999999966 799999999999999999999999
Q ss_pred cCCccccCcc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHH
Q 044996 518 YGLIPVMNQE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSV 590 (678)
Q Consensus 518 fGla~~~~~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~ 590 (678)
||+++..... .....+..|+|||++.+..++.++|||||||++|||++ |+.||... ...+.+...
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~--------~~~~~~~~~ 237 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL--------SNEEVIECI 237 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHH
Confidence 9998754321 11223567999999999999999999999999999999 99998621 112222222
Q ss_pred HhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 591 LANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
. .+... . ........+.+++.+||+.||++||++.||++.|+
T Consensus 238 ~-~~~~~--~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T-QGRLL--Q---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H-cCCcC--C---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2 11110 0 01122345788888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.03 Aligned_cols=252 Identities=19% Similarity=0.213 Sum_probs=206.8
Q ss_pred hccccCccCceeEEEEEecCC-ceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeE-EEEe------CCceEEE
Q 044996 373 SAEILGSGCFGSSYKASLSTG-AMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVA-YYYR------KEEKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~-~~~~------~~~~~lv 443 (678)
+.+.|.+|||+.||.|....+ ..+|+|++-..++...+.+.+||++|++|+ |+|||.+++ .... ..+++|.
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 457899999999999988766 999999998888888899999999999997 999999999 3322 1367899
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
||||.+|.|-+++..+... .|++.++++|+.|+++|+++||.. ...|||||||.+||||+.++..||||||-|..
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred hhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 9999999999999865432 499999999999999999999966 44699999999999999999999999999854
Q ss_pred cCcc-------------ccccccceeeCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHH
Q 044996 524 MNQE-------------SAQELMIAYKSPEFL---QLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWV 587 (678)
Q Consensus 524 ~~~~-------------~~~~~~~~y~aPE~~---~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~ 587 (678)
.... .....|..|+|||++ .+..+++|+|||++||+||-|+..+.||+..
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s-------------- 261 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES-------------- 261 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC--------------
Confidence 3211 122357889999987 4668899999999999999999999999721
Q ss_pred HHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 588 NSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
... .+++-.+.-..+ ..+...+..|+..||+.+|.+||++-+|+..+.++......
T Consensus 262 -------g~l-aIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 262 -------GKL-AILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred -------cce-eEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 011 344433322222 35778899999999999999999999999999988765544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.27 Aligned_cols=238 Identities=18% Similarity=0.215 Sum_probs=192.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 467999999999999865 68899999986432 23346688999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~ 156 (291)
T cd05612 86 GELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW 156 (291)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence 99999997643 488999999999999999999976 89999999999999999999999999988665432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. .................
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~--------~~~~~~~~~i~~~~~~~----------- 217 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD--------DNPFGIYEKILAGKLEF----------- 217 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCcCC-----------
Confidence 23467889999999988899999999999999999999999862 22223333322221111
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
+......+.+++.+|++.||.+||+ +.|+++
T Consensus 218 --~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 218 --PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 0011234677888999999999995 666664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=331.28 Aligned_cols=237 Identities=21% Similarity=0.266 Sum_probs=190.2
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
++||+|+||.||+++. .++..||+|.++.. .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3599999999999976 46889999998753 2234456788999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 9998887543 588999999999999999999976 8999999999999999999999999998753221
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+...-.......... +
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~--------~~~~~~~~~~~~~~~~--------~- 214 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHERLFELILMEEIR--------F- 214 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC--------CCHHHHHHHHhcCCCC--------C-
Confidence 123467889999999988999999999999999999999999862 1111112222211111 0
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+||+.||++|| ++.++++
T Consensus 215 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 011223466777799999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=331.08 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=196.4
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeC-CceEEE
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRK-EEKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lv 443 (678)
+.++||+|+||.||+|.. .+++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... ...+++
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 457899999999999953 234689999987532 23345678899999999 899999999988754 568899
Q ss_pred EeccCCCCHHHHhhccCCC--------------------------------------------------------CCCCC
Q 044996 444 HEFVPKRSLAVNLHGHQAL--------------------------------------------------------GQPSL 467 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~l 467 (678)
|||+++|+|.+++...... ....+
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999999999998643210 01258
Q ss_pred ChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc------cccccceeeCccc
Q 044996 468 DWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES------AQELMIAYKSPEF 541 (678)
Q Consensus 468 ~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~ 541 (678)
+|..+.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.... ...++..|+|||+
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 9999999999999999999966 89999999999999999999999999998653221 1223467999999
Q ss_pred cccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHH
Q 044996 542 LQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLK 620 (678)
Q Consensus 542 ~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~ 620 (678)
+.+..++.++|||||||++|||++ |+.||... ...+.....+..+... . .+......+.+
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~~-~----------~~~~~~~~~~~ 307 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV--------QIDEEFCRRLKEGTRM-R----------APEYATPEIYS 307 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC--------CccHHHHHHHhccCCC-C----------CCccCCHHHHH
Confidence 999999999999999999999998 99998621 1111122222222111 0 01122345788
Q ss_pred HHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 621 IGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 621 l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
++.+||+.+|++||++.||++.|+++..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.43 Aligned_cols=242 Identities=22% Similarity=0.381 Sum_probs=193.8
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
+.||+|+||.||+|... +++.+++|.+... .......|.+|++++++++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999764 6888999987643 234456799999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc---
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA--- 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 529 (678)
.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99997542 2589999999999999999999966 799999999999999999999999999875443211
Q ss_pred ---ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 530 ---QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 530 ---~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...+..|+|||.+.++.++.++|||||||++|||++ |+.||.... . ............. .
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~--------~-~~~~~~~~~~~~~-~------ 216 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS--------N-QQTREAIEQGVRL-P------ 216 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC--------H-HHHHHHHHcCCCC-C------
Confidence 112356999999988889999999999999999998 898886211 1 1111111111110 0
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
........+.+++.+|++.+|++|||+.||.++|+
T Consensus 217 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 ----CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 01122346788888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.42 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=202.7
Q ss_pred hccccCccCceeEEEEEec--------CCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEE
Q 044996 373 SAEILGSGCFGSSYKASLS--------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLL 442 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 442 (678)
..+.||+|+||.||+|+.. ++..+++|.++.. .....+++.+|+.+++.+ +||||+++++++......++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 98 (304)
T cd05101 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 98 (304)
T ss_pred ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence 4578999999999999641 2347889988643 234457789999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC
Q 044996 443 VHEFVPKRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL 511 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 511 (678)
||||+++|+|.+++...... ....++|.+++.++.||+.||+|||+. +++||||||+|||+++++
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~Nili~~~~ 174 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAARNVLVTENN 174 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----CeeecccccceEEEcCCC
Confidence 99999999999999764321 123588999999999999999999976 899999999999999999
Q ss_pred ceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChH
Q 044996 512 EPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLA 584 (678)
Q Consensus 512 ~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~ 584 (678)
.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||. .....
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~--------~~~~~ 246 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP--------GIPVE 246 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc--------cCCHH
Confidence 99999999997654321 1223467999999988889999999999999999998 888875 12333
Q ss_pred HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
++........ .. .. .......+.+++.+||+.+|.+||+|.||++.|+++....+.
T Consensus 247 ~~~~~~~~~~-~~-~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 247 ELFKLLKEGH-RM-DK----------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred HHHHHHHcCC-cC-CC----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 4433332211 11 00 112234577788899999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=332.56 Aligned_cols=238 Identities=19% Similarity=0.224 Sum_probs=192.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|+.. +++.+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999875 57899999987532 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 103 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 103 GELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred ChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 99999997643 478888999999999999999976 89999999999999999999999999998765432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. ................. +
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~--------~~~~~~~~~i~~~~~~~-----p----- 235 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD--------DTPFRIYEKILAGRLKF-----P----- 235 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC--------CCHHHHHHHHhcCCcCC-----C-----
Confidence 23467889999999988899999999999999999999999962 12222222222211111 0
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
......+.+++.+||+.||.+||+ +.|+++
T Consensus 236 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 236 ---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 001234667888999999999996 677664
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=322.78 Aligned_cols=239 Identities=21% Similarity=0.277 Sum_probs=186.5
Q ss_pred ccCccCceeEEEEEecC-------------------------CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccce
Q 044996 376 ILGSGCFGSSYKASLST-------------------------GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPL 430 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l 430 (678)
+||+|+||.||+|.+.. ...|++|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999996421 13478888865444445678899999999999999999
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC
Q 044996 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES 510 (678)
Q Consensus 431 ~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 510 (678)
+++|......++||||+++|+|..++..... .+++..+++++.||++||+|||+. +|+||||||+|||++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEecc
Confidence 9999999999999999999999999875432 588999999999999999999965 79999999999999864
Q ss_pred C-------ceEEeecCCccccCccccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHH-hCCCCccccccCCCCCC
Q 044996 511 L-------EPVLADYGLIPVMNQESAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIM-TGKFPANFLQQGKKADG 581 (678)
Q Consensus 511 ~-------~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~-tg~~P~~~~~~~~~~~~ 581 (678)
+ .+|++|||++..........++..|+|||++.+ ..++.++|||||||++|||+ +|+.||..... .
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~ 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-----S 228 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-----H
Confidence 3 379999999865544334456678999998865 56899999999999999995 69999862211 1
Q ss_pred ChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 582 DLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 582 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
.... ........ .......+.+++.+||+.+|++||+|.+|++.|+
T Consensus 229 ~~~~----~~~~~~~~-------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EKER----FYEKKHRL-------------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH----HHHhccCC-------------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 11111111 0011235778888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.29 Aligned_cols=244 Identities=27% Similarity=0.430 Sum_probs=197.9
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|....+..+++|.++... ...++|.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 46799999999999998778889999987543 34577999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccccc---
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ--- 530 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~--- 530 (678)
+++.... ...++|.++..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 90 EYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred HHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence 9997643 12589999999999999999999976 7999999999999999999999999998766532111
Q ss_pred --cccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 531 --ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 531 --~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
..+..|+|||++.+..++.++||||||+++|||+| |+.||... ....-.. ........
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~-~~~~~~~~---------- 223 (261)
T cd05068 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM--------TNAEVLQ-QVDQGYRM---------- 223 (261)
T ss_pred CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--------CHHHHHH-HHHcCCCC----------
Confidence 12357999999998899999999999999999999 99998621 1111111 11111100
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
.........+.+++.+|++.+|.+||+|+++++.|++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111233567888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=331.01 Aligned_cols=238 Identities=21% Similarity=0.265 Sum_probs=191.7
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
++||+|+||.||+++. .++..+|+|++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999975 46889999998753 2234567889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|..++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence 9998886542 589999999999999999999976 8999999999999999999999999998754221
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. ............... .+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~--------~~~~~~~~~~~~~~~--------~~p 215 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHEKLFELILMEDI--------KFP 215 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC--------CCHHHHHHHhccCCc--------cCC
Confidence 123467889999999988999999999999999999999999962 122222222221111 110
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVEK 642 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~~ 642 (678)
......+.+++.+|++.||.+|| ++.|+++.
T Consensus 216 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 -----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11123466777799999999997 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.53 Aligned_cols=245 Identities=21% Similarity=0.420 Sum_probs=197.3
Q ss_pred ccccCccCceeEEEEEecC----CceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLST----GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|.+.. ...++||.++... .....+|.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 4679999999999998742 4578999887533 3445679999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+++|.+++..... .+++.++++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 89 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 89 NGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999976432 589999999999999999999975 79999999999999999999999999998764211
Q ss_pred ------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 529 ------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 529 ------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
....+..|+|||.+.+..++.++||||||+++|||++ |+.||... ......... ......
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~--------~~~~~~~~~-~~~~~~---- 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM--------SNQDVIKAV-EDGYRL---- 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC--------CHHHHHHHH-HcCCCC----
Confidence 1123467999999998899999999999999999998 99998621 111111111 111110
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
+ ........+.+++.+||+.+|++||+|.||++.|+++
T Consensus 228 -~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -P------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0112234578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=318.10 Aligned_cols=242 Identities=23% Similarity=0.372 Sum_probs=195.5
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|+...+..+++|.++.. ....++|.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 4569999999999998877777999988743 334567999999999999999999999999888999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA---- 529 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 529 (678)
+++..... .+++.+++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 88 ~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 88 NYLREHGK----RFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99976432 589999999999999999999966 799999999999999999999999999876543221
Q ss_pred -ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 530 -QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 530 -~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
..++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+............
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~~~---------- 221 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF--------NNSETVEKVSQGLRLY---------- 221 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC--------CHHHHHHHHhcCCCCC----------
Confidence 123467999999988889999999999999999999 99998621 1122222222211100
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
........+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 --RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00112345788888999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.19 Aligned_cols=245 Identities=25% Similarity=0.380 Sum_probs=198.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|... .+..+++|.+... ....+++.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 467999999999999764 5788999988753 34456799999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc---
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA--- 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 529 (678)
.+++..... ..+++..++.++.|++.||+|||.. +++||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 90 LDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred HHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 999975432 2589999999999999999999966 799999999999999999999999999877654321
Q ss_pred --ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 --QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 --~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...+..|+|||++.+..++.++|||||||++|||++ |+.||.. ....++...... +... .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~--------~~~~~~~~~~~~-~~~~------~-- 225 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--------IDLSQVYELLEK-GYRM------E-- 225 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHHHC-CCCC------C--
Confidence 122457999999998899999999999999999998 9999862 222233222221 1110 0
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
........+.+++.+||+.+|++||+|.++++.|+++
T Consensus 226 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 ---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111234578888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=319.49 Aligned_cols=239 Identities=22% Similarity=0.295 Sum_probs=188.3
Q ss_pred cccCccCceeEEEEEecC-------------CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceE
Q 044996 375 EILGSGCFGSSYKASLST-------------GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKL 441 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~ 441 (678)
+.||+|+||.||+|.+.. ...+++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999997532 2257888876654455567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc-------eE
Q 044996 442 LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE-------PV 514 (678)
Q Consensus 442 lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~-------~k 514 (678)
+||||+++|+|..+++.... .+++..+++++.||+.||+|||+. +|+||||||+|||++.++. +|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeE
Confidence 99999999999998875432 589999999999999999999965 8999999999999987664 89
Q ss_pred EeecCCccccCccccccccceeeCccccc-cCCCCCcchHHHHHHHHHHHH-hCCCCccccccCCCCCCChHHHHHHHHh
Q 044996 515 LADYGLIPVMNQESAQELMIAYKSPEFLQ-LGRITKKTDVWSLGVLILEIM-TGKFPANFLQQGKKADGDLASWVNSVLA 592 (678)
Q Consensus 515 l~DfGla~~~~~~~~~~~~~~y~aPE~~~-~~~~t~ksDvwS~Gvvl~el~-tg~~P~~~~~~~~~~~~~l~~~~~~~~~ 592 (678)
++|||++..........++..|+|||++. +..++.++|||||||++|||+ +|+.|+... ...+. .....
T Consensus 153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--------~~~~~-~~~~~ 223 (262)
T cd05077 153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK--------TLAEK-ERFYE 223 (262)
T ss_pred eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc--------chhHH-HHHHh
Confidence 99999987765544455678899999886 466899999999999999997 588887521 11111 11111
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHH
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L 643 (678)
.. . ... ......+.+++.+||+.||.+||++.++++.|
T Consensus 224 ~~--~-~~~----------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQ--C-MLV----------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cC--c-cCC----------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 10 0 000 01124577888899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.90 Aligned_cols=248 Identities=20% Similarity=0.317 Sum_probs=194.9
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... .+..+|+|++.... .....+|.+|+.+++.++|+||+++++++......++||||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 90 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence 467999999999999753 34679999886432 23456789999999999999999999999988999999999
Q ss_pred cCCCCHHHHhhccCCC-----CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCc
Q 044996 447 VPKRSLAVNLHGHQAL-----GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 521 (678)
+++|+|.++++..... ....++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCCEEECCCCCc
Confidence 9999999999753211 012468899999999999999999975 7999999999999999999999999998
Q ss_pred cccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 522 PVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 522 ~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
+...... ...++..|+|||++.+..++.++|||||||++|||++ |+.||.. ..............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~--------~~~~~~~~~~~~~~ 238 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------MSNEQVLRFVMEGG 238 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHHHcCC
Confidence 7543221 1223567999999988889999999999999999999 7888862 12222222222211
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
.. . ........+.+++.+|++.+|++|||+.|+++.|++
T Consensus 239 -~~-~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 239 -LL-D----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -cC-C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 0 011223457888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.08 Aligned_cols=190 Identities=24% Similarity=0.339 Sum_probs=166.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 457999999999999865 5778888888753 23445679999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--cc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--SA 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 529 (678)
|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 90 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (331)
T cd06649 90 LDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (331)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEcCCCChhhEEEcCCCcEEEccCccccccccccccc
Confidence 999997643 4889999999999999999999642 5999999999999999999999999998765432 22
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
..++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 346788999999998899999999999999999999999996
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=314.04 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=195.6
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
++||+|+||.||+|...++..+++|.++... ......|.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888899999887543 333457899999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... .+++..++.++.|++.||.|||.. +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 81 SFLRKKKD----ELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 99875432 488999999999999999999965 79999999999999999999999999986543321
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....+..|+|||++.+..++.++||||||+++||+++ |+.||... .... .......+... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~--------~~~~-~~~~~~~~~~~-~~------- 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM--------TNQQ-AREQVEKGYRM-SC------- 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC--------CHHH-HHHHHHcCCCC-CC-------
Confidence 1223467999999988899999999999999999999 99998621 1111 11112111111 00
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
.......+.+++.+|++.+|++||++.|+++.|.
T Consensus 216 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 ---PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1122356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=330.42 Aligned_cols=241 Identities=21% Similarity=0.290 Sum_probs=189.4
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||.||+|+.. +++.+|+|.++.. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999864 5788999998753 223445678888888776 899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 99998886542 589999999999999999999976 8999999999999999999999999998753221
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||...............++.......... +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------~ 224 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------I 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-------C
Confidence 2234678899999999889999999999999999999999999632221111223334443333222110 1
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
+......+.+++.+||+.||++||++
T Consensus 225 -----p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 -----PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -----CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11123346778889999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.70 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=194.9
Q ss_pred cccCccCceeEEEEEecC-Cc--eEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLST-GA--MMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999998754 33 4678877743 234456889999999999 899999999999999999999999999
Q ss_pred CCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeec
Q 044996 450 RSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADY 518 (678)
Q Consensus 450 gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 518 (678)
|+|.++++..... ....+++.++..++.|++.||+|||+. +++||||||+|||+++++.+||+||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence 9999999764321 112488999999999999999999965 8999999999999999999999999
Q ss_pred CCccccCcc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 519 GLIPVMNQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 519 Gla~~~~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
|+++..... .....+..|+|||++....++.++|||||||++|||++ |+.||.. ....+....... +
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~--------~~~~~~~~~~~~-~ 227 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAELYEKLPQ-G 227 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc--------cCHHHHHHHHhC-C
Confidence 998643221 11123457999999988889999999999999999997 9999862 122222222211 1
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
... +. .......+.+++.+||+.+|.+|||+.|+++.|+++.
T Consensus 228 ~~~-~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL-EK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC-CC----------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111 00 0112235778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.34 Aligned_cols=237 Identities=20% Similarity=0.273 Sum_probs=190.0
Q ss_pred cccCccCceeEEEEEe----cCCceEEEEEecccC----hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 375 EILGSGCFGSSYKASL----STGAMMVVKRFKQMN----NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
+.||+|+||.||+++. ..++.+|+|.++... ......+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4699999999999975 357889999987532 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+++|+|.+++.... .+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999987543 478888899999999999999976 899999999999999999999999999874322
Q ss_pred c----ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 527 E----SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 527 ~----~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+....+..........
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~--------~~~~~~~~~~~~~~~~~----- 219 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA--------ENRKKTIDKILKGKLNL----- 219 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCCCC-----
Confidence 2 122467889999999988899999999999999999999999962 22223333332221111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+|++.+|++|| ++.++++
T Consensus 220 --------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 --------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 001123467788899999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.68 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=194.7
Q ss_pred ccccCccCceeEEEEEec-CCc----eEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGA----MMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||+||+|.+. ++. .+++|.+.... .....++..|+..+++++||||+++++++. ....++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 467999999999999864 343 36777765432 233467888888999999999999999875 45678999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .++|..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 91 PLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred CCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999976432 589999999999999999999975 7999999999999999999999999999765332
Q ss_pred c------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 S------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
. ...++..|+|||++.++.++.++|||||||++|||+| |+.||... . ..-+...+..+...
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--------~-~~~~~~~~~~~~~~--- 230 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM--------R-PHEVPDLLEKGERL--- 230 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC--------C-HHHHHHHHHCCCcC---
Confidence 1 1124568999999988899999999999999999998 99998621 1 11122223332211
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
..+. .....+.+++.+||+.+|++|||+.|+++.|+.+.+..+
T Consensus 231 ~~~~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 231 AQPQ--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred CCCC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 1111 112346778889999999999999999999999887554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=326.29 Aligned_cols=238 Identities=25% Similarity=0.344 Sum_probs=195.9
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
++||+|.||.||||.. .+++.||+|.+... .....+++++|+.++.+++|+||.++||.|..+..++++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 5699999999999965 57889999999853 345568899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.+.|.... .+++..+.-|++++..||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+... .
T Consensus 99 ~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 99 LDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred hhhhccCC-----CCccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99997653 346777778999999999999977 7899999999999999999999999998776544 3
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...||+.|||||++....|+.|+||||+|++.+||.+|..|+....+... .+ .+.+-.-|.+.+
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----------lf----lIpk~~PP~L~~- 233 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----------LF----LIPKSAPPRLDG- 233 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----------EE----eccCCCCCcccc-
Confidence 34578899999999988999999999999999999999999974332110 00 000111122322
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.....+.+++..|++.||+.||++.++++
T Consensus 234 ----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 ----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22344777888999999999999999876
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=345.29 Aligned_cols=243 Identities=15% Similarity=0.141 Sum_probs=194.8
Q ss_pred ccccCccCceeEEEEEec-C-CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-T-GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... + +..||+|++..........+.+|+++++.++|||||++++++...+..||||||+++|+
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~ 151 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence 467999999999999653 3 56788887765555555678899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.++++.... ....+++.++..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 152 L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 152 LNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred HHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 9998865322 122588999999999999999999975 89999999999999999999999999998764321
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+.+......... +
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~--------~~~~~~~~~~~~~~~~------~-- 290 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG--------PSQREIMQQVLYGKYD------P-- 290 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCC------C--
Confidence 22367889999999988999999999999999999999999862 2223333333322110 0
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
........+.+++.+||+.||++||++.+++.
T Consensus 291 ----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01112245778888999999999999999875
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=330.37 Aligned_cols=246 Identities=20% Similarity=0.282 Sum_probs=193.1
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||.||+|... +++.||+|.++... ....+.++.|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 35899999999999764 67899999997532 23345688999999988 799999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc-c-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ-E- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~-~- 527 (678)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 99999886542 589999999999999999999976 899999999999999999999999999874321 1
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||+.............++........... +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 224 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-------I 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-------C
Confidence 2234678899999999889999999999999999999999999743221111223334444333332111 1
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCC------HHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLD------LKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs------~~ev~~ 641 (678)
+......+.+++.+|++.||.+||+ +.++++
T Consensus 225 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 -----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 0112234677888999999999997 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.53 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=193.4
Q ss_pred ccccCccCceeEEEEEecCCc---eEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEE
Q 044996 374 AEILGSGCFGSSYKASLSTGA---MMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~l 442 (678)
.++||+|+||.||+|...... .+|+|.++.. .....+.|.+|++++++++|+||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 467999999999999875432 5888887643 344467889999999999999999999988542 24689
Q ss_pred EEeccCCCCHHHHhhccCCC-CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCc
Q 044996 443 VHEFVPKRSLAVNLHGHQAL-GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 521 (678)
||||+++|+|.+++...... ....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988533211 123589999999999999999999975 7999999999999999999999999999
Q ss_pred cccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 522 PVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 522 ~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
+.+.... ....+..|+|||++....++.++|||||||++|||++ |+.||... ....... .+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~~~-~~~~~ 230 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--------ENSEIYD-YLRQG 230 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHH-HHHcC
Confidence 8764321 1123467999999998899999999999999999999 88998621 1112222 22222
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
... . ........+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 231 ~~~-~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL-K----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC-C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 0 0111234578888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.65 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=197.7
Q ss_pred hccccCccCceeEEEEEec------CCceEEEEEecccC-hhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEE
Q 044996 373 SAEILGSGCFGSSYKASLS------TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 444 (678)
+.+.||+|+||.||+|++. .+..||+|+++... ....+.+.+|+++|.++. |||||+++++|...+..++||
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 4578999999999999853 34579999997543 233457889999999997 999999999999999999999
Q ss_pred eccCCCCHHHHhhccCC---------------------------------------------------------------
Q 044996 445 EFVPKRSLAVNLHGHQA--------------------------------------------------------------- 461 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~--------------------------------------------------------------- 461 (678)
||+++|+|.++++....
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 99999999999975421
Q ss_pred ------------------------------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC
Q 044996 462 ------------------------------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL 511 (678)
Q Consensus 462 ------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 511 (678)
...+.++|.++++|+.||+.||+|||+. +++||||||+|||+++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCCcceEEEeCCC
Confidence 0113478888999999999999999965 799999999999999999
Q ss_pred ceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChH
Q 044996 512 EPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLA 584 (678)
Q Consensus 512 ~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~ 584 (678)
.+||+|||+++.+.... ...++..|+|||++....++.++|||||||++|||++ |+.||... ...
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~--------~~~ 348 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL--------PMN 348 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC--------Cch
Confidence 99999999997653221 1224567999999988889999999999999999998 89998621 111
Q ss_pred HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
+.....+..+... . . .......+.+++.+||+.+|.+||+|+||++.|+++.
T Consensus 349 ~~~~~~~~~~~~~-~--~--------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQFYNAIKRGYRM-A--K--------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHcCCCC-C--C--------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2222222222111 0 0 1112345778888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.53 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=198.7
Q ss_pred ccccCccCceeEEEEEecC-C--ceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLST-G--AMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|++++.++ +||||+++++++...+..++||||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 4579999999999997643 3 24678877743 334456789999999999 79999999999999889999999999
Q ss_pred CCCHHHHhhccCCCC-----------CCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEee
Q 044996 449 KRSLAVNLHGHQALG-----------QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLAD 517 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 517 (678)
+|+|.++++...... ...+++..+..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~d 162 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLASKIAD 162 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCeEEECC
Confidence 999999997543111 12488999999999999999999965 899999999999999999999999
Q ss_pred cCCccccCcc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 518 YGLIPVMNQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 518 fGla~~~~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
||++...... .....+..|+|||++.+..++.++|||||||++|||+| |+.||.. ....++.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~--------~~~~~~~~~~~~~ 234 (297)
T cd05089 163 FGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG--------MTCAELYEKLPQG 234 (297)
T ss_pred cCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHHhcC
Confidence 9998643321 11122457999999988889999999999999999998 9999862 2222333222211
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
. .. .. .......+.+++.+||+.+|.+||++.++++.|+++......
T Consensus 235 ~-~~------~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 235 Y-RM------EK-----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred C-CC------CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 00 00 011234577888899999999999999999999998875533
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=323.54 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=200.0
Q ss_pred hccccCccCceeEEEEEec--------CCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEE
Q 044996 373 SAEILGSGCFGSSYKASLS--------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLL 442 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 442 (678)
..+.||+|+||.||++... +...+|+|.++.. ......++.+|++++.++ +|+||++++++|...+..++
T Consensus 22 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (307)
T cd05098 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 101 (307)
T ss_pred EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 4578999999999999752 2346899988753 234456788999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC
Q 044996 443 VHEFVPKRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL 511 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 511 (678)
||||+++|+|.+++...... ....++|.++++++.|++.||+|||+. +++||||||+|||+++++
T Consensus 102 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 102 IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDN 177 (307)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHHheEEcCCC
Confidence 99999999999999764321 123589999999999999999999965 899999999999999999
Q ss_pred ceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChH
Q 044996 512 EPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLA 584 (678)
Q Consensus 512 ~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~ 584 (678)
.+||+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||.. ....
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~--------~~~~ 249 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VPVE 249 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc--------CCHH
Confidence 99999999987654321 1123357999999988889999999999999999998 8888851 2222
Q ss_pred HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
+..... ..+... + ........+.+++.+|++.+|++||+|.||++.|+++...
T Consensus 250 ~~~~~~-~~~~~~-~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFKLL-KEGHRM-D----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHH-HcCCCC-C----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 332222 221111 0 0112234577888899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.60 Aligned_cols=245 Identities=21% Similarity=0.437 Sum_probs=197.2
Q ss_pred ccccCccCceeEEEEEecC-C---ceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLST-G---AMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|.... + ..+++|+++.. .....+++..|++++++++|+||+++++++...+..++||||++
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 4679999999999998642 3 36889988754 33446779999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+++|.+++..... .+++.++..++.|++.||+|||.. +++||||||+||++++++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 90 NGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999976432 589999999999999999999966 79999999999999999999999999987654321
Q ss_pred cc-------cccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 529 AQ-------ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 529 ~~-------~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
.. ..+..|+|||++....++.++|||||||++|||++ |+.||... ...++...... ....
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~--------~~~~~~~~i~~-~~~~--- 229 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM--------SNHEVMKAIND-GFRL--- 229 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC--------CHHHHHHHHhc-CCCC---
Confidence 11 12346999999988889999999999999999998 99998621 22233332221 1111
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
+ ........+.+++.+||+.+|++||+|.+|++.|+++
T Consensus 230 --~------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 --P------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0112345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.73 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=195.9
Q ss_pred ccccCccCceeEEEEEe-----cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-----STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~Ey 446 (678)
.+.||+|+||.||++.. .++..|++|++........+.|.+|++++++++||||+++++++... ...++||||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 88 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence 46799999999999974 35788999998876666677899999999999999999999987643 468899999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+++|+|.+++..... .++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 89 ~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 89 LPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred cCCCCHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999975432 589999999999999999999976 899999999999999999999999999886543
Q ss_pred ccc-------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCC-------CCCCChHHHHHHHHh
Q 044996 527 ESA-------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGK-------KADGDLASWVNSVLA 592 (678)
Q Consensus 527 ~~~-------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~-------~~~~~l~~~~~~~~~ 592 (678)
... ...+..|+|||++.+..++.++|||||||++|||++|..|+....... .....+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 221 112345999999988889999999999999999999887754111000 000000001111111
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
..... .........+.+++.+||+.+|++||||+||++.|+.++
T Consensus 241 ~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 241 NNGRL-----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cCCcC-----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 11000 011122346888999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=341.82 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=211.0
Q ss_pred HhccccCccCceeEEEEEe-cCC----ceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 372 ASAEILGSGCFGSSYKASL-STG----AMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 372 ~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
...++||+|+||+||||.+ ..| ..|++|++.... ....++|.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457899999999999975 333 478899887643 345678999999999999999999999998765 889999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
||+.|+|.+|++.++. .+.-...+.|..|||+||.|||.+ ++|||||..+|||+.+-..+||.|||+++.+.
T Consensus 778 ~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred hcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999998754 588888999999999999999976 79999999999999999999999999999887
Q ss_pred ccccc------cccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 526 QESAQ------ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 526 ~~~~~------~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
..... ...+.|||-|.+...+|+.++|||||||++||++| |..||+. .-.+-+...++.++.+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g---------i~~~eI~dlle~geRL- 919 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG---------IPAEEIPDLLEKGERL- 919 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC---------CCHHHhhHHHhccccC-
Confidence 65332 23578999999999999999999999999999999 9999872 2344455666665433
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
..++-+..++..++.+||..|+..||+++++...+.++....+
T Consensus 920 ----------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 920 ----------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred ----------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 1233467789999999999999999999999999988765443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=333.43 Aligned_cols=239 Identities=25% Similarity=0.359 Sum_probs=185.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+++|+
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 467999999999999764 68899999986532 3445678999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.... ...+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 159 L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 159 LEGTH---------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred ccccc---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 86432 356677889999999999999976 7999999999999999999999999999866433
Q ss_pred ccccccceeeCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 528 SAQELMIAYKSPEFLQL-----GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~-----~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
....++..|+|||++.. ...+.++|||||||++|||++|+.||... ...+|........... .
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~--------~~~~~~~~~~~~~~~~----~ 293 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG--------RQGDWASLMCAICMSQ----P 293 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC--------CCccHHHHHHHHhccC----C
Confidence 23356789999998743 23356899999999999999999999621 1112222111110000 0
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+.. .......+.+++.+||+.||++||++.|+++.
T Consensus 294 ~~~-----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEA-----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCC-----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 11123457788889999999999999999873
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.97 Aligned_cols=247 Identities=18% Similarity=0.154 Sum_probs=195.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++..++||||+++++++...+..|+||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999875 57899999987532 22345788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-c
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-S 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~ 528 (678)
|+|.+++.... .+++.++..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++..... .
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~ 156 (333)
T cd05600 86 GDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN 156 (333)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCcccccccC
Confidence 99999997543 488999999999999999999976 8999999999999999999999999999765442 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+............ ..+.....
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~--------~~~~~~~~~i~~~~~~~---~~~~~~~~ 225 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG--------STPNETWENLKYWKETL---QRPVYDDP 225 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC--------CCHHHHHHHHHhccccc---cCCCCCcc
Confidence 33467899999999988999999999999999999999999962 12222222222111110 00110000
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
. ......+.+++.+|+..+|.+||++.|+++.
T Consensus 226 ~--~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 R--FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred c--cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 0123456778889999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.19 Aligned_cols=246 Identities=26% Similarity=0.366 Sum_probs=191.5
Q ss_pred cccCccCceeEEEEEec----CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEe-CCceEEEEeccC
Q 044996 375 EILGSGCFGSSYKASLS----TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR-KEEKLLVHEFVP 448 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~Ey~~ 448 (678)
++||+|+||.||+|... ....+++|++... .....+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999753 2357899988643 33456788899999999999999999998764 456889999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|.+++..... .+.+..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.+....
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999975432 467888899999999999999965 79999999999999999999999999987543211
Q ss_pred --------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhC-CCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 529 --------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTG-KFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 529 --------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg-~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
...++..|+|||++....++.++|||||||++|||++| ..||.. ....+....... +...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~--------~~~~~~~~~~~~-~~~~-- 221 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD--------VDSFDITVYLLQ-GRRL-- 221 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHHhc-CCCC--
Confidence 12235679999999888899999999999999999995 555541 122233322221 1111
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
. ........+.+++.+||+.+|++||++.||++.|+++..
T Consensus 222 ----~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 ----L-----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----C-----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 001123457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.23 Aligned_cols=239 Identities=20% Similarity=0.194 Sum_probs=190.8
Q ss_pred ccccCccCceeEEEEEecC--CceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLST--GAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~ 114 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence 4679999999999997543 358999988643 22345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 115 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 115 GGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 999999997643 488999999999999999999966 8999999999999999999999999999876433
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||... +............... .+
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~--------~~~~~~~~i~~~~~~~----p~---- 249 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN--------EPLLIYQKILEGIIYF----PK---- 249 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC--------CHHHHHHHHhcCCCCC----CC----
Confidence 2334678899999999888999999999999999999999999621 1111112222111000 00
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVEK 642 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~~ 642 (678)
.....+.+++.+|++.||.+|+ +++|+++.
T Consensus 250 -----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 -----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1112356777799999999995 78887653
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=314.15 Aligned_cols=241 Identities=20% Similarity=0.355 Sum_probs=191.2
Q ss_pred cCccCceeEEEEEec---CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 377 LGSGCFGSSYKASLS---TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
||+|+||.||+|.+. .+..||+|.+.... ....+.|.+|+.++++++|+||+++++++. ....++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999764 34568999887543 334567999999999999999999999885 4578999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc---
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA--- 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 529 (678)
.+++..... .+++.++++++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 82 NKFLSGKKD----EITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999975432 589999999999999999999976 799999999999999999999999999875433211
Q ss_pred ----ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 530 ----QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 530 ----~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
...+..|+|||++....++.++|||||||++||+++ |+.||... ...++... +..+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~-~~~~~~~-~----- 218 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM--------KGPEVMSF-IEQGKRL-D----- 218 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC--------CHHHHHHH-HHCCCCC-C-----
Confidence 112467999999988889999999999999999996 99998621 22222222 2222111 0
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 219 -----~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 -----CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0112234577788899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=315.68 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=195.7
Q ss_pred ccccCccCceeEEEEEecC----CceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc------eE
Q 044996 374 AEILGSGCFGSSYKASLST----GAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE------KL 441 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~ 441 (678)
.+.||+|+||.||+|.... +..+|+|+++.. .....+.+.+|++.++.++|+||+++++++..... .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 4679999999999997642 367999998753 23445679999999999999999999999876554 78
Q ss_pred EEEeccCCCCHHHHhhccCCC-CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCC
Q 044996 442 LVHEFVPKRSLAVNLHGHQAL-GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL 520 (678)
Q Consensus 442 lv~Ey~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 520 (678)
+||||+++|+|..++...... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECCccc
Confidence 999999999999998654321 123589999999999999999999976 799999999999999999999999999
Q ss_pred ccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 521 IPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 521 a~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
++.+.... ....+..|+|||++....++.++|||||||++|||++ |..||... .-.++..... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~--------~~~~~~~~~~-~ 230 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV--------ENHEIYDYLR-H 230 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHH-c
Confidence 87654321 1223467999999988889999999999999999999 88988621 1112222221 1
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
+... .. .......+.+++.+||+.||++||++.||++.|+++
T Consensus 231 ~~~~-~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL-KQ----------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC-CC----------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 00 112344688888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=319.15 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=197.6
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.|...+..++||||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 467999999999999753 22468888776433 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCC-------------------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe
Q 044996 447 VPKRSLAVNLHGHQAL-------------------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL 507 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl 507 (678)
+.+|+|.+++...... ....+++.+++.++.|++.||+|||+. +++||||||+|||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~nill 160 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAARNVLV 160 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----CeehhhhhhheEEE
Confidence 9999999998653211 112588999999999999999999966 79999999999999
Q ss_pred cCCCceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCC
Q 044996 508 NESLEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKAD 580 (678)
Q Consensus 508 ~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~ 580 (678)
++++.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-------- 232 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-------- 232 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC--------
Confidence 999999999999987653221 1223567999999988889999999999999999999 9999862
Q ss_pred CChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 581 GDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 581 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.....+.. ........ .. .......+.+++.+|++.+|++||++.|+++.|+++...
T Consensus 233 ~~~~~~~~-~~~~~~~~------~~-----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 233 IAPERLFN-LLKTGYRM------ER-----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCHHHHHH-HHhCCCCC------CC-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 12222221 22111110 00 111234577888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.15 Aligned_cols=242 Identities=23% Similarity=0.379 Sum_probs=194.7
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
..+.||+|+||.||+|....+..+++|.+... ....++|.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 34679999999999998877778999988643 23456788999999999999999999999998999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc---
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA--- 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 529 (678)
.++++.... .++|..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 87 ~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 87 LNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred HHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999976432 589999999999999999999976 799999999999999999999999999876543211
Q ss_pred --ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 --QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 --~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...+..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+...... .+... ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~-~~~~~------~~- 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS--------NSEVVESVS-AGYRL------YR- 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC--------HHHHHHHHH-cCCcC------CC-
Confidence 112357999999998899999999999999999999 899986211 111111111 11000 00
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L 643 (678)
.......+.+++.+||+.+|++||||.|+++.|
T Consensus 223 ----~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 ----PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011234588899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.24 Aligned_cols=243 Identities=19% Similarity=0.230 Sum_probs=189.0
Q ss_pred cCccCceeEEEEEec-CCceEEEEEecccCh---hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 377 LGSGCFGSSYKASLS-TGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
||+|+||+||++... +++.+|+|++..... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999764 688999999864322 2335678899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
..++..... ....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 988864322 123589999999999999999999976 89999999999999999999999999987654322
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... ................ .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~----~~~~~~~~~~~~~~~~----------~--- 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG----EKVENKELKQRILNDS----------V--- 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----cchhHHHHHHhhcccC----------C---
Confidence 2246778999999999999999999999999999999999996211 0011111111111110 0
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
.........+.+++.+|++.||++|| +++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 01112234577888899999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=324.41 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=202.6
Q ss_pred HhccccCccCceeEEEEEec--------CCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceE
Q 044996 372 ASAEILGSGCFGSSYKASLS--------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKL 441 (678)
Q Consensus 372 ~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 441 (678)
.+.+.||+|+||.||+|... ....+++|.++.. .....+++.+|++++.++ +|+||++++++|...+..+
T Consensus 15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (334)
T cd05100 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 94 (334)
T ss_pred eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence 34678999999999999642 1236889987753 234457899999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhhccCC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC
Q 044996 442 LVHEFVPKRSLAVNLHGHQA-----------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES 510 (678)
Q Consensus 442 lv~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 510 (678)
+||||+++|+|.+++..... .....++|.+++.++.|++.||+|||.. +++||||||+|||++++
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~Nill~~~ 170 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLAARNVLVTED 170 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCC
Confidence 99999999999999975431 1123589999999999999999999975 89999999999999999
Q ss_pred CceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCCh
Q 044996 511 LEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDL 583 (678)
Q Consensus 511 ~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l 583 (678)
+.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |+.||. ....
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~--------~~~~ 242 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP--------GIPV 242 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC--------CCCH
Confidence 999999999987654321 1122457999999998899999999999999999999 888886 2233
Q ss_pred HHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 584 ASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
.++........ .. .. .......+.+++.+||+.+|.+||+|.|+++.|+++......
T Consensus 243 ~~~~~~~~~~~-~~-~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 243 EELFKLLKEGH-RM-DK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHHHHHHcCC-CC-CC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 44443332211 11 00 111234577888999999999999999999999999865544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=313.43 Aligned_cols=240 Identities=21% Similarity=0.338 Sum_probs=191.4
Q ss_pred ccCccCceeEEEEEe---cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 376 ILGSGCFGSSYKASL---STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.||+|+||.||+|.+ .++..+++|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 489999999999965 356789999886432 334578999999999999999999999885 45678999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA- 529 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 529 (678)
+|.+++.... .+++..+.+++.|++.||+|||.. +|+||||||+||++++++.+||+|||+++.+.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999997542 488999999999999999999966 799999999999999999999999999876543221
Q ss_pred ------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 530 ------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 530 ------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
..++..|+|||.+....++.++|||||||++|||++ |+.||... ...++... +..+... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~-i~~~~~~-~--- 218 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--------KGNEVTQM-IESGERM-E--- 218 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH-HHCCCCC-C---
Confidence 112467999999988889999999999999999998 99998621 12222222 2222111 0
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
. +......+.+++.+||+.||++||+|.+|++.|++
T Consensus 219 --~-----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 --C-----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --C-----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1 11123457788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=314.55 Aligned_cols=238 Identities=19% Similarity=0.301 Sum_probs=199.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|.||.|-+|.. ..|+.||||.+++.. +++.-.+.+||++|+.|+||||+.++.+|.+.+...|||||..+
T Consensus 58 ~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~ 137 (668)
T KOG0611|consen 58 TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASG 137 (668)
T ss_pred HHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCC
Confidence 45699999999999964 689999999988643 34455688999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
|.|++|+..++ .|++.+...+++||..|+.|+|.+ +++|||||.+|||||+|+++||+|||++.++.+...
T Consensus 138 GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 138 GELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF 208 (668)
T ss_pred ccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence 99999998775 489999999999999999999987 899999999999999999999999999988876643
Q ss_pred ---ccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 530 ---QELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 530 ---~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
..|++-|.+||++.+..| .+.+|-||+||+||-|+.|..||+ +.+....++++- .| ....|
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD--------G~Dhk~lvrQIs-~G----aYrEP-- 273 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD--------GRDHKRLVRQIS-RG----AYREP-- 273 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC--------CchHHHHHHHhh-cc----cccCC--
Confidence 345677999999999988 688999999999999999999998 233333333332 22 11111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+.+....-++.+|+..+|++|.|+.+|...
T Consensus 274 -------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 -------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 223345667789999999999999999764
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.83 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=198.1
Q ss_pred hccccCccCceeEEEEEec------CCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 373 SAEILGSGCFGSSYKASLS------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
..+.||+|+||.||++... ....+++|.+... ......++.+|++++.++ +|+||+++++++...+..++||
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence 3467999999999999763 2357889988753 233456788999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHhhccCC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCce
Q 044996 445 EFVPKRSLAVNLHGHQA-----------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEP 513 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~ 513 (678)
||+++|+|..+++.... .....+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CccccccceeeEEEcCCCeE
Confidence 99999999999975321 1123689999999999999999999965 79999999999999999999
Q ss_pred EEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHH
Q 044996 514 VLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASW 586 (678)
Q Consensus 514 kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~ 586 (678)
||+|||+++.+.... ....+..|+|||++.+..++.++|||||||++|||++ |..||.. ....+.
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~--------~~~~~~ 243 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG--------IPVEEL 243 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC--------CCHHHH
Confidence 999999998654321 1123467999999988889999999999999999998 9999862 111111
Q ss_pred HHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 587 VNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
. .....+... .........+.+++.+||+.+|++||||.|+++.|+++.
T Consensus 244 ~-~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 F-KLLKEGYRM-----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-HHHHcCCcC-----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 111111110 011123446788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.97 Aligned_cols=238 Identities=21% Similarity=0.252 Sum_probs=190.4
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
+.||+|+||.||++.. .++..+|+|.++... ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999975 468899999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|..++.... .+++.++..++.||+.||+|||+. .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 9999886543 589999999999999999999963 27999999999999999999999999998753221
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .................
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~--------~~~~~~~~~i~~~~~~~--------- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHEKLFELILMEEIRF--------- 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC--------CCHHHHHHHHhcCCCCC---------
Confidence 123467899999999988999999999999999999999999962 12222222222111111
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+|++.||++|+ ++.++++
T Consensus 216 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 ----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 011123466777899999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=313.64 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=201.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|.. .+++.++||.++.. .......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 46799999999999976 46889999987642 234456789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 87 GDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 999998864322 122578899999999999999999965 89999999999999999999999999987765332
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+..++.++||||||+++|||++|+.||... ..+...+........ . +..
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~------~~~~~~~~~~~~~~~-~------~~~ 228 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLFSLCQKIEQCD-Y------PPL 228 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc------cccHHHHHHHHhcCC-C------CCC
Confidence 224567899999998888999999999999999999999998521 122333333222111 0 110
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
........+.+++.+||+.+|++||++.||++.|++++
T Consensus 229 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 ----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11123355788888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=317.78 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=194.2
Q ss_pred ccccCccCceeEEEEEe-----cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASL-----STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|.. ..+..+++|.++... .....+|.+|++++++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 46799999999999974 345789999987533 334467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCC------------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEE
Q 044996 448 PKRSLAVNLHGHQA------------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVL 515 (678)
Q Consensus 448 ~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 515 (678)
++|+|.+++..... .....+++.+.+.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCCCcEEe
Confidence 99999999864321 0122488999999999999999999976 7999999999999999999999
Q ss_pred eecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHH
Q 044996 516 ADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVN 588 (678)
Q Consensus 516 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~ 588 (678)
+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||.. ........
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~--------~~~~~~~~ 237 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG--------FSNQEVIE 237 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CCHHHHHH
Confidence 9999987653221 1223467999999988889999999999999999999 9999851 11111111
Q ss_pred HHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 589 SVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
........ . ........+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 238 -~~~~~~~~-~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 -MVRKRQLL-P----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHcCCcC-C----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 0 011123457778889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=312.74 Aligned_cols=244 Identities=27% Similarity=0.436 Sum_probs=195.6
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
+.+.||+|+||.||+|....+..+++|.++... ...+.|.+|+.++++++|+||+++++++. ....++||||+++++|
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence 346799999999999998888889999987533 24567999999999999999999999875 4568999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc---
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA--- 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 529 (678)
.++++.... ..+++.++..++.+++.||+|||+. +++||||||+||++++++.+||+|||++..+.....
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 88 LDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 999976432 2589999999999999999999976 799999999999999999999999999876543221
Q ss_pred --ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 --QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 --~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+...... .+... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--------~~~~~~~~~~-~~~~~-~------- 223 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--------NNREVLEQVE-RGYRM-P------- 223 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHH-cCCCC-C-------
Confidence 123467999999988889999999999999999999 89998621 1122222221 11111 0
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
........+.+++.+|++.+|++||||.++.+.|++
T Consensus 224 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 ---CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223457888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=316.88 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=195.8
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... .+..||+|+++... ....+.|.+|+.++.+++||||+++++++......++++||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05091 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY 89 (283)
T ss_pred HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEc
Confidence 467999999999999753 24679999987543 23356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEE
Q 044996 447 VPKRSLAVNLHGHQA-----------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVL 515 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 515 (678)
+++++|.+++..... .....+++..+.+++.|++.||+|||+. +|+||||||+|||+++++.+||
T Consensus 90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCCCceEe
Confidence 999999999863211 0112488899999999999999999966 7999999999999999999999
Q ss_pred eecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHH
Q 044996 516 ADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVN 588 (678)
Q Consensus 516 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~ 588 (678)
+|||+++...... ....+..|+|||++.++.++.++|||||||++|||++ |..||.. ....++..
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--------~~~~~~~~ 237 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG--------YSNQDVIE 237 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHH
Confidence 9999987653321 1123467999999988889999999999999999998 8888752 22233333
Q ss_pred HHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 589 SVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
........ . ........+.+++..||+.+|.+||++++|++.|+.
T Consensus 238 ~i~~~~~~--~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVL--P----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcC--C----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 33322110 0 011233457788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=312.47 Aligned_cols=245 Identities=26% Similarity=0.415 Sum_probs=195.2
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
+.+.||+|+||.||+|...+...+++|+++... ...++|.+|++++++++|+||+++++++. .+..++||||+++|+|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (262)
T cd05071 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (262)
T ss_pred EeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcH
Confidence 356799999999999988777789999987532 34567899999999999999999999874 4568999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc---
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA--- 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 529 (678)
.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++.+.....
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 88 LDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred HHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 999975422 2579999999999999999999976 799999999999999999999999999876543321
Q ss_pred --ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 --QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 --~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..++..|+|||+..+..++.++|||||||++|||+| |+.||... .-.+...... .+...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~--------~~~~~~~~~~-~~~~~--------- 222 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQVE-RGYRM--------- 222 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------ChHHHHHHHh-cCCCC---------
Confidence 223467999999988889999999999999999999 88888621 1111111111 11000
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.........+.+++.+|++.+|++||++.++++.|++.
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=295.13 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=203.2
Q ss_pred ccccCccCceeEEEEE-ecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC-----ceEEEEecc
Q 044996 374 AEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE-----EKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~Ey~ 447 (678)
.+.||+|||+.||.++ ..++..+|+|++.-....+.+..++|++..++++||||+++++++..+. ..||++.|.
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy 105 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYY 105 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehh
Confidence 4579999999999996 5678899999998777778889999999999999999999998876443 489999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
..|+|.+.+......+. .+++.+.+.|+.+|++||++||...+ .+.||||||.|||+.+.+.+++.|||.+....-.
T Consensus 106 ~~Gsl~d~i~~~k~kg~-~~sE~~iL~if~gic~gL~~lH~~~~--~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 106 KRGSLLDEIERLKIKGN-FVSEAQILWIFLGICRGLEALHEKEP--PYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ 182 (302)
T ss_pred ccccHHHHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHHhccCC--cccccCCCcceeEecCCCceEEEeccCccccceE
Confidence 99999999987655443 69999999999999999999998743 4889999999999999999999999998654321
Q ss_pred -------------ccccccceeeCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHH
Q 044996 528 -------------SAQELMIAYKSPEFLQL---GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL 591 (678)
Q Consensus 528 -------------~~~~~~~~y~aPE~~~~---~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~ 591 (678)
....-|+.|+|||.+.- .-.++++|||||||+||+|+.|..||+....
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------------- 246 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------------- 246 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------------
Confidence 11224688999998853 3468999999999999999999999984322
Q ss_pred hcCCcc-ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 592 ANGDNR-TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 592 ~~~~~~-~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
.|..+ ..+....+..... ......+.+++.+|++.||.+||+..+++..++.+.
T Consensus 247 -~GgSlaLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 -QGGSLALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -cCCeEEEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 22222 1233333321111 124556788888999999999999999999988653
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=319.54 Aligned_cols=240 Identities=21% Similarity=0.320 Sum_probs=189.3
Q ss_pred cccCccCceeEEEEEecC--------CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 375 EILGSGCFGSSYKASLST--------GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997532 224777777655445567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc--------eEEeec
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE--------PVLADY 518 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~--------~kl~Df 518 (678)
+++|+|.++++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +|++||
T Consensus 81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999986532 589999999999999999999976 8999999999999987765 699999
Q ss_pred CCccccCccccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCC-CCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 519 GLIPVMNQESAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGK-FPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 519 Gla~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~-~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
|++..........++..|+|||++.+ ..++.++|||||||++|||++|. .|+... ....... .......
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~--------~~~~~~~-~~~~~~~ 223 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL--------DSQKKLQ-FYEDRHQ 223 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc--------cHHHHHH-HHHcccc
Confidence 99876655544556788999999976 45799999999999999999985 555411 1111111 1111100
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
+ +.....++.+++.+||+.+|++|||++++++.|+
T Consensus 224 --------~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 --------L-----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------C-----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 0111235788888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=312.53 Aligned_cols=243 Identities=22% Similarity=0.319 Sum_probs=196.5
Q ss_pred cccCccCceeEEEEEecC--C--ceEEEEEecccCh-hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLST--G--AMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||.||+|.+.+ + ..+++|.+..... ...++|.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 2 3589999886554 566789999999999999999999999988 889999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++..... ..++|..+..++.|++.||+|||.. +++||||||+||+++.++.+||+|||+++.+....
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999986532 2589999999999999999999976 89999999999999999999999999987764421
Q ss_pred ------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 529 ------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 529 ------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
...++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+..+.........
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~--------~~~~~~~~~~~~~~~~~---- 220 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG--------LSGSQILKKIDKEGERL---- 220 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHHhcCCcC----
Confidence 1234568999999988899999999999999999999 9999862 12222222222211111
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
.........+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 -------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001122356788888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=324.65 Aligned_cols=191 Identities=25% Similarity=0.350 Sum_probs=166.4
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
..+.||+|+||.||++... ++..+++|.++.. .....+.+.+|++++++++|+||++++++|...+..++||||+++|
T Consensus 9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (333)
T cd06650 9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (333)
T ss_pred eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCC
Confidence 3467999999999999875 5778888887653 3344567999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--c
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--S 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~ 528 (678)
+|.+++.... .+++.....++.+++.||.|||+.. +|+||||||+|||+++++.+||+|||++..+... .
T Consensus 89 ~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 160 (333)
T cd06650 89 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160 (333)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccc
Confidence 9999997543 4788899999999999999999642 5999999999999999999999999998765432 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 2346788999999998889999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.26 Aligned_cols=237 Identities=24% Similarity=0.277 Sum_probs=188.9
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||.||+|+.. +++.+|+|.++... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999764 57899999987532 23345677888888866 799999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|..++.... .+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 99999887543 488999999999999999999976 7999999999999999999999999998753221
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+............... +.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~--------~~~~~~~~~i~~~~~~~-----p~- 217 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA--------DNEDDLFESILHDDVLY-----PV- 217 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCCCC-----CC-
Confidence 122367889999999988999999999999999999999999972 22223333333221111 10
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCC-------CHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRL-------DLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-------s~~ev~~ 641 (678)
.....+.+++.+|++.||++|| ++.++++
T Consensus 218 -------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 218 -------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1123466777899999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.48 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=196.8
Q ss_pred ccccCccCceeEEEEEe------cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASL------STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||++.. .++..+++|.+........+.|.+|+++++.++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 46799999999999964 235678899888766667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCC----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEee
Q 044996 448 PKRSLAVNLHGHQAL----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLAD 517 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 517 (678)
++|+|.++++..... ....+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCCCEEECC
Confidence 999999999764311 112589999999999999999999965 799999999999999999999999
Q ss_pred cCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHH
Q 044996 518 YGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSV 590 (678)
Q Consensus 518 fGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~ 590 (678)
||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||... .-.+.+...
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~~~~~ 237 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL--------SNTEAIECI 237 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC--------CHHHHHHHH
Confidence 99987543221 1123467999999998899999999999999999999 99998521 111122211
Q ss_pred HhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 591 LANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
. .+... . ........+.+++.+||+.||.+||++.||.+.|+
T Consensus 238 ~-~~~~~-~----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 T-QGREL-E----------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-cCccC-C----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 11111 0 01112345778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=316.47 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=200.0
Q ss_pred ccccCccCceeEEEEEecC-----CceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEe-CCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLST-----GAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR-KEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~Ey 446 (678)
.++||+|+||.||+|.... +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.. ....++++||
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 4679999999999998765 678899988753 33446778999999999999999999999876 4678999999
Q ss_pred cCCCCHHHHhhccCCC---CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 447 VPKRSLAVNLHGHQAL---GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
+++|+|.+++...... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 9999999999764321 113589999999999999999999965 799999999999999999999999999986
Q ss_pred cCcccc------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 524 MNQESA------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 524 ~~~~~~------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
+..... ..++..|+|||++.+..++.++|||||||++||+++ |+.||... ...++..... .+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~-~~~~ 237 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--------DPFEMAAYLK-DGYR 237 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--------CHHHHHHHHH-cCCC
Confidence 543211 223567999999988889999999999999999999 99998621 2222222111 1111
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
. . . .......+.+++.+||+.+|++|||+.||++.|+++...
T Consensus 238 ~-~--~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 L-A--Q--------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred C-C--C--------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1 0 0 011234578888999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.91 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=195.3
Q ss_pred ccccCccCceeEEEEEe-----cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-----STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 445 (678)
.+.||+|+||+||++.. .++..+|+|.++... ....+.|.+|++++++++||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 45799999999988643 357789999987543 33467788999999999999999999998754 35789999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++|+|.+++... .+++.++..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 89 ~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 89 YVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999753 489999999999999999999976 79999999999999999999999999987664
Q ss_pred cccc-------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 526 QESA-------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 526 ~~~~-------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
.... ...+..|+|||++....++.++||||||+++|||+||+.|+....... .....+....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~-~~~~ 234 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF---EEMIGPKQGQMTV-VRLI 234 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh---hhhhcccccccch-hhhh
Confidence 3211 123456999999988889999999999999999999999986321100 0000000000000 0000
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
+.++..... .........+.+++.+||+.+|++||||++|++.|+++.
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111100 011123456888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=312.71 Aligned_cols=238 Identities=24% Similarity=0.345 Sum_probs=189.3
Q ss_pred cccCccCceeEEEEEecCCc-----------eEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEE
Q 044996 375 EILGSGCFGSSYKASLSTGA-----------MMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 443 (678)
+.||+|+||.||+|...... .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999875433 4677766544332 6789999999999999999999999988 778999
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-------ceEEe
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-------EPVLA 516 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-------~~kl~ 516 (678)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999986532 589999999999999999999965 899999999999999888 79999
Q ss_pred ecCCccccCccccccccceeeCccccccC--CCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 517 DYGLIPVMNQESAQELMIAYKSPEFLQLG--RITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 517 DfGla~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
|||++..........+...|+|||++... .++.++|||||||++|||++ |..|+.... ...+..... .
T Consensus 151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--------~~~~~~~~~-~ 221 (259)
T cd05037 151 DPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--------SSEKERFYQ-D 221 (259)
T ss_pred CCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--------chhHHHHHh-c
Confidence 99999876554444556789999999876 78999999999999999999 577775321 111211111 1
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
.... .. .....+.+++.+||..+|.+|||+.||++.|+
T Consensus 222 ~~~~---------~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHRL---------PM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCC---------CC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1000 00 01145788888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=313.58 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=187.5
Q ss_pred ccCccCceeEEEEEecC---CceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 376 ILGSGCFGSSYKASLST---GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.||+|+||.||+|...+ +..+++|+++... ......|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999997643 4578899887543 3344578999999999999999999999998889999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.++++..........++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999765432223567888889999999999999966 79999999999999999999999999987543221
Q ss_pred ---cccccceeeCccccccC-------CCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 529 ---AQELMIAYKSPEFLQLG-------RITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~-------~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
...++..|+|||++... .++.++|||||||++|||++ |+.||..... .....+ ..... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~~~~~~---~~~~~-~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----EQVLTY---TVREQ-QL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHH---Hhhcc-cC
Confidence 12245679999988532 35889999999999999996 9999963211 111111 11111 11
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
...++.+... ....+.+++.+|+ .+|++|||++||++.|+
T Consensus 229 -~~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 -KLPKPRLKLP-----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -CCCCCccCCC-----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222222111 1223566777998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=314.15 Aligned_cols=245 Identities=21% Similarity=0.436 Sum_probs=195.7
Q ss_pred ccccCccCceeEEEEEecC-C---ceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLST-G---AMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|.... + ..|++|.++.. ......+|..|+.++++++||||+++++++..++..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 4679999999999998643 2 36899998754 34456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|.+++..... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 89 NGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred CCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999976432 589999999999999999999976 89999999999999999999999999987654321
Q ss_pred cc---------cccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 529 AQ---------ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 529 ~~---------~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
.. ..+..|+|||++.+..++.++|||||||++|||++ |+.||... +..+...... .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~--------~~~~~~~~i~-~~~~~- 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------SNQDVINAIE-QDYRL- 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC--------CHHHHHHHHH-cCCcC-
Confidence 11 11347999999998899999999999999999987 99998621 1111111111 11110
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
....+....+.+++.+||+.+|.+||+|.+|+..|+++
T Consensus 231 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 ----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00112234577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=324.55 Aligned_cols=232 Identities=23% Similarity=0.262 Sum_probs=186.2
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||.||+|+.. +++.||+|.++.. .....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999864 5789999998743 123345677888888876 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 99999887543 488999999999999999999976 8999999999999999999999999998753221
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+............... +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~--------~~~~~~~~~i~~~~~~~-----~-- 216 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA--------ENEDDLFEAILNDEVVY-----P-- 216 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC--------CCHHHHHHHHhcCCCCC-----C--
Confidence 223467899999999988999999999999999999999999962 22233333333221111 1
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
......+.+++.+|++.||.+||++
T Consensus 217 ------~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 ------TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0112346778889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=328.96 Aligned_cols=234 Identities=21% Similarity=0.242 Sum_probs=187.8
Q ss_pred cccCccCceeEEEEEe----cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 375 EILGSGCFGSSYKASL----STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
+.||+|+||.||+++. .+++.+|+|+++... ......+..|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999864 367899999987532 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999986542 589999999999999999999976 7999999999999999999999999998765433
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+...............
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~--------~~~~~~~~~i~~~~~~~------- 217 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG--------KDRKETMTMILKAKLGM------- 217 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC--------CCHHHHHHHHHcCCCCC-------
Confidence 122467889999999888899999999999999999999999962 12222222222211111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKE 638 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e 638 (678)
+......+.+++.+||+.||++||++.+
T Consensus 218 ------p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 ------PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0111234667778999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=318.68 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=188.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... ++..||+|.++... ......+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence 457999999999999764 67899999887432 2234567899999999999999999999999889999999997 59
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 89 l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 89 LKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 9998875432 478899999999999999999965 8999999999999999999999999998754322
Q ss_pred ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC-----------
Q 044996 528 SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD----------- 595 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~----------- 595 (678)
....++..|+|||++.+ ..++.++||||+||++|||+||+.||... ...+.+......-.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS--------TVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHHhCCCChHHhhccc
Confidence 12345778999998865 56899999999999999999999998621 11222211111000
Q ss_pred ---ccccccchhhhccc---CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 596 ---NRTEVFDKEMADER---NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 596 ---~~~~~~d~~l~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+...... .......+..+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000000 00001234677888999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=320.28 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=197.3
Q ss_pred ccccCccCceeEEEEEec-CCc--eEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGA--MMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... ++. .+++|.++.. .....+.|.+|++++.++ +|+||+++++++...+..++||||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 467999999999999864 343 4577776643 234456789999999999 89999999999999999999999999
Q ss_pred CCCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEee
Q 044996 449 KRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLAD 517 (678)
Q Consensus 449 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 517 (678)
+|+|.++++..... ....+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~~~kl~d 167 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIAD 167 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCCcEEeCc
Confidence 99999999754321 113588999999999999999999965 899999999999999999999999
Q ss_pred cCCccccCcc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 518 YGLIPVMNQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 518 fGla~~~~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
||+++..... .....+..|+|||++.+..++.++|||||||++|||+| |..||... ...+...... .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~~~-~ 238 (303)
T cd05088 168 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELYEKLP-Q 238 (303)
T ss_pred cccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC--------ChHHHHHHHh-c
Confidence 9998643221 11223467999999988889999999999999999998 99998621 1122222111 1
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
+... + . .......+.+++.+||+.+|++||++.++++.|+++.....
T Consensus 239 ~~~~-~-----~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 239 GYRL-E-----K-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred CCcC-C-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 1000 0 0 01122357788889999999999999999999998866554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=320.87 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=200.4
Q ss_pred hccccCccCceeEEEEEec--------CCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEE
Q 044996 373 SAEILGSGCFGSSYKASLS--------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLL 442 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 442 (678)
..+.||+|+||.||+|... ....+++|.++.. ......++.+|+++++++ +||||++++++|...+..++
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 4578999999999999642 2456888988753 234456788999999999 69999999999998889999
Q ss_pred EEeccCCCCHHHHhhccCC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC
Q 044996 443 VHEFVPKRSLAVNLHGHQA-----------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL 511 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 511 (678)
||||+++|+|.+++..... .....++|.++++++.|++.||.|||+. +++||||||+|||+++++
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAARNVLVTEDN 171 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeeccccceeEEEcCCC
Confidence 9999999999999976431 1123589999999999999999999976 899999999999999999
Q ss_pred ceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChH
Q 044996 512 EPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLA 584 (678)
Q Consensus 512 ~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~ 584 (678)
.+||+|||+++...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||.. ....
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~--------~~~~ 243 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG--------IPVE 243 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC--------CCHH
Confidence 99999999997654321 1122356999999988889999999999999999999 8999862 1222
Q ss_pred HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
+... ....+... +. .......+.+++.+||+.+|++||++.|+++.|+++.....+
T Consensus 244 ~~~~-~~~~~~~~-~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 244 ELFK-LLREGHRM-DK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred HHHH-HHHcCCCC-CC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 2222 22222111 00 111234577888899999999999999999999999875544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.16 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=193.9
Q ss_pred ccccCccCceeEEEEEecC------CceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLST------GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|.... +..|++|.+.... ......|.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 4679999999999998753 5678888876433 33456799999999999999999999999998999999999
Q ss_pred cCCCCHHHHhhccCCC--CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC---ceEEeecCCc
Q 044996 447 VPKRSLAVNLHGHQAL--GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL---EPVLADYGLI 521 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla 521 (678)
+++|+|.++++..... ....++|.++++++.||+.||+|||.. +++||||||+|||++.++ .+||+|||++
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceEeccCccc
Confidence 9999999999765321 112589999999999999999999976 799999999999998754 6999999999
Q ss_pred cccCcccc------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 522 PVMNQESA------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 522 ~~~~~~~~------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
+.+..... ...+..|+|||++.+..++.++|||||||++|||++ |+.||... .....+.......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~--------~~~~~~~~~~~~~ 238 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR--------TNQEVMEFVTGGG 238 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHcCC
Confidence 86633211 112457999999988899999999999999999997 99998621 1122222221111
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
.. . ........+.+++.+|++.+|++||++.+|++.|+
T Consensus 239 -~~-~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 -RL-D----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -cC-C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 10 0 01112345788888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=293.45 Aligned_cols=249 Identities=23% Similarity=0.294 Sum_probs=200.0
Q ss_pred ccchHHHHHHhccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC
Q 044996 363 RFDLHDLLRASAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE 438 (678)
Q Consensus 363 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 438 (678)
.++++++ .+++.||+|.||.||.|+.+ ++-.||+|++.+.. .....++.+|+++-+.|+||||+++|++|.+..
T Consensus 18 ~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 18 TWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 4455554 35788999999999999864 56789999986532 233567899999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeec
Q 044996 439 EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADY 518 (678)
Q Consensus 439 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 518 (678)
..||++||.++|.|...|..... ..++......++.|+|.||.|+|.. +|+||||||+|+|++.++..||+||
T Consensus 96 riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999999999985543 2578888889999999999999965 7999999999999999999999999
Q ss_pred CCccccCc--cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 519 GLIPVMNQ--ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 519 Gla~~~~~--~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
|.+..-.. ...-.+|+-|.+||+..+..++.++|+|++||+.||++.|..||+... .+-..+.+. .
T Consensus 169 GwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---------~~etYkrI~---k 236 (281)
T KOG0580|consen 169 GWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---------HSETYKRIR---K 236 (281)
T ss_pred CceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---------hHHHHHHHH---H
Confidence 99765432 233457888999999999999999999999999999999999997211 111111111 1
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ++.+|. .......+++.+|+..+|.+|.+..||++
T Consensus 237 ~-~~~~p~--------~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 237 V-DLKFPS--------TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred c-cccCCc--------ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1 223331 22344678888999999999999999986
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=314.29 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=185.9
Q ss_pred ccCccCceeEEEEEecC---CceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 376 ILGSGCFGSSYKASLST---GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.||+|+||.||+|.... ...+++|.+.... ......|.+|+++++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3467788765432 3345678899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++...........++...+.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999765432223457888899999999999999976 7999999999999999999999999998654322
Q ss_pred --ccccccceeeCcccccc-------CCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 528 --SAQELMIAYKSPEFLQL-------GRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~-------~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
....++..|+|||++.. ..++.++|||||||++|||++ |+.||.... . .+-..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-------~-~~~~~~~~~~~~~- 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-------D-EQVLKQVVREQDI- 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-------H-HHHHHHHhhccCc-
Confidence 11223567999998743 356889999999999999999 788886211 1 1112222222111
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L 643 (678)
...++.+. ......+.+++..|| .||++|||++||++.|
T Consensus 229 -~~~~~~~~-----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 -KLPKPQLD-----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -cCCCCccc-----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 12222221 112234566777888 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=310.75 Aligned_cols=243 Identities=25% Similarity=0.380 Sum_probs=193.5
Q ss_pred cccCccCceeEEEEEecC----CceEEEEEecccCh-hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLST----GAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||.||+|.+.. +..+++|.+..... ...+++.+|+.++++++|+|||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999996532 26899999875433 34567999999999999999999999876 4568999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
|+|.+++.... .+++..++.++.|++.||+|||.. +++||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999997653 489999999999999999999976 799999999999999999999999999876543221
Q ss_pred c-------cccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 530 Q-------ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 530 ~-------~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
. .++..|+|||.+.+..++.++|||||||++|||++ |+.||... .-.+...... ..... .
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~--------~~~~~~~~~~-~~~~~-~-- 218 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--------KGAEVIAMLE-SGERL-P-- 218 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHH-cCCcC-C--
Confidence 1 12357999999988899999999999999999998 99998632 1122222211 11111 0
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
........+.+++.+||+.+|++||++.++++.|+++.
T Consensus 219 --------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 --------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01112345778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.29 Aligned_cols=252 Identities=19% Similarity=0.311 Sum_probs=197.3
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... .+..|++|.++... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 467999999999999653 24578999876443 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCC-----CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCc
Q 044996 447 VPKRSLAVNLHGHQA-----LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 521 (678)
+++|+|.++++.... .+.+.+++..+.+++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCcEEECcCCcc
Confidence 999999999975321 1224567888999999999999999976 7999999999999999999999999998
Q ss_pred cccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 522 PVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 522 ~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
+...... ...++..|+|||++.+..++.++|||||||++|||++ |+.||.. ....++.......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~--------~~~~~~~~~~~~~~ 238 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG--------LSNEQVLKFVMDGG 238 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHHcCC
Confidence 7543321 1123467999999988889999999999999999999 7888862 12223222222111
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.. . ........+.+++.+|++.+|++||||.++++.|++....
T Consensus 239 -~~-~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 239 -YL-D----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred -CC-C----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 11 0 0112234688888899999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=316.70 Aligned_cols=245 Identities=18% Similarity=0.224 Sum_probs=190.3
Q ss_pred cCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 377 LGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 377 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
||+|+||.||+++. .+|+.+++|.+.... ......+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 468999999986421 12234556799999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---A 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 529 (678)
.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....... .
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 988865432 2588999999999999999999965 89999999999999999999999999987654332 2
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|+|||++.+..++.++|||||||++|||++|+.||.... ......+..+....... . ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~------~--~~~~- 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK----EKVAKEELKRRTLEDEV------K--FEHQ- 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc----chhhHHHHHHHhhcccc------c--cccc-
Confidence 346788999999988889999999999999999999999986211 11111122222211110 0 0000
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
.....+.+++.+||+.||++||+++|+++.+.
T Consensus 221 ---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 221 ---NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ---cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 12234678888999999999999988764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.05 Aligned_cols=235 Identities=24% Similarity=0.290 Sum_probs=183.9
Q ss_pred ccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhc-cCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 376 ILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGR-LRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
+||+|+||.||+|... +++.||+|.++... ....+.+..|..++.. .+||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5999999999999864 57889999987532 2233455667777665 48999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|..++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 82 DLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 9999987542 488899999999999999999975 8999999999999999999999999998754321
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+............
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~--------~~~~~~~~~i~~~~~~~--------- 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG--------EDEDELFDSILNDRPHF--------- 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCCC---------
Confidence 223467889999999988999999999999999999999999962 12222222222111111
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHH-HHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLK-EAV 640 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-ev~ 640 (678)
+......+.+++.+||+.||.+||++. ++.
T Consensus 216 ----~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 ----PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 011123456777799999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.04 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=198.3
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|... ++.+++|.++.... ..+++.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 467999999999999874 78899999986543 5678999999999999999999999999889999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-ccc
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA-QEL 532 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~ 532 (678)
+++..... ..++|..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++....... ...
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 161 (256)
T cd05039 89 DYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL 161 (256)
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEcccccccccccccccCCC
Confidence 99976532 2589999999999999999999976 799999999999999999999999999987643322 223
Q ss_pred cceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCC
Q 044996 533 MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNS 611 (678)
Q Consensus 533 ~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 611 (678)
+..|+|||++..+.++.++||||||+++|||++ |+.||.. ....+ +......+... +. .
T Consensus 162 ~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~--------~~~~~-~~~~~~~~~~~-~~----------~ 221 (256)
T cd05039 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------IPLKD-VVPHVEKGYRM-EA----------P 221 (256)
T ss_pred cccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC--------CCHHH-HHHHHhcCCCC-CC----------c
Confidence 567999999988889999999999999999998 9999862 11111 11122111110 00 0
Q ss_pred HHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 612 EGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
......+.+++.+||+.+|++||++.|++++|+.+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11234577888899999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=301.16 Aligned_cols=189 Identities=22% Similarity=0.309 Sum_probs=162.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhh--HHHHHHHHHHHhccCCCCccceeEEEEe--CCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVG--REEFQEHMRRLGRLRHPNLLPLVAYYYR--KEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~Ey~~ 448 (678)
.+.|++|.||.||+|+. ++++.||+|+++-..+.. .-.-.+||.+|.+++|||||.+..+... -+..|||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 46799999999999976 568899999998543211 2235789999999999999999988764 357999999997
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+ ||..+++.... ++...+..-++.|+++|++|||.+ -|+|||||++|+|+...|.+||+|||+||.+....
T Consensus 161 h-DLksl~d~m~q----~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 161 H-DLKSLMETMKQ----PFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred h-hHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 6 99999987542 688899999999999999999987 69999999999999999999999999999987652
Q ss_pred ----cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 529 ----AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
....|..|+|||.+.+ ..|++..|+||+|||+.||++++.-|.
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 2346789999998876 468999999999999999999998775
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=321.37 Aligned_cols=235 Identities=24% Similarity=0.301 Sum_probs=185.3
Q ss_pred ccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhc-cCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 376 ILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGR-LRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 5899999999999865 57889999987532 2234456677777776 49999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 82 DLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 9999997542 488999999999999999999976 8999999999999999999999999998653211
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+......... +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~--------~~~~~~~~~i~~~~--------~~~- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG--------HDEEELFQSIRMDN--------PCY- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCC--------CCC-
Confidence 223467889999999988999999999999999999999999962 12222222221111 101
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHH-HHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLK-EAV 640 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-ev~ 640 (678)
+......+.+++.+|++.||++||++. ++.
T Consensus 216 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 ----PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ----CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 011123456778899999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=310.58 Aligned_cols=243 Identities=25% Similarity=0.383 Sum_probs=194.5
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEE-eCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYY-RKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||++... +..+++|.++.. ...+.|.+|+.++++++|+||+++++++. ..+..++||||+++|+|
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 467999999999999764 777899988643 33567899999999999999999999865 44578999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-cccc
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-SAQE 531 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~~~~ 531 (678)
.++++.... ..+++..++.++.|++.||+|||.. +++||||||+||++++++.+||+|||+++..... ....
T Consensus 88 ~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 160 (256)
T cd05082 88 VDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 160 (256)
T ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccCCCCc
Confidence 999976432 2588999999999999999999966 7999999999999999999999999998754432 2223
Q ss_pred ccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccC
Q 044996 532 LMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERN 610 (678)
Q Consensus 532 ~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (678)
.+..|+|||++....++.++|||||||++|||++ |+.||.. ..+.+...... .+... ..
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~--------~~~~~~~~~~~-~~~~~-~~---------- 220 (256)
T cd05082 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------IPLKDVVPRVE-KGYKM-DA---------- 220 (256)
T ss_pred cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHh-cCCCC-CC----------
Confidence 4567999999988889999999999999999998 9999861 23333332222 11111 10
Q ss_pred CHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 611 SEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011234577888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=311.93 Aligned_cols=262 Identities=21% Similarity=0.292 Sum_probs=191.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC-----ceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE-----EKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~Ey~ 447 (678)
.+++|+|+||.||+|.+. +++.||||+.-.... .-.+|+++|++++|||||+|+-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 367999999999999864 568999999865433 2246899999999999999998887532 245899999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC-CceEEeecCCccccCc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES-LEPVLADYGLIPVMNQ 526 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~ 526 (678)
+. +|.++++.... ....++...+.-+..||.+||+|||.. +|+||||||.|+|+|.+ +.+||||||.|+.+..
T Consensus 105 P~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 87 89998875311 112466677788999999999999975 89999999999999976 9999999999998865
Q ss_pred cccc---cccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC-------
Q 044996 527 ESAQ---ELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD------- 595 (678)
Q Consensus 527 ~~~~---~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~------- 595 (678)
.... ..+..|+|||.+.+ ..|+.+.||||.|||+.||+-|+.-|. +......++..++-+-...+
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp----G~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP----GDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC----CCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 5433 34567999998876 579999999999999999999998886 22212233332221111110
Q ss_pred -ccccccchhhhccc----CCHHHHHHHHHHHhhcCccccccCCCHHHHHHH--HHHhhcc
Q 044996 596 -NRTEVFDKEMADER----NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK--IEEVKER 649 (678)
Q Consensus 596 -~~~~~~d~~l~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L~~i~~~ 649 (678)
...+.-.+.+.... .......+.++++.++++.+|.+|.++.|++.. ..++++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 01111222222211 122335567888899999999999999999863 5555554
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.51 Aligned_cols=233 Identities=22% Similarity=0.289 Sum_probs=184.7
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHH-HHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMR-RLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||+||+|... +++.||+|.+.... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 35999999999999864 68899999987432 222344555544 56789999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999987542 588999999999999999999976 8999999999999999999999999998753221
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+............ .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~--------~~~~~~~~~i~~~~~~~----~~-- 217 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RDTAEMYDNILNKPLRL----KP-- 217 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC--------CCHHHHHHHHHcCCCCC----CC--
Confidence 122367889999999988999999999999999999999999962 23333333333221111 01
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLK 637 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ 637 (678)
.....+.+++.+|++.||.+||+++
T Consensus 218 -------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -------NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -------CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1123467788899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.31 Aligned_cols=248 Identities=22% Similarity=0.322 Sum_probs=201.0
Q ss_pred hccccCccCceeEEEEEecC--C--ceEEEEEecccChh-hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 373 SAEILGSGCFGSSYKASLST--G--AMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
..|+||+|.||.|++|.|.. | ..||||.++..... ..++|.+|+.+|.+|+|+|+++|||+..+ ...+||||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 45789999999999998753 3 46899999865433 67899999999999999999999999987 7789999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
+.|+|.+.|+... ...|-......++.|||.||.||..+ ++|||||..+|+||-..-.+||+|||+.+-+...
T Consensus 193 plGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred ccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999998732 23577778889999999999999865 7999999999999999999999999999887654
Q ss_pred ccc-------cccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 528 SAQ-------ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 528 ~~~-------~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
... ...+.|.|||.+...+++.++|||+|||++|||+| |..||.... -.+ ++ +
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~q----IL-------~ 326 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQ----IL-------K 326 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHH----HH-------H
Confidence 332 23578999999999999999999999999999999 899986211 111 11 2
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
.+|..-. ......+..+|.+++..||..+|.+|||+..+.+.+-....
T Consensus 327 ~iD~~er-LpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 327 NIDAGER-LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred hcccccc-CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 2221100 11234577889999999999999999999999866544433
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.94 Aligned_cols=248 Identities=21% Similarity=0.366 Sum_probs=196.0
Q ss_pred ccccCccCceeEEEEEe-cCCc----eEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASL-STGA----MMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.++||+|+||+||+|.+ .++. .||+|.++.. .....+++.+|+.++..++|+||+++++++.. ...+++|||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~ 90 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM 90 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence 46799999999999975 3444 3789988753 33446678999999999999999999999975 4578999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.++++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 91 PYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred CCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999976432 589999999999999999999976 7999999999999999999999999999876432
Q ss_pred cc------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 SA------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~~------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
.. ...+..|+|||.+.+..++.++|||||||++|||++ |+.||+... ...+..+ +..+... ..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~----~~~~~~~-~~ 232 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDL----LEKGERL-PQ 232 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH----HHCCCcC-CC
Confidence 21 123467999999988889999999999999999998 999986211 1112222 2221111 00
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.......+.+++.+||+.||++||++.|+++.|+++....
T Consensus 233 ----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 233 ----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0112345778888999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.52 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=196.2
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
..+.||+|+||.||++.. ..+..+|+|.++... ....+.+.+|+++++++ +|+||+++++++...+..++||
T Consensus 39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 118 (302)
T cd05055 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVIT 118 (302)
T ss_pred EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEE
Confidence 457899999999999964 234578999887543 33456789999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+++|+|.++++.... ..+++.++..++.|++.||+|||+. +|+|+||||+|||+++++.+|++|||+++..
T Consensus 119 e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 119 EYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999975432 2489999999999999999999976 7999999999999999999999999998765
Q ss_pred Ccccc------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 525 NQESA------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 525 ~~~~~------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
..... ..++..|+|||++....++.++|||||||++|||+| |+.||... ....-.......+...
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~~ 263 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM--------PVDSKFYKLIKEGYRM 263 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC--------CchHHHHHHHHcCCcC
Confidence 43211 123467999999988889999999999999999998 99998621 1111111222221110
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
. ........+.+++.+|++.+|++|||+.||++.|+++
T Consensus 264 -~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 -A----------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -C----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 0001124578888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.98 Aligned_cols=190 Identities=22% Similarity=0.302 Sum_probs=166.8
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccCh---hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
+...||+|+||.||+|+. .+|..+|+|++++..- ...+....|-.+|...++|.||+|+..|++.+.+||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 457899999999999975 5799999999987543 345667889999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc--
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ-- 526 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~-- 526 (678)
|||+..+|...+ .|+......++.+++.|++-||+. |+|||||||+|+|||..|++||+||||+.-+..
T Consensus 225 GGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 225 GGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred CccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999998764 588888899999999999999976 899999999999999999999999999742110
Q ss_pred ---------------------c-c---------------------------cccccceeeCccccccCCCCCcchHHHHH
Q 044996 527 ---------------------E-S---------------------------AQELMIAYKSPEFLQLGRITKKTDVWSLG 557 (678)
Q Consensus 527 ---------------------~-~---------------------------~~~~~~~y~aPE~~~~~~~t~ksDvwS~G 557 (678)
. . ...||+-|||||++.+..|+..+|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 0 01256779999999999999999999999
Q ss_pred HHHHHHHhCCCCcc
Q 044996 558 VLILEIMTGKFPAN 571 (678)
Q Consensus 558 vvl~el~tg~~P~~ 571 (678)
||+|||+.|-.||.
T Consensus 376 ~ImyEmLvGyPPF~ 389 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFC 389 (550)
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999999997
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=321.42 Aligned_cols=237 Identities=25% Similarity=0.290 Sum_probs=189.5
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||+||+|... ++..+|+|.++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999765 57889999987532 23345677888888887 799999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|..++.... .+++.++..++.|++.||+|||.. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 99999887543 589999999999999999999965 8999999999999999999999999998653211
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+...............
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~--------~~~~~~~~~i~~~~~~~-------- 215 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG--------DDEDELFQSILEDEVRY-------- 215 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC--------CCHHHHHHHHHcCCCCC--------
Confidence 122357889999999989999999999999999999999999962 12222222222221110
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCH-----HHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDL-----KEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~ev~~ 641 (678)
.......+.+++.+||+.||.+||++ .++++
T Consensus 216 -----~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 -----PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 01122346778889999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.39 Aligned_cols=242 Identities=20% Similarity=0.277 Sum_probs=204.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc-eEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE-KLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lv~Ey~~~ 449 (678)
.+.+|+|+||.++..+.+ ++..+|+|++.-. +...++...+|+.++++++|||||.+++.|..++. .+|||+|++|
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 467999999999999754 5678999988743 34556678899999999999999999999999888 9999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+.+...+. ..+.+.++.+++.|++.|+.|||++ .|+|||||+.||+++++..+||.|||+|+.+....
T Consensus 89 g~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 89 GDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred CCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999987652 2588999999999999999999966 79999999999999999999999999999988764
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...||+.||+||.+.+.+|..|+||||+||++|||++-+.+|. ..++...+..+.... ++|
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~--------a~~m~~Li~ki~~~~------~~P-- 225 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK--------ASNMSELILKINRGL------YSP-- 225 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC--------ccchHHHHHHHhhcc------CCC--
Confidence 3457899999999999999999999999999999999999997 345555554444332 111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.+..+...+..++..|++.+|..||++.+++.+
T Consensus 226 ----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 ----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123345567777889999999999999999986
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.14 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=195.6
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeC-CceEEE
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRK-EEKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~~~lv 443 (678)
..+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||++++++|... ...++|
T Consensus 11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (343)
T cd05103 11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (343)
T ss_pred ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence 467899999999999963 356789999997533 23346788999999999 689999999988754 467899
Q ss_pred EeccCCCCHHHHhhccCCC-------------------------------------------------------------
Q 044996 444 HEFVPKRSLAVNLHGHQAL------------------------------------------------------------- 462 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~------------------------------------------------------------- 462 (678)
|||+++|+|.++++.....
T Consensus 91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T cd05103 91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170 (343)
T ss_pred EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence 9999999999998753210
Q ss_pred -CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc------cccccce
Q 044996 463 -GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES------AQELMIA 535 (678)
Q Consensus 463 -~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~ 535 (678)
....++|.++.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...++..
T Consensus 171 ~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 171 LYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 012478889999999999999999965 89999999999999999999999999987643221 1223467
Q ss_pred eeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHH
Q 044996 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGE 614 (678)
Q Consensus 536 y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 614 (678)
|+|||++.+..++.++|||||||++|||++ |..||... .........+..+... .. +. ..
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~~~~~~~-~~--~~--------~~ 307 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--------KIDEEFCRRLKEGTRM-RA--PD--------YT 307 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc--------cccHHHHHHHhccCCC-CC--CC--------CC
Confidence 999999988889999999999999999997 99998621 1111112222222111 00 00 11
Q ss_pred HHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 615 MVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 615 ~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
...+.+++..||+.+|++|||+.||++.|+.+.+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 23578889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=320.81 Aligned_cols=236 Identities=24% Similarity=0.269 Sum_probs=185.6
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhc-cCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGR-LRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||.||+|+.. ++..||+|.++... ....+.+..|.+++.. ++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999864 67899999987532 2234456677777775 4899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc---
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ--- 526 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~--- 526 (678)
|+|..++.... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 99999987542 488999999999999999999976 899999999999999999999999999864321
Q ss_pred -cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 527 -ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 527 -~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+............ +.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~--------~~~~~~~~~~~~~~--------~~~ 215 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG--------DDEDELFESIRVDT--------PHY 215 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCC--------CCC
Confidence 1223467899999999988999999999999999999999999962 12222222222111 111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHH-HHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLK-EAV 640 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-ev~ 640 (678)
.. .....+.+++.+|++.||++||++. ++.
T Consensus 216 ~~-----~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PR-----WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CC-----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00 1123456777799999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=323.20 Aligned_cols=237 Identities=25% Similarity=0.311 Sum_probs=186.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHH---hccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRL---GRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ ++++||||+++++++...+..|+||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 457999999999999764 68899999987532 22345566676654 567899999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+++|+|..+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999888642 589999999999999999999975 899999999999999999999999999875322
Q ss_pred c----ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 527 E----SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 527 ~----~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+............
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~--------~~~~~~~~~i~~~~~~~----- 220 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG--------DDEEEVFDSIVNDEVRY----- 220 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC-----
Confidence 1 123467889999999988999999999999999999999999962 22223333322221111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+||+.||.+|| ++.++++
T Consensus 221 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 --------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111223467788899999999999 4556554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.99 Aligned_cols=252 Identities=21% Similarity=0.279 Sum_probs=201.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +++.+++|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 457999999999999875 7889999988632 233466899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++..... ....+++.++..++.+++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 87 ~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 87 GDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999875322 123589999999999999999999965 89999999999999999999999999987654322
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||... ..++.++........ . +.+
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~--~-----~~~ 228 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEKCD--Y-----PPL 228 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC------CccHHHHHhhhhcCC--C-----CCC
Confidence 223567899999998888999999999999999999999998521 123333332222110 0 000
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
........+.+++.+||+.+|++||++.+|+++|+++.
T Consensus 229 ----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 ----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01123345778888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.89 Aligned_cols=252 Identities=20% Similarity=0.264 Sum_probs=200.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|.. .++..++||.+... ......++.+|+++++.++|+||+++++++..++..+++|||+++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 35699999999999985 57889999987643 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|.+++..... ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 87 GDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999874322 123589999999999999999999976 89999999999999999999999999987654322
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+..++.++||||||+++|||++|+.||... ......+....... ..+.+
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~-------~~~~~ 228 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEQC-------DYPPL 228 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc------cchHHHHhhhhhcC-------CCCCC
Confidence 224567899999998888999999999999999999999998521 11222222221111 01111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
. .......+.+++.+||+.+|.+||||.+|++.++++.
T Consensus 229 ~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 P----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 1123345778888999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.20 Aligned_cols=243 Identities=26% Similarity=0.436 Sum_probs=193.4
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|....+..+++|.+.... ...+.+.+|++++++++|+||+++++++. .+..++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 35699999999999988777789999876532 34567899999999999999999999875 45689999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
++++.... ..++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 89 DFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred HHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 99976432 2589999999999999999999966 79999999999999999999999999997654321
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....+..|+|||++.+..++.++|||||||++|||+| |+.||... .-.+...... .+...
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~~~-~~~~~---------- 222 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--------VNREVLEQVE-RGYRM---------- 222 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHH-cCCCC----------
Confidence 1223567999999988899999999999999999999 99998621 1111111111 11000
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
.........+.+++.+||+.+|.+||++++|++.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011223457788889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=314.40 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=196.1
Q ss_pred hccccCccCceeEEEEEec------CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASLS------TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
..+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++|+||+++++++......++|||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence 3567999999999999764 23679999986542 3445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCC-----CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCC
Q 044996 446 FVPKRSLAVNLHGHQAL-----GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL 520 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 520 (678)
|+++|+|.+++...... ....++|..++.++.|++.||.|||+. +++||||||+|||+++++.+||+|||+
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCCEEECCccc
Confidence 99999999999754321 122478999999999999999999965 799999999999999999999999999
Q ss_pred ccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 521 IPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 521 a~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
++.+.... ...++..|+|||.+..+.++.++|||||||++|||+| |+.||... .......... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--------~~~~~~~~~~-~ 236 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--------SNEEVLKFVI-D 236 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC--------CHHHHHHHHh-c
Confidence 87654321 2234578999999988889999999999999999998 99998621 1122222111 1
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
+... . . .......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 237 ~~~~-~-----~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHL-D-----L-----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCC-C-----C-----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111 0 0 1112446788899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=317.43 Aligned_cols=255 Identities=20% Similarity=0.353 Sum_probs=193.5
Q ss_pred ccccCccCceeEEEEEecC---------------CceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC
Q 044996 374 AEILGSGCFGSSYKASLST---------------GAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK 437 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~ 437 (678)
.+.||+|+||.||++.... ...||+|.++.. .......|.+|++++++++|+||+++++++...
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 89 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD 89 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 4679999999999986532 235889988753 334456799999999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHHhhccCCC-------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC
Q 044996 438 EEKLLVHEFVPKRSLAVNLHGHQAL-------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES 510 (678)
Q Consensus 438 ~~~~lv~Ey~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 510 (678)
+..++||||+++++|.+++...... ..+.++|.++++++.|++.||+|||.. +++||||||+||+++++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nill~~~ 165 (295)
T cd05097 90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRNCLVGNH 165 (295)
T ss_pred CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChhhEEEcCC
Confidence 9999999999999999999653210 112478999999999999999999966 79999999999999999
Q ss_pred CceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh--CCCCccccccCCCCCCC
Q 044996 511 LEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT--GKFPANFLQQGKKADGD 582 (678)
Q Consensus 511 ~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t--g~~P~~~~~~~~~~~~~ 582 (678)
+.+||+|||+++...... ...++..|+|||++..+.++.++|||||||++|||++ |..||..... ..
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-----~~ 240 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-----EQ 240 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-----HH
Confidence 999999999987543221 1123567999999988889999999999999999998 6677752211 11
Q ss_pred hHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 583 LASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 583 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
....+............... .......+.+++.+||+.+|++||+|++|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQ--------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHhhhhccccccCCC--------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111100000000 01123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=307.59 Aligned_cols=242 Identities=24% Similarity=0.381 Sum_probs=195.6
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccCh-hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
++||+|+||.||++....++.|++|.++.... ...+.|.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999887799999998876433 35678999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... .+++..++.++.+++.||+|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 81 TFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99975432 588999999999999999999976 79999999999999999999999999987654211
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....+..|+|||++.++.++.++|||||||++|||+| |..||... ....+..... .....
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~--------~~~~~~~~~~-~~~~~--------- 214 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM--------SNQQTRERIE-SGYRM--------- 214 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC--------CHHHHHHHHh-cCCCC---------
Confidence 1122456999999988889999999999999999999 88888621 1112221111 11000
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
.........+.+++.+|++.+|.+||++.|+++.|+
T Consensus 215 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 --PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 011122346888889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=316.55 Aligned_cols=258 Identities=18% Similarity=0.203 Sum_probs=190.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|+.. +++.+|+|+++... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence 467999999999999875 57889999987532 334567889999999999999999999999999999999999987
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
.+..+.... ..+++..+..++.|++.||.|||.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 86 MLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 776544322 2588999999999999999999965 79999999999999999999999999998764321
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCC-------CCCChHHHHHHHHhcCCccc
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKK-------ADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~-------~~~~l~~~~~~~~~~~~~~~ 598 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||........ ......++........ ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP-RFH 235 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc-hhc
Confidence 12357789999999888899999999999999999999999962110000 0000001111111110 000
Q ss_pred cccchhhhccc-----CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADER-----NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
....+...... ........+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 00012345788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=338.94 Aligned_cols=244 Identities=19% Similarity=0.217 Sum_probs=194.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC--------ceEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE--------EKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~l 442 (678)
.++||+|+||+||+|+. .+++.||||.+... .......+++|+.++..++|+||+++...+...+ ..++
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l 116 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence 46799999999999975 57899999998643 3445567889999999999999999988775432 3679
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
||||+++|+|.++++..... ...+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 117 V~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 117 VLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 99999999999999754322 23588999999999999999999976 89999999999999999999999999987
Q ss_pred ccCcc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 523 VMNQE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 523 ~~~~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
.+... ....++..|+|||++.+..++.++|||||||++|||++|+.||. .......+.........
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~--------~~~~~~~~~~~~~~~~~ 263 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------GENMEEVMHKTLAGRYD 263 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC--------CCCHHHHHHHHhcCCCC
Confidence 65432 12346788999999998899999999999999999999999996 23344444443322110
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+ + +......+.+++.+||+.||.+||++.++++.
T Consensus 264 ------~-~-----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 ------P-L-----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ------C-C-----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 0 11123457788889999999999999999863
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.47 Aligned_cols=243 Identities=24% Similarity=0.421 Sum_probs=195.5
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.++||+|+||.||+|...+++.+++|.+.... ...++|.+|+.++++++|+||+++++++. .+..++||||+++|+|.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHH
Confidence 46799999999999998888999999987543 34568999999999999999999999874 56789999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 89 ~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 89 DFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence 99875432 2589999999999999999999965 79999999999999999999999999987655221
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++....++.++|||||||++|||++ |+.||... .-.+..... ..+... ..
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~-~~~~~~-~~------- 224 (260)
T cd05067 162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM--------TNPEVIQNL-ERGYRM-PR------- 224 (260)
T ss_pred CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC--------ChHHHHHHH-HcCCCC-CC-------
Confidence 1223467999999988889999999999999999999 99998621 112222211 111111 00
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
.......+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 ---PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01123457888889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.72 Aligned_cols=245 Identities=22% Similarity=0.430 Sum_probs=195.2
Q ss_pred ccccCccCceeEEEEEec----CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS----TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... .+..+++|.++... ....+.|.+|+.++++++||||+++++++..++..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 467999999999999763 23368899886532 3445689999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|.+++..... .+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.+....
T Consensus 89 ~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 89 NGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999976432 589999999999999999999965 79999999999999999999999999987654321
Q ss_pred c-------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 529 A-------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 529 ~-------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
. ...+..|+|||++.+..++.++|||||||++||+++ |+.||... ...+.... +.++...
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~--------~~~~~~~~-~~~~~~~--- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM--------SNQDVIKA-IEEGYRL--- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC--------CHHHHHHH-HhCCCcC---
Confidence 1 112357999999998889999999999999999887 99998622 11111111 1111110
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
+ ........+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 229 --~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 --P------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --C------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0111234567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=319.36 Aligned_cols=252 Identities=20% Similarity=0.302 Sum_probs=187.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh-hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|+.. +++.+|+|+++.... .....+.+|+.++++++||||+++++++.+.+..++||||+. ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 457999999999999875 688999999875332 233467889999999999999999999999999999999995 68
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 89 l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 89 LCQYMDKHPG----GLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 8888865432 488899999999999999999976 7999999999999999999999999998754322
Q ss_pred ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh---cCCc--cc---
Q 044996 528 SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA---NGDN--RT--- 598 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~---~~~~--~~--- 598 (678)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||... .+..+....... .... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM-------KDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-------ccHHHHHHHHHHHhCCCChhhccchh
Confidence 12345678999998865 45799999999999999999999999632 112222211111 0000 00
Q ss_pred --cccchh---------hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 --EVFDKE---------MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 --~~~d~~---------l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..+++. +............+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 0000000001234667888999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.73 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=196.5
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... ++..+++|.+.... ....++|.+|+.++++++||||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 457999999999999753 46789999887543 34456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCC-----------------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC
Q 044996 447 VPKRSLAVNLHGHQA-----------------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE 509 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~ 509 (678)
+++|+|.+++..... .....+++.+++.++.|++.||+|||.. +++||||||+||++++
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p~nil~~~ 165 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLATRNCLVGE 165 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccHhheEecC
Confidence 999999999974321 1123578999999999999999999966 7999999999999999
Q ss_pred CCceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCC
Q 044996 510 SLEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGD 582 (678)
Q Consensus 510 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~ 582 (678)
++.+||+|||+++.+.... ....+..|+|||++.+..++.++|||||||++|||++ |..||.. ..
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~--------~~ 237 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG--------MA 237 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------CC
Confidence 9999999999987543221 1223467999999988899999999999999999998 8888751 22
Q ss_pred hHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 583 LASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 583 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
..++..... .+... . ........+.+++.+|++.+|++|||+.|+++.|++
T Consensus 238 ~~~~~~~~~-~~~~~-~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HEEVIYYVR-DGNVL-S----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHh-cCCCC-C----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 233333222 22111 0 011223457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.64 Aligned_cols=246 Identities=29% Similarity=0.441 Sum_probs=197.9
Q ss_pred cccCccCceeEEEEEecC----CceEEEEEecccChh-hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLST----GAMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
+.||+|+||.||+|.... +..+++|.++..... ..+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999998754 788999998864333 367899999999999999999999999998999999999999
Q ss_pred CCHHHHhhccCCC----CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 450 RSLAVNLHGHQAL----GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 450 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
++|.+++...... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999865211 013689999999999999999999965 79999999999999999999999999998765
Q ss_pred cc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 526 QE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 526 ~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
.. .....+..|+|||.+....++.++|||||||++|||++ |+.||... ...+....... +...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~-~~~~- 226 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--------SNEEVLEYLRK-GYRL- 226 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHHc-CCCC-
Confidence 43 12334678999999988889999999999999999999 69998732 22222222221 1111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
. ........+.+++.+||+.+|++|||+.|+++.|+
T Consensus 227 --~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 --P--------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --C--------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 01122345788888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=317.19 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=195.5
Q ss_pred ccccCccCceeEEEEEecC-----------------CceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEE
Q 044996 374 AEILGSGCFGSSYKASLST-----------------GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYY 435 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 435 (678)
.+.||+|+||.||+|.... +..+++|.+.... ....+.|.+|++++++++||||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 4679999999999987532 2457889887543 345678999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHhhccCCC------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC
Q 044996 436 RKEEKLLVHEFVPKRSLAVNLHGHQAL------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE 509 (678)
Q Consensus 436 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~ 509 (678)
.++..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+. +++||||||+||++++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~Nili~~ 165 (296)
T cd05051 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATRNCLVGK 165 (296)
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----CccccccchhceeecC
Confidence 999999999999999999999765421 122589999999999999999999965 7999999999999999
Q ss_pred CCceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh--CCCCccccccCCCCCC
Q 044996 510 SLEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT--GKFPANFLQQGKKADG 581 (678)
Q Consensus 510 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t--g~~P~~~~~~~~~~~~ 581 (678)
++.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |..||.... ..
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-----~~ 240 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-----DQ 240 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-----hH
Confidence 9999999999987543221 2223568999999988889999999999999999998 777875211 11
Q ss_pred ChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 582 DLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 582 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
.+...+.......... ... + .......++.+++.+|++.||.+||||.||++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~-~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQ-IYL-P------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhcccccccc-ccC-C------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111211111111111 000 0 01112346888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=306.67 Aligned_cols=242 Identities=21% Similarity=0.286 Sum_probs=195.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... ++..+++|.+... .....+++.+|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 357999999999999764 6788999988642 3455678999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.++++.... ..+++.++.+++.|++.||.|||.. +++|+||||+||++++++.+||+|||+++.+....
T Consensus 85 ~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 85 DLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred cHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99999986422 2589999999999999999999965 89999999999999999999999999987654432
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||... .-.......... ... .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~-~~~------~~- 221 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN--------NQGALILKIIRG-VFP------PV- 221 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcC-CCC------CC-
Confidence 123567899999999888999999999999999999999998621 111112222111 100 00
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.......+.+++.+||+.+|++||+|.++++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11233457888889999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.32 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=187.4
Q ss_pred ccCccCceeEEEEEecCC---ceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 376 ILGSGCFGSSYKASLSTG---AMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.||+|+||.||+|...++ ..+++|.++... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975443 345667665433 3446789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc-----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ----- 526 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~----- 526 (678)
|.++++..... ...+++..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999764321 22467778889999999999999965 799999999999999999999999999764221
Q ss_pred -cccccccceeeCcccccc-------CCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 527 -ESAQELMIAYKSPEFLQL-------GRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 527 -~~~~~~~~~y~aPE~~~~-------~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||.. ....+.......... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~--------~~~~~~~~~~~~~~~-~ 227 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH--------LSDREVLNHVIKDQQ-V 227 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHHhhcc-c
Confidence 122335678999998753 245789999999999999997 5678752 122333333333221 1
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
...++.+... ...++.+++..|| .+|++||+|++|++.|.
T Consensus 228 -~~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 -KLFKPQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -ccCCCccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3344443221 1234666777899 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.87 Aligned_cols=255 Identities=22% Similarity=0.376 Sum_probs=194.6
Q ss_pred ccccCccCceeEEEEEec-----------------CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEE
Q 044996 374 AEILGSGCFGSSYKASLS-----------------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYY 435 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 435 (678)
.+.||+|+||.||+++.. +...+++|.+... ......+|.+|++++++++|+||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI 89 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 467999999999998532 2346889988754 3345678999999999999999999999999
Q ss_pred eCCceEEEEeccCCCCHHHHhhccCCCC------CCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC
Q 044996 436 RKEEKLLVHEFVPKRSLAVNLHGHQALG------QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE 509 (678)
Q Consensus 436 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~ 509 (678)
..+..++||||+++|+|.+++....... ...+++.++..++.|++.||+|||+. +++||||||+|||+++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp~Nili~~ 165 (296)
T cd05095 90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATRNCLVGK 165 (296)
T ss_pred cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCChheEEEcC
Confidence 9999999999999999999997643211 12478899999999999999999976 7999999999999999
Q ss_pred CCceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh--CCCCccccccCCCCCC
Q 044996 510 SLEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT--GKFPANFLQQGKKADG 581 (678)
Q Consensus 510 ~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t--g~~P~~~~~~~~~~~~ 581 (678)
++.+||+|||+++.+.... ....+..|+|||+...+.++.++|||||||++|||++ |..||..... .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-----~ 240 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-----E 240 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-----H
Confidence 9999999999987653321 1122467999999888889999999999999999998 7788862211 1
Q ss_pred ChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 582 DLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 582 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
.....+.......... ...+. ...+...+.+++.+||+.||.+||+|.||++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~--~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGEFFRDQGRQ--VYLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHhhcccc--ccCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111000 00000 11233567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.06 Aligned_cols=242 Identities=21% Similarity=0.257 Sum_probs=188.7
Q ss_pred ccccCccCceeEEEEEe----cCCceEEEEEecccC----hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 374 AEILGSGCFGSSYKASL----STGAMMVVKRFKQMN----NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
.+.||+|+||.||+++. .++..+|+|.++... ....+.+..|++++.++ +|+||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 46799999999999975 357899999987432 22345678899999999 5999999999999999999999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 85 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 85 DYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999997543 488999999999999999999976 7999999999999999999999999998764
Q ss_pred Cccc-----cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 525 NQES-----AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 525 ~~~~-----~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
.... ...++..|+|||++.+. .++.++|||||||++|||+||+.||..... ...............
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~~~~~~~~~~---- 227 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE----RNTQSEVSRRILKCD---- 227 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC----CCCHHHHHHHHhcCC----
Confidence 3221 23467889999999765 478999999999999999999999963211 111112222222111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+.+. ......+.+++.+|++.||++|| +++++++
T Consensus 228 ----~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 ----PPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CCCC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111 11223466778899999999999 7777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.80 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=196.5
Q ss_pred hccccCccCceeEEEEEe-----cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEE
Q 044996 373 SAEILGSGCFGSSYKASL-----STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 444 (678)
..+.||+|+||.||++.. .++..+++|.++... ....+.+.+|++++++++|+||+++++++... ...++||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05079 8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 87 (284)
T ss_pred hceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEE
Confidence 456799999999999974 357789999987543 34456799999999999999999999998875 5688999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+++++|.+++..... .++|.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.+
T Consensus 88 e~~~g~~L~~~l~~~~~----~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 88 EFLPSGSLKEYLPRNKN----KINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EccCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999865422 589999999999999999999976 8999999999999999999999999998765
Q ss_pred Cccc-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccC-------CCCCCChHHHHHHH
Q 044996 525 NQES-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQG-------KKADGDLASWVNSV 590 (678)
Q Consensus 525 ~~~~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~-------~~~~~~l~~~~~~~ 590 (678)
.... ...++..|+|||++.+..++.++|||||||++|||+|++.|....... ......+..++ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HH
Confidence 4321 122345699999998888999999999999999999988764311000 00111112221 11
Q ss_pred HhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 591 LANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
+..+... . ........+.+++.+|++.+|++||++.++++.|+++
T Consensus 239 ~~~~~~~-~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRL-P----------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccC-C----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 2221111 0 0112345688899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=323.53 Aligned_cols=254 Identities=18% Similarity=0.271 Sum_probs=186.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC-----ceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE-----EKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~E 445 (678)
.++||+|+||.||+|.. .++..||||+++.. .......+.+|++++++++||||+++++++.... ..|+|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 46799999999999975 46889999998742 2233457889999999999999999999986432 4799999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 85 LME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred cCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 995 78999887542 489999999999999999999976 89999999999999999999999999987543
Q ss_pred cc-------ccccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC-
Q 044996 526 QE-------SAQELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD- 595 (678)
Q Consensus 526 ~~-------~~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~- 595 (678)
.. ....++..|+|||++.+ ..++.++|||||||++|||+||+.||..... .....++........
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLLGTPSP 229 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCCH
Confidence 22 12246778999999865 6789999999999999999999999862110 000111111110000
Q ss_pred ---------ccccccchhhhccc--CC---HHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 596 ---------NRTEVFDKEMADER--NS---EGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 596 ---------~~~~~~d~~l~~~~--~~---~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
...+.++....... .. ......+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000000 00 0112346788889999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=293.28 Aligned_cols=197 Identities=24% Similarity=0.337 Sum_probs=173.4
Q ss_pred cchHHHHHHhccccCccCceeEEEEEec-CCceEEEEEecccCh---hhHHHHHHHHHHHhccCCCCccceeEEEEeCCc
Q 044996 364 FDLHDLLRASAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE 439 (678)
Q Consensus 364 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 439 (678)
+++++.. ....||.|+||.|.+++.+ +|..+|+|.++...- ...+...+|..+|+.+.||+++++++.|.+.+.
T Consensus 41 ~~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 3444442 3467999999999999864 678999999986443 334567789999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecC
Q 044996 440 KLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519 (678)
Q Consensus 440 ~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 519 (678)
+||||||+++|.|..+|++.+ .++.....-+|.||+.||+|||+. .|++|||||+|||||.+|.+||.|||
T Consensus 119 lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEecc
Confidence 999999999999999998765 488888999999999999999966 79999999999999999999999999
Q ss_pred CccccCcc-ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 520 LIPVMNQE-SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 520 la~~~~~~-~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
+|+.+... -.-.||+.|+|||.+....|..++|.|||||++|||+.|..||.
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 99887654 23457899999999999999999999999999999999999997
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.72 Aligned_cols=244 Identities=22% Similarity=0.273 Sum_probs=191.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||+||++... ++..||+|++.... ......+.+|+.++++++|+||+++++++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 357999999999999764 68899999986532 22235578899999999999999999999998999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 85 GDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99998886532 12589999999999999999999976 79999999999999999999999999987654322
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+...+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~---------- 222 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK-----EKVKREEVERRVKEDQE---------- 222 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc-----hhhHHHHHHHHhhhccc----------
Confidence 2345788999999988889999999999999999999999997211 01111111111111100
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
.........+.+++.+||+.||++|| +++++++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 --EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred --ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 01112234567888899999999999 7777755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=307.37 Aligned_cols=241 Identities=22% Similarity=0.404 Sum_probs=195.4
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|.+.++..+++|.++.. .....+|.+|++++++++||||+++++++......++||||+++++|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 4679999999999998877888999988643 234567999999999999999999999999989999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... .+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 88 DYLRAQRG----KFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred HHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99975432 488999999999999999999976 79999999999999999999999999987543321
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....+.+|+|||++.++.++.++|||||||++|||++ |+.||.. ......+.... ++. ...++..
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--------~~~~~~~~~~~-~~~---~~~~~~~-- 225 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN--------RSNSEVVETIN-AGF---RLYKPRL-- 225 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc--------CCHHHHHHHHh-CCC---CCCCCCC--
Confidence 1123468999999988899999999999999999998 9999862 22222332222 111 1111111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L 643 (678)
....+.+++.+||+.+|++||+|.||++.|
T Consensus 226 ------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124578889999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.89 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=186.7
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHH-HHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMR-RLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||+||+|+. .+++.+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3599999999999976 468899999986431 223345555654 46789999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|..++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99998887542 588999999999999999999965 8999999999999999999999999998753221
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+........... +.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~--------~~~~~~~~~~~~~~~~----~~~-- 217 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC--------RDVAEMYDNILHKPLV----LRP-- 217 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC--------CCHHHHHHHHHcCCcc----CCC--
Confidence 223467889999999988999999999999999999999999962 2222333333222110 111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L 643 (678)
.....+.+++.+|++.+|.+||++++.++.+
T Consensus 218 -------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 218 -------GASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred -------CCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 1123466778899999999999887544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=328.40 Aligned_cols=241 Identities=19% Similarity=0.268 Sum_probs=189.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||.||+|+.. +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 467999999999999864 68899999997532 23345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 86 GDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred cHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999997643 489999999999999999999976 79999999999999999999999999986542110
Q ss_pred -----------------------------------------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCC
Q 044996 529 -----------------------------------------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGK 567 (678)
Q Consensus 529 -----------------------------------------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~ 567 (678)
...+|..|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 123678899999999889999999999999999999999
Q ss_pred CCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCC---HHHHHH
Q 044996 568 FPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLD---LKEAVE 641 (678)
Q Consensus 568 ~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~ev~~ 641 (678)
.||.. .+............... .. + .... ....+.+++.+|+. +|.+|++ +.|+++
T Consensus 237 ~Pf~~--------~~~~~~~~~i~~~~~~~-~~--~---~~~~---~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCS--------DNPQETYRKIINWKETL-QF--P---DEVP---LSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCC--------CCHHHHHHHHHcCCCcc-CC--C---CCCC---CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99962 12222222222111111 00 0 0001 12234566667886 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=328.74 Aligned_cols=189 Identities=20% Similarity=0.263 Sum_probs=164.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||+||+|+. .+++.+|+|++.... ....+.+.+|++++.+++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 45799999999999975 467899999987532 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.||+.||+|||.. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 86 GDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999997643 478888899999999999999975 8999999999999999999999999997533100
Q ss_pred -------------------------------------------------ccccccceeeCccccccCCCCCcchHHHHHH
Q 044996 528 -------------------------------------------------SAQELMIAYKSPEFLQLGRITKKTDVWSLGV 558 (678)
Q Consensus 528 -------------------------------------------------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gv 558 (678)
....+|..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0124678899999998888999999999999
Q ss_pred HHHHHHhCCCCcc
Q 044996 559 LILEIMTGKFPAN 571 (678)
Q Consensus 559 vl~el~tg~~P~~ 571 (678)
++|||+||+.||.
T Consensus 237 il~elltG~~Pf~ 249 (381)
T cd05626 237 ILFEMLVGQPPFL 249 (381)
T ss_pred HHHHHHhCCCCCc
Confidence 9999999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.27 Aligned_cols=246 Identities=26% Similarity=0.420 Sum_probs=192.8
Q ss_pred ccCccCceeEEEEEecC-------CceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 376 ILGSGCFGSSYKASLST-------GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.||+|+||.||+|...+ +..+++|.+.... ......|.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999997642 2578888876432 244667899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCC--CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-----ceEEeecCC
Q 044996 448 PKRSLAVNLHGHQAL--GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-----EPVLADYGL 520 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-----~~kl~DfGl 520 (678)
++|+|.++++..... ....++|.+++.++.|++.||+|||+. +++|+||||+||+++.+. .+|++|||+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999754321 123588999999999999999999965 799999999999999887 899999999
Q ss_pred ccccCcc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 521 IPVMNQE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 521 a~~~~~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
++..... .....+..|+|||++.++.++.++|||||||++|||+| |+.||... .-.+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~--------~~~~~~~~~-~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--------NNQEVLQHV-TA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc--------CHHHHHHHH-hc
Confidence 8755322 11223568999999998899999999999999999998 99998621 111111111 11
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
+... .........+.+++.+||+.+|.+||++++|++.|++
T Consensus 229 ~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGRL-----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCcc-----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1100 0011234457788889999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=328.23 Aligned_cols=242 Identities=20% Similarity=0.246 Sum_probs=193.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 467999999999999865 68899999987532 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++.... .+++..+..++.||+.||+|||.. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 86 GDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999997652 588999999999999999999975 89999999999999999999999999987654332
Q ss_pred --------------------------------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccC
Q 044996 529 --------------------------------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQG 576 (678)
Q Consensus 529 --------------------------------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~ 576 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~---- 232 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS---- 232 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC----
Confidence 22367889999999999999999999999999999999999972
Q ss_pred CCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCC-HHHHHHH
Q 044996 577 KKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLD-LKEAVEK 642 (678)
Q Consensus 577 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~ev~~~ 642 (678)
................. .-+. .. .....+.+++.+|+. ||.+||+ +.|+++.
T Consensus 233 ----~~~~~~~~~i~~~~~~~---~~p~---~~---~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 ----DTLQETYNKIINWKESL---RFPP---DP---PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----CCHHHHHHHHhccCCcc---cCCC---CC---CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 12222222222211000 0000 00 023346677779997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.31 Aligned_cols=189 Identities=20% Similarity=0.274 Sum_probs=165.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||+||+|... +++.+|+|+++... ......+.+|+.++.+++|+||+++++++.+....|+||||+++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 467999999999999754 68899999987532 23345688899999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 86 GDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999997642 589999999999999999999965 8999999999999999999999999998754321
Q ss_pred -------------------------------------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCc
Q 044996 528 -------------------------------------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPA 570 (678)
Q Consensus 528 -------------------------------------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~ 570 (678)
....+|..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 1124678899999999889999999999999999999999999
Q ss_pred c
Q 044996 571 N 571 (678)
Q Consensus 571 ~ 571 (678)
.
T Consensus 237 ~ 237 (363)
T cd05628 237 C 237 (363)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=322.40 Aligned_cols=233 Identities=22% Similarity=0.317 Sum_probs=183.5
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHH-HHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMR-RLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
++||+|+||.||+|+.. +++.+|+|.+.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 67889999986432 222344555554 57889999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|..++.... .+.+.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 99998886542 478888899999999999999965 7999999999999999999999999998753221
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+.............. +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--------~~~~~~~~~i~~~~~~--------~ 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RDVSQMYDNILHKPLQ--------L 215 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC--------CCHHHHHHHHhcCCCC--------C
Confidence 122357889999999988899999999999999999999999962 2333333333322110 0
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLK 637 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ 637 (678)
+......+.+++.+|++.||.+||++.
T Consensus 216 -----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 -----PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111233567888899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=307.38 Aligned_cols=244 Identities=26% Similarity=0.428 Sum_probs=197.4
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|...++..++||.+... ....+++.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 4679999999999999887888999988753 344578999999999999999999999999888999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... ..+++.++..++.+++.||.|||++ +++|+||||+||++++++.+||+|||+++......
T Consensus 90 ~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (261)
T cd05034 90 DFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE 162 (261)
T ss_pred HHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence 99976432 2589999999999999999999976 79999999999999999999999999987654321
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....+..|+|||.+.+..++.++|||||||++|||+| |+.||... ........... +... .
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--------~~~~~~~~~~~-~~~~---~------ 224 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--------TNREVLEQVER-GYRM---P------ 224 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHc-CCCC---C------
Confidence 1123457999999998889999999999999999999 99998621 11112221111 1000 0
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
........+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 --RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001123457888889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=308.42 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=195.8
Q ss_pred hccccCccCceeEEEEEecC----CceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 373 SAEILGSGCFGSSYKASLST----GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
..+.||+|+||.||+|...+ ...+++|...... ....+.|.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 35679999999999997643 2468888887544 4456789999999999999999999999865 5678999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++..++.++.+++.||+|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 89 PLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred CCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999976432 589999999999999999999965 7999999999999999999999999998765433
Q ss_pred cc-----ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 528 SA-----QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 528 ~~-----~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
.. ...+..|+|||.+....++.++|||||||++|||++ |+.||.... ......+ +..+... .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~----~~~~~~~-~-- 228 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-----NNDVIGR----IENGERL-P-- 228 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHH----HHcCCcC-C--
Confidence 21 122357999999988889999999999999999996 999986221 0111111 1111111 0
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
........+.+++.+|+..+|++|||+.++++.|+++...
T Consensus 229 --------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 229 --------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0112234577888899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=313.49 Aligned_cols=240 Identities=23% Similarity=0.329 Sum_probs=193.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|.. .++..+++|.+........+.+.+|+.+++.++|+||+++++++......++||||+++++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 35699999999999975 46889999998765555567889999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.+++... .+++.++..++.|++.||+|||.. +|+||||||+|||+++++.+||+|||++.......
T Consensus 105 ~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 9998643 478999999999999999999966 79999999999999999999999999987654321
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||... ....+.......... .+.
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~--------~~~~~~~~~~~~~~~-------~~~-- 237 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--------NPLRALYLIATNGTP-------ELQ-- 237 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC--------CHHHhHHHHhcCCCC-------CCC--
Confidence 224567899999998888999999999999999999999999621 111111111111100 000
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
........+.+++.+||..+|++||++.|+++
T Consensus 238 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 01122345778888999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.55 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=184.1
Q ss_pred ccccCccCceeEEEEEec--CCceEEEEEecccC--hhhHHHHHHHHHHHhcc---CCCCccceeEEEEe-----CCceE
Q 044996 374 AEILGSGCFGSSYKASLS--TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRL---RHPNLLPLVAYYYR-----KEEKL 441 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~~~~ 441 (678)
.+.||+|+||.||+|+.. ++..||+|+++... ......+.+|+.+++++ +||||++++++|.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 457999999999999763 46789999887432 22234566777776665 69999999999863 34689
Q ss_pred EEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCc
Q 044996 442 LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521 (678)
Q Consensus 442 lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 521 (678)
+||||+. ++|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 86 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred EEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 9999996 699999875432 2589999999999999999999976 8999999999999999999999999999
Q ss_pred cccCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC--c
Q 044996 522 PVMNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD--N 596 (678)
Q Consensus 522 ~~~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~--~ 596 (678)
+...... ...++..|+|||++....++.++|||||||++|||++|+.||..... ......+........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-----~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIGLPGEED 232 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHHhCCCChhh
Confidence 7654332 23457889999999888899999999999999999999999962111 111111111100000 0
Q ss_pred c-------ccccchhhhc--ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 R-------TEVFDKEMAD--ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 ~-------~~~~d~~l~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ...+.+.-.. ..........+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000000 0000011234678888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.51 Aligned_cols=243 Identities=18% Similarity=0.216 Sum_probs=190.4
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
..++||+|+||.||+++.. ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 47 VIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCC
Confidence 3567999999999999764 6889999998642 12334567899999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++... .++...+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 127 gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 127 GGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999998653 377788889999999999999976 8999999999999999999999999998765432
Q ss_pred ----ccccccceeeCccccccC----CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 528 ----SAQELMIAYKSPEFLQLG----RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 528 ----~~~~~~~~y~aPE~~~~~----~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
....++..|+|||++... .++.++|||||||++|||++|+.||.. .+............... .
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~~~~~~-~ 267 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA--------DSLVGTYSKIMDHKNSL-T 267 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC--------CCHHHHHHHHHcCCCcC-C
Confidence 123467889999998643 478999999999999999999999962 22222233333221111 0
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCcccccc--CCCHHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEK--RLDLKEAVEK 642 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~ev~~~ 642 (678)
. + .. ......+.+++.+|++.+|.+ ||++.|+++.
T Consensus 268 ~--~---~~---~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 F--P---DD---IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C--C---Cc---CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 0 00 012234667777999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.68 Aligned_cols=238 Identities=20% Similarity=0.261 Sum_probs=184.7
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHH-HHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMR-RLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 35999999999999865 56789999987532 122234444444 56789999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+.+.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999997543 477888889999999999999976 8999999999999999999999999998754221
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+........... +.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--------~~~~~~~~~i~~~~~~----~~~-- 217 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RNTAEMYDNILNKPLQ----LKP-- 217 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC--------CCHHHHHHHHHhCCcC----CCC--
Confidence 223467899999999988999999999999999999999999962 2223333333222111 111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.....+.+++.+|++.+|.+||++.+.+..
T Consensus 218 -------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 218 -------NITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -------CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 112345677779999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=325.05 Aligned_cols=182 Identities=21% Similarity=0.276 Sum_probs=158.9
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++|||||++++++......++|+||+. ++|
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 46799999999999976 467889998643 2457889999999999999999999999999999999995 789
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----- 527 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----- 527 (678)
..++.... .+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 170 YCYLAAKR-----NIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 88886542 488999999999999999999976 8999999999999999999999999998754321
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
....+|..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 12346889999999998899999999999999999999998864
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=308.93 Aligned_cols=247 Identities=21% Similarity=0.357 Sum_probs=197.5
Q ss_pred ccccCccCceeEEEEEecC-Cc----eEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLST-GA----MMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|.... +. .+++|.+.... .....++.+|+.++++++|+||+++++++.. ...++||||+
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 90 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM 90 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence 4679999999999997642 32 57888876543 3345678999999999999999999999987 7899999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++..++.++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 91 PLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred CCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999976532 489999999999999999999975 8999999999999999999999999999876533
Q ss_pred cc------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 SA------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~~------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
.. ...+..|+|||.+....++.++|||||||++||+++ |+.||+. ....++..... .+...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~--------~~~~~~~~~~~-~~~~~--- 230 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG--------IPAVEIPDLLE-KGERL--- 230 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC--------CCHHHHHHHHh-CCCCC---
Confidence 21 112457999999988889999999999999999999 9999862 22233332222 22111
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
- .+..+...+.+++.+||..+|.+||++.++++.|+++...
T Consensus 231 ~--------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 P--------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred C--------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0 0011224577888899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=324.70 Aligned_cols=242 Identities=21% Similarity=0.237 Sum_probs=192.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+++.. +++.+|+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 467999999999999764 68899999987532 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++..... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 86 GDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999976532 589999999999999999999976 89999999999999999999999999997664332
Q ss_pred ----cccccceeeCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 529 ----AQELMIAYKSPEFLQ------LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~------~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
...++..|+|||++. ...++.++|||||||++|||++|+.||.. ..........+......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~--------~~~~~~~~~i~~~~~~~- 228 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE--------GTSAKTYNNIMNFQRFL- 228 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC--------CCHHHHHHHHHcCCCcc-
Confidence 224678899999986 45678999999999999999999999962 22233333333222111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..- ... .....+.+++.+|++ +|.+||++.++++
T Consensus 229 ~~~-----~~~---~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFP-----EDP---KVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC-----CCC---CCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 110 000 112345667778997 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.59 Aligned_cols=238 Identities=20% Similarity=0.261 Sum_probs=187.7
Q ss_pred ccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 376 ILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
+||+|+||.||+|+.. +++.+|+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 5999999999999764 57889999997532 23345688999999888 6999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc----
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ---- 526 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~---- 526 (678)
+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 82 DLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 9998886542 589999999999999999999976 899999999999999999999999999875321
Q ss_pred cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 527 ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 527 ~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
.....++..|+|||++.+..++.++|||||||++|||++|+.||...... ......+++.......... +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~-------~- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN--PDMNTEDYLFQVILEKPIR-------I- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC--cccccHHHHHHHHHhCCCC-------C-
Confidence 12234678899999999899999999999999999999999999632211 1122333333333222110 0
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
+......+.+++.+|++.||++|+++
T Consensus 223 ----p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 ----PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ----CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 01112345677889999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.80 Aligned_cols=249 Identities=22% Similarity=0.398 Sum_probs=195.0
Q ss_pred ccccCccCceeEEEEEec-CCc----eEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGA----MMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|... ++. .+++|.+.... .....++.+|+.++++++||||++++++|... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 467999999999999763 343 46888776543 23345788999999999999999999998754 567999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 91 PHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred CCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999876432 488999999999999999999976 7999999999999999999999999999865432
Q ss_pred cc------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 SA------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~~------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
.. ...+..|+|||++.+..++.++|||||||++|||++ |+.||... .. ......+..+... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~--------~~-~~~~~~~~~~~~~-~- 231 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------PT-REIPDLLEKGERL-P- 231 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC--------CH-HHHHHHHHCCCCC-C-
Confidence 21 123467999999988889999999999999999998 99998621 11 1122222222111 0
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
. .......+.+++..||..+|++||+|.|+++.|+++.....
T Consensus 232 -~--------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 232 -Q--------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -C--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 0 01123457888999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.71 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=202.8
Q ss_pred eeecCcccccchHHHHHHhccccCccCceeEEEEEe-cCCceEEEEEecccCh---hhHHHHHHHHHHHhccCCCCccce
Q 044996 355 SFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPL 430 (678)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l 430 (678)
-|+.+|.+.+ +.|+. .||.|+||.||-|+. .+.++||||++.-..+ ....++..|+..|.+++|||+|.+
T Consensus 18 LF~k~DPEkl-f~dLr-----EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieY 91 (948)
T KOG0577|consen 18 LFFKDDPEKL-FSDLR-----EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEY 91 (948)
T ss_pred HHccCCHHHH-HHHHH-----HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccc
Confidence 3455554332 44553 499999999999975 5778999999975433 345678899999999999999999
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC
Q 044996 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES 510 (678)
Q Consensus 431 ~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 510 (678)
.|+|..+...||||||| -|+-.++|.-++. ++..-++..|+.+.+.||+|||+. +.||||||+-|||+.+.
T Consensus 92 kgCyLre~TaWLVMEYC-lGSAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~ 162 (948)
T KOG0577|consen 92 KGCYLREHTAWLVMEYC-LGSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEP 162 (948)
T ss_pred cceeeccchHHHHHHHH-hccHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCC
Confidence 99999999999999999 6788888876543 688999999999999999999976 78999999999999999
Q ss_pred CceEEeecCCccccCccccccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHH
Q 044996 511 LEPVLADYGLIPVMNQESAQELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWV 587 (678)
Q Consensus 511 ~~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~ 587 (678)
+.+||+|||.|.+..+.....||+.|||||++. .+.|+.|+||||+||+..||.-.+.|+.. ++-..-+
T Consensus 163 g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn--------MNAMSAL 234 (948)
T KOG0577|consen 163 GLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSAL 234 (948)
T ss_pred CeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC--------chHHHHH
Confidence 999999999999999988899999999999884 47899999999999999999999999752 2222222
Q ss_pred HHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 588 NSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..+-++.. |.+. . .+-...+..++-.|++.-|.+|||..++++
T Consensus 235 YHIAQNes-------PtLq-s---~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 235 YHIAQNES-------PTLQ-S---NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHhcCC-------CCCC-C---chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 22222211 2221 1 122344666677999999999999988764
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.77 Aligned_cols=254 Identities=21% Similarity=0.350 Sum_probs=198.0
Q ss_pred ccccCccCceeEEEEEec-----CCceEEEEEecccChh-hHHHHHHHHHHHhccCCCCccceeEEEEe--CCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLS-----TGAMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLVAYYYR--KEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~E 445 (678)
.+.||+|+||.||+|.+. ++..+|+|.++..... ..++|.+|++++++++|+||+++++++.. ....++|||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 367999999999999753 3678999998865433 56789999999999999999999999877 557899999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++++|.+++..... .++|..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 89 ~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 89 YLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred cCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999976532 489999999999999999999975 79999999999999999999999999988765
Q ss_pred ccc-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCC------CCChHHHHHHHHh
Q 044996 526 QES-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKA------DGDLASWVNSVLA 592 (678)
Q Consensus 526 ~~~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~------~~~l~~~~~~~~~ 592 (678)
... ....+..|+|||++....++.++||||||+++|||+||+.|+......... .......+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 221 112345699999998888999999999999999999999997632111000 0000111111111
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
..... .........+.+++.+||+.+|++||||.||+++|+++
T Consensus 241 ~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERL-----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcC-----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11100 00112235688899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.28 Aligned_cols=243 Identities=22% Similarity=0.275 Sum_probs=188.3
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh--------------hhHHHHHHHHHHHhccCCCCccceeEEEEeC-
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN--------------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRK- 437 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~- 437 (678)
.+.||+|.||.|-+|+. .+++.||||++.+... ...+...+||.+|++++|||||+|+.+..+.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 45699999999999975 4789999999964211 1235789999999999999999999998764
Q ss_pred -CceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEe
Q 044996 438 -EEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLA 516 (678)
Q Consensus 438 -~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 516 (678)
+.+|||+|||..|.+...=. ..+.+++.+..+|++++..||+|||.+ +||||||||+|+||++++++||+
T Consensus 182 s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred cCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcCCCcEEee
Confidence 57999999999988753211 122399999999999999999999976 89999999999999999999999
Q ss_pred ecCCccccCcc---------ccccccceeeCccccccCC----CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCCh
Q 044996 517 DYGLIPVMNQE---------SAQELMIAYKSPEFLQLGR----ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDL 583 (678)
Q Consensus 517 DfGla~~~~~~---------~~~~~~~~y~aPE~~~~~~----~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l 583 (678)
|||.+...... ....||+.|||||...++. .+.+.||||+||+||-|+.|+.||.. ...
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~--------~~~ 324 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD--------DFE 324 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc--------chH
Confidence 99998765221 2245789999999887632 36789999999999999999999961 222
Q ss_pred HHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 584 ASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
.+...++..+. +.-.. ..+...++.+++.++|..||++|.+..||....=
T Consensus 325 ~~l~~KIvn~p----------L~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 LELFDKIVNDP----------LEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHHHhcCc----------ccCCC-cccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 23333333221 11111 1133455677888999999999999999877653
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.37 Aligned_cols=244 Identities=20% Similarity=0.299 Sum_probs=191.9
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++...+..++||||+++|+
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~ 88 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 88 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence 3467999999999999875 467788888876555667789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|..++.... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 89 l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 89 VDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 999886532 2589999999999999999999975 8999999999999999999999999998654322
Q ss_pred ccccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 528 SAQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
....++..|+|||++. ...++.++|||||||++|||++|+.||... ....-+......... ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~~~--~~~~ 230 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAKSEPP--TLAQ 230 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc--------CHHHHHHHHhhcCCC--CCCC
Confidence 2234567899999884 345788999999999999999999998621 111111111111100 0000
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+ ......+.+++.+||+.+|.+||++.++++.
T Consensus 231 ~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 P--------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred c--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 1122356788889999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=316.80 Aligned_cols=233 Identities=21% Similarity=0.250 Sum_probs=184.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCC-CccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHP-NLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... +++.||+|+++.. .....+.+..|++++..++|+ +|+++++++...+..|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 467999999999999764 5678999998753 223456678899999999765 58889999998899999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 85 GGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999987542 488999999999999999999976 8999999999999999999999999998643211
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+-...........
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~--------~~~~~~~~~i~~~~~~~------- 220 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG--------EDEDELFQSIMEHNVSY------- 220 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCCC-------
Confidence 123467889999999988999999999999999999999999962 11122222222111100
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
+......+.+++.+|+..||.+|++.
T Consensus 221 ------~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 ------PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01112346778889999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.48 Aligned_cols=242 Identities=17% Similarity=0.197 Sum_probs=186.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 46799999999999975 478899999986432 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 g~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 86 GDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999997542 478888999999999999999966 8999999999999999999999999998632110
Q ss_pred -------------------------------------------------ccccccceeeCccccccCCCCCcchHHHHHH
Q 044996 528 -------------------------------------------------SAQELMIAYKSPEFLQLGRITKKTDVWSLGV 558 (678)
Q Consensus 528 -------------------------------------------------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gv 558 (678)
....++..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0123678899999999889999999999999
Q ss_pred HHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccC---CC
Q 044996 559 LILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKR---LD 635 (678)
Q Consensus 559 vl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~R---Ps 635 (678)
++|||+||+.||... ...+............ .. + ... .....+.+++.+|+. +|.+| ++
T Consensus 237 il~elltG~~Pf~~~--------~~~~~~~~i~~~~~~~-~~--p---~~~---~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 237 IMFECLIGWPPFCSE--------NSHETYRKIINWRETL-YF--P---DDI---HLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhcCCCCCCCC--------CHHHHHHHHHccCCcc-CC--C---CCC---CCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 999999999999621 1112222222111111 00 0 000 112345667778887 66665 59
Q ss_pred HHHHHHH
Q 044996 636 LKEAVEK 642 (678)
Q Consensus 636 ~~ev~~~ 642 (678)
+.|+++.
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.00 Aligned_cols=244 Identities=20% Similarity=0.254 Sum_probs=191.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|.. .+++.+++|++........+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L 93 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence 45799999999999986 56788999998755444556788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.++++... .+++.++..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++..... .
T Consensus 94 ~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 94 QDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99987542 588999999999999999999976 7999999999999999999999999998765422 1
Q ss_pred cccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 AQELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||.+. ...++.++|||||||++|||++|+.||....... ....+ ... ....+..
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~----~~~~~-----~~~----~~~~~~~ 231 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----ALFLM-----SKS----NFQPPKL 231 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh----hheee-----ecC----CCCCCCC
Confidence 233567899999884 3457889999999999999999999985221100 00000 000 0000111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.. .......+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 KD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred cc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 11 01123457788889999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=324.95 Aligned_cols=232 Identities=28% Similarity=0.339 Sum_probs=188.1
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEecc
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
...+||+|.||+|+++..+ +++.+|||.+++.. ..+.+....|.+++... +||.++.++..|++++++|+||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 4578999999999999864 67899999998743 34455667787777766 5999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC-c
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN-Q 526 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~-~ 526 (678)
.+|++..+.+.. .+++.++.-++..|+.||.|||++ +||+||||.+|||||.+|.+||+|||+++..- .
T Consensus 452 ~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 452 AGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred CCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999954443322 589999999999999999999987 89999999999999999999999999998643 2
Q ss_pred ---cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 527 ---ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 527 ---~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
.....||+.|||||++.+..|+.++|.|||||+||||++|+.||.. .+-. +++|.
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g--------ddEe--------------e~Fds 579 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG--------DDEE--------------EVFDS 579 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC--------CCHH--------------HHHHH
Confidence 2333478889999999999999999999999999999999999971 1111 33333
Q ss_pred hhhcc-cCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 604 EMADE-RNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 604 ~l~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
.+..+ .++.....+.+.|+.+.+..+|++|--+
T Consensus 580 I~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 33221 1233345567778889999999999976
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=303.92 Aligned_cols=243 Identities=25% Similarity=0.436 Sum_probs=194.6
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||++....+..+++|.+... ....+.|.+|++++++++|+||+++++++.. ...+++|||+++|+|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 4679999999999998877888999987753 3345688999999999999999999999887 7789999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... ..+++.+++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 89 DFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred HHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCCCccccc
Confidence 99976432 2588999999999999999999965 79999999999999999999999999987654321
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++....++.++|||||||++||++| |+.||... +..... .....+... ..
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--------~~~~~~-~~~~~~~~~-~~------- 224 (260)
T cd05073 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------SNPEVI-RALERGYRM-PR------- 224 (260)
T ss_pred CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC--------CHHHHH-HHHhCCCCC-CC-------
Confidence 1123466999999988889999999999999999999 99998621 111111 111111111 00
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
.......+.+++.+|++.+|++||+++++.+.|+.
T Consensus 225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01223457788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.99 Aligned_cols=233 Identities=21% Similarity=0.253 Sum_probs=184.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... ++..+|+|.++... ....+.+..|..++..+ +|++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 467999999999999764 57789999987532 22334566778888777 58999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 85 GGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999987543 488999999999999999999976 8999999999999999999999999998754321
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+...............
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~--------~~~~~~~~~i~~~~~~~------- 220 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--------EDEDELFQSIMEHNVAY------- 220 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC-------
Confidence 123467889999999999999999999999999999999999962 12222222222211110
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
+......+.+++.+|++.+|.+|++.
T Consensus 221 ------p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 ------PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11122346778889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=297.05 Aligned_cols=255 Identities=21% Similarity=0.271 Sum_probs=190.7
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccCh--hhHHHHHHHHHHHhccCCCC-ccceeEEEEeCC------ceEEEE
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNN--VGREEFQEHMRRLGRLRHPN-LLPLVAYYYRKE------EKLLVH 444 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~------~~~lv~ 444 (678)
++||+|+||+||+|+. .+|+.||+|+++...+ .......+|+.++++++|+| ||.+++++...+ ..++||
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 5699999999999975 5788999999986433 23345679999999999999 999999999877 788999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+. -+|..++......+ ..++-..+..+++||++||+|||++ +|+||||||.||||+++|.+||+|||+|+.+
T Consensus 97 e~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 97 EFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred Eeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 9995 59999998765321 1356678999999999999999977 8999999999999999999999999999866
Q ss_pred Ccc----ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc---
Q 044996 525 NQE----SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN--- 596 (678)
Q Consensus 525 ~~~----~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~--- 596 (678)
.-. ....+|..|+|||++.+. .|++..||||+|||+.||++++.-|... .++.+..+-+.--+..
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~-------se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD-------SEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC-------cHHHHHHHHHHHcCCCCcc
Confidence 522 233467889999999875 7899999999999999999998777521 1111111111111100
Q ss_pred ---c-cccc--chhhhc---ccCCHH-H---HHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 597 ---R-TEVF--DKEMAD---ERNSEG-E---MVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 597 ---~-~~~~--d~~l~~---~~~~~~-~---~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
. .... +..... ...... . .....+++.+|++.+|.+|.|++.+++.
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 0000 100000 000000 1 1357888999999999999999999875
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=307.18 Aligned_cols=244 Identities=22% Similarity=0.298 Sum_probs=191.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.++||+|+||.||+|.. .++..+++|.+... .....+++.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 46799999999999975 56788999988643 33445678999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--cc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--SA 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 529 (678)
|..+. .+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++...... ..
T Consensus 86 l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 86 LDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred hHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence 97542 367888899999999999999976 8999999999999999999999999998765433 22
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|+|||++.+..++.++|||||||++|||++|+.||........ ......+........ .+.+...
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~-------~~~~~~~- 223 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG-SLMPLQLLQCIVDED-------PPVLPVG- 223 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc-ccchHHHHHHHhccC-------CCCCCCC-
Confidence 3467789999999988899999999999999999999999974321111 011112221111111 0111111
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.....+.+++.+|++.+|++||+++|+++.
T Consensus 224 ---~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 ---QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 122357788889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=325.23 Aligned_cols=189 Identities=20% Similarity=0.257 Sum_probs=163.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||.||+|+. .+++.+|+|++.... ....+.+.+|++++++++|+|||++++++.+.+..++|||||++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 46799999999999976 467889999987532 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 86 GDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999997542 478888899999999999999976 7999999999999999999999999997532100
Q ss_pred -------------------------------------------------ccccccceeeCccccccCCCCCcchHHHHHH
Q 044996 528 -------------------------------------------------SAQELMIAYKSPEFLQLGRITKKTDVWSLGV 558 (678)
Q Consensus 528 -------------------------------------------------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gv 558 (678)
....+|..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 0123678899999999889999999999999
Q ss_pred HHHHHHhCCCCcc
Q 044996 559 LILEIMTGKFPAN 571 (678)
Q Consensus 559 vl~el~tg~~P~~ 571 (678)
++|||++|+.||.
T Consensus 237 il~elltG~~Pf~ 249 (382)
T cd05625 237 ILYEMLVGQPPFL 249 (382)
T ss_pred HHHHHHhCCCCCC
Confidence 9999999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=322.77 Aligned_cols=242 Identities=17% Similarity=0.226 Sum_probs=187.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++..|+||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999865 5788999988642 223345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 128 g~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 128 GDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999998643 378888999999999999999976 89999999999999999999999999998664321
Q ss_pred ----cccccceeeCccccccC----CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 529 ----AQELMIAYKSPEFLQLG----RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~----~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
...++..|+|||++... .++.++|||||||++|||++|+.||.. .+............... ..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~--------~~~~~~~~~i~~~~~~~-~~ 268 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA--------DSLVGTYSKIMDHKNSL-NF 268 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCccc-CC
Confidence 23478899999998653 378999999999999999999999962 22222333333221111 10
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccc--cCCCHHHHHHH
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVE--KRLDLKEAVEK 642 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~--~RPs~~ev~~~ 642 (678)
.. .......+.+++..|+..++. .|+++.|+++.
T Consensus 269 -----p~---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 -----PE---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----CC---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 001123345566678875554 38899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=303.14 Aligned_cols=242 Identities=27% Similarity=0.416 Sum_probs=192.8
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
..+.||+|+||.||++.. ++..+++|.++.. ...+.+.+|+.++++++||||+++++++.. +..++||||+++|+|
T Consensus 10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L 85 (254)
T cd05083 10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNL 85 (254)
T ss_pred eeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCCCH
Confidence 356799999999999975 6778999988653 234678999999999999999999999865 457999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-ccc
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-AQE 531 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 531 (678)
.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...... ...
T Consensus 86 ~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (254)
T cd05083 86 VNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK 158 (254)
T ss_pred HHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceeccccCCCCC
Confidence 999976432 2588999999999999999999975 89999999999999999999999999987644321 222
Q ss_pred ccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccC
Q 044996 532 LMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERN 610 (678)
Q Consensus 532 ~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (678)
.+..|+|||++.+..++.++|||||||++|||++ |+.||.. .....+.... ..+... ++
T Consensus 159 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--------~~~~~~~~~~-~~~~~~----~~------- 218 (254)
T cd05083 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK--------MSLKEVKECV-EKGYRM----EP------- 218 (254)
T ss_pred CCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc--------CCHHHHHHHH-hCCCCC----CC-------
Confidence 3467999999988899999999999999999998 9999862 2222322222 111111 00
Q ss_pred CHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 611 SEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
.......+.+++.+||+.+|++||+++++++.|++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01123457788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=339.23 Aligned_cols=257 Identities=17% Similarity=0.235 Sum_probs=198.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||.||+|... +++.||+|++... .....++|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 467999999999999764 5889999998753 233456799999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCC------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 450 RSLAVNLHGHQAL------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 450 gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
|+|.+++...... ....+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEecCccee
Confidence 9999998742110 112467888999999999999999976 899999999999999999999999999976
Q ss_pred cCcc----------------------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCC
Q 044996 524 MNQE----------------------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADG 581 (678)
Q Consensus 524 ~~~~----------------------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~ 581 (678)
.... ....++..|||||++.+..++.++|||||||++|||+||+.||..... .
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-----~ 237 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-----R 237 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch-----h
Confidence 5211 012367889999999988999999999999999999999999962110 0
Q ss_pred ChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCC-CHHHHHHHHHHhhccCCC
Q 044996 582 DLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRL-DLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 582 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~ev~~~L~~i~~~~~~ 652 (678)
.+. + .. .+.++.-.. ...+....+.+++.+|++.||++|| +++++.+.|+......++
T Consensus 238 ki~-~-~~---------~i~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 238 KIS-Y-RD---------VILSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred hhh-h-hh---------hccChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 000 0 00 011110000 0012234577888899999999996 788888889887665443
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.43 Aligned_cols=189 Identities=19% Similarity=0.264 Sum_probs=163.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|+. .+++.+|+|.+.... ......+.+|++++.+++|+||+++++++.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 46799999999999975 468899999986432 22345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 86 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 86 GDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999997643 478888889999999999999976 8999999999999999999999999997532100
Q ss_pred ---------------------------------------------ccccccceeeCccccccCCCCCcchHHHHHHHHHH
Q 044996 528 ---------------------------------------------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILE 562 (678)
Q Consensus 528 ---------------------------------------------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~e 562 (678)
....++..|||||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 01236778999999998899999999999999999
Q ss_pred HHhCCCCcc
Q 044996 563 IMTGKFPAN 571 (678)
Q Consensus 563 l~tg~~P~~ 571 (678)
|++|+.||.
T Consensus 237 ll~G~~Pf~ 245 (376)
T cd05598 237 MLVGQPPFL 245 (376)
T ss_pred hhhCCCCCC
Confidence 999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=302.89 Aligned_cols=242 Identities=17% Similarity=0.261 Sum_probs=194.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||++... ++..+++|.++.. .....+.+.+|+.++++++|+||+++++++..++..++||||+++|+
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 467999999999999764 6788999988643 33455778899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.+++..... ..+++...+.++.|++.||.|||+. +|+|+||||+||++++++.++++|||+++......
T Consensus 85 l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 85 LMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred HHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9998865322 2478899999999999999999966 89999999999999999999999999987654322
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.++||||||+++|||++|+.||.. .+............ .. . +
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~--------~~~~~~~~~~~~~~-~~-~-~------ 220 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA--------NSWKNLILKVCQGS-YK-P-L------ 220 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC--------CCHHHHHHHHhcCC-CC-C-C------
Confidence 22356779999999888899999999999999999999999962 22222222222111 10 0 0
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+......+.+++.+||+.||++||++.|++..
T Consensus 221 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122346778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=305.25 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=189.6
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
..||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 36999999999999854 56789999887766666778999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCC--ChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCccccCcc---
Q 044996 454 VNLHGHQALGQPSL--DWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 454 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~--- 527 (678)
++++.... .+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++......
T Consensus 94 ~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 94 ALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred HHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 99976422 24 7888899999999999999965 8999999999999986 679999999998765322
Q ss_pred -ccccccceeeCccccccCC--CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 -SAQELMIAYKSPEFLQLGR--ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~--~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.... ++.++|||||||++|||++|+.||..... .....|....... .+.
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~--------~~~ 232 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-----PQAAMFKVGMFKI--------HPE 232 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC-----hhhhHhhhhhhcc--------CCC
Confidence 1223567899999986543 78999999999999999999999863211 1111111111100 011
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+ +......+.+++.+||+.+|.+||||.|+++
T Consensus 233 ~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 233 I-----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred C-----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1 1112334677888999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.51 Aligned_cols=257 Identities=21% Similarity=0.322 Sum_probs=198.4
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhc--cCCCCccceeEEEEeCC----ceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGR--LRHPNLLPLVAYYYRKE----EKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~Ey~ 447 (678)
.+.||+|.||.||+|+++ |+.||||+|... +.+.+.+|.++.+. |+|+||+.+++.-..+. ++|||++|-
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 578999999999999995 788999999764 34567778887765 59999999998866543 589999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC----CCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL----PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
++|||.+||.+. .++-...++++..+|.||++||.+. ..+.|.|||||+.|||+.+++.+-|+|+|||-.
T Consensus 292 e~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 292 EHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred cCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999999999864 5899999999999999999999763 234699999999999999999999999999865
Q ss_pred cCcc--------ccccccceeeCccccccCC----C--CCcchHHHHHHHHHHHHhC----------CCCccccccCCCC
Q 044996 524 MNQE--------SAQELMIAYKSPEFLQLGR----I--TKKTDVWSLGVLILEIMTG----------KFPANFLQQGKKA 579 (678)
Q Consensus 524 ~~~~--------~~~~~~~~y~aPE~~~~~~----~--t~ksDvwS~Gvvl~el~tg----------~~P~~~~~~~~~~ 579 (678)
.... ....||.+|||||++.... + -..+||||||.|+||+.-+ +.||.+..+...
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP- 444 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP- 444 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-
Confidence 4332 3456889999999996431 1 1359999999999999753 366654333211
Q ss_pred CCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 580 DGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 580 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
++. -++..+-. +.+.|.+.....+.+.+..+.+++..||..+|..|-|+-.+-+.|.++.+.
T Consensus 445 --s~e-eMrkVVCv-----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 445 --SFE-EMRKVVCV-----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred --CHH-HHhcceee-----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 111 11111111 112233333334557889999999999999999999999999999998863
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.32 Aligned_cols=240 Identities=23% Similarity=0.332 Sum_probs=194.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||.|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 35699999999999975 57889999998765555567889999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.+++... .+++.++..++.+++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 104 TDVVTET------CMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 9988643 489999999999999999999976 89999999999999999999999999987654332
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||.+.+..++.++|||||||++|||++|+.||... +....+.......... +.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~--------~~~~~~~~~~~~~~~~-------~~-- 236 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--------NPLRALYLIATNGTPE-------LQ-- 236 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcCCcc-------cC--
Confidence 223567899999998888999999999999999999999999621 1112222111111000 00
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
........+.+++.+||..||.+||++.++++
T Consensus 237 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 -NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01112334677888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=307.08 Aligned_cols=239 Identities=23% Similarity=0.323 Sum_probs=192.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 356999999999999754 57789999887432 3445679999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc--
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA-- 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 529 (678)
|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..+.....
T Consensus 89 L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 89 ALDLLKPG------PLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred HHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 99988642 588999999999999999999965 799999999999999999999999999876543321
Q ss_pred --ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 530 --QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 530 --~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
..++..|+|||++.+..++.++|||||||++|||+||+.|+..... ..+.. ...... .+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--------~~~~~-~~~~~~------~~~~-- 221 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP--------MRVLF-LIPKNS------PPTL-- 221 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch--------hhHHh-hhhcCC------CCCC--
Confidence 2346789999999988899999999999999999999999862211 11111 111110 1111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.......+.+++.+||+.+|++||+|.||++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11233457788889999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.55 Aligned_cols=242 Identities=21% Similarity=0.300 Sum_probs=191.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+||+++++++..++..++||||+++++|
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 96 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV 96 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcH
Confidence 467999999999999875 5788999998876666678899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
..++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus 97 ~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 97 DAIMLELDR----GLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred HHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 988765432 589999999999999999999965 8999999999999999999999999998654322 1
Q ss_pred cccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 AQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
...++..|+|||++. ...++.++|||||||++|||++|+.||... +............. +
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~~-------~ 233 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAKSEP-------P 233 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc--------cHHHHHHHHhcCCC-------c
Confidence 223567899999984 345688999999999999999999998621 11111211111110 0
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+.. .......+.+++.+||+.+|++||++.|+++
T Consensus 234 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQ---PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1000 1112335777888999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.60 Aligned_cols=239 Identities=22% Similarity=0.289 Sum_probs=186.8
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
++||+|+||+||+|.. .+++.+|+|.+.... ......+.+|++++++++|+||+.+.+++..++..++||||+++|
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence 5699999999999976 468899999986532 223345788999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|.+++..... ..+++..+..++.|++.||.|||.. +|+||||||+||++++++.+||+|||++......
T Consensus 86 ~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 86 DLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred cHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99988865422 2589999999999999999999965 7999999999999999999999999998665322
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+. ....... .. .
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~~~~~~~~-~~~~~~~---~~----~-- 224 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----KVKREEVD-RRVLETE---EV----Y-- 224 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-Hhhhccc---cc----c--
Confidence 123467889999999888999999999999999999999999962110 00011111 1111110 00 0
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLK 637 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ 637 (678)
.......+.+++.+|++.||++||++.
T Consensus 225 ---~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 225 ---SAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ---CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 111223467788899999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=318.85 Aligned_cols=186 Identities=20% Similarity=0.299 Sum_probs=158.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------ceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------EKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 444 (678)
.+.||+|+||.||++.. .++..+|+|++... .......+.+|+.+++.++||||+++++++.... ..|+||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 46799999999999976 46889999998643 2344567889999999999999999999986543 479999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+++ +|...++. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 106 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 106 ELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 99965 67666642 378888999999999999999976 8999999999999999999999999999765
Q ss_pred Cccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 525 NQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 525 ~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.... ...++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 4322 2345778999999998899999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.98 Aligned_cols=190 Identities=26% Similarity=0.333 Sum_probs=165.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||++... ++..+++|.++.. ......++.+|++++.+++||||++++++|..++..++||||+++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 467999999999999764 5778888887643 23345678899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--cc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--SA 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 529 (678)
|.++++... .+++..+..++.|++.||.|||+.+ +++||||||+|||+++++.+||+|||++...... ..
T Consensus 86 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (308)
T cd06615 86 LDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 157 (308)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccccccc
Confidence 999997642 5889999999999999999999642 6999999999999999999999999998765432 22
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
..++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 345678999999988889999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.79 Aligned_cols=241 Identities=20% Similarity=0.287 Sum_probs=191.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-----hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-----NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|.. .++..+++|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 46799999999999975 468899999886432 123457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 87 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 87 PGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999987543 488899999999999999999976 7999999999999999999999999998755332
Q ss_pred c-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 S-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
. ...++..|+|||++.+..++.++||||||+++|||++|+.||... +...-..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~~~---- 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF--------EAMAAIFKIATQPTN---- 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc--------chHHHHHHHhccCCC----
Confidence 1 123456799999999888999999999999999999999998621 111111111111100
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
..+ .......+.+++.+||+.+|.+|||+.|+++.
T Consensus 226 --~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 --PQL-----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCC-----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011 11123356778889999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.22 Aligned_cols=192 Identities=22% Similarity=0.280 Sum_probs=161.0
Q ss_pred ccccCcc--CceeEEEEEe-cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSG--CFGSSYKASL-STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+| +|++||++.. .+++.||+|+++... ....+.+++|+++++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3569999 7899999976 578999999987532 3334567889999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++..+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++||+........
T Consensus 83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999975432 2489999999999999999999966 7999999999999999999999999864332111
Q ss_pred ----------ccccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 044996 528 ----------SAQELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPANF 572 (678)
Q Consensus 528 ----------~~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~~ 572 (678)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 11123567999999975 3589999999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.82 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=192.8
Q ss_pred ccccCccCceeEEEEEecC-CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLST-GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|.... +..+++|.+..... .+++.+|++++++++|+||+++++++......++++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 3569999999999998765 78899999875432 67899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.+++.... ..+++..+..++.|++.||.|||.. +++||||+|+||++++++.+||+|||++.......
T Consensus 86 ~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 86 SDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 99997543 2589999999999999999999976 79999999999999999999999999987665432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||...... ... .... . .. .+.+.
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-------~~~-~~~~-~--~~----~~~~~-- 220 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-------RAI-FMIP-N--KP----PPTLS-- 220 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-------hhh-hhhc-c--CC----CCCCC--
Confidence 123467899999998889999999999999999999999998732110 000 0000 0 00 00000
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
........+.+++.+||+.+|++|||+.||++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01112345778888999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=301.81 Aligned_cols=239 Identities=22% Similarity=0.306 Sum_probs=193.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.++++++|+||+++++++.+....++||||+++|+
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 356999999999999864 57889999887432 3455778999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.+++... .+++.+...++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 89 L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 89 ALDLLRAG------PFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 99998642 478899999999999999999965 79999999999999999999999999987654322
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.++|||||||++|||+||+.||.... ....... ..... . +
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--------~~~~~~~-~~~~~-~-----~---- 219 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH--------PMRVLFL-IPKNN-P-----P---- 219 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC--------hHhHhhh-hhcCC-C-----C----
Confidence 1234677999999988889999999999999999999999986221 1111111 11110 0 0
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.........+.+++.+||+.+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 -TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1122345668889999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.08 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=192.6
Q ss_pred ccccCccCceeEEEEEec----CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------ceE
Q 044996 374 AEILGSGCFGSSYKASLS----TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------EKL 441 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~ 441 (678)
.+.||+|+||.||+|.+. ++..+++|.+... .....+++.+|++++++++||||+++++++...+ ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 457999999999999753 4678999988753 2345667899999999999999999999986542 247
Q ss_pred EEEeccCCCCHHHHhhccCCC-CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCC
Q 044996 442 LVHEFVPKRSLAVNLHGHQAL-GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL 520 (678)
Q Consensus 442 lv~Ey~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 520 (678)
+++||+++|+|.+++...... ....+++...++++.||+.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECcccc
Confidence 899999999999887543211 112478899999999999999999965 799999999999999999999999999
Q ss_pred ccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 521 IPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 521 a~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
++...... ....+..|++||.+....++.++|||||||++|||++ |+.||... ...+...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~--------~~~~~~~~~~-~ 230 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV--------ENSEIYNYLI-K 230 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC--------CHHHHHHHHH-c
Confidence 87654221 1123467999999988889999999999999999999 88888621 1111111111 1
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.... . ........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 231 ~~~~-~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL-K----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC-C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 0 0012234688899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.56 Aligned_cols=233 Identities=21% Similarity=0.258 Sum_probs=185.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... +++.||+|+++... ....+.+..|.+++..+. |++|+++++++...+..|+||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 357999999999999764 68899999987532 233456778888888885 5778889999998899999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 85 GGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999987542 589999999999999999999976 8999999999999999999999999998754322
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. .................
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~--------~~~~~~~~~i~~~~~~~------- 220 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG--------EDEDELFQSIMEHNVSY------- 220 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC-------
Confidence 123367889999999988899999999999999999999999962 12222223222221111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
+......+.+++.+|++.+|.+|++.
T Consensus 221 ------p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 ------PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122346778889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.09 Aligned_cols=184 Identities=23% Similarity=0.246 Sum_probs=158.8
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.+.||+|+||.||+|... .++.|+||... ...+.+|++++++++|+|||++++++...+..++||||+ .++
T Consensus 173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~ 245 (461)
T PHA03211 173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSD 245 (461)
T ss_pred EEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCC
Confidence 3567999999999999875 46788998543 234678999999999999999999999999999999999 479
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.+++..... .++|.+++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 246 L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 246 LYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9988865422 599999999999999999999976 89999999999999999999999999997654321
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
...++..|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 1236789999999999899999999999999999999887653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.09 Aligned_cols=191 Identities=21% Similarity=0.347 Sum_probs=156.2
Q ss_pred ccccCccCceeEEEEEec---CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe--CCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS---TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR--KEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~Ey~~ 448 (678)
+.+||+|+||.||+|+.. ++..+|+|.+.... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 45789999886532 23457889999999999999999999864 346889999995
Q ss_pred CCCHHHHhhccCCC----CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe----cCCCceEEeecCC
Q 044996 449 KRSLAVNLHGHQAL----GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL----NESLEPVLADYGL 520 (678)
Q Consensus 449 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGl 520 (678)
++|.+++...... ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5888887643211 112488899999999999999999976 79999999999999 4668999999999
Q ss_pred ccccCcc-------ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 521 IPVMNQE-------SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 521 a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
++..... ....++..|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9765432 12345778999999876 458999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=301.91 Aligned_cols=241 Identities=23% Similarity=0.346 Sum_probs=191.0
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccC------hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMN------NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|...++..+|+|.++... ......+.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 46799999999999988889999999886432 122356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++++|.+++.... .+++..+..++.|++.||+|||.. +|+|+||||+||++++++.+||+|||++......
T Consensus 85 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 85 PGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999997542 478999999999999999999965 7999999999999999999999999998654211
Q ss_pred ----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 528 ----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 528 ----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~-~~~~~~~~~ 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD-------RLAAMF-YIGAHRGLM 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC-------hHHHHH-HhhhccCCC
Confidence 12235678999999998889999999999999999999999996211 111111 111000000
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.+. ......+.+++.+||+.+|++||++.|+++
T Consensus 228 -----~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 -----PRLP-----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCC-----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 112334677888999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=336.02 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=205.1
Q ss_pred HhccccCccCceeEEEEEec--------CCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceE
Q 044996 372 ASAEILGSGCFGSSYKASLS--------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKL 441 (678)
Q Consensus 372 ~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~ 441 (678)
...+.||+|.||.|++|... ....||||.++.. .....+.+..|+++|+.+ +|+||+.++|+|..++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 44568999999999999642 1457899998853 345678899999999998 6999999999999999999
Q ss_pred EEEeccCCCCHHHHhhccC---------CCCCC--CCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC
Q 044996 442 LVHEFVPKRSLAVNLHGHQ---------ALGQP--SLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES 510 (678)
Q Consensus 442 lv~Ey~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 510 (678)
+|+||+..|+|..+|+..+ ..... .++..+.+.++.|||.||+||++. .+|||||.++|||+.++
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----CccchhhhhhhEEecCC
Confidence 9999999999999998776 11111 388999999999999999999965 79999999999999999
Q ss_pred CceEEeecCCccccCccccc-------cccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCC
Q 044996 511 LEPVLADYGLIPVMNQESAQ-------ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGD 582 (678)
Q Consensus 511 ~~~kl~DfGla~~~~~~~~~-------~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~ 582 (678)
..+||+|||+++........ ..++.|||||.+....|+.|+|||||||+||||+| |..||.. ..
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~--------~~ 526 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG--------IP 526 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--------CC
Confidence 99999999999864432211 14577999999999999999999999999999999 9999862 11
Q ss_pred -hHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 583 -LASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 583 -l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
..+. ...+.+|... ..+..+..++.+++..||+.+|++||++.++++.++....
T Consensus 527 ~~~~l-~~~l~~G~r~-----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEEL-LEFLKEGNRM-----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHH-HHHHhcCCCC-----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1222 2244444322 1123346678899999999999999999999999998543
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=299.34 Aligned_cols=242 Identities=19% Similarity=0.279 Sum_probs=196.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.++||+|+||.||.++. .++..+++|.+... +....+++.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 46799999999999975 46788999987643 3455677899999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++..... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 85 ~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 85 TLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99999976531 2589999999999999999999965 79999999999999999999999999987654332
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||++.+..++.++||||||+++|||++|+.||.. ....+.+.......... .
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~--------~~~~~~~~~~~~~~~~~--~------ 221 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA--------TNPLNLVVKIVQGNYTP--V------ 221 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHcCCCCC--C------
Confidence 23356789999999888889999999999999999999999862 23333333333221110 0
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.......+.+++.+||+.+|.+||++.|+++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 ----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 01123457788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.77 Aligned_cols=253 Identities=24% Similarity=0.301 Sum_probs=198.2
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
+.+.||+|+||+||++... ++..+++|++.... ....+.+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (284)
T cd06620 9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG 88 (284)
T ss_pred HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCC
Confidence 3467999999999999764 57888998876432 344678999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--c
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--S 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~ 528 (678)
+|.+++.... .+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++...... .
T Consensus 89 ~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 89 SLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred CHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 9999987542 4899999999999999999999642 6999999999999999999999999998654322 1
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCC---CCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKK---ADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~---~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+..++.++|||||||++|||+||+.||........ ....+.+++........ +.+
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 233 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-------PRL 233 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-------CCC
Confidence 23467889999999888899999999999999999999999973221100 01122233333322211 011
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
. .......+.+++.+|++.||++|||+.||++..-
T Consensus 234 ~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 234 P----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred C----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0 0112345778888999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.60 Aligned_cols=243 Identities=21% Similarity=0.305 Sum_probs=193.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||++... ++..+++|.++.......+.|.+|++++++++|+||+++++++..+...++||||+++++|
T Consensus 10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (280)
T cd06611 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL 89 (280)
T ss_pred HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcH
Confidence 456999999999999864 6789999998876666677899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.+++..... .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++...... .
T Consensus 90 ~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 90 DSIMLELER----GLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred HHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 999876432 589999999999999999999976 7999999999999999999999999997654322 1
Q ss_pred cccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 AQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
...++..|+|||++. ...++.++|||||||++|||++|+.||... +....+....... . +
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~------~ 226 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL--------NPMRVLLKILKSE-P------P 226 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC--------CHHHHHHHHhcCC-C------C
Confidence 223567899999874 345688999999999999999999998621 1112222221111 0 0
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.+.. .......+.+++.+||+.+|.+||++.+|++.
T Consensus 227 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLDQ---PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcCC---cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1100 11122346778889999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.85 Aligned_cols=251 Identities=19% Similarity=0.279 Sum_probs=187.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|+.. ++..+|+|.++... ......+.+|++++++++||||+++++++..++..++||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 467999999999999764 67889999987533 22345678899999999999999999999999999999999974 8
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 90 l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 90 LKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 8888865432 478899999999999999999976 8999999999999999999999999998754322
Q ss_pred ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC-c---------
Q 044996 528 SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD-N--------- 596 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~-~--------- 596 (678)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||... ...+.+......-. .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS--------TVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 12235678999998865 46899999999999999999999999621 11111111111000 0
Q ss_pred -cccccchhhhccc------CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 -RTEVFDKEMADER------NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 -~~~~~d~~l~~~~------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..+..+....... ........+.+++.+|++.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000000 00011234678888999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.53 Aligned_cols=256 Identities=19% Similarity=0.288 Sum_probs=188.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC-----ceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE-----EKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~E 445 (678)
.+.||+|+||.||++.. .+++.||+|++... .....+++.+|+++++.++|+||+++++++...+ ..|+|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 46799999999999986 47899999998643 2334567889999999999999999999998766 7899999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 85 LMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred ccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 996 68888876432 589999999999999999999976 89999999999999999999999999987654
Q ss_pred ccc-----cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCC--------CCCChHHH-----
Q 044996 526 QES-----AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKK--------ADGDLASW----- 586 (678)
Q Consensus 526 ~~~-----~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~--------~~~~l~~~----- 586 (678)
... ...++..|+|||++.+. .++.++|||||||++|||++|+.||........ +.....++
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 321 12346789999998764 479999999999999999999999962210000 00000000
Q ss_pred -HHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 587 -VNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 587 -~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
....+.......... ..+. .........+.+++.+|++.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSL-PVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCch-HHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000 0000 0001113457788889999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.88 Aligned_cols=244 Identities=20% Similarity=0.273 Sum_probs=190.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++|+||+.+++.+...+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 357999999999999764 68899999886432 22234577899999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++..... ..+++.++..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 85 GDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999865432 2588999999999999999999965 89999999999999999999999999987654322
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||...... ..... ........ ....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~~~~-~~~~~~~~-------~~~~- 224 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREE-VERLVKEV-------QEEY- 224 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----chHHH-HHhhhhhh-------hhhc-
Confidence 234678899999999889999999999999999999999999731100 00000 11111000 0000
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
.......+.+++.+||+.||++||| +.|+++
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 ----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112234677888999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.94 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence 46799999999999975 57899999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.+++... .+++.++..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 104 TDVVTET------CMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 9998643 478999999999999999999965 79999999999999999999999999987654322
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...... .........+. +.+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~--------~~~~~~~~~~~-------~~~~-- 236 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGT-------PELQ-- 236 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--------hheeeeccCCC-------CCCC--
Confidence 223567899999998888999999999999999999999999621110 00000000000 0000
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
........+.+++.+||+.+|++||++.++++
T Consensus 237 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 -NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01122334677888999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=297.81 Aligned_cols=254 Identities=21% Similarity=0.313 Sum_probs=193.2
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEec--ccChhhHHHHHHHHHHHhccCCCCccceeEEEEe-----CCceEEEEec
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFK--QMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR-----KEEKLLVHEF 446 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~~~lv~Ey 446 (678)
+.||+|+||.|+.+.. .+|+.||||++. -.+....++-.+|+++|+.++|+||+.+++++.. -+..|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 5699999999999965 578999999997 3455667888999999999999999999999865 3468999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
| .-+|...++..+ .|+......++.|+++||.|+|+. +|+||||||+|+|++.+...||+|||+|+....
T Consensus 108 M-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred H-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEeccccceeeccc
Confidence 9 569999998653 488889999999999999999966 899999999999999999999999999998853
Q ss_pred c------ccccccceeeCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHH-------------
Q 044996 527 E------SAQELMIAYKSPEFLQ-LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASW------------- 586 (678)
Q Consensus 527 ~------~~~~~~~~y~aPE~~~-~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~------------- 586 (678)
. .....|..|+|||.+. ...||.+.||||.|||+.||++|+.-|-.. ..+.+.
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~-------d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK-------DYVHQLQLILELLGTPSEE 250 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC-------chHHHHHHHHHhcCCCCHH
Confidence 2 2234578899999875 468999999999999999999999887521 111111
Q ss_pred ---------HHHHHhcCCccc-cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhccCC
Q 044996 587 ---------VNSVLANGDNRT-EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKERDG 651 (678)
Q Consensus 587 ---------~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~~~~ 651 (678)
++..+..-.... .-+...+. ..-...+++..+++..||.+|+|++|+++ .|....+...
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp------~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP------NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcC------CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 111111000000 00000000 11234566777999999999999999998 4666555433
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.19 Aligned_cols=257 Identities=21% Similarity=0.285 Sum_probs=184.9
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeC--------CceEEE
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--------EEKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~lv 443 (678)
..++||+|+||.||+|.. .++..||||++.... ....+|+.+|++++|||||++++++... ...++|
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 356799999999999976 467899999885432 2345799999999999999999987542 136799
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-ceEEeecCCcc
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-EPVLADYGLIP 522 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~ 522 (678)
|||++ ++|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 146 mE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 146 MEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 99997 478777654221 122589999999999999999999976 799999999999999664 79999999998
Q ss_pred ccCccc---cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCc-
Q 044996 523 VMNQES---AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDN- 596 (678)
Q Consensus 523 ~~~~~~---~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~- 596 (678)
.+.... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||.... ..+-+...... +..
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~--------~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS--------SVDQLVRIIQVLGTPT 291 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCC
Confidence 654322 2345778999998865 468999999999999999999999996211 11111111110 000
Q ss_pred ----------cc-----cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhc
Q 044996 597 ----------RT-----EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKE 648 (678)
Q Consensus 597 ----------~~-----~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~ 648 (678)
.. .+....+... .+.....++.+++.+||+.||.+|||+.|+++ .++++.+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~-~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKV-FPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHH-hccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 00 0000001000 01112345778888999999999999999985 4555544
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.68 Aligned_cols=243 Identities=19% Similarity=0.235 Sum_probs=187.2
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
..+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 47 i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (371)
T cd05622 47 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 126 (371)
T ss_pred EEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 3567999999999999865 5788999988642 22334567899999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|.+++... .++...+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 127 gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 127 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 99999998653 377888889999999999999976 89999999999999999999999999997664321
Q ss_pred -----cccccceeeCccccccC----CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 529 -----AQELMIAYKSPEFLQLG----RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 529 -----~~~~~~~y~aPE~~~~~----~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
...++..|+|||++... .++.++|||||||++|||++|+.||.. .+............... .
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--------~~~~~~~~~i~~~~~~~-~ 267 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA--------DSLVGTYSKIMNHKNSL-T 267 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCcc-c
Confidence 23468899999998653 378999999999999999999999962 22222333333221111 1
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCcccccc--CCCHHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEK--RLDLKEAVEK 642 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~ev~~~ 642 (678)
..+ . ......+.+++.+|+..++.+ |+++.|+++.
T Consensus 268 ~~~-----~---~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 268 FPD-----D---NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCC-----c---CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 100 0 012234566777888744433 7788888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.33 Aligned_cols=243 Identities=20% Similarity=0.263 Sum_probs=190.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|.. .++..+++|.++.........+++|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 93 (267)
T cd06645 14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93 (267)
T ss_pred HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcH
Confidence 45699999999999975 46888999998765555556788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.+++.... .+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...... .
T Consensus 94 ~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 94 QDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 99987543 588999999999999999999976 7999999999999999999999999998654322 2
Q ss_pred cccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 AQELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... ...+....... .. .+..
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~--------~~~~~~~~~~~-~~----~~~~ 231 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP--------MRALFLMTKSN-FQ----PPKL 231 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc--------hhhHHhhhccC-CC----CCcc
Confidence 234678899999874 45688999999999999999999999852111 00111111110 00 0111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... .....+.+++.+|++.+|++||++++|++
T Consensus 232 ~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDKM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccC---CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000 11234677888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.02 Aligned_cols=248 Identities=19% Similarity=0.315 Sum_probs=193.5
Q ss_pred ccccCccCceeEEEEEecC--CceEEEEEeccc----------ChhhHHHHHHHHHHHhc-cCCCCccceeEEEEeCCce
Q 044996 374 AEILGSGCFGSSYKASLST--GAMMVVKRFKQM----------NNVGREEFQEHMRRLGR-LRHPNLLPLVAYYYRKEEK 440 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~ 440 (678)
.+.||+|+||.||+|.... ++.+++|.+... ......++..|+.++.+ ++|+||+++++++...+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 3569999999999998754 678999987532 12234557788888765 7999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCC
Q 044996 441 LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL 520 (678)
Q Consensus 441 ~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 520 (678)
++||||+++++|.+++...... ...+++..+++++.|++.||.|||.. .+++|+||||+||++++++.+||+|||+
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKE---KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccC---CceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999988543211 12588999999999999999999953 2699999999999999999999999999
Q ss_pred ccccCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 521 IPVMNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 521 a~~~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
+....... ...++..|+|||++.+..++.++||||||+++|||++|+.||.. ................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~- 231 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS--------TNMLSLATKIVEAVYE- 231 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc--------cCHHHHHHHHhhccCC-
Confidence 87665432 23356789999999988899999999999999999999999862 2223333222211100
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
+.. .......+.+++.+||+.||++||+|.||.++++
T Consensus 232 -----~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 -----PLP-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----cCC-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 0012345778888999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=300.33 Aligned_cols=239 Identities=24% Similarity=0.359 Sum_probs=189.9
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh---------hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN---------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 443 (678)
...||+|+||.||+|.. .++..+++|.+..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 45799999999999976 4578899998864321 1235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 85 LEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999997542 488899999999999999999976 799999999999999999999999999876
Q ss_pred cCccc----------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 524 MNQES----------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 524 ~~~~~----------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
..... ...++..|+|||++.+..++.++|||||||++|||++|+.||.... .. .-+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~-~~~~~~~~- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-------QL-QAIFKIGE- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-------HH-HHHHHHhc-
Confidence 64211 1134578999999988889999999999999999999999997211 11 11111110
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...+.+ .......+.+++.+||+.||.+||++.||++
T Consensus 227 ------~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ------NASPEI-----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------cCCCcC-----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001111 1112345677888999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.16 Aligned_cols=250 Identities=16% Similarity=0.233 Sum_probs=187.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 444 (678)
.+.||+|+||.||++.. ..++.+|||++... .......+.+|+.+++.++||||+++++++... ...++||
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 46799999999999975 46788999998753 233456788899999999999999999998643 2479999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+++ +|.+.+.. .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 102 e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred hhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 99964 67766642 378899999999999999999976 8999999999999999999999999999865
Q ss_pred Cccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHH--------------
Q 044996 525 NQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWV-------------- 587 (678)
Q Consensus 525 ~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~-------------- 587 (678)
.... ...++..|+|||++.+..++.++|||||||++|||++|+.||.... ....|.
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-------YIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHHhCCCCHHHH
Confidence 4432 2346788999999998899999999999999999999999996211 111111
Q ss_pred -------HHHHhcCCccccccchhh-hc------ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 588 -------NSVLANGDNRTEVFDKEM-AD------ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 588 -------~~~~~~~~~~~~~~d~~l-~~------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
...............+.. .. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 111111100000000000 00 00011123457888999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=301.02 Aligned_cols=241 Identities=21% Similarity=0.339 Sum_probs=186.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeC------CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRK------EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~------~~~~lv~E 445 (678)
.+.||+|+||.||+|... +++.+++|.+... ......+..|+.++.++ +|+||+++++++... ...++|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 356999999999999764 5788999988653 33456788999999998 799999999998753 35789999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++|+|.+++..... ..++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 90 ~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 90 FCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred cCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999976432 2588999999999999999999976 79999999999999999999999999987654
Q ss_pred cc----ccccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 526 QE----SAQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 526 ~~----~~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
.. ....++..|+|||++. ...++.++|||||||++|||++|+.||.... ....+. ......
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-------~~~~~~--~~~~~~- 232 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-------PMRALF--LIPRNP- 232 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-------HHHHHH--HHhcCC-
Confidence 32 2234567899999986 3457889999999999999999999986221 111111 011100
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. +.+... .....+.+++.+||..+|.+|||+.|+++
T Consensus 233 ~-----~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 A-----PRLKSK----KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C-----CCCCCC----CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 111011 12235778888999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.07 Aligned_cols=248 Identities=22% Similarity=0.344 Sum_probs=194.1
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEecccChh-hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|+.. ....+++|.+...... ..+++.+|++++++++|+||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 356999999999999863 2457888888654333 457899999999999999999999999988899999999
Q ss_pred cCCCCHHHHhhccCCCC----CCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 447 VPKRSLAVNLHGHQALG----QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
+++|+|.+++....... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||+++
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEccccccc
Confidence 99999999997654211 12589999999999999999999976 79999999999999999999999999986
Q ss_pred ccCcc-----ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 523 VMNQE-----SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 523 ~~~~~-----~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
..... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.... ....+.... .+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--------~~~~~~~~~-~~~~ 236 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--------DEEVLNRLQ-AGKL 236 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--------hHHHHHHHH-cCCc
Confidence 54321 12234567999999988888999999999999999999 888885211 111222111 1110
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
. .. ........+.+++.+||+.+|.+||++.|++..|.
T Consensus 237 ~--~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 E--LP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C--CC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0 00 00112345788889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=316.28 Aligned_cols=236 Identities=19% Similarity=0.213 Sum_probs=181.0
Q ss_pred cCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc---CCCCccceeEEEEeCCceEEEEeccCC
Q 044996 377 LGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL---RHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
||+|+||+||+|+.. ++..||+|++.... ......+..|..++.++ +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999764 68899999986432 12233455666776655 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 99999987542 488999999999999999999976 8999999999999999999999999998753221
Q ss_pred --ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 --SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.. .+..+...........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~~-------- 215 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA--------EDTQQMYRNIAFGKVR-------- 215 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC--------CCHHHHHHHHHcCCCC--------
Confidence 123467889999998754 479999999999999999999999862 2222222222211110
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCC----HHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLD----LKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs----~~ev~~ 641 (678)
+.... ....+.+++.+||+.||.+||+ +.++++
T Consensus 216 ~~~~~----~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 FPKNV----LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCcc----CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 10111 1234567777999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=296.38 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=193.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..+++|||+++++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 356999999999999764 5778999998865555677899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.+++..... .+++.++..++.|++.||+|||.. +++|+||||+||++++++.+||+|||++.......
T Consensus 88 ~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 88 QDIYQVTRG----PLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred HHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 999876422 588999999999999999999965 79999999999999999999999999987654321
Q ss_pred cccccceeeCccccccC---CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 AQELMIAYKSPEFLQLG---RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~---~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||.+... .++.++|||||||++|||+||+.||..... ..-........ ...+.+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--------~~~~~~~~~~~-----~~~~~~ 226 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--------MRALFLISKSN-----FPPPKL 226 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcc-----CCCccc
Confidence 22345679999999776 789999999999999999999999862211 11111111110 000011
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ........+.+++.+||+.+|.+|||+.+|+.
T Consensus 227 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 K---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 11123455788888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=319.69 Aligned_cols=189 Identities=20% Similarity=0.289 Sum_probs=165.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||++... +++.+|+|+++... ......+.+|+.++.+++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999764 68899999987432 23345788899999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 86 GDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999997543 488999999999999999999965 8999999999999999999999999998654211
Q ss_pred -------------------------------------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCc
Q 044996 528 -------------------------------------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPA 570 (678)
Q Consensus 528 -------------------------------------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~ 570 (678)
....+|..|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0124678899999999899999999999999999999999999
Q ss_pred c
Q 044996 571 N 571 (678)
Q Consensus 571 ~ 571 (678)
.
T Consensus 237 ~ 237 (360)
T cd05627 237 C 237 (360)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=303.66 Aligned_cols=245 Identities=23% Similarity=0.344 Sum_probs=192.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||++... ++..+++|.++.. .......+.+|++++++++|+||+++++++...+..++||||+++++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS 85 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCC
Confidence 467999999999999875 7889999988753 33445678999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--c
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--A 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--~ 529 (678)
|..++..... ...+++..+..++.+++.||.|||+.+ +|+||||||+||+++.++.+||+|||++..+.... .
T Consensus 86 l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (286)
T cd06622 86 LDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT 160 (286)
T ss_pred HHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcccc
Confidence 9999875421 225899999999999999999999642 69999999999999999999999999987653322 2
Q ss_pred ccccceeeCccccccC------CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHH--hcCCcccccc
Q 044996 530 QELMIAYKSPEFLQLG------RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL--ANGDNRTEVF 601 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~------~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~~ 601 (678)
..++..|+|||++.+. .++.++|||||||++|||++|+.||... ....+..... ..+..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--------~~~~~~~~~~~~~~~~~----- 227 (286)
T cd06622 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE--------TYANIFAQLSAIVDGDP----- 227 (286)
T ss_pred CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc--------chhhHHHHHHHHhhcCC-----
Confidence 2356789999998544 3488999999999999999999999621 1111111111 01100
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+.+ .......+.+++.+||+.+|++||++.++++.
T Consensus 228 -~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 -PTL-----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -CCC-----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 011 11233456778889999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=298.28 Aligned_cols=241 Identities=20% Similarity=0.290 Sum_probs=195.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||++.. .+++.+++|.+... .....+++.+|+.++++++|+||+++++++...+..++||||++++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 46799999999999975 46788999988642 3344568899999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++..... ..+++.++++++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 85 ~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 85 DLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999875432 2478999999999999999999965 79999999999999999999999999987654322
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+.......... .
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~--------~~~~~~~~~~~~~~~~~-------~- 221 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA--------GNMKNLVLKIIRGSYPP-------V- 221 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC--------CCHHHHHHHHhcCCCCC-------C-
Confidence 12356779999999888899999999999999999999999862 23334443333221110 0
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.+|++||+|+||++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 ----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122345778888999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=304.77 Aligned_cols=241 Identities=26% Similarity=0.355 Sum_probs=191.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +++.|++|.+.... ....+++.+|+++++.++||||++++++|...+..++||||+.
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL- 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence 367999999999999764 68899999886432 2334578899999999999999999999999999999999996
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
|++.+++..... .+++..+..++.|++.||.|||.. +++||||+|+||++++++.+||+|||++........
T Consensus 99 g~l~~~~~~~~~----~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 99 GSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred CCHHHHHHHccc----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 678777754322 589999999999999999999965 799999999999999999999999999887665555
Q ss_pred ccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 QELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 ~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..++..|+|||++. ...++.++||||||+++|||+||+.||... +........... .. +.+
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~--------~~~~~~~~~~~~-~~------~~~- 234 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQN-DS------PTL- 234 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc--------cHHHHHHHHhcC-CC------CCC-
Confidence 55677899999874 356889999999999999999999998621 111111111111 00 001
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
........+.+++.+||+.+|++||+|.+|+..
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 ---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011233457888889999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=294.30 Aligned_cols=242 Identities=20% Similarity=0.308 Sum_probs=198.6
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.++||+|+||.||||.+ +.|+.+|||++.. ..+.+++..|+.+|++++.|++|++||.|.....+|+|||||..|+
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 346799999999999954 5799999998865 3457789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
..+.++.++. +|++.++..|+++.++||+|||.- .-+|||||+-|||++.+|.+||+|||.|..+...
T Consensus 115 iSDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 115 ISDIMRARRK----PLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred HHHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999987654 799999999999999999999965 5679999999999999999999999999877654
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....+|+-|||||++..-.|.+++||||+|++..||..|+.||.+..+...- ..+.... . |.+
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------FMIPT~P-P-----PTF-- 249 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------FMIPTKP-P-----PTF-- 249 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------EeccCCC-C-----CCC--
Confidence 3334678899999999889999999999999999999999999743221100 0000000 0 111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
..+++-..++-+++..|+-..|++|-|+.++++.
T Consensus 250 -~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 -KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1123345567888889999999999998887653
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.67 Aligned_cols=240 Identities=20% Similarity=0.251 Sum_probs=192.0
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
..||+|+||.||++.. .++..++||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 5699999999999976 468899999987655556677999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----cc
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----SA 529 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 529 (678)
+++... .+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++...... ..
T Consensus 108 ~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 108 DIVTHT------RMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 988542 488999999999999999999976 7999999999999999999999999998654322 12
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|+|||++.+..++.++|||||||++|||++|+.||... ....-+.... . .+.+.+....
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~-~------~~~~~~~~~~ 242 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE--------PPLQAMRRIR-D------NLPPRVKDSH 242 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHH-h------cCCCcccccc
Confidence 33567899999998888999999999999999999999998621 1111111111 1 0111111110
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.....+..++.+|+..||.+|||+.|+++.
T Consensus 243 ---~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 ---KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122346677779999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=298.08 Aligned_cols=243 Identities=28% Similarity=0.436 Sum_probs=195.3
Q ss_pred ccccCccCceeEEEEEecC-----CceEEEEEecccChh-hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLST-----GAMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||++.... +..+++|.++..... ..+.+..|++.+..++|+||+++++++...+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4679999999999998753 478999998765433 5678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++++|.+++...... .+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 84 EGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred CCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999764321 289999999999999999999966 7999999999999999999999999998765433
Q ss_pred c-----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 528 S-----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 528 ~-----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
. ...++..|+|||.+.+..++.++||||+|+++|||++ |+.||.. .............. .. .
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~--------~~~~~~~~~~~~~~-~~-~-- 224 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG--------MSNEEVLEYLKKGY-RL-P-- 224 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHhcCC-CC-C--
Confidence 1 1224578999999988889999999999999999999 8888762 22222222222111 11 0
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHH
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L 643 (678)
........+.+++.+|++.+|++|||+.|+++.|
T Consensus 225 --------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 --------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111234577888899999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=334.39 Aligned_cols=254 Identities=19% Similarity=0.295 Sum_probs=192.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~Ey~~ 448 (678)
.+.||+|+||+||+|... .+..+++|.+... .......|..|+.++++++|||||+++++|... ...||||||++
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~ 97 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD 97 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence 467999999999999764 5677888887642 334567789999999999999999999988653 46899999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCC---CCCCcccCCCCCCEEecC----------------
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP---SLIAPHGHIKSSNVLLNE---------------- 509 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~---~~~ivHrdlk~~NILl~~---------------- 509 (678)
+|+|.++|...... ...+++..++.|+.||+.||+|||.... ..+||||||||+||||+.
T Consensus 98 gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 98 AGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 99999999753221 1258999999999999999999997421 135999999999999964
Q ss_pred -CCceEEeecCCccccCccc---cccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCCh
Q 044996 510 -SLEPVLADYGLIPVMNQES---AQELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDL 583 (678)
Q Consensus 510 -~~~~kl~DfGla~~~~~~~---~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l 583 (678)
...+||+|||+++.+.... ...+++.|+|||++.+ ..++.++||||||||||||+||+.||.. ...+
T Consensus 177 g~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~-------~~~~ 249 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK-------ANNF 249 (1021)
T ss_pred CCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc-------CCcH
Confidence 2358999999998764332 2346789999999854 4589999999999999999999999962 1122
Q ss_pred HHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhc
Q 044996 584 ASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKE 648 (678)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~ 648 (678)
...+. .+..... +... .....+.+++..||+.+|.+||++.|++. .+..+..
T Consensus 250 ~qli~-~lk~~p~--------lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 250 SQLIS-ELKRGPD--------LPIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHH-HHhcCCC--------CCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 22222 2221111 1001 11235777888999999999999999984 5555544
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=287.55 Aligned_cols=243 Identities=20% Similarity=0.259 Sum_probs=191.5
Q ss_pred hccccCccCceeEEEEE-ecCCceEEEEEecc--cChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 373 SAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQ--MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
+.+.||+|.|+.||++. ..+|+.+++|.+.. ....+.+++.+|+++.+.|+|||||++...+......|||+|+|.+
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 34679999999999985 46788888887763 2344678899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---CCceEEeecCCccccCc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---SLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~ 526 (678)
|+|..-+-.+. ..++...-..++||+.+|.|+|.+ +|||||+||+|+|+.. ..-+||+|||+|..++.
T Consensus 95 ~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 95 GELFEDIVARE-----FYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred hHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99987665442 467778889999999999999977 8999999999999953 45689999999988874
Q ss_pred c---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 527 E---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 527 ~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
. ....||++|||||++...+|+..+|||+.|||||-|+.|..||.. .+-....+.+.+.. .-+++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~--------~~~~rlye~I~~g~----yd~~~ 233 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--------EDQHRLYEQIKAGA----YDYPS 233 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC--------ccHHHHHHHHhccc----cCCCC
Confidence 3 234578999999999999999999999999999999999999972 12222223333221 11222
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. ..........++.+|+..||.+|.|+.|.++
T Consensus 234 ~~-----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PE-----WDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cc-----cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11 1111223456667999999999999988764
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.43 Aligned_cols=245 Identities=20% Similarity=0.234 Sum_probs=186.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+++.. +++.+|+|.+... .....+.|.+|+.++..++|+||+++++++.+.+..|+||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 467999999999999864 5889999998642 223345688999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 86 ~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 86 GDLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999975322 488999999999999999999976 79999999999999999999999999986554321
Q ss_pred ----cccccceeeCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 529 ----AQELMIAYKSPEFLQL-----GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~-----~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
...++..|+|||++.. ..++.++|||||||++|||++|+.||. .....+............ .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~--------~~~~~~~~~~i~~~~~~~-~ 228 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY--------AESLVETYGKIMNHKEHF-Q 228 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC--------CCCHHHHHHHHHcCCCcc-c
Confidence 1246789999999863 457889999999999999999999996 223334433333322111 1
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcC--ccccccCCCHHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACC--EEEVEKRLDLKEAVEK 642 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl--~~~P~~RPs~~ev~~~ 642 (678)
+ .+.. ...+ +. +.+++.+|+ ..++..||++.++++.
T Consensus 229 ~-~~~~--~~~~-~~---~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 F-PPDV--TDVS-EE---AKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C-CCcc--CCCC-HH---HHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1 0100 0011 23 344444544 4555558899998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.69 Aligned_cols=239 Identities=19% Similarity=0.257 Sum_probs=191.6
Q ss_pred ccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHHH
Q 044996 376 ILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAV 454 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~ 454 (678)
.||+|+||.||+|... ++..+++|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++|..
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 5999999999999764 688999999876545556778899999999999999999999999999999999999999998
Q ss_pred HhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----ccc
Q 044996 455 NLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----SAQ 530 (678)
Q Consensus 455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~~ 530 (678)
++... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...... ...
T Consensus 108 ~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 108 IVSQT------RLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred HHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 87542 488999999999999999999966 7999999999999999999999999998654332 223
Q ss_pred cccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccC
Q 044996 531 ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERN 610 (678)
Q Consensus 531 ~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (678)
.++..|+|||++.+..++.++|||||||++|||++|+.||... ....-+.... ..... ....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~--------~~~~~~~~~~-~~~~~------~~~~--- 239 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD--------SPVQAMKRLR-DSPPP------KLKN--- 239 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHh-ccCCC------Cccc---
Confidence 4567899999998888999999999999999999999998621 1111111111 11000 0000
Q ss_pred CHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 611 SEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.......+.+++.+|++.+|.+||++.|+++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00112346778889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.49 Aligned_cols=186 Identities=18% Similarity=0.269 Sum_probs=159.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 444 (678)
.+.||+|+||.||++.. ..++.+|||++... .......+.+|+.+++.++||||+++++++... ...|+||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 46799999999999975 46788999998753 233456788999999999999999999987643 3479999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||++ ++|..++.. .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 109 ELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 9996 477777642 378899999999999999999976 8999999999999999999999999999866
Q ss_pred Cccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 525 NQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 525 ~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.... ...++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 4432 2346788999999998899999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=300.70 Aligned_cols=239 Identities=23% Similarity=0.322 Sum_probs=192.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||.|+||.||+|... +++.+++|.+.... ......+.+|++++++++|+||+++++++.+....++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 356999999999999864 67899999887543 3445678899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++... .+++..+..++.|++.||.|||.. +++||||+|+||++++++.++|+|||+++.....
T Consensus 86 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 86 CLDLLKPG------KLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99998753 589999999999999999999965 7999999999999999999999999998776543
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||... +......... .... +.+..
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~--------~~~~~~~~~~-~~~~------~~~~~ 220 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL--------HPMRVLFLIP-KNNP------PSLEG 220 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC--------chHHHHHHhh-hcCC------CCCcc
Confidence 1223456799999999888999999999999999999999998621 1111111111 1100 11111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. ....+.+++.+||..+|++|||++++++
T Consensus 221 ~~----~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 NK----FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cc----cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 10 2234777888999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=302.58 Aligned_cols=191 Identities=23% Similarity=0.361 Sum_probs=161.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... ++..|++|+++... ....+.+.+|+.++++++||||+++++++..++..++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 356999999999999864 68899999886432 2334678899999999999999999999999999999999997 6
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 84 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 84 DLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 89888865432 12589999999999999999999966 7999999999999999999999999998754322
Q ss_pred -ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 528 -SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 122346789999988654 57899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=283.63 Aligned_cols=242 Identities=21% Similarity=0.312 Sum_probs=194.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC--------hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN--------NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 443 (678)
.++||.|..++|-++.. .+|..+++|++.... ....+.-.+|+.+|+++ .||+|+.+.++|+.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 35699999999998854 567889999886421 11234556899999998 699999999999999999999
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
+|.|+.|.|.++|...- .+++++..+|++|+..|++|||.. .||||||||+|||+|+++++||+|||+++.
T Consensus 102 Fdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999997643 589999999999999999999987 799999999999999999999999999999
Q ss_pred cCcccc---ccccceeeCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 524 MNQESA---QELMIAYKSPEFLQL------GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 524 ~~~~~~---~~~~~~y~aPE~~~~------~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
+..... -.||++|.|||.+.. ..|+..+|+|+.|||||.|+.|..||-...+ ..+-..+.+|
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---------mlMLR~ImeG 243 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---------MLMLRMIMEG 243 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---------HHHHHHHHhc
Confidence 887643 358999999998853 3578899999999999999999999853211 1112222232
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. +.-.|+. .+......+++.+|++.||.+|.|++|+++
T Consensus 244 ky--qF~speW------adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 244 KY--QFRSPEW------ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cc--ccCCcch------hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11 2222222 234456778888999999999999999987
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=295.54 Aligned_cols=240 Identities=25% Similarity=0.344 Sum_probs=191.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-----hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-----NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 357999999999999875 78899999886432 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++++|.+++.... .+++..+..++.|++.||+|||.. +++|+||+|+||++++++.+||+|||++......
T Consensus 85 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 85 PGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999997542 488999999999999999999966 7999999999999999999999999998765433
Q ss_pred c---cccccceeeCccccccCC-CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 528 S---AQELMIAYKSPEFLQLGR-ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 528 ~---~~~~~~~y~aPE~~~~~~-~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
. ...++..|+|||.+.... ++.++|||||||++|||++|+.||... .-.+......... .. .
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~--------~~~~~~~~~~~~~-~~-~---- 221 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL--------EGVAAVFKIGRSK-EL-P---- 221 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC--------cHHHHHHHHHhcc-cC-C----
Confidence 2 233567899999987666 899999999999999999999998621 1111221111101 01 0
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+ +......+.+++.+||+.+|.+||++.++++
T Consensus 222 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PI-----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred Cc-----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00 1112244677888999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=297.27 Aligned_cols=239 Identities=20% Similarity=0.289 Sum_probs=184.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-----hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-----NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 445 (678)
.+.||+|+||.||+|.. .++..+++|++.... ....+.+.+|+.++++++||||+++++++... ...+++||
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 46799999999999976 468899999876321 22345788999999999999999999998753 56789999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 87 YMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 999999999997542 488999999999999999999965 79999999999999999999999999987543
Q ss_pred cc-------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 526 QE-------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 526 ~~-------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||... .....+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~--------~~~~~~~~~~~~~---- 225 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY--------EAMAAIFKIATQP---- 225 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc--------chHHHHHHHhcCC----
Confidence 21 1123567899999998888999999999999999999999998621 1111121111111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..+.+. ......+..++ .||..+|++||+|+||++
T Consensus 226 --~~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 --TNPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011111 11112233343 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.07 Aligned_cols=241 Identities=22% Similarity=0.303 Sum_probs=192.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC-CceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-EEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||++... +++.+++|++... .....+.+.+|++++++++|+||+++++.+... ...++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 467999999999999764 5678999998643 234456788999999999999999999987644 457899999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
++|.+++..... ..+++.++..++.+++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 85 ~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 85 GDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred CcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999976422 2589999999999999999999976 7999999999999999999999999998765432
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||+. .+...+....... .. +.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~--------~~~~~~~~~~~~~-~~------~~~ 222 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA--------KDMNSLVYRIIEG-KL------PPM 222 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHhc-CC------CCC
Confidence 122356789999999988899999999999999999999999862 2333333322221 11 001
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+|++.+|++||++.|+++
T Consensus 223 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 -----PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -----ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1122345778888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=315.84 Aligned_cols=183 Identities=21% Similarity=0.299 Sum_probs=158.7
Q ss_pred ccccCccCceeEEEEEec---CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS---TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||++... .+..|++|.+... +.+.+|++++++++|||||++++++......++||||+. +
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 467999999999999653 3567888877542 245689999999999999999999999999999999995 6
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++... ..+++.+++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 171 ~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 171 DLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 898888433 2589999999999999999999976 89999999999999999999999999987654321
Q ss_pred ----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 529 ----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 2346788999999998899999999999999999999999986
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=306.01 Aligned_cols=192 Identities=21% Similarity=0.343 Sum_probs=155.9
Q ss_pred ccccCccCceeEEEEEec---CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe--CCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS---TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR--KEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~Ey~~ 448 (678)
+.+||+|+||.||+|+.. ++..+|+|.+.... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999864 45689999886532 23467889999999999999999999864 456889999986
Q ss_pred CCCHHHHhhccCC----CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe----cCCCceEEeecCC
Q 044996 449 KRSLAVNLHGHQA----LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL----NESLEPVLADYGL 520 (678)
Q Consensus 449 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGl 520 (678)
++|.+++..... .....+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 578877753221 1122588899999999999999999965 79999999999999 5678999999999
Q ss_pred ccccCccc-------cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 044996 521 IPVMNQES-------AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANF 572 (678)
Q Consensus 521 a~~~~~~~-------~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~ 572 (678)
++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 98654321 2235678999999876 4579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.70 Aligned_cols=241 Identities=23% Similarity=0.311 Sum_probs=196.3
Q ss_pred ccCccCceeEEEEEecC-CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHHH
Q 044996 376 ILGSGCFGSSYKASLST-GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAV 454 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~ 454 (678)
+||+|.||+||-|+..+ ...+|||.+...+....+-+.+||.+-++|+|.|||+++|.|.+++...+.||-+++|+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999998654 45789999887777777788999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCC--ChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec-CCCceEEeecCCccccCc----c
Q 044996 455 NLHGHQALGQPSL--DWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIPVMNQ----E 527 (678)
Q Consensus 455 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~----~ 527 (678)
+|+.... ++ .+.++--+.+||++||.|||++ .|||||||-.||||+ -.|.+||+|||.++.+.. .
T Consensus 662 LLrskWG----PlKDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 662 LLRSKWG----PLKDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred HHHhccC----CCccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 9987653 34 6777788999999999999987 699999999999997 579999999998876532 3
Q ss_pred ccccccceeeCccccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 SAQELMIAYKSPEFLQLG--RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~--~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....||..|||||++..+ .|..++|||||||++.||.||+.||..+... .-..+ .-| . -.+.|.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-----qAAMF-----kVG-m--yKvHP~- 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-----QAAMF-----KVG-M--YKVHPP- 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-----hHhhh-----hhc-c--eecCCC-
Confidence 455688999999999765 5899999999999999999999999743221 11111 111 0 111222
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.+++...+...++++|..+||.+||++.++++.
T Consensus 800 ----iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 800 ----IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ----CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 234455667788999999999999999999873
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=303.63 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=187.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++|+||+++++++...+..++||||++ ++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~ 89 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 89 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence 356999999999999764 57889999887432 2334567889999999999999999999999999999999997 69
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 90 l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 90 LKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 9988875432 588999999999999999999965 89999999999999999999999999987543221
Q ss_pred -cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcc----cccc
Q 044996 529 -AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNR----TEVF 601 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~----~~~~ 601 (678)
...++..|+|||++.+ ..++.++|||||||++|||+||+.||... +..+.+...... +... ..++
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS--------TVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHHcCCCChhhchhhh
Confidence 2234678999998865 35789999999999999999999998621 111111111100 0000 0000
Q ss_pred ------c---hhhhccc---CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 602 ------D---KEMADER---NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 602 ------d---~~l~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. +...... ........+.+++.+|++.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0000000 00011234678888999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=301.57 Aligned_cols=244 Identities=24% Similarity=0.333 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||++.. .++..+++|++.... .....++.+|++++++++|+|++++++++..++..++||||+.
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL- 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence 45799999999999986 467889999886432 2334578899999999999999999999999999999999996
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
|+|.+.+..... .++|.++..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++........
T Consensus 109 g~l~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (317)
T cd06635 109 GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180 (317)
T ss_pred CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCCccc
Confidence 588887764432 589999999999999999999976 799999999999999999999999999887665555
Q ss_pred ccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 QELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 ~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..++..|+|||++. .+.++.++|||||||++|||++|+.||... ................ .
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~~~~-------~- 244 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNESPT-------L- 244 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHhccCCC-------C-
Confidence 56778899999874 456899999999999999999999998621 1111122222111100 0
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
........+.+++.+||+.+|.+||++.+|++.+--
T Consensus 245 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 245 ---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 011223457788889999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.61 Aligned_cols=239 Identities=20% Similarity=0.263 Sum_probs=194.2
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
+.||+|++|.||++.. .++..+++|+++.......+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 5799999999999975 467889999887655555667889999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----cc
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----SA 529 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 529 (678)
+++... .+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...... ..
T Consensus 105 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 105 DIVTHT------RMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred HHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 998752 488999999999999999999976 7999999999999999999999999987654332 12
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|+|||++.+..++.++|||||||++|||++|+.||.. .+............. +.+..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~--------~~~~~~~~~~~~~~~-------~~~~~-- 237 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN--------EPPLQAMKRIRDNLP-------PKLKN-- 237 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC--------CCHHHHHHHHHhcCC-------CCCcc--
Confidence 2356789999999888899999999999999999999999862 222333332222210 01100
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0012345788888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.33 Aligned_cols=241 Identities=20% Similarity=0.325 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||++.. .+++.+++|.+... .....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence 45799999999999976 46788999988643 2344678999999999999999999999999889999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC-CceEEeecCCccccCccc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES-LEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~~~- 528 (678)
+|.+++..... ..+++..+.+++.+++.||+|||+. +++|+||||+||+++++ +.+||+|||++.......
T Consensus 85 ~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 85 TLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999976432 2589999999999999999999976 89999999999999854 568999999987664332
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.. .+....+......... .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~--------~~~~~~~~~~~~~~~~--~~------ 221 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA--------ANLPALVLKIMSGTFA--PI------ 221 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc--------CchHHHHHHHHhcCCC--CC------
Confidence 23356789999999888899999999999999999999999862 2223333322221110 01
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0112335778888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=290.51 Aligned_cols=253 Identities=21% Similarity=0.243 Sum_probs=204.9
Q ss_pred hccccCccCceeEEEEEec------CCceEEEEEecc-cChhhHHHHHHHHHHHhccCCCCccceeEEEEeC-CceEEEE
Q 044996 373 SAEILGSGCFGSSYKASLS------TGAMMVVKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-EEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~ 444 (678)
...++-+|.||.||+|-+. +.+.|.+|.++. .++.....|..|.-.+..+.|||+..+.+++.+. +..+++|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 3456899999999999553 345677887764 3455667888999999999999999999998764 5678999
Q ss_pred eccCCCCHHHHhhccCC---CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCc
Q 044996 445 EFVPKRSLAVNLHGHQA---LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 521 (678)
.++.-|+|..+|...+. .....++-.+...++.|++.||+|||++ +|||.||..+|++||+..++||+|=.++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----CcccchhhhhcceehhheeEEeccchhc
Confidence 99999999999984331 1233577788899999999999999977 8999999999999999999999999999
Q ss_pred cccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 522 PVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 522 ~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
|.+-+.. ....++.||+||.+....|+.++|||||||+||||+| |+.||...++ ..+...+.+|
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---------fEm~~ylkdG 514 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---------FEMEHYLKDG 514 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---------HHHHHHHhcc
Confidence 8765542 2234688999999999999999999999999999999 9999873322 2244455555
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
..+ .. +-.++.++..++..||...|++||++.+++..|.+....
T Consensus 515 yRl--------aQ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 515 YRL--------AQ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred cee--------cC---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 322 11 224677899999999999999999999999999987643
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.70 Aligned_cols=245 Identities=19% Similarity=0.227 Sum_probs=187.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+++.. +++.+|+|.+... .......+.+|+.++..++|+||+++++++.+.+..|+||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999864 5788999988642 223345688899999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 g~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 86 GDLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999976422 588999999999999999999975 89999999999999999999999999987654332
Q ss_pred ----cccccceeeCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 529 ----AQELMIAYKSPEFLQL-----GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~-----~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
...++..|+|||++.+ +.++.++|||||||++|||++|+.||.. .+..+............ .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~--------~~~~~~~~~i~~~~~~~-~ 228 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHEERF-Q 228 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC--------CCHHHHHHHHHcCCCcc-c
Confidence 2346789999999865 4678999999999999999999999962 22333333333221111 0
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCcccccc--CCCHHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEK--RLDLKEAVEK 642 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~ev~~~ 642 (678)
+.+.+ ......+.+++.+|+..++.+ |++++++++.
T Consensus 229 -~p~~~------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 -FPSHI------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -CCCcc------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 01111 011234556666777755543 5688888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.11 Aligned_cols=254 Identities=22% Similarity=0.237 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~Ey~~~ 449 (678)
.+.||.|++|.||++... +++.+++|.+.... .....++.+|++++++++||||++++++|... +..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 357999999999999874 57889999887532 24457789999999999999999999998654 368999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|.+++..... ....+++..+..++.|++.||+|||.. +++|+||+|+||++++++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 999998764322 122588899999999999999999975 79999999999999999999999999987544322
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+......... .. ...+ ...
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~~-~~~~-~~~- 233 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP---PLGPIELLSYIVNMP-NP-ELKD-EPG- 233 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC---CCChHHHHHHHhcCC-ch-hhcc-CCC-
Confidence 223467899999998889999999999999999999999999732110 011122222222111 00 1100 000
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
........+.+++.+||+.+|++||||.||++
T Consensus 234 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 --NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00112345788999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.72 Aligned_cols=238 Identities=21% Similarity=0.336 Sum_probs=190.2
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEe--cc--cChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc--eEEEEecc
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRF--KQ--MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE--KLLVHEFV 447 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~--~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lv~Ey~ 447 (678)
++||+|+|-+||||... +|..||--.+ .. .+....++|..|+++|+.|+|+|||++|.++.+... .-+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 56999999999999764 4555552222 21 234456889999999999999999999999987665 66899999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCccccCc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~ 526 (678)
..|+|+.|+++++ .++...+.++++||++||.|||.+.+ +|+|||||.+||+|+. .|.+||+|+|||..+..
T Consensus 126 TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~P--PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 126 TSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQDP--PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCCC--CccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999876 47888899999999999999999854 6999999999999985 48999999999998877
Q ss_pred cccc--cccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc--cccccc
Q 044996 527 ESAQ--ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN--RTEVFD 602 (678)
Q Consensus 527 ~~~~--~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~d 602 (678)
.... .||+.|||||++. ..|++.+||||||+.|+||+|+..||... .+.++.-+++...... +.++-|
T Consensus 199 s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-------~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 199 SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-------TNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-------CCHHHHHHHHHcCCCHHHhhccCC
Confidence 6544 4899999999998 78999999999999999999999999843 2334433333322211 111112
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
| ++.+++-+|+.. .++|||+.|+++
T Consensus 271 P-------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 P-------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred H-------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 2 256677799999 999999999986
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=301.13 Aligned_cols=255 Identities=20% Similarity=0.281 Sum_probs=183.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhcc---CCCCccceeEEEEeC-----CceEE
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRL---RHPNLLPLVAYYYRK-----EEKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~-----~~~~l 442 (678)
.+.||+|+||.||+|... +++.+|+|.++... ......+.+|+++++++ +||||+++++++... ...++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 356999999999999764 68899999887432 12233556677776655 799999999998642 35789
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
||||++ ++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 85 v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 85 VFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 999997 589888875432 2589999999999999999999976 79999999999999999999999999998
Q ss_pred ccCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC--cc
Q 044996 523 VMNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD--NR 597 (678)
Q Consensus 523 ~~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~--~~ 597 (678)
...... ...++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..... ...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~----~~~~~~~~~-~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIFD-LIGLPPEDDW 231 (288)
T ss_pred cccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH----HHHHHHHHH-HhCCCChhhC
Confidence 765332 22356789999999888999999999999999999999999852110 001111110 000000 00
Q ss_pred -------ccccchhhhc--ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 -------TEVFDKEMAD--ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 -------~~~~d~~l~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...+.+.... ..........+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 0000112345678888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.20 Aligned_cols=245 Identities=17% Similarity=0.191 Sum_probs=193.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 357999999999999764 57889999887543 23345788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 86 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 86 GDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999997542 588999999999999999999975 7999999999999999999999999998642100
Q ss_pred -----------------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHH
Q 044996 528 -----------------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSV 590 (678)
Q Consensus 528 -----------------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~ 590 (678)
....++..|+|||++....++.++|||||||++|||++|+.||.. ....++....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~--------~~~~~~~~~~ 228 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG--------DTPEELFGQV 228 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHH
Confidence 011245679999999888899999999999999999999999861 2223333333
Q ss_pred HhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 591 LANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
...... .+.... .....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~~~-----~~~~~~-----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDDIE-----WPEGDE-----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HhcccC-----CCCccc-----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 222111 111000 123346788889999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.93 Aligned_cols=254 Identities=20% Similarity=0.294 Sum_probs=189.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... +++.+++|++.... ....+.+.+|++++++++|+||+++++++......++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 356999999999999875 58899999886432 223456889999999999999999999999999999999999998
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
.|..++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 86 VLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred HHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 8887765432 489999999999999999999975 79999999999999999999999999998765432
Q ss_pred --cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh-----------cC
Q 044996 529 --AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA-----------NG 594 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~-----------~~ 594 (678)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ............ ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChHHhhhcccc
Confidence 2234577999999875 4578999999999999999999999862211 000001111100 00
Q ss_pred CccccccchhhhcccC----CHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 DNRTEVFDKEMADERN----SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
........+....... .......+.+++.+||+.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000000000 0011345778899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=310.01 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=185.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 444 (678)
.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|++++++++||||+++++++... ...++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 46799999999999975 467889999987532 23345678899999999999999999987543 3578999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 100 ~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 100 NLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 998 78998887532 489999999999999999999976 8999999999999999999999999999876
Q ss_pred Cccc-cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcccccc
Q 044996 525 NQES-AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTEVF 601 (678)
Q Consensus 525 ~~~~-~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~ 601 (678)
.... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||... +..+-+...... +....+..
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN--------DYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHHhCCCCHHHH
Confidence 5432 2346788999999876 56899999999999999999999998621 111111111110 00000000
Q ss_pred c-----------hhhhcccC------CHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 602 D-----------KEMADERN------SEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 602 d-----------~~l~~~~~------~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
. ..+..... .......+.+++.+|++.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000000 00011236788889999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=296.00 Aligned_cols=244 Identities=28% Similarity=0.414 Sum_probs=191.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhH--HHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGR--EEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||+++.. +++.+|+|.+........ ....+|+.++++++||||+++++++......++||||++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 467999999999999875 456899999987543332 23456999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc----Cc
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM----NQ 526 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~----~~ 526 (678)
+|.+++.... .+++.++..++.|+++||+|||+. +++|+||||+||++++++.+||+|||.+... ..
T Consensus 84 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 84 SLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp BHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccc-----cccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccc
Confidence 9999998332 589999999999999999999986 8999999999999999999999999998643 12
Q ss_pred cccccccceeeCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 527 ESAQELMIAYKSPEFLQ-LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 527 ~~~~~~~~~y~aPE~~~-~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
.....++..|+|||++. ...++.++||||+|+++|||++|+.||.... ..+.......... ..+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~----------~~~ 219 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILK----------RPL 219 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHH----------THH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhccc----------ccc
Confidence 22344577899999998 7889999999999999999999999987210 0011111111111 001
Q ss_pred hcccCC-HHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNS-EGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~-~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...... ......+.+++.+||+.||++||++.++++
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 011256788888999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.53 Aligned_cols=239 Identities=24% Similarity=0.331 Sum_probs=192.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|++++.+++||||+++++++..++..++||||+++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence 45799999999999975 467889999876432 3345678899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.+++... .+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++..+....
T Consensus 89 l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 89 ALDLLEPG------PLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 99998642 588999999999999999999965 89999999999999999999999999987654322
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||... ....+.... .... . +.+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~-~~~~-~-----~~~-- 221 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL--------HPMKVLFLI-PKNN-P-----PTL-- 221 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc--------chHHHHHHH-hcCC-C-----CCC--
Confidence 123567799999998888999999999999999999999998621 111222211 1111 1 001
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.......+.+++.+||+.+|.+||+|.++++.
T Consensus 222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11123456778889999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=321.78 Aligned_cols=188 Identities=22% Similarity=0.276 Sum_probs=154.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCC------CCccceeEEEEeC-CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRH------PNLLPLVAYYYRK-EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~~~~~~~-~~~~lv~E 445 (678)
.++||+|+||+||+|.. ..++.||||+++... ...+++..|++++++++| .+|+++++++... ...|+|||
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~ 212 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMP 212 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEe
Confidence 46799999999999976 457889999986532 233456667777777655 4588888888764 46889999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC--------------
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-------------- 511 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-------------- 511 (678)
++ +++|.+++.... .+++..+..|+.||+.||+|||+++ +||||||||+|||++.++
T Consensus 213 ~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 213 KY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred cc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 88 778998887542 5899999999999999999999642 799999999999998765
Q ss_pred --ceEEeecCCccccCcc-ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 512 --EPVLADYGLIPVMNQE-SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 512 --~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.+||+|||.+...... ....+|..|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus 284 ~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred CceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4999999987654322 23456789999999999999999999999999999999999996
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.51 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=193.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEe--CCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR--KEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||++.. .++..+++|.+... .....+.+..|++++++++|+||+++++++.. ....+++|||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence 35699999999999975 46788999988642 34456678899999999999999999998764 345789999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC-CCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL-PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
+++|.+++..... ....+++..++.++.|++.||+|||..+ ...+++|+||||+||++++++.+||+|||++......
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 9999999976432 1236899999999999999999999321 0237999999999999999999999999998876543
Q ss_pred c----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 528 S----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 528 ~----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
. ...++..|+|||++....++.++||||||+++|+|++|+.||... +...+... ...+.. +
T Consensus 164 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~-~~~~~~------~ 228 (265)
T cd08217 164 SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR--------NQLQLASK-IKEGKF------R 228 (265)
T ss_pred cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc--------CHHHHHHH-HhcCCC------C
Confidence 3 234567899999998888999999999999999999999998721 12222221 111111 0
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.+ .......+.+++.+|++.+|++||++.+|++.
T Consensus 229 ~~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 RI-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC-----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 11234567888889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=311.12 Aligned_cols=183 Identities=19% Similarity=0.256 Sum_probs=156.0
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.+.||+|+||.||+|... ++..||+|..... ....|+.++++++|+||+++++++......++||||+ .++
T Consensus 70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~ 142 (357)
T PHA03209 70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSD 142 (357)
T ss_pred EEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCc
Confidence 3567999999999999865 4678888864332 2356899999999999999999999999999999999 568
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---c
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---S 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---~ 528 (678)
|.+++..... .++|..+..|+.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 143 l~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 143 LYTYLTKRSR----PLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred HHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 9988865432 589999999999999999999976 7999999999999999999999999998754322 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPA 570 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~ 570 (678)
...++..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 234678899999999889999999999999999999965554
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.83 Aligned_cols=245 Identities=17% Similarity=0.204 Sum_probs=186.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||.||+++.. +++.+|+|.+.... ......|.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 467999999999999865 46789999886421 22344588899999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.++++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 86 GDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred CcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999976422 588999999999999999999975 89999999999999999999999999986543221
Q ss_pred ----cccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 529 ----AQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
...++..|+|||++. ...++.++|||||||++|||++|+.||. ..+..+............ .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~--------~~~~~~~~~~i~~~~~~~-~ 228 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY--------AESLVETYGKIMNHKERF-Q 228 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC--------CCCHHHHHHHHhCCCccc-c
Confidence 234678999999986 3468999999999999999999999996 223344444443322111 0
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCc--cccccCCCHHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCE--EEVEKRLDLKEAVEK 642 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~--~~P~~RPs~~ev~~~ 642 (678)
. .... ......+.+++.+|+. .++..|+++.|+++.
T Consensus 229 ~-p~~~------~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 F-PAQV------TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C-CCcc------ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0000 0112234455556554 444457899998775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.52 Aligned_cols=244 Identities=21% Similarity=0.308 Sum_probs=189.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh----------hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN----------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l 442 (678)
.+.||+|+||.||+|.. .+++.+++|.++.... ...+.+.+|+.++++++|+||+++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 46799999999999975 4688999998753211 113467889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
||||+++|+|.++++... .+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++
T Consensus 86 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999997652 588999999999999999999975 79999999999999999999999999987
Q ss_pred ccCccc------cccccceeeCccccccCC--CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 523 VMNQES------AQELMIAYKSPEFLQLGR--ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 523 ~~~~~~------~~~~~~~y~aPE~~~~~~--~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
...... ...++..|+|||++.... ++.++||||||+++||+++|+.||... .....+. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-------~~~~~~~-~~~~~~ 228 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-------EAIAAMF-KLGNKR 228 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc-------chHHHHH-Hhhccc
Confidence 654321 123567899999987654 799999999999999999999998621 1111111 111111
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. ..++.... ......+.+++.+||+.+|++||+|.+|++
T Consensus 229 -~~-~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 -SA-PPIPPDVS-----MNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -cC-CcCCcccc-----ccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 01 11111110 112345777888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.33 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=187.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|+.. +++.++||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 356999999999999764 68899999887432 2234578899999999999999999999999999999999995 6
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|..++..... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++......
T Consensus 84 ~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 84 DLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred CHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 89988875432 2589999999999999999999966 79999999999999999999999999987654321
Q ss_pred --cccccceeeCccccccCC-CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccccc----
Q 044996 529 --AQELMIAYKSPEFLQLGR-ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF---- 601 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~-~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~---- 601 (678)
...++..|+|||++.+.. ++.++|||||||++|||+||+.||... ...+...............+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD--------SEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHHhCCCChhhhhhh
Confidence 122457799999887644 588999999999999999999998621 11111111111000000000
Q ss_pred --------------chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 602 --------------DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 602 --------------d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...+... .......+.+++.+|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hHHHHHHhhcccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000 0001234567888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.75 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=190.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... +++.|++|+++.. .....+.+.+|++++++++|+||+++++++..++..++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 457999999999999875 5789999988743 2334578899999999999999999999999999999999999987
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
.+..++... ..+++.++..++.||+.||+|||.. +++|+||+|+||++++++.+||+|||++.......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 86 LLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 776655432 1489999999999999999999976 79999999999999999999999999987765432
Q ss_pred ---cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHH------------h
Q 044996 529 ---AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL------------A 592 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~------------~ 592 (678)
...++..|+|||++.+. .++.++||||||+++|||++|+.||..... .+......... .
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHhhhccc
Confidence 12345679999999887 789999999999999999999999862110 00000000000 0
Q ss_pred cCC----ccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 593 NGD----NRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 593 ~~~----~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
... ...+..++......+.......+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000111110011111122466888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=311.72 Aligned_cols=190 Identities=25% Similarity=0.343 Sum_probs=162.7
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccC-C-----CCccceeEEEEeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-H-----PNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~~~~~~~~~~~lv~E 445 (678)
+.++||+|.||.|.||.. .+++.||||+++... ....+-+.|+.+|..|+ | -|+|++++||...++.|||+|
T Consensus 190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 357899999999999964 579999999998643 34456678999999997 4 489999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC--CCceEEeecCCccc
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE--SLEPVLADYGLIPV 523 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~ 523 (678)
.+. -+|.++|+.++.. .++...+..|+.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.++.
T Consensus 269 LL~-~NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 269 LLS-TNLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred hhh-hhHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 885 5999999987654 488999999999999999999965 8999999999999974 34799999999987
Q ss_pred cCcccc-ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 524 MNQESA-QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 524 ~~~~~~-~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
..+... ..-+..|+|||++.+.+|+.+.||||||||+.||++|..-|.
T Consensus 341 ~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 341 ESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 765433 223467999999999999999999999999999999976554
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.08 Aligned_cols=247 Identities=22% Similarity=0.293 Sum_probs=196.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||++... +++.+++|.+.... ....+++.+|++++++++||||+++++++...+..++|+||+++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS 85 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence 356999999999999875 57889999887543 3455678999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--c
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--A 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--~ 529 (678)
|.+++.... ..+++..+..++.|++.||+|||.. .+++|+||||+||++++++.+||+|||.+....... .
T Consensus 86 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 86 LDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEK---HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred HHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCC---CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 999997653 2588999999999999999999961 389999999999999999999999999987654321 2
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|+|||++.+..++.++||||||+++|||++|+.||..... ......+.+......... .+..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~-------~~~~-- 226 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND---PPDGIFELLQYIVNEPPP-------RLPS-- 226 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---ccccHHHHHHHHhcCCCC-------CCCh--
Confidence 3456789999999888999999999999999999999999863211 112233333333322110 0100
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||..+|++|||+.+++.
T Consensus 227 --~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 --GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 012344778888999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.25 Aligned_cols=243 Identities=21% Similarity=0.319 Sum_probs=192.0
Q ss_pred HhccccCccCceeEEEEEecCCceEEEEEecc--cChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccC
Q 044996 372 ASAEILGSGCFGSSYKASLSTGAMMVVKRFKQ--MNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 372 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
...+.||+||.+.||++...+.+.+|+|++.. .+......|.+|+..|.+|+ |.+||++++|-..++.+||||||=
T Consensus 364 eilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G- 442 (677)
T KOG0596|consen 364 EILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG- 442 (677)
T ss_pred hHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-
Confidence 44578999999999999988888889888763 45667788999999999995 999999999999999999999976
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+-+|..+|...... ..+| .+..+..|++.++.++|.+ +|||.||||.|.|+- .|.+||+|||+|..+..+
T Consensus 443 d~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 443 DIDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 66999999876532 3445 7788999999999999988 899999999999985 578999999999887755
Q ss_pred -----ccccccceeeCccccccC-----------CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHH
Q 044996 528 -----SAQELMIAYKSPEFLQLG-----------RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL 591 (678)
Q Consensus 528 -----~~~~~~~~y~aPE~~~~~-----------~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~ 591 (678)
....||+.||+||.+... +++.++||||+|||||+|+.|+.||... ...|.+ +.
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------~n~~aK-l~ 583 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------INQIAK-LH 583 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------HHHHHH-HH
Confidence 345689999999988532 3568999999999999999999999622 112221 11
Q ss_pred hcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 592 ANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+.||...-+.........+++++..||+.||++||+..|+++
T Consensus 584 -------aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 -------AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -------hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2333321111111111223788888999999999999999986
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=300.89 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=189.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh--hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN--VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... +++.+|+|++..... ...+.+.+|++++++++||||+++++++..++..++||||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 467999999999999875 578999998764322 23567889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA- 529 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 529 (678)
+|.++..... .++|.+++.++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 86 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 86 VLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred HHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 9988765432 489999999999999999999976 799999999999999999999999999876543221
Q ss_pred ---ccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc---ccc--
Q 044996 530 ---QELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR---TEV-- 600 (678)
Q Consensus 530 ---~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~-- 600 (678)
..++..|+|||++.+ ..++.++|||||||++|||++|+.||... ..+..+.......+... .+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD-------SDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC-------chHHHHHHHHHHhCCCchhhHHHhc
Confidence 234678999998865 45788999999999999999999988521 11111111110000000 000
Q ss_pred --------cchhhhccc----CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 601 --------FDKEMADER----NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 601 --------~d~~l~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..+...... ........+.+++.+||+.+|++||+|.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 00112355788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=293.04 Aligned_cols=239 Identities=19% Similarity=0.249 Sum_probs=185.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-----hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-----NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 445 (678)
.++||+|+||.||+|.. .++..|++|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 46799999999999976 458899999875321 22346788999999999999999999988764 45789999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++++|.+++.... .+++..+++++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 87 HMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999987542 478888999999999999999966 79999999999999999999999999987543
Q ss_pred cc-------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 526 QE-------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 526 ~~-------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||... ..... ........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-------~~~~~-~~~~~~~~-~-- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-------EAMAA-IFKIATQP-T-- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc-------chHHH-HHHHhcCC-C--
Confidence 21 1223567899999998888999999999999999999999998621 11111 11111110 0
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+. ........+..++.+|+. +|++||++.||++
T Consensus 227 ---~~~-----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 ---NPV-----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCC-----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011 112233446667778884 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.28 Aligned_cols=243 Identities=21% Similarity=0.194 Sum_probs=187.2
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccCh---hhHHHHHHHHHH-HhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNN---VGREEFQEHMRR-LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
+.||+|+||.||+|.. .+++.+|+|.+..... .....+..|..+ ....+|+||+++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4589999999999976 4678999999865321 122334455444 4455899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
++|.+++.... .+++..+..++.|++.||.|||.. +++||||+|+||++++++.+||+|||+++.......
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceecccccc
Confidence 99999997542 488899999999999999999975 799999999999999999999999999876554444
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|+|||.+.+..++.++||||||+++|||+||+.||.. .+............... ....
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~----~~~~---- 216 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA--------ETPDAVFDNILSRRINW----PEEV---- 216 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhcccCC----CCcc----
Confidence 4567789999999888889999999999999999999999962 12222222222111110 0000
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L 643 (678)
.......+.+++.+||+.+|++||++.++.+.|
T Consensus 217 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 -KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred -cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 011234578888899999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.78 Aligned_cols=241 Identities=24% Similarity=0.339 Sum_probs=192.3
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||++.. .++..+++|.+........+.+.+|+.++++++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence 45799999999999975 46788999998755555567889999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.+++... .+++.++..++.|++.||.|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 104 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 9998653 478999999999999999999966 79999999999999999999999999886554322
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++....++.++|||||||++||+++|+.||..... ...+......+ . +..
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~--------~~~~~~~~~~~-~------~~~--- 235 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNG-T------PEL--- 235 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------hhheeehhcCC-C------CCC---
Confidence 12355679999999888899999999999999999999999962111 00000000000 0 000
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.........+.+++.+||+.+|++||++++++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123456778889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=295.38 Aligned_cols=240 Identities=23% Similarity=0.340 Sum_probs=193.7
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
+.||+|+||.||+|... ++..+++|.+..... ..+.+.+|++.+++++|+||+++++++...+..++|+||+++++|.
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 56999999999999876 688899999876443 5677899999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----cc
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----SA 529 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 529 (678)
+++.... ..+++..+..++.+++.||+|||.. +++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 104 ~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 104 DIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence 9998754 2589999999999999999999975 8999999999999999999999999987655432 12
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|++||++.+..++.++|||||||++|||++|+.||... ............. .. ...+
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~~-~~~~------- 238 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE--------PPLRALFLITTKG-IP-PLKN------- 238 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcC-CC-CCcc-------
Confidence 23457899999998888999999999999999999999998621 1111221111111 00 1100
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+|++.+|.+||++.++++
T Consensus 239 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 -PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0112345777888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=292.77 Aligned_cols=241 Identities=21% Similarity=0.277 Sum_probs=193.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|++++++++|+||+++++++......++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 467999999999999865 5788999988643 2234567889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-ceEEeecCCccccCccc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-EPVLADYGLIPVMNQES- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~- 528 (678)
+|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++ .+||+|||.+.......
T Consensus 85 ~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 85 DLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999975432 2589999999999999999999966 799999999999999885 56999999987664332
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+++....... . .+.
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~--------~~~~~~~~~~~~~~--~----~~~- 222 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG--------NNLHQLVLKICQGY--F----API- 222 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------ccHHHHHHHHhccc--C----CCC-
Confidence 12356789999999888899999999999999999999999862 23344444333221 1 110
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 223 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 -----SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0011235778888999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=295.76 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=186.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHH-HhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRR-LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||++... +|..||+|+++... .....++..|+.+ ++.++||||+++++++..++..++||||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 356999999999999764 68999999987532 2233455566665 666799999999999999999999999996 7
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA- 529 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 529 (678)
+|.+++...... ...+++..+..++.||+.||+|||+++ +++||||||+||++++++.+||+|||+++.+.....
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 85 SLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKL---SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred cHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 898888653322 236899999999999999999999653 699999999999999999999999999876543321
Q ss_pred --ccccceeeCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 530 --QELMIAYKSPEFLQL----GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 530 --~~~~~~y~aPE~~~~----~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
..++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ... +-......... +
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~-~~~~~~~~~~~-------~ 226 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK------TPF-QQLKQVVEEPS-------P 226 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc------cCH-HHHHHHHhcCC-------C
Confidence 235678999998864 456899999999999999999999986211 111 11111111110 1
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+... .....+.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 QLPAE----KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 12345778888999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=295.09 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=191.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... ++..+++|++.... ....+.+.+|+.++++++|+||+++++++......++||||+ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 467999999999999864 68899999987543 334567999999999999999999999999999999999999 99
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++.... ..+++.++..++.||+.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 84 DLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9999987543 2589999999999999999999965 79999999999999999999999999987665432
Q ss_pred ---cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHH--HHHHHhcCCc------
Q 044996 529 ---AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASW--VNSVLANGDN------ 596 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~--~~~~~~~~~~------ 596 (678)
...++..|+|||++.+. .++.++||||+||++|||+||+.||... .....+ +...+.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE-------NDIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC-------CHHHHHHHHHHHcCCCChHHHhhc
Confidence 22356789999998654 4689999999999999999998777521 111111 1111100000
Q ss_pred -----cccccch-----hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 -----RTEVFDK-----EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 -----~~~~~d~-----~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...+..+ .+... ..+....+.+++.+|++.+|.+||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEI--FPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cCcchhhcccCCCCCcchHHHh--CCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000 00000 0112356788888999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=292.07 Aligned_cols=243 Identities=23% Similarity=0.360 Sum_probs=191.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC------hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN------NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.++||+|+||.||+|.. .+++.+++|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999975 568899999886432 12346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-ceEEeecCCccccC
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-EPVLADYGLIPVMN 525 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~ 525 (678)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||++..+.
T Consensus 85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 85 MAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred cCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999997542 588999999999999999999976 899999999999998775 69999999987654
Q ss_pred ccc--------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 526 QES--------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 526 ~~~--------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
... ...++..|+|||++.+..++.++||||+|+++|||++|+.||..... ...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIASATT-- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhccCC--
Confidence 321 12346789999999888899999999999999999999999862110 111111111111000
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+. ........+.+++.+|+..+|++||++.|+++
T Consensus 229 ----~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ----APS-----IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCC-----CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000 11123355778888999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=292.45 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=193.3
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||.|+||+||+|.. .++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 46799999999999985 467889999886432 2356789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc--
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA-- 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 529 (678)
|.++++.... ...+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||++..+.....
T Consensus 86 l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 86 LLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred HHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 9999976432 12589999999999999999999965 799999999999999999999999999866543321
Q ss_pred ------ccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 530 ------QELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 530 ------~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
..++..|+|||++... .++.++|||||||++|||++|+.||..... ..-.........
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~------- 224 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--------MKVLMLTLQNDP------- 224 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh--------hhhHHHHhcCCC-------
Confidence 1356789999998776 789999999999999999999999963211 111111111111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.+............+.+++.+|++.||++||++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011000000122345778888999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=299.64 Aligned_cols=243 Identities=21% Similarity=0.229 Sum_probs=189.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh---hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|++++++++|+||+++++++...+..++||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 356999999999999865 488999999875432 2456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|.+++..... ..+++..+..++.|++.||+|||.. +++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 86 GELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999875422 2589999999999999999999965 79999999999999999999999999976543211
Q ss_pred --------------------------------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccC
Q 044996 529 --------------------------------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQG 576 (678)
Q Consensus 529 --------------------------------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~ 576 (678)
...++..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~-- 236 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN-- 236 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc--
Confidence 1124567999999998889999999999999999999999986211
Q ss_pred CCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 577 KKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 577 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
...-........... . ........+.+++.+||+.+|++||++...++.
T Consensus 237 ------~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ 285 (316)
T cd05574 237 ------RDETFSNILKKEVTF--------P---GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE 285 (316)
T ss_pred ------hHHHHHHHhcCCccC--------C---CccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence 111111111111000 0 001134557888889999999999994443333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=300.39 Aligned_cols=252 Identities=19% Similarity=0.233 Sum_probs=186.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... +|..+++|+++... ......+.+|++++++++|+||+++++++.+....++|+||++ +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 356999999999999864 68899999886432 2233567889999999999999999999999999999999996 5
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++..... .+++..+..++.||++||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 84 DLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 88888765422 589999999999999999999976 79999999999999999999999999987654321
Q ss_pred --cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc------------
Q 044996 529 --AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN------------ 593 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~------------ 593 (678)
...++..|+|||++.+. .++.++|||||||++|||+||+.|+.... +...........
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-------DVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC-------CHHHHHHHHHHHhCCCChHHhHHh
Confidence 22346789999988764 47999999999999999999999964211 111111111100
Q ss_pred --CCcc--ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 594 --GDNR--TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 594 --~~~~--~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... ...+................+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 00000000000000112345678888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=290.93 Aligned_cols=243 Identities=25% Similarity=0.360 Sum_probs=197.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh-hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|++|.||+|... +++.+++|++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 467999999999999875 589999999876543 456789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHH-hCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR-ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA- 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 529 (678)
|.+++... ..+++..++.++.|+++||+|||. . +++||||+|+||+++.++.+||+|||++........
T Consensus 86 L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 86 LADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999764 258999999999999999999996 4 899999999999999999999999999877654322
Q ss_pred ---ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 ---QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 ---~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..++..|+|||.+....++.++||||||+++|||+||+.||..... ....+......... . +.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~-~------~~~- 223 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGP-P------PSL- 223 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCC-C------CCC-
Confidence 2356789999999988899999999999999999999999863221 12222222222111 0 111
Q ss_pred cccCCHH-HHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 607 DERNSEG-EMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 607 ~~~~~~~-~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
... ....+.+++.+|++.+|++||++.|+++.
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 23457788889999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=290.46 Aligned_cols=242 Identities=26% Similarity=0.358 Sum_probs=191.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh--hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN--VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... ++..+++|.++.... ...+.+.+|+.++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 357999999999999764 678999999875443 35678999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA- 529 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 529 (678)
+|.+++.... .+++..+..|+.+++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 85 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 85 TLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999997542 478899999999999999999976 799999999999999999999999999876543211
Q ss_pred -------ccccceeeCccccccCC---CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 530 -------QELMIAYKSPEFLQLGR---ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 530 -------~~~~~~y~aPE~~~~~~---~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
..++..|+|||++.... ++.++||||||+++|||++|+.||.... .-......... + .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-------~~~~~~~~~~~-~-~--- 223 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------NEFQIMFHVGA-G-H--- 223 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-------chHHHHHHHhc-C-C---
Confidence 23457899999998766 8999999999999999999999996221 11111111111 1 0
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+.+... ......+.+++.+||+.+|.+||++.|++.
T Consensus 224 --~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 --KPPIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111111 011344667888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=296.39 Aligned_cols=239 Identities=19% Similarity=0.245 Sum_probs=191.3
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+||+|+||.||++.. .++..+++|++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4699999999999976 478899999987655556677999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----cc
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----SA 529 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 529 (678)
+++... .+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||++...... ..
T Consensus 106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 106 DIVTHT------RMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 987542 478999999999999999999976 7999999999999999999999999987655332 12
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|+|||++.+..++.++|||||||++|||++|+.||.. ......+........ +.+..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~--------~~~~~~~~~~~~~~~-------~~~~~-- 238 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN--------EPPLKAMKMIRDNLP-------PKLKN-- 238 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhhCC-------cccCC--
Confidence 2356789999999888899999999999999999999999862 111111111111100 00000
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.+|.+||++.++++
T Consensus 239 -~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0012234667788999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=298.27 Aligned_cols=251 Identities=21% Similarity=0.274 Sum_probs=189.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChh-----hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNV-----GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|... +++.|++|+++..... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 356999999999999864 6889999999754322 3456778999999999999999999999989999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
+|+|.+++.... ..+++..+..++.||++||+|||.. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999999997643 2589999999999999999999976 7999999999999999999999999998766433
Q ss_pred c----cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CC------
Q 044996 528 S----AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GD------ 595 (678)
Q Consensus 528 ~----~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~------ 595 (678)
. ....+..|+|||.+.+ ..++.++|||||||++|||++|..||.... ..... ...... +.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-------~~~~~-~~~~~~~~~~~~~~~ 227 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-------DIDQL-GKIFEALGTPTEENW 227 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-------cHHHH-HHHHHHcCCCchhhh
Confidence 1 1234567999998854 467899999999999999999977765211 11111 111100 00
Q ss_pred ----ccccccchhhhcc----cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 596 ----NRTEVFDKEMADE----RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 596 ----~~~~~~d~~l~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
............. .........+.+++.+||+.+|++|||+.||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000000 000122456788999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=293.85 Aligned_cols=240 Identities=19% Similarity=0.264 Sum_probs=181.5
Q ss_pred ccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHH---HhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 376 ILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRR---LGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~---l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..+ +...+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 58899999886432 1222334444433 334479999999999998899999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++..+..++.|++.||+|||.. +|+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999987542 589999999999999999999976 7999999999999999999999999998654322
Q ss_pred -ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 -SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||.+.. ..++.++|||||||++|||++|+.||..... ... ..+...... ....+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~-~~~~~~~~~-------~~~~~ 218 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDK-HEIDRMTLT-------VNVEL 218 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC-----cCH-HHHHHHhhc-------CCcCC
Confidence 22346788999998864 5689999999999999999999999963211 111 111111100 01111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVEK 642 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~~ 642 (678)
+......+.+++.+|++.||++|| +++|+++.
T Consensus 219 -----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 -----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111234567778899999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=294.05 Aligned_cols=239 Identities=24% Similarity=0.381 Sum_probs=190.3
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc-ChhhHHHHHHHHHHHhccC---CCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLR---HPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|.. .++..+++|.++.. .....+++.+|+.++++++ ||||+++++++......++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 35699999999999986 56889999988643 2344567889999999997 9999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+++|.+++... .+++...+.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999998643 588999999999999999999966 79999999999999999999999999987654332
Q ss_pred ----cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 ----AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
...++..|+|||++.++ .++.++|||||||++|||++|+.||... ....+.... ... ..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~--------~~~~~~~~~-~~~------~~~ 220 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV--------DAFRAMMLI-PKS------KPP 220 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC--------Chhhhhhcc-ccC------CCC
Confidence 12356779999988654 4689999999999999999999999621 111121110 000 011
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+... .....+.+++.+||+.||++||++.|+++
T Consensus 221 ~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 12345778888999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=293.13 Aligned_cols=240 Identities=22% Similarity=0.256 Sum_probs=191.4
Q ss_pred cCccCceeEEEEEec-CCceEEEEEecccCh---hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 377 LGSGCFGSSYKASLS-TGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
||+|+||.||++... +++.+++|.+..... ...+.+.+|++++++++|+||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 488999999875432 3456788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.+++.... .+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99997643 589999999999999999999976 79999999999999999999999999986543221
Q ss_pred --------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 529 --------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 529 --------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
...++..|+|||+.....++.++||||||+++|||++|+.||.. .................
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~--- 220 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG--------ETPEEIFQNILNGKIEW--- 220 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHhcCCcCC---
Confidence 11245679999999888899999999999999999999999862 22223332222211000
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
+ ........+.+++.+|++.+|++|||+.+|.+.|+
T Consensus 221 --~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 --P------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --C------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 00001345678888999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=296.85 Aligned_cols=241 Identities=20% Similarity=0.322 Sum_probs=185.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEe------CCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYR------KEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~------~~~~~lv~E 445 (678)
.+.||+|+||.||+|.. .+++.+++|.+... .....++..|+.++.++ +|+||+++++++.. ....+++||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 35799999999999986 46788999987643 33446788899999998 79999999999863 356899999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 100 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 100 FCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred eCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 9999999999876432 2478888999999999999999976 79999999999999999999999999987553
Q ss_pred cc----ccccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 526 QE----SAQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 526 ~~----~~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
.. ....++..|+|||.+. ...++.++|||||||++|||++|+.||....+. .. .. ......
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~~-~~-~~~~~~- 242 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RA-LF-LIPRNP- 242 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------hh-hh-hHhhCC-
Confidence 22 2233567899999885 346788999999999999999999999632110 00 00 000000
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+.+.. ......+.+++.+||+.||.+||++.|+++
T Consensus 243 -----~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 -----PPKLKS----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----CCCCcc----cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 011111 112345788888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=286.77 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=196.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|++|.||++... ++..+++|++........+.+.+|++.+++++|+||+++++++......++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 356999999999999875 6888999999875555667899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---A 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 529 (678)
.+++.... ..+++..+..++.+++.||+|||.. +++||||+|+||++++++.+||+|||.+....... .
T Consensus 85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 99987643 2589999999999999999999975 79999999999999999999999999987765542 3
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|+|||++....++.++||||||+++|||++|+.||... +........... ......+
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~--~~~~~~~------- 219 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL--------PPMKALFKIATN--GPPGLRN------- 219 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------chHHHHHHHHhc--CCCCcCc-------
Confidence 34567899999998888999999999999999999999998621 112222111111 1101110
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||++|||+.|+++
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0011345778888999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=301.09 Aligned_cols=240 Identities=22% Similarity=0.286 Sum_probs=195.0
Q ss_pred cccCccCceeEEEEEecC-CceEEEEEecccCh---hhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLST-GAMMVVKRFKQMNN---VGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
+.||+|.||.||++.... |+.+|+|.+..... ...+.+.+|+.+|+++. |||||.++++|.+....++|||++.+
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 579999999999998654 99999999976433 24568999999999998 99999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC----CceEEeecCCccccC
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES----LEPVLADYGLIPVMN 525 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~~~~ 525 (678)
|.|.+.+... .+++.....+++||+.++.|||.. +|+||||||+|+|+... +.+|++|||++....
T Consensus 121 GeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 121 GELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred chHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999765 288999999999999999999965 89999999999999643 579999999998887
Q ss_pred cc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 526 QE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 526 ~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
.. ....+|+.|+|||++....|+.++||||.||++|.|++|..||.... ..... ..+. .++. ++-+
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~-------~~~~~-~~i~-~~~~--~f~~ 259 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET-------EFEIF-LAIL-RGDF--DFTS 259 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC-------hhHHH-HHHH-cCCC--CCCC
Confidence 63 23457899999999999999999999999999999999999997211 11111 1112 1111 1111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+. .........+++..|+..||.+|+|+.++++
T Consensus 260 ~~------w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 260 EP------WDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CC------ccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11 1122344566777999999999999999998
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=294.14 Aligned_cols=237 Identities=22% Similarity=0.265 Sum_probs=189.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 467999999999999764 57899999886432 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+|||+++++.+||+|||+++......
T Consensus 86 ~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 156 (290)
T cd05580 86 GELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY 156 (290)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCC
Confidence 99999997652 588999999999999999999975 89999999999999999999999999987765432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||.+.+..++.++||||||+++|||++|+.||... ....-..... .+.. .+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~-~~~~-------~~--- 217 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD--------NPIQIYEKIL-EGKV-------RF--- 217 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHh-cCCc-------cC---
Confidence 224567899999998888899999999999999999999998621 1111111111 1110 01
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCC-----CHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAV 640 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~ 640 (678)
+......+.+++.+||..+|.+|+ +++|++
T Consensus 218 --~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 218 --PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 011123466788899999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=295.77 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=186.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEe-----CCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYR-----KEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-----~~~~~lv~Ey 446 (678)
.+.||+|+||.||++.. .+++.+++|.++... ....++.+|+.++.++ +|+||+++++++.. ++..++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 35699999999999976 457889999876432 2346788899999999 69999999998853 3568999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+++|+|.++++..... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.+..
T Consensus 102 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 102 CNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred cCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 9999999988643221 22588999999999999999999975 799999999999999999999999999876543
Q ss_pred c----ccccccceeeCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 527 E----SAQELMIAYKSPEFLQL-----GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 527 ~----~~~~~~~~y~aPE~~~~-----~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
. ....++..|+|||++.. ..++.++|||||||++|||++|+.||.... ....+. ... .....
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~-------~~~~~~-~~~-~~~~~ 247 (286)
T cd06638 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-------PMRALF-KIP-RNPPP 247 (286)
T ss_pred CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc-------hhHHHh-hcc-ccCCC
Confidence 2 12346778999998853 457899999999999999999999986221 111111 000 00000
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
...++. .....+.+++.+||+.+|++|||+.||++.
T Consensus 248 -~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 248 -TLHQPE--------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -cccCCC--------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 111111 112347788889999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=289.91 Aligned_cols=239 Identities=20% Similarity=0.216 Sum_probs=190.8
Q ss_pred cCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 377 LGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
||.|+||.||++... ++..+++|.+.... ....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999875 48899999986532 23456799999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---A 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 529 (678)
.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 99997643 488999999999999999999975 79999999999999999999999999988765431 2
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|++||++....++.++|+||||+++|||++|+.||.... .+............... .
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~-----------~ 214 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD------EDPMEIYNDILKGNGKL-----------E 214 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC------CCHHHHHHHHhccCCCC-----------C
Confidence 235678999999988889999999999999999999999996221 11233333332111110 0
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
.+......+.+++.+||+.+|++||+ +.|+++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11111345788888999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=305.17 Aligned_cols=240 Identities=19% Similarity=0.249 Sum_probs=192.0
Q ss_pred ccCccCceeEEEEEecC-CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHHH
Q 044996 376 ILGSGCFGSSYKASLST-GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAV 454 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~ 454 (678)
-||.|+||.||||..+. +...|.|.+........++|.-||+||..++||+||+|++.|+..+.++++.|||.||-.+.
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa 118 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA 118 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence 48999999999997654 44556777777777888999999999999999999999999999999999999999999998
Q ss_pred HhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc----Cccccc
Q 044996 455 NLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM----NQESAQ 530 (678)
Q Consensus 455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~----~~~~~~ 530 (678)
++-.-.. .|+..++.-++.+++.||.|||++ .|||||||+-|||++-+|.++|+|||.+... ......
T Consensus 119 imlEL~r----~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 119 IMLELGR----VLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred HHHHhcc----ccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 8865533 699999999999999999999976 7999999999999999999999999997433 223455
Q ss_pred cccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 531 ELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 531 ~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
.||+.|||||+.. ..+|+.++|||||||+|.||..+..|.... +...-+- .+.+... |.|
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--------npMRVll-KiaKSeP------PTL 255 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLL-KIAKSEP------PTL 255 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc--------chHHHHH-HHhhcCC------Ccc
Confidence 6899999999875 358999999999999999999999997622 2111111 1111111 222
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... .-...+.++..+|+..+|..||++.++++
T Consensus 256 lqPS---~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 LQPS---HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cCcc---hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2221 22344666777999999999999998875
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=295.56 Aligned_cols=189 Identities=23% Similarity=0.355 Sum_probs=160.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh-hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... +++.|++|.+..... .....+.+|++++++++|+||+++++++...+..++||||++ ++
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TD 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CC
Confidence 457999999999999865 678999999875322 223457789999999999999999999999999999999997 59
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... .+++.....++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 89 L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 89 LKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9998875432 588999999999999999999966 7999999999999999999999999998654321
Q ss_pred ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 528 SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11234677999998865 457999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=294.10 Aligned_cols=244 Identities=22% Similarity=0.314 Sum_probs=187.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeC-----CceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRK-----EEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-----~~~~lv~Ey 446 (678)
.+.||+|+||.||++.. .+++.+++|.+.... .....+.+|+.++.++ +||||+++++++... +..++||||
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 35699999999999976 467889999886532 2346678899999999 899999999998754 358999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+++|+|.++++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 106 ~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 106 CNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred CCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 9999999988643221 12589999999999999999999965 799999999999999999999999999876543
Q ss_pred cc----cccccceeeCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 527 ES----AQELMIAYKSPEFLQLG-----RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 527 ~~----~~~~~~~y~aPE~~~~~-----~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
.. ...++..|+|||++... .++.++|||||||++|||++|+.||.... ...-+.... .....
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~--------~~~~~~~~~-~~~~~ 251 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH--------PVKTLFKIP-RNPPP 251 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc--------HHHHHHHHh-cCCCC
Confidence 21 23356789999988643 36899999999999999999999986211 111111111 11010
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+.+ .++....+.+++.+||+.+|++||++.|+++
T Consensus 252 -~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 252 -TLLH--------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -CCCc--------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 1122345788899999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=292.89 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=188.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|++|.||+|.. .+|..+++|++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 35799999999999976 478999999887432 2234678899999999999999999999999999999999995 6
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++..... ..+++..++.++.|+++||+|||+. +++||||+|+||++++++.+||+|||+++......
T Consensus 83 ~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 83 DLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred CHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 99999876432 2589999999999999999999975 79999999999999999999999999987653221
Q ss_pred --cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC-----------
Q 044996 529 --AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG----------- 594 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~----------- 594 (678)
...++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...++......
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhhhhhch
Confidence 12346779999988654 5789999999999999999999998621100 00111111000000
Q ss_pred C---ccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 D---NRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 ~---~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ............. .......+.+++.+|++.+|++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKV--VPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhh--cCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000000000 0111245778899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=295.82 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=187.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||++... +++.+++|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||+. +
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~ 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-I 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-C
Confidence 357999999999999764 57899999887432 344567899999999996 9999999999999999999999986 4
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
++.++...........+++..+.+++.+++.||+|||+.. +++||||||+||+++.++.+||+|||+++.+...
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 6554432110011125899999999999999999999642 6999999999999999999999999998755432
Q ss_pred ccccccceeeCccccccC---CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 SAQELMIAYKSPEFLQLG---RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~---~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++... .++.++|||||||++|||++|+.||... ....+-+....... .+.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-------~~~~~~~~~~~~~~-------~~~ 230 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW-------NSVFDQLTQVVKGD-------PPI 230 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc-------chHHHHHhhhcCCC-------CCc
Confidence 223456789999998766 6899999999999999999999998621 11111111111110 011
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+.... .......+.+++.+||+.+|++|||+.||++.
T Consensus 231 ~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSE-EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110 11234457888889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=294.83 Aligned_cols=251 Identities=18% Similarity=0.223 Sum_probs=187.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh--hhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN--VGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... +..++||||++
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 357999999999999875 578899999875332 2234577899999999999999999999877 78999999997
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
++|.+++..... .+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 90 -~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 90 -HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred -cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 599998876432 589999999999999999999976 79999999999999999999999999987654431
Q ss_pred ----cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh-----------
Q 044996 529 ----AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA----------- 592 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~----------- 592 (678)
...++..|+|||.+.+. .++.++||||||+++|||++|+.||.... ..+.......
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~--------~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS--------EIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCchHHHH
Confidence 22345779999988754 46899999999999999999999986221 1111111100
Q ss_pred --------cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 593 --------NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 593 --------~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.....+............+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000001111111000002345678888999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=294.31 Aligned_cols=241 Identities=24% Similarity=0.312 Sum_probs=190.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|.. .++..+++|++.... ....+.+.+|++++++++|||++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 45699999999999976 467889999886432 2334568899999999999999999999999999999999995
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
|++.+++..... .+++.++..++.||+.||.|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 105 ~~l~~~l~~~~~----~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~ 176 (313)
T cd06633 105 GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS 176 (313)
T ss_pred CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCcccCCCCC
Confidence 688887765432 589999999999999999999966 799999999999999999999999999876554444
Q ss_pred ccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 QELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 ~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..++..|+|||++. ...++.++|||||||++|||++|+.||.. .+....+......... ...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~--------~~~~~~~~~~~~~~~~--~~~----- 241 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSALYHIAQNDSP--TLQ----- 241 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHHhcCCC--CCC-----
Confidence 55678899999984 35688999999999999999999999862 1222222222211110 010
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
. ......+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~----~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 S----NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred c----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0112346778889999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=293.69 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=190.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... +++.+++|++.... ......+.+|++++++++|+||+++++++... +..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 356999999999999875 57899999998652 33456788999999999999999999999887 78999999997
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
++|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 84 -~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 84 -HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred -ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 48988886542 2589999999999999999999976 79999999999999999999999999987665432
Q ss_pred -----cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc------
Q 044996 529 -----AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN------ 596 (678)
Q Consensus 529 -----~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~------ 596 (678)
....+..|+|||.+.+ ..++.++||||||+++|||+||+.||.... ....+.........
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST--------ELEQLEKIFELCGSPTDENW 226 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCchhhc
Confidence 1234567999998764 457999999999999999999999986211 11111111110000
Q ss_pred -------------cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 -------------RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 -------------~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
........+... ....+...+.+++.+||+.+|.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREF-FKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccccchhhhhccccccchhHHHHH-hcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000011000 00112456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=291.86 Aligned_cols=240 Identities=20% Similarity=0.250 Sum_probs=192.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|++++++++||||+++++++...+..++|+||+++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 467999999999999875 58899999987532 23457889999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
++|.+++... ..+++..+..++.|++.||.|||.. +++|+||||+||++++++.+||+|||++......
T Consensus 85 ~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 85 GDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 9999999754 2588999999999999999999966 7999999999999999999999999998765443
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++....++.++||||||+++|+|++|+.||..... ....++....... . ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~--~-~~------ 220 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR------TIRDQIRAKQETA--D-VL------ 220 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc------cHHHHHHHHhccc--c-cc------
Confidence 223456789999999888899999999999999999999999873211 1122322222111 0 00
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCH--HHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDL--KEAV 640 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~--~ev~ 640 (678)
.+......+.+++.+||+.||.+||++ +|++
T Consensus 221 ---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 ---YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111223557788889999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.82 Aligned_cols=254 Identities=19% Similarity=0.226 Sum_probs=186.7
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.+|.|+++.||++.. +++.+|+|++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455666666666654 6889999998753 34456789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..+...
T Consensus 86 l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 86 CEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred HHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999986432 1478889999999999999999976 7999999999999999999999999987644221
Q ss_pred -------ccccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-----
Q 044996 528 -------SAQELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN----- 593 (678)
Q Consensus 528 -------~~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~----- 593 (678)
.....+..|+|||++.. ..++.++|||||||++|||++|+.||...... ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~ 231 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEKVRGTVPCLL 231 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCcccc
Confidence 11224567999999875 35889999999999999999999999732110 0001100000
Q ss_pred --------CCcccc----ccchhhh---cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 594 --------GDNRTE----VFDKEMA---DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 594 --------~~~~~~----~~d~~l~---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
...... ..++... ...........+.+++.+||+.||++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 0000000 000111223467789999999999999999999983
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.97 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=190.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... ++..+++|.+... .....+++.+|+++++.++|+|++++++++......++||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 356999999999999864 5788999988642 22334578899999999999999999999999999999999996
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
|++.+++..... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~l~~~~~~~~~----~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (308)
T cd06634 99 GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170 (308)
T ss_pred CCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence 688887764322 588999999999999999999965 799999999999999999999999999887665555
Q ss_pred ccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 QELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 ~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..++..|+|||++. .+.++.++|||||||++|||++|+.||... .-........... . +...
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~-~------~~~~ 235 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNE-S------PALQ 235 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc--------cHHHHHHHHhhcC-C------CCcC
Confidence 55678899999874 356789999999999999999999998521 1111221111111 0 0000
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
. ......+.+++.+||+.+|.+||++.+|++.--
T Consensus 236 ~----~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 236 S----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred c----ccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0 112344677888999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.02 Aligned_cols=238 Identities=19% Similarity=0.250 Sum_probs=184.4
Q ss_pred cCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 377 LGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 377 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
||+|+||+||++.. .+++.+++|.+.... ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999975 468899999886432 22345677899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---A 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---~ 529 (678)
.+++..... ..+++.++..++.|++.||.|||.. +++||||+|+||++++++.+||+|||++....... .
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 999976532 2589999999999999999999976 79999999999999999999999999987654321 2
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|+|||++.+..++.++|||||||++|||++|+.||...... ............. ...+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~--------~~~~---- 217 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VEKEELKRRTLEM--------AVEY---- 217 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----ccHHHHHhccccc--------cccC----
Confidence 23456899999998888999999999999999999999998632110 0111111100000 0000
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKE 638 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e 638 (678)
.......+.+++.+||+.+|.+||+.+|
T Consensus 218 -~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 218 -PDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred -CccCCHHHHHHHHHHccCChhHccCCCc
Confidence 1112334677888999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.93 Aligned_cols=189 Identities=23% Similarity=0.327 Sum_probs=158.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|.. .++..+++|.+.... ......+.+|+++++.++|+||+++++++..++..++||||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 35699999999999975 468899999986533 2233467889999999999999999999999899999999995 78
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... .+.+.++..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 89 l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 89 LAQYMIQHPG----GLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred HHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 8777754322 478888999999999999999976 7999999999999999999999999998754322
Q ss_pred ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 528 SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~ 205 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP 205 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 122346789999998753 57899999999999999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=290.52 Aligned_cols=252 Identities=21% Similarity=0.248 Sum_probs=186.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHHhccC-CCCccceeEEEEeC--CceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRK--EEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|.. .++..+++|+++... ........+|+.++.++. |+||+++++++.+. +..++||||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 45699999999999975 468889999887532 222334457888899885 99999999999987 88999999996
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
|+|.+++.... ..++|.++..++.|++.||+|||.. +++||||||+||++++ +.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 68888887543 2589999999999999999999976 7999999999999999 999999999997664332
Q ss_pred ---cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC----------
Q 044996 529 ---AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG---------- 594 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~---------- 594 (678)
...++..|+|||++.. ..++.++|||||||++|||++|+.||.... ......+....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-----ELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-----HHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 1234678999997654 557899999999999999999999996211 011112221111110
Q ss_pred -Cccccccchhhhcc---cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 -DNRTEVFDKEMADE---RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 -~~~~~~~d~~l~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
... ....+..... .........+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHM-NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccc-cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000 0000000000 000123467888999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=291.25 Aligned_cols=243 Identities=20% Similarity=0.262 Sum_probs=197.9
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.||+|.|+.|-+|++ -+|+.||||++.+. +......+.+|++.|+-++|||||++|.+......+|||+|.-.+|+
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD 103 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD 103 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence 4599999999999964 58999999999864 34455678889999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe-cCCCceEEeecCCccccCcccc-
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL-NESLEPVLADYGLIPVMNQESA- 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl-~~~~~~kl~DfGla~~~~~~~~- 529 (678)
|++|+..+.. -+.+....+++.||..|+.|+|+- .+|||||||+||.+ .+-|-+||.|||++..+.+...
T Consensus 104 l~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 104 LFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred HHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence 9999988765 488889999999999999999965 69999999999976 5678999999999987766533
Q ss_pred --ccccceeeCccccccCCCC-CcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 --QELMIAYKSPEFLQLGRIT-KKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 --~~~~~~y~aPE~~~~~~~t-~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..|.+.|-|||++.+..|+ +++||||+|||||-|+.|+.||....+. ..+..++|=...
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS------------------ETLTmImDCKYt 237 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS------------------ETLTMIMDCKYT 237 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch------------------hhhhhhhccccc
Confidence 3466889999999998885 7899999999999999999999732211 112223333221
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHh
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEV 646 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i 646 (678)
.+.....+..+++..|+..||.+|.+.+||+. +|+.+
T Consensus 238 ---vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 238 ---VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred ---CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 12234455677788999999999999999986 35443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=282.60 Aligned_cols=259 Identities=21% Similarity=0.306 Sum_probs=193.5
Q ss_pred ccchHHHHHHhccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHH-hccCCCCccceeEEEEeCCc
Q 044996 363 RFDLHDLLRASAEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRL-GRLRHPNLLPLVAYYYRKEE 439 (678)
Q Consensus 363 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~~~~ 439 (678)
.|+.+++.. ...||.|+||+|+|-.+ +.|+..|||+++... ....+++..|.+.. +.=+.||||++||.+..++.
T Consensus 60 ~F~~~~Lqd--lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQD--LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHH--HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 444444432 24599999999999865 579999999998654 36677888888764 44578999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecC
Q 044996 440 KLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519 (678)
Q Consensus 440 ~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 519 (678)
.|+.||.|. -||+.+.+.--......+++...-+|...+..||.||-+++ .|+|||+||+|||||..|.+||||||
T Consensus 138 cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l---kiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 138 CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL---KIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh---hhhhccCChhheEEecCCCEeeeccc
Confidence 999999994 57765543211111225777778889999999999998875 69999999999999999999999999
Q ss_pred CccccCcccc---ccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 520 LIPVMNQESA---QELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 520 la~~~~~~~~---~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
++..+....+ ..|...|||||.+.. ..|+.+|||||+|++|||+.||+.||.. ..++.+-+..+....
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~-------w~svfeql~~Vv~gd 286 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK-------WDSVFEQLCQVVIGD 286 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch-------HHHHHHHHHHHHcCC
Confidence 9987765533 346778999999853 3489999999999999999999999861 122333333333222
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
... -..|. ...+....+..++-.|+-.|-.+||+.+++.+
T Consensus 287 pp~-l~~~~------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 287 PPI-LLFDK------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCe-ecCcc------cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 11111 11123455777888999999999999998875
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.90 Aligned_cols=257 Identities=19% Similarity=0.237 Sum_probs=190.7
Q ss_pred ccCcc--CceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 376 ILGSG--CFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 376 ~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.||+| +||+||++.. .+++.||+|.+... .....+.+.+|+.+++.++||||++++++|..++..++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999986 47899999998743 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+......
T Consensus 85 ~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 85 SANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999876532 2488999999999999999999965 7999999999999999999999999854322111
Q ss_pred --------ccccccceeeCccccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC--
Q 044996 528 --------SAQELMIAYKSPEFLQLG--RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD-- 595 (678)
Q Consensus 528 --------~~~~~~~~y~aPE~~~~~--~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~-- 595 (678)
....++..|+|||++.+. .++.++|||||||++|||++|+.||...... .-....+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~ 229 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--------QMLLQKLKGPPYS 229 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--------HHHHHHhcCCCCC
Confidence 011234569999999763 4789999999999999999999999632110 00000000000
Q ss_pred ------------------------cc---------ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH-
Q 044996 596 ------------------------NR---------TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE- 641 (678)
Q Consensus 596 ------------------------~~---------~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~- 641 (678)
.. ..+.+..+.. .........+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT-PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred Cccccccchhhhhhccchhhhhcccccchhccccccccccccccc-hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 0000111111 111234567889999999999999999999986
Q ss_pred -HHHHhhc
Q 044996 642 -KIEEVKE 648 (678)
Q Consensus 642 -~L~~i~~ 648 (678)
.++.+..
T Consensus 309 ~~~~~~~~ 316 (328)
T cd08226 309 AFFKQVKE 316 (328)
T ss_pred HHHHHHHH
Confidence 4565555
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=318.35 Aligned_cols=192 Identities=21% Similarity=0.296 Sum_probs=151.6
Q ss_pred hccccCccCceeEEEEEecC--CceEEEE------------------EecccChhhHHHHHHHHHHHhccCCCCccceeE
Q 044996 373 SAEILGSGCFGSSYKASLST--GAMMVVK------------------RFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~ 432 (678)
..+.||+|+||+||++..+. +...++| +++ ........+.+|+.+|++++|+|||++++
T Consensus 152 ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 230 (501)
T PHA03210 152 VIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENILKIEE 230 (501)
T ss_pred EEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcCcEeE
Confidence 35679999999999986532 2212211 111 11223456889999999999999999999
Q ss_pred EEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc
Q 044996 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE 512 (678)
Q Consensus 433 ~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~ 512 (678)
++...+..|+|+|++. ++|.+++..............+...|+.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 231 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 231 ILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred EEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCC
Confidence 9999999999999994 6788777643221112234566778999999999999965 8999999999999999999
Q ss_pred eEEeecCCccccCccc-----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCc
Q 044996 513 PVLADYGLIPVMNQES-----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPA 570 (678)
Q Consensus 513 ~kl~DfGla~~~~~~~-----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~ 570 (678)
+||+|||+++.+.... ...++..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999998765332 234678899999999889999999999999999999988643
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.77 Aligned_cols=253 Identities=19% Similarity=0.219 Sum_probs=186.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCc-----eEEEE
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEE-----KLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~-----~~lv~ 444 (678)
.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++ |+||+++++++...+. .|+||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 457999999999999864 68899999876432 223457888999999995 6999999999987665 89999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIPV 523 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~ 523 (678)
||+++ +|.+++..........+++..+..++.||+.||+|||.. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 99975 899888754332123589999999999999999999966 7999999999999998 89999999999875
Q ss_pred cCcc----ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcc
Q 044996 524 MNQE----SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNR 597 (678)
Q Consensus 524 ~~~~----~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~ 597 (678)
+... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||... .... ........ +...
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~-------~~~~-~~~~~~~~~~~~~ 232 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD-------SELQ-QLLHIFKLLGTPT 232 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC-------CHHH-HHHHHHHHhCCCC
Confidence 5322 11234567999998865 45799999999999999999999998621 1111 11111110 0000
Q ss_pred cccc-------c---------hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 TEVF-------D---------KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 ~~~~-------d---------~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+.. + ..+.. ........+.+++.+|++.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSR--AVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHH--hccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0 00000 00112345778889999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=288.23 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=187.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCC------ceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKE------EKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~------~~~lv~E 445 (678)
.+.||+|+||.||+|... +++.+++|.+.... ...+++.+|+.+++++ +|+||+++++++.... ..++|||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 467999999999999874 56789999887543 3456799999999999 7999999999997644 4899999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....
T Consensus 90 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 90 LCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred cCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999998754311 12589999999999999999999965 79999999999999999999999999986543
Q ss_pred cc----ccccccceeeCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 526 QE----SAQELMIAYKSPEFLQL-----GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 526 ~~----~~~~~~~~y~aPE~~~~-----~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
.. ....++..|+|||++.. ..++.++|||||||++|||++|+.||.... . ..-...... ..
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~-~~~~~~~~~-~~- 234 (275)
T cd06608 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-------P-MRALFKIPR-NP- 234 (275)
T ss_pred cchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-------h-HHHHHHhhc-cC-
Confidence 32 12235678999998753 346789999999999999999999986211 1 111111111 10
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. +.+. ........+.+++.+||..||++|||+.|+++
T Consensus 235 ~-----~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 P-----PTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred C-----CCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 1110 11113345778888999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=281.49 Aligned_cols=242 Identities=19% Similarity=0.202 Sum_probs=190.6
Q ss_pred ccccCccCceeEEEEEecC-CceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLST-GAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||.|.-|+||++++.. +..+|+|++.+.. .....+.+.|-+||+.++||.++.||+.++.++..|||||||++
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 4679999999999998754 5899999998643 23345677899999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC----
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN---- 525 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~---- 525 (678)
|+|...++++.. ..++...+.-++.+|+.||+|||.. |||.|||||+||||.++|++.|+||.|+....
T Consensus 162 GdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 162 GDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred ccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999998876543 3689999999999999999999965 99999999999999999999999999853210
Q ss_pred ---c--------------------------c-c--------------------------cccccceeeCccccccCCCCC
Q 044996 526 ---Q--------------------------E-S--------------------------AQELMIAYKSPEFLQLGRITK 549 (678)
Q Consensus 526 ---~--------------------------~-~--------------------------~~~~~~~y~aPE~~~~~~~t~ 549 (678)
. . . ...||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0 001345699999999999999
Q ss_pred cchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccc
Q 044996 550 KTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEE 629 (678)
Q Consensus 550 ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~ 629 (678)
++|.|+|||++|||+.|+.||.. .+-.+-+..++...... .+. .+......+++.+-|..|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG--------~~~~~Tl~NIv~~~l~F--------p~~---~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKG--------SNNKETLRNIVGQPLKF--------PEE---PEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCC--------CCchhhHHHHhcCCCcC--------CCC---CcchhHHHHHHHHHhccC
Confidence 99999999999999999999972 11122233333222111 111 133456777888999999
Q ss_pred cccCCC----HHHHHH
Q 044996 630 VEKRLD----LKEAVE 641 (678)
Q Consensus 630 P~~RPs----~~ev~~ 641 (678)
|.+|.- +.||-+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999998 556543
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.67 Aligned_cols=234 Identities=22% Similarity=0.254 Sum_probs=182.2
Q ss_pred cCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCCCHHH
Q 044996 377 LGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAV 454 (678)
Q Consensus 377 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~ 454 (678)
||+|+||.||++.. .++..+++|.+........ |+.....+ +|+||+++++++...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 69999999999975 4677888888764321111 22222222 79999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-ceEEeecCCccccCcccccccc
Q 044996 455 NLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-EPVLADYGLIPVMNQESAQELM 533 (678)
Q Consensus 455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~ 533 (678)
++.... .++|.++..++.||++||.|||+. +++||||||+||+++.++ .+||+|||+++.........++
T Consensus 99 ~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 169 (267)
T PHA03390 99 LLKKEG-----KLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGT 169 (267)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCC
Confidence 997643 589999999999999999999976 799999999999999998 9999999998877655555678
Q ss_pred ceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHH
Q 044996 534 IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEG 613 (678)
Q Consensus 534 ~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 613 (678)
..|+|||++.+..++.++|||||||++|||++|+.||.... .....+..|.... .... .. ...
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-~~~~---~~----------~~~ 232 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEELDLESLLKRQ-QKKL---PF----------IKN 232 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---cchhhHHHHHHhh-cccC---Cc----------ccc
Confidence 89999999998889999999999999999999999997221 1112333343322 1100 00 011
Q ss_pred HHHHHHHHHhhcCccccccCCC-HHHHHH
Q 044996 614 EMVKLLKIGLACCEEEVEKRLD-LKEAVE 641 (678)
Q Consensus 614 ~~~~~~~l~~~Cl~~~P~~RPs-~~ev~~ 641 (678)
....+.+++.+||+.+|.+||+ ++|+++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 2334677788999999999995 688774
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.03 Aligned_cols=243 Identities=15% Similarity=0.196 Sum_probs=173.6
Q ss_pred ccccCccCceeEEEEEecCC----ceEEEEEecccChhh-----------HHHHHHHHHHHhccCCCCccceeEEEEeCC
Q 044996 374 AEILGSGCFGSSYKASLSTG----AMMVVKRFKQMNNVG-----------REEFQEHMRRLGRLRHPNLLPLVAYYYRKE 438 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 438 (678)
.++||+|+||.||+|....+ ..+++|......... ......+...+..++|+||+++++++....
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 96 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR 96 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence 46799999999999986543 455555433221111 011223344566779999999999876543
Q ss_pred ----ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceE
Q 044996 439 ----EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPV 514 (678)
Q Consensus 439 ----~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~k 514 (678)
..++++|++. .++.+.+.... ..++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 97 CRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred CCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCcEE
Confidence 3467888774 46666665432 356788899999999999999965 799999999999999999999
Q ss_pred EeecCCccccCcc-----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCCh
Q 044996 515 LADYGLIPVMNQE-----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDL 583 (678)
Q Consensus 515 l~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l 583 (678)
|+|||+++.+... ....+|..|+|||++.+..++.++|||||||++|||++|+.||..... ...+
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~----~~~~ 242 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH----NGNL 242 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc----chHH
Confidence 9999999765321 112467889999999989999999999999999999999999973211 1111
Q ss_pred H-----HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 584 A-----SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 584 ~-----~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
. ++...... ..+. .......+.+++..|++.+|++||++.++.+.|+
T Consensus 243 ~~~~~~~~~~~~~~----------~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKRLHE----------GKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHHhhh----------hhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 11111111 1110 0112345778888999999999999999998763
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.63 Aligned_cols=194 Identities=22% Similarity=0.339 Sum_probs=161.4
Q ss_pred ccccCccCceeEEEEEec---CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLS---TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 445 (678)
.+.||+|+||.||+|... .+..+|+|.+.... ....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 356999999999999864 47899999988632 33446778899999999999999999999987 78999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC----CCceEEeecCCc
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE----SLEPVLADYGLI 521 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~----~~~~kl~DfGla 521 (678)
|+++ +|.+++..........+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9964 777777544332223688899999999999999999965 7999999999999999 999999999998
Q ss_pred cccCccc-------cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 044996 522 PVMNQES-------AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANF 572 (678)
Q Consensus 522 ~~~~~~~-------~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~ 572 (678)
+...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 7654321 1234677999998865 4579999999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=284.10 Aligned_cols=243 Identities=21% Similarity=0.280 Sum_probs=194.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||++.. .+++.+++|.+... ......++.+|++++++++|+||+++++++......++||||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 46799999999999965 46788999998743 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++..... ....+++..++.++.|++.||+|||.. +++|+||+|+||++++++.+||+|||+++......
T Consensus 85 ~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 85 DLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred CHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 99999876332 123689999999999999999999965 89999999999999999999999999987765431
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|++||.+.+..++.++|+||||+++|||++|+.||.. .+......... .+ ....
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~--------~~~~~~~~~~~-~~-~~~~--------- 220 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA--------RSMQDLRYKVQ-RG-KYPP--------- 220 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHh-cC-CCCC---------
Confidence 22356789999999888899999999999999999999999862 12222111111 11 1100
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
........+.+++.+|++.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 -IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11123455788888999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=273.21 Aligned_cols=243 Identities=22% Similarity=0.345 Sum_probs=188.6
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEeccc-ChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
..||+|..|.|++++.+ +|..+|||.+... +....+++...++++.+.+ .|.||+-+|||..+...++.||.|. -.
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TC 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HH
Confidence 45999999999999875 5889999999764 4455677888888877664 8999999999999999999999994 35
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc--
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA-- 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 529 (678)
++.+|++-.. ++++...-++...+.+||.||-+.+ +|+|||+||+|||+|+.|++|+||||++..+.+..+
T Consensus 177 ~ekLlkrik~----piPE~ilGk~tva~v~AL~YLKeKH---~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 177 AEKLLKRIKG----PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHHHHHHhcC----CchHHhhhhhHHHHHHHHHHHHHhc---ceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 6666655432 5777777799999999999998775 799999999999999999999999999977655433
Q ss_pred -ccccceeeCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 530 -QELMIAYKSPEFLQL---GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 530 -~~~~~~y~aPE~~~~---~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
..|...|||||.+.- .+|+.++|||||||.|+||.||+.||.... .++ +-+..++.+.. |.|
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~------tdF-e~ltkvln~eP-------P~L 315 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK------TDF-EVLTKVLNEEP-------PLL 315 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC------ccH-HHHHHHHhcCC-------CCC
Confidence 346788999999864 368999999999999999999999997321 121 12222332211 222
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.... .-...+.++...|+..|+.+||...++++.
T Consensus 316 ~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Cccc---CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2111 023457778889999999999999988763
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=281.99 Aligned_cols=239 Identities=22% Similarity=0.373 Sum_probs=193.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh--hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN--VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++.+++|+|++++++++...+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 467999999999999764 578899999876543 45678999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA- 529 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 529 (678)
+|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 85 ~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 85 SLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999987542 589999999999999999999965 899999999999999999999999999876654332
Q ss_pred ---ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 ---QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 ---~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..++..|+|||+..+..++.++||||||+++|||++|+.||... ........ ..... . +.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~-------~~~~~~~~-~~~~~--~-----~~~- 219 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL-------NPMAALFR-IVQDD--H-----PPL- 219 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHH-HhccC--C-----CCC-
Confidence 24567899999998878899999999999999999999998621 11111111 11110 0 001
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+|++.+|++||++.|++.
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112345678888999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=282.48 Aligned_cols=243 Identities=22% Similarity=0.318 Sum_probs=196.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||++... ++..+++|++.... ....+.+.+|++++++++|+|++++++.+...+..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 356999999999999865 58899999987543 355677899999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++...... ...+++.++..++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 85 ~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 85 DLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred cHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999865321 13699999999999999999999976 89999999999999999999999999987654432
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||.+....++.++||||||+++|||++|+.||.. ....+......... . +.+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~--------~~~~~~~~~~~~~~--~-----~~~- 223 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG--------ENLLELALKILKGQ--Y-----PPI- 223 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC--------CcHHHHHHHHhcCC--C-----CCC-
Confidence 22346679999999888899999999999999999999999862 22233333222211 1 001
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.+|++||++.|+++
T Consensus 224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0112345778888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=292.81 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=185.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh--hhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN--VGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++||||+.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 457999999999999864 688999999874322 2233567899999999999999999998765 46899999996
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
++|.+++.... ..+++.++..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 92 -~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 92 -QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred -CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 58988887543 2589999999999999999999976 79999999999999999999999999987665321
Q ss_pred ----cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc-ccccc-
Q 044996 529 ----AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN-RTEVF- 601 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~- 601 (678)
....+..|+|||++.+ ..++.++|||||||++|||++|+.||... +..+.+......-.. .....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~--------~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK--------SEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHhcCCCChhhch
Confidence 1123567999999865 45799999999999999999999998621 112222222111000 00000
Q ss_pred ---------chhhhcccC------CHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 602 ---------DKEMADERN------SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 602 ---------d~~l~~~~~------~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...+..... .......+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0011345677888999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=290.78 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=186.9
Q ss_pred hccccCccCceeEEEEEecC-CceEEEEEecccC-hhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCC
Q 044996 373 SAEILGSGCFGSSYKASLST-GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
..+.||+|+||.||+|.... +..++||.++... .....++..|+.++.+.. |+||+++++++......++||||+.
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 97 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS- 97 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-
Confidence 35689999999999998764 8899999987532 233456677887777765 9999999999999999999999985
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|.+++..... .+++..+..++.||+.||+|||... +|+||||+|+||++++++.+||+|||++..+....
T Consensus 98 ~~l~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 98 TCLDKLLKRIQG----PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred cCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 577777654322 5899999999999999999999642 69999999999999999999999999987654322
Q ss_pred --cccccceeeCccccccCC----CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 529 --AQELMIAYKSPEFLQLGR----ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~----~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
...++..|+|||++.+.. ++.++||||||+++|||++|+.||.... .-.+.....+.....
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~------ 237 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK-------TEFEVLTKILQEEPP------ 237 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch-------hHHHHHHHHhcCCCC------
Confidence 123456899999987554 7899999999999999999999986211 111222222222111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.+.. .......+.+++.+||+.||.+||++.++++.
T Consensus 238 -~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 -SLPP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00123457888889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.64 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=190.0
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccCh--hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN--VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.||+|++|.||+|... +++.+++|.++.... .....+.+|++++++++|+||+++++++..++..++||||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 56999999999999764 688899998875432 3456788999999999999999999999999999999999975 8
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.+++.... ..+++.++..++.|++.||.|||.. +|+|+||||+||++++++.+||+|||.+.......
T Consensus 84 l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 84 LYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred HHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 888887643 2589999999999999999999976 79999999999999999999999999987665432
Q ss_pred -cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcc----cccc
Q 044996 529 -AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNR----TEVF 601 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~----~~~~ 601 (678)
...++..|+|||.+.+. .++.++||||||+++|||+||+.||.... . .+-....... +... ....
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS-------E-IDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------H-HHHHHHHHHHcCCCchHhcccch
Confidence 12345679999998776 78999999999999999999999986211 1 1111111100 0000 0000
Q ss_pred c------hhhhc------ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 602 D------KEMAD------ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 602 d------~~l~~------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+ ..... ..........+.+++.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00000 0001123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=290.90 Aligned_cols=251 Identities=18% Similarity=0.258 Sum_probs=185.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... +++.+++|++.... ....+.+.+|++++++++|+||+++++++......++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 356999999999999864 68899999886432 2334678899999999999999999999999999999999995 5
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCccccCcc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~-- 527 (678)
+|.+++..... ..+++.....++.||+.||+|||+. +++||||||+||++++ ++.+||+|||++......
T Consensus 86 ~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 86 DLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 88888764432 1367888889999999999999976 7999999999999985 567999999998754322
Q ss_pred --ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccccc---
Q 044996 528 --SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF--- 601 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~--- 601 (678)
....++..|+|||++.+. .++.++|||||||++|||+||+.||.... ......+.....+....+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS-------EIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHHhCCCChhhcccc
Confidence 122346789999988654 57899999999999999999999986211 11111111000000000000
Q ss_pred --------------chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 602 --------------DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 602 --------------d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...+... .......+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATV--VPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHh--CcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0011234678888999999999999999986
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=281.97 Aligned_cols=241 Identities=25% Similarity=0.346 Sum_probs=194.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~Ey~~ 448 (678)
.+.||+|++|.||+|... ++..+++|.+.... ....+.+.+|++++++++|+||+++++++... ...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 357999999999999875 68899999987543 24567899999999999999999999999988 88999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+++|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999997643 589999999999999999999975 79999999999999999999999999987665432
Q ss_pred ------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 529 ------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 529 ------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
...++..|+|||.+....++.++||||||+++|||++|+.||.... ....-+..... ....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~-~~~~----- 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGS-SGEP----- 222 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccc-cCCC-----
Confidence 2335678999999988889999999999999999999999987321 11111111110 0011
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.+ .......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~-----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEI-----PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCC-----CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 001 1122455788888999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=288.00 Aligned_cols=251 Identities=19% Similarity=0.265 Sum_probs=188.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|++|.||+|+.. ++..+++|.++... ....+.+.+|++++++++|+||+++++++...+..++||||++ |+
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KD 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-cc
Confidence 357999999999999874 68889999887543 2234667889999999999999999999999999999999998 58
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 84 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 84 LKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred HHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9888865432 22589999999999999999999965 7999999999999999999999999998754322
Q ss_pred ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC------------
Q 044996 528 SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG------------ 594 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~------------ 594 (678)
....++..|++||++.+. .++.++|||||||++|||++|+.||.... ..+-........
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN--------NEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHHHhCCCChhhHHHHh
Confidence 122346789999988654 56899999999999999999999986321 111111111000
Q ss_pred --Cc----cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 --DN----RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 --~~----~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. .....+..... ........+.+++.+|++.||.+||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQ--LFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHH--HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 00000000000 00112345778888999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=286.80 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=188.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhcc---CCCCccceeEEEEeCCc-----eEE
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRL---RHPNLLPLVAYYYRKEE-----KLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~-----~~l 442 (678)
.+.||+|+||.||+|... ++..+++|+++... ......+.+|+.++.++ +|+||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 457999999999999876 48899999987432 22234566787777665 69999999999988776 899
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
+|||+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 84 ~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 84 VFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred Eehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999996 589988875432 2589999999999999999999976 79999999999999999999999999987
Q ss_pred ccCcccc---ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc---
Q 044996 523 VMNQESA---QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN--- 596 (678)
Q Consensus 523 ~~~~~~~---~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~--- 596 (678)
.+..... ..++..|+|||++.+..++.++|||||||++|||++|+.||... ...+.....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT--------SEADQLDKIFDVIGLPSE 227 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC--------ChHHHHHHHHHHcCCCCh
Confidence 7643322 23467799999999889999999999999999999999998621 112222222211000
Q ss_pred ----cc-----cccchhhhc--ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 ----RT-----EVFDKEMAD--ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 ----~~-----~~~d~~l~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. ..+...... ..........+.+++.+||+.||++||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 000000000 0000122355678889999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=289.07 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=191.1
Q ss_pred ccccCccCceeEEEEEe----cCCceEEEEEecccC----hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 374 AEILGSGCFGSSYKASL----STGAMMVVKRFKQMN----NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
.+.||+|+||.||+++. .++..++||.++... ....+.+.+|++++.++ +|+||+++++.+......++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 46799999999999964 356789999887432 22345788999999999 5999999999999888999999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+++|+|.+++.... .+++..+..++.|+++||+|||.. +++||||||+||+++.++.+||+|||+++..
T Consensus 85 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 85 DYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred ecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999987532 488999999999999999999965 7999999999999999999999999998765
Q ss_pred Cccc-----cccccceeeCccccccCC--CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 525 NQES-----AQELMIAYKSPEFLQLGR--ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 525 ~~~~-----~~~~~~~y~aPE~~~~~~--~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
.... ...++..|+|||.+.+.. .+.++||||||+++|||++|+.||.... .......+.+........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~- 230 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG----EQNSQSEISRRILKSKPP- 230 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc----ccchHHHHHHHHHccCCC-
Confidence 4322 123567899999987655 7889999999999999999999985211 011122222222211110
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
. .......+.+++.+||+.+|++|||+.+|.+.|+-
T Consensus 231 -------~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 -------F-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------C-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 01122346778889999999999999988887664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=297.41 Aligned_cols=186 Identities=19% Similarity=0.290 Sum_probs=158.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 444 (678)
.+.||+|+||.||+|.. .++..+|+|.+... .....+.+.+|+.++++++|+||+++++++... ...++||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 46799999999999976 46889999998642 233445678899999999999999999998643 3479999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+. ++|.+.+.. .+++.++..++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 101 ELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred eccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 9995 588887753 278889999999999999999976 7999999999999999999999999999866
Q ss_pred Cccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 525 NQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 525 ~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.... ...++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 4432 2235678999999998899999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=286.47 Aligned_cols=239 Identities=20% Similarity=0.278 Sum_probs=181.3
Q ss_pred ccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHH---HHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 376 ILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMR---RLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~---~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
+||+|+||.||+|.. .+++.||+|.+.... ......+..|.. .++..+||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999976 457899999886432 111222334433 4455689999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 999999886532 589999999999999999999975 7999999999999999999999999998755432
Q ss_pred -ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 -SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.++ .++.++|||||||++|||++|+.||...... .... ....... .+..+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~-~~~~~~~-------~~~~~ 218 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHE-IDRMTLT-------MAVEL 218 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHH-HHHHhhc-------cCCCC
Confidence 223467889999998754 6899999999999999999999999732110 1111 1111100 01111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
.. .....+.+++.+|+..+|.+|| ++.|+++
T Consensus 219 ~~-----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PD-----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC-----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 1134577788899999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=287.41 Aligned_cols=242 Identities=21% Similarity=0.286 Sum_probs=187.6
Q ss_pred ccccCccCceeEEEEEe----cCCceEEEEEecccC----hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 374 AEILGSGCFGSSYKASL----STGAMMVVKRFKQMN----NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
.+.||+|+||.||++.. .+|..+|+|.++... ....+.+.+|++++.++ +|+||+++++++..+...++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 45799999999999975 368899999987532 22346788999999999 5999999999999888999999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++..
T Consensus 85 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 85 DYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999997542 478889999999999999999965 7999999999999999999999999998765
Q ss_pred Cccc-----cccccceeeCccccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 525 NQES-----AQELMIAYKSPEFLQLG--RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 525 ~~~~-----~~~~~~~y~aPE~~~~~--~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
.... ...++..|+|||++... .++.++||||||+++|||++|+.||.... .......+...........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~ 231 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSEPPY 231 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC----ccccHHHHHHHhhccCCCC
Confidence 4322 12356789999998753 46889999999999999999999986211 1122233332222211111
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+|++.+|++|| ++.++++
T Consensus 232 -------------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 232 -------------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111223467788899999999997 5566544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=294.58 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=187.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeC--CceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRK--EEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|... ++..+++|++... .......+.+|+.+++++ +|+||++++++|... ...++||||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 467999999999999865 5788999988542 233445677899999999 999999999998654 3579999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
+ ++|..++... .++|..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 92 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 92 E-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred c-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 7 6999888653 478999999999999999999965 8999999999999999999999999998765332
Q ss_pred c---------cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCc
Q 044996 528 S---------AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDN 596 (678)
Q Consensus 528 ~---------~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~ 596 (678)
. ...++..|+|||++.+ ..++.++|||||||++|||+||+.||..... . +-....... +..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~-------~-~~~~~~~~~~~~~ 232 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST-------L-NQLEKIIEVIGPP 232 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh-------H-HHHHHHHHHhCCC
Confidence 1 1234677999998754 4578999999999999999999999852110 0 000000000 000
Q ss_pred ------------cccccchhhhccc-----CCHHHHHHHHHHHhhcCccccccCCCHHHHHHH--HHHhh
Q 044996 597 ------------RTEVFDKEMADER-----NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK--IEEVK 647 (678)
Q Consensus 597 ------------~~~~~d~~l~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L~~i~ 647 (678)
..++++....... ........+.+++.+||+.+|++|||+.++++. ++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0000000000000 000123457888999999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.65 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=196.6
Q ss_pred cccCccCceeEEEEE-ecCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------ceEEEEec
Q 044996 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------EKLLVHEF 446 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~Ey 446 (678)
+.||+|+||.||+|+ ..+|..||||.++... ....+..-+|+++|++++|+|||+++++-.+.. ...+||||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy 98 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY 98 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence 569999999999998 5689999999998643 455678889999999999999999999865443 46799999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec--CCC--ceEEeecCCcc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN--ESL--EPVLADYGLIP 522 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~~--~~kl~DfGla~ 522 (678)
|.+|||+..|.+.... .-|++.+.+.++.++..||.|||++ +|+||||||.||++- +++ .-||+|||.|+
T Consensus 99 C~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 99 CSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred cCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 9999999999865432 2499999999999999999999976 899999999999983 333 47999999999
Q ss_pred ccCccc---cccccceeeCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC-cc
Q 044996 523 VMNQES---AQELMIAYKSPEFLQ-LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD-NR 597 (678)
Q Consensus 523 ~~~~~~---~~~~~~~y~aPE~~~-~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~-~~ 597 (678)
.+.+.. ...||..|.+||++. .+.|+..+|.|||||++||.+||..||.... +..+....+.....+.. ..
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~----~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG----GPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC----CccccchhhhhhhccCCCce
Confidence 988764 335788899999998 4889999999999999999999999997322 11112122222222211 11
Q ss_pred ccccchhhhccc-----------CCHHHHHHHHHHHhhcCccccccCC--CHHHHHHHHHHhhc
Q 044996 598 TEVFDKEMADER-----------NSEGEMVKLLKIGLACCEEEVEKRL--DLKEAVEKIEEVKE 648 (678)
Q Consensus 598 ~~~~d~~l~~~~-----------~~~~~~~~~~~l~~~Cl~~~P~~RP--s~~ev~~~L~~i~~ 648 (678)
.-..++...+.. .......++-++...++..+|.+|- ...+....+..|..
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 111222221110 1122344455666677788899998 66666666665543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.22 Aligned_cols=239 Identities=19% Similarity=0.266 Sum_probs=192.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
...||+|.|+.|..|++ .++..||||.+++. +......+.+|+++|+.++|||||+++.+......+|+||||+.+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 45799999999999975 46889999999864 3344556889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
.++++|..+.. ........++.|+.+|++|+|.+ .|||||||++|||||.++++||+|||++..+....
T Consensus 141 e~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 141 ELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred hhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeecccccc
Confidence 99999987753 44577788999999999999977 79999999999999999999999999998776442
Q ss_pred -cccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 -AQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|.|||++.+.+| ++++|+||+||+||-|+.|..||+. ..+...-.. ++-..+.
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG--------~~lk~Lr~r----------vl~gk~r 273 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG--------QNLKELRPR----------VLRGKYR 273 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC--------cccccccch----------heeeeec
Confidence 3346788999999998877 6899999999999999999999982 222211111 1111111
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
-..+. ..+.-+++.+.+-.+|.+|++++++.+.
T Consensus 274 Ip~~m---s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 IPFYM---SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cccee---echhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111 1223455668889999999999998763
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=293.09 Aligned_cols=251 Identities=20% Similarity=0.264 Sum_probs=186.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhh--------------HHHHHHHHHHHhccCCCCccceeEEEEeCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVG--------------REEFQEHMRRLGRLRHPNLLPLVAYYYRKE 438 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~ 438 (678)
.+.||+|+||.||+|... .++.||+|+++...... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999754 68899999886432211 125778999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeec
Q 044996 439 EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADY 518 (678)
Q Consensus 439 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 518 (678)
..++||||+. |+|.+++.... .+++.....++.|++.||+|||.. +++||||||+||+++.++.+||+||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEEECCc
Confidence 9999999996 69999886532 488999999999999999999965 7999999999999999999999999
Q ss_pred CCccccCcc------------------ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCC
Q 044996 519 GLIPVMNQE------------------SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKA 579 (678)
Q Consensus 519 Gla~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~ 579 (678)
|+++..... ....++..|+|||++.+. .++.++|||||||++|||+||+.||....+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~---- 239 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE---- 239 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 998765411 011235679999998754 469999999999999999999999862110
Q ss_pred CCChHHHHHHHHhcCCcc--------------ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 580 DGDLASWVNSVLANGDNR--------------TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 580 ~~~l~~~~~~~~~~~~~~--------------~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+...+...... .....+.+... .......+.+++.+|++.+|++||++.|++.
T Consensus 240 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 -IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI--FPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh--CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111111100000 00000000000 0012345778889999999999999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=284.87 Aligned_cols=258 Identities=18% Similarity=0.248 Sum_probs=189.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh-hhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||+|... +++.+++|++..... .......+|+..+.+++ |+||+++++++..++..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 357999999999999875 478899998865322 23334567899999999 999999999999999999999999 88
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++..... ..+++.++..++.|++.+|.|||+. +++|+||+|+||++++++.+||+|||+++......
T Consensus 83 ~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 83 NLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred CHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 99998876531 2589999999999999999999976 79999999999999999999999999987665432
Q ss_pred -cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCC--------CCCCChHHHHHHHHhcCCc--
Q 044996 529 -AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGK--------KADGDLASWVNSVLANGDN-- 596 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~--------~~~~~l~~~~~~~~~~~~~-- 596 (678)
...++..|+|||++.. ..++.++||||||+++|||++|+.||....... .+...-..|..........
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2235678999998854 457999999999999999999999985221000 0000001121111100000
Q ss_pred -cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 -RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 -~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
........+... . ......+.+++.+||+.+|++|||++|++.
T Consensus 236 ~~~~~~~~~~~~~-~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 236 RFPQFAPTSLHQL-I-PNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccHHHH-c-ccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000 0 011356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=288.41 Aligned_cols=189 Identities=24% Similarity=0.351 Sum_probs=156.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC--------ceEE
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE--------EKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~l 442 (678)
.+.||+|+||.||+|... ++..+|||.+.... ......+.+|++++++++||||++++++|...+ ..++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 457999999999999764 68899999886432 222345678999999999999999999987654 3499
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
||||+. ++|.+++..... .+++.++..++.||+.||+|||+. +++|+||||+||++++++.+||+|||++.
T Consensus 97 v~e~~~-~~l~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 97 VFEFCE-HDLAGLLSNKNV----KFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred EEcCCC-cCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 999996 588888765422 589999999999999999999976 79999999999999999999999999987
Q ss_pred ccCccc--------cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 523 VMNQES--------AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 523 ~~~~~~--------~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.+.... ...++..|+|||++.+. .++.++||||||+++|||+||+.||.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 654321 12245679999988654 46899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=289.97 Aligned_cols=190 Identities=23% Similarity=0.351 Sum_probs=169.7
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
++||+|+||.||-++. .+|+++|.|++.+. .........+|-.+|.+++.+.||.+--.|.+++.+|||+..|.+|
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 5799999999999975 47999999988642 2233445678999999999999999998999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|.-+|.... .+.+++.+..-++.+|+.||++||+. +||.|||||+|||||++|+++|+|.|+|..+...
T Consensus 271 DLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 271 DLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred ceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 9999998664 35699999999999999999999977 7999999999999999999999999999887654
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
....||.+|||||++..+.|+...|.||+||++|||+.|+.||.
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchh
Confidence 33468999999999999999999999999999999999999997
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=291.47 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=189.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------ceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------EKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 444 (678)
.+.||+|+||.||+|.. .+++.+|+|+++.. .......+.+|+.++++++|+||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46799999999999975 46889999988642 2223456889999999999999999999987543 468999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+.. +|..++.. .+++..+..++.|++.||+|||.. +++||||||+|||++.++.+||+|||+++..
T Consensus 100 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 100 PYMQT-DLQKIMGH-------PLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred ccccc-CHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 99964 77766521 488999999999999999999976 7999999999999999999999999998765
Q ss_pred Cccc-cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC-Cccccc-
Q 044996 525 NQES-AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG-DNRTEV- 600 (678)
Q Consensus 525 ~~~~-~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~- 600 (678)
.... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||... +...-+....... ....+.
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--------DYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHhcCCCCHHHH
Confidence 4332 2234677999999876 46899999999999999999999999621 1111111111100 000000
Q ss_pred -----------c-------chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH--HHHhhccCCCC
Q 044996 601 -----------F-------DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK--IEEVKERDGDE 653 (678)
Q Consensus 601 -----------~-------d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L~~i~~~~~~~ 653 (678)
+ .+.+... .......+.+++.+||+.||.+||++.|++.. ++++++..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTL--FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHH--hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence 0 0000000 00112346788889999999999999999954 77776654443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.53 Aligned_cols=249 Identities=24% Similarity=0.281 Sum_probs=185.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC----------ce
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE----------EK 440 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----------~~ 440 (678)
.+.||+|+||.||+|... +++.|++|.++... ......+.+|++++++++||||+++++++.... ..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 467999999999999875 57899999987432 233456788999999999999999999987654 78
Q ss_pred EEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCC
Q 044996 441 LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL 520 (678)
Q Consensus 441 ~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 520 (678)
++|+||+++ ++...+.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 92 ~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred EEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEEeCcccc
Confidence 999999975 7777776432 2589999999999999999999976 799999999999999999999999999
Q ss_pred ccccCcccc-----ccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh--
Q 044996 521 IPVMNQESA-----QELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA-- 592 (678)
Q Consensus 521 a~~~~~~~~-----~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~-- 592 (678)
+........ ...+..|+|||++.+ ..++.++|||||||++|||++|+.||... +..+-+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~--------~~~~~~~~~~~~~ 234 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN--------QELAQLELISRLC 234 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHHh
Confidence 876643321 123567999998864 35789999999999999999999998621 11111111111
Q ss_pred -cCCc--cccc--------cch------hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 593 -NGDN--RTEV--------FDK------EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 593 -~~~~--~~~~--------~d~------~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... ...+ .++ ..... .......+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE--FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh--cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000 000 00000 0012345788888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=292.28 Aligned_cols=258 Identities=21% Similarity=0.306 Sum_probs=196.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC-----ceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE-----EKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~E 445 (678)
.+.||+|+||.||+|... +++.+++|++.... ....+.+.+|+++++.++|+||+++++++...+ ..|+|||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 467999999999999865 48899999987643 344567899999999999999999999988765 7899999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|++ ++|.+++.... .+++..+..++.+++.||+|||.. +|+||||||+|||+++++.+||+|||++....
T Consensus 85 ~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 85 LME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred chh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 997 58988886542 589999999999999999999966 79999999999999999999999999987665
Q ss_pred ccc-------cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc-
Q 044996 526 QES-------AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN- 596 (678)
Q Consensus 526 ~~~-------~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~- 596 (678)
... ...++..|+|||++.+. .++.++||||||+++|||++|+.||... ...+...........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR--------DYIDQLNLIVEVLGTP 226 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC--------CHHHHHHHHHHhcCCC
Confidence 432 12346679999999877 7899999999999999999999998621 111111111111000
Q ss_pred ------------cccccchhhhccc-----CCHHHHHHHHHHHhhcCccccccCCCHHHHHHH--HHHhhcc
Q 044996 597 ------------RTEVFDKEMADER-----NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK--IEEVKER 649 (678)
Q Consensus 597 ------------~~~~~d~~l~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L~~i~~~ 649 (678)
..+.+...-.... ........+.+++.+||+.+|.+||++.++++. ++++...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000000000 000123457788889999999999999999984 7776654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=279.07 Aligned_cols=239 Identities=19% Similarity=0.265 Sum_probs=185.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc-----ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM-----NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 445 (678)
.+.||+|+||.||+|.. .++..+++|.+... .......+.+|++++++++|+||+++++++.+. ...++|+|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 46799999999999975 46889999987421 123446789999999999999999999998764 45789999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++++|.+++.... .+++....+++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 87 YMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred eCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 999999999987542 478899999999999999999966 79999999999999999999999999987653
Q ss_pred cc-------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 526 QE-------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 526 ~~-------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||... ....-+....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~~- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY--------EAMAAIFKIATQP-TK- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc--------CHHHHHHHHHcCC-CC-
Confidence 21 1123567899999998888999999999999999999999998621 1111111111110 00
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.+ +......+.+++.+|++ +|..||+..++++
T Consensus 228 ----~~~-----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 ----PML-----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCC-----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111 11223446777779999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=294.50 Aligned_cols=258 Identities=19% Similarity=0.277 Sum_probs=188.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC-----ceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE-----EKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~Ey 446 (678)
.++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.... ..++|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 46799999999999975 468899999986432 334567888999999999999999999876543 47999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+. ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 90 ME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 96 5888877543 589999999999999999999976 799999999999999999999999999876543
Q ss_pred cc-------cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc--
Q 044996 527 ES-------AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN-- 596 (678)
Q Consensus 527 ~~-------~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~-- 596 (678)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ......++...+.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~-----~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD-----YLHQLNLILGVLGTPSQED 233 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHcCCCCHHH
Confidence 21 1234677999998754 468999999999999999999999986211 00111111111111000
Q ss_pred cccccchh-------hhccc------CCHHHHHHHHHHHhhcCccccccCCCHHHHHHH--HHHhh
Q 044996 597 RTEVFDKE-------MADER------NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK--IEEVK 647 (678)
Q Consensus 597 ~~~~~d~~-------l~~~~------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L~~i~ 647 (678)
...+.+.. ..... ........+.+++.+||+.+|++|||+.|+++. ++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000000 00000 000123457889999999999999999999986 65544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=281.71 Aligned_cols=242 Identities=19% Similarity=0.272 Sum_probs=186.4
Q ss_pred ccccCccCceeEEEEEecC-CceEEEEEeccc-----ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLST-GAMMVVKRFKQM-----NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 4579999999999997643 344555554431 1223446778999999999999999999999888999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++++|.+++...... ...+++.+++.++.|++.||.|||+. +++|+||||+||++++ +.+||+|||+++.....
T Consensus 85 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 85 EGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred CCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 999999988753221 23689999999999999999999975 8999999999999975 56999999998765432
Q ss_pred c----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 528 S----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 528 ~----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
. ...++..|+|||++.+..++.++||||||+++|||++|+.||.. .............. . +
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~-~------~ 223 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG--------QNFLSVVLRIVEGP-T------P 223 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC--------ccHHHHHHHHHcCC-C------C
Confidence 1 22356789999999888889999999999999999999999861 22233332222111 0 1
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+ .......+.+++.+||+.+|++||++.|+++
T Consensus 224 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 SL-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CC-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 1123346778888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=284.11 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=190.1
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.||+|+||.||+|... +++.+++|.+.... ....+.+..|+.++++++|+||+++++++...+..++||||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 56999999999999875 58899999987643 3334678889999999999999999999999999999999997 59
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.+++.... ..+++..+..++.+++.||+|||.. +|+||||+|+||++++++.+||+|||+++......
T Consensus 84 l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 84 LKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 999998653 2589999999999999999999976 79999999999999999999999999987654332
Q ss_pred -cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc--------c
Q 044996 529 -AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR--------T 598 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~--------~ 598 (678)
....+..|+|||++.+. .++.++|||||||++|||++|+.||... ...+............ .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD--------SEIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHHHhCCCcHHHHHhhc
Confidence 12235679999998766 7899999999999999999999998621 1111111111100000 0
Q ss_pred cc--cchhhhc---cc---CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EV--FDKEMAD---ER---NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~--~d~~l~~---~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+ .+..+.. .. ........+.+++.+||+.+|++||++.+|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 0000000 00 00011346888999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=294.51 Aligned_cols=252 Identities=19% Similarity=0.286 Sum_probs=186.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEe----CCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYR----KEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|.. .++..|++|++.... ....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 45799999999999975 468899999987532 2345677889999999999999999998763 3468999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+. |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 90 ~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 90 ME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred hh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 95 68998886532 489999999999999999999976 799999999999999999999999999876533
Q ss_pred cc--------cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 527 ES--------AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 527 ~~--------~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
.. ...++..|+|||++.. ..++.++|||||||++|||++|+.||..... ......+.... +...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~-----~~~~~~~~~~~--g~~~ 232 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY-----VHQLKLILSVL--GSPS 232 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh-----HHHHHHHHHHh--CCCh
Confidence 21 1234677999998865 4689999999999999999999999962110 00011111100 0000
Q ss_pred ccccc----h-------hhhc-ccC-----CHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 598 TEVFD----K-------EMAD-ERN-----SEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 598 ~~~~d----~-------~l~~-~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.++++ . .... ... .......+.+++.+|++.+|.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 0 0000 000 01124567888889999999999999999883
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=276.88 Aligned_cols=232 Identities=25% Similarity=0.267 Sum_probs=188.0
Q ss_pred cCccCceeEEEEEec-CCceEEEEEecccCh---hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 377 LGSGCFGSSYKASLS-TGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
||+|+||.||++... +++.+++|.+..... ...+.+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 588999998875322 2456789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.+++.... .+++..+..++.|++.||.|||.. +++|+||||+||++++++.++|+|||++...... .
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 99997543 489999999999999999999975 7999999999999999999999999998765432 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|++||...+...+.++|+||||+++|||++|+.||... +...............
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--------~~~~~~~~~~~~~~~~----------- 212 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE--------DRKEIYEKILKDPLRF----------- 212 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHhcCCCCC-----------
Confidence 233567899999998888899999999999999999999999621 1122222222211111
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKE 638 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e 638 (678)
+......+.+++.+||..||++||++.+
T Consensus 213 --~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 213 --PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1111345677888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.14 Aligned_cols=257 Identities=21% Similarity=0.287 Sum_probs=189.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------ceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------EKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 444 (678)
.+.||+|+||.||+|.. .++..||||++... .....+.+.+|++++++++|+||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 35799999999999975 47889999988642 2333457889999999999999999999987543 358999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 100 e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 100 PFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 999 77998887642 589999999999999999999975 7999999999999999999999999998766
Q ss_pred Cccc-cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 525 NQES-AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 525 ~~~~-~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
.... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||... ...................+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH--------DHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHhcCCCCHHHH
Confidence 5432 2345678999998875 45889999999999999999999998621 111111111111000000000
Q ss_pred hh------------hhccc------CCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhcc
Q 044996 603 KE------------MADER------NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKER 649 (678)
Q Consensus 603 ~~------------l~~~~------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~~ 649 (678)
.. +.... ........+.+++.+|++.||++|||+.++++ .++.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 00 00000 00012234778888999999999999999994 56655443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=323.16 Aligned_cols=239 Identities=26% Similarity=0.359 Sum_probs=187.8
Q ss_pred ccccCccCceeEEEEE-ecCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
+..||.|.||.||.|. ..+|...|+|-++-.. ....+.+.+|+.++..|+|||+|+++|+-.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 4689999999999985 5788999999876432 334456789999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+.+...+ ..++.....+..|++.|++|||++ +||||||||.||+||.+|.+|++|||.|..+....
T Consensus 1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999997654 355666667899999999999987 89999999999999999999999999998765432
Q ss_pred ------cccccceeeCccccccCC---CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHH-hcCCccc
Q 044996 529 ------AQELMIAYKSPEFLQLGR---ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL-ANGDNRT 598 (678)
Q Consensus 529 ------~~~~~~~y~aPE~~~~~~---~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~ 598 (678)
...||..|||||++.+.. ...+.||||+|||++||+||+.||...+. +|.-..- .-|..
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy~V~~gh~-- 1459 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMYHVAAGHK-- 1459 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHhHHhccCC--
Confidence 234788999999997643 46789999999999999999999984432 2321111 11111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
|.+ ++.-...-.+++-.|+..||++|.++.|+++
T Consensus 1460 ----Pq~-----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 ----PQI-----PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ----CCC-----chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 111 2222333456666999999999988775543
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.98 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=182.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh--hhHHHHHHHHHHHhccCCCCccceeEEEEeCC--------ceEE
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN--VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE--------EKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------~~~l 442 (678)
.+.||+|+||.||+|... +++.+++|++..... .....+.+|++++++++|+||+++++++.... ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 457999999999999864 678899998864322 22346788999999999999999999875433 4699
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
||||+.. +|...+.... ..+++.++..++.|+++||+|||.. +|+|+||||+||++++++.+||+|||+++
T Consensus 93 v~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 93 VTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred EEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 9999964 7777776432 2589999999999999999999965 79999999999999999999999999987
Q ss_pred ccCcccc---------------ccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHH
Q 044996 523 VMNQESA---------------QELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASW 586 (678)
Q Consensus 523 ~~~~~~~---------------~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~ 586 (678)
....... ..++..|+|||++.+. .++.++|||||||++|||++|+.||... +....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~--------~~~~~ 235 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK--------SDIDQ 235 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC--------CHHHH
Confidence 5532211 1234669999987654 5799999999999999999999998621 11111
Q ss_pred HHHHHhcCC-------------------ccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 587 VNSVLANGD-------------------NRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 587 ~~~~~~~~~-------------------~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......... .......+.+... . ......+.+++.+|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-F-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-c-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111000 0000001111000 0 011245778899999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=293.35 Aligned_cols=261 Identities=18% Similarity=0.257 Sum_probs=191.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC-----CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-----EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~E 445 (678)
.+.||+|+||+||+|.. .++..|+||.++.. .......+.+|+.+++.++|+||+++++++... ...++|||
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 45799999999999975 46889999998753 233345677899999999999999999988644 34799999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 90 ~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 90 LMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred CCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 995 78988886532 589999999999999999999976 79999999999999999999999999987664
Q ss_pred cc----ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-------
Q 044996 526 QE----SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN------- 593 (678)
Q Consensus 526 ~~----~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~------- 593 (678)
.. ....++..|+|||++.. ..++.++|||||||++|||++|+.||..... .............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCChHHhh
Confidence 33 12235678999998764 4689999999999999999999999862110 0000000000000
Q ss_pred ----CCc------cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH--HHHhhccCC
Q 044996 594 ----GDN------RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK--IEEVKERDG 651 (678)
Q Consensus 594 ----~~~------~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L~~i~~~~~ 651 (678)
... .....++.+... .......+.+++.+||+.+|++|||+.|+++. ++.+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARL--FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHH--cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 000 000000000000 01123557888999999999999999999986 776655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=269.57 Aligned_cols=193 Identities=24% Similarity=0.371 Sum_probs=160.6
Q ss_pred ccccCccCceeEEEEEecC-----CceEEEEEecccChh--hHHHHHHHHHHHhccCCCCccceeEEEEe-CCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLST-----GAMMVVKRFKQMNNV--GREEFQEHMRRLGRLRHPNLLPLVAYYYR-KEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~E 445 (678)
...||+|.||.||||.-.+ ...+|+|+++..+.. -.....+|+.+++.++||||+.+..++.. +...+|++|
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd 108 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD 108 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence 4569999999999994322 236899999864321 12346789999999999999999999887 778999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC----CceEEeecCCc
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES----LEPVLADYGLI 521 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla 521 (678)
|.+. +|...++-++......++-.....|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|||++
T Consensus 109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9976 899998866544345688888999999999999999987 48999999999999877 99999999999
Q ss_pred cccCcc-------ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 522 PVMNQE-------SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 522 ~~~~~~-------~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
+.+... .....|+.|+|||.+.+. .||.+.||||.|||+.||+|-+.-|.
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 987653 233468999999998874 68999999999999999999887665
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.02 Aligned_cols=238 Identities=22% Similarity=0.274 Sum_probs=190.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... +++.+++|.+... .....+.+.+|++++.+++ |+||+++++++...+..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 456999999999999764 6889999988652 2334567889999999998 9999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+++|.+++.... .+++..+..|+.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 86 NGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999997643 599999999999999999999976 79999999999999999999999999987654322
Q ss_pred c------------------------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChH
Q 044996 529 A------------------------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLA 584 (678)
Q Consensus 529 ~------------------------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~ 584 (678)
. ..++..|+|||++....++.++||||||+++||+++|+.||.... -.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~ 228 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--------EY 228 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--------HH
Confidence 1 123567999999988889999999999999999999999987211 11
Q ss_pred HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCH----HHHHH
Q 044996 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDL----KEAVE 641 (678)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~----~ev~~ 641 (678)
.-.......... ........+.+++.+||+.+|.+||++ .++++
T Consensus 229 ~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKILKLEYS-------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHhcCCC-------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111111100 111123457788889999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=267.95 Aligned_cols=259 Identities=19% Similarity=0.298 Sum_probs=197.8
Q ss_pred hHHHHHHhccccCccCceeEEEEE-ecCCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEE
Q 044996 366 LHDLLRASAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 366 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv 443 (678)
++|+..-+.++||+|+|+.|-.+. +.+|..+|||++.+.....+.+..+|++++.+++ |+||+.++.+|+++...|||
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 566666678899999999999984 6789999999999887778889999999999995 99999999999999999999
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC---ceEEeecCC
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL---EPVLADYGL 520 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGl 520 (678)
||-|.+|+|..+++.+. .+++.+.-+++++||.||.|||.. +|.||||||+|||-.+-. -+|||||.+
T Consensus 155 fEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999998765 488999999999999999999976 899999999999986543 489999988
Q ss_pred ccccCcc-----------ccccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCC--CCCCC
Q 044996 521 IPVMNQE-----------SAQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGK--KADGD 582 (678)
Q Consensus 521 a~~~~~~-----------~~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~--~~~~~ 582 (678)
..-+... ....++..|||||+.. ...|+.++|.||+|||||-|++|-.||.....+. ...+.
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 6433211 1122445699999763 3468999999999999999999999998543221 11122
Q ss_pred hHHHHHH----HHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 583 LASWVNS----VLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 583 l~~~~~~----~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...-.+. .+++|. . ++-|+... .......+++..-+..|+.+|-++..+++
T Consensus 306 ~Cr~CQ~~LFesIQEGk-Y-eFPdkdWa------hIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGK-Y-EFPDKDWA------HISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccC-C-cCChhhhH------HhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 2222222 222221 1 33333321 12233444555666789999999988887
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=288.71 Aligned_cols=253 Identities=21% Similarity=0.254 Sum_probs=184.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeC--------------C
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--------------E 438 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------------~ 438 (678)
.+.||+|+||.||+|.. .++..|++|++........+.+.+|++++++++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 45799999999999976 46889999998766555667789999999999999999999876543 3
Q ss_pred ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec-CCCceEEee
Q 044996 439 EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLAD 517 (678)
Q Consensus 439 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~D 517 (678)
..++||||++ ++|.+++... .+++.....++.||+.||.|||+. +|+||||||+||+++ ++..+||+|
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred eEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEEECC
Confidence 5789999997 5898887532 488999999999999999999976 799999999999998 456789999
Q ss_pred cCCccccCccc-------cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHH
Q 044996 518 YGLIPVMNQES-------AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNS 589 (678)
Q Consensus 518 fGla~~~~~~~-------~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~ 589 (678)
||+++...... ...++..|+|||++.. ..++.++|||||||++|||++|+.||.... -..-...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--------~~~~~~~ 230 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH--------ELEQMQL 230 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 99987653221 1234667999997654 567899999999999999999999996211 0111111
Q ss_pred HHhcCCcc-----c---cccchhhh----cccC-----CHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHH
Q 044996 590 VLANGDNR-----T---EVFDKEMA----DERN-----SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEE 645 (678)
Q Consensus 590 ~~~~~~~~-----~---~~~d~~l~----~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~ 645 (678)
.+...... . ......+. .... .......+.+++.+|++.||.+|||+.|+++ .++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 11000000 0 00000000 0000 0012245678888999999999999999985 3543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=309.26 Aligned_cols=140 Identities=23% Similarity=0.278 Sum_probs=124.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +++.||||+++... ......+..|+.++..++|+||+++++++...+..||||||+.+
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999875 68899999987532 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
++|.++++... .+++..++.|+.||+.||+|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 89 ~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999997543 478899999999999999999975 79999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=283.40 Aligned_cols=266 Identities=19% Similarity=0.268 Sum_probs=191.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEe-CCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR-KEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|.. .++..+++|++... .....+.+.+|++++.+++||||+++++++.. ....++|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 46799999999999975 47889999987642 22345678899999999999999999999875 45789999999 5
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|..+++.. .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 94 ~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 163 (328)
T cd07856 94 TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT 163 (328)
T ss_pred cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCccccccccCCCcC
Confidence 6898888642 478888889999999999999965 79999999999999999999999999987654332
Q ss_pred cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCC-------CCCChHHHHHHHHhcCCccccc
Q 044996 529 AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKK-------ADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
...++..|+|||++.+ ..++.++|||||||++|||+||+.||........ ......+|........ .. ++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~ 241 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN-TL-RF 241 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh-hH-HH
Confidence 2234678999998865 5689999999999999999999999862110000 0000011111111110 00 00
Q ss_pred cchhhhcccCCH-----HHHHHHHHHHhhcCccccccCCCHHHHHHH--HHHhhccCCC
Q 044996 601 FDKEMADERNSE-----GEMVKLLKIGLACCEEEVEKRLDLKEAVEK--IEEVKERDGD 652 (678)
Q Consensus 601 ~d~~l~~~~~~~-----~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L~~i~~~~~~ 652 (678)
+........... .....+.+++.+|++.+|++||++.+++.. ++.......+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~ 300 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence 000000000000 113467888889999999999999999875 5554444333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=289.66 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=186.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc------eEEEE
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE------KLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~lv~ 444 (678)
.+.||+|+||.||+|+.. ++..+++|++... .....+.+.+|+.++++++|+||+++++++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 357999999999999875 5788999988642 22334667889999999999999999998766554 89999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+ +++|.+++... .+++..+..++.|++.||+|||.. +|+||||||+||++++++.+||+|||++...
T Consensus 100 e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 100 HLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 999 67999988642 589999999999999999999975 7999999999999999999999999998766
Q ss_pred Ccc-ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc-cc-
Q 044996 525 NQE-SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT-EV- 600 (678)
Q Consensus 525 ~~~-~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~- 600 (678)
... ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||... .....+........... +.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~--------~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS--------DHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHhcCCCCHHHH
Confidence 433 22345677999998865 36789999999999999999999998621 11122222111100000 00
Q ss_pred -----------cc-------hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 601 -----------FD-------KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 601 -----------~d-------~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
++ +.+... .......+.+++.+|++.+|++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEV--FSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHH--hccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 000000 0011345778888999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=284.40 Aligned_cols=253 Identities=20% Similarity=0.246 Sum_probs=182.1
Q ss_pred ccccCccCceeEEEEEec-C--CceEEEEEeccc--ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeC----CceEEE
Q 044996 374 AEILGSGCFGSSYKASLS-T--GAMMVVKRFKQM--NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRK----EEKLLV 443 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~----~~~~lv 443 (678)
.+.||+|+||.||+++.. . +..+|+|++... .....+.+.+|+++++++ +||||+++++++... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 457999999999999864 3 678999988642 222356788899999999 599999999876432 457889
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
+||+. ++|.+++.... .+++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 85 ~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 85 EELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred Eeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 99985 68999886532 589999999999999999999976 799999999999999999999999999876
Q ss_pred cCccc--------cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 524 MNQES--------AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 524 ~~~~~--------~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
+.... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...+...
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~ 229 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-----VDQLNQILQVLGTP 229 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-----HHHHHHHHHHhCCC
Confidence 54221 1235678999998765 4689999999999999999999999862110 00000000000000
Q ss_pred C--ccccccch-------hhhcc------cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 D--NRTEVFDK-------EMADE------RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 ~--~~~~~~d~-------~l~~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ...++.++ .+... .........+.+++.+|++.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 00000000 00000 000011345788899999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=286.26 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=184.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 444 (678)
.+.||+|+||.||+|.. .+++.||+|+++.. .....+.+.+|++++.+++|+||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 35799999999999975 56889999998753 223356788899999999999999999988643 3467888
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
|++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 887 78998887542 489999999999999999999976 7999999999999999999999999998765
Q ss_pred Cccc-cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcccccc
Q 044996 525 NQES-AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTEVF 601 (678)
Q Consensus 525 ~~~~-~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~ 601 (678)
.... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ........... +.....+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--------HIDQLKLILRLVGTPGAELL 242 (345)
T ss_pred cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCCCCHHHH
Confidence 4432 2345678999998865 467899999999999999999999985211 01111111100 00000000
Q ss_pred ----c-------hhhh---cccC---CHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 602 ----D-------KEMA---DERN---SEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 602 ----d-------~~l~---~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+ ..+. ...+ .......+.+++.+|++.||.+||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0000 0000 00112346788889999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-33 Score=308.10 Aligned_cols=240 Identities=21% Similarity=0.297 Sum_probs=174.1
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC---------------
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--------------- 437 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------------- 437 (678)
++||+||||.|||++.+ +|+.+|||++.-. +......+.+|+..+++|+|||||+++..+.+.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 57999999999999864 8999999999754 334456788999999999999999976433100
Q ss_pred --------------------------------------------------------------------------------
Q 044996 438 -------------------------------------------------------------------------------- 437 (678)
Q Consensus 438 -------------------------------------------------------------------------------- 437 (678)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ------------------------CceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCC
Q 044996 438 ------------------------EEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493 (678)
Q Consensus 438 ------------------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 493 (678)
-.+||-||||+.-.+++++++..... .-...++++++|+.||+|+|..
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYIH~~---- 716 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYIHDQ---- 716 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHHHhC----
Confidence 01367788888877777776553211 3455679999999999999976
Q ss_pred CCcccCCCCCCEEecCCCceEEeecCCccccC----------------------ccccccccceeeCccccccC---CCC
Q 044996 494 IAPHGHIKSSNVLLNESLEPVLADYGLIPVMN----------------------QESAQELMIAYKSPEFLQLG---RIT 548 (678)
Q Consensus 494 ~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~----------------------~~~~~~~~~~y~aPE~~~~~---~~t 548 (678)
+||||||||.||+||++..+||+|||+|+... ......||.-|+|||++.+. +|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 89999999999999999999999999997621 00122467779999999764 599
Q ss_pred CcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCcc
Q 044996 549 KKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEE 628 (678)
Q Consensus 549 ~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~ 628 (678)
.|+|+||+|||++||+. ||.. .++-+.-+ ..+.++... .- +. +.......-.+++.++++.
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~T-------sMERa~iL-~~LR~g~iP-~~--~~-----f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGT-------SMERASIL-TNLRKGSIP-EP--AD-----FFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCc-------hHHHHHHH-HhcccCCCC-CC--cc-----cccccchHHHHHHHHHhcC
Confidence 99999999999999995 4541 11111111 111121111 00 11 1122334456788899999
Q ss_pred ccccCCCHHHHHH
Q 044996 629 EVEKRLDLKEAVE 641 (678)
Q Consensus 629 ~P~~RPs~~ev~~ 641 (678)
||.+|||+.|+++
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=269.48 Aligned_cols=221 Identities=17% Similarity=0.185 Sum_probs=173.4
Q ss_pred cCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHHHHhhc
Q 044996 380 GCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHG 458 (678)
Q Consensus 380 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~ 458 (678)
|.||.||+++. .+++.+|+|+++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999976 467899999987542 234455556666799999999999999999999999999999999875
Q ss_pred cCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-cccccceee
Q 044996 459 HQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-AQELMIAYK 537 (678)
Q Consensus 459 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~ 537 (678)
.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+....... ....+..|+
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~ 149 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC 149 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCcccc
Confidence 42 489999999999999999999965 79999999999999999999999999876554432 223356799
Q ss_pred CccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHH
Q 044996 538 SPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVK 617 (678)
Q Consensus 538 aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 617 (678)
|||++....++.++||||+||++|||++|+.|+...... + ... ....+. ......
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~-----~~~------~~~~~~-----~~~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------I-----NTH------TTLNIP-----EWVSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------c-----ccc------cccCCc-----ccCCHH
Confidence 999998888999999999999999999999887521100 0 000 000010 011234
Q ss_pred HHHHHhhcCccccccCCCHHHH
Q 044996 618 LLKIGLACCEEEVEKRLDLKEA 639 (678)
Q Consensus 618 ~~~l~~~Cl~~~P~~RPs~~ev 639 (678)
+.+++.+|++.||++||++.+.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCcc
Confidence 6778889999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=247.75 Aligned_cols=193 Identities=24% Similarity=0.376 Sum_probs=161.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecc-cChhhHHHHHHHHHHHhc-cCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQ-MNNVGREEFQEHMRRLGR-LRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|++|.|-+-++ .+|...|+|++.. ...+..++..+|+.+..+ ...|.+|++||.+.+....++.||.|. -
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence 45699999999999876 5789999999985 345566778888887554 579999999999999999999999994 5
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccccc
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ 530 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 530 (678)
||+.+.+.--..+ ..+++...-+|+..|.+||.|||+++ .++|||+||+||||+.+|++|+||||++.++.+.-+.
T Consensus 130 Sldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~kL---~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHSKL---SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHHHh---hhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 8876654321111 25778888899999999999999985 6999999999999999999999999999888766443
Q ss_pred ---cccceeeCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 531 ---ELMIAYKSPEFLQL----GRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 531 ---~~~~~y~aPE~~~~----~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.+.-.|||||.+.. ..|+.|+||||+|+++.||.+++.||+
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 46677999998853 368999999999999999999999997
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=238.16 Aligned_cols=187 Identities=24% Similarity=0.357 Sum_probs=160.2
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
++||+|.||+||||+. ++++.||+|+++-. ++.......+|+.+++.++|.|||+++++...+....+|+|||. .+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HH
Confidence 5799999999999974 56889999998743 23334567899999999999999999999999999999999995 58
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|..+...... .++......++.|+++||.|+|++ ++.||||||.|.||+.+|+.|++|||+++.+.-.
T Consensus 87 lkkyfdslng----~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 87 LKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 8888876543 588888999999999999999976 7999999999999999999999999999876543
Q ss_pred ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHh-CCCCc
Q 044996 528 SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMT-GKFPA 570 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~t-g~~P~ 570 (678)
+....|..|++|.++.+. -|++..|+||.|||+.|+.. |+.-|
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 344568899999999875 47999999999999999998 55444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=262.35 Aligned_cols=235 Identities=26% Similarity=0.311 Sum_probs=189.7
Q ss_pred CceeEEEEEec-CCceEEEEEecccChhh-HHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHHHHhhc
Q 044996 381 CFGSSYKASLS-TGAMMVVKRFKQMNNVG-REEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHG 458 (678)
Q Consensus 381 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~ 458 (678)
+||.||+|... ++..+++|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 48899999998654444 68899999999999999999999999998999999999999999999875
Q ss_pred cCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---ccccccce
Q 044996 459 HQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---SAQELMIA 535 (678)
Q Consensus 459 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---~~~~~~~~ 535 (678)
.. .+++..+..++.+++.++.|||.. +++|+||+|+||++++++.++|+|||.+...... ....++..
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 43 288999999999999999999976 7999999999999999999999999998776543 23345678
Q ss_pred eeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHH
Q 044996 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEM 615 (678)
Q Consensus 536 y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 615 (678)
|++||.+....++.++||||||+++|||++|+.||... .+......... ..... . . .......
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-------~~~~~~~~~~~-~~~~~--~---~----~~~~~~~ 214 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-------DQLLELFKKIG-KPKPP--F---P----PPEWKIS 214 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHh-ccCCC--C---c----cccccCC
Confidence 99999998888999999999999999999999998621 12222222111 11110 0 0 0000023
Q ss_pred HHHHHHHhhcCccccccCCCHHHHHH
Q 044996 616 VKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 616 ~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..+.+++.+|+..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 46788899999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=277.60 Aligned_cols=240 Identities=23% Similarity=0.348 Sum_probs=187.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.++||+|.||+||-|.+ ++|+.||||.+.+.. ......+.+|+.+|++++||.||.+-..|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 57899999999999975 579999999998643 344578899999999999999999999999999999999999 56
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC---CceEEeecCCccccCcc
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES---LEPVLADYGLIPVMNQE 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~~ 527 (678)
++.+.+-.... ..|++....-++.||+.||.|||.. +|+|+||||+|||+... -++||||||+|+++...
T Consensus 648 DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSSEK---GRLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 77666654332 2588777788999999999999976 89999999999999753 47999999999999876
Q ss_pred c---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 S---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
. ...+|+.|.|||+++.+.|...-|+||.|||+|--++|.+||.. +.++.+-+ ++. .++-|.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE-------dEdIndQI----QNA----aFMyPp 785 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE-------DEDINDQI----QNA----AFMYPP 785 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC-------ccchhHHh----hcc----ccccCC
Confidence 4 34588999999999999999999999999999999999999972 22332222 111 111111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAV 640 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~ 640 (678)
- ...+.....++++..-++..-.+|-|.+..+
T Consensus 786 ~----PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 N----PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred C----chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1 1222333455666666777777887776654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=282.90 Aligned_cols=231 Identities=21% Similarity=0.263 Sum_probs=181.8
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
..+|.|+|+.|-++.. .+++..++|++... ..+-.+|+.++... +||||+++.++|.+..+.|+|||++.+|-+
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el 403 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL 403 (612)
T ss_pred cccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence 3499999999999865 56788899998764 23345677666655 799999999999999999999999999988
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe-cCCCceEEeecCCccccCcccc-c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL-NESLEPVLADYGLIPVMNQESA-Q 530 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl-~~~~~~kl~DfGla~~~~~~~~-~ 530 (678)
.+.+..... .. .++..|+.+|+.|+.|||.+ +||||||||+|||+ ++.++++|+|||.++....... .
T Consensus 404 l~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp 473 (612)
T KOG0603|consen 404 LRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTP 473 (612)
T ss_pred HHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCchhhccc
Confidence 887765432 23 67778999999999999976 89999999999999 5889999999999998876622 2
Q ss_pred cccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccC
Q 044996 531 ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERN 610 (678)
Q Consensus 531 ~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (678)
..|..|.|||++....||+++|+||||++||||++|+.||..-. . . .-+...+..+ .+
T Consensus 474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P----~--~--~ei~~~i~~~--------------~~ 531 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP----A--G--IEIHTRIQMP--------------KF 531 (612)
T ss_pred chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC----c--h--HHHHHhhcCC--------------cc
Confidence 45788999999999999999999999999999999999997211 1 1 0111111111 11
Q ss_pred CHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 611 SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+.......+++.+||+.||.+||+|.++..
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1222334556677999999999999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=257.01 Aligned_cols=244 Identities=18% Similarity=0.258 Sum_probs=185.7
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEe----CCceEEEEec
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYR----KEEKLLVHEF 446 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~~~lv~Ey 446 (678)
..++||-|-.|.|..+.. .+++.+|+|++... ....+|+++--.. .|||||.++++|.+ ...+++|||.
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 347899999999999865 57888999987642 3345677664443 69999999999865 3457899999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec---CCCceEEeecCCccc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN---ESLEPVLADYGLIPV 523 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~ 523 (678)
|++|.|...+..++. ..+++.+.-.|++||+.|+.|||.. +|.||||||+|+|.. .|..+||+|||+|+.
T Consensus 141 meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred ccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhheeeecCCCCcceEecccccccc
Confidence 999999999987643 3699999999999999999999955 899999999999996 456799999999987
Q ss_pred cCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 524 MNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 524 ~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
..... ....|+.|.|||++...+|+..+|+||+||++|-|+.|-.||.-. . +.-+..-++..+..+.. ++
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~-h----g~aispgMk~rI~~gqy--~F 286 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN-H----GLAISPGMKRRIRTGQY--EF 286 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc-C----CccCChhHHhHhhccCc--cC
Confidence 66432 233578899999999999999999999999999999999998611 1 11222222222222211 11
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
-+++ .........+++...+..+|.+|.|+.|++.
T Consensus 287 P~pE------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 287 PEPE------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CChh------HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1121 1123445566777888999999999999986
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=258.72 Aligned_cols=189 Identities=22% Similarity=0.319 Sum_probs=164.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHH---HHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGRE---EFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|.||+|.+++- .+++.+|+|++++.--..++ .-..|-++|+..+||.+..+.-.|+..+.+|+||||+.+
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 46799999999999974 57899999999864333333 345688999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc---
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ--- 526 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~--- 526 (678)
|.|.-+|.+.+ .+++....-+-.+|..||.|||+. +||.||||.+|.|+|+||++||+|||+++.--.
T Consensus 253 GeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 253 GELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred ceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999887654 467777777889999999999965 899999999999999999999999999975322
Q ss_pred -cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 527 -ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 527 -~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.....+|+.|.|||++....|..++|.|.+|||||||+.|+.||.
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 233457889999999999999999999999999999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=281.09 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=171.5
Q ss_pred hccccCccCceeEEEEEe-----------------cCCceEEEEEecccChhhHHHH--------------HHHHHHHhc
Q 044996 373 SAEILGSGCFGSSYKASL-----------------STGAMMVVKRFKQMNNVGREEF--------------QEHMRRLGR 421 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e~~~l~~ 421 (678)
..++||+|+||+||+|.. ..++.||||+++.......++| ..|+..+.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 357899999999999953 2346799999875443333333 346667777
Q ss_pred cCCCCc-----cceeEEEEe--------CCceEEEEeccCCCCHHHHhhccCCC-------------------CCCCCCh
Q 044996 422 LRHPNL-----LPLVAYYYR--------KEEKLLVHEFVPKRSLAVNLHGHQAL-------------------GQPSLDW 469 (678)
Q Consensus 422 l~H~ni-----v~l~~~~~~--------~~~~~lv~Ey~~~gsL~~~l~~~~~~-------------------~~~~l~~ 469 (678)
++|.++ ++++++|.. .+..+|||||+++|+|.++|+..... ....++|
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 776654 677888753 35689999999999999999753210 1123678
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-----ccccceeeCcccccc
Q 044996 470 PSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA-----QELMIAYKSPEFLQL 544 (678)
Q Consensus 470 ~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~-----~~~~~~y~aPE~~~~ 544 (678)
..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+|||+++....... ...+..|+|||.+..
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 88999999999999999976 799999999999999999999999999876543211 123578999998754
Q ss_pred CC--------------------C--CCcchHHHHHHHHHHHHhCCC-CccccccC----CCCCCChHHHHHHHHhcCCcc
Q 044996 545 GR--------------------I--TKKTDVWSLGVLILEIMTGKF-PANFLQQG----KKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 545 ~~--------------------~--t~ksDvwS~Gvvl~el~tg~~-P~~~~~~~----~~~~~~l~~~~~~~~~~~~~~ 597 (678)
.. + ..+.||||+||++|||++|.. |+.....- .....++..|... ...
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~~~--- 459 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--KGQ--- 459 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--ccc---
Confidence 32 1 235799999999999999986 66421100 0011222233210 000
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCcccc---ccCCCHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEV---EKRLDLKEAVE 641 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P---~~RPs~~ev~~ 641 (678)
..+-...+ .......+++.+++..+| .+|+|+.|+++
T Consensus 460 --~~~~~~~d-----~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 --KYDFSLLD-----RNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred --CCCccccc-----ccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 01111100 112335556667777655 78999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=287.07 Aligned_cols=254 Identities=19% Similarity=0.208 Sum_probs=160.9
Q ss_pred ccccCccCceeEEEEEecC-----CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEE------EEeCCceEE
Q 044996 374 AEILGSGCFGSSYKASLST-----GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY------YYRKEEKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------~~~~~~~~l 442 (678)
.+.||+|+||.||+|.+.. +..||+|++..... .+.+..| .+.+..+.+++.++.. +......++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 5679999999999998754 68899998764321 1111111 1222223333332221 234567999
Q ss_pred EEeccCCCCHHHHhhccCCC---------------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe
Q 044996 443 VHEFVPKRSLAVNLHGHQAL---------------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL 507 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl 507 (678)
||||+.+++|.++++..... .........+..|+.||+.||+|||+. +|+||||||+|||+
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDLKP~NILl 288 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDVKPQNIIF 288 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcCCHHHEEE
Confidence 99999999999998754210 000112334567999999999999976 79999999999999
Q ss_pred cC-CCceEEeecCCccccCcc-----ccccccceeeCccccccC----------------------CCCCcchHHHHHHH
Q 044996 508 NE-SLEPVLADYGLIPVMNQE-----SAQELMIAYKSPEFLQLG----------------------RITKKTDVWSLGVL 559 (678)
Q Consensus 508 ~~-~~~~kl~DfGla~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~t~ksDvwS~Gvv 559 (678)
++ ++.+||+|||+++.+... ....++..|||||.+... .++.++|||||||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 86 589999999999865432 123456789999965322 23456799999999
Q ss_pred HHHHHhCCCCcccccc-----CCCCCCChHHHHHHHHhcCCccccccchhhhcc-cCCHHHHHHHHHHHhhcCccccccC
Q 044996 560 ILEIMTGKFPANFLQQ-----GKKADGDLASWVNSVLANGDNRTEVFDKEMADE-RNSEGEMVKLLKIGLACCEEEVEKR 633 (678)
Q Consensus 560 l~el~tg~~P~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~~l~~~Cl~~~P~~R 633 (678)
||||+++..|++.... -...+.++..|........ .+.+... ...........+++.+|++.||++|
T Consensus 369 L~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 369 FLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRA-------SPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcccc-------chhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 9999998877642100 0001122333322211110 0000000 0000011234578889999999999
Q ss_pred CCHHHHHHH
Q 044996 634 LDLKEAVEK 642 (678)
Q Consensus 634 Ps~~ev~~~ 642 (678)
||++|+++.
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999873
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=279.18 Aligned_cols=242 Identities=22% Similarity=0.352 Sum_probs=193.3
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEe-----CCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYR-----KEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-----~~~~~lv~Ey 446 (678)
.+.||.|.+|.||+++. ++++.+|+|++... ....++.+.|.++++.. +|||++.++|+|.. ++++||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 46799999999999974 56778888877653 34456778888888877 79999999999974 4689999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
|.+||..++++... + ..+.|..+..|++++++||.+||.+ .++|||||-.|||+++++.+|++|||++..+..
T Consensus 103 C~gGSVTDLVKn~~--g-~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTK--G-NRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred cCCccHHHHHhhhc--c-cchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999998765 2 2699999999999999999999987 699999999999999999999999999877654
Q ss_pred c----ccccccceeeCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 527 E----SAQELMIAYKSPEFLQLG-----RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 527 ~----~~~~~~~~y~aPE~~~~~-----~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
. ....+|+.|||||++... -|+..+|+||+|++..||.-|..|+-++-+ ++..+...++.
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------mraLF~IpRNP 244 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALFLIPRNP 244 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------hhhhccCCCCC
Confidence 4 344577889999999643 467899999999999999999999863321 12222222211
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
-|.+.. +..-.+++.+++..|+..|..+||++.++++
T Consensus 245 ----PPkLkr---p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 245 ----PPKLKR---PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----Cccccc---hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 122221 2344667889999999999999999988764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=289.51 Aligned_cols=204 Identities=24% Similarity=0.285 Sum_probs=173.2
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
+.++||+|+||.|..++++ +++.+|+|++.+. ......-|..|-.+|..-+.+-||.+.-.|++..++|+|||||+
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 4578999999999999874 6889999999873 34455679999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
||+|..+|.... .++.....-++..|..||.-||+ +|+|||||||+|||||.+|++||+|||.+-.+..+
T Consensus 159 GGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~----mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 159 GGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHS----MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred CchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHh----ccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 999999998664 37777778889999999999995 49999999999999999999999999988665533
Q ss_pred ----ccccccceeeCccccc----c-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 528 ----SAQELMIAYKSPEFLQ----L-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 528 ----~~~~~~~~y~aPE~~~----~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
....||+-|++||++. + +.|+..+|.||+||++|||+.|..||. ...++.--..++..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY--------adslveTY~KIm~h 296 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY--------ADSLVETYGKIMNH 296 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch--------HHHHHHHHHHHhch
Confidence 3446889999999985 2 679999999999999999999999997 24555544444443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=262.02 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=184.3
Q ss_pred ccccCccCceeEEEEE-ecCCceEEEEEecccC---hh----hHHHHHHHHHHHhccCCCCccceeEEEE-eCCceEEEE
Q 044996 374 AEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMN---NV----GREEFQEHMRRLGRLRHPNLLPLVAYYY-RKEEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~ 444 (678)
..+||+|+|+.||||. +...+.||||+-.... .. ..+...+|.++-+.|+||.||++|+|+. +.+..|-|+
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 3579999999999996 4566788888754321 11 1234567889999999999999999997 456789999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec---CCCceEEeecCCc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN---ESLEPVLADYGLI 521 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla 521 (678)
|||++.+|+-||+.++ .+++.+...|+.||..||.||.+. ...|||-||||.||||- ..|.+||.|||++
T Consensus 548 EYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 9999999999998775 488999999999999999999877 34699999999999995 4588999999999
Q ss_pred cccCcccc-----------ccccceeeCccccccC----CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHH
Q 044996 522 PVMNQESA-----------QELMIAYKSPEFLQLG----RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASW 586 (678)
Q Consensus 522 ~~~~~~~~-----------~~~~~~y~aPE~~~~~----~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~ 586 (678)
+++..+.. ..+|..|++||.+.-+ +++.|+||||.|||+|..+.|+.||.....
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs----------- 689 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS----------- 689 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-----------
Confidence 99876532 2367889999987533 578999999999999999999999963211
Q ss_pred HHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 587 VNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
-..++++...+ ....-.+...+. ...+...++.+|+++.-++|....++..
T Consensus 690 QQdILqeNTIl-kAtEVqFP~KPv---VsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 690 QQDILQENTIL-KATEVQFPPKPV---VSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHHHhhhchh-cceeccCCCCCc---cCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11233332222 111111211111 1223455666999999999987766543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-31 Score=248.58 Aligned_cols=188 Identities=25% Similarity=0.381 Sum_probs=154.7
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecc--cChhhHHHHHHHHHHHhccCCCCccceeEEEEeC--------CceEEE
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQ--MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--------EEKLLV 443 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~lv 443 (678)
.+||+|.||.||+|+.+ +|+.|++|+.-- ........-.+|+++|..++|+|++.++..|... ...|||
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 56999999999999765 466677765432 1222334567899999999999999999888542 247999
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
|++|+. +|.-+|..... .++..++.+++.++..||.|+|+. .|+|||+|+.|+||+.++.+||+|||+++.
T Consensus 103 f~~ceh-DLaGlLsn~~v----r~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKV----RFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred HHHhhh-hHHHHhcCccc----cccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 999976 88888865432 588899999999999999999987 699999999999999999999999999977
Q ss_pred cCcccc--------ccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 524 MNQESA--------QELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 524 ~~~~~~--------~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
+..... ...|..|++||.+.+ ..|+++.|||..|||+.||.||..-+.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 653321 234788999998876 578999999999999999999987765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=258.10 Aligned_cols=189 Identities=22% Similarity=0.317 Sum_probs=158.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHH---HHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREE---FQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~---~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
..+||+|+||.|.+|.. .+.+.+|||++++.--...++ -..|-++|.-- +-|.++.+..+|+..+.+|+||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 45799999999999964 457789999998643222222 23455555554 56889999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|..+++.-. .+.++...-+|.+||-||-|||+. +|+.||||..|||||.+|.+||+|||+++.---.
T Consensus 434 GGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 434 GGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred CchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 999999998654 366777888999999999999965 8999999999999999999999999998753221
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
....+|+.|+|||++...+|+..+|.|||||+||||+.|+.||+
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence 23346788999999999999999999999999999999999998
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=265.47 Aligned_cols=191 Identities=18% Similarity=0.270 Sum_probs=161.3
Q ss_pred cccCccCceeEEEEE-ecCCceEEEEEecccChh---hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNV---GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
+.||-|+||.|.+++ ..+...+|+|.+++.+.. .....+.|-.||...+.+-||+||-.|++++.+|+||||+++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 569999999999996 455678899988765432 3345778999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc--------
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP-------- 522 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~-------- 522 (678)
++..+|.+.+ .+.+....-++.++..|+++.|.. |+|||||||+|||||.+|.+||.||||+.
T Consensus 715 DmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 715 DMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999998654 366666677888999999999965 89999999999999999999999999974
Q ss_pred -ccCccc-------------------------------------cccccceeeCccccccCCCCCcchHHHHHHHHHHHH
Q 044996 523 -VMNQES-------------------------------------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIM 564 (678)
Q Consensus 523 -~~~~~~-------------------------------------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~ 564 (678)
++.... .-.||..|+|||++....|+..+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 222110 012456799999999999999999999999999999
Q ss_pred hCCCCccccc
Q 044996 565 TGKFPANFLQ 574 (678)
Q Consensus 565 tg~~P~~~~~ 574 (678)
.|+.||-...
T Consensus 866 ~g~~pf~~~t 875 (1034)
T KOG0608|consen 866 VGQPPFLADT 875 (1034)
T ss_pred hCCCCccCCC
Confidence 9999997443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=256.22 Aligned_cols=254 Identities=19% Similarity=0.256 Sum_probs=189.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCC--C----CccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRH--P----NLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~----niv~l~~~~~~~~~~~lv~Ey 446 (678)
...+|+|.||.|-.+.. ..+..||+|+++.. ...++...-|+++++++.+ | -+|.+.++|.-.++.|+|+|.
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfel 172 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFEL 172 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEec
Confidence 34699999999999964 34789999998865 3445667789999999942 2 267888888889999999998
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec------------------
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN------------------ 508 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~------------------ 508 (678)
| +-|+.++|..+.. .+++..++..|+.|++++++|||+. .++|-||||+|||+-
T Consensus 173 l-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 173 L-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred c-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEEEeccCCccceec
Confidence 8 6699999987644 3688889999999999999999966 899999999999983
Q ss_pred --CCCceEEeecCCccccCccccc-cccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHH
Q 044996 509 --ESLEPVLADYGLIPVMNQESAQ-ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLAS 585 (678)
Q Consensus 509 --~~~~~kl~DfGla~~~~~~~~~-~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~ 585 (678)
++..+||+|||-|+...+.... ..|..|+|||++.+-.++..+||||+||||.|+.||..-|..-+ ...++ .
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe----n~EHL-a 319 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE----NLEHL-A 319 (415)
T ss_pred cCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC----cHHHH-H
Confidence 1345899999999876655433 34678999999999999999999999999999999998876211 11122 2
Q ss_pred HHHHHHh-----------------cCCc----------cccccchhh---hcccCCHHHHHHHHHHHhhcCccccccCCC
Q 044996 586 WVNSVLA-----------------NGDN----------RTEVFDKEM---ADERNSEGEMVKLLKIGLACCEEEVEKRLD 635 (678)
Q Consensus 586 ~~~~~~~-----------------~~~~----------~~~~~d~~l---~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs 635 (678)
.++.++. .++. ...+.++.. ........+..++++++.+++..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 2222221 1100 000111100 000122346777999999999999999999
Q ss_pred HHHHHH
Q 044996 636 LKEAVE 641 (678)
Q Consensus 636 ~~ev~~ 641 (678)
++|++.
T Consensus 400 l~EAL~ 405 (415)
T KOG0671|consen 400 LREALS 405 (415)
T ss_pred HHHHhc
Confidence 999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=261.41 Aligned_cols=233 Identities=20% Similarity=0.230 Sum_probs=185.6
Q ss_pred cccCccCceeEEEEEecCCc-eEEEEEecc---cChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASLSTGA-MMVVKRFKQ---MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
..||-|+||.|-++...... .+|+|.+++ .+....+....|-++|..++.|.||++|..|.+....|+.||-|-+|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 45999999999999875544 367776664 34455667888999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccccc
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ 530 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 530 (678)
.|...|+.++ .++..+..-++..+..|++|||.. +||.|||||+|.|||.+|-+||.|||+|+.+......
T Consensus 506 ElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 506 ELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 9999998775 367777778999999999999976 8999999999999999999999999999988765443
Q ss_pred ---cccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 531 ---ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 531 ---~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
.||+.|.|||++.....+.++|.||+||++|||+||+.||+.. +...--..++..-+ ++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~--------dpmktYn~ILkGid----~i------ 638 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV--------DPMKTYNLILKGID----KI------ 638 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC--------chHHHHHHHHhhhh----hh------
Confidence 4788999999999999999999999999999999999999722 22111122221111 11
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCC
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLD 635 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs 635 (678)
.++........+++.+-+..+|.+|--
T Consensus 639 -~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 112223344556666777889999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=271.13 Aligned_cols=238 Identities=20% Similarity=0.253 Sum_probs=177.3
Q ss_pred ccccCccCce-eEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFG-SSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+++|.|+-| .||+|.. .++.||||++-. ...+..++|+..|+.- .|||||++++.-.+....||..|.| ..+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 4568999877 4789987 577999998754 2334567899999888 5999999999988899999999999 569
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---C--CceEEeecCCccccCc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---S--LEPVLADYGLIPVMNQ 526 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~--~~~kl~DfGla~~~~~ 526 (678)
|.+++..... ......-.....+..|++.||++||. .+||||||||.||||+. + .+++|+|||+++.+..
T Consensus 589 L~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLHs----l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 589 LQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLHS----LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred HHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHHh----cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9999987411 10011113446789999999999996 38999999999999975 2 5799999999987754
Q ss_pred c-------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 527 E-------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 527 ~-------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
+ ....||-+|+|||++....-+.++||||+|||+|..++ |+.||... +..-+ .++.......
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~---------~~R~~-NIl~~~~~L~ 733 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS---------LERQA-NILTGNYTLV 733 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch---------HHhhh-hhhcCcccee
Confidence 3 23357889999999998888899999999999999999 59999621 11100 1111111110
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+ ....++ ...+++.+|++.+|..||++.+|+.
T Consensus 734 ~L--------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HL--------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ee--------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11 011111 4567777999999999999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=232.78 Aligned_cols=206 Identities=30% Similarity=0.434 Sum_probs=179.4
Q ss_pred cCccCceeEEEEEecC-CceEEEEEecccChh-hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHHH
Q 044996 377 LGSGCFGSSYKASLST-GAMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAV 454 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~ 454 (678)
||+|.+|.||++.... +..+++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 889999998864332 35779999999999999999999999999899999999999999999
Q ss_pred HhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCccccCcc----cc
Q 044996 455 NLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIPVMNQE----SA 529 (678)
Q Consensus 455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~----~~ 529 (678)
++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+...... ..
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 987643 2589999999999999999999976 7999999999999999 899999999998766543 22
Q ss_pred ccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 530 QELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
......|++||.+... .++.+.|+|++|++++||
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 3345779999999876 788999999999999998
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 236778889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=238.86 Aligned_cols=239 Identities=20% Similarity=0.260 Sum_probs=188.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
..+||+|+|++|..+++. +.+.+|+|++++. ...+.+-.+.|-.+..+. +||.+|.+..+|+.+..+++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 467999999999999864 5778899988753 334445567777777776 79999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.-++++.+ .|++....-+..+|..||.|||+. +|+.||||..|||||..+.+|+.|||+++.--..
T Consensus 335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 999988887654 588888888999999999999966 8999999999999999999999999998753222
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
+...+|+.|+|||.+++..|...+|.|++||+|+||+.|+.||+-.- ....+.+-.+++-+++.+.... -|+
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg-m~n~d~ntedylfqvilekqir----ipr 480 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG-MDNPDMNTEDYLFQVILEKQIR----IPR 480 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec-CCCcccchhHHHHHHHhhhccc----ccc
Confidence 33457888999999999999999999999999999999999998432 2223456666666655443221 011
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCC
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRL 634 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP 634 (678)
.-..+...+...-++.||.+|-
T Consensus 481 --------slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 --------SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --------eeehhhHHHHHHhhcCCcHHhc
Confidence 1122334444567788998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=240.24 Aligned_cols=268 Identities=19% Similarity=0.254 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccC-----C---CCccceeEEEEe----CCce
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-----H---PNLLPLVAYYYR----KEEK 440 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~~~~~~----~~~~ 440 (678)
.++||-|.|++||++... ..+.||+|+.+.. ....+....||++|++++ | ..||+|+++|.. +.++
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HV 161 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHV 161 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEE
Confidence 468999999999999654 5678889988764 455667788999999984 3 469999999975 4579
Q ss_pred EEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC----------
Q 044996 441 LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES---------- 510 (678)
Q Consensus 441 ~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---------- 510 (678)
|||+||+ +-+|..+|...... -+....+.+|++||+.||.|||++| +|||-||||+|||+..+
T Consensus 162 CMVfEvL-GdnLLklI~~s~Yr---Glpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 162 CMVFEVL-GDNLLKLIKYSNYR---GLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred EEEehhh-hhHHHHHHHHhCCC---CCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeeeeccccchhhhhhh
Confidence 9999999 66888888876544 3788899999999999999999998 79999999999997111
Q ss_pred --------------------------------------------------------------------------------
Q 044996 511 -------------------------------------------------------------------------------- 510 (678)
Q Consensus 511 -------------------------------------------------------------------------------- 510 (678)
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence
Q ss_pred ----------------------------------------------------------------------------CceE
Q 044996 511 ----------------------------------------------------------------------------LEPV 514 (678)
Q Consensus 511 ----------------------------------------------------------------------------~~~k 514 (678)
.++|
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 0023
Q ss_pred EeecCCccccCccccc-cccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCC--CCCCChHHHHH---
Q 044996 515 LADYGLIPVMNQESAQ-ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGK--KADGDLASWVN--- 588 (678)
Q Consensus 515 l~DfGla~~~~~~~~~-~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~--~~~~~l~~~~~--- 588 (678)
|+|||-|+.+...... .-|..|+|||++.+..|++.+|||||+|+++||+||..-|+.-.... ..+.+++..++
T Consensus 395 IaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG 474 (590)
T KOG1290|consen 395 IADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLG 474 (590)
T ss_pred EeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHh
Confidence 3333333322211111 12456999999999999999999999999999999999988433221 12234443331
Q ss_pred ----HHHhcCCccccccch------------------hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHH
Q 044996 589 ----SVLANGDNRTEVFDK------------------EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIE 644 (678)
Q Consensus 589 ----~~~~~~~~~~~~~d~------------------~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~ 644 (678)
.+...|+...++|+. .......++++..++.++..-|++.+|++|||+.++++ .|.
T Consensus 475 ~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn 554 (590)
T KOG1290|consen 475 KIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLN 554 (590)
T ss_pred hccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCcccc
Confidence 122222221222222 11222356788999999999999999999999999996 566
Q ss_pred Hhhcc
Q 044996 645 EVKER 649 (678)
Q Consensus 645 ~i~~~ 649 (678)
.+...
T Consensus 555 ~~~~~ 559 (590)
T KOG1290|consen 555 PVAGP 559 (590)
T ss_pred CCCCC
Confidence 55543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=236.26 Aligned_cols=247 Identities=18% Similarity=0.278 Sum_probs=186.1
Q ss_pred cccCccCceeEEEEE-ecCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEEEEe
Q 044996 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLLVHE 445 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~E 445 (678)
..+|.|.- .|..+. .-.++.|++|++... .....++..+|..++..+.|+||++++.++.-. .+.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 34777776 455553 235788999987642 234456778999999999999999999998633 35799999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|| .++|...++. .++-.+...|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+.-.
T Consensus 102 ~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 102 LM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred hh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchhhcccC
Confidence 99 5689988873 377788899999999999999966 89999999999999999999999999997655
Q ss_pred cc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 526 QE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 526 ~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
.. .....+..|.|||++.+..+.+.+||||.||++.||++|+.-|. +...+.+|.+..-.-+......++
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~-------g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP-------GKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec-------CchHHHHHHHHHHHhcCCCHHHHH
Confidence 44 23345677999999998889999999999999999999998875 245666775443333221111111
Q ss_pred h----------------------hhhccc------CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 603 K----------------------EMADER------NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 603 ~----------------------~l~~~~------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+ .+.+.. ...-.......++.+||..+|++|.+++++++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 011100 01122445667888999999999999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=236.39 Aligned_cols=187 Identities=24% Similarity=0.397 Sum_probs=157.2
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC-----CceEEEEec
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-----EEKLLVHEF 446 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~Ey 446 (678)
+-||-|+||.||-+.. ++|+.|+.|++... +-...+.+-+|+++|.-++|.|++..++..+-. .+.|+|+|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 4599999999999875 57899999988642 234457788999999999999999998877543 357889999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
| ..+|...+..-+ .|+-..+.-++.||++||.|||+. +|.||||||-|.|++.|...||||||+++..+.
T Consensus 139 m-QSDLHKIIVSPQ-----~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 139 M-QSDLHKIIVSPQ-----ALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred H-HhhhhheeccCC-----CCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEecccccccccch
Confidence 8 458887776433 577777888999999999999976 899999999999999999999999999998776
Q ss_pred ccccc-----ccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 527 ESAQE-----LMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 527 ~~~~~-----~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
+.... .|-.|+|||.+.+ +.|+.+.||||.|||+.||+.++.-|.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 54433 4567999999987 468999999999999999999998886
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=230.75 Aligned_cols=190 Identities=29% Similarity=0.427 Sum_probs=166.5
Q ss_pred ccccCccCceeEEEEEecC-CceEEEEEecccChh-hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLST-GAMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|++|.||++.... +..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 3569999999999998765 788999999865444 57789999999999999999999999998899999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... .+++..+..++.+++.++.|||.. +++|+||+++||+++.++.++|+|||.+......
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999976432 178999999999999999999976 7999999999999999999999999998776543
Q ss_pred -ccccccceeeCcccc-ccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 528 -SAQELMIAYKSPEFL-QLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~-~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
....+...|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 223345679999998 66678889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=222.74 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=184.1
Q ss_pred ccccCccCceeEEEEE-ecCCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCC--ceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKE--EKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~lv~Ey~~~ 449 (678)
.+++|+|.|+.||.|. ..+.+.++||.++. ...+.+.+|+.+|..|+ ||||++++++..+.. ...||+||+.+
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 4579999999999996 46778899999875 45678899999999997 999999999988754 46799999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCccccCccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~ 528 (678)
-+...+.. .|+-..+..++.++++||.|+|+ +||+|||+||.|++||. .-..+|+|+|+|.++.+..
T Consensus 120 ~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS----~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 120 TDFKQLYP--------TLTDYDIRYYIYELLKALDYCHS----MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred ccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHh----cCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 88876543 47777888999999999999995 49999999999999995 5679999999999887664
Q ss_pred cc---cccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC-----Ccccc
Q 044996 529 AQ---ELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG-----DNRTE 599 (678)
Q Consensus 529 ~~---~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~ 599 (678)
.. ..+..|.-||.+.. ..|+..-|+|||||+|.+|+..+.||... ......++..++-.-.+. ....-
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG---~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG---HDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC---CCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 33 23456889998854 56789999999999999999999998632 111223332221110000 00000
Q ss_pred ccchhhhc---c-------c--CCH---HHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 600 VFDKEMAD---E-------R--NSE---GEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 600 ~~d~~l~~---~-------~--~~~---~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+|+++.+ . . .++ -...+.+++.-+-+..|-.+|+|++|++.
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 12333211 0 0 000 01244566666888999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=224.81 Aligned_cols=258 Identities=19% Similarity=0.326 Sum_probs=180.3
Q ss_pred cccchHHHHHHhccccCccCceeEEEEEecC-CceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEE-EEeCC
Q 044996 362 ERFDLHDLLRASAEILGSGCFGSSYKASLST-GAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAY-YYRKE 438 (678)
Q Consensus 362 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~-~~~~~ 438 (678)
+.+++.|.. .+.+.+|+|.||.+-+++++. .+.+++|.+... ....++|.+|...--.| .|.||+.-|++ |+..+
T Consensus 18 ~kv~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 18 KKVDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cccchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 344454432 356779999999999998764 566777776543 45678999999876666 58999988765 56677
Q ss_pred ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec--CCCceEEe
Q 044996 439 EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN--ESLEPVLA 516 (678)
Q Consensus 439 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~~~~kl~ 516 (678)
.+.+++||++.|+|.+.+... -+.+....+++.|++.|+.|+|+. ++||||||.+||||- +..++|||
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKlc 165 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKLC 165 (378)
T ss_pred eEEEeeccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEee
Confidence 888999999999999887543 366777889999999999999966 899999999999993 44589999
Q ss_pred ecCCccccCcccc-ccccceeeCcccccc---C--CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHH
Q 044996 517 DYGLIPVMNQESA-QELMIAYKSPEFLQL---G--RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSV 590 (678)
Q Consensus 517 DfGla~~~~~~~~-~~~~~~y~aPE~~~~---~--~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~ 590 (678)
|||+.+.....-. ...+..|.+||.... + ...+.+|||.|||+++.++||+.||.... ..+...+.|..-.
T Consensus 166 DFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~---~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 166 DFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS---IMDKPYWEWEQWL 242 (378)
T ss_pred ecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh---ccCchHHHHHHHh
Confidence 9999765443211 123456899997643 2 34778999999999999999999997221 1123334443322
Q ss_pred HhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 591 LANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 591 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
-.......+.+. .++ .+.+++-.+-+..++++|-...++.++.+
T Consensus 243 ~rk~~~~P~~F~------~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 243 KRKNPALPKKFN------PFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cccCccCchhhc------ccC----HHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 211111111111 122 23444555788999999966666555443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-28 Score=254.08 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=197.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.+|+|.||.|||++. .+++..|+|.++-.......-.++|+-+++.++|||||.++|.|...+..++.||||.+|+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 35799999999999975 57889999999876666667788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc----cc
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ----ES 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~----~~ 528 (678)
.+.-+... ++++.++..++++..+||+|||.. +-+|||||-.|||+++.+.+|++|||.+..+.. ..
T Consensus 100 Qdiy~~Tg-----plselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 100 QDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred cceeeecc-----cchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 99877553 689999999999999999999955 678999999999999999999999999876543 34
Q ss_pred cccccceeeCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch-h
Q 044996 529 AQELMIAYKSPEFL---QLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK-E 604 (678)
Q Consensus 529 ~~~~~~~y~aPE~~---~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~-~ 604 (678)
...||..|||||+. ..+.|..++|||+.|+...|+---+.|... +...-..++-.. ..+++ .
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd----------lhpmr~l~LmTk----S~~qpp~ 236 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD----------LHPMRALFLMTK----SGFQPPT 236 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc----------cchHHHHHHhhc----cCCCCCc
Confidence 55689999999976 346789999999999999999877777431 111111111111 11222 2
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHH---------------HHHHHHhhccCCC
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEA---------------VEKIEEVKERDGD 652 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev---------------~~~L~~i~~~~~~ 652 (678)
+++.... ...+.+++..|+-.+|++||++..+ +++|++.......
T Consensus 237 lkDk~kw---s~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~ 296 (829)
T KOG0576|consen 237 LKDKTKW---SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPV 296 (829)
T ss_pred ccCCccc---hHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCc
Confidence 2222112 2345666678899999999998765 4566677666633
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=245.77 Aligned_cols=190 Identities=23% Similarity=0.291 Sum_probs=161.2
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEecccCh--------hhHHHHHHHHHHHhccC---CCCccceeEEEEeCCce
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN--------VGREEFQEHMRRLGRLR---HPNLLPLVAYYYRKEEK 440 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~ 440 (678)
+.+.+|+|+||.|+.|.++ +...|+||.+.+..- ...-..-.||.+|..++ |+||++++++|++++.+
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 4567999999999999765 456788888764311 11112457999999997 99999999999999999
Q ss_pred EEEEecc-CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecC
Q 044996 441 LLVHEFV-PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519 (678)
Q Consensus 441 ~lv~Ey~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 519 (678)
||+||-- ++-+|.+++..+. .+++.+...|++||+.|+++||.. +|||||||-+||.+|.+|-+||+|||
T Consensus 645 yl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred EEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEeecc
Confidence 9999975 4568899997653 589999999999999999999966 89999999999999999999999999
Q ss_pred CccccCcc--ccccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCcc
Q 044996 520 LIPVMNQE--SAQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 520 la~~~~~~--~~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.+.+.... ....||+.|.|||++.+.+| ...-|||++||+||.++....||.
T Consensus 716 saa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98876654 34568999999999999988 567999999999999999999975
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=270.50 Aligned_cols=190 Identities=16% Similarity=0.085 Sum_probs=137.6
Q ss_pred ccCC-CCccceeEEE-------EeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCC
Q 044996 421 RLRH-PNLLPLVAYY-------YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492 (678)
Q Consensus 421 ~l~H-~niv~l~~~~-------~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 492 (678)
.++| .||++++++| ...+..++++||+ +++|.++|.... ..+++.+++.|+.||++||+|||+.
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~--- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQ--- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 4456 6888888887 2334567889988 669999997532 2589999999999999999999965
Q ss_pred CCCcccCCCCCCEEecC-------------------CCceEEeecCCccccCcc--------------------cccccc
Q 044996 493 LIAPHGHIKSSNVLLNE-------------------SLEPVLADYGLIPVMNQE--------------------SAQELM 533 (678)
Q Consensus 493 ~~ivHrdlk~~NILl~~-------------------~~~~kl~DfGla~~~~~~--------------------~~~~~~ 533 (678)
+|+||||||+||||+. ++.+|++|||+++..... ....+|
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 8999999999999954 456677777776542110 001246
Q ss_pred ceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHH
Q 044996 534 IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEG 613 (678)
Q Consensus 534 ~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 613 (678)
..|||||++.+..++.++|||||||+||||++|..|+... ...+..... ..+.+.. ..
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~----------~~~~~~~~~------~~~~~~~------~~ 236 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK----------SRTMSSLRH------RVLPPQI------LL 236 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH----------HHHHHHHHH------hhcChhh------hh
Confidence 6799999999999999999999999999999998886511 011111110 0111111 01
Q ss_pred HHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 614 EMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 614 ~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......++.+||+.+|.+||+|.||++
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 1233567778999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=211.97 Aligned_cols=169 Identities=21% Similarity=0.205 Sum_probs=126.8
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
|+|.++++.... .++|.++..|+.||+.||+|||+. + ||+|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVRGR----PLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeecccc-
Confidence 789999976432 599999999999999999999965 2 999999999999999 99988765433
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|||||++.+..++.++|||||||++|||+||+.||... ..+.............. ++.- ..
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~-------~~~~~~~~~~~~~~~~~----~~~~--~~ 130 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE-------RELSAILEILLNGMPAD----DPRD--RS 130 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc-------chhcHHHHHHHHHhccC----Cccc--cc
Confidence 35678999999999999999999999999999999999998632 11222222222111110 0000 00
Q ss_pred CCHHHH--HHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 610 NSEGEM--VKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 610 ~~~~~~--~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
...... ..+.+++.+||+.+|.+||++.|+++.+..+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 011111 258889999999999999999999999877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=233.41 Aligned_cols=189 Identities=22% Similarity=0.258 Sum_probs=158.2
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccC------CCCccceeEEEEeCCceEEEEecc
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR------HPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
...|+|-|++|.+|.. ..|..||||++... +...+.=+.|+++|++|+ --|+++|+-.|...+++|||+|-+
T Consensus 438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L 516 (752)
T KOG0670|consen 438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL 516 (752)
T ss_pred eccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh
Confidence 3579999999999975 35779999998764 445556678999999995 357999999999999999999987
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC-CceEEeecCCccccCc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES-LEPVLADYGLIPVMNQ 526 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~ 526 (678)
.-+|.++|+..+. ..-|....+..++.|+..||..|-.. +|+|.||||.|||+++. ..+||||||.|.....
T Consensus 517 -slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 517 -SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred -hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEeccCcceeeeccCcccccccc
Confidence 5699999987643 23477888899999999999999754 89999999999999975 5789999999877654
Q ss_pred cccc--cccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 527 ESAQ--ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 527 ~~~~--~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.... -.+.-|.|||++.+-.|+...|+||.||+||||.||+.-|.
T Consensus 590 neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 590 NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 4322 23345999999999999999999999999999999998886
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=216.50 Aligned_cols=247 Identities=21% Similarity=0.317 Sum_probs=187.5
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecc--cChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQ--MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+|.+...|..|+|++..+ .+++|+++. .+....++|..|+-.|+.+.||||+.++|.|.......++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 3588899999999999644 455666653 3444557899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccccccc
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 532 (678)
+..||+.... .++-.+.++++.+||+||+|||+-. +-|.--.|.+..|+||++.+++|+ .+-+++.-+......
T Consensus 275 ynvlhe~t~v---vvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsfqe~gr~y 348 (448)
T KOG0195|consen 275 YNVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVGRAY 348 (448)
T ss_pred HHHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeeeecccccc
Confidence 9999976432 5788899999999999999999763 235566799999999999999875 222233333334445
Q ss_pred cceeeCccccccCCC---CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 533 MIAYKSPEFLQLGRI---TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 533 ~~~y~aPE~~~~~~~---t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
.+.||+||.+...+- -.++|+|||.|++|||.|...||.+..+..-+ ++-.+ +-+...+
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mkial-------eglrv~i---- 410 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MKIAL-------EGLRVHI---- 410 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hhhhh-------ccccccC----
Confidence 678999999986554 35799999999999999999999854332111 11111 1111111
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
+......+.+++.-|.+.||.+||.++.|+-.||++.
T Consensus 411 -ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 -PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1123345778888999999999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=218.40 Aligned_cols=185 Identities=23% Similarity=0.360 Sum_probs=155.7
Q ss_pred ccccCccCceeEEEEEec----CCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS----TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+|.|++||++.+. ....||+|.+..... ...+.+|+++|..+. +.||+++.+++...+...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 578999999999999653 467899999876543 345889999999994 8999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCccccC--
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIPVMN-- 525 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~-- 525 (678)
+-...+++. .++..++..+++.+.+||.|+|++ +||||||||+|+|.+. .+.-.|.|||+|...+
T Consensus 119 H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 119 HDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred ccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999998886 367888999999999999999976 8999999999999985 4677899999985110
Q ss_pred ---------------c-c------------------------------ccccccceeeCcccccc-CCCCCcchHHHHHH
Q 044996 526 ---------------Q-E------------------------------SAQELMIAYKSPEFLQL-GRITKKTDVWSLGV 558 (678)
Q Consensus 526 ---------------~-~------------------------------~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gv 558 (678)
+ . ....||.||+|||++.. ..-++++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0 00135788999999864 45689999999999
Q ss_pred HHHHHHhCCCCccc
Q 044996 559 LILEIMTGKFPANF 572 (678)
Q Consensus 559 vl~el~tg~~P~~~ 572 (678)
|++-+++++.||-.
T Consensus 267 I~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFK 280 (418)
T ss_pred eeehhhcccccccc
Confidence 99999999999863
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=209.70 Aligned_cols=162 Identities=17% Similarity=0.238 Sum_probs=122.8
Q ss_pred ccccCccCceeEEEEEec--CCceEEEEEeccc-----ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS--TGAMMVVKRFKQM-----NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||+||+|... +++.+|||++... .....+.|.+|+++|++++|+||+..+.. .+..++||||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~ 99 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGW 99 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEc
Confidence 457999999999999764 5777899986532 22345679999999999999999864322 2568999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCC-CCCCEEecCCCceEEeecCCccccC
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHI-KSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdl-k~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
+++++|... .. .. ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+|||+++.+.
T Consensus 100 ~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 100 TEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred cCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999632 11 00 146788999999999976 8999999 9999999999999999999998665
Q ss_pred cccc------------ccccceeeCccccccCC------CCCcchHH
Q 044996 526 QESA------------QELMIAYKSPEFLQLGR------ITKKTDVW 554 (678)
Q Consensus 526 ~~~~------------~~~~~~y~aPE~~~~~~------~t~ksDvw 554 (678)
.... ..++..|+|||++...+ .+..+|-|
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 4321 12346699999986432 23346766
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=208.36 Aligned_cols=215 Identities=25% Similarity=0.389 Sum_probs=164.5
Q ss_pred HhccCCCCccceeEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCccc
Q 044996 419 LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHG 498 (678)
Q Consensus 419 l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHr 498 (678)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..... .++|.....++++|++||+|||.. + ...|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~----~~d~~F~~s~~rdi~~Gl~ylh~s--~-i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI----KLDYFFILSFIRDISKGLAYLHNS--P-IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc----CccHHHHHHHHHHHHHHHHHHhcC--c-ceeee
Confidence 4678999999999999999999999999999999999987432 699999999999999999999964 3 34899
Q ss_pred CCCCCCEEecCCCceEEeecCCccccCcc------ccccccceeeCccccccC---C----CCCcchHHHHHHHHHHHHh
Q 044996 499 HIKSSNVLLNESLEPVLADYGLIPVMNQE------SAQELMIAYKSPEFLQLG---R----ITKKTDVWSLGVLILEIMT 565 (678)
Q Consensus 499 dlk~~NILl~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~---~----~t~ksDvwS~Gvvl~el~t 565 (678)
.|+++|+++|..+.+||+|||+....... .......-|.|||.+... . .+.++||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999998766421 111122559999999763 1 4778999999999999999
Q ss_pred CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHH
Q 044996 566 GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645 (678)
Q Consensus 566 g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~ 645 (678)
.+.||+....... ...+..+++. .+. ..+-|.+.... +....+..++..||..+|.+||+++.|-..++.
T Consensus 154 r~~~~~~~~~~~~-~~eii~~~~~---~~~---~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 154 RSGPFDLRNLVED-PDEIILRVKK---GGS---NPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred ccCccccccccCC-hHHHHHHHHh---cCC---CCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 9999984321111 1123333322 111 22333332111 223358888899999999999999999999998
Q ss_pred hhccC
Q 044996 646 VKERD 650 (678)
Q Consensus 646 i~~~~ 650 (678)
+....
T Consensus 224 ~~~~~ 228 (484)
T KOG1023|consen 224 INKGG 228 (484)
T ss_pred hcccc
Confidence 87755
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=233.51 Aligned_cols=178 Identities=35% Similarity=0.601 Sum_probs=119.9
Q ss_pred ChHHHHHHHHhcCCCCC-CCCCCCCCCCCCCCCCCCcceEEec-CCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccC
Q 044996 2 TDSQTLLTLKQSLSNPT-ALANWDDRTPPCNENGANWNGVLCH-RGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMR 79 (678)
Q Consensus 2 ~~~~aLl~~k~~l~~~~-~l~~W~~~~~~c~~~~~~w~gv~C~-~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~ 79 (678)
.|+.||++||+++.+|. .+.+|+...++| .|.||+|+ .++|+.|+|++++++|.++. .+..|++|+.|+|++
T Consensus 29 ~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-----~w~gv~c~~~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~ 102 (968)
T PLN00113 29 EELELLLSFKSSINDPLKYLSNWNSSADVC-----LWQGITCNNSSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSN 102 (968)
T ss_pred HHHHHHHHHHHhCCCCcccCCCCCCCCCCC-----cCcceecCCCCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCC
Confidence 47899999999998775 588998777777 69999997 57999999999999988875 578888888888888
Q ss_pred CcccccCCc-cc-ccCCCCccEEEcccCccccccC----------------------hhhhcCCcccceeeccccccccC
Q 044996 80 NNLEGPMPD-LR-QLGNGALRSVYLSNNRFSGEIP----------------------TDAFDGMTSLRKLLLADNQFNGP 135 (678)
Q Consensus 80 N~l~g~~p~-~~-~~~~~~L~~L~Ls~N~l~G~ip----------------------~~~~~~l~~L~~l~l~~N~~~g~ 135 (678)
|+++|.+|. +. .+ .+|++|+|++|+++|.+| .. ++++++|++|+|++|.+++.
T Consensus 103 n~~~~~ip~~~~~~l--~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~ 179 (968)
T PLN00113 103 NQLSGPIPDDIFTTS--SSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPND-IGSFSSLKVLDLGGNVLVGK 179 (968)
T ss_pred CccCCcCChHHhccC--CCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChH-HhcCCCCCEEECccCccccc
Confidence 888888874 21 23 456666666665555554 33 44555555555555555555
Q ss_pred CchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhc
Q 044996 136 IPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRE 188 (678)
Q Consensus 136 ~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~ 188 (678)
+|..++++++|++|+|++|.++|.+|.. .+.+|+.|+|++|.++|.+|..+.+
T Consensus 180 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 234 (968)
T PLN00113 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG 234 (968)
T ss_pred CChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhc
Confidence 5555555555555555555555555542 3445555555555555555554443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-20 Score=192.69 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=187.9
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChh---hHHHHHHHHHHHhccCCC-CccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNV---GREEFQEHMRRLGRLRHP-NLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +|+++++++......++++||+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 356899999999999876 77888888754332 467899999999999988 799999999777778999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-ceEEeecCCccccCcc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-EPVLADYGLIPVMNQE- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~- 527 (678)
+++.+++...... ..+.......++.|++.++.|+|.. +++|||+||+||+++... .+|++|||.++.....
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999777654311 2478889999999999999999976 699999999999999988 7999999998755432
Q ss_pred ---------ccccccceeeCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh-cC
Q 044996 528 ---------SAQELMIAYKSPEFLQL---GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA-NG 594 (678)
Q Consensus 528 ---------~~~~~~~~y~aPE~~~~---~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~-~~ 594 (678)
....++..|+|||.+.+ ..++...|+||+|++++++++|..||...... .........+. ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~ 231 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILELP 231 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHhcC
Confidence 23346788999999987 57899999999999999999999996521100 01111111111 11
Q ss_pred Cc-cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 595 DN-RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 595 ~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.. ......+... ......+.+++..|+..+|..|.++.+....
T Consensus 232 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TPSLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CcccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 0000000000 1123456777889999999999999988775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-20 Score=191.64 Aligned_cols=254 Identities=18% Similarity=0.155 Sum_probs=184.7
Q ss_pred hccccCccCceeEEEEEecCC--ceEEEEEecccChhhHHHHHHHHHHHhccCC----CCccceeEEE-EeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASLSTG--AMMVVKRFKQMNNVGREEFQEHMRRLGRLRH----PNLLPLVAYY-YRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~~lv~E 445 (678)
+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.+ .++..+++.. ......++||+
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~ 101 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS 101 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence 356799999999999986553 4677777665433332367888888888863 5888888888 46778999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC-----CceEEeecCC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES-----LEPVLADYGL 520 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-----~~~kl~DfGl 520 (678)
.+ +.+|.++..... ...++-.+.++|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||+
T Consensus 102 l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 102 LL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred cc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 77 789999876543 23699999999999999999999965 89999999999999864 4689999999
Q ss_pred cc--ccC-cc-----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHH
Q 044996 521 IP--VMN-QE-----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASW 586 (678)
Q Consensus 521 a~--~~~-~~-----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~ 586 (678)
++ .+. .. ....+|..|.++....+...+.+.|+||++.++.|++.|..||...... .. ..-
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~----~~-~~~ 248 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT----DL-KSK 248 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc----ch-HHH
Confidence 98 321 11 1123789999999999999999999999999999999999998632211 01 111
Q ss_pred HHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 587 VNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
+...... ..... . ......+ +.++...+-+.+..++|....+...|++.....
T Consensus 249 ~~~~~~~-----~~~~~-~--~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 FEKDPRK-----LLTDR-F--GDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHhhh-----hcccc-c--cCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111100 01110 0 0112233 444444555689999999999999998876654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=180.55 Aligned_cols=141 Identities=18% Similarity=0.190 Sum_probs=107.9
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChh--h-------H-----------------HHHHHHHHHHhccCCCCcc
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNV--G-------R-----------------EEFQEHMRRLGRLRHPNLL 428 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~H~niv 428 (678)
..||+|+||.||+|...+|+.||||+++..... . . .....|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 569999999999998878999999999753211 1 1 1223599999999888875
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec
Q 044996 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN 508 (678)
Q Consensus 429 ~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~ 508 (678)
....+.. ...+|||||++++++...+... ..+++.+...++.|++.+|.|+|+. .+|+||||||+|||++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 5443322 2348999999988776543222 1578899999999999999999533 2799999999999998
Q ss_pred CCCceEEeecCCccccCc
Q 044996 509 ESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 509 ~~~~~kl~DfGla~~~~~ 526 (678)
++.++|+|||++.....
T Consensus 153 -~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CCcEEEEEccccccCCC
Confidence 47899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-21 Score=214.94 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=175.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEec----c-cChhh-HHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFK----Q-MNNVG-REEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+++|.|++|.|+..... .......|.++ . ..... ...+..|+.+-..++|+|++..+..+.+....+-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 467999999988877532 33334444332 1 11111 12256677778889999999888777776666666999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
|+. +|..++.... .+.-.++-.++.|+..|+.|+|.. +|.|||+|++|++++.++.+||+|||.+....-
T Consensus 403 ~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred ccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 999 9999987642 367778889999999999999965 899999999999999999999999999865543
Q ss_pred cc--------cccccceeeCccccccCCCCC-cchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 527 ES--------AQELMIAYKSPEFLQLGRITK-KTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 527 ~~--------~~~~~~~y~aPE~~~~~~~t~-ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
.. ...+.-.|+|||++...+|.+ ..||||.||++..|++|+.||......+. .. ......+ ..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~---~~----~~~~~~~-~~ 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN---SF----KTNNYSD-QR 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc---ch----hhhcccc-cc
Confidence 21 123456799999999999965 69999999999999999999974322211 00 0000000 00
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHh
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEV 646 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i 646 (678)
.+... ..........+...++.++++.||.+|.||.+|++ .+++|
T Consensus 545 -~~~~~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 545 -NIFEG---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred -ccccC---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 00000 00011122344567888999999999999999987 34444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=181.13 Aligned_cols=164 Identities=12% Similarity=0.106 Sum_probs=127.1
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHH---------HHHHHHHHHhccCCCCccceeEEEEeC------
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGRE---------EFQEHMRRLGRLRHPNLLPLVAYYYRK------ 437 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~e~~~l~~l~H~niv~l~~~~~~~------ 437 (678)
..+++|.|+||.||.+.. ++..+|+|.+......... .+.+|++.+.+++|++|..+..++...
T Consensus 35 ~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 35 TIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence 357899999999999766 5678999999754322222 268999999999999999999886643
Q ss_pred --CceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEE
Q 044996 438 --EEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVL 515 (678)
Q Consensus 438 --~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 515 (678)
...+|||||+++.+|.++.. ++. ....+++.+|..+|.. +++|||+||+||+++.++ ++|
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCCC-EEE
Confidence 35789999999999987632 222 3566999999999976 899999999999999988 999
Q ss_pred eecCCccccCccccccccceeeCccccccCCCCCcchHHHHHHHHHHH
Q 044996 516 ADYGLIPVMNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEI 563 (678)
Q Consensus 516 ~DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el 563 (678)
+|||..+.......... +.....|..++|+|+||+++.-.
T Consensus 176 iDfg~~~~~~e~~a~d~--------~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 176 IDLSGKRCTAQRKAKDR--------IDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EECCCcccccchhhHHH--------HHHHhHhcccccccceeEeehHH
Confidence 99998776543322211 33344567899999999988654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-20 Score=206.65 Aligned_cols=131 Identities=39% Similarity=0.659 Sum_probs=80.9
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCCCcceEEecC------CcEEEEEeCCCCceeecChHHhhcCCCCCEE
Q 044996 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHR------GKIWGLKLEDMGLQGNIDITILKELREMRTL 75 (678)
Q Consensus 2 ~~~~aLl~~k~~l~~~~~l~~W~~~~~~c~~~~~~w~gv~C~~------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L 75 (678)
.|++||+++|+++.++.. .+|.. ++|....+.|.||.|+. ..|+.|+|++++|.|.+|.+ ++.|++|+.|
T Consensus 372 ~~~~aL~~~k~~~~~~~~-~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~-i~~L~~L~~L 447 (623)
T PLN03150 372 EEVSALQTLKSSLGLPLR-FGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND-ISKLRHLQSI 447 (623)
T ss_pred hHHHHHHHHHHhcCCccc-CCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHH-HhCCCCCCEE
Confidence 478999999999976543 48963 57765556899999952 13666666666666666643 4445555544
Q ss_pred EccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCc
Q 044996 76 SLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNK 155 (678)
Q Consensus 76 ~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~ 155 (678)
+|++|+|+|.||.. ++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+
T Consensus 448 -------------------------~Ls~N~l~g~iP~~-~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~ 501 (623)
T PLN03150 448 -------------------------NLSGNSIRGNIPPS-LGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501 (623)
T ss_pred -------------------------ECCCCcccCcCChH-HhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence 55555555555543 4555555555555555555555555555555555555555
Q ss_pred ccccCCc
Q 044996 156 FEGQIPD 162 (678)
Q Consensus 156 l~g~~p~ 162 (678)
|+|.+|.
T Consensus 502 l~g~iP~ 508 (623)
T PLN03150 502 LSGRVPA 508 (623)
T ss_pred ccccCCh
Confidence 5555554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=174.11 Aligned_cols=139 Identities=19% Similarity=0.252 Sum_probs=110.4
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChh--------------------------hHHHHHHHHHHHhccCCCCcc
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNV--------------------------GREEFQEHMRRLGRLRHPNLL 428 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~H~niv 428 (678)
..||+|+||.||+|...+|+.||||.++..... ....+..|.+.+.++.|++|.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 569999999999998878999999998753210 012346789999999999986
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHH-hhccCCCCCCCCChHHHHHHHHHHHHHHHHHHH-hCCCCCCcccCCCCCCEE
Q 044996 429 PLVAYYYRKEEKLLVHEFVPKRSLAVN-LHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR-ELPSLIAPHGHIKSSNVL 506 (678)
Q Consensus 429 ~l~~~~~~~~~~~lv~Ey~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrdlk~~NIL 506 (678)
....+... ..+|||||++++++... +... .++..+..+++.+++.+|.|+|+ . +|+||||||+|||
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIl 150 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNIL 150 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEE
Confidence 55544433 34899999998865433 3221 46778889999999999999997 4 8999999999999
Q ss_pred ecCCCceEEeecCCccccCc
Q 044996 507 LNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 507 l~~~~~~kl~DfGla~~~~~ 526 (678)
++ ++.++|+|||+++....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 88999999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-20 Score=206.67 Aligned_cols=241 Identities=24% Similarity=0.317 Sum_probs=175.0
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccC-hhhHHHHHHHHHH--HhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMN-NVGREEFQEHMRR--LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||++.|=+|.+|+.++|. |+||++-... ....+.|.++++. ...++|||.+.+..+-......|||-+|+.+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 356999999999999998887 7888886543 4455666655544 4445899999998887777788999999965
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc--cCccc
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV--MNQES 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~--~~~~~ 528 (678)
+|++.|..+ |.|...+..-|+.|++.||.-+|+. +|+|||||.+||||+.-.-+.|+||.--+. +..+.
T Consensus 106 nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 106 NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 888888643 3577778888999999999999976 899999999999999998999999976542 22211
Q ss_pred ccc---------ccceeeCccccccC-----------CCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHH
Q 044996 529 AQE---------LMIAYKSPEFLQLG-----------RITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWV 587 (678)
Q Consensus 529 ~~~---------~~~~y~aPE~~~~~-----------~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~ 587 (678)
... .-.+|.|||.+... ..+++-||||+|||+.||++ |+.||...+ +..+-
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--------L~aYr 248 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--------LLAYR 248 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--------HHhHh
Confidence 111 11469999977431 15788999999999999999 788887321 11110
Q ss_pred HHHHhcCCccccccchhhh-cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 588 NSVLANGDNRTEVFDKEMA-DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.+ .-.|++.. .... -..+.++++.|++.||++|-++++.++.-..+
T Consensus 249 -----~~----~~~~~e~~Le~Ie----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 -----SG----NADDPEQLLEKIE----DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -----cc----CccCHHHHHHhCc----CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11 01111110 0000 11467788899999999999999999985543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-18 Score=168.75 Aligned_cols=262 Identities=14% Similarity=0.162 Sum_probs=193.8
Q ss_pred hccccCccCceeEEEEE-ecCCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCCC
Q 044996 373 SAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
++++||+|.||.+|.|. +-+++.||||.-...+ ..-++..|.+..+.|. .++|..++-|-.++.+-.||+|.+ +-
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 56789999999999995 5689999999754322 2345667777777774 688998888888888889999988 88
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-----CCceEEeecCCccccC
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-----SLEPVLADYGLIPVMN 525 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-----~~~~kl~DfGla~~~~ 525 (678)
||+++..-... .++.++++-||.|++.-++|+|++ .+|.|||||+|.||.. ...+.|+|||+|+.+.
T Consensus 109 SLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 109 SLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99998876543 599999999999999999999977 6899999999999964 3468999999998875
Q ss_pred cc-----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 526 QE-----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 526 ~~-----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
+. ..-.||.+||+--...+.+-+.+-|+=|+|-|++..+-|..||..... ....+--+.+-...
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA-----~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-----DTNKEKYEKIGETK 255 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC-----cchHHHHHHhcccc
Confidence 43 233578999999988888999999999999999999999999974321 11111111111111
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC--Cccccc
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD--EDFYSS 658 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~--~~~~~~ 658 (678)
+.. .+ ..|. ..+ .+++.+-++.+. ..+=.+-|.-+-+-..+..+.+..+. +-.|+|
T Consensus 256 r~T-~i--~~Lc-~g~-P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW 313 (449)
T KOG1165|consen 256 RST-PI--EVLC-EGF-PEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDW 313 (449)
T ss_pred ccC-CH--HHHH-hcC-HHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 110 11 1111 112 355666666666 66777889988888888887666554 344455
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6e-19 Score=168.17 Aligned_cols=177 Identities=18% Similarity=0.153 Sum_probs=131.1
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccCh----hhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNN----VGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
...|++|+||+||.+.- .+..++.+.+..... .....|.+|+++|++|+ |++|.+++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35699999999997765 566777776664322 11235889999999995 5889999886 45799999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCC-CCCCEEecCCCceEEeecCCccccCcc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHI-KSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdl-k~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
+.+|...+.. ....++.|++.+|.|+|.. +|+|||| ||+|||++.++.++|+|||++......
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9888654321 1135788999999999976 8999999 799999999999999999999855433
Q ss_pred cc-----------------ccccceeeCcccccc-CCCC-CcchHHHHHHHHHHHHhCCCCcc
Q 044996 528 SA-----------------QELMIAYKSPEFLQL-GRIT-KKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 528 ~~-----------------~~~~~~y~aPE~~~~-~~~t-~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.. ...+..|++|+.-.- ...+ ...+.++-|.-+|.++|++.++-
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 21 012334555543221 1223 46789999999999999998853
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.8e-19 Score=170.82 Aligned_cols=134 Identities=16% Similarity=0.196 Sum_probs=105.0
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhcc-----CCCCccceeEEEEeCC---ceE-EEE
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-----RHPNLLPLVAYYYRKE---EKL-LVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~~~-lv~ 444 (678)
.++||+|+||.||. +......+||++........+.+.+|+.+++++ .||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 35799999999996 433344578888764444567899999999999 5799999999998863 333 789
Q ss_pred ec--cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHH-HHHHHhCCCCCCcccCCCCCCEEecC----CCceEEee
Q 044996 445 EF--VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGL-QYLYRELPSLIAPHGHIKSSNVLLNE----SLEPVLAD 517 (678)
Q Consensus 445 Ey--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~~ivHrdlk~~NILl~~----~~~~kl~D 517 (678)
|| +..|+|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+|
T Consensus 85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 99 5579999999653 24443 35678888888 999977 7999999999999974 34899999
Q ss_pred cCCc
Q 044996 518 YGLI 521 (678)
Q Consensus 518 fGla 521 (678)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.4e-19 Score=165.53 Aligned_cols=188 Identities=18% Similarity=0.200 Sum_probs=154.1
Q ss_pred ccccCccCceeEEEEE-ecCCceEEEEEecccChhhHHHHHHHHHHHhccCC-CCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRH-PNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.+|.|. ..+|..||||.-... ....++..|.++...|+| ..|..+..|..+.....||||.+ +.+
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs 96 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS 96 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence 4679999999999995 578999999976543 223457788899999976 56777888888888899999988 889
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---CCceEEeecCCccccCcc-
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---SLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~- 527 (678)
|.+++.-... .++..+.+-++-|++.-++|+|.. +++||||||+|.|..- ..++.++|||+++.+.+.
T Consensus 97 LEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 97 LEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred HHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 9998865432 588899999999999999999987 6999999999999863 356889999999865432
Q ss_pred ----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 044996 528 ----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANF 572 (678)
Q Consensus 528 ----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~ 572 (678)
..-.+|.+|.+--...+..-+.+-|+-|+|.+|...--|+.||..
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 223467888887776666678899999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-19 Score=192.54 Aligned_cols=185 Identities=23% Similarity=0.307 Sum_probs=155.5
Q ss_pred ccCccCceeEEEEE----ecCCceEEEEEecccChh--hHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccC
Q 044996 376 ILGSGCFGSSYKAS----LSTGAMMVVKRFKQMNNV--GREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
++|+|.||.|+.++ ...+..+++|.++..... .+.....|..++..++ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999874 345667788777653321 1224556778888887 9999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|...+.... .+++.....+...++.+++++|.. +|+|||+|++||+++.+|.+|+.|||+.+..-...
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999988876543 366667777888999999999976 89999999999999999999999999998877666
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
...+++.|||||++. .....+|.||||++++||+||..||.
T Consensus 152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 667899999999997 57889999999999999999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=168.04 Aligned_cols=229 Identities=19% Similarity=0.280 Sum_probs=145.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCC----------CCccceeEEEE----
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRH----------PNLLPLVAYYY---- 435 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H----------~niv~l~~~~~---- 435 (678)
.+.||.|+++.||.+.. .+++.+++|.+.... ....+++++|.-....+.+ -.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 45799999999999987 468999999886432 2345677777655555432 12222222221
Q ss_pred -----eCC--------ceEEEEeccCCCCHHHHhhc---cCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccC
Q 044996 436 -----RKE--------EKLLVHEFVPKRSLAVNLHG---HQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGH 499 (678)
Q Consensus 436 -----~~~--------~~~lv~Ey~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrd 499 (678)
... ..+++|+-+ .+||.+++.. .... ...+....++.+..|+++.+++||+. ++||+|
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~----GlVHgd 170 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSY----GLVHGD 170 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHT----TEEEST
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhc----ceEecc
Confidence 111 236778877 6788877542 2211 11345566788889999999999987 899999
Q ss_pred CCCCCEEecCCCceEEeecCCccccCcccc-ccccceeeCcccccc--------CCCCCcchHHHHHHHHHHHHhCCCCc
Q 044996 500 IKSSNVLLNESLEPVLADYGLIPVMNQESA-QELMIAYKSPEFLQL--------GRITKKTDVWSLGVLILEIMTGKFPA 570 (678)
Q Consensus 500 lk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~y~aPE~~~~--------~~~t~ksDvwS~Gvvl~el~tg~~P~ 570 (678)
|||+|++++++|.++|+||+.......... ...+..|.+||.... -.+|.+.|.|++|+++|.|.+|+.||
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf 250 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF 250 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence 999999999999999999988765554433 344567999997643 24789999999999999999999999
Q ss_pred cccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccC
Q 044996 571 NFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKR 633 (678)
Q Consensus 571 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~R 633 (678)
......... +| .+.. .. +.+..+..++...++.+|.+|
T Consensus 251 ~~~~~~~~~-----~~-----------------~f~~--C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 251 GLSSPEADP-----EW-----------------DFSR--CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCCGGGSTS-----GG-----------------GGTT--SS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCccccc-----cc-----------------cchh--cC-CcCHHHHHHHHHHccCCcccC
Confidence 743222110 00 1111 11 345567777789999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.7e-17 Score=159.78 Aligned_cols=134 Identities=19% Similarity=0.311 Sum_probs=112.8
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccCh--------hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNN--------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|++++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 667788887653211 1234688899999999999998888888778889999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
+++++|.+++... .+ ++..++.+++.+|.++|.. +++|||++|.|||++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988642 12 7889999999999999976 799999999999999 78999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.6e-17 Score=161.74 Aligned_cols=140 Identities=19% Similarity=0.242 Sum_probs=107.4
Q ss_pred hccccCccCceeEEEEE--ecCCceEEEEEecccChh------------------------hHHHHHHHHHHHhccCCCC
Q 044996 373 SAEILGSGCFGSSYKAS--LSTGAMMVVKRFKQMNNV------------------------GREEFQEHMRRLGRLRHPN 426 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~H~n 426 (678)
+.+.||+|+||.||+|. ..+|+.||+|.++..... ....+..|++.+.++.+..
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 45789999999999998 568999999998743210 1124678999999997633
Q ss_pred --ccceeEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCC-CcccCCCCC
Q 044996 427 --LLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI-APHGHIKSS 503 (678)
Q Consensus 427 --iv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~-ivHrdlk~~ 503 (678)
+.+++++ ...++||||+++++|...+... ..+...+...++.||+.+|+|||.. + |+||||||+
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dikp~ 178 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKE----GELVHGDLSEY 178 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCChh
Confidence 3333432 2458999999998887654221 1355556789999999999999976 7 999999999
Q ss_pred CEEecCCCceEEeecCCccccCc
Q 044996 504 NVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 504 NILl~~~~~~kl~DfGla~~~~~ 526 (678)
||+++ ++.++|+|||.+.....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCC
Confidence 99999 88999999999875443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.5e-17 Score=157.84 Aligned_cols=131 Identities=20% Similarity=0.305 Sum_probs=107.6
Q ss_pred ccCccCceeEEEEEecCCceEEEEEecccC--------hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 376 ILGSGCFGSSYKASLSTGAMMVVKRFKQMN--------NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
+||+|+||.||+|.+ ++..+++|...... ....+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 56788888865321 112356788999999999988776666666777789999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
++++|.+++.... . .++.+++.+|.+||.. +++|+|++|.||+++ ++.+++.|||+++..
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875421 0 7899999999999976 899999999999999 889999999997653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=179.91 Aligned_cols=133 Identities=21% Similarity=0.275 Sum_probs=108.4
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEeccc-C------hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQM-N------NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.++||+|+||+||+|.+.....++.++.... . ....+.+.+|++++.+++|++|+....++......++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 4679999999999998755443333322221 1 12235688999999999999999988888887888999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
+++++|.+++. .+..++.+++.+|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 418 ~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 418 IGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred cCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999998875 2457899999999999976 89999999999999 6789999999998753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=160.17 Aligned_cols=192 Identities=18% Similarity=0.216 Sum_probs=133.3
Q ss_pred CCCCccceeEEEEeC---------------------------CceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHH
Q 044996 423 RHPNLLPLVAYYYRK---------------------------EEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKI 475 (678)
Q Consensus 423 ~H~niv~l~~~~~~~---------------------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 475 (678)
+|||||+++++|.+. ..+|+||.-++. +|++++..+ ..+...+.-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC------CCchHHHHHH
Confidence 599999998877531 246899988854 999999754 2455566678
Q ss_pred HHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe--cCCC--ceEEeecCCccccCc----------cccccccceeeCccc
Q 044996 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL--NESL--EPVLADYGLIPVMNQ----------ESAQELMIAYKSPEF 541 (678)
Q Consensus 476 ~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl--~~~~--~~kl~DfGla~~~~~----------~~~~~~~~~y~aPE~ 541 (678)
+.|+++|+.|||++ +|.|||+|++|||| |+|. ...|+|||.+--... .-...+...-||||+
T Consensus 347 laQlLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 88999999999987 89999999999998 4444 467999998632211 111224456899998
Q ss_pred cccC--CC----CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHH
Q 044996 542 LQLG--RI----TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEM 615 (678)
Q Consensus 542 ~~~~--~~----t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 615 (678)
.... +. -.|+|.|+.|.+.||+++...||.. .++..+.. +...+--=|.+ ++...
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-----rGem~L~~---------r~Yqe~qLPal-----p~~vp 483 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-----RGEMLLDT---------RTYQESQLPAL-----PSRVP 483 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc-----cchheech---------hhhhhhhCCCC-----cccCC
Confidence 7532 11 3689999999999999999999972 11111110 01101100111 12234
Q ss_pred HHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 616 VKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 616 ~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
..+.+++..-++.||++|++.+-..+.|.
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 45677888899999999999888777765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-16 Score=153.06 Aligned_cols=135 Identities=14% Similarity=0.161 Sum_probs=105.8
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccCh----------------------hhHHHHHHHHHHHhccCCCC--cc
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNN----------------------VGREEFQEHMRRLGRLRHPN--LL 428 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~H~n--iv 428 (678)
..+.||+|+||.||++...+|+.++||++..... .....+..|+.++.++.|++ +.
T Consensus 19 ~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~ 98 (198)
T cd05144 19 LGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVP 98 (198)
T ss_pred cCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCC
Confidence 3577999999999999888899999998754210 01123678899999998874 44
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec
Q 044996 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN 508 (678)
Q Consensus 429 ~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~ 508 (678)
+.++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||||+||+++
T Consensus 99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~Nill~ 159 (198)
T cd05144 99 KPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH----GIIHGDLSEFNILVD 159 (198)
T ss_pred ceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCcccEEEc
Confidence 4443 2456899999999998765321 23457899999999999975 899999999999999
Q ss_pred CCCceEEeecCCccccCc
Q 044996 509 ESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 509 ~~~~~kl~DfGla~~~~~ 526 (678)
+++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6e-16 Score=176.25 Aligned_cols=184 Identities=23% Similarity=0.266 Sum_probs=142.7
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccC---CCCccceeEEEEeCCceEEEEeccCC
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR---HPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
+...||+|+||+||+|...+|+.||+|+-+..... +|---.+++.+|+ -+-|.++...+.-.+.-+||+||.+.
T Consensus 702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~ 778 (974)
T KOG1166|consen 702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY 778 (974)
T ss_pred EEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence 34679999999999999888999999987754322 1111122334444 23344455555557778999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec-------CCCceEEeecCCcc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN-------ESLEPVLADYGLIP 522 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-------~~~~~kl~DfGla~ 522 (678)
|+|.+++... ..++|.-.+.++.|+++-++.||.. +|||+||||+|.||. +...++|+|||.+-
T Consensus 779 Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 779 GTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred ccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9999999833 3589999999999999999999976 799999999999994 34568999999874
Q ss_pred cc---Ccc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 044996 523 VM---NQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKF 568 (678)
Q Consensus 523 ~~---~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~ 568 (678)
.+ .+. .....|-.+-++|+..+..++.+.|-|.+.-+++-|+.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 33 222 22234567889999999999999999999999999999983
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.5e-17 Score=167.89 Aligned_cols=169 Identities=20% Similarity=0.279 Sum_probs=125.1
Q ss_pred ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeec
Q 044996 439 EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADY 518 (678)
Q Consensus 439 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 518 (678)
..|+.|++|...+|.++|.+.... ...+|...+.++.|++.|+.| . +.+|||+||.||+...+.++||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhhhh
Confidence 578999999999999999765432 257888899999999999999 2 6889999999999999999999999
Q ss_pred CCccccCccc----------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHH
Q 044996 519 GLIPVMNQES----------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWV 587 (678)
Q Consensus 519 Gla~~~~~~~----------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~ 587 (678)
|+........ ...+|..||+||.+.+..|+.|+||||+|+||+|+++ =..+++-.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-------------- 466 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-------------- 466 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH--------------
Confidence 9975543322 2346788999999999999999999999999999997 33333210
Q ss_pred HHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHH
Q 044996 588 NSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEA 639 (678)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev 639 (678)
.++. +.....++|...... +. -..+..+++.+.|.+||++.++
T Consensus 467 -~t~~--d~r~g~ip~~~~~d~-p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 -ATLT--DIRDGIIPPEFLQDY-PE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -Hhhh--hhhcCCCChHHhhcC-cH-----HHHHHHHhcCCCcccCchHHHH
Confidence 0111 111233343332221 11 2345568999999999954443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.6e-15 Score=140.39 Aligned_cols=135 Identities=16% Similarity=0.123 Sum_probs=112.1
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCC--CCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRH--PNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.++++++...+..+++|||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 469999999999998755 6788998765433 5678999999999977 5899999988877889999999988766
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
..+ +......++.+++.+|+++|... ..+++|+|++|+||++++++.+++.|||.++...
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 532 45566789999999999999642 2369999999999999999999999999986543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-14 Score=144.79 Aligned_cols=137 Identities=16% Similarity=0.190 Sum_probs=106.4
Q ss_pred hccccC-ccCceeEEEEEecCCceEEEEEecccC-------------hhhHHHHHHHHHHHhccCCCCc--cceeEEEEe
Q 044996 373 SAEILG-SGCFGSSYKASLSTGAMMVVKRFKQMN-------------NVGREEFQEHMRRLGRLRHPNL--LPLVAYYYR 436 (678)
Q Consensus 373 ~~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~ 436 (678)
...+|| .|+.|+||++... +..+++|.+.... ......+.+|++++.+|+|++| ++.+++...
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 356798 8999999999875 6678888875311 1233567889999999998885 677776544
Q ss_pred CC-c---eEEEEeccCC-CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC
Q 044996 437 KE-E---KLLVHEFVPK-RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL 511 (678)
Q Consensus 437 ~~-~---~~lv~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 511 (678)
.. . .++||||+++ .+|.+++... .++. ..+.+|+.+|.+||.. +|+||||||.|||++.++
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~----~~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA------PLSE----EQWQAIGQLIARFHDA----GVYHADLNAHNILLDPDG 179 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC------CCCH----HHHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCCC
Confidence 32 2 3599999997 6999887542 2333 3467899999999976 899999999999999999
Q ss_pred ceEEeecCCcccc
Q 044996 512 EPVLADYGLIPVM 524 (678)
Q Consensus 512 ~~kl~DfGla~~~ 524 (678)
.++|+|||.++..
T Consensus 180 ~v~LIDfg~~~~~ 192 (239)
T PRK01723 180 KFWLIDFDRGELR 192 (239)
T ss_pred CEEEEECCCcccC
Confidence 9999999997654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.5e-15 Score=141.00 Aligned_cols=137 Identities=20% Similarity=0.276 Sum_probs=97.5
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChh--hHHH----------------------HHHHHHHHhccCCCC--cc
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNV--GREE----------------------FQEHMRRLGRLRHPN--LL 428 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~H~n--iv 428 (678)
+.||+|+||+||+|...+++.||||.++..... .... ...|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 569999999999999888999999988753211 1111 134566666665443 44
Q ss_pred ceeEEEEeCCceEEEEeccCCCCHHHH-hhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe
Q 044996 429 PLVAYYYRKEEKLLVHEFVPKRSLAVN-LHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL 507 (678)
Q Consensus 429 ~l~~~~~~~~~~~lv~Ey~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl 507 (678)
+.+++ ...++||||++++.+... +.... .. .+..+++.+++.++.++|.. .+|+||||||+||++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~---~~ivH~Dl~p~Nili 148 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYRE---AGLVHGDLSEYNILV 148 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhc---cCcCcCCCChhhEEE
Confidence 44433 346899999998654321 11110 11 55678999999999999972 279999999999999
Q ss_pred cCCCceEEeecCCccccCc
Q 044996 508 NESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 508 ~~~~~~kl~DfGla~~~~~ 526 (678)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 89999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.2e-15 Score=165.28 Aligned_cols=152 Identities=20% Similarity=0.293 Sum_probs=109.7
Q ss_pred ccccCccCceeEEEEEecC-CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLST-GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.++|..|+||.||..+++. .+.+|+| +.+.+-. .+- ++.....|.+| ||-
T Consensus 88 IklisngAygavylvrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhc-ccccchh-----hhc--cccccCCccee---------------------chh
Confidence 4679999999999998753 5667773 3322110 000 22222233332 566
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc------
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ------ 526 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~------ 526 (678)
...++.... +. .+++.+++|||++ +|+|||+||+|.||+.-|.+|+.|||+.+..-.
T Consensus 139 ~tllk~~g~-----lP--------vdmvla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 139 ATLLKNIGP-----LP--------VDMVLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred hhhcccCCC-----Cc--------chhhHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 666654321 21 1227899999976 899999999999999999999999999764211
Q ss_pred -------------cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 527 -------------ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 527 -------------~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.....+|+.|+|||++....|...+|+|++|+|+||.+.|+.||.
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 011246788999999998999999999999999999999999997
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.2e-13 Score=145.03 Aligned_cols=142 Identities=17% Similarity=0.265 Sum_probs=101.0
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhh----------------------------------------HHHHHH
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVG----------------------------------------REEFQE 414 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 414 (678)
+.||+|++|.||+|++.+|+.||||+.+...... .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999999999999999986431110 012455
Q ss_pred HHHHHhccC----CCCccceeEEEE-eCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHH-HHHHHH
Q 044996 415 HMRRLGRLR----HPNLLPLVAYYY-RKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG-LQYLYR 488 (678)
Q Consensus 415 e~~~l~~l~----H~niv~l~~~~~-~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~ 488 (678)
|++.+.+++ |.+-+.+-.+|. .....+|||||+++++|.++...... .. .+.+++..++.. +..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence 666555552 333333333332 23457999999999999887653211 12 245677776663 677786
Q ss_pred hCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 489 ~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
. +++|+|+||.||+++++++++++|||++..+...
T Consensus 276 ~----g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 276 D----GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred C----CceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 5 8999999999999999999999999998776543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-14 Score=162.41 Aligned_cols=242 Identities=24% Similarity=0.286 Sum_probs=173.1
Q ss_pred ccCccCceeEEEEEec--CCceEEEEEecccC--hhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCCC
Q 044996 376 ILGSGCFGSSYKASLS--TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.||+|+|+.|-..... ....+++|.+.... ....+....|..+-..+. |.|++++++.....+..++++||..+|
T Consensus 27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 4899999999888653 33455666555432 222344455777777776 999999999999999999999999999
Q ss_pred CHHHHh-hccCCCCCCCCChHHHHHHHHHHHHHHHHHH-HhCCCCCCcccCCCCCCEEecCCC-ceEEeecCCccccCc-
Q 044996 451 SLAVNL-HGHQALGQPSLDWPSRLKIVKGVAKGLQYLY-RELPSLIAPHGHIKSSNVLLNESL-EPVLADYGLIPVMNQ- 526 (678)
Q Consensus 451 sL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~- 526 (678)
++.+.+ +.... ..+....-.+..|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..+..
T Consensus 107 ~~f~~i~~~~~~----~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 107 SLFSKISHPDST----GTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccccccccCCcc----CCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999887 43221 2444556688999999999999 55 799999999999999999 999999999977655
Q ss_pred cc------cccc-cceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 527 ES------AQEL-MIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 527 ~~------~~~~-~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
.. ...+ +..|+|||...+. ...+..|+||.|+++.-+++|..|++...... .....|..... ..
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~----~~- 250 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKG----RF- 250 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeeccccc----cc-
Confidence 21 2235 7889999999874 44778999999999999999999987433221 12222221110 00
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ............++..+++..+|..|.+.+++..
T Consensus 251 ---~-----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 ---T-----QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---c-----cCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 0001112233556666888899999999887754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.5e-13 Score=131.97 Aligned_cols=200 Identities=17% Similarity=0.172 Sum_probs=136.6
Q ss_pred HHHHhccCCCCccceeEEEEeCC-----ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC
Q 044996 416 MRRLGRLRHPNLLPLVAYYYRKE-----EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490 (678)
Q Consensus 416 ~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 490 (678)
+.-+-++.|.|||++..|+.+.. ...++.|||.-|+|..+|++.+..+ ..+....-.+++.||..||.|||..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 34466678999999999986543 4689999999999999998765422 2466666689999999999999976
Q ss_pred CCCCCcccCCCCCCEEecCCCceEEeecCCccc---c-----CccccccccceeeCccccccCCCCCcchHHHHHHHHHH
Q 044996 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV---M-----NQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILE 562 (678)
Q Consensus 491 ~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~---~-----~~~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~e 562 (678)
.+.|+|+++..+-|++..++-+|+.----... . .......+..+|.|||+-.....+.++|||+||...+|
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 34689999999999999998888743211100 0 01112234578999999887788899999999999999
Q ss_pred HHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 563 IMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 563 l~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
|..+..--..... ...++ +-+...+.+... ..-...+.+|++.+|..||+|++++.
T Consensus 275 mailEiq~tnseS-----~~~~e-------------e~ia~~i~~len-----~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 275 MAILEIQSTNSES-----KVEVE-------------ENIANVIIGLEN-----GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHheeccCCCcc-----eeehh-------------hhhhhheeeccC-----ccccCcCcccccCCCCCCcchhhhhc
Confidence 9888754221000 00000 000000000000 01133556999999999999999764
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-13 Score=123.63 Aligned_cols=148 Identities=26% Similarity=0.389 Sum_probs=126.6
Q ss_pred CCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 44 RGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
..+++.|.|+.|.|+ .+|+. +..|.+|+.|++++|++..-.+.+..+ ++|+.|+++-|++. .+|.. |+.++.|+
T Consensus 32 ~s~ITrLtLSHNKl~-~vppn-ia~l~nlevln~~nnqie~lp~~issl--~klr~lnvgmnrl~-~lprg-fgs~p~le 105 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPN-IAELKNLEVLNLSNNQIEELPTSISSL--PKLRILNVGMNRLN-ILPRG-FGSFPALE 105 (264)
T ss_pred hhhhhhhhcccCcee-ecCCc-HHHhhhhhhhhcccchhhhcChhhhhc--hhhhheecchhhhh-cCccc-cCCCchhh
Confidence 357899999999998 67764 789999999999999999776677777 78999999999998 78887 99999999
Q ss_pred eeecccccccc-CCchhhcCCCCCCeEeccCCcccccCCc-cCCCCCcEEEeecCcccccCchhhhcCC---CCCCCCCC
Q 044996 124 KLLLADNQFNG-PIPESLTRLSRLVELRLEGNKFEGQIPD-FQQKDLVSFNVSNNALFGSISPALRELD---PSSFSGNR 198 (678)
Q Consensus 124 ~l~l~~N~~~g-~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~~l~~l~l~~N~l~g~ip~~~~~l~---~~~~~gn~ 198 (678)
+|||.+|+++. .+|..|.-++.|+.|+|+.|.|.-..|+ ..+++|+.|.+..|.|- ++|.+++.+. ...++||+
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 99999999975 6899999999999999999999844444 37899999999999985 5788877554 55788885
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.7e-12 Score=133.95 Aligned_cols=246 Identities=20% Similarity=0.185 Sum_probs=170.4
Q ss_pred hHHHHHHhccccCc--cCceeEEEEEe---cCCceEEEEEecccC--hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeC
Q 044996 366 LHDLLRASAEILGS--GCFGSSYKASL---STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRK 437 (678)
Q Consensus 366 ~~~~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~ 437 (678)
+.+........+|+ |.+|.||.+.. .++..+++|+-+... ......=.+|+....++ .|+|.|+.+..+...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 33333334567899 99999999976 467788888754321 22233334566555666 499999988889999
Q ss_pred CceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHH----HHHHHHHhCCCCCCcccCCCCCCEEecCC-Cc
Q 044996 438 EEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAK----GLQYLYRELPSLIAPHGHIKSSNVLLNES-LE 512 (678)
Q Consensus 438 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~ 512 (678)
+..++-+|++. .+|..+.+.... .+.......+..+... ||.++|.. .++|-|+||.||++.++ ..
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCC----cccccccchhheecccccce
Confidence 99999999884 788888876543 2444555566777777 99999965 79999999999999999 89
Q ss_pred eEEeecCCccccCccccc---------cccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCCh
Q 044996 513 PVLADYGLIPVMNQESAQ---------ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDL 583 (678)
Q Consensus 513 ~kl~DfGla~~~~~~~~~---------~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l 583 (678)
.++.|||+...+...... .+-..|++||... +.++.+.|+|++|.+.+|..++..+.... ..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g--------~~ 332 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG--------KN 332 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC--------CC
Confidence 999999998766543211 2346699999986 57899999999999999999988775521 11
Q ss_pred HHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 584 ASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..|.+ .+.. .+-+.-. +....++......+++.+|..|++.+++..
T Consensus 333 ~~W~~-----~r~~-~ip~e~~------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 SSWSQ-----LRQG-YIPLEFC------EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CCccc-----cccc-cCchhhh------cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 12311 0010 0000000 001122333677889999999999877654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.1e-11 Score=131.67 Aligned_cols=165 Identities=25% Similarity=0.302 Sum_probs=125.7
Q ss_pred ecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCCh
Q 044996 390 LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDW 469 (678)
Q Consensus 390 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~ 469 (678)
..++..|.|...+..+....+...+-++.|+.+|||||++++..+...+..|||+|-+. .|..++... .-
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------GK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------HH
Confidence 44677777877776555334456677888999999999999999999999999999884 577777643 23
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc----ccccceeeCccccccC
Q 044996 470 PSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA----QELMIAYKSPEFLQLG 545 (678)
Q Consensus 470 ~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~----~~~~~~y~aPE~~~~~ 545 (678)
....-.+.||+.||.|||+.| +++|++|.-..|++++.|..||++|-++........ ......|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 444567899999999999876 699999999999999999999999988654433221 1112346677655432
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCC
Q 044996 546 RITKKTDVWSLGVLILEIMTGKFP 569 (678)
Q Consensus 546 ~~t~ksDvwS~Gvvl~el~tg~~P 569 (678)
. ...|.|-||++++|++.|..+
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcccC
Confidence 2 456999999999999999443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=2e-11 Score=115.74 Aligned_cols=131 Identities=18% Similarity=0.195 Sum_probs=96.0
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccc-eeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLP-LVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
+.|+.|.++.||+++.. +..+++|....... ....+..|++++..+.+.+++. ++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 45899999999999875 67799998764322 2335678999999987666554 44433 34568999999998775
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCC-CCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP-SLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
.. . . ....++.+++++|+.||.... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~----~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE----D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 32 0 0 113467899999999997521 22469999999999999 66899999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.6e-11 Score=132.16 Aligned_cols=142 Identities=17% Similarity=0.195 Sum_probs=91.3
Q ss_pred cccCccCceeEEEEEecC-CceEEEEEecccChh----------------------------------hH------HHHH
Q 044996 375 EILGSGCFGSSYKASLST-GAMMVVKRFKQMNNV----------------------------------GR------EEFQ 413 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~------~~~~ 413 (678)
+.||+|++|+||+|++.+ |+.||||+.+..-.. .. -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999987 999999999743110 01 1244
Q ss_pred HHHHHHhccC----CCCccceeEEEEe-CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHH-HHHHH
Q 044996 414 EHMRRLGRLR----HPNLLPLVAYYYR-KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG-LQYLY 487 (678)
Q Consensus 414 ~e~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH 487 (678)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.++.+.++-.-... ..+ +..++...+.. +.-++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~----g~d---~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA----GTD---MKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc----CCC---HHHHHHHHHHHHHHHHH
Confidence 5555454442 4444544444443 4567899999999999874221111 111 11222222221 11122
Q ss_pred HhCCCCCCcccCCCCCCEEecCCC----ceEEeecCCccccCcc
Q 044996 488 RELPSLIAPHGHIKSSNVLLNESL----EPVLADYGLIPVMNQE 527 (678)
Q Consensus 488 ~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla~~~~~~ 527 (678)
.. +++|+|+||.||+++.++ ++++.|||++..+...
T Consensus 278 ~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 RD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred hC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 22 799999999999999988 9999999998776543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.1e-11 Score=137.28 Aligned_cols=107 Identities=34% Similarity=0.547 Sum_probs=98.1
Q ss_pred ccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEee
Q 044996 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVS 174 (678)
Q Consensus 97 L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~ 174 (678)
++.|+|++|.|+|.+|.. ++.+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|.. .+++|+.|+|+
T Consensus 420 v~~L~L~~n~L~g~ip~~-i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPND-ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEECCCCCccccCCHH-HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 788999999999999987 899999999999999999999999999999999999999999999984 77899999999
Q ss_pred cCcccccCchhhhcC----CCCCCCCCCCCCCCC
Q 044996 175 NNALFGSISPALREL----DPSSFSGNRDLCGEP 204 (678)
Q Consensus 175 ~N~l~g~ip~~~~~l----~~~~~~gn~~lc~~~ 204 (678)
+|+|+|.+|..+..+ ....+.+|+.+|+.+
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999987653 345688999999754
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5e-12 Score=132.99 Aligned_cols=132 Identities=25% Similarity=0.288 Sum_probs=100.9
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|..|+++ .+....+.+|+.|+.|+||+|.+...-++-+.+. ++|+.|||++|+++ .++++.|..|..|+.
T Consensus 269 ~kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft-qkL~~LdLs~N~i~-~l~~~sf~~L~~Le~ 345 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT-QKLKELDLSSNRIT-RLDEGSFRVLSQLEE 345 (873)
T ss_pred cccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhc-ccceeEeccccccc-cCChhHHHHHHHhhh
Confidence 35788999999987 5555678899999999999999987655433332 67999999999999 788877888888888
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc-----CCCCCcEEEeecCccc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF-----QQKDLVSFNVSNNALF 179 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-----~~~~l~~l~l~~N~l~ 179 (678)
|+|+.|+++-.--..|-.+++|+.|||.+|.+++.|.+. .+..|+.|+|.+|+|.
T Consensus 346 LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk 405 (873)
T KOG4194|consen 346 LNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK 405 (873)
T ss_pred hcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee
Confidence 888888887555556777788888888888888777652 3456666777777664
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.3e-12 Score=117.12 Aligned_cols=126 Identities=25% Similarity=0.394 Sum_probs=108.9
Q ss_pred hhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCC
Q 044996 66 LKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSR 145 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~ 145 (678)
+.++.+++.|.||+|+++-..|.+..+ .+|+.|+|++|++. .+|.+ ++++++|+.|+++.|++. .+|..||.++.
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l--~nlevln~~nnqie-~lp~~-issl~klr~lnvgmnrl~-~lprgfgs~p~ 103 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAEL--KNLEVLNLSNNQIE-ELPTS-ISSLPKLRILNVGMNRLN-ILPRGFGSFPA 103 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHh--hhhhhhhcccchhh-hcChh-hhhchhhhheecchhhhh-cCccccCCCch
Confidence 556777888999999999999988888 77999999999999 89988 899999999999999998 79999999999
Q ss_pred CCeEeccCCccccc-CCc--cCCCCCcEEEeecCcccccCchhhhcCCCCCCCCC
Q 044996 146 LVELRLEGNKFEGQ-IPD--FQQKDLVSFNVSNNALFGSISPALRELDPSSFSGN 197 (678)
Q Consensus 146 L~~l~l~~N~l~g~-~p~--~~~~~l~~l~l~~N~l~g~ip~~~~~l~~~~~~gn 197 (678)
|++|||++|+++.. +|. +.+..|..|+|++|.|. .+|+.++++...++-++
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~l 157 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSL 157 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEee
Confidence 99999999999854 465 35678899999999985 57888887776654443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.6e-10 Score=105.91 Aligned_cols=137 Identities=16% Similarity=0.136 Sum_probs=97.5
Q ss_pred cccCccCceeEEEEEecC-------CceEEEEEecccCh----------------------hhHHHHH----HHHHHHhc
Q 044996 375 EILGSGCFGSSYKASLST-------GAMMVVKRFKQMNN----------------------VGREEFQ----EHMRRLGR 421 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~e~~~l~~ 421 (678)
..||.|.=+.||.|...+ +..+|||..+.... ..++.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 358999999999997543 47899998863110 0122233 79999999
Q ss_pred cCC--CCccceeEEEEeCCceEEEEeccCCCCHHH-HhhccCCCCCCCCChHHHHHHHHHHHHHHHHH-HHhCCCCCCcc
Q 044996 422 LRH--PNLLPLVAYYYRKEEKLLVHEFVPKRSLAV-NLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL-YRELPSLIAPH 497 (678)
Q Consensus 422 l~H--~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~~ivH 497 (678)
+.. -++.+++++ ...+|||||+.+..+.. .++.. .++..+...+..+++.+|.+| |.. ++||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~----glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKEC----NLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhC----Ceec
Confidence 854 456666654 56789999997654422 22211 244455677889999999999 544 7999
Q ss_pred cCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 498 GHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 498 rdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+||++.|||++ ++.+.|+|||.+-....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999999997 46799999998765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.5e-12 Score=132.32 Aligned_cols=136 Identities=30% Similarity=0.419 Sum_probs=99.3
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccc-----------------
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS----------------- 108 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~----------------- 108 (678)
..+-|+|+.|++. +||.+.+-+|+.|-.||||+|+|.--+|.+.++ ..|+.|+|++|-|.
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL--~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLh 203 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRL--SMLQTLKLSNNPLNHFQLRQLPSMTSLSVLH 203 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHH--hhhhhhhcCCChhhHHHHhcCccchhhhhhh
Confidence 3566777777776 788888889999999999999998877766665 44666666665442
Q ss_pred --------cccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCc-cCCCCCcEEEeecCccc
Q 044996 109 --------GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQKDLVSFNVSNNALF 179 (678)
Q Consensus 109 --------G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~~l~~l~l~~N~l~ 179 (678)
..||++ +..|.+|..+|||.|++. .+|+.+.++.+|+.|+|++|.++-.--. ..+.+|++|+||.|+|+
T Consensus 204 ms~TqRTl~N~Pts-ld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt 281 (1255)
T KOG0444|consen 204 MSNTQRTLDNIPTS-LDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT 281 (1255)
T ss_pred cccccchhhcCCCc-hhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc
Confidence 246766 677888888899999887 7888888999999999999988732111 24457777788877775
Q ss_pred ccCchhhh
Q 044996 180 GSISPALR 187 (678)
Q Consensus 180 g~ip~~~~ 187 (678)
. +|..+.
T Consensus 282 ~-LP~avc 288 (1255)
T KOG0444|consen 282 V-LPDAVC 288 (1255)
T ss_pred c-chHHHh
Confidence 3 555443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.3e-10 Score=112.28 Aligned_cols=143 Identities=20% Similarity=0.181 Sum_probs=109.2
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccCh-hhHHHHHHHHHHHhccCC--CCccceeEEEEeCC---ceEEEEeccC
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRH--PNLLPLVAYYYRKE---EKLLVHEFVP 448 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~---~~~lv~Ey~~ 448 (678)
+.|+.|.++.||++...+|..+++|....... ....++..|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999887778899998764322 235578899999999976 34577777766532 5689999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL-------------------------------------- 490 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 490 (678)
+.++.+.+.. ..++..++..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888765431 13677778888888888888888421
Q ss_pred --------------CCCCCcccCCCCCCEEecC--CCceEEeecCCccc
Q 044996 491 --------------PSLIAPHGHIKSSNVLLNE--SLEPVLADYGLIPV 523 (678)
Q Consensus 491 --------------~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~ 523 (678)
....++|+|+++.||+++. +..+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245789999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-11 Score=130.89 Aligned_cols=145 Identities=31% Similarity=0.430 Sum_probs=103.9
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccc-cccChhhhcCCcccce
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS-GEIPTDAFDGMTSLRK 124 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~-G~ip~~~~~~l~~L~~ 124 (678)
+++=|.|...+|. .+|. .++.|.+|+.|.+++|+|....-++..+ +.|+.+++..|+|. ..||++ +-.|..|..
T Consensus 33 ~~~WLkLnrt~L~-~vPe-EL~~lqkLEHLs~~HN~L~~vhGELs~L--p~LRsv~~R~N~LKnsGiP~d-iF~l~dLt~ 107 (1255)
T KOG0444|consen 33 QMTWLKLNRTKLE-QVPE-ELSRLQKLEHLSMAHNQLISVHGELSDL--PRLRSVIVRDNNLKNSGIPTD-IFRLKDLTI 107 (1255)
T ss_pred heeEEEechhhhh-hChH-HHHHHhhhhhhhhhhhhhHhhhhhhccc--hhhHHHhhhccccccCCCCch-hccccccee
Confidence 3444444444443 3453 4888889999999999887544445555 66888888888883 348887 457888888
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEeecCcccccCchhhhc---CCCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGNR 198 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn~ 198 (678)
||||+|++. ..|..+-.-.++-+|+|++|++. +||.. ++..|-+||||+|.|. .+|+.++. |....+++||
T Consensus 108 lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 108 LDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred eecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh
Confidence 888888887 78888888888888888888887 67763 5677888888888885 45655443 3445666665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2e-09 Score=99.40 Aligned_cols=130 Identities=21% Similarity=0.289 Sum_probs=99.3
Q ss_pred ccCccCceeEEEEEecCCceEEEEEec-cc-------ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 376 ILGSGCFGSSYKASLSTGAMMVVKRFK-QM-------NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+++|+=+.+|.+.+.... +++|.-. +. .....++-.+|++++.+++--.|-..+=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999774333 5555332 21 0122345678999999987666655555666788899999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
++-.|.+.+... +..++..|-.-+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888653 246888888899999987 899999999999998765 89999999764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.6e-11 Score=118.36 Aligned_cols=88 Identities=24% Similarity=0.318 Sum_probs=60.8
Q ss_pred hcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCc--c-CCCCCcEEEeecCcccccCchhhh---cC
Q 044996 116 FDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--F-QQKDLVSFNVSNNALFGSISPALR---EL 189 (678)
Q Consensus 116 ~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~-~~~~l~~l~l~~N~l~g~ip~~~~---~l 189 (678)
|..|++|+.|+|++|++++.-+.+|..+..|++|.|..|++. .+-. + .+..|+.|+|.+|+|+---|..+. .+
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l 348 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL 348 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence 445666666667777766666666666666666666666664 1211 1 457899999999999977776654 35
Q ss_pred CCCCCCCCCCCCCCC
Q 044996 190 DPSSFSGNRDLCGEP 204 (678)
Q Consensus 190 ~~~~~~gn~~lc~~~ 204 (678)
....+.+||+.|.+.
T Consensus 349 ~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 349 STLNLLSNPFNCNCR 363 (498)
T ss_pred eeeehccCcccCccc
Confidence 566788999999653
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.9e-12 Score=125.46 Aligned_cols=140 Identities=28% Similarity=0.457 Sum_probs=106.5
Q ss_pred EEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeecc
Q 044996 49 GLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLA 128 (678)
Q Consensus 49 ~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~ 128 (678)
.+++.+|.+. .+|+..+. ++.|+.||...|-+...+|+++.+ .+|.-|||..|.+. .+| + |+++..|+.|.++
T Consensus 164 ~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~tlP~~lg~l--~~L~~LyL~~Nki~-~lP-e-f~gcs~L~Elh~g 236 (565)
T KOG0472|consen 164 KLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLETLPPELGGL--ESLELLYLRRNKIR-FLP-E-FPGCSLLKELHVG 236 (565)
T ss_pred Hhhccccchh-hCCHHHHH-HHHHHhcccchhhhhcCChhhcch--hhhHHHHhhhcccc-cCC-C-CCccHHHHHHHhc
Confidence 3444444444 34444444 777777888877777666667666 66888888888888 787 4 8888888888888
Q ss_pred ccccccCCchhhc-CCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhcC--CCCCCCCCC
Q 044996 129 DNQFNGPIPESLT-RLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALREL--DPSSFSGNR 198 (678)
Q Consensus 129 ~N~~~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~l--~~~~~~gn~ 198 (678)
.|++. .+|.+.+ +|.+|.+|||..|++. +.|+. .+.+|..||+|||.+++ +|.+++++ ....+.|||
T Consensus 237 ~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnlhL~~L~leGNP 308 (565)
T KOG0472|consen 237 ENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNLHLKFLALEGNP 308 (565)
T ss_pred ccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccceeeehhhcCCc
Confidence 88887 6888776 8999999999999998 78875 56789999999999986 78888876 355677886
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.8e-11 Score=132.98 Aligned_cols=149 Identities=27% Similarity=0.433 Sum_probs=119.2
Q ss_pred cEEEEEeCCCCceeecChHHh-------------------------hcCCCCCEEEccCCccccc-CCcccccCCCCccE
Q 044996 46 KIWGLKLEDMGLQGNIDITIL-------------------------KELREMRTLSLMRNNLEGP-MPDLRQLGNGALRS 99 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l-------------------------~~l~~L~~L~Ls~N~l~g~-~p~~~~~~~~~L~~ 99 (678)
.+..|+|..|+|. .+|+..+ ..+..|+.|+|.+|.|+-. +|.+.+. ..|++
T Consensus 311 sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~--~hLKV 387 (1081)
T KOG0618|consen 311 SLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNF--KHLKV 387 (1081)
T ss_pred eeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccc--cceee
Confidence 4888999998886 4443211 1234566788888888753 5655555 67999
Q ss_pred EEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc-CCCCCcEEEeecCcc
Q 044996 100 VYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF-QQKDLVSFNVSNNAL 178 (678)
Q Consensus 100 L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l 178 (678)
|+|++|+|. ++|...+.++..|+.|+||+|.|+ .+|..+.++..|++|...+|++. .+|.. .++.|+.+|||.|+|
T Consensus 388 LhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L 464 (1081)
T KOG0618|consen 388 LHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNL 464 (1081)
T ss_pred eeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchh
Confidence 999999998 899998999999999999999999 79999999999999999999998 67764 778999999999999
Q ss_pred c-ccCchhh--hcCCCCCCCCCCCC
Q 044996 179 F-GSISPAL--RELDPSSFSGNRDL 200 (678)
Q Consensus 179 ~-g~ip~~~--~~l~~~~~~gn~~l 200 (678)
+ +.+|..+ .+|.-.+++||+++
T Consensus 465 ~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 465 SEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhhhhhhhCCCcccceeeccCCccc
Confidence 7 4555443 36667789999864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-09 Score=124.83 Aligned_cols=163 Identities=21% Similarity=0.328 Sum_probs=101.0
Q ss_pred ChHHHHHHHHhcCCCCCCCCC----CCCCCCCCCCCC-----------CCcceEEecCCcEEEEEeCC------------
Q 044996 2 TDSQTLLTLKQSLSNPTALAN----WDDRTPPCNENG-----------ANWNGVLCHRGKIWGLKLED------------ 54 (678)
Q Consensus 2 ~~~~aLl~~k~~l~~~~~l~~----W~~~~~~c~~~~-----------~~w~gv~C~~~~v~~l~l~~------------ 54 (678)
.|...++++.+.|..|..+.+ |+..+++|..+. ..=.-|.|..+.|+.+...+
T Consensus 63 ~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~~~~~~~ 142 (754)
T PRK15370 63 EEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASSASGSKD 142 (754)
T ss_pred HHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCcccccccccccccccCCCCCC
Confidence 367889999999998876666 999899997554 23334778655555444333
Q ss_pred ---------------------------------------------CCceeecChHHhhcCCCCCEEEccCCcccccCCcc
Q 044996 55 ---------------------------------------------MGLQGNIDITILKELREMRTLSLMRNNLEGPMPDL 89 (678)
Q Consensus 55 ---------------------------------------------~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~ 89 (678)
++|. .+|.. + .+.|+.|+|++|+|+. +|..
T Consensus 143 ~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~-I--p~~L~~L~Ls~N~Lts-LP~~ 217 (754)
T PRK15370 143 AVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPAC-I--PEQITTLILDNNELKS-LPEN 217 (754)
T ss_pred hhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcc-c--ccCCcEEEecCCCCCc-CChh
Confidence 2222 22221 1 1346666666666663 3421
Q ss_pred cccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCc
Q 044996 90 RQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLV 169 (678)
Q Consensus 90 ~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~ 169 (678)
.. .+|+.|+|++|+|+ .||.. +. .+|+.|+|++|++. .+|..+. .+|+.|+|++|+|+ .+|.....+|+
T Consensus 218 -l~--~nL~~L~Ls~N~Lt-sLP~~-l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~~sL~ 286 (754)
T PRK15370 218 -LQ--GNIKTLYANSNQLT-SIPAT-LP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLPEELR 286 (754)
T ss_pred -hc--cCCCEEECCCCccc-cCChh-hh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccCCCCc
Confidence 11 35777777777776 56654 22 35777777777776 5666553 46777777777777 45654445677
Q ss_pred EEEeecCcccc
Q 044996 170 SFNVSNNALFG 180 (678)
Q Consensus 170 ~l~l~~N~l~g 180 (678)
.|+|++|+|++
T Consensus 287 ~L~Ls~N~Lt~ 297 (754)
T PRK15370 287 YLSVYDNSIRT 297 (754)
T ss_pred EEECCCCcccc
Confidence 77777777764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3e-10 Score=121.89 Aligned_cols=240 Identities=17% Similarity=0.156 Sum_probs=163.4
Q ss_pred cccCccCceeEEEEEe--cCCceEEEEEecccChhhHHH--HHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASL--STGAMMVVKRFKQMNNVGREE--FQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
..||.|.|+.||+... .++..+++|.+.........+ -..|+.+...+ .|.++++++..+......|+-.||+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 4699999999999864 457788888776533222222 23455555554 588889888777777788899999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC-CceEEeecCCccccCccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES-LEPVLADYGLIPVMNQES 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~~~ 528 (678)
+++...+.-.. .++...++++..+++.++.++|.. .++|+|+||+||++..+ +..++.|||.+..+.-..
T Consensus 351 ~s~~l~~~~~~-----~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 351 GSSSLRSVTSQ-----MLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cchhhhhHHHH-----hcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhccccccccccceec
Confidence 99886663221 477788899999999999999954 79999999999999886 888999999986432211
Q ss_pred -cccccceee--CccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 -AQELMIAYK--SPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 -~~~~~~~y~--aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
.....-+++ +++......+-.+.|+||||.-+.|.+++..--. ....|... ..+.. +.+
T Consensus 422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~----------~~~~~~~i--~~~~~------p~~ 483 (524)
T KOG0601|consen 422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE----------SGVQSLTI--RSGDT------PNL 483 (524)
T ss_pred ccccccccccccchhhccccccccccccccccccccccccCcccCc----------ccccceee--ecccc------cCC
Confidence 111223344 5555566678899999999999999999875422 11222110 00000 111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
.+ ....+..++..+...++..||.+.+.....+...
T Consensus 484 ~~------~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 484 PG------LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred Cc------hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 11 1123444455677999999999888877655444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.6e-09 Score=95.39 Aligned_cols=141 Identities=18% Similarity=0.276 Sum_probs=103.2
Q ss_pred cccCccCceeEEEEEecCCceEEEEE-eccc-------ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKR-FKQM-------NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+|-+|+-+.|+++.+ .|+..+||. +.+. ....+.+..+|++.+.+++--.|.-..=++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5688999999999988 456655553 2221 123456778999999998766665555566677778899999
Q ss_pred cCC-CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC---ceEEeecCCcc
Q 044996 447 VPK-RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL---EPVLADYGLIP 522 (678)
Q Consensus 447 ~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla~ 522 (678)
+++ -++.+++...... ...-.....+++.|-..+.-||.+ .|+|+||..+||+|..++ .+.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchh
Confidence 965 3788888765432 122222367889999999999977 799999999999997554 35899999964
Q ss_pred c
Q 044996 523 V 523 (678)
Q Consensus 523 ~ 523 (678)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=5.1e-10 Score=118.14 Aligned_cols=131 Identities=24% Similarity=0.295 Sum_probs=79.2
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCccccc-CCccccc----------------------CCCCccEEEc
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGP-MPDLRQL----------------------GNGALRSVYL 102 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~-~p~~~~~----------------------~~~~L~~L~L 102 (678)
.++.|.|+.|.++ ++|.-.|.+|++|+.|+|..|++.-. .-.|.++ +..++++|+|
T Consensus 198 sL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L 276 (873)
T KOG4194|consen 198 SLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNL 276 (873)
T ss_pred hheeeecccCccc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeec
Confidence 5777888888887 78888888899999999999987632 0011222 1134555666
Q ss_pred ccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEeecCccc
Q 044996 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNNALF 179 (678)
Q Consensus 103 s~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N~l~ 179 (678)
+.|+++ .+-.+.+-+|++|+.|+||+|.++...++++..+++|++|+|++|+++ .+++. .+..|+.|+|++|.++
T Consensus 277 ~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~ 354 (873)
T KOG4194|consen 277 ETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSID 354 (873)
T ss_pred ccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchH
Confidence 666655 344444455566666666666666555555666666666666666655 33321 3345556666666553
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.9e-08 Score=99.53 Aligned_cols=142 Identities=15% Similarity=0.085 Sum_probs=101.1
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChh-----------hHHHHHHHHHHHhccCCCC--ccceeEEEEe----
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNV-----------GREEFQEHMRRLGRLRHPN--LLPLVAYYYR---- 436 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~---- 436 (678)
.+.+-+-....|++..+ +|+.+.||+....... ....+.+|.+.+.+|...+ +.+++++...
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34455444555777766 5678999977532211 1124788999988885443 3455666543
Q ss_pred -CCceEEEEeccCCC-CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-----
Q 044996 437 -KEEKLLVHEFVPKR-SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE----- 509 (678)
Q Consensus 437 -~~~~~lv~Ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~----- 509 (678)
....+||+|++++- +|.+++..... ...+...+..++.+++..+.-||.. +|+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCC
Confidence 23478999999875 89988853211 1345567779999999999999977 8999999999999985
Q ss_pred --CCceEEeecCCccc
Q 044996 510 --SLEPVLADYGLIPV 523 (678)
Q Consensus 510 --~~~~kl~DfGla~~ 523 (678)
+..+.++||+.++.
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 57899999998753
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.2e-09 Score=82.81 Aligned_cols=61 Identities=34% Similarity=0.572 Sum_probs=53.0
Q ss_pred CCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcc
Q 044996 95 GALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156 (678)
Q Consensus 95 ~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l 156 (678)
++|+.|+|++|+|+ .||++.|.++++|++|+|++|.++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 35888999999998 78888889999999999999999877778889999999999999875
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.4e-08 Score=95.24 Aligned_cols=127 Identities=17% Similarity=0.248 Sum_probs=83.5
Q ss_pred eEEEEEecCCceEEEEEecccCh--------------------------hhHHHHHHHHHHHhccCCC--CccceeEEEE
Q 044996 384 SSYKASLSTGAMMVVKRFKQMNN--------------------------VGREEFQEHMRRLGRLRHP--NLLPLVAYYY 435 (678)
Q Consensus 384 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~H~--niv~l~~~~~ 435 (678)
.||.|...+|..+|+|..+.... ......++|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999988999999998763110 0123467899999999866 45566544
Q ss_pred eCCceEEEEeccC--CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCce
Q 044996 436 RKEEKLLVHEFVP--KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEP 513 (678)
Q Consensus 436 ~~~~~~lv~Ey~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~ 513 (678)
....|||||++ +..+..+.... ++......++.+++..+..+++. .+|+|+||.+.|||++++ .+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 24579999998 54444332211 22344567888888877776533 289999999999999988 99
Q ss_pred EEeecCCccccC
Q 044996 514 VLADYGLIPVMN 525 (678)
Q Consensus 514 kl~DfGla~~~~ 525 (678)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999876544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=7e-09 Score=118.30 Aligned_cols=34 Identities=29% Similarity=0.332 Sum_probs=19.1
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccc
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEG 84 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g 84 (678)
+++.|+|.+|+|. .||. .+++|++|+|++|+|+.
T Consensus 223 ~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lts 256 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS 256 (788)
T ss_pred CCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccCc
Confidence 3455555555555 3442 24566666666666663
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.8e-09 Score=120.43 Aligned_cols=112 Identities=28% Similarity=0.493 Sum_probs=80.6
Q ss_pred CCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeE
Q 044996 70 REMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVEL 149 (678)
Q Consensus 70 ~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l 149 (678)
.+|+.|+|++|+|++ +|.+ . .+|+.|++++|+|+ .||.. ..+|+.|+|++|+|++ +|.. .++|+.|
T Consensus 342 ~~Lq~LdLS~N~Ls~-LP~l--p--~~L~~L~Ls~N~L~-~LP~l----~~~L~~LdLs~N~Lt~-LP~l---~s~L~~L 407 (788)
T PRK15387 342 SGLQELSVSDNQLAS-LPTL--P--SELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNRLTS-LPVL---PSELKEL 407 (788)
T ss_pred cccceEecCCCccCC-CCCC--C--cccceehhhccccc-cCccc----ccccceEEecCCcccC-CCCc---ccCCCEE
Confidence 468899999999986 5542 1 45888888888888 47743 2578888888888884 6653 3578888
Q ss_pred eccCCcccccCCccCCCCCcEEEeecCcccccCchhhhcC---CCCCCCCCC
Q 044996 150 RLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALREL---DPSSFSGNR 198 (678)
Q Consensus 150 ~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~l---~~~~~~gn~ 198 (678)
+|++|+|++ +|.. ..+|+.|++++|+|+ .+|..+.++ ....+.+|+
T Consensus 408 dLS~N~Lss-IP~l-~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~ 456 (788)
T PRK15387 408 MVSGNRLTS-LPML-PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 456 (788)
T ss_pred EccCCcCCC-CCcc-hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCC
Confidence 888888874 6653 346778888888886 678766544 344566775
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.2e-09 Score=108.75 Aligned_cols=126 Identities=25% Similarity=0.416 Sum_probs=71.5
Q ss_pred EEEEEeCCCCceeecCh-----------------------HHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEc
Q 044996 47 IWGLKLEDMGLQGNIDI-----------------------TILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYL 102 (678)
Q Consensus 47 v~~l~l~~~~l~g~~~~-----------------------~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~L 102 (678)
|+.++++.|.|. ++|. ..++.+++|..|+|++|-+.. +| +++.+ ..|+.|||
T Consensus 390 Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~l--v~Lq~Lnl 465 (565)
T KOG0472|consen 390 VTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLND-LPEEMGSL--VRLQTLNL 465 (565)
T ss_pred eEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhh-cchhhhhh--hhhheecc
Confidence 899999999876 4443 234555555555555555543 33 33333 33555555
Q ss_pred ccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCccc
Q 044996 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALF 179 (678)
Q Consensus 103 s~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~ 179 (678)
|.|+|. .+|.. +-.+..|+.+-.++|++...-|..+.++.+|..|||.+|.+. .||+. ++++|++|.+.+|.|.
T Consensus 466 S~NrFr-~lP~~-~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 466 SFNRFR-MLPEC-LYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccccc-cchHH-HhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 555555 45543 344444444444555554333334666666666666666665 44442 5566666666666664
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.9e-09 Score=118.95 Aligned_cols=120 Identities=26% Similarity=0.400 Sum_probs=92.9
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
..++.|+|++|.|. .+|... ..+|+.|+|++|+|+. +|.. +. .+|+.|+|++|++. .||.. +. .+|+.
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l---~~nL~~L~Ls~N~Lts-LP~~--l~-~~L~~L~Ls~N~L~-~LP~~-l~--s~L~~ 266 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENL---QGNIKTLYANSNQLTS-IPAT--LP-DTIQEMELSINRIT-ELPER-LP--SALQS 266 (754)
T ss_pred cCCcEEEecCCCCC-cCChhh---ccCCCEEECCCCcccc-CChh--hh-ccccEEECcCCccC-cCChh-Hh--CCCCE
Confidence 35889999999998 687653 3589999999999984 5631 11 46999999999998 78876 43 57899
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g 180 (678)
|+|++|+|+ .+|..+. .+|+.|+|++|+|++ +|.....+|+.|++++|+|++
T Consensus 267 L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 267 LDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLTA 318 (754)
T ss_pred EECcCCccC-ccccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCcccc
Confidence 999999998 5787664 589999999999984 565444567788888888874
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.5e-09 Score=96.77 Aligned_cols=107 Identities=27% Similarity=0.425 Sum_probs=25.4
Q ss_pred hhcCCCCCEEEccCCcccccCCccc-ccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhh-cCC
Q 044996 66 LKELREMRTLSLMRNNLEGPMPDLR-QLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESL-TRL 143 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N~l~g~~p~~~-~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~-~~l 143 (678)
+.+...++.|+|.+|.++- |..+. .+ .+|+.|||++|.++ .|+ . +..++.|+.|+|++|+++. +...+ ..+
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie~L~~~l--~~L~~L~Ls~N~I~-~l~-~-l~~L~~L~~L~L~~N~I~~-i~~~l~~~l 87 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IENLGATL--DKLEVLDLSNNQIT-KLE-G-LPGLPRLKTLDLSNNRISS-ISEGLDKNL 87 (175)
T ss_dssp ----------------------S--TT---TT--EEE-TTS--S---T-T-----TT--EEE--SS---S--CHHHHHH-
T ss_pred ccccccccccccccccccc-ccchhhhh--cCCCEEECCCCCCc-ccc-C-ccChhhhhhcccCCCCCCc-cccchHHhC
Confidence 3344455666666666543 22222 12 34666666666665 443 2 5556666666666666653 33333 245
Q ss_pred CCCCeEeccCCccccc--C-CccCCCCCcEEEeecCccc
Q 044996 144 SRLVELRLEGNKFEGQ--I-PDFQQKDLVSFNVSNNALF 179 (678)
Q Consensus 144 ~~L~~l~l~~N~l~g~--~-p~~~~~~l~~l~l~~N~l~ 179 (678)
++|+.|+|++|++..- + +-..+++|+.|+|.+|.++
T Consensus 88 p~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 88 PNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 6666666666665421 1 1113455666666666554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.8e-09 Score=120.16 Aligned_cols=189 Identities=22% Similarity=0.247 Sum_probs=130.6
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
+-+-+|.++.++.++-. .|....+|...... ....+....+-.++-..+||-++....-+......+||++|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 35778889988877532 33333333332221 111222223333333345677776655555567889999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC-----
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN----- 525 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~----- 525 (678)
+|...|+.... .+..-....+..+..+++|||.. .+.|||++|.|+|+..++..+++|||......
T Consensus 890 ~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 890 DLPSKLHNSGC-----LSAEPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred CchhhhhcCCC-----cccccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999986542 22222234556677889999954 47899999999999999999999998432110
Q ss_pred --c----------------------------cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 044996 526 --Q----------------------------ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANF 572 (678)
Q Consensus 526 --~----------------------------~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~ 572 (678)
. .....++..|.+||.+.+......+|.|++|++++|.++|..||..
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0111245779999999999999999999999999999999999973
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.3e-07 Score=99.57 Aligned_cols=170 Identities=16% Similarity=0.258 Sum_probs=124.7
Q ss_pred CceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe----CCceEEEEeccCC-CCHHH
Q 044996 381 CFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR----KEEKLLVHEFVPK-RSLAV 454 (678)
Q Consensus 381 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~Ey~~~-gsL~~ 454 (678)
--.+.||+.. .+|..++.|+++..........-.-++..+++.|.|||++..++.. +..+++||+|.+. ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457889854 5789999999943222222122234678899999999999988873 3468899999986 66766
Q ss_pred HhhccCC----------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 455 NLHGHQA----------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 455 ~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
+-..... .....+.+...+.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|+...+
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeee
Confidence 5432211 1123467788999999999999999976 6777999999999999999999999987666
Q ss_pred CccccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCC
Q 044996 525 NQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGK 567 (678)
Q Consensus 525 ~~~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~ 567 (678)
..+.. |-+. --.+-|.=.||.+++-|.||.
T Consensus 444 ~~d~~----------~~le---~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 444 QEDPT----------EPLE---SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred cCCCC----------cchh---HHhhhhHHHHHHHHHHHhhcc
Confidence 54431 1121 134678999999999999995
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.1e-07 Score=91.23 Aligned_cols=139 Identities=21% Similarity=0.242 Sum_probs=97.9
Q ss_pred HHHHHHhccccCccCceeEEEEEecCCceEEEEEecccC----------------------hhhHHHHHHHHHHHhccCC
Q 044996 367 HDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMN----------------------NVGREEFQEHMRRLGRLRH 424 (678)
Q Consensus 367 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~H 424 (678)
.....++++.||-|.=+.||.|....|..++||.-+... ...+...++|.++|.+|.-
T Consensus 89 r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 89 RGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred cChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 344556789999999999999999999999999643210 1123456789999999975
Q ss_pred C--CccceeEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCC
Q 044996 425 P--NLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKS 502 (678)
Q Consensus 425 ~--niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~ 502 (678)
. .|.+.+++ +...+||||+++--|...- ++-...-.|+..|+.-+.-+-+. ++||+|+..
T Consensus 169 ~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSe 230 (304)
T COG0478 169 EGVKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSE 230 (304)
T ss_pred cCCCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHc----CccccCCch
Confidence 4 66666654 5668999999885554321 11222234444444444444432 799999999
Q ss_pred CCEEecCCCceEEeecCCccc
Q 044996 503 SNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 503 ~NILl~~~~~~kl~DfGla~~ 523 (678)
-||++++|+.+.++||-.+..
T Consensus 231 fNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 231 FNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred heEEEecCCCEEEEeCccccc
Confidence 999999999999999965543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.5e-09 Score=117.77 Aligned_cols=125 Identities=26% Similarity=0.409 Sum_probs=104.6
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc--ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.+..|.|.+|.|.-..-+ .|-+..+|+.|+|++|+|. .+|. +.++ ..|+.|+||+|.|+ .||.. +.++..|+
T Consensus 360 ~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~-~fpas~~~kl--e~LeeL~LSGNkL~-~Lp~t-va~~~~L~ 433 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLN-SFPASKLRKL--EELEELNLSGNKLT-TLPDT-VANLGRLH 433 (1081)
T ss_pred HHHHHHHhcCcccccchh-hhccccceeeeeecccccc-cCCHHHHhch--HHhHHHhcccchhh-hhhHH-HHhhhhhH
Confidence 477788888888765433 4889999999999999996 4663 3344 66999999999999 99976 89999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCccccc-CCcc-CCCCCcEEEeecCcc
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQ-IPDF-QQKDLVSFNVSNNAL 178 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~-~p~~-~~~~l~~l~l~~N~l 178 (678)
+|...+|++. .+| ++.++++|+.+||+.|+|+-. +|.. ...+|++|||++|.-
T Consensus 434 tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 434 TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999998 678 899999999999999999843 4543 338999999999973
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.62 E-value=3e-08 Score=93.12 Aligned_cols=120 Identities=28% Similarity=0.397 Sum_probs=50.0
Q ss_pred cEEEEEeCCCCceeecChHHhh-cCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 46 KIWGLKLEDMGLQGNIDITILK-ELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
++..|+|.+|.+. .|. .++ .|++|+.|+|++|.++. ++.+..+ ..|+.|+|++|+++ .|.+.+...+++|+.
T Consensus 20 ~~~~L~L~~n~I~-~Ie--~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L--~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE--NLGATLDKLEVLDLSNNQITK-LEGLPGL--PRLKTLDLSNNRIS-SISEGLDKNLPNLQE 92 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS----S-CHHHHHH-TT--E
T ss_pred ccccccccccccc-ccc--chhhhhcCCCEEECCCCCCcc-ccCccCh--hhhhhcccCCCCCC-ccccchHHhCCcCCE
Confidence 5678999999887 443 355 58899999999999985 5555556 77999999999999 676553357899999
Q ss_pred eeccccccccC-CchhhcCCCCCCeEeccCCcccccCCcc------CCCCCcEEEe
Q 044996 125 LLLADNQFNGP-IPESLTRLSRLVELRLEGNKFEGQIPDF------QQKDLVSFNV 173 (678)
Q Consensus 125 l~l~~N~~~g~-~p~~~~~l~~L~~l~l~~N~l~g~~p~~------~~~~l~~l~l 173 (678)
|+|++|++... -=..+..+++|+.|+|.+|.++-. +.. .+++|+.||-
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 99999999752 124578899999999999998743 432 4567777763
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.7e-09 Score=112.71 Aligned_cols=127 Identities=21% Similarity=0.352 Sum_probs=104.1
Q ss_pred HhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCC
Q 044996 65 ILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLS 144 (678)
Q Consensus 65 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~ 144 (678)
.+.+|..|++|||+.|+++-..+.+..+ -|+.|-+++|+++ .+|++ ++.+..|..||.+.|++. .+|..++.|.
T Consensus 116 ~i~~L~~lt~l~ls~NqlS~lp~~lC~l---pLkvli~sNNkl~-~lp~~-ig~~~tl~~ld~s~nei~-slpsql~~l~ 189 (722)
T KOG0532|consen 116 AICNLEALTFLDLSSNQLSHLPDGLCDL---PLKVLIVSNNKLT-SLPEE-IGLLPTLAHLDVSKNEIQ-SLPSQLGYLT 189 (722)
T ss_pred hhhhhhHHHHhhhccchhhcCChhhhcC---cceeEEEecCccc-cCCcc-cccchhHHHhhhhhhhhh-hchHHhhhHH
Confidence 3788999999999999998766666665 3899999999998 89988 788899999999999998 7899999999
Q ss_pred CCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCchhhhcCC---CCCCCCCC
Q 044996 145 RLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALRELD---PSSFSGNR 198 (678)
Q Consensus 145 ~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~l~---~~~~~gn~ 198 (678)
+|+.|++..|++.-..+....-.|..||+|+|+++ .||-.+.++. ...+..||
T Consensus 190 slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 190 SLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNP 245 (722)
T ss_pred HHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCC
Confidence 99999999999985444455567889999999985 5888776654 44566665
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.8e-07 Score=114.42 Aligned_cols=63 Identities=24% Similarity=0.305 Sum_probs=35.6
Q ss_pred ccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc-CCCCCcEEEeecCcccccCc
Q 044996 121 SLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 121 ~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ip 183 (678)
+|+.|+|++|...+.+|.++++|++|+.|+|++|...+.+|.. .+++|+.|+|++|.....+|
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p 842 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFP 842 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccc
Confidence 4556666666666666666666666777766666544455543 34455555555544333333
|
syringae 6; Provisional |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.5e-06 Score=87.92 Aligned_cols=265 Identities=16% Similarity=0.166 Sum_probs=150.9
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEE----E--eCCc-eEEEEe
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYY----Y--RKEE-KLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~----~--~~~~-~~lv~E 445 (678)
+.-||+|+-+.+|-.--- .-.+.|++..-......+. +..|... .||-+-.-+.+- + +... .-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 456999999999965221 1234566654333222222 2233333 466443312221 1 1112 446666
Q ss_pred ccCCC-CHHHHhh-ccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 446 FVPKR-SLAVNLH-GHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 446 y~~~g-sL~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
.+++. -...++. ..+...-+..+|...+++++.+|.+.+-||+. +.+-+|+.++|+|+.+++.+.|.|-..-.+
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~----Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH----GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc----CCcccccCccceeeecCceEEEEcccceee
Confidence 66542 2223332 11222345789999999999999999999987 667799999999999999999987543222
Q ss_pred cCccc---cccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhC-CCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 524 MNQES---AQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTG-KFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 524 ~~~~~---~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg-~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
..... ...+...|.+||.-. +..-+...|-|.+||++++++.| +.||+.+........-+.. .+..+
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~----~Ia~g 242 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET----DIAHG 242 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh----hhhcc
Confidence 22221 223456799999654 33457789999999999999985 9999854322111111110 00111
Q ss_pred Cccccccchh--hh---cccCCHHHHHHHHHHHhhcCcc--ccccCCCHHHHHHHHHHhhccCCC
Q 044996 595 DNRTEVFDKE--MA---DERNSEGEMVKLLKIGLACCEE--EVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 595 ~~~~~~~d~~--l~---~~~~~~~~~~~~~~l~~~Cl~~--~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
... ..-|.. ++ .....+.-...+-.+-.+|... ++.-||+++--+..|.++.+....
T Consensus 243 ~f~-ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 243 RFA-YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred eee-echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 000 011110 00 0001111223344455577643 367999999998888877665443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.4e-07 Score=113.26 Aligned_cols=111 Identities=23% Similarity=0.283 Sum_probs=50.8
Q ss_pred CCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCe
Q 044996 69 LREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVE 148 (678)
Q Consensus 69 l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~ 148 (678)
+.+|+.|+|++|++.-....+..+ ++|+.|+|++|+..+.+|. ++.+++|+.|+|++|..-..+|.+++++++|+.
T Consensus 610 ~~~L~~L~L~~s~l~~L~~~~~~l--~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~ 685 (1153)
T PLN03210 610 PENLVKLQMQGSKLEKLWDGVHSL--TGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLED 685 (1153)
T ss_pred ccCCcEEECcCccccccccccccC--CCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCE
Confidence 344555555555444221122222 3455555554443334442 444555555555554444455555555555555
Q ss_pred EeccCCcccccCCcc-CCCCCcEEEeecCcccccCc
Q 044996 149 LRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 149 l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ip 183 (678)
|+|++|...+.+|.. .+++|+.|++++|...+.+|
T Consensus 686 L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p 721 (1153)
T PLN03210 686 LDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFP 721 (1153)
T ss_pred EeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccc
Confidence 555554444444432 34445555555444434444
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.8e-08 Score=101.93 Aligned_cols=134 Identities=26% Similarity=0.299 Sum_probs=81.8
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCC---CCEEEccCCccccc-CCc----ccccCCCCccEEEcccCccccccChh--
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELRE---MRTLSLMRNNLEGP-MPD----LRQLGNGALRSVYLSNNRFSGEIPTD-- 114 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~---L~~L~Ls~N~l~g~-~p~----~~~~~~~~L~~L~Ls~N~l~G~ip~~-- 114 (678)
.++..|+|+++.+.+..+. .+..+.. |+.|+|++|++++. .+. +..+ ..+|+.|+|++|++++.....
T Consensus 81 ~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~-~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 81 CGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL-PPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred CceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhC-CCCceEEEcCCCcCCchHHHHHH
Confidence 4688888888887754432 3444444 88888888887731 110 1111 145777888888777432211
Q ss_pred -hhcCCcccceeeccccccccC----CchhhcCCCCCCeEeccCCcccccCCc------cCCCCCcEEEeecCcccc
Q 044996 115 -AFDGMTSLRKLLLADNQFNGP----IPESLTRLSRLVELRLEGNKFEGQIPD------FQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 115 -~~~~l~~L~~l~l~~N~~~g~----~p~~~~~l~~L~~l~l~~N~l~g~~p~------~~~~~l~~l~l~~N~l~g 180 (678)
.+..+.+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.-.. ...++|+.|++++|.+++
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 245566777778777777742 344455666777777777777643221 134567777777777765
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.1e-07 Score=73.31 Aligned_cols=60 Identities=37% Similarity=0.585 Sum_probs=50.5
Q ss_pred CCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccceeecccccc
Q 044996 70 REMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQF 132 (678)
Q Consensus 70 ~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~ 132 (678)
++|+.|+|++|+|+...+. +..+ ++|++|+|++|+++ .||++.|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l--~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNL--PNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTG--TTESEEEETSSSES-EEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCC--CCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCcC
Confidence 4688999999999865553 4445 78999999999998 67777799999999999999975
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=8e-07 Score=97.43 Aligned_cols=141 Identities=17% Similarity=0.274 Sum_probs=92.6
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhh----------------------------------------HHHHHH
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVG----------------------------------------REEFQE 414 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 414 (678)
+-|+.++-|.||+|++.+|+.||||+.+..-... .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5678999999999999999999999986421110 012345
Q ss_pred HHHHHhccC-----CCCccceeEEEEe-CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHH-HHH
Q 044996 415 HMRRLGRLR-----HPNLLPLVAYYYR-KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ-YLY 487 (678)
Q Consensus 415 e~~~l~~l~-----H~niv~l~~~~~~-~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH 487 (678)
|..-+.+++ .++| ++=.+|++ .....|+|||++|-.+.+...-... .++- ..|+..++++.- -+-
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d~---k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GIDR---KELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCCH---HHHHHHHHHHHHHHHH
Confidence 555555542 2332 23333432 4677899999999888877432221 2442 334433333321 122
Q ss_pred HhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 488 ~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
.. +++|.|..|-||+++.++++.+.|||+...+.+.
T Consensus 283 ~d----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 RD----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred hc----CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 22 7999999999999999999999999998776543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.4e-08 Score=102.18 Aligned_cols=135 Identities=21% Similarity=0.238 Sum_probs=99.5
Q ss_pred CcEEEEEeCCCCcee------ecChHHhhcCCCCCEEEccCCcccccCCc-ccccC-CCCccEEEcccCcccc----ccC
Q 044996 45 GKIWGLKLEDMGLQG------NIDITILKELREMRTLSLMRNNLEGPMPD-LRQLG-NGALRSVYLSNNRFSG----EIP 112 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g------~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~-~~~L~~L~Ls~N~l~G----~ip 112 (678)
..++.+++.++.+.+ .++ ..+..+++|+.|+|++|.+.+..+. +..+. ..+|++|+|++|++++ .+.
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~-~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~ 129 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLL-QGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129 (319)
T ss_pred CCceEEeccccccCCcchHHHHHH-HHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence 358899999888763 122 3477789999999999999875542 22220 0349999999999983 233
Q ss_pred hhhhcCC-cccceeeccccccccC----CchhhcCCCCCCeEeccCCcccccC----Cc--cCCCCCcEEEeecCccccc
Q 044996 113 TDAFDGM-TSLRKLLLADNQFNGP----IPESLTRLSRLVELRLEGNKFEGQI----PD--FQQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 113 ~~~~~~l-~~L~~l~l~~N~~~g~----~p~~~~~l~~L~~l~l~~N~l~g~~----p~--~~~~~l~~l~l~~N~l~g~ 181 (678)
.. +..+ ++|+.|+|++|.+++. ++..+..+.+|+.|+|++|.|++.. +. ....+|+.|+|++|.+++.
T Consensus 130 ~~-l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 130 KG-LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HH-HHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 22 5566 8999999999999953 4455777889999999999998632 21 1346899999999998754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-06 Score=84.15 Aligned_cols=107 Identities=25% Similarity=0.310 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhccCCC--CccceeEEEEeCC----ceEEEEeccCC-CCHHHHhhccCCCCCCCCChHHHHHHHHHHHH
Q 044996 409 REEFQEHMRRLGRLRHP--NLLPLVAYYYRKE----EKLLVHEFVPK-RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAK 481 (678)
Q Consensus 409 ~~~~~~e~~~l~~l~H~--niv~l~~~~~~~~----~~~lv~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 481 (678)
.....+|.+.+.+|... .+.+.+++..... ..+||+|++++ -+|.+++..... .+...+..++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHH
Confidence 44677888888887543 4566677766532 35899999987 489998875321 455567889999999
Q ss_pred HHHHHHHhCCCCCCcccCCCCCCEEecCCC---ceEEeecCCcccc
Q 044996 482 GLQYLYRELPSLIAPHGHIKSSNVLLNESL---EPVLADYGLIPVM 524 (678)
Q Consensus 482 gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla~~~ 524 (678)
.++-||.. +|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999977 899999999999999887 8999999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.2e-08 Score=106.93 Aligned_cols=146 Identities=25% Similarity=0.266 Sum_probs=97.5
Q ss_pred HHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccccc-------------cccceeeCcccc
Q 044996 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ-------------ELMIAYKSPEFL 542 (678)
Q Consensus 476 ~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-------------~~~~~y~aPE~~ 542 (678)
+.+++.||.|+|.. ..+||++|.|++|.++.++..||+.|+++......... .-...|.|||++
T Consensus 105 l~~v~dgl~flh~s---Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS---AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhccC---cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34555999999975 37999999999999999999999999987544331100 112459999999
Q ss_pred ccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHH
Q 044996 543 QLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKI 621 (678)
Q Consensus 543 ~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l 621 (678)
.....+.++|+||+||++|-+.. |+.-+.. . .....+-..... .+-.. ..+..+...++.+-
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a----~---~~~~~~~~~~~~--------~~~~~--~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAA----N---GGLLSYSFSRNL--------LNAGA--FGYSNNLPSELRES 244 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhc----c---CCcchhhhhhcc--------ccccc--ccccccCcHHHHHH
Confidence 98888999999999999999995 4443331 0 111111100000 01111 11122334556777
Q ss_pred HhhcCccccccCCCHHHHHH
Q 044996 622 GLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 622 ~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.+.+..++..||++.++..
T Consensus 245 l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 245 LKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHhcCCcccCcchhhhhc
Confidence 77889999999998777654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=7.6e-06 Score=78.65 Aligned_cols=137 Identities=17% Similarity=0.146 Sum_probs=100.4
Q ss_pred cCccCceeEEEEEecCCceEEEEEecc-c----C-hhhHHHHHHHHHHHhccCCCC--ccceeEEEE-eC----CceEEE
Q 044996 377 LGSGCFGSSYKASLSTGAMMVVKRFKQ-M----N-NVGREEFQEHMRRLGRLRHPN--LLPLVAYYY-RK----EEKLLV 443 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~~~~~vavK~~~~-~----~-~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~-~~----~~~~lv 443 (678)
-|+||-+-|++..+. |..+-+|+... . . ......|.+|+..+.+|...+ +.+.+ ++. .. ...+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367888889998764 44677887651 1 1 335678999999999986433 44444 332 21 236799
Q ss_pred EeccC-CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc--eEEeecCC
Q 044996 444 HEFVP-KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE--PVLADYGL 520 (678)
Q Consensus 444 ~Ey~~-~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGl 520 (678)
+|-+. .-+|.+++..... .+.+...+..++.+|+..+.-||.. ++.|+|+.+.|||++.++. ++++||.-
T Consensus 104 Te~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 99775 3688888865422 1456777889999999999999976 8999999999999986666 99999976
Q ss_pred cc
Q 044996 521 IP 522 (678)
Q Consensus 521 a~ 522 (678)
++
T Consensus 177 ~r 178 (216)
T PRK09902 177 SR 178 (216)
T ss_pred cc
Confidence 54
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.8e-08 Score=103.48 Aligned_cols=126 Identities=25% Similarity=0.347 Sum_probs=106.7
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.-++-|||+.|.|+ .+|.. ++.|+ |+.|.+++|++.-..++++.+ ..|..||.+.|++. ++|++ ++++.+|+.
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~-lC~lp-Lkvli~sNNkl~~lp~~ig~~--~tl~~ld~s~nei~-slpsq-l~~l~slr~ 193 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDG-LCDLP-LKVLIVSNNKLTSLPEEIGLL--PTLAHLDVSKNEIQ-SLPSQ-LGYLTSLRD 193 (722)
T ss_pred hHHHHhhhccchhh-cCChh-hhcCc-ceeEEEecCccccCCcccccc--hhHHHhhhhhhhhh-hchHH-hhhHHHHHH
Confidence 34677899999998 77765 56565 899999999998765566644 67999999999999 89988 899999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g 180 (678)
|++..|++. .+|++++. =.|..||++.|+++ .||.. .++.|++|-|.+|-|..
T Consensus 194 l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 194 LNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred HHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 999999998 68888884 46899999999998 78874 78899999999999974
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.35 E-value=4e-07 Score=64.33 Aligned_cols=37 Identities=43% Similarity=1.053 Sum_probs=28.5
Q ss_pred ChHHHHHHHHhcCC-CC-CCCCCCCCC--CCCCCCCCCCcceEEec
Q 044996 2 TDSQTLLTLKQSLS-NP-TALANWDDR--TPPCNENGANWNGVLCH 43 (678)
Q Consensus 2 ~~~~aLl~~k~~l~-~~-~~l~~W~~~--~~~c~~~~~~w~gv~C~ 43 (678)
.|++||++||++|. ++ ..+.+|+.. .+|| +|.||+|+
T Consensus 3 ~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-----~W~GV~Cd 43 (43)
T PF08263_consen 3 QDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-----SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-----CSTTEEE-
T ss_pred HHHHHHHHHHHhcccccCcccccCCCcCCCCCe-----eeccEEeC
Confidence 58999999999998 45 479999987 6788 69999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.2e-05 Score=79.75 Aligned_cols=140 Identities=14% Similarity=0.134 Sum_probs=85.7
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCC--ccceeEEEEeCCceEEEEeccCCCC-
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN--LLPLVAYYYRKEEKLLVHEFVPKRS- 451 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~Ey~~~gs- 451 (678)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24457788776532 3455788999999886444 4667777777777889999998863
Q ss_pred HHHH---------------------hhccCCCCCCCCChHHHHH-HHH----------HHHH-HHHHHHHhCCCCCCccc
Q 044996 452 LAVN---------------------LHGHQALGQPSLDWPSRLK-IVK----------GVAK-GLQYLYRELPSLIAPHG 498 (678)
Q Consensus 452 L~~~---------------------l~~~~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~~~~~~~ivHr 498 (678)
+... ||.... +......+.. +.. .+.. ...+|...-....++|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~---~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC---DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC---CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 2111 121100 0111111111 000 1111 12233222123356899
Q ss_pred CCCCCCEEecCCCceEEeecCCccc
Q 044996 499 HIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 499 dlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
|+.|.||++++++ +.|+||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999988653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.2e-06 Score=90.18 Aligned_cols=143 Identities=17% Similarity=0.174 Sum_probs=92.7
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChh-------------------------------------hHHHHHHHHH
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNV-------------------------------------GREEFQEHMR 417 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~e~~ 417 (678)
+-||.-+.|.||+|++++|+.||||+.+..-.. ..-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 568899999999999999999999988642111 0113455554
Q ss_pred HHhcc----CCCCc---cceeEEEEe-CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHh
Q 044996 418 RLGRL----RHPNL---LPLVAYYYR-KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489 (678)
Q Consensus 418 ~l~~l----~H~ni---v~l~~~~~~-~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 489 (678)
-..++ .|-+. |.+=.++++ .....|+||||+|.-+.+.-.-... .++-..+..-+.++..-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~~i~~~l~~~~~~qIf~~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR----GISPHDILNKLVEAYLEQIFKT-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc----CCCHHHHHHHHHHHHHHHHHhc--
Confidence 43333 45551 112233332 3468899999999877654322111 2444444444444333333333
Q ss_pred CCCCCCcccCCCCCCEEecC----CCceEEeecCCccccCcc
Q 044996 490 LPSLIAPHGHIKSSNVLLNE----SLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 490 ~~~~~ivHrdlk~~NILl~~----~~~~kl~DfGla~~~~~~ 527 (678)
|++|+|=.|-||+++. ++.+.+-|||+...+.+.
T Consensus 321 ----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 ----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 7999999999999984 678999999998776654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.6e-07 Score=92.10 Aligned_cols=82 Identities=24% Similarity=0.337 Sum_probs=35.1
Q ss_pred CCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCe
Q 044996 69 LREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVE 148 (678)
Q Consensus 69 l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~ 148 (678)
...|+.||||+|.++- |.+...+. +.++.|+||+|.+. .+- . +..+++|+.||||+|.++ .+-.+=..|.+.+.
T Consensus 283 Wq~LtelDLS~N~I~~-iDESvKL~-Pkir~L~lS~N~i~-~v~-n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQ-IDESVKLA-PKLRRLILSQNRIR-TVQ-N-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT 356 (490)
T ss_pred Hhhhhhccccccchhh-hhhhhhhc-cceeEEecccccee-eeh-h-hhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence 3444555555554432 11111111 34555555555554 232 1 344455555555555544 22222234444455
Q ss_pred EeccCCcc
Q 044996 149 LRLEGNKF 156 (678)
Q Consensus 149 l~l~~N~l 156 (678)
|.|+.|.+
T Consensus 357 L~La~N~i 364 (490)
T KOG1259|consen 357 LKLAQNKI 364 (490)
T ss_pred eehhhhhH
Confidence 55555544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.3e-07 Score=89.10 Aligned_cols=79 Identities=23% Similarity=0.406 Sum_probs=57.2
Q ss_pred CCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEE
Q 044996 95 GALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFN 172 (678)
Q Consensus 95 ~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~ 172 (678)
..|+.||||+|.++ .|.++ ..-++.++.|+||+|.+. .+- .+..|++|+.|||++|.++ .+-.+ .+.+++.|.
T Consensus 284 q~LtelDLS~N~I~-~iDES-vKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDES-VKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred hhhhhccccccchh-hhhhh-hhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 34888899999888 67655 667788899999999886 232 3778888899999998887 23222 445666777
Q ss_pred eecCcc
Q 044996 173 VSNNAL 178 (678)
Q Consensus 173 l~~N~l 178 (678)
|+.|.+
T Consensus 359 La~N~i 364 (490)
T KOG1259|consen 359 LAQNKI 364 (490)
T ss_pred hhhhhH
Confidence 777765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.08 E-value=6.8e-05 Score=73.19 Aligned_cols=138 Identities=20% Similarity=0.313 Sum_probs=93.6
Q ss_pred ccCccCceeEEEEEecCCceEEEEEecccChhhH-------------------HH-----HHHHHHHHhccC--CCCccc
Q 044996 376 ILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGR-------------------EE-----FQEHMRRLGRLR--HPNLLP 429 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~-----~~~e~~~l~~l~--H~niv~ 429 (678)
.|.+|.-+.||+|...++..+|||+++......+ ++ ..+|+.-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 5788999999999988899999999975322111 11 235666676663 344445
Q ss_pred eeEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC
Q 044996 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE 509 (678)
Q Consensus 430 l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~ 509 (678)
-+++. ...|||||+...... ........+...+...+..+++++|.-|...+ ++||+||..=|||+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~p-----AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~- 201 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLP-----APRLKDVPLELEEAEGLYEDVVEYMRRLYKEA---GLVHGDLSEYNILVH- 201 (268)
T ss_pred ceeec----CCeEEEEeccCCCCC-----CCCcccCCcCchhHHHHHHHHHHHHHHHHHhc---CcccccchhhheEEE-
Confidence 55543 346999999653110 00001112222356677888888888887643 799999999999999
Q ss_pred CCceEEeecCCccccCc
Q 044996 510 SLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 510 ~~~~kl~DfGla~~~~~ 526 (678)
++.+.|+|||.|....+
T Consensus 202 ~~~p~iID~~QaV~~~h 218 (268)
T COG1718 202 DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CCeEEEEECccccccCC
Confidence 88999999999866553
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.06 E-value=8.4e-07 Score=91.53 Aligned_cols=110 Identities=28% Similarity=0.316 Sum_probs=47.6
Q ss_pred hcCCCCCEEEccCCcccccCC--cc-cccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccC-CchhhcC
Q 044996 67 KELREMRTLSLMRNNLEGPMP--DL-RQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGP-IPESLTR 142 (678)
Q Consensus 67 ~~l~~L~~L~Ls~N~l~g~~p--~~-~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~-~p~~~~~ 142 (678)
..|++++.||||+|-|+---| .+ ..+ ++|+.|+|+.|.|.-.+-...-..++.|+.|.|+.+.|+.. +-.-+..
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqL--p~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~ 220 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQL--PSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT 220 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhc--ccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence 345555555555555543222 11 112 44555555555554222222222344555555555555532 2222334
Q ss_pred CCCCCeEeccCCccccc--CCccCCCCCcEEEeecCcc
Q 044996 143 LSRLVELRLEGNKFEGQ--IPDFQQKDLVSFNVSNNAL 178 (678)
Q Consensus 143 l~~L~~l~l~~N~l~g~--~p~~~~~~l~~l~l~~N~l 178 (678)
+++|..|+|.+|...+. .+....+.|+.|||++|++
T Consensus 221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~l 258 (505)
T KOG3207|consen 221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNL 258 (505)
T ss_pred CCcHHHhhhhcccccceecchhhhhhHHhhccccCCcc
Confidence 45555555555531111 1112334455555555554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.3e-05 Score=76.76 Aligned_cols=104 Identities=18% Similarity=0.085 Sum_probs=80.2
Q ss_pred HHHHHHHhccCC-CCccceeEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCC
Q 044996 413 QEHMRRLGRLRH-PNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491 (678)
Q Consensus 413 ~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 491 (678)
..|.-+|+.+++ +++.+++|+| ..++|.||...+++...-..-. .--.-+|..|.+||.++++.+.++++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~--~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLS--QFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccc--cccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 457788888876 6999999999 2467999998776642200000 00136899999999999999999998654
Q ss_pred CCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 492 ~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
.. +.-.|++++|+-+++++++|+.|...+..
T Consensus 81 ~~-~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GF-FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred Cc-EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 43 66799999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1e-06 Score=95.26 Aligned_cols=176 Identities=17% Similarity=0.158 Sum_probs=127.3
Q ss_pred cCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCC-ccceeEEEEeCCceEEEEeccCCC-CHHH
Q 044996 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN-LLPLVAYYYRKEEKLLVHEFVPKR-SLAV 454 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~Ey~~~g-sL~~ 454 (678)
.++|+++++||.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++++|+..| +-..
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~ 324 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL 324 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence 5889999999997655554455554332 34456788999999999 777777777778899999999876 2211
Q ss_pred HhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---ccc
Q 044996 455 NLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---AQE 531 (678)
Q Consensus 455 ~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---~~~ 531 (678)
-... ....+...+...+.+.-+++++|+|.. .-+|+| ||+..+ ...|..||+....+.... ...
T Consensus 325 ~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~----~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 325 EMTV----SEIALEQYQFAYPLRKETRPLAELHSS----YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred cCCh----hhHhhhhhhhhhhhhhhcccccccccc----cccCcc----cccccc-cccccccccCCcccCcccccccCC
Confidence 1110 011234444556788888999999954 247998 777665 678999999987766542 234
Q ss_pred ccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCc
Q 044996 532 LMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPA 570 (678)
Q Consensus 532 ~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~ 570 (678)
++..|+|||+...+.+..+.|+|+.|+--.++.-|-.|-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 567899999999999999999999998777777676663
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.7e-06 Score=92.21 Aligned_cols=133 Identities=29% Similarity=0.384 Sum_probs=99.2
Q ss_pred cceEEecCCcEE---EEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCC-CccEEEcccCccccccC
Q 044996 37 WNGVLCHRGKIW---GLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNG-ALRSVYLSNNRFSGEIP 112 (678)
Q Consensus 37 w~gv~C~~~~v~---~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~-~L~~L~Ls~N~l~G~ip 112 (678)
+.+..+....+. .+++..+.+...+. .+..++.++.|++.+|+++-..|....+ . +|+.|++++|++. .+|
T Consensus 82 ~l~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~~i~~~~~~~--~~nL~~L~l~~N~i~-~l~ 156 (394)
T COG4886 82 SLDGSENLLNLLPLPSLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNITDIPPLIGLL--KSNLKELDLSDNKIE-SLP 156 (394)
T ss_pred cccccccccCCCCCceeeccccccccCch--hhhcccceeEEecCCcccccCccccccc--hhhcccccccccchh-hhh
Confidence 455555544444 47777777754443 3566788999999999988655543322 2 6899999999998 776
Q ss_pred hhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCc
Q 044996 113 TDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNA 177 (678)
Q Consensus 113 ~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~ 177 (678)
.. +..++.|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|.. ....|+.|.+++|.
T Consensus 157 ~~-~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 157 SP-LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred hh-hhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 54 788999999999999998 67777778889999999999988 66664 55568889998885
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.7e-07 Score=101.79 Aligned_cols=125 Identities=26% Similarity=0.272 Sum_probs=80.1
Q ss_pred CCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCch-hhcCCCCCCeE
Q 044996 71 EMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPE-SLTRLSRLVEL 149 (678)
Q Consensus 71 ~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~-~~~~l~~L~~l 149 (678)
.|...+.++|.|.-.=-.+.-+ +.|++|||++|+|+ .+- .+-.|++|++|||++|.+. .+|. +...+ .|+.|
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll--~ale~LnLshNk~~-~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L 237 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLL--PALESLNLSHNKFT-KVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLL 237 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHH--HHhhhhccchhhhh-hhH--HHHhcccccccccccchhc-cccccchhhh-hheee
Confidence 4555666677665321122223 55888888888887 343 3677888888888888887 3443 22233 38888
Q ss_pred eccCCcccccCCccCCCCCcEEEeecCccccc---Cc-hhhhcCCCCCCCCCCCCCC
Q 044996 150 RLEGNKFEGQIPDFQQKDLVSFNVSNNALFGS---IS-PALRELDPSSFSGNRDLCG 202 (678)
Q Consensus 150 ~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~---ip-~~~~~l~~~~~~gn~~lc~ 202 (678)
.|.||.++...--.++++|+.|||++|.|++. -| ..+..|....+.|||--|.
T Consensus 238 ~lrnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 238 NLRNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred eecccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 88888887443335778888888888888763 12 2344555667888875553
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2e-06 Score=87.68 Aligned_cols=93 Identities=27% Similarity=0.448 Sum_probs=62.7
Q ss_pred ChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhh
Q 044996 62 DITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESL 140 (678)
Q Consensus 62 ~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~ 140 (678)
|..-|..|++|+.|+|++|++++.-+. |..+ ..|+.|+|..|+|. .+-...|.++..|+.|+|.+|+++-.-|..|
T Consensus 266 P~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~--a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF 342 (498)
T KOG4237|consen 266 PAKCFKKLPNLRKLNLSNNKITRIEDGAFEGA--AELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAF 342 (498)
T ss_pred hHHHHhhcccceEeccCCCccchhhhhhhcch--hhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccc
Confidence 333466777777777777777765542 3333 55777777777776 5555567777777777777777777777777
Q ss_pred cCCCCCCeEeccCCccc
Q 044996 141 TRLSRLVELRLEGNKFE 157 (678)
Q Consensus 141 ~~l~~L~~l~l~~N~l~ 157 (678)
..+.+|..|+|-.|.|.
T Consensus 343 ~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 343 QTLFSLSTLNLLSNPFN 359 (498)
T ss_pred cccceeeeeehccCccc
Confidence 77777777777766654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.3e-05 Score=75.70 Aligned_cols=142 Identities=17% Similarity=0.168 Sum_probs=84.4
Q ss_pred cCccCc-eeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCCCCHHH
Q 044996 377 LGSGCF-GSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKRSLAV 454 (678)
Q Consensus 377 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~ 454 (678)
|-.|.+ ..||+..... ..+++|...... ..++.+|++++..+. +--+.+++++....+..++||||+++.++..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 7899997653 677788765432 345678888888874 3335567777766667899999999877764
Q ss_pred Hh-------------------hccCCCCCCCCC--hHHHHHHHH--------------------HHHHHHHHHHHhC---
Q 044996 455 NL-------------------HGHQALGQPSLD--WPSRLKIVK--------------------GVAKGLQYLYREL--- 490 (678)
Q Consensus 455 ~l-------------------~~~~~~~~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~~~--- 490 (678)
.. |.....+. .+. +..++.... .+...+..|-...
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADC-PFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccC-CcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 31 11110000 111 001111000 0111122222211
Q ss_pred CCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 491 ~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 134589999999999999988889999987643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.5e-06 Score=91.40 Aligned_cols=117 Identities=29% Similarity=0.490 Sum_probs=82.5
Q ss_pred EEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCc-ccceeeccccccccCCchhhcCCCCCCeEecc
Q 044996 74 TLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMT-SLRKLLLADNQFNGPIPESLTRLSRLVELRLE 152 (678)
Q Consensus 74 ~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~-~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~ 152 (678)
.|+++.|.+...+..+..+ ..++.|++.+|+++ .||+. ...+. +|+.|++++|++. .+|..+..+++|+.|+++
T Consensus 97 ~l~~~~~~~~~~~~~~~~~--~~l~~L~l~~n~i~-~i~~~-~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~ 171 (394)
T COG4886 97 SLDLNLNRLRSNISELLEL--TNLTSLDLDNNNIT-DIPPL-IGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLS 171 (394)
T ss_pred eeeccccccccCchhhhcc--cceeEEecCCcccc-cCccc-cccchhhcccccccccchh-hhhhhhhccccccccccC
Confidence 5788888876665554444 56888888888888 77765 55553 8888888888887 566778888888888888
Q ss_pred CCcccccCCcc--CCCCCcEEEeecCcccccCchh---hhcCCCCCCCCC
Q 044996 153 GNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA---LRELDPSSFSGN 197 (678)
Q Consensus 153 ~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~---~~~l~~~~~~gn 197 (678)
+|+++ .+|.. ....|+.|++++|+++ .+|.. ...+....+.+|
T Consensus 172 ~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N 219 (394)
T COG4886 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN 219 (394)
T ss_pred Cchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCC
Confidence 88887 44443 6678888888888875 35553 222455555555
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.93 E-value=8.7e-07 Score=77.36 Aligned_cols=132 Identities=22% Similarity=0.198 Sum_probs=91.1
Q ss_pred EEEEEeCCCCceeecCh--HHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 47 IWGLKLEDMGLQGNIDI--TILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 47 v~~l~l~~~~l~g~~~~--~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
...++|++..|. .|+. ..+....+|+..+|++|.|....+.+... .+.++.|+|++|.++ .+|.+ ++.++.|+.
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~k-f~t~t~lNl~~neis-dvPeE-~Aam~aLr~ 104 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIK-FPTATTLNLANNEIS-DVPEE-LAAMPALRS 104 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhc-cchhhhhhcchhhhh-hchHH-HhhhHHhhh
Confidence 556777777664 3432 23556677788899999988655544322 246888999999999 89988 899999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCch
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISP 184 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~ 184 (678)
|+++.|.|+ ..|.-+..|.+|-.|+..+|... +||.. ..+..-..++.+|.+.|.-|.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 999999998 67777888999999999888875 55532 112222233455555444433
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.90 E-value=5.5e-05 Score=75.26 Aligned_cols=144 Identities=17% Similarity=0.197 Sum_probs=85.2
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCC--ccceeEEEEe---CCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN--LLPLVAYYYR---KEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~---~~~~~lv~Ey~~~ 449 (678)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+.... +.+++.++.. ....+++|+|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 458899999999999877 58888887653 45667888998888885433 4566665433 2346899999998
Q ss_pred CCHHH----------------Hh---hccCCCCCCCCChHHH---------HHH------------HHHHHH-HHHHHHH
Q 044996 450 RSLAV----------------NL---HGHQALGQPSLDWPSR---------LKI------------VKGVAK-GLQYLYR 488 (678)
Q Consensus 450 gsL~~----------------~l---~~~~~~~~~~l~~~~~---------~~i------------~~~ia~-gL~yLH~ 488 (678)
..+.. .+ |.... ......+... ... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPP-PFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHT-TCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccc-cccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 87776 11 11110 1111111110 000 112222 3444443
Q ss_pred hC---CCCCCcccCCCCCCEEec-CCCceEEeecCCcc
Q 044996 489 EL---PSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIP 522 (678)
Q Consensus 489 ~~---~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~ 522 (678)
.. ....++|+|+.+.|||++ +++.+-|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 31 245689999999999999 66666899998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00021 Score=68.81 Aligned_cols=130 Identities=14% Similarity=0.180 Sum_probs=88.8
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccC----------------hhhHHHHHHHHHHHhccC------CCCccceeE
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMN----------------NVGREEFQEHMRRLGRLR------HPNLLPLVA 432 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------H~niv~l~~ 432 (678)
..||+|+.-.||.- +.....+||+..... ....+++.+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 46999999999965 445556788877544 123456777777666665 889999999
Q ss_pred EEEeCCceEEEEeccCC------CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEE
Q 044996 433 YYYRKEEKLLVHEFVPK------RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVL 506 (678)
Q Consensus 433 ~~~~~~~~~lv~Ey~~~------gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NIL 506 (678)
+..++...-+|+|.+.+ -+|.+++... .++. ...+.+.+. ..||-.+ .|+.+||+|+||+
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~~~L~~f---~~~l~~~----~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELRQALDEF---KRYLLDH----HIVIRDLNPHNIV 150 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHHHHHHHH---HHHHHHc----CCeecCCCcccEE
Confidence 99999888999998753 3577777543 2443 333333333 3455443 5999999999999
Q ss_pred ecCCC----ceEEee-cCC
Q 044996 507 LNESL----EPVLAD-YGL 520 (678)
Q Consensus 507 l~~~~----~~kl~D-fGl 520 (678)
+..+. .+.|+| ||-
T Consensus 151 ~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEecCCCceEEEEEeCCCC
Confidence 96432 466776 343
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 678 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-31 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-23 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-10 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 5e-62
Identities = 97/328 (29%), Positives = 160/328 (48%), Gaps = 30/328 (9%)
Query: 344 VVGGKKPEIKLSFVRDDVERFDLHDLLRA-----SAEILGSGCFGSSYKASLSTGAMMVV 398
V + PE+ L ++ RF L +L A + ILG G FG YK L+ G ++ V
Sbjct: 4 VPAEEDPEVHLGQLK----RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAV 59
Query: 399 KRFKQMNNVGRE-EFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLH 457
KR K+ G E +FQ + + H NLL L + E+LLV+ ++ S+A L
Sbjct: 60 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 119
Query: 458 GHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL-PSLIAPHGHIKSSNVLLNESLEPVLA 516
QP LDWP R +I G A+GL YL+ P +I H +K++N+LL+E E V+
Sbjct: 120 ERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKII--HRDVKAANILLDEEFEAVVG 176
Query: 517 DYGL---IPVMNQESAQELM--IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571
D+GL + + + I + +PE+L G+ ++KTDV+ GV++LE++TG+ +
Sbjct: 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236
Query: 572 FLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVE 631
+ D L WV +L + D ++ E E+ +L+++ L C +
Sbjct: 237 LARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDE-EVEQLIQVALLCTQSSPM 294
Query: 632 KR---------LDLKEAVEKIEEVKERD 650
+R L+ E+ EE ++ +
Sbjct: 295 ERPKMSEVVRMLEGDGLAERWEEWQKEE 322
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-53
Identities = 76/314 (24%), Positives = 138/314 (43%), Gaps = 35/314 (11%)
Query: 354 LSFVRDDVERFDLHDLLRA-----------SAEILGSGCFGSSYKASLSTGAMMVVKRFK 402
L F ++L +G G FG YK ++ + VK+
Sbjct: 5 LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLA 63
Query: 403 QMNNV----GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHG 458
M ++ +++F + ++ + + +H NL+ L+ + ++ LV+ ++P SL L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 459 HQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADY 518
G P L W R KI +G A G+ +L+ I H IKS+N+LL+E+ ++D+
Sbjct: 124 LD--GTPPLSWHMRCKIAQGAANGINFLHEN--HHI--HRDIKSANILLDEAFTAKISDF 177
Query: 519 GL--IPVMNQESAQELMIA----YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANF 572
GL ++ I Y +PE L+ G IT K+D++S GV++LEI+TG +
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 573 LQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEK 632
+ L + + DK+M D + + + C E+ K
Sbjct: 237 ----HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA--DSTSVEAMYSVASQCLHEKKNK 290
Query: 633 RLDLKEAVEKIEEV 646
R D+K+ + ++E+
Sbjct: 291 RPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 83/296 (28%), Positives = 144/296 (48%), Gaps = 22/296 (7%)
Query: 363 RFDLHDLLRA-----SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMR 417
R L DL A ++G G FG YK L GA + +KR ++ G EEF+ +
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 418 RLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVK 477
L RHP+L+ L+ + + E +L+++++ +L +L+G + W RL+I
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS-MSWEQRLEICI 146
Query: 478 GVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMNQE--SAQEL 532
G A+GL YL+ ++I H +KS N+LL+E+ P + D+G+ ++Q S +
Sbjct: 147 GAARGLHYLHT--RAII--HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-V 201
Query: 533 M--IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSV 590
+ Y PE+ GR+T+K+DV+S GV++ E++ + Q + +LA W
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV--QSLPREMVNLAEWAVES 259
Query: 591 LANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646
NG ++ D +AD+ E + K + C E R + + + K+E
Sbjct: 260 HNNGQLE-QIVDPNLADKIRPE-SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-38
Identities = 51/232 (21%), Positives = 82/232 (35%), Gaps = 41/232 (17%)
Query: 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNI 61
+ L++ K L + L +W PC ++GV C K+ + L L
Sbjct: 12 REIHQLISFKDVLPDKNLLPDWSSNKNPCT-----FDGVTCRDDKVTSIDLSSKPLNVGF 66
Query: 62 -------------------------DITILKELREMRTLSLMRNNLEGPMPDLRQLGN-G 95
++ K + +L L RN+L GP+ L LG+
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126
Query: 96 ALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTR---LSRLVELRLE 152
L+ + +S+N + SL L L+ N +G L L +
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 153 GNKFEGQIPDFQQKDLVSFNVSNNALFGSI-----SPALRELDPSS--FSGN 197
GNK G + + +L +VS+N I AL+ LD S SG+
Sbjct: 187 GNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGD 238
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 32/143 (22%), Positives = 61/143 (42%), Gaps = 15/143 (10%)
Query: 57 LQGNI--DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTD 114
+ G + E++ L++ N + G + + + N L + +S+N FS IP
Sbjct: 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVN--LEFLDVSSNNFSTGIP-- 217
Query: 115 AFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVS 174
++L+ L ++ N+ +G +++ + L L + N+F G IP K L +++
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLA 277
Query: 175 NNALFGSISPALRELDPSSFSGN 197
N G I P SG
Sbjct: 278 ENKFTGEI--------PDFLSGA 292
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 11/150 (7%)
Query: 56 GLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDA 115
L G+ I E++ L++ N GP+P L L + L+ + L+ N+F+GEIP
Sbjct: 234 KLSGDFSRAIST-CTELKLLNISSNQFVGPIPPLP-LKS--LQYLSLAENKFTGEIPDFL 289
Query: 116 FDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD---FQQKDLVSFN 172
+L L L+ N F G +P S L L L N F G++P + + L +
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349
Query: 173 VSNNALFGSISPALRELDPS----SFSGNR 198
+S N G + +L L S S N
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNN 379
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-25
Identities = 37/174 (21%), Positives = 60/174 (34%), Gaps = 32/174 (18%)
Query: 75 LSLMRNNLEGPMPDLRQLGN-GALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFN 133
+ +G + QL +++ + G FD S+ L ++ N +
Sbjct: 589 GAGNLLEFQGIRSE--QLNRLSTRNPCNITSRVYGGHTSPT-FDNNGSMMFLDMSYNMLS 645
Query: 134 GPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQ-KDLVSFNVSNNALFGSISPALREL-- 189
G IP+ + + L L L N G IPD + L ++S+N L G I A+ L
Sbjct: 646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM 705
Query: 190 ------------------------DPSSFSGNRDLCGEPLGSPCPTPSPSPSPG 219
P+ F N LCG PL P+ + +
Sbjct: 706 LTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHH 759
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 48/147 (32%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 57 LQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDA 115
G + ++ + TL L NN GP+ +L Q L+ +YL NN F+G+IP
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP-PT 413
Query: 116 FDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDLVSFNV 173
+ L L L+ N +G IP SL LS+L +L+L N EG+IP K L + +
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 174 SNNALFGSISPALRELDPSSFSGNRDL 200
N L G I PS S +L
Sbjct: 474 DFNDLTGEI--------PSGLSNCTNL 492
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-22
Identities = 44/141 (31%), Positives = 65/141 (46%), Gaps = 11/141 (7%)
Query: 57 LQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGN-GALRSVYLSNNRFSGEIPTDA 115
L+G I + ++ + TL L N+L G +P L N L + LSNNR +GEIP
Sbjct: 454 LEGEIPQEL-MYVKTLETLILDFNDLTGEIP--SGLSNCTNLNWISLSNNRLTGEIPKW- 509
Query: 116 FDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDLVSFNV 173
+ +L L L++N F+G IP L L+ L L N F G IP F+Q S +
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKI 565
Query: 174 SNNALFGSISPALRELDPSSF 194
+ N + G ++
Sbjct: 566 AANFIAGKRYVYIKNDGMKKE 586
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-21
Identities = 49/149 (32%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 51 KLEDMGLQGN-IDITI---LKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSN 104
L + L GN + + +L+L NN G +P L ++ L+ + LS
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG--LKVLDLSF 352
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESL--TRLSRLVELRLEGNKFEGQIPD 162
N FSGE+P + SL L L+ N F+GPI +L + L EL L+ N F G+IP
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412
Query: 163 F--QQKDLVSFNVSNNALFGSISPALREL 189
+LVS ++S N L G+I +L L
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-15
Identities = 37/141 (26%), Positives = 53/141 (37%), Gaps = 15/141 (10%)
Query: 66 LKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124
L + +SL N L G +P + +L N L + LSNN FSG IP SL
Sbjct: 486 LSNCTNLNWISLSNNRLTGEIPKWIGRLEN--LAILKLSNNSFSGNIP-AELGDCRSLIW 542
Query: 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF----QQKDLVSFNVSNNALFG 180
L L N FNG IP ++ + S + N G+ + K + G
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQG 598
Query: 181 SISPA---LRELDPSSFSGNR 198
S L +P + +
Sbjct: 599 IRSEQLNRLSTRNPCNITSRV 619
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 62/299 (20%), Positives = 112/299 (37%), Gaps = 35/299 (11%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY- 433
E+ G FG +KA L + VK F + + + + L ++H N+L +
Sbjct: 30 EVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAE 87
Query: 434 ---YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ L+ F K SL+ L + + W I + +A+GL YL+ ++
Sbjct: 88 KRGTSVDVDLWLITAFHEKGSLSDFLKANV------VSWNELCHIAETMARGLAYLHEDI 141
Query: 491 PSLIAP------HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA------YKS 538
P L H IKS NVLL +L +AD+GL + Y +
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 539 PEFLQLG-----RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593
PE L+ + D++++G+++ E+ + A+ + +
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML--PFEEEIGQHPSL 259
Query: 594 GDNRTEVFDK----EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648
D + V K + D M L + C + + E RL E+I +++
Sbjct: 260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 54/203 (26%), Positives = 74/203 (36%), Gaps = 37/203 (18%)
Query: 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNI 61
D Q LL +K+ L NPT L++W T CN W GVLC
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDT----------------- 45
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGN-GALRSVYLSN-NRFSGEIPTDAFDGM 119
+ + L L NL P P L N L +Y+ N G IP +
Sbjct: 46 ----DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA-IAKL 100
Query: 120 TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDLVSFNVSNNA 177
T L L + +G IP+ L+++ LV L N G +P +LV N
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 178 LFGSISPALRELDPSSFSGNRDL 200
+ G+I P S+ L
Sbjct: 161 ISGAI--------PDSYGSFSKL 175
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 38/184 (20%), Positives = 67/184 (36%), Gaps = 39/184 (21%)
Query: 57 LQGNI--DITILKELREMRTLSLMRNNLEGPMPDLRQLGN--GALRSVYLSNNRFSGEIP 112
L G + I+ L L ++ N + G +PD G+ S+ +S NR +G+IP
Sbjct: 137 LSGTLPPSISSLPNLVG---ITFDGNRISGAIPD--SYGSFSKLFTSMTISRNRLTGKIP 191
Query: 113 TDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KDLVSF 171
+L + L+ N G ++ L N + K+L
Sbjct: 192 PT--FANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL 249
Query: 172 NVSNNALFGSI--------------------------SPALRELDPSSFSGNRDLCGEPL 205
++ NN ++G++ L+ D S+++ N+ LCG PL
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309
Query: 206 GSPC 209
C
Sbjct: 310 -PAC 312
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E+LG GCFG + K + TG +MV+K + + + F + ++ + L HPN+L +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
Y+ + + E++ +L + W R+ K +A G+ YL ++
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYL--HSMNI 129
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGL--IPVMNQESAQELMIAYK-------------- 537
I H + S N L+ E+ V+AD+GL + V + + L K
Sbjct: 130 I--HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 538 --SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+PE + +K DV+S G+++ EI+
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
E++G G FG KA + +K+ + + R+ F +R+L R+ HPN++ L
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
LV E+ SL LHG + L P + ++G+ YL+ P +
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 495 APHGHIKSSNVLLNESLEPV-LADYGLIPVMNQESAQEL-MIAYKSPEFLQLGRITKKTD 552
H +K N+LL + + D+G + A+ +PE + ++K D
Sbjct: 127 I-HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 553 VWSLGVLILEIMTGKFP 569
V+S G+++ E++T + P
Sbjct: 186 VFSWGIILWEVITRRKP 202
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 46/202 (22%), Positives = 82/202 (40%), Gaps = 14/202 (6%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGR--EEFQEHMRRLGRLRHPNLLPLVA 432
L G +K G +VVK K + R +F E RL HPN+LP++
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 433 YYYRKEEKLL--VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ ++P SL LH +D +K +A+G+ +L+
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE 131
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSPEFLQ---LGRI 547
P + + S +V+++E + ++ + Q + A+ +PE LQ
Sbjct: 132 PLIP--RHALNSRSVMIDEDMTARISMADVKFSF-QSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 548 TKKTDVWSLGVLILEIMTGKFP 569
+ D+WS VL+ E++T + P
Sbjct: 189 RRSADMWSFAVLLWELVTREVP 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 70/307 (22%), Positives = 120/307 (39%), Gaps = 46/307 (14%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQE--HMRRLGRLRHPNLLPLVA 432
E++G G +G+ YK SL + VK F N R+ F ++ R+ + H N+ +
Sbjct: 19 ELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 433 YYYR-----KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
R + E LLV E+ P SL L H + DW S ++ V +GL YL+
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLH 128
Query: 488 RELPSLIAP-----HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--------- 533
ELP H + S NVL+ V++D+GL +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 534 ---IAYKSPEFLQ-------LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDL 583
I Y +PE L+ K+ D+++LG++ EI + +
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 584 ASWVNSVLANGDNRTEVFDKEM-----ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKE 638
+ V + D + V ++ + + + L + C +++ E RL +
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308
Query: 639 AVEKIEE 645
A E++ E
Sbjct: 309 AEERMAE 315
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFK----QMNNVGREEFQEHMRRLGRLRHPNLLPL 430
EI+G G FG Y+A G + VK + + + E ++ + L+HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
++ LV EF L L G + + + +A+G+ YL+ E
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDEA 125
Query: 491 PSLIAPHGHIKSSNVLLNESLEPV--------LADYGLIPVMNQESAQELM--IAYKSPE 540
I H +KSSN+L+ + +E + D+GL ++ + A+ +PE
Sbjct: 126 IVPII-HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE 184
Query: 541 FLQLGRITKKTDVWSLGVLILEIMTGKFP 569
++ +K +DVWS GVL+ E++TG+ P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 50/231 (21%), Positives = 96/231 (41%), Gaps = 26/231 (11%)
Query: 355 SFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMV-VKRFKQMNNVGREEFQ 413
F + + +++ + +G G FG +K L +V +K ++ G E
Sbjct: 7 EFPKSRLPTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 414 EHMRR-------LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPS 466
E + + L HPN++ L +V EFVP L L
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKA----HP 118
Query: 467 LDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPV-----LADYGLI 521
+ W +L+++ +A G++Y+ + P ++ H ++S N+ L E +AD+GL
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQNQNPPIV--HRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
Query: 522 PVMNQESAQEL-MIAYKSPEFL--QLGRITKKTDVWSLGVLILEIMTGKFP 569
+ L + +PE + + T+K D +S +++ I+TG+ P
Sbjct: 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 61/241 (25%), Positives = 110/241 (45%), Gaps = 18/241 (7%)
Query: 337 SPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMM 396
P S + + + + DD++ DL E +G+G FG+ ++A G+ +
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMD-IPWCDLNIK--EKIGAGSFGTVHRAEWH-GSDV 63
Query: 397 VVKRFK--QMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAV 454
VK + EF + + RLRHPN++ + + +V E++ + SL
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 455 NLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPV 514
LH A + LD RL + VAKG+ YL+ P ++ H ++KS N+L+++
Sbjct: 124 LLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPPIV--HRNLKSPNLLVDKKYTVK 179
Query: 515 LADYGLIPVMNQESAQELM------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKF 568
+ D+GL + + +PE L+ +K+DV+S GV++ E+ T +
Sbjct: 180 VCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 569 P 569
P
Sbjct: 238 P 238
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQ--MNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+ +GSG FG+ YK A VK + F+ + L + RH N+L +
Sbjct: 30 QRIGSGSFGTVYKGKWHGDVA---VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
Y + +V ++ SL +LH + + + I + A+G+ YL
Sbjct: 87 GYS-TAPQLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYL--HAK 139
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM------IAYKSPEFLQ-- 543
S+I H +KS+N+ L+E + D+GL ++ S I + +PE ++
Sbjct: 140 SII--HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 544 -LGRITKKTDVWSLGVLILEIMTGKFP 569
+ ++DV++ G+++ E+MTG+ P
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 62/321 (19%), Positives = 121/321 (37%), Gaps = 47/321 (14%)
Query: 361 VERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQE-HMRRL 419
V+R ++ E +G G FG ++ G + VK F R F+E + +
Sbjct: 36 VQRTIARTIVLQ--ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQT 90
Query: 420 GRLRHPNLLPLVAYYYRKEEK----LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKI 475
LRH N+L +A + LV ++ SL L + ++ +K+
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL------FDYLNRYTVTVEGMIKL 144
Query: 476 VKGVAKGLQYLYRELPSL-----IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ 530
A GL +L+ E+ IA H +KS N+L+ ++ +AD GL + +
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIA-HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 531 ELMIA--------YKSPEFL------QLGRITKKTDVWSLGVLILEIMTGKFPANFLQQG 576
+ Y +PE L + K+ D++++G++ EI +
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
Query: 577 KKADGDLASW------VNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEV 630
+ DL + V+ R + ++ + E M K+++ C
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR--VMAKIMR---ECWYANG 318
Query: 631 EKRLDLKEAVEKIEEVKERDG 651
RL + + ++ +++G
Sbjct: 319 AARLTALRIKKTLSQLSQQEG 339
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 64/298 (21%), Positives = 117/298 (39%), Gaps = 39/298 (13%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQE-HMRRLGRLRHPNLLPLVAY 433
E +G G +G ++ S G + VK F + + F+E + LRH N+L +A
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIAS 70
Query: 434 YYRKEEK----LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L+ + SL + L +LD S L+IV +A GL +L+ E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSL------YDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 490 LPSLIAPHG--H--IKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA--------YK 537
+ H +KS N+L+ ++ + +AD GL + +Q + Q + Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 538 SPEFL------QLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL 591
+PE L K+ D+W+ G+++ E+ ++ K D+ V +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV---VPNDP 241
Query: 592 ANGDNRTEVFDK----EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645
+ D R V + + S+ + L K+ C + RL + + +
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 59/306 (19%), Positives = 111/306 (36%), Gaps = 49/306 (16%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQE-HMRRLGRLRHPNLLPLVAY 433
+ +G G +G + G + VK F F+E + + +RH N+L +A
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAA 99
Query: 434 YYRKEEK----LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
+ L+ ++ SL + L +LD S LK+ GL +L+ E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSL------YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 490 LPSL-----IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA--------Y 536
+ S IA H +KS N+L+ ++ +AD GL ++ + + Y
Sbjct: 154 IFSTQGKPAIA-HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 537 KSPEFLQLGRI-------TKKTDVWSLGVLILEIMTGKFPANFLQQGK-------KADGD 582
PE L + D++S G+++ E+ +++ + +D
Sbjct: 213 MPPEVLD-ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 583 LASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642
V R ++ +DE +M KL+ C RL +
Sbjct: 272 YEDMREIVCIKK-LRPSFPNRWSSDECLR--QMGKLMT---ECWAHNPASRLTALRVKKT 325
Query: 643 IEEVKE 648
+ ++ E
Sbjct: 326 LAKMSE 331
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+ LG G F L G +KR REE Q HPN+L LVAY
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 434 YYRKEEK----LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
R+ L+ F + +L + + G L L ++ G+ +GL+ ++
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEAIHA- 152
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGL--IPVMNQESAQELMI-----------AY 536
H +K +N+LL + +PVL D G ++ E +++ + +Y
Sbjct: 153 -KGYA--HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 537 KSPEFLQLGR---ITKKTDVWSLGVLILEIMTGKFP 569
++PE + I ++TDVWSLG ++ +M G+ P
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 46/253 (18%), Positives = 97/253 (38%), Gaps = 39/253 (15%)
Query: 339 SSTEAVVGGKKPEIKLSFVRD-DVERFDLHDLLRASAEILGSGCFGSSYKASLS-TGAMM 396
S A +K F+++ D+ L E++G G FG Y A
Sbjct: 7 SLLSARSFPRKASQTSIFLQEWDIPFEQLEIG-----ELIGKGRFGQVYHGRWHGEVA-- 59
Query: 397 VVKRFK--QMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAV 454
++ + N + F+ + + RH N++ + ++ R+L
Sbjct: 60 -IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 455 NLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPV 514
+ + LD +I + + KG+ YL+ ++ H +KS NV + + V
Sbjct: 119 VVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA--KGIL--HKDLKSKNVFYDNG-KVV 169
Query: 515 LADYGL---IPVMNQESAQELM------IAYKSPEFLQLGRI---------TKKTDVWSL 556
+ D+GL V+ ++ + + + +PE ++ +K +DV++L
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229
Query: 557 GVLILEIMTGKFP 569
G + E+ ++P
Sbjct: 230 GTIWYELHAREWP 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-21
Identities = 29/156 (18%), Positives = 51/156 (32%), Gaps = 9/156 (5%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFS 108
L + L+ + ++ LR + L + + L + L + ++ N F
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS--LEVLKMAGNSFQ 458
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQK 166
D F + +L L L+ Q P + LS L L + N F
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 167 DLVSFNVSNNALFGSISPALRELDPS----SFSGNR 198
L + S N + S L+ S + + N
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-18
Identities = 23/142 (16%), Positives = 45/142 (31%), Gaps = 14/142 (9%)
Query: 66 LKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125
++ L L N + + L L + ++ F + +L L
Sbjct: 369 DFGTTSLKYLDLSFNGVITMSSNFLGLEQ--LEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 126 LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFNVSNNALFGSI 182
++ LS L L++ GN F+ F + ++L ++S L
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 183 S------PALRELDPSSFSGNR 198
+L+ L+ S N
Sbjct: 487 PTAFNSLSSLQVLN---MSHNN 505
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 27/146 (18%), Positives = 52/146 (35%), Gaps = 12/146 (8%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNN 105
L + L GN + + L ++ L + NL + L L+ + +++N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT--LKELNVAHN 134
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRL----VELRLEGNKFEGQIP 161
+ F +T+L L L+ N+ L L ++ + L L N P
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
Query: 162 D-FQQKDLVSFNVSNNALFGSISPAL 186
F++ L + NN ++
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 27/128 (21%), Positives = 53/128 (41%), Gaps = 7/128 (5%)
Query: 66 LKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124
E++ L L R ++ + L + L ++ L+ N AF G++SL+K
Sbjct: 48 FFSFPELQVLDLSRCEIQTIEDGAYQSLSH--LSTLILTGNPIQSLAL-GAFSGLSSLQK 104
Query: 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG-QIPDFQQ--KDLVSFNVSNNALFGS 181
L+ + + L L EL + N + ++P++ +L ++S+N +
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 182 ISPALREL 189
LR L
Sbjct: 165 YCTDLRVL 172
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-16
Identities = 27/136 (19%), Positives = 41/136 (30%), Gaps = 16/136 (11%)
Query: 73 RTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQ 131
+ L L N L L+ + LS A+ ++ L L+L N
Sbjct: 31 KNLDLSFNPLRHLGSYSFFSFPE--LQVLDLSRCEIQTIED-GAYQSLSHLSTLILTGNP 87
Query: 132 FNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA---- 185
+ + LS L +L K L NV++N + P
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 186 ---LRELDPSSFSGNR 198
L LD S N+
Sbjct: 148 LTNLEHLD---LSSNK 160
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 18/95 (18%), Positives = 28/95 (29%), Gaps = 3/95 (3%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
+++ LS N F L+ L L+ + + LS L L L GN
Sbjct: 30 TKNLDLSFNPLRHLGSYS-FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 157 EGQIPD-FQQ-KDLVSFNVSNNALFGSISPALREL 189
+ F L L + + L
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 28/177 (15%), Positives = 51/177 (28%), Gaps = 34/177 (19%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSG 109
+L + + I + L + + SL+ +E N + + L N +F
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF---SYNFGWQHLELVNCKFGQ 318
Query: 110 EIPTD------------------AFDGMTSLRKLLLADNQFN--GPIPESLTRLSRLVEL 149
+ + SL L L+ N + G +S + L L
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 150 RLEGNKFEGQIPDFQQ-KDLVSFNVSNNALFGSISPA-------LRELDPSSFSGNR 198
L N +F + L + ++ L + L LD S
Sbjct: 379 DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD---ISHTH 432
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 27/166 (16%), Positives = 43/166 (25%), Gaps = 16/166 (9%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE-- 110
L N I KE+R + L+L N + G L L F E
Sbjct: 184 LSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 111 IPTDAFDGMTSLRKLLLADNQFN------GPIPESLTRLSRLVELRLEGNKFEGQIPDFQ 164
+ + L L + + + I + L+ + L E
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 165 QKDLVSFNVSNN---ALFGSISPALRELDPSSFSGNRDLCGEPLGS 207
+ N +L+ L +S G L S
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 16/93 (17%), Positives = 28/93 (30%), Gaps = 6/93 (6%)
Query: 99 SVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG 158
+ F +IP + S + L L+ N S L L L + +
Sbjct: 11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 159 QIPD-FQQ-KDLVSFNVSNNALFGSISPALREL 189
+Q L + ++ N + A L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 26/132 (19%), Positives = 46/132 (34%), Gaps = 10/132 (7%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNN 105
L + L + T L ++ L++ NN + L + L+ + S N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS--LQVLDYSLN 528
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNG--PIPESLTRLSRLVELRLEGNKFEGQIP-D 162
+ +SL L L N F L + +L +E + E P D
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
Query: 163 FQQKDLVSFNVS 174
Q ++S N++
Sbjct: 589 KQGMPVLSLNIT 600
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 6e-21
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 375 EILGSGCFGSSYKASLSTGAMMV-VKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
LG G +G Y+ ++ V VK K+ + + EEF + + ++HPNL+ L+
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
R+ ++ EF+ +L L + + L + ++ ++YL E +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYL--EKKNF 339
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-----SAQELMIAYKSPEFLQLGRIT 548
I H ++ + N L+ E+ +AD+GL +M + + + I + +PE L + +
Sbjct: 340 I--HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 549 KKTDVWSLGVLILEIMT-GKFP 569
K+DVW+ GVL+ EI T G P
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSP 419
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
+ +GSG FG + + +K ++ + E+F E + +L HP L+ L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+ LV EF+ L+ L + + L + V +G+ YL E +I
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYL--EEACVI 126
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---SAQELMIAYK--SPEFLQLGRITK 549
H + + N L+ E+ ++D+G+ + + S+ K SPE R +
Sbjct: 127 --HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 550 KTDVWSLGVLILEIMT-GKFP 569
K+DVWS GVL+ E+ + GK P
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIP 205
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 46/212 (21%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK--QMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+G G F + YK T + + ++ R+ F+E L L+HPN+ V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI---V 88
Query: 432 AYY------YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ 484
+Y + ++ + LV E + +L L + + + + KGLQ
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM-----KIKVLRSWCRQILKGLQ 143
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPV-LADYGLIPVMNQESAQEL------MIAYK 537
+L+ P +I H +K N+ + V + D GL + A+ + M
Sbjct: 144 FLHTRTPPII--HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM---- 197
Query: 538 SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+PE + + DV++ G+ +LE+ T ++P
Sbjct: 198 APEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
LG GCFG + + + + +K K + E F + + + +LRH L+ L A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+E +V E++ K SL L G L P + + +A G+ Y+ E + +
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYV--ERMNYV 302
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-----SAQELMIAYKSPEFLQLGRITK 549
H ++++N+L+ E+L +AD+GL ++ + I + +PE GR T
Sbjct: 303 --HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 550 KTDVWSLGVLILEIMT-GKFP 569
K+DVWS G+L+ E+ T G+ P
Sbjct: 361 KSDVWSFGILLTELTTKGRVP 381
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 49/256 (19%), Positives = 98/256 (38%), Gaps = 41/256 (16%)
Query: 331 RESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA-S 389
+ G P + + ++ + + F + + +G G F Y+A
Sbjct: 4 QSQGMQGPPVPQFQ---PQKALRPDMGYNTLANFRI-------EKKIGRGQFSEVYRAAC 53
Query: 390 LSTGAMMVVKR---FKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY--YRKEEKL-LV 443
L G + +K+ F M+ R + + + L +L HPN+ + YY + ++ +L +V
Sbjct: 54 LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV---IKYYASFIEDNELNIV 110
Query: 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGH---- 499
E L+ + + + + + K + L+++ H
Sbjct: 111 LELADAGDLSRMIKHFKKQKRL-IPERTVWKYFVQLCSALEHM----------HSRRVMH 159
Query: 500 --IKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQLGRITKKTDV 553
IK +NV + + L D GL + ++ + Y SPE + K+D+
Sbjct: 160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219
Query: 554 WSLGVLILEIMTGKFP 569
WSLG L+ E+ + P
Sbjct: 220 WSLGCLLYEMAALQSP 235
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 24/209 (11%)
Query: 375 EILGSGCFGSSYKASLST----GAMMV-VKRFKQ--MNNVGREEFQEHMRRLGRLRHPNL 427
++LGSG FG+ YK + V +K ++ +E + + + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNPHV 79
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
L+ L+ + +P L + H+ ++ L +AKG+ YL
Sbjct: 80 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYL- 133
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----AQELMIAYK--SPEF 541
E L+ H + + NVL+ + D+GL ++ E A+ + K + E
Sbjct: 134 -EDRRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 542 LQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ T ++DVWS GV + E+MT G P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
+ LG+G FG + A+ + + VK K ++ E F + L+H L+ L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 435 YRKEEKLLVHEFVPKRSLAVNL--HGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
KE ++ EF+ K SL L P L + +A+G+ ++ E +
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFI--EQRN 304
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---SAQELMIAYK--SPEFLQLGRI 547
I H ++++N+L++ SL +AD+GL V+ + + K +PE + G
Sbjct: 305 YI--HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 548 TKKTDVWSLGVLILEIMT-GKFP 569
T K+DVWS G+L++EI+T G+ P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP 385
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 3e-20
Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 375 EILGSGCFGSSYKASLSTGAMMV-VKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+ LGSG FG G V VK K+ ++ +EF + + + +L HP L+
Sbjct: 14 KELGSGQFGVVKLGKW-KGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
++ +V E++ L L H L+ L++ V +G+ +L E
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFL--ESHQF 125
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---SAQELMIAYK--SPEFLQLGRIT 548
I H + + N L++ L ++D+G+ + + S+ K +PE + +
Sbjct: 126 I--HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 549 KKTDVWSLGVLILEIMT-GKFP 569
K+DVW+ G+L+ E+ + GK P
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 375 EILGSGCFGSSYKASLSTGAMMV-VKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
LG G +G Y+ ++ V VK K+ + + EEF + + ++HPNL+ L+
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
R+ ++ EF+ +L L + + L + ++ ++YL E +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYL--EKKNF 132
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---SAQELMIAYK--SPEFLQLGRIT 548
I H + + N L+ E+ +AD+GL +M + + K +PE L + +
Sbjct: 133 I--HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 549 KKTDVWSLGVLILEIMT-GKFP 569
K+DVW+ GVL+ EI T G P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 375 EILGSGCFGSSYKASLSTGAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
E +G G FG + L +V VK ++ + + +F + R L + HPN++ L+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+K+ +V E V L L + L++V A G++YL E
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYL--ESKC 233
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----SAQELMIAYK--SPEFLQLGR 546
I H + + N L+ E ++D+G+ S + K +PE L GR
Sbjct: 234 CI--HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 547 ITKKTDVWSLGVLILEIMT-GKFP 569
+ ++DVWS G+L+ E + G P
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-20
Identities = 50/216 (23%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 367 HDLLRASAEILGSGCFGSSYKASLSTGAMMV---VKRFKQ--MNNVGREEFQEHMRRLGR 421
LL + LGSG FG+ K ++ VK K + ++E + +
Sbjct: 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 74
Query: 422 LRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAK 481
L +P ++ ++ E +LV E L L ++ + ++ +++V V+
Sbjct: 75 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSM 128
Query: 482 GLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----AQE---LMI 534
G++YL E + + H + + NVLL ++D+GL + + AQ +
Sbjct: 129 GMKYL--EESNFV--HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 535 AYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ +PE + + + K+DVWS GVL+ E + G+ P
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 66/320 (20%), Positives = 113/320 (35%), Gaps = 38/320 (11%)
Query: 270 GSSNSTLVIASATTVSVVAIAAVV---------AAIFVIERKRKRERGVSIENPPPLPPP 320
+ L + + + +A ++ A I R +K P
Sbjct: 291 AGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGE------RALPSIP 344
Query: 321 SSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSG 380
+ G+R S S S T+ E + + +G G
Sbjct: 345 KLANNEKQGVR-SHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELG--RCIGEG 401
Query: 381 CFGSSYKASL---STGAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYY 435
FG ++ AM V +K K ++ RE+F + + + HP+++ L+
Sbjct: 402 QFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI- 460
Query: 436 RKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIA 495
+ ++ E L L + SLD S + ++ L YL E +
Sbjct: 461 TENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYL--ESKRFV- 513
Query: 496 PHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-----SAQELMIAYKSPEFLQLGRITKK 550
H I + NVL++ + L D+GL M S +L I + +PE + R T
Sbjct: 514 -HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 551 TDVWSLGVLILEIMT-GKFP 569
+DVW GV + EI+ G P
Sbjct: 573 SDVWMFGVCMWEILMHGVKP 592
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 47/202 (23%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 375 EILGSGCFGSSYKASLSTGAMMV-VKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+ LG+G FG G V +K K+ ++ +EF E + + L H L+ L
Sbjct: 30 KELGTGQFGVVKYGKWR-GQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
++ ++ E++ L L + L++ K V + ++YL E
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYL--ESKQF 141
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---SAQELMIAYK--SPEFLQLGRIT 548
+ H + + N L+N+ ++D+GL + + S+ + PE L + +
Sbjct: 142 L--HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 549 KKTDVWSLGVLILEIMT-GKFP 569
K+D+W+ GVL+ EI + GK P
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMP 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
LG GCFG + + + + +K K + E F + + + +LRH L+ L A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+E +V E++ K SL L G L P + + +A G+ Y+ E + +
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYV--ERMNYV 385
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-----SAQELMIAYKSPEFLQLGRITK 549
H ++++N+L+ E+L +AD+GL ++ + I + +PE GR T
Sbjct: 386 --HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 550 KTDVWSLGVLILEIMT-GKFP 569
K+DVWS G+L+ E+ T G+ P
Sbjct: 444 KSDVWSFGILLTELTTKGRVP 464
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 26/213 (12%)
Query: 375 EILGSGCFGSSYKASL-------STGAMMV-VKRFKQMNNVGREEFQEHMRRLGRLRHPN 426
E LG G F +K V +K + + E F E + +L H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 427 LLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
L+ +E +LV EFV SL L + + ++ +L++ K +A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFL 129
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPV--------LADYGLIPVMNQESAQELMIAYKS 538
E +LI HG++ + N+LL + L+D G+ + + + I +
Sbjct: 130 --EENTLI--HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 539 PEFLQLGRI-TKKTDVWSLGVLILEIMT-GKFP 569
PE ++ + TD WS G + EI + G P
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 18/233 (7%)
Query: 341 TEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKR 400
+ V + F R ++ +L + +G G FG G + VK
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWA-LNMKEL--KLLQTIGKGEFGDVMLGDY-RGNKVAVKC 223
Query: 401 FKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGH 459
K + + F + +LRH NL+ L+ ++ L +V E++ K SL L
Sbjct: 224 IKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 281
Query: 460 QALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519
G+ L LK V + ++YL E + + H + + NVL++E ++D+G
Sbjct: 282 ---GRSVLGGDCLLKFSLDVCEAMEYL--EGNNFV--HRDLAARNVLVSEDNVAKVSDFG 334
Query: 520 LIPVMNQESAQELMIAYK--SPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
L + + + K +PE L+ + + K+DVWS G+L+ EI + G+ P
Sbjct: 335 LTKEAS-STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 52/237 (21%), Positives = 95/237 (40%), Gaps = 42/237 (17%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKR-----FKQMNNVGREEFQEHMRRLGRLRHPNLL 428
+L G F Y+A + +G +KR ++ + +E M++L HPN++
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEV--CFMKKL--SGHPNIV 89
Query: 429 PLVAYYYRKEEK-------LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAK 481
+ +E+ L+ + K L L ++ G L + LKI +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCR 147
Query: 482 GLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMI-- 534
+Q+++R+ P +I H +K N+LL+ L D+G SAQ +
Sbjct: 148 AVQHMHRQKPPII--HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 535 ---------AYKSPEFLQLGR---ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKA 579
Y++PE + L I +K D+W+LG ++ + + P F K
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FEDGAKLR 260
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 7e-19
Identities = 51/275 (18%), Positives = 94/275 (34%), Gaps = 38/275 (13%)
Query: 309 VSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHD 368
VS L + S + E V+ +K + R++V
Sbjct: 5 VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQP 64
Query: 369 LLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL 427
+ G G FG ++ TG VK ++ + +E + L P +
Sbjct: 65 RV-------GRGSFGEVHRMKDKQTGFQCAVK---KVR-LEVFRVEE-LVACAGLSSPRI 112
Query: 428 LPLVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ 484
V Y R+ + + E + SL + L + L + +GL+
Sbjct: 113 ---VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-----LYYLGQALEGLE 164
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPV-LADYGLIPVMNQESAQELMIAYKS----- 538
YL+ ++ HG +K+ NVLL+ L D+G + + + ++
Sbjct: 165 YLHTR--RIL--HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 539 ----PEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
PE + K D+WS ++L ++ G P
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 21/208 (10%)
Query: 375 EILGSGCFGSSYKASLST---GAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLP 429
+I+GSG G L + V +K K R +F +G+ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L R ++V E++ SL L H + +++GV G++YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYL--S 168
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-----AQELMIAYK--SPEFL 542
+ H + + NVL++ +L ++D+GL V+ + I + +PE +
Sbjct: 169 DLGYV--HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 543 QLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ +DVWS GV++ E++ G+ P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 55/272 (20%), Positives = 86/272 (31%), Gaps = 41/272 (15%)
Query: 312 ENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLR 371
+ + + NL + Q P + + E F R
Sbjct: 6 HHSSGVDLGTENLY----FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQR 61
Query: 372 ASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQ--MNNVGREEFQEHMRRLGRL-RHPNL 427
LG G +G +K S G + VKR R + ++ +HP
Sbjct: 62 L--SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 428 LPLVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ 484
V + + L L E SL + +A G L ++ L
Sbjct: 120 ---VRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGAS-LPEAQVWGYLRDTLLALA 171
Query: 485 YLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI---A 535
+L H +K +N+ L L D+GL+ + A E+
Sbjct: 172 HL----------HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR 221
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMTGK 567
Y +PE LQ G DV+SLG+ ILE+
Sbjct: 222 YMAPELLQ-GSYGTAADVFSLGLTILEVACNM 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 39/226 (17%), Positives = 84/226 (37%), Gaps = 47/226 (20%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKR--FKQMNNVGREEFQEHMRRLGRL-RHPNLLPL 430
E +GSG FGS +K G + +KR +V + + L +H ++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV--- 73
Query: 431 VAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
V Y+ + +++ + + +E+ SLA + + + ++ V +GL+Y+
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY-FKEAELKDLLLQVGRGLRYI- 131
Query: 488 RELPSLIAPHGH------IKSSNVLLNESLEPV-------------------LADYGLIP 522
H IK SN+ ++ + P + D G +
Sbjct: 132 ---------HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 523 VMNQESAQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGK 567
++ +E + + E LQ K D+++L + ++ +
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 24/210 (11%)
Query: 375 EILGSGCFGSSYKASL---STGAMMV-VKRFKQ---MNNVGREEFQEHMRRLGRLRHPNL 427
E LG G FG + S + V VK K ++F + + L H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
+ L +V E P SL L HQ + + VA+G+ YL
Sbjct: 84 IRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYL- 137
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-----SAQELMIAYK--SPE 540
E I H + + N+LL + D+GL+ + Q + + + +PE
Sbjct: 138 -ESKRFI--HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
L+ + +D W GV + E+ T G+ P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 375 EILGSGCFGSSYKASL---STGAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLP 429
+G G FG ++ A+ V +K K ++ RE+F + + + HP+++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L+ + ++ E L L + SLD S + ++ L YL E
Sbjct: 81 LIGVI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYL--E 133
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---SAQELMIAYK--SPEFLQL 544
+ H I + NVL++ + L D+GL M A + + K +PE +
Sbjct: 134 SKRFV--HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 545 GRITKKTDVWSLGVLILEIMT-GKFP 569
R T +DVW GV + EI+ G P
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 60/241 (24%), Positives = 101/241 (41%), Gaps = 43/241 (17%)
Query: 345 VGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQM 404
+GG F R ++ +L + +G G FG G + VK K
Sbjct: 1 MGGSVAAQDE-FYRSGWA-LNMKEL--KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN- 54
Query: 405 NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALG 463
+ + F + +LRH NL+ L+ ++ L +V E++ K SL L G
Sbjct: 55 -DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---G 110
Query: 464 QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL--- 520
+ L LK V + ++YL E + + H + + NVL++E ++D+GL
Sbjct: 111 RSVLGGDCLLKFSLDVCEAMEYL--EGNNFV--HRDLAARNVLVSEDNVAKVSDFGLTKE 166
Query: 521 ---------IPVMNQESAQELMIAYK--SPEFLQLGRITKKTDVWSLGVLILEIMT-GKF 568
+PV K +PE L+ + + K+DVWS G+L+ EI + G+
Sbjct: 167 ASSTQDTGKLPV-------------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
Query: 569 P 569
P
Sbjct: 214 P 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 375 EILGSGCFGSSYKASLST----GAMMV-VKRFKQMNNVG-REEFQEHMRRLGRLRHPNLL 428
++LGSG FG+ YK + V +K ++ + +E + + + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L+ L+ + +P L + H+ ++ L +AKG+ YL
Sbjct: 81 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----SAQELMIAYK--SPEFL 542
E L+ H + + NVL+ + D+GL ++ E A+ + K + E +
Sbjct: 134 EDRRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 543 QLGRITKKTDVWSLGVLILEIMT-GKFP 569
T ++DVWS GV + E+MT G P
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 62/326 (19%), Positives = 119/326 (36%), Gaps = 49/326 (15%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLP 429
LG G FGS +TGA++ VK+ + + +FQ ++ L L ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 430 L--VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
V+Y ++ LV E++P L L H+ LD L + KG++YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYL- 143
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----AQE---LMIAYKSPE 540
+ H + + N+L+ +AD+GL ++ + +E I + +PE
Sbjct: 144 -GSRRCV--HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599
L ++++DVWS GV++ E+ T + V A +
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPAL----SR 252
Query: 600 VFDKEMADERNSEGEM-------VKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652
+ + +R + ++ ++ C + R +++ +
Sbjct: 253 LLELLEEGQR-----LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG--- 304
Query: 653 EDFYSSYASEADLRSPRGKSDEFTFS 678
+ A P GK +FS
Sbjct: 305 ---SRGCETHAFTAHPEGKHHSLSFS 327
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 11/205 (5%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVK--RFKQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+G+G +G K S G ++V K + M ++ + L L+HPN++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 432 AYYYRKEEKLL--VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL-YR 488
+ L V E+ LA + Q LD L+++ + L+ R
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRR 130
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQL 544
H +K +NV L+ L D+GL ++N +++ Y SPE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 545 GRITKKTDVWSLGVLILEIMTGKFP 569
+K+D+WSLG L+ E+ P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
E LG+G FG + + + VK KQ ++ + F + +L+H L+ L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+E ++ E++ SL L L L + +A+G+ ++ E + I
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFI--EERNYI 131
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQ---ESAQELMIAYK--SPEFLQLGRITK 549
H ++++N+L++++L +AD+GL ++ + + K +PE + G T
Sbjct: 132 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 550 KTDVWSLGVLILEIMT-GKFP 569
K+DVWS G+L+ EI+T G+ P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-18
Identities = 28/148 (18%), Positives = 54/148 (36%), Gaps = 12/148 (8%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNN 105
+L + + N ++ + ++L ++ L+L N L N L ++L +N
Sbjct: 50 QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN--LTELHLMSN 107
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--- 162
I + F +L L L+ N + + +L L EL L NK + +
Sbjct: 108 SIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELD 166
Query: 163 -FQQKDLVSFNVSNNALFGSISPALREL 189
F L +S+N + +
Sbjct: 167 IFANSSLKKLELSSNQIKEFSPGCFHAI 194
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-17
Identities = 26/137 (18%), Positives = 48/137 (35%), Gaps = 16/137 (11%)
Query: 73 RTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQ 131
L+L +N + D LG+ L + L N E+ + G+ ++ ++ L+ N+
Sbjct: 384 HILNLTKNKISKIESDAFSWLGH--LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441
Query: 132 FNGPIPESLTRLSRLVELRLEGNKFEG--QIPDF--QQKDLVSFNVSNNALFGSIS---- 183
+ S + L L L + P ++L ++SNN +
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501
Query: 184 --PALRELDPSSFSGNR 198
L LD N
Sbjct: 502 GLEKLEILD---LQHNN 515
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-16
Identities = 29/135 (21%), Positives = 55/135 (40%), Gaps = 15/135 (11%)
Query: 73 RTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQ 131
L+L N L P + + L S+ + N S + + + L+ L L N+
Sbjct: 28 TVLNLTHNQLRRLPAANFTRYSQ--LTSLDVGFNTISK-LEPELCQKLPMLKVLNLQHNE 84
Query: 132 FNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDLVSFNVSNNALFGSISPA---- 185
+ ++ + L EL L N + + +QK+L++ ++S+N L +
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 186 --LRELDPSSFSGNR 198
L+EL S N+
Sbjct: 145 ENLQELL---LSNNK 156
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-16
Identities = 31/154 (20%), Positives = 53/154 (34%), Gaps = 15/154 (9%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEI 111
L N + ++ +L + N + P+ ++L L+ + L +N S +
Sbjct: 32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM--LKVLNLQHNELSQ-L 88
Query: 112 PTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQ-KDLV 169
F T+L +L L N + L+ L L N Q ++L
Sbjct: 89 SDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQ 148
Query: 170 SFNVSNNALFGSISPALRELDPSS-----FSGNR 198
+SNN + S L SS S N+
Sbjct: 149 ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-16
Identities = 30/136 (22%), Positives = 50/136 (36%), Gaps = 15/136 (11%)
Query: 60 NIDITILKELREMRTLSLMRNNLE---------GPMPDLRQLGNGALRSVYLSNNRFSGE 110
NI+ +L+ L ++ L L NNL GP+ L+ L + L + L +N F
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH--LHILNLESNGFDE- 550
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ---KD 167
IP + F + L+ + L N N L L L+ N ++
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 168 LVSFNVSNNALFGSIS 183
L ++ N +
Sbjct: 611 LTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-16
Identities = 35/164 (21%), Positives = 61/164 (37%), Gaps = 18/164 (10%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
L ++ L N I + + + TL L N L + QL N L+ + LSNN
Sbjct: 98 NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN--LQELLLSNN 155
Query: 106 RFSGEIPTD-AFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-- 162
+ + +SL+KL L+ NQ P + RL L L + + +
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 163 ---FQQKDLVSFNVSNNALFGSISPALRELDPSS-----FSGNR 198
+ + ++SN+ L + + L ++ S N
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 30/169 (17%), Positives = 52/169 (30%), Gaps = 28/169 (16%)
Query: 51 KLEDMGLQGN-------IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102
+L + L + + +R LSL + L L L + L
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD 162
S N + + D+F + L L N SL L + L L+ + + I
Sbjct: 256 SYNNLNV-VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 163 FQ-----------QKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
K L N+ +N + + + F+G +L
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDN--------DIPGIKSNMFTGLINL 355
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 28/152 (18%), Positives = 59/152 (38%), Gaps = 18/152 (11%)
Query: 60 NIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFS-GEIPTDAFD 117
ID + L+ + L++ N++ G + L N L+ + LSN+ S + + F
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN--LKYLSLSNSFTSLRTLTNETFV 376
Query: 118 GM--TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFN 172
+ + L L L N+ + ++ + L L L L N+ ++ ++ +++
Sbjct: 377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIY 436
Query: 173 VSNNALFGSIS------PALRELDPSSFSGNR 198
+S N P+L+ L
Sbjct: 437 LSYNKYLQLTRNSFALVPSLQRLM---LRRVA 465
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 26/167 (15%), Positives = 48/167 (28%), Gaps = 23/167 (13%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFS 108
L L + + + L + + L N + + + L+ + L
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS--LQRLMLRRVALK 467
Query: 109 G-EIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNK--------FEGQ 159
+ F + +L L L++N + L L +L L L+ N G
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527
Query: 160 IPDF--QQKDLVSFNVSNNALFGSIS------PALRELDPSSFSGNR 198
F L N+ +N L+ +D N
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID---LGLNN 571
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 14/106 (13%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
S+ + + ++P D T++ L L NQ + TR S+L L + N
Sbjct: 6 HEVADCSHLKLT-QVPDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 157 EGQIPD-FQQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
P+ Q+ L N+ +N L +L +F+ +L
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHN--------ELSQLSDKTFAFCTNL 99
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 50/208 (24%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 375 EILGSGCFGSSYKASL---STGAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLP 429
+++G+G FG L S + V +K K R +F +G+ HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L + + ++V E++ SL L H + +++G+A G++YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYL--S 164
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-----SAQELMIAYK--SPEFL 542
+ H + + N+L+N +L ++D+GL V+ + + + I + SPE +
Sbjct: 165 DMGYV--HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 543 QLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ T +DVWS G+++ E+M+ G+ P
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 32/212 (15%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+LG G +G Y LS + +K + ++ + E + L+H N+ V Y
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI---VQY 84
Query: 434 Y--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ + + + E VP SL+ L G + + K + +GL+YL
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYL---- 138
Query: 491 PSLIAPHGH------IKSSNVLLNESLEPV-LADYGLIPVMNQESAQELMIA----YKSP 539
H + IK NVL+N + ++D+G + + Y +P
Sbjct: 139 ------HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
Query: 540 EFLQLGRI--TKKTDVWSLGVLILEIMTGKFP 569
E + G K D+WSLG I+E+ TGK P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 375 EILGSGCFGSSYKASL----STGAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLL 428
++LGSG FG+ +K + + V +K + + +HM +G L H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L+ LV +++P SL ++ H+ +L L +AKG+ YL
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYL-- 131
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGL---IPVMNQESAQE---LMIAYKSPEFL 542
E ++ H ++ + NVLL + +AD+G+ +P +++ I + + E +
Sbjct: 132 EEHGMV--HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 543 QLGRITKKTDVWSLGVLILEIMT-GKFP 569
G+ T ++DVWS GV + E+MT G P
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 24/254 (9%)
Query: 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLP 429
LG+G G +K S +G +M K ++ + + + R L P +
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKL---IHLEIKPAIRNQIIRELQVLHECNSPYI-- 93
Query: 430 LVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
V +Y + + ++ + E + SL L + + L K+ V KGL YL
Sbjct: 94 -VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 147
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--IAYKSPEFLQL 544
+ ++ H +K SN+L+N E L D+G+ + A + +Y SPE LQ
Sbjct: 148 REKH-KIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG 204
Query: 545 GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604
+ ++D+WS+G+ ++E+ G++P +
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 605 MADERNSEGEMVKL 618
+S M
Sbjct: 265 NKFGMDSRPPMAIF 278
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 46/205 (22%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 377 LGSGCFGSSYKASL--STGAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
LG G FGS + + V +K KQ EE + + +L +P ++ L+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+ E +LV E L L G + + + +++ V+ G++YL E +
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYL--EEKN 130
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-------IAYKSPEFLQLG 545
+ H + + NVLL ++D+GL + + + + + +PE +
Sbjct: 131 FV--HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 546 RITKKTDVWSLGVLILEIMT-GKFP 569
+ + ++DVWS GV + E ++ G+ P
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 1e-17
Identities = 55/296 (18%), Positives = 109/296 (36%), Gaps = 32/296 (10%)
Query: 297 FVIERKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSF 356
G + P P ++ Q+ S +P K + +
Sbjct: 253 ACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDT 312
Query: 357 VRDDVERFDLHDLLRASAEI-----------LGSGCFGSSYKASLST--GAMMV-VKRFK 402
+ D +L + LG G FGS + + V +K K
Sbjct: 313 SVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK 372
Query: 403 Q-MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQA 461
Q EE + + +L +P ++ L+ + E +LV E L L G +
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR- 430
Query: 462 LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521
+ + +++ V+ G++YL E + + H ++ + NVLL ++D+GL
Sbjct: 431 ---EEIPVSNVAELLHQVSMGMKYL--EEKNFV--HRNLAARNVLLVNRHYAKISDFGLS 483
Query: 522 PVMNQESAQELM-------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ + + + + +PE + + + ++DVWS GV + E ++ G+ P
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 24/231 (10%)
Query: 349 KPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASL-----STGAMMVVKRFKQ 403
+ + +F D +F+ L + LG G FGS +TG ++ VK+ +
Sbjct: 23 QGAMGSAFEDRDPTQFEERHLKFL--QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH 80
Query: 404 MNNVGREEFQEHMRRLGRLRHPNLLPL--VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQA 461
+F+ + L L+H N++ V Y + L+ E++P SL L H+
Sbjct: 81 STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK- 139
Query: 462 LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521
+D L+ + KG++YL I H + + N+L+ + D+GL
Sbjct: 140 ---ERIDHIKLLQYTSQICKGMEYL--GTKRYI--HRDLATRNILVENENRVKIGDFGLT 192
Query: 522 PVMNQES----AQE---LMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
V+ Q+ +E I + +PE L + + +DVWS GV++ E+ T
Sbjct: 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLP 429
+ LG G FGS +TG ++ VK+ + +F+ + L L+H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 430 L--VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
V Y + L+ E++P SL L H+ +D L+ + KG++YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYL- 130
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----AQE---LMIAYKSPE 540
I H + + N+L+ + D+GL V+ Q+ +E I + +PE
Sbjct: 131 -GTKRYI--HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT 565
L + + +DVWS GV++ E+ T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 47/209 (22%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 375 EILGSGCFGSSYKASL----STGAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLL 428
+++G+G FG YK L + V +K K R +F +G+ H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L + + +++ E++ +L L + +++G+A G++YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-----AQELMIAYK--SPEF 541
+ + H + + N+L+N +L ++D+GL V+ + I + +PE
Sbjct: 164 ANMNYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 542 LQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ + T +DVWS G+++ E+MT G+ P
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 50/225 (22%), Positives = 93/225 (41%), Gaps = 49/225 (21%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E++GSG FG +KA G V+KR E+ + ++ L +L H N+ V Y
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI---VHY 69
Query: 434 Y------------------YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK 474
K + L + EF K +L + + G+ LD L+
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEK-LDKVLALE 126
Query: 475 IVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQES 528
+ + + KG+ Y+ H +K SN+ L ++ + + D+GL+ + +
Sbjct: 127 LFEQITKGVDYI----------HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 529 AQELMI---AYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPA 570
+ Y SPE + K+ D+++LG+++ E++ A
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 30/178 (16%), Positives = 59/178 (33%), Gaps = 20/178 (11%)
Query: 36 NWNGVLCHRGKIWGL-KLEDMGLQGN-----IDITILKELREMRTLSLMRNNLEGPMPD- 88
++NG + GL +L+ + Q + + + L ++ L + N +
Sbjct: 384 SFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 89 LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVE 148
L + L ++ ++ N F ++ F T+L L L+ Q L RL
Sbjct: 444 FLGLTS--LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501
Query: 149 LRLEGNKFEGQIPDF--QQKDLVSFNVSNNAL------FGSISPALRELDPSSFSGNR 198
L + N Q L + + S N + +L + + N
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN---LTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 23/160 (14%), Positives = 45/160 (28%), Gaps = 21/160 (13%)
Query: 51 KLEDMGLQGNIDITILKE-------LREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLS 103
L + L N ++ +R L L N + L L+ +
Sbjct: 351 SLSYLDLSRN-ALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEE--LQHLDFQ 407
Query: 104 NNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF 163
++ AF + L L ++ L+ L L++ GN F+
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
Query: 164 QQKDLVS---FNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ + ++S L ++ F L
Sbjct: 468 VFANTTNLTFLDLSKC--------QLEQISWGVFDTLHRL 499
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 32/163 (19%), Positives = 59/163 (36%), Gaps = 27/163 (16%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEI 111
L I+ L + L L N ++ P L + L ++ + + +
Sbjct: 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS--LENLVAVETKLA-SL 119
Query: 112 PTDAFDGMTSLRKLLLADNQFNG-PIPESLTRLSRLVELRLEGNKFEGQIP-DFQ----- 164
+ + +L+KL +A N + +P + L+ LV + L N + D Q
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 165 QKDLVSFNVSNNAL-------FGSISPALRELDPSSFSGNRDL 200
+ +S ++S N + F I L EL GN +
Sbjct: 180 PQVNLSLDMSLNPIDFIQDQAFQGIK--LHELT---LRGNFNS 217
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-15
Identities = 30/136 (22%), Positives = 44/136 (32%), Gaps = 16/136 (11%)
Query: 73 RTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQ 131
+ + L N L+ L+ + LS I A+ G+ L L+L N
Sbjct: 35 KNIDLSFNPLKILKSYSFSNFSE--LQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNP 91
Query: 132 FNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQ-KDLVSFNVSNNALFGSISPA---- 185
P S + L+ L L K Q L NV++N + PA
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 186 ---LRELDPSSFSGNR 198
L +D S N
Sbjct: 152 LTNLVHVD---LSYNY 164
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 18/108 (16%), Positives = 34/108 (31%), Gaps = 4/108 (3%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFS 108
LK+ + N + + L L + LE L L+ + +S+N
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR--LQLLNMSHNNLL 510
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
+ + ++ + SL L + N+ L L N
Sbjct: 511 F-LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 28/157 (17%), Positives = 45/157 (28%), Gaps = 18/157 (11%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEI 111
L GN L + L + L + QL L+ + +++N
Sbjct: 87 LTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT--LKKLNVAHNFIHSCK 144
Query: 112 PTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRL----VELRLEGNKFEGQIPD--FQQ 165
F +T+L + L+ N L L + L + N + I D FQ
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQG 203
Query: 166 KDLVSFNVSNNALFGSISP----ALRELDPSSFSGNR 198
L + N +I L L
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGE 240
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 20/104 (19%), Positives = 37/104 (35%), Gaps = 14/104 (13%)
Query: 99 SVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG 158
+ + + S ++P D +S + + L+ N S + S L L L + E
Sbjct: 15 TYQCMDQKLS-KVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 159 QIPD-FQQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ L + ++ N ++ P SFSG L
Sbjct: 71 IEDKAWHGLHHLSNLILTGN--------PIQSFSPGSFSGLTSL 106
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 22/133 (16%), Positives = 37/133 (27%), Gaps = 23/133 (17%)
Query: 74 TLSLMRNNL----EGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLAD 129
T M L + + + LS N + + +F + L+ L L+
Sbjct: 15 TYQCMDQKLSKVPDDIPSSTKNI--------DLSFNPLK-ILKSYSFSNFSELQWLDLSR 65
Query: 130 NQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQ-KDLVSFNVSNNALFGSISPALR 187
+ ++ L L L L GN + P F L + L
Sbjct: 66 CEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET--------KLA 117
Query: 188 ELDPSSFSGNRDL 200
L+ L
Sbjct: 118 SLESFPIGQLITL 130
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 20/157 (12%), Positives = 40/157 (25%), Gaps = 20/157 (12%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE-- 110
+ N I + ++ + L+L N + L L F E
Sbjct: 188 MSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN 246
Query: 111 ---IPTDAFDGMTSLRK--LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ 165
+G+ + L L+ + + L G + +
Sbjct: 247 LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKH 306
Query: 166 KDLVSFNVSNNALFGSIS----PALRELDPSSFSGNR 198
S ++ L P L+ L + N+
Sbjct: 307 FKWQSLSIIRCQL-KQFPTLDLPFLKSLT---LTMNK 339
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 26/171 (15%), Positives = 48/171 (28%), Gaps = 29/171 (16%)
Query: 51 KLEDMGLQGN----IDITILKELREMR----TLSLMRNNLEGPMPDLRQLGNGALRSVYL 102
L + L N I + L+ LRE +L + N ++ L + L
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA--FQGIKLHELTL 211
Query: 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNG---------PIPESLTRLSRLVELRLEG 153
N S I + L L +F I E L ++ E RL
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID-EFRLTY 270
Query: 154 NKFEGQIPD-FQQ-KDLVSFNVSNNALF----GSISPALRELDPSSFSGNR 198
F ++ + +++ ++ + L +
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLS---IIRCQ 318
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 26/176 (14%), Positives = 49/176 (27%), Gaps = 33/176 (18%)
Query: 50 LKLEDMGLQGNIDIT-----ILKELREMRT--LSLMRNNLEGPMPD-LRQLGNGALRSVY 101
+L + ++ I++ L ++ L N L N + ++
Sbjct: 234 HRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN--VSAMS 291
Query: 102 LSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIP 161
L+ + + L + Q L L L L NK
Sbjct: 292 LAGVSIK-YLEDVPK--HFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSISFK 345
Query: 162 DFQQKDLVSFNVSNN--------ALFGSISPALRELD---------PSSFSGNRDL 200
L ++S N + + +LR LD ++F G +L
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEEL 401
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 19/85 (22%), Positives = 29/85 (34%), Gaps = 5/85 (5%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFS 108
L L L+ I + L ++ L++ NNL QL + L ++ S NR
Sbjct: 478 LDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS--LSTLDCSFNRIE 534
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFN 133
SL L +N
Sbjct: 535 T-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 20/206 (9%)
Query: 375 EILGSGCFGSSYKASL---STGAMMV-VKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLP 429
ILG G FG Y+ + V VK K+ +E+F + L HP+++
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L+ +E ++ E P L L ++ SL + + + K + YL E
Sbjct: 78 LIGII-EEEPTWIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYL--E 130
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---SAQELMIAYK--SPEFLQL 544
+ + H I N+L+ L D+GL + E A + K SPE +
Sbjct: 131 SINCV--HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 545 GRITKKTDVWSLGVLILEIMT-GKFP 569
R T +DVW V + EI++ GK P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 377 LGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLL 428
LG G FG+ Y A + A+ V+ + + + + +RR LRHPN+L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFK----AQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L Y++ L+ E+ P ++ L + + + +A L Y +
Sbjct: 73 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TA-TYITELANALSYCHS 127
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM---IAYKSPEFLQLG 545
+ +I H IK N+LL + E +AD+G V S + + + Y PE ++
Sbjct: 128 K--RVI--HRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 546 RITKKTDVWSLGVLILEIMTGKFP 569
+K D+WSLGVL E + GK P
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 63/290 (21%), Positives = 109/290 (37%), Gaps = 29/290 (10%)
Query: 301 RKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDD 360
+R+ I P P + + S G I LS + +
Sbjct: 15 GRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPE 74
Query: 361 VERFDLHDLLRASA------EILGSGCFGSSYKASLSTG---AMMV-VKRFKQMNNVG-R 409
+ + H ++ S+ E++G G FG Y +L + VK ++ ++G
Sbjct: 75 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 134
Query: 410 EEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLL-VHEFVPKRSLAVNLHGHQALGQPSLD 468
+F + HPN+L L+ R E L V ++ L + +
Sbjct: 135 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPT 190
Query: 469 WPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL------IP 522
+ VAKG+++L + H + + N +L+E +AD+GL
Sbjct: 191 VKDLIGFGLQVAKGMKFL--ASKKFV--HRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
Query: 523 VMNQESAQELMIAYK--SPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ + + K + E LQ + T K+DVWS GVL+ E+MT G P
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 23/206 (11%)
Query: 375 EILGSGCFGSSYKASLST----GAMMV-VKRFKQMNNV-GREEFQEHMRRLGRLRHPNLL 428
LG G FG V VK K + + ++ + L L H N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 429 PLVAYYYRKEEK--LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
L+ EF+P SL L ++ ++ +LK + KG+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYL 142
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----AQE---LMIAYKSP 539
+ H + + NVL+ + + D+GL + + ++ + + +P
Sbjct: 143 --GSRQYV--HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMT 565
E L + +DVWS GV + E++T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 375 EILGSGCFGSSYKASLSTG---AMMV-VKRFKQMNNVG-REEFQEHMRRLGRLRHPNLLP 429
E++G G FG Y +L + VK ++ ++G +F + HPN+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 430 LVAYYYRKEEKLL-VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L+ R E L V ++ L + + + VAKG++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYL-- 144
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM------NQESAQELMIAYK--SPE 540
+ H + + N +L+E +AD+GL M + + + K + E
Sbjct: 145 ASKKFV--HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
LQ + T K+DVWS GVL+ E+MT G P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-16
Identities = 28/139 (20%), Positives = 51/139 (36%), Gaps = 11/139 (7%)
Query: 63 ITILKELREMRTLSLMRNNL-EGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMT 120
+ +++ + + NNL P+ L+++ L + N+ G++P AF
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK--LGMLECLYNQLEGKLP--AFGSEI 353
Query: 121 SLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ----KDLVSFNVSNN 176
L L LA NQ ++ L NK + IP+ + + + S N
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYN 412
Query: 177 ALFGSISPALRELDPSSFS 195
+ LDP+ F
Sbjct: 413 EIGSVDGKNFDPLDPTPFK 431
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 33/178 (18%), Positives = 60/178 (33%), Gaps = 37/178 (20%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG--PMPDLRQLGNGALRSVYLSN 104
KL + L N I ++ LS N L+ + D + + + ++ S
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSV--MSAIDFSY 411
Query: 105 NRFSGEIPTDAFDGM-------TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFE 157
N + FD + ++ + L++NQ + E + S L + L GN
Sbjct: 412 NEIGS-VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470
Query: 158 G--------QIPDFQQ-KDLVSFNVSNNALFGSISPA--------LRELDPSSFSGNR 198
+ +F+ L S ++ N L +S L +D S N
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGID---LSYNS 524
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 23/129 (17%), Positives = 43/129 (33%), Gaps = 13/129 (10%)
Query: 66 LKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125
K + ++ L N L D R L + LS N FS PT + ++L+
Sbjct: 484 FKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN-SSTLKGF 541
Query: 126 ------LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDLVSFNVSNNA 177
N+ PE +T L +L++ N + + + ++ +N
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPN--ISVLDIKDNP 598
Query: 178 LFGSISPAL 186
+
Sbjct: 599 NISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 22/173 (12%), Positives = 53/173 (30%), Gaps = 35/173 (20%)
Query: 50 LKLEDMGLQGNIDITILKELR----EMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNN 105
L + + +K+ + + + NN+ + +L LR Y+ N+
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTK--LRQFYMGNS 216
Query: 106 RFSGEIPT------------------DAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLV 147
F E +D + L + + + +P L L +
Sbjct: 217 PFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ 276
Query: 148 ELRLEGNKFEG--QIPD--------FQQKDLVSFNVSNNALF-GSISPALREL 189
+ + N+ Q+ D + + + N L + +L+++
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 34/199 (17%), Positives = 59/199 (29%), Gaps = 32/199 (16%)
Query: 1 LTDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWN--GVLCHRGKIWGLKLEDMGLQ 58
+ D L + +L+ NW + GANWN L G G+ L G
Sbjct: 29 IKDYLALKEIWDALNGK----NWSQQGFGTQP-GANWNFNKELDMWGAQPGVSLNSNG-- 81
Query: 59 GNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPT---D 114
+ LSL G +PD + QL L + L ++
Sbjct: 82 ------------RVTGLSLEGFGASGRVPDAIGQLTE--LEVLALGSHGEKVNERLFGPK 127
Query: 115 AFDGMTSLRKLLLADNQFNGPIPESLTRL--SRLVELRLEGNKFEGQIPDFQQ--KDLVS 170
S + + + R S L++ + + + I +
Sbjct: 128 GISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187
Query: 171 FNVSNNALFGSISPALREL 189
+N + +S A+ L
Sbjct: 188 IGQLSNNI-TFVSKAVMRL 205
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 14/109 (12%), Positives = 30/109 (27%), Gaps = 7/109 (6%)
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF----- 163
G P + + + L L +G +P+++ +L+ L L L + + F
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 164 -QQKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDLCGEPLGSPCPT 211
+ D S + + +P
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD-CINSDPQQKSIKK 177
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 11/91 (12%), Positives = 23/91 (25%), Gaps = 7/91 (7%)
Query: 66 LKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124
LK N P+ + + L + + +N + ++
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITLCPS--LTQLQIGSNDIRK-VNEKIT---PNISV 591
Query: 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNK 155
L + DN + L +K
Sbjct: 592 LDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 32/211 (15%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVK--RFKQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+ +G G FG + S G V+K +M++ REE + + L ++HPN+ V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI---V 86
Query: 432 AYYYRKEEK---LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
Y EE +V ++ L ++ + G L + L+++
Sbjct: 87 QYRESFEENGSLYIVMDYCEGGDLFKRINAQK--GVL-FQEDQILDWFVQICLALKHV-- 141
Query: 489 ELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKS 538
H IKS N+ L + L D+G+ V+N Y S
Sbjct: 142 --------HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
PE + K+D+W+LG ++ E+ T K
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 25/206 (12%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLL 428
LG G FG TG M+ VK K R +++ + L L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 429 PL--VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
LV E+VP SL L H S+ L + + +G+ YL
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYL 150
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----AQE---LMIAYKSP 539
I H + + NVLL+ + D+GL + + +E + + +P
Sbjct: 151 --HAQHYI--HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMT 565
E L+ + +DVWS GV + E++T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 45/286 (15%), Positives = 87/286 (30%), Gaps = 37/286 (12%)
Query: 309 VSIENPPPLPPPSSNLQKT--SGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDL 366
V N P L SG+ + P++ E + K F + + +
Sbjct: 11 VDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEF-QLGSKLVYV 69
Query: 367 HDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRF---KQMNNVGREEFQ---EHMRRLG 420
H LL G G F Y+A+ K+ K EF + M RL
Sbjct: 70 HHLL-------GEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 421 RLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVA 480
+ + + + +LV E +L ++ ++ + + + +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEP-----------VLADYGLIPVMNQESA 529
++ ++ +I HG IK N +L L D G M
Sbjct: 183 YMIEQVHDC--EII--HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 530 QELMIA------YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ A ++ E L + D + + + ++ G +
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 23/210 (10%)
Query: 375 EILGSGCFGSSYKASLST---GAMMV-VKRFKQMNNVG-REEFQEHMRRLGRLRHPNLLP 429
++G G FG Y + +K ++ + E F + L HPN+L
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 430 LVAYYYRKEE-KLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L+ E ++ ++ L + Q + + VA+G++YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYL-- 140
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM------NQESAQELMIAYK--SPE 540
+ H + + N +L+ES +AD+GL + + + + + K + E
Sbjct: 141 AEQKFV--HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
LQ R T K+DVWS GVL+ E++T G P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 50/228 (21%)
Query: 375 EILGSGCFGSSYKASL---STGAMMV-VKRFKQ--MNNVGREEFQEHMRRLGRLRHPNLL 428
+LG G FGS +A L + V VK K + + EEF + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 429 PLVA------YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQP-SLDWPSRLKIVKGVAK 481
LV R +++ F+ L L + P +L + ++ + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 482 GLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL-----------------IPV- 523
G++YL + I H + + N +L E + +AD+GL +PV
Sbjct: 149 GMEYL--SSRNFI--HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 524 -MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ + E L T +DVW+ GV + EIMT G+ P
Sbjct: 205 WL-------------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 51/232 (21%), Positives = 86/232 (37%), Gaps = 54/232 (23%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQMNNVGREEFQEHMRRLGRLRHPNLL 428
LG G FG + A + M+V VK K R++FQ L L+H +++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSL-----------AVNLHGHQALGQPSLDWPSRLKIVK 477
+ ++V E++ L + + G + L L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 478 GVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL----------------- 520
+A G+ YL + H + + N L+ +L + D+G+
Sbjct: 141 QIASGMVYL--ASQHFV--HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 521 IPV--MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+P+ M PE + + T ++DVWS GV++ EI T GK P
Sbjct: 197 LPIRWM-------------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 34/235 (14%)
Query: 351 EIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGR 409
+ + R E DL +L +GSG G +K TG ++ VK+ ++ + +
Sbjct: 12 YLTIGGQRYQAEINDLENL-----GEMGSGTCGQVWKMRFRKTGHVIAVKQMRR--SGNK 64
Query: 410 EEFQEHMRRLGRL----RHPNLLPLVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQAL 462
EE + + L + P + V + + + + E + + + +
Sbjct: 65 EENKRILMDLDVVLKSHDCPYI---VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121
Query: 463 GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522
+ L K+ + K L YL + +I H +K SN+LL+E + L D+G+
Sbjct: 122 PERILG-----KMTVAIVKALYYLKEKH-GVI--HRDVKPSNILLDERGQIKLCDFGISG 173
Query: 523 VMNQESAQELMI---AYKSPEFLQLGRITK-----KTDVWSLGVLILEIMTGKFP 569
+ + A++ AY +PE + TK + DVWSLG+ ++E+ TG+FP
Sbjct: 174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 28/233 (12%)
Query: 353 KLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREE 411
KL + F DL +G G +GS K +G +M VKR + + E+
Sbjct: 8 KLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKR---IRSTVDEK 62
Query: 412 FQEHMRR-----LGRLRHPNLLPLVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALG 463
Q+ + + P + V +Y +E + E + + + L
Sbjct: 63 EQKQLLMDLDVVMRSSDCPYI---VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLD 119
Query: 464 QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523
+ KI K L +L L +I H IK SN+LL+ S L D+G+
Sbjct: 120 DV-IPEEILGKITLATVKALNHLKENL-KII--HRDIKPSNILLDRSGNIKLCDFGISGQ 175
Query: 524 MNQESAQELMI---AYKSPEFLQLGRITK----KTDVWSLGVLILEIMTGKFP 569
+ A+ Y +PE + + ++DVWSLG+ + E+ TG+FP
Sbjct: 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 56/250 (22%), Positives = 90/250 (36%), Gaps = 55/250 (22%)
Query: 356 FVRDDVERFDLHDLLRASAEILGSGCFGSSYKASL-----STGAMMV-VKRFKQMNNVGR 409
F V D+ LG G FG + A M+V VK K+ + R
Sbjct: 30 FSDACVHHIKRRDI--VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR 87
Query: 410 EEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK----------RSLAVNLHGH 459
++FQ L L+H +++ L+V E++ A L G
Sbjct: 88 QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 147
Query: 460 QALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519
+ + L L + VA G+ YL + H + + N L+ + L + D+G
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFV--HRDLATRNCLVGQGLVVKIGDFG 203
Query: 520 L-----------------IPV--MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLI 560
+ +P+ M PE + + T ++DVWS GV++
Sbjct: 204 MSRDIYSTDYYRVGGRTMLPIRWM-------------PPESILYRKFTTESDVWSFGVVL 250
Query: 561 LEIMT-GKFP 569
EI T GK P
Sbjct: 251 WEIFTYGKQP 260
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 52/227 (22%), Positives = 89/227 (39%), Gaps = 49/227 (21%)
Query: 375 EILGSGCFGSSYKASL---STGAMMV-VKRFKQ--MNNVGREEFQEHMRRLGRLRHPNLL 428
+ILG G FGS + +L ++ V VK K + EEF + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 429 PLVA-----YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQP-SLDWPSRLKIVKGVAKG 482
L+ + +++ F+ L L + P + + LK + +A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL-----------------IPV-- 523
++YL + + H + + N +L + + +AD+GL +PV
Sbjct: 160 MEYL--SNRNFL--HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 524 MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ + E L T K+DVW+ GV + EI T G P
Sbjct: 216 I-------------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 40/239 (16%), Positives = 77/239 (32%), Gaps = 60/239 (25%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+LG G FG KA + +K+ + + L L H + V Y
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYV---VRY 67
Query: 434 YYRKEEKL----------------LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVK 477
Y E+ + E+ +L +H Q W ++ +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLFR 123
Query: 478 GVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQE 531
+ + L Y+ H +K N+ ++ES + D+GL +++
Sbjct: 124 QILEALSYI----------HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 532 LMIA------------------YKSPEFLQ-LGRITKKTDVWSLGVLILEIMTGKFPAN 571
+ + Y + E L G +K D++SLG++ E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 37/210 (17%)
Query: 377 LGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLL 428
LG G FG+ Y A A+ V+ + + + +E + +RR LRHPN+L
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFK----SQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
+ Y++ ++ L+ EF P+ L L H + S ++ +A L Y
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD----EQRSA-TFMEELADALHYC-- 130
Query: 489 ELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQELM---IAYKSP 539
H IK N+L+ E +AD+G V + M + Y P
Sbjct: 131 --------HERKVIHRDIKPENLLMGYKGELKIADFGW-SVHAPSLRRRTMCGTLDYLPP 181
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
E ++ +K D+W GVL E + G P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 31/174 (17%), Positives = 58/174 (33%), Gaps = 28/174 (16%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNN 105
L + + N + + ++L +++L + N+L L + L + L
Sbjct: 105 NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS--LEQLTLEKC 162
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--F 163
+ IPT+A + L L L N S RL RL L + + +
Sbjct: 163 NLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL 221
Query: 164 QQKDLVSFNVSNNALFGSIS-------PALRELD----------PSSFSGNRDL 200
+L S ++++ L ++ LR L+ S L
Sbjct: 222 YGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL 274
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 36/158 (22%), Positives = 59/158 (37%), Gaps = 20/158 (12%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNN-LEGPMPDLRQLGNGALRSVYLSNN 105
L + L+ I K L ++ L + L+ P+ N L S+ +++
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN--LTSLSITHC 234
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--F 163
+ +P A + LR L L+ N + L L RL E++L G + + F
Sbjct: 235 NLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAF 292
Query: 164 QQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ L NVS N L L+ S F +L
Sbjct: 293 RGLNYLRVLNVSGN--------QLTTLEESVFHSVGNL 322
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 31/152 (20%), Positives = 50/152 (32%), Gaps = 20/152 (13%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEI 111
L N ++ + L L N + P L N LR++ L +NR I
Sbjct: 39 LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN--LRTLGLRSNRLK-LI 95
Query: 112 PTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDL 168
P F G+++L KL +++N+ + L L L + N I F L
Sbjct: 96 PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSL 154
Query: 169 VSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ L + + S L
Sbjct: 155 EQLTLEKC--------NLTSIPTEALSHLHGL 178
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 24/113 (21%), Positives = 43/113 (38%), Gaps = 8/113 (7%)
Query: 49 GLKLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLS 103
GL L + + + ++ L +R L+L N + L +L L+ + L
Sbjct: 223 GLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR--LQEIQLV 280
Query: 104 NNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
+ + + AF G+ LR L ++ NQ + L L L+ N
Sbjct: 281 GGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 22/110 (20%), Positives = 36/110 (32%), Gaps = 16/110 (14%)
Query: 94 NGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEG 153
+ R+V RF +P T R L L N+ + L EL L
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNE 65
Query: 154 NKFEGQIPD--FQ-QKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
N + F +L + + +N L+ + F+G +L
Sbjct: 66 NIVS-AVEPGAFNNLFNLRTLGLRSN--------RLKLIPLGVFTGLSNL 106
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 48/227 (21%), Positives = 83/227 (36%), Gaps = 49/227 (21%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQMNNVG-REEFQEHMRRLGRLRHPNL 427
LG G FG Y+ V +K + ++ R EF + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNL--HGHQALGQPSLDWPSR---LKIVKGVAKG 482
+ L+ + + L++ E + + L L P L PS +++ +A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL-----------------IPV-- 523
+ YL + H + + N ++ E + D+G+ +PV
Sbjct: 151 MAYL--NANKFV--HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 524 MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
M SPE L+ G T +DVWS GV++ EI T + P
Sbjct: 207 M-------------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-15
Identities = 24/155 (15%), Positives = 51/155 (32%), Gaps = 14/155 (9%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFS 108
L L L+ + + L ++ L+L + L+ L L+ + L N F
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA--LQHLNLQGNHFP 462
Query: 109 G--EIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQ 165
T++ + L L+L+ + + T L + + L N+ +
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 166 KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ N+++N + + PS
Sbjct: 523 LKGIYLNLASN--------HISIILPSLLPILSQQ 549
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-15
Identities = 28/135 (20%), Positives = 39/135 (28%), Gaps = 15/135 (11%)
Query: 73 RTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQ 131
L N L +L N L + L+ + I D F L L+L N
Sbjct: 36 ECLEFSFNVLPTIQNTTFSRLIN--LTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANP 92
Query: 132 FNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA---- 185
+L+ L L QK L S + +N + P
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 186 --LRELDPSSFSGNR 198
L+ LD F N
Sbjct: 153 EKLKVLD---FQNNA 164
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 25/140 (17%), Positives = 39/140 (27%), Gaps = 10/140 (7%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEI 111
N I T L + L L R + D + L ++ L+ N +
Sbjct: 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR--LDTLVLTANPLIF-M 96
Query: 112 PTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQ-KDLV 169
A G +L+ L + L L L L N + L
Sbjct: 97 AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLK 156
Query: 170 SFNVSNNALFGSISPALREL 189
+ NNA+ + L
Sbjct: 157 VLDFQNNAIHYLSKEDMSSL 176
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 31/171 (18%), Positives = 50/171 (29%), Gaps = 22/171 (12%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
L + L I + + TL L N L L L+ ++
Sbjct: 58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA--LKHLFFIQT 115
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--- 162
S I +L L L N + +L L + N +
Sbjct: 116 GISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMS 174
Query: 163 -FQQKDLVSFNVSNNALFGSISPA------LRELDPSSFSGNRDLCGEPLG 206
QQ +S N++ N + I P + L+ F G ++L G
Sbjct: 175 SLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLN---FGGTQNLLVIFKG 221
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 33/167 (19%), Positives = 70/167 (41%), Gaps = 22/167 (13%)
Query: 46 KIWGLKLEDMGLQGNIDITILKELREM--RTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102
+W EDM + +I + + L EM +++L ++ + L+ + L
Sbjct: 229 SLWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG--LQELDL 285
Query: 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD 162
+ S E+P G+++L+KL+L+ N+F S + L L ++GN ++
Sbjct: 286 TATHLS-ELP-SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
Query: 163 FQQKDLVS---FNVSNNALFGSIS--------PALRELDPSSFSGNR 198
++L + ++S++ + S L+ L+ S N
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN---LSYNE 387
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 32/185 (17%), Positives = 56/185 (30%), Gaps = 39/185 (21%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGP---------MPDLRQL---GNG-- 95
L ++ + + L+ L +R L L +++E + L+ L N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 96 -----------ALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLS 144
L + L+ R + F + L+ L L+ + + + L
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
Query: 145 RLVELRLEGNKFEGQIPD----FQQ-KDLVSFNVSNNALFGSIS------PALRELDPSS 193
L L L+GN F Q L +S L + +D
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD--- 506
Query: 194 FSGNR 198
S NR
Sbjct: 507 LSHNR 511
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 32/160 (20%), Positives = 52/160 (32%), Gaps = 22/160 (13%)
Query: 51 KLEDMGLQGN-------IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102
L+ + LQGN L+ L + L L +L L + V L
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKM--MNHVDL 507
Query: 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD 162
S+NR + +A + + L LA N + +P L LS+ + L N +
Sbjct: 508 SHNRLTS-SSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC---T 562
Query: 163 FQQKDLVSFNVSNNALFGSIS-------PALRELDPSSFS 195
+ + N P LR + S +
Sbjct: 563 CSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 22/155 (14%), Positives = 29/155 (18%), Gaps = 31/155 (20%)
Query: 68 ELREMRTLSLMRNNL----EGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123
E +T + L L S N I F + +L
Sbjct: 10 EKEVNKTYNCENLGLNEIPGTLPNSTECL--------EFSFNVLP-TIQNTTFSRLINLT 60
Query: 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQ-KDLVSFNVSNNALFGS 181
L L Q ++ RL L L N K L +
Sbjct: 61 FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI 120
Query: 182 IS------PALRELD----------PSSFSGNRDL 200
L L L
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKL 155
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 27/166 (16%), Positives = 54/166 (32%), Gaps = 25/166 (15%)
Query: 51 KLEDMGLQGN-------IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLS 103
KL+ + Q N D++ L++ + +L+L N++ G P +S+
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDIAGIEPGAFDSAV--FQSLNFG 210
Query: 104 NNRFSGEIPTD-AFDGMTSLRKLLLADNQFNGPIPESLTRLSR--LVELRLEGNKFEGQI 160
+ I + SL D P L + + L+ + F
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 161 PD-FQQ-KDLVSFNVSNNALFGSISPA------LRELDPSSFSGNR 198
+ F L +++ L + L++L S N+
Sbjct: 271 SNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLV---LSANK 312
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 26/131 (19%), Positives = 53/131 (40%), Gaps = 10/131 (7%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
+L + + N D++ L L ++ L + N + ++ L L+ + + +N+ S
Sbjct: 222 RLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDI-NAVKDLTK--LKMLNVGSNQIS 278
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KD 167
+I + ++ L L L +NQ E + L+ L L L N I
Sbjct: 279 -DIS--VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSK 334
Query: 168 LVSFNVSNNAL 178
+ S + +N +
Sbjct: 335 MDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 8e-13
Identities = 29/156 (18%), Positives = 53/156 (33%), Gaps = 20/156 (12%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
+ LQ D+ +EL + L + + + + L N L + L+ N+ +
Sbjct: 23 EGIRAVLQKASVTDVVTQEELESITKLVVAGEKVAS-IQGIEYLTN--LEYLNLNGNQIT 79
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KD 167
P + L L + N+ +L L+ L EL L + I
Sbjct: 80 DISP---LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTK 133
Query: 168 LVSFNVSNNALFGSISP-----ALRELDPSSFSGNR 198
+ S N+ N +SP L L + ++
Sbjct: 134 MYSLNLGANHNLSDLSPLSNMTGLNYLT---VTESK 166
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 31/156 (19%), Positives = 59/156 (37%), Gaps = 20/156 (12%)
Query: 51 KLEDMGLQGNIDITILKELREM---RTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRF 107
K+ + L N +++ L L M L++ + ++ + + L + L S+ L+ N+
Sbjct: 133 KMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTD--LYSLSLNYNQI 189
Query: 108 SGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKD 167
P +TSL NQ P + ++RL L++ NK P
Sbjct: 190 EDISP---LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQ 244
Query: 168 LVSFNVSNNALFGSISP-----ALRELDPSSFSGNR 198
L + N + I+ L+ L+ N+
Sbjct: 245 LTWLEIGTNQI-SDINAVKDLTKLKMLN---VGSNQ 276
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 50/214 (23%), Positives = 79/214 (36%), Gaps = 23/214 (10%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQMNNVG-REEFQEHMRRLGRLRHPNL 427
LG G FG Y+ + + V VK ++ + +F + + H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNL--HGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
+ + + + ++ E + L L + SL L + + +A G QY
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPVL---ADYGLI-PVMNQE---SAQELMIAYK- 537
L E I H I + N LL + D+G+ + M+ K
Sbjct: 156 L--EENHFI--HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 538 -SPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
PE G T KTD WS GVL+ EI + G P
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 50/228 (21%)
Query: 375 EILGSGCFGSSYKASLS--TGAMMV-VKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLP 429
+++G G FG KA + M +KR K+ + +F + L +L HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQ-----------PSLDWPSRLKIVKG 478
L+ + L E+ P +L L + L +L L
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL--------------IPV- 523
VA+G+ YL I H + + N+L+ E+ +AD+GL +PV
Sbjct: 151 VARGMDYL--SQKQFI--HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 524 -MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
M + E L T +DVWS GVL+ EI++ G P
Sbjct: 207 WM-------------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 49/214 (22%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRR-----LGRLRHPNLL 428
LG G +G K + +G +M VKR + + Q+ + + + P
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKR---IRATVNSQEQKRLLMDLDISMRTVDCPFT- 68
Query: 429 PLVAYY--YRKEEKL-LVHEFVP---KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG 482
V +Y +E + + E + + + Q + + L KI + K
Sbjct: 69 --VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKA 121
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI---AYKSP 539
L++L+ +L S+I H +K SNVL+N + + D+G+ + + A+++ Y +P
Sbjct: 122 LEHLHSKL-SVI--HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 540 E----FLQLGRITKKTDVWSLGVLILEIMTGKFP 569
E L + K+D+WSLG+ ++E+ +FP
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 49/256 (19%), Positives = 93/256 (36%), Gaps = 71/256 (27%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK-QMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+ LG G FG ++A + +KR + + RE+ ++ L +L HP + V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI---VR 67
Query: 433 YYYRKEEKLLVH---------------EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVK 477
Y+ EK + K +L ++G + + + L I
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER--ERSVCLHIFL 125
Query: 478 GVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQE 531
+A+ +++L H +K SN+ + D+GL+ M+Q+ ++
Sbjct: 126 QIAEAVEFL----------HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 532 LMIA----------------YKSPEFLQLGRITKKTDVWSLGVLILE------------- 562
++ Y SPE + + K D++SLG+++ E
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVR 235
Query: 563 ----IMTGKFPANFLQ 574
+ KFP F Q
Sbjct: 236 TLTDVRNLKFPPLFTQ 251
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 33/156 (21%), Positives = 59/156 (37%), Gaps = 4/156 (2%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSG 109
+ L + L+ + L + ++ L L +N D N +L ++L N
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 110 ----EIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ 165
E+ D F+G++ L+ L L N N P + L+ L L L N+ +
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP 525
Query: 166 KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDLC 201
+L ++S N L L + N+ +C
Sbjct: 526 ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 9e-13
Identities = 33/146 (22%), Positives = 58/146 (39%), Gaps = 7/146 (4%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSG 109
L+L ID + L +R L L + + PD Q G L + L S
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ-GLFHLFELRLYFCGLSD 111
Query: 110 E-IPTDAFDGMTSLRKLLLADNQFNG-PIPESLTRLSRLVELRLEGNKF----EGQIPDF 163
+ F + +L +L L+ NQ + S +L+ L + N+ E ++
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171
Query: 164 QQKDLVSFNVSNNALFGSISPALREL 189
Q K L F+++ N+L+ +S +
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKC 197
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 33/175 (18%), Positives = 54/175 (30%), Gaps = 19/175 (10%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGN-GALRSVYLSNN 105
L + L + + + L + L L L + N AL + LS N
Sbjct: 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLS--RLVELRLEGNKFEGQIPD- 162
+ +F + SL+ + + NQ L L L L N ++
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193
Query: 163 -------FQQKDLVSFNVSNNALF----GSISPALRELDPSSFSGNRDLCGEPLG 206
F+ L +VS N G+ S A+ + S + G G
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 33/147 (22%), Positives = 56/147 (38%), Gaps = 19/147 (12%)
Query: 65 ILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123
+ + L L L N + L L+ + L + I +AF + +LR
Sbjct: 19 VPQVLNTTERLLLSFNYIRTVTASSFPFLEQ--LQLLELGSQYTPLTIDKEAFRNLPNLR 76
Query: 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD---FQQ-KDLVSFNVSNNAL- 178
L L ++ P++ L L ELRL + F+ K L ++S N +
Sbjct: 77 ILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
Query: 179 -------FGSISPALRELDPSSFSGNR 198
FG + +L+ +D FS N+
Sbjct: 137 SLYLHPSFGKL-NSLKSID---FSSNQ 159
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 29/157 (18%), Positives = 51/157 (32%), Gaps = 22/157 (14%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSN 104
E + L N + + L +++ L L + R L N LR + L +
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN--LRILDLGS 82
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPI--PESLTRLSRLVELRLEGNKFEGQIPD 162
++ + DAF G+ L +L L + + L L L L N+
Sbjct: 83 SKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 163 --FQQ-KDLVSFNVSNNALFGSISPALRELDPSSFSG 196
F + L S + S+N + +
Sbjct: 142 PSFGKLNSLKSIDFSSN--------QIFLVCEHELEP 170
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 8e-11
Identities = 32/158 (20%), Positives = 63/158 (39%), Gaps = 18/158 (11%)
Query: 52 LEDMGLQGN----IDITILKELREM--RTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSN 104
+ G + D L R L L + L + L+ + L+
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD--LKVLNLAY 299
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-- 162
N+ + +I +AF G+ +L+ L L+ N + L ++ + L+ N I D
Sbjct: 300 NKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQT 357
Query: 163 FQQ-KDLVSFNVSNNAL-FGSISPALRELDPSSFSGNR 198
F+ + L + ++ +NAL P++ ++ SGN+
Sbjct: 358 FKFLEKLQTLDLRDNALTTIHFIPSIPDIF---LSGNK 392
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 36/176 (20%), Positives = 59/176 (33%), Gaps = 34/176 (19%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLE--GPMPDLRQL------------ 92
K+ + LQ N I K L +++TL L N L +P + +
Sbjct: 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPK 398
Query: 93 GNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNG-PIPESLTRLSRLVELRL 151
N ++LS NR + L+ L+L N+F+ ++ + L +L L
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 152 EGNKFEGQIPDFQQKD-------LVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
N + D L +++N L L P FS L
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHN--------YLNSLPPGVFSHLTAL 506
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 19/106 (17%), Positives = 36/106 (33%), Gaps = 16/106 (15%)
Query: 98 RSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFE 157
R + + ++P + + +LLL+ N S L +L L L
Sbjct: 7 RIAFYRFCNLT-QVP----QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 158 GQIPD--FQ-QKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
I F+ +L ++ ++ + L P +F G L
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSS--------KIYFLHPDAFQGLFHL 99
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 38/212 (17%)
Query: 377 LGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLL 428
LG G F Y+A S+ TG A+ ++ + K M G + ++ +L+HP++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDK-KAMYKAGMVQ---RVQNEVKIHCQLKHPSIL 74
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L Y+ LV E + L +P + +R + + G+ YL
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEAR-HFMHQIITGMLYL-- 128
Query: 489 ELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-----IAYK 537
H H + SN+LL ++ +AD+GL + ++ Y
Sbjct: 129 --------HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-EKHYTLCGTPNYI 179
Query: 538 SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
SPE ++DVWSLG + ++ G+ P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 59/305 (19%), Positives = 96/305 (31%), Gaps = 53/305 (17%)
Query: 297 FVIERKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSF 356
+ + EN S LQ + S T+ +
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTD--YNPNYCFAGKTS 60
Query: 357 VRDDVERFDLHDLLRASAEILGSGCFGSSYKASL-----STGAMMV-VKRFKQMNNVG-R 409
D++ ++ LG G FG Y+ + + V VK ++ +
Sbjct: 61 SISDLKEVPRKNI--TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 118
Query: 410 EEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNL--HGHQALGQPSL 467
+F + + H N++ + + + ++ E + L L + SL
Sbjct: 119 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178
Query: 468 DWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVL---ADYGL---- 520
L + + +A G QYL E I H I + N LL + D+G+
Sbjct: 179 AMLDLLHVARDIACGCQYL--EENHFI--HRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 521 -------------IPV--MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT 565
+PV M PE G T KTD WS GVL+ EI +
Sbjct: 235 YRAGYYRKGGCAMLPVKWM-------------PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
Query: 566 -GKFP 569
G P
Sbjct: 282 LGYMP 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMN----NVGREEFQEHMRRLGRLRHPNLLP 429
E +G G FG +K T ++ +K ++ E+ Q+ + L + P +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVLSQCDSPYV-- 82
Query: 430 LVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
YY Y K+ KL ++ E++ S +L L + + I++ + KGL YL
Sbjct: 83 -TKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIAT-----ILREILKGLDYL 135
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYK--------- 537
+ E I H IK++NVLL+E E LAD+G+ + Q K
Sbjct: 136 HSE--KKI--HRDIKAANVLLSEHGEVKLADFGV-------AGQLTDTQIKRNTFVGTPF 184
Query: 538 --SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+PE ++ K D+WSLG+ +E+ G+ P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-14
Identities = 27/151 (17%), Positives = 53/151 (35%), Gaps = 20/151 (13%)
Query: 66 LKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125
K + T+ L N L D R L ++ +S N FS PT + + L+
Sbjct: 724 YKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLN-SSQLKAF 781
Query: 126 ------LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNN--- 176
N+ P +T L++L++ N + + L ++++N
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYILDIADNPNI 840
Query: 177 -----ALFGSISPALRELDPSSFSGNRDLCG 202
++ I + L + +D+ G
Sbjct: 841 SIDVTSVCPYIEAGMYVLL---YDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-13
Identities = 32/230 (13%), Positives = 62/230 (26%), Gaps = 48/230 (20%)
Query: 1 LTDSQTLLTLKQSLSNP------------TALANWDDRTPPCNENGANWNGVLC-HRGKI 47
+ D + L + ++L NW+ + GV + G++
Sbjct: 268 IKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWG--DQPGVDLDNNGRV 325
Query: 48 WGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRF 107
GL L G +G + I +L E++ LS ++ L +R
Sbjct: 326 TGLSLAGFGAKGRVPDAI-GQLTELKVLSFGTHSETVS-GRLFGDEELTPDMSEERKHRI 383
Query: 108 SGEIPTDAFDGMTSLRKLLLADNQFNG----------------------------PIPES 139
D L L + N I ++
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKA 443
Query: 140 LTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALREL 189
+ RL++L + + F +D N + + + L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDA---NSDYAKQYENEELSWSNL 490
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 34/176 (19%), Positives = 57/176 (32%), Gaps = 35/176 (19%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGN-GALRSVYLSNN 105
KL D+ L N I ++ L N L+ +P++ + + SV S N
Sbjct: 596 KLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYN 654
Query: 106 RFSGEIPTDAFDGM-----TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQI 160
+ + M + + L+ N+ E S + + L N I
Sbjct: 655 KIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SI 712
Query: 161 PDFQQKD----------LVSFNVSNNALFGSIS--------PALRELDPSSFSGNR 198
P+ K L + ++ N L S+S P L +D S N
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMD---VSYNC 764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 31/175 (17%), Positives = 55/175 (31%), Gaps = 30/175 (17%)
Query: 51 KLEDMGLQGN-----IDITILKELREMRTLSLMRNNLEGPMPD----LRQLGNGALRSVY 101
++E +G N +I K + M ++ N + + + +V
Sbjct: 620 QVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679
Query: 102 LSNNRFSGEIPTDAFDGMTSLRKLLLADNQF-------NGPIPESLTRLSRLVELRLEGN 154
LS N PT+ F + + ++L++N P + L + L N
Sbjct: 680 LSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 155 KFEGQIPDFQQKDLVS---FNVSNNAL------FGSISPALRELDPSSFSGNRDL 200
K DF+ L +VS N + S L+ RD
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSS-QLKAFG---IRHQRDA 789
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 26/189 (13%), Positives = 59/189 (31%), Gaps = 45/189 (23%)
Query: 50 LKLEDMGLQGNIDITILKELR----EMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNN 105
L + N ++ +K+ + + + N + +++L L+ +Y +N+
Sbjct: 401 SDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTK--LQIIYFANS 458
Query: 106 RFSGEIPT------------------DAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLV 147
F+ + ++ + L + L + +P+ L L L
Sbjct: 459 PFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518
Query: 148 ELRLEGNKFEG---------QIPD--FQQKDLVSFNVSNNALFGSISPA-------LREL 189
L + N+ ++ D + F + N L + A L L
Sbjct: 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLL 578
Query: 190 DPSSFSGNR 198
D N+
Sbjct: 579 D---CVHNK 584
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 25/120 (20%), Positives = 43/120 (35%), Gaps = 14/120 (11%)
Query: 66 LKELREMRTLSLMRNNLEG--PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123
+++ + NNLE L+++ L + +N+ + AF L
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMVK--LGLLDCVHNKVR-HLE--AFGTNVKLT 598
Query: 124 KLLLADNQFNGPIPESL-TRLSRLVELRLEGNKFEGQIPDFQQ----KDLVSFNVSNNAL 178
L L NQ IPE ++ L NK + IP+ + S + S N +
Sbjct: 599 DLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKI 656
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 24/145 (16%), Positives = 49/145 (33%), Gaps = 17/145 (11%)
Query: 69 LREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS------GEIPTDAFDGMTSL 122
+++ + L + L+G + R +++ N F+ G+ P D +
Sbjct: 268 IKDYKALKAIWEALDGK--NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRV 325
Query: 123 RKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLV---------SFNV 173
L LA G +P+++ +L+ L L + F ++L +
Sbjct: 326 TGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385
Query: 174 SNNALFGSISPALRELDPSSFSGNR 198
+F L D + NR
Sbjct: 386 HYKKMFLDYDQRLNLSDLLQDAINR 410
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 55/233 (23%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQM-NNVGREEFQEHMRRLGRLRHPNL 427
E LG FG YK L V +K K REEF+ RL+HPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSL-----------AVNLHGHQALGQPSLDWPSRLKIV 476
+ L+ + + ++ + L V + +L+ P + +V
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 477 KGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL---------------- 520
+A G++YL ++ H + + NVL+ + L ++D GL
Sbjct: 135 AQIAAGMEYL--SSHHVV--HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 521 -IPV--MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+P+ M +PE + G+ + +D+WS GV++ E+ + G P
Sbjct: 191 LLPIRWM-------------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 30/230 (13%), Positives = 55/230 (23%), Gaps = 40/230 (17%)
Query: 375 EILGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPL 430
E L G + + A+ V + + E E RL +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 431 VAYY--------------------------YRKEEKLLVHEFVPKRSLAV-NLHGHQALG 463
Y LL+ + + +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 464 QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523
+ + + + + L + L+ HGH N+ + +L D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK--GLV--HGHFTPDNLFIMPDGRLMLGDVSAL-W 242
Query: 524 MNQESAQELM--IAYKSPEFLQLGRI--TKKTDVWSLGVLILEIMTGKFP 569
+ Y EFL T + W LG+ I + P
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 33/167 (19%), Positives = 57/167 (34%), Gaps = 22/167 (13%)
Query: 51 KLEDMGLQGN-----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSN 104
+LE + Q + + ++ LR + L + + L + L + ++
Sbjct: 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS--LEVLKMAG 159
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQ 164
N F D F + +L L L+ Q P + LS L L + N F + F
Sbjct: 160 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFP 218
Query: 165 QKDLVS---FNVSNNAL-------FGSISPALRELDPSSFSGNRDLC 201
K L S + S N + +L L+ + N C
Sbjct: 219 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN---LTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 29/158 (18%), Positives = 50/158 (31%), Gaps = 22/158 (13%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLE-GPMPDLRQLGNGALRSVYLSNNRFSGEI 111
L+ N + + +L ++ LSL N L G +L+ + LS N +
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 93
Query: 112 PTDAFDGMTSLRKLLLADNQFNGPIPESL-TRLSRLVELRLEGNKFEGQIPD--FQQ-KD 167
F G+ L L + S+ L L+ L + + F
Sbjct: 94 S-SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSS 151
Query: 168 LVSFNVSNNALFGSISP-------ALRELDPSSFSGNR 198
L ++ N+ + P L LD S +
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLD---LSQCQ 186
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 19/111 (17%), Positives = 36/111 (32%), Gaps = 18/111 (16%)
Query: 98 RSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFE 157
+ ++ + +PT +S +L L N+ +L++L +L L N
Sbjct: 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 158 GQ-IPDFQQKDLVS---FNVSNNAL------FGSISPALRELDPSSFSGNR 198
+ S ++S N + F L LD F +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG-LEQLEHLD---FQHSN 112
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 37/154 (24%), Positives = 61/154 (39%), Gaps = 18/154 (11%)
Query: 51 KLEDMGLQGNI-DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSG 109
L+ + + D+ L L + L + N + L +L N L S+ +NN+ S
Sbjct: 157 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI-SVLAKLTN--LESLIATNNQISD 213
Query: 110 EIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLV 169
P +T+L +L L NQ +L L+ L +L L N+ P L
Sbjct: 214 ITP---LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLT 268
Query: 170 SFNVSNNALFGSISP-----ALRELDPSSFSGNR 198
+ N + +ISP AL L+ + N+
Sbjct: 269 ELKLGANQI-SNISPLAGLTALTNLE---LNENQ 298
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 39/155 (25%), Positives = 64/155 (41%), Gaps = 19/155 (12%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
LE + + N DI++L +L + +L N + + L L N L + L+ N+
Sbjct: 178 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISD-ITPLGILTN--LDELSLNGNQLK 234
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KD 167
+I T +T+L L LA+NQ + P L+ L++L EL+L N+ I
Sbjct: 235 -DIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTA 288
Query: 168 LVSFNVSNNALFGSIS----PALRELDPSSFSGNR 198
L + ++ N L L L N
Sbjct: 289 LTNLELNENQLEDISPISNLKNLTYLT---LYFNN 320
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 30/141 (21%), Positives = 52/141 (36%), Gaps = 10/141 (7%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
KL ++ L N +I+ L L + L L N LE + L N L + L N S
Sbjct: 266 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDI-SPISNLKN--LTYLTLYFNNIS 322
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL 168
P +T L++L +N+ + SL L+ + L N+ P +
Sbjct: 323 DISP---VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRI 377
Query: 169 VSFNVSNNALFGSISPALREL 189
+++ A + +
Sbjct: 378 TQLGLNDQAWTNAPVNYKANV 398
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 33/146 (22%), Positives = 58/146 (39%), Gaps = 15/146 (10%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
L + L N DI LK L + L L N + L L + L+ + N +
Sbjct: 113 NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI-SALSGLTS--LQQLSFGNQ-VT 168
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL 168
P +T+L +L ++ N+ + L +L+ L L N+ P +L
Sbjct: 169 DLKP---LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNL 223
Query: 169 VSFNVSNNAL--FGSIS--PALRELD 190
+++ N L G+++ L +LD
Sbjct: 224 DELSLNGNQLKDIGTLASLTNLTDLD 249
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 33/147 (22%), Positives = 56/147 (38%), Gaps = 16/147 (10%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
+ L D +L ++ TL R ++ + L N L + SNN+ +
Sbjct: 25 EKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI-DGVEYLNN--LTQINFSNNQLT 81
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL 168
P +T L +L+ +NQ P L L+ L L L N+ P +L
Sbjct: 82 DITP---LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNL 136
Query: 169 VSFNVSNNALFGSISP-----ALRELD 190
+S+N + IS +L++L
Sbjct: 137 NRLELSSNTI-SDISALSGLTSLQQLS 162
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 24/141 (17%), Positives = 47/141 (33%), Gaps = 15/141 (10%)
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
I L E L + N+ + L + ++ D + + +
Sbjct: 16 QIFTDTALAEKMKTVLGKTNVTDTVS-QTDLDQ--VTTLQADRLGIKS---IDGVEYLNN 69
Query: 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGS 181
L ++ ++NQ P L L++LV++ + N+ P +L + NN +
Sbjct: 70 LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDI 127
Query: 182 IS----PALRELDPSSFSGNR 198
L L+ S N
Sbjct: 128 DPLKNLTNLNRLE---LSSNT 145
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 20/130 (15%), Positives = 41/130 (31%), Gaps = 8/130 (6%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
L + L N DI+ + L +++ L N + L L N + + +N+ S
Sbjct: 310 NLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV-SSLANLTN--INWLSAGHNQIS 366
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL 168
P +T + +L L D + +S ++
Sbjct: 367 DLTP---LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSY 423
Query: 169 VSFNVSNNAL 178
+++ N
Sbjct: 424 TEPDITWNLP 433
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 14/129 (10%), Positives = 34/129 (26%), Gaps = 14/129 (10%)
Query: 74 TLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFN 133
+ ++ ++ + L L + + + + L
Sbjct: 5 SATITQDTPINQIFTDTALAE--KMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIK 59
Query: 134 GPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSIS----PALREL 189
+ + L+ L ++ N+ P LV ++NN + L L
Sbjct: 60 --SIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL 117
Query: 190 DPSSFSGNR 198
N+
Sbjct: 118 T---LFNNQ 123
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 32/186 (17%), Positives = 67/186 (36%), Gaps = 26/186 (13%)
Query: 29 PCNENGANWNGVLCHRGKIWGL------KLEDMGLQGN----IDITILKELREMRTLSLM 78
PC E N C + + +++ L N + E++ L L
Sbjct: 2 PCVEVVPNIT-YQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 79 RNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIP 137
R ++ + L + L ++ L+ N + AF G++SL+KL+ +
Sbjct: 61 RCEIQTIEDGAYQSLSH--LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLEN 117
Query: 138 ESLTRLSRLVELRLEGNKF-EGQIPD-FQQ-KDLVSFNVSNNALFGSISPALRELDPSSF 194
+ L L EL + N ++P+ F +L ++S+N ++ + +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN--------KIQSIYCTDL 169
Query: 195 SGNRDL 200
+
Sbjct: 170 RVLHQM 175
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 25/124 (20%), Positives = 46/124 (37%), Gaps = 7/124 (5%)
Query: 57 LQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDA 115
L+ + ++ LR + L + + L + L + ++ N F D
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS--LEVLKMAGNSFQENFLPDI 465
Query: 116 FDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFN 172
F + +L L L+ Q P + LS L L + N+ + +PD F + L
Sbjct: 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIW 524
Query: 173 VSNN 176
+ N
Sbjct: 525 LHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 27/145 (18%), Positives = 52/145 (35%), Gaps = 14/145 (9%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
L + L GN + + L ++ L + NL + L L+ + +++N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT--LKELNVAHN 134
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRL----VELRLEGNKFEGQIP 161
+ F +T+L L L+ N+ L L ++ + L L N I
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193
Query: 162 D--FQQKDLVSFNVSNNALFGSISP 184
F++ L + NN ++
Sbjct: 194 PGAFKEIRLHKLTLRNNFDSLNVMK 218
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 23/112 (20%), Positives = 43/112 (38%), Gaps = 9/112 (8%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSN 104
L + + I L + L + N+ + +L N L + LS
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN--LTFLDLSQ 479
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
+ ++ AF+ ++SL+ L +A NQ RL+ L ++ L N +
Sbjct: 480 CQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 4/85 (4%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFS 108
LK+ Q N I ELR + L L + LE P L + L+ + +++N+
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS--LQVLNMASNQLK 507
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFN 133
+P FD +TSL+K+ L N ++
Sbjct: 508 -SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 27/142 (19%), Positives = 44/142 (30%), Gaps = 18/142 (12%)
Query: 69 LREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLL 127
L + L L RN L G +L+ + LS N + ++ F G+ L L
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN-FLGLEQLEHLDF 403
Query: 128 ADNQFNGPIPES-LTRLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFNVSNNALFGSIS 183
+ S L L+ L + + F L ++ N+ +
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 184 P-------ALRELDPSSFSGNR 198
P L LD S +
Sbjct: 463 PDIFTELRNLTFLD---LSQCQ 481
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 25/157 (15%), Positives = 49/157 (31%), Gaps = 22/157 (14%)
Query: 51 KLEDMGLQGN-------IDITILKELR-EMRTLSLMRNNLEG-PMPDLRQLGNGALRSVY 101
LE + L N D+ +L ++ +L L N + +++ L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI---RLHKLT 206
Query: 102 LSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIP 161
L NN S + G+ L L +F + L + + LEG
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF-----RNEGNLEKFDKSALEGLCNL---- 257
Query: 162 DFQQKDLVSFNVSNNALFGSISPALRELDPSSFSGNR 198
++ L + + + + L + S
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNC-LTNVSSFSLVSVT 293
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 63/275 (22%), Positives = 112/275 (40%), Gaps = 37/275 (13%)
Query: 309 VSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGG-KKPEIKLSFVRDDVERFDLH 367
+S + ++ T + G P G K P++ F +DD E L
Sbjct: 1 MSYYHHHHHHDY--DIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPE--KLF 56
Query: 368 DLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR---LGRLR 423
L +G G FG+ Y A + ++ +K+ E++Q+ ++ L +LR
Sbjct: 57 SDL----REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 424 HPNLLPLVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVA 480
HPN + Y Y +E LV E+ + + + L + + + G
Sbjct: 113 HPNT---IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-----VTHGAL 164
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---YK 537
+GL YL+ ++I H +K+ N+LL+E L D+G + + + +
Sbjct: 165 QGLAYLHSH--NMI--HRDVKAGNILLSEPGLVKLGDFG---SASIMAPANSFVGTPYWM 217
Query: 538 SPE---FLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+PE + G+ K DVWSLG+ +E+ K P
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 36/164 (21%), Positives = 59/164 (35%), Gaps = 31/164 (18%)
Query: 51 KLEDMGLQGNIDITILKE-----LREMRTLSLMRNNLEGPMPDLRQLGNGA------LRS 99
LE + L N + + L + TL L R L ++LG G L+
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-------QELGPGLFRGLAALQY 133
Query: 100 VYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQ 159
+YL +N +P D F + +L L L N+ + + L L L L N+
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-H 191
Query: 160 IPD--FQQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ F+ L++ + N L L + + R L
Sbjct: 192 VHPHAFRDLGRLMTLYLFAN--------NLSALPTEALAPLRAL 227
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 32/152 (21%), Positives = 49/152 (32%), Gaps = 19/152 (12%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEI 111
L GN + + R + L L N L L L + LS+N +
Sbjct: 39 LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL--LEQLDLSDNAQLRSV 96
Query: 112 PTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDL 168
F G+ L L L P L+ L L L+ N + +PD F+ +L
Sbjct: 97 DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNL 155
Query: 169 VSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ N + + +F G L
Sbjct: 156 THLFLHGN--------RISSVPERAFRGLHSL 179
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 28/109 (25%), Positives = 42/109 (38%), Gaps = 8/109 (7%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNN 105
L+ + LQ N + ++L + L L N + R L + L + L N
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS--LDRLLLHQN 187
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGN 154
R + + AF + L L L N + E+L L L LRL N
Sbjct: 188 RVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 24/94 (25%), Positives = 39/94 (41%), Gaps = 20/94 (21%)
Query: 51 KLEDMGLQGNIDITILKE-----LREMRTLSLMRNNLEGPMPDLRQLGNGA------LRS 99
L + L GN I+ + E L + L L +N + + A L +
Sbjct: 154 NLTHLFLHGN-RISSVPERAFRGLHSLDRLLLHQNRV-------AHVHPHAFRDLGRLMT 205
Query: 100 VYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFN 133
+YL N S +PT+A + +L+ L L DN +
Sbjct: 206 LYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 38/238 (15%)
Query: 348 KKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMN- 405
P +L + +D ++ ++ G G +GS YKA TG ++ +K Q+
Sbjct: 9 NPPRRQLKKLDEDSLTKQPEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVAIK---QVPV 64
Query: 406 NVGREEFQEHMRRLGRLRHPNLLPLVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQAL 462
+E + + + + P++ V YY Y K L +V E+ S++ +
Sbjct: 65 ESDLQEIIKEISIMQQCDSPHV---VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-- 119
Query: 463 GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522
+L I++ KGL+YL+ I H IK+ N+LLN LAD+G+
Sbjct: 120 --KTLTEDEIATILQSTLKGLEYLHFM--RKI--HRDIKAGNILLNTEGHAKLADFGV-- 171
Query: 523 VMNQESAQELMIAYK-----------SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ Q K +PE +Q D+WSLG+ +E+ GK P
Sbjct: 172 -----AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 56/246 (22%), Positives = 103/246 (41%), Gaps = 52/246 (21%)
Query: 348 KKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNN 406
K E + D ++ +++ LG G FG YKA + TGA+ K +
Sbjct: 4 KSREYEHVRRDLDPN--EVWEIV----GELGDGAFGKVYKAKNKETGALAAAK---VIET 54
Query: 407 VGREEFQEHMRR---LGRLRHPNLLPLVAYY--YRKEEKL-LVHEFVPKRSLA-VNLHGH 459
EE ++++ L HP + V Y + KL ++ EF P ++ + L
Sbjct: 55 KSEEELEDYIVEIEILATCDHPYI---VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD 111
Query: 460 QALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519
+ L +P + + + + + L +L+ + +I H +K+ NVL+ + LAD+G
Sbjct: 112 RGLTEPQIQV-----VCRQMLEALNFLHSK--RII--HRDLKAGNVLMTLEGDIRLADFG 162
Query: 520 LIPVMNQESAQELMIAYK-----------SPEFLQLGRITK-----KTDVWSLGVLILEI 563
+ SA+ L K +PE + + K D+WSLG+ ++E+
Sbjct: 163 V-------SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
Query: 564 MTGKFP 569
+ P
Sbjct: 216 AQIEPP 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 46/216 (21%), Positives = 86/216 (39%), Gaps = 47/216 (21%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E +G G G+ Y A ++TG + +++ +E + + ++PN+ V Y
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI---VNY 82
Query: 434 Y--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK------IVKGVAKGLQ 484
Y ++L +V E++ SL + + + + + + L+
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLT------------DVVTETCMDEGQIAAVCRECLQALE 130
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYK------- 537
+L+ +I H IKS N+LL L D+G AQ K
Sbjct: 131 FLHSN--QVI--HRDIKSDNILLGMDGSVKLTDFGF-------CAQITPEQSKRSTMVGT 179
Query: 538 ----SPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+PE + K D+WSLG++ +E++ G+ P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 53/231 (22%), Positives = 86/231 (37%), Gaps = 48/231 (20%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQM-NNVGREEFQ---EHMRRLGRLRH 424
+ LG+G FG +A+ S AM V VK K + RE + + LG H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--H 86
Query: 425 PNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSR------------ 472
N++ L+ L++ E+ L L + S P+
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 473 -LKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQE 531
L VAKG+ +L + I H + + N+LL + D+GL + +S
Sbjct: 147 LLSFSYQVAKGMAFL--ASKNCI--HRDLAARNILLTHGRITKICDFGLARDIKNDSN-- 200
Query: 532 LMIAYK------------SPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
Y +PE + T ++DVWS G+ + E+ + G P
Sbjct: 201 ----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 64/308 (20%), Positives = 109/308 (35%), Gaps = 62/308 (20%)
Query: 298 VIERKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFV 357
+ R++ S + P + S ++ + S + K E
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFP---- 79
Query: 358 RDDVERFDLHDLLRASAEILGSGCFGSSYKASL-------STGAMMV-VKRFKQM-NNVG 408
RD + L + LG GCFG A A+ V VK K
Sbjct: 80 RDKLT------LGK----PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD 129
Query: 409 REEFQ---EHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL-----------AV 454
+ E M+ +G+ H N++ L+ + ++ E+ K +L
Sbjct: 130 LSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 455 NLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPV 514
+ + + + + + +A+G++YL I H + + NVL+ E+
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCI--HRDLAARNVLVTENNVMK 243
Query: 515 LADYGLIPVMNQESAQELMIAYK------------SPEFLQLGRITKKTDVWSLGVLILE 562
+AD+GL +N YK +PE L T ++DVWS GVL+ E
Sbjct: 244 IADFGLARDINNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297
Query: 563 IMT-GKFP 569
I T G P
Sbjct: 298 IFTLGGSP 305
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 53/274 (19%), Positives = 100/274 (36%), Gaps = 53/274 (19%)
Query: 314 PPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRAS 373
P P P + + + P+ V + R+ L
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR---------RYVRGRFL--- 49
Query: 374 AEILGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHP 425
G G F ++ T A +V + + + + +E M L H
Sbjct: 50 ----GKGGFAKCFEISDADTKEVFAGKIVPK----SLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 426 NLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
+++ ++ + +V E +RSL +AL +P +R ++ + G QY
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE----AR-YYLRQIVLGCQY 156
Query: 486 LYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI----A 535
L H + +K N+ LNE LE + D+GL + + ++ ++
Sbjct: 157 L----------HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 206
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y +PE L + + DVWS+G ++ ++ GK P
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 40/278 (14%), Positives = 89/278 (32%), Gaps = 51/278 (18%)
Query: 347 GKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRF--KQM 404
G P ++ ++ + + ++LG G G+ + + VKR +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF 61
Query: 405 NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQ 464
+ RE + +R HPN++ ++ + + E L +
Sbjct: 62 SFADREV--QLLRES--DEHPNVIRYFCTEKDRQFQYIAIELCAA-----TLQEYVEQKD 112
Query: 465 PSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLL-----NESLEP 513
+ + +++ GL +L H +K N+L+ + ++
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHL----------HSLNIVHRDLKPHNILISMPNAHGKIKA 162
Query: 514 VLADYGLIPVMNQESAQELMIA-------YKSPEFLQ---LGRITKKTDVWSLGVLILEI 563
+++D+GL + + + +PE L T D++S G + +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 564 MTGKFP---------ANFLQQGKKADGDLASWVNSVLA 592
++ AN L D V+A
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIA 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 9e-13
Identities = 47/211 (22%), Positives = 88/211 (41%), Gaps = 37/211 (17%)
Query: 377 LGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLL 428
LG G F ++ T A +V + + + + +E M L H +++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPK----SLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
++ + +V E +RSL +AL +P +R ++ + G QYL
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE----AR-YYLRQIVLGCQYL-- 131
Query: 489 ELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI----AYKS 538
H + +K N+ LNE LE + D+GL + + ++ ++ Y +
Sbjct: 132 --------HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
PE L + + DVWS+G ++ ++ GK P
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 39/223 (17%), Positives = 81/223 (36%), Gaps = 33/223 (14%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+ILG G G+ G + VKR + E + + HPN++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEI--KLLTES--DDHPNVIRYYC 76
Query: 433 YYYRKEEKLLVHEFVPKRSLA--VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY--- 487
+ E +L V + + +++ +A G+ +L+
Sbjct: 77 SETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 488 ---REL-PS--LIAPHGHIKSSNVLLNESLEPVLADYGL--IPVMNQESAQELM------ 533
R+L P L++ + E+L +++D+GL Q S + +
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 534 IAYKSPEFLQ-------LGRITKKTDVWSLGVLILEIMTGKFP 569
+++PE L+ R+T+ D++S+G + I++
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 35/210 (16%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+G G G A +G + VK RE + + +H N+ V
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV---VEM 107
Query: 434 Y--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
Y Y E+L ++ EF+ +L + Q L+ + + V + L YL+ +
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALT------DIVSQVRLNEEQIATVCEAVLQALAYLHAQ- 160
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYK-----------SP 539
+I H IKS ++LL L+D+G AQ K +P
Sbjct: 161 -GVI--HRDIKSDSILLTLDGRVKLSDFGF-------CAQISKDVPKRKSLVGTPYWMAP 210
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
E + + D+WSLG++++E++ G+ P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 53/238 (22%), Positives = 88/238 (36%), Gaps = 62/238 (26%)
Query: 375 EILGSGCFGSSYKASL-------STGAMMV-VKRFKQM-NNVGREEFQ---EHMRRLGRL 422
+ LG G FG A A+ V VK K + E M+ +G+
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 99
Query: 423 RHPNLLPLVAYYYRKEEKLLVHEFVPKRSL-----------AVNLHGHQALGQPSLDWPS 471
H N++ L+ + ++ E+ K +L + + + + +
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 472 RLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL----------- 520
+ +A+G++YL I H + + NVL+ E+ +AD+GL
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI--HRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 521 ------IPV--MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+PV M +PE L T ++DVWS GVL+ EI T G P
Sbjct: 215 KTTNGRLPVKWM-------------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMN----NVGREEFQEHMRRLGRLRHPNLLP 429
E++GSG A + +K ++N +E + ++ + + HPN+
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIK---RINLEKCQTSMDELLKEIQAMSQCHHPNI-- 75
Query: 430 LVAYY--YRKEEKL-LVHEFVPKRSLA---VNLHGHQALGQPSLDWPSRLKIVKGVAKGL 483
V+YY + +++L LV + + S+ ++ LD + I++ V +GL
Sbjct: 76 -VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 484 QYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKS----- 538
+YL++ I H +K+ N+LL E +AD+G+ + K+
Sbjct: 135 EYLHKN--GQI--HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 539 ----PEFLQLGRI-TKKTDVWSLGVLILEIMTGKFP 569
PE ++ R K D+WS G+ +E+ TG P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 45/234 (19%), Positives = 89/234 (38%), Gaps = 42/234 (17%)
Query: 359 DDVERFDLHDLLRASAEILGSGC--FGSSYKA-SLSTGAMMVVKRFK--QMNNVGREEFQ 413
+ ++L ++G G + A TG + V+R +N Q
Sbjct: 22 PEGGCYELL-------TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ 74
Query: 414 EHMRRLGRLRHPNLLPLVAYY--YRKEEKL-LVHEFVPKRSLA--VNLHGHQALGQPSLD 468
+ HPN+ V Y + + +L +V F+ S + H + + ++
Sbjct: 75 GELHVSKLFNHPNI---VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA 131
Query: 469 WPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG----LIPVM 524
+ I++GV K L Y++ + H +K+S++L++ + L+ +I
Sbjct: 132 Y-----ILQGVLKALDYIHHM--GYV--HRSVKASHILISVDGKVYLSGLRSNLSMISHG 182
Query: 525 NQESAQELMIAYK-------SPEFLQLGRI--TKKTDVWSLGVLILEIMTGKFP 569
++ Y SPE LQ K+D++S+G+ E+ G P
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 53/231 (22%), Positives = 83/231 (35%), Gaps = 48/231 (20%)
Query: 375 EILGSGCFGSSYKASL-------STGAMMV-VKRFKQM-NNVGREEF-QEH--MRRLGRL 422
+ LG G FG A V VK K + E M+ +G+
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK- 133
Query: 423 RHPNLLPLVAYYYRKEEKLLVHEFVPKRSL-----------AVNLHGHQALGQPSLDWPS 471
H N++ L+ + ++ E+ K +L + + L
Sbjct: 134 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 472 RLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQE 531
+ VA+G++YL I H + + NVL+ E +AD+GL ++
Sbjct: 193 LVSCAYQVARGMEYL--ASKKCI--HRDLAARNVLVTEDNVMKIADFGLARDIHHIDY-- 246
Query: 532 LMIAYK------------SPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
YK +PE L T ++DVWS GVL+ EI T G P
Sbjct: 247 ----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 27/158 (17%), Positives = 52/158 (32%), Gaps = 20/158 (12%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
+ + + + + +L R++ L+L +E ++ +Y+ N
Sbjct: 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHT--IQKLYMGFN 103
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--F 163
+P F + L L+L N + +L L + N E +I D F
Sbjct: 104 AIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 161
Query: 164 QQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
Q L + +S+N L +D S
Sbjct: 162 QATTSLQNLQLSSN--------RLTHVDLSLIPSLFHA 191
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 31/158 (19%), Positives = 55/158 (34%), Gaps = 10/158 (6%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRF 107
+L + LQ N D L + + L N LE ++ L +Y+SNNR
Sbjct: 227 ELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR--LERLYISNNRL 284
Query: 108 SGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKD 167
+ + +L+ L L+ N + + + RL L L+ N +
Sbjct: 285 V-ALN-LYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHT 340
Query: 168 LVSFNVSNNAL-FGSISPALRELDPSSFSGNRDLCGEP 204
L + +S+N S+ R + + C
Sbjct: 341 LKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 33/174 (18%), Positives = 58/174 (33%), Gaps = 34/174 (19%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
++ + + N + + + + + L L RN+L P L ++ +SNN
Sbjct: 94 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK--LTTLSMSNN 151
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIP-----------------ESLTRLSRLVE 148
I D F TSL+ L L+ N+ + +L + E
Sbjct: 152 NLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDLSLIPSLFHANVSYNLLSTLAIPIAVEE 209
Query: 149 LRLEGNKFEGQIPDFQQKDLVSFNVSNNAL--FGSIS--PALRELDPSSFSGNR 198
L N + +L + +N L + P L E+D S N
Sbjct: 210 LDASHNSIN-VVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVD---LSYNE 259
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 23/142 (16%), Positives = 49/142 (34%), Gaps = 12/142 (8%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
L + N ++ L + L N++ +R N L + L +N + +
Sbjct: 187 SLFHANVSYN-LLSTLAIPIAVEELDASHNSIN----VVRGPVNVELTILKLQHNNLT-D 240
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIP-DFQQ-KDL 168
L ++ L+ N+ + ++ RL L + N+ + Q L
Sbjct: 241 TA--WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 297
Query: 169 VSFNVSNNALFGSISPALRELD 190
++S+N L + + D
Sbjct: 298 KVLDLSHNHL-LHVERNQPQFD 318
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 22/129 (17%), Positives = 38/129 (29%), Gaps = 16/129 (12%)
Query: 75 LSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNG 134
+ + ++ D+ L N + V N+ ++P D + L L D Q
Sbjct: 28 IDMQTQDVYFGFEDIT-LNN--QKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE 83
Query: 135 PIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFNVSNNALFGSISPALRELDP 191
+ + +L + N +P FQ L + N L L
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN--------DLSSLPR 134
Query: 192 SSFSGNRDL 200
F L
Sbjct: 135 GIFHNTPKL 143
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 50/230 (21%), Positives = 85/230 (36%), Gaps = 47/230 (20%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQM-NNVGREEFQ---EHMRRLGRLRH 424
+ LG G FG +A + V VK K+ + + + +G H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--H 90
Query: 425 PNLLPLVAYYYRKEEKLLV-HEFVPKRSL-----------AVNLHGHQALGQPSLDWPSR 472
N++ L+ + L+V EF +L + L + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 473 LKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532
+ VAKG+++L I H + + N+LL+E + D+GL + ++
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCI--HRDLAARNILLSEKNVVKICDFGLARDIYKDPD--- 203
Query: 533 MIAYK------------SPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
Y +PE + T ++DVWS GVL+ EI + G P
Sbjct: 204 ---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 52/252 (20%), Positives = 85/252 (33%), Gaps = 85/252 (33%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQM-NNVGREEFQEHMRRLGRLRHPNL 427
+G G FG ++A MV VK K+ + + +FQ + +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSL-------------------AVNLHGHQALGQPSLD 468
+ L+ + L+ E++ L + G P L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 469 WPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSS-----------NVLLNESLEPVLAD 517
+L I + VA G+ YL S N L+ E++ +AD
Sbjct: 173 CAEQLCIARQVAAGMAYL---------------SERKFVHRDLATRNCLVGENMVVKIAD 217
Query: 518 YGL-----------------IPV--MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGV 558
+GL IP+ M PE + R T ++DVW+ GV
Sbjct: 218 FGLSRNIYSADYYKADGNDAIPIRWM-------------PPESIFYNRYTTESDVWAYGV 264
Query: 559 LILEIMT-GKFP 569
++ EI + G P
Sbjct: 265 VLWEIFSYGLQP 276
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 8/132 (6%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSG 109
L L ++ I + L ++ L+L N++ MP+L L L + +S N F
Sbjct: 176 LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVG--LEELEMSGNHFP- 231
Query: 110 EIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-K 166
EI +F G++SL+KL + ++Q + + L+ LVEL L N +P F +
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLR 290
Query: 167 DLVSFNVSNNAL 178
LV ++ +N
Sbjct: 291 YLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 44/182 (24%), Positives = 65/182 (35%), Gaps = 45/182 (24%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
LE + L N I++ L + TL L N L P L LR ++L NN
Sbjct: 100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSK--LRELWLRNN 157
Query: 106 R--------FSG----------------EIPTDAFDGMTSLRKLLLADNQFNGPIPESLT 141
F+ I AF+G+ +L+ L L +P +LT
Sbjct: 158 PIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLT 215
Query: 142 RLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNR 198
L L EL + GN F +I F L V N+ + ++ ++F G
Sbjct: 216 PLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNS--------QVSLIERNAFDGLA 266
Query: 199 DL 200
L
Sbjct: 267 SL 268
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 21/110 (19%), Positives = 35/110 (31%), Gaps = 16/110 (14%)
Query: 94 NGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEG 153
+ V + S E+P ++ R L L +N ++ L L L+L
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGR 108
Query: 154 NKFEGQIPD--FQQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
N QI F L + + +N L + +F L
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDN--------WLTVIPSGAFEYLSKL 149
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 36/237 (15%), Positives = 77/237 (32%), Gaps = 46/237 (19%)
Query: 375 EILGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRRLGRLR------- 423
+LG + +A TG + V ++ + ++ +E + RL LR
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 424 ---------------HPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLH------GHQAL 462
P ++ + + ++ F + NL +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 463 GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522
SL +RL++ V + L L+ L+ H +++ +++L++ L + +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY--GLV--HTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 523 VMNQESAQELMIAYKSPEFL----------QLGRITKKTDVWSLGVLILEIMTGKFP 569
+ + + PE +T D W+LG+ I I P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 55/298 (18%), Positives = 97/298 (32%), Gaps = 45/298 (15%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEH-MRRLGRLRHPNLLPLVA 432
+ILG G + ++ TG + +K F ++ + + Q L +L H N++ L A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 433 YYYRKEEKL--LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ L+ EF P SL L L L +++ V G+ +L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY--GLPESEFLIVLRDVVGGMNHL---- 128
Query: 491 PSLIAPHGH------IKSSNVLLNESLEPV----LADYGLIPVMNQESAQELMI---AYK 537
+ IK N++ + L D+G + + + Y
Sbjct: 129 ------RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 538 SPEFLQLGRI--------TKKTDVWSLGVLILEIMTGKFP-------ANFLQQGKKADGD 582
P+ + + D+WS+GV TG P + K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 583 LASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACC-EEEVEKRLDLKEA 639
S S + +N + +M + + LL LA E + EK +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 44/227 (19%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQM-NNVGREEFQ---EHMRRLGRLRH 424
+ LG+G FG +A+ + V VK K + +E + M LG+ H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ--H 109
Query: 425 PNLLPLVAYYYRKEEKLLVHEFVPKRSL---------AVNLHGHQALGQPSLDWPSRLKI 475
N++ L+ L++ E+ L + A+ + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA 535
VA+G+ +L + I H + + NVLL + D+GL + +S
Sbjct: 170 SSQVAQGMAFL--ASKNCI--HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN------ 219
Query: 536 YK------------SPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
Y +PE + T ++DVWS G+L+ EI + G P
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 30/106 (28%), Positives = 45/106 (42%), Gaps = 4/106 (3%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSG 109
L L ++ I + L +R L+L NL +P+L L L + LS N S
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIK--LDELDLSGNHLS- 220
Query: 110 EIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNK 155
I +F G+ L+KL + +Q + L LVE+ L N
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 43/171 (25%), Positives = 62/171 (36%), Gaps = 43/171 (25%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEI 111
L N I + K LR + L L RN++ L N L ++ L +NR + I
Sbjct: 71 LHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN--LNTLELFDNRLT-TI 127
Query: 112 PTDAFDGMTSLRKLLLADNQ--------FNG----------------PIPE-SLTRLSRL 146
P AF ++ L++L L +N FN I E + LS L
Sbjct: 128 PNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL 187
Query: 147 VELRLEGNKFEGQIPDFQQ-KDLVSFNVSNNALFGSISPALRELDPSSFSG 196
L L +IP+ L ++S N L + P SF G
Sbjct: 188 RYLNLAMCNLR-EIPNLTPLIKLDELDLSGN--------HLSAIRPGSFQG 229
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 26/107 (24%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRF 107
L + L +I L L ++ L L N+L P + L + L+ +++ ++
Sbjct: 186 NLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMH--LQKLWMIQSQI 243
Query: 108 SGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGN 154
I +AFD + SL ++ LA N + T L L + L N
Sbjct: 244 Q-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 41/162 (25%), Positives = 66/162 (40%), Gaps = 22/162 (13%)
Query: 48 WGL-KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVY 101
GL L + L N I L +++ L L N +E P ++ + LR +
Sbjct: 109 NGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPS--LRRLD 166
Query: 102 LSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIP 161
L + I AF+G+++LR L LA IP +LT L +L EL L GN I
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLS-AIR 223
Query: 162 D--FQQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
FQ L + + ++ ++ ++F + L
Sbjct: 224 PGSFQGLMHLQKLWMIQS--------QIQVIERNAFDNLQSL 257
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 22/110 (20%), Positives = 33/110 (30%), Gaps = 16/110 (14%)
Query: 94 NGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEG 153
+ V E+P T+ R L L +NQ S L L L+L
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSR 97
Query: 154 NKFEGQIPD--FQQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
N I F +L + + +N L + +F L
Sbjct: 98 NHIR-TIEIGAFNGLANLNTLELFDN--------RLTTIPNGAFVYLSKL 138
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 54/241 (22%), Positives = 89/241 (36%), Gaps = 63/241 (26%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQM-NNVGREEFQEHMRRLGRLRHPNL 427
+ LG G FG KA+ G V VK K+ + + L ++ HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSL-------------------AVNLHGHQALGQPSLD 468
+ L + LL+ E+ SL + N + +L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 469 WPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL-------- 520
+ +++G+QYL L+ H + + N+L+ E + ++D+GL
Sbjct: 149 MGDLISFAWQISQGMQYL--AEMKLV--HRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 521 ---------IPV--MNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKF 568
IPV M + E L T ++DVWS GVL+ EI+T G
Sbjct: 205 SYVKRSQGRIPVKWM-------------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 569 P 569
P
Sbjct: 252 P 252
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 45/218 (20%), Positives = 81/218 (37%), Gaps = 38/218 (17%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLP 429
E LG+G FG + TG + +K+ +Q + + +E + +L HPN++
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS---PKNRERWCLEIQIMKKLNHPNVVS 76
Query: 430 LVAYY------YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGL 483
+ LL E+ L L+ + L ++ ++ L
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC--GLKEGPIRTLLSDISSAL 134
Query: 484 QYLYRELPSLIAPHGH------IKSSNVLLNESLEPV---LADYGLIPVMNQESAQELMI 534
+YL H + +K N++L + + + D G ++Q +
Sbjct: 135 RYL----------HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184
Query: 535 ---AYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y +PE L+ + T D WS G L E +TG P
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 42/310 (13%), Positives = 87/310 (28%), Gaps = 72/310 (23%)
Query: 375 EILGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRRLGRLR------- 423
+LG + +A TG + V ++ + ++ +E + RL LR
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 424 ------------------HPNLLPLVAYYYRKEEK---LLVHEFVPKRSLAVNLHGHQAL 462
++ + L + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 463 GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522
SL +RL++ V + L L+ L+ H +++ +++L++ L + +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY--GLV--HTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 523 VMNQESAQELMIAYKSPEFLQL-----------GRITKKTDVWSLGVLILEIMTGKFPAN 571
+ ++ PE +T D W+LG++I I P
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP-- 312
Query: 572 FLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVE 631
D + +N + LL+ E
Sbjct: 313 I--------------------TKDAALGGSEWIFRSCKNIPQPVRALLE---GFLRYPKE 349
Query: 632 KRLDLKEAVE 641
RL +A+E
Sbjct: 350 DRLLPLQAME 359
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 47/286 (16%), Positives = 106/286 (37%), Gaps = 52/286 (18%)
Query: 312 ENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLS-FVRDDVERFDLHDLL 370
+ L P S +++T+ + Q S K + + + + +
Sbjct: 5 HHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQI 64
Query: 371 RASAEILGSGCFGSSYKASLSTGAMMVVKR--FKQMNNVGREEFQEHMRRLGRLRHPNLL 428
GSG ++ + +K ++ +N + ++ + L +L+ +
Sbjct: 65 -------GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD- 116
Query: 429 PLVAYY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
++ Y ++ + +V E L L + S+D R K + + +
Sbjct: 117 KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHT 170
Query: 486 LYRELPSLIAPHG--H--IKSSNVLLNESLEPV-LADYGLIPVMNQESAQELM------I 534
+++ HG H +K +N L+ + + + L D+G+ M ++ + +
Sbjct: 171 IHQ--------HGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 535 AYKSPEFLQ-----------LGRITKKTDVWSLGVLILEIMTGKFP 569
Y PE ++ +I+ K+DVWSLG ++ + GK P
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 53/236 (22%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMV-VKRFKQM-NNVGREEFQ---EHMRRLGRLRH 424
++LGSG FG A+ + ++ V VK K+ ++ RE + M +LG H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--H 108
Query: 425 PNLLPLVAYYYRKEEKLLVHEFVPKRSL------------AVNLHGHQALGQPSLDWPSR 472
N++ L+ L+ E+ L + + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 473 L------KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526
L VAKG+++L E S + H + + NVL+ + D+GL +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL--EFKSCV--HRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 527 ESAQELMIAYK------------SPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+S Y +PE L G T K+DVWS G+L+ EI + G P
Sbjct: 225 DSN------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 25/140 (17%), Positives = 49/140 (35%), Gaps = 8/140 (5%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
L + L N + L + TL NN+ + +++YL+NN+ +
Sbjct: 81 TLRTLDLNNN-YVQELLVGPSIETLHAANNNIS----RVSCSRGQGKKNIYLANNKIT-M 134
Query: 111 IPTDAFDGMTSLRKLLLADNQFNG-PIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLV 169
+ + ++ L L N+ + E L L L+ N L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLK 194
Query: 170 SFNVSNNALFGSISPALREL 189
+ ++S+N L + P +
Sbjct: 195 TLDLSSNKL-AFMGPEFQSA 213
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 18/115 (15%), Positives = 46/115 (40%), Gaps = 10/115 (8%)
Query: 87 PDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRL 146
+++Q GN + ++++ + ++++L L+ N + L ++L
Sbjct: 3 HEIKQNGN-RYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 147 VELRLEGNKFEGQIPDFQQ-KDLVSFNVSNNALFGSIS--PALRELDPSSFSGNR 198
L L N + D + L + +++NN + + P++ L + N
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYV-QELLVGPSIETLH---AANNN 110
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 32/157 (20%), Positives = 61/157 (38%), Gaps = 22/157 (14%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
KLE + L N + L+ L +RTL L N ++ +L + + +++ +NN S
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ----ELLVGPS--IETLHAANNNIS 112
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG-QIPDF--QQ 165
+ + + LA+N+ SR+ L L+ N+ + +
Sbjct: 113 -RVSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 166 KDLVSFNVSNNALF----GSISPALRELDPSSFSGNR 198
L N+ N ++ + L+ LD S N+
Sbjct: 169 DTLEHLNLQYNFIYDVKGQVVFAKLKTLD---LSSNK 202
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 22/155 (14%), Positives = 49/155 (31%), Gaps = 24/155 (15%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
+ + + + ++ + ++ L L N L DL L + LS+N
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK--LELLNLSSN 68
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ 165
E + +++LR L L +N + L + L N ++ +
Sbjct: 69 VLY-ETL--DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 166 KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ + ++NN + L +
Sbjct: 120 QGKKNIYLANN--------KITMLRDLDEGCRSRV 146
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 24/152 (15%), Positives = 42/152 (27%), Gaps = 10/152 (6%)
Query: 51 KLEDMGLQGNIDITILKE----LREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNR 106
KL+ + L N + + + +SL N L LR N L L N
Sbjct: 192 KLKTLDLSSN-KLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQN--LEHFDLRGNG 248
Query: 107 FSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQK 166
F D F ++ + ++ + E +P
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFAD 305
Query: 167 DLVSFNVSNNALFGSISPALRELDPSSFSGNR 198
L++ +AL L+ + R
Sbjct: 306 RLIALKRKEHALLSGQGSETERLECERENQAR 337
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 58/306 (18%), Positives = 103/306 (33%), Gaps = 41/306 (13%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEH-MRRLGRLRHPNLLPLVA 432
+ILG G + ++ TG + +K F ++ + + Q L +L H N++ L A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 433 YYYRKEEKL--LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ L+ EF P SL L L L +++ V G+ +L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY--GLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 491 PSLIAPHG--H--IKSSNVLLNESLEPV----LADYGLIPVMNQESAQELMI---AYKSP 539
+G H IK N++ + L D+G + + + Y P
Sbjct: 131 ------NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 540 EFLQLGRI--------TKKTDVWSLGVLILEIMTGKFP-------ANFLQQGKKADGDLA 584
+ + + D+WS+GV TG P + K
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACC-EEEVEKRLDLKEAVEKI 643
S S + +N + +M + + LL LA E + EK + +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 644 EEVKER 649
++ R
Sbjct: 305 SDILHR 310
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 33/153 (21%), Positives = 55/153 (35%), Gaps = 20/153 (13%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEI 111
L N I L+ ++ L L + + D LG+ L + LS+N S +
Sbjct: 33 LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS--LEHLDLSDNHLS-SL 89
Query: 112 PTDAFDGMTSLRKLLLADNQFNG-PIPESLTRLSRLVELRLEGNKFEGQIP--DFQQ-KD 167
+ F ++SL+ L L N + + L+ L LR+ + +I DF
Sbjct: 90 SSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149
Query: 168 LVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
L + +LR S RD+
Sbjct: 150 LNELEIKAL--------SLRNYQSQSLKSIRDI 174
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 35/137 (25%), Positives = 53/137 (38%), Gaps = 17/137 (12%)
Query: 73 RTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQ 131
++L L N + DLR N L+ + L ++R + I DAF + SL L L+DN
Sbjct: 29 KSLDLSFNKITYIGHGDLRACAN--LQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNH 85
Query: 132 FNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFNVSNNALFGSIS----- 183
+ LS L L L GN ++ F +L + + N F I
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
Query: 184 --PALRELDPSSFSGNR 198
+L EL+
Sbjct: 146 GLTSLNELE---IKALS 159
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 33/176 (18%), Positives = 63/176 (35%), Gaps = 18/176 (10%)
Query: 36 NWNGVLCHRGKIWGLKLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLR 90
+ + V+ GK+ + + + + T+ L +++ +++ + + P +
Sbjct: 272 SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQ 331
Query: 91 QLGNGALRSVYLSNNRFSGEIPTD--AFDGMTSLRKLLLADNQFN--GPIPESLTRLSRL 146
L + L + LS N E + SL+ L+L+ N E L L L
Sbjct: 332 HLKS--LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL 389
Query: 147 VELRLEGNKFEGQIPDFQQ-KDLVSFNVSNN---ALFGSISPALRELDPSSFSGNR 198
L + N F Q + + N+S+ + I L LD S N
Sbjct: 390 TSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLD---VSNNN 442
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 25/129 (19%), Positives = 46/129 (35%), Gaps = 5/129 (3%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNR 106
LE + L N + + L ++ L+LM N + L+++ + N
Sbjct: 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 107 FSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQK 166
EI F G+TSL +L + +SL + + L L ++ + +
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFAD 193
Query: 167 DLVSFNVSN 175
L S
Sbjct: 194 ILSSVRYLE 202
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 28/163 (17%), Positives = 57/163 (34%), Gaps = 18/163 (11%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
L+ + L+ + I+ L + L L N+L L + L+ + L N
Sbjct: 51 NLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS--LKYLNLMGN 108
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPE-SLTRLSRLVELRLEGNKFEGQIPD-- 162
+ T F +T+L+ L + + + I L+ L EL ++
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQS 167
Query: 163 FQQ-KDLVSFNVSNNAL------FGSISPALRELDPSSFSGNR 198
+ +D+ + + F I ++R L+ + R
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 26/173 (15%), Positives = 57/173 (32%), Gaps = 28/173 (16%)
Query: 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEG------PMPDLRQLGNGALRS 99
+ L +G + ++ EL ++ T+++ R ++ L ++
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK--VKR 314
Query: 100 VYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFN---GPIPESLTRLSRLVELRLEGNKF 156
+ + N++ +P + SL L L++N L L L N
Sbjct: 315 ITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
Query: 157 EGQIPDFQQ-----KDLVSFNVSNNALFGSISPA------LRELDPSSFSGNR 198
+ + K+L S ++S N + + +R L+ S
Sbjct: 374 R-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLN---LSSTG 421
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 23/111 (20%), Positives = 45/111 (40%), Gaps = 11/111 (9%)
Query: 48 WGLKLEDMGLQGNIDITILKE--LREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNN 105
W K+ + L I ++K + + L + NNL+ L +L + +Y+S N
Sbjct: 408 WPEKMRFLNLSST-GIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRL-----QELYISRN 461
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
+ +P + L + ++ NQ RL+ L ++ L N +
Sbjct: 462 KLK-TLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 26/136 (19%), Positives = 46/136 (33%), Gaps = 18/136 (13%)
Query: 65 ILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124
IL L+ + +L + RN + +R + LS+ + T +L
Sbjct: 382 ILLTLKNLTSLDISRNTFHPMPDSCQWPEK--MRFLNLSSTGIR-VVKTCIP---QTLEV 435
Query: 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISP 184
L +++N + L RL EL + NK + L+ +S N
Sbjct: 436 LDVSNNNLDS-FSLFLPRLQ---ELYISRNKLKTLPDASLFPVLLVMKISRN-------- 483
Query: 185 ALRELDPSSFSGNRDL 200
L+ + F L
Sbjct: 484 QLKSVPDGIFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 21/108 (19%), Positives = 36/108 (33%), Gaps = 16/108 (14%)
Query: 96 ALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNK 155
A + F+ IP+ +++ L L+ N+ L + L L L+ ++
Sbjct: 6 ASGVCDGRSRSFT-SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 156 FEGQIPD--FQQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
I F L ++S+N L L S F L
Sbjct: 62 IN-TIEGDAFYSLGSLEHLDLSDN--------HLSSLSSSWFGPLSSL 100
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 22/83 (26%), Positives = 39/83 (46%), Gaps = 4/83 (4%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
LE + + N + L ++ L + RN L+ +PD L + +S N+
Sbjct: 432 TLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT-LPDASLFPV--LLVMKISRNQLK-S 487
Query: 111 IPTDAFDGMTSLRKLLLADNQFN 133
+P FD +TSL+K+ L N ++
Sbjct: 488 VPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 16/134 (11%), Positives = 42/134 (31%), Gaps = 10/134 (7%)
Query: 51 KLEDMGLQGNIDITILKE-----LREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSN 104
L+ + + + ++ L + L + +L L+ + + + + L
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD--IHHLTLHL 181
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQ 164
+ + + D ++S+R L L D L ++ + + D
Sbjct: 182 SESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR-GSVLTDES 239
Query: 165 QKDLVSFNVSNNAL 178
+L+ L
Sbjct: 240 FNELLKLLRYILEL 253
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 65/250 (26%), Positives = 107/250 (42%), Gaps = 60/250 (24%)
Query: 351 EIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG- 408
EI LS +RD F+L E++G+G +G YK + TG + +K M+ G
Sbjct: 13 EIDLSALRDPAGIFELV-------ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGD 62
Query: 409 -REEFQEHMRRLGRL-RHPNLLPLVAYY--YRK------EEKL-LVHEFVPKRSLA--VN 455
EE ++ + L + H N+ YY + K +++L LV EF S+ +
Sbjct: 63 EEEEIKQEINMLKKYSHHRNI---ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 456 LHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVL 515
L + + + I + + +GL +L++ +I H IK NVLL E+ E L
Sbjct: 120 NTKGNTLKEEWIAY-----ICREILRGLSHLHQH--KVI--HRDIKGQNVLLTENAEVKL 170
Query: 516 ADYGLIPVMNQESAQELMIAYK-----------SPEFLQLGRITK-----KTDVWSLGVL 559
D+G+ SAQ + +PE + K+D+WSLG+
Sbjct: 171 VDFGV-------SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223
Query: 560 ILEIMTGKFP 569
+E+ G P
Sbjct: 224 AIEMAEGAPP 233
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 39/224 (17%), Positives = 87/224 (38%), Gaps = 48/224 (21%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKR--FKQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+ +GSG ++ + +K ++ +N + ++ + L +L+ + ++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD-KIIR 92
Query: 433 YY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
Y ++ + +V E L L + S+D R K + + + +
Sbjct: 93 LYDYEITDQYIYMVMECG-NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTI--- 143
Query: 490 LPSLIAPHGH------IKSSNVLLNESLEPV-LADYGLIPVMNQESAQELM------IAY 536
H H +K +N L+ + + + L D+G+ M ++ + + Y
Sbjct: 144 -------HQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194
Query: 537 KSPEFLQ-----------LGRITKKTDVWSLGVLILEIMTGKFP 569
PE ++ +I+ K+DVWSLG ++ + GK P
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 22/102 (21%), Positives = 34/102 (33%), Gaps = 3/102 (2%)
Query: 78 MRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIP 137
R+ + L N L +Y+ N + + G+ LR L + + P
Sbjct: 16 TRDGALDSLHHLPGAEN--LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 138 ESLTRLSRLVELRLEGNKFEGQIPD-FQQKDLVSFNVSNNAL 178
++ RL L L N E Q L +S N L
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 24/132 (18%), Positives = 44/132 (33%), Gaps = 40/132 (30%)
Query: 38 NGVLCHRGK-------IWGL-KLEDMGLQGNIDITIL-----KELREMRTLSLMRNNLEG 84
+G+ C R + G L ++ ++ + L + L E+R L+++++ L
Sbjct: 11 SGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR- 69
Query: 85 PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLS 144
+ DAF L +L L+ N + +
Sbjct: 70 -------------------------FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGL 103
Query: 145 RLVELRLEGNKF 156
L EL L GN
Sbjct: 104 SLQELVLSGNPL 115
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 27/159 (16%), Positives = 56/159 (35%), Gaps = 26/159 (16%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGA---LRSVYLS 103
L + L N I L ++ L L +N L++L L+ + +
Sbjct: 77 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ-------LKELPEKMPKTLQELRVH 129
Query: 104 NNRFSGEIPTDAFDGMTSLRKLLLADNQF-NGPIPE-SLTRLSRLVELRLEGNKFEGQIP 161
N + ++ F+G+ + + L N + I + + +L +R+ IP
Sbjct: 130 ENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP 187
Query: 162 DFQQKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
L ++ N + ++D +S G +L
Sbjct: 188 QGLPPSLTELHLDGN--------KITKVDAASLKGLNNL 218
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 27/117 (23%), Positives = 38/117 (32%), Gaps = 15/117 (12%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNR 106
L +GL N +D L +R L L N L L ++ VYL NN
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY--IQVVYLHNNN 274
Query: 107 FSGEIPTDAF------DGMTSLRKLLLADNQFN-GPIPESL-TRLSRLVELRLEGNK 155
S I ++ F S + L N I S + ++L K
Sbjct: 275 IS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 24/104 (23%), Positives = 45/104 (43%), Gaps = 10/104 (9%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
+ L NN+ + EI F + +L L+L +N+ + P + L +L L L N+
Sbjct: 54 TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 157 EGQIPDFQQKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ ++P+ K L V N + ++ S F+G +
Sbjct: 113 K-ELPEKMPKTLQELRVHEN--------EITKVRKSVFNGLNQM 147
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 25/138 (18%), Positives = 51/138 (36%), Gaps = 16/138 (11%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFS 108
L L+ + +D LK L + L L N++ L + LR ++L+NN+
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH--LRELHLNNNKLV 253
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNG------PIPESLTRLSRLVELRLEGNKFE-GQIP 161
++P ++ + L +N + P T+ + + L N + +I
Sbjct: 254 -KVP-GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311
Query: 162 D--FQQ-KDLVSFNVSNN 176
F+ + + N
Sbjct: 312 PSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 16/101 (15%), Positives = 32/101 (31%), Gaps = 16/101 (15%)
Query: 43 HRGKIWGL-KLEDMGLQGNIDITI----LKELREMRTLSLMRNNLE-------GPMPDLR 90
G + L ++ L N + L + + ++ + L NN+ P
Sbjct: 232 DNGSLANTPHLRELHLNNN-KLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 290
Query: 91 QLGNGALRSVYLSNNRFS-GEIPTDAFDGMTSLRKLLLADN 130
+ + V L +N EI F + + L +
Sbjct: 291 KKAS--YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 31/159 (19%), Positives = 55/159 (34%), Gaps = 10/159 (6%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRF 107
+L + LQ N D L + + L N LE ++ L +Y+SNNR
Sbjct: 233 ELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR--LERLYISNNRL 290
Query: 108 SGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKD 167
+ + +L+ L L+ N + + + RL L L+ N +
Sbjct: 291 V-ALNL-YGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHT 346
Query: 168 LVSFNVSNNAL-FGSISPALRELDPSSFSGNRDLCGEPL 205
L + +S+N S+ R + + C
Sbjct: 347 LKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDY 385
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 27/158 (17%), Positives = 52/158 (32%), Gaps = 20/158 (12%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
+ + + + + +L R++ L+L +E ++ +Y+ N
Sbjct: 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHT--IQKLYMGFN 109
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--F 163
+P F + L L+L N + +L L + N E +I D F
Sbjct: 110 AIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 167
Query: 164 QQ-KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
Q L + +S+N L +D S
Sbjct: 168 QATTSLQNLQLSSN--------RLTHVDLSLIPSLFHA 197
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 30/156 (19%), Positives = 56/156 (35%), Gaps = 20/156 (12%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
++ + + N + + + + + L L RN+L P L ++ +SNN
Sbjct: 100 TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK--LTTLSMSNN 157
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ 165
I D F TSL+ L L+ N+ + SL + L + N +
Sbjct: 158 NLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLS-TLAIPIA 212
Query: 166 KDLVSFNVSNN---ALFGSISPALRELDPSSFSGNR 198
+ + S+N + G ++ L L N
Sbjct: 213 --VEELDASHNSINVVRGPVNVELTILK---LQHNN 243
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 24/142 (16%), Positives = 49/142 (34%), Gaps = 12/142 (8%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
L + N ++ L + L N++ +R N L + L +N +
Sbjct: 193 SLFHANVSYN-LLSTLAIPIAVEELDASHNSIN----VVRGPVNVELTILKLQHNNLT-- 245
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIP-DFQQ-KDL 168
T L ++ L+ N+ + ++ RL L + N+ + Q L
Sbjct: 246 -DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 303
Query: 169 VSFNVSNNALFGSISPALRELD 190
++S+N L + + D
Sbjct: 304 KVLDLSHNHL-LHVERNQPQFD 324
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 22/129 (17%), Positives = 38/129 (29%), Gaps = 16/129 (12%)
Query: 75 LSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNG 134
+ + ++ D+ L N + V N+ ++P D + L L D Q
Sbjct: 34 IDMQTQDVYFGFEDIT-LNN--QKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE 89
Query: 135 PIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFNVSNNALFGSISPALRELDP 191
+ + +L + N +P FQ L + N L L
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN--------DLSSLPR 140
Query: 192 SSFSGNRDL 200
F L
Sbjct: 141 GIFHNTPKL 149
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 30/161 (18%), Positives = 62/161 (38%), Gaps = 21/161 (13%)
Query: 51 KLEDMGLQGNIDITIL-----KELREMRTLSLMRNNLEGPMPDLRQL-GNGALRSVYLSN 104
K+ + ++ ++T + KEL ++ L + L+ PDL ++ + +++
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITD 139
Query: 105 NRFSGEIPTDAFDGMTS-LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD- 162
N + IP +AF G+ + L L +N F + ++L + L NK+ I
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKD 198
Query: 163 -FQ--QKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
F +VS ++ L ++L
Sbjct: 199 AFGGVYSGPSLLDVSQT--------SVTALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 23/161 (14%), Positives = 51/161 (31%), Gaps = 31/161 (19%)
Query: 52 LEDMGLQGNIDITIL-----KELREMRTLSLMRNNLEGPMPDLRQLGNGA------LRSV 100
+ + L + + L + + + + L+QL + + + +
Sbjct: 33 TQTLKLIET-HLRTIPSHAFSNLPNISRIYVSIDV------TLQQLESHSFYNLSKVTHI 85
Query: 101 YLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNG-PIPESLTRLSRLVELRLEGNKFEGQ 159
+ N R I DA + L+ L + + P + L + N +
Sbjct: 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTS 145
Query: 160 IPD--FQ--QKDLVSFNVSNNALFGSISPALRELDPSSFSG 196
IP FQ + ++ + NN + +F+G
Sbjct: 146 IPVNAFQGLCNETLTLKLYNN--------GFTSVQGYAFNG 178
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 25/110 (22%), Positives = 37/110 (33%), Gaps = 22/110 (20%)
Query: 57 LQGNIDITILKE------LREMRTLSLMRNNLEGPMPDLRQLGNGA-----LRSVYLSNN 105
+ N +T + E TL L N + A L +VYL+ N
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-------TSVQGYAFNGTKLDAVYLNKN 189
Query: 106 RFSGEIPTDAFDGMTS-LRKLLLADNQFNGPIPESLTRLSRLVELRLEGN 154
++ I DAF G+ S L ++ +P L L EL
Sbjct: 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKG--LEHLKELIARNT 236
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 21/149 (14%), Positives = 52/149 (34%), Gaps = 15/149 (10%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGN-GALRSVYLSNNRF 107
L + L D+T ++ ++ L++ + + + L + +
Sbjct: 45 SLTYITLANINVTDLTGIEYAHNIKDLTINNIHAT----NYNPISGLSNLERLRIMGKDV 100
Query: 108 SGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-K 166
+ + + G+TSL L ++ + + I + L ++ + L N I +
Sbjct: 101 TSDKIPN-LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP 159
Query: 167 DLVSFNVSNNALFGSISP-----ALRELD 190
+L S N+ + + L +L
Sbjct: 160 ELKSLNIQFDGV-HDYRGIEDFPKLNQLY 187
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 17/110 (15%), Positives = 36/110 (32%), Gaps = 11/110 (10%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
LE + + G I L L + L + + + + + L + S+ LS N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK--VNSIDLSYN 146
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNK 155
+I + L+ L + + + + +L +L
Sbjct: 147 GAITDI--MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 40/222 (18%), Positives = 90/222 (40%), Gaps = 44/222 (19%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKR--FKQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+ +GSG ++ + +K ++ +N + ++ + L +L+ + ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD-KIIR 73
Query: 433 YY--YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
Y ++ + +V E L L + S+D R K + + + +++
Sbjct: 74 LYDYEITDQYIYMVMECG-NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ- 126
Query: 490 LPSLIAPHG--H--IKSSNVLLNESLEPV-LADYGLIPVMNQESAQELM------IAYKS 538
HG H +K +N L+ + + + L D+G+ M ++ + + Y
Sbjct: 127 -------HGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 539 PEFLQ-----------LGRITKKTDVWSLGVLILEIMTGKFP 569
PE ++ +I+ K+DVWSLG ++ + GK P
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 24/142 (16%), Positives = 53/142 (37%), Gaps = 13/142 (9%)
Query: 44 RGKIWGL-KLEDMGLQGN----IDI-TILKELREMRTLSLMRNNLEGPMPDLRQLGNGAL 97
+++ + L+ N ++ + + L+L N + + L
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVFAK--L 193
Query: 98 RSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFE 157
+++ LS+N+ + + F + + L +N+ I ++L L L GN F
Sbjct: 194 KTLDLSSNKLA-FMG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250
Query: 158 -GQIPDFQQKDLVSFNVSNNAL 178
G + DF K+ V+ +
Sbjct: 251 CGTLRDFFSKNQRVQTVAKQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 15/105 (14%), Positives = 40/105 (38%), Gaps = 9/105 (8%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
+ ++++ + ++++L L+ N + L ++L L L N
Sbjct: 12 YKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 157 EGQIPDFQQ-KDLVSFNVSNNALFGSIS--PALRELDPSSFSGNR 198
+ D + L + +++NN + + P++ L + N
Sbjct: 71 Y-ETLDLESLSTLRTLDLNNNYV-QELLVGPSIETLH---AANNN 110
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 25/160 (15%), Positives = 53/160 (33%), Gaps = 27/160 (16%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
+ + + + ++ + ++ L L N L DL L + LS+N
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK--LELLNLSSN 68
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ 165
E + +++LR L L +N + L + L N ++ +
Sbjct: 69 VLY-ETL--DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 166 KDLVSFNVSNNAL-------FGSISPALRELDPSSFSGNR 198
+ + ++NN + G ++ LD N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCR-SRVQYLD---LKLNE 155
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 33/177 (18%), Positives = 59/177 (33%), Gaps = 38/177 (21%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNR 106
++++ L GN I L ++ L+L N L DL L LR++ L+NN
Sbjct: 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET-LDLESLST--LRTLDLNNNY 91
Query: 107 FS------------------GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVE 148
+ + + LA+N+ SR+
Sbjct: 92 VQELLVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 149 LRLEGNKFEG-QIPDF--QQKDLVSFNVSNNALF----GSISPALRELDPSSFSGNR 198
L L+ N+ + + L N+ N ++ + L+ LD S N+
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD---LSSNK 202
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 34/176 (19%), Positives = 76/176 (43%), Gaps = 32/176 (18%)
Query: 410 EEFQEHMRR----LGRLRHPNLLPLVAYY-YRKEEKL--LVHEFVPKRSLAVNLHGHQAL 462
EE + R +L H N+ V+ +E+ LV E++ +L+ + H L
Sbjct: 52 EETLKRFEREVHNSSQLSHQNI---VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL 108
Query: 463 GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHG--H--IKSSNVLLNESLEPVLADY 518
+ + + G+++ + H IK N+L++ + + D+
Sbjct: 109 -----SVDTAINFTNQILDGIKHAHD--------MRIVHRDIKPQNILIDSNKTLKIFDF 155
Query: 519 GLIPVMNQES---AQELM--IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
G+ +++ S ++ + Y SPE + + TD++S+G+++ E++ G+ P
Sbjct: 156 GIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 37/177 (20%), Positives = 65/177 (36%), Gaps = 34/177 (19%)
Query: 410 EEFQEHMRR----LGRLRHPNLLPLVAYYYRKEEK---LLVHEFVPKRSLAVNLHGHQAL 462
F+ M+R GRL+ P++ V + E + + LA L L
Sbjct: 75 PVFRTRMQREARTAGRLQEPHV---VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPL 131
Query: 463 GQPSLDWPSR-LKIVKGVAKGLQYLYRELPSLIAPHG--H--IKSSNVLLNESLEPVLAD 517
P R + IV+ + L + G H +K N+L++ L D
Sbjct: 132 A------PPRAVAIVRQIGSALDAAHA--------AGATHRDVKPENILVSADDFAYLVD 177
Query: 518 YGLIPVMNQES---AQELM--IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+G+ E + + Y +PE T + D+++L ++ E +TG P
Sbjct: 178 FGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 31/224 (13%), Positives = 68/224 (30%), Gaps = 42/224 (18%)
Query: 377 LGSGCFGSSYKASLSTG---AMMVVKR----------FKQMNNVGREEFQEHMRR----L 419
L G F A+ ++ + + + + + +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 420 GRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL---AVNLHGHQALGQPSLDWPSRLKIV 476
+++ L +E +++E++ S+ + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 477 KGVAKGLQYLYRELPSLIAPHGH-------IKSSNVLLNESLEPVLADYGLIPVMNQESA 529
K V Y+ H +K SN+L++++ L+D+G M +
Sbjct: 158 KSVLNSFSYI----------HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 530 QELM--IAYKSPEFLQ--LGRITKKTDVWSLGVLILEIMTGKFP 569
+ + PEF K D+WSLG+ + + P
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 36/182 (19%), Positives = 70/182 (38%), Gaps = 32/182 (17%)
Query: 402 KQMNNVGREEFQEHMRR----LGRLRHPNLLPLVAYYYRKEEKL--------LVHEFVPK 449
K + + G E Q L + HP++ V + E +V E+V
Sbjct: 112 KGLVHSGDAEAQAMAMAERQFLAEVVHPSI---VQIFNFVEHTDRHGDPVGYIVMEYVGG 168
Query: 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE 509
+SL ++ GQ L + + + L YL+ L+ + +K N++L E
Sbjct: 169 QSLK------RSKGQK-LPVAEAIAYLLEILPALSYLHSI--GLV--YNDLKPENIMLTE 217
Query: 510 SLEPVLADYGLIPVMNQESAQELM--IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGK 567
+ L D G + +N L +++PE ++ T TD++++G + +
Sbjct: 218 E-QLKLIDLGAVSRINSFGY--LYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDL 273
Query: 568 FP 569
Sbjct: 274 PT 275
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 28/159 (17%), Positives = 53/159 (33%), Gaps = 12/159 (7%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLE--GPMPDLRQLGNGALRSVYLSN 104
LE + L N + + K L + L+L+ N + G L L+ + + N
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK--LQILRVGN 158
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQ 164
+I F G+T L +L + + P+SL + + L L + + +
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217
Query: 165 QKDLVS---FNVSNNALFGSISPALRELDPSSFSGNRDL 200
S + + L L + +S
Sbjct: 218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 33/138 (23%), Positives = 54/138 (39%), Gaps = 19/138 (13%)
Query: 73 RTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQ 131
++L L N + DL++ N L+++ L++N + I D+F + SL L L+ N
Sbjct: 55 KSLDLSNNRITYISNSDLQRCVN--LQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 132 FNGPIPESLTRLSRLVELRLEGNKFEGQIPD---FQQ-KDLVSFNVSNNALFGSISP--- 184
+ LS L L L GN ++ + + F L V N F I
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 185 ----ALRELDPSSFSGNR 198
L EL+ +
Sbjct: 171 AGLTFLEELE---IDASD 185
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 10/88 (11%)
Query: 50 LKLEDMGLQGN-------IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYL 102
L+L D L + L + R + + +L M L Q+ L +
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISG--LLELEF 284
Query: 103 SNNRFSGEIPTDAFDGMTSLRKLLLADN 130
S N+ +P FD +TSL+K+ L N
Sbjct: 285 SRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 20/121 (16%), Positives = 44/121 (36%), Gaps = 21/121 (17%)
Query: 51 KLEDMGLQGNIDITILKE-----LREMRTLSLMRNNLEGPMPDLRQLGNGA--------- 96
+ + L +L E + L L +L+ +L G
Sbjct: 199 NVSHLILHMK-QHILLLEIFVDVTSSVECLELRDTDLDTF--HFSELSTGETNSLIKKFT 255
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPES-LTRLSRLVELRLEGNK 155
R+V +++ ++ + ++ L +L + NQ +P+ RL+ L ++ L N
Sbjct: 256 FRNVKITDESLF-QVM-KLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNP 312
Query: 156 F 156
+
Sbjct: 313 W 313
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 28/155 (18%), Positives = 57/155 (36%), Gaps = 19/155 (12%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNR 106
L + L N I LR+++ L + +N+L P+L +L + + +NR
Sbjct: 79 HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPS----SLVELRIHDNR 134
Query: 107 FSGEIPTDAFDGMTSLRKLLLADNQF-NGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ 165
++P F G+ ++ + + N N +L LR+ K IP
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP 192
Query: 166 KDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ L ++ +N ++ ++ L
Sbjct: 193 ETLNELHLDHN--------KIQAIELEDLLRYSKL 219
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 35/129 (27%), Positives = 58/129 (44%), Gaps = 17/129 (13%)
Query: 72 MRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADN 130
L L N++ D + L + L ++ L NN+ S +I AF + L+KL ++ N
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQH--LYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKN 112
Query: 131 QFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFNVSNNALFGSISPALR 187
IP +L S LVELR+ N+ ++P F +++ + N L S
Sbjct: 113 HLVE-IPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENS------ 162
Query: 188 ELDPSSFSG 196
+P +F G
Sbjct: 163 GFEPGAFDG 171
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 31/162 (19%), Positives = 55/162 (33%), Gaps = 23/162 (14%)
Query: 51 KLEDMGLQGN------IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSN 104
+ + + GN + L+ + L + L G DL + L ++L +
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPKDLPE----TLNELHLDH 202
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-- 162
N+ I + + L +L L NQ SL+ L L EL L+ NK ++P
Sbjct: 203 NKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
Query: 163 FQQKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDLCGEP 204
K L + N + ++ + F
Sbjct: 261 PDLKLLQVVYLHTN--------NITKVGVNDFCPVGFGVKRA 294
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 17/100 (17%), Positives = 35/100 (35%), Gaps = 12/100 (12%)
Query: 43 HRGKIWGL-KLEDMGLQGNIDITI----LKELREMRTLSLMRNNL----EGPMPDLRQLG 93
G + L L ++ L N ++ L +L+ ++ + L NN+ +
Sbjct: 233 ENGSLSFLPTLRELHLDNN-KLSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV 291
Query: 94 NGA-LRSVYLSNNRFS-GEIPTDAFDGMTSLRKLLLADNQ 131
A + L NN E+ F +T + + +
Sbjct: 292 KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 54/231 (23%), Positives = 89/231 (38%), Gaps = 62/231 (26%)
Query: 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+ G G FG+ TG + +K+ Q E Q M+ L L HPN++ L +Y
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQSY 87
Query: 434 YYRKEEK-------LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ-- 484
+Y E+ +V E+VP LH + + +
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPD-----TLH----------------RCCRNYYRRQVAP 126
Query: 485 -------YLYRELPSLIAPHGH--------IKSSNVLLNES-LEPVLADYGLIPVMNQES 528
+L++ + S+ H IK NVL+NE+ L D+G ++
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP-- 184
Query: 529 AQELMIA------YKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FP 569
E +A Y++PE + G T D+WS+G + E+M G+ F
Sbjct: 185 -SEPNVAYICSRYYRAPELI-FGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 28/111 (25%), Positives = 43/111 (38%), Gaps = 8/111 (7%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
LE + L N ID L + L+L +N L L L + LS N
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK--LEVLDLSYN 357
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
+ +F G+ +L++L L NQ RL+ L ++ L N +
Sbjct: 358 HIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 35/159 (22%), Positives = 51/159 (32%), Gaps = 9/159 (5%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRF- 107
LK+E I + L + L L N L N L + L+
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLAN--LEVLTLTQCNLD 116
Query: 108 SGEIPTDAFDGMTSLRKLLLADNQFNGPIPESL-TRLSRLVELRLEGNKF----EGQIPD 162
+ + F +TSL L+L DN P S + R L L NK E + +
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLN 176
Query: 163 FQQKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDLC 201
FQ K +S+ L L + N +
Sbjct: 177 FQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 25/119 (21%), Positives = 43/119 (36%), Gaps = 8/119 (6%)
Query: 72 MRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADN 130
+ + L N++ +L + L+ + + I + F G++SL L L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQD--LQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 131 QFNGPIPESLTRLSRLVELRLEGNKF-EGQIPDFQQKDLVS---FNVSNNALFGSISPA 185
QF + L+ L L L + K L S + +N + I PA
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPA 147
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 36/194 (18%), Positives = 65/194 (33%), Gaps = 26/194 (13%)
Query: 20 LANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMR 79
L++ + G G I L L G + ++ + + SL+
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 80 NNLEGPMPDLRQ-------------LGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLL 126
+N L +++ LS ++ + F T L +L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLT 305
Query: 127 LADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFNVSNNALFGSIS 183
LA N+ N + L+ L++L L N G I F+ L ++S N + ++
Sbjct: 306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHI-RALG 363
Query: 184 -------PALRELD 190
P L+EL
Sbjct: 364 DQSFLGLPNLKELA 377
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 24/93 (25%), Positives = 42/93 (45%), Gaps = 18/93 (19%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGA------LRSV 100
L + L N ID + + L ++ L L N++ R LG+ + L+ +
Sbjct: 324 HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-------RALGDQSFLGLPNLKEL 376
Query: 101 YLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFN 133
L N+ +P FD +TSL+K+ L N ++
Sbjct: 377 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 30/116 (25%), Positives = 45/116 (38%), Gaps = 13/116 (11%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
L + L N I + +R L L N+L L L + L NN
Sbjct: 65 NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQA--LEVLLLYNN 122
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPE----SLTRLSRLVELRLEGNKFE 157
+ +AF+ M L+KL L+ NQ + P +L +L+ L L NK +
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 16/55 (29%), Positives = 22/55 (40%)
Query: 101 YLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNK 155
LS+N S +T+L LLL+ N N E+ + L L L N
Sbjct: 45 DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 63/304 (20%), Positives = 108/304 (35%), Gaps = 57/304 (18%)
Query: 375 EILGSGCFGSSYKAS-LSTG---AMMVVKRFKQMNNVGREEFQ--EHMRRLGRLRHP--- 425
LG G F + + A + AM +V+ K +E + + + +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 426 --NLLPLVAY-YYRKEEKL---LVHEFVPKRSLAVNLHGHQALGQPSLDWPSR---LKIV 476
++L L+ + ++ + +V E L NL + R L V
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIK------KYEHRGIPLIYV 133
Query: 477 KGVAK----GLQYLYRELPSLIAPHGHIKSSNVLLNESLEPV------LADYGLIPVMNQ 526
K ++K GL Y++R +I H IK NVL+ P +AD G ++
Sbjct: 134 KQISKQLLLGLDYMHRRC-GII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 527 ESAQELMI-AYKSPE-FLQLGRITKKTDVWSLGVLILEIMTGK--FPANFLQQGKKADGD 582
+ Y+SPE L D+WS LI E++TG F + K D
Sbjct: 191 HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 583 LASWV-------NSVLANGDNRTEVFDKEMADERNSEGEMVKL---LKIGLACCEEEVEK 632
+A + + +L NG F+ S+ + L L ++E ++
Sbjct: 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309
Query: 633 RLDL 636
D
Sbjct: 310 ISDF 313
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 30/136 (22%), Positives = 53/136 (38%), Gaps = 11/136 (8%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
L+ + L N +I+ L L ++ LS+ + + L L L ++ +N+ S
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD-LTPLANLSK--LTTLKADDNKIS 186
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL 168
+I + +L ++ L +NQ + L S L + L P F +L
Sbjct: 187 -DIS--PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT-NQPVFYNNNL 240
Query: 169 VSFNVSNNALFGSISP 184
V NV I+P
Sbjct: 241 VVPNVVKGPSGAPIAP 256
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 25/155 (16%), Positives = 53/155 (34%), Gaps = 19/155 (12%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
+ + D +L + TLS + + ++ L N L + L +N+ +
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTT-IEGVQYLNN--LIGLELKDNQIT 76
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL 168
++ +T + +L L+ N ++ L + L L + P +L
Sbjct: 77 -DLA--PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 169 VSFNVSNNALFGSISP-----ALRELDPSSFSGNR 198
+ N + +ISP L+ L +
Sbjct: 132 QVLYLDLNQI-TNISPLAGLTNLQYLS---IGNAQ 162
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 22/135 (16%), Positives = 50/135 (37%), Gaps = 16/135 (11%)
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
I L ++ ++N+ + L + ++ + I + +
Sbjct: 11 VIFPDPALANAIKIAAGKSNVTDTVT-QADLDG--ITTLSAFGTGVT-TIE--GVQYLNN 64
Query: 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KDLVSFNVSNNALFG 180
L L L DNQ P L L+++ EL L GN + + + + + ++++ +
Sbjct: 65 LIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQI-T 120
Query: 181 SISP-----ALRELD 190
++P L+ L
Sbjct: 121 DVTPLAGLSNLQVLY 135
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 53/235 (22%), Positives = 93/235 (39%), Gaps = 76/235 (32%)
Query: 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGR-------LRHPN 426
+++G+G FG Y+A L +G ++ +K+ Q R R L H N
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----------DKRFKNRELQIMRKLDHCN 108
Query: 427 LLPLVAYYYRKEEKL------LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVA 480
++ L ++Y EK LV ++VP+ ++ ++ + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-----TVY----------------RVARHYS 147
Query: 481 KGLQ---------YLYRELPSLIAPHGH------IKSSNVLLNESLEPV-LADYGLIPVM 524
+ Q Y+Y+ SL H IK N+LL+ + L D+G
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS---A 204
Query: 525 NQESAQELMIA------YKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FP 569
Q E ++ Y++PE + G T DVWS G ++ E++ G+ FP
Sbjct: 205 KQLVRGEPNVSYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFP 258
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 35/182 (19%), Positives = 74/182 (40%), Gaps = 38/182 (20%)
Query: 410 EEFQEHMRR----LGRLRHPNLLPLVAYYYRKEEKL-------LVHEFVPKRSLAVNLHG 458
F RR L HP + VA Y E + +V E+V +L +H
Sbjct: 53 PSFYLRFRREAQNAAALNHPAI---VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT 109
Query: 459 HQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHG--H--IKSSNVLLNESLEPV 514
+ ++++ + L + ++ +G H +K +N++++ +
Sbjct: 110 EGPM-----TPKRAIEVIADACQALNFSHQ--------NGIIHRDVKPANIMISATNAVK 156
Query: 515 LADYGLIPVMNQESA-----QELM--IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGK 567
+ D+G+ + ++ Y SPE + + ++DV+SLG ++ E++TG+
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 568 FP 569
P
Sbjct: 217 PP 218
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 25/109 (22%), Positives = 45/109 (41%), Gaps = 8/109 (7%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
KL + L N + + LR + +L L N + P L + L+ + L+ N
Sbjct: 57 KLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFS--LQLLLLNAN 114
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGN 154
+ + + DAF + +L L L DN+ + + L + + L N
Sbjct: 115 KIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 31/110 (28%), Positives = 46/110 (41%), Gaps = 8/110 (7%)
Query: 73 RTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQ 131
+ L +N ++ P LR + LSNN+ S E+ DAF G+ SL L+L N+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKK--LRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 132 FNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQ-KDLVSFNVSNNAL 178
L L L L NK + FQ +L ++ +N L
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 19/91 (20%), Positives = 35/91 (38%), Gaps = 14/91 (15%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNL----EGPMPDLRQLGNGALRSVYL 102
L + L GN + ++ + L ++ L L N + DL L + L
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNL-----NLLSL 135
Query: 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFN 133
+N+ I F + +++ + LA N F
Sbjct: 136 YDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 63/228 (27%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGR-------LRHPNL 427
+++G+G FG ++A L + +K+ Q R R ++HPN+
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----------DKRFKNRELQIMRIVKHPNV 94
Query: 428 LPLVAYYY-----RKEEKL-LVHEFVP---KRSLAVNLHGHQALGQPSLDWPSRLKIVKG 478
+ L A++Y + E L LV E+VP R+ Q + + ++K
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP---------MLLIK- 144
Query: 479 VAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPV-LADYGLIPVMNQESAQE 531
Y+Y+ L SL H IK N+LL+ + L D+G A E
Sbjct: 145 -----LYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS---AKILIAGE 196
Query: 532 LMIA------YKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FP 569
++ Y++PE + G T D+WS G ++ E+M G+ FP
Sbjct: 197 PNVSYICSRYYRAPELI-FGATNYTTNIDIWSTGCVMAELMQGQPLFP 243
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 51/218 (23%), Positives = 83/218 (38%), Gaps = 46/218 (21%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLP 429
+LG G FG TG VK + V ++ +E + R L +L HPN++
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISK-RQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 430 LVAYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKGL 483
L ++ K LV E L + A +I++ V G+
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----------RIIRQVLSGI 139
Query: 484 QYLYRELPSLIAPHGH------IKSSNVLL---NESLEPVLADYGLIPVMNQESAQELMI 534
Y+ H + +K N+LL ++ + D+GL + I
Sbjct: 140 TYM----------HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 535 ---AYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y +PE L G +K DVWS GV++ +++G P
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 50/216 (23%), Positives = 81/216 (37%), Gaps = 43/216 (19%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVK--RFKQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+ LGSG +G T +K R ++ + E + L L HPN++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 432 AYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKGLQY 485
++ K LV E L + A I+K V G+ Y
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-----------VIIKQVLSGVTY 151
Query: 486 LYRELPSLIAPHGH------IKSSNVLL---NESLEPVLADYGLIPVMNQESAQELMI-- 534
L H H +K N+LL + + D+GL V + + +
Sbjct: 152 L----------HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201
Query: 535 -AYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y +PE L+ + +K DVWS+GV++ ++ G P
Sbjct: 202 AYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 23/134 (17%), Positives = 40/134 (29%), Gaps = 16/134 (11%)
Query: 70 REMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLA 128
R L + L G+ L + +S N I D F + L ++ +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGD--LEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 129 D-NQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNV----SNNAL----- 178
N PE+ L L L + + +PD + + + N +
Sbjct: 88 KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 179 --FGSISPALRELD 190
F +S L
Sbjct: 147 NSFVGLSFESVILW 160
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 37/220 (16%), Positives = 69/220 (31%), Gaps = 30/220 (13%)
Query: 50 LKLEDMGLQGNIDITILKE------LREMRTLSLMRNNLEGPMPDLRQLGNGALRS---- 99
L+ + +Q NI+I ++ E L L +N + +++ N A
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-------QEIHNSAFNGTQLD 180
Query: 100 --VYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFE 157
NN E+P D F G + L ++ + + L L +L K
Sbjct: 181 ELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK-- 237
Query: 158 GQIPDFQQ-KDLVSFNVSNN---ALFGSISPALRELDPSSFSGNRDLCGEPLGSPCPTPS 213
++P ++ L+ +++ F + + EL P + + S
Sbjct: 238 -KLPTLEKLVALMEASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRS 296
Query: 214 PSP---SPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDP 250
S T + L N + SP D
Sbjct: 297 SLAEDNESSYSRGFDMTYTEFDYDLCNEVVDVTCSPKPDA 336
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 49/245 (20%), Positives = 79/245 (32%), Gaps = 51/245 (20%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVK-----RFKQMNNVGREEFQEHMRRLGRLRHPNLL 428
+G G +G A T A+ +K + +Q+N E + +R + +L HPN+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSL--AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
L Y ++ LV E L +N+ + G+ ++D
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 487 YRELPSLIAPHG---------------------------H--IKSSNVLL--NESLEPVL 515
+ H IK N L N+S E L
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211
Query: 516 ADYGL---IPVMNQESAQELMIA-----YKSPEFLQLG--RITKKTDVWSLGVLILEIM- 564
D+GL +N + + +PE L K D WS GV +L ++
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV-LLHLLL 270
Query: 565 TGKFP 569
G P
Sbjct: 271 MGAVP 275
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 47/239 (19%), Positives = 90/239 (37%), Gaps = 48/239 (20%)
Query: 349 KPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNV 407
+++ F + +++ + D + S ++LG G G + TG +K
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68
Query: 408 GREEFQEHMRRLGRLRHPNLLPLVAYY----YRKEEKLLVHEFVPKRSL--AVNLHGHQA 461
+E +H + P+++ ++ Y + K L++ E + L + G QA
Sbjct: 69 RQEV--DHHWQA--SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124
Query: 462 LG--QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLL---NES 510
+ + +I++ + +Q+L H H +K N+L +
Sbjct: 125 FTEREAA-------EIMRDIGTAIQFL----------HSHNIAHRDVKPENLLYTSKEKD 167
Query: 511 LEPVLADYGLIPVMNQESAQELMIA-----YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
L D+G Q L Y +PE L + K D+WSLGV I+ I+
Sbjct: 168 AVLKLTDFGFAKETTQ---NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV-IMYIL 222
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 36/156 (23%), Positives = 61/156 (39%), Gaps = 21/156 (13%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
+ + L GN DI L L+ + L L N ++ + L+ L L+S+ L +N S
Sbjct: 69 NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LSSLKDLKK--LKSLSLEHNGIS 125
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KD 167
+I + + L L L +N+ L+RL++L L LE N+ I
Sbjct: 126 -DI--NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTK 179
Query: 168 LVSFNVSNNALFGSISP-----ALRELDPSSFSGNR 198
L + +S N + + L L+
Sbjct: 180 LQNLYLSKNHI-SDLRALAGLKNLDVLE---LFSQE 211
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 15/130 (11%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
KL+ + L+ N DI L L ++ +L L N + + L +L L ++ L +N+ S
Sbjct: 113 KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD-ITVLSRLTK--LDTLSLEDNQIS 169
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIP--ESLTRLSRLVELRLEGNKFEGQIPDFQQK 166
+I G+T L+ L L+ N I +L L L L L + P Q
Sbjct: 170 -DIV--PLAGLTKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECL-NKPINHQS 221
Query: 167 DLVSFNVSNN 176
+LV N N
Sbjct: 222 NLVVPNTVKN 231
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 29/157 (18%), Positives = 59/157 (37%), Gaps = 23/157 (14%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSG 109
+++ + D EL + + ++++ + ++ L N + ++L+ N+ +
Sbjct: 26 TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS-VQGIQYLPN--VTKLFLNGNKLT- 81
Query: 110 EIPTDAFDGMTSLRKLLLADNQFNGPIP--ESLTRLSRLVELRLEGNKFEGQIPDFQQ-K 166
+I + +L L L +N+ + SL L +L L LE N I
Sbjct: 82 DI--KPLANLKNLGWLFLDENK----VKDLSSLKDLKKLKSLSLEHNGIS-DINGLVHLP 134
Query: 167 DLVSFNVSNNALFGSISP-----ALRELDPSSFSGNR 198
L S + NN + I+ L L N+
Sbjct: 135 QLESLYLGNNKIT-DITVLSRLTKLDTLS---LEDNQ 167
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 28/109 (25%), Positives = 46/109 (42%), Gaps = 10/109 (9%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGN-GALRSVYLSNNRF 107
+LE + L N DIT+L L ++ TLSL N + D+ L L+++YLS N
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS----DIVPLAGLTKLQNLYLSKNHI 190
Query: 108 SGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
S ++ A G+ +L L L + + L ++
Sbjct: 191 S-DL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 23/137 (16%), Positives = 49/137 (35%), Gaps = 20/137 (14%)
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
I E +L + ++ +L + + + +N+ + + +
Sbjct: 16 QIFSDDAFAETIKDNLKKKSVTD-AVTQNELNS--IDQIIANNSDIK-SV--QGIQYLPN 69
Query: 122 LRKLLLADNQFNGPIP--ESLTRLSRLVELRLEGNKFEGQIPDFQQ-KDLVSFNVSNNAL 178
+ KL L N+ + + L L L L L+ NK + + + K L S ++ +N +
Sbjct: 70 VTKLFLNGNK----LTDIKPLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGI 124
Query: 179 FGSISP-----ALRELD 190
I+ L L
Sbjct: 125 -SDINGLVHLPQLESLY 140
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 34/150 (22%), Positives = 55/150 (36%), Gaps = 19/150 (12%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
L + N + + ++ N LE P+L+ L L ++Y NN
Sbjct: 196 FLTAIYADNNSLKKLPDLPLSLESIVAGNNILEEL-PELQNLPF--LTTIYADNNLLK-T 251
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVS 170
+P D SL L + DN +PE L+ L + P +L
Sbjct: 252 LP----DLPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP-----NLYY 301
Query: 171 FNVSNNAL--FGSISPALRELDPSSFSGNR 198
N S+N + + P+L EL+ S N+
Sbjct: 302 LNASSNEIRSLCDLPPSLEELN---VSNNK 328
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 20/144 (13%)
Query: 60 NIDITILKEL-REMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDG 118
N ++ L +L + L + N LE +P+L+ L+ + + NN ++P D
Sbjct: 120 NNNLKALSDLPPLLEYLGVSNNQLEK-LPELQNSSF--LKIIDVDNNSLK-KLP----DL 171
Query: 119 MTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNAL 178
SL + +NQ +PE L L L + + N + ++PD L S NN L
Sbjct: 172 PPSLEFIAAGNNQLEE-LPE-LQNLPFLTAIYADNNSLK-KLPDLPLS-LESIVAGNNIL 227
Query: 179 --FGSIS--PALRELDPSSFSGNR 198
+ P L + N
Sbjct: 228 EELPELQNLPFLTTIY---ADNNL 248
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 28/168 (16%), Positives = 58/168 (34%), Gaps = 36/168 (21%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLE------GPMPDLRQLGN--------- 94
L+L ++GL ++ + + +L N+L + L N
Sbjct: 76 LELNNLGLS-----SLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALSDLP 130
Query: 95 GALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGN 154
L + +SNN+ ++P + L+ + + +N +P+ L + N
Sbjct: 131 PLLEYLGVSNNQLE-KLPE--LQNSSFLKIIDVDNNSLKK-LPDLPP---SLEFIAAGNN 183
Query: 155 KFEGQIPDFQQ-KDLVSFNVSNN---ALFGSISPALRELDPSSFSGNR 198
+ E ++P+ Q L + NN L +L + N
Sbjct: 184 QLE-ELPELQNLPFLTAIYADNNSLKKLPDLPL-SLESIV---AGNNI 226
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 25/149 (16%), Positives = 41/149 (27%), Gaps = 30/149 (20%)
Query: 66 LKELREMRTLSLMRNNLEGPMP------------DLRQLGNGALRSVYLSNNRFSGEIPT 113
+ ++ + E P LR + + L+N S +P
Sbjct: 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLP- 87
Query: 114 DAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNV 173
+ L L+ + N +PE L L+ P L V
Sbjct: 88 ---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-----LLEYLGV 138
Query: 174 SNNAL--FGSIS--PALRELDPSSFSGNR 198
SNN L + L+ +D N
Sbjct: 139 SNNQLEKLPELQNSSFLKIID---VDNNS 164
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 27/128 (21%), Positives = 50/128 (39%), Gaps = 16/128 (12%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
LE + ++ N + + + + L + N G + +L N L + S+N
Sbjct: 258 SLEALNVRDNYLTDLPELPQSLTFLDVSENIFSG-LSEL--PPN--LYYLNASSNEIR-S 311
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVS 170
+ D SL +L +++N+ +P RL L N ++P+ Q L
Sbjct: 312 LC----DLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPELPQN-LKQ 361
Query: 171 FNVSNNAL 178
+V N L
Sbjct: 362 LHVEYNPL 369
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/119 (13%), Positives = 37/119 (31%), Gaps = 19/119 (15%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGN--------------GA 96
+LE + N + + + ++ L + N L + +
Sbjct: 338 RLERLIASFNHLAEVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQN 397
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNK 155
L+ +++ N E P D S+ L + + P + +L + E +
Sbjct: 398 LKQLHVETNPLR-EFP----DIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 10/110 (9%)
Query: 51 KLEDMGLQGNIDITILKE-----LREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSN 104
+L + N IT ++E + + L N LE + L + L+++ L +
Sbjct: 58 QLRKINFSNN-KITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLES--LKTLMLRS 114
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGN 154
NR + + D+F G++S+R L L DNQ P + L L L L N
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 23/114 (20%), Positives = 44/114 (38%), Gaps = 5/114 (4%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFS 108
L+L + I K+L ++R ++ N + + + L++NR
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG--VNEILLTSNRLE 94
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD 162
+ F G+ SL+ L+L N+ +S LS + L L N+ +
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAP 146
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 20/83 (24%), Positives = 32/83 (38%), Gaps = 1/83 (1%)
Query: 73 RTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQF 132
L L N LR + SNN+ + +I AF+G + + ++LL N+
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 133 NGPIPESLTRLSRLVELRLEGNK 155
+ L L L L N+
Sbjct: 94 ENVQHKMFKGLESLKTLMLRSNR 116
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 23/88 (26%), Positives = 39/88 (44%), Gaps = 8/88 (9%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDL-RQLGNGALRSVYLSNN 105
+ ++ L N + + K L ++TL L N + D L + +R + L +N
Sbjct: 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSS--VRLLSLYDN 139
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFN 133
+ + + AFD + SL L L N FN
Sbjct: 140 QIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 15/130 (11%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
KL+ + L+ N DI L L ++ +L L N + + L +L L ++ L +N+ S
Sbjct: 110 KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD-ITVLSRLTK--LDTLSLEDNQIS 166
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIP--ESLTRLSRLVELRLEGNKFEGQIPDFQQK 166
+I G+T L+ L L+ N I +L L L L L + P Q
Sbjct: 167 -DIV--PLAGLTKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECL-NKPINHQS 218
Query: 167 DLVSFNVSNN 176
+LV N N
Sbjct: 219 NLVVPNTVKN 228
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 38/132 (28%), Positives = 61/132 (46%), Gaps = 18/132 (13%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
L + L N D++ LK+L+++++LSL N + + L L L S+YL NN+ +
Sbjct: 88 NLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISD-INGLVHLPQ--LESLYLGNNKIT 144
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ--- 165
+I +T L L L DNQ + I L L++L L L N I D +
Sbjct: 145 -DI--TVLSRLTKLDTLSLEDNQISD-I-VPLAGLTKLQNLYLSKN----HISDLRALAG 195
Query: 166 -KDLVSFNVSNN 176
K+L + +
Sbjct: 196 LKNLDVLELFSQ 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 31/128 (24%), Positives = 50/128 (39%), Gaps = 8/128 (6%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
+LE + L N DIT+L L ++ TLSL N + + L L L+++YLS N S
Sbjct: 132 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTK--LQNLYLSKNHIS 188
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL 168
++ A G+ +L L L + + L ++ D
Sbjct: 189 -DL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDY 245
Query: 169 VSFNVSNN 176
NV +
Sbjct: 246 EKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 30/157 (19%), Positives = 59/157 (37%), Gaps = 23/157 (14%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSG 109
+++ + D EL + + ++++ + ++ L N + ++L+ N+ +
Sbjct: 23 TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS-VQGIQYLPN--VTKLFLNGNKLT- 78
Query: 110 EIPTDAFDGMTSLRKLLLADNQFNGPIP--ESLTRLSRLVELRLEGNKFEGQIPDFQQ-K 166
+I + +L L L +N+ I SL L +L L LE N I
Sbjct: 79 DIK--PLTNLKNLGWLFLDENK----IKDLSSLKDLKKLKSLSLEHNGIS-DINGLVHLP 131
Query: 167 DLVSFNVSNNALFGSISP-----ALRELDPSSFSGNR 198
L S + NN + I+ L L N+
Sbjct: 132 QLESLYLGNNKIT-DITVLSRLTKLDTLS---LEDNQ 164
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 26/143 (18%), Positives = 52/143 (36%), Gaps = 19/143 (13%)
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
I E +L + ++ +L + + + +N+ + + +
Sbjct: 13 QIFPDDAFAETIKDNLKKKSVTD-AVTQNELNS--IDQIIANNSDIK-SV--QGIQYLPN 66
Query: 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KDLVSFNVSNNALFG 180
+ KL L N+ I + LT L L L L+ NK + + + K L S ++ +N +
Sbjct: 67 VTKLFLNGNKLTD-I-KPLTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNGI-S 122
Query: 181 SISP-----ALRELDPSSFSGNR 198
I+ L L N+
Sbjct: 123 DINGLVHLPQLESLY---LGNNK 142
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 58/283 (20%), Positives = 95/283 (33%), Gaps = 72/283 (25%)
Query: 319 PPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILG 378
+ + + + +P V K+ +I E + LG
Sbjct: 4 HHHHSSGRENLYFQGIAINPGM---YVRKKEGKIG--------ESYFKV-------RKLG 45
Query: 379 SGCFGSSYKA-SLSTGAMMVVK---------RFKQMNNVGREEFQEHMRR----LGRLRH 424
SG +G + + +K +N E+F E + L L H
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 425 PNLLPLVAYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKG 478
PN++ L + K+ LV EF L + A I+K
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-----------NIMKQ 154
Query: 479 VAKGLQYLYRELPSLIAPHGH------IKSSNVLL---NESLEPVLADYGL-IPVMNQES 528
+ G+ YL H H IK N+LL N L + D+GL
Sbjct: 155 ILSGICYL----------HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 529 AQELM--IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
++ + Y +PE L+ + +K DVWS GV++ ++ G P
Sbjct: 205 LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 29/154 (18%), Positives = 49/154 (31%), Gaps = 21/154 (13%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
L + + D+T +++L + L NN+ DL Q N L + +N+ +
Sbjct: 43 TLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITT--LDLSQNTN--LTYLACDSNKLT 98
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL 168
+ +T L L N+ + S L L N +I L
Sbjct: 99 -NLD---VTPLTKLTYLNCDTNKLT-KLDVSQ--NPLLTYLNCARNTLT-EIDVSHNTQL 150
Query: 169 VSFNVSNNALFGSIS----PALRELDPSSFSGNR 198
+ N + L LD S N+
Sbjct: 151 TELDCHLNKKITKLDVTPQTQLTTLD---CSFNK 181
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 30/148 (20%), Positives = 48/148 (32%), Gaps = 23/148 (15%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNR 106
+L + N +D++ K L L+ NN+ DL Q L + S+N+
Sbjct: 171 QLTTLDCSFNKITELDVSQNKLLNR---LNCDTNNIT--KLDLNQNIQ--LTFLDCSSNK 223
Query: 107 FSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQK 166
+ EI +T L + N + S LS+L L +I
Sbjct: 224 LT-EID---VTPLTQLTYFDCSVNPLT-ELDVST--LSKLTTLHCIQTDLL-EIDLTHNT 275
Query: 167 DLVSFNVSNNALFGSIS----PALRELD 190
L+ F + L LD
Sbjct: 276 QLIYFQAEGCRKIKELDVTHNTQLYLLD 303
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 29/165 (17%), Positives = 49/165 (29%), Gaps = 36/165 (21%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLE----GPMPDLRQL---------- 92
L + N +D+T L +L L+ N L P L L
Sbjct: 86 NLTYLACDSNKLTNLDVTPLTKLTY---LNCDTNKLTKLDVSQNPLLTYLNCARNTLTEI 142
Query: 93 ---GNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVEL 149
N L + N+ ++ T L L + N+ +++ L L
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRL 196
Query: 150 RLEGNKFEGQIPDFQQKDLVSFNVSNNAL----FGSISPALRELD 190
+ N ++ Q L + S+N L + L D
Sbjct: 197 NCDTNNIT-KLDLNQNIQLTFLDCSSNKLTEIDVTPL-TQLTYFD 239
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 24/114 (21%), Positives = 39/114 (34%), Gaps = 15/114 (13%)
Query: 88 DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLV 147
QL L S+ N+ + + +T L KL+ N + L++ + L
Sbjct: 37 SEEQLAT--LTSLDCHNSSITD---MTGIEKLTGLTKLICTSNNITT-LD--LSQNTNLT 88
Query: 148 ELRLEGNKFEGQIPDFQQKDLVSFNVSNN---ALFGSISPALRELDPSSFSGNR 198
L + NK + L N N L S +P L L+ + N
Sbjct: 89 YLACDSNKLT-NLDVTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLN---CARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 21/148 (14%), Positives = 44/148 (29%), Gaps = 22/148 (14%)
Query: 50 LKLEDMGLQGNIDITI--LKELREMRTLSLMRNNLE----GPMPDLRQL----------- 92
+L +G I + ++ L + P L L
Sbjct: 275 TQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELD 334
Query: 93 --GNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELR 150
N L+S+ N + + + +L A+ Q E+LT S + +
Sbjct: 335 VSHNTKLKSLSCVNAHIQ-DFS--SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVS 391
Query: 151 LEGNKFEGQIPDFQQKDLVSFNVSNNAL 178
+ G + + D ++ + N +
Sbjct: 392 PDLLDQFGNPMNIEPGDGGVYDQATNTI 419
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 27/128 (21%), Positives = 50/128 (39%), Gaps = 12/128 (9%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
+L + N ++ ++ L + N L +P L L+ + +S NR +
Sbjct: 202 ELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVL--PSE--LKELMVSGNRLT-S 255
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVS 170
+P + L L + NQ +PESL LS + LEGN + +++ S
Sbjct: 256 LP----MLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS-ERTLQALREITS 309
Query: 171 FNVSNNAL 178
+ +
Sbjct: 310 APGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 33/163 (20%), Positives = 59/163 (36%), Gaps = 27/163 (16%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLE------GPMPDLRQLGN---------G 95
L + + GN ++ ++ LS+ N L + L N
Sbjct: 122 GLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPS 181
Query: 96 ALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNK 155
L+ + +S+N+ + +P + L KL +N+ +P + L EL + GN+
Sbjct: 182 GLQELSVSDNQLA-SLP----TLPSELYKLWAYNNRLT-SLPALPSGLK---ELIVSGNR 232
Query: 156 FEGQIPDFQQKDLVSFNVSNNALFGSISPALRELDPSSFSGNR 198
+P + L VS N L S+ L S N+
Sbjct: 233 LT-SLPVLPSE-LKELMVSGNRL-TSLPMLPSGLLSLSVYRNQ 272
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 30/151 (19%), Positives = 47/151 (31%), Gaps = 23/151 (15%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
+ + + N ++ E+RTL + N L L L
Sbjct: 62 HITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSLPVLPPGLLE--LSIFSNPLTHLPAL 119
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVS 170
+ L KL + NQ +P L EL + N+ +P +L
Sbjct: 120 P--------SGLCKLWIFGNQLTS-LPVLPPGLQ---ELSVSDNQLA-SLPA-LPSELCK 165
Query: 171 FNVSNN---ALFGSISPALRELDPSSFSGNR 198
NN +L S L+EL S N+
Sbjct: 166 LWAYNNQLTSLPMLPS-GLQELS---VSDNQ 192
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 19/130 (14%), Positives = 50/130 (38%), Gaps = 7/130 (5%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
L+++ + GN ++ E++ L + N L +P L L S+ + N+ +
Sbjct: 222 GLKELIVSGNRLTSLPVLPSELKELMVSGNRLTS-LPML--PSG--LLSLSVYRNQLT-R 275
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVS 170
+P ++ ++S + L N + ++L ++ +F+ ++
Sbjct: 276 LP-ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334
Query: 171 FNVSNNALFG 180
+ + L
Sbjct: 335 HLAAADWLVP 344
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 54/286 (18%), Positives = 102/286 (35%), Gaps = 59/286 (20%)
Query: 301 RKRKRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEA-VVGGKKPEIKLSFVRD 359
R E N ++TS + P+ + +V K+ +
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVN------ 86
Query: 360 DVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR 418
+ + EILG G FG +K +TG + K K +EE + +
Sbjct: 87 --SFYTVS-----KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISV 139
Query: 419 LGRLRHPNLLPLVAYYYRKEEKLLVHEFVP---------KRSLAVNLHGHQALGQPSLDW 469
+ +L H NL+ L + K + +LV E+V S NL
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES--YNLTELDT-------- 189
Query: 470 PSRLKIVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLL-NESLEPV-LADYGLI 521
+ +K + +G++++ H +K N+L N + + + D+GL
Sbjct: 190 ---ILFMKQICEGIRHM----------HQMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 522 PVMNQESAQELMIA---YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
++ + +PE + ++ TD+WS+GV I ++
Sbjct: 237 RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYML 281
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 25/130 (19%), Positives = 49/130 (37%), Gaps = 7/130 (5%)
Query: 55 MGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQL--GNGALRSVYLSNNRFSGEIP 112
+G +G I + ++ L+L +E P L L+ + LS+N
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 113 TDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KDLVSF 171
+ D + L L L+ +P+ L ++L L L N+ + P + + +
Sbjct: 246 APSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDR-NPSPDELPQVGNL 301
Query: 172 NVSNNALFGS 181
++ N S
Sbjct: 302 SLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 34/189 (17%), Positives = 54/189 (28%), Gaps = 25/189 (13%)
Query: 46 KIWGLKLEDMGLQGNIDITILKELR--EMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYL 102
+ L + + I L+ L ++ L+L + G P L + L + L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 103 SNNRFSG---EIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQ 159
N ++ + L+ L +A E + L L L N G+
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 160 IP------DFQQKDLVSFNVSNN---ALFGSIS------PALRELDPSSFSGNRDLCGEP 204
+ L + N G S L+ LD S N L
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLD---LSHNS-LRDAA 244
Query: 205 LGSPCPTPS 213
C PS
Sbjct: 245 GAPSCDWPS 253
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 16/149 (10%), Positives = 40/149 (26%), Gaps = 6/149 (4%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
+ + + + L+ L ++ L + +
Sbjct: 37 RHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-Q 95
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDL 168
P D ++ L+ + + +P+++ + + L L L N +P L
Sbjct: 96 FP-DQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL 152
Query: 169 VSFNVSNNALFGSISPALRELDPSSFSGN 197
++ + L D S
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 9e-07
Identities = 24/153 (15%), Positives = 44/153 (28%), Gaps = 14/153 (9%)
Query: 52 LEDMGLQGNIDITIL-KELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
E++ QG+ + L + + N N + +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNN--PQIETRTGRALKAT 71
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDL 168
L L P+ RLS L + ++ ++PD Q L
Sbjct: 72 ADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGL 129
Query: 169 VSFNVSNNAL------FGSISPALRELDPSSFS 195
+ ++ N L S++ LREL +
Sbjct: 130 ETLTLARNPLRALPASIASLN-RLRELSIRACP 161
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 20/127 (15%), Positives = 43/127 (33%), Gaps = 8/127 (6%)
Query: 66 LKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125
+ L +++L L + + L N L+S+ + N+ S + A + L +L
Sbjct: 179 HQGLVNLQSLRLEWTGIRSLPASIANLQN--LKSLKIRNSPLS-ALG-PAIHHLPKLEEL 234
Query: 126 LLADNQFNGPIPESLTRLSRLVELRLEG-NKFEGQIPD-FQQ-KDLVSFNVSNNALFGSI 182
L P + L L L+ + +P + L ++ +
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 183 SPALREL 189
+ +L
Sbjct: 294 PSLIAQL 300
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 27/146 (18%), Positives = 51/146 (34%), Gaps = 21/146 (14%)
Query: 66 LKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125
L ++ +++ L ++Q L ++ L+ N +P + + LR+L
Sbjct: 100 AFRLSHLQHMTIDAAGLMELPDTMQQFAG--LETLTLARNPLR-ALP-ASIASLNRLREL 155
Query: 126 LLAD-NQF--------NGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDLVSFNVS 174
+ + + L L LRLE +P ++L S +
Sbjct: 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIR 214
Query: 175 NNALFG---SIS--PALRELDPSSFS 195
N+ L +I P L ELD +
Sbjct: 215 NSPLSALGPAIHHLPKLEELDLRGCT 240
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 21/164 (12%), Positives = 47/164 (28%), Gaps = 40/164 (24%)
Query: 409 REEFQEHMRRLGRLRHPNLLPLVAYYYRKEEK---LLVHEFVPKRSLAVNLHGHQALGQP 465
+E RL R+ P + + L+V E++ SL
Sbjct: 75 LQETLSRTLRLSRIDKPGV---ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------ 125
Query: 466 SLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525
++ ++ +A +R + S V ++ + VLA +P
Sbjct: 126 -PSPVGAIRAMQSLAAAADAAHRA--GVA--LSIDHPSRVRVSIDGDVVLAYPATMP--- 177
Query: 526 QESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ D+ +G + ++ ++P
Sbjct: 178 --------------------DANPQDDIRGIGASLYALLVNRWP 201
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 47/239 (19%), Positives = 84/239 (35%), Gaps = 52/239 (21%)
Query: 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+ LG+G FG + +G +K+ Q E M+ L H N++ LV Y
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDI-MKVL---DHVNIIKLVDY 68
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRL-----------------KIV 476
+Y ++ P + + + K++
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 477 KGVAKGLQ---------YLYRELPSLIAPHGH------IKSSNVLLN-ESLEPVLADYGL 520
K + + Y+Y+ ++ H IK N+L+N + L D+G
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188
Query: 521 IPVMNQESAQELMIA------YKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FP 569
+ E +A Y++PE + LG T D+WS+G + E++ GK F
Sbjct: 189 AKKLIP---SEPSVAYICSRFYRAPELM-LGATEYTPSIDLWSIGCVFGELILGKPLFS 243
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 31/128 (24%), Positives = 59/128 (46%), Gaps = 11/128 (8%)
Query: 51 KLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
L+++ L N D++ LK+L ++ LS+ RN L+ +L + + L ++L NN
Sbjct: 64 NLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLK----NLNGIPSACLSRLFLDNNELR 119
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL 168
TD+ + +L L + +N+ L LS+L L L GN+ + K +
Sbjct: 120 D---TDSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGLTRLKKV 174
Query: 169 VSFNVSNN 176
+++
Sbjct: 175 NWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 24/144 (16%), Positives = 49/144 (34%), Gaps = 22/144 (15%)
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
+ L +L + ++ + ++L +++ N+ + T+
Sbjct: 11 QVFPDPGLANAVKQNLGKQSVTD-LVSQKELSG--VQNFNGDNSNIQ-SL--AGMQFFTN 64
Query: 122 LRKLLLADNQFNGPIP--ESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALF 179
L++L L+ NQ I L L++L EL + N+ + + L + NN L
Sbjct: 65 LKELHLSHNQ----ISDLSPLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNELR 119
Query: 180 GSISP-----ALRELDPSSFSGNR 198
L L N+
Sbjct: 120 -DTDSLIHLKNLEILS---IRNNK 139
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 31/143 (21%), Positives = 58/143 (40%), Gaps = 20/143 (13%)
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121
D+ KEL ++ + +N++ + ++ N L+ ++LS+N+ S ++ +T
Sbjct: 33 DLVSQKELSGVQNFNGDNSNIQS-LAGMQFFTN--LKELHLSHNQIS-DL--SPLKDLTK 86
Query: 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KDLVSFNVSNNALFG 180
L +L + N+ + L L L+ N+ K+L ++ NN L
Sbjct: 87 LEELSVNRNRLK--NLNGIPSAC-LSRLFLDNNELR-DTDSLIHLKNLEILSIRNNKL-K 141
Query: 181 SISP-----ALRELDPSSFSGNR 198
SI L LD GN
Sbjct: 142 SIVMLGFLSKLEVLD---LHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 18/112 (16%), Positives = 34/112 (30%), Gaps = 9/112 (8%)
Query: 49 GLKLEDMGLQGN--IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNR 106
L + L N D L L+ + LS+ N L+ + L L L + L N
Sbjct: 105 SACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKS-IVMLGFLSK--LEVLDLHGNE 161
Query: 107 FSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELR-LEGNKFE 157
+ + + + L + + L ++ +G
Sbjct: 162 IT-NT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 30/213 (14%), Positives = 74/213 (34%), Gaps = 25/213 (11%)
Query: 378 GSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK 437
+ K + + ++ R+ + V
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 438 EEKLLVH---EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
K+ ++ + K +L ++ + + L I +A+ +++L+ + L+
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMN--RRCSLEDREHGVCLHIFIQIAEAVEFLHSK--GLM 186
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----------------YKS 538
H +K SN+ + D+GL+ M+Q+ ++ ++ Y S
Sbjct: 187 --HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571
PE + + K D++SLG+++ E++
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 50/274 (18%), Positives = 102/274 (37%), Gaps = 42/274 (15%)
Query: 309 VSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERF-DLH 367
V I ++ + I S+ + V + V + D +
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159
Query: 368 DLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN 426
D+ E LG+G FG ++ +TG K + +E ++ ++ + LRHP
Sbjct: 160 DIH----EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 427 LLPLVAYYYRKEEKLLVHEFVPKRSL---AVNLHGHQALGQPSLDWPSRLKIVKGVAKGL 483
L+ L + E ++++EF+ L + H + ++ ++ V KGL
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-------MSEDEAVEYMRQVCKGL 268
Query: 484 QYLYRELPSLIAPHGH------IKSSNVLLNESLEPVL--ADYGLIPVMNQESAQELMIA 535
++ H + +K N++ L D+GL ++ + Q + +
Sbjct: 269 CHM----------HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVT 316
Query: 536 YKSPEF-----LQLGRITKKTDVWSLGVLILEIM 564
+ EF + + TD+WS+GV + I+
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGV-LSYIL 349
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 47/268 (17%), Positives = 99/268 (36%), Gaps = 54/268 (20%)
Query: 320 PSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDD--VERFDLHDLLRASAEIL 377
+ K G + + + KK + V+ + +D+ E L
Sbjct: 7 HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDIL-------EEL 59
Query: 378 GSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436
GSG FG ++ +TG + V K + + + + + +L HP L+ L +
Sbjct: 60 GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED 119
Query: 437 KEEKLLVHEFVP---------KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
K E +L+ EF+ + + + ++ +GL+++
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAED--YKMSEAEV-----------INYMRQACEGLKHM- 165
Query: 488 RELPSLIAPHGH------IKSSNVLL-NESLEPV-LADYGLIPVMNQESAQELMIA---Y 536
H H IK N++ + V + D+GL +N + ++ A +
Sbjct: 166 ---------HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 537 KSPEFLQLGRITKKTDVWSLGVLILEIM 564
+PE + + TD+W++GV + ++
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGV-LGYVL 243
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-08
Identities = 26/106 (24%), Positives = 42/106 (39%), Gaps = 5/106 (4%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSG 109
L L++ + E E+ LS + L + +L +L L+ + LS+NR SG
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNK--LKKLELSDNRVSG 78
Query: 110 EIPTDAFDGMTSLRKLLLADNQFNGP-IPESLTRLSRLVELRLEGN 154
+ +L L L+ N+ E L +L L L L
Sbjct: 79 -GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 45/220 (20%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMN-NVG------REEFQEHMRRLGRLRHPN 426
++G G +G K + TG ++ +K+F + + + RE ++ L +LRH N
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE-----IKLLKQLRHEN 85
Query: 427 LLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
L+ L+ +K+ LV EFV + L LD+ K + + G+ +
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-----TILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 487 YRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMIA 535
H H IK N+L+++S L D+G P +
Sbjct: 141 ----------HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYDDEVATRW 189
Query: 536 YKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
Y++PE L +G + K DVW++G L+ E+ G+ FP +
Sbjct: 190 YRAPELL-VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 29/111 (26%), Positives = 37/111 (33%), Gaps = 7/111 (6%)
Query: 69 LREMRTLSLMRNNLEGPMPDL-RQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLL 127
L + L + N L R LG L+ +YL N +P L KL L
Sbjct: 99 LPALTVLDVSFNRLTSLPLGALRGLGE--LQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155
Query: 128 ADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDLVSFNVSNN 176
A+N L L L L L+ N IP F L + N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 24/103 (23%), Positives = 41/103 (39%), Gaps = 9/103 (8%)
Query: 57 LQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIP 112
L N + L + L+L R L + L L ++ LS+N+ +P
Sbjct: 38 LSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPV--LGTLDLSHNQLQ-SLP 93
Query: 113 TDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNK 155
+ +L L ++ N+ +L L L EL L+GN+
Sbjct: 94 L-LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 13/101 (12%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
V + +P D L L++N +L +RL +L L+ +
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 157 EGQIPDFQQ-KDLVSFNVSNNAL------FGSISPALRELD 190
++ L + ++S+N L ++ PAL LD
Sbjct: 68 T-KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLD 106
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 50/219 (22%), Positives = 78/219 (35%), Gaps = 49/219 (22%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+LG G FG K T VK N + L +L HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 432 AYYYRKEEKLLVH---EFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKG 482
E+ + E L + A +I+K V G
Sbjct: 88 EIL---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----------RIIKQVFSG 133
Query: 483 LQYLYRELPSLIAPHGH------IKSSNVLL---NESLEPVLADYGLIPVMNQESAQELM 533
+ Y+ H H +K N+LL + + + D+GL Q + +
Sbjct: 134 ITYM----------HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 534 I---AYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
I Y +PE L+ G +K DVWS GV++ +++G P
Sbjct: 184 IGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 28/145 (19%), Positives = 51/145 (35%), Gaps = 26/145 (17%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLE-------GPMPDLRQLGNGALRS 99
L + L GN + + L ++ L + NL G + L++L
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL------- 129
Query: 100 VYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRL----VELRLEGNK 155
+++N + F +T+L L L+ N+ L L ++ + L L N
Sbjct: 130 -NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 156 FEGQIPD--FQQKDLVSFNVSNNAL 178
I F++ L + N L
Sbjct: 189 MN-FIQPGAFKEIRLKELALDTNQL 212
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 20/89 (22%), Positives = 32/89 (35%), Gaps = 14/89 (15%)
Query: 73 RTLSLMRNNLEGPMPDLRQLGNGA------LRSVYLSNNRFSGEIPTDAFDGMTSLRKLL 126
+ L L N L R LG+ + L+ + LS I A+ ++ L L+
Sbjct: 31 KNLDLSFNPL-------RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 127 LADNQFNGPIPESLTRLSRLVELRLEGNK 155
L N + + LS L +L
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETN 111
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 52/248 (20%), Positives = 95/248 (38%), Gaps = 50/248 (20%)
Query: 357 VRDDVERFDLHDLLRASAEILGSGCFGSSYKA---SLSTGAMMVVKRFKQMN---NVGRE 410
V+ ER + DL +G G +G YKA +K+ + + RE
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE 68
Query: 411 EFQEHMRRLGRLRHPNLLPLV-AYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLD 468
+ L L+HPN++ L + + K+ L+ ++ + L + H+A
Sbjct: 69 -----IALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKP 122
Query: 469 WPSRLKIVKGVA----KGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPV---- 514
+VK + G+ YL H + +K +N+L+
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYL----------HANWVLHRDLKPANILVMGEGPERGRVK 172
Query: 515 LADYGL-----IPVMNQESAQELMIA--YKSPEFLQLG--RITKKTDVWSLGVLILEIMT 565
+AD G P+ +++ Y++PE L LG TK D+W++G + E++T
Sbjct: 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLT 231
Query: 566 GK--FPAN 571
+ F
Sbjct: 232 SEPIFHCR 239
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 25/120 (20%), Positives = 53/120 (44%), Gaps = 8/120 (6%)
Query: 51 KLEDMGLQGNI--DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
+ + L N I+ L + +R LSL RN ++ + +L + + L +++S N+ +
Sbjct: 49 ACKHLALSTNNIEKISSLSGMENLRILSLGRNLIKK-IENLDAVAD-TLEELWISYNQIA 106
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIP-ESLTRLSRLVELRLEGNKFEGQIPDFQQKD 167
+ + + +LR L +++N+ + L L +L +L L GN +
Sbjct: 107 -SL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 32/160 (20%), Positives = 53/160 (33%), Gaps = 24/160 (15%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDL----RQLGNGALRSVYL 102
+ N L E+ TL L N L+ + + Q+ + L+ + +
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKS--LQQLDI 381
Query: 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD 162
S N S + SL L ++ N I L + L L NK + IP
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPK 438
Query: 163 --FQQKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
+ + L NV++N L+ + F L
Sbjct: 439 QVVKLEALQELNVASN--------QLKSVPDGIFDRLTSL 470
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 30/154 (19%), Positives = 52/154 (33%), Gaps = 11/154 (7%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNR 106
KL + + N +DI++ K +E+ L L N L N L+ + LS N
Sbjct: 46 KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVN--LKHLDLSFNA 101
Query: 107 FSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQK 166
F F M+ L+ L L+ + L+ L + G + +
Sbjct: 102 FDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY---GEKEDPE 158
Query: 167 DLVSFNVSNNALFGSISPALRELDPSSFSGNRDL 200
L FN + + + + S +L
Sbjct: 159 GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 19/82 (23%), Positives = 31/82 (37%), Gaps = 2/82 (2%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
+ +S N S E+ T ++ LR L+++ N+ L L L NK
Sbjct: 23 TTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 157 EGQIPDFQQKDLVSFNVSNNAL 178
I +L ++S NA
Sbjct: 82 VK-ISCHPTVNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 19/108 (17%), Positives = 42/108 (38%), Gaps = 7/108 (6%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNL-EGPMPDLRQLGNGALRSVYLSNNRFS 108
L + + + + + +L++ N L + L ++ + L +N+
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR----IKVLDLHSNKIK 434
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
IP + +L++L +A NQ RL+ L ++ L N +
Sbjct: 435 -SIPKQVVK-LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 17/113 (15%), Positives = 42/113 (37%), Gaps = 8/113 (7%)
Query: 50 LKLEDMGLQGNIDITILK----ELREMRTLSLMRNNLEGPMPDL-RQLGNGALRSVYLSN 104
+ ++ LQG +D L+ + ++ + P + N +++ +S
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFE 157
R + ++ L ++N + E+ L+ L L L+ N+ +
Sbjct: 312 TRM---VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 20/88 (22%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 48 WGLKLEDMGLQGNI--DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNN 105
W L + + NI D ++ L L N ++ + +L L+ + +++N
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEA--LQELNVASN 454
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFN 133
+ +P FD +TSL+K+ L N ++
Sbjct: 455 QLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 49/224 (21%), Positives = 82/224 (36%), Gaps = 64/224 (28%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVK--RFKQMNNVGREEFQEHMRR----LGRLRHPNL 427
E LGSG F K STG K + +Q R +E + R L ++ H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 428 LPLVAYYYRKEEKLLVHEFVP----------KRSL----AVNLHGHQALGQPSLDWPSRL 473
+ L Y + + +L+ E V K SL A +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF----------------- 120
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPV----LADYGLIPV 523
+K + G+ YL H +K N++L + P+ L D+GL
Sbjct: 121 --IKQILDGVNYL----------HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 524 MNQESAQELMIA---YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
+ + + + +PE + + + D+WS+GV I I+
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV-ITYIL 211
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 58/276 (21%), Positives = 103/276 (37%), Gaps = 43/276 (15%)
Query: 312 ENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLR 371
E + + L+K + + S + + + R + F+ L+
Sbjct: 98 EWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY---LK 154
Query: 372 ASAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHM---RR-LGRLRHPN 426
+LG G FG +TG +K K+ V ++E H R L RHP
Sbjct: 155 ----LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE-VAHTLTENRVLQNSRHPF 209
Query: 427 LLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VAKGLQ 484
L L Y ++ ++L V E+ L +L + + R + + L
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALD 262
Query: 485 YL-------YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL--IPVMNQESAQEL--M 533
YL YR+L K N++L++ + D+GL + + + +
Sbjct: 263 YLHSEKNVVYRDL----------KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 312
Query: 534 IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y +PE L+ + D W LGV++ E+M G+ P
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 12/106 (11%)
Query: 57 LQGNIDITILKE-----LREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGE 110
LQ N ++ L L ++R L L N L+ P ++L N L ++++++N+
Sbjct: 44 LQSN-KLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN--LETLWVTDNKLQ-A 99
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESL-TRLSRLVELRLEGNK 155
+P FD + +L +L L NQ +P + L++L L L N+
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNE 144
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 10/110 (9%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSN 104
L ++ L N + + L ++ LSL N L+ +P +L + L+ + L N
Sbjct: 110 NLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTS--LKELRLYN 166
Query: 105 NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGN 154
N+ +P AFD +T L+ L L +NQ + L +L L+L+ N
Sbjct: 167 NQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 17/97 (17%)
Query: 73 RTLSLMRNNLEGPMPDLRQLGNGA------LRSVYLSNNRFSGEIPTDAFDGMTSLRKLL 126
+ L L N L L + A LR +YL++N+ +P F + +L L
Sbjct: 40 KKLDLQSNKLS-------SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLW 91
Query: 127 LADNQFNGPIPESL-TRLSRLVELRLEGNKFEGQIPD 162
+ DN+ +P + +L L ELRL+ N+ + +P
Sbjct: 92 VTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPP 126
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 52/228 (22%), Positives = 88/228 (38%), Gaps = 63/228 (27%)
Query: 377 LGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLL 428
LG G +G + T A+ ++K+ K++ + E +++ L RLRH N++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEAN--VKKEIQLLRRLRHKNVI 69
Query: 429 PL--VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-----VAK 481
L V Y K++ +V E+ G Q + LD + + A
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCV--------CGMQEM----LD-----SVPEKRFPVCQAH 112
Query: 482 --------GLQYLYRELPSLIAPHG--H--IKSSNVLLNESLEPVLADYGLIPVMNQESA 529
GL+YL+ G H IK N+LL ++ G+ ++ +A
Sbjct: 113 GYFCQLIDGLEYLHS--------QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 530 QELMI------AYKSPEFLQLGRI--TKKTDVWSLGVLILEIMTGKFP 569
+ A++ PE K D+WS GV + I TG +P
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 46/228 (20%), Positives = 85/228 (37%), Gaps = 61/228 (26%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR--------LGRLRHP 425
+G G +G +K + TG ++ +K+F + E +++ L +L+HP
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLE------SEDDPVIKKIALREIRMLKQLKHP 62
Query: 426 NLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
NL+ L+ + RK LV E+ + Q + I + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-----TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 486 LYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---- 535
H H +K N+L+ + L D+G A+ L
Sbjct: 118 C----------HKHNCIHRDVKPENILITKHSVIKLCDFGF--------ARLLTGPSDYY 159
Query: 536 --------YKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
Y+SPE L +G + DVW++G + E+++G +P
Sbjct: 160 DDEVATRWYRSPELL-VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 43/212 (20%), Positives = 76/212 (35%), Gaps = 48/212 (22%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E +G G + + +T VK + EE + +R HPN++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ---HPNIITLKDV 84
Query: 434 YYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKGLQYLY 487
Y + +V E + L + +A ++ + K ++YL
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKFFSEREA-----------SAVLFTITKTVEYL- 132
Query: 488 RELPSLIAPHGH------IKSSNVLL---NESLEPV-LADYGLIPVMNQESAQELMIA-- 535
H +K SN+L + + E + + D+G + E+ LM
Sbjct: 133 ---------HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCY 182
Query: 536 ---YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
+ +PE L+ D+WSLGV +L M
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGV-LLYTM 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 48/222 (21%), Positives = 77/222 (34%), Gaps = 47/222 (21%)
Query: 375 EILGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRR-----LGRLRHP 425
+ LGSG G A T A+ ++ + K RE L +L HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 426 NLLPLVAYYYRKEEKL-LVHEFVPKRSL--AVNLHGHQALGQPSLDWPSRLKIVKGVAKG 482
++ + ++ E +V E + L V + L + +
Sbjct: 201 CIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKR-------LKEATCKLYFYQMLLA 251
Query: 483 LQYLYRELPSLIAPHGH------IKSSNVLLNESLEPV---LADYGLIPVMNQESAQELM 533
+QYL H + +K NVLL+ E + D+G ++ + S +
Sbjct: 252 VQYL----------HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301
Query: 534 I---AYKSPEFLQLGRI---TKKTDVWSLGVLILEIMTGKFP 569
Y +PE L + D WSLGV IL I +P
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV-ILFICLSGYP 342
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 6e-07
Identities = 15/76 (19%), Positives = 28/76 (36%), Gaps = 13/76 (17%)
Query: 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKERDGDE--DFYSSYAS 661
AD E E ++ + EE KRL +A +E +E+ + ++ +
Sbjct: 77 ADRLTQEPESIRKWR-------EEQRKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSE 129
Query: 662 --EADLRSPRGKSDEF 675
E + + R F
Sbjct: 130 QVEKNKINNRIADKAF 145
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 51/211 (24%), Positives = 74/211 (35%), Gaps = 44/211 (20%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+LG G FG K T VK N + L +L HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 432 AYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKGLQY 485
+V E L + A +I+K V G+ Y
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-----------ARIIKQVFSGITY 136
Query: 486 LYRELPSLIAPHGH------IKSSNVLL---NESLEPVLADYGLIPVMNQESAQELMI-- 534
+ H H +K N+LL + + + D+GL Q + + I
Sbjct: 137 M----------HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186
Query: 535 -AYKSPEFLQLGRITKKTDVWSLGVLILEIM 564
Y +PE L+ G +K DVWS GV IL I+
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAGV-ILYIL 215
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 50/224 (22%), Positives = 84/224 (37%), Gaps = 64/224 (28%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVK--RFKQMNNVGREEFQEHMRR----LGRLRHPNL 427
E LGSG F K STG K + +Q R +E + R L ++ HPN+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 428 LPLVAYYYRKEEKLLVHEFVP----------KRSL----AVNLHGHQALGQPSLDWPSRL 473
+ L Y + + +L+ E V K SL A +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF----------------- 120
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPV----LADYGL-IP 522
+K + G+ YL H +K N++L + P+ L D+GL
Sbjct: 121 --IKQILDGVNYL----------HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 523 VMNQESAQELM--IAYKSPEFLQLGRITKKTDVWSLGVLILEIM 564
+ + + + + +PE + + + D+WS+GV I I+
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV-ITYIL 211
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 8e-07
Identities = 48/224 (21%), Positives = 84/224 (37%), Gaps = 64/224 (28%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVK--RFKQMNNVGREEFQEHMRR----LGRLRHPNL 427
E LGSG F K TG K + +++++ R +E + R L +RHPN+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 428 LPLVAYYYRKEEKLLVHEFVP----------KRSL----AVNLHGHQALGQPSLDWPSRL 473
+ L + K + +L+ E V K SL A
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF----------------- 113
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPV----LADYGLIPV 523
+K + G+ YL H +K N++L + P L D+G+
Sbjct: 114 --LKQILDGVHYL----------HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 524 MNQESAQELMIA---YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
+ + + + + +PE + + + D+WS+GV I I+
Sbjct: 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV-ITYIL 204
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 8e-07
Identities = 42/214 (19%), Positives = 74/214 (34%), Gaps = 47/214 (21%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRF-KQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
LGSG FG + S+G V+K K + V E+ + + L L HPN++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 433 YYYRKEEKLLVHEF----------VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG 482
+ +V E V ++ L +++K +
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV-----------AELMKQMMNA 136
Query: 483 LQYLYRELPSLIAPHGH------IKSSNVLL---NESLEPVLADYGLIPVMNQESAQELM 533
L Y H +K N+L + + D+GL + +
Sbjct: 137 LAYF----------HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186
Query: 534 I---AYKSPEFLQLGRITKKTDVWSLGVLILEIM 564
Y +PE + +T K D+WS GV ++ +
Sbjct: 187 AGTALYMAPEVFK-RDVTFKCDIWSAGV-VMYFL 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 44/208 (21%), Positives = 76/208 (36%), Gaps = 40/208 (19%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E+LGSG F + TG + +K K+ + + L +++H N++ L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 434 YYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKGLQYLY 487
Y LV + V L + G A +++ V ++YL
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDA-----------SLVIQQVLSAVKYL- 122
Query: 488 RELPSLIAPHGH------IKSSNVLL---NESLEPVLADYGLIPVMNQESAQELM--IAY 536
H + +K N+L E+ + ++ D+GL + Y
Sbjct: 123 ---------HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY 173
Query: 537 KSPEFLQLGRITKKTDVWSLGVLILEIM 564
+PE L +K D WS+GV I I+
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGV-ITYIL 200
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 1e-06
Identities = 65/408 (15%), Positives = 121/408 (29%), Gaps = 124/408 (30%)
Query: 355 SFVRDDVERFDLHDLLRASAEIL------------GSGCFGSSYKASLSTGAMMVVKRFK 402
F + +V R + LR + L GSG K + A+ V +K
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG------KTWV---ALDVCLSYK 175
Query: 403 ---QMN------NVGR----EEFQEHMRRLGRLRHPNLLPLV----AYYYRKEE-----K 440
+M+ N+ E E +++L PN R +
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 441 LLVHEFVPKRSLAVNLHGHQALGQPSLD--WPSRL--------KIV-----KGVAKGLQY 485
L+ + L V L ++ KI+ K V L
Sbjct: 236 RLLKSKPYENCLLV------------LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPVLADY------GLIPVMNQESAQEL-MIAYKS 538
SL S + +E +L Y L + + + L +IA
Sbjct: 284 ATTTHISLDHH-----SMTLTPDEVKS-LLLKYLDCRPQDLPREVLTTNPRRLSIIA--- 334
Query: 539 PEFLQLGRIT----KKTDVWSLGVLI---LEIMTGKFPANFLQQGKK-----ADGDLASW 586
E ++ G T K + L +I L ++ PA + + + + +
Sbjct: 335 -ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE---PAEYRKMFDRLSVFPPSAHIPTI 390
Query: 587 VNSVLANGDNRTEVFD--KEMAD----ERNSEGEMVKLLKIGLACCEEEVEKRLDL-KEA 639
+ S++ +++V ++ E+ + + + I L ++E L +
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK-VKLENEYALHRSI 449
Query: 640 VEKIEEVKERDGD------ED--FYS--SY-ASEADLRSPRGKSDEFT 676
V+ K D D D FYS + + + F
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE---HPERMTLFR 494
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 102/658 (15%), Positives = 175/658 (26%), Gaps = 217/658 (32%)
Query: 91 QLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLA---DNQFNGPIPESLTRL---- 143
Q + SV+ F D D + +L D+ S T
Sbjct: 15 QYQYKDILSVFEDA--FVDNF--DCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70
Query: 144 ---------SRLVELRLEGN--------KFEGQIPDFQQKDLVS--------------FN 172
+ VE L N K E + P + + +N
Sbjct: 71 LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYN 130
Query: 173 VSNNALFGSISPALRELDPSSF--------SGNRDLCGEPLGSPCPTPSPSPSPGP---- 220
VS + + AL EL P+ SG + + S
Sbjct: 131 VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM---DFKIFWL 187
Query: 221 ------SPESSPTP--------SPIPLPLPNHPPNPIPSPSHDPHASS----HSPPAPPP 262
SPE+ P +H N I H A S P
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN-IKLRIHSIQAELRRLLKSKPYE-- 244
Query: 263 GNDSAGSGSSNSTLV---IASATTVSVVAI----------AAVVAAIFVIERKRKRERGV 309
N LV + +A + + V +
Sbjct: 245 ----------NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS---- 290
Query: 310 SIENPPPLPPPSSN--LQKTSGIRESGQCSPSSTEAVVGGKKP-EIKL--SFVRDDVERF 364
+ L P L K R Q P E + P + + +RD + +
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRP--QDLPR--EVLTTN--PRRLSIIAESIRDGLATW 344
Query: 365 D--LHDLLRASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRL 422
D H I+ ++SL N + E+++ RL
Sbjct: 345 DNWKHVNCDKLTTII---------ESSL--------------NVLEPAEYRKMFDRLSVF 381
Query: 423 RHPNLLP---LVAYYY---RKEEKLLVHEFVPKRSLA--------VNLHGHQALGQPSLD 468
+P L ++ + + ++V++ K SL +++ L+
Sbjct: 382 PPSAHIPTILLSLIWFDVIKSDVMVVVNKLH-KYSLVEKQPKESTISIPSIY------LE 434
Query: 469 WPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLAD--------YGL 520
++K+ + L+R S++ H ++ L P D + L
Sbjct: 435 --LKVKL-----ENEYALHR---SIVD---HYNIPKTFDSDDLIPPYLDQYFYSHIGHHL 481
Query: 521 IPVMNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKAD 580
+ + E + + FL+ +I + W+ IL N LQQ K
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLE-QKIRHDSTAWNASGSIL---------NTLQQLKFY- 530
Query: 581 GDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEV--EKRLDL 636
+ + D + ER +V + L EE + K DL
Sbjct: 531 ----------------KPYICDNDPKYER-----LVNAILDFLPKIEENLICSKYTDL 567
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 3e-04
Identities = 48/369 (13%), Positives = 105/369 (28%), Gaps = 102/369 (27%)
Query: 355 SFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQ 413
+FV + FD D+ IL + +G + + ++F
Sbjct: 28 AFVDN----FDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF- 82
Query: 414 EHMRRLGRLRHPNLLPLVAYYYRKEEK---LLVHEFVPKRSLAVNLHGHQALGQPSLDWP 470
+ + N + + E++ ++ ++ +R L+ Q +
Sbjct: 83 -----VEEVLRIN-YKFLMSPIKTEQRQPSMMTRMYIEQRD---RLYND---NQVFAKYN 130
Query: 471 -SRLKIVKGVAKGLQYLYRELPSLIAPHGHI---KSSNVLLNESLEPVLADYGLIPVMNQ 526
SRL+ + + L L + G + K+ + + V Y + M+
Sbjct: 131 VSRLQPYLKLRQALLELRPA--KNVLIDGVLGSGKT--WVALD----VCLSYKVQCKMDF 182
Query: 527 ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQG---------- 576
+ I + L L V + +L+ + + N+ +
Sbjct: 183 K------IFW-----LNLKNCNSPETV----LEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 577 ---KKADGDLASW---VNS--VLAN-GDNRT-EVFD-----------KEMADERNSEGEM 615
+ L N VL N + + F+ K++ D ++
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 616 VKLL---KIGLACCEEEVEKRL---------DLKEAVEKI---------EEVKERDGDED 654
L + L +EV+ L DL V E +++ D
Sbjct: 288 HISLDHHSMTLT--PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD 345
Query: 655 FYSSYASEA 663
+ +
Sbjct: 346 NWKHVNCDK 354
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 48/223 (21%), Positives = 85/223 (38%), Gaps = 57/223 (25%)
Query: 376 ILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLPL 430
ILG G F + A L+T +K ++ ++ +E ++ R + RL HP + L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 431 VAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAK-------- 481
+ ++ +EKL + L + + + +
Sbjct: 96 Y-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------------CTRFYTAEIVS 141
Query: 482 GLQYL------YREL-PS--LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532
L+YL +R+L P L+ HI+ + D+G V++ ES Q
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQ-------------ITDFGTAKVLSPESKQAR 188
Query: 533 M------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y SPE L K +D+W+LG +I +++ G P
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 58/283 (20%), Positives = 95/283 (33%), Gaps = 53/283 (18%)
Query: 305 RERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERF 364
+G S P P P P + Q P + + +K
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQ---QFPQFHVKSGLQIKKNAII 60
Query: 365 DLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR 423
D + + ++LG G G + + T +K + RE E R +
Sbjct: 61 DDYKVTS---QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREV--ELHWRA--SQ 113
Query: 424 HPNLLPLVAYY---YRKEEKL-LVHEFVPKRSL--AVNLHGHQALG--QPSLDWPSRLKI 475
P+++ +V Y Y + L +V E + L + G QA + S +I
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EI 166
Query: 476 VKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLE--PV-LADYGLIPVMNQ 526
+K + + +QYL H +K N+L + L D+G
Sbjct: 167 MKSIGEAIQYL----------HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 527 ESAQELMIA-----YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
L Y +PE L + K D+WSLGV I+ I+
Sbjct: 217 H--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV-IMYIL 256
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 18/118 (15%), Positives = 28/118 (23%), Gaps = 4/118 (3%)
Query: 204 PLGSPCPTPSPSPSPGPS-PESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPP 262
+ P +S T + HPP +P P+ P + + PP
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPA-PPPPPAPAAGNPPD 63
Query: 263 GNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIERKRKRERGVSIENPPPLPPP 320
G L + + +A A E P P
Sbjct: 64 T--VTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHP 119
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 6e-04
Identities = 14/82 (17%), Positives = 23/82 (28%), Gaps = 4/82 (4%)
Query: 202 GEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPP 261
G + P + + + S + P P P P P P P S
Sbjct: 18 GSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTGDSVLQRILRG 77
Query: 262 PGNDSAGSGSSNSTLVIASATT 283
P G G+++ +
Sbjct: 78 P----TGPGTTSLAPAVRYGRQ 95
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG------REEFQEHMRRLGRLRHPNL 427
E LG+G + + YK + +TG + +K K + G RE + + L+H N+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE-----ISLMKELKHENI 65
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-IVKGVAKGLQYL 486
+ L + + + LV EF+ L + P + +K + +GL +
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 487 YRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMIA 535
H + +K N+L+N+ + L D+GL IPV N S++ + +
Sbjct: 125 ----------HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVVTLW 173
Query: 536 YKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
Y++P+ L +G + D+WS G ++ E++TGK FP
Sbjct: 174 YRAPDVL-MGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 11/98 (11%)
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES------AQEL 532
VAKG+++L S H + + N+LL+E + D+GL + ++ L
Sbjct: 202 VAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 533 MIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFP 569
+ + +PE + T ++DVWS GVL+ EI + G P
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 47/220 (21%), Positives = 85/220 (38%), Gaps = 56/220 (25%)
Query: 375 EILGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPN 426
E LGSG F K STG A +K+ ++ + R +E + R L ++HPN
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKK-RRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 427 LLPLVAYYYRKEEKLLVHEFVP-----KRSLAVNLHGH----QALGQPSLDWPSRLKIVK 477
++ L Y K + +L+ E V +A + +K
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEA-----------TEFLK 121
Query: 478 GVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPV----LADYGLIPVMNQE 527
+ G+ YL H +K N++L + P + D+GL ++
Sbjct: 122 QILNGVYYL----------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 528 SAQELMIA---YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
+ + + + +PE + + + D+WS+GV I I+
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV-ITYIL 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 50/231 (21%)
Query: 376 ILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHM---RRLGRLRHPNLLPLV 431
+LG G FG + +TG M K+ ++ R+ + + L ++ ++ L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 432 AYYYRKEEKL-LVHEFVPKRSLAVNLHGH-QALGQPSLDWPSRLKIVKG-VAKGLQYL-- 486
AY Y ++ L LV + +L H +GQ +R + GL+ L
Sbjct: 250 AYAYETKDALCLVLTLMN----GGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLEDLHR 304
Query: 487 ----YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--------- 533
YR+L K N+LL++ ++D GL A +
Sbjct: 305 ERIVYRDL----------KPENILLDDHGHIRISDLGL--------AVHVPEGQTIKGRV 346
Query: 534 --IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGD 582
+ Y +PE ++ R T D W+LG L+ E++ G+ P F Q+ KK +
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQRKKKIKRE 395
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 19/85 (22%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---YKSPEFLQLGRITKKTDV 553
H +K SN+++ + D+GL + Y++PE + + D+
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 554 WSLGVLILEIMTGK--FP-ANFLQQ 575
WS+G ++ E++ G FP + + Q
Sbjct: 210 WSVGCIMGEMIKGGVLFPGTDHIDQ 234
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 74/454 (16%), Positives = 132/454 (29%), Gaps = 87/454 (19%)
Query: 187 RELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSP 246
R +R++ + P+ P P P I S
Sbjct: 160 RGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSS 219
Query: 247 SHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAV-VAAIFVIERKRKR 305
+ + D S + + + ++ + V +
Sbjct: 220 LNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLL 279
Query: 306 ERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFD 365
+ P+PP S + + T+A I + +R
Sbjct: 280 SQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMK 339
Query: 366 LHD--LLRASAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHM---RR- 418
L D L +LG G FG + T + VK K+ + ++ E +R
Sbjct: 340 LTDFNFLM----VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD-VECTMVEKRV 394
Query: 419 -LGRLRHPNLLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIV 476
+ P L L ++ ++L V E+V L ++ +P
Sbjct: 395 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFY 447
Query: 477 KG-VAKGLQYL------YRELP---SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526
+A GL +L YR+L ++ GHIK +AD+G+
Sbjct: 448 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK-------------IADFGM------ 488
Query: 527 ESAQELMIA------------YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQ 574
+E + Y +PE + K D W+ GVL+ E++ G+ P F
Sbjct: 489 --CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--F-- 542
Query: 575 QGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608
G++ E+F M
Sbjct: 543 ------------------EGEDEDELFQSIMEHN 558
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 50/273 (18%), Positives = 89/273 (32%), Gaps = 53/273 (19%)
Query: 312 ENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDV-ERFDLHDLL 370
+ S + S+ RD + + F++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSS--VTASAAPGTASLVPDYWIDGSNRDALSDFFEVE--- 58
Query: 371 RASAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLP 429
LG G Y+ T +K K+ V ++ + + L RL HPN++
Sbjct: 59 ----SELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 430 LVAYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKGL 483
L + E LV E V L + G+ A VK + + +
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA-----------ADAVKQILEAV 161
Query: 484 QYLYRELPSLIAPHGH------IKSSNVLL---NESLEPVLADYGLIPVMNQESAQELMI 534
YL H + +K N+L +AD+GL ++ + + +
Sbjct: 162 AYL----------HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211
Query: 535 ---AYKSPEFLQLGRITKKTDVWSLGVLILEIM 564
Y +PE L+ + D+WS+G+ I I+
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGI-ITYIL 243
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 42/219 (19%), Positives = 76/219 (34%), Gaps = 52/219 (23%)
Query: 370 LRASAEILGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRRLGRLRHP 425
L + LG G F K + A+ ++ + + N +E ++ HP
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-RMEANTQKEI--TALKLCE--GHP 66
Query: 426 NLLPLVAYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGV 479
N++ L ++ + LV E + L + H +A I++ +
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA-----------SYIMRKL 115
Query: 480 AKGLQYLYRELPSLIAPHGH------IKSSNVLL-NESLEPVL--ADYGLIPVMNQESAQ 530
+ ++ H +K N+L +E+ + D+G + Q
Sbjct: 116 VSAVSHM----------HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGF-ARLKPPDNQ 164
Query: 531 ELMIA-----YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
L Y +PE L + D+WSLGV IL M
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGV-ILYTM 202
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 52/296 (17%), Positives = 109/296 (36%), Gaps = 66/296 (22%)
Query: 304 KRERGVSIENPPPLPPPSSNLQKTSGIRESGQCSPSSTEAVVG-GKKPEIKLSFVRDDV- 361
+ +R I + P S+NL + Q + G + E+ +
Sbjct: 34 REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93
Query: 362 ERFDLHDLLRASAEILGSGCFGSSYKAS-LSTGAMMVVK----RFKQMNNVGREEFQEHM 416
+++D +++G G + +TG VK ++++ EE +E
Sbjct: 94 QKYDPK-------DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 417 RR----LGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQP 465
RR L ++ HP+++ L+ Y LV + + K L + +
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET---- 202
Query: 466 SLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYG 519
I++ + + + +L H + +K N+LL+++++ L+D+G
Sbjct: 203 -------RSIMRSLLEAVSFL----------HANNIVHRDLKPENILLDDNMQIRLSDFG 245
Query: 520 LIPVMNQESAQELMIA-----YKSPEFLQLGRI------TKKTDVWSLGVLILEIM 564
+ ++L Y +PE L+ K+ D+W+ GV IL +
Sbjct: 246 FSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV-ILFTL 298
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 5e-06
Identities = 30/164 (18%), Positives = 56/164 (34%), Gaps = 18/164 (10%)
Query: 50 LKLEDMGLQGNIDITILKELREMR-TLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS 108
L + + LK + MR + + ++ +R ++L++ +
Sbjct: 395 LDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT 454
Query: 109 GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KD 167
+ + + + L L+ N+ +P +L L L L+ N E +
Sbjct: 455 -VLC--HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDGVANLPR 509
Query: 168 LVSFNVSNNAL--FGSIS-----PALRELDPSSFSGNRDLCGEP 204
L + NN L +I P L L+ GN LC E
Sbjct: 510 LQELLLCNNRLQQSAAIQPLVSCPRLVLLN---LQGNS-LCQEE 549
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 45/235 (19%), Positives = 89/235 (37%), Gaps = 55/235 (23%)
Query: 376 ILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHM---RR-LGRLRHPNLLPL 430
+LG G FG + + +TG + K+ + R+ + ++ L ++ ++ L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG-YQGAMVEKKILAKVHSRFIVSL 250
Query: 431 VAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VAKGLQYL-- 486
AY + + L LV + + +++ + P R + GL++L
Sbjct: 251 -AYAFETKTDLCLVMTIMNGGDIRYHIY-NVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQ 307
Query: 487 ----YREL-PS--LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM------ 533
YR+L P L+ G+++ ++D GL A EL
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVR-------------ISDLGL--------AVELKAGQTKT 346
Query: 534 ------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGD 582
+ +PE L D ++LGV + E++ + P F +G+K +
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP--FRARGEKVENK 399
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 20/138 (14%), Positives = 41/138 (29%), Gaps = 18/138 (13%)
Query: 63 ITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSL 122
+ + + RN + + + + L+ S +P + +
Sbjct: 30 FSAWDKWEKQALPGENRNEAVSLLKEC-LINQ--FSELQLNRLNLS-SLPDNLP---PQI 82
Query: 123 RKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNAL--FG 180
L + N +PE L L N+ +P+ L +V NN L
Sbjct: 83 TVLEITQNAL-ISLPELPASLEY---LDACDNRLS-TLPELPAS-LKHLDVDNNQLTMLP 136
Query: 181 SISPALRELDPSSFSGNR 198
+ L ++ N+
Sbjct: 137 ELPALLEYIN---ADNNQ 151
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 28/134 (20%), Positives = 50/134 (37%), Gaps = 21/134 (15%)
Query: 51 KLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE 110
LE + N T+ + ++ L + N L +P+L L + NN+ +
Sbjct: 101 SLEYLDACDNRLSTLPELPASLKHLDVDNNQLTM-LPEL----PALLEYINADNNQLT-M 154
Query: 111 IPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF------Q 164
+P + TSL L + +NQ +PE L L + N E +P
Sbjct: 155 LP----ELPTSLEVLSVRNNQLTF-LPELPESLE---ALDVSTNLLE-SLPAVPVRNHHS 205
Query: 165 QKDLVSFNVSNNAL 178
++ + F N +
Sbjct: 206 EETEIFFRCRENRI 219
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 21/142 (14%), Positives = 45/142 (31%), Gaps = 6/142 (4%)
Query: 51 KLEDMGLQGNIDITIL-KELREMRTLSLMRNNLEGPMPDLRQLGN--GALRSVYLSNNRF 107
LE + ++ N +T L + + L + N LE + + NR
Sbjct: 161 SLEVLSVRNN-QLTFLPELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRI 219
Query: 108 SGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKD 167
+ IP + + ++L DN + I ESL++ + + F
Sbjct: 220 T-HIP-ENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
Query: 168 LVSFNVSNNALFGSISPALREL 189
+ + + ++
Sbjct: 278 RPLADAVTAWFPENKQSDVSQI 299
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 51/229 (22%), Positives = 88/229 (38%), Gaps = 53/229 (23%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK-QMNNVGREEF-----QE--HMRRLGRLRHP 425
+G G +G+ YKA +G + +K + G +E +RRL HP
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 426 NLLPL----VAYYYRKEEKL-LVHEFVPKRSLAVNLHGH-QALGQPSLDWPSRLKIVKGV 479
N++ L +E K+ LV E V + +L + P L + +++
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-----DLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 480 AKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPV-MNQE 527
+GL +L H + +K N+L+ LAD+GL + +
Sbjct: 130 LRGLDFL----------HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV 179
Query: 528 SAQELMIA--YKSPEFLQLG-RITKKTDVWSLGVLILEIMTGK--FPAN 571
++ Y++PE L L D+WS+G + E+ K F N
Sbjct: 180 -----VVTLWYRAPEVL-LQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 46.7 bits (112), Expect = 1e-05
Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 48/221 (21%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVG--------REEFQEHMRRLGRLRHPN 426
E +G G +G YKA + G +K+ + + RE + L L+H N
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIRE-----ISILKELKHSN 61
Query: 427 LLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-IVKGVAKGLQY 485
++ L + K+ +LV E + + +L + + L+ K + + G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-----DLKKLLDVCEGGLE-SVTAKSFLLQLLNGIAY 115
Query: 486 LYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMI 534
H +K N+L+N E +AD+GL IPV + + + + +
Sbjct: 116 C----------HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTL 164
Query: 535 AYKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
Y++P+ L +G + + D+WS+G + E++ G FP
Sbjct: 165 WYRAPDVL-MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 43/229 (18%), Positives = 78/229 (34%), Gaps = 58/229 (25%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVK-----RFKQMNNVGREEFQEHMRR----LGRL-R 423
EILG G + T VK + +E +E + L ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 424 HPNLLPLVAYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVK 477
HPN++ L Y LV + + K L + + KI++
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-----------KIMR 131
Query: 478 GVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQE 531
+ + + L H +K N+LL++ + L D+G ++ ++
Sbjct: 132 ALLEVICAL----------HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EK 179
Query: 532 LMIA-----YKSPEFLQLGRI------TKKTDVWSLGVLILEIMTGKFP 569
L Y +PE ++ K+ D+WS GV I+ + P
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV-IMYTLLAGSP 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 40/209 (19%), Positives = 67/209 (32%), Gaps = 42/209 (20%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+G G +G A T K+ + + F++ + + L HPN++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 434 YYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKGLQYLY 487
+ + LV E L V A +I+K V + Y
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDA-----------ARIMKDVLSAVAYC- 122
Query: 488 RELPSLIAPHGH------IKSSNVLL---NESLEPVLADYGLIPVMNQESAQELMI---A 535
H +K N L + L D+GL +
Sbjct: 123 ---------HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY 173
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
Y SP+ L+ G + D WS GV ++ ++
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAGV-MMYVL 200
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 47/234 (20%), Positives = 87/234 (37%), Gaps = 55/234 (23%)
Query: 365 DLHDLLRASAEILGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRRLG 420
+ ++ +++ LG G F + S STG A +K+ ++ R E + L
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK-RRRGQDCRAEILHEIAVLE 83
Query: 421 RLRH-PNLLPLVAYYYRKEEKLLVHEFVP-----KRSLAVNLHGH----QALGQPSLDWP 470
+ P ++ L Y E +L+ E+ L
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL-CLPELAEMVSENDV--------- 133
Query: 471 SRLKIVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLL--NESLEPV-LADYGLI 521
++++K + +G+ YL H + +K N+LL L + + D+G+
Sbjct: 134 --IRLIKQILEGVYYL----------HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
Query: 522 PVMNQESAQELMIA-----YKSPEFLQLGRITKKTDVWSLGVLILEIM-TGKFP 569
+ EL Y +PE L IT TD+W++G+ I ++ T P
Sbjct: 182 RKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGI-IAYMLLTHTSP 232
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 45/215 (20%), Positives = 79/215 (36%), Gaps = 50/215 (23%)
Query: 375 EILGSGCFGSSYKAS-LSTG---AMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPL 430
E LG G F + + G A M++ K+++ ++ + R L+HPN++ L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 431 VAYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKGLQ 484
+ L+ + V L + + A ++ + + +
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA-----------SHCIQQILEAVL 124
Query: 485 YLYRELPSLIAPHGH------IKSSNVLL---NESLEPVLADYGLIPVMNQESAQELM-- 533
+ H +K N+LL + LAD+GL + E Q+
Sbjct: 125 HC----------HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFG 172
Query: 534 IA----YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
A Y SPE L+ K D+W+ GV IL I+
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGV-ILYIL 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 41/213 (19%), Positives = 76/213 (35%), Gaps = 50/213 (23%)
Query: 375 EILGSGCFGSSYKA-SLSTGAM----MVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLP 429
E LG G FG ++ S+ V + V +E + L RH N+L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKE-----ISILNIARHRNILH 65
Query: 430 LVAYYYRKEEKLLVHEFVP-----KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ 484
L + EE +++ EF+ +R L+ + V V + LQ
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFE---------LNEREIVSYVHQVCEALQ 116
Query: 485 YLYRELPSLIAPHGH------IKSSNVLLNESLEPVL--ADYGLIPVMNQESAQELMIAY 536
+L H H I+ N++ + ++G + + +
Sbjct: 117 FL----------HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLF 164
Query: 537 KSPEF-----LQLGRITKKTDVWSLGVLILEIM 564
+PE+ Q ++ TD+WSLG ++ ++
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGT-LVYVL 196
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 48/221 (21%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVG--------REEFQEHMRRLGRLRHPN 426
E +G G +G YKA S G ++ +KR + ++ RE + L L HPN
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIRE-----ISLLKELHHPN 80
Query: 427 LLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-IVKGVAKGLQY 485
++ L+ + + LV EF+ K +L + L S++K + + +G+ +
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-----DLKKVLDENKTGLQ-DSQIKIYLYQLLRGVAH 134
Query: 486 LYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMI 534
H H +K N+L+N LAD+GL IPV + + + +
Sbjct: 135 C----------HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVVTL 183
Query: 535 AYKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
Y++P+ L +G + + D+WS+G + E++TGK FP
Sbjct: 184 WYRAPDVL-MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 53/252 (21%), Positives = 90/252 (35%), Gaps = 50/252 (19%)
Query: 334 GQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKAS-LST 392
G S T G+ E ++ + +D+ E LG G F + +T
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVK-------EELGKGAFSVVRRCVHKTT 53
Query: 393 GAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450
G K K+++ ++ + R +L+HPN++ L + LV + V
Sbjct: 54 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113
Query: 451 SL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGH----- 499
L + A ++ + + + Y H +
Sbjct: 114 ELFEDIVAREFYSEADA-----------SHCIQQILESIAYC----------HSNGIVHR 152
Query: 500 -IKSSNVLLNESLE--PV-LADYGLIPVMNQESAQELMI---AYKSPEFLQLGRITKKTD 552
+K N+LL + V LAD+GL +N A Y SPE L+ +K D
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVD 212
Query: 553 VWSLGVLILEIM 564
+W+ GV IL I+
Sbjct: 213 IWACGV-ILYIL 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 54/261 (20%), Positives = 92/261 (35%), Gaps = 66/261 (25%)
Query: 339 SSTEAVVGGKKPEIKLSFVRDDVERFDLHD--LLRASAEILGSGCFG----SSYKASLST 392
S + + K + + L ++ LG+G FG +K S +
Sbjct: 13 ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFGRVMLVKHKESGNH 68
Query: 393 GAMMVVKRFKQMNNVGREEFQEHM---RR-LGRLRHPNLLPLVAYYYRKEEKL-LVHEFV 447
AM ++ KQ V + + EH +R L + P L+ L + ++ L +V E+V
Sbjct: 69 YAMKILD--KQ--KVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYV 123
Query: 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VAKGLQYL------YREL-PS--LIAPH 497
+ +L +P + + +YL YR+L P LI
Sbjct: 124 AGGEMFSHLRRIGRFSEP------HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 498 GHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM---------IAYKSPEFLQLGRIT 548
G+I+ + D+G A+ + +PE +
Sbjct: 178 GYIQ-------------VTDFGF--------AKRVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 549 KKTDVWSLGVLILEIMTGKFP 569
K D W+LGVLI E+ G P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 46/221 (20%), Positives = 73/221 (33%), Gaps = 55/221 (24%)
Query: 375 EILGSGCFGSSYKAS-LSTG---AMMVVKRFKQMNNVGREEFQEHMRR-----LGRLRHP 425
+ LGSG G A T A+ ++ + K RE L +L HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 426 NLLPLVAYYYRKEEKL-LVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKG 478
++ + ++ E +V E + L V +
Sbjct: 76 CIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATC-----------KLYFYQ 122
Query: 479 VAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPV---LADYGLIPVMNQESA 529
+ +QYL H + +K NVLL+ E + D+G ++ + S
Sbjct: 123 MLLAVQYL----------HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 530 QELMI---AYKSPEFLQLGRI---TKKTDVWSLGVLILEIM 564
+ Y +PE L + D WSLGV IL I
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV-ILFIC 212
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 46/229 (20%), Positives = 91/229 (39%), Gaps = 41/229 (17%)
Query: 377 LGSGCFGSSYKAS-LSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRH--PN 426
LGSG FGS Y +S A+ V++ ++++ G + L ++
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 427 LLPLVAYYYRKEEKLLVHEFV-PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
++ L+ ++ R + +L+ E P + L + AL + +R V + +++
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----AR-SFFWQVLEAVRH 164
Query: 486 LYRELPSLIAPHG--H--IKSSNVLLNESLEPV-LADYGLIPVMNQESAQELM-----IA 535
+ G H IK N+L++ + + L D+G
Sbjct: 165 CHN--------CGVLHRDIKDENILIDLNRGELKLIDFGS---GALLKDTVYTDFDGTRV 213
Query: 536 YKSPEFLQLGRIT-KKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDL 583
Y PE+++ R + VWSLG+L+ +++ G P F + G +
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQV 260
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 50/253 (19%), Positives = 96/253 (37%), Gaps = 55/253 (21%)
Query: 348 KKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNN 406
K E+ + +D F +H I+G G FG Y TG M +K +
Sbjct: 178 KNVELNIHLTMND---FSVH-------RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227
Query: 407 VGREEFQEHMR-------RLGRLRHPNLLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHG 458
++ + + P ++ + +Y + +KL + + + L +L
Sbjct: 228 KMKQG-ETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQ 285
Query: 459 HQALGQPSLDWPSRLKIVKG-VAKGLQYL------YREL-PS--LIAPHGHIKSSNVLLN 508
H + ++ + GL+++ YR+L P+ L+ HGH++
Sbjct: 286 HGVFSEA------DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR------- 332
Query: 509 ESLEPVLADYGLIPVMNQESAQELM--IAYKSPEFLQLG-RITKKTDVWSLGVLILEIMT 565
++D GL +++ + Y +PE LQ G D +SLG ++ +++
Sbjct: 333 ------ISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
Query: 566 GKFPANFLQQGKK 578
G P F Q K
Sbjct: 387 GHSP--FRQHKTK 397
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 73/339 (21%), Positives = 118/339 (34%), Gaps = 44/339 (12%)
Query: 348 KKPEIKLSFVRDDVE---RFDLHDLLRASAEI---LGSGCFGSSYKAS-LSTG---AMMV 397
KK + DD + EI +G G FG KA A+ +
Sbjct: 27 KKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKI 86
Query: 398 VKRFKQMNNVGREEFQ--EHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVN 455
+K K N + E + E M + ++ L ++ + LV E L+ N
Sbjct: 87 IKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYN 141
Query: 456 LHGHQALGQPSLDWPSRLKIVKGVAK----GLQYLYRELPSLIAPHGHIKSSNVLLNESL 511
L+ L + L + + A+ L +L S+I H +K N+LL
Sbjct: 142 LY--DLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATPELSII--HCDLKPENILLCNPK 196
Query: 512 EPV--LADYGLIPVMNQESAQELMIA---YKSPEFLQLG-RITKKTDVWSLGVLILEIMT 565
+ D+G + Q Q I Y+SPE L LG D+WSLG +++E+ T
Sbjct: 197 RSAIKIVDFGSSCQLGQRIYQ--YIQSRFYRSPEVL-LGMPYDLAIDMWSLGCILVEMHT 253
Query: 566 GK--FP-ANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE------MADERNSEGEMV 616
G+ F AN + Q K L +L + F+K + ++ + E
Sbjct: 254 GEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYK 313
Query: 617 KLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDF 655
L + A E V + +D
Sbjct: 314 PPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 46/232 (19%), Positives = 90/232 (38%), Gaps = 41/232 (17%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRF--KQMNNVGREEFQEH-------MRRLGR-LR 423
+LG G FG+ + L+ + +K ++ + ++G
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 424 HPNLLPLVAYYYRKEEKLLVHEF-VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG 482
HP ++ L+ ++ +E +LV E +P + L + LG+ SR V
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP----SR-CFFGQVVAA 151
Query: 483 LQYLYRELPSLIAPHG--H--IKSSNVLLNESLEPV-LADYGLIPVMNQESAQELM---- 533
+Q+ + G H IK N+L++ L D+G +++ E
Sbjct: 152 IQHCHS--------RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDG 200
Query: 534 -IAYKSPEFLQLGRIT-KKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDL 583
Y PE++ + VWSLG+L+ +++ G P F + + + +L
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP--FERDQEILEAEL 250
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 51/232 (21%), Positives = 90/232 (38%), Gaps = 57/232 (24%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG--------REEFQEHMRRLGRLRHP 425
+G G FG +KA TG + +K+ M N RE ++ L L+H
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALRE-----IKILQLLKHE 76
Query: 426 NLLPLV-------AYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVK 477
N++ L+ + Y R + + LV +F +L G + ++++
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-----DLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 478 GVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQ 526
+ GL Y+ H + +K++NVL+ LAD+GL + +Q
Sbjct: 132 MLLNGLYYI----------HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 527 ESA-QELMIA--YKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
+ ++ Y+ PE L LG D+W G ++ E+ T N
Sbjct: 182 PNRYTNRVVTLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 27/106 (25%), Positives = 36/106 (33%), Gaps = 15/106 (14%)
Query: 191 PSSFSGNRDLCGEPLGSPCPTPSPSP--------SPGPSPES------SPTPSP-IPLPL 235
F+ SP +P SPG SP S SP SP P
Sbjct: 1505 AGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYS 1564
Query: 236 PNHPPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASA 281
P P SPS+ P + S+SP +P S ++ + S
Sbjct: 1565 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1610
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 22/103 (21%), Positives = 32/103 (31%), Gaps = 7/103 (6%)
Query: 180 GSISPALRELDPSSFSGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP 239
G ++ L D FS D + T G + P P
Sbjct: 1478 GLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGE----APTSP 1533
Query: 240 PNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNSTLVIASAT 282
+ SP P + ++SP +P S S S + T S T
Sbjct: 1534 GFGVSSPGFSPTSPTYSPTSPAY---SPTSPSYSPTSPSYSPT 1573
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 25/120 (20%), Positives = 45/120 (37%), Gaps = 9/120 (7%)
Query: 39 GVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNL-EGPMPDLRQLGNGAL 97
+ + + L + L + + L+L N L L +
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK----V 452
Query: 98 RSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPE-SLTRLSRLVELRLEGNKF 156
+ + L NNR IP D + +L++L +A NQ +P+ RL+ L + L N +
Sbjct: 453 KVLDLHNNRIM-SIPKD-VTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 17/83 (20%), Positives = 32/83 (38%), Gaps = 4/83 (4%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESL-TRLSRLVELRLEGNK 155
+++ LS N S E+ ++ LR L L+ N+ + + L L + N+
Sbjct: 54 TKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNR 111
Query: 156 FEGQIPDFQQKDLVSFNVSNNAL 178
+ I L ++S N
Sbjct: 112 LQN-ISCCPMASLRHLDLSFNDF 133
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 19/136 (13%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLE----GPMPDLRQLGNGALRSVYL 102
+L + L N +D + +++ L + N L+ PM LR L L
Sbjct: 77 ELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHL--------DL 128
Query: 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD 162
S N F F +T L L L+ +F L ++ L + + I
Sbjct: 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKG 185
Query: 163 FQQKDLVSFNVSNNAL 178
+ + L N + L
Sbjct: 186 GETESLQIPNTTVLHL 201
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 6e-05
Identities = 47/211 (22%), Positives = 78/211 (36%), Gaps = 43/211 (20%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRF--KQMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
E LG G F + +TG K K+++ ++ + R +L+HPN++ L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 432 AYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLKIVKGVAKGLQY 485
+ LV + V L + A ++ + + + Y
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA-----------SHCIQQILESIAY 120
Query: 486 LYRELPSLIAPHGH------IKSSNVLLNESLE--PV-LADYGLIPVMNQESAQELMI-- 534
H + +K N+LL + V LAD+GL +N A
Sbjct: 121 C----------HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 535 -AYKSPEFLQLGRITKKTDVWSLGVLILEIM 564
Y SPE L+ +K D+W+ GV IL I+
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGV-ILYIL 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 6e-05
Identities = 34/145 (23%), Positives = 50/145 (34%), Gaps = 49/145 (33%)
Query: 482 GLQYL------YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-- 533
L YL YR+L K NVLL+ L DYG+ +E +
Sbjct: 122 ALNYLHERGIIYRDL----------KLDNVLLDSEGHIKLTDYGM--------CKEGLRP 163
Query: 534 ----------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDL 583
Y +PE L+ D W+LGVL+ E+M G+ P F G + D
Sbjct: 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDNPD- 220
Query: 584 ASWVNSVLANGDNRTEVFDKEMADE 608
+ +F + +
Sbjct: 221 ----------QNTEDYLFQVILEKQ 235
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 30/112 (26%), Positives = 42/112 (37%), Gaps = 16/112 (14%)
Query: 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGA------LRSVYLS 103
L L D L + L + L L RN L G + A ++ + L
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-------IEPNAFEGASHIQELQLG 86
Query: 104 NNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPE-SLTRLSRLVELRLEGN 154
N+ EI F G+ L+ L L DNQ + + S L+ L L L N
Sbjct: 87 ENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 6e-05
Identities = 48/271 (17%), Positives = 94/271 (34%), Gaps = 62/271 (22%)
Query: 331 RESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA-S 389
+ G + + ++R+ LG G +G YKA
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRR-------ITKLGEGTYGEVYKAID 55
Query: 390 LSTGAMMVVKRFKQMNNVG--------REEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKL 441
T + +KR + + + RE + L L+H N++ L + +
Sbjct: 56 TVTNETVAIKRIR-LEHEEEGVPGTAIRE-----VSLLKELQHRNIIELKSVIHHNHRLH 109
Query: 442 LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-IVKGVAKGLQYLYRELPSLIAPHGH- 499
L+ E+ L + + + +K + + G+ + H
Sbjct: 110 LIFEYAEN-DLKKYMDKNPDVS------MRVIKSFLYQLINGVNFC----------HSRR 152
Query: 500 -----IKSSNVLLNESLEPV-----LADYGL-----IPVMNQESAQELMIAYKSPEFLQL 544
+K N+LL+ S + D+GL IP+ Q + + + + Y+ PE L L
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI-RQFTHEIITLWYRPPEIL-L 210
Query: 545 G--RITKKTDVWSLGVLILEIMTGK--FPAN 571
G + D+WS+ + E++ FP +
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 6e-05
Identities = 54/266 (20%), Positives = 96/266 (36%), Gaps = 77/266 (28%)
Query: 368 DLLRASAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHM---RR-LGRL 422
D L+ +LG G FG +TG +K ++ + ++E H R L
Sbjct: 8 DYLK----LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNT 62
Query: 423 RHPNLLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VA 480
RHP L L Y ++ ++L V E+ L +L + + R + +
Sbjct: 63 RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE------RARFYGAEIV 115
Query: 481 KGLQYL------YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM- 533
L+YL YR++ K N++L++ + D+GL +E +
Sbjct: 116 SALEYLHSRDVVYRDI----------KLENLMLDKDGHIKITDFGL--------CKEGIS 157
Query: 534 -----------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGD 582
Y +PE L+ + D W LGV++ E+M G+ P F
Sbjct: 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--F---------- 205
Query: 583 LASWVNSVLANGDNRTEVFDKEMADE 608
+ +F+ + +E
Sbjct: 206 ----------YNQDHERLFELILMEE 221
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 49/235 (20%), Positives = 85/235 (36%), Gaps = 59/235 (25%)
Query: 365 DLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQ---EHMRRLG 420
D+ + ++LG G +L T VK ++ R E + +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 421 RLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL--AVNLHGH----QALGQPSLDWPSRLK 474
H N+L L+ ++ ++ LV E + S+ ++ H +A
Sbjct: 69 --GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA-----------SV 115
Query: 475 IVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLL--NESLEPV-LADYGL----- 520
+V+ VA L +L H +K N+L + PV + D+ L
Sbjct: 116 VVQDVASALDFL----------HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165
Query: 521 -IPVMNQESAQELMIA-----YKSPEFLQLGRIT-----KKTDVWSLGVLILEIM 564
+ S EL+ Y +PE ++ K+ D+WSLGV IL I+
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV-ILYIL 219
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 46/236 (19%), Positives = 78/236 (33%), Gaps = 67/236 (28%)
Query: 350 PEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKAS-LSTGAMMVVKRFKQMNNVG 408
P +K D + + ++LG G G + T +K +
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTS---QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR 58
Query: 409 REEFQEHMRRLGRLRHPNLLPLVAYY----YRKEEKLLVHEFVP-----KRSLAVNLHGH 459
RE E R + P+++ +V Y ++ L+V E + R G
Sbjct: 59 REV--ELHWRA--SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD---RGD 111
Query: 460 QALG--QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLL---N 508
QA + S +I+K + + +QYL H +K N+L
Sbjct: 112 QAFTEREAS-------EIMKSIGEAIQYL----------HSINIAHRDVKPENLLYTSKR 154
Query: 509 ESLEPVLADYGLIPVMNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIM 564
+ L D+G + E + K D+WSLGV I+ I+
Sbjct: 155 PNAILKLTDFGF-----------------AKETTG-EKYDKSCDMWSLGV-IMYIL 191
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 375 EILGSGCFGSSYKAS-LSTG---AMMVVKRFKQMNNVGREEFQ--EHMRRLGRLRHPNLL 428
+++G G FG KA A+ +V+ K+ + EE + EH+R+ + N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAK----GLQ 484
++ + + + E L++NL+ + L +V+ A L
Sbjct: 163 HMLENFTFRNHICMTFE-----LLSMNLYELIKKNK---FQGFSLPLVRKFAHSILQCLD 214
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPV--LADYGLIPVMNQESAQELMIA-YKSPEF 541
L++ +I H +K N+LL + + D+G +Q + Y++PE
Sbjct: 215 ALHKN--RII--HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEV 270
Query: 542 LQLG-RITKKTDVWSLGVLILEIMTGK--FP 569
+ LG R D+WSLG ++ E++TG P
Sbjct: 271 I-LGARYGMPIDMWSLGCILAELLTGYPLLP 300
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 21/99 (21%), Positives = 31/99 (31%), Gaps = 11/99 (11%)
Query: 62 DITILKELREMRTLSLMRNNLEGPMPDLRQLGNGA--LRSVYLSNNRFSGEIPT-DAFDG 118
R L L + + LG ++ S+N EI D F
Sbjct: 11 QAAQYTNAVRDRELDLRGYKIP----VIENLGATLDQFDAIDFSDN----EIRKLDGFPL 62
Query: 119 MTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFE 157
+ L+ LL+ +N+ L L EL L N
Sbjct: 63 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 34/148 (22%), Positives = 52/148 (35%), Gaps = 49/148 (33%)
Query: 479 VAKGLQYL------YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532
++ L YL YR+L K NVLL+ L DYG+ +E
Sbjct: 162 ISLALNYLHERGIIYRDL----------KLDNVLLDSEGHIKLTDYGM--------CKEG 203
Query: 533 M------------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKAD 580
+ Y +PE L+ D W+LGVL+ E+M G+ P F G +
Sbjct: 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDN 261
Query: 581 GDLASWVNSVLANGDNRTEVFDKEMADE 608
D + +F + +
Sbjct: 262 PD-----------QNTEDYLFQVILEKQ 278
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 7e-05
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 46/220 (20%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG------REEFQEHMRRLGRLRHPNL 427
+ LG G + + YK S T ++ +K + + G RE + L L+H N+
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE-----VSLLKDLKHANI 62
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-IVKGVAKGLQYL 486
+ L + ++ LV E++ K +L + ++ +K + + +GL Y
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-----DLKQYLDDCGNIIN-MHNVKLFLFQLLRGLAYC 116
Query: 487 YRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELMIA 535
H +K N+L+NE E LAD+GL IP + + +
Sbjct: 117 ----------HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLW 165
Query: 536 YKSPEFLQLG--RITKKTDVWSLGVLILEIMTGK--FPAN 571
Y+ P+ L LG + + D+W +G + E+ TG+ FP +
Sbjct: 166 YRPPDIL-LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 48/279 (17%), Positives = 99/279 (35%), Gaps = 42/279 (15%)
Query: 320 PSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHDLLRASA-EILG 378
P+ +++ Q S K ++ F +V L R + +G
Sbjct: 12 PTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIG 71
Query: 379 SGCFGSSYKAS-LSTGAMMVVKRFKQMNNVGREEFQEHM--RR-------LGRLRHPNLL 428
SG G A + +K+ ++ FQ +R + + H N++
Sbjct: 72 SGAQGIVCAAYDAVLDRNVAIKK---LSRP----FQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 429 PLV------AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG 482
L+ ++ LV E + NL Q + ++ + G
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMEL-----MDANLC--QVIQMELDHERMSY-LLYQMLCG 176
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---YKSP 539
+++L+ S H +K SN+++ + D+GL + Y++P
Sbjct: 177 IKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGK--FPA-NFLQQ 575
E + + D+WS+G ++ E++ K FP +++ Q
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 26/90 (28%), Positives = 47/90 (52%), Gaps = 11/90 (12%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-------YKSPE-FLQLGRIT 548
H +K SN+LLN + + + D+GL V + + + Y++PE L T
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 549 KKTDVWSLGVLILEIMTGK--FPA-NFLQQ 575
K D+WS+G ++ E+++ + FP ++L Q
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 43.1 bits (100), Expect = 1e-04
Identities = 14/59 (23%), Positives = 17/59 (28%)
Query: 206 GSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPPPGN 264
GSP TP + P P TP P+ P P H S +
Sbjct: 2 GSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILS 60
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 32/208 (15%)
Query: 377 LGSGCFGSSYKAS-LSTG---AMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
+G G F A + TG A+ ++ + Q+N ++ +R + L HPN++ L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK---IVKGVAKGLQYLYRE 489
++ L+ E+ + L H + + +R K IV V QY +++
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE----ARSKFRQIVSAV----QYCHQK 133
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM------IAYKSPEFLQ 543
I H +K+ N+LL+ + +AD+G N+ + + Y +PE Q
Sbjct: 134 R---IV-HRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPYAAPELFQ 186
Query: 544 LGR--ITKKTDVWSLGVLILEIMTGKFP 569
G+ + DVWSLGV++ +++G P
Sbjct: 187 -GKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 25/86 (29%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---YKSPE-FLQLGRITKKTD 552
H +K N+ +NE E + D+GL + E + Y++PE L + D
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY--VVTRWYRAPEVILSWMHYNQTVD 206
Query: 553 VWSLGVLILEIMTGK--FPA-NFLQQ 575
+WS+G ++ E++TGK F ++L Q
Sbjct: 207 IWSVGCIMAEMLTGKTLFKGKDYLDQ 232
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 15/100 (15%), Positives = 31/100 (31%), Gaps = 3/100 (3%)
Query: 179 FGSISPALRELDPSSF---SGNRDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPL 235
F P L D S F + +P SP+ + ++ + +P
Sbjct: 221 FEGHVPELVNWDLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSA 280
Query: 236 PNHPPNPIPSPSHDPHASSHSPPAPPPGNDSAGSGSSNST 275
P + S +P ++ S + S+++
Sbjct: 281 PTERTRRSETESVNPVSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 32/174 (18%), Positives = 52/174 (29%), Gaps = 35/174 (20%)
Query: 56 GLQGNIDITILKELREMRTLSLMRNNLEGP-MPDLRQL--GNGALRSVYLSNNRFSGE-- 110
LQ K +R++ RN LE M + + + L +V + N E
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 111 --IPTDAFDGMTSLRKLLLADNQFNGP-----IPESLTRLSRLVELRLEGNKFEGQ---- 159
+ + L+ L L DN F + +L L EL L +
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTF-THLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263
Query: 160 ----IPDFQQKDLVSFNVSNNAL-----------FGSISPALRELDPSSFSGNR 198
+ L + + N + P L L+ +GNR
Sbjct: 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE---LNGNR 314
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 37/211 (17%)
Query: 377 LGSGCFGSSYKAS-LSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLL 428
LG G FG TG A+ ++ R K + + ++R L RHP+++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQK----IRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK---IVKGVAKGLQY 485
L + +V E+V L + H + + +R I+ V Y
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME----ARRLFQQILSAV----DY 126
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI------AYKSP 539
+R + + H +K NVLL+ + +AD+GL +M+ E + Y +P
Sbjct: 127 CHRHM---VV-HRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAP 179
Query: 540 EFLQ-LGRITKKTDVWSLGVLILEIMTGKFP 569
E + + D+WS GV++ ++ G P
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 46/271 (16%), Positives = 81/271 (29%), Gaps = 91/271 (33%)
Query: 459 HQALGQPSLDWPSRLK-----------IVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL 507
+ LG L W + I++ V +GL YL+ + +I H IK N+LL
Sbjct: 124 FEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-RII--HTDIKPENILL 180
Query: 508 N-------------------------------------------------ESLEPVLADY 518
+ E L+ +AD
Sbjct: 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADL 240
Query: 519 GLIPVMNQESAQELM-IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGK--FPANFLQQ 575
G +++ +++ Y+S E L D+WS + E+ TG F + ++
Sbjct: 241 GNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300
Query: 576 GKKADGDLASWVN-------SVLANGDNRTEVFDKE------------------MADERN 610
+ + +A + ++ G E F K+ +
Sbjct: 301 YTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEW 360
Query: 611 SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641
S+ E L E EKR E +
Sbjct: 361 SQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 24/84 (28%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 73 RTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQF 132
L L L + D G L + L N+ + FD +T L L LA+NQ
Sbjct: 38 EKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQL 95
Query: 133 NGPIPESL-TRLSRLVELRLEGNK 155
+P + L++L +L L GN+
Sbjct: 96 AS-LPLGVFDHLTQLDKLYLGGNQ 118
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 31/109 (28%), Positives = 51/109 (46%), Gaps = 8/109 (7%)
Query: 51 KLEDMGLQGN----IDITILKELREMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNN 105
+L +GL N + + + L ++ L L N L+ P +L L+ + L+ N
Sbjct: 84 ELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTK--LKELRLNTN 141
Query: 106 RFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGN 154
+ IP AFD +T+L+ L L+ NQ + RL +L + L GN
Sbjct: 142 QLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3ghp_A Cellulosomal scaffoldin adaptor protein B; linker segments, beta barrel, alpha helix, beta flaps, structural protein; 2.49A {Acetivibrio cellulolyticus} Length = 227 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 2e-04
Identities = 11/50 (22%), Positives = 18/50 (36%), Gaps = 1/50 (2%)
Query: 206 GSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSH 255
+P T +P+ P + PT + P P IP+ + H
Sbjct: 174 SAPIATATPTTKPTAFASTMPTVTLTPTPTAT-TTTTIPTAVPTTESLEH 222
|
| >3ghp_A Cellulosomal scaffoldin adaptor protein B; linker segments, beta barrel, alpha helix, beta flaps, structural protein; 2.49A {Acetivibrio cellulolyticus} Length = 227 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 11/49 (22%), Positives = 17/49 (34%), Gaps = 1/49 (2%)
Query: 208 PCPTPSPSPSPGPSPESSPTPSPIPLPLPNHP-PNPIPSPSHDPHASSH 255
TP+ P+ S + T +P P P +P+ H H
Sbjct: 178 ATATPTTKPTAFASTMPTVTLTPTPTATTTTTIPTAVPTTESLEHHHHH 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 50/233 (21%), Positives = 91/233 (39%), Gaps = 63/233 (27%)
Query: 375 EILGSGCFGSSYKA--SLSTGAMMVVKRFKQMNNVGREEFQE-----------HMRRLGR 421
+G G +G +KA + G + +KR + + +E +R L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRV------QTGEEGMPLSTIREVAVLRHLET 70
Query: 422 LRHPNLLPL----VAYYYRKEEKL-LVHEFVPKRSLAVNLHGH-QALGQPSLDWPSRLKI 475
HPN++ L +E KL LV E V + +L + + +P + + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-----DLTTYLDKVPEPGVPTETIKDM 125
Query: 476 VKGVAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPV- 523
+ + +GL +L H H +K N+L+ S + LAD+GL +
Sbjct: 126 MFQLLRGLDFL----------HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 524 MNQESAQELMIA--YKSPEFLQLG-RITKKTDVWSLGVLILEIMTGK--FPAN 571
+ ++ Y++PE L L D+WS+G + E+ K F +
Sbjct: 176 LTSV-----VVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 27/91 (29%), Positives = 47/91 (51%), Gaps = 12/91 (13%)
Query: 497 HGHIKSSNVLLN-ESLEPVLADYGLIPVMNQESAQELMIA-------YKSPE-FLQLGRI 547
H +K +N+ +N E L + D+GL +M+ + + ++ Y+SP L
Sbjct: 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY 202
Query: 548 TKKTDVWSLGVLILEIMTGK--FP-ANFLQQ 575
TK D+W+ G + E++TGK F A+ L+Q
Sbjct: 203 TKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 47/218 (21%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG--------REEFQEHMRRLGRLRHP 425
E +G G +G+ +KA + T ++ +KR + +++ RE + L L+H
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALRE-----ICLLKELKHK 61
Query: 426 NLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK-IVKGVAKGLQ 484
N++ L + ++ LV EF + +L + LD P +K + + KGL
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ-----DLKKYFDSCNGDLD-PEIVKSFLFQLLKGLG 115
Query: 485 YLYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGL-----IPVMNQESAQELM 533
+ H +K N+L+N + E LA++GL IPV SA+ +
Sbjct: 116 FC----------HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVT 164
Query: 534 IAYKSPEFLQLG--RITKKTDVWSLGVLILEIMTGKFP 569
+ Y+ P+ L G + D+WS G + E+ P
Sbjct: 165 LWYRPPDVL-FGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 21/86 (24%), Positives = 39/86 (45%), Gaps = 7/86 (8%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---YKSPE-FLQLGRITKKTD 552
H + N+LL ++ + + D+ L ++ + + Y++PE +Q TK D
Sbjct: 157 HRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVD 216
Query: 553 VWSLGVLILEIMTGK--FPA-NFLQQ 575
+WS G ++ E+ K F F Q
Sbjct: 217 MWSAGCVMAEMFNRKALFRGSTFYNQ 242
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 3e-04
Identities = 55/243 (22%), Positives = 89/243 (36%), Gaps = 59/243 (24%)
Query: 357 VRDDVERFDLHD--LLRASAEILGSGCFG----SSYKASLSTGAMMVVKRFKQMNNVGRE 410
V E+ LLR +LG G +G +TG + +K K+ V
Sbjct: 7 VNRGPEKIRPECFELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA 62
Query: 411 EFQEHM---RR-LGRLRHPNLLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQP 465
+ H R L ++HP ++ L Y ++ KL L+ E++ L + L +
Sbjct: 63 KDTAHTKAERNILEEVKHPFIVDL-IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 466 SLDWPSRLKIVKG-VAKGLQYL------YRELPSLIAPHGHIKSSNVLLNESLEPVLADY 518
++ L +L YR+L K N++LN L D+
Sbjct: 122 ------TACFYLAEISMALGHLHQKGIIYRDL----------KPENIMLNHQGHVKLTDF 165
Query: 519 GLIPVMNQESAQELM------------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTG 566
GL +E + I Y +PE L + D WSLG L+ +++TG
Sbjct: 166 GL--------CKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 567 KFP 569
P
Sbjct: 218 APP 220
|
| >1eys_C Photosynthetic reaction center; membrane protein complex, electron transport; HET: BGL BCL BPH MQ8 HEM CRT LDA PEF; 2.20A {Thermochromatium tepidum} SCOP: a.138.1.2 Length = 382 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 3e-04
Identities = 10/54 (18%), Positives = 18/54 (33%)
Query: 207 SPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAP 260
+ P+ + P + P+ +P P + S +P PAP
Sbjct: 324 ASEAAPAAATEAAPEAPAQEVPAAEAVPAAAEPGAAEAAGSVEPAPVEEVAPAP 377
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 42/221 (19%), Positives = 73/221 (33%), Gaps = 55/221 (24%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVK-----RFKQMNNVGREEFQEHMRRLGRLRHPNLL 428
E++G G F + TG VK +F + E+ + L+HP+++
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 429 PLVAYYYRKEEKLLVHEF----------VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG 478
L+ Y +V EF V + A ++
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-----------SHYMRQ 138
Query: 479 VAKGLQYLYRELPSLIAPHGH------IKSSNVLLNESLE--PV-LADYGLIPVMNQESA 529
+ + L+Y H + +K VLL PV L +G+ + +
Sbjct: 139 ILEALRYC----------HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-- 186
Query: 530 QELMIA------YKSPEFLQLGRITKKTDVWSLGVLILEIM 564
+ + +PE ++ K DVW GV IL I+
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGV-ILFIL 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 25/84 (29%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA-YKSPE-FLQLGRITKKTDVW 554
H +K SN+ +NE E + D+GL E + Y++PE L + D+W
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 555 SLGVLILEIMTGK--FPA-NFLQQ 575
S+G ++ E++TG+ FP + + Q
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQ 238
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 9/86 (10%)
Query: 497 HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---YKSPE-FLQLGRITKKTD 552
H +K N+ +NE E + D+GL + E + Y++PE L R T+ D
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--VVTRWYRAPEVILNWMRYTQTVD 208
Query: 553 VWSLGVLILEIMTGK--FPA-NFLQQ 575
+WS+G ++ E++TGK F + L Q
Sbjct: 209 IWSVGCIMAEMITGKTLFKGSDHLDQ 234
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 4e-04
Identities = 21/123 (17%), Positives = 32/123 (26%), Gaps = 1/123 (0%)
Query: 198 RDLCGEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSP 257
R L + P + P P P + P P S +S +
Sbjct: 7 RRLSDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAA 66
Query: 258 PAPPPGNDSAGSGSSNSTLVIASATTVSVVAIAAVVAAIFVIERKRKRERGVSIENPPPL 317
P+P G SS S V + + V R R + + + P
Sbjct: 67 PSPGSSG-GGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHT 125
Query: 318 PPP 320
Sbjct: 126 DWA 128
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 16/123 (13%), Positives = 35/123 (28%), Gaps = 2/123 (1%)
Query: 202 GEPLGSPCPTPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPP 261
+ + S S + G ++P+ P P P + SP + + P
Sbjct: 12 DDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPG-QLHSPISTLSSPINGMGPPF 70
Query: 262 PGNDSAGSGSSNSTLVIASAT-TVSVVAIAAVVAAIFVIERKRKRERGVSIENPPPLPPP 320
S S S + + +++ + + E + + P P
Sbjct: 71 SVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSG 130
Query: 321 SSN 323
+
Sbjct: 131 NMA 133
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 16/81 (19%), Positives = 28/81 (34%), Gaps = 4/81 (4%)
Query: 203 EPLGSPCP-TPSPSPSPGPSPESSPTPSPIPLPLPNHPPNPIPSPSHDPHASSHSPPAPP 261
+P P TP + + + TP+P P P P P + + +PP P
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGPATPAP---PALGAAPTGDPKPKKNKKPKNPTPPRPA 57
Query: 262 PGNDSAGSGSSNSTLVIASAT 282
N + +G + +
Sbjct: 58 GDNATVAAGHATLREHLRDIK 78
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 55/239 (23%), Positives = 97/239 (40%), Gaps = 53/239 (22%)
Query: 357 VRDDVERFDLHD--LLRASAEILGSGCFGSSYKA-SLSTG---AM------MVVKRFKQM 404
V D+ E + +LRA +G G FG T AM V+R ++
Sbjct: 5 VFDENEDVNFDHFEILRA----IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEV 59
Query: 405 NNVGREEFQEHMRR-LGRLRHPNLLPLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQAL 462
NV +E + + L HP L+ L Y ++ EE + +V + + L +L +
Sbjct: 60 RNVFKE------LQIMQGLEHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHF 112
Query: 463 GQPSLDWPSRLKIVKGVAKGLQYL------YRELPSLIAPHGHIKSSNVLLNESLEPVLA 516
+ + +L I + + L YL +R++ K N+LL+E +
Sbjct: 113 KEET----VKLFICE-LVMALDYLQNQRIIHRDM----------KPDNILLDEHGHVHIT 157
Query: 517 DYGLIPVMNQESAQELM---IAYKSPEFLQLGRI---TKKTDVWSLGVLILEIMTGKFP 569
D+ + ++ +E+ M Y +PE + + D WSLGV E++ G+ P
Sbjct: 158 DFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 45/218 (20%), Positives = 85/218 (38%), Gaps = 50/218 (22%)
Query: 377 LGSGCFGSSYKA-SLSTG---AMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLL 428
LG G +G A + T A+ +V + ++ E++++ L H N++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP------ENIKKEICINKMLNHENVV 68
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK---IVKGVAKGLQY 485
+ + L E+ L + + +P ++ ++ GV Y
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD----AQRFFHQLMAGV----VY 120
Query: 486 LYRELPSLIAPHGH------IKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI----- 534
L HG IK N+LL+E ++D+GL V + + L+
Sbjct: 121 L----------HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 535 -AYKSPEFLQLGR--ITKKTDVWSLGVLILEIMTGKFP 569
Y +PE L+ R + DVWS G+++ ++ G+ P
Sbjct: 171 LPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 25/99 (25%)
Query: 483 LQYLYREL-PS--LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA---- 535
+ +++R++ P L+ GH+K LAD+G MN+E A
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLK-------------LADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 536 -YKSPEFLQ----LGRITKKTDVWSLGVLILEIMTGKFP 569
Y SPE L+ G ++ D WS+GV + E++ G P
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 6e-04
Identities = 35/151 (23%), Positives = 53/151 (35%), Gaps = 64/151 (42%)
Query: 479 VAKGLQYL------YRELPS---LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529
+ GLQ+L YR+L L+ GHIK +AD+G+
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIK-------------IADFGM--------C 165
Query: 530 QELMIA------------YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGK 577
+E M+ Y +PE L + D WS GVL+ E++ G+ P F
Sbjct: 166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--F----- 218
Query: 578 KADGDLASWVNSVLANGDNRTEVFDKEMADE 608
+G + E+F D
Sbjct: 219 ---------------HGQDEEELFHSIRMDN 234
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 25/102 (24%), Positives = 41/102 (40%), Gaps = 23/102 (22%)
Query: 485 YLYRELPSLIAPHGH------IKSSNVLLN-ESLEPVLADYGL------IPVMNQESAQE 531
Y+Y L +L H +K NV+++ E + L D+GL N
Sbjct: 135 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---- 190
Query: 532 LMIA---YKSPE-FLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+A +K PE + D+WSLG ++ ++ K P
Sbjct: 191 --VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 7e-04
Identities = 32/148 (21%), Positives = 52/148 (35%), Gaps = 58/148 (39%)
Query: 479 VAKGLQYL------YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532
+A GL +L YR+L K NV+L+ +AD+G+ +E
Sbjct: 130 IAIGLFFLQSKGIIYRDL----------KLDNVMLDSEGHIKIADFGM--------CKEN 171
Query: 533 M------------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKAD 580
+ Y +PE + K D W+ GVL+ E++ G+ P F
Sbjct: 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--F-------- 221
Query: 581 GDLASWVNSVLANGDNRTEVFDKEMADE 608
G++ E+F M
Sbjct: 222 ------------EGEDEDELFQSIMEHN 237
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 47/213 (22%), Positives = 79/213 (37%), Gaps = 31/213 (14%)
Query: 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFK----QMNNVGREEFQEHMRR----LGRLRHP 425
LGSG FG + A +VVK K + + + L R+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 426 NLLPLVAYYYRKEEKLLVHEF-VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ 484
N++ ++ + + LV E L + H L +P + I + + +
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL----AS-YIFRQLVSAVG 144
Query: 485 YLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM------IAYKS 538
YL + I H IK N+++ E L D+G +L I Y +
Sbjct: 145 YLRLKD---II-HRDIKDENIVIAEDFTIKLIDFGS---AAYLERGKLFYTFCGTIEYCA 197
Query: 539 PEFLQLGR--ITKKTDVWSLGVLILEIMTGKFP 569
PE L G + ++WSLGV + ++ + P
Sbjct: 198 PEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 61/287 (21%), Positives = 114/287 (39%), Gaps = 69/287 (24%)
Query: 320 PSSNLQKTSGIRESGQCSPSSTEAVVGGKKPEIKLSFVRDDVERFDLHD--LLRASAEIL 377
+SG + K E++ + + E+ + + LL+ +L
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK----VL 62
Query: 378 GSGCFGSSY----KASLSTGAMMVVKRFKQMNNVGREEFQEHM---RR-LGRLRH-PNLL 428
G+G +G + + TG + +K K+ V + + EH R+ L +R P L+
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122
Query: 429 PLVAYYYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG-VAKGLQYL 486
L Y ++ E KL L+ +++ L +L + + ++I G + L++L
Sbjct: 123 TLH-YAFQTETKLHLILDYINGGELFTHL---SQRERFTEH---EVQIYVGEIVLALEHL 175
Query: 487 ------YREL-PS--LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM---- 533
YR++ L+ +GH+ L D+GL ++E +
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVV-------------LTDFGL--------SKEFVADET 214
Query: 534 ---------IAYKSPEFLQLGRI--TKKTDVWSLGVLILEIMTGKFP 569
I Y +P+ ++ G K D WSLGVL+ E++TG P
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 678 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.85 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.76 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.72 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.7 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.69 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.68 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.66 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.66 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.65 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.63 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.63 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.62 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.62 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.62 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.62 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.61 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.61 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.61 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.6 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.6 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.6 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.59 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.59 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.58 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.58 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.57 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.57 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.57 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.57 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.56 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.55 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.55 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.54 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.54 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.53 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.53 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.52 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.51 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.51 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.51 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.51 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.51 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.51 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.5 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.5 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.5 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.5 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.5 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.5 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.49 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.49 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.49 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.48 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.48 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.48 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.48 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.48 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.47 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.47 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.47 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.47 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.46 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.45 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.45 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.43 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.42 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.42 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.42 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.42 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.42 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.42 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.4 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.4 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.4 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.4 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.4 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.39 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.39 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.39 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.39 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.39 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.38 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.38 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.38 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.38 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.37 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.37 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.36 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.36 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.36 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.36 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.36 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.36 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.35 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.35 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.34 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.33 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.33 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.33 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.32 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.32 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.31 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.3 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.29 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.28 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.28 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.28 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.26 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.26 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.25 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.21 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.21 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.19 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.18 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.17 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.17 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.15 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.11 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.08 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.85 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.83 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.75 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.58 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.41 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.24 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.14 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.09 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.87 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.84 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.79 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.64 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.59 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.51 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.33 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.23 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.0 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.92 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.54 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.37 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.1 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.97 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.72 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.4 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.35 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.01 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 94.71 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.35 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.07 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 93.73 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 93.5 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 92.33 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 92.21 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.91 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.42 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.24 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 84.76 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 83.84 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=452.08 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=210.1
Q ss_pred hccccCccCceeEEEEEec------CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 373 SAEILGSGCFGSSYKASLS------TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
..+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..||||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 3567999999999999863 4778999999887777788999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccC--------CCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeec
Q 044996 447 VPKRSLAVNLHGHQ--------ALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADY 518 (678)
Q Consensus 447 ~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 518 (678)
|++|+|.++|+... ......++|.++++|+.|||+||+|||++ +||||||||+||||++++.+||+||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCCcEEECCc
Confidence 99999999998643 11234699999999999999999999976 7999999999999999999999999
Q ss_pred CCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHH
Q 044996 519 GLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVL 591 (678)
Q Consensus 519 Gla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~ 591 (678)
|+++...... ...+|+.|||||++.++.|+.|+|||||||+||||+| |+.||.. ....+.+....
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~--------~~~~~~~~~i~ 244 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ--------LSNNEVIECIT 244 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--------SCHHHHHHHHH
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------CCHHHHHHHHH
Confidence 9998654432 1236788999999999999999999999999999999 9999972 22233333332
Q ss_pred hcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 592 ANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
. +... . .+......+.+++.+||+.||++||||.||++.|+++....+.
T Consensus 245 ~-~~~~-~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~ 293 (299)
T 4asz_A 245 Q-GRVL-Q----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293 (299)
T ss_dssp H-TCCC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred c-CCCC-C----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence 2 2111 0 1112344578888999999999999999999999999876553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-55 Score=456.22 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=206.0
Q ss_pred hccccCccCceeEEEEEec------CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 373 SAEILGSGCFGSSYKASLS------TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
..+.||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..||||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3567999999999999864 4788999999987777788999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCC----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEe
Q 044996 447 VPKRSLAVNLHGHQAL----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLA 516 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 516 (678)
|++|+|.++|+..... ...+++|.++++|+.|||+||+|||+. +||||||||+||||++++.+||+
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEEC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCCCcEEEc
Confidence 9999999999865321 123699999999999999999999976 79999999999999999999999
Q ss_pred ecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHH
Q 044996 517 DYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNS 589 (678)
Q Consensus 517 DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~ 589 (678)
|||+++.+.... ...+|+.|||||++.+..|+.++|||||||+||||+| |+.||.. ....+.+..
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~--------~~~~~~~~~ 272 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ--------LSNTEAIDC 272 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--------SCHHHHHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC--------CCHHHHHHH
Confidence 999998764331 2346789999999999999999999999999999999 9999972 222233332
Q ss_pred HHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 590 VLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
+. .+... . .+......+.+++.+||+.||++||||.||++.|+.+.+..+
T Consensus 273 i~-~g~~~-~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 273 IT-QGREL-E----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp HH-HTCCC-C----------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred HH-cCCCC-C----------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 22 22111 0 111233457888899999999999999999999999987543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=447.49 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=204.2
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||+||+|.+. +++.||||+++.. .....++|.+|+.+|++++|||||+++|+|.+++..+|||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 467999999999999862 5678999999753 334567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEE
Q 044996 447 VPKRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVL 515 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 515 (678)
|++|+|.++|+..... ....++|.++++|+.|||+||+|||+. +||||||||+||||++++.+||
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEE
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEECCCCCEEE
Confidence 9999999999754321 123599999999999999999999976 7999999999999999999999
Q ss_pred eecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHH
Q 044996 516 ADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVN 588 (678)
Q Consensus 516 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~ 588 (678)
+|||+++.+.... ...+|+.|||||++.++.|+.++|||||||+||||+| |+.||.. ....+.+.
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~--------~~~~~~~~ 258 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG--------YSNQDVVE 258 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--------CCHHHHHH
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC--------CCHHHHHH
Confidence 9999998764332 2346789999999999999999999999999999999 8999972 22233333
Q ss_pred HHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 589 SVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 589 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
.+. .+... . .+..+...+.+++.+||+.||++||||.||++.|+...
T Consensus 259 ~i~-~~~~~-~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 259 MIR-NRQVL-P----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHH-TTCCC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHH-cCCCC-C----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 222 22211 1 11233456788999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=438.85 Aligned_cols=253 Identities=22% Similarity=0.370 Sum_probs=202.1
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
..+.||+|+||+||+|++.. .||||+++.. +....+.|.+|+++|++++|||||+++|+|. ++..+||||||++|
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gG 116 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGS 116 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSC
T ss_pred EeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCC
Confidence 35679999999999998753 5899998743 3455678999999999999999999999885 45789999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|.++|+.... .++|.++++|+.|||+||+|||+. +||||||||+||||++++.+||+|||+|+.....
T Consensus 117 sL~~~l~~~~~----~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 117 SLYKHLHVQET----KFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp BHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CHHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999986532 599999999999999999999976 7999999999999999999999999999876432
Q ss_pred ---ccccccceeeCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 528 ---SAQELMIAYKSPEFLQL---GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~---~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
....||+.|||||++.+ +.|+.++|||||||+||||+||+.||.. .+-...+...+..+...
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~--------~~~~~~~~~~~~~~~~~---- 256 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH--------INNRDQIIFMVGRGYAS---- 256 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT--------CCCHHHHHHHHHTTCCC----
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC--------CChHHHHHHHHhcCCCC----
Confidence 22357899999999853 4689999999999999999999999972 22233333333333211
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
+.+.. ........+.+++.+||+.||++||||.||++.|+.++...+
T Consensus 257 -p~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 257 -PDLSK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -CCSTT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -CCccc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11111 111234567888899999999999999999999999876554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=433.87 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=201.1
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC----ceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE----EKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~Ey~~~ 449 (678)
.+.||+|+||+||+|++ +|+.||||+++... .....++.|+..+.+++|||||+++|+|.+++ ..|||||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 46799999999999988 68999999997532 22233445666678899999999999998764 57999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC----CCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL----PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+|.++|+.. .++|.++++|+.|+++||+|||+++ +..+||||||||+|||||+++++||+|||+++...
T Consensus 86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999864 4899999999999999999999652 23479999999999999999999999999998654
Q ss_pred ccc--------cccccceeeCccccccC------CCCCcchHHHHHHHHHHHHhCCCCccccccCCC-------CCCChH
Q 044996 526 QES--------AQELMIAYKSPEFLQLG------RITKKTDVWSLGVLILEIMTGKFPANFLQQGKK-------ADGDLA 584 (678)
Q Consensus 526 ~~~--------~~~~~~~y~aPE~~~~~------~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~-------~~~~l~ 584 (678)
... ...+|+.|||||++.+. .++.|+|||||||+||||+||+.||........ .....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~- 238 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV- 238 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH-
Confidence 321 22478999999998754 467899999999999999999888753221110 01112
Q ss_pred HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
..+....... ..++.+.......+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 239 ~~~~~~~~~~-----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcc-----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 2222222221 12233322222345677889999999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=435.21 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=206.6
Q ss_pred hccccCccCceeEEEEEecC------CceEEEEEecccC-hhhHHHHHHHHHHHhccCC-CCccceeEEEEeC-CceEEE
Q 044996 373 SAEILGSGCFGSSYKASLST------GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRH-PNLLPLVAYYYRK-EEKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~-~~~~lv 443 (678)
..+.||+|+||+||+|.+.. ++.||||+++... ....++|.+|+++|.+++| ||||+++|+|.+. +..+||
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 45789999999999998642 3579999997643 3456789999999999965 8999999999764 568999
Q ss_pred EeccCCCCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc
Q 044996 444 HEFVPKRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE 512 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~ 512 (678)
||||++|+|.++|+..... ....++|.+++.|+.|||+||+|||+. +||||||||+|||+++++.
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~~ 223 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNV 223 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGC
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecCccCccceeeCCCCC
Confidence 9999999999999864321 123589999999999999999999976 7999999999999999999
Q ss_pred eEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHH
Q 044996 513 PVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLAS 585 (678)
Q Consensus 513 ~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~ 585 (678)
+||+|||+|+.+.... ...+|+.|||||++.++.|+.++|||||||+||||+| |+.||.. ....+
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~--------~~~~~ 295 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--------VKIDE 295 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT--------CCCSH
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC--------CCHHH
Confidence 9999999998764332 2246788999999999999999999999999999998 9999972 22223
Q ss_pred HHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 586 WVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
.+...+.++... .. +.....++.+++.+||+.||++||||.||++.|+++.+....
T Consensus 296 ~~~~~i~~g~~~-~~----------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 296 EFCRRLKEGTRM-RA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp HHHHHHHHTCCC-CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred HHHHHHHcCCCC-CC----------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 343444433221 11 112234577888899999999999999999999998765544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=426.30 Aligned_cols=241 Identities=20% Similarity=0.289 Sum_probs=197.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.|.+|+++|++|+|||||++++++.+++..|||||||++|
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 46799999999999986 46899999999753 3455678999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.++|...+. ..+++.++..|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.+....
T Consensus 109 ~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 109 DLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp BHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred cHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999976532 2578999999999999999999976 89999999999999999999999999999876542
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...||+.|||||++.+..|+.++|||||||+||||+||+.||. ..+..+.+.......... +
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~--------~~~~~~~~~~i~~~~~~~-------~- 245 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE--------AGSMKNLVLKIISGSFPP-------V- 245 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC--------CSSHHHHHHHHHHTCCCC-------C-
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC--------CcCHHHHHHHHHcCCCCC-------C-
Confidence 2347899999999999999999999999999999999999997 234445555444332110 0
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||++|||+.|+++
T Consensus 246 ----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 ----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112234677888999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=425.03 Aligned_cols=240 Identities=18% Similarity=0.233 Sum_probs=199.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||+||+|... +|+.||||+++.......+.+.+|+++|++++|||||+++++|.+++..|||||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 356999999999999864 6899999999765555567789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.+++... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+... .
T Consensus 159 ~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 159 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred HHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 9999753 489999999999999999999976 8999999999999999999999999999876543 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...||+.|||||++.+..|+.++|||||||++|||++|+.||.. .+..+.+..+...... .+..
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~--------~~~~~~~~~i~~~~~~-------~~~~- 292 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN--------EPPLKAMKMIRDNLPP-------RLKN- 292 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSSCC-------CCSC-
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHHcCCCC-------CCCc-
Confidence 34588999999999999999999999999999999999999962 2333333333322111 1100
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||++|||+.|+++
T Consensus 293 --~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111234667788999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=412.12 Aligned_cols=241 Identities=20% Similarity=0.333 Sum_probs=192.3
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEe----CCceEEEEecc
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR----KEEKLLVHEFV 447 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~Ey~ 447 (678)
+.||+|+||+||+|... ++..||+|++... .....+.|.+|+++|++++|||||+++++|.+ ++..|||||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 46999999999999864 6889999998643 34456789999999999999999999999875 34589999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec-CCCceEEeecCCccccCc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~ 526 (678)
++|+|.++++... .+++..+..|+.||+.||+|||++. .+||||||||+||||+ +++.+||+|||+|+....
T Consensus 112 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~--~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 112 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT--PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS--SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999998653 5899999999999999999999761 2399999999999998 489999999999986554
Q ss_pred c--ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 527 E--SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 527 ~--~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
. ....||+.|||||++. ++|+.++|||||||+||||+||+.||.. .......... +..+... ..++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~-------~~~~~~~~~~-i~~~~~~-~~~~-- 252 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE-------CQNAAQIYRR-VTSGVKP-ASFD-- 252 (290)
T ss_dssp TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT-------CSSHHHHHHH-HTTTCCC-GGGG--
T ss_pred CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC-------CCcHHHHHHH-HHcCCCC-CCCC--
Confidence 3 2335789999999886 4799999999999999999999999962 1222333322 2222111 1111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
... ...+.+++.+||+.||++|||+.|+++
T Consensus 253 ---~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 ---KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 124677888999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=421.77 Aligned_cols=246 Identities=20% Similarity=0.219 Sum_probs=199.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.++||+|+||+||+|+. .+|+.||||+++.... +.+|+.+|++++|||||++++++.+++..|||||||++|+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 46799999999999986 4689999999975321 24699999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-ceEEeecCCccccCccc---
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-EPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~--- 528 (678)
.++|+... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+.+....
T Consensus 138 ~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 138 GQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99998653 599999999999999999999965 899999999999999987 69999999998765431
Q ss_pred ------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 529 ------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 529 ------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
...||+.|||||++.+..|+.++|||||||+||||+||+.||.... ...+ +..+.......
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~---~~~i~~~~~~~----- 275 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF-----RGPL---CLKIASEPPPI----- 275 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC-----CSCC---HHHHHHSCCGG-----
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-----HHHH---HHHHHcCCCCc-----
Confidence 1247899999999999999999999999999999999999997321 1111 12222221111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
..+ .......+.+++.+||+.||.+|||+.|+++.|..+.....
T Consensus 276 ~~~-----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 276 REI-----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp GGS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hhc-----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 011 11223456778889999999999999999999988876544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=426.27 Aligned_cols=240 Identities=19% Similarity=0.236 Sum_probs=200.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||+++++|.+.+..|||||||++|+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 45799999999999986 46899999999866555667799999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.++++.. .+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+... .
T Consensus 236 ~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 236 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 9999753 489999999999999999999976 8999999999999999999999999999876543 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...||+.|||||++.+..|+.++|||||||++|||++|+.||.. .+..+.+..+...... .+...
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~--------~~~~~~~~~i~~~~~~-------~~~~~ 370 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN--------EPPLKAMKMIRDNLPP-------RLKNL 370 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSCCC-------CCSCT
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHHcCCCC-------CCccc
Confidence 34578999999999999999999999999999999999999962 2333333333322111 11110
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||+.||++|||+.|+++
T Consensus 371 ---~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 ---HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ---TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111234667778999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=398.02 Aligned_cols=237 Identities=20% Similarity=0.293 Sum_probs=186.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+++..|+||||+ +
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~ 96 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence 46799999999999986 468999999987532 334567999999999999999999999999999999999999 6
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 97 g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 97 NELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 89999997653 599999999999999999999976 8999999999999999999999999999876543
Q ss_pred -ccccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....||+.|||||++.+..+ +.++||||+||++|||+||+.||. ..+.....+..........
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~--------~~~~~~~~~~i~~~~~~~p------- 232 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD--------DESIPVLFKNISNGVYTLP------- 232 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC--------CSSHHHHHHHHHHTCCCCC-------
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC--------CCCHHHHHHHHHcCCCCCC-------
Confidence 23457899999999988776 579999999999999999999996 2344444444443321110
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||+.||++|||+.|+++
T Consensus 233 ------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 233 ------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011234567788999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=407.99 Aligned_cols=239 Identities=21% Similarity=0.273 Sum_probs=199.6
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
+.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|+++|++++|||||++++++.+++..|||||||+
T Consensus 36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 356799999999999976 56899999999743 23346789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++.++..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.+...
T Consensus 116 gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 116 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999998653 589999999999999999999976 8999999999999999999999999999876432
Q ss_pred -----ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 528 -----SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 528 -----~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
....||+.|||||++.+..|+.++||||+||+||||+||+.||. ..+..+....+.......
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~--------~~~~~~~~~~i~~~~~~~----- 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR--------AGNEGLIFAKIIKLEYDF----- 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC--------CSSHHHHHHHHHHTCCCC-----
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC--------CCCHHHHHHHHHcCCCCC-----
Confidence 22357899999999999999999999999999999999999996 233444444444332111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.....++.+++.+||+.||++|||++|++.
T Consensus 254 --------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 254 --------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp --------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred --------CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 0111234667788999999999999998743
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=404.97 Aligned_cols=234 Identities=20% Similarity=0.224 Sum_probs=187.2
Q ss_pred hccccCccCceeEEEEEec----CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 373 SAEILGSGCFGSSYKASLS----TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
..+.||+|+||+||+|+.. +++.||||+++... ......+.+|+++|++++|||||++++++.+++..||||||
T Consensus 28 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEc
Confidence 3578999999999999752 46789999987532 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
|++|+|.++|.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 108 LRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp CTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999998653 589999999999999999999976 899999999999999999999999999986543
Q ss_pred c----ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 527 E----SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 527 ~----~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
. ....||+.|||||++.+..|+.++|||||||+||||+||+.||. ..+..+.+..........
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~--------~~~~~~~~~~i~~~~~~~----- 245 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ--------GKDRKETMTMILKAKLGM----- 245 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC--------CSSHHHHHHHHHHCCCCC-----
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCC--------CcCHHHHHHHHHcCCCCC-----
Confidence 2 23457899999999999999999999999999999999999997 234444444444332111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
+......+.+++.+||+.||++|||+
T Consensus 246 --------p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 246 --------PQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --------CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 01112346677889999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=394.01 Aligned_cols=240 Identities=20% Similarity=0.298 Sum_probs=182.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------------c
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------------E 439 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------------~ 439 (678)
.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+.+ .
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 46799999999999986 468999999987533 445678999999999999999999999987654 3
Q ss_pred eEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecC
Q 044996 440 KLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519 (678)
Q Consensus 440 ~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 519 (678)
.|+|||||++|+|.+++...... ...++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred EEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEccCc
Confidence 68999999999999999865432 2356777889999999999999976 89999999999999999999999999
Q ss_pred CccccCccc----------------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCCh
Q 044996 520 LIPVMNQES----------------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDL 583 (678)
Q Consensus 520 la~~~~~~~----------------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l 583 (678)
+|+.+.... ...||+.|||||++.+..|+.++|||||||++|||++ ||... .+.
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-------~~~ 233 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-------MER 233 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------HHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------cHH
Confidence 998765431 1247889999999999999999999999999999996 77511 011
Q ss_pred HHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 584 ASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...+.... ... . .+.. ........+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~-~~~-~----p~~~------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDVR-NLK-F----PPLF------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH-TTC-C----CHHH------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHh-cCC-C----CCCC------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 110 0 0111 112233567888999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=387.19 Aligned_cols=256 Identities=18% Similarity=0.269 Sum_probs=193.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 444 (678)
.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++... +..||||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 46799999999999986 57899999999753 234456789999999999999999999997643 5789999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
|||+ |+|.+++.... .+++.++..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+
T Consensus 139 E~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 139 DLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp ECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred eCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 9995 78999997643 599999999999999999999976 8999999999999999999999999999876
Q ss_pred Ccc--------ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-C
Q 044996 525 NQE--------SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-G 594 (678)
Q Consensus 525 ~~~--------~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~ 594 (678)
... ....+|..|||||++.+. .++.++||||+||++|||++|+.||.. .+..+.+..+... +
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g--------~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG--------KNYVHQLQLIMMVLG 280 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC--------SSHHHHHHHHHHHHC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC--------CCHHHHHHHHHHhcC
Confidence 432 233578999999998765 569999999999999999999999962 2222222222211 1
Q ss_pred Cccccccc-----------hhhhcc-cCCH-----HHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhh
Q 044996 595 DNRTEVFD-----------KEMADE-RNSE-----GEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVK 647 (678)
Q Consensus 595 ~~~~~~~d-----------~~l~~~-~~~~-----~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~ 647 (678)
....+... ..+... .... .....+.+++.+||..||.+|||+.|+++ .+++..
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 00000000 000000 0000 01234677888999999999999999987 355443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=372.42 Aligned_cols=269 Identities=28% Similarity=0.489 Sum_probs=225.4
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|...++..||||++........+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46799999999999998889999999988766666788999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc------
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE------ 527 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~------ 527 (678)
+++..... ....++|.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 ~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp GGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99976532 223599999999999999999999976 8999999999999999999999999998764322
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||..... ........|.......+.. .+.+++.+..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 275 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP--REMVNLAEWAVESHNNGQL-EQIVDPNLAD 275 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS--SSCCCHHHHTHHHHTTTCC-CSSSSSSCTT
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc--HHHHHHHHHhhhccccccH-HHhcChhhcc
Confidence 122367889999999888999999999999999999999999974322 2234667776655544433 2556655533
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
. ...+....+.+++.+||+.||++|||+.||++.|+.+....+
T Consensus 276 ~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 276 K-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp C-SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred c-cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 2 345678889999999999999999999999999999876543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=400.12 Aligned_cols=244 Identities=20% Similarity=0.286 Sum_probs=201.9
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+++|++++|||||+++++|.+.+..|||||||++|+
T Consensus 161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 356799999999999976 4789999999987666677889999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC--CceEEeecCCccccCccc-
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES--LEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~--~~~kl~DfGla~~~~~~~- 528 (678)
|.++|..... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 241 L~~~i~~~~~----~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 241 LFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp HHHHHTCTTS----CEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred HHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999965432 589999999999999999999976 89999999999999854 899999999998876542
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...||+.|||||++.+..|+.++||||+||+||||++|+.||. +.+..+.+..+....... -++...
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~--------~~~~~~~~~~i~~~~~~~---~~~~~~ 381 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG--------GENDDETLRNVKSCDWNM---DDSAFS 381 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC--------CSSHHHHHHHHHTTCCCC---CSGGGT
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC--------CcCHHHHHHHHHhCCCCC---Cccccc
Confidence 3357899999999999999999999999999999999999996 223334444443322111 111110
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. ...+.+++.+||+.||.+|||+.|+++
T Consensus 382 --~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 --GI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 234567778999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=378.70 Aligned_cols=185 Identities=20% Similarity=0.344 Sum_probs=161.3
Q ss_pred hccccCccCceeEEEEEec----CCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEecc
Q 044996 373 SAEILGSGCFGSSYKASLS----TGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
+.+.||+|+||+||+|+.+ +++.||+|++.... ...++.+|+++|+++ +|||||++++++.+.+..|+|||||
T Consensus 25 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 25 IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 3568999999999999753 46789999987543 345688999999998 6999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC-CceEEeecCCccccCc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES-LEPVLADYGLIPVMNQ 526 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~ 526 (678)
++|+|.+++. .+++.++..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 103 ~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 103 EHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999984 388999999999999999999976 89999999999999877 7999999999975432
Q ss_pred c--------------------------------ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 527 E--------------------------------SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 527 ~--------------------------------~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
. ....||+.|||||++.+. .|+.++||||+||++|||+||+.||.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 1 112478999999999765 58999999999999999999999995
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=373.75 Aligned_cols=280 Identities=32% Similarity=0.563 Sum_probs=228.4
Q ss_pred ccchHHHHHH-----hccccCccCceeEEEEEecCCceEEEEEecccCh-hhHHHHHHHHHHHhccCCCCccceeEEEEe
Q 044996 363 RFDLHDLLRA-----SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLLPLVAYYYR 436 (678)
Q Consensus 363 ~~~~~~~~~~-----~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~ 436 (678)
.|++.++... ..+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 4455554433 2467999999999999988899999999875432 223468999999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEe
Q 044996 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLA 516 (678)
Q Consensus 437 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 516 (678)
.+..++||||+++|+|.++++.... ....++|..+..|+.|++.||+|||+.+ ..+|+||||||+|||+++++.+||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEECTTCCEEEC
T ss_pred CCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEECCCCCEEec
Confidence 9999999999999999999987543 2335999999999999999999999764 2379999999999999999999999
Q ss_pred ecCCccccCcc-----ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHH
Q 044996 517 DYGLIPVMNQE-----SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL 591 (678)
Q Consensus 517 DfGla~~~~~~-----~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~ 591 (678)
|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||+...........+.+|+....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999865432 1223688999999998888999999999999999999999999754433444567778877666
Q ss_pred hcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 592 ANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
...... .+.+..+... ....+...+.+++.+||+.||.+|||+.||++.|++.
T Consensus 257 ~~~~~~-~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 257 KEKKLE-ALVDVDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SSCCST-TSSCTTCTTS-CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hchhhh-hhcChhhccc-cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 554333 5556555433 3567788999999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=362.54 Aligned_cols=250 Identities=23% Similarity=0.421 Sum_probs=205.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.++||+|+||+||+|... ++..||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 567999999999999874 6889999998877777788999999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.+++..... .++|.+++.|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 95 ~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 95 RGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp HHHHHHCCT----TSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999986432 599999999999999999999976 79999999999999999999999999997654322
Q ss_pred --------------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCC-CCChHHHHHHHHhc
Q 044996 529 --------------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKA-DGDLASWVNSVLAN 593 (678)
Q Consensus 529 --------------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~-~~~l~~~~~~~~~~ 593 (678)
...++..|+|||++.+..++.++|||||||++|||++|..|+......... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~------- 239 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF------- 239 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH-------
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc-------
Confidence 224678899999999999999999999999999999999998632211110 0011111
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.+... .......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 240 -------~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 240 -------LDRYC-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -------HHHTC-----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------ccccC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11110 1112234778888999999999999999999999987653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=389.23 Aligned_cols=242 Identities=19% Similarity=0.235 Sum_probs=191.1
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHH---HHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQ---EHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
+.++||+|+||+||+|+. .+|+.||||+++... ......+. .++.+++.++|||||+++++|.+.+..|||||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 357899999999999986 468999999996421 12222333 34667778899999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
||++|+|.++|.... .+++..+..|+.||+.||+|||+. +||||||||+|||||.++.+||+|||+|+.+.
T Consensus 273 y~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 273 LMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp CCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999998653 589999999999999999999965 89999999999999999999999999998775
Q ss_pred cc--ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 526 QE--SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 526 ~~--~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
.. ....||+.|||||++.. ..|+.++||||+||+||||++|+.||.... ..+.....+.........
T Consensus 344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~-----~~~~~~i~~~i~~~~~~~----- 413 (689)
T 3v5w_A 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----TKDKHEIDRMTLTMAVEL----- 413 (689)
T ss_dssp SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG-----CCCHHHHHHHHHHCCCCC-----
T ss_pred CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhhcCCCCCC-----
Confidence 44 33468999999999964 579999999999999999999999996321 112222222222221111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
+......+.+++.+||+.||.+|++ +.||.+
T Consensus 414 --------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 414 --------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111234667777999999999998 677764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=371.76 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=204.6
Q ss_pred ccccCccCceeEEEEEec--------CCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEE
Q 044996 374 AEILGSGCFGSSYKASLS--------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 443 (678)
.+.||+|+||.||+|+.. ++..||||+++.. .....+++.+|+++++++ +||||++++++|...+..|+|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 567999999999999752 3457999999754 334567899999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc
Q 044996 444 HEFVPKRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE 512 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~ 512 (678)
|||+++|+|.+++...... ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~ 241 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTENNV 241 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCC
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchhhEEECCCCC
Confidence 9999999999999865321 123589999999999999999999976 8999999999999999999
Q ss_pred eEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHH
Q 044996 513 PVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLAS 585 (678)
Q Consensus 513 ~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~ 585 (678)
+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+
T Consensus 242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~--------~~~~ 313 (370)
T 2psq_A 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--------PVEE 313 (370)
T ss_dssp EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CGGG
T ss_pred EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHH
Confidence 9999999998654321 2234578999999998999999999999999999999 99998621 2222
Q ss_pred HHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 586 WVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
..... ..+... . ........+.+++.+||+.||.+|||+.|+++.|+++.....+
T Consensus 314 ~~~~~-~~~~~~-~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 LFKLL-KEGHRM-D----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp HHHHH-HTTCCC-C----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHH-hcCCCC-C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 22222 221111 0 0112234577888899999999999999999999998765444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.46 Aligned_cols=274 Identities=27% Similarity=0.460 Sum_probs=219.1
Q ss_pred ccccchHHHHHHh-----------ccccCccCceeEEEEEecCCceEEEEEeccc----ChhhHHHHHHHHHHHhccCCC
Q 044996 361 VERFDLHDLLRAS-----------AEILGSGCFGSSYKASLSTGAMMVVKRFKQM----NNVGREEFQEHMRRLGRLRHP 425 (678)
Q Consensus 361 ~~~~~~~~~~~~~-----------~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~H~ 425 (678)
...|++.++..++ .+.||+|+||.||+|.. ++..||||++... .....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3456666666654 26799999999999987 6788999998753 233467899999999999999
Q ss_pred CccceeEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCE
Q 044996 426 NLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNV 505 (678)
Q Consensus 426 niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NI 505 (678)
||+++++++.+.+..++||||+++|+|.+++..... ...++|..+..++.||+.||+|||+. +|+||||||+||
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Ni 164 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANI 164 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHE
Confidence 999999999999999999999999999999975432 23699999999999999999999976 899999999999
Q ss_pred EecCCCceEEeecCCccccCcc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCC
Q 044996 506 LLNESLEPVLADYGLIPVMNQE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKA 579 (678)
Q Consensus 506 Ll~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~ 579 (678)
|+++++.+||+|||+++..... ....++..|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---- 239 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE---- 239 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS----
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc----
Confidence 9999999999999998765432 12346788999998864 589999999999999999999999974321
Q ss_pred CCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 580 DGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 580 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
...+..+............+.+++.+.. ........+.+++.+||+.||.+|||+.||++.|+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 240 PQLLLDIKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SSBTTHHHHHHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hHHHHHHHHHhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2234444444443333333344444322 244567788999999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=361.92 Aligned_cols=251 Identities=22% Similarity=0.378 Sum_probs=203.1
Q ss_pred ccccCccCceeEEEEEec----CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS----TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... .+..||||+++.. .....+.|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 567999999999999874 3456999999864 34556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|.++++.... .+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 134 ~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 134 NGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp TCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred CCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999975432 599999999999999999999976 89999999999999999999999999998765432
Q ss_pred c-------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 529 A-------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 529 ~-------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
. ..++..|+|||++.+..++.++|||||||++|||++ |+.||.. ....+........ ... .
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~--------~~~~~~~~~~~~~-~~~-~- 274 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN--------MTNRDVISSVEEG-YRL-P- 274 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------SCHHHHHHHHHTT-CCC-C-
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc--------CCHHHHHHHHHcC-CCC-C-
Confidence 1 123567999999998899999999999999999999 9999962 2222222222221 111 0
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
........+.+++.+||+.||.+|||+.||++.|+.+....+.
T Consensus 275 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 275 ---------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ---------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 0112234577888899999999999999999999999876544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=357.20 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=197.1
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
..+.||+|+||+||+|+. ++..||||++.... ....++|.+|++++++++||||+++++++...+..++||||+++|
T Consensus 41 i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 356799999999999987 68889999987543 344568999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCC--CcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI--APHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|.+++..... ...+++..++.++.||+.||+|||+. + |+||||||+|||+++++.+||+|||+++.....
T Consensus 120 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 120 SLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp BHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99999976431 11389999999999999999999966 6 999999999999999999999999999765433
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.+..++.++|||||||++|||+||+.||.. ....+............ ..
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~--------~~~~~~~~~~~~~~~~~-~~---- 260 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN--------LNPAQVVAAVGFKCKRL-EI---- 260 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT--------SCHHHHHHHHHHSCCCC-CC----
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhcCCCC-CC----
Confidence 233467889999999999999999999999999999999999972 22223322222121111 10
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.......+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus 261 ------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 261 ------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1112234778888999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=349.16 Aligned_cols=247 Identities=22% Similarity=0.380 Sum_probs=204.6
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|...++..||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 46799999999999999888899999997543 34577999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~~l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 94 DYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp HHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred HHHHhcCc----ccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99976432 589999999999999999999976 79999999999999999999999999998664432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.++||||||+++|||++ |+.||.. ....+........... ..+.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~--------~~~~~~~~~~~~~~~~----~~~~--- 230 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------RSNSEVVEDISTGFRL----YKPR--- 230 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTTCCC----CCCT---
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC--------CCHHHHHHHHhcCccC----CCCC---
Confidence 2234567999999998899999999999999999999 9999862 2223333333222111 1111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.....+.+++.+||+.||.+|||+.|+++.|+++.+.
T Consensus 231 -----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 231 -----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1123477788899999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=372.29 Aligned_cols=249 Identities=22% Similarity=0.383 Sum_probs=203.7
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
..+.||+|+||.||+|.+. +++.||||.++... ....++|.+|+++|++++|||||++++++...+..++||||+++|
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 3567999999999999885 78899999987542 334567899999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.++++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 198 ~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 198 DFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp BHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999986532 489999999999999999999976 79999999999999999999999999997654321
Q ss_pred ----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 ----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
...++..|+|||++.++.++.++|||||||++|||+| |+.||... . ...+...+..+... .
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~--------~-~~~~~~~~~~~~~~-~---- 335 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL--------S-NQQTREFVEKGGRL-P---- 335 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS--------C-HHHHHHHHHTTCCC-C----
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------C-HHHHHHHHHcCCCC-C----
Confidence 1224567999999998899999999999999999999 99998621 1 12222233222111 0
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.+......+.+++.+||+.||++|||+.+|++.|+++...
T Consensus 336 ------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 ------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0111234577888899999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=361.21 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=201.3
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc----eEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE----KLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----~~lv~Ey~~~ 449 (678)
.++||+|+||+||+|+.. ++.||||++... ......+.+|+.++++++|||||++++++..... .++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 467999999999999875 789999998754 3344566779999999999999999999987543 6999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC------CCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL------PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
|+|.++++.. .++|..+..|+.|++.||+|||+.+ +..+|+||||||+|||++.++.+||+|||+++.
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 9999999764 4899999999999999999999531 122799999999999999999999999999976
Q ss_pred cCccc------cccccceeeCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCccccccCCC--------CCCChH
Q 044996 524 MNQES------AQELMIAYKSPEFLQL-----GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKK--------ADGDLA 584 (678)
Q Consensus 524 ~~~~~------~~~~~~~y~aPE~~~~-----~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~--------~~~~l~ 584 (678)
+.... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||........ ......
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 54322 2346889999999976 3456789999999999999999999873221110 001222
Q ss_pred HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.+......... . +.+............+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 261 ~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 261 DMQEVVVHKKK-R-----PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHTTSCC-C-----CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhcccC-C-----CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 22222222111 1 11111111224566788999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=354.73 Aligned_cols=240 Identities=23% Similarity=0.324 Sum_probs=198.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 46799999999999985 57889999999866556677899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.+++... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 9999764 489999999999999999999976 8999999999999999999999999998766533 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. .+............... ...
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~~~~~~~~~~~~--~~~------ 238 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN--------ENPLRALYLIATNGTPE--LQN------ 238 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHHCSCC--CSC------
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC--CCC------
Confidence 23467889999999999999999999999999999999999962 22222222222222111 000
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||++|||+.|+++
T Consensus 239 --~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 --PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1112234677888999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=368.39 Aligned_cols=249 Identities=22% Similarity=0.411 Sum_probs=194.4
Q ss_pred ccccCccCceeEEEEEec----CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS----TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|+.. ++..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 567999999999999865 5678999999754 34556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|.++++.... .+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 130 ~~sL~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 130 NGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp TCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999976532 589999999999999999999976 79999999999999999999999999998765432
Q ss_pred c-------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 529 A-------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 529 ~-------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
. ..++..|+|||++.+..++.++|||||||++|||++ |+.||.. ....+.... +..+...
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~--------~~~~~~~~~-i~~~~~~--- 269 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE--------MSNQDVIKA-VDEGYRL--- 269 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT--------CCHHHHHHH-HHTTEEC---
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHH-HHcCCCC---
Confidence 1 123467999999998999999999999999999998 9999862 122222222 2111100
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.........+.+++.+||+.||.+||+|.||++.|+++....
T Consensus 270 --------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 270 --------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp --------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred --------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 011123445788889999999999999999999999986543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=355.34 Aligned_cols=258 Identities=22% Similarity=0.385 Sum_probs=201.2
Q ss_pred ccccCccCceeEEEEEe-----cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-----STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~Ey 446 (678)
.+.||+|+||+||+|++ .+++.||||++........+.|.+|++++++++||||+++++++... ...++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 46799999999999984 36789999999877777778899999999999999999999999653 458999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 95 LPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred CCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999986542 489999999999999999999976 899999999999999999999999999987643
Q ss_pred cc-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccC-------CCCCCChHHHHHHHHh
Q 044996 527 ES-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQG-------KKADGDLASWVNSVLA 592 (678)
Q Consensus 527 ~~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~-------~~~~~~l~~~~~~~~~ 592 (678)
.. ...++..|+|||++.+..++.++|||||||++|||+||..|+...... ..........+...+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 32 223456799999999899999999999999999999999997621100 0000000111111111
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.+... .........+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 247 ~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 247 NNGRL-----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TTCCC-----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccCcC-----------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11110 011123356788888999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=376.60 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=204.9
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++|||||++++++. .+..++|||||++|+|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 46799999999999999888899999998643 45788999999999999999999999986 66789999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
++++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 271 ~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 343 (454)
T 1qcf_A 271 DFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343 (454)
T ss_dssp HHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred HHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence 99975432 1488999999999999999999976 79999999999999999999999999998765431
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++....++.++|||||||+||||+| |+.||.. ....+...... .+... -
T Consensus 344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~--------~~~~~~~~~i~-~~~~~---~------ 405 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG--------MSNPEVIRALE-RGYRM---P------ 405 (454)
T ss_dssp SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHHHHHHHHH-HTCCC---C------
T ss_pred CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHH-cCCCC---C------
Confidence 2234578999999998899999999999999999999 9999962 22222222222 21111 0
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
.+......+.+++.+||+.||++||||.+|++.|+++....+.
T Consensus 406 --~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 406 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 0112334578888999999999999999999999988765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=354.80 Aligned_cols=239 Identities=18% Similarity=0.250 Sum_probs=198.3
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 57999999999999875 78999999998766666788999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----cc
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----SA 529 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~~ 529 (678)
+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 131 ~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 131 DIVSQV------RLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp HHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 998643 589999999999999999999976 8999999999999999999999999998766433 23
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
..++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+........... .+...
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~--------~~~~~~~~~~~~~~~~-------~~~~~- 264 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS--------DSPVQAMKRLRDSPPP-------KLKNS- 264 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSSCC-------CCTTG-
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHhcCCCC-------CcCcc-
Confidence 3568899999999988999999999999999999999999962 2222333322222111 11000
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||+.||++|||+.|+++
T Consensus 265 --~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 265 --HKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp --GGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011234677888999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=354.91 Aligned_cols=238 Identities=20% Similarity=0.278 Sum_probs=198.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 46799999999999986 67899999998753 3445677899999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 100 EVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 9999997653 489999999999999999999976 8999999999999999999999999999765533
Q ss_pred ccccccceeeCccccccCCCC-CcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 SAQELMIAYKSPEFLQLGRIT-KKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t-~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++.+..++ .++|||||||++|||++|+.||. ..+..+............
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~--------~~~~~~~~~~i~~~~~~~--------- 233 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD--------GQNLKELRERVLRGKYRI--------- 233 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC--------CSSHHHHHHHHHHCCCCC---------
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC--------CCCHHHHHHHHHhCCCCC---------
Confidence 233578899999999887775 79999999999999999999997 234444444444332111
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+......+.+++.+||+.||.+|||+.|+++
T Consensus 234 ----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 234 ----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0011234667788999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.02 Aligned_cols=248 Identities=22% Similarity=0.387 Sum_probs=203.2
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|+..++..||+|+++... ...+++.+|++++.+++||||+++++++.+.+..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 46799999999999999888889999987543 34577999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 92 NYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp HHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred HHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 99976532 489999999999999999999976 89999999999999999999999999997654432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.++||||||+++|||+| |+.||.. ................ ..+.
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~--------~~~~~~~~~~~~~~~~----~~~~--- 228 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL--------YTNSEVVLKVSQGHRL----YRPH--- 228 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT--------SCHHHHHHHHHTTCCC----CCCT---
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc--------cChHHHHHHHHcCCCC----CCCC---
Confidence 1224567999999988889999999999999999999 9999962 2222222222222111 1111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.....+.+++.+||+.||.+|||+.|+++.|+++.+..
T Consensus 229 -----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 229 -----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp -----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred -----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 11234778888999999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=347.00 Aligned_cols=247 Identities=21% Similarity=0.341 Sum_probs=201.3
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|...++..||+|+++... ...+++.+|++++.+++||||+++++++.+.+..++||||+++|+|.
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 46799999999999999888899999997543 34577999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 108 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 108 NYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp HHHHCGGG----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred HHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 99976432 589999999999999999999976 89999999999999999999999999998664432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.++||||||+++|||+| |+.||.. ................. .+
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~--------~~~~~~~~~~~~~~~~~----~~---- 243 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER--------FTNSETAEHIAQGLRLY----RP---- 243 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT--------SCHHHHHHHHHTTCCCC----CC----
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc--------cChhHHHHHHhcccCCC----CC----
Confidence 2234567999999998899999999999999999999 9999972 22222222222211110 01
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
......+.+++.+||+.||.+|||+.|+++.|+++.+.
T Consensus 244 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 244 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11123577888899999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.56 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=193.9
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhc--cCCCCccceeEEEEeC----CceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGR--LRHPNLLPLVAYYYRK----EEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~~~~lv~Ey~ 447 (678)
.+.||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...++||||+
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 46799999999999987 6889999998653 34556667666665 8999999999997653 4589999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC----CCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL----PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
++|+|.++++.. .+++..+++|+.||+.||+|||... ...+|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 89 EMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp TTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 999999999643 5899999999999999999999311 023899999999999999999999999999976
Q ss_pred cCccc--------cccccceeeCccccccC------CCCCcchHHHHHHHHHHHHhC----------CCCccccccCCCC
Q 044996 524 MNQES--------AQELMIAYKSPEFLQLG------RITKKTDVWSLGVLILEIMTG----------KFPANFLQQGKKA 579 (678)
Q Consensus 524 ~~~~~--------~~~~~~~y~aPE~~~~~------~~t~ksDvwS~Gvvl~el~tg----------~~P~~~~~~~~~~ 579 (678)
..... ...++..|+|||++.+. .++.++|||||||++|||+|| +.||......
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~--- 239 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN--- 239 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS---
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC---
Confidence 54322 12578899999999876 445799999999999999999 7777532211
Q ss_pred CCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 580 DGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 580 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
....... .......... +.+............+.+++.+||+.||.+|||+.||++.|+++
T Consensus 240 ~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDM-RKVVCVDQQR-----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHH-HHHHTTSCCC-----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccchhhh-hHHHhccCCC-----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1222222 2222221111 11111111234567789999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=362.27 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=207.7
Q ss_pred hccccCccCceeEEEEEec--------CCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEE
Q 044996 373 SAEILGSGCFGSSYKASLS--------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLL 442 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 442 (678)
..+.||+|+||.||+|+.. .+..||||+++.. .....+++.+|+++++++ +|||||++++++...+..++
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 3567999999999999752 2357999998754 344557899999999999 99999999999999999999
Q ss_pred EEeccCCCCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC
Q 044996 443 VHEFVPKRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL 511 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 511 (678)
||||+++|+|.+++...... ....+++.+++.|+.||+.||+|||+. +|+||||||+|||+++++
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~ 228 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDN 228 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTC
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCcceEEEcCCC
Confidence 99999999999999865421 123599999999999999999999976 899999999999999999
Q ss_pred ceEEeecCCccccCcc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChH
Q 044996 512 EPVLADYGLIPVMNQE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLA 584 (678)
Q Consensus 512 ~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~ 584 (678)
.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~--------~~~~ 300 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VPVE 300 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------CCHH
Confidence 9999999999866432 22235678999999999999999999999999999999 9999862 2333
Q ss_pred HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCC
Q 044996 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDE 653 (678)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~ 653 (678)
+...... .+... .. .......+.+++.+||+.||++|||+.||++.|+++.......
T Consensus 301 ~~~~~~~-~~~~~-~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 301 ELFKLLK-EGHRM-DK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHHHHH-TTCCC-CC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHHHHH-cCCCC-CC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 3333332 22111 00 0112345778888999999999999999999999998766554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=371.93 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=200.5
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC-ceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE-EKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|.+. ++.||||.++... ..+.|.+|+++|++++|||||++++++...+ ..++|||||++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 567999999999999875 7799999998643 4578999999999999999999999988765 78999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-cccc
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-SAQE 531 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~~~~ 531 (678)
.++++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus 275 ~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 347 (450)
T 1k9a_A 275 VDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 347 (450)
T ss_dssp HHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEECC------C
T ss_pred HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCC
Confidence 999986532 2479999999999999999999976 7999999999999999999999999999865432 2234
Q ss_pred ccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccC
Q 044996 532 LMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERN 610 (678)
Q Consensus 532 ~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (678)
++..|+|||++.+..++.++|||||||++|||+| |+.||.... ...+ +.. +..+... . .
T Consensus 348 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-----~~~~---~~~-i~~~~~~-~----------~ 407 (450)
T 1k9a_A 348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDV---VPR-VEKGYKM-D----------A 407 (450)
T ss_dssp CCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-----TTTH---HHH-HHTTCCC-C----------C
T ss_pred CCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHH---HHH-HHcCCCC-C----------C
Confidence 5678999999999999999999999999999999 999997321 1122 221 2222111 0 1
Q ss_pred CHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 611 SEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
+......+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 112334577888899999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=362.22 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=202.2
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|.+. ++..||||+++.. ......++.+|+.++++++|||||++++++......++||||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 567999999999999853 4668999998753 345566799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCC--CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC---ceEEeecCCc
Q 044996 447 VPKRSLAVNLHGHQAL--GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL---EPVLADYGLI 521 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla 521 (678)
+++|+|.+++...... ....+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 9999999999865421 123589999999999999999999977 899999999999999544 5999999999
Q ss_pred cccCc------cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 522 PVMNQ------ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 522 ~~~~~------~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
+.+.. .....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+.........
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~--------~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS--------KSNQEVLEFVTSGG 303 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHHHHHHHHHTTC
T ss_pred cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHHcCC
Confidence 75422 122345778999999998999999999999999999998 9999962 22233333222221
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
... ........+.+++.+||+.||.+|||+.||++.|+.+...
T Consensus 304 ~~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 RMD------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 110 0111233577888899999999999999999999988664
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=357.37 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=203.4
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|+.. +++.||||.++.. .....+.|.+|++++++++||||+++++++.+.+..++||||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 467999999999999874 3478999999754 334467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCC-------------------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe
Q 044996 447 VPKRSLAVNLHGHQAL-------------------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL 507 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl 507 (678)
+++|+|.+++...... ....+++.+++.|+.||+.||+|||+. +|+||||||+|||+
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLV 207 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEE
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEE
Confidence 9999999999864311 113699999999999999999999976 89999999999999
Q ss_pred cCCCceEEeecCCccccCcc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCC
Q 044996 508 NESLEPVLADYGLIPVMNQE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKAD 580 (678)
Q Consensus 508 ~~~~~~kl~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~ 580 (678)
++++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-------- 279 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-------- 279 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--------
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC--------
Confidence 99999999999998765432 22345678999999998899999999999999999999 9999862
Q ss_pred CChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 581 GDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 581 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
....+...... .+... . ........+.+++.+||+.||.+|||+.||++.|+++.+..
T Consensus 280 ~~~~~~~~~~~-~~~~~-~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 280 MAHEEVIYYVR-DGNIL-A----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp SCHHHHHHHHH-TTCCC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CChHHHHHHHh-CCCcC-C----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 22223332222 22111 0 01112345778888999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=376.87 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=203.9
Q ss_pred hccccCccCceeEEEEEecC-CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 373 SAEILGSGCFGSSYKASLST-GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
..+.||+|+||.||+|.+.. +..||||.++... ...++|.+|+++|++++|||||+++++|...+..++|||||++|+
T Consensus 224 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~ 302 (495)
T 1opk_A 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 302 (495)
T ss_dssp EEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCC
Confidence 35679999999999998764 7889999997643 356789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.++++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 303 L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 303 LLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp HHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred HHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 9999986432 2589999999999999999999976 79999999999999999999999999998765332
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...+++.|+|||++....++.++|||||||+||||+| |+.||... +..+.. ..+..+... .
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~--------~~~~~~-~~~~~~~~~-~------ 439 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQVY-ELLEKDYRM-E------ 439 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--------CGGGHH-HHHHTTCCC-C------
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC--------CHHHHH-HHHHcCCCC-C------
Confidence 1224578999999998899999999999999999999 99998622 111111 122221111 0
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.+......+.+++.+||+.||.+||||.||++.|+.+...
T Consensus 440 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 440 ----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ----CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 0112234577888899999999999999999999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=370.93 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=200.1
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|.+..+..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++|||||++|+|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 46799999999999999888889999998643 346789999999999999999999999875 6789999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
++++.... ..+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 267 ~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 339 (452)
T 1fmk_A 267 DFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339 (452)
T ss_dssp HHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred HHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence 99975422 2589999999999999999999976 79999999999999999999999999998765321
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.++.++.++|||||||++|||+| |+.||.. ....+..... ..+... .
T Consensus 340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~--------~~~~~~~~~i-~~~~~~-~-------- 401 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--------MVNREVLDQV-ERGYRM-P-------- 401 (452)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--------CCHHHHHHHH-HTTCCC-C--------
T ss_pred CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC--------CCHHHHHHHH-HcCCCC-C--------
Confidence 2234578999999998999999999999999999999 9999862 2222222222 222111 0
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
.+......+.+++.+||+.||++|||+.++++.|+++....+
T Consensus 402 --~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 402 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 011233457788889999999999999999999998875543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=354.13 Aligned_cols=247 Identities=21% Similarity=0.386 Sum_probs=193.6
Q ss_pred ccccCccCceeEEEEEec-CCce----EEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGAM----MVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.++||+|+||+||+|.+. ++.. |++|.++.. .....++|.+|+.++++++||||++++++|... ..++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~ 98 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 98 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEec
Confidence 467999999999999863 3433 578877643 234567899999999999999999999999865 478999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 99 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp TTCBHHHHHHHSTT----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred CCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999987542 599999999999999999999976 7999999999999999999999999999765433
Q ss_pred c------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 S------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
. ...++..|+|||++.+..++.++|||||||++|||+| |+.||..... ..+ ...+..+...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~----~~~~~~~~~~--- 238 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEI----SSILEKGERL--- 238 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGH----HHHHHTTCCC---
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHH----HHHHHcCCCC---
Confidence 2 2234668999999999999999999999999999999 9999972211 111 1222222111
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.........+.+++.+||+.||.+||+|.|+++.|+++...
T Consensus 239 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 00112234578888899999999999999999999988653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=347.76 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=199.9
Q ss_pred ccccCccCceeEEEEEecC-C-------ceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLST-G-------AMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
.+.||+|+||.||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 4679999999999997643 3 4699999987666777889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc--------eEEee
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE--------PVLAD 517 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~--------~kl~D 517 (678)
|+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 93 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp CCTTCBHHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999986532 489999999999999999999976 7999999999999998887 99999
Q ss_pred cCCccccCccccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 518 YGLIPVMNQESAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 518 fGla~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
||+++.........++..|+|||++.+ ..++.++|||||||++|||++|..|+.. ........ ........
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~-------~~~~~~~~-~~~~~~~~ 236 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-------ALDSQRKL-QFYEDRHQ 236 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT-------TSCHHHHH-HHHHTTCC
T ss_pred CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc-------ccchHHHH-HHhhccCC
Confidence 999987766655567888999999987 6789999999999999999996554431 11111111 11111111
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
... .....+.+++.+||+.||.+|||+.|+++.|+++..+
T Consensus 237 ~~~-------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 237 LPA-------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp CCC-------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred CCC-------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 100 0112367788899999999999999999999987663
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.60 Aligned_cols=247 Identities=22% Similarity=0.380 Sum_probs=204.2
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 46799999999999998888899999997643 34578999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 92 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 92 DYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp HHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred HHHhhCcc----cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99976532 589999999999999999999976 79999999999999999999999999998664321
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.++||||||+++|||++ |+.||.. ................ ..+.
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~--------~~~~~~~~~i~~~~~~----~~~~--- 228 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--------RSNSEVVEDISTGFRL----YKPR--- 228 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTTCCC----CCCT---
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC--------CCHHHHHHHHhcCCcC----CCCc---
Confidence 2234567999999998899999999999999999999 8999862 2223333332222110 0011
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.....+.+++.+||+.||.+|||+.|+++.|+++.+.
T Consensus 229 -----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 229 -----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1123467788899999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=359.54 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=201.0
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCc-eEEE
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEE-KLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~-~~lv 443 (678)
..+.||+|+||.||+|++ .+++.||||+++.. .....+.+.+|++++.++ +|||||+++++|...+. .++|
T Consensus 26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEE
Confidence 356799999999999974 34578999999764 334457799999999999 79999999999987654 8999
Q ss_pred EeccCCCCHHHHhhccCCCC------------------------------------------------------------
Q 044996 444 HEFVPKRSLAVNLHGHQALG------------------------------------------------------------ 463 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~------------------------------------------------------------ 463 (678)
|||+++|+|.++++......
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 99999999999998653210
Q ss_pred -CCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc------ccccccee
Q 044996 464 -QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES------AQELMIAY 536 (678)
Q Consensus 464 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~------~~~~~~~y 536 (678)
...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...++..|
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred hccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 11288999999999999999999976 79999999999999999999999999998654321 22356789
Q ss_pred eCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHH
Q 044996 537 KSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEM 615 (678)
Q Consensus 537 ~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 615 (678)
+|||++.+..++.++|||||||++|||+| |+.||... .....+...+..+... .. .....
T Consensus 262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~~~~~~~~~-~~----------~~~~~ 322 (359)
T 3vhe_A 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--------KIDEEFCRRLKEGTRM-RA----------PDYTT 322 (359)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC--------CCSHHHHHHHHHTCCC-CC----------CTTCC
T ss_pred EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc--------chhHHHHHHHHcCCCC-CC----------CCCCC
Confidence 99999998999999999999999999999 99999621 1112222222222111 00 01122
Q ss_pred HHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 616 VKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 616 ~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
..+.+++.+||+.||.+||||.||++.|+++...
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 3477888899999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.71 Aligned_cols=254 Identities=17% Similarity=0.272 Sum_probs=203.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|+. .++..||+|.+... .....+.|.+|+.++++++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 46799999999999986 46889999998542 234457899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 96 PTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999997653 589999999999999999999976 79999999999999999999999999998765432
Q ss_pred ----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 529 ----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
...++..|+|||++.+..++.++|||||||++|||+||+.||.. ................. ....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~--------~~~~~~~~~~~~~~~~~---~~~~ 235 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG--------ETAVSIAIKHIQDSVPN---VTTD 235 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS--------SCHHHHHHHHHSSCCCC---HHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHhhccCCC---cchh
Confidence 22467889999999998999999999999999999999999972 22233333333222110 0011
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCC-CHHHHHHHHHHhhccCCC
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRL-DLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~ev~~~L~~i~~~~~~ 652 (678)
. .......+.+++.+|++.||.+|| +++++.+.|+.+......
T Consensus 236 ~-----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 236 V-----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp S-----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred c-----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 1 111234577888899999999999 999999999987665443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.36 Aligned_cols=254 Identities=20% Similarity=0.389 Sum_probs=199.7
Q ss_pred ccccCccCceeEEEEEecC-----CceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLST-----GAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|.... +..||+|.++.. .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4679999999999997643 235999998754 3345667999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 129 ~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 129 ENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp TTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred CCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999976432 589999999999999999999976 7999999999999999999999999999876533
Q ss_pred c-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 528 S-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 528 ~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
. ...++..|+|||++.+..++.++|||||||++|||++ |+.||.. ....+...... .+... .
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~--------~~~~~~~~~~~-~~~~~-~ 270 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--------LSNHEVMKAIN-DGFRL-P 270 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHH-TTCCC-C
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc--------CCHHHHHHHHH-CCCcC-C
Confidence 1 1123567999999998899999999999999999999 9999962 22222222222 22111 0
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCcc
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDF 655 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~~ 655 (678)
........+.+++.+||+.||.+||++.|+++.|+++.......+.
T Consensus 271 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~ 316 (333)
T 1mqb_A 271 ----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316 (333)
T ss_dssp ----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGS
T ss_pred ----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhh
Confidence 0111234577888899999999999999999999998875544333
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=359.18 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=195.7
Q ss_pred ccccCccCceeEEEEEecC--C--ceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEe-CCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLST--G--AMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR-KEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~Ey~ 447 (678)
.++||+|+||.||+|.+.. + ..||+|.++.. .....++|.+|+.++++++||||++++++|.. .+..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 4679999999999997632 2 36889988753 33456789999999999999999999999765 45789999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.++++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 174 ~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 174 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp TTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999976432 588999999999999999999976 8999999999999999999999999999865432
Q ss_pred c--------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 528 S--------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 528 ~--------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
. ...++..|+|||++.+..++.++|||||||++|||+| |..||.... ...+... .. .+...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-----~~~~~~~---~~-~~~~~- 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVY---LL-QGRRL- 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----SSCHHHH---HH-TTCCC-
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-----HHHHHHH---HH-cCCCC-
Confidence 1 1234567999999998999999999999999999999 677775221 1222222 11 11111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCccc
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFY 656 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~~~ 656 (678)
..+ ......+.+++.+||+.||++|||+.|+++.|+++......+.+.
T Consensus 316 --~~p--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~ 363 (373)
T 3c1x_A 316 --LQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 363 (373)
T ss_dssp --CCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred --CCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccccee
Confidence 011 112345778888999999999999999999999999887776553
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=351.02 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=191.2
Q ss_pred hccccCccCceeEEEEEecCCc----eEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCce------
Q 044996 373 SAEILGSGCFGSSYKASLSTGA----MMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEK------ 440 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~------ 440 (678)
..+.||+|+||.||+|...... .||||.++.. .....+.+.+|++++++++||||+++++++......
T Consensus 27 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CE
T ss_pred EeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCcc
Confidence 3567999999999999865432 7999998753 344567899999999999999999999999876655
Q ss_pred EEEEeccCCCCHHHHhhccCCCC-CCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecC
Q 044996 441 LLVHEFVPKRSLAVNLHGHQALG-QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519 (678)
Q Consensus 441 ~lv~Ey~~~gsL~~~l~~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 519 (678)
++||||+++|+|.+++....... ...+++.++..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEEcCCCCEEEeecc
Confidence 99999999999999997543211 22589999999999999999999976 89999999999999999999999999
Q ss_pred CccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHh
Q 044996 520 LIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLA 592 (678)
Q Consensus 520 la~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~ 592 (678)
+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||... ...+.......
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--------~~~~~~~~~~~ 254 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI--------ENAEIYNYLIG 254 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CGGGHHHHHHT
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc--------ChHHHHHHHhc
Confidence 997654322 2234567999999998999999999999999999999 99998722 11122222222
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
..... ........+.+++.+||+.||.+|||+.|+++.|+++.....
T Consensus 255 ~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 255 GNRLK------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp TCCCC------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred CCCCC------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 21110 011223457788889999999999999999999999977543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=357.49 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=195.2
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
++||+|+||.||+|.. .++..||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 5799999999999986 468899999998766667788999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe--cCCCceEEeecCCccccCccc---
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL--NESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl--~~~~~~kl~DfGla~~~~~~~--- 528 (678)
+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.+....
T Consensus 175 ~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 175 DRIIDESY----NLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp HHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred HHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99875432 589999999999999999999976 79999999999999 677899999999998765432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+.+...+...... .+....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~--------~~~~~~~~~i~~~~~~~---~~~~~~-- 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG--------DNDAETLNNILACRWDL---EDEEFQ-- 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCCCS---CSGGGT--
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhccCCC---Chhhhc--
Confidence 23467889999999988899999999999999999999999962 23333444444332211 111110
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.....+.+++.+||+.||.+|||+.|+++
T Consensus 314 ----~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 ----DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11234677888999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=347.46 Aligned_cols=238 Identities=21% Similarity=0.255 Sum_probs=196.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||+||+|+.. +++.||+|+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 467999999999999865 6899999999753 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|..++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999997653 589999999999999999999976 8999999999999999999999999999764322
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.. .+...............
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~~~~~~~-------- 224 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHERLFELILMEEIRF-------- 224 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC--------
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCCCC--------
Confidence 233468899999999999999999999999999999999999962 23333333333322111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+||+.||.+|| ++.||++
T Consensus 225 -----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 225 -----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 011123467777899999999999 8999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=343.40 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=190.5
Q ss_pred hccccCccCceeEEEEEecC----CceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 373 SAEILGSGCFGSSYKASLST----GAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
..+.||+|+||.||+|.... +..|++|.++.. .....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~ 97 (281)
T 1mp8_A 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 97 (281)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecC
Confidence 35679999999999998643 456899988753 3445678999999999999999999999984 56789999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 98 TLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp TTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999976532 589999999999999999999976 8999999999999999999999999999876543
Q ss_pred c-----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 528 S-----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 528 ~-----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
. ...++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+........ ... .
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~--------~~~~~~~i~~~-~~~-~-- 237 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIENG-ERL-P-- 237 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--------GGGHHHHHHTT-CCC-C--
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC--------HHHHHHHHHcC-CCC-C--
Confidence 2 2234567999999998899999999999999999997 999987321 11222222211 111 0
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 238 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 238 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0111234577888899999999999999999999998653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.96 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=199.9
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|+.. +..+|||+++.. .....+.|.+|+.++++++||||+++++++.+. +..++||||+++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 467999999999999985 888999998754 344567899999999999999999999999876 678999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCC--CcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI--APHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
|+|.++++.... ..+++.++..++.||+.||+|||+. + |+||||||+|||+++++.+||+|||+......
T Consensus 94 ~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 94 GSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp CBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred CcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999986532 2589999999999999999999965 5 99999999999999999999999988755433
Q ss_pred ccccccceeeCccccccCCCCC---cchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 SAQELMIAYKSPEFLQLGRITK---KTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~---ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.+..++. ++|||||||++|||+||+.||.. ....+........+... .
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~--------~~~~~~~~~~~~~~~~~------~ 231 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD--------LSNMEIGMKVALEGLRP------T 231 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT--------SCHHHHHHHHHHSCCCC------C
T ss_pred cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc--------cChHHHHHHHHhcCCCC------C
Confidence 2345678999999998655544 89999999999999999999962 22233333333222111 1
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
+ .......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 232 ~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 232 I-----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1 11123357788889999999999999999999999865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=356.99 Aligned_cols=260 Identities=18% Similarity=0.166 Sum_probs=199.9
Q ss_pred ccccCccCceeEEEEEecC------CceEEEEEecccChhh-----------HHHHHHHHHHHhccCCCCccceeEEEEe
Q 044996 374 AEILGSGCFGSSYKASLST------GAMMVVKRFKQMNNVG-----------REEFQEHMRRLGRLRHPNLLPLVAYYYR 436 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~H~niv~l~~~~~~ 436 (678)
.+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++||||+++++++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 4679999999999998754 4789999987543211 1224456667788899999999999986
Q ss_pred C----CceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec--CC
Q 044996 437 K----EEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN--ES 510 (678)
Q Consensus 437 ~----~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~ 510 (678)
. ...+|||||+ +|+|.+++..... .+++.+++.|+.||+.||+|||+. +|+||||||+|||++ .+
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEANAK----RFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEESSCT
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEEecCCC
Confidence 5 4489999999 9999999986432 599999999999999999999977 899999999999999 88
Q ss_pred CceEEeecCCccccCccc-----------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCC
Q 044996 511 LEPVLADYGLIPVMNQES-----------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKA 579 (678)
Q Consensus 511 ~~~kl~DfGla~~~~~~~-----------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~ 579 (678)
+.+||+|||+++.+.... ...+|..|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~---- 266 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK---- 266 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT----
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc----
Confidence 999999999997765432 12278899999999988999999999999999999999999973211
Q ss_pred CCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 580 DGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 580 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
......+....... ...+++++.+..... ...+.+++..||+.||.+||++.+|++.|+++......
T Consensus 267 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 267 DPKYVRDSKIRYRE--NIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp CHHHHHHHHHHHHH--CHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHhhh--hHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 11222222222211 122344444322222 34577788899999999999999999999998765443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.44 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=187.3
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccCh----hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNN----VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +..+|||+++.... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 467999999999999874 88899999875322 2356789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC--------CCceEEeecCCc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE--------SLEPVLADYGLI 521 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~--------~~~~kl~DfGla 521 (678)
++|.+++... .+++..+..++.|++.||+|||+.. ..+|+||||||+|||++. ++.+||+|||++
T Consensus 91 ~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~-~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 91 GPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEA-IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSS-SSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC-CCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 9999998632 5899999999999999999999861 012889999999999986 778999999999
Q ss_pred cccCccc--cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 522 PVMNQES--AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 522 ~~~~~~~--~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
+...... ...++..|+|||++.+..++.++||||||+++|||++|+.||... .-.............. .
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~~~~~-~ 234 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--------DGLAVAYGVAMNKLAL-P 234 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS--------CHHHHHHHHHTSCCCC-C
T ss_pred cccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHhhhcCCCCC-C
Confidence 7655432 334678899999999889999999999999999999999999621 1112222222111111 0
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
........+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 235 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 235 ----------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0111234577888899999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.69 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=204.9
Q ss_pred hccccCccCceeEEEEEec--------CCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEE
Q 044996 373 SAEILGSGCFGSSYKASLS--------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLL 442 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 442 (678)
..+.||+|+||.||+|... ++..||+|+++.. .....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence 3567999999999999863 4678999999754 334567899999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC
Q 044996 443 VHEFVPKRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL 511 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 511 (678)
||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~ 194 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTENN 194 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTC
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCccceEEEcCCC
Confidence 99999999999999865421 112489999999999999999999976 899999999999999999
Q ss_pred ceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChH
Q 044996 512 EPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLA 584 (678)
Q Consensus 512 ~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~ 584 (678)
.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~--------~~~~ 266 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG--------IPVE 266 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc--------CCHH
Confidence 99999999997664321 2234577999999988889999999999999999999 9999862 2333
Q ss_pred HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCcccc
Q 044996 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFYS 657 (678)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~~~~ 657 (678)
+......... .. . ........+.+++.+||+.||.+|||+.|+++.|+++......++++.
T Consensus 267 ~~~~~~~~~~-~~-~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~~~ 327 (334)
T 2pvf_A 267 ELFKLLKEGH-RM-D----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327 (334)
T ss_dssp HHHHHHHHTC-CC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC------
T ss_pred HHHHHHhcCC-CC-C----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCcccC
Confidence 3332222211 11 0 011123457788889999999999999999999999988776665543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.24 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=205.7
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
..+.||+|+||.||+|.. .++..||+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 356799999999999975 346789999997543 34567899999999999 9999999999999999999999
Q ss_pred eccCCCCHHHHhhccCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC
Q 044996 445 EFVPKRSLAVNLHGHQAL-------------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL 511 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~ 511 (678)
||+++|+|.+++...... ....+++.+++.++.||+.||+|||+. +|+||||||+|||+++++
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGR 182 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETTT
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEcCCC
Confidence 999999999999865321 112489999999999999999999976 899999999999999999
Q ss_pred ceEEeecCCccccCcccc------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChH
Q 044996 512 EPVLADYGLIPVMNQESA------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLA 584 (678)
Q Consensus 512 ~~kl~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~ 584 (678)
.+||+|||+++....... ..++..|+|||++.+..++.++|||||||++|||+| |+.||... ...
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~ 254 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM--------PVD 254 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--------CSS
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc--------cch
Confidence 999999999987654321 234567999999988899999999999999999999 99998621 111
Q ss_pred HHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 585 SWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 585 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
..+......+... . ........+.+++.+||+.||.+|||+.|+++.|+++.....+
T Consensus 255 ~~~~~~~~~~~~~--~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 255 SKFYKMIKEGFRM--L---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HHHHHHHHHTCCC--C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred hHHHHHhccCCCC--C---------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 2222222222111 0 0111234577888899999999999999999999998876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.92 Aligned_cols=241 Identities=23% Similarity=0.319 Sum_probs=197.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 46799999999999986 578899999987532 2334678999999999999999999999999999999999997
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 138 g~l~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 138 GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 788888865432 589999999999999999999977 799999999999999999999999999988876666
Q ss_pred ccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 QELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 ~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..++..|+|||++. .+.++.++|||||||++|||++|+.||.. ......+.......... +.
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~--------~~~~~~~~~~~~~~~~~-------~~ 274 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSALYHIAQNESPA-------LQ 274 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSCCCC-------CC
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHHhcCCCC-------CC
Confidence 67889999999884 56789999999999999999999999862 23333333333322111 10
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
... ....+.+++.+||+.||++|||+.++++.
T Consensus 275 ~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 SGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC----CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 12346778889999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=375.68 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=204.1
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
..+.||+|+||.||+|.+..+..||||+++... ...++|.+|+++|++++|||||++++++.+ +..+||||||++|+|
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL 348 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 348 (535)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred hheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence 356799999999999999888889999998643 346789999999999999999999999865 678999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.++|+.... ..+++.+++.|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 349 ~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 349 LDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp HHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred HHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 999975422 1589999999999999999999976 79999999999999999999999999998765431
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||++....++.++|||||||+||||+| |+.||.. ....+.+... ..+... .
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~--------~~~~~~~~~i-~~~~~~-~------- 484 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--------MVNREVLDQV-ERGYRM-P------- 484 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT--------CCHHHHHHHH-HTTCCC-C-------
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHH-HcCCCC-C-------
Confidence 2234678999999998999999999999999999999 9999962 2222222222 222111 0
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
........+.+++.+||+.||++|||+.+|++.|+++....+
T Consensus 485 ---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 485 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 011223457788889999999999999999999998865443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.79 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=195.1
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|+.. ++.||+|++... ...+.|.+|++++++++||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 467999999999999874 788999998643 45678999999999999999999999885 4589999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc-eEEeecCCccccCcc-cccc
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE-PVLADYGLIPVMNQE-SAQE 531 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~-~kl~DfGla~~~~~~-~~~~ 531 (678)
+++..... .+.+++..++.++.|+++||+|||+.. ..+|+||||||+|||++.++. +||+|||+++..... ....
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (307)
T 2eva_A 88 NVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164 (307)
T ss_dssp HHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred HHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCC
Confidence 99986532 224789999999999999999999732 137999999999999998886 799999999765433 2335
Q ss_pred ccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCC
Q 044996 532 LMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNS 611 (678)
Q Consensus 532 ~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 611 (678)
++..|+|||++.+..++.++|||||||++|||+||+.||.... ........... .+... .. .
T Consensus 165 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~-~~~~~-~~----------~ 226 (307)
T 2eva_A 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG------GPAFRIMWAVH-NGTRP-PL----------I 226 (307)
T ss_dssp CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC------SSHHHHHHHHH-TTCCC-CC----------B
T ss_pred CCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC------ccHHHHHHHHh-cCCCC-Cc----------c
Confidence 7889999999998899999999999999999999999997321 11111111111 11111 10 0
Q ss_pred HHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 612 EGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 612 ~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
......+.+++.+||+.||.+|||+.|+++.|+.+......
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11223467788899999999999999999999999876554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=378.00 Aligned_cols=246 Identities=21% Similarity=0.331 Sum_probs=198.8
Q ss_pred ccCccCceeEEEEEec---CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 376 ILGSGCFGSSYKASLS---TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++++|.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999764 45679999998643 3457889999999999999999999999976 56999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.+++..... .+++.++..|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 422 L~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 9999975432 599999999999999999999976 79999999999999999999999999998764332
Q ss_pred ----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 ----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
...+++.|+|||++.+..++.++|||||||+||||+| |+.||... ...+... .+..+... .
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--------~~~~~~~-~i~~~~~~-~---- 559 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEVMA-FIEQGKRM-E---- 559 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CSHHHHH-HHHTTCCC-C----
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------CHHHHHH-HHHcCCCC-C----
Confidence 1223468999999998999999999999999999998 99999721 1222222 22222111 0
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.+......+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 560 ------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 560 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp ------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 11123346788889999999999999999999999875543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=353.52 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=199.9
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
..+.||+|+||.||+|.. .++..||+|.++... ....+.+.+|+.++.++ +||||+++++++...+..++||
T Consensus 49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence 457899999999999985 245679999997532 33456899999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHhhccCCC------------------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEE
Q 044996 445 EFVPKRSLAVNLHGHQAL------------------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVL 506 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NIL 506 (678)
||+++|+|.+++...... ....+++..++.++.||+.||+|||+. +|+||||||+|||
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl 204 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVL 204 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGEE
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEE
Confidence 999999999999865321 012489999999999999999999976 8999999999999
Q ss_pred ecCCCceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCC
Q 044996 507 LNESLEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKA 579 (678)
Q Consensus 507 l~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~ 579 (678)
++.++.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~------ 278 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI------ 278 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC------
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC------
Confidence 9999999999999997664332 1234567999999988899999999999999999998 99999622
Q ss_pred CCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCcc
Q 044996 580 DGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDF 655 (678)
Q Consensus 580 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~~ 655 (678)
.....+...+..+... . ........+.+++.+||+.||.+|||+.|+++.|+.+.....++.+
T Consensus 279 --~~~~~~~~~~~~~~~~-~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 341 (344)
T 1rjb_A 279 --PVDANFYKLIQNGFKM-D----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMY 341 (344)
T ss_dssp --CCSHHHHHHHHTTCCC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--------
T ss_pred --CcHHHHHHHHhcCCCC-C----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHHh
Confidence 1112222333322111 0 0111234577788899999999999999999999999887665543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=354.67 Aligned_cols=243 Identities=21% Similarity=0.302 Sum_probs=199.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|... +++.+|+|.+..........+.+|+++|++++||||+++++++.+.+..++||||+++|+|
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L 135 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence 467999999999999864 6889999999876666677899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC--CCceEEeecCCccccCccc--
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE--SLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~~-- 528 (678)
.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 136 ~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 136 FDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp HHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999875432 589999999999999999999976 8999999999999974 5789999999998765432
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...+|..|+|||++.+..++.++|||||||++|||++|+.||.. ....+.+.......... ++...
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~--------~~~~~~~~~i~~~~~~~----~~~~~- 274 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG--------EDDLETLQNVKRCDWEF----DEDAF- 274 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHHCCCCC----CSSTT-
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC----Ccccc-
Confidence 23568899999999988999999999999999999999999962 22233333333222111 11110
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||+.||.+|||+.|+++
T Consensus 275 ----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 ----SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 112235678888999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.06 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=202.5
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
..+.||+|+||.||+|.. .++..||||+++.. .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence 356799999999999975 23578999998754 34456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCC-------------------CCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEE
Q 044996 446 FVPKRSLAVNLHGHQALG-------------------QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVL 506 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NIL 506 (678)
|+++|+|.+++......+ ...+++.+++.++.||+.||+|||+. +|+||||||+|||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dikp~NIl 182 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KLVHRDLAARNIL 182 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CCcccccchheEE
Confidence 999999999998654211 12488999999999999999999976 7999999999999
Q ss_pred ecCCCceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCC
Q 044996 507 LNESLEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKA 579 (678)
Q Consensus 507 l~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~ 579 (678)
+++++.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----- 257 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP----- 257 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence 9999999999999997654321 2234577999999988889999999999999999999 999986221
Q ss_pred CCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 580 DGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 580 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
..... ..+..+... . ........+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 258 ---~~~~~-~~~~~~~~~-~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 ---PERLF-NLLKTGHRM-E----------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp ---GGGHH-HHHHTTCCC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HHHHH-HHhhcCCcC-C----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 11111 112221111 0 0111234577888899999999999999999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=349.41 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=197.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh------hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... +|..||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence 467999999999999865 688999999975432 2357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC----ceEEeecCCcc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL----EPVLADYGLIP 522 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla~ 522 (678)
+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||+++++ .+||+|||+++
T Consensus 97 ~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 97 VSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp CCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999997542 589999999999999999999976 899999999999998877 79999999998
Q ss_pred ccCcc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 523 VMNQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 523 ~~~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
.+... ....++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+...........
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~--------~~~~~~~~~i~~~~~~--- 236 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANITAVSYD--- 236 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHTTCCC---
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhcCCC---
Confidence 76543 233478899999999988999999999999999999999999962 2223333333322111
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+++..... ....+.+++.+||..||.+|||+.|+++
T Consensus 237 -~~~~~~~~-----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FDEEFFSQ-----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCHHHHTT-----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCchhccC-----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11221111 1234677888999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=344.68 Aligned_cols=243 Identities=22% Similarity=0.300 Sum_probs=197.2
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEecccCh------hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
..+.||+|+||.||+|... ++..||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEE
Confidence 3567999999999999874 688999999875322 246789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC----ceEEeecCCc
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL----EPVLADYGLI 521 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla 521 (678)
|+++|+|.+++.... .+++.++..++.||+.||.|||+. +|+||||||+|||+++++ .+||+|||++
T Consensus 95 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 95 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp CCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred cCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999997542 589999999999999999999976 899999999999999887 8999999999
Q ss_pred cccCcc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 522 PVMNQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 522 ~~~~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
+..... ....++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+............
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~~~~~~~~~- 236 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANVSAVNYEF- 236 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHHTCCCC-
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC--------CCHHHHHHHHHhcCCCc-
Confidence 876432 233467889999999988999999999999999999999999962 22223332222221111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...... .....+.+++.+||+.||.+|||+.|+++
T Consensus 237 ---~~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 ---EDEYFS-----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ---CHHHHT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---Cccccc-----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111 11234677888999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=338.70 Aligned_cols=246 Identities=23% Similarity=0.375 Sum_probs=194.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhh-------HHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVG-------REEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
.+.||+|+||.||+|+. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+. .++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--TEEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--CeEEEE
Confidence 46799999999999987 478899999986432211 16789999999999999999999998554 379999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCC--CcccCCCCCCEEecCCCc-----eEEeec
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI--APHGHIKSSNVLLNESLE-----PVLADY 518 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrdlk~~NILl~~~~~-----~kl~Df 518 (678)
|+++|+|.+++..... .+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +||+||
T Consensus 102 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 102 FVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp CCTTCBHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred ecCCCCHHHHHhcccC----CccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 9999999998876432 599999999999999999999966 6 999999999999988776 999999
Q ss_pred CCccccCcc-ccccccceeeCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC
Q 044996 519 GLIPVMNQE-SAQELMIAYKSPEFLQ--LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD 595 (678)
Q Consensus 519 Gla~~~~~~-~~~~~~~~y~aPE~~~--~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 595 (678)
|+++..... ....++..|+|||++. ...++.++|||||||++|||++|+.||.... ..-..+.......+.
T Consensus 174 g~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 174 GLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS------YGKIKFINMIREEGL 247 (287)
T ss_dssp TTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC------CCHHHHHHHHHHSCC
T ss_pred CccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc------ccHHHHHHHHhccCC
Confidence 999765543 2345678899999984 4557899999999999999999999997321 112222222222221
Q ss_pred ccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 596 NRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.. .+ .......+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 248 ~~------~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 RP------TI-----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CC------CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CC------CC-----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 11 112234577888899999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.90 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=196.4
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhc--cCCCCccceeEEEEeC----CceEEEEec
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGR--LRHPNLLPLVAYYYRK----EEKLLVHEF 446 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~----~~~~lv~Ey 446 (678)
..+.||+|+||.||+|+.. ++.||||++... ....+..|.+++.. ++||||+++++++... ...++||||
T Consensus 41 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred EEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 3578999999999999875 889999998643 23444555555555 4999999999999887 678999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC----CCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL----PSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
+++|+|.++++.. .+++..++.++.|++.||+|||..+ +..+|+||||||+|||++.++.+||+|||+++
T Consensus 117 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 117 HENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 9999999999754 4899999999999999999999641 12279999999999999999999999999997
Q ss_pred ccCccc--------cccccceeeCccccccCCCCCc------chHHHHHHHHHHHHhC----------CCCccccccCCC
Q 044996 523 VMNQES--------AQELMIAYKSPEFLQLGRITKK------TDVWSLGVLILEIMTG----------KFPANFLQQGKK 578 (678)
Q Consensus 523 ~~~~~~--------~~~~~~~y~aPE~~~~~~~t~k------sDvwS~Gvvl~el~tg----------~~P~~~~~~~~~ 578 (678)
.+.... ...++..|+|||++.+..++.+ +|||||||++|||+|| +.||......
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~-- 268 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS-- 268 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS--
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC--
Confidence 654332 2346789999999987766665 9999999999999999 5555422111
Q ss_pred CCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 579 ADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 579 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
...... +......... .+.+.......+....+.+++.+||+.||.+|||+.||++.|+++.+..
T Consensus 269 -~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 269 -DPSYED-MREIVCIKKL-----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp -SCCHHH-HHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -CCchhh-hHHHHhhhcc-----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 112222 2222211111 1111111112356777899999999999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=339.21 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=201.7
Q ss_pred ccccCccCceeEEEEEecC-C---ceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCce-EEEEecc
Q 044996 374 AEILGSGCFGSSYKASLST-G---AMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEK-LLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lv~Ey~ 447 (678)
.++||+|+||+||+|...+ + ..+|+|.+.... ....+.|.+|++++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4679999999999997532 2 368999987543 34567899999999999999999999999876655 9999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
.+|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 106 ~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 106 CHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999997643 2589999999999999999999977 7999999999999999999999999999765432
Q ss_pred --------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 528 --------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 528 --------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
....++..|+|||.+.+..++.++|||||||++|||++|+.|+... .+..+...... .+... .
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~-------~~~~~~~~~~~-~~~~~-~ 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH-------IDPFDLTHFLA-QGRRL-P 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-------SCGGGHHHHHH-TTCCC-C
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc-------CCHHHHHHHhh-cCCCC-C
Confidence 1223567899999999989999999999999999999966664311 11111211111 11111 0
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCcc
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDF 655 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~~ 655 (678)
........+.+++.+||+.||.+|||+.|+++.|+++......+.+
T Consensus 249 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 249 ----------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred ----------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 0111223577888899999999999999999999999887766554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=340.97 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=198.5
Q ss_pred ccccCccCceeEEEEEecC----CceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEe-CCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLST----GAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYR-KEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~Ey~ 447 (678)
.++||+|+||.||+|.... ...+++|.+.... ....+.+.+|+.++++++||||++++++|.. ++..++||||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 4679999999999998632 2358899887533 3456789999999999999999999999754 55789999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 110 ~~~~L~~~l~~~~~----~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 110 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp TTCBHHHHHHCTTC----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999975432 589999999999999999999976 8999999999999999999999999999866433
Q ss_pred c--------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 528 S--------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 528 ~--------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
. ...++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...+ ...........
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~---~~~~~~~~~~~- 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDI---TVYLLQGRRLL- 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-----TTTH---HHHHHTTCCCC-
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-----HHHH---HHHHhcCCCCC-
Confidence 2 2234567999999998899999999999999999999 555554211 1121 22222111110
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCc
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDED 654 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 654 (678)
.+ ......+.+++.+||+.||.+|||+.|+++.|+++......+.
T Consensus 253 ---~~--------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~~ 297 (298)
T 3f66_A 253 ---QP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297 (298)
T ss_dssp ---CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCSC
T ss_pred ---CC--------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence 01 1122357788889999999999999999999999988665543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.94 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=202.1
Q ss_pred cccCccCceeEEEEEec---CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASLS---TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
+.||+|+||.||+|... ++..||+|.++.. .....+.+.+|++++++++||||+++++++ ..+..++||||+++|
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 37999999999999753 5778999999864 344567899999999999999999999999 556799999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++..... .+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 95 PLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CHHHHHHhCCc----cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 99999975432 589999999999999999999976 89999999999999999999999999998764321
Q ss_pred -----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 529 -----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 529 -----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...+...... .+... .
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~i~-~~~~~-~--- 233 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEVMAFIE-QGKRM-E--- 233 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CTHHHHHHHH-TTCCC-C---
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHh-cCCcC-C---
Confidence 1234678999999988889999999999999999999 99999621 2222222222 22111 0
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCC
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDE 653 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~ 653 (678)
.+......+.+++.+||+.||.+||++.|+++.|+++....+..
T Consensus 234 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 234 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp -------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 01122345778888999999999999999999999987655443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=349.98 Aligned_cols=243 Identities=20% Similarity=0.252 Sum_probs=196.9
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
..+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 33 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 3578999999999999864 6889999999753 334557789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC---CceEEeecCCccccCc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES---LEPVLADYGLIPVMNQ 526 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~ 526 (678)
|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 113 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 113 GELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999987542 589999999999999999999977 89999999999999865 4599999999987654
Q ss_pred cc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 527 ES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 527 ~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||.. .+............... ..+
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~--------~~~~~~~~~i~~~~~~~---~~~ 252 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--------EDQHRLYAQIKAGAYDY---PSP 252 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCCCC---CTT
T ss_pred CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhCCCCC---Ccc
Confidence 32 23568899999999988999999999999999999999999962 22233333333222111 011
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. ......+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 253 EW------DTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp GG------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc------cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 011234677888999999999999999876
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=343.91 Aligned_cols=242 Identities=20% Similarity=0.264 Sum_probs=198.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|... ++..+|+|.++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 467999999999999865 5788999988753 34556789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC--CCceEEeecCCccccCccc--
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE--SLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~~-- 528 (678)
.+++..... .+++.++..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+....
T Consensus 89 ~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 89 FERINTSAF----ELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp HHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 999975432 589999999999999999999976 8999999999999997 7899999999998765432
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+.+.......... +.....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~~~----~~~~~~ 228 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA--------ETNQQIIENIMNAEYTF----DEEAFK 228 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCCCC----CHHHHT
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC--------CCHHHHHHHHHcCCCCC----Chhhhc
Confidence 23467889999999888889999999999999999999999962 23334444444332111 111100
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.....+.+++.+||+.||.+|||+.|+++
T Consensus 229 -----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 229 -----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11234677888999999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=345.27 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=193.7
Q ss_pred hccccCccCceeEEEEEec----CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC-----ceE
Q 044996 373 SAEILGSGCFGSSYKASLS----TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE-----EKL 441 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~ 441 (678)
..+.||+|+||.||+|... ++..||+|.++.. .....+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence 4578999999999999764 3457999998753 3444577999999999999999999999998755 359
Q ss_pred EEEeccCCCCHHHHhhccCC-CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCC
Q 044996 442 LVHEFVPKRSLAVNLHGHQA-LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL 520 (678)
Q Consensus 442 lv~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 520 (678)
+||||+++|+|.+++..... .....+++.+++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEEeecCc
Confidence 99999999999999864321 1234699999999999999999999965 899999999999999999999999999
Q ss_pred ccccCcc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 521 IPVMNQE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 521 a~~~~~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
++..... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||... ............
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~~~~~~~~ 265 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV--------QNHEMYDYLLHG 265 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CGGGHHHHHHTT
T ss_pred ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC--------CHHHHHHHHHcC
Confidence 9765432 12234678999999998999999999999999999999 89998621 112222222221
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
. .. . ........+.+++.+||+.||.+|||+.++++.|+++....++
T Consensus 266 ~-~~-~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 266 H-RL-K----------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp C-CC-C----------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred C-CC-C----------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1 11 0 0111234577888899999999999999999999999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.03 Aligned_cols=264 Identities=20% Similarity=0.291 Sum_probs=205.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC--ceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE--EKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~Ey~~~ 449 (678)
.++||+|+||+||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 467999999999999875 48899999997543 344677889999999999999999999998765 67999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe----cCCCceEEeecCCccccC
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL----NESLEPVLADYGLIPVMN 525 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGla~~~~ 525 (678)
|+|.+++...... ..+++.++..|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 ~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 94 GSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999865431 2489999999999999999999976 89999999999999 888899999999998765
Q ss_pred ccc---cccccceeeCccccc--------cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 526 QES---AQELMIAYKSPEFLQ--------LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 526 ~~~---~~~~~~~y~aPE~~~--------~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
... ...++..|+|||++. +..++.++|||||||++|||+||+.||..... .....+.+...+...
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG----PRRNKEVMYKIITGK 243 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC----GGGCHHHHHHHHHHC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----cchhHHHHHHHhcCC
Confidence 432 234678999999886 46789999999999999999999999973221 122233344443322
Q ss_pred Cc--cccc---------cchhhh-cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 595 DN--RTEV---------FDKEMA-DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 595 ~~--~~~~---------~d~~l~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
.. ...+ .++.+. ...........+.+++.+||+.||++|||++|+++...+..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11 0000 000111 01123455667888999999999999999999999887653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=346.63 Aligned_cols=254 Identities=13% Similarity=0.094 Sum_probs=202.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|.. .+++.||||.+.... ..+.+.+|+++++++ +||||+++++++...+..++||||+ +|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 46799999999999985 578899999987532 234688999999999 9999999999999999999999999 999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc-----eEEeecCCccccCc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE-----PVLADYGLIPVMNQ 526 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~-----~kl~DfGla~~~~~ 526 (678)
|.+++..... .+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.+..
T Consensus 91 L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 91 LEDLFDLCDR----TFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred HHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999986422 599999999999999999999976 8999999999999999887 99999999986543
Q ss_pred c-----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC
Q 044996 527 E-----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD 595 (678)
Q Consensus 527 ~-----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 595 (678)
. ....+|..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+..........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-----~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-----ADTLKERYQKIGDTKR 237 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CSSHHHHHHHHHHHHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-----cccHHHHHHHHHhhhc
Confidence 2 13346789999999999999999999999999999999999997321 1233333322221110
Q ss_pred ccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 596 NRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
.. ....+ .. ... .+.+++..||+.||.+||++.+|++.|+++....+.
T Consensus 238 ~~---~~~~~-~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 238 AT---PIEVL-CE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HS---CHHHH-TT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cC---CHHHH-hc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 00 00000 00 012 688888899999999999999999999998766543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=345.12 Aligned_cols=240 Identities=19% Similarity=0.282 Sum_probs=190.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc------------
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE------------ 439 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------------ 439 (678)
.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++|||||+++++|.+...
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 467999999999999875 78999999997533 3456789999999999999999999999866432
Q ss_pred ---------------------------------------------eEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHH
Q 044996 440 ---------------------------------------------KLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK 474 (678)
Q Consensus 440 ---------------------------------------------~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~ 474 (678)
.++||||+++|+|.+++...... ....+..++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~ 168 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--EDREHGVCLH 168 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG--GGSCHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc--cchhhHHHHH
Confidence 79999999999999999865432 2467778999
Q ss_pred HHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----------------cccccceeeC
Q 044996 475 IVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----------------AQELMIAYKS 538 (678)
Q Consensus 475 i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----------------~~~~~~~y~a 538 (678)
++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...++..|+|
T Consensus 169 i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 169 IFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 999999999999976 89999999999999999999999999998765431 2246788999
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHH
Q 044996 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKL 618 (678)
Q Consensus 539 PE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 618 (678)
||++.+..++.++|||||||++|||++|..|+... ........ ... . +.. .......+
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~~-~~~-~-----~~~-----~~~~~~~~ 302 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDVR-NLK-F-----PLL-----FTQKYPQE 302 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHHH-TTC-C-----CHH-----HHHHCHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHhh-ccC-C-----Ccc-----cccCChhH
Confidence 99999889999999999999999999998876411 11111111 110 0 000 01223456
Q ss_pred HHHHhhcCccccccCCCHHHHHH
Q 044996 619 LKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 619 ~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+++.+||+.||.+|||+.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 78888999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=348.80 Aligned_cols=238 Identities=22% Similarity=0.246 Sum_probs=193.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|.+++..+ +||||+++++++.+.+..|+||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 467999999999999864 6889999999753 233456788999999988 79999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 108 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 108 GGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 999999997653 489999999999999999999976 8999999999999999999999999999864322
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....+.......
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--------~~~~~~~~~i~~~~~~~------- 243 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA--------ENEDDLFEAILNDEVVY------- 243 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC-------
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCCC-------
Confidence 223478899999999988899999999999999999999999962 23334444444332111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCH------HHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDL------KEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~------~ev~~ 641 (678)
+......+.+++.+||+.||.+||++ .|+++
T Consensus 244 ------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 ------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11112346677889999999999998 66654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=350.76 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=194.4
Q ss_pred ccccCccCceeEEEEEec-CCce----EEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGAM----MVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|... ++.. |++|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 467999999999999864 4443 7777775432 233456788999999999999999999986 56789999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 97 ~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 97 PLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp TTCBSHHHHHSSGG----GSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred CCCCHHHHHHHccc----cCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999976532 589999999999999999999977 7999999999999999999999999999876443
Q ss_pred c------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 S------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
. ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ...... ..+..+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~-~~~~~~~~~--- 236 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL--------RLAEVP-DLLEKGERL--- 236 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--------CTTHHH-HHHHTTCBC---
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc--------CHHHHH-HHHHcCCCC---
Confidence 2 2234568999999998999999999999999999999 99999721 111111 222222111
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
..+. .....+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 237 ~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 AQPQ--------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CCCT--------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCC--------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011 1122367788899999999999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=356.43 Aligned_cols=243 Identities=19% Similarity=0.215 Sum_probs=196.1
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
..+.||+|+||.||+|.. .+++.+|+|++.... ....+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 15 i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 356799999999999975 578899999987533 34456789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec---CCCceEEeecCCccccCc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN---ESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~ 526 (678)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++....
T Consensus 95 g~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 95 GELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999998653 589999999999999999999976 899999999999998 568899999999987654
Q ss_pred cc----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 527 ES----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 527 ~~----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||.. .+............... ..
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~--------~~~~~~~~~i~~~~~~~---~~ 234 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD--------EDQHRLYQQIKAGAYDF---PS 234 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHTCCCC---CT
T ss_pred CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC--------ccHHHHHHHHHhCCCCC---Cc
Confidence 32 23578899999999988999999999999999999999999962 22233333333222111 11
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.. ......+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 PEW------DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTT------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccc------ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111 012234677888999999999999999987
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=352.98 Aligned_cols=242 Identities=20% Similarity=0.274 Sum_probs=189.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+|+||+||+|+.. +++.+|+|+++... ....+.+.+|..++.++ +|||||++++++.+.+..++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 568999999999999875 57889999997532 22334578899999887 89999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc--
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ-- 526 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~-- 526 (678)
+|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 137 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 137 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 999999998653 489999999999999999999976 899999999999999999999999999986322
Q ss_pred --cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 527 --ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 527 --~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
.....+|..|+|||++.+..++.++|||||||++|||++|+.||..............+++..........
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------- 280 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------- 280 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-------
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-------
Confidence 12335788999999999999999999999999999999999999632211111112222232222221110
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
.+......+.+++.+||+.||.+||++
T Consensus 281 -----~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 -----IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 011122346778889999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=350.65 Aligned_cols=246 Identities=16% Similarity=0.240 Sum_probs=195.8
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccC-----hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-----NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 107 (351)
T 3c0i_A 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF 107 (351)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 457899999999999976 468999999986421 22467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc---eEEeecCCccc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE---PVLADYGLIPV 523 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGla~~ 523 (678)
+++|+|.+++...... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 108 ~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 108 MDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp CSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 9999999888654321 12589999999999999999999976 8999999999999986654 99999999987
Q ss_pred cCccc----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 524 MNQES----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 524 ~~~~~----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
..... ...++..|+|||++.+..++.++|||||||++|||++|+.||.. .-.............
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~---------~~~~~~~~i~~~~~~--- 250 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG---------TKERLFEGIIKGKYK--- 250 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS---------SHHHHHHHHHHTCCC---
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC---------cHHHHHHHHHcCCCC---
Confidence 65432 23478899999999988999999999999999999999999962 111222222222111
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 251 -~~~~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 -MNPRQWS-----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CCHHHHT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCccccc-----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111 11235677888999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=338.42 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=203.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence 467999999999999875 4788999998754 34567899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 97 LDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp HHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred HHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 999976432 2589999999999999999999987 79999999999999999999999999998765432
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||++.+..++.++||||||+++|||++ |+.||... +............ .. .
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~--------~~~~~~~~~~~~~-~~------~-- 232 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQVYELLEKDY-RM------E-- 232 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CGGGHHHHHHTTC-CC------C--
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhccC-CC------C--
Confidence 1224567999999998899999999999999999999 99998621 1222222121111 10 0
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
........+.+++.+|++.||.+|||+.|+++.|+++....
T Consensus 233 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 233 ---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 01112345778888999999999999999999999887654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=346.88 Aligned_cols=262 Identities=21% Similarity=0.309 Sum_probs=201.8
Q ss_pred ccccCccCceeEEEEEe-----cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe--CCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-----STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR--KEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|++ .++..||||++........+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 46799999999999984 4678999999987766777889999999999999999999999874 4568999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+++|+|.+++..... .+++.+++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 108 LPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp CTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred cCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999986432 489999999999999999999976 899999999999999999999999999986643
Q ss_pred cc-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccC------CCCCCChHHHHHHHHhc
Q 044996 527 ES-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQG------KKADGDLASWVNSVLAN 593 (678)
Q Consensus 527 ~~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~------~~~~~~l~~~~~~~~~~ 593 (678)
.. ...++..|+|||++.+..++.++|||||||++|||++|+.||...... ..........+......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 22 223566799999998888999999999999999999999998632110 00000111111111111
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCc
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDED 654 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~ 654 (678)
+... .........+.+++.+||+.||.+|||+.|+++.|+++.......+
T Consensus 260 ~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 260 GQRL-----------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp TCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred ccCC-----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 1110 0111233457888889999999999999999999999877665443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=339.46 Aligned_cols=249 Identities=21% Similarity=0.394 Sum_probs=189.7
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|+... .+|+|+++.. .....+.|.+|++++++++||||+++++++ .....++||||+++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~ 105 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS 105 (289)
T ss_dssp EEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEE
T ss_pred eeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCc
Confidence 4679999999999998643 5899988743 344567899999999999999999999965 4567899999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 106 LYHHLHASET----KFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp HHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred HHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999975432 589999999999999999999976 7999999999999999999999999998765432
Q ss_pred --ccccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 528 --SAQELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
....++..|+|||++. +..++.++|||||||++|||++|+.||... .-.+.+......+...
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~~~~----- 244 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------NNRDQIIEMVGRGSLS----- 244 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC--------CCHHHHHHHHHHTSCC-----
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc--------chHHHHHHHhcccccC-----
Confidence 1224678899999986 567889999999999999999999999621 1122222222222111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
+.+.. ........+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 245 ~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLSK--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTTS--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchhh--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11100 011223467888889999999999999999999999865
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=342.92 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=201.3
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe----CCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR----KEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.. ....++||||++
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 113 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence 46799999999999986 5789999999877666677889999999999999999999999973 346899999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|.+++...... ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 114 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 114 RGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp TCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 99999999764221 23699999999999999999999977 89999999999999999999999999987654321
Q ss_pred -------------cccccceeeCccccccCC---CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh
Q 044996 529 -------------AQELMIAYKSPEFLQLGR---ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA 592 (678)
Q Consensus 529 -------------~~~~~~~y~aPE~~~~~~---~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~ 592 (678)
...++..|+|||++.... ++.++|||||||++|||++|+.||...... ...+... ..
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~----~~ 261 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVALA----VQ 261 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHHH----HH
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhHH----hh
Confidence 122478899999987543 689999999999999999999999732211 1111111 11
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCC
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDE 653 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~ 653 (678)
..... .........+.+++.+||+.||.+|||+.|+++.|+.+....+.+
T Consensus 262 ~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 262 NQLSI-----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp CC--C-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred ccCCC-----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 11000 000112345778888999999999999999999999998766554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=341.23 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=193.4
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||+||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++ |+
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KD 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EE
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CC
Confidence 46799999999999999889999999987532 2235678899999999999999999999999999999999997 58
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 105 LKKVLDENKT----GLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp HHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred HHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 8888875432 589999999999999999999976 8999999999999999999999999999876432
Q ss_pred ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc--cc-----
Q 044996 528 SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR--TE----- 599 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~--~~----- 599 (678)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+...+...... ..
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT-----DDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----TTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 22346788999999876 568999999999999999999999997321 122222222222111100 00
Q ss_pred --------ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 600 --------VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 600 --------~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.++...... .......++.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000 00011245678888999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=341.67 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=197.6
Q ss_pred ccccCccCceeEEEEEe-----cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-----STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 445 (678)
.+.||+|+||.||+|++ .+++.||+|+++... ....+.+.+|++++++++||||+++++++... ...++|||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 46799999999999983 468899999997532 34457899999999999999999999999876 66899999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 106 FLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred eCCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999965432 589999999999999999999976 89999999999999999999999999998765
Q ss_pred ccc-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcccccc-------CCCCCCChHHHHHHHH
Q 044996 526 QES-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQ-------GKKADGDLASWVNSVL 591 (678)
Q Consensus 526 ~~~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~-------~~~~~~~l~~~~~~~~ 591 (678)
... ...++..|+|||++.+..++.++||||||+++|||+||+.|+..... .... ......+....
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG-QMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG-GGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc-ccCHHHHHHHH
Confidence 432 22356679999999988899999999999999999999999752110 0000 00011111111
Q ss_pred hcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhh
Q 044996 592 ANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647 (678)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~ 647 (678)
..+... .........+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 257 ~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKRL-----------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCCC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCC-----------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111100 011122345778888999999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=346.77 Aligned_cols=237 Identities=19% Similarity=0.245 Sum_probs=191.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 46799999999999986 578899999987431 222457899999999999999999999999999999999999 7
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++.... .+++.++..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 93 g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 93 GELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 89999987653 489999999999999999999987 79999999999999999999999999998765432
Q ss_pred --cccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 --AQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+..+ +.++|||||||++|||++|+.||...... . ....+.....
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~-------------~~~~i~~~~~ 225 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----N-------------LFKKVNSCVY 225 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----T-------------CBCCCCSSCC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----H-------------HHHHHHcCCC
Confidence 3346789999999987776 78999999999999999999999732110 0 0000000000
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..+......+.+++.+||+.||.+|||+.|+++
T Consensus 226 ---~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 ---VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ---CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 001112234677888999999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.46 Aligned_cols=238 Identities=19% Similarity=0.257 Sum_probs=187.0
Q ss_pred ccccCccCceeEEEEEe----cCCceEEEEEecccC----hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL----STGAMMVVKRFKQMN----NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++...+..|+|||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 101 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence 46799999999999986 478999999997542 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 102 YLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999997643 488999999999999999999976 89999999999999999999999999987643
Q ss_pred cc----ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 526 QE----SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 526 ~~----~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||.. .+....+..........
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--------~~~~~~~~~i~~~~~~~---- 240 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG--------ENRKKTIDKILKCKLNL---- 240 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHTCCCC----
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhCCCCC----
Confidence 22 223467889999999988999999999999999999999999962 23333333333322111
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+||+.||.+|| ++.|+++
T Consensus 241 ---------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 241 ---------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011123467788899999999999 6777765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.15 Aligned_cols=239 Identities=21% Similarity=0.243 Sum_probs=187.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh--------------------------hhHHHHHHHHHHHhccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN--------------------------VGREEFQEHMRRLGRLRHPN 426 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~H~n 426 (678)
.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 46799999999999986 4688999999865321 11356889999999999999
Q ss_pred ccceeEEEEe--CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCC
Q 044996 427 LLPLVAYYYR--KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSN 504 (678)
Q Consensus 427 iv~l~~~~~~--~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~N 504 (678)
|+++++++.+ .+..++||||+++|+|.+++.. ..+++.++..++.||+.||+|||+. +|+||||||+|
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~N 167 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDIKPSN 167 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGG
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHH
Confidence 9999999986 5678999999999999876532 2589999999999999999999977 89999999999
Q ss_pred EEecCCCceEEeecCCccccCcc----ccccccceeeCccccccCC---CCCcchHHHHHHHHHHHHhCCCCccccccCC
Q 044996 505 VLLNESLEPVLADYGLIPVMNQE----SAQELMIAYKSPEFLQLGR---ITKKTDVWSLGVLILEIMTGKFPANFLQQGK 577 (678)
Q Consensus 505 ILl~~~~~~kl~DfGla~~~~~~----~~~~~~~~y~aPE~~~~~~---~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~ 577 (678)
||++.++.+||+|||+++..... ....++..|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~----- 242 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD----- 242 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-----
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-----
Confidence 99999999999999999876543 2335688999999997655 37889999999999999999999962
Q ss_pred CCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 578 KADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 578 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.....+........... +. . ......+.+++.+||+.||++|||+.|+++
T Consensus 243 ---~~~~~~~~~~~~~~~~~-----~~---~---~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ---ERIMCLHSKIKSQALEF-----PD---Q---PDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ---SSHHHHHHHHHHCCCCC-----CS---S---SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---ccHHHHHHHHhcccCCC-----CC---c---cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 23333333333221111 00 0 011234677888999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.23 Aligned_cols=238 Identities=18% Similarity=0.220 Sum_probs=197.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 467999999999999874 68899999987532 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-c
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-S 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~ 528 (678)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 91 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 91 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 99999998643 489999999999999999999965 8999999999999999999999999999876543 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...+|..|+|||++.+..++.++|||||||++|||++|+.||.. .+........+......
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~~~~i~~~~~~~----------- 222 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD--------SNTMKTYEKILNAELRF----------- 222 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHCCCCC-----------
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC-----------
Confidence 34578899999999988999999999999999999999999962 23333444444332111
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+|++.||.+|| ++.|+++
T Consensus 223 --p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 --PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 011123466777899999999999 8888874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=337.27 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=201.2
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||.||+|...++..||+|.++... ...+.+.+|++++++++||||+++++++. .+..++||||+++++|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 46799999999999998888899999987543 34678999999999999999999999986 45689999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 96 ~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 96 DFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp HHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred HHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 99975421 1489999999999999999999976 89999999999999999999999999998765432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.++||||||+++|||++ |+.||.. ....+...... .+... ..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~--------~~~~~~~~~~~-~~~~~---~~----- 231 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--------MTNPEVIQNLE-RGYRM---VR----- 231 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--------CCHHHHHHHHH-TTCCC---CC-----
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc--------cCHHHHHHHHh-cccCC---CC-----
Confidence 1234567999999988889999999999999999999 9999862 22222222222 11111 00
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
.......+.+++.+|++.||++|||+.++++.|+++.....
T Consensus 232 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 01123457788889999999999999999999999876543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=375.62 Aligned_cols=244 Identities=22% Similarity=0.337 Sum_probs=197.3
Q ss_pred cccCccCceeEEEEEec---CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLS---TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
+.||+|+||.||+|.+. .+..||||+++... ....++|.+|+++|++++|||||+++++|. .+..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 46999999999999653 45789999997532 344688999999999999999999999996 4568999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.++++... .+++.+++.|+.||+.||+|||+. +|+||||||+||||++++.+||+|||+++.+....
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999997543 589999999999999999999976 79999999999999999999999999998764332
Q ss_pred ------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 529 ------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 529 ------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
...++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+ +...+..+... .
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~--------~~~~~-~~~~i~~~~~~-~-- 592 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG--------MKGSE-VTAMLEKGERM-G-- 592 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--------CCHHH-HHHHHHTTCCC-C--
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CCHHH-HHHHHHcCCCC-C--
Confidence 1234577999999998899999999999999999999 9999962 12222 22222222111 0
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
........+.+++.+||+.||++||++.+|++.|+++..
T Consensus 593 --------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 --------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011223457888889999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=335.84 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=196.2
Q ss_pred ccccCccCceeEEEEEecC----CceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLST----GAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|.... +..||+|.+... .....+.|.+|++++++++||||+++++++.+ +..++||||++
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 95 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYP 95 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCC
Confidence 4679999999999997643 235899998754 34456789999999999999999999999864 56789999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 96 YGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp TCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred CCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999976532 589999999999999999999976 89999999999999999999999999998765432
Q ss_pred -----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 529 -----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 529 -----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
...++..|+|||++.+..++.++||||||+++|||+| |+.||..... ..+ ... +..+... .
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~---~~~-~~~~~~~-~--- 234 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDV---IGV-LEKGDRL-P--- 234 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGH---HHH-HHHTCCC-C---
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHH---HHH-HhcCCCC-C---
Confidence 2234678999999988899999999999999999998 9999962211 111 111 1111111 0
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 235 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 -------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0011223477888899999999999999999999998654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=343.56 Aligned_cols=247 Identities=21% Similarity=0.371 Sum_probs=192.7
Q ss_pred ccccCccCceeEEEEEec-CCce----EEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGAM----MVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|... +++. |++|.+... .....+.+.+|+.++++++||||+++++++... ..++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~~ 98 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 98 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECCC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEec
Confidence 467999999999999864 4443 477776543 344567899999999999999999999999865 488999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 99 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp SSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred CCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999986532 589999999999999999999976 8999999999999999999999999999876433
Q ss_pred c------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 S------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
. ...++..|+|||++.+..++.++|||||||++|||++ |+.||.... .... ...+..+... .
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~-~~~~~~~~~~-~- 239 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEI-SSILEKGERL-P- 239 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------GGGH-HHHHHTTCCC-C-
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC--------HHHH-HHHHHcCCCC-C-
Confidence 2 1234567999999999999999999999999999999 999997321 1111 1122222111 0
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
........+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 240 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 240 ---------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111233577888899999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.61 Aligned_cols=241 Identities=20% Similarity=0.227 Sum_probs=181.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|+.. +++.||||+++.. ...+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 467999999999999875 5788999998754 2456788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---CCceEEeecCCccccCccc-
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---SLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~~- 528 (678)
.+++.... .+++.++..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 136 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 136 FDRIVEKG-----YYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp HHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 99997542 589999999999999999999976 7999999999999975 8999999999998765432
Q ss_pred --cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 --AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||... ..-............. ...+..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~~~~~~~~i~~~~~~---~~~~~~- 275 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE-------RGDQFMFRRILNCEYY---FISPWW- 275 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT-------TCHHHHHHHHHTTCCC---CCTTTT-
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC-------cccHHHHHHHHhCCCc---cCCchh-
Confidence 234678999999999889999999999999999999999999621 1111122222222111 111110
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||+.||++|||+.|+++
T Consensus 276 -----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 276 -----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112335678888999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.81 Aligned_cols=242 Identities=21% Similarity=0.281 Sum_probs=190.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..|+||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 467999999999999875 5889999999753 233456788999999988 89999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 94 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 999999997643 489999999999999999999976 8999999999999999999999999999864221
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....+|..|+|||++.+..++.++|||||||++|||++|+.||................+..........
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------- 237 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------- 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-------
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-------
Confidence 2335788999999999889999999999999999999999999632111110111122222222221110
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
.+......+.+++.+||+.||.+||++
T Consensus 238 -----~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 -----IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 011122346778889999999999995
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=340.97 Aligned_cols=253 Identities=18% Similarity=0.223 Sum_probs=194.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc----eEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE----KLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----~~lv~E 445 (678)
.+.||+|+||.||+|+. .+++.||||+++... ......+.+|++++++++||||+++++++..... .|+|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 46799999999999986 578899999997542 3345678999999999999999999999886554 399999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++|+|.++++... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 97 ~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 97 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 999999999997653 589999999999999999999976 79999999999999999999999999997654
Q ss_pred ccc-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 526 QES-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 526 ~~~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
... ...++..|+|||++.+..++.++|||||||++|||+||+.||.. .................
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~--------~~~~~~~~~~~~~~~~~- 238 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--------DSPVSVAYQHVREDPIP- 238 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHCCCCC-
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHhcCCCCC-
Confidence 321 22367889999999988999999999999999999999999962 23333333333332111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHH-HHHHHHHhhccCCC
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKE-AVEKIEEVKERDGD 652 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e-v~~~L~~i~~~~~~ 652 (678)
+..... .....+.+++.+||+.||.+||++.+ +...+.++....+.
T Consensus 239 ----~~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~ 285 (311)
T 3ork_A 239 ----PSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP 285 (311)
T ss_dssp ----HHHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred ----cccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence 111111 12235777888999999999995554 55567776554433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=345.60 Aligned_cols=237 Identities=22% Similarity=0.284 Sum_probs=193.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++.+.+..|+||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 467999999999999875 68899999997532 23456788899999877 99999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 102 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 999999998643 489999999999999999999976 8999999999999999999999999999864321
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.. .+...............
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~~~~~~~------- 237 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--------QDEEELFHSIRMDNPFY------- 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC-------
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC--------CCHHHHHHHHHhCCCCC-------
Confidence 233568899999999988999999999999999999999999962 23333333333322111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHH-HHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLK-EAV 640 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-ev~ 640 (678)
+......+.+++.+||+.||.+||++. |+.
T Consensus 238 ------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 ------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011123467778899999999999997 664
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=335.88 Aligned_cols=251 Identities=19% Similarity=0.265 Sum_probs=193.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence 467999999999999864 68899999987542 23357799999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 119 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 119 VDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999998643 589999999999999999999976 79999999999999999999999999987664432
Q ss_pred ----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 529 ----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
...++..|+|||++.+..++.++||||||+++|||++|+.||.. .. ...+...+...........
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~-~~~~~~~~~~~~~~~~~~~-- 258 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG--------DQ-LSVMGAHINQAIPRPSTVR-- 258 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS--------CH-HHHHHHHHHSCCCCGGGTS--
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC--------ch-HHHHHHHhccCCCCccccC--
Confidence 23467889999999988999999999999999999999999962 11 1223333322211101111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCC-CHHHHHHHHHHhhccCC
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRL-DLKEAVEKIEEVKERDG 651 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~ev~~~L~~i~~~~~ 651 (678)
. .....+.+++.+||+.||++|| +++++++.|+++.....
T Consensus 259 ---~----~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 259 ---P----GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp ---T----TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ---C----CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 1 1123477788899999999999 99999999998866543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=342.58 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=202.3
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... .+..||+|.+.... ......|.+|++++++++||||+++++++.+.+..++||||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 109 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 109 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence 567999999999999754 36789999987543 34456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCC-----CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCc
Q 044996 447 VPKRSLAVNLHGHQA-----LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 521 (678)
+++|+|.+++..... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIli~~~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMT 185 (322)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEEEcCCCeEEECcCccc
Confidence 999999999975321 1113579999999999999999999977 8999999999999999999999999999
Q ss_pred cccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 522 PVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 522 ~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
+...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+.........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~--------~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNEQVLRFVMEGG 257 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHHHHHHHHHTTC
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc--------CCHHHHHHHHHcCC
Confidence 7654332 2234677999999998899999999999999999999 8999862 22233333322221
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.. .. .......+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 258 -~~-~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 258 -LL-DK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp -CC-CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -cC-CC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11 00 111234577888899999999999999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.72 Aligned_cols=262 Identities=19% Similarity=0.181 Sum_probs=194.5
Q ss_pred ccccCccCceeEEEEEec----CCceEEEEEecccChh-----------hHHHHHHHHHHHhccCCCCccceeEEEEe--
Q 044996 374 AEILGSGCFGSSYKASLS----TGAMMVVKRFKQMNNV-----------GREEFQEHMRRLGRLRHPNLLPLVAYYYR-- 436 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~H~niv~l~~~~~~-- 436 (678)
.+.||+|+||.||+|... .+..+|+|++...... ....+.+|+..+..++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 467999999999999875 5778999998754321 12346788899999999999999999988
Q ss_pred --CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC--c
Q 044996 437 --KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL--E 512 (678)
Q Consensus 437 --~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~--~ 512 (678)
....++||||+ +++|.+++.... .+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++ .
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEESSSTTS
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEccCCCCc
Confidence 67899999999 999999997653 589999999999999999999976 899999999999999887 9
Q ss_pred eEEeecCCccccCcc-----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCC
Q 044996 513 PVLADYGLIPVMNQE-----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADG 581 (678)
Q Consensus 513 ~kl~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~ 581 (678)
+||+|||+++.+... ....++..|+|||++.+..++.++|||||||++|||+||+.||..... ..
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~ 267 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK----DP 267 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT----CH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc----cc
Confidence 999999999766432 222467889999999988999999999999999999999999962110 00
Q ss_pred ChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCcc
Q 044996 582 DLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDF 655 (678)
Q Consensus 582 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~~ 655 (678)
............. +...+............+.+++.+||+.||++||++.+|++.|+++....+..++
T Consensus 268 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~ 335 (345)
T 2v62_A 268 VAVQTAKTNLLDE------LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDF 335 (345)
T ss_dssp HHHHHHHHHHHHT------TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCC
T ss_pred HHHHHHHHhhccc------ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCc
Confidence 1111111111110 1111100000001234577888899999999999999999999987765554444
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.93 Aligned_cols=259 Identities=21% Similarity=0.290 Sum_probs=202.4
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhc--cCCCCccceeEEEEeCC----ceEEEEec
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGR--LRHPNLLPLVAYYYRKE----EKLLVHEF 446 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~lv~Ey 446 (678)
..+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++.... ..++||||
T Consensus 46 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp EEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred EEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 357899999999999987 5889999998643 34677888888887 79999999999998776 78999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC----CCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL----PSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
+++|+|.+++... .+++.+++.++.|++.||+|||... +..+|+||||||+|||++.++.+||+|||+++
T Consensus 122 ~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 195 (342)
T 1b6c_B 122 HEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195 (342)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence 9999999999753 4899999999999999999999310 12379999999999999999999999999997
Q ss_pred ccCccc--------cccccceeeCccccccCC------CCCcchHHHHHHHHHHHHhC----------CCCccccccCCC
Q 044996 523 VMNQES--------AQELMIAYKSPEFLQLGR------ITKKTDVWSLGVLILEIMTG----------KFPANFLQQGKK 578 (678)
Q Consensus 523 ~~~~~~--------~~~~~~~y~aPE~~~~~~------~t~ksDvwS~Gvvl~el~tg----------~~P~~~~~~~~~ 578 (678)
...... ...++..|+|||++.+.. ++.++|||||||++|||+|| +.||.....
T Consensus 196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~--- 272 (342)
T 1b6c_B 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP--- 272 (342)
T ss_dssp EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC---
T ss_pred eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc---
Confidence 654322 224678899999987652 34689999999999999999 778763221
Q ss_pred CCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 579 ADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 579 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.......+........ . .+.+.......+....+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 273 ~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQK-L-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SSCCHHHHHHHHTTSC-C-----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CcccHHHHHHHHHHHH-h-----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 1123344443333221 1 1111111122356778899999999999999999999999999997754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=345.82 Aligned_cols=241 Identities=18% Similarity=0.248 Sum_probs=190.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh-hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN-VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 467999999999999865 788999999865332 234678899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 92 L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999986542 489999999999999999999976 8999999999999999999999999999765422
Q ss_pred --ccccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 --SAQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.+..+ +.++|||||||++|||++|+.||..... .... ........... .+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~-~~~~~~~~~~~----~~- 230 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------SCQE-YSDWKEKKTYL----NP- 230 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT------TSHH-HHHHHTTCTTS----TT-
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch------HHHH-HHHHhcccccC----Cc-
Confidence 12346788999999987765 7899999999999999999999973211 1111 11111111110 00
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ......+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~------~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 W------KKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp G------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c------ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 111234667888999999999999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=337.43 Aligned_cols=256 Identities=20% Similarity=0.260 Sum_probs=196.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|.. .++..||+|+++.. .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence 46799999999999986 57889999998752 344567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++...... ...+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 117 ~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 117 GDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp CBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred CCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 9999998753221 22589999999999999999999976 89999999999999999999999999987664432
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+..++.++||||||+++|||++|+.||... ......+........ .. . +
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~-~~-~-----~ 258 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEQCD-YP-P-----L 258 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHHTTC-SC-C-----C
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc------chhHHHHHHHhhccc-CC-C-----C
Confidence 234678899999999889999999999999999999999998621 123333333332211 11 0 0
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
... .....+.+++.+||+.||.+|||+.||++.|+++.....
T Consensus 259 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 259 PSD----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccc----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 001 122357778889999999999999999999999876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.79 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=200.9
Q ss_pred ccccCccCceeEEEEEe-----cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-----STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~E 445 (678)
.+.||+|+||+||++.+ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 46799999999999865 267899999998643 34567899999999999999999999999874 56899999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++|+|.+++... .+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 116 ~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 116 YVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp CCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred cccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999754 489999999999999999999976 79999999999999999999999999998765
Q ss_pred ccc-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccC------CCCCCChHHHHHHHHh
Q 044996 526 QES-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQG------KKADGDLASWVNSVLA 592 (678)
Q Consensus 526 ~~~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~------~~~~~~l~~~~~~~~~ 592 (678)
... ...++..|+|||++.+..++.++|||||||++|||+||+.||...... ......-...+...+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 432 223456799999999888999999999999999999999998632100 0000000000111111
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
.+... .........+.+++.+||+.||.+|||+.|+++.|+++.+...
T Consensus 266 ~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 266 RGERL-----------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccCC-----------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 11100 0111233567888889999999999999999999999876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=343.73 Aligned_cols=238 Identities=17% Similarity=0.191 Sum_probs=197.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999875 68899999987532 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-c
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-S 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~ 528 (678)
|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 126 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence 99999998653 489999999999999999999976 8999999999999999999999999999876543 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...+|..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+............
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~~~~~~~----------- 257 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA--------DQPIQIYEKIVSGKVRF----------- 257 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC-----------
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC--------CCHHHHHHHHHcCCCCC-----------
Confidence 34578899999999988999999999999999999999999962 23334444443322111
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
+......+.+++.+||+.||.+||+ +.||++
T Consensus 258 --p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 --PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0111234677888999999999998 788765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.56 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=191.6
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||+||+|+..+++.+|+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 46799999999999998889999999987543 22346788999999999999999999999999999999999975 9
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 86 LKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp HHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 9999876432 589999999999999999999976 8999999999999999999999999998765422
Q ss_pred ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh---cCCc--cc---
Q 044996 528 SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA---NGDN--RT--- 598 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~---~~~~--~~--- 598 (678)
....++..|+|||++.+. .++.++|||||||++|||+||+.||... .-.+....... .... ..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV--------SEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHHHCCCChhhchhhh
Confidence 223467889999998754 5899999999999999999999999621 11111111111 1000 00
Q ss_pred --cccchhhhc------ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 --EVFDKEMAD------ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 --~~~d~~l~~------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..+++.+.. ..........+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001111100 0000112345678888999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=343.78 Aligned_cols=257 Identities=23% Similarity=0.398 Sum_probs=202.2
Q ss_pred ccccCccCceeEEEEEe-----cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC--ceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-----STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE--EKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~Ey 446 (678)
.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 125 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence 56799999999999984 468899999998766667788999999999999999999999987654 68999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+++|+|.+++..... .+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 126 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 126 LPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CTTCBHHHHHHHSTT----SSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred CCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999986532 589999999999999999999976 899999999999999999999999999987654
Q ss_pred cc-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcccccc------CCCCC-CChHHHHHHHHh
Q 044996 527 ES-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQ------GKKAD-GDLASWVNSVLA 592 (678)
Q Consensus 527 ~~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~------~~~~~-~~l~~~~~~~~~ 592 (678)
.. ...++..|+|||++.+..++.++|||||||++|||+||+.|+..... ..... ......+...+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 32 12345679999999888899999999999999999999999862110 00000 000111111111
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.+... .........+.+++.+||+.||.+|||+.||++.|+++.+.
T Consensus 278 ~~~~~-----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 278 NNGRL-----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TTCCC-----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCC-----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11110 01112334578888899999999999999999999998763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=339.01 Aligned_cols=255 Identities=14% Similarity=0.125 Sum_probs=201.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++++ +|+||+++++++......++||||+ +++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 46799999999999985 578999999886532 334688899999999 7999999999999999999999999 999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc-----eEEeecCCccccCc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE-----PVLADYGLIPVMNQ 526 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~-----~kl~DfGla~~~~~ 526 (678)
|.+++..... .+++.++..|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 92 L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 92 LEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred HHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999986532 589999999999999999999965 8999999999999987776 99999999976643
Q ss_pred c-----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC
Q 044996 527 E-----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD 595 (678)
Q Consensus 527 ~-----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 595 (678)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ...............
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-----ATNKQKYERIGEKKQ 238 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS-----CCHHHHHHHHHHHHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc-----cccHHHHHHHHhhcc
Confidence 2 122467889999999988999999999999999999999999973211 112222211111100
Q ss_pred ccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 596 NRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
. ...+.+.. .....+.+++.+||+.||++||++++|++.|+++......
T Consensus 239 ~---~~~~~~~~-----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 239 S---TPLRELCA-----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp H---SCHHHHTT-----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred C---ccHHHHHh-----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 0 00011100 1234577888899999999999999999999999876544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.50 Aligned_cols=241 Identities=18% Similarity=0.277 Sum_probs=194.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..|+||||+.+
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 467999999999999864 57889999986432 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 100 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 100 GDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp EEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 99999997642 589999999999999999999976 8999999999999999999999999999876543
Q ss_pred -ccccccceeeCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 528 -SAQELMIAYKSPEFLQL---GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~---~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
....+|..|+|||++.. ..++.++|||||||++|||++|+.||.... ..................
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~~~~~~~~~~~~------ 239 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS-----STSSKEIVHTFETTVVTY------ 239 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT-----TSCHHHHHHHHHHCCCCC------
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC-----CccHHHHHHHHhhcccCC------
Confidence 23457889999999864 458999999999999999999999996221 122233332222221111
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCC-HHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLD-LKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~ev~~ 641 (678)
+......+.+++.+||+.||.+||+ +.+|.+
T Consensus 240 -------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 -------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1112245677888999999999998 666654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=342.25 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=201.4
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCC-ceEEE
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKE-EKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-~~~lv 443 (678)
..+.||+|+||.||+|.. .+++.||||.++... ....+.+.+|++++.++ +||||+++++++...+ ..++|
T Consensus 31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 356799999999999974 356789999997643 34456799999999999 7999999999998755 48999
Q ss_pred EeccCCCCHHHHhhccCCCC-----------CCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc
Q 044996 444 HEFVPKRSLAVNLHGHQALG-----------QPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE 512 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~ 512 (678)
|||+++|+|.+++....... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGC
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCC
Confidence 99999999999998653210 11388999999999999999999976 7999999999999999999
Q ss_pred eEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHH
Q 044996 513 PVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLAS 585 (678)
Q Consensus 513 ~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~ 585 (678)
+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... ....
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--------~~~~ 258 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV--------KIDE 258 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CCSH
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc--------chhH
Confidence 9999999998664322 2234678999999998899999999999999999998 99998621 1112
Q ss_pred HHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 586 WVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.+...+..+... .. .......+.+++.+||+.||.+|||+.||++.|+++....
T Consensus 259 ~~~~~~~~~~~~-~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 259 EFCRRLKEGTRM-RA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHTCCC-CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhccCccC-CC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 222222222111 00 0112235778888999999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=355.22 Aligned_cols=239 Identities=21% Similarity=0.249 Sum_probs=188.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||.||+|.. .+++.||||+++.. .......+.+|++++++++||||++++++|...+..++|||||++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 232 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence 56899999999999976 46889999998753 233446678899999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.||+.||+|||+. .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 233 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 233 GELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhc---CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 99999997653 589999999999999999999972 27999999999999999999999999999864322
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.. .+...............
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--------~~~~~~~~~i~~~~~~~-------- 368 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHEKLFELILMEEIRF-------- 368 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC--------
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC--------CCHHHHHHHHHhCCCCC--------
Confidence 233478899999999999999999999999999999999999962 23333444333332111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+||+.||.+|| ++.|+++
T Consensus 369 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 -----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 011123467788899999999999 9999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=342.10 Aligned_cols=237 Identities=22% Similarity=0.252 Sum_probs=186.4
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
..++||+|+||+||+|... +++.||||++... .......+..|+..+.++ +||||++++++|.+.+..++||||+
T Consensus 61 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~- 139 (311)
T 3p1a_A 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC- 139 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-
T ss_pred eeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-
Confidence 3567999999999999875 7899999988653 233344556666666555 8999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|.+++..... .++|..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 140 ~~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 140 GPSLQQHCEAWGA----SLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp CCBHHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 7799999876532 599999999999999999999976 79999999999999999999999999987765432
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+ .++.++|||||||++|||++|+.|+... ..|. .+..+ ...+.+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~--~~~~~-----~~~~~~ 273 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQ--QLRQG-----YLPPEF 273 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHH--HHTTT-----CCCHHH
T ss_pred CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHH--HHhcc-----CCCccc
Confidence 2346889999999875 7999999999999999999997665411 1111 11111 111122
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 274 ~~-----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TA-----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc-----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 11245778888999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=336.26 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=192.3
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeC-CceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-EEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|.. ++..||+|.++.. ...+.+.+|++++++++||||+++++++... +..++||||+++|+|
T Consensus 26 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 56799999999999987 4889999998753 3457899999999999999999999997654 478999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-cccc
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-SAQE 531 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~~~~ 531 (678)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 103 ~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 175 (278)
T 1byg_A 103 VDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 175 (278)
T ss_dssp HHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred HHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeeccccccccccccCCC
Confidence 999976431 1378999999999999999999976 7999999999999999999999999998765433 2234
Q ss_pred ccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccC
Q 044996 532 LMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERN 610 (678)
Q Consensus 532 ~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 610 (678)
++..|+|||++.+..++.++||||||+++|||+| |+.||... ...+...... .+... ..
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--------~~~~~~~~~~-~~~~~------~~----- 235 (278)
T 1byg_A 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPRVE-KGYKM------DA----- 235 (278)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--------CGGGHHHHHT-TTCCC------CC-----
T ss_pred ccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHh-cCCCC------CC-----
Confidence 5678999999998899999999999999999998 99998621 1122222211 11110 00
Q ss_pred CHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 611 SEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 611 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.......+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 111234577888899999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=346.48 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=201.0
Q ss_pred ccccCccCceeEEEEEecC-C-----ceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLST-G-----AMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E 445 (678)
.+.||+|+||.||+|.... + ..||+|.++... ....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 5679999999999998642 2 479999987543 34567799999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCC---------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEe
Q 044996 446 FVPKRSLAVNLHGHQAL---------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLA 516 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 516 (678)
|+++|+|.+++...... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~ 206 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNVLLTNGHVAKIG 206 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGCEEEGGGEEEBC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceEEECCCCeEEEC
Confidence 99999999999754210 122589999999999999999999976 89999999999999999999999
Q ss_pred ecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHH
Q 044996 517 DYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNS 589 (678)
Q Consensus 517 DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~ 589 (678)
|||+++...... ...++..|+|||++.+..++.++|||||||++|||+| |+.||... .....+..
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--------~~~~~~~~ 278 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI--------LVNSKFYK 278 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC--------CSSHHHHH
T ss_pred ccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc--------chhHHHHH
Confidence 999998654332 1234567999999988899999999999999999999 99998621 11122222
Q ss_pred HHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 590 VLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
....+... .. .......+.+++.+||+.||.+|||+.||++.|+++...
T Consensus 279 ~~~~~~~~---~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 279 LVKDGYQM---AQ--------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHTCCC---CC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCC---CC--------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 22222111 00 011124577888899999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=339.45 Aligned_cols=255 Identities=19% Similarity=0.273 Sum_probs=185.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 88 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND 88 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence 467999999999999864 68899999987543 2334678899999999999999999999999999999999997 69
Q ss_pred HHHHhhccCCC-CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 452 LAVNLHGHQAL-GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 452 L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
|.+++...... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence 99998754321 123589999999999999999999976 8999999999999999999999999999865432
Q ss_pred -ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh---cCCc--ccc-
Q 044996 528 -SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA---NGDN--RTE- 599 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~---~~~~--~~~- 599 (678)
....++..|+|||++.+ ..++.++|||||||++|||+||+.||... .-.+.+..... .... ...
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT--------NDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHHhCCCChhHhhhh
Confidence 23346788999999876 46899999999999999999999999621 11111111111 1000 000
Q ss_pred ----ccchhhh-----------cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 600 ----VFDKEMA-----------DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 600 ----~~d~~l~-----------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...+.+. ...........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000 00000011235778888999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=343.56 Aligned_cols=246 Identities=17% Similarity=0.265 Sum_probs=178.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... +++.||||++.. .....+.+|+.+++++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 367999999999999874 688999999864 34567889999999997 9999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC---ceEEeecCCccccCcc-
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL---EPVLADYGLIPVMNQE- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla~~~~~~- 527 (678)
|.+++.... .+++.++..|+.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 93 LFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp HHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999998653 589999999999999999999976 899999999999997665 8999999999865433
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||........ .....+...... .+... ...+.
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~-~~~~~--~~~~~ 239 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIK-KGDFS--FEGEA 239 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHT-TTCCC--CCSHH
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHH-cCCCC--CCccc
Confidence 223457889999999999999999999999999999999999973221110 112222222222 21110 00010
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ......+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 W------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp H------HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred c------cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0 011345677888999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.06 Aligned_cols=244 Identities=19% Similarity=0.226 Sum_probs=189.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 467999999999999875 78899999987543 3346788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc--eEEeecCCccccCcc---
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE--PVLADYGLIPVMNQE--- 527 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGla~~~~~~--- 527 (678)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 104 ~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 104 YERICNAG-----RFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 99997643 489999999999999999999976 8999999999999987765 999999998754322
Q ss_pred ccccccceeeCccccccCCCCCc-chHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 SAQELMIAYKSPEFLQLGRITKK-TDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~k-sDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++.+..++.+ +|||||||++|||++|+.||.... ........+...........
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~-------- 242 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE----EPRDYRKTIQRILSVKYSIP-------- 242 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTCCCCC--------
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc----cHHHHHHHHHHHhcCCCCCC--------
Confidence 23457889999999988877655 899999999999999999997321 12334444444433221110
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.. ......+.+++.+||+.||.+|||+.|+++.
T Consensus 243 ~~---~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 DD---IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TT---SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred Cc---CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 0112346778889999999999999999873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.46 Aligned_cols=244 Identities=21% Similarity=0.331 Sum_probs=196.1
Q ss_pred ccCccCceeEEEEEe---cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 376 ILGSGCFGSSYKASL---STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.||+|+||.||+|.+ ..+..||||+++... ....+++.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 799999999999964 246789999987542 23367899999999999999999999999 567789999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc-
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA- 529 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 529 (678)
+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 103 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 103 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 9999998643 489999999999999999999976 899999999999999999999999999976643321
Q ss_pred ------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 530 ------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 530 ------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
..++..|+|||++.+..++.++||||||+++|||+| |+.||.. ....+.. ..+..+... .
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~--------~~~~~~~-~~~~~~~~~-~--- 240 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG--------MKGSEVT-AMLEKGERM-G--- 240 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT--------CCHHHHH-HHHHTTCCC-C---
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC--------CCHHHHH-HHHHcCCCC-C---
Confidence 223577999999988889999999999999999999 9999972 1222222 222222111 0
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
........+.+++.+||+.||.+||++.||++.|+++...
T Consensus 241 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 241 -------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0111234577888899999999999999999999988553
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=341.54 Aligned_cols=238 Identities=21% Similarity=0.250 Sum_probs=194.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++.+.+..|+||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 467999999999999875 47889999987532 23456788999999988 89999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc--
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ-- 526 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~-- 526 (678)
+|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 999999998643 489999999999999999999976 899999999999999999999999999986432
Q ss_pred --cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 527 --ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 527 --~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
.....+|..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+............
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--------~~~~~~~~~i~~~~~~~------- 240 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--------EDEDELFQSIMEHNVAY------- 240 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC-------
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC--------CCHHHHHHHHHhCCCCC-------
Confidence 1233578899999999989999999999999999999999999962 23334444444332111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
+......+.+++.+||+.||.+||+ ++|+++
T Consensus 241 ------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 ------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0111234677888999999999995 466654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.52 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=191.5
Q ss_pred ccccCccCceeEEEEEec--CCc--eEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS--TGA--MMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|.+. ++. .||+|+++.. .....+.+.+|++++++++||||+++++++.... .++||||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~ 101 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL 101 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence 467999999999999853 233 5899988753 2345678999999999999999999999997654 8999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+++|+|.+++..... .+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 102 APLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred ccCCCHHHHHHhccC----CcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999986532 589999999999999999999976 899999999999999999999999999977643
Q ss_pred cc-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 527 ES-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 527 ~~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
.. ...++..|+|||++.+..++.++||||||+++|||++ |+.||.. ....+.+..........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~--------~~~~~~~~~~~~~~~~~- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG--------LNGSQILHKIDKEGERL- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTSCCCC-
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc--------CCHHHHHHHHHccCCCC-
Confidence 32 1234567999999988889999999999999999999 9999962 23333443333322111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCC
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDE 653 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~ 653 (678)
. ........+.+++.+||+.||.+|||+.++++.|+++...+...
T Consensus 245 ~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 289 (291)
T 1u46_A 245 P----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289 (291)
T ss_dssp C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred C----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchhh
Confidence 0 01112345778888999999999999999999999987755443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.70 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=198.4
Q ss_pred hccccCccCceeEEEEEe------cCCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASL------STGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
..+.||+|+||.||+|.. .++..||||.+... ......++.+|+.++++++||||+++++++...+..++|||
T Consensus 34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence 356799999999999974 35678999999743 34556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCC--CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---CCceEEeecCC
Q 044996 446 FVPKRSLAVNLHGHQAL--GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---SLEPVLADYGL 520 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGl 520 (678)
|+++|+|.+++...... ....+++.+++.++.||+.||.|||+. +|+||||||+|||++. +..+||+|||+
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 99999999999865421 113589999999999999999999976 7999999999999994 45699999999
Q ss_pred ccccCcc------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 521 IPVMNQE------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 521 a~~~~~~------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~--------~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS--------KSNQEVLEFVTSG 261 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCHHHHHHHHHTT
T ss_pred ccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------cCHHHHHHHHhcC
Confidence 8654221 22345678999999988899999999999999999999 9999862 2222333222222
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
. .. . ........+.+++.+||+.||.+||++.||++.|+.+...
T Consensus 262 ~-~~-~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 G-RM-D----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp C-CC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C-CC-C----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 1 11 0 0011223577888899999999999999999999988653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=348.86 Aligned_cols=192 Identities=22% Similarity=0.282 Sum_probs=167.6
Q ss_pred ccccCcc--CceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSG--CFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+| +||.||+|+.. +++.||||+++... ....+.+.+|++++++++|||||++++++.+.+..++|||||+
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 109 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence 4679999 99999999875 68999999997532 3445778899999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++..... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 110 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 110 YGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp TCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred CCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 9999999986532 2589999999999999999999976 8999999999999999999999999987543211
Q ss_pred ----------ccccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 044996 528 ----------SAQELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPANF 572 (678)
Q Consensus 528 ----------~~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~~ 572 (678)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 11245678999999987 5789999999999999999999999963
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=341.03 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=199.8
Q ss_pred ccccCccCceeEEEEEec-CCce--EEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAM--MVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|+.. ++.. +++|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 567999999999999764 4554 488888753 234456789999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhccCC-----------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEee
Q 044996 449 KRSLAVNLHGHQA-----------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLAD 517 (678)
Q Consensus 449 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 517 (678)
+|+|.+++..... .....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kL~D 185 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIAD 185 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECC
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCCCeEEEcc
Confidence 9999999976530 1123589999999999999999999976 899999999999999999999999
Q ss_pred cCCccccCcc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 518 YGLIPVMNQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 518 fGla~~~~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
||+++..... ....++..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+..... ..
T Consensus 186 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~--------~~~~~~~~~~-~~ 256 (327)
T 1fvr_A 186 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAELYEKL-PQ 256 (327)
T ss_dssp TTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHG-GG
T ss_pred cCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC--------CcHHHHHHHh-hc
Confidence 9998754432 22234678999999988889999999999999999998 9999962 2222322222 12
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
+... . ........+.+++.+||+.||.+|||+.|+++.|+++.+....
T Consensus 257 ~~~~------~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 257 GYRL------E-----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp TCCC------C-----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CCCC------C-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 1111 0 0111224577888899999999999999999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=354.54 Aligned_cols=242 Identities=19% Similarity=0.248 Sum_probs=193.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+.+++.++|||||+++++|.+.+..|+||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999875 57899999986521 12234588999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.++++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 9999999753 488999999999999999999976 89999999999999999999999999998765432
Q ss_pred ----cccccceeeCccccccCC----CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 529 ----AQELMIAYKSPEFLQLGR----ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~~----~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
...+|..|+|||++.+.. ++.++|||||||++|||+||+.||. ..+.......++......
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~--------~~~~~~~~~~i~~~~~~~--- 292 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--------ADSLVGTYSKIMNHKNSL--- 292 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC--------CSSHHHHHHHHHTHHHHC---
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC--------CCChhhHHHHHHhccccc---
Confidence 345789999999997655 7899999999999999999999996 223333333333211000
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCcccccc--CCCHHHHHHH
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEK--RLDLKEAVEK 642 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~ev~~~ 642 (678)
...... .....+.+++.+||..+|.+ ||++.||++.
T Consensus 293 ---~~p~~~---~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 ---TFPDDN---DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---CCCTTC---CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---cCCCcc---cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000000 11234667777999999988 9999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.20 Aligned_cols=243 Identities=21% Similarity=0.333 Sum_probs=196.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe----------------
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR---------------- 436 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~---------------- 436 (678)
.+.||+|+||.||+|... +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence 567999999999999875 78999999997543 356789999999999999999999864
Q ss_pred CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEe
Q 044996 437 KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLA 516 (678)
Q Consensus 437 ~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~ 516 (678)
....++||||+++|+|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEEC
T ss_pred cceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCCCCEEEC
Confidence 3457999999999999999976432 2589999999999999999999976 89999999999999999999999
Q ss_pred ecCCccccCcc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 517 DYGLIPVMNQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 517 DfGla~~~~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.|+... ..+.... ..
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~~~~~-~~ 233 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKFFTDL-RD 233 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHHHHHH-HT
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHHHHHh-hc
Confidence 99998776543 2234678899999999889999999999999999999999997521 1111111 11
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
+. . . ... ...+.+++.+||+.||.+|||+.|+++.|+.+....+.
T Consensus 234 ~~-~----~-----~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 234 GI-I----S-----DIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp TC-C----C-----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred cc-c----c-----ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 11 1 0 111 22366788899999999999999999999998776544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=335.74 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=197.9
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEecccCh------hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
..+.||+|+||.||+|... ++..||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence 3567999999999999865 688999999875322 246789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC----ceEEeecCCc
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL----EPVLADYGLI 521 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla 521 (678)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++ .+||+|||++
T Consensus 96 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 96 LVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp CCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999997542 589999999999999999999976 899999999999999888 7999999999
Q ss_pred cccCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 522 PVMNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 522 ~~~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
+...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+..........
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~i~~~~~--- 235 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANITSVSY--- 235 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHTTCC---
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhccc---
Confidence 8765432 23467889999999988999999999999999999999999962 222333333332211
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..++.+... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 -DFDEEFFSH-----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -CCCHHHHTT-----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -ccChhhhcc-----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111221111 1234677888999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=328.83 Aligned_cols=247 Identities=18% Similarity=0.213 Sum_probs=198.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL 93 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence 467999999999999865 4678999999876556678899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe---cCCCceEEeecCCccccCcc--
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL---NESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~-- 527 (678)
.+++.... .+++.++..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++......
T Consensus 94 ~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 94 FERVVHKR-----VFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp HHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99987643 489999999999999999999976 79999999999999 78899999999999766543
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....++..|+|||++.+ .++.++||||||+++|||++|+.||.. ....+............ .....
T Consensus 165 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~---~~~~~- 231 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA--------PTDSEVMLKIREGTFTF---PEKDW- 231 (277)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC---CHHHH-
T ss_pred hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhCCCCC---Cchhh-
Confidence 23346788999999865 589999999999999999999999962 12222222222221111 00000
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhh
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVK 647 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~ 647 (678)
. .....+.+++.+|++.||.+|||+.|+++ .+++..
T Consensus 232 -~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 232 -L----NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp -T----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred -h----cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 0 11235677888999999999999999986 444443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.25 Aligned_cols=238 Identities=20% Similarity=0.321 Sum_probs=196.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999875 78999999997532 12356789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 101 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 101 GELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999997542 589999999999999999999965 89999999999999999999999999998765432
Q ss_pred --cccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 --AQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+..+ +.++|||||||++|||++|+.||.. .+............... +
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~~~-----p-- 236 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD--------DHVPTLFKKICDGIFYT-----P-- 236 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC--------SSSHHHHHHHHTTCCCC-----C--
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC--------CCHHHHHHHHhcCCcCC-----C--
Confidence 3346788999999987765 6899999999999999999999972 23333333333221111 0
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||+.||.+|||+.|+++
T Consensus 237 ------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 237 ------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011234677888999999999999999997
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.82 Aligned_cols=244 Identities=17% Similarity=0.189 Sum_probs=192.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh---hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||+||+|+.. +++.||+|+++.... ...+.+.+|+.++..++||||++++++|.+.+..|+|||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 568999999999999875 478899999875321 2233488999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 159 g~L~~~l~~~~~----~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 159 GDLLTLLSKFED----RLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHHccC----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 999999986422 599999999999999999999976 89999999999999999999999999997654332
Q ss_pred ----cccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 529 ----AQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
...+|..|+|||++. ...++.++|||||||++|||++|+.||.. .+..+....++...... .
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~--------~~~~~~~~~i~~~~~~~-~ 301 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHKERF-Q 301 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTHHHHC-C
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC--------CChhHHHHhhhhccccc-c
Confidence 235789999999986 45789999999999999999999999962 23333333332211000 0
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCcccccc--CCCHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEK--RLDLKEAVE 641 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~ev~~ 641 (678)
-+.. .......+.+++.+|+..+|++ ||++.|+++
T Consensus 302 --~p~~-----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 302 --FPTQ-----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp --CCSS-----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred --CCcc-----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000 0011234566777999888888 999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.10 Aligned_cols=246 Identities=15% Similarity=0.108 Sum_probs=196.1
Q ss_pred ccccCccCceeEEEEE------ecCCceEEEEEecccChhhHHHHHHHHHHHhccC---CCCccceeEEEEeCCceEEEE
Q 044996 374 AEILGSGCFGSSYKAS------LSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR---HPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 444 (678)
.++||+|+||+||+|. ..+++.||||+++.. ...++..|++++.+++ |+||+++++++...+..++||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 4679999999999993 457889999999754 3456778888888886 999999999999999999999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-----------CCce
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-----------SLEP 513 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-----------~~~~ 513 (678)
|||++|+|.+++..........++|..++.|+.||+.||+|||+. +|+||||||+||||+. ++.+
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccCccccccccCCE
Confidence 999999999999864433334699999999999999999999965 8999999999999998 8999
Q ss_pred EEeecCCccccCc------cccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHH
Q 044996 514 VLADYGLIPVMNQ------ESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWV 587 (678)
Q Consensus 514 kl~DfGla~~~~~------~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~ 587 (678)
||+|||+++.+.. .....+|..|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------- 292 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---------- 292 (365)
T ss_dssp EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----------
T ss_pred EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----------
Confidence 9999999965431 123347889999999999899999999999999999999999986322110
Q ss_pred HHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccC-CCHHHHHHHHHHhhccCC
Q 044996 588 NSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKR-LDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 588 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~R-Ps~~ev~~~L~~i~~~~~ 651 (678)
...+..+... ...+ .+.+++..|++.+|.+| |+++++.+.|+++.....
T Consensus 293 -----------~~~~~~~~~~-~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 293 -----------CKPEGLFRRL-PHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp -----------EEECSCCTTC-SSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----------eeechhcccc-CcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0011111111 1122 34556668999999998 589999999998876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.51 Aligned_cols=239 Identities=22% Similarity=0.319 Sum_probs=175.3
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 46799999999999986 578899999986432 12346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 96 GEMNRYLKNRVK----PFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EEHHHHHHTCSS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CcHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999986432 589999999999999999999976 89999999999999999999999999997664321
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||++.+..++.++||||||+++|||++|+.||..... ......... .+..+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~--------~~~~~ 231 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV--------KNTLNKVVL--------ADYEM 231 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC--------C-----CCS--------SCCCC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH--------HHHHHHHhh--------cccCC
Confidence 23467889999999988899999999999999999999999973211 011100000 00011
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+......+.+++.+||+.||++|||+.|+++
T Consensus 232 -----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 -----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1112235677888999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=348.18 Aligned_cols=266 Identities=20% Similarity=0.282 Sum_probs=208.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC--ceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE--EKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~Ey~~~ 449 (678)
.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 467999999999999875 58899999997543 334677889999999999999999999998765 67999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe----cCCCceEEeecCCccccC
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL----NESLEPVLADYGLIPVMN 525 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGla~~~~ 525 (678)
|+|.+++...... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 94 GSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp EEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999765321 2389999999999999999999976 89999999999999 788889999999998765
Q ss_pred ccc---cccccceeeCcccccc--------CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 526 QES---AQELMIAYKSPEFLQL--------GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 526 ~~~---~~~~~~~y~aPE~~~~--------~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||..... .....+.+...+...
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~----~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG----PRRNKEVMYKIITGK 243 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC----TTTCHHHHHHHHHSC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----ccchHHHHHHHhcCC
Confidence 443 2346788999999864 5678899999999999999999999973221 123334444444332
Q ss_pred Ccc-cccc----------chhhh-cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 595 DNR-TEVF----------DKEMA-DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 595 ~~~-~~~~----------d~~l~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
... ...+ ...+. ...........+.+++.+||+.||++||+++|+++.++++...
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 110 0000 00110 0112345667788899999999999999999999999988664
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=348.41 Aligned_cols=243 Identities=18% Similarity=0.248 Sum_probs=184.5
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHh-ccCCCCccceeEEEEe----CCceEEEEeccC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLG-RLRHPNLLPLVAYYYR----KEEKLLVHEFVP 448 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~----~~~~~lv~Ey~~ 448 (678)
++||+|+||+||+|... +++.||||+++.. ..+.+|++++. ..+||||++++++|.. ....|||||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 57999999999999864 6889999998642 35678888874 4589999999999875 557899999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---CCceEEeecCCccccC
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---SLEPVLADYGLIPVMN 525 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~ 525 (678)
+|+|.+++..... ..+++.++..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 143 gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 143 GGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 9999999986432 2599999999999999999999976 8999999999999997 7899999999998765
Q ss_pred cc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 526 QE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 526 ~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
.. ....+|..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. ... .+.. ..-.
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~---~i~-~~~~--~~~~ 288 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKT---RIR-MGQY--EFPN 288 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-CCSHHH---HHH-HTCC--CCCT
T ss_pred CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-cHHHHH---HHH-cCcc--cCCC
Confidence 33 223457889999999989999999999999999999999999963211100 001111 111 1111 0000
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+.. ......+.+++.+||+.||.+|||+.|+++.
T Consensus 289 ~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 PEW------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 100 1123356778889999999999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=335.24 Aligned_cols=249 Identities=18% Similarity=0.223 Sum_probs=191.2
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
++||+|+||.||+|.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 5699999999999985 47889999999876556678899999999985 799999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc---eEEeecCCccccCcc--
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE---PVLADYGLIPVMNQE-- 527 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGla~~~~~~-- 527 (678)
.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 99 LSHIHKRR-----HFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 99998653 489999999999999999999977 7999999999999998776 999999998765321
Q ss_pred ---------ccccccceeeCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCC---CC----hHHH
Q 044996 528 ---------SAQELMIAYKSPEFLQL-----GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKAD---GD----LASW 586 (678)
Q Consensus 528 ---------~~~~~~~~y~aPE~~~~-----~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~---~~----l~~~ 586 (678)
....++..|+|||++.. ..++.++|||||||++|||++|+.||.......... .. ....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 11236788999999864 568999999999999999999999997432111000 00 0111
Q ss_pred HHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 587 VNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 587 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......... ..+... . .....+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~i~~~~~~---~~~~~~--~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 250 FESIQEGKYE---FPDKDW--A----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHCCCC---CCHHHH--T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhccCcc---cCchhc--c----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1111111100 000000 0 11235778888999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=328.83 Aligned_cols=239 Identities=22% Similarity=0.293 Sum_probs=193.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 467999999999999764 56789999986432 22356789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 94 GTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 99999997653 489999999999999999999965 8999999999999999999999999998665433
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....++..|+|||++.+..++.++||||||+++|||++|+.||.. ....+............
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~---------- 226 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--------NTYQETYKRISRVEFTF---------- 226 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCCCC----------
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC--------CcHHHHHHHHHhCCCCC----------
Confidence 233467889999999988999999999999999999999999962 22223322222211111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 227 ---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 ---PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11122346778889999999999999999973
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=341.90 Aligned_cols=240 Identities=19% Similarity=0.294 Sum_probs=189.2
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCC--CCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRH--PNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++| +||+++++++...+..++|||| .+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CC
Confidence 4679999999999999888999999998743 34455789999999999986 9999999999999999999995 58
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++.... .+++.++..|+.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 93 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 93 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 89999998653 589999999999999999999976 799999999999997 5789999999998765432
Q ss_pred -----cccccceeeCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh
Q 044996 529 -----AQELMIAYKSPEFLQL-----------GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA 592 (678)
Q Consensus 529 -----~~~~~~~y~aPE~~~~-----------~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~ 592 (678)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||... ............
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~~~~~~~~~~~ 235 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKLHAIID 235 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHHHHHHC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh-------hhHHHHHHHHhc
Confidence 2346889999999864 67899999999999999999999999621 122222222221
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
..... . .+......+.+++.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~-~----------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 236 PNHEI-E----------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TTSCC-C----------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCccc-C----------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11110 0 001112346778889999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.30 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=200.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh------hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 89 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence 567999999999999875 688999999875321 2467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC----ceEEeecCCcc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL----EPVLADYGLIP 522 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla~ 522 (678)
+++++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||++++++ .+||+|||+++
T Consensus 90 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 90 VSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999997643 589999999999999999999976 899999999999999877 89999999997
Q ss_pred ccCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 523 VMNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 523 ~~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
...... ...++..|+|||++.+..++.++||||||+++|||++|+.||.. ....+...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~--- 229 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------ETKQETLTNISAVNYD--- 229 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTTCCC---
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC--------cchHHHHHHhHhcccC---
Confidence 664432 23467889999999988999999999999999999999999962 1222222222211111
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhccC
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKERD 650 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~~~ 650 (678)
.+..... .....+.+++.+||+.||.+|||+.|+++ .++++....
T Consensus 230 -~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 230 -FDEEYFS-----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp -CCHHHHT-----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred -Ccchhcc-----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 1111111 11234677888999999999999999998 567665543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.30 Aligned_cols=248 Identities=22% Similarity=0.226 Sum_probs=192.3
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEeccc-----ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQM-----NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
..+.||+|+||.||+|.. .++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 357899999999999986 46788999998643 234567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCC-----------------------------------CCCCChHHHHHHHHHHHHHHHHHHHhCC
Q 044996 447 VPKRSLAVNLHGHQALG-----------------------------------QPSLDWPSRLKIVKGVAKGLQYLYRELP 491 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~-----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 491 (678)
+++|+|.+++....... ...+++..+..|+.||+.||+|||+.
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-- 187 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-- 187 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 99999999986311100 11235667888999999999999976
Q ss_pred CCCCcccCCCCCCEEecCCC--ceEEeecCCccccCcc--------ccccccceeeCcccccc--CCCCCcchHHHHHHH
Q 044996 492 SLIAPHGHIKSSNVLLNESL--EPVLADYGLIPVMNQE--------SAQELMIAYKSPEFLQL--GRITKKTDVWSLGVL 559 (678)
Q Consensus 492 ~~~ivHrdlk~~NILl~~~~--~~kl~DfGla~~~~~~--------~~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvv 559 (678)
+|+||||||+|||++.++ .+||+|||+++.+... ....++..|+|||++.+ ..++.++|||||||+
T Consensus 188 --~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp --TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred --CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 799999999999998776 8999999999765321 23346788999999865 678999999999999
Q ss_pred HHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHH
Q 044996 560 ILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEA 639 (678)
Q Consensus 560 l~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev 639 (678)
+|||++|+.||.. ....+............ ..+... .....+.+++.+||+.||.+|||+.|+
T Consensus 266 l~el~~g~~pf~~--------~~~~~~~~~~~~~~~~~---~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 266 LHLLLMGAVPFPG--------VNDADTISQVLNKKLCF---ENPNYN------VLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCT---TSGGGG------GSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHCCCCCCC--------CChHHHHHHHHhccccc---CCcccc------cCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999962 23333344444332211 111110 112346778889999999999999999
Q ss_pred HH
Q 044996 640 VE 641 (678)
Q Consensus 640 ~~ 641 (678)
++
T Consensus 329 l~ 330 (345)
T 3hko_A 329 LQ 330 (345)
T ss_dssp HH
T ss_pred hc
Confidence 87
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=331.14 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=191.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 467999999999999874 68899999997532 33457788999999999999999999999999999999999975
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
++.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 86 DLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 66666654322 599999999999999999999977 8999999999999999999999999999765432
Q ss_pred -ccccccceeeCccccccCC-CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcccccc---
Q 044996 528 -SAQELMIAYKSPEFLQLGR-ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTEVF--- 601 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~-~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~--- 601 (678)
....++..|+|||++.+.. ++.++|||||||++|||++|+.|+.. ..+..+........ +....+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~-------~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-------GNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC-------CSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC-------CCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 2334678899999997765 79999999999999999999988641 11222222222211 00000000
Q ss_pred ch--hh----------hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 602 DK--EM----------ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 602 d~--~l----------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. .. ............+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00 000000112345678888999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=331.83 Aligned_cols=244 Identities=21% Similarity=0.300 Sum_probs=191.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 106 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence 467999999999999864 67899999987543 3456789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe---cCCCceEEeecCCccccCcc-
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL---NESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~- 527 (678)
|.+++...... ...+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 107 L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 107 LLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp HHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred HHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 99998653211 12589999999999999999999976 89999999999999 45688999999999876543
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++. +.++.++|||||||++|||++|+.||.. ....+............ .. .
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~--------~~~~~~~~~~~~~~~~~-~~---~- 247 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG--------TSLEEVQQKATYKEPNY-AV---E- 247 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC-CC-----
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC--------CCHHHHHhhhccCCccc-cc---c-
Confidence 2334678899999886 5789999999999999999999999962 22333322222221111 00 0
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
... ....+.+++.+||+.||++|||+.||++
T Consensus 248 -~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 -CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001 1234677888999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.53 Aligned_cols=256 Identities=15% Similarity=0.121 Sum_probs=199.7
Q ss_pred ccccCccCceeEEEEEecC---------CceEEEEEecccChhhHHHHHHHHHHHhccCCCCccc---------------
Q 044996 374 AEILGSGCFGSSYKASLST---------GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLP--------------- 429 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~--------------- 429 (678)
.+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 4679999999999998753 789999998753 46889999999999999987
Q ss_pred eeEEEEe-CCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec
Q 044996 430 LVAYYYR-KEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN 508 (678)
Q Consensus 430 l~~~~~~-~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~ 508 (678)
+++++.. .+..++||||+ +|+|.+++..... ..+++.+++.|+.||+.||+|||+. +|+||||||+|||++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAENIFVD 193 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGGEEEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEEc
Confidence 6778776 67889999999 9999999986521 2599999999999999999999977 899999999999999
Q ss_pred CCC--ceEEeecCCccccCccc-----------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcccccc
Q 044996 509 ESL--EPVLADYGLIPVMNQES-----------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQ 575 (678)
Q Consensus 509 ~~~--~~kl~DfGla~~~~~~~-----------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~ 575 (678)
.++ .+||+|||+++.+.... ...++..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 99999999998765432 12467889999999988999999999999999999999999973221
Q ss_pred CCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 576 GKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 576 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
. ...+............ ...+........ ...+.+++.+||+.||.+|||+.||++.|+++......
T Consensus 274 ~---~~~~~~~~~~~~~~~~---~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 274 N---TEDIMKQKQKFVDKPG---PFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp C---HHHHHHHHHHHHHSCC---CEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred C---HHHHHHHHHhccCChh---hhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 1 1112222222222111 122211111111 24577788899999999999999999999999876554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.16 Aligned_cols=266 Identities=26% Similarity=0.364 Sum_probs=193.6
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHH--HhccCCCCccceeEEEEe-----CCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRR--LGRLRHPNLLPLVAYYYR-----KEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~~-----~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ....++||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 46799999999999976 68899999987432 3344444444 556899999999987653 2256899999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCC-----CCCCcccCCCCCCEEecCCCceEEeecCCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP-----SLIAPHGHIKSSNVLLNESLEPVLADYGLI 521 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-----~~~ivHrdlk~~NILl~~~~~~kl~DfGla 521 (678)
+++|+|.+++... ..++..+.+|+.||+.||+|||+.+. ..+|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 94 YPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 9999999999764 36899999999999999999995421 117999999999999999999999999999
Q ss_pred cccCccc------------cccccceeeCcccccc-------CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCC
Q 044996 522 PVMNQES------------AQELMIAYKSPEFLQL-------GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGD 582 (678)
Q Consensus 522 ~~~~~~~------------~~~~~~~y~aPE~~~~-------~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~ 582 (678)
+.+.... ...++..|+|||++.+ ..++.++|||||||++|||+||+.|+............
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 7654321 2246789999999976 45678999999999999999998887532211110001
Q ss_pred h---------HHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCC
Q 044996 583 L---------ASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDE 653 (678)
Q Consensus 583 l---------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~ 653 (678)
+ .............. ..+.... .........+.+++.+||+.||++|||+.||++.|+++...-...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQR-PKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCC-CCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hhcccCCCchHHHHHhhhcccccC-CCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 0 11111111111111 0000100 112235667899999999999999999999999999998766554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=333.65 Aligned_cols=242 Identities=19% Similarity=0.269 Sum_probs=194.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|+.. +++.||+|.++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence 567999999999999874 6889999999865555567799999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe---cCCCceEEeecCCccccCccc-
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL---NESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~~- 528 (678)
.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++......
T Consensus 94 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 94 FDRILERG-----VYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp HHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 99987643 489999999999999999999976 89999999999999 788999999999987654432
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||.. ................. ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~i~~~~~~~----~~~~-- 230 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE--------ETESKLFEKIKEGYYEF----ESPF-- 230 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHCCCCC----CTTT--
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHcCCCCC----Cccc--
Confidence 22467889999999988999999999999999999999999962 22223333322221111 0111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||.+|||+.|+++
T Consensus 231 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 ---WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0112345778888999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.45 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=185.3
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEe--------CCceEE
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYR--------KEEKLL 442 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--------~~~~~l 442 (678)
..++||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.++. ||||+++++++.. ....++
T Consensus 32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l 111 (337)
T 3ll6_A 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111 (337)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred EEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence 356799999999999986 478899999987766666788999999999996 9999999999953 334789
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCC--CcccCCCCCCEEecCCCceEEeecCC
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI--APHGHIKSSNVLLNESLEPVLADYGL 520 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~--ivHrdlk~~NILl~~~~~~kl~DfGl 520 (678)
||||+. |+|.+++...... ..+++.+++.|+.||+.||+|||.. + |+||||||+|||++.++.+||+|||+
T Consensus 112 v~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 112 LTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 999995 7999998753321 2599999999999999999999965 6 99999999999999999999999999
Q ss_pred ccccCccc----------------cccccceeeCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCC
Q 044996 521 IPVMNQES----------------AQELMIAYKSPEFL---QLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADG 581 (678)
Q Consensus 521 a~~~~~~~----------------~~~~~~~y~aPE~~---~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~ 581 (678)
++...... ...++..|+|||++ .+..++.++|||||||++|||+||+.||.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------ 258 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK------ 258 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH------
Confidence 98765321 22367889999998 566789999999999999999999999962111
Q ss_pred ChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 582 DLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 582 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
...+. ..... .+ .. .....+.+++.+||+.||.+|||+.|+++.|+++......
T Consensus 259 --~~~~~----~~~~~----~~---~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 259 --LRIVN----GKYSI----PP---HD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp -------------CCC----CT---TC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred --HHhhc----CcccC----Cc---cc----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 01110 00000 00 00 0112366788899999999999999999999999765443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=328.91 Aligned_cols=242 Identities=20% Similarity=0.256 Sum_probs=196.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 467999999999999864 5889999998653 3345577899999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc---eEEeecCCccccCcc
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE---PVLADYGLIPVMNQE 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGla~~~~~~ 527 (678)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++......
T Consensus 91 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 91 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999887653 489999999999999999999976 7999999999999986655 999999999766543
Q ss_pred c---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 S---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
. ...++..|+|||++.+..++.++||||||+++|||++|+.||.. ................. ..+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~--------~~~~~~~~~~~~~~~~~---~~~~ 230 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--------EDQHRLYAQIKAGAYDY---PSPE 230 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCCCC---CTTT
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC--------CchhHHHHHHHhccccC---Cchh
Confidence 2 23567889999999998999999999999999999999999962 22223333322221111 0111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 231 W------DTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp T------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 012234677888999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.11 Aligned_cols=189 Identities=19% Similarity=0.261 Sum_probs=166.9
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccC-----CCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-----HPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||+||+|+. .+++.||||+++.. ....+.+..|++++++++ |||||++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 46799999999999987 46889999998753 344567788999999986 999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC------------------
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE------------------ 509 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~------------------ 509 (678)
+++|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 119 -~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 119 -GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp -CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred -CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999999986542 2589999999999999999999976 8999999999999976
Q ss_pred -------CCceEEeecCCccccCcc-ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 510 -------SLEPVLADYGLIPVMNQE-SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 510 -------~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 789999999999865543 33456889999999999999999999999999999999999996
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=343.46 Aligned_cols=240 Identities=20% Similarity=0.258 Sum_probs=185.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHH-HhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRR-LGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+|+||.||+|+.. ++..+|+|+++... ....+.+.+|..+ ++.++|||||++++++.+.+..|+||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 467999999999999875 57889999997542 2234456677776 577899999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 123 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 123 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999998653 488999999999999999999976 8999999999999999999999999999763221
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.. .+..+....++...... .+
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~--------~~~~~~~~~i~~~~~~~----~~- 260 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS--------RNTAEMYDNILNKPLQL----KP- 260 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC--------SBHHHHHHHHHHSCCCC----CS-
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHhcccCC----CC-
Confidence 233578899999999999999999999999999999999999962 23333444444332111 01
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKI 643 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L 643 (678)
.....+.+++.+||+.||.+||++.+.++.+
T Consensus 261 --------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 261 --------NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp --------SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred --------CCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 1123466777899999999999986544443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=346.31 Aligned_cols=240 Identities=19% Similarity=0.300 Sum_probs=189.7
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEeccc--ChhhHHHHHHHHHHHhccC--CCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLR--HPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|...+++.||||++... .....+.+.+|+++|.+++ |||||++++++...+..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 4679999999999999888999999998643 3445678999999999996 5999999999999999999999 568
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|.+++.... .+++.++..|+.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 140 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 140 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 89999998653 588999999999999999999965 899999999999996 5889999999998765432
Q ss_pred -----cccccceeeCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh
Q 044996 529 -----AQELMIAYKSPEFLQL-----------GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA 592 (678)
Q Consensus 529 -----~~~~~~~y~aPE~~~~-----------~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~ 592 (678)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||... ......+...+.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-------~~~~~~~~~~~~ 282 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKLHAIID 282 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC-------CCHHHHHHHHHC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh-------hHHHHHHHHHhC
Confidence 2347889999999864 36899999999999999999999999621 122222333332
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
..... . + +......+.+++.+||+.||.+|||+.||++.
T Consensus 283 ~~~~~-~-----~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 PNHEI-E-----F-----PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TTSCC-C-----C-----CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccC-C-----C-----CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 21111 0 0 00112346778889999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=354.43 Aligned_cols=244 Identities=15% Similarity=0.104 Sum_probs=187.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecc---cChhhHHHHHHHH---HHHhccCCCCcccee-------EEEEeCCc
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQ---MNNVGREEFQEHM---RRLGRLRHPNLLPLV-------AYYYRKEE 439 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~~~~~~~ 439 (678)
.+.||+|+||.||+|.. .+++.||||++.. ......+.|.+|+ +.+++++|||||+++ +++...+.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 46799999999999986 5689999999973 2334567899999 555666899999998 77665532
Q ss_pred -----------------eEEEEeccCCCCHHHHhhccCCCCC--CCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCC
Q 044996 440 -----------------KLLVHEFVPKRSLAVNLHGHQALGQ--PSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHI 500 (678)
Q Consensus 440 -----------------~~lv~Ey~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdl 500 (678)
.|+||||+ +|+|.+++........ ..++|..++.|+.||+.||+|||+. +|+||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDi 232 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTYL 232 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCC
Confidence 78999999 6899999986432111 1345688899999999999999977 8999999
Q ss_pred CCCCEEecCCCceEEeecCCccccCccc-cccccceeeCccccccC-----------CCCCcchHHHHHHHHHHHHhCCC
Q 044996 501 KSSNVLLNESLEPVLADYGLIPVMNQES-AQELMIAYKSPEFLQLG-----------RITKKTDVWSLGVLILEIMTGKF 568 (678)
Q Consensus 501 k~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~~~~-----------~~t~ksDvwS~Gvvl~el~tg~~ 568 (678)
||+|||++.++.+||+|||+++...... ...+ ..|+|||++.+. .++.++|||||||++|||+||+.
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~ 311 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999998655432 2335 889999999877 89999999999999999999999
Q ss_pred CccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHh
Q 044996 569 PANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEV 646 (678)
Q Consensus 569 P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i 646 (678)
||...... +.......... .....+.+++.+||+.||.+|||+.|+++ .++++
T Consensus 312 Pf~~~~~~----------------------~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 312 PITKDAAL----------------------GGSEWIFRSCK---NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp CC----------------------------CCSGGGGSSCC---CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred CCcccccc----------------------cchhhhhhhcc---CCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 99622110 00111111001 11234677888999999999999999996 45554
Q ss_pred hc
Q 044996 647 KE 648 (678)
Q Consensus 647 ~~ 648 (678)
.+
T Consensus 367 ~~ 368 (377)
T 3byv_A 367 RT 368 (377)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.18 Aligned_cols=233 Identities=22% Similarity=0.267 Sum_probs=191.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh--------hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN--------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 444 (678)
.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 56799999999999975 5688999999875421 13346778999999999999999999999999999999
Q ss_pred eccCCC-CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 445 EFVPKR-SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 445 Ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
||+..| +|.+++.... .+++..+..|+.||+.||+|||.. +|+||||||+|||+++++.+||+|||+++.
T Consensus 109 e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 109 EKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp ECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999877 9999997643 589999999999999999999976 899999999999999999999999999987
Q ss_pred cCccc---cccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 524 MNQES---AQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 524 ~~~~~---~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
..... ...++..|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------------- 236 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------------- 236 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------------
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------------
Confidence 65432 2346889999999988776 78999999999999999999999632110
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.......... ....+.+++.+||+.||++|||+.|+++.
T Consensus 237 -~~~~~~~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAAIHPPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTCCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HhhccCCCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 12346778889999999999999999884
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=337.11 Aligned_cols=238 Identities=21% Similarity=0.283 Sum_probs=196.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||++... +++.+++|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 467999999999999875 5788999988643 234567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 126 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 126 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 99999987643 589999999999999999999976 8999999999999999999999999999765422
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+............
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~~~~~~~~~-------- 260 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKNEYSI-------- 260 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCCCC--------
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC--------CCHHHHHHHHhcCCCCC--------
Confidence 223467889999999988899999999999999999999999962 22333332222221111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||++|||+.|+++
T Consensus 261 -----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 -----PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011234667888999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.50 Aligned_cols=239 Identities=21% Similarity=0.282 Sum_probs=196.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 467999999999999875 5788999988653 234567889999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
++|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 100 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999987643 589999999999999999999976 8999999999999999999999999999765422
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....++..|+|||++.+..++.++||||||+++|||++|+.||.. ....+............
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~-------- 234 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--------SCLKETYLRIKKNEYSI-------- 234 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTTCCCC--------
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHhhccCCC--------
Confidence 223467889999999988899999999999999999999999962 22233322222221111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 235 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 -----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00112346778889999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.07 Aligned_cols=238 Identities=20% Similarity=0.310 Sum_probs=189.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 467999999999999875 78899999987532 23356789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 96 GELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred CcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 99999997653 489999999999999999999987 79999999999999999999999999998765432
Q ss_pred --cccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 --AQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...++..|+|||.+.+..+ +.++||||||+++|||++|+.||.. .................
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~-------- 230 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD--------EHVPTLFKKIRGGVFYI-------- 230 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC--------
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC--------CcHHHHHHHhhcCcccC--------
Confidence 2346788999999987765 6899999999999999999999962 22233332222211111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||.+|||+.|+++
T Consensus 231 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 231 -----PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0111234677888999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=331.05 Aligned_cols=255 Identities=15% Similarity=0.176 Sum_probs=198.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEE-EeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY-YRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++++++|++++..+.++ ...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 46799999999999986 6789999999875432 34688999999999998877777666 4566789999999 999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe---cCCCceEEeecCCccccCcc-
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL---NESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~- 527 (678)
|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 91 L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 91 LEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999975432 599999999999999999999976 89999999999999 58899999999999765443
Q ss_pred ----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 528 ----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 528 ----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
....++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh-hhhhhhhcccccCCc---
Confidence 223467889999999998999999999999999999999999974321111 011111111111100
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
.+.+. . .....+.+++.+||+.||.+|||+.+|++.|+++......
T Consensus 239 ----~~~~~-~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 ----IEVLC-K----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ----HHHHT-T----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ----hHHHH-h----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 00010 1 1124577888899999999999999999999999776654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=329.65 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=194.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEe--CCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR--KEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~Ey~~ 448 (678)
.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++.. ....++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 467999999999999874 6889999998753 34456789999999999999999999998864 567899999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCC-CCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP-SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
+|+|.+++...... ...+++..++.++.|++.||+|||+... ..+|+||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~ 169 (279)
T 2w5a_A 91 GGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169 (279)
T ss_dssp TEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---
T ss_pred CCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc
Confidence 99999999764321 2258999999999999999999998720 012999999999999999999999999998776543
Q ss_pred c----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 528 S----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 528 ~----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
. ...++..|+|||++.+..++.++||||||+++|||++|+.||.. ....+....... +... .
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~i~~-~~~~-~---- 235 (279)
T 2w5a_A 170 TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA--------FSQKELAGKIRE-GKFR-R---- 235 (279)
T ss_dssp CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHH-TCCC-C----
T ss_pred cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc--------cCHHHHHHHHhh-cccc-c----
Confidence 2 22457889999999988999999999999999999999999862 122222222222 1110 0
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
+ .......+.+++.+||+.||.+|||+.||++.+.
T Consensus 236 -~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 -I-----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -C-----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 0 1112245778888999999999999999998654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=355.67 Aligned_cols=244 Identities=20% Similarity=0.251 Sum_probs=196.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||.||+|+.. +|+.||+|++.... ......+.+|+++|++++|||||++++++.+.+..|+||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 467999999999999874 68999999987532 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+...
T Consensus 269 g~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 269 GDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 999999976532 2489999999999999999999976 8999999999999999999999999999876543
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.... ...................
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~----~~~~~~~i~~~i~~~~~~~--------- 408 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK----KKIKREEVERLVKEVPEEY--------- 408 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS----SCCCHHHHHHHHHHCCCCC---------
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc----cchhHHHHHHHhhcccccC---------
Confidence 23457889999999998889999999999999999999999997321 1112222222222111111
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
.......+.+++.+||+.||.+|| ++.||++
T Consensus 409 ----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 ----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111223467788899999999999 7888875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.27 Aligned_cols=243 Identities=19% Similarity=0.180 Sum_probs=192.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.++.+++||||+++++++.+.+..|+||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 467999999999999874 68999999997532 12234588999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 146 g~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 146 GDLLTLLSKFGE----RIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CBHHHHHHHHSS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999986432 589999999999999999999976 89999999999999999999999999998765432
Q ss_pred ----cccccceeeCccccc-------cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 529 ----AQELMIAYKSPEFLQ-------LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~-------~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
...+|..|+|||++. ...++.++|||||||++|||++|+.||.. .+..+....++......
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA--------DSTAETYGKIVHYKEHL 289 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTHHHHC
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC--------CCHHHHHHHHHhcccCc
Confidence 235788999999987 35689999999999999999999999962 22233333332211000
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccC---CCHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKR---LDLKEAVE 641 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~R---Ps~~ev~~ 641 (678)
.-+.+ . ......+.+++.+||. +|.+| |++.|+++
T Consensus 290 ---~~p~~-~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 290 ---SLPLV-D----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ---CCC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ---CCCcc-c----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00100 0 0112346777779999 99998 58998875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.38 Aligned_cols=242 Identities=20% Similarity=0.319 Sum_probs=191.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEe----CCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR----KEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|.. .++..|++|.+... .....+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 45699999999999976 46778999988743 34556789999999999999999999999875 3458999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec-CCCceEEeecCCccccC
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIPVMN 525 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~ 525 (678)
+++|+|.+++.... .+++..+..++.||+.||.|||+.. .+|+||||||+|||++ +++.+||+|||++....
T Consensus 111 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT--PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS--SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred cCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCC--CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999997643 5899999999999999999999661 1299999999999998 78999999999997654
Q ss_pred ccc--cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 526 QES--AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 526 ~~~--~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
... ...++..|+|||++. +.++.++|||||||++|||++|+.||... .............. .. ..++
T Consensus 184 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~~~~~~~~-~~-~~~~- 252 (290)
T 1t4h_A 184 ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSGV-KP-ASFD- 252 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTTC-CC-GGGG-
T ss_pred ccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc-------CcHHHHHHHHhccC-Cc-cccC-
Confidence 432 234678999999886 56999999999999999999999999621 22333332222211 11 1111
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
... ...+.+++.+||+.||.+|||+.|+++
T Consensus 253 ----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 253 ----KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111 234778888999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=344.36 Aligned_cols=187 Identities=26% Similarity=0.374 Sum_probs=154.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCC--ceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKE--EKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..|+|||||
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 46799999999999976 56889999998642 3455667889999999997 999999999998654 689999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
+ |+|..++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7 6999998753 589999999999999999999976 8999999999999999999999999999765321
Q ss_pred -------------------------ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 528 -------------------------SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 528 -------------------------~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 11246788999999876 678999999999999999999999996
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.84 Aligned_cols=240 Identities=18% Similarity=0.272 Sum_probs=193.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +++.||+|+++.. ......++.+|+..+.++ +||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 467999999999999875 7899999998753 234566788999999999 999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-------------------C
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-------------------S 510 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-------------------~ 510 (678)
|+|.+++...... ...+++.++..|+.||+.||+|||+. +|+||||||+|||++. .
T Consensus 96 ~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 96 GSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp CBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC--------------------C
T ss_pred CcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 9999999764221 12589999999999999999999976 8999999999999984 4
Q ss_pred CceEEeecCCccccCccccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHH
Q 044996 511 LEPVLADYGLIPVMNQESAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNS 589 (678)
Q Consensus 511 ~~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~ 589 (678)
..+||+|||++..........++..|+|||++.+. .++.++|||||||++|||++|+.|+.. . ..| ..
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--------~--~~~-~~ 239 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN--------G--DQW-HE 239 (289)
T ss_dssp CCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS--------S--HHH-HH
T ss_pred eEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc--------h--hHH-HH
Confidence 47999999999887766666788999999999765 567899999999999999999977641 1 111 11
Q ss_pred HHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 590 VLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 590 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. .+.. +.+. ......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~-~~~~------~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 240 IR-QGRL------PRIP-----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HH-TTCC------CCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-cCCC------CCCC-----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11 1111 0110 111234677888999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.62 Aligned_cols=249 Identities=16% Similarity=0.236 Sum_probs=185.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------ceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------EKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 444 (678)
.+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+.++++++|||||++++++...+ ..|+||
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 46799999999999975 46889999999753 3445678899999999999999999999997543 569999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
|||++ +|.+.+.. .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 147 E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 147 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp ECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 99975 57666642 388999999999999999999976 8999999999999999999999999999876
Q ss_pred Ccc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHH-------------
Q 044996 525 NQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVN------------- 588 (678)
Q Consensus 525 ~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~------------- 588 (678)
... ....+|..|+|||++.+..|+.++|||||||++|||++|+.||... .....|..
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~-------~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR-------DYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHHHCSCCHHHH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHhcCCCCHHHH
Confidence 543 2235678899999999999999999999999999999999999621 11111111
Q ss_pred --------HHHhcCCccccccchhh-hcc---cC---CHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 589 --------SVLANGDNRTEVFDKEM-ADE---RN---SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 589 --------~~~~~~~~~~~~~d~~l-~~~---~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..+..........-+.+ ... .. .......+.+++.+||+.||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111000000000000 000 00 0112456788999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=331.89 Aligned_cols=255 Identities=15% Similarity=0.168 Sum_probs=197.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEE-EeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY-YRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|++++++++|++++..++++ ...+..++||||+ +|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 46799999999999986 578899999866432 224588899999999998888777766 4566789999999 999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe---cCCCceEEeecCCccccCccc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL---NESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~~ 528 (678)
|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++......
T Consensus 91 L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 91 LEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp HHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999975432 599999999999999999999977 79999999999999 789999999999997654321
Q ss_pred -----------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 529 -----------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 529 -----------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
...++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+...........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHHHHSC---
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh-hhhhhhhhcccccch---
Confidence 23467889999999998999999999999999999999999974322111 011111111111000
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCC
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGD 652 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~ 652 (678)
.+.+ .. .....+.+++.+||+.||++|||+.+|++.|+++......
T Consensus 239 ----~~~~-~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 ----IEVL-CK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ----HHHH-TT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred ----hhhh-hc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 0000 00 1124577888899999999999999999999999876654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=325.79 Aligned_cols=243 Identities=22% Similarity=0.279 Sum_probs=197.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 467999999999999875 57789999986432 22356789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 99 GELYKELQKHG-----RFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 99999997653 489999999999999999999965 8999999999999999999999999998665432
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....++..|+|||++.+..++.++||||||+++|||++|+.||.. .................
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--------~~~~~~~~~~~~~~~~~---------- 231 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS--------PSHTETHRRIVNVDLKF---------- 231 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTTCCCC----------
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC--------CCHhHHHHHHhccccCC----------
Confidence 233467889999999988999999999999999999999999962 22222222222211111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHh
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEV 646 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i 646 (678)
.......+.+++.+|++.||.+|||+.|+++ .++..
T Consensus 232 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 232 ---PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 0111234677888999999999999999987 44443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=341.60 Aligned_cols=243 Identities=21% Similarity=0.278 Sum_probs=193.9
Q ss_pred ccccCccCceeEEEEEe----cCCceEEEEEecccC----hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 374 AEILGSGCFGSSYKASL----STGAMMVVKRFKQMN----NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++...+..++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 56799999999999987 478999999987432 23345677899999999 6999999999999999999999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+++|+|.+++.... .+++.++..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 139 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 139 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999998653 489999999999999999999976 7999999999999999999999999999765
Q ss_pred Cccc-----cccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 525 NQES-----AQELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 525 ~~~~-----~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
.... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||.... ...................
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~ 285 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSEPPY 285 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT----SCCCHHHHHHHHHHCCCCC
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC----ccchHHHHHHHHhccCCCC
Confidence 4321 2346788999999975 347899999999999999999999996321 1123333433333222111
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVEK 642 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~~ 642 (678)
.......+.+++.+||+.||.+|| +++|+++.
T Consensus 286 -------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 286 -------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 111223467788899999999999 99998874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.63 Aligned_cols=239 Identities=24% Similarity=0.316 Sum_probs=196.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 46799999999999976 468899999987543 3456789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 107 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 107 ALDLLEPG------PLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp HHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 99998642 589999999999999999999976 8999999999999999999999999999765433
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....++..|+|||++.+..++.++||||||+++|||++|+.||.. .............. .. .+.
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~~~~~~-~~------~~~- 240 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE--------LHPMKVLFLIPKNN-PP------TLE- 240 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSC-CC------CCC-
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC--------cCHHHHHHHhhcCC-CC------CCc-
Confidence 223467889999999988999999999999999999999999862 12222222221111 10 010
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
. .....+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 G----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp S----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred c----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 112347788889999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.81 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=189.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-----hhhHHHHHHHHHHHhcc---CCCCccceeEEEEeCC-----c
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-----NVGREEFQEHMRRLGRL---RHPNLLPLVAYYYRKE-----E 439 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~-----~ 439 (678)
.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+++++++ +||||++++++|.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 46799999999999986 568899999987422 11234566777777666 4999999999998765 4
Q ss_pred eEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecC
Q 044996 440 KLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519 (678)
Q Consensus 440 ~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 519 (678)
.++||||+. |+|.+++..... ..+++.++..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred EEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 799999996 699999986532 2489999999999999999999977 79999999999999999999999999
Q ss_pred CccccCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CC
Q 044996 520 LIPVMNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GD 595 (678)
Q Consensus 520 la~~~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~ 595 (678)
+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+........ +.
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~--------~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG--------NSEADQLGKIFDLIGL 237 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC--------SSHHHHHHHHHHHHCC
T ss_pred cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHHHhCC
Confidence 998765432 23467889999999989999999999999999999999999962 1222222222211 00
Q ss_pred cccc-------ccchhhhcc-cC-----CHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 596 NRTE-------VFDKEMADE-RN-----SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 596 ~~~~-------~~d~~l~~~-~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... .....+... .. ..+....+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000 000000000 00 0012345678888999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.06 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=190.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 467999999999999875 58899999886533 334567889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 88 VLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp HHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred hHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9998886542 489999999999999999999976 89999999999999999999999999998765332
Q ss_pred --cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-----------C
Q 044996 529 --AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-----------G 594 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-----------~ 594 (678)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...+.. .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhcccccccccccccc
Confidence 2346788999999875 5789999999999999999999999962110 0111111111110 0
Q ss_pred Cccc--cccchhhhcc--cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 DNRT--EVFDKEMADE--RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 ~~~~--~~~d~~l~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... ...++.-... .........+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0000000000 000012345778888999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.00 Aligned_cols=243 Identities=19% Similarity=0.222 Sum_probs=193.1
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++.++ +||||+++++++.+.+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 67999999999999865 68899999987532 33467899999999999 4699999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---CCceEEeecCCccccCcc
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---SLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~ 527 (678)
+|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 115 ~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 115 EIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred cHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99999865322 2589999999999999999999976 8999999999999998 789999999999876543
Q ss_pred c---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 S---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
. ...++..|+|||++.+..++.++|||||||++|||++|+.||.. ....+............ ..+.
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~~~---~~~~ 256 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG--------EDNQETYLNISQVNVDY---SEET 256 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCCCC---CTTT
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCchHHHHHHHhccccc---Cchh
Confidence 2 23468899999999989999999999999999999999999962 12222222222211111 0000
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ......+.+++.+||+.||.+|||+.|+++
T Consensus 257 ~------~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 257 F------SSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp T------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred h------cccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 112334677888999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=337.91 Aligned_cols=265 Identities=18% Similarity=0.267 Sum_probs=192.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChh-hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... +++.||+|+++..... ....+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 467999999999999875 6889999998753322 12245679999999999999999999999999999999997 69
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 86 LKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 9999876532 589999999999999999999976 89999999999999999999999999987654322
Q ss_pred -cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc--cccccch-
Q 044996 529 -AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN--RTEVFDK- 603 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~d~- 603 (678)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+...+..... .....+.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-----VEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2345788999999876 568999999999999999999999996211 01112222222211100 0000000
Q ss_pred hhhccc-----------CCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhccCCC
Q 044996 604 EMADER-----------NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKERDGD 652 (678)
Q Consensus 604 ~l~~~~-----------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~~~~~ 652 (678)
...... ........+.+++.+||+.||.+|||+.|+++ .+.++.+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 294 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence 000000 00011245678888999999999999999988 46655544333
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=363.42 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=198.8
Q ss_pred hccccCccCceeEEEEEecC----CceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 373 SAEILGSGCFGSSYKASLST----GAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
..+.||+|+||.||+|.+.. +..||+|+++.. .....+.|.+|+.++++++||||+++++++. .+..++||||+
T Consensus 394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcC
Confidence 45789999999999998642 457899988753 3344578999999999999999999999984 56789999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 473 ~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 473 TLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp TTCBHHHHHHHTTT----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred CCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999986532 589999999999999999999976 8999999999999999999999999999876543
Q ss_pred c-----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 528 S-----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 528 ~-----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
. ...++..|+|||++.+..++.++|||||||++|||++ |+.||.. ....+......... .. .
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~--------~~~~~~~~~i~~~~-~~-~-- 612 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG--------VKNNDVIGRIENGE-RL-P-- 612 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHHTC-CC-C--
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHcCC-CC-C--
Confidence 2 1234578999999998899999999999999999997 9999862 22223332222221 11 0
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
........+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 613 --------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 613 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011223457788889999999999999999999999865
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=331.82 Aligned_cols=242 Identities=20% Similarity=0.291 Sum_probs=191.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 467999999999999875 5889999999876666678899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc----cc
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ----ES 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~----~~ 528 (678)
.+++..... .+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++..... ..
T Consensus 104 ~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 104 DAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp HHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred HHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 999876432 589999999999999999999976 799999999999999999999999998754321 12
Q ss_pred cccccceeeCcccc-----ccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 AQELMIAYKSPEFL-----QLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 ~~~~~~~y~aPE~~-----~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
...++..|+|||++ ....++.++||||||+++|||++|+.||.. .+............... ...+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~--~~~~ 245 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE--------LNPMRVLLKIAKSDPPT--LLTP 245 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSCCCC--CSSG
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc--------CCHHHHHHHHhccCCcc--cCCc
Confidence 23467889999988 356789999999999999999999999862 22223333332221111 1000
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||+.||.+|||+.|+++
T Consensus 246 --------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 246 --------SKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111234777888999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=351.26 Aligned_cols=241 Identities=18% Similarity=0.247 Sum_probs=195.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 357999999999999874 68999999997532 23356788999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 270 g~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 270 GDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp CBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 999999976532 123599999999999999999999976 89999999999999999999999999998765432
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...+|..|+|||++.+..++.++|||||||++|||+||+.||.... ............+......
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~----~~~~~~~~~~~i~~~~~~~-------- 412 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG----EKVENKELKQRVLEQAVTY-------- 412 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT----CCCCHHHHHHHHHHCCCCC--------
T ss_pred ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc----cchhHHHHHHHHhhcccCC--------
Confidence 2357889999999999899999999999999999999999997321 1123333444333322111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
+......+.+++.+||+.||.+||++
T Consensus 413 -----p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 413 -----PDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----CcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11122346677889999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.35 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=192.1
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999986 567899999998766666788999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCccccCcc----c
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~----~ 528 (678)
+++..... ...+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++..... .
T Consensus 108 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 108 ALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp HHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred HHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 99986532 22467889999999999999999976 8999999999999997 899999999999766432 2
Q ss_pred cccccceeeCccccccCC--CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 529 AQELMIAYKSPEFLQLGR--ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~--~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
...++..|+|||++.+.. ++.++||||||+++|||++|+.||..... ............. .+.+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~-------~~~~- 247 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMFKVGMFKV-------HPEI- 247 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------HHHHHHHHHHHCC-------CCCC-
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------hhHHHHhhccccc-------cccc-
Confidence 334678899999987643 88999999999999999999999963210 1111111111110 0111
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||++||++.|+++
T Consensus 248 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 ----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112335677888999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=338.48 Aligned_cols=190 Identities=25% Similarity=0.351 Sum_probs=168.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 467999999999999875 6889999998754 34456789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--cc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--SA 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 529 (678)
|.+++.... .+++..+..++.+++.||+|||+.+ +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 118 L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 189 (360)
T 3eqc_A 118 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189 (360)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccccccC
Confidence 999997653 4899999999999999999999742 6999999999999999999999999998655332 23
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
..++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 356788999999999899999999999999999999999996
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.10 Aligned_cols=249 Identities=18% Similarity=0.234 Sum_probs=183.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh--hhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN--VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++ |
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-N 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-C
Confidence 46799999999999975 4788999999975432 234568899999999999999999999999999999999997 5
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe-----cCCCceEEeecCCccccC
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL-----NESLEPVLADYGLIPVMN 525 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl-----~~~~~~kl~DfGla~~~~ 525 (678)
+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 118 ~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 118 DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999997653 489999999999999999999976 89999999999999 455669999999997654
Q ss_pred cc----ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCccc-
Q 044996 526 QE----SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRT- 598 (678)
Q Consensus 526 ~~----~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~- 598 (678)
.. ....++..|+|||++.+. .++.++|||||||++|||++|+.||.. ....+.+...... +....
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG--------DSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHHHCCCCTT
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC--------CCHHHHHHHHHHHhCCCchh
Confidence 32 223457889999999764 489999999999999999999999962 1112222222111 00000
Q ss_pred ----------------cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 ----------------EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ----------------~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.....+... ........+.+++.+||+.||.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRV-LGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHH-HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhh-cccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000000 00001245678888999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.49 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=188.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------ceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------EKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 444 (678)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+ ..|+||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 46799999999999986 56899999998642 3344677899999999999999999999997653 469999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 110 e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 110 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 999 88999998753 489999999999999999999976 8999999999999999999999999999876
Q ss_pred Ccc-ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcccccc
Q 044996 525 NQE-SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTEVF 601 (678)
Q Consensus 525 ~~~-~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~ 601 (678)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+.+...... +....+.+
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG--------SDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHHhcCCCCHHHH
Confidence 543 23456788999999876 6799999999999999999999999962 1222222222111 10000000
Q ss_pred -------------------chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHh
Q 044996 602 -------------------DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEV 646 (678)
Q Consensus 602 -------------------d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i 646 (678)
...+.. ........+.+++.+||+.||.+|||+.|+++ .++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHH--HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000000 00112345677888999999999999999988 35444
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.57 Aligned_cols=242 Identities=19% Similarity=0.293 Sum_probs=193.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh--------hhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEE
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN--------VGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 443 (678)
.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++.++ +||||+++++++......++|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 478999999999999875 789999999875321 1245688999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 179 ~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp ECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 99999999999997543 589999999999999999999976 899999999999999999999999999877
Q ss_pred cCcc---ccccccceeeCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 524 MNQE---SAQELMIAYKSPEFLQL------GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 524 ~~~~---~~~~~~~~y~aPE~~~~------~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
+... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.. ..............
T Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~--------~~~~~~~~~i~~~~ 321 (365)
T 2y7j_A 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH--------RRQILMLRMIMEGQ 321 (365)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTC
T ss_pred cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhCC
Confidence 6543 23346789999998863 3588999999999999999999999962 12222222222211
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. ...+.. .. ....+.+++.+||+.||++|||+.|+++
T Consensus 322 ~~---~~~~~~--~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 322 YQ---FSSPEW--DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CC---CCHHHH--SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC---CCCccc--cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 111111 01 1234777888999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=337.65 Aligned_cols=241 Identities=18% Similarity=0.239 Sum_probs=190.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... +++.||+|.++.... .+.+|++++.++ +||||+++++++.+.+..|+||||+++|+
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 467999999999999864 688999999975432 345688888888 79999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC----CceEEeecCCccccCcc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES----LEPVLADYGLIPVMNQE 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~~~~~~ 527 (678)
|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++.....
T Consensus 103 L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 103 LLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp HHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999997543 589999999999999999999976 89999999999998543 35999999999866433
Q ss_pred c----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 528 S----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 528 ~----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
. ...++..|+|||++.+..++.++|||||||++|||++|+.||... ......+............ ..
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~~~~i~~~~~~~----~~ 244 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG-----PDDTPEEILARIGSGKFSL----SG 244 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS-----TTSCHHHHHHHHHHCCCCC----CS
T ss_pred CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC-----CcCCHHHHHHHHccCCccc----Cc
Confidence 2 234578899999998878999999999999999999999999621 1123333333333222111 00
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. .......+.+++.+||+.||++||++.|+++
T Consensus 245 ~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 GY-----WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TT-----TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0112234677888999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=323.08 Aligned_cols=241 Identities=19% Similarity=0.270 Sum_probs=192.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 467999999999999875 68899999987432 3445789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 92 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred HHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999986532 589999999999999999999976 8999999999999999999999999998765322
Q ss_pred --ccccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 --SAQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++.+..+ +.++||||||+++|||++|+.||...... ...+..| ....... . .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~~~~~~----~-~ 230 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDW----KEKKTYL----N-P 230 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SHHHHHH----HTTCTTS----T-T
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHh----hhccccc----C-c
Confidence 22346788999999987665 78999999999999999999999732110 0111111 1111110 0 0
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ......+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 W------KKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp G------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h------hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 011234677888999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=348.21 Aligned_cols=247 Identities=20% Similarity=0.270 Sum_probs=197.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||+|... +++.||||++... .......+.+|++++++++|||||++++++.+....++||||+++|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 467999999999999874 7889999998642 2345678999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec---CCCceEEeecCCccccCcc
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN---ESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~~ 527 (678)
+|.+++.... .+++..+..|+.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 107 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999887653 489999999999999999999976 899999999999995 5668999999999876543
Q ss_pred c---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 S---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
. ...++..|+|||++.+ .++.++|||||||++|||++|+.||.. ....+............ . .+.
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~~~-~--~~~ 245 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG--------KNEYDILKRVETGKYAF-D--LPQ 245 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCCCS-C--SGG
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC-C--Ccc
Confidence 2 3357889999999875 699999999999999999999999962 22233333333222111 0 011
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH--HHHhh
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK--IEEVK 647 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L~~i~ 647 (678)
.. .....+.+++.+||+.||.+|||+.|+++. +++..
T Consensus 246 ~~------~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 246 WR------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp GG------GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred cC------CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 10 112346778889999999999999999983 55443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=350.30 Aligned_cols=246 Identities=21% Similarity=0.292 Sum_probs=198.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++||||+.+
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 567999999999999875 78999999986432 34567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe---cCCCceEEeecCCccccCc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL---NESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~ 526 (678)
|+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 111 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 111 GELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999987543 589999999999999999999977 89999999999999 5678999999999976654
Q ss_pred cc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 527 ES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 527 ~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
.. ...++..|+|||++.+ .++.++|||||||++|||++|+.||.. ....+.+.......... . .+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~~~-~--~~ 249 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG--------ANEYDILKKVEKGKYTF-E--LP 249 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC-C--SG
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHcCCCCC-C--Cc
Confidence 32 2347889999999875 799999999999999999999999962 22233333333222111 0 01
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHh
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEV 646 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i 646 (678)
... .....+.+++.+||+.||.+|||+.|+++ .++..
T Consensus 250 ~~~------~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 250 QWK------KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp GGG------GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred ccc------cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 111 11234677888999999999999999997 45544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=343.28 Aligned_cols=247 Identities=17% Similarity=0.128 Sum_probs=175.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhcc--CCCCcccee-------EEEEeCC--
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRL--RHPNLLPLV-------AYYYRKE-- 438 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~H~niv~l~-------~~~~~~~-- 438 (678)
.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+++++.+ +||||++++ +++...+
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence 467999999999999864 78899999998643 23456678885544444 699987754 5554332
Q ss_pred ---------------ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHH------HHHHHHHHHHHHHHHHhCCCCCCcc
Q 044996 439 ---------------EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSR------LKIVKGVAKGLQYLYRELPSLIAPH 497 (678)
Q Consensus 439 ---------------~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~~ivH 497 (678)
..++|||||+ |+|.+++..... .+.+..+ +.++.||+.||+|||+. +|+|
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~ivH 217 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSK----GLVH 217 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----TEEE
T ss_pred CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC----CCcc
Confidence 3799999998 899999986532 3566666 78889999999999976 8999
Q ss_pred cCCCCCCEEecCCCceEEeecCCccccCccc-cccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCccccc
Q 044996 498 GHIKSSNVLLNESLEPVLADYGLIPVMNQES-AQELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPANFLQ 574 (678)
Q Consensus 498 rdlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~ 574 (678)
|||||+|||++.++.+||+|||+++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999999998776554 4456689999999987 679999999999999999999999997432
Q ss_pred cCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 575 QGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 575 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..... .| ... .........+... ........+.+++.+||+.||++|||+.|+++
T Consensus 298 ~~~~~-----~~-----~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 298 PGIKG-----SW-----KRP-SLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTCTT-----CC-----CBC-CTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccc-----ch-----hhh-hhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11100 00 000 0000000000000 00112345777888999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.49 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=189.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 467999999999999875 58899999986532 334567889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 110 ILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp HHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred hHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9988765432 489999999999999999999977 8999999999999999999999999999765432
Q ss_pred -ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHH--------------
Q 044996 528 -SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL-------------- 591 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~-------------- 591 (678)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.... -.+......
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS--------DIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHHHhCCCChhhhhHh
Confidence 223467889999999765 78999999999999999999999996211 111111111
Q ss_pred hcCCccccccchhhhcccC----CHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 592 ANGDNRTEVFDKEMADERN----SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 592 ~~~~~~~~~~d~~l~~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...........+.+..... .......+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1100000000000000000 0012345788888999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=327.41 Aligned_cols=240 Identities=22% Similarity=0.302 Sum_probs=190.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 467999999999999875 58899999987532 346789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.+++.... ..+++.++..++.||+.||.|||.. +++||||||+||+++.++.+||+|||++...... .
T Consensus 112 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 112 SDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp HHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBC
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccC
Confidence 99997432 2589999999999999999999976 7999999999999999999999999999765432 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...++..|+|||++.+..++.++||||||+++|||++|+.||... ............... ....+
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~~~--~~~~~----- 248 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI--------HPMRAIFMIPTNPPP--TFRKP----- 248 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCCC--CCSSG-----
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHhcCCCc--ccCCc-----
Confidence 234678899999999889999999999999999999999999621 111211111111111 01001
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||+.||.+|||+.++++
T Consensus 249 ---~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ---ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111235778888999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=340.55 Aligned_cols=189 Identities=20% Similarity=0.282 Sum_probs=164.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhcc------CCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRL------RHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.++||+|+||.||+|... +++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++...+..++||||
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 180 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEec
Confidence 467999999999999764 5889999998753 34456778888888877 577999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc--eEEeecCCcccc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE--PVLADYGLIPVM 524 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGla~~~ 524 (678)
+. ++|.+++..... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 181 ~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 181 LS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp CC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred cC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 95 699999986543 2489999999999999999999987 7999999999999999887 999999999765
Q ss_pred Ccc-ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 525 NQE-SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 525 ~~~-~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
... ....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 253 HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp TCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 543 23456788999999999999999999999999999999999996
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.96 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=177.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 46799999999999975 468899999886532 3345678899999999999999999999999999999999999999
Q ss_pred HHHHhhccC---CCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 452 LAVNLHGHQ---ALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 452 L~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
|.+++.... ......+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 999987421 11123589999999999999999999976 7999999999999999999999999998765432
Q ss_pred --------ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc-c
Q 044996 528 --------SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN-R 597 (678)
Q Consensus 528 --------~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~-~ 597 (678)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... .............. .
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP--------PMKVLMLTLQNDPPSL 247 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC--------GGGHHHHHHTSSCCCT
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc--------hhhHHHHHhccCCCcc
Confidence 12246778999999875 568999999999999999999999997321 11111222222111 0
Q ss_pred -ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 -TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 -~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
....++.+. ......+.+++.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ETGVQDKEML-----KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC-----CCC-----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccchhh-----hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001111111 112235778888999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=349.64 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=193.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||+|+.. ++..+|+|++.... ......+.+|+.++++++|||||+++++|.+....++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 121 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 567999999999999875 67899999987532 334577899999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---CCceEEeecCCccccCcc
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---SLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~ 527 (678)
+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.+...
T Consensus 122 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 122 ELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999887653 489999999999999999999976 8999999999999976 455999999999876543
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....++..|+|||++. +.++.++|||||||++|||++|+.||.. ....+............ ..+.
T Consensus 193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~~~~~---~~~~ 260 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG--------QTDQEILRKVEKGKYTF---DSPE 260 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTCCCC---CSGG
T ss_pred ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC---Cchh
Confidence 2334788999999986 5799999999999999999999999962 23333333333222111 1111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHh
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEV 646 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i 646 (678)
.. .....+.+++.+||+.||.+|||+.|+++ .+++.
T Consensus 261 ~~------~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 261 WK------NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp GT------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred cc------cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 11 11234677888999999999999999986 35544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=323.40 Aligned_cols=242 Identities=20% Similarity=0.246 Sum_probs=194.3
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---------hhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEE
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---------NVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 442 (678)
.+.||+|+||.||+|... +++.||||.++... ....+.+.+|++++++++ ||||+++++++...+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 467999999999999874 68899999987532 123467889999999996 9999999999999999999
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 102 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999997643 589999999999999999999976 89999999999999999999999999997
Q ss_pred ccCccc---cccccceeeCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 523 VMNQES---AQELMIAYKSPEFLQ------LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 523 ~~~~~~---~~~~~~~y~aPE~~~------~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
...... ...++..|+|||++. ...++.++||||||+++|||++|+.||.. .............
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~~~ 244 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--------RKQMLMLRMIMSG 244 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHT
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC--------ccHHHHHHHHhcC
Confidence 765432 234678899999885 45689999999999999999999999862 2222333333322
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... ..+.. ......+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~---~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQF---GSPEW------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCC---CTTTG------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Cccc---Ccccc------cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 2111 01111 112345778888999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.95 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=189.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChh-----hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNV-----GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 94 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcC
Confidence 467999999999999874 5889999998743221 1246889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++ +|.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 95 ~~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 95 ET-DLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp SE-EHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred CC-CHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 75 89988875432 588999999999999999999976 7999999999999999999999999999876432
Q ss_pred ----ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcccccc
Q 044996 528 ----SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTEVF 601 (678)
Q Consensus 528 ----~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~ 601 (678)
....++..|+|||++.+. .++.++|||||||++|||++|+.||.. ....+.+...+.. +....+..
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~--------~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG--------DSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHHHcCCCChhhh
Confidence 223467889999998654 589999999999999999999999862 1222222222211 10000000
Q ss_pred -------ch----hhhccc---CCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 602 -------DK----EMADER---NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 602 -------d~----~l~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+. ...... ........+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000000 001123457888889999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.69 Aligned_cols=248 Identities=18% Similarity=0.242 Sum_probs=184.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------ceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------EKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 444 (678)
.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 46799999999999976 46889999998753 3345577899999999999999999999997654 679999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||++ |+|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 110 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 110 ELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp ECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 9996 578888852 488999999999999999999976 8999999999999999999999999999876
Q ss_pred Ccc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh---------
Q 044996 525 NQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA--------- 592 (678)
Q Consensus 525 ~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~--------- 592 (678)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||... +..+-....+.
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT--------DHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHC-CCCCCHHH
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHHhCCCCHHH
Confidence 543 2234678899999999889999999999999999999999999621 11111111111
Q ss_pred -------------cCCccc-cccchhhhcc---cC---CHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 593 -------------NGDNRT-EVFDKEMADE---RN---SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 593 -------------~~~~~~-~~~d~~l~~~---~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
...... ..++..+... .. .......+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 100000 0000000000 00 0122456788999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=323.63 Aligned_cols=252 Identities=19% Similarity=0.276 Sum_probs=183.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hh-hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NV-GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|.. .+++.||+|+++... .. ..+.+.++...++.++||||+++++++.+.+..++||||++ |
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-T 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-E
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-c
Confidence 46799999999999986 578899999997542 22 23344555556888999999999999999999999999997 5
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++...... ...+++..+..|+.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 91 SLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHSKL---SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp EHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHHS---CCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred chHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 888887642211 126999999999999999999999763 69999999999999999999999999997765432
Q ss_pred -cccccceeeCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 -AQELMIAYKSPEFL----QLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 -~~~~~~~y~aPE~~----~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
...++..|+|||++ ....++.++|||||||++|||+||+.||... ..-...+.......... .
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~~--~--- 234 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW-------GTPFQQLKQVVEEPSPQ--L--- 234 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC-------SCHHHHHHHHHHSCCCC--C---
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc-------CchHHHHHHHhccCCCC--c---
Confidence 23467889999996 5567899999999999999999999999621 11222222222222111 0
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhc
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKE 648 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~ 648 (678)
... .....+.+++.+||+.||++|||+.|+++ .++....
T Consensus 235 --~~~----~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 235 --PAD----KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp --CTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred --ccc----cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 001 12235778888999999999999999998 5555443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=342.20 Aligned_cols=243 Identities=21% Similarity=0.270 Sum_probs=183.5
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccC--------hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEE
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMN--------NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 443 (678)
..+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++|++++|||||++++++. .+..++|
T Consensus 139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEE
T ss_pred EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEE
Confidence 356799999999999976 467899999987532 112235889999999999999999999975 4568999
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC---CceEEeecCC
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES---LEPVLADYGL 520 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGl 520 (678)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 218 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 218 LELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred EEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 99999999999886542 589999999999999999999976 79999999999999754 4599999999
Q ss_pred ccccCccc---cccccceeeCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 521 IPVMNQES---AQELMIAYKSPEFLQL---GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 521 a~~~~~~~---~~~~~~~y~aPE~~~~---~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
++...... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||.... ....+... +..+
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~----i~~~ 360 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQ----ITSG 360 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS----SSCCHHHH----HHTT
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc----chHHHHHH----HhcC
Confidence 98775442 2346789999999853 578899999999999999999999996321 11122221 1111
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.. . ..+.... .....+.+++.+||+.||.+|||+.|+++
T Consensus 361 ~~--~-~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KY--N-FIPEVWA-----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CC--C-CCHHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC--C-CCchhhc-----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11 0 0111111 11345778888999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=327.70 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=185.1
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEE--------------eCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYY--------------RKE 438 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--------------~~~ 438 (678)
.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++. ...
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 467999999999999875 48899999998766667788999999999999999999999874 335
Q ss_pred ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec-CCCceEEee
Q 044996 439 EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLAD 517 (678)
Q Consensus 439 ~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~D 517 (678)
..++||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|
T Consensus 96 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp EEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCeEEEcc
Confidence 7899999997 6999998642 589999999999999999999976 899999999999997 577999999
Q ss_pred cCCccccCcc-------ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHH
Q 044996 518 YGLIPVMNQE-------SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNS 589 (678)
Q Consensus 518 fGla~~~~~~-------~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~ 589 (678)
||+++..... ....++..|+|||.+.. ..++.++|||||||++|||+||+.||.. ....+....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~--------~~~~~~~~~ 236 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG--------AHELEQMQL 236 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCC--------CCHHHHHHH
Confidence 9999876432 12234677999998865 6789999999999999999999999972 122222222
Q ss_pred HHhcCCccc------------cccchhhhcccCC-----HHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 590 VLANGDNRT------------EVFDKEMADERNS-----EGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 590 ~~~~~~~~~------------~~~d~~l~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......... ..+.......... ......+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 222111000 0000000000000 012345778888999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=346.27 Aligned_cols=184 Identities=18% Similarity=0.342 Sum_probs=147.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC-----CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-----EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~E 445 (678)
.++||+|+||+||+|... +++.||||++... .....+.+.+|+++|++++|||||++++++... ...|+|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 467999999999999764 6889999998653 344567899999999999999999999999543 46899999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+ +|+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 138 ~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 138 IA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred cc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 98 579999987542 589999999999999999999976 89999999999999999999999999998764
Q ss_pred cc-------------------------------ccccccceeeCcccc-ccCCCCCcchHHHHHHHHHHHHhCC
Q 044996 526 QE-------------------------------SAQELMIAYKSPEFL-QLGRITKKTDVWSLGVLILEIMTGK 567 (678)
Q Consensus 526 ~~-------------------------------~~~~~~~~y~aPE~~-~~~~~t~ksDvwS~Gvvl~el~tg~ 567 (678)
.. ....+|..|+|||++ ....++.++|||||||+||||+||.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 21 112347789999976 4567999999999999999999943
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=331.38 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=188.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeC--------CceEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--------EEKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~~~~l 442 (678)
.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++... +..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 46799999999999987 578899999886432 23346788999999999999999999999873 46899
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
||||++ |+|.+.+..... .+++.++..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 102 v~e~~~-~~l~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 102 VFDFCE-HDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEECCS-EEHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEeccC-CCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 999997 588888765432 589999999999999999999976 89999999999999999999999999997
Q ss_pred ccCcc--------ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 523 VMNQE--------SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 523 ~~~~~--------~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
.+... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.... .......+......
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQLCGS 247 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCC
Confidence 65421 12245788999998876 458999999999999999999999997211 01111111111111
Q ss_pred CCc--cccccchhh-------hcccCC-HHH------HHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 594 GDN--RTEVFDKEM-------ADERNS-EGE------MVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 594 ~~~--~~~~~d~~l-------~~~~~~-~~~------~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
... ....-+..+ ...... .+. ...+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000 000000000 000000 001 234678888999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=334.48 Aligned_cols=251 Identities=18% Similarity=0.249 Sum_probs=185.1
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccC-----------hhhHHHHHHHHHHHhccCCCCccceeEEEEeC-----
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMN-----------NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK----- 437 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----- 437 (678)
.+.||+|+||.||+|...++..||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 46799999999999998889999999986422 12247899999999999999999999998653
Q ss_pred CceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEee
Q 044996 438 EEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLAD 517 (678)
Q Consensus 438 ~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 517 (678)
...++||||++ |+|.+++..... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQRI----VISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC
T ss_pred ceEEEEEccCC-CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChHHEEEcCCCCEEEEe
Confidence 35799999997 689988875432 589999999999999999999987 799999999999999999999999
Q ss_pred cCCccccCccc---cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 518 YGLIPVMNQES---AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 518 fGla~~~~~~~---~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
||+++...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.. ....+........
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~--------~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG--------STFYNQLNKIVEV 249 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHH
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHHH
Confidence 99997554332 2345778999999876 6789999999999999999999999962 1222222222110
Q ss_pred CCcc--cc-----------ccchhhhccc------CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 594 GDNR--TE-----------VFDKEMADER------NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 594 ~~~~--~~-----------~~d~~l~~~~------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... .. .+...+.... ........+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0000 00 0000000000 00011345778888999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.40 Aligned_cols=254 Identities=15% Similarity=0.178 Sum_probs=197.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCC-CccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHP-NLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.++||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++|+ +|..+..++...+..+|||||+ +++
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s 88 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence 46799999999999986 5688999998765332 34588999999999874 5556666667778899999999 999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe---cCCCceEEeecCCccccCccc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL---NESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~~ 528 (678)
|.+++..... .+++.+++.|+.||+.||+|||.. +|+||||||+|||| ++++.+||+|||+++.+....
T Consensus 89 L~~ll~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 89 LEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred HHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9999975432 599999999999999999999976 89999999999999 688999999999998665432
Q ss_pred -----------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 529 -----------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 529 -----------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
...++..|+|||++.+..++.++|||||||+||||++|+.||..... ......+....... ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~i~~~~-~~ 234 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----GTKKQKYEKISEKK-VA 234 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----SSHHHHHHHHHHHH-HH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc-----hhHHHHHHHHhhcc-cc
Confidence 33467889999999999999999999999999999999999973221 12222222221110 00
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
..++ .+.. . ....+.+++..||+.+|++||++.+|++.|+++.....
T Consensus 235 -~~~~-~l~~-~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 235 -TSIE-ALCR-G----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp -SCHH-HHHT-T----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -ccHH-HHhc-C----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 0000 1111 1 12457888889999999999999999999999865443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=358.01 Aligned_cols=238 Identities=21% Similarity=0.267 Sum_probs=195.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+|+||.||+|+.. +++.||||+++.. .....+.+..|.+++..+ +||||+++++++.+.+..||||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 568999999999999864 6788999998753 223456788899999988 79999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.++++... .+++.++..|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 999999998653 489999999999999999999976 8999999999999999999999999999854322
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....+|..|+|||++.+..|+.++|||||||+||||++|+.||. ..+..+....++......
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~--------~~~~~~~~~~i~~~~~~~------- 561 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE--------GEDEDELFQSIMEHNVAY------- 561 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSC--------CSSHHHHHHHHHSSCCCC-------
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCC--------CCCHHHHHHHHHhCCCCC-------
Confidence 23347889999999999999999999999999999999999997 223344444444332111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCH-----HHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDL-----KEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~ev~~ 641 (678)
+......+.+++.+||+.||.+||++ +||.+
T Consensus 562 ------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 562 ------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11122346777789999999999997 56653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.57 Aligned_cols=247 Identities=19% Similarity=0.300 Sum_probs=190.0
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||.||+|.... .+++|+++... ....+.|.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 4679999999999998754 48899887432 2334567889999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 116 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 116 LYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp HHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 999997643 2589999999999999999999976 899999999999998 679999999998754321
Q ss_pred -----ccccccceeeCcccccc---------CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 528 -----SAQELMIAYKSPEFLQL---------GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 528 -----~~~~~~~~y~aPE~~~~---------~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
....++..|+|||++.. ..++.++|||||||++|||++|+.||.. .............
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~--------~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT--------QPAEAIIWQMGTG 258 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS--------CCHHHHHHHHHTT
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHhccC
Confidence 12236788999999864 4578999999999999999999999962 2222222222211
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
. .. .+.... ....+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 259 ~-~~------~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 259 M-KP------NLSQIG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp C-CC------CCCCSS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred C-CC------CCCcCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 11 110101 1123678888999999999999999999999887654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=340.46 Aligned_cols=191 Identities=21% Similarity=0.350 Sum_probs=151.0
Q ss_pred ccccCccCceeEEEEEec---CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe--CCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS---TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR--KEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~Ey~~ 448 (678)
+++||+|+||+||+|+.. ++..||||++.... ....+.+|+++|++++|||||++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 568999999999999865 57889999987532 23568899999999999999999999965 567899999996
Q ss_pred CCCHHHHhhccCC----CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe----cCCCceEEeecCC
Q 044996 449 KRSLAVNLHGHQA----LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL----NESLEPVLADYGL 520 (678)
Q Consensus 449 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGl 520 (678)
|+|.+++..... .....+++..+..|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 588888763321 1112489999999999999999999976 79999999999999 7789999999999
Q ss_pred ccccCcc-------ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 521 IPVMNQE-------SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 521 a~~~~~~-------~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
++.+... ....+|..|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 9876532 123457889999999874 58999999999999999999999996
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=333.26 Aligned_cols=253 Identities=15% Similarity=0.207 Sum_probs=194.7
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhh-----------------HHHHHHHHHHHhccCCCCccceeEEEEe
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVG-----------------REEFQEHMRRLGRLRHPNLLPLVAYYYR 436 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~H~niv~l~~~~~~ 436 (678)
.+.||+|+||.||+|.. +++.||+|.+....... .+.+.+|++++++++||||+++++++.+
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 114 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN 114 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence 46799999999999998 89999999987432111 1789999999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHH------hhccCCCCCCCCChHHHHHHHHHHHHHHHHHHH-hCCCCCCcccCCCCCCEEecC
Q 044996 437 KEEKLLVHEFVPKRSLAVN------LHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR-ELPSLIAPHGHIKSSNVLLNE 509 (678)
Q Consensus 437 ~~~~~lv~Ey~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~~ivHrdlk~~NILl~~ 509 (678)
.+..++||||+++|+|.++ +.... ...+++..+..++.||+.||+|||+ . +|+||||||+|||++.
T Consensus 115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPSNILMDK 187 (348)
T ss_dssp SSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGGGEEECT
T ss_pred CCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChHhEEEcC
Confidence 9999999999999999998 44321 2369999999999999999999997 4 7999999999999999
Q ss_pred CCceEEeecCCccccCcc--ccccccceeeCccccccC-CCCC-cchHHHHHHHHHHHHhCCCCccccccCCCCCCChHH
Q 044996 510 SLEPVLADYGLIPVMNQE--SAQELMIAYKSPEFLQLG-RITK-KTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLAS 585 (678)
Q Consensus 510 ~~~~kl~DfGla~~~~~~--~~~~~~~~y~aPE~~~~~-~~t~-ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~ 585 (678)
++.+||+|||+++..... ....++..|+|||++.+. .++. ++|||||||++|||++|+.||... ....+
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~ 260 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK-------ISLVE 260 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS-------SCSHH
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC-------CcHHH
Confidence 999999999999775433 334567889999999876 6666 999999999999999999999721 11123
Q ss_pred HHHHHHhcCCcccc----ccchhhhc--ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 586 WVNSVLANGDNRTE----VFDKEMAD--ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 586 ~~~~~~~~~~~~~~----~~d~~l~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.............. ...+.... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 33322222111100 00000000 0000112345778888999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.34 Aligned_cols=246 Identities=23% Similarity=0.277 Sum_probs=194.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh-------------hhHHHHHHHHHHHhccCCCCccceeEEEEeCCc
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN-------------VGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE 439 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~ 439 (678)
.+.||+|+||+||+|... ++..+|+|++..... ...+.+.+|+.++++++|||||+++++|.+...
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 467999999999999875 578899999875321 235678999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC---ceEEe
Q 044996 440 KLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL---EPVLA 516 (678)
Q Consensus 440 ~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~---~~kl~ 516 (678)
.++||||+++|+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999987653 589999999999999999999976 899999999999998775 69999
Q ss_pred ecCCccccCcc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 517 DYGLIPVMNQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 517 DfGla~~~~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
|||+++..... ....++..|+|||++. +.++.++|||||||++|||++|+.||.. ....+.+......
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~--------~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG--------QNDQDIIKKVEKG 262 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHC
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHcC
Confidence 99999876543 2335788999999987 5799999999999999999999999962 2333333333322
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHh
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEV 646 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i 646 (678)
.... +..... .....+.+++.+||+.||.+|||+.|+++ .+++.
T Consensus 263 ~~~~----~~~~~~-----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 263 KYYF----DFNDWK-----NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CCCC----CHHHHT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCCC----CccccC-----CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 2111 111000 11234677888999999999999999986 35443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.66 Aligned_cols=183 Identities=22% Similarity=0.313 Sum_probs=161.3
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEe--CCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYR--KEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++||||+++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 46799999999999975 57889999998743 3567899999999997 9999999999987 5678999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-ceEEeecCCccccCccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-EPVLADYGLIPVMNQES 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~ 528 (678)
++|.+++. .+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 118 ~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 118 TDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred hhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999885 378899999999999999999976 899999999999999776 89999999998665432
Q ss_pred ---cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 529 ---AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 3346778999999876 678999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.78 Aligned_cols=240 Identities=21% Similarity=0.273 Sum_probs=189.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC----hhhHHHHHHHHHHHhccCCCCccceeEEEEe--CCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN----NVGREEFQEHMRRLGRLRHPNLLPLVAYYYR--KEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~Ey 446 (678)
.+.||+|+||.||+|.. .++..+|+|.++... ....+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 46799999999999986 467899999987532 2345789999999999999999999999853 4578999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
++++ |.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 90 CVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp CSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred ccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9876 7777765432 2589999999999999999999976 899999999999999999999999999976542
Q ss_pred c------ccccccceeeCccccccCC--CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 527 E------SAQELMIAYKSPEFLQLGR--ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 527 ~------~~~~~~~~y~aPE~~~~~~--~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
. ....++..|+|||++.+.. ++.++|||||||++|||++|+.||.. .................
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--------~~~~~~~~~i~~~~~~~- 232 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG--------DNIYKLFENIGKGSYAI- 232 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHCCCCC-
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC--------chHHHHHHHHhcCCCCC-
Confidence 2 2234678899999987643 37899999999999999999999962 23333333332221111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 233 ------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 233 ------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------------CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01122346778889999999999999999973
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=337.85 Aligned_cols=188 Identities=21% Similarity=0.335 Sum_probs=160.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC-----CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-----EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~E 445 (678)
.+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+++|++++||||+++++++... ...|+|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 46799999999999986 46788999999753 344567899999999999999999999999766 56899999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+. |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 111 IAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred cCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 996 69999997542 589999999999999999999977 89999999999999999999999999998764
Q ss_pred cc--------------------------ccccccceeeCcccc-ccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 526 QE--------------------------SAQELMIAYKSPEFL-QLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 526 ~~--------------------------~~~~~~~~y~aPE~~-~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.. ....+|..|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 32 223457889999986 55679999999999999999999766654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.74 Aligned_cols=241 Identities=21% Similarity=0.320 Sum_probs=186.9
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEe------CCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYR------KEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~------~~~~~lv~E 445 (678)
.+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. .+..++|||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 46799999999999987 478899999987542 3456889999999999 89999999999987 457899999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++|+|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 108 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp CCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred cCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 9999999999986532 2589999999999999999999976 79999999999999999999999999987654
Q ss_pred cc----ccccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 526 QE----SAQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 526 ~~----~~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
.. ....++..|+|||++. ...++.++|||||||++|||++|+.||... ....-.........
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~~- 251 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM--------HPMRALFLIPRNPA- 251 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCC-
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHHhhcCcc-
Confidence 32 2234678899999986 567899999999999999999999998621 11111111111111
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.+.... ....+.+++.+||+.||.+||++.|+++
T Consensus 252 ------~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 ------PRLKSKK----WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ------CCCSCSC----SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------ccCCccc----cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0110111 1235677888999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.56 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=174.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 444 (678)
.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++... ...++|+
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 46799999999999975 56889999998653 334567888999999999999999999999754 5679999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 114 e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 114 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp ECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred ccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 999 78999888642 589999999999999999999976 8999999999999999999999999999876
Q ss_pred Ccc-ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcccccc
Q 044996 525 NQE-SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTEVF 601 (678)
Q Consensus 525 ~~~-~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~ 601 (678)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+.+...... +....+.+
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~--------~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG--------TDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHHHhCCCCHHHH
Confidence 543 23456788999999876 6789999999999999999999999962 1222222222110 00000000
Q ss_pred c----h-------hhhcc-cCC-----HHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 602 D----K-------EMADE-RNS-----EGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 602 d----~-------~l~~~-~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. . .+... ... ......+.+++.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 0 00000 000 011234678888999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.68 Aligned_cols=258 Identities=21% Similarity=0.241 Sum_probs=193.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccC--------CCCccceeEEEE----eCCce
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR--------HPNLLPLVAYYY----RKEEK 440 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~----~~~~~ 440 (678)
.++||+|+||+||+|+. .+++.||||+++.. ....+.+.+|++++++++ |+||+++++++. .....
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 120 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence 46799999999999975 46789999998753 445677899999999985 788999999987 45578
Q ss_pred EEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC---------
Q 044996 441 LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL--------- 511 (678)
Q Consensus 441 ~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~--------- 511 (678)
++||||+ +|+|.+++..... ..+++..+..|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 121 ~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 121 CMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred EEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccchhhhhhhhh
Confidence 9999999 6677777665422 25899999999999999999999753 699999999999999775
Q ss_pred ----------------------------------------ceEEeecCCccccCcc-ccccccceeeCccccccCCCCCc
Q 044996 512 ----------------------------------------EPVLADYGLIPVMNQE-SAQELMIAYKSPEFLQLGRITKK 550 (678)
Q Consensus 512 ----------------------------------------~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~t~k 550 (678)
.+||+|||+++..... ....+|..|+|||++.+..++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 273 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcH
Confidence 8999999999876543 23456889999999998899999
Q ss_pred chHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHH---Hhc--------CCccccccch----------------
Q 044996 551 TDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSV---LAN--------GDNRTEVFDK---------------- 603 (678)
Q Consensus 551 sDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~---~~~--------~~~~~~~~d~---------------- 603 (678)
+|||||||++|||+||+.||........ ..-...+... +.. +....+.++.
T Consensus 274 ~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (397)
T 1wak_A 274 ADIWSTACMAFELATGDYLFEPHSGEEY--TRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351 (397)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCCCCSSS--CHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred HHHHHHHHHHHHHhhCCCCCCCCccccc--CchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence 9999999999999999999973221100 0001111111 100 0000000000
Q ss_pred --hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 --EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 --~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
..............+.+++.+||+.||++|||+.|+++
T Consensus 352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00011123456677899999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=317.29 Aligned_cols=247 Identities=20% Similarity=0.261 Sum_probs=196.1
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
..+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (287)
T 2wei_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCC
Confidence 3567999999999999875 6889999998643 234567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC---CceEEeecCCccccCc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES---LEPVLADYGLIPVMNQ 526 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~ 526 (678)
++|.+++.... .+++.++..++.||+.||.|||.. +++||||||+||+++.+ +.+||+|||+++....
T Consensus 106 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999887543 489999999999999999999976 89999999999999754 4799999999876654
Q ss_pred cc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 527 ES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 527 ~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
.. ...++..|+|||.+.+ .++.++||||||+++|||++|+.||.. ....+............ . .+
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~-~--~~ 244 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG--------KNEYDILKRVETGKYAF-D--LP 244 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC-C--SG
T ss_pred CCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCCC-C--ch
Confidence 32 2235778999999875 589999999999999999999999862 22233333333221111 0 01
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHh
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEV 646 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i 646 (678)
.. . .....+.+++.+||+.||.+|||+.|+++ .+++.
T Consensus 245 ~~--~----~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 245 QW--R----TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp GG--T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred hh--h----hcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 10 0 11234677888999999999999999998 44443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.38 Aligned_cols=253 Identities=18% Similarity=0.259 Sum_probs=194.7
Q ss_pred ccccCccCceeEEEEEe--cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCC------ccceeEEEEeCCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL--STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN------LLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~~~lv~E 445 (678)
.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|++++++++|+| |+++++++...+..++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 46799999999999976 36789999998753 345577889999999887654 9999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC----------------
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---------------- 509 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---------------- 509 (678)
|+ +++|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 98 ~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 98 LL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp CC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred CC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 99 8999999976532 2589999999999999999999976 8999999999999987
Q ss_pred ---CCceEEeecCCccccCcc-ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHH
Q 044996 510 ---SLEPVLADYGLIPVMNQE-SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLAS 585 (678)
Q Consensus 510 ---~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~ 585 (678)
++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~ 244 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS-----KEHLA 244 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH-----HHHHH
T ss_pred cccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-----HHHHH
Confidence 678999999999865543 234568899999999988999999999999999999999999962110 01111
Q ss_pred HHHHHHhcC--------Ccccccc---------------------chhhhcccCCHHHHHHHHHHHhhcCccccccCCCH
Q 044996 586 WVNSVLANG--------DNRTEVF---------------------DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDL 636 (678)
Q Consensus 586 ~~~~~~~~~--------~~~~~~~---------------------d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 636 (678)
.+......- ... ..+ .+..............+.+++.+||+.||.+|||+
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKR-KYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCG-GGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHhCCCCHHHHhhccch-hHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 111111100 000 000 00000001123456678899999999999999999
Q ss_pred HHHHH
Q 044996 637 KEAVE 641 (678)
Q Consensus 637 ~ev~~ 641 (678)
.|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.89 Aligned_cols=256 Identities=21% Similarity=0.257 Sum_probs=187.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeC---------------
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK--------------- 437 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------------- 437 (678)
.+.||+|+||.||+|.. .+++.||||++..... ...+|+++++.++|||||++++++...
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 46799999999999976 5789999999875422 234799999999999999999998543
Q ss_pred -----------------------CceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCC
Q 044996 438 -----------------------EEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494 (678)
Q Consensus 438 -----------------------~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ 494 (678)
...++||||++ |+|.+.+...... ...+++..+..++.||+.||+|||+. +
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----g 161 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVGFIHSL----G 161 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHTT----T
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----c
Confidence 23789999997 6888877642211 12699999999999999999999965 8
Q ss_pred CcccCCCCCCEEec-CCCceEEeecCCccccCccc---cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCC
Q 044996 495 APHGHIKSSNVLLN-ESLEPVLADYGLIPVMNQES---AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFP 569 (678)
Q Consensus 495 ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~~~---~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P 569 (678)
|+||||||+|||++ +++.+||+|||+++.+.... ...++..|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 241 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL 241 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence 99999999999998 68999999999998664332 33457789999998764 489999999999999999999999
Q ss_pred ccccccCCCCCCChHHHHHHHHh-cCCcc-----------ccc-----cchhhhcccCCHHHHHHHHHHHhhcCcccccc
Q 044996 570 ANFLQQGKKADGDLASWVNSVLA-NGDNR-----------TEV-----FDKEMADERNSEGEMVKLLKIGLACCEEEVEK 632 (678)
Q Consensus 570 ~~~~~~~~~~~~~l~~~~~~~~~-~~~~~-----------~~~-----~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~ 632 (678)
|... .-.+.+..... .+... .+. ........ ........+.+++.+||+.||.+
T Consensus 242 f~~~--------~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 242 FSGE--------TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI-LPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp SCCS--------SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHH-SCTTCCHHHHHHHHHHCCSSGGG
T ss_pred CCCC--------ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhh-CCCCCCHHHHHHHHHHccCChhh
Confidence 9721 11111111111 00000 000 00000000 01112345778888999999999
Q ss_pred CCCHHHHHH--HHHHhhc
Q 044996 633 RLDLKEAVE--KIEEVKE 648 (678)
Q Consensus 633 RPs~~ev~~--~L~~i~~ 648 (678)
|||+.|+++ .++++..
T Consensus 313 R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SCCHHHHHTSGGGHHHHH
T ss_pred CCCHHHHhcCHHHHHHHh
Confidence 999999985 4555544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.18 Aligned_cols=252 Identities=18% Similarity=0.276 Sum_probs=189.7
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeC-----CceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-----EEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++.+++||||+++++++... ...++||||
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~ 111 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence 467999999999999764 67889999997533 34457899999999999999999999999765 368999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+. |+|.+++... .+++.++..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 112 ~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 112 ME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 96 6999998753 489999999999999999999976 899999999999999999999999999987654
Q ss_pred cc-------cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc-
Q 044996 527 ES-------AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR- 597 (678)
Q Consensus 527 ~~-------~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~- 597 (678)
.. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+...+......
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH-----YLDQLNHILGILGSPSQED 255 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS-----GGGHHHHHHHHHCSCCHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHHHhCCCCHHH
Confidence 32 2246788999998754 458999999999999999999999996211 111111111111110000
Q ss_pred -ccccch-------hhhc-ccC-----CHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 -TEVFDK-------EMAD-ERN-----SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 -~~~~d~-------~l~~-~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
....+. .+.. ... .......+.+++.+||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000 000 0011245778888999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=329.43 Aligned_cols=248 Identities=21% Similarity=0.299 Sum_probs=187.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCce------EEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEK------LLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~------~lv~ 444 (678)
.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++...+.. ++||
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 46799999999999976 46889999999753 334467889999999999999999999999876654 9999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+. |+|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 127 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 127 PFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp ECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred cccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 9997 688887742 489999999999999999999977 8999999999999999999999999999876
Q ss_pred Ccc-ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC-Ccccccc
Q 044996 525 NQE-SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG-DNRTEVF 601 (678)
Q Consensus 525 ~~~-~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~ 601 (678)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+.+...+... ....+.+
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~--------~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 195 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG--------KDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC--------CChHHHHHHHHHHhCCCcHHHH
Confidence 543 23356788999999876 6789999999999999999999999962 22222222222110 0000000
Q ss_pred c-----------hhhhccc-C-----CHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 602 D-----------KEMADER-N-----SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 602 d-----------~~l~~~~-~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+ ..+.... . .......+.+++.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 0000000 0 0012345778888999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.52 Aligned_cols=256 Identities=20% Similarity=0.281 Sum_probs=185.3
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc------eEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE------KLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~lv~Ey~ 447 (678)
.++||+|+||+||+|+...+..+|+|++..... ...+|+++++.++||||+++++++...+. .++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 467999999999999987777799998865322 22369999999999999999999976443 78999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec-CCCceEEeecCCccccCc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~ 526 (678)
+++.+....+.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++.+..
T Consensus 121 ~~~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 121 PETVYRASRHYAKL--KQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp SEEHHHHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred CccHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 86544433322111 12589999999999999999999976 899999999999999 799999999999987643
Q ss_pred c---ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcccc--
Q 044996 527 E---SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTE-- 599 (678)
Q Consensus 527 ~---~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~-- 599 (678)
. ....++..|+|||++.+. .++.++|||||||++|||++|+.||.. .+-.+.+...... +....+
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~--------~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG--------ESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHHHhCCCCHHHH
Confidence 3 233467889999998764 589999999999999999999999962 1111111111110 000000
Q ss_pred -ccchhh--------hc----ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH--HHHhh
Q 044996 600 -VFDKEM--------AD----ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK--IEEVK 647 (678)
Q Consensus 600 -~~d~~l--------~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L~~i~ 647 (678)
.+++.. .. ..........+.+++.+||+.||.+|||+.|+++. ++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 000000 00 00001123457888889999999999999999873 44443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.94 Aligned_cols=240 Identities=18% Similarity=0.273 Sum_probs=185.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe-------------CCc
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR-------------KEE 439 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-------------~~~ 439 (678)
.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++||||+++++++.+ .+.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 46799999999999986 47889999998653 3456789999999999999999999999865 346
Q ss_pred eEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecC
Q 044996 440 KLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519 (678)
Q Consensus 440 ~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 519 (678)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSENL----NQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSCG----GGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEecCCCCCHHHhhhcccc----ccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEEeeCc
Confidence 7999999999999999986432 478899999999999999999977 79999999999999999999999999
Q ss_pred CccccCcc------------------ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCC
Q 044996 520 LIPVMNQE------------------SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKAD 580 (678)
Q Consensus 520 la~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~ 580 (678)
+++..... ....++..|+|||++.+. .++.++|||||||++|||++ ||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~------- 231 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG------- 231 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-------
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-------
Confidence 99765421 122356789999998754 78999999999999999998 44310
Q ss_pred CChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 581 GDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 581 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
................ +.+. ........+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~----~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 MERVNILKKLRSVSIE----FPPD-----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHHHSTTCC----CCTT-----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHhccccccc----cCcc-----ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0111222222211111 1111 11123345678888999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.88 Aligned_cols=257 Identities=20% Similarity=0.265 Sum_probs=186.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------ceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------EKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~Ey 446 (678)
.++||+|+||.||+|+.. +++.||||++.... +.+.+|+++|++++|||||+++++|.... ..++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 467999999999999875 68999999986532 22347999999999999999999986422 36799999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC-CceEEeecCCccccC
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES-LEPVLADYGLIPVMN 525 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~ 525 (678)
+++ +|.+.+..... ....+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 975 67666643211 122699999999999999999999965 89999999999999965 678999999998654
Q ss_pred cc---ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CC-----
Q 044996 526 QE---SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GD----- 595 (678)
Q Consensus 526 ~~---~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~----- 595 (678)
.. ....++..|+|||++.+. .++.++|||||||++|||++|+.||.. .+-.+.+...+.. +.
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~--------~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--------DSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHHHCSCCHHH
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHHHhCCCCHHH
Confidence 33 233467889999998764 789999999999999999999999962 1111111111110 00
Q ss_pred ------ccccccchhhhcc----cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhc
Q 044996 596 ------NRTEVFDKEMADE----RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKE 648 (678)
Q Consensus 596 ------~~~~~~d~~l~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~ 648 (678)
...+..-+.+... .+.......+.+++.+||+.||.+|||+.|+++ .++++..
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 0000000110000 000112345778888999999999999999986 4555543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.44 Aligned_cols=243 Identities=21% Similarity=0.274 Sum_probs=187.0
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEecccC--------hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEE
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN--------NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv 443 (678)
..+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++...+ .++|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEE
T ss_pred EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEE
Confidence 3567999999999999864 57899999986432 122345889999999999999999999987654 8999
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc---eEEeecCC
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE---PVLADYGL 520 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGl 520 (678)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 93 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 93 LELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred EecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 99999999999987542 589999999999999999999976 8999999999999987654 99999999
Q ss_pred ccccCccc---cccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcC
Q 044996 521 IPVMNQES---AQELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594 (678)
Q Consensus 521 a~~~~~~~---~~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~ 594 (678)
++...... ...++..|+|||++. ...++.++|||||||++|||++|+.||.... ....+...+ ..+
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~----~~~ 235 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR----TQVSLKDQI----TSG 235 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT----CSSCHHHHH----HHT
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hHHHHHHHH----HhC
Confidence 98765432 234678899999873 4678999999999999999999999996321 111222222 111
Q ss_pred CccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 595 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
... ..+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~---~~~~~~~-----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KYN---FIPEVWA-----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCC---CCHHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc---cCchhhh-----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 110 1111111 11245778888999999999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.82 Aligned_cols=191 Identities=23% Similarity=0.273 Sum_probs=163.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccC-CC-----CccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HP-----NLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||+||+|... +++.||||+++.. ....+++..|+++++.++ |+ +|+++++++...+..++||||
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 137 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEec
Confidence 467999999999999864 6788999998753 344567888999988885 55 499999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec--CCCceEEeecCCcccc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN--ESLEPVLADYGLIPVM 524 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGla~~~ 524 (678)
++ |+|.+++..... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++..
T Consensus 138 ~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 138 LS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp CC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred CC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 95 699999986532 2589999999999999999999953 34799999999999994 5788999999999876
Q ss_pred Ccc-ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 525 NQE-SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 525 ~~~-~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
... ....++..|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 212 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 212 GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 543 33456788999999999899999999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.52 Aligned_cols=240 Identities=19% Similarity=0.303 Sum_probs=188.4
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEeccc--ChhhHHHHHHHHHHHhccC--CCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLR--HPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ |+||+++++++...+..++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 4679999999999999888999999998643 3445678999999999997 5999999999999999999999 558
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
++|.+++.... .+++.++..++.||+.||.|||+. +|+||||||+|||+++ +.+||+|||+++......
T Consensus 112 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 112 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 89999998653 589999999999999999999976 7999999999999965 899999999998765432
Q ss_pred -----cccccceeeCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh
Q 044996 529 -----AQELMIAYKSPEFLQL-----------GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA 592 (678)
Q Consensus 529 -----~~~~~~~y~aPE~~~~-----------~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~ 592 (678)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||... ..-...+.....
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-------~~~~~~~~~~~~ 254 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKLHAIID 254 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHHHHHHC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH-------HHHHHHHHHHHh
Confidence 2246788999999865 47889999999999999999999999621 112222222222
Q ss_pred cCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 593 NGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 593 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
..... . + .......+.+++.+||+.||.+||++.|+++.
T Consensus 255 ~~~~~-~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 PNHEI-E-----F-----PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTSCC-C-----C-----CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccc-C-----C-----cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11110 0 0 00112346778889999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.89 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=179.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc-------eEEEEe
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE-------KLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-------~~lv~E 445 (678)
.+.||+|+||.||+|... ++..||||++.... .....+.+|++.+..++||||+++++++...+. .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 467999999999999874 68899999886532 333456778888999999999999999976443 789999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCcccc
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIPVM 524 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~ 524 (678)
|+++ +|...+..... ....+++..+..++.|++.||.|||.+ ..+|+||||||+|||++. ++.+||+|||+++..
T Consensus 107 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp CCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTST--TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred cccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCC--CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 9976 55554442111 122588999999999999999999932 338999999999999997 899999999999876
Q ss_pred Cccc---cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcccc
Q 044996 525 NQES---AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTE 599 (678)
Q Consensus 525 ~~~~---~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~ 599 (678)
.... ...++..|+|||++.+. .++.++|||||||++|||+||+.||... .....+...... +....+
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--------~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD--------NSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCCCCHH
T ss_pred CCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC--------ChHHHHHHHHHHcCCCCHH
Confidence 5432 23467889999998654 4899999999999999999999999721 111111111110 000000
Q ss_pred cc---ch-----hhh--------c--ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhc
Q 044996 600 VF---DK-----EMA--------D--ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKE 648 (678)
Q Consensus 600 ~~---d~-----~l~--------~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~ 648 (678)
.+ ++ ... . ..........+.+++.+||+.||.+|||+.|+++ .++++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00 00 000 0 0001123456888999999999999999999986 3554433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=326.62 Aligned_cols=255 Identities=16% Similarity=0.251 Sum_probs=191.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeC-----CceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-----EEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~Ey 446 (678)
.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++... ...++||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 467999999999999875 68899999997533 34456788999999999999999999998754 578999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+. |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 96 MQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 96 6999998753 589999999999999999999976 899999999999999999999999999986643
Q ss_pred cc--------------cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHH
Q 044996 527 ES--------------AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVL 591 (678)
Q Consensus 527 ~~--------------~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~ 591 (678)
.. ...++..|+|||++.. ..++.++|||||||++|||++|+.||... +..+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~~~ 236 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR--------DYRHQLLLIF 236 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHH
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC--------CcHHHHHHHH
Confidence 21 1235788999998754 67899999999999999999999999621 1111111111
Q ss_pred ---hcCC---ccccccchh-------hhc-ccC-----CHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhh
Q 044996 592 ---ANGD---NRTEVFDKE-------MAD-ERN-----SEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVK 647 (678)
Q Consensus 592 ---~~~~---~~~~~~d~~-------l~~-~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~ 647 (678)
.... ....+.+.. +.. ... .......+.+++.+||+.||++|||+.|+++ .++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0000 000000000 000 000 0012345678888999999999999999987 354443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.38 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=189.1
Q ss_pred ccccCccCceeEEEEEe--cCCceEEEEEecccC--hhhHHHHHHHHHHHhcc---CCCCccceeEEEE-----eCCceE
Q 044996 374 AEILGSGCFGSSYKASL--STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRL---RHPNLLPLVAYYY-----RKEEKL 441 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~-----~~~~~~ 441 (678)
.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.+++++ +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 46799999999999987 467889999987432 12233566777777666 8999999999997 456789
Q ss_pred EEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCc
Q 044996 442 LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521 (678)
Q Consensus 442 lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 521 (678)
+||||+. |+|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 96 lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred EEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEecCccc
Confidence 9999997 699999986532 2489999999999999999999976 8999999999999999999999999999
Q ss_pred cccCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcc
Q 044996 522 PVMNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNR 597 (678)
Q Consensus 522 ~~~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~ 597 (678)
+...... ...++..|+|||++.+..++.++|||||||++|||++|+.||... .-.+.+...+.. +...
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--------SDVDQLGKILDVIGLPG 239 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCC
T ss_pred ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHHHcCCCC
Confidence 8765432 234578899999999889999999999999999999999999621 112222222210 0000
Q ss_pred ccc-------cchhhh------cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 TEV-------FDKEMA------DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 ~~~-------~d~~l~------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+. ....+. ...........+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 000000 00000112345677888999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=326.82 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=187.1
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc------eEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE------KLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~lv~ 444 (678)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+. .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 46799999999999986 46889999998753 33445778999999999999999999999987654 49999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+. |+|.+++.. .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 109 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 109 PFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp ECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred cccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 9997 688877642 489999999999999999999976 8999999999999999999999999999876
Q ss_pred Ccc-ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcccc--
Q 044996 525 NQE-SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTE-- 599 (678)
Q Consensus 525 ~~~-~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~-- 599 (678)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+.+...... +....+
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~--------~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG--------KDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS--------SCHHHHHHHHHHHHCBCCHHHH
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHHHhCCCCHHHH
Confidence 543 22346788999999876 6789999999999999999999999972 1222222222110 000000
Q ss_pred --ccch-------hhhc------ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 600 --VFDK-------EMAD------ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 600 --~~d~-------~l~~------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.+. .+.. ..........+.+++.+|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0000 0000122345778888999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.57 Aligned_cols=248 Identities=18% Similarity=0.235 Sum_probs=168.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe----CCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR----KEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~Ey~~ 448 (678)
.++||+|+||.||+|... +++.||||++.... ....+....+..++||||+++++++.. ....++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 356999999999999875 68999999986531 122223334667799999999999976 445899999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---CCceEEeecCCccccC
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---SLEPVLADYGLIPVMN 525 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~ 525 (678)
+|+|.+++..... ..+++.++..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 110 gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 110 GGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp TEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999986532 2599999999999999999999977 8999999999999986 4569999999997665
Q ss_pred cc--ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 526 QE--SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 526 ~~--~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||...... ............... ....+
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~--~~~~~ 255 (336)
T 3fhr_A 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ-----AISPGMKRRIRLGQY--GFPNP 255 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCTT
T ss_pred ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch-----hhhhhHHHhhhcccc--ccCch
Confidence 43 2334678899999998888999999999999999999999999632111 100000000000000 00000
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEE 645 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~ 645 (678)
. .......+.+++.+||+.||.+|||+.|+++ .+.+
T Consensus 256 ~------~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 256 E------WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp T------STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred h------hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0 0112345778888999999999999999998 4444
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=335.19 Aligned_cols=244 Identities=17% Similarity=0.216 Sum_probs=182.8
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+.+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 3679999999998777778999999998653 245678999999886 89999999999999999999999995 799
Q ss_pred HHHhhccCCCCC--CCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC-------------CceEEee
Q 044996 453 AVNLHGHQALGQ--PSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES-------------LEPVLAD 517 (678)
Q Consensus 453 ~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~-------------~~~kl~D 517 (678)
.+++........ ....+..++.|+.||+.||+|||+. +|+||||||+|||++.+ +.+||+|
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 999986543211 1124456788999999999999976 89999999999999754 5899999
Q ss_pred cCCccccCccc--------cccccceeeCcccccc-------CCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCC
Q 044996 518 YGLIPVMNQES--------AQELMIAYKSPEFLQL-------GRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADG 581 (678)
Q Consensus 518 fGla~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~ 581 (678)
||+++.+.... ...++..|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~-------- 243 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK-------- 243 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST--------
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc--------
Confidence 99998765432 2246788999999865 578999999999999999999 99998621
Q ss_pred ChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 582 DLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 582 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... ...+......... ...........+.+++.+||+.||.+|||+.||++
T Consensus 244 ~~~~--~~i~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDEM------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTHH--HHHHHTCCCCCCC------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhH--HHHhcCCCCcccc------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1011 1111111111000 00112344567888999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=321.77 Aligned_cols=249 Identities=20% Similarity=0.290 Sum_probs=172.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHH-HHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMR-RLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... +++.||||+++... .....++..|+. +++.++||||+++++++...+..++||||++ |
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~ 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-T 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-C
Confidence 467999999999999874 68899999997542 334455666666 6778899999999999999999999999997 4
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|.+++..........+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 182 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH---SCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC---CEeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence 8888776422111236899999999999999999999752 69999999999999999999999999998765432
Q ss_pred -cccccceeeCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 -AQELMIAYKSPEFL----QLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 -~~~~~~~y~aPE~~----~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
...++..|+|||++ .+..++.++|||||||++|||++|+.||..... ..+.+.... ....+
T Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~-------~~~~~ 248 (327)
T 3aln_A 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS-------VFDQLTQVV-------KGDPP 248 (327)
T ss_dssp -----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCC-------CSCCC
T ss_pred ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch-------HHHHHHHHh-------cCCCC
Confidence 22467889999998 456789999999999999999999999963111 000000000 00001
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+... ........+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 249 QLSNS-EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCC-SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCc-ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11100 00112345778888999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.85 Aligned_cols=238 Identities=17% Similarity=0.216 Sum_probs=180.3
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+....|+||||+. |+|
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 467999999997766666889999999865322 2356899999999 79999999999999999999999996 699
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-----CCceEEeecCCccccCcc
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-----SLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-----~~~~kl~DfGla~~~~~~ 527 (678)
.+++..... .+.+.++..++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 105 ~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 105 QEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp HHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred HHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 999986542 355567789999999999999976 7999999999999943 346889999999876532
Q ss_pred -------ccccccceeeCccccc---cCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 528 -------SAQELMIAYKSPEFLQ---LGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 528 -------~~~~~~~~y~aPE~~~---~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
....+|..|+|||++. ...++.++|||||||++|||+| |+.||... ........... ..
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~---------~~~~~~~~~~~-~~ 246 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS---------LQRQANILLGA-CS 246 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST---------TTHHHHHHTTC-CC
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh---------hHHHHHHHhcc-CC
Confidence 2234788999999997 4567889999999999999999 99998521 11111111111 11
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ....+ .......+.+++.+||+.||.+|||+.||++
T Consensus 247 ~-~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 L-DCLHP-------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-TTSCT-------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-cccCc-------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 11111 1123344678888999999999999999983
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.34 Aligned_cols=258 Identities=20% Similarity=0.257 Sum_probs=193.3
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccC-----------CCCccceeEEEEeCC---
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-----------HPNLLPLVAYYYRKE--- 438 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~~~--- 438 (678)
.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 46799999999999986 56889999998753 345677889999999886 899999999998654
Q ss_pred -ceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec------CCC
Q 044996 439 -EKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN------ESL 511 (678)
Q Consensus 439 -~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~------~~~ 511 (678)
..++||||+ +++|.+++..... ..+++..+..|+.||+.||+|||+.+ +|+||||||+|||++ .++
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChHHeEEeccCCCcCcc
Confidence 689999999 8999999986532 24899999999999999999999753 699999999999994 445
Q ss_pred ceEEeecCCccccCcc-ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHH
Q 044996 512 EPVLADYGLIPVMNQE-SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSV 590 (678)
Q Consensus 512 ~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~ 590 (678)
.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||........ ..-.+.+...
T Consensus 176 ~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 253 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY--TKDDDHIAQI 253 (373)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----------CHHHHHHHH
T ss_pred eEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc--CChHHHHHHH
Confidence 8999999999876543 234568899999999988999999999999999999999999973221100 0011111111
Q ss_pred Hhc-CC--------------------ccccc-------cchhh-hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 591 LAN-GD--------------------NRTEV-------FDKEM-ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 591 ~~~-~~--------------------~~~~~-------~d~~l-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
... +. ....+ ....+ ............+.+++.+||+.||++|||+.||++
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 100 00 00000 00000 011233456778889999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.90 Aligned_cols=254 Identities=16% Similarity=0.236 Sum_probs=191.9
Q ss_pred ccccCccCceeEEEEEec-CC-ceEEEEEecccChhhHHHHHHHHHHHhccCCCC------ccceeEEEEeCCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLS-TG-AMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN------LLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~~~lv~E 445 (678)
.+.||+|+||.||+|... ++ ..||+|+++.. ....+.+.+|++++++++|++ ++.+++++...+..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 467999999999999864 34 68999998753 345677889999999997766 8999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe------------------
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL------------------ 507 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl------------------ 507 (678)
|+ +++|.+++..... ..+++.++..|+.||+.||+|||+. +|+||||||+|||+
T Consensus 103 ~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 103 LL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp CC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred cc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeccccccccccccccccc
Confidence 99 6778877765432 2589999999999999999999965 89999999999999
Q ss_pred -cCCCceEEeecCCccccCcc-ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHH
Q 044996 508 -NESLEPVLADYGLIPVMNQE-SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLAS 585 (678)
Q Consensus 508 -~~~~~~kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~ 585 (678)
+.++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~ 249 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN-----REHLV 249 (355)
T ss_dssp EESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH
T ss_pred ccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence 67889999999999865443 334578899999999988999999999999999999999999962110 11111
Q ss_pred HHHHHHhcC--------Cccccccch--------------------hhhcccCCHHHHHHHHHHHhhcCccccccCCCHH
Q 044996 586 WVNSVLANG--------DNRTEVFDK--------------------EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLK 637 (678)
Q Consensus 586 ~~~~~~~~~--------~~~~~~~d~--------------------~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ 637 (678)
.+......- .......+. ..........+...+.+++.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 111111100 000000000 0000011223455788999999999999999999
Q ss_pred HHHH
Q 044996 638 EAVE 641 (678)
Q Consensus 638 ev~~ 641 (678)
|+++
T Consensus 330 e~l~ 333 (355)
T 2eu9_A 330 EALL 333 (355)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.07 Aligned_cols=232 Identities=19% Similarity=0.265 Sum_probs=188.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh------hhHHHHHHHHHHHhccC--CCCccceeEEEEeCCceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN------VGREEFQEHMRRLGRLR--HPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 444 (678)
.+.||+|+||.||+|.. .+++.||||.++.... ...+.+.+|+.++++++ |+||+++++++...+..++||
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 46799999999999975 5688999999875321 12345778999999996 599999999999999999999
Q ss_pred eccCC-CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec-CCCceEEeecCCcc
Q 044996 445 EFVPK-RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIP 522 (678)
Q Consensus 445 Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~ 522 (678)
||+.. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++
T Consensus 128 e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 128 ERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp ECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99976 89999997643 589999999999999999999976 899999999999999 78999999999998
Q ss_pred ccCccc--cccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 523 VMNQES--AQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 523 ~~~~~~--~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
...... ...++..|+|||++.+..+ +.++|||||||++|||++|+.||.... . ........
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~----~~~~~~~~-- 262 (320)
T 3a99_A 199 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E----IIRGQVFF-- 262 (320)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----HHHCCCCC--
T ss_pred ccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------h----hhcccccc--
Confidence 765432 2346788999999987665 688999999999999999999986210 1 11111000
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. .. ....+.+++.+||+.||.+|||+.||++
T Consensus 263 --~-----~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 263 --R-----QR----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --S-----SC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --c-----cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 11 1234677888999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=323.29 Aligned_cols=232 Identities=19% Similarity=0.273 Sum_probs=183.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh------hhHHHHHHHHHHHhcc----CCCCccceeEEEEeCCceEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN------VGREEFQEHMRRLGRL----RHPNLLPLVAYYYRKEEKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~H~niv~l~~~~~~~~~~~l 442 (678)
.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.++ +|+||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 46799999999999976 4688999999875432 1233466799999988 89999999999999999999
Q ss_pred EEec-cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec-CCCceEEeecCC
Q 044996 443 VHEF-VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGL 520 (678)
Q Consensus 443 v~Ey-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGl 520 (678)
|||| +.+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+
T Consensus 116 v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp EEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999 78999999998643 489999999999999999999987 799999999999999 899999999999
Q ss_pred ccccCccc--cccccceeeCccccccCCCC-CcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 521 IPVMNQES--AQELMIAYKSPEFLQLGRIT-KKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 521 a~~~~~~~--~~~~~~~y~aPE~~~~~~~t-~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
++...... ...++..|+|||++.+..+. .++|||||||++|||++|+.||... . .........
T Consensus 187 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----------~----~~~~~~~~~ 252 (312)
T 2iwi_A 187 GALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----------Q----EILEAELHF 252 (312)
T ss_dssp CEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----------H----HHHHTCCCC
T ss_pred hhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----------H----HHhhhccCC
Confidence 98765432 33467889999998776664 5899999999999999999998621 0 111111000
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||++|||+.|+++
T Consensus 253 -------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 253 -------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112234677888999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.23 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=179.0
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccCh-h-hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN-V-GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||.||+|... +++.||||++..... . ..+.+.++..+++.++||||+++++++...+..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 467999999999999875 688999999975432 2 2334455556788889999999999999999999999999 55
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
.+..+..... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++......
T Consensus 109 ~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 109 CAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence 5555554322 25899999999999999999999732 69999999999999999999999999987654432
Q ss_pred -cccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 529 -AQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
...++..|+|||++. ...++.++|||||||++|||++|+.||... ....+.+..........
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~~~~~~~~~~~----- 249 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC-------KTDFEVLTKVLQEEPPL----- 249 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHHHHHHHSCCCC-----
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC-------CccHHHHHHHhccCCCC-----
Confidence 234678899999984 457899999999999999999999999621 12223333333322111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhccCCC
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKERDGD 652 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~~~~~ 652 (678)
+.... .....+.+++.+||+.||.+||++.|+++ .+++......+
T Consensus 250 --~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 296 (318)
T 2dyl_A 250 --LPGHM---GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296 (318)
T ss_dssp --CCSSS---CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCCC
T ss_pred --CCccC---CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccch
Confidence 00000 11234677888999999999999999997 45555544433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=350.37 Aligned_cols=234 Identities=17% Similarity=0.187 Sum_probs=188.8
Q ss_pred ccccCccCceeEEEEEec--CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc-----eEEEEe
Q 044996 374 AEILGSGCFGSSYKASLS--TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE-----KLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----~~lv~E 445 (678)
.+.||+|+||.||+|... +++.||||++... .....+.|.+|++++++++|||||++++++...+. .|||||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 467999999999999875 5889999988653 33455678999999999999999999999987765 699999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++++|.+++.. .++|.+++.|+.||+.||.|||+. +|+||||||+|||++++ .+||+|||+++...
T Consensus 165 ~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp CCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred eCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 9999999887643 489999999999999999999976 79999999999999986 89999999998877
Q ss_pred ccccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 526 QESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 526 ~~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
......+|..|+|||++.++ ++.++|||||||++|||++|..||...... .. ....+.
T Consensus 233 ~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------~~-~~~~~~- 290 (681)
T 2pzi_A 233 SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------GL-PEDDPV- 290 (681)
T ss_dssp CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------SC-CTTCHH-
T ss_pred cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-------------------cc-cccccc-
Confidence 66666788999999998764 489999999999999999999887621100 00 000000
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCC-CHHHHHHHHHHhh
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRL-DLKEAVEKIEEVK 647 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~ev~~~L~~i~ 647 (678)
......+.+++.+||+.||.+|| +++++.+.|..+.
T Consensus 291 ------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 291 ------LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ------HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 01223577888899999999999 5777777777653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=307.19 Aligned_cols=238 Identities=11% Similarity=0.077 Sum_probs=176.9
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|... +++.||||.+.... ....+.|.+|+.++.+++||||+++++++...+..|+||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 357999999999999875 48899999997542 33457899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
++|.+++... ....++.+|+.|++.||+|||+. +|+||||||+|||+++++.+||+++|
T Consensus 116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999532 34557889999999999999977 89999999999999999999998654
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
|++ .++.++|||||||++|||+||+.||....... .+... . . ........+.....
T Consensus 175 ------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~----~~~~~----~-~-~~~~~~~~~~~~~~- 230 (286)
T 3uqc_A 175 ------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS----GLAPA----E-R-DTAGQPIEPADIDR- 230 (286)
T ss_dssp ------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC----CSEEC----C-B-CTTSCBCCHHHHCT-
T ss_pred ------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch----hhHHH----H-H-HhccCCCChhhccc-
Confidence 333 37899999999999999999999997322110 00000 0 0 00000000000001
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCccccccc
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFYSSYA 660 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~~~~~~~ 660 (678)
.....+.+++.+||+.||.+| |+.|+++.|+++.....+.+......
T Consensus 231 ---~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~~~~p~~ 277 (286)
T 3uqc_A 231 ---DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTEVLGPID 277 (286)
T ss_dssp ---TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC------------
T ss_pred ---CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccCCCCCCC
Confidence 123447788889999999999 99999999999998777666655443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.99 Aligned_cols=265 Identities=20% Similarity=0.252 Sum_probs=198.5
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEe------CCceEEEE
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR------KEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~~~lv~ 444 (678)
..+.||+|+||.||+|.. .++..||||+++.. .....+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence 356799999999999976 46889999998753 44556789999999999999999999999765 56789999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc---eEEeecCCc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE---PVLADYGLI 521 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGla 521 (678)
||+++|+|.+++..... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 98 Ey~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp ECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 99999999999986542 22589999999999999999999976 8999999999999997664 999999999
Q ss_pred cccCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc-
Q 044996 522 PVMNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR- 597 (678)
Q Consensus 522 ~~~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~- 597 (678)
+...... ...++..|+|||++.+..++.++|||||||++|||++|+.||... .....|...........
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~-------~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN-------WQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS-------CHHHHSSTTCC------C
T ss_pred cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc-------cchhhhhhhhhcccchhh
Confidence 8765432 234678899999999999999999999999999999999999621 11122211111000000
Q ss_pred --ccc------cchhhhc-ccCCHHHHHHHHHHHhhcCccccccCCCHHH-----HHHHHHHhhccC
Q 044996 598 --TEV------FDKEMAD-ERNSEGEMVKLLKIGLACCEEEVEKRLDLKE-----AVEKIEEVKERD 650 (678)
Q Consensus 598 --~~~------~d~~l~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e-----v~~~L~~i~~~~ 650 (678)
.+. +...+.. ..........+.+++.+||+.||++|||+.| ..+.++.+....
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000 0001000 0112234567888999999999999999988 556676665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.70 Aligned_cols=237 Identities=16% Similarity=0.080 Sum_probs=173.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh---hhHHHHHHHHHHHhccCC-CCccc---------eeEE------
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN---VGREEFQEHMRRLGRLRH-PNLLP---------LVAY------ 433 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H-~niv~---------l~~~------ 433 (678)
.++||+|+||+||+|.. .+|+.||||+++.... ...+.|.+|+.+++.++| +|+.. .+..
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 46799999999999985 5789999999884322 235779999999999987 32211 1111
Q ss_pred ------EEe-----CCceEEEEeccCCCCHHHHhhccC--CCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCC
Q 044996 434 ------YYR-----KEEKLLVHEFVPKRSLAVNLHGHQ--ALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHI 500 (678)
Q Consensus 434 ------~~~-----~~~~~lv~Ey~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdl 500 (678)
+.. ....+++|+++ +++|.+++.... ......++|..++.|+.||+.||+|||+. +|+||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~iiHrDi 237 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTYL 237 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCc
Confidence 111 12456777766 689999885210 00122588999999999999999999976 8999999
Q ss_pred CCCCEEecCCCceEEeecCCccccCccc-cccccceeeCcccc----------ccCCCCCcchHHHHHHHHHHHHhCCCC
Q 044996 501 KSSNVLLNESLEPVLADYGLIPVMNQES-AQELMIAYKSPEFL----------QLGRITKKTDVWSLGVLILEIMTGKFP 569 (678)
Q Consensus 501 k~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~y~aPE~~----------~~~~~t~ksDvwS~Gvvl~el~tg~~P 569 (678)
||+||||+.++.+||+|||+++...... ...+ ..|+|||++ ....++.++|||||||++|||+||+.|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999988765542 2335 889999999 555688999999999999999999999
Q ss_pred ccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 570 ANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 570 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
|...... +..+..+..... ....+.+++.+||+.||++||++.|+++
T Consensus 317 f~~~~~~----------------------~~~~~~~~~~~~---~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 317 NTDDAAL----------------------GGSEWIFRSCKN---IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCTTGGG----------------------SCSGGGGSSCCC---CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcchh----------------------hhHHHHHhhccc---CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9632110 111111111111 1245777888999999999999877754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=302.01 Aligned_cols=225 Identities=18% Similarity=0.237 Sum_probs=173.7
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHH-hccCCCCccceeEEEEe----CCceEEEEeccC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRL-GRLRHPNLLPLVAYYYR----KEEKLLVHEFVP 448 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~~lv~Ey~~ 448 (678)
++||+|+||.||+|.. .+++.||+|+++.. ..+.+|++++ +.++||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 5799999999999986 56889999998642 4567888887 56699999999999987 667899999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---CCceEEeecCCccccC
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---SLEPVLADYGLIPVMN 525 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~ 525 (678)
+|+|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 99 ~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 99 GGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp SCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred CCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999987532 2589999999999999999999976 8999999999999998 7899999999986533
Q ss_pred ccccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 526 QESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 526 ~~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
+..++.++|||||||++|||+||+.||....... .. .. ....+.....
T Consensus 172 ------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~------------~~-~~-~~~~~~~~~~ 219 (299)
T 3m2w_A 172 ------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------------IS-PG-MKTRIRMGQY 219 (299)
T ss_dssp ------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CC-SCCSSCTTCC
T ss_pred ------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh------------hh-HH-HHHHHhhccc
Confidence 2457889999999999999999999996321100 00 00 0000000000
Q ss_pred hcccCC----HHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHh
Q 044996 606 ADERNS----EGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEV 646 (678)
Q Consensus 606 ~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i 646 (678)
... ......+.+++.+||+.||.+|||+.|+++ .+.+.
T Consensus 220 ---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 220 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp ---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 000 012345778888999999999999999997 34443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=308.21 Aligned_cols=235 Identities=12% Similarity=0.096 Sum_probs=178.8
Q ss_pred HhccccCccCceeEEEEEecCCceEEEEEecccC--------hhhHHHHHHHHHHHhccC---------CCCccceeEEE
Q 044996 372 ASAEILGSGCFGSSYKASLSTGAMMVVKRFKQMN--------NVGREEFQEHMRRLGRLR---------HPNLLPLVAYY 434 (678)
Q Consensus 372 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------H~niv~l~~~~ 434 (678)
...+.||+|+||+||+|+. +++.||||+++... ....+.+.+|++++++++ |||||++.+++
T Consensus 23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 3467899999999999987 78999999997542 223478899999988885 88888877765
Q ss_pred E------------------------------eCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHH
Q 044996 435 Y------------------------------RKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ 484 (678)
Q Consensus 435 ~------------------------------~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ 484 (678)
. ..+..|+||||+++|++.+.+... .+++.++..|+.||+.||+
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~------~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK------LSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT------CCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc------CCCHHHHHHHHHHHHHHHH
Confidence 3 157899999999999877666431 4899999999999999999
Q ss_pred HHH-HhCCCCCCcccCCCCCCEEecCCC--------------------ceEEeecCCccccCccccccccceeeCccccc
Q 044996 485 YLY-RELPSLIAPHGHIKSSNVLLNESL--------------------EPVLADYGLIPVMNQESAQELMIAYKSPEFLQ 543 (678)
Q Consensus 485 yLH-~~~~~~~ivHrdlk~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~ 543 (678)
||| +. +|+||||||+|||++.++ .+||+|||+++..... ...+|..|+|||++.
T Consensus 176 ~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 176 VAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGC
T ss_pred HHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhc
Confidence 999 77 799999999999999887 8999999999876543 346788999999998
Q ss_pred cCCCCCcchHHHHHHH-HHHHHhCCCCccccccCCCCCCChHHHHHHH---HhcCCccccccchhhhcccCCHHHHHHHH
Q 044996 544 LGRITKKTDVWSLGVL-ILEIMTGKFPANFLQQGKKADGDLASWVNSV---LANGDNRTEVFDKEMADERNSEGEMVKLL 619 (678)
Q Consensus 544 ~~~~t~ksDvwS~Gvv-l~el~tg~~P~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 619 (678)
+.. +.++||||++++ .+++++|..||.. ..|.... +............. ........+.
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~ 313 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFKTKCNTP-----AMKQIKRKIQ 313 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCSSCCCSH-----HHHHHHHHHH
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccCcccchh-----hhhhcCHHHH
Confidence 655 899999998777 7888999999862 1232211 11110110000000 0123456688
Q ss_pred HHHhhcCccccccCCCHHHHH
Q 044996 620 KIGLACCEEEVEKRLDLKEAV 640 (678)
Q Consensus 620 ~l~~~Cl~~~P~~RPs~~ev~ 640 (678)
+++.+||+.| |+.|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 8899999866 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=285.24 Aligned_cols=183 Identities=17% Similarity=0.077 Sum_probs=130.0
Q ss_pred cccCccCceeEEEEE-ecCCceEEEEEeccc----------ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEE
Q 044996 375 EILGSGCFGSSYKAS-LSTGAMMVVKRFKQM----------NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLL 442 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l 442 (678)
...+.|++|.+..++ ...|+.+++|.+... .....++|.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346778888777763 456889999998642 123456799999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
||||++||+|.++|.... +++. .+|+.||+.||+|+|++ +||||||||+||||++++.+||+|||+|+
T Consensus 320 VMEyv~G~~L~d~i~~~~-----~l~~---~~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr 387 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE-----EIDR---EKILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIV 387 (569)
T ss_dssp EEECCCSEEHHHHHHTTC-----CCCH---HHHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred EEecCCCCcHHHHHHhCC-----CCCH---HHHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCe
Confidence 999999999999998653 3554 35899999999999987 89999999999999999999999999998
Q ss_pred ccCccc----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCc
Q 044996 523 VMNQES----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPA 570 (678)
Q Consensus 523 ~~~~~~----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~ 570 (678)
...... ...+|+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 388 ~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 388 TTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp SCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred eCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 775432 2346889999999974 5778899999999998887765554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=238.67 Aligned_cols=182 Identities=34% Similarity=0.605 Sum_probs=164.9
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCCCcceEEecC----CcEEEEEeCCCCcee--ecChHHhhcCCCCCEE
Q 044996 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHR----GKIWGLKLEDMGLQG--NIDITILKELREMRTL 75 (678)
Q Consensus 2 ~~~~aLl~~k~~l~~~~~l~~W~~~~~~c~~~~~~w~gv~C~~----~~v~~l~l~~~~l~g--~~~~~~l~~l~~L~~L 75 (678)
+|++||++||+++.+|..+++|..+++||. +.|.||+|+. ++|+.|+|+++++.| .+|. .+..|++|+.|
T Consensus 6 ~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~---~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~~L 81 (313)
T 1ogq_A 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFL 81 (313)
T ss_dssp HHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSEE
T ss_pred HHHHHHHHHHHhcCCcccccCCCCCCCCCc---CCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCCee
Confidence 588999999999988878899988778884 3599999974 799999999999999 8886 58999999999
Q ss_pred EccC-CcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccC
Q 044996 76 SLMR-NNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEG 153 (678)
Q Consensus 76 ~Ls~-N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~ 153 (678)
+|++ |++.|.+|. +..+ ++|++|+|++|+++|.+|.. |.++++|++|+|++|.++|.+|..+.++++|++|+|++
T Consensus 82 ~L~~~n~l~~~~p~~l~~l--~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 82 YIGGINNLVGPIPPAIAKL--TQLHYLYITHTNVSGAIPDF-LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp EEEEETTEESCCCGGGGGC--TTCSEEEEEEECCEEECCGG-GGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred eCCCCCcccccCChhHhcC--CCCCEEECcCCeeCCcCCHH-HhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 9995 999999994 6666 78999999999999999976 89999999999999999999999999999999999999
Q ss_pred CcccccCCcc--CCC-CCcEEEeecCcccccCchhhhcCC
Q 044996 154 NKFEGQIPDF--QQK-DLVSFNVSNNALFGSISPALRELD 190 (678)
Q Consensus 154 N~l~g~~p~~--~~~-~l~~l~l~~N~l~g~ip~~~~~l~ 190 (678)
|.++|.+|.. ... +|+.|++++|.++|.+|..+..+.
T Consensus 159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 198 (313)
T 1ogq_A 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC
T ss_pred CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc
Confidence 9999999974 455 899999999999999999887654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=256.74 Aligned_cols=178 Identities=13% Similarity=0.172 Sum_probs=143.9
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccC--------hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMN--------NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
.++||+|+||.||+|.. .+..+++|+..... ....+.|.+|++++++++||||+++..++...+..+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 56778888764321 1124568999999999999999977777778888999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++|+|.+++.. +..|+.|++.||+|||+. +|+||||||+|||+++ .+||+|||+++...
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999864 347999999999999976 7999999999999999 99999999998876
Q ss_pred ccc-----------cccccceeeCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 526 QES-----------AQELMIAYKSPEFLQL--GRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 526 ~~~-----------~~~~~~~y~aPE~~~~--~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
... ...+|..|||||++.. ..|+.++|+|+..+-.++.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 532 2346788999999976 568889999999999999988887763
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=250.21 Aligned_cols=176 Identities=24% Similarity=0.363 Sum_probs=138.7
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCCCcceEEecCCcEEEEEeCCCCceee---cCh---------------
Q 044996 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGN---IDI--------------- 63 (678)
Q Consensus 2 ~~~~aLl~~k~~l~~~~~l~~W~~~~~~c~~~~~~w~gv~C~~~~v~~l~l~~~~l~g~---~~~--------------- 63 (678)
+|++||++||+++.||..+++|+.+++|| .|.||+|+.++|+.|+|+++++.|. +|+
T Consensus 12 ~~~~all~~k~~~~~~~~l~~W~~~~~~C-----~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~ 86 (768)
T 3rgz_A 12 REIHQLISFKDVLPDKNLLPDWSSNKNPC-----TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSN 86 (768)
T ss_dssp HHHHHHHHHHTTCSCTTSSTTCCTTSCGG-----GSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTT
T ss_pred HHHHHHHHHHhhCCCcccccCCCCCCCCc-----CCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCcC
Confidence 58999999999999887899998777888 6999999999999999999999998 654
Q ss_pred -------HHhhcCCCCCEEEccCCcccccCCc---ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccc
Q 044996 64 -------TILKELREMRTLSLMRNNLEGPMPD---LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFN 133 (678)
Q Consensus 64 -------~~l~~l~~L~~L~Ls~N~l~g~~p~---~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~ 133 (678)
+.++.|++|++|+|++|.|+|.+|. +..+ ++|++|+|++|.++|.+|...+.++++|++|+|++|+++
T Consensus 87 ~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l--~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~ 164 (768)
T 3rgz_A 87 SHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSC--SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164 (768)
T ss_dssp SCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGC--TTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCE
T ss_pred CCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCC--CCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccC
Confidence 2356677888888888888887764 4444 668888888888888777664477788888888888888
Q ss_pred cCCchh---hcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCch
Q 044996 134 GPIPES---LTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISP 184 (678)
Q Consensus 134 g~~p~~---~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~ 184 (678)
+.+|.. +.++++|++|+|++|.++|.+|...+.+|+.|+|++|++++.+|.
T Consensus 165 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 218 (768)
T 3rgz_A 165 GANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF 218 (768)
T ss_dssp EETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB
T ss_pred CcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc
Confidence 777776 677777777777777777766666666777777777777776665
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=243.70 Aligned_cols=184 Identities=21% Similarity=0.350 Sum_probs=149.6
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCC-----CCCCCCCCCc------------ceEEec-CCcEEEEEeCCCCceeecCh
Q 044996 2 TDSQTLLTLKQSLSNPTALANWDDRT-----PPCNENGANW------------NGVLCH-RGKIWGLKLEDMGLQGNIDI 63 (678)
Q Consensus 2 ~~~~aLl~~k~~l~~~~~l~~W~~~~-----~~c~~~~~~w------------~gv~C~-~~~v~~l~l~~~~l~g~~~~ 63 (678)
+|++||++||+++.+| +|+.++ +|| +|+| .||+|+ .++|++|+|++++|.|.+|+
T Consensus 269 ~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~---~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 269 KDYKALKAIWEALDGK----NWRYYSGTINNTIH---SLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHTTGG----GCCCCCSSCSSCCC---CCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred HHHHHHHHHHHHcCCC----CCCcCCCcccccCC---ccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 4899999999999876 897654 452 3589 999998 58999999999999999996
Q ss_pred HHhhcCCCCCEEEc-cCCccccc---------------------------------------------------------
Q 044996 64 TILKELREMRTLSL-MRNNLEGP--------------------------------------------------------- 85 (678)
Q Consensus 64 ~~l~~l~~L~~L~L-s~N~l~g~--------------------------------------------------------- 85 (678)
.+++|++|+.|+| ++|.++|.
T Consensus 342 -~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 342 -AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp -GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred -HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 5999999999999 88888776
Q ss_pred -------------------CC-cccccCCCCccEEEcccCcccc-----------------ccChhhhc--CCcccceee
Q 044996 86 -------------------MP-DLRQLGNGALRSVYLSNNRFSG-----------------EIPTDAFD--GMTSLRKLL 126 (678)
Q Consensus 86 -------------------~p-~~~~~~~~~L~~L~Ls~N~l~G-----------------~ip~~~~~--~l~~L~~l~ 126 (678)
|| .+..+ ++|++|+|++|+|+| .||.. ++ ++++|++|+
T Consensus 421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L--~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~ 497 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITFISKAIQRL--TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVE 497 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEEECGGGGGC--TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEE
T ss_pred cccchhhceeccccCcccchhHHHhcC--CCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEE
Confidence 44 23444 678999999999988 48876 56 889999999
Q ss_pred ccccccccCCchhhcCCCCCCeEeccCCc-ccc-cCCcc---------CCCCCcEEEeecCcccccCch--hhhcCCC--
Q 044996 127 LADNQFNGPIPESLTRLSRLVELRLEGNK-FEG-QIPDF---------QQKDLVSFNVSNNALFGSISP--ALRELDP-- 191 (678)
Q Consensus 127 l~~N~~~g~~p~~~~~l~~L~~l~l~~N~-l~g-~~p~~---------~~~~l~~l~l~~N~l~g~ip~--~~~~l~~-- 191 (678)
|++|++.|.+|..|+++++|+.|+|++|+ |+| .+|.. ...+|+.|+|++|+|+ .||. .+.++..
T Consensus 498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~ 576 (876)
T 4ecn_A 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLG 576 (876)
T ss_dssp EESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCC
T ss_pred CcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCC
Confidence 99999999999889999999999999998 888 77752 2348889999999988 7887 6665443
Q ss_pred -CCCCCC
Q 044996 192 -SSFSGN 197 (678)
Q Consensus 192 -~~~~gn 197 (678)
..+.+|
T Consensus 577 ~L~Ls~N 583 (876)
T 4ecn_A 577 LLDCVHN 583 (876)
T ss_dssp EEECTTS
T ss_pred EEECCCC
Confidence 345555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=232.48 Aligned_cols=178 Identities=22% Similarity=0.354 Sum_probs=148.2
Q ss_pred ChHHHHHHHHhcCCCCC---------CCCCCCCCCCCCCCCCCCc---ceEEec-CCcEEEEEeCCCCceeecChHHhhc
Q 044996 2 TDSQTLLTLKQSLSNPT---------ALANWDDRTPPCNENGANW---NGVLCH-RGKIWGLKLEDMGLQGNIDITILKE 68 (678)
Q Consensus 2 ~~~~aLl~~k~~l~~~~---------~l~~W~~~~~~c~~~~~~w---~gv~C~-~~~v~~l~l~~~~l~g~~~~~~l~~ 68 (678)
.|+.||.+||+++.++. ...+|+.+.++| .| .||+|+ .++|++|+|+++++.|.+|+ .+++
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-----~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~-~l~~ 103 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-----MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPD-AIGQ 103 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-----GTTCCTTEEECTTCCEEEEECTTSCCEEEECG-GGGG
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-----cccCCCCeEEcCCCCEEEEEecCcccCCcCCh-HHhc
Confidence 48899999999987542 234899887777 69 999997 58999999999999999996 5999
Q ss_pred CCCCCEEEccCCcc------------------------------------------------------------------
Q 044996 69 LREMRTLSLMRNNL------------------------------------------------------------------ 82 (678)
Q Consensus 69 l~~L~~L~Ls~N~l------------------------------------------------------------------ 82 (678)
|++|+.|+|++|++
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l 183 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred CccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence 99999999999844
Q ss_pred ------------cccCC-cccccCCCCccEEEcccCccccc-----------------cChhhhc--CCcccceeecccc
Q 044996 83 ------------EGPMP-DLRQLGNGALRSVYLSNNRFSGE-----------------IPTDAFD--GMTSLRKLLLADN 130 (678)
Q Consensus 83 ------------~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~-----------------ip~~~~~--~l~~L~~l~l~~N 130 (678)
+| || .+..+ ++|++|+|++|+|+|. ||.. ++ ++++|++|+|++|
T Consensus 184 ~~l~l~~~~n~l~~-ip~~l~~l--~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 184 KDTQIGQLSNNITF-VSKAVMRL--TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp CTTTTTCCSCEEEE-ECGGGGGC--TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECC
T ss_pred hhhhhccccCCCcc-CCHHHhcc--cCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCC
Confidence 45 55 35555 6799999999999986 8876 77 8999999999999
Q ss_pred ccccCCchhhcCCCCCCeEeccCCc-ccc-cCCcc--C------CCCCcEEEeecCcccccCch--hhhcCC
Q 044996 131 QFNGPIPESLTRLSRLVELRLEGNK-FEG-QIPDF--Q------QKDLVSFNVSNNALFGSISP--ALRELD 190 (678)
Q Consensus 131 ~~~g~~p~~~~~l~~L~~l~l~~N~-l~g-~~p~~--~------~~~l~~l~l~~N~l~g~ip~--~~~~l~ 190 (678)
++.|.+|..|+++++|++|+|++|. |+| .+|.. . +++|+.|++++|+++ .+|. .+.++.
T Consensus 260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~ 330 (636)
T 4eco_A 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMK 330 (636)
T ss_dssp TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCT
T ss_pred cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCC
Confidence 9999999999999999999999998 988 78863 2 278888888888888 7887 666544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.5e-23 Score=209.43 Aligned_cols=140 Identities=16% Similarity=0.203 Sum_probs=114.5
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccCh------------------hhHHHHHHHHHHHhccCCCCccceeEEEE
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNN------------------VGREEFQEHMRRLGRLRHPNLLPLVAYYY 435 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~H~niv~l~~~~~ 435 (678)
.+.||+|+||.||+|...+|+.||+|.++.... .....+.+|+++|++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 478999999999999987799999999864221 13567899999999999 5 66766554
Q ss_pred eCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEE
Q 044996 436 RKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVL 515 (678)
Q Consensus 436 ~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl 515 (678)
.+..++||||+++|+|.+ +.. .....++.||+.||.|||+. +|+||||||+|||++ ++.+||
T Consensus 172 -~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 172 -WEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp -EETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE-TTEEEE
T ss_pred -ccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEEE-CCcEEE
Confidence 356799999999999987 421 23457999999999999976 899999999999999 999999
Q ss_pred eecCCccccCccccccccceeeCccccc
Q 044996 516 ADYGLIPVMNQESAQELMIAYKSPEFLQ 543 (678)
Q Consensus 516 ~DfGla~~~~~~~~~~~~~~y~aPE~~~ 543 (678)
+|||+++... .|+|||++.
T Consensus 234 ~DFG~a~~~~---------~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVEVG---------EEGWREILE 252 (282)
T ss_dssp CCCTTCEETT---------STTHHHHHH
T ss_pred EECCCCeECC---------CCCHHHHHH
Confidence 9999986432 467888875
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=229.07 Aligned_cols=165 Identities=33% Similarity=0.508 Sum_probs=142.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-cccc-------------------------------
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQL------------------------------- 92 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~------------------------------- 92 (678)
.++..|+|++|.+.|.+|. .++.+++|+.|+|++|.++|.+|. +...
T Consensus 514 ~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (768)
T 3rgz_A 514 ENLAILKLSNNSFSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN 592 (768)
T ss_dssp TTCCEEECCSSCCEEECCG-GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEE
T ss_pred CCCCEEECCCCcccCcCCH-HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccc
Confidence 3577888888888888885 488899999999999999988883 1110
Q ss_pred -------------------------------------CCCCccEEEcccCccccccChhhhcCCcccceeeccccccccC
Q 044996 93 -------------------------------------GNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGP 135 (678)
Q Consensus 93 -------------------------------------~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~ 135 (678)
...+|++|||++|+|+|.||.+ |+++++|+.|+|++|+|+|.
T Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~-l~~l~~L~~L~Ls~N~l~g~ 671 (768)
T 3rgz_A 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE-IGSMPYLFILNLGHNDISGS 671 (768)
T ss_dssp EEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGG-GGGCTTCCEEECCSSCCCSC
T ss_pred ccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHH-HhccccCCEEeCcCCccCCC
Confidence 0145889999999999999987 89999999999999999999
Q ss_pred CchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchh--hhcCCCCCCCCCCCCCCCCCCCCCCC
Q 044996 136 IPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA--LRELDPSSFSGNRDLCGEPLGSPCPT 211 (678)
Q Consensus 136 ~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~--~~~l~~~~~~gn~~lc~~~~~~~c~~ 211 (678)
||.+|+++++|+.|+|++|+|+|.+|.. .++.|+.|+|++|+|+|.||.. +..++...|.||++|||.++. +|..
T Consensus 672 ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp CCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred CChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence 9999999999999999999999999985 6789999999999999999974 677888899999999998876 7864
Q ss_pred C
Q 044996 212 P 212 (678)
Q Consensus 212 ~ 212 (678)
.
T Consensus 751 ~ 751 (768)
T 3rgz_A 751 S 751 (768)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.80 E-value=2e-20 Score=196.08 Aligned_cols=183 Identities=20% Similarity=0.323 Sum_probs=152.8
Q ss_pred ChHHHHHHHHhcCC-CCC-CCCCCC----CCCCCCCCCCCCcceEEec----------CCcEEEEEeCCCCceeecChHH
Q 044996 2 TDSQTLLTLKQSLS-NPT-ALANWD----DRTPPCNENGANWNGVLCH----------RGKIWGLKLEDMGLQGNIDITI 65 (678)
Q Consensus 2 ~~~~aLl~~k~~l~-~~~-~l~~W~----~~~~~c~~~~~~w~gv~C~----------~~~v~~l~l~~~~l~g~~~~~~ 65 (678)
+|++||++||..+. |+. .+.+|. ...++| .|.|+.|. ..+|+.|+|+++++. .+|..
T Consensus 27 ~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-----~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~- 99 (328)
T 4fcg_A 27 PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-----TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ- 99 (328)
T ss_dssp CHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-----CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC-
T ss_pred hHHHHHHHHHHhccCCchhhhhhhccccccccccc-----ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh-
Confidence 58899999999884 553 357783 334455 79999994 278999999999998 88865
Q ss_pred hhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcC--
Q 044996 66 LKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTR-- 142 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~-- 142 (678)
++.|++|+.|+|++|.++ .+|. +..+ ++|++|+|++|+|+ .||.. |+++++|++|+|++|++.+.+|..++.
T Consensus 100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l--~~L~~L~Ls~n~l~-~lp~~-l~~l~~L~~L~L~~n~~~~~~p~~~~~~~ 174 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQF--AGLETLTLARNPLR-ALPAS-IASLNRLRELSIRACPELTELPEPLASTD 174 (328)
T ss_dssp GGGGTTCSEEEEESSCCC-CCCSCGGGG--TTCSEEEEESCCCC-CCCGG-GGGCTTCCEEEEEEETTCCCCCSCSEEEC
T ss_pred hhhCCCCCEEECCCCCcc-chhHHHhcc--CCCCEEECCCCccc-cCcHH-HhcCcCCCEEECCCCCCccccChhHhhcc
Confidence 778999999999999999 7774 6666 77999999999999 89977 899999999999999999999998775
Q ss_pred -------CCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhcCC---CCCCCCCC
Q 044996 143 -------LSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRELD---PSSFSGNR 198 (678)
Q Consensus 143 -------l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~l~---~~~~~gn~ 198 (678)
+++|++|+|++|.|+ .+|.. .+++|+.|+|++|.+++ +|..+..+. ...+.+|.
T Consensus 175 ~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~ 240 (328)
T 4fcg_A 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT 240 (328)
T ss_dssp -CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCT
T ss_pred chhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCc
Confidence 999999999999999 88874 67899999999999996 666665543 34566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.1e-19 Score=178.09 Aligned_cols=134 Identities=17% Similarity=0.214 Sum_probs=104.4
Q ss_pred ccccCccCceeEEEEEe-cCCce--EEEEEecccCh------------------------hhHHHHHHHHHHHhccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAM--MVVKRFKQMNN------------------------VGREEFQEHMRRLGRLRHPN 426 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l~H~n 426 (678)
.+.||+|+||.||+|.. .+|+. ||||.++.... .....+.+|++.|.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 46799999999999987 78888 99998754211 11236889999999999886
Q ss_pred c--cceeEEEEeCCceEEEEeccCC-C----CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHH-HhCCCCCCccc
Q 044996 427 L--LPLVAYYYRKEEKLLVHEFVPK-R----SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY-RELPSLIAPHG 498 (678)
Q Consensus 427 i--v~l~~~~~~~~~~~lv~Ey~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~~ivHr 498 (678)
| ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| .. +|+||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~----givHr 195 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEA----ELVHA 195 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTS----CEECS
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHC----CEEeC
Confidence 5 333432 367899999942 4 67665432 234567899999999999999 55 79999
Q ss_pred CCCCCCEEecCCCceEEeecCCccccC
Q 044996 499 HIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 499 dlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
||||+|||+++ .+||+|||++....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999987653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=181.45 Aligned_cols=160 Identities=29% Similarity=0.476 Sum_probs=100.6
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChh----------
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTD---------- 114 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~---------- 114 (678)
++..|+|++|.+.|.+|. .+..+++|+.|+|++|+++|.+|. +..+. .+|++|+|++|+++|.+|..
T Consensus 126 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~ 203 (313)
T 1ogq_A 126 TLVTLDFSYNALSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFS-KLFTSMTISRNRLTGKIPPTFANLNLAFVD 203 (313)
T ss_dssp TCCEEECCSSEEESCCCG-GGGGCTTCCEEECCSSCCEEECCGGGGCCC-TTCCEEECCSSEEEEECCGGGGGCCCSEEE
T ss_pred CCCEEeCCCCccCCcCCh-HHhcCCCCCeEECcCCcccCcCCHHHhhhh-hcCcEEECcCCeeeccCChHHhCCcccEEE
Confidence 566677777777766664 366677777777777777766663 33331 14555555555555555433
Q ss_pred ------------hhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccc
Q 044996 115 ------------AFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 115 ------------~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g 180 (678)
.|..+++|+.|+|++|.+++.+|. +..+++|++|+|++|.|+|.+|.. .+++|+.|+|++|+|+|
T Consensus 204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 245555555555555555554444 555666666666666666666653 45677778888888877
Q ss_pred cCchh--hhcCCCCCCCCCCCCCCCCCCCCC
Q 044996 181 SISPA--LRELDPSSFSGNRDLCGEPLGSPC 209 (678)
Q Consensus 181 ~ip~~--~~~l~~~~~~gn~~lc~~~~~~~c 209 (678)
.+|.. +.++....+.+|+++||.++. +|
T Consensus 283 ~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 283 EIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp ECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 77753 445666778999999987664 45
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=166.60 Aligned_cols=153 Identities=27% Similarity=0.385 Sum_probs=128.5
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.+..|+|++|++.+.. +..+..+++|+.|+|++|.|++..|. +..+ ++|++|+|++|+|+ .+|+..|..+++|++
T Consensus 36 ~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~ 111 (251)
T 3m19_A 36 DTEKLDLQSTGLATLS-DATFRGLTKLTWLNLDYNQLQTLSAGVFDDL--TELGTLGLANNQLA-SLPLGVFDHLTQLDK 111 (251)
T ss_dssp TCCEEECTTSCCCCCC-TTTTTTCTTCCEEECTTSCCCCCCTTTTTTC--TTCCEEECTTSCCC-CCCTTTTTTCTTCCE
T ss_pred CCCEEEccCCCcCccC-HhHhcCcccCCEEECCCCcCCccCHhHhccC--CcCCEEECCCCccc-ccChhHhcccCCCCE
Confidence 4778999999998644 45689999999999999999997774 4555 78999999999999 566666899999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCc-c-CCCCCcEEEeecCcccccCchhhh---cCCCCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-F-QQKDLVSFNVSNNALFGSISPALR---ELDPSSFSGNRD 199 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~-~~~~l~~l~l~~N~l~g~ip~~~~---~l~~~~~~gn~~ 199 (678)
|+|++|++++..+..|..+++|++|+|++|.|++..+. + .+.+|+.|+|++|+|++..+..+. ++....+.+|++
T Consensus 112 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 191 (251)
T 3m19_A 112 LYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191 (251)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred EEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCce
Confidence 99999999987777789999999999999999976664 2 568999999999999987665555 445567889988
Q ss_pred CCC
Q 044996 200 LCG 202 (678)
Q Consensus 200 lc~ 202 (678)
.|.
T Consensus 192 ~c~ 194 (251)
T 3m19_A 192 DCS 194 (251)
T ss_dssp CTT
T ss_pred eCC
Confidence 774
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.3e-17 Score=160.38 Aligned_cols=146 Identities=20% Similarity=0.278 Sum_probs=106.9
Q ss_pred CCcceEEecCC-----------cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEc
Q 044996 35 ANWNGVLCHRG-----------KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYL 102 (678)
Q Consensus 35 ~~w~gv~C~~~-----------~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~L 102 (678)
|.|..+.|+.. .+..|+|++|.+.+..+...+..+++|+.|+|++|++++..+ .+..+ .+|++|+|
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l--~~L~~L~L 88 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA--SGVNEILL 88 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTC--TTCCEEEC
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCC--CCCCEEEC
Confidence 57888888531 356778888888766555557778888888888888877666 35555 66888888
Q ss_pred ccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccc
Q 044996 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 103 s~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g 180 (678)
++|+|++ +|+..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..|.. .+.+|+.|+|++|.|++
T Consensus 89 s~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 89 TSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CSSCCCC-CCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCCccCc-cCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 8888874 44455778888888888888888777777888888888888888888766653 45678888888888776
Q ss_pred cCc
Q 044996 181 SIS 183 (678)
Q Consensus 181 ~ip 183 (678)
..+
T Consensus 168 ~c~ 170 (220)
T 2v70_A 168 NCY 170 (220)
T ss_dssp SGG
T ss_pred CCc
Confidence 554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-16 Score=158.68 Aligned_cols=153 Identities=20% Similarity=0.265 Sum_probs=103.2
Q ss_pred CCCCCCCCCCCCCCCCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-
Q 044996 21 ANWDDRTPPCNENGANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD- 88 (678)
Q Consensus 21 ~~W~~~~~~c~~~~~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~- 88 (678)
.-|......| +|.+|.|+. ..+..|+|++|.+.+..+ ..+..+++|+.|+|++|+|.+..+.
T Consensus 10 ~~~~~~~~~C-----s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~i~~~~ 83 (229)
T 3e6j_A 10 SAACPSQCSC-----SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEP-GVFDSLINLKELYLGSNQLGALPVGV 83 (229)
T ss_dssp -CCCCTTCEE-----ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred hccCCCCCEE-----eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCH-HHhhCccCCcEEECCCCCCCCcChhh
Confidence 3455555666 699999963 246677777777775444 4567777777777777777554433
Q ss_pred ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCC
Q 044996 89 LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQK 166 (678)
Q Consensus 89 ~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~ 166 (678)
+..+ ++|++|+|++|+|+ .+|+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+.. .+.
T Consensus 84 ~~~l--~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 159 (229)
T 3e6j_A 84 FDSL--TQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159 (229)
T ss_dssp TTTC--TTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred cccC--CCcCEEECCCCcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCC
Confidence 3334 56777777777777 455555677777777777777777 67777777777777777777777544432 456
Q ss_pred CCcEEEeecCcccccCc
Q 044996 167 DLVSFNVSNNALFGSIS 183 (678)
Q Consensus 167 ~l~~l~l~~N~l~g~ip 183 (678)
+|+.|+|++|.+.+..+
T Consensus 160 ~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 160 SLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TCCEEECTTSCBCTTBG
T ss_pred CCCEEEeeCCCccCCcc
Confidence 77777777777776544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-16 Score=155.96 Aligned_cols=145 Identities=23% Similarity=0.315 Sum_probs=118.7
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEc
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~L 102 (678)
|.|.+|.|.. .+++.|+|++|.+. .+++..+..+++|+.|+|++|++++..+. +..+ ++|++|+|
T Consensus 7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L 83 (208)
T 2o6s_A 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKL--TSLTYLNL 83 (208)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTC--TTCCEEEC
T ss_pred ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCC--CCcCEEEC
Confidence 5899999963 25888999999998 56666688899999999999999876554 3445 77999999
Q ss_pred ccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccc
Q 044996 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 103 s~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g 180 (678)
++|+|+ .+|+..|.++++|++|+|++|++++..+..+.++++|++|+|++|.|++..+.. ...+|+.|++++|.+.+
T Consensus 84 s~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 84 STNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CCCcCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 999999 566666889999999999999999877777899999999999999998655542 56789999999988877
Q ss_pred cCc
Q 044996 181 SIS 183 (678)
Q Consensus 181 ~ip 183 (678)
..|
T Consensus 163 ~~~ 165 (208)
T 2o6s_A 163 TCP 165 (208)
T ss_dssp CTT
T ss_pred CCC
Confidence 665
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-16 Score=156.60 Aligned_cols=142 Identities=25% Similarity=0.375 Sum_probs=92.4
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEc
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~L 102 (678)
|.|..|.|.. ..++.|+|++|++.+ +++..+..+++|+.|+|++|++++..|. +..+ .+|++|+|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l--~~L~~L~L 87 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL--RSLNSLVL 87 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTC--SSCCEEEC
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCC--cCCCEEEC
Confidence 5788888853 146667777776663 4444566677777777777777666553 4444 55777777
Q ss_pred ccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccc
Q 044996 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 103 s~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g 180 (678)
++|+|+ .||+..|.++++|+.|+|++|++++..|..|..+++|++|+|++|.|++..+.. .+.+|+.|+|++|.|..
T Consensus 88 s~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 88 YGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 777776 566555666777777777777777666666777777777777777776555432 34566777777766653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.8e-16 Score=168.22 Aligned_cols=164 Identities=21% Similarity=0.226 Sum_probs=136.6
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhh-cCCCCCEEEccCCcccccCCc-ccccCCCCccEEE
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILK-ELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVY 101 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~-~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~ 101 (678)
|.|.-|.|.. ..+..|+|++|.|.+ +++..+. .+++|+.|+|++|+|++..|. +..+ ++|++|+
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~-l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l--~~L~~L~ 94 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPV--PNLRYLD 94 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCE-ECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTC--TTCCEEE
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCc-cChhhhhhcccccCEEECCCCcCCccChhhccCC--CCCCEEE
Confidence 5788899953 247789999999985 5555676 899999999999999988774 5555 7899999
Q ss_pred cccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc------CCCCCcEEEeec
Q 044996 102 LSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF------QQKDLVSFNVSN 175 (678)
Q Consensus 102 Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~------~~~~l~~l~l~~ 175 (678)
|++|+|+ .+|+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|.|++ +|.. .+.+|+.|+|++
T Consensus 95 Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~ 172 (361)
T 2xot_A 95 LSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSS 172 (361)
T ss_dssp CCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CTTCCEEECCS
T ss_pred CCCCcCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCC
Confidence 9999999 5666669999999999999999999999999999999999999999996 5542 368999999999
Q ss_pred CcccccCchhhhcC-----CCCCCCCCCCCCCC
Q 044996 176 NALFGSISPALREL-----DPSSFSGNRDLCGE 203 (678)
Q Consensus 176 N~l~g~ip~~~~~l-----~~~~~~gn~~lc~~ 203 (678)
|+|++..+..+..+ ....+.+|++.|.+
T Consensus 173 N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp SCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred CCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 99986554556555 34678999998864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.66 E-value=6.1e-17 Score=155.70 Aligned_cols=149 Identities=25% Similarity=0.356 Sum_probs=116.5
Q ss_pred EEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc--ccccCCCCccEEEcccCccccccChhhhcCCcccceee
Q 044996 49 GLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLL 126 (678)
Q Consensus 49 ~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~ 126 (678)
.+++++++|. .+|..+ ..+|+.|+|++|++++..+. +..+ ++|++|+|++|+|++.+|.. |.++++|++|+
T Consensus 12 ~l~~s~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~ 84 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDI---PLHTTELLLNDNELGRISSDGLFGRL--PHLVKLELKRNQLTGIEPNA-FEGASHIQELQ 84 (192)
T ss_dssp EEECTTSCCS-SCCSCC---CTTCSEEECCSCCCCSBCCSCSGGGC--TTCCEEECCSSCCCCBCTTT-TTTCTTCCEEE
T ss_pred EEEcCCCCcC-cCccCC---CCCCCEEECCCCcCCccCCccccccC--CCCCEEECCCCCCCCcCHhH-cCCcccCCEEE
Confidence 3455666774 677532 23899999999999988774 5666 77999999999999776755 89999999999
Q ss_pred ccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchh-hh-cCCCCCCCCCCCCCC
Q 044996 127 LADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA-LR-ELDPSSFSGNRDLCG 202 (678)
Q Consensus 127 l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~-~~-~l~~~~~~gn~~lc~ 202 (678)
|++|+|++..|..|.++++|++|+|++|+|++.+|.. .+.+|+.|+|++|.|++..+.. +. .+....+.++...|+
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence 9999999999988999999999999999999988874 5679999999999999887632 21 122223445555665
Q ss_pred CC
Q 044996 203 EP 204 (678)
Q Consensus 203 ~~ 204 (678)
.|
T Consensus 165 ~P 166 (192)
T 1w8a_A 165 AP 166 (192)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.6e-16 Score=152.37 Aligned_cols=155 Identities=20% Similarity=0.260 Sum_probs=129.0
Q ss_pred eEEecCCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc--ccccCCCCccEEEcccCccccccChhhh
Q 044996 39 GVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSNNRFSGEIPTDAF 116 (678)
Q Consensus 39 gv~C~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~~~L~~L~Ls~N~l~G~ip~~~~ 116 (678)
+-.|.. ..++++++.|. .+|..+ ...++.|+|++|+|++..|. +..+ ++|++|+|++|+|++ +++..|
T Consensus 8 ~C~C~~---~~l~~s~n~l~-~iP~~~---~~~~~~L~L~~N~l~~~~~~~~~~~l--~~L~~L~L~~N~i~~-i~~~~~ 77 (220)
T 2v70_A 8 KCRCEG---TTVDCSNQKLN-KIPEHI---PQYTAELRLNNNEFTVLEATGIFKKL--PQLRKINFSNNKITD-IEEGAF 77 (220)
T ss_dssp TCEEET---TEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCEECCCCCGGGC--TTCCEEECCSSCCCE-ECTTTT
T ss_pred CCEECC---CEeEeCCCCcc-cCccCC---CCCCCEEEcCCCcCCccCchhhhccC--CCCCEEECCCCcCCE-ECHHHh
Confidence 345643 37999999997 577532 34578999999999998763 5556 789999999999995 555559
Q ss_pred cCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhcC---CC
Q 044996 117 DGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALREL---DP 191 (678)
Q Consensus 117 ~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~l---~~ 191 (678)
.++++|++|+|++|++++..|..|..+++|++|+|++|.|++..|.. .+.+|+.|+|++|+|++..|..+..+ ..
T Consensus 78 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 157 (220)
T 2v70_A 78 EGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLST 157 (220)
T ss_dssp TTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCE
T ss_pred CCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCE
Confidence 99999999999999999988889999999999999999999887764 56899999999999999888777654 45
Q ss_pred CCCCCCCCCCCC
Q 044996 192 SSFSGNRDLCGE 203 (678)
Q Consensus 192 ~~~~gn~~lc~~ 203 (678)
..+.+|++.|..
T Consensus 158 L~L~~N~l~c~c 169 (220)
T 2v70_A 158 LNLLANPFNCNC 169 (220)
T ss_dssp EECCSCCEECSG
T ss_pred EEecCcCCcCCC
Confidence 578999988854
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.1e-15 Score=153.42 Aligned_cols=153 Identities=25% Similarity=0.295 Sum_probs=128.7
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.++..|+|++|.+.+ ++ .+..+++|+.|+|++|.+++..+. +..+ ++|++|+|++|++++ +|+..|+++++|+
T Consensus 63 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~-~~~~~~~~l~~L~ 136 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKL--TNLKELVLVENQLQS-LPDGVFDKLTNLT 136 (272)
T ss_dssp TTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTC--TTCCEEECTTSCCCC-CCTTTTTTCTTCC
T ss_pred CCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCC--cCCCEEECCCCcCCc-cCHHHhccCCCCC
Confidence 578999999999986 43 588999999999999999987774 4555 789999999999995 5555589999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhh---cCCCCCCCCCC
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALR---ELDPSSFSGNR 198 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~---~l~~~~~~gn~ 198 (678)
+|+|++|++++..|..++.+++|++|+|++|.|++..|.. .+++|+.|++++|.+++..|..+. ++....+.+|+
T Consensus 137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (272)
T 3rfs_A 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence 9999999999888888899999999999999999766653 578999999999999987776554 44556788898
Q ss_pred CCCCC
Q 044996 199 DLCGE 203 (678)
Q Consensus 199 ~lc~~ 203 (678)
+.|..
T Consensus 217 ~~~~~ 221 (272)
T 3rfs_A 217 WDCTC 221 (272)
T ss_dssp BCCCT
T ss_pred ccccC
Confidence 87753
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.9e-15 Score=149.55 Aligned_cols=156 Identities=23% Similarity=0.281 Sum_probs=128.5
Q ss_pred cceEEecCCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhh
Q 044996 37 WNGVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDA 115 (678)
Q Consensus 37 w~gv~C~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~ 115 (678)
|..-.|+. +.++++++++. .+|..+ .++|+.|+|++|++++..|. +..+ .+|++|+|++|+|+ .+|+..
T Consensus 14 ~~~~~Cs~---~~v~c~~~~l~-~ip~~~---~~~L~~L~Ls~n~i~~~~~~~~~~l--~~L~~L~L~~N~l~-~i~~~~ 83 (229)
T 3e6j_A 14 PSQCSCSG---TTVDCRSKRHA-SVPAGI---PTNAQILYLHDNQITKLEPGVFDSL--INLKELYLGSNQLG-ALPVGV 83 (229)
T ss_dssp CTTCEEET---TEEECTTSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTC--TTCCEEECCSSCCC-CCCTTT
T ss_pred CCCCEEeC---CEeEccCCCcC-ccCCCC---CCCCCEEEcCCCccCccCHHHhhCc--cCCcEEECCCCCCC-CcChhh
Confidence 44556753 45889998886 777532 48899999999999998774 4555 78999999999997 688777
Q ss_pred hcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhh---cCC
Q 044996 116 FDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALR---ELD 190 (678)
Q Consensus 116 ~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~---~l~ 190 (678)
|.++++|++|+|++|+|++..+..|..+++|++|+|++|.|+ .+|.. .+.+|+.|+|++|+|++..+..+. ++.
T Consensus 84 ~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 162 (229)
T 3e6j_A 84 FDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162 (229)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred cccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCC
Confidence 899999999999999999877788899999999999999999 77764 678999999999999976555454 445
Q ss_pred CCCCCCCCCCCCC
Q 044996 191 PSSFSGNRDLCGE 203 (678)
Q Consensus 191 ~~~~~gn~~lc~~ 203 (678)
...+.+|++.|..
T Consensus 163 ~L~l~~N~~~c~c 175 (229)
T 3e6j_A 163 HAYLFGNPWDCEC 175 (229)
T ss_dssp EEECTTSCBCTTB
T ss_pred EEEeeCCCccCCc
Confidence 5678999988753
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.7e-16 Score=162.66 Aligned_cols=148 Identities=18% Similarity=0.274 Sum_probs=122.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-cc---------ccCCCCccEEEcccCccccccChh
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LR---------QLGNGALRSVYLSNNRFSGEIPTD 114 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~---------~~~~~~L~~L~Ls~N~l~G~ip~~ 114 (678)
.++..|+|++|.+. .+|. .++.|++|+.|+|++|++.|.+|. +. .+ ++|++|+|++|+|+ .||..
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~-~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l--~~L~~L~L~~n~l~-~lp~~ 201 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPA-SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL--VNLQSLRLEWTGIR-SLPAS 201 (328)
T ss_dssp TTCSEEEEESCCCC-CCCG-GGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEES--TTCCEEEEEEECCC-CCCGG
T ss_pred CCCCEEECCCCccc-cCcH-HHhcCcCCCEEECCCCCCccccChhHhhccchhhhccC--CCCCEEECcCCCcC-cchHh
Confidence 46889999999998 8876 489999999999999999999984 22 24 67999999999998 88876
Q ss_pred hhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhcCC--
Q 044996 115 AFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRELD-- 190 (678)
Q Consensus 115 ~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~l~-- 190 (678)
|+++++|++|+|++|++++ +|..++.+++|++|+|++|++.+.+|.. .+.+|+.|+|++|++.+.+|..+.++.
T Consensus 202 -l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L 279 (328)
T 4fcg_A 202 -IANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL 279 (328)
T ss_dssp -GGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTC
T ss_pred -hcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCC
Confidence 8889999999999999985 6777889999999999999999988874 567889999999988888888776554
Q ss_pred -CCCCCCCCC
Q 044996 191 -PSSFSGNRD 199 (678)
Q Consensus 191 -~~~~~gn~~ 199 (678)
...+.+|..
T Consensus 280 ~~L~L~~n~~ 289 (328)
T 4fcg_A 280 EKLDLRGCVN 289 (328)
T ss_dssp CEEECTTCTT
T ss_pred CEEeCCCCCc
Confidence 345666643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=146.93 Aligned_cols=165 Identities=22% Similarity=0.247 Sum_probs=126.0
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEc
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~L 102 (678)
|.|..+.|+. .+++.|+|++|.+.+..+...+..+++|+.|+|++|+|++.+|. +..+ .+|++|+|
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L 85 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA--SHIQELQL 85 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC--TTCCEEEC
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCc--ccCCEEEC
Confidence 5799999963 26889999999998554444588999999999999999998874 5555 77999999
Q ss_pred ccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCC-CCCcEEEeecCccccc
Q 044996 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQ-KDLVSFNVSNNALFGS 181 (678)
Q Consensus 103 s~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~-~~l~~l~l~~N~l~g~ 181 (678)
++|+|++..|. .|.++++|++|+|++|+|++.+|..|..+++|++|+|++|.|++..+.... ..++...+..+.....
T Consensus 86 s~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 86 GENKIKEISNK-MFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CSCCCCEECSS-SSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred CCCcCCccCHH-HhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence 99999976554 489999999999999999999999999999999999999999988764211 1122223344555555
Q ss_pred CchhhhcCCCCCCCCCCCCCC
Q 044996 182 ISPALRELDPSSFSGNRDLCG 202 (678)
Q Consensus 182 ip~~~~~l~~~~~~gn~~lc~ 202 (678)
.|..+.......+..+...|.
T Consensus 165 ~P~~l~~~~l~~l~~~~~~C~ 185 (192)
T 1w8a_A 165 APSKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp SSTTTTTSBGGGSCTTTCCCC
T ss_pred CChHHcCCChhhCcHhhcCcC
Confidence 677766665555555555554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-15 Score=148.65 Aligned_cols=155 Identities=23% Similarity=0.281 Sum_probs=126.7
Q ss_pred eEEecCCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhc
Q 044996 39 GVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFD 117 (678)
Q Consensus 39 gv~C~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~ 117 (678)
+=.|.. ..+++++++|. .+|.. + .+.|+.|+|++|++++..+ .+..+ ++|+.|+|++|++++..|.. |.
T Consensus 8 ~C~C~~---~~v~c~~~~l~-~iP~~-l--~~~l~~L~l~~n~i~~i~~~~~~~l--~~L~~L~Ls~N~i~~~~~~~-~~ 77 (220)
T 2v9t_B 8 ACTCSN---NIVDCRGKGLT-EIPTN-L--PETITEIRLEQNTIKVIPPGAFSPY--KKLRRIDLSNNQISELAPDA-FQ 77 (220)
T ss_dssp TSEEET---TEEECTTSCCS-SCCSS-C--CTTCCEEECCSSCCCEECTTSSTTC--TTCCEEECCSSCCCEECTTT-TT
T ss_pred CCEECC---CEEEcCCCCcC-cCCCc-c--CcCCCEEECCCCcCCCcCHhHhhCC--CCCCEEECCCCcCCCcCHHH-hh
Confidence 345643 35889999987 67753 2 2689999999999998776 45555 78999999999999766654 99
Q ss_pred CCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhc---CCCC
Q 044996 118 GMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRE---LDPS 192 (678)
Q Consensus 118 ~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~ 192 (678)
++++|++|+|++|+|++..+..|..+++|++|+|++|.|++..|.. .+.+|+.|+|++|+|++..+..+.. +...
T Consensus 78 ~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 157 (220)
T 2v9t_B 78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM 157 (220)
T ss_dssp TCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEE
Confidence 9999999999999999666666899999999999999999887764 5689999999999999877765554 4556
Q ss_pred CCCCCCCCCCC
Q 044996 193 SFSGNRDLCGE 203 (678)
Q Consensus 193 ~~~gn~~lc~~ 203 (678)
.+.+|++.|.+
T Consensus 158 ~L~~N~~~c~c 168 (220)
T 2v9t_B 158 HLAQNPFICDC 168 (220)
T ss_dssp ECCSSCEECSG
T ss_pred EeCCCCcCCCC
Confidence 78999988854
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=174.21 Aligned_cols=166 Identities=20% Similarity=0.283 Sum_probs=128.9
Q ss_pred CCCCCCCCCCCCCCCCCCcc----eEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCccc
Q 044996 19 ALANWDDRTPPCNENGANWN----GVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLE 83 (678)
Q Consensus 19 ~l~~W~~~~~~c~~~~~~w~----gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~ 83 (678)
.++.|+.+.+.| +..|.|. -|.|.. ..++.|+|++|.|+ .|++..|.+|++|+.|+|++|+|+
T Consensus 12 ~~~~~~~~~p~~-~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~ 89 (635)
T 4g8a_A 12 KLAAANSSIPES-WEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ 89 (635)
T ss_dssp --------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCC
T ss_pred hhhcccCCCCCC-CCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCC
Confidence 577777554322 1122332 477852 35899999999998 677677999999999999999999
Q ss_pred ccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccc-cCC
Q 044996 84 GPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG-QIP 161 (678)
Q Consensus 84 g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p 161 (678)
+..|. +..+ ++|++|+|++|+|+ .+|+..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++ .+|
T Consensus 90 ~i~~~~f~~L--~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~ 166 (635)
T 4g8a_A 90 TIEDGAYQSL--SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 166 (635)
T ss_dssp EECTTTTTTC--TTCCEEECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCC
T ss_pred CcChhHhcCC--CCCCEEEccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCc
Confidence 87774 5556 78999999999999 5777779999999999999999998777889999999999999999986 456
Q ss_pred cc--CCCCCcEEEeecCcccccCchhhhcC
Q 044996 162 DF--QQKDLVSFNVSNNALFGSISPALREL 189 (678)
Q Consensus 162 ~~--~~~~l~~l~l~~N~l~g~ip~~~~~l 189 (678)
.. .+++|+.|+|++|+|++..|..+..+
T Consensus 167 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L 196 (635)
T 4g8a_A 167 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 196 (635)
T ss_dssp GGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred hhhccchhhhhhcccCccccccccccccch
Confidence 64 57899999999999999888776544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.4e-15 Score=151.61 Aligned_cols=131 Identities=23% Similarity=0.363 Sum_probs=79.6
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.+..|+|++|.+. .+++..+..+++|+.|+|++|.++...+. +..+ ++|++|+|++|+++ .+|+..|.++++|++
T Consensus 38 ~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l--~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~ 113 (270)
T 2o6q_A 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL--KNLETLWVTDNKLQ-ALPIGVFDQLVNLAE 113 (270)
T ss_dssp TCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSC--TTCCEEECCSSCCC-CCCTTTTTTCSSCCE
T ss_pred CCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCC--CCCCEEECCCCcCC-cCCHhHcccccCCCE
Confidence 4778899998887 45555577788888888888887754443 2333 55666666666666 344444566666666
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g 180 (678)
|+|++|++++..|..|..+++|++|+|++|.+++..+.. .+.+|+.|+|++|.+++
T Consensus 114 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 171 (270)
T 2o6q_A 114 LRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR 171 (270)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred EECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence 666666666555555566666666666666555433221 33444555555554443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.9e-15 Score=153.53 Aligned_cols=156 Identities=21% Similarity=0.347 Sum_probs=127.1
Q ss_pred CCcceEEec-CCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccC
Q 044996 35 ANWNGVLCH-RGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIP 112 (678)
Q Consensus 35 ~~w~gv~C~-~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip 112 (678)
|.|.|+.|. .+.+..+++++++|. .+|.. + .++|+.|+|++|++++..+ .+..+ ++|++|+|++|+++ .+|
T Consensus 5 C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~-~--~~~l~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~-~i~ 77 (270)
T 2o6q_A 5 CKKDGGVCSCNNNKNSVDCSSKKLT-AIPSN-I--PADTKKLDLQSNKLSSLPSKAFHRL--TKLRLLYLNDNKLQ-TLP 77 (270)
T ss_dssp BGGGTCSBEEETTTTEEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCSCCCTTSSSSC--TTCCEEECCSSCCS-CCC
T ss_pred CCCCCCCCEeCCCCCEEEccCCCCC-ccCCC-C--CCCCCEEECcCCCCCeeCHHHhcCC--CCCCEEECCCCccC-eeC
Confidence 479999986 455678999999998 57753 2 3679999999999998666 45555 78999999999999 688
Q ss_pred hhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhc--
Q 044996 113 TDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRE-- 188 (678)
Q Consensus 113 ~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~-- 188 (678)
..+|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..|.. .+++|+.|+|++|.+++..+..+..
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 777899999999999999999877778899999999999999999776653 6789999999999998755544443
Q ss_pred -CCCCCCCCC
Q 044996 189 -LDPSSFSGN 197 (678)
Q Consensus 189 -l~~~~~~gn 197 (678)
|....+.+|
T Consensus 158 ~L~~L~L~~n 167 (270)
T 2o6q_A 158 SLKELRLYNN 167 (270)
T ss_dssp TCCEEECCSS
T ss_pred ccceeEecCC
Confidence 333445555
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-16 Score=181.78 Aligned_cols=176 Identities=17% Similarity=0.207 Sum_probs=114.1
Q ss_pred ChHHHHHHHHhcCCCC--CCCCCCCCCCCCCCCCCCCcceEEecCCcEEEEEeCCCCcee--------------------
Q 044996 2 TDSQTLLTLKQSLSNP--TALANWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQG-------------------- 59 (678)
Q Consensus 2 ~~~~aLl~~k~~l~~~--~~l~~W~~~~~~c~~~~~~w~gv~C~~~~v~~l~l~~~~l~g-------------------- 59 (678)
.+.++|+++..++... ..-..|.....++. .|.++.++.++++.|+|..+++..
T Consensus 132 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 132 CTKQALMEMADTLTDSKTAKKQQPTGDSTPSG----TATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp CCCHHHHHHHHHHHHHHTTC------------------------------------------------------------
T ss_pred cchhhhhhhhhhcccccCcccCCCcCCCCccc----cCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 4678899998776422 22345654433332 699988887777777776554432
Q ss_pred ------ecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccceeecccccc
Q 044996 60 ------NIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQF 132 (678)
Q Consensus 60 ------~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~ 132 (678)
.++++.+..++.|+.|+|++|.+. .+| .+..+ .+|++|+|++|.|+ .||.. |++|++|++|+|++|.|
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l--~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKY--DFLTRLYLNGNSLT-ELPAE-IKNLSNLRVLDLSHNRL 282 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGC--CSCSCCBCTTSCCS-CCCGG-GGGGTTCCEEECTTSCC
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCC--CCCCEEEeeCCcCc-ccChh-hhCCCCCCEEeCcCCcC
Confidence 123455788999999999999998 555 55555 77999999999999 89976 89999999999999999
Q ss_pred ccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhc
Q 044996 133 NGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRE 188 (678)
Q Consensus 133 ~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~ 188 (678)
+ .+|..|++|++|++|+|++|.|+ .+|.. .+.+|+.|+|++|.|+|.+|..+..
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE 338 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence 9 89999999999999999999997 78874 6789999999999999999987654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=9.6e-16 Score=180.87 Aligned_cols=140 Identities=22% Similarity=0.308 Sum_probs=119.2
Q ss_pred HhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccc-----cccChhhhcCCcccceeeccccccccCCchh
Q 044996 65 ILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFS-----GEIPTDAFDGMTSLRKLLLADNQFNGPIPES 139 (678)
Q Consensus 65 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~-----G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~ 139 (678)
.+..+++|+.|+|++|++++..+.......++|+.|+|++|.++ +..| ..|.++++|+.|+|++|++++..|..
T Consensus 421 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~ 499 (844)
T 3j0a_A 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW-DVFEGLSHLQVLYLNHNYLNSLPPGV 499 (844)
T ss_dssp HHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCS-SCSSCBCCEECCCCCHHHHTTCCTTS
T ss_pred hhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccch-hhhcCcccccEEECCCCcccccChhH
Confidence 35689999999999999998655311122378999999999997 3333 45889999999999999999999999
Q ss_pred hcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCchhhhcCCCCCCCCCCCCCCCCC
Q 044996 140 LTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALRELDPSSFSGNRDLCGEPL 205 (678)
Q Consensus 140 ~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~~~~~gn~~lc~~~~ 205 (678)
|..+++|+.|+|++|+|++..|.....+|+.|+|++|+|+|.+|..+..+....+.||++.|.+.+
T Consensus 500 ~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 500 FSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred ccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 999999999999999999876666558999999999999999999988888889999999996543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.9e-15 Score=153.35 Aligned_cols=153 Identities=25% Similarity=0.353 Sum_probs=81.4
Q ss_pred EEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCccccee
Q 044996 47 IWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125 (678)
Q Consensus 47 v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l 125 (678)
+..|+|++|..-+.+++..+..+++|+.|+|++|.+.+..|. +..+ ++|++|+|++|++++ +|+..|+.+++|+.|
T Consensus 82 L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L 158 (285)
T 1ozn_A 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL--AALQYLYLQDNALQA-LPDDTFRDLGNLTHL 158 (285)
T ss_dssp CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC--TTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCC--cCCCEEECCCCcccc-cCHhHhccCCCccEE
Confidence 444444444422233333344555555555555555544332 2223 446666666666653 333335556666666
Q ss_pred eccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhc---CCCCCCCCCCCC
Q 044996 126 LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGNRDL 200 (678)
Q Consensus 126 ~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn~~l 200 (678)
+|++|++++..+..+..+++|+.|+|++|.+++..|.. ..++|+.|++++|.+++..+..+.. +....+.+|++.
T Consensus 159 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence 66666666544445666666666666666666555542 3456666666666666544443433 334456777766
Q ss_pred CC
Q 044996 201 CG 202 (678)
Q Consensus 201 c~ 202 (678)
|.
T Consensus 239 c~ 240 (285)
T 1ozn_A 239 CD 240 (285)
T ss_dssp CS
T ss_pred CC
Confidence 64
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.8e-15 Score=165.62 Aligned_cols=152 Identities=17% Similarity=0.247 Sum_probs=129.9
Q ss_pred CCCcce--EEecC----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc--ccccCCCCccE
Q 044996 34 GANWNG--VLCHR----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRS 99 (678)
Q Consensus 34 ~~~w~g--v~C~~----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~~~L~~ 99 (678)
.|.|.+ |.|.. .+++.|+|++|.+.+..| ..+..|++|+.|+|++|.+.+.++. +..+ ++|++
T Consensus 7 ~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l--~~L~~ 83 (455)
T 3v47_A 7 ECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNE-TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGL--SSLII 83 (455)
T ss_dssp CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECT-TTTSSCTTCCEEECCCCSTTCEECTTTTTTC--TTCCE
T ss_pred eeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCCh-hHhccCccccEEECcCCcccceECccccccc--ccCCE
Confidence 455666 88863 358999999999986555 4689999999999999999888763 5555 78999
Q ss_pred EEcccCccccccChhhhcCCcccceeeccccccccCCchh--hcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEee
Q 044996 100 VYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPES--LTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVS 174 (678)
Q Consensus 100 L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~--~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~ 174 (678)
|+|++|++++.+|.. |+++++|++|+|++|++++.+|.. +.++++|++|+|++|.+++..|.. .+++|+.|+++
T Consensus 84 L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~ 162 (455)
T 3v47_A 84 LKLDYNQFLQLETGA-FNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT 162 (455)
T ss_dssp EECTTCTTCEECTTT-TTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECT
T ss_pred EeCCCCccCccChhh-ccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCC
Confidence 999999999777765 999999999999999999977776 999999999999999999888863 67899999999
Q ss_pred cCcccccCchhhhcC
Q 044996 175 NNALFGSISPALREL 189 (678)
Q Consensus 175 ~N~l~g~ip~~~~~l 189 (678)
+|.+++..|..+..+
T Consensus 163 ~n~l~~~~~~~l~~l 177 (455)
T 3v47_A 163 FNKVKSICEEDLLNF 177 (455)
T ss_dssp TCCBSCCCTTTSGGG
T ss_pred CCcccccChhhhhcc
Confidence 999999888777654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.59 E-value=6.2e-15 Score=151.32 Aligned_cols=153 Identities=25% Similarity=0.287 Sum_probs=87.5
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccC---------------------C-cccccCCCCccEEEcc
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPM---------------------P-DLRQLGNGALRSVYLS 103 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~---------------------p-~~~~~~~~~L~~L~Ls 103 (678)
.++.|+|++|.+.+..+ ..+..+++|+.|+|++|.+++.. | .+..+ ++|++|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l--~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSL-ATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL--PALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEG-GGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCSSCCCCTTTC--TTCCEEECC
T ss_pred CCCEEEcCCCcCCccCH-HHhhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCCcCchhhccC--CCCCEEECC
Confidence 46667777777664333 34566666666666666655432 2 12222 456666666
Q ss_pred cCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCccccc
Q 044996 104 NNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 104 ~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ 181 (678)
+|+|+ .+|+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+.. .+.+|+.|+|++|+|+ .
T Consensus 109 ~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ 186 (290)
T 1p9a_G 109 FNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (290)
T ss_dssp SSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred CCcCc-ccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-c
Confidence 66666 344344666666666666666666555555566666666666666666322221 3456667777777665 4
Q ss_pred Cchhhhc---CCCCCCCCCCCCCCC
Q 044996 182 ISPALRE---LDPSSFSGNRDLCGE 203 (678)
Q Consensus 182 ip~~~~~---l~~~~~~gn~~lc~~ 203 (678)
+|..+.. +....+.||++.|.+
T Consensus 187 ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 187 IPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cChhhcccccCCeEEeCCCCccCcC
Confidence 5554433 333457788888753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=9.3e-16 Score=149.30 Aligned_cols=138 Identities=22% Similarity=0.330 Sum_probs=120.6
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.++..|+|++|.+. .+++..+..+++|++|+|++|++++..+. +..+ ++|++|+|++|+|++ +|+..|.++++|+
T Consensus 52 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~L~~N~l~~-~~~~~~~~l~~L~ 127 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKL--TQLKELALNTNQLQS-LPDGVFDKLTQLK 127 (208)
T ss_dssp TTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC--TTCCEEECCSSCCCC-CCTTTTTTCTTCC
T ss_pred ccCcEEECCCCccC-ccChhhcCCCCCcCEEECCCCcCCccCHhHhcCc--cCCCEEEcCCCcCcc-cCHhHhccCCcCC
Confidence 46899999999998 56666789999999999999999976664 4455 789999999999995 6656689999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCchhhhcCCC
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALRELDP 191 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~ 191 (678)
+|+|++|++++..+..+..+++|+.|+|++|.+.+..| +|+.|+++.|+++|.+|.+++.+..
T Consensus 128 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-----~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 128 DLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-----GIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT-----TTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred EEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC-----CHHHHHHHHHhCCceeeccCccccC
Confidence 99999999998777779999999999999999987665 6889999999999999998887654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2e-15 Score=158.57 Aligned_cols=136 Identities=13% Similarity=0.096 Sum_probs=98.3
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccCh--------------hhH--------HHHHHHHHHHhccCCCCccce
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNN--------------VGR--------EEFQEHMRRLGRLRHPNLLPL 430 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~--------~~~~~e~~~l~~l~H~niv~l 430 (678)
+.+.||+|+||.||+|...+|+.||||+++.... ... ....+|...|.++.+.++.-.
T Consensus 99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 3578999999999999998999999998753110 001 112456777777765554322
Q ss_pred eEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCC
Q 044996 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNES 510 (678)
Q Consensus 431 ~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~ 510 (678)
.-+.. ...+|||||+++++|..+.. ......++.|++.+|.|||+. +||||||||.|||++++
T Consensus 179 ~p~~~--~~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 179 EPIAQ--SRHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAKH----GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CEEEE--ETTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEEEE
T ss_pred eeeec--cCceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeCC
Confidence 22222 23479999999988865432 123457899999999999976 79999999999999887
Q ss_pred C----------ceEEeecCCccccC
Q 044996 511 L----------EPVLADYGLIPVMN 525 (678)
Q Consensus 511 ~----------~~kl~DfGla~~~~ 525 (678)
+ .+.|+||+.+-...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCcccccccccceEEEEeCCcccCC
Confidence 6 38899999875443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.7e-15 Score=168.16 Aligned_cols=174 Identities=15% Similarity=0.186 Sum_probs=134.8
Q ss_pred CCCCCCCCCCCCCCCCCCcceEEecC------------------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCC
Q 044996 19 ALANWDDRTPPCNENGANWNGVLCHR------------------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRN 80 (678)
Q Consensus 19 ~l~~W~~~~~~c~~~~~~w~gv~C~~------------------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N 80 (678)
.+++|....+||. ....|.++.|+. ..+..+++.++.+. .+|+..+..+++|+.|+|++|
T Consensus 8 ~l~~~~~~~~C~~-~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n 85 (597)
T 3oja_B 8 NVKPRQPEYKCID-SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 85 (597)
T ss_dssp ---CCCSEECCCC-C--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTS
T ss_pred cccCCCCCCcCcc-cCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCC
Confidence 4788987766653 233577776641 23566778887775 688888999999999999999
Q ss_pred cccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCccccc
Q 044996 81 NLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQ 159 (678)
Q Consensus 81 ~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~ 159 (678)
.+.+..| .+..+ ++|++|+|++|.|++. |+..|+++++|++|+|++|.|++..+..|+++++|++|+|++|.|++.
T Consensus 86 ~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~ 162 (597)
T 3oja_B 86 QIEEIDTYAFAYA--HTIQKLYMGFNAIRYL-PPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 162 (597)
T ss_dssp CCCEECTTTTTTC--TTCCEEECCSSCCCCC-CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred CCCCCChHHhcCC--CCCCEEECCCCcCCCC-CHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCC
Confidence 9999887 56656 7899999999999974 445589999999999999999966666679999999999999999988
Q ss_pred CCcc--CCCCCcEEEeecCcccccCchhhhcCCCCCCCCC
Q 044996 160 IPDF--QQKDLVSFNVSNNALFGSISPALRELDPSSFSGN 197 (678)
Q Consensus 160 ~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~l~~~~~~gn 197 (678)
.|.. .+++|+.|+|++|.|++.-+..+..+....+.+|
T Consensus 163 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 163 EDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred ChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 8763 6789999999999998865555555554455554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.9e-15 Score=169.52 Aligned_cols=151 Identities=21% Similarity=0.253 Sum_probs=128.6
Q ss_pred CCcceEEecC-------------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEE
Q 044996 35 ANWNGVLCHR-------------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSV 100 (678)
Q Consensus 35 ~~w~gv~C~~-------------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L 100 (678)
|.|.|+ |+. .+++.|+|++|.+.+..| ..+..+++|++|+|++|++++..|. +..+ ++|++|
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l--~~L~~L 79 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGH-GDLRACANLQVLILKSSRINTIEGDAFYSL--GSLEHL 79 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECS-STTSSCTTCCEEECTTSCCCEECTTTTTTC--TTCCEE
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccCh-hhhhcCCcccEEECCCCCcCccChhhcccc--ccCCEE
Confidence 479998 752 268999999999986555 4689999999999999999998874 5555 789999
Q ss_pred EcccCccccccChhhhcCCcccceeecccccccc-CCchhhcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEeecC
Q 044996 101 YLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNG-PIPESLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNN 176 (678)
Q Consensus 101 ~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N 176 (678)
+|++|++++..| ..|+++++|++|+|++|.+++ .+|..++++++|++|+|++|.+.+.+|.. .+++|+.|++++|
T Consensus 80 ~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n 158 (549)
T 2z81_A 80 DLSDNHLSSLSS-SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158 (549)
T ss_dssp ECTTSCCCSCCH-HHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred ECCCCccCccCH-HHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCC
Confidence 999999996544 559999999999999999997 57888999999999999999988888752 5678999999999
Q ss_pred cccccCchhhhcCC
Q 044996 177 ALFGSISPALRELD 190 (678)
Q Consensus 177 ~l~g~ip~~~~~l~ 190 (678)
.+++.+|..+..+.
T Consensus 159 ~l~~~~~~~l~~l~ 172 (549)
T 2z81_A 159 SLRNYQSQSLKSIR 172 (549)
T ss_dssp TCCEECTTTTTTCS
T ss_pred cccccChhhhhccc
Confidence 99999988776543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.9e-15 Score=170.25 Aligned_cols=155 Identities=17% Similarity=0.178 Sum_probs=109.7
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccc-cChhhhcCCcccc
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGE-IPTDAFDGMTSLR 123 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~-ip~~~~~~l~~L~ 123 (678)
++..|+|++|.+.+..+...+..+++|+.|+|++|.+.+.+|. +..+ ++|++|+|++|.+++. +|. .|+.+++|+
T Consensus 400 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~-~~~~l~~L~ 476 (606)
T 3vq2_A 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL--TSLNTLKMAGNSFKDNTLSN-VFANTTNLT 476 (606)
T ss_dssp TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTC--TTCCEEECTTCEEGGGEECS-CCTTCTTCC
T ss_pred CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCC--CCCCEEECCCCcCCCcchHH-hhccCCCCC
Confidence 3445555555555444434566677777777777777776663 3344 6688888888888874 454 478888888
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhcC----CCCCCCCC
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALREL----DPSSFSGN 197 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~l----~~~~~~gn 197 (678)
.|+|++|++++.+|..+.++++|+.|+|++|++++.+|.. .+++|+.|+|++|+|+ .+|..+..+ ....+.+|
T Consensus 477 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N 555 (606)
T 3vq2_A 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNN 555 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSC
T ss_pred EEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCC
Confidence 8888888888888888888888888888888888777763 4678888888888887 577666544 34468899
Q ss_pred CCCCCCC
Q 044996 198 RDLCGEP 204 (678)
Q Consensus 198 ~~lc~~~ 204 (678)
++.|.++
T Consensus 556 ~~~c~c~ 562 (606)
T 3vq2_A 556 SVACICE 562 (606)
T ss_dssp CCCCSST
T ss_pred CcccCCc
Confidence 9888644
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.57 E-value=7.6e-15 Score=147.33 Aligned_cols=133 Identities=26% Similarity=0.365 Sum_probs=116.6
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.++..|+|++|.+.+ +++..+..+++|+.|+|++|+|++..+. +..+ ++|++|+|++|+|+ .+|+..|.++++|+
T Consensus 59 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~N~l~-~~~~~~~~~l~~L~ 134 (251)
T 3m19_A 59 TKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASLPLGVFDHL--TQLDKLYLGGNQLK-SLPSGVFDRLTKLK 134 (251)
T ss_dssp TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC--TTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred ccCCEEECCCCcCCc-cCHhHhccCCcCCEEECCCCcccccChhHhccc--CCCCEEEcCCCcCC-CcChhHhccCCccc
Confidence 579999999999996 4445689999999999999999987664 3445 78999999999999 56666689999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCccccc
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ 181 (678)
.|+|++|++++..|..|..+++|++|+|++|.|++..+.. .+.+|+.|+|++|.|++.
T Consensus 135 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 135 ELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred EEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999999877778999999999999999999766643 568999999999999987
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.57 E-value=8.3e-15 Score=148.93 Aligned_cols=135 Identities=22% Similarity=0.307 Sum_probs=118.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.++..|+|++|.+.+ +++..+..+++|+.|+|++|++++..|. +..+ ++|++|+|++|+|++ +|+..|..+++|+
T Consensus 85 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~-~~~~~~~~l~~L~ 160 (272)
T 3rfs_A 85 TNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL--TNLTYLNLAHNQLQS-LPKGVFDKLTNLT 160 (272)
T ss_dssp TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC--TTCCEEECCSSCCCC-CCTTTTTTCTTCC
T ss_pred CCCCEEECCCCccCc-cChhHhcCCcCCCEEECCCCcCCccCHHHhccC--CCCCEEECCCCccCc-cCHHHhccCccCC
Confidence 579999999999984 5556689999999999999999987775 4555 779999999999995 5556689999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCc
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip 183 (678)
.|+|++|++++..|..++.+++|+.|+|++|.|++..|.. .+++|+.|+|++|.+.|..|
T Consensus 161 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 161 ELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 9999999999888888899999999999999999877753 67899999999999998877
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.9e-16 Score=173.44 Aligned_cols=156 Identities=22% Similarity=0.357 Sum_probs=125.3
Q ss_pred CCCCCCCCCCCCCCCCCcceE-EecCCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCcc
Q 044996 20 LANWDDRTPPCNENGANWNGV-LCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALR 98 (678)
Q Consensus 20 l~~W~~~~~~c~~~~~~w~gv-~C~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~ 98 (678)
+.+|....++|......|.|+ .|..++++.|+|++|+|++ ||..+ +++|+.|+|++|+|+ .+| ..+ ++|+
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l---~~~L~~L~Ls~N~l~-~ip--~~l--~~L~ 103 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNL---PPQITVLEITQNALI-SLP--ELP--ASLE 103 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCC---CTTCSEEECCSSCCS-CCC--CCC--TTCC
T ss_pred HHHHhccCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhH---cCCCCEEECcCCCCc-ccc--ccc--CCCC
Confidence 567876667784322259999 7877789999999999997 88653 488999999999999 577 334 7799
Q ss_pred EEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcc
Q 044996 99 SVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNAL 178 (678)
Q Consensus 99 ~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l 178 (678)
+|+|++|+|++ ||. |.+ +|++|+|++|+|++ +|. .+++|+.|+|++|.|++ +|. ..++|+.|+|++|+|
T Consensus 104 ~L~Ls~N~l~~-ip~--l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 104 YLDACDNRLST-LPE--LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRNNQL 172 (571)
T ss_dssp EEECCSSCCSC-CCC--CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCC
T ss_pred EEEccCCCCCC-cch--hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECCCCCC
Confidence 99999999997 886 554 99999999999998 777 68999999999999997 776 678999999999999
Q ss_pred cccCchhhh-cCCCCCCCCC
Q 044996 179 FGSISPALR-ELDPSSFSGN 197 (678)
Q Consensus 179 ~g~ip~~~~-~l~~~~~~gn 197 (678)
++ +|. +. +|....+.+|
T Consensus 173 ~~-lp~-l~~~L~~L~Ls~N 190 (571)
T 3cvr_A 173 TF-LPE-LPESLEALDVSTN 190 (571)
T ss_dssp SC-CCC-CCTTCCEEECCSS
T ss_pred CC-cch-hhCCCCEEECcCC
Confidence 88 776 43 3333445555
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.5e-15 Score=157.55 Aligned_cols=149 Identities=19% Similarity=0.217 Sum_probs=74.7
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCccccc--C-Cc--ccccCCCCccEEEcccCccc--cccChhhhcC
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGP--M-PD--LRQLGNGALRSVYLSNNRFS--GEIPTDAFDG 118 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~--~-p~--~~~~~~~~L~~L~Ls~N~l~--G~ip~~~~~~ 118 (678)
++..|+|++|.+.+ +++..+..+++|+.|+|++|++.|. + +. +..+ ++|++|+|++|+++ +.++...+.+
T Consensus 146 ~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l--~~L~~L~Ls~N~l~~l~~~~~~l~~~ 222 (310)
T 4glp_A 146 GLKVLSIAQAHSPA-FSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF--PAIQNLALRNTGMETPTGVCAALAAA 222 (310)
T ss_dssp CCCEEEEECCSSCC-CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS--CCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred CCCEEEeeCCCcch-hhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC--CCCCEEECCCCCCCchHHHHHHHHhc
Confidence 45555555555543 2223345555555555555555442 1 11 1122 44555555555554 1111112345
Q ss_pred CcccceeeccccccccCCchhhcCC---CCCCeEeccCCcccccCCccCCCCCcEEEeecCcccc-cCchhhhcCCCCCC
Q 044996 119 MTSLRKLLLADNQFNGPIPESLTRL---SRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG-SISPALRELDPSSF 194 (678)
Q Consensus 119 l~~L~~l~l~~N~~~g~~p~~~~~l---~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g-~ip~~~~~l~~~~~ 194 (678)
+++|++|+|++|++++.+|..++.+ ++|++|+|++|+|+ .+|....++|+.|+|++|+|++ +++..+.++....+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L 301 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNRAPQPDELPEVDNLTL 301 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCSCCCTTSCCCCSCEEC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCCCchhhhCCCccEEEC
Confidence 5566666666666665555555554 35666666666665 4555434556666666666655 34444444444455
Q ss_pred CCCC
Q 044996 195 SGNR 198 (678)
Q Consensus 195 ~gn~ 198 (678)
.+|+
T Consensus 302 ~~N~ 305 (310)
T 4glp_A 302 DGNP 305 (310)
T ss_dssp SSTT
T ss_pred cCCC
Confidence 5553
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=4.9e-15 Score=153.26 Aligned_cols=153 Identities=19% Similarity=0.236 Sum_probs=97.4
Q ss_pred EEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCcccc-ccChhhhcCCcccce
Q 044996 47 IWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSG-EIPTDAFDGMTSLRK 124 (678)
Q Consensus 47 v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G-~ip~~~~~~l~~L~~ 124 (678)
+..|+|++|.+.+..+...+..+++|+.|+|++|.+.+.+|. +..+ ++|++|+|++|.+++ .+|.. |..+++|++
T Consensus 103 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~-~~~l~~L~~ 179 (306)
T 2z66_A 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL--SSLEVLKMAGNSFQENFLPDI-FTELRNLTF 179 (306)
T ss_dssp CCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTC--TTCCEEECTTCEEGGGEECSC-CTTCTTCCE
T ss_pred CCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccC--cCCCEEECCCCccccccchhH-HhhCcCCCE
Confidence 444444444444322223456666666666666666665553 3333 567777777777776 35543 677777777
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCc--cCCCCCcEEEeecCcccccCchhhhcC----CCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDLVSFNVSNNALFGSISPALREL----DPSSFSGNR 198 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~~l~~l~l~~N~l~g~ip~~~~~l----~~~~~~gn~ 198 (678)
|+|++|++++..|..+..+++|+.|+|++|.+++..+. ....+|+.|+|++|.+++.+|..+..+ ....+.+|+
T Consensus 180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~ 259 (306)
T 2z66_A 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 259 (306)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCC
T ss_pred EECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCC
Confidence 77777777777777777777777777777777765443 245677888888888877777665443 334567777
Q ss_pred CCCC
Q 044996 199 DLCG 202 (678)
Q Consensus 199 ~lc~ 202 (678)
.-|.
T Consensus 260 ~~~~ 263 (306)
T 2z66_A 260 FACT 263 (306)
T ss_dssp EECS
T ss_pred eecc
Confidence 6653
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-14 Score=137.89 Aligned_cols=132 Identities=22% Similarity=0.308 Sum_probs=108.1
Q ss_pred CCcceEEecCCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccCh
Q 044996 35 ANWNGVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPT 113 (678)
Q Consensus 35 ~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~ 113 (678)
|.|.+|.|+. +++. .+|.. ..++|+.|+|++|++++..+. +..+ ++|++|+|++|+|+ .+|+
T Consensus 7 C~~~~l~~~~----------~~l~-~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~-~~~~ 69 (177)
T 2o6r_A 7 CSGTEIRCNS----------KGLT-SVPTG---IPSSATRLELESNKLQSLPHGVFDKL--TQLTKLSLSQNQIQ-SLPD 69 (177)
T ss_dssp EETTEEECCS----------SCCS-SCCTT---CCTTCSEEECCSSCCCCCCTTTTTTC--TTCSEEECCSSCCC-CCCT
T ss_pred eCCCEEEecC----------CCCc-cCCCC---CCCCCcEEEeCCCcccEeCHHHhcCc--ccccEEECCCCcce-EeCh
Confidence 5788888854 3343 45532 247899999999999976664 3455 78999999999999 5666
Q ss_pred hhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCc
Q 044996 114 DAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 114 ~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip 183 (678)
..|.++++|+.|+|++|++++..+..+.++++|++|+|++|.|++..+.. .+.+|+.|+|++|.+++..|
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 66899999999999999999888888899999999999999999554442 46899999999999999876
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.7e-15 Score=171.32 Aligned_cols=135 Identities=18% Similarity=0.254 Sum_probs=113.8
Q ss_pred CceeecChHHhhcCCCCCEEEccCCccccc-----------------CC-ccc--ccCCCCccEEEcccCccccccChhh
Q 044996 56 GLQGNIDITILKELREMRTLSLMRNNLEGP-----------------MP-DLR--QLGNGALRSVYLSNNRFSGEIPTDA 115 (678)
Q Consensus 56 ~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~-----------------~p-~~~--~~~~~~L~~L~Ls~N~l~G~ip~~~ 115 (678)
+++| ||. .+++|++|++|+|++|+|+|. +| .+. .+ ++|++|+|++|++.|.+|..
T Consensus 194 ~l~~-ip~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l--~~L~~L~L~~n~l~~~~p~~- 268 (636)
T 4eco_A 194 NITF-VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNL--KDLTDVEVYNCPNLTKLPTF- 268 (636)
T ss_dssp EEEE-ECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGC--TTCCEEEEECCTTCSSCCTT-
T ss_pred CCcc-CCH-HHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhccc--CCCCEEEecCCcCCccChHH-
Confidence 4456 776 489999999999999999995 77 455 56 77999999999999999976
Q ss_pred hcCCcccceeeccccc-ccc-CCchhhcCC------CCCCeEeccCCcccccCCc--c--CCCCCcEEEeecCcccccCc
Q 044996 116 FDGMTSLRKLLLADNQ-FNG-PIPESLTRL------SRLVELRLEGNKFEGQIPD--F--QQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 116 ~~~l~~L~~l~l~~N~-~~g-~~p~~~~~l------~~L~~l~l~~N~l~g~~p~--~--~~~~l~~l~l~~N~l~g~ip 183 (678)
|+++++|++|+|++|+ |+| .+|..++++ ++|++|+|++|.|+ .+|. . .+++|+.|++++|.++|.+|
T Consensus 269 l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip 347 (636)
T 4eco_A 269 LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP 347 (636)
T ss_dssp TTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC
T ss_pred HhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh
Confidence 8999999999999998 999 999999887 99999999999999 8887 3 67899999999999999999
Q ss_pred hhhhc---CCCCCCCCC
Q 044996 184 PALRE---LDPSSFSGN 197 (678)
Q Consensus 184 ~~~~~---l~~~~~~gn 197 (678)
.+.. +....+.+|
T Consensus 348 -~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 348 -AFGSEIKLASLNLAYN 363 (636)
T ss_dssp -CCEEEEEESEEECCSS
T ss_pred -hhCCCCCCCEEECCCC
Confidence 5543 333445555
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=8.1e-15 Score=154.93 Aligned_cols=148 Identities=22% Similarity=0.302 Sum_probs=122.2
Q ss_pred CcceEEec--C-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEE
Q 044996 36 NWNGVLCH--R-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVY 101 (678)
Q Consensus 36 ~w~gv~C~--~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~ 101 (678)
.|.|+ |+ . .+++.|+|++|++.+ ++...+..+++|+.|+|++|++++..|. +..+ ++|++|+
T Consensus 31 ~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~ 106 (353)
T 2z80_A 31 DRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL--GSLEHLD 106 (353)
T ss_dssp CTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC--TTCCEEE
T ss_pred CCCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCC--CCCCEEE
Confidence 69987 64 1 268899999999984 6655689999999999999999998774 5555 7799999
Q ss_pred cccCccccccChhhhcCCcccceeeccccccccCCch--hhcCCCCCCeEeccCCcccccC-Ccc--CCCCCcEEEeecC
Q 044996 102 LSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPE--SLTRLSRLVELRLEGNKFEGQI-PDF--QQKDLVSFNVSNN 176 (678)
Q Consensus 102 Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~--~~~~l~~L~~l~l~~N~l~g~~-p~~--~~~~l~~l~l~~N 176 (678)
|++|+++ .+|+..|.++++|++|+|++|++++ +|. .+.++++|++|++++|+..+.+ |.. ..++|+.|++++|
T Consensus 107 Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 107 LSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp CCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred CCCCcCC-cCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 9999999 5777778999999999999999995 554 7899999999999999644444 432 5678999999999
Q ss_pred cccccCchhhhcC
Q 044996 177 ALFGSISPALREL 189 (678)
Q Consensus 177 ~l~g~ip~~~~~l 189 (678)
.+++..|..+..+
T Consensus 185 ~l~~~~~~~l~~l 197 (353)
T 2z80_A 185 DLQSYEPKSLKSI 197 (353)
T ss_dssp TCCEECTTTTTTC
T ss_pred CcCccCHHHHhcc
Confidence 9999888776554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=2e-14 Score=154.03 Aligned_cols=173 Identities=15% Similarity=0.181 Sum_probs=127.8
Q ss_pred CCCCCCCCCCCCCCCCCcceEEecC------------------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCc
Q 044996 20 LANWDDRTPPCNENGANWNGVLCHR------------------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNN 81 (678)
Q Consensus 20 l~~W~~~~~~c~~~~~~w~gv~C~~------------------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~ 81 (678)
+++|....+||.. ...|.++.|+. ..+..|++.++.+. .+|...+..+++|+.|+|++|.
T Consensus 3 ~~~~~~~~~C~~~-~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~ 80 (390)
T 3o6n_A 3 VKPRQPEYKCIDS-NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQ 80 (390)
T ss_dssp ----CCEECBCC-------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSC
T ss_pred cCCCCCccceehh-hhhhccceeeeeeecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCc
Confidence 5788877676631 12354544430 24667888888776 6888889999999999999999
Q ss_pred ccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccC
Q 044996 82 LEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQI 160 (678)
Q Consensus 82 l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~ 160 (678)
+.+..+ .+..+ .+|++|+|++|++++..| ..|+++++|++|+|++|+++...+..|.++++|++|+|++|.+++..
T Consensus 81 i~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~ 157 (390)
T 3o6n_A 81 IEEIDTYAFAYA--HTIQKLYMGFNAIRYLPP-HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 157 (390)
T ss_dssp CCEECTTTTTTC--TTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred ccccChhhccCC--CCcCEEECCCCCCCcCCH-HHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence 998776 45555 789999999999996544 55899999999999999999544444699999999999999999877
Q ss_pred Ccc--CCCCCcEEEeecCcccccCchhhhcCCCCCCCCC
Q 044996 161 PDF--QQKDLVSFNVSNNALFGSISPALRELDPSSFSGN 197 (678)
Q Consensus 161 p~~--~~~~l~~l~l~~N~l~g~ip~~~~~l~~~~~~gn 197 (678)
|.. .+++|+.|++++|.+++.-...+.++....+.+|
T Consensus 158 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 158 DDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp TTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred hhhccCCCCCCEEECCCCcCCccccccccccceeecccc
Confidence 753 5689999999999998754444445544445544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.6e-14 Score=145.12 Aligned_cols=148 Identities=20% Similarity=0.218 Sum_probs=118.7
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCc-cccccChhhhcCCcccc
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNR-FSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~-l~G~ip~~~~~~l~~L~ 123 (678)
.+..|+|+++.+.+ +++..+..+++|+.|+|++|.+++..| .+..+ ++|++|+|++|. ++ .+++..|..+++|+
T Consensus 33 ~l~~L~l~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~~l~-~~~~~~~~~l~~L~ 108 (285)
T 1ozn_A 33 ASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGL--ALLEQLDLSDNAQLR-SVDPATFHGLGRLH 108 (285)
T ss_dssp TCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC--TTCCEEECCSCTTCC-CCCTTTTTTCTTCC
T ss_pred CceEEEeeCCcCCc-cCHHHcccCCCCCEEECCCCccceeCHhhcCCc--cCCCEEeCCCCCCcc-ccCHHHhcCCcCCC
Confidence 58899999999985 555568999999999999999998766 35555 779999999998 65 56445589999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhc---CCCCCCCCC
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGN 197 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn 197 (678)
+|+|++|.+++..|..+.++++|++|+|++|.+++..+.. ..++|+.|+|++|++++..+..+.. +....+.+|
T Consensus 109 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 187 (285)
T 1ozn_A 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187 (285)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCC
Confidence 9999999999888889999999999999999998665542 5778999999999998655544443 333345555
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.53 E-value=8.9e-15 Score=151.30 Aligned_cols=149 Identities=17% Similarity=0.214 Sum_probs=112.5
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCccccc--CC-cccccCCCCccEE
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGP--MP-DLRQLGNGALRSV 100 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~--~p-~~~~~~~~~L~~L 100 (678)
|.|.+|.|+. .+++.|+|++|.+. .+|...+..+++|+.|+|++|.++.. +| .+..+ .+|++|
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~--~~L~~L 83 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT--TSLKYL 83 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSC--SCCCEE
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccc--cccCEE
Confidence 5899999963 26889999999998 78877789999999999999998843 23 23333 668888
Q ss_pred EcccCccccccChhhhcCCcccceeeccccccccCCc-hhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCc
Q 044996 101 YLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIP-ESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNA 177 (678)
Q Consensus 101 ~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~ 177 (678)
+|++|.++ .+|.. +..+++|++|+|++|++++..+ ..+..+++|++|+|++|.+++.+|.. ...+|+.|++++|.
T Consensus 84 ~Ls~n~i~-~l~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 161 (306)
T 2z66_A 84 DLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161 (306)
T ss_dssp ECCSCSEE-EEEEE-EETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred ECCCCccc-cChhh-cCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence 88888887 56665 7778888888888888876554 56777888888888888887776653 45678888888888
Q ss_pred ccc-cCchhhhc
Q 044996 178 LFG-SISPALRE 188 (678)
Q Consensus 178 l~g-~ip~~~~~ 188 (678)
+++ .+|..+..
T Consensus 162 l~~~~~~~~~~~ 173 (306)
T 2z66_A 162 FQENFLPDIFTE 173 (306)
T ss_dssp EGGGEECSCCTT
T ss_pred cccccchhHHhh
Confidence 776 45554443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.5e-14 Score=145.60 Aligned_cols=155 Identities=19% Similarity=0.254 Sum_probs=98.3
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.++..|+|++|.+.+ +++..+..+++|+.|+|++|.+.+..|. +..+ ++|++|+|++|++++ +++..|+++++|+
T Consensus 52 ~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~-~~~~~~~~l~~L~ 127 (276)
T 2z62_A 52 PELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL--SSLQKLVAVETNLAS-LENFPIGHLKTLK 127 (276)
T ss_dssp TTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC--TTCCEEECTTSCCCC-STTCCCTTCTTCC
T ss_pred cCCcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhcCC--ccccEEECCCCCccc-cCchhcccCCCCC
Confidence 357777777777763 4444567777777777777777766553 3344 557777777777764 3332366667777
Q ss_pred eeecccccccc-CCchhhcCCCCCCeEeccCCcccccCCc-----------------------------cCCCCCcEEEe
Q 044996 124 KLLLADNQFNG-PIPESLTRLSRLVELRLEGNKFEGQIPD-----------------------------FQQKDLVSFNV 173 (678)
Q Consensus 124 ~l~l~~N~~~g-~~p~~~~~l~~L~~l~l~~N~l~g~~p~-----------------------------~~~~~l~~l~l 173 (678)
+|+|++|++++ .+|..++++++|++|+|++|.+++..+. +...+|+.|+|
T Consensus 128 ~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L 207 (276)
T 2z62_A 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELAL 207 (276)
T ss_dssp EEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEEC
T ss_pred EEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEEC
Confidence 77777777665 3566666677777777777666654322 12236778888
Q ss_pred ecCcccccCchhhh---cCCCCCCCCCCCCCCC
Q 044996 174 SNNALFGSISPALR---ELDPSSFSGNRDLCGE 203 (678)
Q Consensus 174 ~~N~l~g~ip~~~~---~l~~~~~~gn~~lc~~ 203 (678)
++|++++..+..+. ++....+.+|++.|..
T Consensus 208 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 208 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp CSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred CCCceeecCHhHhcccccccEEEccCCcccccC
Confidence 88888765443333 3445568888887754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=3.1e-14 Score=155.74 Aligned_cols=157 Identities=19% Similarity=0.204 Sum_probs=123.0
Q ss_pred CcEEEEEeCCCCceeecChHHhh--------------------------------------cCCCCCEEEccCCcccccC
Q 044996 45 GKIWGLKLEDMGLQGNIDITILK--------------------------------------ELREMRTLSLMRNNLEGPM 86 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~--------------------------------------~l~~L~~L~Ls~N~l~g~~ 86 (678)
.++..|+|++|.+.+.+|..... ..++|+.|+|++|.+.+.+
T Consensus 212 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 291 (455)
T 3v47_A 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALL 291 (455)
T ss_dssp CEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEEC
T ss_pred ceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccc
Confidence 46888999999887766543211 1257889999999999887
Q ss_pred Cc-ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--
Q 044996 87 PD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF-- 163 (678)
Q Consensus 87 p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-- 163 (678)
|. +..+ ++|+.|+|++|++++..|.. |.++++|++|+|++|.+++..|..+.++++|++|+|++|.+++..|..
T Consensus 292 ~~~~~~l--~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 368 (455)
T 3v47_A 292 KSVFSHF--TDLEQLTLAQNEINKIDDNA-FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368 (455)
T ss_dssp TTTTTTC--TTCCEEECTTSCCCEECTTT-TTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred hhhcccC--CCCCEEECCCCcccccChhH-hcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcc
Confidence 74 4445 67999999999999766654 889999999999999999888889999999999999999998887763
Q ss_pred CCCCCcEEEeecCcccccCchhhh---cCCCCCCCCCCCCCCCC
Q 044996 164 QQKDLVSFNVSNNALFGSISPALR---ELDPSSFSGNRDLCGEP 204 (678)
Q Consensus 164 ~~~~l~~l~l~~N~l~g~ip~~~~---~l~~~~~~gn~~lc~~~ 204 (678)
.+++|+.|+|++|+|++..+..+. ++....+.+|+..|..+
T Consensus 369 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 369 GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 568899999999999875444433 45556788888877543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.2e-14 Score=154.16 Aligned_cols=155 Identities=22% Similarity=0.240 Sum_probs=110.9
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-cccc-----------------------CCCCccEEE
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQL-----------------------GNGALRSVY 101 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~-----------------------~~~~L~~L~ 101 (678)
++..|+|++|.+. .+++..+..|++|+.|+|++|.+.+..+. +..+ ..++|++|+
T Consensus 113 ~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 191 (440)
T 3zyj_A 113 NLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191 (440)
T ss_dssp SCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEE
T ss_pred cCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeec
Confidence 5777888888877 55555677777888888888777654431 1111 114567777
Q ss_pred cccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCccc
Q 044996 102 LSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALF 179 (678)
Q Consensus 102 Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~ 179 (678)
|++|+|+ .+|. +..+++|+.|+|++|++++..|..|.++++|+.|+|++|.+++..|.. .+.+|+.|+|++|+|+
T Consensus 192 L~~n~l~-~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 268 (440)
T 3zyj_A 192 LAMCNLR-EIPN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268 (440)
T ss_dssp CTTSCCS-SCCC--CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC
T ss_pred CCCCcCc-cccc--cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC
Confidence 7777776 5662 667777888888888888777888888888888888888888766653 5678999999999998
Q ss_pred ccCchhhh---cCCCCCCCCCCCCCCCC
Q 044996 180 GSISPALR---ELDPSSFSGNRDLCGEP 204 (678)
Q Consensus 180 g~ip~~~~---~l~~~~~~gn~~lc~~~ 204 (678)
+..+..+. ++....+.+|++.|.+.
T Consensus 269 ~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 269 LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 75555444 44556789999988653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.51 E-value=5e-14 Score=144.49 Aligned_cols=143 Identities=17% Similarity=0.151 Sum_probs=104.3
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.++..+++++++|. .+|..+ .+.|+.|+|++|.+++..|. +..+ ++|++|+|++|+|++ +|. .+.+++|+
T Consensus 10 ~~l~~l~~~~~~l~-~ip~~~---~~~l~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~n~l~~-~~~--~~~l~~L~ 80 (290)
T 1p9a_G 10 ASHLEVNCDKRNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPY--TRLTQLNLDRAELTK-LQV--DGTLPVLG 80 (290)
T ss_dssp TTCCEEECTTSCCS-SCCSCC---CTTCCEEECTTSCCSEEEGGGGTTC--TTCCEEECTTSCCCE-EEC--CSCCTTCC
T ss_pred CCccEEECCCCCCC-cCCCCC---CCCCCEEEcCCCcCCccCHHHhhcC--CCCCEEECCCCccCc-ccC--CCCCCcCC
Confidence 46888999999998 677543 37899999999999987663 4445 678888888888884 553 36778888
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhh---cCCCCCCCCC
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALR---ELDPSSFSGN 197 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~---~l~~~~~~gn 197 (678)
+|+|++|+++ .+|..+..+++|++|+|++|+|++..|.. .+.+|+.|+|++|+|++..+..+. ++....+.+|
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 8888888887 67777788888888888888887655542 566788888888888765444333 3333445555
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.1e-14 Score=155.83 Aligned_cols=150 Identities=23% Similarity=0.260 Sum_probs=128.1
Q ss_pred CcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcc
Q 044996 36 NWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLS 103 (678)
Q Consensus 36 ~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls 103 (678)
.|..|.|.. ..+..|+|++|.+.+-. +..|..+++|+.|+|++|.+++..|. +..+ .+|++|+|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~L~ 88 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLN-QDEFASFPHLEELELNENIVSAVEPGAFNNL--FNLRTLGLR 88 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEEC-TTTTTTCTTCCEEECTTSCCCEECTTTTTTC--TTCCEEECC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceEC-HhHccCCCCCCEEECCCCccCEeChhhhhCC--ccCCEEECC
Confidence 478899963 25789999999999644 45699999999999999999998773 5555 789999999
Q ss_pred cCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCccccc
Q 044996 104 NNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 104 ~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ 181 (678)
+|+++ .+|...|.++++|++|+|++|++++..|..|.++++|+.|+|++|.+++..|.. .+.+|+.|+|++|.+++.
T Consensus 89 ~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 167 (477)
T 2id5_A 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167 (477)
T ss_dssp SSCCC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred CCcCC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence 99999 677777899999999999999999999999999999999999999999877753 568999999999999875
Q ss_pred CchhhhcC
Q 044996 182 ISPALREL 189 (678)
Q Consensus 182 ip~~~~~l 189 (678)
.+..+..+
T Consensus 168 ~~~~l~~l 175 (477)
T 2id5_A 168 PTEALSHL 175 (477)
T ss_dssp CHHHHTTC
T ss_pred ChhHhccc
Confidence 55555443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.51 E-value=8.6e-15 Score=134.32 Aligned_cols=124 Identities=23% Similarity=0.273 Sum_probs=75.2
Q ss_pred cEEEEEeCCCCce-eecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 46 KIWGLKLEDMGLQ-GNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 46 ~v~~l~l~~~~l~-g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
+++.|+|++|.+. |.+|. .+..+++|+.|+|++|.+++. +.+..+ ++|++|+|++|++++.+|.. +..+++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l--~~L~~L~Ls~n~i~~~~~~~-~~~l~~L~~ 92 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI-ANLPKL--NKLKKLELSDNRVSGGLEVL-AEKCPNLTH 92 (149)
T ss_dssp GCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC-TTCCCC--TTCCEEECCSSCCCSCTHHH-HHHCTTCCE
T ss_pred cCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc-hhhhcC--CCCCEEECCCCcccchHHHH-hhhCCCCCE
Confidence 4566666666666 56654 456666666666666666654 444444 55666666666666555543 555666666
Q ss_pred eeccccccccC-CchhhcCCCCCCeEeccCCcccccCC---c--cCCCCCcEEEee
Q 044996 125 LLLADNQFNGP-IPESLTRLSRLVELRLEGNKFEGQIP---D--FQQKDLVSFNVS 174 (678)
Q Consensus 125 l~l~~N~~~g~-~p~~~~~l~~L~~l~l~~N~l~g~~p---~--~~~~~l~~l~l~ 174 (678)
|+|++|.+++. .|..+..+++|++|++++|.+++..+ . ..+++|+.|+++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 66666666652 34566666666666666666665544 1 134566666554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.6e-14 Score=137.76 Aligned_cols=147 Identities=12% Similarity=0.195 Sum_probs=116.6
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.+++.|+|+++++. .++ .+..+++|+.|+|++|.+.. ++.+..+ ++|++|+|++|++++..|.. |+.+++|++
T Consensus 44 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~~-~~~l~~l--~~L~~L~l~~n~l~~~~~~~-l~~l~~L~~ 116 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHATN-YNPISGL--SNLERLRIMGKDVTSDKIPN-LSGLTSLTL 116 (197)
T ss_dssp HTCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCSC-CGGGTTC--TTCCEEEEECTTCBGGGSCC-CTTCTTCCE
T ss_pred CCccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCCc-chhhhcC--CCCCEEEeECCccCcccChh-hcCCCCCCE
Confidence 35889999999988 676 38889999999999997653 3455555 77999999999999877766 899999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc-CCCCCcEEEeecCcccccCc-hhhhcCCCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGSIS-PALRELDPSSFSGNR 198 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ip-~~~~~l~~~~~~gn~ 198 (678)
|+|++|++++..|..++.+++|++|+|++|.+.+.+|.. .+++|+.|++++|.+++..+ ..+.++....+.+|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcc
Confidence 999999999989999999999999999999866677754 67889999999999987321 122333444455553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.1e-14 Score=163.56 Aligned_cols=157 Identities=18% Similarity=0.225 Sum_probs=130.0
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCccccee
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l 125 (678)
.+..+++..+++.+..+...+..++.|+.++++.|.+.+..|.... ..+.|+.|+|++|++.+.++++.|..+++|++|
T Consensus 421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~-~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L 499 (635)
T 4g8a_A 421 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN-GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 499 (635)
T ss_dssp TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTT-TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccccccc-cchhhhhhhhhhcccccccCchhhhhccccCEE
Confidence 4556666666666555555688899999999999999998875322 227799999999987655554569999999999
Q ss_pred eccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhcC----CCCCCCCCCC
Q 044996 126 LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALREL----DPSSFSGNRD 199 (678)
Q Consensus 126 ~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~l----~~~~~~gn~~ 199 (678)
+|++|++++.+|..|.++++|++|+|++|+|++..|.. .+++|+.|+|++|+|++..|..+..+ ....+.+||+
T Consensus 500 ~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~ 579 (635)
T 4g8a_A 500 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 579 (635)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence 99999999999999999999999999999999877763 57899999999999999999887654 4457999999
Q ss_pred CCCC
Q 044996 200 LCGE 203 (678)
Q Consensus 200 lc~~ 203 (678)
.|.+
T Consensus 580 ~C~C 583 (635)
T 4g8a_A 580 ACTC 583 (635)
T ss_dssp CCSG
T ss_pred cccC
Confidence 9964
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.7e-14 Score=135.27 Aligned_cols=130 Identities=22% Similarity=0.224 Sum_probs=102.8
Q ss_pred CcEEEEEeCCCCce-eecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQ-GNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~-g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.+++.|+|++|.+. |.+|. .+..+++|+.|+|++|.+++. +.+..+ ++|++|+|++|++++.+|.. +.++++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l--~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~ 98 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV-SNLPKL--PKLKKLELSENRIFGGLDML-AEKLPNLT 98 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC-SSCCCC--SSCCEEEEESCCCCSCCCHH-HHHCTTCC
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh-hhhccC--CCCCEEECcCCcCchHHHHH-HhhCCCCC
Confidence 46888888888887 77875 367888899999999988876 655555 67889999999988777754 77788999
Q ss_pred eeeccccccccC-CchhhcCCCCCCeEeccCCcccccCC----c-cCCCCCcEEEeecCccc
Q 044996 124 KLLLADNQFNGP-IPESLTRLSRLVELRLEGNKFEGQIP----D-FQQKDLVSFNVSNNALF 179 (678)
Q Consensus 124 ~l~l~~N~~~g~-~p~~~~~l~~L~~l~l~~N~l~g~~p----~-~~~~~l~~l~l~~N~l~ 179 (678)
+|+|++|.+++. .+..+..+++|++|+|++|.+++..+ . ..+++|+.|++++|.+.
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 999999988863 23678888899999999998886655 2 25678888888888774
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.6e-14 Score=162.31 Aligned_cols=135 Identities=18% Similarity=0.241 Sum_probs=80.9
Q ss_pred hhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccc-cCh-hhhcCCcccceeeccccccccCCchhhcC
Q 044996 66 LKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGE-IPT-DAFDGMTSLRKLLLADNQFNGPIPESLTR 142 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~-ip~-~~~~~l~~L~~l~l~~N~~~g~~p~~~~~ 142 (678)
+..+++|+.|+|++|.+.+.+|. +..+ ++|+.|+|++|.+++. +|. ..+..+++|+.|+|++|++++..|..|..
T Consensus 421 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 498 (606)
T 3t6q_A 421 FQNLHLLKVLNLSHSLLDISSEQLFDGL--PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498 (606)
T ss_dssp TTTCTTCCEEECTTCCCBTTCTTTTTTC--TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTT
T ss_pred hhCcccCCEEECCCCccCCcCHHHHhCC--CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhcc
Confidence 44444444444444444444442 2222 4566666666666542 211 23566666667777777776666667777
Q ss_pred CCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhh---hcCCCCCCCCCCCCCCC
Q 044996 143 LSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPAL---RELDPSSFSGNRDLCGE 203 (678)
Q Consensus 143 l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~---~~l~~~~~~gn~~lc~~ 203 (678)
+++|++|+|++|++++.+|.. .++.| .|++++|++++.+|..+ .++....+.+|++.|.+
T Consensus 499 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 499 LKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp CTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred ccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 777777777777777666653 45566 77777777776666543 34556678888887743
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.50 E-value=5.9e-14 Score=153.54 Aligned_cols=155 Identities=21% Similarity=0.207 Sum_probs=116.0
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-cccc-----------------------CCCCccEEE
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQL-----------------------GNGALRSVY 101 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~-----------------------~~~~L~~L~ 101 (678)
++..|+|++|.+. .+++..+..|++|+.|+|++|++.+..+. +..+ ...+|++|+
T Consensus 124 ~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 202 (452)
T 3zyi_A 124 SLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202 (452)
T ss_dssp TCCEEECCSSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEE
T ss_pred cCCEEECCCCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEE
Confidence 5778888888887 55556677888888888888887754431 1111 115677777
Q ss_pred cccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCccc
Q 044996 102 LSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALF 179 (678)
Q Consensus 102 Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~ 179 (678)
|++|+|+ .+| . +..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|.. .+.+|+.|+|++|+|+
T Consensus 203 L~~n~l~-~~~-~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 279 (452)
T 3zyi_A 203 LGMCNIK-DMP-N-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279 (452)
T ss_dssp CTTSCCS-SCC-C-CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCccc-ccc-c-ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCC
Confidence 7777777 355 3 677888888888888888888888999999999999999998877763 5678999999999998
Q ss_pred ccCchhhh---cCCCCCCCCCCCCCCCC
Q 044996 180 GSISPALR---ELDPSSFSGNRDLCGEP 204 (678)
Q Consensus 180 g~ip~~~~---~l~~~~~~gn~~lc~~~ 204 (678)
+..+..+. ++....+.+|++.|.+.
T Consensus 280 ~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 280 SLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred ccChHHhccccCCCEEEccCCCcCCCCC
Confidence 65554443 45566789999988653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=5e-14 Score=143.37 Aligned_cols=139 Identities=21% Similarity=0.304 Sum_probs=118.9
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++.|+|++|.+.+ +++..+..+++|+.|+|++|++.+..+ .+..+ ++|++|+|++|++++..| ..|.++++|++
T Consensus 29 ~l~~L~ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~ 104 (276)
T 2z62_A 29 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSL--SHLSTLILTGNPIQSLAL-GAFSGLSSLQK 104 (276)
T ss_dssp TCCEEECTTCCCCE-ECTTTTTTCTTCSEEECTTCCCCEECTTTTTTC--TTCCEEECTTCCCCEECT-TTTTTCTTCCE
T ss_pred CccEEECCCCcccc-cCHhHhccccCCcEEECCCCcCCccCHHHccCC--cCCCEEECCCCccCccCh-hhhcCCccccE
Confidence 58899999999985 444568999999999999999998776 35555 789999999999996555 45999999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccc-cCCcc--CCCCCcEEEeecCcccccCchhhhc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG-QIPDF--QQKDLVSFNVSNNALFGSISPALRE 188 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~ 188 (678)
|+|++|++++..+..++++++|++|+|++|.+++ .+|.. .+++|+.|++++|++++..+..+..
T Consensus 105 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 171 (276)
T 2z62_A 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171 (276)
T ss_dssp EECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH
T ss_pred EECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhh
Confidence 9999999998888789999999999999999987 46763 5689999999999999876665543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=3e-14 Score=168.04 Aligned_cols=150 Identities=19% Similarity=0.145 Sum_probs=125.9
Q ss_pred CCCcceEEecCCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC--cccccCCCCccEEEcccCcccccc
Q 044996 34 GANWNGVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP--DLRQLGNGALRSVYLSNNRFSGEI 111 (678)
Q Consensus 34 ~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~L~~L~Ls~N~l~G~i 111 (678)
.++|..|.+-..+++.|+|++|.+++-.+ ..+.+|++|+.|+|++|.+.+.++ .+..+ ++|++|+|++|++++..
T Consensus 13 ~~~L~~vP~lp~~l~~LdLs~N~i~~i~~-~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L--~~L~~L~Ls~N~l~~~~ 89 (844)
T 3j0a_A 13 FCNLTQVPQVLNTTERLLLSFNYIRTVTA-SSFPFLEQLQLLELGSQYTPLTIDKEAFRNL--PNLRILDLGSSKIYFLH 89 (844)
T ss_dssp CCCSSCCCSSCTTCCEEEEESCCCCEECS-SSCSSCCSCSEEEECTTCCCCEECTTTTSSC--TTCCEEECTTCCCCEEC
T ss_pred CCCCCCCCCCCCCcCEEECCCCcCCccCh-hHCcccccCeEEeCCCCCCccccCHHHhcCC--CCCCEEECCCCcCcccC
Confidence 34677777745789999999999986555 458999999999999998888774 35555 77999999999999777
Q ss_pred ChhhhcCCcccceeeccccccccCCchh--hcCCCCCCeEeccCCcccccCCc---cCCCCCcEEEeecCcccccCchhh
Q 044996 112 PTDAFDGMTSLRKLLLADNQFNGPIPES--LTRLSRLVELRLEGNKFEGQIPD---FQQKDLVSFNVSNNALFGSISPAL 186 (678)
Q Consensus 112 p~~~~~~l~~L~~l~l~~N~~~g~~p~~--~~~l~~L~~l~l~~N~l~g~~p~---~~~~~l~~l~l~~N~l~g~ip~~~ 186 (678)
|.. |+++++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..|. ..+++|+.|+|++|.+++..|..+
T Consensus 90 p~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l 168 (844)
T 3j0a_A 90 PDA-FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL 168 (844)
T ss_dssp TTS-SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGG
T ss_pred HhH-ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHc
Confidence 755 899999999999999999988776 89999999999999999987664 267899999999999998888765
Q ss_pred h
Q 044996 187 R 187 (678)
Q Consensus 187 ~ 187 (678)
.
T Consensus 169 ~ 169 (844)
T 3j0a_A 169 E 169 (844)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.4e-14 Score=150.41 Aligned_cols=148 Identities=22% Similarity=0.179 Sum_probs=100.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcC-----CCCCEEEccCCcccccCC-cccccCCCCccEEEcccCcccccc--Chh-h
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKEL-----REMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEI--PTD-A 115 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l-----~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~i--p~~-~ 115 (678)
.++..|+|++|.+.+. | ..+..+ ++|+.|+|++|++.+..| .+..+ ++|++|+|++|++.|.+ |.. .
T Consensus 121 ~~L~~L~Ls~N~l~~~-~-~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~~ 196 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-D-AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF--PALSTLDLSDNPELGERGLISALC 196 (312)
T ss_dssp CCCSEEEEESCBCSSS-S-SHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC--SSCCEEECCSCTTCHHHHHHHHSC
T ss_pred CCccEEEccCCCCcch-h-HHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC--CCCCEEECCCCCcCcchHHHHHHH
Confidence 4677888888888765 4 345555 788888888888877765 34444 66888888888877663 333 1
Q ss_pred hcCCcccceeecccccccc--CCch-hhcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEeecCcccccCchhhh-c
Q 044996 116 FDGMTSLRKLLLADNQFNG--PIPE-SLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNNALFGSISPALR-E 188 (678)
Q Consensus 116 ~~~l~~L~~l~l~~N~~~g--~~p~-~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N~l~g~ip~~~~-~ 188 (678)
+.++++|++|+|++|++++ .++. .+.++++|++|+|++|.|++.+|.. ...+|+.|+|++|.|+ .+|..+. +
T Consensus 197 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~ 275 (312)
T 1wwl_A 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAK 275 (312)
T ss_dssp TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSE
T ss_pred hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCC
Confidence 2777888888888888873 3333 3457788888888888888766532 3467888888888887 6666543 3
Q ss_pred CCCCCCCCC
Q 044996 189 LDPSSFSGN 197 (678)
Q Consensus 189 l~~~~~~gn 197 (678)
+....+.+|
T Consensus 276 L~~L~Ls~N 284 (312)
T 1wwl_A 276 LSVLDLSYN 284 (312)
T ss_dssp EEEEECCSS
T ss_pred ceEEECCCC
Confidence 333344444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.3e-14 Score=169.29 Aligned_cols=147 Identities=20% Similarity=0.319 Sum_probs=127.2
Q ss_pred CcEEEEEeCCCCcee-----------------ecChHHhh--cCCCCCEEEccCCcccccCCc-ccccCCCCccEEEccc
Q 044996 45 GKIWGLKLEDMGLQG-----------------NIDITILK--ELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSN 104 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g-----------------~~~~~~l~--~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~ 104 (678)
.++..|+|++|.|+| .+|.. ++ +|++|+.|+|++|++.|.+|. +..+ ++|+.|+|++
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L--~~L~~L~Ls~ 524 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVELYNCPNMTQLPDFLYDL--PELQSLNIAC 524 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEESCTTCCSCCGGGGGC--SSCCEEECTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEECcCCCCCccChHHHhCC--CCCCEEECcC
Confidence 579999999999998 48865 55 999999999999999999994 6666 7899999999
Q ss_pred Cc-ccc-ccChhhhcCCc-------ccceeeccccccccCCch--hhcCCCCCCeEeccCCcccccCCcc-CCCCCcEEE
Q 044996 105 NR-FSG-EIPTDAFDGMT-------SLRKLLLADNQFNGPIPE--SLTRLSRLVELRLEGNKFEGQIPDF-QQKDLVSFN 172 (678)
Q Consensus 105 N~-l~G-~ip~~~~~~l~-------~L~~l~l~~N~~~g~~p~--~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~l~~l~ 172 (678)
|+ |+| .||.. +++++ +|+.|+|++|+|+ .+|. .|+++++|+.|+|++|.|+ .+|.+ .+++|+.|+
T Consensus 525 N~~lsg~~iP~~-i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~ 601 (876)
T 4ecn_A 525 NRGISAAQLKAD-WTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLK 601 (876)
T ss_dssp CTTSCHHHHHHH-HHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEE
T ss_pred CCCcccccchHH-HHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEE
Confidence 98 999 99976 66665 9999999999999 8999 9999999999999999999 88854 567899999
Q ss_pred eecCcccccCchhhhcCC----CCCCCCCC
Q 044996 173 VSNNALFGSISPALRELD----PSSFSGNR 198 (678)
Q Consensus 173 l~~N~l~g~ip~~~~~l~----~~~~~gn~ 198 (678)
|++|+++ .+|..+..+. ...+.+|.
T Consensus 602 Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 630 (876)
T 4ecn_A 602 LDYNQIE-EIPEDFCAFTDQVEGLGFSHNK 630 (876)
T ss_dssp CCSSCCS-CCCTTSCEECTTCCEEECCSSC
T ss_pred CcCCccc-cchHHHhhccccCCEEECcCCC
Confidence 9999999 8998776544 34566664
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.4e-14 Score=159.90 Aligned_cols=152 Identities=20% Similarity=0.222 Sum_probs=125.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCccccc--CC-cccccCCCCccEEEcccCccccccChhhhcCCcc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGP--MP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~--~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~ 121 (678)
.++..|+|++|.+.+.+|. .+..+++|+.|+|++|++++. +| .+..+ ++|+.|+|++|++++.+|...|..+++
T Consensus 353 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l--~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNM--SSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp CCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTC--TTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred CCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCC--CCCCEEECCCCcCCCccChhhhcCccc
Confidence 5688999999999987764 588999999999999999873 33 24455 779999999999998899877889999
Q ss_pred cceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchh-hh---cCCCCCCC
Q 044996 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA-LR---ELDPSSFS 195 (678)
Q Consensus 122 L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~-~~---~l~~~~~~ 195 (678)
|+.|+|++|++++.+|..+. ++|++|+|++|+|+ .+|.. .+++|+.|+|++|+|+ .+|.. +. ++....+.
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~ 505 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECC
T ss_pred CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEec
Confidence 99999999999988887665 78999999999998 67763 6789999999999998 57765 44 44556789
Q ss_pred CCCCCCCC
Q 044996 196 GNRDLCGE 203 (678)
Q Consensus 196 gn~~lc~~ 203 (678)
+|++.|.+
T Consensus 506 ~N~~~c~c 513 (562)
T 3a79_B 506 DNPWDCTC 513 (562)
T ss_dssp SCCBCCCH
T ss_pred CCCcCCCc
Confidence 99988853
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.9e-14 Score=157.30 Aligned_cols=148 Identities=22% Similarity=0.181 Sum_probs=94.1
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc--cccc-------------CCCCccEEEcccCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD--LRQL-------------GNGALRSVYLSNNRFSG 109 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~-------------~~~~L~~L~Ls~N~l~G 109 (678)
.++..|+|++|.+.+..| +..+++|+.|+|++|.|++..+. +..+ ..++|+.|+|++|.|++
T Consensus 58 ~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~ 134 (487)
T 3oja_A 58 TKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (487)
T ss_dssp TTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCS
T ss_pred CCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCC
Confidence 346666666666665443 55566666666666665543210 0000 01456777777777776
Q ss_pred ccChhhhcCCcccceeeccccccccCCchhhc-CCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCchhhhc
Q 044996 110 EIPTDAFDGMTSLRKLLLADNQFNGPIPESLT-RLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALRE 188 (678)
Q Consensus 110 ~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~ 188 (678)
..|.. |+++++|+.|+|++|.|++.+|..+. .+++|+.|+|++|.|++..+...+++|+.|+|++|.|++..| .+..
T Consensus 135 ~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~ 212 (487)
T 3oja_A 135 LRDLD-EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGP-EFQS 212 (487)
T ss_dssp GGGBC-GGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECG-GGGG
T ss_pred CCchh-hcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCCCH-hHcC
Confidence 55544 77788888888888888887777775 678888888888888776555567788888888888877433 3443
Q ss_pred ---CCCCCCCCC
Q 044996 189 ---LDPSSFSGN 197 (678)
Q Consensus 189 ---l~~~~~~gn 197 (678)
|....+.+|
T Consensus 213 l~~L~~L~Ls~N 224 (487)
T 3oja_A 213 AAGVTWISLRNN 224 (487)
T ss_dssp GTTCSEEECTTS
T ss_pred CCCccEEEecCC
Confidence 333345555
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.7e-14 Score=159.06 Aligned_cols=151 Identities=24% Similarity=0.267 Sum_probs=99.5
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccc--cCCc-ccccCCCCccEEEcccCccccccChhhhcCCcc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEG--PMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g--~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~ 121 (678)
..+..|+|++|.+.+.+|. .+..+++|+.|+|++|++++ .+|. +..+ ++|++|+|++|++++.+|...|..+++
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l--~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQM--KSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp CCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTC--TTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred CcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhC--CCCCEEECCCCcCCcccccchhccCcc
Confidence 3466677777777665553 36667777777777777765 3442 3344 567777777777776677655667777
Q ss_pred cceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchh-hh---cCCCCCCC
Q 044996 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA-LR---ELDPSSFS 195 (678)
Q Consensus 122 L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~-~~---~l~~~~~~ 195 (678)
|+.|+|++|++++.+|..+. ++|+.|+|++|+++ .+|.. .+++|+.|+|++|+|+ .+|.. +. ++....+.
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~ 476 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLH 476 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECc
Confidence 77777777777776666554 67777777777777 66652 5667777778777777 46654 43 33445677
Q ss_pred CCCCCCC
Q 044996 196 GNRDLCG 202 (678)
Q Consensus 196 gn~~lc~ 202 (678)
+|+..|.
T Consensus 477 ~N~~~c~ 483 (520)
T 2z7x_B 477 TNPWDCS 483 (520)
T ss_dssp SSCBCCC
T ss_pred CCCCccc
Confidence 7777664
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=150.94 Aligned_cols=140 Identities=23% Similarity=0.300 Sum_probs=102.3
Q ss_pred CcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcc
Q 044996 36 NWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLS 103 (678)
Q Consensus 36 ~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls 103 (678)
.|..|.|.. .++..|+|++|++.+-.+ ..|.+|++|+.|+|++|++++..|. +..+ ++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l--~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQA-DTFRHLHHLEVLQLGRNSIRQIEVGAFNGL--ASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTC--TTCCEEECC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECH-HHcCCCCCCCEEECCCCccCCcChhhccCc--ccCCEEECC
Confidence 467899963 258899999999986544 5689999999999999999987763 4445 679999999
Q ss_pred cCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEeecCccc
Q 044996 104 NNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNNALF 179 (678)
Q Consensus 104 ~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N~l~ 179 (678)
+|+|+ .+|+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|+..+.+|.. .+.+|+.|+|++|+++
T Consensus 132 ~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 209 (452)
T 3zyi_A 132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209 (452)
T ss_dssp SSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred CCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence 99998 566666888999999999999888666656666666666666665544454432 3344445555544444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=6.5e-14 Score=161.36 Aligned_cols=138 Identities=21% Similarity=0.258 Sum_probs=120.0
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.+++.|+|++|.+.+ +++..+.++++|+.|+|++|.+++..|. +..+ ++|++|+|++|+++ .+|+..|+++++|+
T Consensus 25 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~-~l~~~~~~~l~~L~ 100 (680)
T 1ziw_A 25 TNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKL--PMLKVLNLQHNELS-QLSDKTFAFCTNLT 100 (680)
T ss_dssp TTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHC--TTCCEEECCSSCCC-CCCTTTTTTCTTCS
T ss_pred CCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcc--cCcCEEECCCCccC-ccChhhhccCCCCC
Confidence 368999999999985 5666799999999999999999998885 4556 77999999999999 67776699999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhh
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPAL 186 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~ 186 (678)
+|+|++|++++..|..|+++++|++|+|++|.+++..|.. .+++|+.|++++|.+++..|..+
T Consensus 101 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 165 (680)
T 1ziw_A 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165 (680)
T ss_dssp EEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHH
T ss_pred EEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHh
Confidence 9999999999888889999999999999999999887764 67899999999999988777654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=6.9e-14 Score=158.83 Aligned_cols=140 Identities=20% Similarity=0.237 Sum_probs=122.3
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.+++.|+|++|.+.+-. +..+.++++|+.|+|++|++++..|. +..+ .+|++|+|++|++++..|.. |+++++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l--~~L~~L~Ls~n~l~~~~p~~-~~~l~~L~ 107 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILK-SYSFSNFSELQWLDLSRCEIETIEDKAWHGL--HHLSNLILTGNPIQSFSPGS-FSGLTSLE 107 (606)
T ss_dssp TTCCEEECTTSCCCEEC-TTTTTTCTTCCEEECTTCCCCEECTTTTTTC--TTCCEEECTTCCCCCCCTTS-STTCTTCC
T ss_pred CCcCEEECCCCCcCEeC-hhhccCCccCcEEeCCCCcccccCHHHhhch--hhcCEeECCCCcccccChhh-cCCcccCC
Confidence 46899999999998544 45699999999999999999998774 5556 78999999999999766755 99999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccc-cCCcc--CCCCCcEEEeecCcccccCchhhhc
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG-QIPDF--QQKDLVSFNVSNNALFGSISPALRE 188 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~ 188 (678)
+|+|++|.+++..|..++++++|++|+|++|.+++ .+|.. .+++|+.|++++|++++..|..+..
T Consensus 108 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 175 (606)
T 3vq2_A 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175 (606)
T ss_dssp EEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHH
T ss_pred EEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhh
Confidence 99999999998888899999999999999999986 67874 6789999999999999987766543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-13 Score=132.50 Aligned_cols=124 Identities=27% Similarity=0.405 Sum_probs=101.4
Q ss_pred EEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccceeecc
Q 044996 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLA 128 (678)
Q Consensus 50 l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~ 128 (678)
+++++++|. .+|..+ .++|+.|+|++|+|+ .+| .+..+ .+|+.|+|++|+|++ +++..|.++++|+.|+|+
T Consensus 15 l~~~~~~l~-~ip~~~---~~~l~~L~L~~n~i~-~ip~~~~~l--~~L~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~Ls 86 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGI---PRDVTELYLDGNQFT-LVPKELSNY--KHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILS 86 (193)
T ss_dssp EECTTSCCS-SCCSCC---CTTCCEEECCSSCCC-SCCGGGGGC--TTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECC
T ss_pred EEcCCCCCC-cCCCCC---CCCCCEEECCCCcCc-hhHHHhhcc--cCCCEEECCCCcCCE-eCHhHccCCCCCCEEECC
Confidence 455666666 666432 368999999999998 455 45555 779999999999995 555569999999999999
Q ss_pred ccccccCCchhhcCCCCCCeEeccCCcccccCCc-c-CCCCCcEEEeecCccccc
Q 044996 129 DNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-F-QQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 129 ~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~-~~~~l~~l~l~~N~l~g~ 181 (678)
+|++++..|..|..+++|++|+|++|.|++..+. + .+.+|+.|+|++|.+...
T Consensus 87 ~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 87 YNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 9999998888999999999999999999965554 2 568999999999998754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.3e-14 Score=158.08 Aligned_cols=130 Identities=22% Similarity=0.193 Sum_probs=108.1
Q ss_pred cCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCC
Q 044996 68 ELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRL 146 (678)
Q Consensus 68 ~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L 146 (678)
.+++|+.|+|++|.|++.+| .+..+ ++|++|+|++|+|+|.+|..++.++++|+.|+|++|.|++. |. +..+++|
T Consensus 118 ~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L 193 (487)
T 3oja_A 118 RGQGKKNIYLANNKITMLRDLDEGCR--SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKL 193 (487)
T ss_dssp CCSSCEEEECCSSCCCSGGGBCGGGG--SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTC
T ss_pred ccCCCCEEECCCCCCCCCCchhhcCC--CCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCC
Confidence 46889999999999998877 45555 77999999999999988877445899999999999999976 33 4569999
Q ss_pred CeEeccCCcccccCCcc-CCCCCcEEEeecCcccccCchhhhc---CCCCCCCCCCCCCC
Q 044996 147 VELRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGNRDLCG 202 (678)
Q Consensus 147 ~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn~~lc~ 202 (678)
+.|+|++|.|++..|.+ .+.+|+.|+|++|.|++ +|..+.. +....+.+|+..|+
T Consensus 194 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 194 KTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred CEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 99999999999876664 66899999999999997 7776654 44557889988775
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.47 E-value=5.6e-15 Score=170.65 Aligned_cols=139 Identities=23% Similarity=0.334 Sum_probs=117.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
..+..|+|++|.+. .||.. +..|++|+.|+|++|.|+ .|| .+..+ .+|++|+|++|+|+ .||.. |++|++|+
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l--~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~ 296 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISAN-IFKYDFLTRLYLNGNSLT-ELPAEIKNL--SNLRVLDLSHNRLT-SLPAE-LGSCFQLK 296 (727)
T ss_dssp CCCCEEECTTSCCS-CCCGG-GGGCCSCSCCBCTTSCCS-CCCGGGGGG--TTCCEEECTTSCCS-SCCSS-GGGGTTCS
T ss_pred CCCcEEECCCCCCC-CCChh-hcCCCCCCEEEeeCCcCc-ccChhhhCC--CCCCEEeCcCCcCC-ccChh-hcCCCCCC
Confidence 56889999999998 88875 568999999999999999 777 46667 78999999999999 89987 89999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCccC--C-CCCcEEEeecCcccccCchhhhcCCC
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQ--Q-KDLVSFNVSNNALFGSISPALRELDP 191 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~--~-~~l~~l~l~~N~l~g~ip~~~~~l~~ 191 (678)
+|+|++|.|+ .||..|++|++|++|+|++|.|+|.+|... . ..+..|+|++|.++|.+|..+..++.
T Consensus 297 ~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~l 366 (727)
T 4b8c_D 297 YFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIEI 366 (727)
T ss_dssp EEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC------
T ss_pred EEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeEe
Confidence 9999999997 899999999999999999999999998742 1 22335789999999999998876653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=156.88 Aligned_cols=143 Identities=18% Similarity=0.152 Sum_probs=124.2
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
..++.|+|++|.+.+-. +..+..+++|+.|+|++|++.+..|. +..+ .+|++|+|++|++++..|.. |+++++|+
T Consensus 33 ~~l~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l--~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~ 108 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQ-NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQ--HRLDTLVLTANPLIFMAETA-LSGPKALK 108 (606)
T ss_dssp TTCCEEECTTCCCSEEC-TTTSTTCTTCSEEECTTCCCCEECTTTTTTC--TTCCEEECTTCCCSEECTTT-TSSCTTCC
T ss_pred CcCcEEEccCCccCcCC-hhHhccCccceEEECCCCccceeChhhccCc--cccCeeeCCCCcccccChhh-hccccccc
Confidence 36899999999999544 45699999999999999999998874 5556 78999999999999777755 99999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccc-cCCcc-CCCCCcEEEeecCcccccCchhhhcCCC
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG-QIPDF-QQKDLVSFNVSNNALFGSISPALRELDP 191 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~-~~~~l~~l~l~~N~l~g~ip~~~~~l~~ 191 (678)
+|+|++|++++..|..++++++|++|+|++|.+++ .+|.+ .+++|+.|++++|.+++..|..+..+..
T Consensus 109 ~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 178 (606)
T 3t6q_A 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178 (606)
T ss_dssp EEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTT
T ss_pred EeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcc
Confidence 99999999998778889999999999999999998 44654 5789999999999999888877766553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-13 Score=137.12 Aligned_cols=134 Identities=17% Similarity=0.215 Sum_probs=112.2
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCc-ccccCC-cccccCCCCccEEEccc-CccccccChhhhcCCcc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNN-LEGPMP-DLRQLGNGALRSVYLSN-NRFSGEIPTDAFDGMTS 121 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~-l~g~~p-~~~~~~~~~L~~L~Ls~-N~l~G~ip~~~~~~l~~ 121 (678)
..+..|+|++|.+. .+++..+..+++|+.|+|++|+ +++..+ .+..+ ++|++|+|++ |+++ .+|+..|.++++
T Consensus 31 ~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l--~~L~~L~l~~~n~l~-~i~~~~f~~l~~ 106 (239)
T 2xwt_C 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNL--SKVTHIEIRNTRNLT-YIDPDALKELPL 106 (239)
T ss_dssp TTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESC--TTCCEEEEEEETTCC-EECTTSEECCTT
T ss_pred CcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCC--cCCcEEECCCCCCee-EcCHHHhCCCCC
Confidence 46899999999998 4565678999999999999997 776555 35555 7899999998 9999 566666999999
Q ss_pred cceeeccccccccCCchhhcCCCCCC---eEeccCC-cccccCCc-c-CCCCCc-EEEeecCcccccCchh
Q 044996 122 LRKLLLADNQFNGPIPESLTRLSRLV---ELRLEGN-KFEGQIPD-F-QQKDLV-SFNVSNNALFGSISPA 185 (678)
Q Consensus 122 L~~l~l~~N~~~g~~p~~~~~l~~L~---~l~l~~N-~l~g~~p~-~-~~~~l~-~l~l~~N~l~g~ip~~ 185 (678)
|++|+|++|++++ +|. +..+++|+ +|+|++| .+++..+. + .+.+|+ .|++++|.++ .+|..
T Consensus 107 L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~ 174 (239)
T 2xwt_C 107 LKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174 (239)
T ss_dssp CCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTT
T ss_pred CCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHh
Confidence 9999999999997 777 88999998 9999999 88865554 2 567899 9999999998 67654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=155.18 Aligned_cols=152 Identities=22% Similarity=0.232 Sum_probs=99.3
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC--cccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP--DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
++..|+|++|.+.+. ++. +..+++|+.|+|++|.+.+.+| .+..+ ++|++|+|++|.+++.+|.. |.++++|+
T Consensus 374 ~L~~L~l~~n~l~~~-~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~-~~~l~~L~ 448 (570)
T 2z63_A 374 SLKYLDLSFNGVITM-SSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSL--RNLIYLDISHTHTRVAFNGI-FNGLSSLE 448 (570)
T ss_dssp CCCEEECCSCSEEEE-EEE-EETCTTCCEEECTTSEEESCTTSCTTTTC--TTCCEEECTTSCCEECCTTT-TTTCTTCC
T ss_pred ccCEEECCCCccccc-ccc-ccccCCCCEEEccCCccccccchhhhhcC--CCCCEEeCcCCcccccchhh-hhcCCcCc
Confidence 344455555544432 222 5556666666666666666554 23333 56777777777777666644 77777788
Q ss_pred eeeccccccc-cCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhc---CCCCCCCCC
Q 044996 124 KLLLADNQFN-GPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGN 197 (678)
Q Consensus 124 ~l~l~~N~~~-g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn 197 (678)
.|+|++|.++ +.+|..+..+++|++|+|++|.+++..|.. .+++|+.|++++|++++..|..+.. +....+.+|
T Consensus 449 ~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 528 (570)
T 2z63_A 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528 (570)
T ss_dssp EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred EEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCC
Confidence 8888887776 567777777788888888888877776653 4567888888888887766655543 344467777
Q ss_pred CCCCC
Q 044996 198 RDLCG 202 (678)
Q Consensus 198 ~~lc~ 202 (678)
+..|.
T Consensus 529 ~~~~~ 533 (570)
T 2z63_A 529 PWDCS 533 (570)
T ss_dssp CBCCC
T ss_pred cccCC
Confidence 77664
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-14 Score=147.78 Aligned_cols=153 Identities=18% Similarity=0.178 Sum_probs=119.5
Q ss_pred CcEEEEEeCCCCceeecChHHh-hcCCCCCEEEccCCcccccCCccccc---CCCCccEEEcccCccccccChhhhcCCc
Q 044996 45 GKIWGLKLEDMGLQGNIDITIL-KELREMRTLSLMRNNLEGPMPDLRQL---GNGALRSVYLSNNRFSGEIPTDAFDGMT 120 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l-~~l~~L~~L~Ls~N~l~g~~p~~~~~---~~~~L~~L~Ls~N~l~G~ip~~~~~~l~ 120 (678)
.++..|+|++|.+.|.+|...+ ..+++|+.|+|++|++++..+.+..+ ..++|++|+|++|++++..|. .|++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~-~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE-QVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTT-TCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHH-HhccCC
Confidence 4789999999999999987543 88999999999999999983223322 125799999999999965554 489999
Q ss_pred ccceeeccccccccC--Cchhh--cCCCCCCeEeccCCcccc--cCCcc---CCCCCcEEEeecCcccccCch-hh---h
Q 044996 121 SLRKLLLADNQFNGP--IPESL--TRLSRLVELRLEGNKFEG--QIPDF---QQKDLVSFNVSNNALFGSISP-AL---R 187 (678)
Q Consensus 121 ~L~~l~l~~N~~~g~--~p~~~--~~l~~L~~l~l~~N~l~g--~~p~~---~~~~l~~l~l~~N~l~g~ip~-~~---~ 187 (678)
+|++|+|++|++.|. +|..+ +++++|++|+|++|.|++ .++.. .+++|+.|+|++|++++.+|. .+ .
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 999999999999886 45566 899999999999999984 33332 568999999999999997752 22 3
Q ss_pred cCCCCCCCCCC
Q 044996 188 ELDPSSFSGNR 198 (678)
Q Consensus 188 ~l~~~~~~gn~ 198 (678)
++....+.+|.
T Consensus 254 ~L~~L~Ls~N~ 264 (312)
T 1wwl_A 254 QLNSLNLSFTG 264 (312)
T ss_dssp TCCEEECTTSC
T ss_pred CCCEEECCCCc
Confidence 44445566663
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=131.54 Aligned_cols=129 Identities=16% Similarity=0.178 Sum_probs=106.3
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.++..|+|++|.+. .++ .+..+++|+.|+|++|++++..| .+..+ ++|++|+|++|++++.+|.. +..+++|+
T Consensus 66 ~~L~~L~l~~n~~~-~~~--~l~~l~~L~~L~l~~n~l~~~~~~~l~~l--~~L~~L~Ls~n~i~~~~~~~-l~~l~~L~ 139 (197)
T 4ezg_A 66 HNIKDLTINNIHAT-NYN--PISGLSNLERLRIMGKDVTSDKIPNLSGL--TSLTLLDISHSAHDDSILTK-INTLPKVN 139 (197)
T ss_dssp TTCSEEEEESCCCS-CCG--GGTTCTTCCEEEEECTTCBGGGSCCCTTC--TTCCEEECCSSBCBGGGHHH-HTTCSSCC
T ss_pred CCCCEEEccCCCCC-cch--hhhcCCCCCEEEeECCccCcccChhhcCC--CCCCEEEecCCccCcHhHHH-HhhCCCCC
Confidence 46889999999664 232 58899999999999999998544 56666 78999999999999878865 89999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccc
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g 180 (678)
+|+|++|.+-+.+| .+..+++|+.|+|++|.+++..+-..+++|+.|++++|++.+
T Consensus 140 ~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 140 SIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp EEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred EEEccCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99999999555777 699999999999999999974433477899999999999865
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-13 Score=155.58 Aligned_cols=138 Identities=24% Similarity=0.249 Sum_probs=106.4
Q ss_pred HhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccc----c---ChhhhcCCcccceeeccccccccCC
Q 044996 65 ILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGE----I---PTDAFDGMTSLRKLLLADNQFNGPI 136 (678)
Q Consensus 65 ~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~----i---p~~~~~~l~~L~~l~l~~N~~~g~~ 136 (678)
.+..+++|+.|+|++|++++..|. +..+ .+|++|+|++|++++. + |...|.++++|+.|+|++|+++...
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 552 (680)
T 1ziw_A 475 PFQPLRNLTILDLSNNNIANINDDMLEGL--EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552 (680)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTC--TTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCC
T ss_pred ccccCCCCCEEECCCCCCCcCChhhhccc--cccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCC
Confidence 467788888888888888876664 4444 6789999999988853 1 2123788899999999999998433
Q ss_pred chhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchh----hhcCCCCCCCCCCCCCCCC
Q 044996 137 PESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA----LRELDPSSFSGNRDLCGEP 204 (678)
Q Consensus 137 p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~----~~~l~~~~~~gn~~lc~~~ 204 (678)
+..|.++++|+.|+|++|++++..+.. .+.+|+.|+|++|+|++..|.. +.++....+.+|++.|.+.
T Consensus 553 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred HHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 346899999999999999999544442 5689999999999999877764 4567777899999999654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=7.7e-13 Score=138.23 Aligned_cols=138 Identities=20% Similarity=0.309 Sum_probs=90.2
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEc
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~L 102 (678)
|.|..+.|+. ..++.|+|++|.+.+ +++..+..+++|+.|+|++|++++..|. +..+ ++|++|+|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPL--VKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTC--TTCCEEEC
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHHhcCC--CCCCEEEC
Confidence 5799999962 257889999999985 5555689999999999999999988773 4444 56778888
Q ss_pred ccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccc--cCCcc--CCCCCcEEEeecCcc
Q 044996 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG--QIPDF--QQKDLVSFNVSNNAL 178 (678)
Q Consensus 103 s~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g--~~p~~--~~~~l~~l~l~~N~l 178 (678)
++|+++ .+|..++ ++|+.|+|++|.+++..+..+.++++|++|+|++|.+.. ..+.. .+++|+.|++++|.+
T Consensus 108 s~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 108 SKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 777777 5665422 456666666666655555555555555555555555532 22221 234444444444444
Q ss_pred c
Q 044996 179 F 179 (678)
Q Consensus 179 ~ 179 (678)
+
T Consensus 184 ~ 184 (330)
T 1xku_A 184 T 184 (330)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=4e-13 Score=128.98 Aligned_cols=120 Identities=23% Similarity=0.303 Sum_probs=104.0
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEc
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~L 102 (678)
|.|..|.|+. ..++.|+|++|.+. .+| ..+..+++|+.|+|++|++++..+. +..+ ++|+.|+|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip-~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l--~~L~~L~L 85 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVP-KELSNYKHLTLIDLSNNRISTLSNQSFSNM--TQLLTLIL 85 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCC-GGGGGCTTCCEEECCSSCCCCCCTTTTTTC--TTCCEEEC
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhH-HHhhcccCCCEEECCCCcCCEeCHhHccCC--CCCCEEEC
Confidence 5788899963 25889999999998 788 4699999999999999999987764 5555 78999999
Q ss_pred ccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCccccc
Q 044996 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQ 159 (678)
Q Consensus 103 s~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~ 159 (678)
++|+|++ +|+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.|...
T Consensus 86 s~N~l~~-i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 86 SYNRLRC-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CSSCCCB-CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCccCE-eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 9999995 5555699999999999999999977777799999999999999999753
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.2e-13 Score=137.46 Aligned_cols=147 Identities=18% Similarity=0.183 Sum_probs=117.2
Q ss_pred CcEEEEEeCCCC-ceeecChHHhhcCCCCCEEEccC-CcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcc
Q 044996 45 GKIWGLKLEDMG-LQGNIDITILKELREMRTLSLMR-NNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121 (678)
Q Consensus 45 ~~v~~l~l~~~~-l~g~~~~~~l~~l~~L~~L~Ls~-N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~ 121 (678)
.++..|+|++|. +. .+++..+..+++|+.|+|++ |++++..+. +..+ ++|++|+|++|++++ +|. |..+++
T Consensus 55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l--~~L~~L~l~~n~l~~-lp~--~~~l~~ 128 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKEL--PLLKFLGIFNTGLKM-FPD--LTKVYS 128 (239)
T ss_dssp TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECC--TTCCEEEEEEECCCS-CCC--CTTCCB
T ss_pred CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCC--CCCCEEeCCCCCCcc-ccc--cccccc
Confidence 468999999997 65 67766789999999999998 999976653 4455 779999999999996 885 788888
Q ss_pred cc---eeecccc-ccccCCchhhcCCCCCC-eEeccCCcccccCCcc--CCCCCcEEEeecCc-ccccCchhhhc----C
Q 044996 122 LR---KLLLADN-QFNGPIPESLTRLSRLV-ELRLEGNKFEGQIPDF--QQKDLVSFNVSNNA-LFGSISPALRE----L 189 (678)
Q Consensus 122 L~---~l~l~~N-~~~g~~p~~~~~l~~L~-~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~-l~g~ip~~~~~----l 189 (678)
|+ +|+|++| ++++..+..|.++++|+ .|+|++|.++ .+|.. ...+|+.|+|++|. +++..+..+.. +
T Consensus 129 L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L 207 (239)
T 2xwt_C 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207 (239)
T ss_dssp CCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCC
T ss_pred cccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCC
Confidence 88 9999999 99987777899999999 9999999998 77753 44689999999995 87544444443 3
Q ss_pred CCCCCCCCC
Q 044996 190 DPSSFSGNR 198 (678)
Q Consensus 190 ~~~~~~gn~ 198 (678)
....+.+|.
T Consensus 208 ~~L~l~~N~ 216 (239)
T 2xwt_C 208 SLLDVSQTS 216 (239)
T ss_dssp SEEECTTCC
T ss_pred cEEECCCCc
Confidence 334455553
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.6e-13 Score=152.58 Aligned_cols=137 Identities=20% Similarity=0.229 Sum_probs=116.6
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.++..|+|++|.+.+..+ ..+..+++|+.|+|++|.+++.+|. +..+ ++|++|+|++|.|+ .+|+.+|+++++|+
T Consensus 75 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~-~l~~~~~~~l~~L~ 150 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPPHVFQNV--PLLTVLVLERNDLS-SLPRGIFHNTPKLT 150 (597)
T ss_dssp CCCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTC--TTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred CCCcEEECCCCCCCCCCh-HHhcCCCCCCEEECCCCcCCCCCHHHHcCC--CCCCEEEeeCCCCC-CCCHHHhccCCCCC
Confidence 468899999999996544 4689999999999999999998775 4556 78999999999999 67777789999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccc-cCchhh
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG-SISPAL 186 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g-~ip~~~ 186 (678)
+|+|++|.+++..|..|+++++|++|+|++|.|++. +.....+|+.|++++|.+++ .+|..+
T Consensus 151 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~l~~L~~L~l~~n~l~~l~~~~~L 213 (597)
T 3oja_B 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-DLSLIPSLFHANVSYNLLSTLAIPIAV 213 (597)
T ss_dssp EEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-CGGGCTTCSEEECCSSCCSEEECCTTC
T ss_pred EEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-ChhhhhhhhhhhcccCccccccCCchh
Confidence 999999999999999999999999999999999864 55566778888888888776 334333
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.8e-13 Score=152.49 Aligned_cols=137 Identities=18% Similarity=0.247 Sum_probs=122.8
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccc-cccChhhhcCCccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFS-GEIPTDAFDGMTSL 122 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~-G~ip~~~~~~l~~L 122 (678)
.++..|+|++|.+.+..+...+..+++|+.|+|++|.+.+.+|. +..+ ++|+.|+|++|.++ |.+|.. |..+++|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~p~~-~~~l~~L 472 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL--SSLEVLKMAGNSFQENFLPDI-FTELRNL 472 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTC--TTCCEEECTTCEEGGGEECSC-CTTCTTC
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcC--CcCcEEECcCCcCccccchhh-hhcccCC
Confidence 46889999999999877656689999999999999999998884 4445 78999999999998 689965 8999999
Q ss_pred ceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCch
Q 044996 123 RKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISP 184 (678)
Q Consensus 123 ~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~ 184 (678)
+.|+|++|++++..|..+.++++|++|+|++|.+++.+|.. .+++|+.|++++|.+++.+|.
T Consensus 473 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99999999999999999999999999999999999877753 678999999999999999884
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.1e-13 Score=141.76 Aligned_cols=132 Identities=22% Similarity=0.181 Sum_probs=79.9
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC--ccccc-------------CCCCccEEEcccCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP--DLRQL-------------GNGALRSVYLSNNRFSG 109 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~~-------------~~~~L~~L~Ls~N~l~G 109 (678)
.++..|+|++|.+.+..+ +..+++|+.|+|++|++++..+ .+..+ ..++|+.|+|++|++++
T Consensus 58 ~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 58 TKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (317)
T ss_dssp TTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCS
T ss_pred CcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCC
Confidence 456666666666665443 5666666666666666665321 00000 01345666666666664
Q ss_pred ccChhhhcCCcccceeeccccccccCCchhhc-CCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccc
Q 044996 110 EIPTDAFDGMTSLRKLLLADNQFNGPIPESLT-RLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 110 ~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~-~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g 180 (678)
..| ..|..+++|++|+|++|.+++..|..+. .+++|++|+|++|.+++..+.....+|+.|+|++|.+++
T Consensus 135 ~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~ 205 (317)
T 3o53_A 135 LRD-LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF 205 (317)
T ss_dssp GGG-BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE
T ss_pred ccc-hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCc
Confidence 333 3366677777777777777766666653 567777777777777655333456677777777777765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.5e-14 Score=146.37 Aligned_cols=138 Identities=17% Similarity=0.175 Sum_probs=71.6
Q ss_pred EEEEEeCCCCceeecChHHh-hcCCCCCEEEccCCcccccCCcccc---cCCCCccEEEcccCccccccChhhhcCCccc
Q 044996 47 IWGLKLEDMGLQGNIDITIL-KELREMRTLSLMRNNLEGPMPDLRQ---LGNGALRSVYLSNNRFSGEIPTDAFDGMTSL 122 (678)
Q Consensus 47 v~~l~l~~~~l~g~~~~~~l-~~l~~L~~L~Ls~N~l~g~~p~~~~---~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L 122 (678)
+..|+|++|.+.|.+|...+ ..+++|+.|+|++|.+.+..|.+.. ...++|++|+|++|++++..| ..|.++++|
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L 171 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSC-EQVRAFPAL 171 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCT-TSCCCCTTC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhH-HHhccCCCC
Confidence 55566666666655554322 5566666666666666654442110 011456666666666654333 235566666
Q ss_pred ceeeccccccccC--Cc--hhhcCCCCCCeEeccCCcccccCCc------cCCCCCcEEEeecCcccccCchhh
Q 044996 123 RKLLLADNQFNGP--IP--ESLTRLSRLVELRLEGNKFEGQIPD------FQQKDLVSFNVSNNALFGSISPAL 186 (678)
Q Consensus 123 ~~l~l~~N~~~g~--~p--~~~~~l~~L~~l~l~~N~l~g~~p~------~~~~~l~~l~l~~N~l~g~ip~~~ 186 (678)
++|+|++|++.+. ++ ..++.+++|++|+|++|.++. +|. ....+|+.|+|++|.|++.+|..+
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~ 244 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSA 244 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhH
Confidence 6666666665442 21 112455566666666666542 111 133556666666666666555443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.6e-13 Score=148.25 Aligned_cols=157 Identities=24% Similarity=0.229 Sum_probs=120.2
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-cccc----------------------CCCCccEEE
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQL----------------------GNGALRSVY 101 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~----------------------~~~~L~~L~ 101 (678)
.++..|+|++|.+. .++...+..+++|+.|+|++|.+.+..+. +..+ ...+|+.|+
T Consensus 152 ~~L~~L~l~~n~l~-~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~ 230 (477)
T 2id5_A 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLS 230 (477)
T ss_dssp TTCCEEEEESCCCS-SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEE
T ss_pred CCCCEEECCCCcCc-ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEE
Confidence 35778888888877 45666677788888888888777765441 2111 012577788
Q ss_pred cccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCccc
Q 044996 102 LSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALF 179 (678)
Q Consensus 102 Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~ 179 (678)
|++|+|+ .+|...|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|.+++..|.. .+.+|+.|+|++|+|+
T Consensus 231 l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 309 (477)
T 2id5_A 231 ITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309 (477)
T ss_dssp EESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCS
T ss_pred CcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCc
Confidence 8888887 577666889999999999999999888888999999999999999999877764 5689999999999998
Q ss_pred ccCchhh---hcCCCCCCCCCCCCCCC
Q 044996 180 GSISPAL---RELDPSSFSGNRDLCGE 203 (678)
Q Consensus 180 g~ip~~~---~~l~~~~~~gn~~lc~~ 203 (678)
+..+..+ .+|....+.+|++.|.+
T Consensus 310 ~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 310 TLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp CCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred eeCHhHcCCCcccCEEEccCCCccCcc
Confidence 7555444 45666778999988853
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.9e-13 Score=149.71 Aligned_cols=138 Identities=18% Similarity=0.172 Sum_probs=116.3
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.+++.|+|++|.+.+ +++..+..+++|+.|+|++|++++..| .+..+ ++|++|+|++|+|+ .||.. .+++|+
T Consensus 21 ~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~-~lp~~---~l~~L~ 93 (520)
T 2z7x_B 21 QKTTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQYLDISVFKFN--QELEYLDLSHNKLV-KISCH---PTVNLK 93 (520)
T ss_dssp TTCSEEECCSSCCCC-CCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTC--TTCCEEECCSSCCC-EEECC---CCCCCS
T ss_pred ccccEEECCCCcccc-cChhhccccccccEEecCCCccCCcChHHhhcc--cCCCEEecCCCcee-ecCcc---ccCCcc
Confidence 578999999999985 555678999999999999999998877 45555 77999999999999 78864 799999
Q ss_pred eeecccccccc-CCchhhcCCCCCCeEeccCCcccccCCccCCCCC--cEEEeecCcc--cccCchhhhcCC
Q 044996 124 KLLLADNQFNG-PIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL--VSFNVSNNAL--FGSISPALRELD 190 (678)
Q Consensus 124 ~l~l~~N~~~g-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l--~~l~l~~N~l--~g~ip~~~~~l~ 190 (678)
+|+|++|++++ .+|..|+++++|++|+|++|.+++. .-..+++| +.|++++|.+ ++.+|..+..+.
T Consensus 94 ~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~ 164 (520)
T 2z7x_B 94 HLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS-SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164 (520)
T ss_dssp EEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG-GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred EEeccCCccccccchhhhccCCcceEEEecCcccchh-hccccccceeeEEEeecccccccccccccccccc
Confidence 99999999998 6899999999999999999999873 22345666 9999999999 888888777654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.1e-13 Score=142.72 Aligned_cols=130 Identities=18% Similarity=0.213 Sum_probs=60.2
Q ss_pred EEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC--cccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 47 IWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP--DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 47 v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
+..|+|++|.+. .+++..+..+++|++|+|++|++.+..+ .+..+ ++|++|+|++|+..+.+++..|.++++|+.
T Consensus 102 L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l--~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~ 178 (353)
T 2z80_A 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL--TKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178 (353)
T ss_dssp CCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTC--TTCCEEEEEESSSCCEECTTTTTTCCEEEE
T ss_pred CCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccC--CCCcEEECCCCccccccCHHHccCCCCCCE
Confidence 334444444443 2333334445555555555555443222 12222 445555555553222333333555556666
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEeecCcccc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N~l~g 180 (678)
|+|++|++++..|..+.++++|++|+|++|.++ .+|.. ..++|+.|++++|.+++
T Consensus 179 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~ 236 (353)
T 2z80_A 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT 236 (353)
T ss_dssp EEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTT
T ss_pred EECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCcccc
Confidence 666666665555555555555555555444442 11110 13445555555555544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.40 E-value=7.5e-13 Score=141.76 Aligned_cols=137 Identities=21% Similarity=0.264 Sum_probs=118.2
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
.++..|+|+++.+.+ +++..+..+++|+.|+|++|.+.+..|. +..+ ++|++|+|++|+++ .+|..+|.++++|+
T Consensus 69 ~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~-~l~~~~~~~l~~L~ 144 (390)
T 3o6n_A 69 RQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV--PLLTVLVLERNDLS-SLPRGIFHNTPKLT 144 (390)
T ss_dssp CCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC--TTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred ccCcEEECCCCcccc-cChhhccCCCCcCEEECCCCCCCcCCHHHhcCC--CCCCEEECCCCccC-cCCHHHhcCCCCCc
Confidence 468899999999984 5555689999999999999999998775 4555 78999999999999 78888789999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccc-cCchhh
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG-SISPAL 186 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g-~ip~~~ 186 (678)
+|+|++|.+++..|..+..+++|++|+|++|.+++. +.....+|+.|++++|.+++ ..|..+
T Consensus 145 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~L 207 (390)
T 3o6n_A 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-DLSLIPSLFHANVSYNLLSTLAIPIAV 207 (390)
T ss_dssp EEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-CGGGCTTCSEEECCSSCCSEEECCSSC
T ss_pred EEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-ccccccccceeecccccccccCCCCcc
Confidence 999999999998899999999999999999999864 55567889999999999876 344433
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.39 E-value=9.1e-13 Score=139.60 Aligned_cols=136 Identities=24% Similarity=0.221 Sum_probs=112.4
Q ss_pred eEEecCCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCccc--ccCCCCccEEEcccCccccccChhhh
Q 044996 39 GVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLR--QLGNGALRSVYLSNNRFSGEIPTDAF 116 (678)
Q Consensus 39 gv~C~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~--~~~~~~L~~L~Ls~N~l~G~ip~~~~ 116 (678)
.=.|.. ..+++++++|. .+|... ...|+.|+|++|+|++..+... .+ .+|+.|+|++|+|++ +|+..|
T Consensus 15 ~C~C~~---~~l~c~~~~l~-~iP~~~---~~~l~~L~Ls~N~l~~l~~~~~~~~l--~~L~~L~L~~N~i~~-i~~~~~ 84 (361)
T 2xot_A 15 NCLCAS---NILSCSKQQLP-NVPQSL---PSYTALLDLSHNNLSRLRAEWTPTRL--TNLHSLLLSHNHLNF-ISSEAF 84 (361)
T ss_dssp TCEEET---TEEECCSSCCS-SCCSSC---CTTCSEEECCSSCCCEECTTSSSSCC--TTCCEEECCSSCCCE-ECTTTT
T ss_pred CCEECC---CEEEeCCCCcC-ccCccC---CCCCCEEECCCCCCCccChhhhhhcc--cccCEEECCCCcCCc-cChhhc
Confidence 445643 25899999988 577532 3568999999999999877533 45 789999999999995 555569
Q ss_pred cCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchh
Q 044996 117 DGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA 185 (678)
Q Consensus 117 ~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~ 185 (678)
.++++|++|+|++|+|++..+..|..+++|++|+|++|.|++..|.. .+.+|+.|+|++|+|++ +|..
T Consensus 85 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~ 154 (361)
T 2xot_A 85 VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVE 154 (361)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGG
T ss_pred cCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHH
Confidence 99999999999999999888888999999999999999999877753 67899999999999987 4543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=6.5e-13 Score=144.67 Aligned_cols=131 Identities=25% Similarity=0.329 Sum_probs=109.7
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCccccee
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l 125 (678)
++..|+|++++..+.++...+..|++|+.|+|++|+++ .+|.+..+ .+|+.|+|++|+|++..|. .|.++++|+.|
T Consensus 161 ~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l--~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L 236 (440)
T 3zyj_A 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPL--IKLDELDLSGNHLSAIRPG-SFQGLMHLQKL 236 (440)
T ss_dssp TCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCCCTTC--SSCCEEECTTSCCCEECTT-TTTTCTTCCEE
T ss_pred ccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccccCCC--cccCEEECCCCccCccChh-hhccCccCCEE
Confidence 45566666655555666667888999999999999988 46766666 7899999999999976665 59999999999
Q ss_pred eccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccc
Q 044996 126 LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 126 ~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g 180 (678)
+|++|++++..|..|.++++|+.|+|++|+|++..+.. .+.+|+.|+|++|.+.-
T Consensus 237 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 237 WMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp ECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred ECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 99999999999999999999999999999999655543 56899999999999863
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=5.1e-13 Score=149.64 Aligned_cols=106 Identities=26% Similarity=0.373 Sum_probs=89.2
Q ss_pred CCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEe
Q 044996 71 EMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELR 150 (678)
Q Consensus 71 ~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~ 150 (678)
.|+.|+|++|+|++ +|.+..+ ++|+.|+|++|+|+ .||.. |+++++|+.|+|++|+|++ +| .++++++|+.|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~~~~l--~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~ 514 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCHLEQL--LLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELL 514 (567)
T ss_dssp TCSEEECTTSCCSS-CCCGGGG--TTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEE
T ss_pred CceEEEecCCCCCC-CcCcccc--ccCcEeecCccccc-ccchh-hhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEE
Confidence 58889999999987 6767766 67999999999998 88875 8889999999999999987 77 788999999999
Q ss_pred ccCCcccccC-Ccc--CCCCCcEEEeecCcccccCc
Q 044996 151 LEGNKFEGQI-PDF--QQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 151 l~~N~l~g~~-p~~--~~~~l~~l~l~~N~l~g~ip 183 (678)
|++|+|++.+ |.. .+++|+.|+|++|.|++.+|
T Consensus 515 Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 9999998876 663 67789999999999988655
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.39 E-value=3.7e-13 Score=127.11 Aligned_cols=127 Identities=17% Similarity=0.240 Sum_probs=102.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCC-CCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELR-EMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~-~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
..+..|+|++|.+. .++. +..+. +|+.|+|++|.+++. +.+..+ ++|++|+|++|+|+ .+|+.+|..+++|+
T Consensus 19 ~~L~~L~l~~n~l~-~i~~--~~~~~~~L~~L~Ls~N~l~~~-~~l~~l--~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN--LGATLDQFDAIDFSDNEIRKL-DGFPLL--RRLKTLLVNNNRIC-RIGEGLDQALPDLT 91 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC--GGGGTTCCSEEECCSSCCCEE-CCCCCC--SSCCEEECCSSCCC-EECSCHHHHCTTCC
T ss_pred CCceEEEeeCCCCc-hhHH--hhhcCCCCCEEECCCCCCCcc-cccccC--CCCCEEECCCCccc-ccCcchhhcCCCCC
Confidence 46889999999988 4552 44444 999999999999885 666666 67999999999999 56766678999999
Q ss_pred eeeccccccccCCch--hhcCCCCCCeEeccCCcccccCCcc------CCCCCcEEEeecCcccc
Q 044996 124 KLLLADNQFNGPIPE--SLTRLSRLVELRLEGNKFEGQIPDF------QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~--~~~~l~~L~~l~l~~N~l~g~~p~~------~~~~l~~l~l~~N~l~g 180 (678)
+|+|++|+++ .+|. .+..+++|+.|+|++|.++ .+|.. .+++|+.|++++|.+..
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999999995 5776 7889999999999999998 45542 56789999999988653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.39 E-value=7.6e-13 Score=148.86 Aligned_cols=137 Identities=23% Similarity=0.251 Sum_probs=97.7
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
+++.|+|++|.+.+ +++..+..+++|+.|+|++|++++..|. +..+ ++|++|||++|+|+ .||.. .+++|++
T Consensus 53 ~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~-~lp~~---~l~~L~~ 125 (562)
T 3a79_B 53 RTKALSLSQNSISE-LRMPDISFLSELRVLRLSHNRIRSLDFHVFLFN--QDLEYLDVSHNRLQ-NISCC---PMASLRH 125 (562)
T ss_dssp TCCEEECCSSCCCC-CCGGGTTTCTTCCEEECCSCCCCEECTTTTTTC--TTCCEEECTTSCCC-EECSC---CCTTCSE
T ss_pred CcCEEECCCCCccc-cChhhhccCCCccEEECCCCCCCcCCHHHhCCC--CCCCEEECCCCcCC-ccCcc---ccccCCE
Confidence 57778888887773 4445677788888888888888877664 4444 66888888888887 67754 6788888
Q ss_pred eecccccccc-CCchhhcCCCCCCeEeccCCcccccCCccCCCCC--cEEEeecCcc--cccCchhhhcCC
Q 044996 125 LLLADNQFNG-PIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDL--VSFNVSNNAL--FGSISPALRELD 190 (678)
Q Consensus 125 l~l~~N~~~g-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l--~~l~l~~N~l--~g~ip~~~~~l~ 190 (678)
|+|++|++++ .+|..|+++++|++|+|++|.+++. .-....+| +.|++++|.+ ++..|..+..+.
T Consensus 126 L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~ 195 (562)
T 3a79_B 126 LDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195 (562)
T ss_dssp EECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT-TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECC
T ss_pred EECCCCCccccCchHhhcccCcccEEecCCCccccC-chhhhhhceeeEEEeecccccccccCcccccccC
Confidence 8888888876 5667788888888888888887752 21233444 8888888887 777776665543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.3e-12 Score=136.63 Aligned_cols=136 Identities=19% Similarity=0.275 Sum_probs=90.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccc--cCC-cccccCCCCccEEEcccCccccccChhhhcCCcc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEG--PMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTS 121 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g--~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~ 121 (678)
..+..|+|++|.+. .+++..+..+++|+.|+|++|.+.. ..+ .+..+ ++|++|+|++|+++ .+|... .++
T Consensus 121 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l--~~L~~L~l~~n~l~-~l~~~~---~~~ 193 (330)
T 1xku_A 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM--KKLSYIRIADTNIT-TIPQGL---PPS 193 (330)
T ss_dssp TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGC--TTCCEEECCSSCCC-SCCSSC---CTT
T ss_pred ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCccCcChhhccCC--CCcCEEECCCCccc-cCCccc---ccc
Confidence 35788888888887 4555668888888888888888853 444 23444 55777777777776 466442 156
Q ss_pred cceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhc
Q 044996 122 LRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRE 188 (678)
Q Consensus 122 L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~ 188 (678)
|+.|+|++|++++..|..+..+++|+.|+|++|.+++..+.. ...+|+.|+|++|.++ .+|..+..
T Consensus 194 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 777777777777666666777777777777777776655532 4456677777777666 55655443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.38 E-value=6e-13 Score=125.77 Aligned_cols=114 Identities=26% Similarity=0.439 Sum_probs=98.5
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
..++.|+|++|.+. .+++..+..+++|+.|+|++|+|++..+. +..+ .+|++|+|++|+|++ +|+..|.++++|+
T Consensus 28 ~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~N~l~~-~~~~~~~~l~~L~ 103 (177)
T 2o6r_A 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKL--TKLTILYLHENKLQS-LPNGVFDKLTQLK 103 (177)
T ss_dssp TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTC--TTCCEEECCSSCCCC-CCTTTTTTCTTCC
T ss_pred CCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCC--CccCEEECCCCCccc-cCHHHhhCCcccC
Confidence 46899999999998 56666789999999999999999976664 3455 789999999999995 5556689999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCc
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD 162 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~ 162 (678)
+|+|++|+|++..+..+..+++|++|+|++|.|++..|.
T Consensus 104 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 104 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred EEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 999999999976666678999999999999999987763
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.38 E-value=1e-12 Score=137.54 Aligned_cols=155 Identities=23% Similarity=0.317 Sum_probs=119.9
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEc
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~L 102 (678)
|.|..+.|+. .+++.|+|++|.+.+ +++..+..+++|+.|+|++|++++..|. +..+ ++|++|+|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L 109 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPL--RKLQKLYI 109 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTC--TTCCEEEC
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCHhHhhCc--CCCCEEEC
Confidence 5799999962 257899999999884 4445689999999999999999988774 5555 77999999
Q ss_pred ccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccc--cCCcc-CCCCCcEEEeecCccc
Q 044996 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG--QIPDF-QQKDLVSFNVSNNALF 179 (678)
Q Consensus 103 s~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g--~~p~~-~~~~l~~l~l~~N~l~ 179 (678)
++|+++ .+|..++ ++|++|+|++|++++..+..|.++++|+.|+|++|.++. ..|.. ...+|+.|++++|.++
T Consensus 110 ~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185 (332)
T ss_dssp CSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCS
T ss_pred CCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCC
Confidence 999998 7887633 789999999999997777778999999999999999963 44442 2228889999999987
Q ss_pred ccCchhh-hcCCCCCCCCC
Q 044996 180 GSISPAL-RELDPSSFSGN 197 (678)
Q Consensus 180 g~ip~~~-~~l~~~~~~gn 197 (678)
+ +|..+ .++....+.+|
T Consensus 186 ~-l~~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 186 G-IPKDLPETLNELHLDHN 203 (332)
T ss_dssp S-CCSSSCSSCSCCBCCSS
T ss_pred c-cCccccCCCCEEECCCC
Confidence 6 55433 24444455555
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.38 E-value=6e-13 Score=121.90 Aligned_cols=118 Identities=19% Similarity=0.271 Sum_probs=99.0
Q ss_pred cCCCCCEEEccCCccc-ccCCcc-cccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCC
Q 044996 68 ELREMRTLSLMRNNLE-GPMPDL-RQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSR 145 (678)
Q Consensus 68 ~l~~L~~L~Ls~N~l~-g~~p~~-~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~ 145 (678)
..++|+.|+|++|.++ |.+|.. ..+ ++|++|+|++|++++. . .+.++++|++|+|++|.+++.+|..+..+++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l--~~L~~L~l~~n~l~~~--~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 89 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEF--EELEFLSTINVGLTSI--A-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTC--TTCCEEECTTSCCCCC--T-TCCCCTTCCEEECCSSCCCSCTHHHHHHCTT
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhc--CCCcEEECcCCCCCCc--h-hhhcCCCCCEEECCCCcccchHHHHhhhCCC
Confidence 3578999999999999 888853 445 7899999999999965 3 4899999999999999999999999999999
Q ss_pred CCeEeccCCccccc-CCc--cCCCCCcEEEeecCcccccCc---hhhhcCC
Q 044996 146 LVELRLEGNKFEGQ-IPD--FQQKDLVSFNVSNNALFGSIS---PALRELD 190 (678)
Q Consensus 146 L~~l~l~~N~l~g~-~p~--~~~~~l~~l~l~~N~l~g~ip---~~~~~l~ 190 (678)
|++|+|++|.+++. .|. ..+++|+.|++++|.+++..+ ..+..+.
T Consensus 90 L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~ 140 (149)
T 2je0_A 90 LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLP 140 (149)
T ss_dssp CCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCT
T ss_pred CCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCC
Confidence 99999999999974 223 367899999999999988665 3454443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=1e-12 Score=123.42 Aligned_cols=104 Identities=24% Similarity=0.364 Sum_probs=64.8
Q ss_pred EEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccceeecc
Q 044996 50 LKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLA 128 (678)
Q Consensus 50 l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~ 128 (678)
|++++++|. .+|..+ .++|+.|+|++|+|++..|. +..+ .+|++|+|++|+|+ .+|+..|.++++|++|+|+
T Consensus 14 l~~s~n~l~-~ip~~~---~~~l~~L~L~~N~i~~~~~~~~~~l--~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 14 VDCSGKSLA-SVPTGI---PTTTQVLYLYDNQITKLEPGVFDRL--TQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp EECTTSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTC--TTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred EEeCCCCcC-ccCccC---CCCCcEEEcCCCcCCccChhhhcCc--ccCCEEECCCCCcC-ccChhhccCCCCCCEEECC
Confidence 444555555 355432 35667777777777766553 3444 55777777777776 4555556667777777777
Q ss_pred ccccccCCchhhcCCCCCCeEeccCCcccccC
Q 044996 129 DNQFNGPIPESLTRLSRLVELRLEGNKFEGQI 160 (678)
Q Consensus 129 ~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~ 160 (678)
+|+|++..|..|.++++|++|+|++|.|++..
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 77777655555666777777777766666543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.37 E-value=1.2e-14 Score=140.37 Aligned_cols=133 Identities=22% Similarity=0.287 Sum_probs=113.8
Q ss_pred CcEEEEEeCCCCceeecCh-----HHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCC
Q 044996 45 GKIWGLKLEDMGLQGNIDI-----TILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGM 119 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~-----~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l 119 (678)
.+|+.++|..+.+.|.+|. ..+..+++|+.|+|++|++++ +|.+..+ ++|++|+|++|+++ .+|.. +..+
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l--~~L~~L~l~~n~l~-~l~~~-~~~~ 92 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGM--ENLRILSLGRNLIK-KIENL-DAVA 92 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHH--TTCCEEEEEEEEEC-SCSSH-HHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccC--CCCCEEECCCCCcc-cccch-hhcC
Confidence 4677788888888888764 358999999999999999998 7777777 77999999999999 78864 7888
Q ss_pred cccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCC--c-cCCCCCcEEEeecCcccccCch
Q 044996 120 TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIP--D-FQQKDLVSFNVSNNALFGSISP 184 (678)
Q Consensus 120 ~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p--~-~~~~~l~~l~l~~N~l~g~ip~ 184 (678)
++|+.|+|++|++++ +| .+..+++|++|+|++|.+++..+ . ..+++|+.|++++|.+++.+|.
T Consensus 93 ~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 93 DTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 999999999999997 56 69999999999999999985322 2 3678999999999999988765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=121.71 Aligned_cols=112 Identities=21% Similarity=0.249 Sum_probs=96.5
Q ss_pred hcCCCCCEEEccCCccc-ccCCcc-cccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCC
Q 044996 67 KELREMRTLSLMRNNLE-GPMPDL-RQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLS 144 (678)
Q Consensus 67 ~~l~~L~~L~Ls~N~l~-g~~p~~-~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~ 144 (678)
...++|+.|+|++|+++ |.+|.. ..+ ++|++|+|++|.+++. . .|..+++|++|+|++|++++.+|..+.+++
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l--~~L~~L~l~~n~l~~~--~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 95 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEF--VNLEFLSLINVGLISV--S-NLPKLPKLKKLELSENRIFGGLDMLAEKLP 95 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGG--GGCCEEEEESSCCCCC--S-SCCCCSSCCEEEEESCCCCSCCCHHHHHCT
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhC--CCCCEEeCcCCCCCCh--h-hhccCCCCCEEECcCCcCchHHHHHHhhCC
Confidence 34588999999999998 888864 555 7799999999999964 3 389999999999999999999999999999
Q ss_pred CCCeEeccCCcccccC--Cc-cCCCCCcEEEeecCcccccCc
Q 044996 145 RLVELRLEGNKFEGQI--PD-FQQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 145 ~L~~l~l~~N~l~g~~--p~-~~~~~l~~l~l~~N~l~g~ip 183 (678)
+|++|+|++|.+++.. +. ..+.+|+.|++++|.+++..+
T Consensus 96 ~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 96 NLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp TCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred CCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 9999999999998743 23 267899999999999987655
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=145.43 Aligned_cols=118 Identities=23% Similarity=0.336 Sum_probs=83.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.|. .|| ..+++|+.|+|++|+|++ +|.+. .+|++|+|++|+|++ ||. .+++|+.
T Consensus 80 ~~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~l~----~~L~~L~Ls~N~l~~-lp~----~l~~L~~ 144 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPELP----ASLKHLDVDNNQLTM-LPE----LPALLEY 144 (571)
T ss_dssp TTCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCCCC----TTCCEEECCSSCCSC-CCC----CCTTCCE
T ss_pred CCCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cchhh----cCCCEEECCCCcCCC-CCC----cCccccE
Confidence 35788888888887 676 347888888888888887 66522 267888888888875 774 4677777
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCch
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISP 184 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~ 184 (678)
|+|++|+|++ +|. .+++|++|+|++|.|++ +|.+ ..+|+.|+|++|+|+ .+|.
T Consensus 145 L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l-~~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 145 INADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPEL-PESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp EECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCC-CTTCCEEECCSSCCS-SCCC
T ss_pred EeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cchh-hCCCCEEECcCCCCC-chhh
Confidence 7777777775 665 46677777777777776 5553 366777777777776 4554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.36 E-value=8.1e-13 Score=144.45 Aligned_cols=139 Identities=15% Similarity=0.162 Sum_probs=98.1
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
..+..|+|++|...|.++ +..+++|+.|+|++|++++ +| +..+ ++|+.|+|++|+|++ ++ ++.+++|+.
T Consensus 148 ~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~-l~~l--~~L~~L~l~~N~l~~-~~---l~~l~~L~~ 216 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD-VSQN--KLLNRLNCDTNNITK-LD---LNQNIQLTF 216 (457)
T ss_dssp TTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC-CTTC--TTCCEEECCSSCCSC-CC---CTTCTTCSE
T ss_pred CcCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec-cccC--CCCCEEECcCCcCCe-ec---cccCCCCCE
Confidence 457788888887777774 6778888888888888887 45 4555 668888888888885 33 677888888
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCC----------CCcEEEeecCcccccCch-hhhcCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQK----------DLVSFNVSNNALFGSISP-ALRELDPSS 193 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~----------~l~~l~l~~N~l~g~ip~-~~~~l~~~~ 193 (678)
|+|++|++++ +| ++.+++|+.|+|++|+|+|..+. ... +|+.|++++|.+.|.+|. .+.++....
T Consensus 217 L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~-~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~ 292 (457)
T 3bz5_A 217 LDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS-TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELD 292 (457)
T ss_dssp EECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT-TCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCC
T ss_pred EECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH-HCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEE
Confidence 8888888887 66 77888888888888888865332 222 455666666666676663 234455555
Q ss_pred CCCCC
Q 044996 194 FSGNR 198 (678)
Q Consensus 194 ~~gn~ 198 (678)
+.+|.
T Consensus 293 Ls~n~ 297 (457)
T 3bz5_A 293 VTHNT 297 (457)
T ss_dssp CTTCT
T ss_pred CCCCc
Confidence 66664
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=134.80 Aligned_cols=126 Identities=21% Similarity=0.376 Sum_probs=84.2
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.+.+ +++ +..+++|+.|+|++|.+++ +|.+..+ ++|++|+|++|++++ +|. +..+++|+.
T Consensus 63 ~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l~~-~~~~~~l--~~L~~L~l~~n~l~~-~~~--l~~l~~L~~ 133 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKN-VSAIAGL--QSIKTLDLTSTQITD-VTP--LAGLSNLQV 133 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSC-CGGGTTC--TTCCEEECTTSCCCC-CGG--GTTCTTCCE
T ss_pred CCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcCCC-chhhcCC--CCCCEEECCCCCCCC-chh--hcCCCCCCE
Confidence 457777777777763 332 6677777777777777765 3445544 567777777777774 442 677777777
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCccccc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ 181 (678)
|+|++|++++..+ +..+++|+.|+|++|.+++..+-..+.+|+.|++++|.+++.
T Consensus 134 L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 134 LYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC
T ss_pred EECCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcC
Confidence 7777777775433 677777777777777777544433556777777777777653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=146.13 Aligned_cols=128 Identities=17% Similarity=0.271 Sum_probs=101.9
Q ss_pred HhhcCCCCCEEE-ccCCcccccCCc-------ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCC
Q 044996 65 ILKELREMRTLS-LMRNNLEGPMPD-------LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPI 136 (678)
Q Consensus 65 ~l~~l~~L~~L~-Ls~N~l~g~~p~-------~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~ 136 (678)
.++.|++|+.|+ ++.|.+.. ++. +..+....|+.|+|++|+|++ ||. |+++++|+.|+|++|+|+ .+
T Consensus 404 ~l~~l~~L~~L~~l~~n~~~~-L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~l 478 (567)
T 1dce_A 404 TLQYFSTLKAVDPMRAAYLDD-LRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-AL 478 (567)
T ss_dssp HHHHHHHHHHHCGGGHHHHHH-HHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CC
T ss_pred HHHHHHhcccCcchhhcccch-hhhhhhhcccccccCccCceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-cc
Confidence 467788888888 66665432 110 111111459999999999996 884 899999999999999999 89
Q ss_pred chhhcCCCCCCeEeccCCcccccCCcc-CCCCCcEEEeecCcccccC-chhhhcCC---CCCCCCCC
Q 044996 137 PESLTRLSRLVELRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGSI-SPALRELD---PSSFSGNR 198 (678)
Q Consensus 137 p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~i-p~~~~~l~---~~~~~gn~ 198 (678)
|..|+++++|+.|+|++|.|++ +|.+ .+++|+.|+|++|+|++.+ |..+..+. ...+.+|+
T Consensus 479 p~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~ 544 (567)
T 1dce_A 479 PPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544 (567)
T ss_dssp CGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred chhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCc
Confidence 9999999999999999999997 7754 6789999999999999987 88777654 44677775
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-12 Score=133.27 Aligned_cols=124 Identities=27% Similarity=0.364 Sum_probs=68.6
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCccccee
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l 125 (678)
++..|+|++|.+.+ +++ +..+++|+.|+|++|.+++ +|.+..+ ++|++|+|++|++++ ++ . +..+++|+.|
T Consensus 69 ~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~~l~~l--~~L~~L~L~~n~i~~-~~-~-l~~l~~L~~L 139 (291)
T 1h6t_A 69 NVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LSSLKDL--KKLKSLSLEHNGISD-IN-G-LVHLPQLESL 139 (291)
T ss_dssp TCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GGGGTTC--TTCCEEECTTSCCCC-CG-G-GGGCTTCCEE
T ss_pred CCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-ChhhccC--CCCCEEECCCCcCCC-Ch-h-hcCCCCCCEE
Confidence 45556666665553 222 5556666666666666554 3334434 456666666666653 33 2 5556666666
Q ss_pred eccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccc
Q 044996 126 LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 126 ~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g 180 (678)
+|++|++++. ..+..+++|+.|+|++|.+++..|-..+.+|+.|+|++|.+++
T Consensus 140 ~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 140 YLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp ECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred EccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC
Confidence 6666666543 3455666666666666666554443345556666666666554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.36 E-value=2.4e-12 Score=145.09 Aligned_cols=142 Identities=25% Similarity=0.316 Sum_probs=115.7
Q ss_pred CCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 44 RGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
..++..|+|++|.|.+. ++ +..|++|+.|+|++|.|.+ +|.+..+ ++|+.|+|++|+|++ +| . +..|++|+
T Consensus 64 l~~L~~L~Ls~N~l~~~-~~--l~~l~~L~~L~Ls~N~l~~-l~~l~~l--~~L~~L~Ls~N~l~~-l~-~-l~~l~~L~ 134 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDI-KP--LTNLKNLGWLFLDENKIKD-LSSLKDL--KKLKSLSLEHNGISD-IN-G-LVHLPQLE 134 (605)
T ss_dssp CTTCCEEECTTSCCCCC-GG--GGGCTTCCEEECCSSCCCC-CTTSTTC--TTCCEEECTTSCCCC-CG-G-GGGCTTCS
T ss_pred CCCCCEEEeeCCCCCCC-hh--hccCCCCCEEECcCCCCCC-ChhhccC--CCCCEEEecCCCCCC-Cc-c-ccCCCccC
Confidence 35789999999999864 33 8899999999999999987 5666666 779999999999995 54 3 88999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCchhhhc---CCCCCCCCCC
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGNR 198 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn~ 198 (678)
.|+|++|++++. ..+..|++|+.|+|++|.|++..|-..+.+|+.|+|++|.|++. | .+.. |....+.+|+
T Consensus 135 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 135 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQE 208 (605)
T ss_dssp EEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEE
T ss_pred EEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCc
Confidence 999999999975 67899999999999999999887755778999999999999873 3 3433 3344455554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.35 E-value=1e-12 Score=136.56 Aligned_cols=130 Identities=22% Similarity=0.193 Sum_probs=100.9
Q ss_pred cCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCC
Q 044996 68 ELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRL 146 (678)
Q Consensus 68 ~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L 146 (678)
.+++|+.|+|++|++++..| .+..+ ++|++|+|++|.+++..|..++..+++|++|+|++|.+++. |. ...+++|
T Consensus 118 ~~~~L~~L~l~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L 193 (317)
T 3o53_A 118 RGQGKKNIYLANNKITMLRDLDEGCR--SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKL 193 (317)
T ss_dssp CCSSCEEEECCSSCCCSGGGBCTGGG--SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTC
T ss_pred ccCCCCEEECCCCCCCCccchhhhcc--CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccC
Confidence 36778888888888887666 34445 67999999999999777766446789999999999999865 33 3458999
Q ss_pred CeEeccCCcccccCCcc-CCCCCcEEEeecCcccccCchhhhc---CCCCCCCCCCCCCC
Q 044996 147 VELRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGNRDLCG 202 (678)
Q Consensus 147 ~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn~~lc~ 202 (678)
++|+|++|.+++..+.+ ...+|+.|+|++|.|++ +|..+.. +....+.+|+..|+
T Consensus 194 ~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 194 KTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CEEECCCCcCCcchhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCc
Confidence 99999999999765553 56789999999999984 7766543 44556888887764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.8e-12 Score=122.15 Aligned_cols=106 Identities=24% Similarity=0.382 Sum_probs=75.0
Q ss_pred EEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccceee
Q 044996 48 WGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLL 126 (678)
Q Consensus 48 ~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~ 126 (678)
..+++++++|. .+|..+ .++|+.|+|++|+|++.+|. +..+ ++|++|+|++|+|++ ||+..|.++++|++|+
T Consensus 15 ~~l~~~~n~l~-~iP~~~---~~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~ 87 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGI---PTDKQRLWLNNNQITKLEPGVFDHL--VNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLD 87 (174)
T ss_dssp SEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTC--TTCCEEECCSSCCCC-CCTTTTTTCTTCCEEE
T ss_pred cEEEeCCCCCC-ccCCCc---CCCCcEEEeCCCCccccCHHHhcCC--cCCCEEECCCCCCCc-cChhHhCCcchhhEEE
Confidence 35677777774 666532 36778888888888877663 4444 668888888888874 6666577788888888
Q ss_pred ccccccccCCchhhcCCCCCCeEeccCCcccccC
Q 044996 127 LADNQFNGPIPESLTRLSRLVELRLEGNKFEGQI 160 (678)
Q Consensus 127 l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~ 160 (678)
|++|+|++..+..|..+++|++|+|++|.|....
T Consensus 88 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 88 LNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred CCCCccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 8888887655555777788888888877776443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=3.2e-12 Score=143.25 Aligned_cols=141 Identities=23% Similarity=0.304 Sum_probs=117.0
Q ss_pred EEecCCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhcC
Q 044996 40 VLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDG 118 (678)
Q Consensus 40 v~C~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~ 118 (678)
..|....+ .++++++++ .+|... .++|+.|+|++|++++..| .+..+ ++|++|+|++|++++..|. .|.+
T Consensus 2 ~~C~~~~~--c~~~~~~l~-~ip~~~---~~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~Ls~n~i~~~~~~-~~~~ 72 (549)
T 2z81_A 2 LSCDASGV--CDGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRAC--ANLQVLILKSSRINTIEGD-AFYS 72 (549)
T ss_dssp CEECTTSE--EECTTSCCS-SCCSCC---CTTCCEEECCSSCCCEECSSTTSSC--TTCCEEECTTSCCCEECTT-TTTT
T ss_pred ccCCCCce--EECCCCccc-cccccC---CCCccEEECcCCccCccChhhhhcC--CcccEEECCCCCcCccChh-hccc
Confidence 35765555 788999988 788642 3789999999999999877 46666 7899999999999975554 5999
Q ss_pred CcccceeeccccccccCCchhhcCCCCCCeEeccCCcccc-cCCcc--CCCCCcEEEeecCcccccCch-hhhcC
Q 044996 119 MTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG-QIPDF--QQKDLVSFNVSNNALFGSISP-ALREL 189 (678)
Q Consensus 119 l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~--~~~~l~~l~l~~N~l~g~ip~-~~~~l 189 (678)
+++|++|+|++|++++..|..|+++++|++|+|++|.+++ .+|.. .+++|+.|++++|.+.+.+|. .+..+
T Consensus 73 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp CTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred cccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 9999999999999999888889999999999999999996 35542 678999999999997777774 44443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.6e-12 Score=133.29 Aligned_cols=145 Identities=21% Similarity=0.368 Sum_probs=119.3
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.+.+..| ..+..+++|+.|+|++|++. .+|.. .. .+|++|+|++|+++ .+|+..|.++++|+.
T Consensus 78 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~-~l~~~--~~-~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~ 151 (332)
T 2ft3_A 78 QHLYALVLVNNKISKIHE-KAFSPLRKLQKLYISKNHLV-EIPPN--LP-SSLVELRIHDNRIR-KVPKGVFSGLRNMNC 151 (332)
T ss_dssp TTCCEEECCSSCCCEECG-GGSTTCTTCCEEECCSSCCC-SCCSS--CC-TTCCEEECCSSCCC-CCCSGGGSSCSSCCE
T ss_pred CCCcEEECCCCccCccCH-hHhhCcCCCCEEECCCCcCC-ccCcc--cc-ccCCEEECCCCccC-ccCHhHhCCCccCCE
Confidence 468999999999986544 56899999999999999998 45532 11 67999999999999 567667999999999
Q ss_pred eeccccccc--cCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCchhhhc---CCCCCCCCC
Q 044996 125 LLLADNQFN--GPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGN 197 (678)
Q Consensus 125 l~l~~N~~~--g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn 197 (678)
|+|++|.++ |..|..+..+ +|+.|++++|.+++ +|.....+|+.|++++|.+++..|..+.. +....+.+|
T Consensus 152 L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N 227 (332)
T 2ft3_A 152 IEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN 227 (332)
T ss_dssp EECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSS
T ss_pred EECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence 999999996 5788888888 99999999999986 77766689999999999998877665544 344455555
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.33 E-value=4.5e-12 Score=118.95 Aligned_cols=107 Identities=24% Similarity=0.327 Sum_probs=90.9
Q ss_pred CCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEec
Q 044996 72 MRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRL 151 (678)
Q Consensus 72 L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l 151 (678)
.+.|++++|.|+. +|. .+. .+|++|+|++|+|++..|. .|.++++|++|+|++|+|++..|..|..+++|++|+|
T Consensus 11 ~~~l~~s~n~l~~-ip~--~~~-~~l~~L~L~~N~i~~~~~~-~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 85 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPT--GIP-TTTQVLYLYDNQITKLEPG-VFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSL 85 (170)
T ss_dssp TTEEECTTSCCSS-CCS--CCC-TTCSEEECCSSCCCCCCTT-TTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEEEeCCCCcCc-cCc--cCC-CCCcEEEcCCCcCCccChh-hhcCcccCCEEECCCCCcCccChhhccCCCCCCEEEC
Confidence 4689999999987 553 121 6799999999999965564 5999999999999999999877777899999999999
Q ss_pred cCCcccccCCc-c-CCCCCcEEEeecCcccccCc
Q 044996 152 EGNKFEGQIPD-F-QQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 152 ~~N~l~g~~p~-~-~~~~l~~l~l~~N~l~g~ip 183 (678)
++|+|++..+. + .+.+|+.|+|++|.|++..+
T Consensus 86 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 86 NDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 99999976665 2 67899999999999987654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.6e-12 Score=128.61 Aligned_cols=125 Identities=18% Similarity=0.314 Sum_probs=84.3
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|+++++. .++ .+..+++|+.|+|++|++++..| +..+ ++|++|+|++|++++ +|. +.. ++|+.
T Consensus 41 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~-l~~l--~~L~~L~L~~N~l~~-l~~--~~~-~~L~~ 110 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP-LKDL--TKLEELSVNRNRLKN-LNG--IPS-ACLSR 110 (263)
T ss_dssp TTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTC--SSCCEEECCSSCCSC-CTT--CCC-SSCCE
T ss_pred CcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh-hccC--CCCCEEECCCCccCC-cCc--ccc-CcccE
Confidence 35667777777776 454 36777777777777777776544 5555 567777777777774 553 233 77777
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCccccc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ 181 (678)
|+|++|++++ +| .+..+++|+.|+|++|++++..+-..+++|+.|+|++|.+++.
T Consensus 111 L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 111 LFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp EECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC
T ss_pred EEccCCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch
Confidence 7777777775 33 4777777777777777777542223566777777777777664
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.32 E-value=4.7e-12 Score=127.82 Aligned_cols=125 Identities=21% Similarity=0.312 Sum_probs=107.4
Q ss_pred CCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 44 RGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
-.++..|+|++|.+.+ +++ +..|++|+.|+|++|++++ +|.+.. .+|+.|+|++|++++ +| . +..+++|+
T Consensus 62 l~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~---~~L~~L~L~~N~l~~-~~-~-l~~l~~L~ 131 (263)
T 1xeu_A 62 FTNLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKN-LNGIPS---ACLSRLFLDNNELRD-TD-S-LIHLKNLE 131 (263)
T ss_dssp CTTCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSC-CTTCCC---SSCCEEECCSSCCSB-SG-G-GTTCTTCC
T ss_pred CCCCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCC-cCcccc---CcccEEEccCCccCC-Ch-h-hcCccccc
Confidence 3579999999999985 443 8999999999999999998 454332 679999999999996 55 4 89999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCc-cCCCCCcEEEeecCccccc
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~~l~~l~l~~N~l~g~ 181 (678)
.|+|++|++++. | .+..+++|+.|+|++|.+++. +. ..+.+|+.|++++|.+++.
T Consensus 132 ~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 132 ILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp EEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred EEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 999999999974 4 699999999999999999987 43 3678999999999999765
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.32 E-value=4.5e-12 Score=131.09 Aligned_cols=141 Identities=24% Similarity=0.388 Sum_probs=115.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.+.+ ++ .+..+++|+.|+|++|++++ +|.+..+ ++|++|+|++|++++ +|+ +..+++|+.
T Consensus 85 ~~L~~L~L~~n~l~~-~~--~~~~l~~L~~L~l~~n~l~~-~~~l~~l--~~L~~L~l~~n~l~~-~~~--l~~l~~L~~ 155 (308)
T 1h6u_A 85 TKITELELSGNPLKN-VS--AIAGLQSIKTLDLTSTQITD-VTPLAGL--SNLQVLYLDLNQITN-ISP--LAGLTNLQY 155 (308)
T ss_dssp CSCCEEECCSCCCSC-CG--GGTTCTTCCEEECTTSCCCC-CGGGTTC--TTCCEEECCSSCCCC-CGG--GGGCTTCCE
T ss_pred CCCCEEEccCCcCCC-ch--hhcCCCCCCEEECCCCCCCC-chhhcCC--CCCCEEECCCCccCc-Ccc--ccCCCCccE
Confidence 578999999999985 43 48899999999999999987 4556666 789999999999995 553 789999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCchhhhc---CCCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGNR 198 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn~ 198 (678)
|+|++|++++ ++. +..+++|+.|+|++|.+++..+-..+.+|+.|+|++|.+++..| +.. +....+.+|+
T Consensus 156 L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~ 228 (308)
T 1h6u_A 156 LSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQT 228 (308)
T ss_dssp EECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEE
T ss_pred EEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCe
Confidence 9999999997 444 99999999999999999976554577899999999999987553 333 3334455554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.31 E-value=6.4e-12 Score=128.83 Aligned_cols=127 Identities=20% Similarity=0.295 Sum_probs=109.1
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+++++.+. .++ .+..+++|+.|+|++|++++..+ +..+ ++|++|+|++|++++ +| . +..+++|++
T Consensus 46 ~~L~~L~l~~~~i~-~~~--~~~~l~~L~~L~L~~n~l~~~~~-l~~l--~~L~~L~l~~n~l~~-~~-~-l~~l~~L~~ 116 (291)
T 1h6t_A 46 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP-LANL--KNLGWLFLDENKVKD-LS-S-LKDLKKLKS 116 (291)
T ss_dssp HTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTC--TTCCEEECCSSCCCC-GG-G-GTTCTTCCE
T ss_pred CcccEEEccCCCcc-cCh--hHhcCCCCCEEEccCCccCCCcc-cccC--CCCCEEECCCCcCCC-Ch-h-hccCCCCCE
Confidence 46889999999987 454 38899999999999999998655 6666 789999999999995 55 3 899999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCc-cCCCCCcEEEeecCcccccCc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~~l~~l~l~~N~l~g~ip 183 (678)
|+|++|++++. ..+..+++|+.|+|++|.+++. +. ..+++|+.|++++|.+++..|
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh
Confidence 99999999974 5689999999999999999975 44 367899999999999987554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.30 E-value=5.8e-12 Score=137.54 Aligned_cols=136 Identities=18% Similarity=0.291 Sum_probs=95.9
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.+.+ +| .++.+++|+.|+|++|++++ +|.. . .+|++|+|++|++++ +| + |+++++|+.
T Consensus 131 ~~L~~L~L~~n~l~~-lp--~~~~l~~L~~L~l~~N~l~~-lp~~--~--~~L~~L~L~~n~l~~-l~-~-~~~l~~L~~ 199 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP--ELQNSSFLKIIDVDNNSLKK-LPDL--P--PSLEFIAAGNNQLEE-LP-E-LQNLPFLTA 199 (454)
T ss_dssp TTCCEEECCSSCCSS-CC--CCTTCTTCCEEECCSSCCSC-CCCC--C--TTCCEEECCSSCCSS-CC-C-CTTCTTCCE
T ss_pred CCCCEEECcCCCCCC-Cc--ccCCCCCCCEEECCCCcCcc-cCCC--c--ccccEEECcCCcCCc-Cc-c-ccCCCCCCE
Confidence 356777777777775 66 27788888888888888876 5532 2 468888888888886 66 4 788888888
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc-CCCCCcEEEeecCcccccCchhhhcCCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGSISPALRELDPSSFSGN 197 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ip~~~~~l~~~~~~gn 197 (678)
|+|++|++++ +|... ++|++|++++|.++ .+|.+ .+++|+.|++++|++++ +|..+..+....+.+|
T Consensus 200 L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~N 267 (454)
T 1jl5_A 200 IYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDN 267 (454)
T ss_dssp EECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSS
T ss_pred EECCCCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCCc-ccccccccCEEECCCC
Confidence 8888888876 44422 47777777777777 66653 55678888888888876 5544444444444544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.29 E-value=5e-12 Score=138.70 Aligned_cols=144 Identities=19% Similarity=0.225 Sum_probs=113.1
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.+.+..+ +..+++|+.|+|++|.+++..+ +..+ ++|+.|+|++|++++ +++ +..+++|+.
T Consensus 243 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~-~~~l--~~L~~L~L~~n~l~~-~~~--~~~l~~L~~ 313 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP-LAGL--TALTNLELNENQLED-ISP--ISNLKNLTY 313 (466)
T ss_dssp TTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCCCCGG-GTTC--TTCSEEECCSSCCSC-CGG--GGGCTTCSE
T ss_pred CCCCEEECCCCccccchh---hhcCCCCCEEECCCCccCcccc-ccCC--CccCeEEcCCCcccC-chh--hcCCCCCCE
Confidence 468899999999986543 7889999999999999998655 5555 779999999999996 443 788999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCch-hhhcCCCCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISP-ALRELDPSSFSGNRD 199 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~-~~~~l~~~~~~gn~~ 199 (678)
|+|++|++++..| +..+++|+.|++++|.+++...-..+++|+.|++++|++++.+|- .+..+....+.+|++
T Consensus 314 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~ 387 (466)
T 1o6v_A 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAW 387 (466)
T ss_dssp EECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEE
T ss_pred EECcCCcCCCchh--hccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcc
Confidence 9999999998766 788999999999999998762224678899999999999988771 122333344556643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.29 E-value=5.4e-12 Score=142.22 Aligned_cols=126 Identities=27% Similarity=0.409 Sum_probs=110.5
Q ss_pred CCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccc
Q 044996 44 RGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123 (678)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~ 123 (678)
..++..|+|++|.|.+ ++ .+..|++|+.|+|++|.|.+ ++.+..+ ++|+.|+|++|+|++ ++ . |..+++|+
T Consensus 86 l~~L~~L~Ls~N~l~~-l~--~l~~l~~L~~L~Ls~N~l~~-l~~l~~l--~~L~~L~Ls~N~l~~-l~-~-l~~l~~L~ 156 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-LS--SLKDLKKLKSLSLEHNGISD-INGLVHL--PQLESLYLGNNKITD-IT-V-LSRLTKLD 156 (605)
T ss_dssp CTTCCEEECCSSCCCC-CT--TSTTCTTCCEEECTTSCCCC-CGGGGGC--TTCSEEECCSSCCCC-CG-G-GGSCTTCS
T ss_pred CCCCCEEECcCCCCCC-Ch--hhccCCCCCEEEecCCCCCC-CccccCC--CccCEEECCCCccCC-ch-h-hcccCCCC
Confidence 3578999999999985 44 48999999999999999997 5767777 789999999999996 43 3 89999999
Q ss_pred eeeccccccccCCchhhcCCCCCCeEeccCCcccccCCc-cCCCCCcEEEeecCccccc
Q 044996 124 KLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 124 ~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~~l~~l~l~~N~l~g~ 181 (678)
.|+|++|.|++..| +..|++|+.|+|++|.|++. |. ..+.+|+.|+|++|.+++.
T Consensus 157 ~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 157 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECC
T ss_pred EEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCC
Confidence 99999999998777 99999999999999999974 55 3678999999999999875
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.28 E-value=5.4e-13 Score=139.65 Aligned_cols=145 Identities=19% Similarity=0.240 Sum_probs=113.3
Q ss_pred CcceEEecCCcEEEEEeCCCCceeecChHHhhcC--CCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccc-cC
Q 044996 36 NWNGVLCHRGKIWGLKLEDMGLQGNIDITILKEL--REMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGE-IP 112 (678)
Q Consensus 36 ~w~gv~C~~~~v~~l~l~~~~l~g~~~~~~l~~l--~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~-ip 112 (678)
.|.++.|+...+..|+|+++.+. +..+..+ +.|+.|+|++|.+.+.++.+..+ ++|++|+|++|++++. +|
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~----~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~--~~L~~L~L~~~~l~~~~~~ 111 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLH----PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP--FRVQHMDLSNSVIEVSTLH 111 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCC----HHHHHHHHHTTCSEEECTTCEECSCCCSCCCC--BCCCEEECTTCEECHHHHH
T ss_pred HHHHHhcCchhheeeccccccCC----HHHHHhhhhccceEEEcCCccccccchhhccC--CCCCEEEccCCCcCHHHHH
Confidence 69988887666788899888776 3456666 88889999999998888876555 6789999999888876 76
Q ss_pred hhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCC-ccccc-CCcc--CCCCCcEEEeecC-ccccc-Cchhh
Q 044996 113 TDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGN-KFEGQ-IPDF--QQKDLVSFNVSNN-ALFGS-ISPAL 186 (678)
Q Consensus 113 ~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N-~l~g~-~p~~--~~~~l~~l~l~~N-~l~g~-ip~~~ 186 (678)
.. +..+++|++|+|++|.+++.+|..++.+++|++|+|++| .+++. +|.. .+++|+.|++++| .+++. ++..+
T Consensus 112 ~~-~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~ 190 (336)
T 2ast_B 112 GI-LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 190 (336)
T ss_dssp HH-HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred HH-HhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH
Confidence 54 788889999999999888888888888889999999888 67763 5542 5678888888888 88764 45544
Q ss_pred h
Q 044996 187 R 187 (678)
Q Consensus 187 ~ 187 (678)
.
T Consensus 191 ~ 191 (336)
T 2ast_B 191 A 191 (336)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.4e-11 Score=116.11 Aligned_cols=105 Identities=20% Similarity=0.320 Sum_probs=88.3
Q ss_pred CEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEecc
Q 044996 73 RTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLE 152 (678)
Q Consensus 73 ~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~ 152 (678)
+.+++++|.|. .+|. .+. .+|+.|+|++|+|++..|. .|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 15 ~~l~~~~n~l~-~iP~--~~~-~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPA--GIP-TDKQRLWLNNNQITKLEPG-VFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SEEECCSSCCS-SCCS--CCC-TTCSEEECCSSCCCCCCTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred cEEEeCCCCCC-ccCC--CcC-CCCcEEEeCCCCccccCHH-HhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECC
Confidence 68999999995 5664 122 6799999999999976564 59999999999999999998666668999999999999
Q ss_pred CCcccccCCc-c-CCCCCcEEEeecCcccccC
Q 044996 153 GNKFEGQIPD-F-QQKDLVSFNVSNNALFGSI 182 (678)
Q Consensus 153 ~N~l~g~~p~-~-~~~~l~~l~l~~N~l~g~i 182 (678)
+|+|++..+. + .+.+|+.|+|++|.|....
T Consensus 90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred CCccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 9999966554 2 5789999999999998653
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.28 E-value=9.7e-12 Score=135.87 Aligned_cols=121 Identities=18% Similarity=0.123 Sum_probs=78.3
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.+.+ ++ ++.+++|+.|+|++|++++. + +..+ ++|++|+|++|++.|.++ +..+++|+.
T Consensus 106 ~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l-~-l~~l--~~L~~L~l~~n~~~~~~~---~~~l~~L~~ 174 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTEI-D-VSHN--TQLTELDCHLNKKITKLD---VTPQTQLTT 174 (457)
T ss_dssp TTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSCC-C-CTTC--TTCCEEECTTCSCCCCCC---CTTCTTCCE
T ss_pred CcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCcccee-c-cccC--CcCCEEECCCCCcccccc---cccCCcCCE
Confidence 467888888888876 54 67788888888888888873 3 4444 556666666666555553 556666666
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g 180 (678)
|+|++|++++ +| ++.+++|+.|++++|.+++. +-..+.+|+.|++++|+|++
T Consensus 175 L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 175 LDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp EECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC
T ss_pred EECCCCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcCCcccc
Confidence 6666666665 44 55666666666666666543 33344556666666666655
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.26 E-value=6.7e-12 Score=131.96 Aligned_cols=143 Identities=19% Similarity=0.267 Sum_probs=115.8
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..+++++|.+.+..+ +..+++|+.|+|++|.+++..+ +..+ ++|+.|+|++|.+++ ++ . +..+++|+.
T Consensus 199 ~~L~~L~l~~n~l~~~~~---~~~~~~L~~L~l~~n~l~~~~~-~~~l--~~L~~L~l~~n~l~~-~~-~-~~~l~~L~~ 269 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP---VANMTRLNSLKIGNNKITDLSP-LANL--SQLTWLEIGTNQISD-IN-A-VKDLTKLKM 269 (347)
T ss_dssp TTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCCGG-GTTC--TTCCEEECCSSCCCC-CG-G-GTTCTTCCE
T ss_pred CccceeecccCCCCCCch---hhcCCcCCEEEccCCccCCCcc-hhcC--CCCCEEECCCCccCC-Ch-h-HhcCCCcCE
Confidence 468889999998885432 7889999999999999987554 5555 779999999999985 54 3 889999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCc-hhhhcCCCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSIS-PALRELDPSSFSGNR 198 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip-~~~~~l~~~~~~gn~ 198 (678)
|+|++|.+++. ..+..+++|+.|+|++|.+++..|.. .+++|+.|++++|.+++..| ..+.++...++.+|+
T Consensus 270 L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 270 LNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred EEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhc
Confidence 99999999874 45889999999999999999877763 67899999999999998776 234455555666664
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=135.88 Aligned_cols=141 Identities=27% Similarity=0.326 Sum_probs=117.1
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.+.+ ++ .+..+++|+.|+|++|.+.+..| +..+ ++|+.|+|++|.+++ +|+ +..+++|+.
T Consensus 221 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~-~~~l--~~L~~L~l~~n~l~~-~~~--~~~l~~L~~ 291 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP-LSGL--TKLTELKLGANQISN-ISP--LAGLTALTN 291 (466)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG-GTTC--TTCSEEECCSSCCCC-CGG--GTTCTTCSE
T ss_pred CCCCEEECCCCCccc-ch--hhhcCCCCCEEECCCCccccchh-hhcC--CCCCEEECCCCccCc-ccc--ccCCCccCe
Confidence 468899999999885 43 48899999999999999998766 5556 789999999999996 443 789999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCchhhhc---CCCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGNR 198 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn~ 198 (678)
|+|++|++++..| +..+++|+.|+|++|.+++..|-..+++|+.|++++|.+++. + .+.. +....+.+|.
T Consensus 292 L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~ 364 (466)
T 1o6v_A 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV-S-SLANLTNINWLSAGHNQ 364 (466)
T ss_dssp EECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSC
T ss_pred EEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc-h-hhccCCCCCEEeCCCCc
Confidence 9999999998555 889999999999999999988866889999999999999885 2 3433 3334455553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.25 E-value=9.5e-12 Score=117.39 Aligned_cols=113 Identities=19% Similarity=0.204 Sum_probs=94.1
Q ss_pred hhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCC
Q 044996 66 LKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSR 145 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~ 145 (678)
+..+.+|+.|+|++|+++. +|.+..+. ++|++|+|++|+|++ ++ . |..+++|++|+|++|++++..|..+..+++
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~~~~~~-~~L~~L~Ls~N~l~~-~~-~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IENLGATL-DQFDAIDFSDNEIRK-LD-G-FPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGT-TCCSEEECCSSCCCE-EC-C-CCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred cCCcCCceEEEeeCCCCch-hHHhhhcC-CCCCEEECCCCCCCc-cc-c-cccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 5568899999999999995 57665552 379999999999996 43 4 899999999999999999765565699999
Q ss_pred CCeEeccCCcccccCCc---c-CCCCCcEEEeecCcccccCchh
Q 044996 146 LVELRLEGNKFEGQIPD---F-QQKDLVSFNVSNNALFGSISPA 185 (678)
Q Consensus 146 L~~l~l~~N~l~g~~p~---~-~~~~l~~l~l~~N~l~g~ip~~ 185 (678)
|++|+|++|.|+ .+|. . .+++|+.|++++|.++ .+|..
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~ 131 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHY 131 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhH
Confidence 999999999995 5664 2 5679999999999997 45653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-11 Score=129.70 Aligned_cols=142 Identities=19% Similarity=0.283 Sum_probs=118.3
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.+.+ ++. +..+++|+.|++++|.+.+..+ +..+ ++|+.|+|++|++++ +|+ +..+++|+.
T Consensus 177 ~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~~--~~L~~L~l~~n~l~~-~~~--~~~l~~L~~ 247 (347)
T 4fmz_A 177 TDLYSLSLNYNQIED-ISP--LASLTSLHYFTAYVNQITDITP-VANM--TRLNSLKIGNNKITD-LSP--LANLSQLTW 247 (347)
T ss_dssp TTCSEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG-GGGC--TTCCEEECCSSCCCC-CGG--GTTCTTCCE
T ss_pred CCCCEEEccCCcccc-ccc--ccCCCccceeecccCCCCCCch-hhcC--CcCCEEEccCCccCC-Ccc--hhcCCCCCE
Confidence 468899999999874 443 8899999999999999987655 5555 779999999999995 553 789999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc-CCCCCcEEEeecCcccccCchhhhcCC---CCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGSISPALRELD---PSSFSGNR 198 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ip~~~~~l~---~~~~~gn~ 198 (678)
|+|++|.+++. ..+..+++|++|+|++|.+++. |.. ...+|+.|++++|.+++..|..+..+. ...+.+|+
T Consensus 248 L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 248 LEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred EECCCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence 99999999873 4689999999999999999864 543 678999999999999998887766543 44567775
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.7e-11 Score=129.01 Aligned_cols=106 Identities=26% Similarity=0.337 Sum_probs=65.7
Q ss_pred CCcceEEecCCcEEEEEeCCC-CceeecChHHhhcCCCCCEEEccC-CcccccCCc-ccccCCCCccEEEcccCcccccc
Q 044996 35 ANWNGVLCHRGKIWGLKLEDM-GLQGNIDITILKELREMRTLSLMR-NNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEI 111 (678)
Q Consensus 35 ~~w~gv~C~~~~v~~l~l~~~-~l~g~~~~~~l~~l~~L~~L~Ls~-N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~i 111 (678)
|.|..|.|+ ++ +|. .||. |..+++|+.|+|++ |+|.+..|. +..+ .+|+.|+|++|+|+|..
T Consensus 8 C~~~~v~~~----------~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l--~~L~~L~l~~N~l~~~~ 72 (347)
T 2ifg_A 8 HGSSGLRCT----------RDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGL--GELRNLTIVKSGLRFVA 72 (347)
T ss_dssp SSSSCEECC----------SSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSC--CCCSEEECCSSCCCEEC
T ss_pred ccCCEEEcC----------CCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccc--cCCCEEECCCCccceeC
Confidence 467777774 33 455 3664 66777777777775 777766552 4444 55777777777777544
Q ss_pred ChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCccc
Q 044996 112 PTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFE 157 (678)
Q Consensus 112 p~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~ 157 (678)
| ..|.+|++|+.|+|++|+|++..|..+..+. |+.|+|.+|.|.
T Consensus 73 ~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 73 P-DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp T-TGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred H-HHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 4 3467777777777777777654444444443 666666666655
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=3.8e-11 Score=120.92 Aligned_cols=137 Identities=12% Similarity=0.039 Sum_probs=106.4
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
..++.|+++.||++... +..+++|............+.+|+++++.+. |..+.++++++...+..|+||||+++.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45677888999999754 6789999886532233346889999999885 677889999998888999999999999998
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL------------------------------------------- 490 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 490 (678)
+.+. +......++.+++++|+.||.--
T Consensus 99 ~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 7531 11234578999999999999810
Q ss_pred ------------CCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 491 ------------PSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 491 ------------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
.+..++|+|+++.|||++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11358899999999999877667899998753
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.21 E-value=5.5e-12 Score=142.42 Aligned_cols=144 Identities=24% Similarity=0.377 Sum_probs=107.5
Q ss_pred CCCCCCCCCCCCCCCCCcceEE--------ecCCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccc
Q 044996 20 LANWDDRTPPCNENGANWNGVL--------CHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQ 91 (678)
Q Consensus 20 l~~W~~~~~~c~~~~~~w~gv~--------C~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~ 91 (678)
+..|....++| .|.|.. |....+..|+|++++|. .+|... . ++|+.|+|++|+|+. +|. .
T Consensus 12 w~~W~~~~~~~-----~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l-~--~~L~~L~L~~N~l~~-lp~--~ 79 (622)
T 3g06_A 12 WSAWRRAAPAE-----ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL-P--AHITTLVIPDNNLTS-LPA--L 79 (622)
T ss_dssp HHHHHHTCCGG-----GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCC-C--TTCSEEEECSCCCSC-CCC--C
T ss_pred HHHHHhcCCcc-----hhccccccCcccccccCCCCcEEEecCCCcC-ccChhh-C--CCCcEEEecCCCCCC-CCC--c
Confidence 45676666666 587643 33346889999999998 887643 2 789999999999984 664 3
Q ss_pred cCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEE
Q 044996 92 LGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSF 171 (678)
Q Consensus 92 ~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l 171 (678)
+ ++|++|+|++|+|+ .||. .+++|++|+|++|++++ +|. .+++|+.|+|++|+|++ +|.. .++|++|
T Consensus 80 l--~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~-l~~L~~L 146 (622)
T 3g06_A 80 P--PELRTLEVSGNQLT-SLPV----LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL-PPGLQEL 146 (622)
T ss_dssp C--TTCCEEEECSCCCS-CCCC----CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC-CTTCCEE
T ss_pred C--CCCCEEEcCCCcCC-cCCC----CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC-CCCCCEE
Confidence 3 67999999999998 5885 57889999999999986 554 56788888888888885 5553 4778888
Q ss_pred EeecCcccccCchhhhcC
Q 044996 172 NVSNNALFGSISPALREL 189 (678)
Q Consensus 172 ~l~~N~l~g~ip~~~~~l 189 (678)
+|++|++++ +|..+.++
T Consensus 147 ~Ls~N~l~~-l~~~~~~L 163 (622)
T 3g06_A 147 SVSDNQLAS-LPALPSEL 163 (622)
T ss_dssp ECCSSCCSC-CCCCCTTC
T ss_pred ECcCCcCCC-cCCccCCC
Confidence 888888875 34333333
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.21 E-value=3.3e-11 Score=131.56 Aligned_cols=100 Identities=26% Similarity=0.411 Sum_probs=50.8
Q ss_pred CCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEe
Q 044996 71 EMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELR 150 (678)
Q Consensus 71 ~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~ 150 (678)
+|+.|+|++|++++ +|++..+ ++|++|+|++|++++ +|.. ..+|++|+|++|++++ +| .++++++|++|+
T Consensus 132 ~L~~L~L~~n~l~~-lp~~~~l--~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~ 201 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LPELQNS--SFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIY 201 (454)
T ss_dssp TCCEEECCSSCCSS-CCCCTTC--TTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCEEECcCCCCCC-CcccCCC--CCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEE
Confidence 44445555554444 4443333 445555555555553 4422 1355555555555554 44 355566666666
Q ss_pred ccCCcccccCCccCCCCCcEEEeecCcccccCc
Q 044996 151 LEGNKFEGQIPDFQQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 151 l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip 183 (678)
+++|.+++ +|... .+|+.|++++|.++ .+|
T Consensus 202 l~~N~l~~-l~~~~-~~L~~L~l~~n~l~-~lp 231 (454)
T 1jl5_A 202 ADNNSLKK-LPDLP-LSLESIVAGNNILE-ELP 231 (454)
T ss_dssp CCSSCCSS-CCCCC-TTCCEEECCSSCCS-SCC
T ss_pred CCCCcCCc-CCCCc-CcccEEECcCCcCC-ccc
Confidence 66666554 33321 35666666666665 455
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.6e-11 Score=127.82 Aligned_cols=145 Identities=15% Similarity=0.157 Sum_probs=110.0
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc--ccccCCCCcc-EE
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALR-SV 100 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~~~L~-~L 100 (678)
|.|..|.|++ ..++.|+|++|.|+ .||+..|.+|++|+.|+|++|++.+.+|. +..+ ++|+ .+
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L--~~l~~~l 85 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL--PKLHEIR 85 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSC--TTCCEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcc--hhhhhhh
Confidence 5788999963 24788999999998 78877789999999999999999887774 3344 4444 57
Q ss_pred EcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc----CCCCCcEEEeecC
Q 044996 101 YLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF----QQKDLVSFNVSNN 176 (678)
Q Consensus 101 ~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~----~~~~l~~l~l~~N 176 (678)
+++.|+++ .||++.|.++++|++|+|++|++++..+..+....++..|++.+|.-...+|.. ....++.|+|++|
T Consensus 86 ~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N 164 (350)
T 4ay9_X 86 IEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164 (350)
T ss_dssp EEEETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred cccCCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence 77789998 566666899999999999999998777777777778888888765444455542 2245778888888
Q ss_pred cccccCch
Q 044996 177 ALFGSISP 184 (678)
Q Consensus 177 ~l~g~ip~ 184 (678)
+|+. ||.
T Consensus 165 ~i~~-i~~ 171 (350)
T 4ay9_X 165 GIQE-IHN 171 (350)
T ss_dssp CCCE-ECT
T ss_pred cccC-CCh
Confidence 8864 443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.18 E-value=4.5e-12 Score=135.48 Aligned_cols=152 Identities=24% Similarity=0.319 Sum_probs=120.9
Q ss_pred CCcEEEEEeCCCCceeecC---hHHhhcC---------CCCCEEEccCCccc-ccCCc----ccccCCCCccEEEcccCc
Q 044996 44 RGKIWGLKLEDMGLQGNID---ITILKEL---------REMRTLSLMRNNLE-GPMPD----LRQLGNGALRSVYLSNNR 106 (678)
Q Consensus 44 ~~~v~~l~l~~~~l~g~~~---~~~l~~l---------~~L~~L~Ls~N~l~-g~~p~----~~~~~~~~L~~L~Ls~N~ 106 (678)
..++..|+|++|.+.+..+ ...+..+ ++|+.|+|++|+++ +.+|. +..+ ++|+.|+|++|+
T Consensus 121 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~--~~L~~L~L~~n~ 198 (386)
T 2ca6_A 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH--RLLHTVKMVQNG 198 (386)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC--TTCCEEECCSSC
T ss_pred CCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhC--CCcCEEECcCCC
Confidence 4689999999999974322 2345666 99999999999998 55552 3344 679999999999
Q ss_pred cc--c---ccChhhhcCCcccceeeccccccc----cCCchhhcCCCCCCeEeccCCccccc----CCcc----CCCCCc
Q 044996 107 FS--G---EIPTDAFDGMTSLRKLLLADNQFN----GPIPESLTRLSRLVELRLEGNKFEGQ----IPDF----QQKDLV 169 (678)
Q Consensus 107 l~--G---~ip~~~~~~l~~L~~l~l~~N~~~----g~~p~~~~~l~~L~~l~l~~N~l~g~----~p~~----~~~~l~ 169 (678)
++ | .+|.. +..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.+++. +|.. ..++|+
T Consensus 199 l~~~g~~~l~~~~-l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~ 277 (386)
T 2ca6_A 199 IRPEGIEHLLLEG-LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ 277 (386)
T ss_dssp CCHHHHHHHHHTT-GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCC
T ss_pred CCHhHHHHHHHHH-hhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeE
Confidence 98 3 34423 789999999999999997 78999999999999999999999876 4442 378999
Q ss_pred EEEeecCcccc----cCchhh----hcCCCCCCCCCC
Q 044996 170 SFNVSNNALFG----SISPAL----RELDPSSFSGNR 198 (678)
Q Consensus 170 ~l~l~~N~l~g----~ip~~~----~~l~~~~~~gn~ 198 (678)
.|+|++|.+++ .+|..+ .+|....+.+|+
T Consensus 278 ~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 278 TLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp EEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred EEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 99999999998 588765 445556677775
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.17 E-value=3e-12 Score=136.81 Aligned_cols=154 Identities=21% Similarity=0.269 Sum_probs=118.3
Q ss_pred CCcEEEEEeCCCCcee----ecChHHhhcCCCCCEEEccCCcccccCCc-----cccc-------CCCCccEEEcccCcc
Q 044996 44 RGKIWGLKLEDMGLQG----NIDITILKELREMRTLSLMRNNLEGPMPD-----LRQL-------GNGALRSVYLSNNRF 107 (678)
Q Consensus 44 ~~~v~~l~l~~~~l~g----~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-----~~~~-------~~~~L~~L~Ls~N~l 107 (678)
..++..|+|++|.+.+ .++. .+..+++|+.|+|++|.+.+..+. +..+ ..++|++|+|++|++
T Consensus 93 ~~~L~~L~Ls~n~l~~~~~~~l~~-~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l 171 (386)
T 2ca6_A 93 CPKLHTVRLSDNAFGPTAQEPLID-FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171 (386)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHH-HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCC
T ss_pred CCcccEEECCCCcCCHHHHHHHHH-HHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCC
Confidence 3679999999999987 3553 588999999999999999754331 1111 004699999999999
Q ss_pred c-cccCh--hhhcCCcccceeeccccccc--c---CCchhhcCCCCCCeEeccCCccc----ccCCcc--CCCCCcEEEe
Q 044996 108 S-GEIPT--DAFDGMTSLRKLLLADNQFN--G---PIPESLTRLSRLVELRLEGNKFE----GQIPDF--QQKDLVSFNV 173 (678)
Q Consensus 108 ~-G~ip~--~~~~~l~~L~~l~l~~N~~~--g---~~p~~~~~l~~L~~l~l~~N~l~----g~~p~~--~~~~l~~l~l 173 (678)
+ +.+|. ..+..+++|+.|+|++|+++ | .+|..+..+++|+.|+|++|.|+ +.+|.. .+++|+.|+|
T Consensus 172 ~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L 251 (386)
T 2ca6_A 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 251 (386)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred CcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEEC
Confidence 8 56663 23778999999999999998 4 45558899999999999999997 667653 5679999999
Q ss_pred ecCccccc----Cchhh-----hcCCCCCCCCCC
Q 044996 174 SNNALFGS----ISPAL-----RELDPSSFSGNR 198 (678)
Q Consensus 174 ~~N~l~g~----ip~~~-----~~l~~~~~~gn~ 198 (678)
++|.+++. +|..+ .++....+.+|.
T Consensus 252 ~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~ 285 (386)
T 2ca6_A 252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285 (386)
T ss_dssp TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSC
T ss_pred CCCCCchhhHHHHHHHHhhccCCCeEEEECcCCc
Confidence 99999876 56554 234444566663
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.17 E-value=5.1e-11 Score=125.29 Aligned_cols=104 Identities=23% Similarity=0.303 Sum_probs=87.9
Q ss_pred EEEccCC-cccccCCcccccCCCCccEEEccc-CccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEec
Q 044996 74 TLSLMRN-NLEGPMPDLRQLGNGALRSVYLSN-NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRL 151 (678)
Q Consensus 74 ~L~Ls~N-~l~g~~p~~~~~~~~~L~~L~Ls~-N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l 151 (678)
.+++++| +|++ ||.+..+ ++|+.|+|++ |+|++ +|+..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|
T Consensus 12 ~v~~~~~n~l~~-ip~l~~~--~~L~~L~l~~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHHLPGA--ENLTELYIENQQHLQH-LELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp CEECCSSCCCTT-TTTSCSC--SCCSEEECCSCSSCCE-ECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred EEEcCCCCCCCc-cCCCCCC--CCeeEEEccCCCCCCC-cChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 5789988 8887 5656555 6799999996 99995 55556999999999999999999999999999999999999
Q ss_pred cCCcccccCCcc-CCCCCcEEEeecCccccc
Q 044996 152 EGNKFEGQIPDF-QQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 152 ~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ 181 (678)
++|+|++..+.. ....|+.|+|++|.|...
T Consensus 88 ~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 999999655542 334599999999999754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.15 E-value=5.7e-12 Score=131.81 Aligned_cols=149 Identities=19% Similarity=0.206 Sum_probs=97.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCccccc-CCc-ccccCCCCccEEEcccCccccccChhhhcCCccc
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGP-MPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSL 122 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~-~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L 122 (678)
.++..++|+++.+.+..+. +..+++|+.|+|++|.+++. +|. +..+ ++|++|+|++|++++.+|.. ++.+++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~--~~L~~L~L~~~~l~~~~~~~-l~~~~~L 144 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQC--SKLQNLSLEGLRLSDPIVNT-LAKNSNL 144 (336)
T ss_dssp TTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTB--CCCSEEECTTCBCCHHHHHH-HTTCTTC
T ss_pred ccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhC--CCCCEEeCcCcccCHHHHHH-HhcCCCC
Confidence 4577788888877766553 45677788888888877764 553 3334 56777888777777777654 6777777
Q ss_pred ceeecccc-cccc-CCchhhcCCCCCCeEeccCC-ccccc-CCcc--CCC-CCcEEEeecC--ccc-ccCchhhh---cC
Q 044996 123 RKLLLADN-QFNG-PIPESLTRLSRLVELRLEGN-KFEGQ-IPDF--QQK-DLVSFNVSNN--ALF-GSISPALR---EL 189 (678)
Q Consensus 123 ~~l~l~~N-~~~g-~~p~~~~~l~~L~~l~l~~N-~l~g~-~p~~--~~~-~l~~l~l~~N--~l~-g~ip~~~~---~l 189 (678)
++|+|++| .+++ .+|..+.++++|++|+|++| .+++. ++.. ..+ +|+.|++++| .++ +.+|..+. ++
T Consensus 145 ~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L 224 (336)
T 2ast_B 145 VRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 224 (336)
T ss_dssp SEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTC
T ss_pred CEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCC
Confidence 77877777 5766 36666777777777777777 77654 3432 445 7777777777 454 44554433 33
Q ss_pred CCCCCCCCC
Q 044996 190 DPSSFSGNR 198 (678)
Q Consensus 190 ~~~~~~gn~ 198 (678)
....+.+|.
T Consensus 225 ~~L~l~~~~ 233 (336)
T 2ast_B 225 VHLDLSDSV 233 (336)
T ss_dssp SEEECTTCT
T ss_pred CEEeCCCCC
Confidence 333444443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.1e-10 Score=131.64 Aligned_cols=112 Identities=28% Similarity=0.489 Sum_probs=71.7
Q ss_pred CCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeE
Q 044996 70 REMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVEL 149 (678)
Q Consensus 70 ~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l 149 (678)
++|+.|+|++|+|++ +|.. + ++|+.|+|++|.++ .+|. .+++|+.|+|++|+|++ +| ..+++|+.|
T Consensus 181 ~~L~~L~Ls~N~l~~-l~~~--~--~~L~~L~L~~N~l~-~l~~----~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L 246 (622)
T 3g06_A 181 SGLQELSVSDNQLAS-LPTL--P--SELYKLWAYNNRLT-SLPA----LPSGLKELIVSGNRLTS-LP---VLPSELKEL 246 (622)
T ss_dssp TTCCEEECCSSCCSC-CCCC--C--TTCCEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEE
T ss_pred CCCcEEECCCCCCCC-CCCc--c--chhhEEECcCCccc-ccCC----CCCCCCEEEccCCccCc-CC---CCCCcCcEE
Confidence 666667777776665 3321 1 34666666666665 4542 23677777888887775 55 455777888
Q ss_pred eccCCcccccCCccCCCCCcEEEeecCcccccCchhhhcCCC---CCCCCCC
Q 044996 150 RLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALRELDP---SSFSGNR 198 (678)
Q Consensus 150 ~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~l~~---~~~~gn~ 198 (678)
+|++|.|+ .+|. ...+|+.|+|++|+|+ .||..+.++.. ..+.+|+
T Consensus 247 ~Ls~N~L~-~lp~-~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~ 295 (622)
T 3g06_A 247 MVSGNRLT-SLPM-LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295 (622)
T ss_dssp ECCSSCCS-CCCC-CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCC
T ss_pred ECCCCCCC-cCCc-ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCC
Confidence 88888777 4555 5667778888888777 67766655443 3455664
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.8e-11 Score=127.07 Aligned_cols=139 Identities=21% Similarity=0.237 Sum_probs=76.7
Q ss_pred cEEEEEeCCCCceeecCh----HHhhcCC-CCCEEEccCCcccccCCc-cccc--C-CCCccEEEcccCccccccChhh-
Q 044996 46 KIWGLKLEDMGLQGNIDI----TILKELR-EMRTLSLMRNNLEGPMPD-LRQL--G-NGALRSVYLSNNRFSGEIPTDA- 115 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~----~~l~~l~-~L~~L~Ls~N~l~g~~p~-~~~~--~-~~~L~~L~Ls~N~l~G~ip~~~- 115 (678)
.++.|+|++|.+++ ++. ..+..++ +|+.|+|++|.+++..+. +..+ . ..+|++|+|++|++++..+..+
T Consensus 23 ~L~~L~Ls~n~l~~-~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 23 GVTSLDLSLNNLYS-ISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TCCEEECTTSCGGG-SCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CceEEEccCCCCCh-HHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 36667777766653 222 3455666 677777777766665441 1111 0 1456677777777665444321
Q ss_pred --hcCC-cccceeeccccccccCCchhhcC-----CCCCCeEeccCCcccccCCc----c--CC-CCCcEEEeecCcccc
Q 044996 116 --FDGM-TSLRKLLLADNQFNGPIPESLTR-----LSRLVELRLEGNKFEGQIPD----F--QQ-KDLVSFNVSNNALFG 180 (678)
Q Consensus 116 --~~~l-~~L~~l~l~~N~~~g~~p~~~~~-----l~~L~~l~l~~N~l~g~~p~----~--~~-~~l~~l~l~~N~l~g 180 (678)
+..+ ++|+.|+|++|++++..+..+.. .++|++|+|++|.|++..+. . .. .+|+.|+|++|++++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 2223 56777777777766655544332 24677777777766643221 1 12 366777777777666
Q ss_pred cCchh
Q 044996 181 SISPA 185 (678)
Q Consensus 181 ~ip~~ 185 (678)
..+..
T Consensus 182 ~~~~~ 186 (362)
T 3goz_A 182 KNCAE 186 (362)
T ss_dssp SCHHH
T ss_pred hhHHH
Confidence 55543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.08 E-value=6.1e-11 Score=125.54 Aligned_cols=133 Identities=21% Similarity=0.192 Sum_probs=77.4
Q ss_pred cEEEEEeCCCCceeecChHHhhcC-----CCCCEEEccCCcccccCCc-----ccccCCCCccEEEcccCccccccChhh
Q 044996 46 KIWGLKLEDMGLQGNIDITILKEL-----REMRTLSLMRNNLEGPMPD-----LRQLGNGALRSVYLSNNRFSGEIPTDA 115 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l-----~~L~~L~Ls~N~l~g~~p~-----~~~~~~~~L~~L~Ls~N~l~G~ip~~~ 115 (678)
++..|+|++|.+.+..+. .+..+ ++|+.|+|++|.+++..+. +..+ .++|+.|+|++|+|++..+..+
T Consensus 52 ~L~~L~Ls~N~l~~~~~~-~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~-~~~L~~L~Ls~N~l~~~~~~~l 129 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSD-ELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI-PFTITVLDLGWNDFSSKSSSEF 129 (362)
T ss_dssp TCCEEECCSSCGGGSCHH-HHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTS-CTTCCEEECCSSCGGGSCHHHH
T ss_pred ceeEEECcCCCCCHHHHH-HHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhC-CCCccEEECcCCcCCcHHHHHH
Confidence 577777777777644332 23333 6777777777777665542 1111 0357777777777764333221
Q ss_pred ---hcC-CcccceeeccccccccCC----chhhcCCC-CCCeEeccCCcccccCCcc------CC-CCCcEEEeecCccc
Q 044996 116 ---FDG-MTSLRKLLLADNQFNGPI----PESLTRLS-RLVELRLEGNKFEGQIPDF------QQ-KDLVSFNVSNNALF 179 (678)
Q Consensus 116 ---~~~-l~~L~~l~l~~N~~~g~~----p~~~~~l~-~L~~l~l~~N~l~g~~p~~------~~-~~l~~l~l~~N~l~ 179 (678)
+.. .++|++|+|++|.+++.. +..+..++ +|++|+|++|.+++..+.. .. ++|+.|+|++|.++
T Consensus 130 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~ 209 (362)
T 3goz_A 130 KQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLG 209 (362)
T ss_dssp HHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCC
Confidence 222 257777777777776533 33344554 7777777777776555431 22 46777777777776
Q ss_pred c
Q 044996 180 G 180 (678)
Q Consensus 180 g 180 (678)
+
T Consensus 210 ~ 210 (362)
T 3goz_A 210 L 210 (362)
T ss_dssp G
T ss_pred h
Confidence 5
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.8e-10 Score=115.54 Aligned_cols=129 Identities=17% Similarity=0.148 Sum_probs=96.0
Q ss_pred CccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCC--ccceeEEEEeCCceEEEEeccCCCCHHHH
Q 044996 378 GSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN--LLPLVAYYYRKEEKLLVHEFVPKRSLAVN 455 (678)
Q Consensus 378 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~Ey~~~gsL~~~ 455 (678)
+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998777888999987653 2346788999999886545 456888888777899999999998873
Q ss_pred hhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 044996 456 LHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL--------------------------------------------- 490 (678)
Q Consensus 456 l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 490 (678)
... .+ ...++.++++.|..||...
T Consensus 104 ~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 210 11 2356777777777777531
Q ss_pred ---------CCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 491 ---------PSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 491 ---------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
.+..++|+|++|.|||++++..++|+||+.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 01238999999999999887777899999864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.01 E-value=4.5e-12 Score=122.10 Aligned_cols=126 Identities=25% Similarity=0.311 Sum_probs=103.6
Q ss_pred hhcCCCCCEEEccCCcccccCCc-------ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCch
Q 044996 66 LKELREMRTLSLMRNNLEGPMPD-------LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPE 138 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N~l~g~~p~-------~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~ 138 (678)
+.....++.++|+.|.|+|.+|. +..+ ++|++|+|++|++++ +| . +.++++|++|+|++|.++ .+|.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l--~~L~~L~ls~n~l~~-l~-~-~~~l~~L~~L~l~~n~l~-~l~~ 87 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTL--KACKHLALSTNNIEK-IS-S-LSGMENLRILSLGRNLIK-KIEN 87 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHT--TTCSEEECSEEEESC-CC-C-HHHHTTCCEEEEEEEEEC-SCSS
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcC--CCCCEEECCCCCCcc-cc-c-cccCCCCCEEECCCCCcc-cccc
Confidence 56778899999999999999885 4444 679999999999996 88 4 899999999999999999 7898
Q ss_pred hhcCCCCCCeEeccCCcccccCCcc-CCCCCcEEEeecCcccccCc-hhhh---cCCCCCCCCCC
Q 044996 139 SLTRLSRLVELRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGSIS-PALR---ELDPSSFSGNR 198 (678)
Q Consensus 139 ~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ip-~~~~---~l~~~~~~gn~ 198 (678)
.+..+++|++|+|++|.+++ +|.. .+.+|+.|++++|++++..+ ..+. ++....+.+|+
T Consensus 88 ~~~~~~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~ 151 (198)
T 1ds9_A 88 LDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp HHHHHHHCSEEEEEEEECCC-HHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred hhhcCCcCCEEECcCCcCCc-CCccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence 88889999999999999997 5543 56789999999999986322 2343 34445566665
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=7.1e-10 Score=117.10 Aligned_cols=142 Identities=14% Similarity=0.153 Sum_probs=105.0
Q ss_pred cccCccCceeEEEEEecCCceEEEEEec--ccC-hhhHHHHHHHHHHHhccC--CCCccceeEEEEeC---CceEEEEec
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFK--QMN-NVGREEFQEHMRRLGRLR--HPNLLPLVAYYYRK---EEKLLVHEF 446 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~Ey 446 (678)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..|+||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 458999999999998754 567788765 321 123457889999999997 45678899988766 458999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL------------------------------------ 490 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 490 (678)
+++..+.+.. ...++..++..++.++++.|+.||...
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9987774311 124778888999999999999999731
Q ss_pred ------------------CCCCCcccCCCCCCEEecCCCc--eEEeecCCcccc
Q 044996 491 ------------------PSLIAPHGHIKSSNVLLNESLE--PVLADYGLIPVM 524 (678)
Q Consensus 491 ------------------~~~~ivHrdlk~~NILl~~~~~--~kl~DfGla~~~ 524 (678)
....++|+|+++.|||++.++. +.|.||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 0246899999999999997753 689999997653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.97 E-value=1e-09 Score=115.56 Aligned_cols=134 Identities=16% Similarity=0.216 Sum_probs=105.6
Q ss_pred EecCCcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCC
Q 044996 41 LCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGM 119 (678)
Q Consensus 41 ~C~~~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l 119 (678)
.|+. + .++.++++|+ .||..+ .++|+.|+|++|+|+...+. +..+ ++|++|+|++|++.+.||..+|.++
T Consensus 8 ~C~~-~--~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l--~~L~~L~Ls~N~i~~~i~~~~f~~L 78 (350)
T 4ay9_X 8 HCSN-R--VFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGF--GDLEKIEISQNDVLEVIEADVFSNL 78 (350)
T ss_dssp EEET-T--EEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTC--TTCCEEEEECCTTCCEECTTSBCSC
T ss_pred EeeC-C--EEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCC--CCCCEEECcCCCCCCccChhHhhcc
Confidence 4644 3 4678899998 788643 46899999999999975553 5566 7899999999999989998889999
Q ss_pred cccce-eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCc
Q 044996 120 TSLRK-LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 120 ~~L~~-l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip 183 (678)
++|.. +.+++|+++...|..|..+++|++|++++|.+++..+.. ...++..|++.+|.--..+|
T Consensus 79 ~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 79 PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp TTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred hhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 98775 667789999888999999999999999999998655543 44567788887644333344
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=6.2e-10 Score=114.69 Aligned_cols=182 Identities=19% Similarity=0.180 Sum_probs=121.0
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccC-CCC--ccceeEEEEeCC---ceEEEEeccC
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPN--LLPLVAYYYRKE---EKLLVHEFVP 448 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~Ey~~ 448 (678)
+.++.|.+..||+.. ..+++|+... ......+.+|.++|+.+. +.. +.+++.+....+ ..|+||||++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 357899999999863 4578887653 234567899999998884 333 334444433322 3489999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL-------------------------------------- 490 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 490 (678)
+.+|...... .++..++..++.++++.|+.||...
T Consensus 100 G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9888653321 3677778888888888888888610
Q ss_pred ----------------CCCCCcccCCCCCCEEecC--CCceEEeecCCccccCccccccccc----------------ee
Q 044996 491 ----------------PSLIAPHGHIKSSNVLLNE--SLEPVLADYGLIPVMNQESAQELMI----------------AY 536 (678)
Q Consensus 491 ----------------~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~----------------~y 536 (678)
....++|+|+++.||++++ +..+.|+||+.+........-.... .|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1235799999999999998 5668899999876533211000000 11
Q ss_pred --eC-ccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 537 --KS-PEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 537 --~a-PE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.. |+... +.....+.|+++.++|++.+|+.+|.
T Consensus 253 ~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 22111 11223689999999999999998764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.90 E-value=2.5e-10 Score=124.73 Aligned_cols=134 Identities=21% Similarity=0.233 Sum_probs=84.8
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCccccc----CCc-ccccCCCCccEEEcccCccccccChhhhcCCc
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGP----MPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMT 120 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~----~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~ 120 (678)
+++.|+|+++.++..-....+..+++|+.|+|++|.++.. ++. +..+ ++|++|+|++|.++...+..++..+.
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~--~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVN--PALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTC--TTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhC--CCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 4677777777766433333466677777777777777642 232 2333 55777777777776544444344455
Q ss_pred ----ccceeecccccccc----CCchhhcCCCCCCeEeccCCcccccCCcc-------CCCCCcEEEeecCccccc
Q 044996 121 ----SLRKLLLADNQFNG----PIPESLTRLSRLVELRLEGNKFEGQIPDF-------QQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 121 ----~L~~l~l~~N~~~g----~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-------~~~~l~~l~l~~N~l~g~ 181 (678)
+|++|+|++|+++. .+|..+..+++|++|+|++|.+++..+.. ...+|+.|+|++|.+++.
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~ 157 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA 157 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGG
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHH
Confidence 57777777777773 55777777777777777777776543321 234677777777777653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.85 E-value=3.1e-10 Score=123.99 Aligned_cols=151 Identities=19% Similarity=0.206 Sum_probs=91.1
Q ss_pred CcEEEEEeCCCCceee----cChHHhhcCCCCCEEEccCCccccc----CCc-ccccCCCCccEEEcccCccccccChh-
Q 044996 45 GKIWGLKLEDMGLQGN----IDITILKELREMRTLSLMRNNLEGP----MPD-LRQLGNGALRSVYLSNNRFSGEIPTD- 114 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~----~~~~~l~~l~~L~~L~Ls~N~l~g~----~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~- 114 (678)
.++..|+|++|.+.+. +.+..+..+++|+.|+|++|.+++. ++. +..+ ++|++|+|++|.+++..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~--~~L~~L~Ls~n~i~~~~~~~l 304 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK--ESLKELSLAGNELGDEGARLL 304 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC--TTCCEEECTTCCCHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhC--CCcceEECCCCCCchHHHHHH
Confidence 4677888888877543 2222233577788888888877763 332 2233 56777777777776443322
Q ss_pred ---hhcCCcccceeeccccccccC----CchhhcCCCCCCeEeccCCcccccCCcc-------CCCCCcEEEeecCcccc
Q 044996 115 ---AFDGMTSLRKLLLADNQFNGP----IPESLTRLSRLVELRLEGNKFEGQIPDF-------QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 115 ---~~~~l~~L~~l~l~~N~~~g~----~p~~~~~l~~L~~l~l~~N~l~g~~p~~-------~~~~l~~l~l~~N~l~g 180 (678)
.....++|+.|+|++|.+++. +|..+..+++|++|+|++|.+++..+.. ...+|+.|+|++|.+++
T Consensus 305 ~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred HHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 111235777777777777765 5666666777777777777776543321 14577777777777765
Q ss_pred ----cCchhhh---cCCCCCCCCC
Q 044996 181 ----SISPALR---ELDPSSFSGN 197 (678)
Q Consensus 181 ----~ip~~~~---~l~~~~~~gn 197 (678)
.+|..+. ++....+.+|
T Consensus 385 ~~~~~l~~~l~~~~~L~~L~l~~N 408 (461)
T 1z7x_W 385 SSCSSLAATLLANHSLRELDLSNN 408 (461)
T ss_dssp HHHHHHHHHHHHCCCCCEEECCSS
T ss_pred hhHHHHHHHHHhCCCccEEECCCC
Confidence 5665543 3333345555
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.83 E-value=4e-11 Score=119.93 Aligned_cols=143 Identities=16% Similarity=0.181 Sum_probs=87.6
Q ss_pred CcceEEecCC--cEEEEEeCC---CCceeecChHHhhcCCCCCEEEccCCcccccCC--cccccCCCCccE--EEcccCc
Q 044996 36 NWNGVLCHRG--KIWGLKLED---MGLQGNIDITILKELREMRTLSLMRNNLEGPMP--DLRQLGNGALRS--VYLSNNR 106 (678)
Q Consensus 36 ~w~gv~C~~~--~v~~l~l~~---~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~L~~--L~Ls~N~ 106 (678)
+|.|+.|+.. +|+.+...+ ..+.|.+.++.+..|+. .|...+|..++.++ .+... +.|.. ++++.|+
T Consensus 79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~d--p~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSD--PDLVAQNIDVVLNR 154 (267)
T ss_dssp HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGC--HHHHHTTCCCCTTS
T ss_pred hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCC--cchhhcCccccCCH
Confidence 7999999743 676665555 45567777665544443 23333344433332 11111 22333 5666663
Q ss_pred ---cccccChhhhcCCcccceeecccccccc--CCchhhcCCCCCCeEeccCCcccccCCccCCC--CCcEEEeecCccc
Q 044996 107 ---FSGEIPTDAFDGMTSLRKLLLADNQFNG--PIPESLTRLSRLVELRLEGNKFEGQIPDFQQK--DLVSFNVSNNALF 179 (678)
Q Consensus 107 ---l~G~ip~~~~~~l~~L~~l~l~~N~~~g--~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~--~l~~l~l~~N~l~ 179 (678)
+.+.++. +..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.-.-..+. +|+.|+|++|.++
T Consensus 155 ~~~~~~~l~i-~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 155 RSCMAATLRI-IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLC 233 (267)
T ss_dssp HHHHHHHHHH-HHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTG
T ss_pred HHHHHHHHHH-HHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCc
Confidence 3333332 23567888888888888887 66677778888888888888888641111222 7888888888888
Q ss_pred ccCc
Q 044996 180 GSIS 183 (678)
Q Consensus 180 g~ip 183 (678)
+.+|
T Consensus 234 ~~~~ 237 (267)
T 3rw6_A 234 DTFR 237 (267)
T ss_dssp GGCS
T ss_pred cccC
Confidence 8776
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.75 E-value=7.4e-10 Score=117.35 Aligned_cols=41 Identities=27% Similarity=0.292 Sum_probs=18.0
Q ss_pred cCCcccceeeccccccccC----CchhhcCCCCCCeEeccCCccc
Q 044996 117 DGMTSLRKLLLADNQFNGP----IPESLTRLSRLVELRLEGNKFE 157 (678)
Q Consensus 117 ~~l~~L~~l~l~~N~~~g~----~p~~~~~l~~L~~l~l~~N~l~ 157 (678)
..+++|++|+|++|.++.. ++..+..+++|+.|+|++|.|+
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 3344444444444444421 2333344444444444444443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.58 E-value=2.6e-09 Score=113.19 Aligned_cols=150 Identities=17% Similarity=0.158 Sum_probs=105.2
Q ss_pred CcEEEEEeCCCCceeecChHHhh-----cCCCCCEEEccCCcccccCC-cc-cccCCCCccEEEcccCccccccChhhh-
Q 044996 45 GKIWGLKLEDMGLQGNIDITILK-----ELREMRTLSLMRNNLEGPMP-DL-RQLGNGALRSVYLSNNRFSGEIPTDAF- 116 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~-----~l~~L~~L~Ls~N~l~g~~p-~~-~~~~~~~L~~L~Ls~N~l~G~ip~~~~- 116 (678)
..+..|+|++|.++..-. ..+. ..++|+.|+|++|.++..-. .+ ..+ .+|+.|+|++|+|+..-... +
T Consensus 72 ~~L~~L~Ls~n~l~~~~~-~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L--~~L~~L~Ls~n~l~~~~~~~-L~ 147 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKC-TVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVF--LRARKLGLQLNSLGPEACKD-LR 147 (372)
T ss_dssp TTCCEEECTTSCCCHHHH-HHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHH--HTEEEEECCSSCCCHHHHHH-HH
T ss_pred hhCCEEEecCCCCCHHHH-HHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHH--HhccHhhcCCCCCCHHHHHH-HH
Confidence 468899999999874321 1222 23799999999999865311 11 123 46999999999997543222 3
Q ss_pred ----cCCcccceeecccccccc----CCchhhcCCCCCCeEeccCCcccccC----Cc--cCCCCCcEEEeecCccccc-
Q 044996 117 ----DGMTSLRKLLLADNQFNG----PIPESLTRLSRLVELRLEGNKFEGQI----PD--FQQKDLVSFNVSNNALFGS- 181 (678)
Q Consensus 117 ----~~l~~L~~l~l~~N~~~g----~~p~~~~~l~~L~~l~l~~N~l~g~~----p~--~~~~~l~~l~l~~N~l~g~- 181 (678)
...++|+.|+|++|.++. .++..+..+++|++|+|++|.|+..- +. ....+|+.|+|++|.|+..
T Consensus 148 ~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g 227 (372)
T 3un9_A 148 DLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTA 227 (372)
T ss_dssp HHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHH
T ss_pred HHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHH
Confidence 356889999999999975 35666788999999999999997532 22 1346899999999999753
Q ss_pred ---Cchhh---hcCCCCCCCCCC
Q 044996 182 ---ISPAL---RELDPSSFSGNR 198 (678)
Q Consensus 182 ---ip~~~---~~l~~~~~~gn~ 198 (678)
+...+ ..+...++.+|.
T Consensus 228 ~~~l~~~L~~~~~L~~L~Ls~N~ 250 (372)
T 3un9_A 228 ALALARAAREHPSLELLHLYFNE 250 (372)
T ss_dssp HHHHHHHHHHCSSCCEEECTTSS
T ss_pred HHHHHHHHHhCCCCCEEeccCCC
Confidence 33333 344455566663
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.53 E-value=2.6e-08 Score=112.26 Aligned_cols=112 Identities=9% Similarity=0.083 Sum_probs=55.9
Q ss_pred hhcCCCCCEEEccCCcccccCCc-ccc-cCCCCccEEEcc----cCccccc-----cChhhhcCCcccceeeccc--ccc
Q 044996 66 LKELREMRTLSLMRNNLEGPMPD-LRQ-LGNGALRSVYLS----NNRFSGE-----IPTDAFDGMTSLRKLLLAD--NQF 132 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N~l~g~~p~-~~~-~~~~~L~~L~Ls----~N~l~G~-----ip~~~~~~l~~L~~l~l~~--N~~ 132 (678)
+..+++|+.|+|+.|++++..+. +.. + ++|+.|+|+ .|++++. ++. .+.++++|+.|+|++ |.+
T Consensus 374 ~~~~~~L~~L~l~~~~l~~~~~~~l~~~~--~~L~~L~l~~~~~~n~l~~~p~~~~~~~-~~~~~~~L~~L~L~~~~~~l 450 (592)
T 3ogk_B 374 AQGCQELEYMAVYVSDITNESLESIGTYL--KNLCDFRLVLLDREERITDLPLDNGVRS-LLIGCKKLRRFAFYLRQGGL 450 (592)
T ss_dssp HHHCTTCSEEEEEESCCCHHHHHHHHHHC--CSCCEEEEEECSCCSCCSSCCCHHHHHH-HHHHCTTCCEEEEECCGGGC
T ss_pred HhhCccCeEEEeecCCccHHHHHHHHhhC--CCCcEEEEeecCCCccccCchHHHHHHH-HHHhCCCCCEEEEecCCCCc
Confidence 44566666666666666554331 111 2 446666664 4555542 332 244555666666653 234
Q ss_pred ccCCchhhcC-CCCCCeEeccCCccccc-CCc--cCCCCCcEEEeecCcccc
Q 044996 133 NGPIPESLTR-LSRLVELRLEGNKFEGQ-IPD--FQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 133 ~g~~p~~~~~-l~~L~~l~l~~N~l~g~-~p~--~~~~~l~~l~l~~N~l~g 180 (678)
++..+..++. +++|++|+|++|.+++. ++. ..+++|+.|+|++|.|++
T Consensus 451 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 451 TDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp CHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred cHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence 4444444432 55566666666655542 222 134555666666665543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.41 E-value=2.1e-08 Score=100.22 Aligned_cols=102 Identities=22% Similarity=0.374 Sum_probs=68.0
Q ss_pred hhcCCCCCE--EEccCCc---ccccCCcc-cccCCCCccEEEcccCcccc--ccChhhhcCCcccceeeccccccccCCc
Q 044996 66 LKELREMRT--LSLMRNN---LEGPMPDL-RQLGNGALRSVYLSNNRFSG--EIPTDAFDGMTSLRKLLLADNQFNGPIP 137 (678)
Q Consensus 66 l~~l~~L~~--L~Ls~N~---l~g~~p~~-~~~~~~~L~~L~Ls~N~l~G--~ip~~~~~~l~~L~~l~l~~N~~~g~~p 137 (678)
+...+.|.. ++++.|. +.+.++.. ..+ ++|+.|+|++|+|++ .||.. +..+++|+.|+|++|+|++.
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l--~~L~~L~Ls~N~l~~l~~l~~~-~~~l~~L~~L~Ls~N~i~~~-- 211 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENI--PELLSLNLSNNRLYRLDDMSSI-VQKAPNLKILNLSGNELKSE-- 211 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHC--TTCCEEECTTSCCCCCGGGTTH-HHHSTTCCEEECTTSCCCSG--
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhC--CCCCEEECCCCCCCCCccchhH-HhhCCCCCEEECCCCccCCc--
Confidence 444444544 6677773 33322211 223 568889999999887 56643 67888999999999998875
Q ss_pred hhhcCCC--CCCeEeccCCcccccCCcc---------CCCCCcEEE
Q 044996 138 ESLTRLS--RLVELRLEGNKFEGQIPDF---------QQKDLVSFN 172 (678)
Q Consensus 138 ~~~~~l~--~L~~l~l~~N~l~g~~p~~---------~~~~l~~l~ 172 (678)
..+..+. +|++|+|++|.+.+.+|.. ...+|+.||
T Consensus 212 ~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 212 RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 3344444 8889999999998887731 345666654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.1e-06 Score=88.20 Aligned_cols=136 Identities=17% Similarity=0.102 Sum_probs=92.3
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCC---CccceeEEEE-eCCceEEEEeccCCC
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHP---NLLPLVAYYY-RKEEKLLVHEFVPKR 450 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~Ey~~~g 450 (678)
+.++.|....||+. +..+++|+... ......+.+|.++|..+.+. .+.+++.++. ..+..++||||+++.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 34788888899988 56678887532 33456789999999999753 2556666664 345678999999998
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL---------------------------------------- 490 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 490 (678)
.+...... .++..++..++.++++.|+.||.-.
T Consensus 99 ~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 87653211 1334444455555555555555311
Q ss_pred ----------------CCCCCcccCCCCCCEEecC---CCc-eEEeecCCccc
Q 044996 491 ----------------PSLIAPHGHIKSSNVLLNE---SLE-PVLADYGLIPV 523 (678)
Q Consensus 491 ----------------~~~~ivHrdlk~~NILl~~---~~~-~kl~DfGla~~ 523 (678)
.+..++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335789999999999997 455 58999998644
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.40 E-value=5.1e-07 Score=93.81 Aligned_cols=130 Identities=17% Similarity=0.147 Sum_probs=94.3
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCccccc-------------CCccc--------------c-----c
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGP-------------MPDLR--------------Q-----L 92 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~-------------~p~~~--------------~-----~ 92 (678)
..+..|+|.+ ++. .|+...|.+|++|+.|+|++|.+... +|.-. . +
T Consensus 101 ~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 101 QTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp TTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred CCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 4578888888 676 67777899999999999999975311 11000 0 0
Q ss_pred ---------------------------------------------CCCCccEEEcccCccccccChhhhcCCcccceeec
Q 044996 93 ---------------------------------------------GNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLL 127 (678)
Q Consensus 93 ---------------------------------------------~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l 127 (678)
...+|+.|+|++|+++ .||...|.++++|+.|+|
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEEC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEEC
Confidence 0257888888888888 788888888889999999
Q ss_pred cccccccCCchhhcCCCCCC-eEeccCCcccccCCcc---CCCCCcEEEeecCcccc
Q 044996 128 ADNQFNGPIPESLTRLSRLV-ELRLEGNKFEGQIPDF---QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 128 ~~N~~~g~~p~~~~~l~~L~-~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N~l~g 180 (678)
++| ++..-+..|.+|.+|+ .++|.+ .++ .|+.. .+.+|+.+++++|+++.
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l~l~~n~i~~ 311 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYVLATGDKITT 311 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEEEECSSCCCE
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEEEeCCCccCc
Confidence 888 6655566788888898 888887 454 45432 56788888888887753
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.24 E-value=1.2e-07 Score=106.81 Aligned_cols=132 Identities=6% Similarity=-0.020 Sum_probs=70.9
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEcc-----------CCccccc-CCc-ccccCCCCccEEEcccCccccccC
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLM-----------RNNLEGP-MPD-LRQLGNGALRSVYLSNNRFSGEIP 112 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls-----------~N~l~g~-~p~-~~~~~~~~L~~L~Ls~N~l~G~ip 112 (678)
++..|+|. +.+........+..+++|+.|+|+ .|.+++. ++. ...+ ++|++|+|+.|++++..+
T Consensus 319 ~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~--~~L~~L~l~~~~l~~~~~ 395 (592)
T 3ogk_B 319 NLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC--QELEYMAVYVSDITNESL 395 (592)
T ss_dssp TCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHC--TTCSEEEEEESCCCHHHH
T ss_pred CCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhC--ccCeEEEeecCCccHHHH
Confidence 45666666 333322222344566667777776 2444432 111 1123 456777776677766655
Q ss_pred hhhhcCCcccceeecc----ccccccC-----CchhhcCCCCCCeEeccCC--cccccCCcc---CCCCCcEEEeecCcc
Q 044996 113 TDAFDGMTSLRKLLLA----DNQFNGP-----IPESLTRLSRLVELRLEGN--KFEGQIPDF---QQKDLVSFNVSNNAL 178 (678)
Q Consensus 113 ~~~~~~l~~L~~l~l~----~N~~~g~-----~p~~~~~l~~L~~l~l~~N--~l~g~~p~~---~~~~l~~l~l~~N~l 178 (678)
..+...+++|+.|+|+ .|++++. ++..+.++++|+.|+|+++ .+++..+.. ..++|+.|+|++|.+
T Consensus 396 ~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l 475 (592)
T 3ogk_B 396 ESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGE 475 (592)
T ss_dssp HHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCS
T ss_pred HHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCC
Confidence 5422236667777774 5566653 4444556667777776532 244433321 345667777777766
Q ss_pred cc
Q 044996 179 FG 180 (678)
Q Consensus 179 ~g 180 (678)
++
T Consensus 476 ~~ 477 (592)
T 3ogk_B 476 SD 477 (592)
T ss_dssp SH
T ss_pred CH
Confidence 65
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=5.4e-06 Score=83.27 Aligned_cols=134 Identities=20% Similarity=0.208 Sum_probs=93.1
Q ss_pred cCccCce-eEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 377 LGSGCFG-SSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 377 lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
+..|..+ .||+.... .+..+++|+... ....++.+|...|+.+. +--+.++++++.+.+..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445554 68988764 356788887653 23557888999988874 333667889999889999999999998877
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE-------------------------------------------- 489 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------- 489 (678)
+..... ......++.+++..|.-||..
T Consensus 109 ~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 109 QVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 654321 122334555555666666521
Q ss_pred -------C---CCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 490 -------L---PSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 490 -------~---~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
. ....++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1 12237899999999999988777899998864
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.14 E-value=5.2e-07 Score=85.41 Aligned_cols=112 Identities=17% Similarity=0.264 Sum_probs=80.4
Q ss_pred HhhcCCCCCEEEccCC-ccccc----CC-cccccCCCCccEEEcccCccccc----cChhhhcCCcccceeecccccccc
Q 044996 65 ILKELREMRTLSLMRN-NLEGP----MP-DLRQLGNGALRSVYLSNNRFSGE----IPTDAFDGMTSLRKLLLADNQFNG 134 (678)
Q Consensus 65 ~l~~l~~L~~L~Ls~N-~l~g~----~p-~~~~~~~~~L~~L~Ls~N~l~G~----ip~~~~~~l~~L~~l~l~~N~~~g 134 (678)
.+...+.|+.|+|++| .+... +. .+.. +++|++|+|++|+|+.. |.. .+...++|++|+|++|.++.
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~--~~~L~~L~Ls~n~i~~~g~~~l~~-~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKT--NTYVKKFSIVGTRSNDPVAFALAE-MLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTT--CCSCCEEECTTSCCCHHHHHHHHH-HHHHCSSCCEEECCSSCCCH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHh--CCCcCEEECcCCCCChHHHHHHHH-HHHhCCCcCEEECcCCcCCH
Confidence 4677888999999998 77642 11 1222 26799999999998632 222 25566789999999999875
Q ss_pred C----CchhhcCCCCCCeEec--cCCcccccCCc------cCCCCCcEEEeecCccc
Q 044996 135 P----IPESLTRLSRLVELRL--EGNKFEGQIPD------FQQKDLVSFNVSNNALF 179 (678)
Q Consensus 135 ~----~p~~~~~l~~L~~l~l--~~N~l~g~~p~------~~~~~l~~l~l~~N~l~ 179 (678)
. +...+...++|++|+| ++|.|...--. ...++|+.|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4 5666777889999999 88988754211 13468999999999885
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.12 E-value=4.4e-07 Score=102.23 Aligned_cols=108 Identities=7% Similarity=0.047 Sum_probs=50.5
Q ss_pred cCCCCCEEEccCCcccccCCc-cc-ccCCCCccEEEcc--c----Ccccc-----ccChhhhcCCcccceeecccccccc
Q 044996 68 ELREMRTLSLMRNNLEGPMPD-LR-QLGNGALRSVYLS--N----NRFSG-----EIPTDAFDGMTSLRKLLLADNQFNG 134 (678)
Q Consensus 68 ~l~~L~~L~Ls~N~l~g~~p~-~~-~~~~~~L~~L~Ls--~----N~l~G-----~ip~~~~~~l~~L~~l~l~~N~~~g 134 (678)
.+++|+.|+++.|++++..+. +. .+ ++|+.|+|+ + |++++ .++. ++.++++|+.|+|++ .+++
T Consensus 370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~--~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~-l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 370 GCPKLESVLYFCRQMTNAALITIARNR--PNMTRFRLCIIEPKAPDYLTLEPLDIGFGA-IVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HCTTCCEEEEEESCCCHHHHHHHHHHC--TTCCEEEEEESSTTCCCTTTCCCTHHHHHH-HHHHCTTCCEEECCS-SCCH
T ss_pred hchhHHHHHHhcCCcCHHHHHHHHhhC--CCcceeEeecccCCCcccccCCchhhHHHH-HHhhCCCccEEeecC-cccH
Confidence 456666666666665543221 11 12 445666665 2 33431 1111 134455555555544 4444
Q ss_pred CCchhhcC-CCCCCeEeccCCcccccCCcc---CCCCCcEEEeecCccc
Q 044996 135 PIPESLTR-LSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNNALF 179 (678)
Q Consensus 135 ~~p~~~~~-l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N~l~ 179 (678)
..+..++. +++|+.|+|++|.+++..+.. .+++|+.|+|++|.++
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 44444443 555555555555554432221 2345555555555554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=3e-06 Score=88.94 Aligned_cols=79 Identities=4% Similarity=-0.024 Sum_probs=54.3
Q ss_pred ccc-CccCceeEEEEEec-------CCceEEEEEecccC---hhhHHHHHHHHHHHhccCC---CCccceeEEEEeC---
Q 044996 375 EIL-GSGCFGSSYKASLS-------TGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRH---PNLLPLVAYYYRK--- 437 (678)
Q Consensus 375 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H---~niv~l~~~~~~~--- 437 (678)
+.| +.|....+|+.... ++..+++|...... ......+.+|+++++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 347 88889999998764 25678888765422 1112467788888888742 3467788887654
Q ss_pred CceEEEEeccCCCCHH
Q 044996 438 EEKLLVHEFVPKRSLA 453 (678)
Q Consensus 438 ~~~~lv~Ey~~~gsL~ 453 (678)
+..++||||+++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999886654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.5e-06 Score=97.75 Aligned_cols=117 Identities=14% Similarity=0.192 Sum_probs=70.9
Q ss_pred hhcCCCCCEEEccCCcccccCCc-cc-ccCCCCccEEEcccC-ccccc-cChhhhcCCcccceeeccccccccCCchhhc
Q 044996 66 LKELREMRTLSLMRNNLEGPMPD-LR-QLGNGALRSVYLSNN-RFSGE-IPTDAFDGMTSLRKLLLADNQFNGPIPESLT 141 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N~l~g~~p~-~~-~~~~~~L~~L~Ls~N-~l~G~-ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~ 141 (678)
...+++|+.|+|++|.+++..+. +. .+ ++|+.|+|++| .++.. ++ .++.++++|++|+|++|.+++..+..+.
T Consensus 101 ~~~~~~L~~L~L~~~~~~~~~~~~l~~~~--~~L~~L~L~~~~~~~~~~l~-~~~~~~~~L~~L~L~~~~i~~~~~~~l~ 177 (594)
T 2p1m_B 101 SSSYTWLEEIRLKRMVVTDDCLELIAKSF--KNFKVLVLSSCEGFSTDGLA-AIAATCRNLKELDLRESDVDDVSGHWLS 177 (594)
T ss_dssp HHHCTTCCEEEEESCBCCHHHHHHHHHHC--TTCCEEEEESCEEEEHHHHH-HHHHHCTTCCEEECTTCEEECCCGGGGG
T ss_pred HHhCCCCCeEEeeCcEEcHHHHHHHHHhC--CCCcEEeCCCcCCCCHHHHH-HHHHhCCCCCEEeCcCCccCCcchHHHH
Confidence 44677777788877777665432 21 23 56777888777 45433 33 3355677788888887777765554443
Q ss_pred ----CCCCCCeEeccCCcccccCCc-------cCCCCCcEEEeecCcccccCchhhh
Q 044996 142 ----RLSRLVELRLEGNKFEGQIPD-------FQQKDLVSFNVSNNALFGSISPALR 187 (678)
Q Consensus 142 ----~l~~L~~l~l~~N~l~g~~p~-------~~~~~l~~l~l~~N~l~g~ip~~~~ 187 (678)
.+++|+.|+|++|. +.+.. ...++|+.|+|++|...+.+|..+.
T Consensus 178 ~~~~~~~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~ 232 (594)
T 2p1m_B 178 HFPDTYTSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQ 232 (594)
T ss_dssp GSCTTCCCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHH
T ss_pred HHhhcCCcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHh
Confidence 55677888887776 22221 1346777888877732222554443
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=3.2e-05 Score=80.34 Aligned_cols=142 Identities=15% Similarity=0.225 Sum_probs=79.5
Q ss_pred ccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccC-----CCCcccee-E--EEEeCCceEEEEecc
Q 044996 376 ILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-----HPNLLPLV-A--YYYRKEEKLLVHEFV 447 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~-~--~~~~~~~~~lv~Ey~ 447 (678)
.|+.|..+.||+....++ .+++|+.... ..++..|.+++..|. .|.++... | +....+..++||||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 466677899999987655 4888887652 233444555555442 24443311 1 123456789999999
Q ss_pred CCCCHH--------------HHhhccCC-CC-C-------CCCChHHHH-------------------------------
Q 044996 448 PKRSLA--------------VNLHGHQA-LG-Q-------PSLDWPSRL------------------------------- 473 (678)
Q Consensus 448 ~~gsL~--------------~~l~~~~~-~~-~-------~~l~~~~~~------------------------------- 473 (678)
++..+. ..+|.... .. . ..-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 12232111 00 0 012343211
Q ss_pred HHHHHHHHHHHHHHH--------h-CCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 474 KIVKGVAKGLQYLYR--------E-LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 474 ~i~~~ia~gL~yLH~--------~-~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
.+...+..++.+|+. . ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445667763 1 014579999999999999888899999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=5e-05 Score=80.87 Aligned_cols=74 Identities=14% Similarity=0.153 Sum_probs=48.7
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEecccCh-------hhHHHHHHHHHHHhccCC--CCcc-ceeEEEEeCCceEEE
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQMNN-------VGREEFQEHMRRLGRLRH--PNLL-PLVAYYYRKEEKLLV 443 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~H--~niv-~l~~~~~~~~~~~lv 443 (678)
+.||.|.++.||++... .+..+++|....... ...+.+..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999754 467889997653211 123456778888887742 3333 55543 45567899
Q ss_pred EeccCCC
Q 044996 444 HEFVPKR 450 (678)
Q Consensus 444 ~Ey~~~g 450 (678)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.87 E-value=1.7e-05 Score=82.15 Aligned_cols=99 Identities=16% Similarity=0.148 Sum_probs=77.8
Q ss_pred cCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccc-eeeccccccccCCchhhcCCCC
Q 044996 68 ELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR-KLLLADNQFNGPIPESLTRLSR 145 (678)
Q Consensus 68 ~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~-~l~l~~N~~~g~~p~~~~~l~~ 145 (678)
.+++|+.|+|++|+++...+ .+..+ .+|+.|+|++| +. .|+..+|.++.+|+ .|+|.+ +++..-+..|.+|++
T Consensus 224 ~~~~L~~l~L~~n~i~~I~~~aF~~~--~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~ 298 (329)
T 3sb4_A 224 YMPNLVSLDISKTNATTIPDFTFAQK--KYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDN 298 (329)
T ss_dssp HCTTCCEEECTTBCCCEECTTTTTTC--TTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTT
T ss_pred hcCCCeEEECCCCCcceecHhhhhCC--CCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCcc
Confidence 48999999999998874333 24444 67999999988 76 78888899999999 999988 677566788999999
Q ss_pred CCeEeccCCcccccCCc--c-CCCCCcEEE
Q 044996 146 LVELRLEGNKFEGQIPD--F-QQKDLVSFN 172 (678)
Q Consensus 146 L~~l~l~~N~l~g~~p~--~-~~~~l~~l~ 172 (678)
|+.|+|++|.++ .|+. + .+.+|+.++
T Consensus 299 L~~l~l~~n~i~-~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 299 LRYVLATGDKIT-TLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEEEEECSSCCC-EECTTTTCTTCCCCEEE
T ss_pred CCEEEeCCCccC-ccchhhhcCCcchhhhc
Confidence 999999999887 4443 2 456777765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.84 E-value=6.4e-05 Score=80.70 Aligned_cols=75 Identities=11% Similarity=0.060 Sum_probs=50.5
Q ss_pred CCCCcccCCCCCCEEecCCCceEEeecCCccccCccccc-----cccceeeCccccccC---CCCCcchHHHHHHHHHHH
Q 044996 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ-----ELMIAYKSPEFLQLG---RITKKTDVWSLGVLILEI 563 (678)
Q Consensus 492 ~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-----~~~~~y~aPE~~~~~---~~t~ksDvwS~Gvvl~el 563 (678)
...++|+|+++.|||++.++ ++|+||+.+..-.....- .....|.+|+..... .-....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45789999999999999876 999999998764432111 112346777655321 112235566888888988
Q ss_pred HhCC
Q 044996 564 MTGK 567 (678)
Q Consensus 564 ~tg~ 567 (678)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8765
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.79 E-value=4.6e-06 Score=78.76 Aligned_cols=110 Identities=18% Similarity=0.286 Sum_probs=82.8
Q ss_pred CCcEEEEEeCCC-Cceee----cChHHhhcCCCCCEEEccCCccccc----CCc-ccccCCCCccEEEcccCccccc---
Q 044996 44 RGKIWGLKLEDM-GLQGN----IDITILKELREMRTLSLMRNNLEGP----MPD-LRQLGNGALRSVYLSNNRFSGE--- 110 (678)
Q Consensus 44 ~~~v~~l~l~~~-~l~g~----~~~~~l~~l~~L~~L~Ls~N~l~g~----~p~-~~~~~~~~L~~L~Ls~N~l~G~--- 110 (678)
...++.|+|++| .+... +. ..+...+.|+.|+|++|.+... +.. +.. +..|++|+|++|+|+..
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~-~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~--n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACA-EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV--NNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHH-HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHH--CSSCCEEECCSSCCCHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHH-HHHHhCCCcCEEECcCCCCChHHHHHHHHHHHh--CCCcCEEECcCCcCCHHHHH
Confidence 457999999999 88632 22 2466789999999999998642 111 222 26799999999999853
Q ss_pred -cChhhhcCCcccceeec--cccccccC----CchhhcCCCCCCeEeccCCccc
Q 044996 111 -IPTDAFDGMTSLRKLLL--ADNQFNGP----IPESLTRLSRLVELRLEGNKFE 157 (678)
Q Consensus 111 -ip~~~~~~l~~L~~l~l--~~N~~~g~----~p~~~~~l~~L~~l~l~~N~l~ 157 (678)
|.. .+...++|++|+| ++|.++.. +...+...++|+.|+|++|.+.
T Consensus 112 ~l~~-~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVE-ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHH-GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHH-HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 332 3667789999999 88999864 4455667799999999999885
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.64 E-value=5.1e-05 Score=79.49 Aligned_cols=131 Identities=15% Similarity=0.202 Sum_probs=87.0
Q ss_pred CcEEEEEeCCCCc---------eeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhh
Q 044996 45 GKIWGLKLEDMGL---------QGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDA 115 (678)
Q Consensus 45 ~~v~~l~l~~~~l---------~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~ 115 (678)
.++..|.+.++.. .+.+. ..+..+++|+.|+|++|.-. .++.+. .++|+.|+|..|.++...-..
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~-~ll~~~P~L~~L~L~g~~~l-~l~~~~---~~~L~~L~L~~~~l~~~~l~~- 212 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLS-PVLDAMPLLNNLKIKGTNNL-SIGKKP---RPNLKSLEIISGGLPDSVVED- 212 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCH-HHHHTCTTCCEEEEECCBTC-BCCSCB---CTTCSEEEEECSBCCHHHHHH-
T ss_pred chhhheeecCcchhhcccccccccCHH-HHHhcCCCCcEEEEeCCCCc-eecccc---CCCCcEEEEecCCCChHHHHH-
Confidence 4677787765432 12333 46788999999999988311 244332 378999999988876433222
Q ss_pred hc--CCcccceeeccc--cccccC-----Cchhh--cCCCCCCeEeccCCcccccCCc-----cCCCCCcEEEeecCccc
Q 044996 116 FD--GMTSLRKLLLAD--NQFNGP-----IPESL--TRLSRLVELRLEGNKFEGQIPD-----FQQKDLVSFNVSNNALF 179 (678)
Q Consensus 116 ~~--~l~~L~~l~l~~--N~~~g~-----~p~~~--~~l~~L~~l~l~~N~l~g~~p~-----~~~~~l~~l~l~~N~l~ 179 (678)
+. .+++|+.|+|+. |...|. +-..+ ..+++|++|+|.+|.+.+..+. ..+++|+.|+|+.|.|+
T Consensus 213 l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~ 292 (362)
T 2ra8_A 213 ILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292 (362)
T ss_dssp HHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCB
T ss_pred HHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCC
Confidence 33 789999999863 332222 11122 3578999999999998764432 14678999999999997
Q ss_pred cc
Q 044996 180 GS 181 (678)
Q Consensus 180 g~ 181 (678)
+.
T Consensus 293 d~ 294 (362)
T 2ra8_A 293 DE 294 (362)
T ss_dssp HH
T ss_pred hH
Confidence 64
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00019 Score=73.45 Aligned_cols=140 Identities=18% Similarity=0.146 Sum_probs=91.0
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccC---CCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR---HPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.|+.|.+..+|+... ++..+++|..... ....|..|.+.|+.|. ...+.++++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 3578899999999986 4567888876532 3567889999888884 3568888998887788999999999876
Q ss_pred HH-----------HHhhccCC---CCCC--------------CCChHHHH---HHHH--HH-----------HHHHHHHH
Q 044996 452 LA-----------VNLHGHQA---LGQP--------------SLDWPSRL---KIVK--GV-----------AKGLQYLY 487 (678)
Q Consensus 452 L~-----------~~l~~~~~---~~~~--------------~l~~~~~~---~i~~--~i-----------a~gL~yLH 487 (678)
+. ..||.... .+.+ .-+|.... ++.. +. .+-++.+.
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 42 12343221 1100 12454321 1111 11 11222222
Q ss_pred H----hCCCCCCcccCCCCCCEEecCCCceEEeecC
Q 044996 488 R----ELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519 (678)
Q Consensus 488 ~----~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 519 (678)
. ......++|+|+.+.||+++.++ +.|.||.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 12245689999999999999887 8899973
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00026 Score=71.67 Aligned_cols=74 Identities=18% Similarity=0.229 Sum_probs=54.3
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCC---CccceeEEEEeCCceEEEEeccCCCC
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHP---NLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
+.+|.|..+.||+.++.+|+.+++|+...........|..|.+.|+.|.-. -+.+++++ +..++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 458999999999999999999999987654434445688999998888422 23445544 23579999998765
Q ss_pred H
Q 044996 452 L 452 (678)
Q Consensus 452 L 452 (678)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.51 E-value=2.9e-05 Score=81.37 Aligned_cols=131 Identities=18% Similarity=0.234 Sum_probs=89.4
Q ss_pred CcEEEEEeCCCC-ceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEccc--Cccccc--c---Chhh
Q 044996 45 GKIWGLKLEDMG-LQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSN--NRFSGE--I---PTDA 115 (678)
Q Consensus 45 ~~v~~l~l~~~~-l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~--N~l~G~--i---p~~~ 115 (678)
.++..|+|.++. + .+++ + .+++|+.|+|..|.+....- .+.....++|+.|+|+. |+..|. + -+ .
T Consensus 172 P~L~~L~L~g~~~l--~l~~--~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~-~ 245 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK--K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP-L 245 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS--C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGG-G
T ss_pred CCCcEEEEeCCCCc--eecc--c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHH-H
Confidence 478899998762 2 3443 3 38899999999888754211 12211227799999863 333222 1 11 1
Q ss_pred h--cCCcccceeeccccccccCCchhhc---CCCCCCeEeccCCccccc----CCcc--CCCCCcEEEeecCccccc
Q 044996 116 F--DGMTSLRKLLLADNQFNGPIPESLT---RLSRLVELRLEGNKFEGQ----IPDF--QQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 116 ~--~~l~~L~~l~l~~N~~~g~~p~~~~---~l~~L~~l~l~~N~l~g~----~p~~--~~~~l~~l~l~~N~l~g~ 181 (678)
+ ..+++|++|+|.+|.+++..+..+. .+++|++|+|+.|.+.+. ++.. .+++|+.|+|++|.++..
T Consensus 246 l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp SCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 2 3579999999999999866555554 578999999999999874 2221 457899999999998754
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00053 Score=72.92 Aligned_cols=123 Identities=14% Similarity=0.196 Sum_probs=70.6
Q ss_pred EEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceee
Q 044996 47 IWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLL 126 (678)
Q Consensus 47 v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~ 126 (678)
+..|.|.+ ++. .|....|.+|++|+.++|++|++.-.-...... .+|+.+.|.+| +. .|+..+|.++++|+.++
T Consensus 159 L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~--~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~ 232 (401)
T 4fdw_A 159 VQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFVY--AGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIE 232 (401)
T ss_dssp CCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTTT--CCCSEEECCTT-CC-EECTTTTTTCTTCCCEE
T ss_pred ceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEee--cccCEEEeCCc-hh-eehhhHhhCCCCCCEEe
Confidence 55555554 333 444455677777777777777766433322222 56777777643 55 56666677777777777
Q ss_pred ccccccccCCchhhcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEeecCccc
Q 044996 127 LADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNNALF 179 (678)
Q Consensus 127 l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N~l~ 179 (678)
|..| ++..-...|.+ .+|+.+.|. |.++ .|+.. .+.+|+.+++.+|.+.
T Consensus 233 l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~-~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 233 IPEN-VSTIGQEAFRE-SGITTVKLP-NGVT-NIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp CCTT-CCEECTTTTTT-CCCSEEEEE-TTCC-EECTTTTTTCTTCCEEEEESSCCC
T ss_pred cCCC-ccCcccccccc-CCccEEEeC-CCcc-EEChhHhhCCCCCCEEEeCCcccc
Confidence 7654 33222334444 567777763 3333 34331 4567777777776654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0016 Score=66.87 Aligned_cols=143 Identities=15% Similarity=0.182 Sum_probs=82.0
Q ss_pred cCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCC--CccceeEE-----EEeCCceEEEEeccCC
Q 044996 377 LGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHP--NLLPLVAY-----YYRKEEKLLVHEFVPK 449 (678)
Q Consensus 377 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~-----~~~~~~~~lv~Ey~~~ 449 (678)
++ |....||+....+|+.+++|..... ......+..|..++..+... .+.+++.. ....+..++||||+++
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 55 7778899988777778899988632 12345677788887777422 23444443 1224556789999987
Q ss_pred CCHH-----H---------HhhccCC----CCCCCCChHHH----HHH---------------HHHHHHHHHHHHHhC--
Q 044996 450 RSLA-----V---------NLHGHQA----LGQPSLDWPSR----LKI---------------VKGVAKGLQYLYREL-- 490 (678)
Q Consensus 450 gsL~-----~---------~l~~~~~----~~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~~-- 490 (678)
..+. . .+|.... ...+.+++... ..+ ...+...++.+....
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 4431 1 1221110 00112333211 001 111222234444332
Q ss_pred -CCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 491 -PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 491 -~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 244688999999999999 4 899999987643
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00058 Score=72.64 Aligned_cols=124 Identities=15% Similarity=0.200 Sum_probs=74.4
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC--cccccCCCCccEEEcccCccc----cccChhhhcCC
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP--DLRQLGNGALRSVYLSNNRFS----GEIPTDAFDGM 119 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~L~~L~Ls~N~l~----G~ip~~~~~~l 119 (678)
.+..|+|..+ +. .|+...|.+ .+|+.+.|. |++.- |+ .+..+ .+|+.++|.+|.+. ..|+...|.++
T Consensus 227 ~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~lp-~~i~~-I~~~aF~~c--~~L~~l~l~~~~~~~~~~~~I~~~aF~~c 299 (401)
T 4fdw_A 227 QLKTIEIPEN-VS-TIGQEAFRE-SGITTVKLP-NGVTN-IASRAFYYC--PELAEVTTYGSTFNDDPEAMIHPYCLEGC 299 (401)
T ss_dssp TCCCEECCTT-CC-EECTTTTTT-CCCSEEEEE-TTCCE-ECTTTTTTC--TTCCEEEEESSCCCCCTTCEECTTTTTTC
T ss_pred CCCEEecCCC-cc-Ccccccccc-CCccEEEeC-CCccE-EChhHhhCC--CCCCEEEeCCccccCCcccEECHHHhhCC
Confidence 4566666653 32 455555665 677777774 33332 22 23333 56777777777664 23666677777
Q ss_pred cccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCc--cCCCCCcEEEeecCccc
Q 044996 120 TSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--FQQKDLVSFNVSNNALF 179 (678)
Q Consensus 120 ~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~~l~~l~l~~N~l~ 179 (678)
++|+.++|. |.++-.-...|.+|.+|+.+.|.+| ++ .|.. +...+|+.+++++|.+.
T Consensus 300 ~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 300 PKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNTGIKEVKVEGTTPP 358 (401)
T ss_dssp TTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSSCCCEEEECCSSCC
T ss_pred ccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCCCCCEEEEcCCCCc
Confidence 788887777 3455444556777777877777554 33 3433 22227777777777653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0013 Score=67.40 Aligned_cols=145 Identities=11% Similarity=0.119 Sum_probs=81.1
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCC--ccceeEE------EEeCCceEEEEec
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN--LLPLVAY------YYRKEEKLLVHEF 446 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~------~~~~~~~~lv~Ey 446 (678)
+.|+.|....+|+....++ .+++|..... ...+++..|+.++..+.... +.+++.. ....+..+++|||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3467788889999987665 5778887652 12234556777777664222 2333321 1224567899999
Q ss_pred cCCCCHH--------------HHhhccC-CCCCCC------CChHHHHH------------HHHHHHHHHHHHHHhCC--
Q 044996 447 VPKRSLA--------------VNLHGHQ-ALGQPS------LDWPSRLK------------IVKGVAKGLQYLYRELP-- 491 (678)
Q Consensus 447 ~~~gsL~--------------~~l~~~~-~~~~~~------l~~~~~~~------------i~~~ia~gL~yLH~~~~-- 491 (678)
+++..+. ..+|... ....+. ..|...+. +...+...+++++...+
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 9875532 1123211 111110 12332111 11124556667765432
Q ss_pred -CCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 492 -SLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 492 -~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
+..++|+|+.+.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3468999999999999987666899998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0031 Score=65.07 Aligned_cols=143 Identities=14% Similarity=0.064 Sum_probs=72.9
Q ss_pred ccCccCcee-EEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCC--CCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 376 ILGSGCFGS-SYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRH--PNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 376 ~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.|+.|.... +|+....++..+++|...... .+++..|+.++..+.. -.+.+++.+.. +.-++|||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcch
Confidence 355554443 667765446667777544321 1334556666666632 23556676643 333789999977666
Q ss_pred HHHhhcc---------------------CCCCCCCCChHHHH-------H-------------HHHHHHHHHHHHHHh--
Q 044996 453 AVNLHGH---------------------QALGQPSLDWPSRL-------K-------------IVKGVAKGLQYLYRE-- 489 (678)
Q Consensus 453 ~~~l~~~---------------------~~~~~~~l~~~~~~-------~-------------i~~~ia~gL~yLH~~-- 489 (678)
.+++... ...+.+.++..... . ....+...++.+...
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 5443221 00001112111000 0 001122223333221
Q ss_pred CCCCCCcccCCCCCCEEecCC----CceEEeecCCccc
Q 044996 490 LPSLIAPHGHIKSSNVLLNES----LEPVLADYGLIPV 523 (678)
Q Consensus 490 ~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~~ 523 (678)
..+..++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 124568999999999999875 6789999998754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00099 Score=58.57 Aligned_cols=56 Identities=20% Similarity=0.383 Sum_probs=36.4
Q ss_pred EEEccCCccc-ccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccc
Q 044996 74 TLSLMRNNLE-GPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFN 133 (678)
Q Consensus 74 ~L~Ls~N~l~-g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~ 133 (678)
.++.+++.|+ ..+|. .+. .+|+.|+|++|+|+ .||..+|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~--~lp-~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPT--AFP-VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCS--CCC-TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCC--CCC-cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 4555556554 23442 121 45788888888888 677777777777777777777664
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0033 Score=66.05 Aligned_cols=142 Identities=14% Similarity=0.219 Sum_probs=82.4
Q ss_pred ccCccCceeEEEEEec--------CCceEEEEEecccChhhHHHHHHHHHHHhccCCCC-ccceeEEEEeCCceEEEEec
Q 044996 376 ILGSGCFGSSYKASLS--------TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN-LLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~Ey 446 (678)
.|..|-...+|+.... ++..+++|+.... ......+.+|.++++.+.-.+ ..++++++.+ .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 4666777889998764 2467888876432 224556778999988874323 3566666543 299999
Q ss_pred cCCCCHHH-----------------HhhccCC-CCCCCC-ChHHHHHHHHHHH-------------------HHHHHHHH
Q 044996 447 VPKRSLAV-----------------NLHGHQA-LGQPSL-DWPSRLKIVKGVA-------------------KGLQYLYR 488 (678)
Q Consensus 447 ~~~gsL~~-----------------~l~~~~~-~~~~~l-~~~~~~~i~~~ia-------------------~gL~yLH~ 488 (678)
+++..|.. -||.... .+.... -|.++.++..++. ..+.+|..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 98755431 1222111 111111 2445555544432 23444443
Q ss_pred h----CCCCCCcccCCCCCCEEecCC----CceEEeecCCcc
Q 044996 489 E----LPSLIAPHGHIKSSNVLLNES----LEPVLADYGLIP 522 (678)
Q Consensus 489 ~----~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~ 522 (678)
. ..+..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 223468899999999999876 789999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0013 Score=66.90 Aligned_cols=140 Identities=11% Similarity=0.054 Sum_probs=74.6
Q ss_pred cccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCc-cceeEEEEeCCceEEEEecc-CCCCH
Q 044996 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL-LPLVAYYYRKEEKLLVHEFV-PKRSL 452 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~Ey~-~~gsL 452 (678)
+.|+.|....+|+. ..+++|+....... ..+..+|+.+++.+....+ .+++++ +.+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 35788889999998 45788877643211 1123467777777643333 355544 345568999999 55444
Q ss_pred HH------------------HhhccCCCCCCCCChHHH-HHHHH--------------HHHHHHHHHHH----hCCCCCC
Q 044996 453 AV------------------NLHGHQALGQPSLDWPSR-LKIVK--------------GVAKGLQYLYR----ELPSLIA 495 (678)
Q Consensus 453 ~~------------------~l~~~~~~~~~~l~~~~~-~~i~~--------------~ia~gL~yLH~----~~~~~~i 495 (678)
.. -+|..........+...+ ..+.. .+...+..+.. ...+..+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 21 112111100000111111 11111 11112222221 1223458
Q ss_pred cccCCCCCCEEecCCCceEEeecCCccc
Q 044996 496 PHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 496 vHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
+|+|+.+.||+ .+++.+.|+||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5667789999988654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0038 Score=66.87 Aligned_cols=71 Identities=13% Similarity=0.163 Sum_probs=47.9
Q ss_pred cccCccCceeEEEEEecC--------CceEEEEEecccChhhHHHHHHHHHHHhccCCCCc-cceeEEEEeCCceEEEEe
Q 044996 375 EILGSGCFGSSYKASLST--------GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL-LPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~E 445 (678)
+.|+.|....+|+....+ +..+++|+.... ...+.+..|..++..+...++ .++++.+.+ .+|||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 357888889999998753 467888887431 112456678888888853344 566766532 38999
Q ss_pred ccCCCC
Q 044996 446 FVPKRS 451 (678)
Q Consensus 446 y~~~gs 451 (678)
|+++.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 997633
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0016 Score=68.26 Aligned_cols=71 Identities=7% Similarity=0.084 Sum_probs=42.2
Q ss_pred ccCccCceeEEEEEecC---------CceEEEEEecccChhhHHHHHHHHHHHhccCCCCc-cceeEEEEeCCceEEEEe
Q 044996 376 ILGSGCFGSSYKASLST---------GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL-LPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~E 445 (678)
.|+.|..-.+|+....+ +..+++|........ ..+...|.++++.+...++ .++++.. . -++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 47778888999997654 257788876543221 1123577888877753343 4666544 2 378999
Q ss_pred ccCCCC
Q 044996 446 FVPKRS 451 (678)
Q Consensus 446 y~~~gs 451 (678)
|+++..
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.011 Score=63.68 Aligned_cols=73 Identities=12% Similarity=0.139 Sum_probs=46.1
Q ss_pred cccCccCceeEEEEEecC-CceEEEEEecccChhhHHHHHHHHHHHhccCCCCc-cceeEEEEeCCceEEEEeccCCCCH
Q 044996 375 EILGSGCFGSSYKASLST-GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL-LPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
+.|+.|-...+|+....+ +..+++|+........ -+..+|..++..|...++ .++++++. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 357888889999998765 4678888765322111 112578888888865555 46777662 2 359999987443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0023 Score=56.12 Aligned_cols=57 Identities=23% Similarity=0.336 Sum_probs=44.5
Q ss_pred cEEEcccCccc-cccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCccc
Q 044996 98 RSVYLSNNRFS-GEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFE 157 (678)
Q Consensus 98 ~~L~Ls~N~l~-G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~ 157 (678)
..++.++++|+ ..||.. +. .+|+.|+|++|+|+..-+..|..+++|+.|+|++|.|.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~-lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTA-FP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSC-CC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCC-CC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47888999886 467754 22 46899999999998666666788889999999888775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0081 Score=62.15 Aligned_cols=31 Identities=19% Similarity=0.268 Sum_probs=27.1
Q ss_pred CCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 493 ~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999888899999987643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.10 E-value=0.069 Score=50.60 Aligned_cols=104 Identities=12% Similarity=-0.005 Sum_probs=68.3
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
.-+|.++|..... ++++.+++.++.|.+.+|.-+-.... . ..+=+-+..|+|..+|.+.+.+ ..+
T Consensus 32 ~vSL~eIL~~~~~----PlsEEqaWALc~Qc~~~L~~~~~~~~--~-~~~i~~~~~i~l~~dG~V~f~~-~~s------- 96 (229)
T 2yle_A 32 ALSLEEILRLYNQ----PINEEQAWAVCYQCCGSLRAAARRRQ--P-RHRVRSAAQIRVWRDGAVTLAP-AAD------- 96 (229)
T ss_dssp EEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTC--C-CCCCCSGGGEEEETTSCEEECC-C---------
T ss_pred cccHHHHHHHcCC----CcCHHHHHHHHHHHHHHHHhhhhccc--C-CceecCCcceEEecCCceeccc-ccc-------
Confidence 3479999987654 79999999999999999876622100 1 1223456899999999987764 111
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P 569 (678)
......+.+||... ...+.+.=|||+|+++|.-+--..|
T Consensus 97 -~~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 97 -DAGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -cccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 01123467898774 3557888999999999999875555
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.97 E-value=0.0024 Score=58.97 Aligned_cols=12 Identities=25% Similarity=0.207 Sum_probs=4.8
Q ss_pred CCCCCCeEeccC
Q 044996 142 RLSRLVELRLEG 153 (678)
Q Consensus 142 ~l~~L~~l~l~~ 153 (678)
++++|+.|+|++
T Consensus 137 ~~~~L~~L~L~~ 148 (176)
T 3e4g_A 137 HFRNLKYLFLSD 148 (176)
T ss_dssp GCTTCCEEEEES
T ss_pred cCCCCCEEECCC
Confidence 334444444433
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.72 E-value=0.0034 Score=59.12 Aligned_cols=112 Identities=13% Similarity=0.194 Sum_probs=72.5
Q ss_pred HhhcCCCCCEEEccCC-ccccc----CC-cccccCCCCccEEEcccCccccc----cChhhhcCCcccceeecccccccc
Q 044996 65 ILKELREMRTLSLMRN-NLEGP----MP-DLRQLGNGALRSVYLSNNRFSGE----IPTDAFDGMTSLRKLLLADNQFNG 134 (678)
Q Consensus 65 ~l~~l~~L~~L~Ls~N-~l~g~----~p-~~~~~~~~~L~~L~Ls~N~l~G~----ip~~~~~~l~~L~~l~l~~N~~~g 134 (678)
.+.+=+.|+.|+|++| ++... +- .+. .++.|+.|+|++|+|... |- +.+..-+.|+.|+|++|+++.
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~--~N~~L~~L~L~~n~igd~ga~alA-~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAAC--NSKHIEKFSLANTAISDSEARGLI-ELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHT--TCSCCCEEECTTSCCBHHHHTTHH-HHHHHCSSCCEEECCSSBCCH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHh--hCCCcCEEEccCCCCChHHHHHHH-HHHhcCCccCeEecCCCcCCH
Confidence 3555678999999986 65421 11 121 236799999999999732 21 224456789999999999975
Q ss_pred C----CchhhcCCCCCCeEeccCCc---ccccC----Cc--cCCCCCcEEEeecCccc
Q 044996 135 P----IPESLTRLSRLVELRLEGNK---FEGQI----PD--FQQKDLVSFNVSNNALF 179 (678)
Q Consensus 135 ~----~p~~~~~l~~L~~l~l~~N~---l~g~~----p~--~~~~~l~~l~l~~N~l~ 179 (678)
. |-..+..-+.|+.|+|++|. +.... -. ...+.|+.|+++.|.+.
T Consensus 113 ~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 113 ELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 3 33445566779999998653 22111 11 13467889999887753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.35 E-value=0.0064 Score=56.07 Aligned_cols=82 Identities=12% Similarity=0.178 Sum_probs=57.6
Q ss_pred CCccEEEcccCccccccChhhhcCCcccceeeccccc-cccCCchhhcCC----CCCCeEeccCCc-cccc-CCc-cCCC
Q 044996 95 GALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQ-FNGPIPESLTRL----SRLVELRLEGNK-FEGQ-IPD-FQQK 166 (678)
Q Consensus 95 ~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~-~~g~~p~~~~~l----~~L~~l~l~~N~-l~g~-~p~-~~~~ 166 (678)
-.|+.|||+++.++..==.. +.++++|+.|+|+++. ++..-=..++.+ ++|++|+|+++. ++.. +-. ..++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~-L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDH-MEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGG-GTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred ceEeEEeCcCCCccHHHHHH-hcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 45899999998886431122 6788999999999984 775444456654 479999999975 5531 111 2568
Q ss_pred CCcEEEeecCc
Q 044996 167 DLVSFNVSNNA 177 (678)
Q Consensus 167 ~l~~l~l~~N~ 177 (678)
+|+.|+|++..
T Consensus 140 ~L~~L~L~~c~ 150 (176)
T 3e4g_A 140 NLKYLFLSDLP 150 (176)
T ss_dssp TCCEEEEESCT
T ss_pred CCCEEECCCCC
Confidence 99999999874
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.01 E-value=0.058 Score=56.82 Aligned_cols=109 Identities=15% Similarity=0.304 Sum_probs=75.2
Q ss_pred cChHHhhcCCCCCEEEccCCcccccCCc--ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCch
Q 044996 61 IDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPE 138 (678)
Q Consensus 61 ~~~~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~ 138 (678)
+....|.++..|+.+.+..+... |.. +..+ ..|+.+.+. +.++ .|+...|.++.+|+.++|..| ++-.-..
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~--I~~~aF~~c--~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~ 328 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS--IGTGAFMNC--PALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDD 328 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE--ECTTTTTTC--TTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred cccceeeecccccEEecccccce--ecCcccccc--cccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHh
Confidence 33445788889999988766543 332 3333 668888886 4555 688888888889999888765 4433355
Q ss_pred hhcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEeecCcc
Q 044996 139 SLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNNAL 178 (678)
Q Consensus 139 ~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N~l 178 (678)
+|.+|.+|+.+.|..+ ++ .|... .+.+|+.+++.+|..
T Consensus 329 aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 329 AFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred HhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 6888888988888655 33 45542 567888888887754
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=94.71 E-value=0.1 Score=54.83 Aligned_cols=76 Identities=18% Similarity=0.246 Sum_probs=38.3
Q ss_pred CCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCc--c-CCCCCcEE
Q 044996 95 GALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD--F-QQKDLVSF 171 (678)
Q Consensus 95 ~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~-~~~~l~~l 171 (678)
..|+.+.+.++.. .|....|.++++|+.+.+. +.++..-...|.++.+|+.+.|..| ++ .|.. + .+.+|+.+
T Consensus 265 ~~L~~i~lp~~~~--~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i 339 (394)
T 4gt6_A 265 AYLASVKMPDSVV--SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERI 339 (394)
T ss_dssp SSCCEEECCTTCC--EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEE
T ss_pred ccccEEecccccc--eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEE
Confidence 4466666654433 3555556666666666664 3333222334556666666666543 22 2332 1 33556666
Q ss_pred Eeec
Q 044996 172 NVSN 175 (678)
Q Consensus 172 ~l~~ 175 (678)
.+..
T Consensus 340 ~ip~ 343 (394)
T 4gt6_A 340 AIPS 343 (394)
T ss_dssp EECT
T ss_pred EECc
Confidence 6543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.35 E-value=0.019 Score=53.88 Aligned_cols=81 Identities=22% Similarity=0.304 Sum_probs=59.1
Q ss_pred CCccEEEcccC-ccccc----cChhhhcCCcccceeecccccccc----CCchhhcCCCCCCeEeccCCcccccCCc---
Q 044996 95 GALRSVYLSNN-RFSGE----IPTDAFDGMTSLRKLLLADNQFNG----PIPESLTRLSRLVELRLEGNKFEGQIPD--- 162 (678)
Q Consensus 95 ~~L~~L~Ls~N-~l~G~----ip~~~~~~l~~L~~l~l~~N~~~g----~~p~~~~~l~~L~~l~l~~N~l~g~~p~--- 162 (678)
+.|+.|+|++| ++... |- +.+...+.|+.|+|++|++.. .|-..+..-+.|+.|+|++|.|...--.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la-~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLI-EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHH-HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHH-HHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 67999999986 77521 22 235677899999999999974 2444555668999999999999743211
Q ss_pred ---cCCCCCcEEEeecC
Q 044996 163 ---FQQKDLVSFNVSNN 176 (678)
Q Consensus 163 ---~~~~~l~~l~l~~N 176 (678)
...+.|+.|+|++|
T Consensus 120 ~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHTTTTCCCSEEECCCC
T ss_pred HHHhhCCceeEEECCCC
Confidence 13457999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.07 E-value=0.08 Score=56.24 Aligned_cols=141 Identities=13% Similarity=0.161 Sum_probs=82.2
Q ss_pred ccCccCceeEEEEEecC--------CceEEEEEecccChhhHHHHHHHHHHHhccCCCC-ccceeEEEEeCCceEEEEec
Q 044996 376 ILGSGCFGSSYKASLST--------GAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPN-LLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~Ey 446 (678)
.+..|-...+|+....+ +..+++|+....... .-+..+|.++++.+.-.+ ..++++.+ . -++||||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 46667788899988753 567888876543211 112356788877774323 34556543 2 3789999
Q ss_pred cCCCCHHH-----------------HhhccCC-----C---CCCCCChHHHHHHHHH-------------------HHHH
Q 044996 447 VPKRSLAV-----------------NLHGHQA-----L---GQPSLDWPSRLKIVKG-------------------VAKG 482 (678)
Q Consensus 447 ~~~gsL~~-----------------~l~~~~~-----~---~~~~l~~~~~~~i~~~-------------------ia~g 482 (678)
+++..|.. -||.... . +..+.-|.++.++..+ +...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 98865321 1121111 0 1112234444433322 2233
Q ss_pred HHHHHHhC--------------------CCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 483 LQYLYREL--------------------PSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 483 L~yLH~~~--------------------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
+.+|.+.. .+..++|+|+.+.||+ ++++.+.|+||..+.
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 45554322 1345789999999999 888899999998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=93.73 E-value=0.11 Score=54.30 Aligned_cols=131 Identities=12% Similarity=0.289 Sum_probs=86.7
Q ss_pred EEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc--ccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 47 IWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 47 v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
+..+.+..+ +. .+....+.++..|+.+.+..+ ++ .|.. +..+ .+|+.+.+..+ +. .|+..+|.++++|+.
T Consensus 219 l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~--~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~ 290 (379)
T 4h09_A 219 LKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNC--TALKTLNFYAK-VK-TVPYLLCSGCSNLTK 290 (379)
T ss_dssp CSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTC--TTCCEEEECCC-CS-EECTTTTTTCTTCCE
T ss_pred cceeeeccc-ee-EEccccccCCccceEEEcCCC-cc-EeCcccccee--ehhcccccccc-ce-ecccccccccccccc
Confidence 444444433 22 344456788899999998776 32 2222 2223 66899988654 55 678788999999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEeecCcccccCchhhhcCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNNALFGSISPALRELDPSSFSG 196 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N~l~g~ip~~~~~l~~~~~~g 196 (678)
+.|.+|.++-.-...|.++.+|+.+.|..| ++ .|... .+.+|+.+.+ |..+..+....|.|
T Consensus 291 i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~i---------p~~v~~I~~~aF~~ 354 (379)
T 4h09_A 291 VVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISY---------PKSITLIESGAFEG 354 (379)
T ss_dssp EEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCC---------CTTCCEECTTTTTT
T ss_pred ccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEE---------CCccCEEchhHhhC
Confidence 999988887555677899999999999755 33 45442 4466776654 44444555555554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=93.50 E-value=0.15 Score=53.50 Aligned_cols=77 Identities=18% Similarity=0.157 Sum_probs=51.3
Q ss_pred CCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc---CCCCCcEE
Q 044996 95 GALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSF 171 (678)
Q Consensus 95 ~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l 171 (678)
.+|+.+.+.++ +. .|+..+|.++++|+.++|.++ ++-.-..+|.+|.+|+.+.|..| ++ .|... .+.+|+.+
T Consensus 297 ~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i 371 (394)
T 4fs7_A 297 SSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKV 371 (394)
T ss_dssp TTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEE
T ss_pred ccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEE
Confidence 56777777654 54 577777888888888888644 54333556778888888888666 33 44442 45678888
Q ss_pred EeecC
Q 044996 172 NVSNN 176 (678)
Q Consensus 172 ~l~~N 176 (678)
++..|
T Consensus 372 ~lp~~ 376 (394)
T 4fs7_A 372 ELPKR 376 (394)
T ss_dssp EEEGG
T ss_pred EECCC
Confidence 77654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=92.33 E-value=0.22 Score=51.83 Aligned_cols=104 Identities=12% Similarity=0.133 Sum_probs=74.9
Q ss_pred HhhcCCCCCEEEccCCcccccCC--cccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcC
Q 044996 65 ILKELREMRTLSLMRNNLEGPMP--DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTR 142 (678)
Q Consensus 65 ~l~~l~~L~~L~Ls~N~l~g~~p--~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~ 142 (678)
.+.....|+.+.+..+--. +. .+..+ ..|+.+.+..+ ++ .|...+|.++.+|+.+.+..+ +.-.-...|.+
T Consensus 212 ~f~~~~~l~~i~~~~~~~~--i~~~~f~~~--~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~ 284 (379)
T 4h09_A 212 GFSYGKNLKKITITSGVTT--LGDGAFYGM--KALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSG 284 (379)
T ss_dssp TTTTCSSCSEEECCTTCCE--ECTTTTTTC--SSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTT
T ss_pred ccccccccceeeeccceeE--EccccccCC--ccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceecccccccc
Confidence 4667888999888765221 22 12233 67999999776 55 677778999999999999755 44333456889
Q ss_pred CCCCCeEeccCCcccccCCcc---CCCCCcEEEeecC
Q 044996 143 LSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNN 176 (678)
Q Consensus 143 l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N 176 (678)
+.+|+.+.+.+|.++ .|+.. .+.+|+.+.|.++
T Consensus 285 c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 285 CSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp CTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT
T ss_pred ccccccccccccccc-eehhhhhcCCCCCCEEEcCcc
Confidence 999999999988776 45542 5678999988644
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=92.21 E-value=0.15 Score=53.67 Aligned_cols=86 Identities=15% Similarity=0.175 Sum_probs=63.4
Q ss_pred ChHHhhcCCCCCEEEccCCcccccCCc--ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchh
Q 044996 62 DITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPES 139 (678)
Q Consensus 62 ~~~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~ 139 (678)
+...+..+.+|+.+.+..| +. .|++ +..+ .+|+.++|.++ ++ .|...+|.++++|+.++|..| ++-.-..+
T Consensus 289 ~~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c--~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~a 361 (394)
T 4fs7_A 289 PEKTFYGCSSLTEVKLLDS-VK-FIGEEAFESC--TSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANA 361 (394)
T ss_dssp CTTTTTTCTTCCEEEECTT-CC-EECTTTTTTC--TTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred ccccccccccccccccccc-cc-eechhhhcCC--CCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHH
Confidence 3344667778888887655 22 2332 3333 67999999754 66 788888999999999999877 66444567
Q ss_pred hcCCCCCCeEeccCC
Q 044996 140 LTRLSRLVELRLEGN 154 (678)
Q Consensus 140 ~~~l~~L~~l~l~~N 154 (678)
|.+|.+|+.++|..|
T Consensus 362 F~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 362 FQGCINLKKVELPKR 376 (394)
T ss_dssp BTTCTTCCEEEEEGG
T ss_pred hhCCCCCCEEEECCC
Confidence 999999999999765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.91 E-value=0.78 Score=43.33 Aligned_cols=117 Identities=9% Similarity=0.098 Sum_probs=79.4
Q ss_pred CCCCccceeEEEEeCCceEEEEeccCCC-CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCC
Q 044996 423 RHPNLLPLVAYYYRKEEKLLVHEFVPKR-SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIK 501 (678)
Q Consensus 423 ~H~niv~l~~~~~~~~~~~lv~Ey~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk 501 (678)
.||+++.. .+-...+.+.+.|+.-+.+ ++.. ++ .++...+++++..|+.-..+++. =+|--|.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik--------~~~~~eKlr~l~ni~~l~~~~~~------r~tf~L~ 106 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK--------SFTKNEKLRYLLNIKNLEEVNRT------RYTFVLA 106 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG--------GSCHHHHHHHHHHGGGGGGGGGS------SEECCCS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH--------hcCHHHHHHHHHHHHHHHHHhcC------ceEEEEe
Confidence 68888876 4555566666666654321 2222 22 37788999999999887766652 3477899
Q ss_pred CCCEEecCCCceEEeecCCccccCccccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 044996 502 SSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFL 573 (678)
Q Consensus 502 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~ 573 (678)
|+||++|.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+..
T Consensus 107 P~NL~f~~~~~p~i~~RGik~~l-------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQNVV-------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp GGGEEECTTSCEEESCCEETTTB-------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred cceEEEcCCCCEEEEEccCccCC-------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 99999999999999988874332 221 1222222445778899999999999843
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.42 E-value=0.65 Score=48.83 Aligned_cols=29 Identities=24% Similarity=0.400 Sum_probs=24.4
Q ss_pred CCcccCCCCCCEEe------cCCCceEEeecCCcc
Q 044996 494 IAPHGHIKSSNVLL------NESLEPVLADYGLIP 522 (678)
Q Consensus 494 ~ivHrdlk~~NILl------~~~~~~kl~DfGla~ 522 (678)
.++|+|+.+.|||+ +++..++++||-+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456789999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.24 E-value=2 Score=40.72 Aligned_cols=115 Identities=12% Similarity=0.125 Sum_probs=77.1
Q ss_pred CCCCccceeEEEEeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHH-HHHHhCCCCCCcccCCC
Q 044996 423 RHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQ-YLYRELPSLIAPHGHIK 501 (678)
Q Consensus 423 ~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~~ivHrdlk 501 (678)
.||++ -..+-.+.+...+.|+.-+++.=...++ .++...+++++..|+.-.. +++ .-+|--|.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~------~r~tf~l~ 111 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSA------RRLIFIVC 111 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCS------SSEECCCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhh------CceeEEEe
Confidence 57777 3344456677777777654432223332 3778889999988876555 444 34578899
Q ss_pred CCCEEecCCCceEEeecCCccccCccccccccceeeCccccccCCCCCcch-HHHHHHHHHHHHhCCCCccc
Q 044996 502 SSNVLLNESLEPVLADYGLIPVMNQESAQELMIAYKSPEFLQLGRITKKTD-VWSLGVLILEIMTGKFPANF 572 (678)
Q Consensus 502 ~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksD-vwS~Gvvl~el~tg~~P~~~ 572 (678)
|+||++|.++.+++.-.|+-.. ++|.- .+ ..| .-.+=+++..++.++..|+.
T Consensus 112 P~NL~f~~~~~p~i~hRGi~~~-------------lpP~e-----~~-ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 112 PENLMFNRALEPFFLHVGVKES-------------LPPDE-----WD-DERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GGGEEECTTCCEEESCCEETTT-------------BSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred CceEEEeCCCcEEEEEcCCccc-------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999999998887332 23321 11 223 33577888899999988873
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.76 E-value=0.33 Score=32.99 Aligned_cols=8 Identities=13% Similarity=0.355 Sum_probs=3.2
Q ss_pred heeeeecc
Q 044996 296 IFVIERKR 303 (678)
Q Consensus 296 ~~~~~r~r 303 (678)
++++|||+
T Consensus 32 ~~~~RRr~ 39 (44)
T 2ks1_B 32 GLFMRRRH 39 (44)
T ss_dssp HHHHHTTT
T ss_pred HHHhhhhH
Confidence 34444433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.84 E-value=0.34 Score=32.86 Aligned_cols=8 Identities=25% Similarity=0.393 Sum_probs=3.2
Q ss_pred heeeeecc
Q 044996 296 IFVIERKR 303 (678)
Q Consensus 296 ~~~~~r~r 303 (678)
++++||||
T Consensus 31 ~~~~RRRr 38 (44)
T 2l2t_A 31 AVYVRRKS 38 (44)
T ss_dssp HHHHHTTC
T ss_pred HHHhhhhh
Confidence 34444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 678 | ||||
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-41 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-36 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-32 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-31 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-29 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-26 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-25 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-23 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-20 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-20 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-41
Identities = 55/281 (19%), Positives = 104/281 (37%), Gaps = 37/281 (13%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
+ +GSG FG + + +K ++ + E+F E + +L HP L+ L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+ LV EF+ L+ L + L + L + V +G+ YL
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEEA----C 121
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-----IAYKSPEFLQLGRITK 549
H + + N L+ E+ ++D+G+ + + + + SPE R +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 550 KTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609
K+DVWS GVL+ E+ + + +EV + R
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYE---------------------NRSNSEVVEDISTGFR 220
Query: 610 NSEGEMV--KLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648
+ + + +I C +E E R + ++ E+ E
Sbjct: 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 7e-41
Identities = 53/301 (17%), Positives = 106/301 (35%), Gaps = 33/301 (10%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
E +G G FG ++ G + VK F + + + LRH N+L +A
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 435 YRKEEKL----LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ LV ++ SL L+ + ++ +K+ A GL +L+ E+
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEI 120
Query: 491 PSLIAP----HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--------IAYKS 538
H +KS N+L+ ++ +AD GL + + + Y +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 539 PEFLQ------LGRITKKTDVWSLGVLILEIMTGKFPANFLQ--QGKKADGDLASWVNSV 590
PE L K+ D++++G++ EI + Q D +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 591 LANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650
+ + + + S + + KI C RL + + ++ +++
Sbjct: 241 MRKVVCE-QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
Query: 651 G 651
G
Sbjct: 300 G 300
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-40
Identities = 55/283 (19%), Positives = 125/283 (44%), Gaps = 33/283 (11%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
+ +GSG FG+ YK + + + F+ + L + RH N+L + Y
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-Y 72
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+ +V ++ SL +LH + + + I + A+G+ YL+ S+I
Sbjct: 73 STAPQLAIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHA--KSII 126
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM------IAYKSPEFLQL---G 545
H +KS+N+ L+E L + D+GL V ++ S I + +PE +++
Sbjct: 127 --HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 546 RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605
+ ++DV++ G+++ E+MTG+ P ++ + + ++ G ++
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPY--------SNINNRDQIIFMVGRG-----YLSPDL 231
Query: 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648
+ R++ + + ++ C +++ ++R + + IE +
Sbjct: 232 SKVRSNCPK--AMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 5e-39
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 35/277 (12%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
+ +G G FG G + VK K N+ + F + +LRH NL+ L+
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 435 YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
++ L +V E++ K SL L G+ L LK V + ++YL +
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNF 124
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ-ESAQELMIAYKSPEFLQLGRITKKTD 552
+ H + + NVL++E ++D+GL + + +L + + +PE L+ + + K+D
Sbjct: 125 V--HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 553 VWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNSE 612
VWS G+L+ EI + +V + +
Sbjct: 183 VWSFGILLWEIYSFGRVPY---------------------PRIPLKDVVPRVEKGYKMDA 221
Query: 613 GEMV--KLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647
+ + ++ C + R + E++E +K
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 59/278 (21%), Positives = 109/278 (39%), Gaps = 37/278 (13%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
E LG+G FG + + + VK KQ ++ + F + +L+H L+ L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
+E ++ E++ SL L L L + +A+G+ ++ + I
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEE--RNYI 131
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-----IAYKSPEFLQLGRITK 549
H ++++N+L++++L +AD+GL ++ I + +PE + G T
Sbjct: 132 --HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 550 KTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609
K+DVWS G+L+ EI+T G EV R
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPY---------------------PGMTNPEVIQNLERGYR 228
Query: 610 NSEGEMV--KLLKIGLACCEEEVEKRLDLKEAVEKIEE 645
+ +L ++ C +E E R +E+
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-38
Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 12/199 (6%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRF-KQMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
LG+G G +K +G +M K ++ R + ++ L P ++
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+Y E + E + SL L + K+ V KGL YL +
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--IAYKSPEFLQLGRITKK 550
+ H +K SN+L+N E L D+G+ + A + +Y SPE LQ + +
Sbjct: 127 M---HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 551 TDVWSLGVLILEIMTGKFP 569
+D+WS+G+ ++E+ G++P
Sbjct: 184 SDIWSMGLSLVEMAVGRYP 202
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 55/279 (19%), Positives = 100/279 (35%), Gaps = 35/279 (12%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK--QMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+G+G +G K S G ++V K M ++ + L L+HPN++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 432 AYYYRKEEKLL--VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
+ L V E+ LA + Q LD L+++ + L+ +R
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRR 128
Query: 490 LPSLIAP-HGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ----ELMIAYKSPEFLQL 544
H +K +NV L+ L D+GL ++N +++ Y SPE +
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188
Query: 545 GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604
+K+D+WSLG L+ E+ P ++ E+ K
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPP----------------------FTAFSQKELAGKI 226
Query: 605 MADERNSEGEMV--KLLKIGLACCEEEVEKRLDLKEAVE 641
+ +L +I + R ++E +E
Sbjct: 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-36
Identities = 52/280 (18%), Positives = 106/280 (37%), Gaps = 39/280 (13%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
+ LG+G FG + +K K+ ++ +EF E + + L H L+ L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
++ ++ E++ L + + L++ K V + ++YL +
Sbjct: 69 TKQRPIFIITEYMANGC----LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES--KQFL 122
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-----IAYKSPEFLQLGRITK 549
H + + N L+N+ ++D+GL + + + + + PE L + +
Sbjct: 123 --HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 550 KTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608
K+D+W+ GVL+ EI + GK P +E +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMP----------------------YERFTNSETAEHIAQGL 218
Query: 609 RNSEGEMV--KLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646
R + K+ I +C E+ ++R K + I +V
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 8e-36
Identities = 64/308 (20%), Positives = 113/308 (36%), Gaps = 45/308 (14%)
Query: 375 EILGSGCFGSSYKASL----STGAMMVVKRFKQMNNVG-REEFQEHMRRLGRLRHPNLLP 429
E++G G FG Y +L VK ++ ++G +F + HPN+L
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 430 LVAYYYRKEEK-LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L+ R E L+V ++ L + + VAKG+++L
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDL----RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--------IAYKSPE 540
+ H + + N +L+E +AD+GL M + + + + + E
Sbjct: 149 K----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 541 FLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600
LQ + T K+DVWS GVL+ E+MT P N ++
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---------------------PDVNTFDI 243
Query: 601 FDKEMADERNSEGEMV--KLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFYSS 658
+ R + E L ++ L C + E R E V +I + E +
Sbjct: 244 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV 303
Query: 659 YASEADLR 666
A+ +++
Sbjct: 304 NATYVNVK 311
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 8e-35
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 22/227 (9%)
Query: 350 PEIKLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG 408
P++ F +DD E L LR +G G FG+ Y A + ++ +K+
Sbjct: 2 PDVAELFFKDDPE--KLFSDLR----EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55
Query: 409 REEFQEHMRR---LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQP 465
E++Q+ ++ L +LRHPN + Y R+ LV E+ + + +
Sbjct: 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----- 110
Query: 466 SLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525
L + G +GL YL+ ++I H +K+ N+LL+E L D+G +M
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSH--NMI--HRDVKAGNILLSEPGLVKLGDFGSASIMA 166
Query: 526 QESAQELMIAYKSPEFLQL---GRITKKTDVWSLGVLILEIMTGKFP 569
++ + +PE + G+ K DVWSLG+ +E+ K P
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 2e-34
Identities = 54/291 (18%), Positives = 114/291 (39%), Gaps = 47/291 (16%)
Query: 375 EILGSGCFGSSYKASL----STGAMMVVKRFK-QMNNVGREEFQEHMRRLGRLRHPNLLP 429
+++G+G FG L + +K K R +F +G+ HPN++
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L + +++ EF+ SL L + + +++G+A G++YL
Sbjct: 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLAD- 146
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM---------IAYKSPE 540
+ H + + N+L+N +L ++D+GL + +++ I + +PE
Sbjct: 147 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599
+Q + T +DVWS G+++ E+M+ G+ P +
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERP----------------------YWDMTNQD 241
Query: 600 VFDKEMADERN--SEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648
V + D R L ++ L C +++ R + V ++++
Sbjct: 242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (327), Expect = 3e-34
Identities = 61/334 (18%), Positives = 115/334 (34%), Gaps = 70/334 (20%)
Query: 350 PEI-KLSFVRDDVERFDLHDLLRASAEILGSGCFGSSYKA------SLSTGAMMVVKRFK 402
P++ L + R+++E +R +G G FG ++A M+ VK K
Sbjct: 3 PKLLSLEYPRNNIE------YVR----DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK 52
Query: 403 -QMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQ- 460
+ + + +FQ + +PN++ L+ + L+ E++ L L
Sbjct: 53 EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSP 112
Query: 461 ------------------ALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKS 502
+ G P L +L I + VA G+ YL H + +
Sbjct: 113 HTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLAT 168
Query: 503 SNVLLNESLEPVLADYGLIPVMNQESAQELM------IAYKSPEFLQLGRITKKTDVWSL 556
N L+ E++ +AD+GL + + I + PE + R T ++DVW+
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228
Query: 557 GVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADERNS--EGE 614
GV++ EI + + G EV + E
Sbjct: 229 GVVLWEIFSYGLQPYY---------------------GMAHEEVIYYVRDGNILACPENC 267
Query: 615 MVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648
++L + C + R ++ + E
Sbjct: 268 PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-34
Identities = 53/277 (19%), Positives = 108/277 (38%), Gaps = 36/277 (12%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK--QMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+G G F + YK T + + ++ R+ F+E L L+HPN++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 432 AYYY----RKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
+ K+ +LV E + +L L + + + + KGLQ+L+
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129
Query: 488 RELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIPVMNQESAQELM--IAYKSPEFLQL 544
P +I H +K N+ + + + D GL + A+ ++ + +PE +
Sbjct: 130 TRTPPII--HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 186
Query: 545 GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604
+ + DV++ G+ +LE+ T ++P + + V S + FDK
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPY----SECQNAAQIYRRVTS-----GVKPASFDKV 237
Query: 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641
E + +I C + ++R +K+ +
Sbjct: 238 AIPE---------VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-33
Identities = 65/278 (23%), Positives = 108/278 (38%), Gaps = 37/278 (13%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYY 434
LG GCFG + + + + +K K + E F + + + +LRH L+ L A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLI 494
E +V E++ K SL L G L P + + +A G+ Y+ R
Sbjct: 82 SE-EPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNY--- 134
Query: 495 APHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-----IAYKSPEFLQLGRITK 549
H ++++N+L+ E+L +AD+GL ++ I + +PE GR T
Sbjct: 135 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 550 KTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609
K+DVWS G+L+ E+ T G EV D+ R
Sbjct: 194 KSDVWSFGILLTELTTKGRVPY---------------------PGMVNREVLDQVERGYR 232
Query: 610 --NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645
L + C +E E+R + +E+
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (320), Expect = 2e-33
Identities = 60/282 (21%), Positives = 113/282 (40%), Gaps = 37/282 (13%)
Query: 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
LG G +G Y+ + VK K + + EEF + + ++HPNL+ L+
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
R+ ++ EF+ +L L + + L + ++ ++YL + +
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK--KNF 136
Query: 494 IAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL-----MIAYKSPEFLQLGRIT 548
I H + + N L+ E+ +AD+GL +M ++ I + +PE L + +
Sbjct: 137 I--HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 549 KKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608
K+DVW+ GVL+ EI T G + ++V++ D
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPY---------------------PGIDLSQVYELLEKDY 233
Query: 609 RNS--EGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648
R EG K+ ++ AC + R E + E + +
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 47/223 (21%), Positives = 88/223 (39%), Gaps = 22/223 (9%)
Query: 357 VRDDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEH 415
V D+ D +++ LG G FG YKA + T + K + E++
Sbjct: 4 VTRDLNPEDFWEIIG----ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59
Query: 416 MRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKI 475
+ L HPN++ L+ +Y + ++ EF ++ + + L +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL----ERPLTESQIQVV 115
Query: 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL----IPVMNQESAQE 531
K L YL+ +I H +K+ N+L + LAD+G+ + + +
Sbjct: 116 CKQTLDALNYLHDN--KII--HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
Query: 532 LMIAYKSPEFLQL-----GRITKKTDVWSLGVLILEIMTGKFP 569
+ +PE + K DVWSLG+ ++E+ + P
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 5e-33
Identities = 52/289 (17%), Positives = 112/289 (38%), Gaps = 44/289 (15%)
Query: 375 EILGSGCFGSSYKASLSTG-----AMMVVKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLL 428
+++G+G FG YK L T + +K K R +F +G+ H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L + + +++ E++ +L L + +++G+A G++YL
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-------IAYKSPEF 541
+ H + + N+L+N +L ++D+GL V+ + I + +PE
Sbjct: 129 ----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 542 LQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601
+ + T +DVWS G+++ E+MT + + EV
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYW---------------------ELSNHEVM 223
Query: 602 DKEMADER--NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648
R + ++ + C ++E +R + V ++++
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-32
Identities = 59/314 (18%), Positives = 112/314 (35%), Gaps = 53/314 (16%)
Query: 356 FVRDDVERFDLHDLLRASAEILGSGCFGSSYKASLSTGAMMV---VKRFKQMNNV-GREE 411
+ D +++G G FG KA + + + +KR K+ + +
Sbjct: 4 YPVLDWNDIKFQ-------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 412 FQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQAL-------- 462
F + L +L HPN++ L+ + L E+ P +L L + L
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 463 ---GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYG 519
+L L VA+G+ YL + I H + + N+L+ E+ +AD+G
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFI--HRDLAARNILVGENYVAKIADFG 172
Query: 520 LIPVMNQESAQELM---IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQG 576
L + + + + + E L T +DVWS GVL+ EI++
Sbjct: 173 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY----- 227
Query: 577 KKADGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMV--KLLKIGLACCEEEVEKRL 634
G E+++K R + ++ + C E+ +R
Sbjct: 228 ----------------CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP 271
Query: 635 DLKEAVEKIEEVKE 648
+ + + + E
Sbjct: 272 SFAQILVSLNRMLE 285
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-32
Identities = 61/278 (21%), Positives = 101/278 (36%), Gaps = 46/278 (16%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLP 429
LG G FG+ Y A + ++ +K + + + + +RR LRHPN+L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFK-AQLEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
L Y++ L+ E+ P ++ L D + +A L Y + +
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSK 125
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--IAYKSPEFLQLGRI 547
+I H IK N+LL + E +AD+G L + Y PE ++
Sbjct: 126 --RVI--HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 181
Query: 548 TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK---- 603
+K D+WSLGVL E + GK P F + E + +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPP--F--------------------EANTYQETYKRISRV 219
Query: 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641
E L+ + +R L+E +E
Sbjct: 220 EFTFPDFVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 5e-32
Identities = 45/218 (20%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 357 VRDDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEH 415
V D +++ E +G G G+ Y A ++TG + +++ +E
Sbjct: 15 VGDPKKKYTRF-------EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 416 MRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKI 475
+ + ++PN++ + Y +E +V E++ SL + + +D +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAV 121
Query: 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA 535
+ + L++L+ S H IKS N+LL L D+G + E ++ +
Sbjct: 122 CRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 536 ----YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ +PE + K D+WSLG++ +E++ G+ P
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 6e-32
Identities = 56/295 (18%), Positives = 105/295 (35%), Gaps = 47/295 (15%)
Query: 377 LGSGCFGSSYKASL---STGAMMVVKRFKQ--MNNVGREEFQEHMRRLGRLRHPNLLPLV 431
LGSG FG+ K + VK K + ++E + +L +P ++ ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
E +LV E L L ++ + + +++V V+ G++YL
Sbjct: 75 GICEA-ESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-------IAYKSPEFLQL 544
H + + NVLL ++D+GL + + + + +PE +
Sbjct: 129 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 545 GRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603
+ + K+DVWS GVL+ E + G+ P G +EV
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKP----------------------YRGMKGSEVTAM 222
Query: 604 EMADERNS--EGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFY 656
ER G ++ + C +VE R ++ +E +
Sbjct: 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 277
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 55/297 (18%), Positives = 107/297 (36%), Gaps = 46/297 (15%)
Query: 363 RFDLHDLLRASAEILGSGCFGSSYKA---SLSTGAMMVVKRFKQ-MNNVGREEFQEHMRR 418
+LL A E+ G G FGS + + +K KQ EE +
Sbjct: 4 FLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 419 LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG 478
+ +L +P ++ L+ + E +LV E L L G + + + +++
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQ 117
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM----- 533
V+ G++YL + + H + + NVLL ++D+GL + + +
Sbjct: 118 VSMGMKYLEE--KNFV--HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 534 --IAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSV 590
+ + +PE + + + ++DVWS GV + E ++ G+ P
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--------------------- 212
Query: 591 LANGDNRTEVFDKEMADERNSEGEMV--KLLKIGLACCEEEVEKRLDLKEAVEKIEE 645
EV +R +L + C + E R D +++
Sbjct: 213 -YKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-31
Identities = 59/298 (19%), Positives = 109/298 (36%), Gaps = 49/298 (16%)
Query: 375 EILGSGCFGSSYKASL------STGAMMVVKRFKQMNNVG-REEFQEHMRRLGRL-RHPN 426
+ LG+G FG +A+ + VK K ++ RE ++ L L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 427 LLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQ-------------ALGQPSLDWPSRL 473
++ L+ L++ E+ L L + + +LD L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM 533
VAKG+ +L + + I H + + N+LL + D+GL + +S +
Sbjct: 149 SFSYQVAKGMAFLASK--NCI--HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 534 ------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWV 587
+ + +PE + T ++DVWS G+ + E+ + G D +
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---GMPVDSKFYKMI 261
Query: 588 NSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEE 645
M ++ EM ++K C + + KR K+ V+ IE+
Sbjct: 262 KE------------GFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEK 304
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 8e-31
Identities = 47/218 (21%), Positives = 85/218 (38%), Gaps = 25/218 (11%)
Query: 361 VERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG-REEFQEHMRR 418
VE +DL + LG G +G A + T + VK V E ++ +
Sbjct: 4 VEDWDLV-------QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 419 LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKG 478
L H N++ + + L E+ L + + P +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQ 111
Query: 479 VAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM----- 533
+ G+ YL+ + H IK N+LL+E ++D+GL V + + L+
Sbjct: 112 LMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 534 -IAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFP 569
+ Y +PE L+ + DVWS G+++ ++ G+ P
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 54/319 (16%), Positives = 106/319 (33%), Gaps = 49/319 (15%)
Query: 375 EILGSGCFGSSYKASL-----STGAMMVVKRFKQMNNV-GREEFQEHMRRLGRLRHPNLL 428
++LGSG FG+ YK + +K ++ + +E + + + +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L+ +L+ L + + ++ L +AKG+ YL
Sbjct: 75 RLLGICLTSTVQLITQLMPFG-----CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM------IAYKSPEFL 542
H + + NVL+ + D+GL ++ E + I + + E +
Sbjct: 130 RRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 543 QLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602
T ++DVWS GV + E+MT +G +E+
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPY---------------------DGIPASEISS 224
Query: 603 KEMADER--NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE-----RDGDEDF 655
ER + + I + C + + R +E + + ++ D
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 284
Query: 656 YSSYASEADLRSPRGKSDE 674
S D R DE
Sbjct: 285 RMHLPSPTDSNFYRALMDE 303
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 120 bits (301), Expect = 3e-30
Identities = 44/201 (21%), Positives = 88/201 (43%), Gaps = 14/201 (6%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E LG+G FG ++ +TG K + +E ++ ++ + LRHP L+ L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
+ E ++++EF+ L + + ++ ++ V KGL +++
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENNY-- 145
Query: 494 IAPHGHIKSSNVLLN--ESLEPVLADYGLIPVMNQESA---QELMIAYKSPEFLQLGRIT 548
H +K N++ S E L D+GL ++ + + + +PE + +
Sbjct: 146 --VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 549 KKTDVWSLGVLILEIMTGKFP 569
TD+WS+GVL +++G P
Sbjct: 204 YYTDMWSVGVLSYILLSGLSP 224
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-30
Identities = 54/310 (17%), Positives = 104/310 (33%), Gaps = 47/310 (15%)
Query: 375 EILGSGCFGSSYKASL------STGAMMVVKRFKQMNNVG-REEFQEHMRRLGRLRHPNL 427
LG G FG Y+ + +K + ++ R EF + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQ-----PSLDWPSRLKIVKGVAKG 482
+ L+ + + L++ E + + L L + +++ +A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM------IAY 536
+ YL + H + + N ++ E + D+G+ + + + +
Sbjct: 146 MAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 537 KSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596
SPE L+ G T +DVWS GV++ EI T G +
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---------------------QGLS 240
Query: 597 RTEVFDKEMADERNSEGEMV--KLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDED 654
+V M + + L ++ C + + R E + I+E E E
Sbjct: 241 NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE- 299
Query: 655 FYSSYASEAD 664
S Y SE +
Sbjct: 300 -VSFYYSEEN 308
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 6e-30
Identities = 57/302 (18%), Positives = 105/302 (34%), Gaps = 54/302 (17%)
Query: 375 EILGSGCFGSSYKASL------STGAMMVVKRFKQMNNVG-REEFQEHMRRLGRL-RHPN 426
++LGSG FG A+ + VK K+ + RE ++ + +L H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 427 LLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQ------------------ALGQPSLD 468
++ L+ L+ E+ L L + L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 469 WPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528
+ L VAKG+++L S + H + + NVL+ + D+GL + +S
Sbjct: 163 FEDLLCFAYQVAKGMEFLEF--KSCV--HRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218
Query: 529 AQELM------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGD 582
+ + + +PE L G T K+DVWS G+L+ EI + G D +
Sbjct: 219 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPVDAN 275
Query: 583 LASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642
+ + +M + E+ +++ +C + KR
Sbjct: 276 FYKLIQN------------GFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSF 320
Query: 643 IE 644
+
Sbjct: 321 LG 322
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-29
Identities = 48/205 (23%), Positives = 79/205 (38%), Gaps = 19/205 (9%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQ---MNNVGREEFQEHMRRLGRLRHPNLLPL 430
+ILG G F + A L+T +K ++ + + RL HP + L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ E+ + L + S D + L+YL+
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG-- 126
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM------IAYKSPEFLQL 544
+I H +K N+LLNE + + D+G V++ ES Q Y SPE L
Sbjct: 127 KGII--HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 545 GRITKKTDVWSLGVLILEIMTGKFP 569
K +D+W+LG +I +++ G P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (293), Expect = 3e-29
Identities = 44/201 (21%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E LGSG FG ++ +TG + V K + + + + + +L HP L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
+ K E +L+ EF+ L + + + ++ +GL++++ S+
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH--SI 148
Query: 494 IAPHGHIKSSNVLL--NESLEPVLADYGLIPVMNQESAQELMIA---YKSPEFLQLGRIT 548
+ H IK N++ ++ + D+GL +N + ++ A + +PE + +
Sbjct: 149 V--HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 549 KKTDVWSLGVLILEIMTGKFP 569
TD+W++GVL +++G P
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSP 227
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-29
Identities = 55/303 (18%), Positives = 101/303 (33%), Gaps = 49/303 (16%)
Query: 360 DVERFDLHDLLRASAEILGSGCFGSSYKASL----STGAMMVVKRFKQMNNVG-REEFQE 414
ER +L +G G FG ++ + + +K K + RE+F +
Sbjct: 5 QRERIELG-------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 57
Query: 415 HMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLK 474
+ + HP+++ L+ + ++ E L + + SLD S +
Sbjct: 58 EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGEL----RSFLQVRKYSLDLASLIL 112
Query: 475 IVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM- 533
++ L YL H I + NVL++ + L D+GL M + +
Sbjct: 113 YAYQLSTALAYLES----KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168
Query: 534 ----IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNS 589
I + +PE + R T +DVW GV + EI+
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ----------------- 211
Query: 590 VLANGDNRTEVFDKEMADERNSEGEMV--KLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647
G +V + ER L + C + +R E ++ +
Sbjct: 212 ----GVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267
Query: 648 ERD 650
E +
Sbjct: 268 EEE 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 7e-29
Identities = 58/291 (19%), Positives = 98/291 (33%), Gaps = 49/291 (16%)
Query: 375 EILGSGCFGSSYKASLSTG-------AMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL 427
E LG G FG + A+ +K ++F + + L H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
+ L K+ V E P SL L HQ + + VA+G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE 128
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-------IAYKSPE 540
S H + + N+LL + D+GL+ + Q +M A+ +PE
Sbjct: 129 ----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 541 FLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599
L+ + +D W GV + E+ T G+ P G N ++
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP----------------------WIGLNGSQ 222
Query: 600 VFDKEMADER---NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVK 647
+ K + E + + + C + E R + + E +
Sbjct: 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 5e-28
Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 15/201 (7%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
E LG G FG ++ S+ + K K + + ++ + L RH N+L L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
+ EE +++ EF+ + ++ L+ + V V + LQ+L+ S
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLH----SH 121
Query: 494 IAPHGHIKSSNVLLNESLEPV--LADYGLIPVMNQESAQELMI---AYKSPEFLQLGRIT 548
H I+ N++ + ++G + L+ Y +PE Q ++
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 549 KKTDVWSLGVLILEIMTGKFP 569
TD+WSLG L+ +++G P
Sbjct: 182 TATDMWSLGTLVYVLLSGINP 202
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (270), Expect = 2e-26
Identities = 52/275 (18%), Positives = 106/275 (38%), Gaps = 34/275 (12%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREE-FQEHMRRLGRLRHPNLLPLVA 432
++LG+G F A T ++ +K + G+E + + L +++HPN++ L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
Y L+ + V L + +++ V ++YL+
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLH----D 125
Query: 493 LIAPHGHIKSSNVLL---NESLEPVLADYGLIPVMNQESAQELMI---AYKSPEFLQLGR 546
L H +K N+L +E + +++D+GL + + S Y +PE L
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 547 ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606
+K D WS+GV+ ++ G P D + A +L + +++
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFY--------DENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641
D ++ E++ EKR ++A++
Sbjct: 238 D------SAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 107 bits (267), Expect = 2e-26
Identities = 37/210 (17%), Positives = 80/210 (38%), Gaps = 24/210 (11%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQ---MNNVGREEFQEHMRRLGRLRHPNLLPL 430
EILG G + A L + VK + + F+ + L HP ++ +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 431 VAYYYRKEEKL----LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
+ +V E+V +L +H + ++++ + L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 127
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM-------IAYKSP 539
+ H +K +N++++ + + D+G+ + Y SP
Sbjct: 128 H----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 540 EFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
E + + ++DV+SLG ++ E++TG+ P
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 7e-26
Identities = 58/301 (19%), Positives = 101/301 (33%), Gaps = 54/301 (17%)
Query: 375 EILGSGCFGSSYKA--------SLSTGAMMVVKRFK-QMNNVGREEFQEHMRRLGRL-RH 424
+ LG G FG A + + VK K + M + + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 425 PNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPS-----------LDWPSRL 473
N++ L+ + ++ E+ K +L L + G L +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 474 KIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM 533
VA+G++YL I H + + NVL+ E +AD+GL ++ +
Sbjct: 139 SCAYQVARGMEYLAS--KKCI--HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 534 ------IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWV 587
+ + +PE L T ++DVWS GVL+ EI T
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY---------------- 238
Query: 588 NSVLANGDNRTEVFDKEMADERNSEGEMV--KLLKIGLACCEEEVEKRLDLKEAVEKIEE 645
G E+F R + +L + C +R K+ VE ++
Sbjct: 239 -----PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 646 V 646
+
Sbjct: 294 I 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-25
Identities = 56/300 (18%), Positives = 103/300 (34%), Gaps = 48/300 (16%)
Query: 375 EILGSGCFGSSYKA------SLSTGAMMVVKRFKQ-MNNVGREEFQEHMRRLGRLRHPNL 427
+ LG G FG +A +T + VK K+ + ++ L + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 428 LPLVAYYYRKEEK--LLVHEFVPKRSLAVNLHGHQ-----------ALGQPSLDWPSRLK 474
+ + K +++ EF +L+ L + L + L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 475 IVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM- 533
VAKG+++L S H + + N+LL+E + D+GL + ++
Sbjct: 139 YSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 534 -----IAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVN 588
+ + +PE + T ++DVWS GVL+ EI + +
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFC 247
Query: 589 SVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648
L G R D + + + L C E +R E VE + + +
Sbjct: 248 RRLKEG-TRMRAPDYTTPE----------MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 105 bits (262), Expect = 1e-25
Identities = 55/287 (19%), Positives = 102/287 (35%), Gaps = 46/287 (16%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK---------QMNNVGREEFQEHMRRLGRLR- 423
EILG G + T VK + RE + + L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 424 HPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGL 483
HPN++ L Y LV + + K L L +L KI++ + + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVI 123
Query: 484 QYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI---AYKSPE 540
L+ L H +K N+LL++ + L D+G ++ + +Y +PE
Sbjct: 124 CALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 541 FLQLGR------ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANG 594
++ K+ D+WS GV++ ++ G P F +K L ++ G
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--F--WHRKQMLMLRMIMSGNYQFG 235
Query: 595 DNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641
+ + + D L+ + +KR +EA+
Sbjct: 236 SPEWDDYSDTVKD----------LVS---RFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 25/218 (11%)
Query: 361 VERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR- 418
+E F LH ++LG G FG + A T +K K+ + ++ + M
Sbjct: 1 IEDFILH-------KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 419 ---LGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKI 475
HP L + + KE V E++ L ++ D
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFY 108
Query: 476 VKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA 535
+ GLQ+L+ ++ + +K N+LL++ +AD+G+ A+
Sbjct: 109 AAEIILGLQFLHS--KGIV--YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC 164
Query: 536 ----YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y +PE L + D WS GVL+ E++ G+ P
Sbjct: 165 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-25
Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 16/203 (7%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK--QMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
E +G G +G YKA + TG ++ +K+ + + L L HPN++ L+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
+ + + LV EF+ + + P + + +GL + +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHS--H 121
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQE----LMIAYKSPE-FLQLGR 546
++ H +K N+L+N LAD+GL + + Y++PE L
Sbjct: 122 RVL--HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 547 ITKKTDVWSLGVLILEIMTGKFP 569
+ D+WSLG + E++T +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (262), Expect = 4e-25
Identities = 36/205 (17%), Positives = 79/205 (38%), Gaps = 19/205 (9%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGRE------EFQEHMRRLGRLRHPNL 427
I+G G FG Y TG M +K + ++ + + + P +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
+ + ++ ++ + + + L +L H + GL++++
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH 124
Query: 488 RELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELM--IAYKSPEFLQLG 545
+ + +K +N+LL+E ++D GL +++ + Y +PE LQ G
Sbjct: 125 ----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180
Query: 546 R-ITKKTDVWSLGVLILEIMTGKFP 569
D +SLG ++ +++ G P
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (259), Expect = 5e-25
Identities = 45/201 (22%), Positives = 79/201 (39%), Gaps = 16/201 (7%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR----LGRLRHPNLLP 429
LG+G FG + S G +K K+ V R + EH L + HP ++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 430 LVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
+ + ++ ++ +++ L L Q P V L+YL+
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS- 122
Query: 490 LPSLIAPHGHIKSSNVLLNESLEPVLADYGL-IPVMNQESAQELMIAYKSPEFLQLGRIT 548
+I + +K N+LL+++ + D+G V + Y +PE +
Sbjct: 123 -KDII--YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 549 KKTDVWSLGVLILEIMTGKFP 569
K D WS G+LI E++ G P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 102 bits (255), Expect = 9e-25
Identities = 51/282 (18%), Positives = 111/282 (39%), Gaps = 24/282 (8%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFK--QMNNVGREEFQEHMRRLGRLRHPNLLPLVA 432
E +G G +G YKA + G +K+ + + + + L L+H N++ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+ K+ +LV E + + + L+ + + + G+ Y +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD--RR 120
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL----MIAYKSPEFLQ-LGRI 547
++ H +K N+L+N E +AD+GL + + Y++P+ L +
Sbjct: 121 VL--HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 548 TKKTDVWSLGVLILEIMTGKFP------ANFLQQGKKADG--DLASWVNSVLANGDNRTE 599
+ D+WS+G + E++ G A+ L + + G + +W N +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641
+ + E +G + + + + +R+ K+A+E
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 101 bits (252), Expect = 2e-24
Identities = 41/299 (13%), Positives = 89/299 (29%), Gaps = 40/299 (13%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+G G FG ++ +L + +K + ++ + ++ R L +P V Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 434 YYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSL 493
+ ++ ++ + SL L + K + +Q ++ SL
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE--KSL 122
Query: 494 IAPHGHIKSSNVLLNESLEPV-----LADYGLIPVMNQESAQELM-----------IAYK 537
+ + IK N L+ + D+G++ ++ + Y
Sbjct: 123 V--YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 538 SPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597
S +++ D+ +LG + + + G P QG KA + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLP----WQGLKAATNKQKYERIGEKKQSTP 236
Query: 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFY 656
+E K + D +V ER +
Sbjct: 237 LRELCAGFPEE---------FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-24
Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 356 FVRDDVE-RFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFK------QMNNV 407
F +++V+ +D E LGSG F K STG K K V
Sbjct: 3 FRQENVDDYYDTG-------EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 408 GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSL 467
RE+ + + L ++HPN++ L Y K + +L+ E V L L + SL
Sbjct: 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SL 110
Query: 468 DWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEP----VLADYGLIPV 523
+ +K + G+ YL+ SL H +K N++L + P + D+GL
Sbjct: 111 TEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166
Query: 524 MNQESAQELMI---AYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
++ + + + + +PE + + + D+WS+GV+ +++G P
Sbjct: 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (251), Expect = 4e-24
Identities = 40/298 (13%), Positives = 88/298 (29%), Gaps = 40/298 (13%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+GSG FG Y ++ G + +K + + ++ +P + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 434 YYRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+ + +V E + +L + L + + ++Y++ + +
Sbjct: 71 CGAEGDYNVMVMELLGP-----SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK--N 123
Query: 493 LIAPHGHIKSSNVLLNES---LEPVLADYGLIPVMNQESAQELM-----------IAYKS 538
I H +K N L+ + D+GL + + Y S
Sbjct: 124 FI--HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 539 PEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598
+++ D+ SLG +++ G P L+ A+ +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK---------AATKRQKYERISEKK 232
Query: 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFY 656
E+ + E L C + + D + + R G Y
Sbjct: 233 MSTPIEVLCKGYPS-EFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 6e-24
Identities = 53/278 (19%), Positives = 100/278 (35%), Gaps = 35/278 (12%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
++LG G G + + T +K + RE E R + P+++ +V
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE--VELHWRA--SQCPHIVRIVDV 73
Query: 434 Y---YRKEEKL-LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE 489
Y Y + L +V E + L + G + +I+K + + +QYL+
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH-- 128
Query: 490 LPSLIAPHGHIKSSNVLLNESLEP---VLADYG---LIPVMNQESAQELMIAYKSPEFLQ 543
S+ H +K N+L L D+G N + Y +PE L
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 544 LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603
+ K D+WSLGV++ ++ G P + ++ + +
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPP---------FYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641
SE E+ L++ + E +R+ + E +
Sbjct: 238 NPEWSEVSE-EVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 9e-24
Identities = 45/206 (21%), Positives = 84/206 (40%), Gaps = 20/206 (9%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK-----QMNNVGREEFQEHMRRLGRLRHPNLL 428
+ LG G F + YKA +T ++ +K+ K + + ++ L L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 429 PLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYR 488
L+ + K LV +F+ + L + +GL+YL++
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 489 ELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQL 544
H +K +N+LL+E+ LAD+GL + Y++PE L
Sbjct: 119 HWIL----HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 545 GR-ITKKTDVWSLGVLILEIMTGKFP 569
R D+W++G ++ E++
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-23
Identities = 51/290 (17%), Positives = 112/290 (38%), Gaps = 32/290 (11%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVG-REEFQEHMRRLGRLRHPNLLPLVA 432
+G G +G A + +K+ + + ++ L R RH N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 433 YYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPS 492
+ + ++ + ++ L L + + +GL+Y++ S
Sbjct: 74 IIRAPTIEQMKDVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQILRGLKYIH----S 127
Query: 493 LIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL-------MIAYKSPEFLQLG 545
H +K SN+LLN + + + D+GL V + + Y++PE +
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 546 RI-TKKTDVWSLGVLILEIMTGKFP---ANFLQQ--------GKKADGDLASWVNSVLAN 593
+ TK D+WS+G ++ E+++ + ++L Q G + DL +N N
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 594 GDNRTEVFDKEMADER--NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641
+K + N++ + + LL KR+++++A+
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 1e-23
Identities = 54/296 (18%), Positives = 103/296 (34%), Gaps = 26/296 (8%)
Query: 375 EILGSGCFGSSYKA--SLSTGAMMVVKRFKQMNNVGREEFQ-----EHMRRLGRLRHPNL 427
+G G +G +KA + G + +KR + +R L HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 428 LPLVAYYYRKEEKLLVHEFVPKRSLA-VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYL 486
+ L + + + +P + + ++ + +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 487 YRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI---AYKSPEFLQ 543
+ ++ H +K N+L+ S + LAD+GL + + + A ++ Y++PE L
Sbjct: 133 HSH--RVV--HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 188
Query: 544 LGRITKKTDVWSLGVLILEIMTGKFP----ANFLQQGKKADGDLASWVNSVLANGDNRTE 599
D+WS+G + E+ K ++ Q GK D + +
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 600 VFDKEMADERNSEGEMVKLLKIGL--ACCEEEVEKRLDLKEAVE-----KIEEVKE 648
F + A + L L C KR+ A+ +E KE
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 9e-23
Identities = 52/224 (23%), Positives = 101/224 (45%), Gaps = 13/224 (5%)
Query: 353 KLSFVRDDVER--FDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFKQ--MNNV 407
+ F R +V + +++ + R + +GSG +G+ A TGA + +K+ + + +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 59
Query: 408 GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSL 467
+ +R L +RH N++ L+ + E +F G + L
Sbjct: 60 FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKHEKL 118
Query: 468 DWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527
+V + KGL+Y++ + H +K N+ +NE E + D+GL + E
Sbjct: 119 GEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
Query: 528 -SAQELMIAYKSPE-FLQLGRITKKTDVWSLGVLILEIMTGKFP 569
+ + Y++PE L R T+ D+WS+G ++ E++TGK
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 3e-22
Identities = 41/232 (17%), Positives = 89/232 (38%), Gaps = 21/232 (9%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMR------RLGRLR--HP 425
+LGSG FGS Y +S + +K ++ E R L ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 426 NLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
++ L+ ++ R + +L+ E + + +L V + +++
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRH 125
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPV-LADYGLIPVMNQESAQELM--IAYKSPEFL 542
+ + H IK N+L++ + + L D+G ++ + Y PE++
Sbjct: 126 CH----NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 181
Query: 543 QLGR-ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593
+ R + VWSLG+L+ +++ G P ++ + V+S +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 233
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 5e-22
Identities = 46/207 (22%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAY 433
+++G+G FG Y+A +G ++ +K+ Q + ++ + +L H N++ L +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 434 YYRKEEK------LLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLY 487
+Y EK LV ++VP+ V H + + +L + + + L Y++
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 488 RELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIPVMNQESAQELMI---AYKSP-EFL 542
S H IK N+LL+ ++ L D+G + + I Y++P
Sbjct: 140 ----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 543 QLGRITKKTDVWSLGVLILEIMTGKFP 569
T DVWS G ++ E++ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.1 bits (230), Expect = 1e-21
Identities = 49/284 (17%), Positives = 95/284 (33%), Gaps = 26/284 (9%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFK--QMNNVGREEFQEHMRRLGRLRHPNLLPLV 431
E +G G +G+ +KA + T ++ +KR + + + L L+H N++ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
+ ++ LV EF + + LD + + KGL + +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR-- 120
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQ-----ELMIAYKSPEFLQLGR 546
H +K N+L+N + E LA++GL +
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 547 ITKKTDVWSLGVLILEIMTGKFP----ANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602
+ D+WS G + E+ P + Q K+ L + + +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 603 KEMADERNSEGEMVKLLKIGL-----ACCEEEVEKRLDLKEAVE 641
M S +V L + +R+ +EA++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 89.9 bits (222), Expect = 4e-20
Identities = 41/200 (20%), Positives = 70/200 (35%), Gaps = 14/200 (7%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQ---MNNVGREEFQEHMRRLGRLRHPNLLPL 430
+ LG+G FG +G +K + + E R L + P L+ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ +V E+V + +L P + +YL+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL- 160
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGL-IPVMNQESAQELMIAYKSPEFLQLGRITK 549
LI + +K N+L+++ + D+G V + +PE + K
Sbjct: 161 -DLI--YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 550 KTDVWSLGVLILEIMTGKFP 569
D W+LGVLI E+ G P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 8e-20
Identities = 43/203 (21%), Positives = 76/203 (37%), Gaps = 17/203 (8%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRR---LGRLRHPNLLPL 430
++LG G FG +TG +K ++ + ++E + L RHP L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 431 VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ + V E+ L +L + + L+YL+
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD 125
Query: 491 PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMIA----YKSPEFLQLGR 546
+ IK N++L++ + D+GL + A Y +PE L+
Sbjct: 126 V----VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 547 ITKKTDVWSLGVLILEIMTGKFP 569
+ D W LGV++ E+M G+ P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 1e-19
Identities = 52/312 (16%), Positives = 110/312 (35%), Gaps = 43/312 (13%)
Query: 359 DDVERFDLHDLLRASAEILGSGCFGSSYKA-SLSTGAMMVVKRFK--QMNNVGREEFQEH 415
D+V +++ +G G FG +KA TG + +K+
Sbjct: 7 DEVSKYEKL-------AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE 59
Query: 416 MRRLGRLRHPNLLPLVAYYYRKEEKLLVHE---FVPKRSLAVNLHGHQALGQPSLDWPSR 472
++ L L+H N++ L+ K + ++ +L G +
Sbjct: 60 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 119
Query: 473 LKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL 532
++++ + GL Y++R ++ H +K++NVL+ LAD+GL + +
Sbjct: 120 KRVMQMLLNGLYYIHR--NKIL--HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 533 M--------IAYKSPEFLQLGR-ITKKTDVWSLGVLILEIMTGKFP------ANFLQQGK 577
+ Y+ PE L R D+W G ++ E+ T + L
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
Query: 578 KADGDLASWVNSVLANGDNRTEV--------FDKEMADERNSEGEMVKLLKIGLACCEEE 629
+ G + V + N + ++ K+ + + L+ +
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLD 292
Query: 630 VEKRLDLKEAVE 641
+R+D +A+
Sbjct: 293 PAQRIDSDDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 2e-19
Identities = 56/239 (23%), Positives = 103/239 (43%), Gaps = 31/239 (12%)
Query: 349 KPEIKLSFVRDDVERFDLHD--LLRASAEILGSGCFGSSYKA----SLSTGAMMVVKRFK 402
K E++ + + E+ + + LL+ +LG+G +G + TG + +K K
Sbjct: 6 KHELRTANLTGHAEKVGIENFELLK----VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK 61
Query: 403 QMNNVGREEFQEHMRR----LGRLRHPNLLPLVAYYYRKEEKLLVH-EFVPKRSLAVNLH 457
+ V + + EH R L +R L + Y ++ E KL + +++ L +L
Sbjct: 62 KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS 121
Query: 458 GHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLAD 517
+ V + L++L++ +I + IK N+LL+ + VL D
Sbjct: 122 QRE-----RFTEHEVQIYVGEIVLALEHLHK--LGII--YRDIKLENILLDSNGHVVLTD 172
Query: 518 YGLIPVMNQESAQELM-----IAYKSPEFLQLGR--ITKKTDVWSLGVLILEIMTGKFP 569
+GL + + I Y +P+ ++ G K D WSLGVL+ E++TG P
Sbjct: 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 7e-18
Identities = 44/200 (22%), Positives = 86/200 (43%), Gaps = 10/200 (5%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQ--MNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+GSG +GS A TG + VK+ + + + + +R L ++H N++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 432 AYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELP 491
+ ++ L + Q L ++ + +GL+Y++
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIH---- 138
Query: 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-SAQELMIAYKSPE-FLQLGRITK 549
S H +K SN+ +NE E + D+GL + E + Y++PE L +
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 550 KTDVWSLGVLILEIMTGKFP 569
D+WS+G ++ E++TG+
Sbjct: 199 TVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.4 bits (202), Expect = 2e-17
Identities = 44/214 (20%), Positives = 75/214 (35%), Gaps = 23/214 (10%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL------ 427
LG G F + + A + + +K + + V E ++ ++ L R+ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 428 -----LPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKG 482
L L+ ++ K + V + L + + +I K + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 483 LQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIPVMNQESAQELMI------A 535
L Y++R H IK NVL+ L + + N E
Sbjct: 138 LDYMHRRCGI---IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 536 YKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFP 569
Y+SPE L D+WS LI E++TG F
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 80.3 bits (197), Expect = 6e-17
Identities = 42/204 (20%), Positives = 80/204 (39%), Gaps = 24/204 (11%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVA 432
LG G + ++A +++ +VVK K + +++ + ++ L LR PN++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97
Query: 433 YYYRKEEKL--LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL 490
+ LV E V +L + + K L Y +
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH--- 146
Query: 491 PSLIAPHGHIKSSNVLL-NESLEPVLADYGLIPVMNQESAQELMI---AYKSPE-FLQLG 545
S+ H +K NV++ +E + L D+GL + + + +K PE +
Sbjct: 147 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 546 RITKKTDVWSLGVLILEIMTGKFP 569
D+WSLG ++ ++ K P
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.7 bits (190), Expect = 5e-16
Identities = 33/207 (15%), Positives = 75/207 (36%), Gaps = 24/207 (11%)
Query: 375 EILGSGCFGSSYKA-SLSTGAMMVVKRFKQ--MNNVGREEFQEHMRRLGRLRHPNLLPLV 431
+ +GSG G A + +K+ + N + + + + H N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 432 AYYYRK------EEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQY 485
+ + ++ LV E + V D ++ + G+++
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKH 134
Query: 486 LYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQELMI---AYKSPEFL 542
L+ H +K SN+++ + D+GL + Y++PE +
Sbjct: 135 LHSAGII----HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 543 QLGRITKKTDVWSLGVLILEIMTGKFP 569
+ D+WS+G ++ E++ K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.1 bits (175), Expect = 2e-14
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHR----GKIWGLKLEDMGL 57
D Q LL +K+ L NPT L++W T CN W GVLC ++ L L + L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNR---TWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 58 QGNIDI-TILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAF 116
I + L L + L + N L +Y+++ SG IP
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-L 121
Query: 117 DGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQ 164
+ +L L + N +G +P S++ L LV + +GN+ G IPD
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 25/91 (27%), Positives = 38/91 (41%), Gaps = 21/91 (23%)
Query: 119 MTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNAL 178
+L L L +N+ G +P+ LT+L L L + N G+IP
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN------------- 289
Query: 179 FGSISPALRELDPSSFSGNRDLCGEPLGSPC 209
L+ D S+++ N+ LCG PL C
Sbjct: 290 -------LQRFDVSAYANNKCLCGSPL-PAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.8 bits (143), Expect = 3e-10
Identities = 17/61 (27%), Positives = 22/61 (36%), Gaps = 2/61 (3%)
Query: 101 YLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQI 160
L NNR G +P + L L ++ N G IP+ L R NK
Sbjct: 250 DLRNNRIYGTLP-QGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307
Query: 161 P 161
P
Sbjct: 308 P 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.0 bits (115), Expect = 8e-07
Identities = 20/69 (28%), Positives = 29/69 (42%), Gaps = 7/69 (10%)
Query: 72 MRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADN 130
+ L L N + G +P L QL L S+ +S N GEIP + A+N
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKF--LHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANN 301
Query: 131 QF--NGPIP 137
+ P+P
Sbjct: 302 KCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 18/91 (19%), Positives = 34/91 (37%), Gaps = 3/91 (3%)
Query: 22 NWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNN 81
+ + A G + + GL L + + G + L +L+ + +L++ NN
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQG-LTQLKFLHSLNVSFNN 279
Query: 82 LEGPMPDLRQLGNGALRSVYLSNNRFSGEIP 112
L G +P L +NN+ P
Sbjct: 280 LCGEIPQGGNLQR--FDVSAYANNKCLCGSP 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.7 bits (162), Expect = 3e-13
Identities = 31/204 (15%), Positives = 64/204 (31%), Gaps = 34/204 (16%)
Query: 375 EILGSGCFGSSYKASLSTGAMMVVKRFK----------QMNNVGREEFQEHMRRLGRLRH 424
+++G G + + VVK K + + G F R R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 425 PNLLPL----VAYYYRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVA 480
L L V Y E ++ E + + L + +++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113
Query: 481 KGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESAQEL--MIAYKS 538
+ + Y ++ HG + NVL++E + D+ + +E +E+
Sbjct: 114 EEVAKFYH--RGIV--HGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNI 168
Query: 539 PEFLQLGRITKKTDVWSLGVLILE 562
+ + D+ S IL+
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.3 bits (168), Expect = 4e-13
Identities = 28/158 (17%), Positives = 49/158 (31%), Gaps = 27/158 (17%)
Query: 39 GVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP----------- 87
G L + L L + + ++ L +L E L L N + P
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAPLSGLTKLTE---LKLGANQISNISPLAGLTALTNLE 291
Query: 88 --------DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPES 139
L + L N S P +T L++L A+N+ + S
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFANNKVSDV--SS 346
Query: 140 LTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNA 177
L L+ + L N+ P + +++ A
Sbjct: 347 LANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.8 bits (133), Expect = 7e-09
Identities = 42/201 (20%), Positives = 63/201 (31%), Gaps = 36/201 (17%)
Query: 22 NWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNN 81
+ N + VL + L + + + IL L E LSL N
Sbjct: 174 LTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDE---LSLNGNQ 230
Query: 82 LEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIP---- 137
L+ L L N L + L+NN+ S P G+T L +L L NQ + P
Sbjct: 231 LKDI-GTLASLTN--LTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISPLAGL 284
Query: 138 ----------------ESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG- 180
++ L L L L N P L +NN +
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDV 344
Query: 181 -SIS--PALRELDPSSFSGNR 198
S++ + L N+
Sbjct: 345 SSLANLTNINWLS---AGHNQ 362
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 3e-04
Identities = 15/73 (20%), Positives = 28/73 (38%), Gaps = 6/73 (8%)
Query: 53 EDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIP 112
+G D +L ++ TL R ++ + + L N L + SNN+ + P
Sbjct: 27 TVLGKTNVTDTVSQTDLDQVTTLQADRLGIKS-IDGVEYLNN--LTQINFSNNQLTDITP 83
Query: 113 TDAFDGMTSLRKL 125
+T L +
Sbjct: 84 ---LKNLTKLVDI 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 1e-07
Identities = 13/86 (15%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNG----PIPESLTRLSRLVELRLE 152
++S+ + S + + + + L D I +L L EL L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 153 GNKFEGQIPDFQQKDLVSFNVSNNAL 178
N+ + L + + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKL 89
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 6e-06
Identities = 22/129 (17%), Positives = 43/129 (33%), Gaps = 8/129 (6%)
Query: 22 NWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNN 81
+ + +I +LED G++ + + +R L L +
Sbjct: 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ-GLGQPGSVLRVLWLADCD 380
Query: 82 L--EGPMPDLRQLG-NGALRSVYLSNNRFSGEIPTDAFDGM----TSLRKLLLADNQFNG 134
+ L N +LR + LSNN + + L +L+L D ++
Sbjct: 381 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440
Query: 135 PIPESLTRL 143
+ + L L
Sbjct: 441 EMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 2e-05
Identities = 16/78 (20%), Positives = 27/78 (34%), Gaps = 8/78 (10%)
Query: 97 LRSVYLSNNRFSGEIP---TDAFDGMTSLRKLLLADNQFNGPIPESLTR-----LSRLVE 148
LR ++L++ S SLR+L L++N L L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 149 LRLEGNKFEGQIPDFQQK 166
L L + ++ D Q
Sbjct: 431 LVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 15/99 (15%), Positives = 35/99 (35%), Gaps = 18/99 (18%)
Query: 50 LKLEDMGLQGNIDIT------ILKELREMRTLSLMRNNLEGPMPDLRQLG-----NGALR 98
L ++ + +Q +++ +L L++ + + L L + + N AL
Sbjct: 2 LDIQSLDIQCE-ELSDARWAELLPLLQQCQVVRLDDCGLTEA--RCKDISSALRVNPALA 58
Query: 99 SVYLSNNRFSGEIPTDAFDGM----TSLRKLLLADNQFN 133
+ L +N G+ ++KL L +
Sbjct: 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.3 bits (118), Expect = 4e-07
Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 10/90 (11%)
Query: 77 LMRNNLEGP-----MPDLRQLGNGALRSVYLSNNRFSGE----IPTDAFDGMTSLRKLLL 127
L L + +L N L+++ L N + + T + M L L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 128 ADNQFNGPIPESLTRLSRLVELRLEGNKFE 157
N+F + + + + R G E
Sbjct: 310 NGNRF-SEEDDVVDEIREVFSTRGRGELDE 338
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.003
Identities = 13/75 (17%), Positives = 25/75 (33%), Gaps = 10/75 (13%)
Query: 101 YLSNNRFSGEIPTD-----AFDGMTSLRKLLLADNQFNGPIPESL-----TRLSRLVELR 150
L++ S + L+ L L N+ +L ++ L+ L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 151 LEGNKFEGQIPDFQQ 165
L GN+F + +
Sbjct: 309 LNGNRFSEEDDVVDE 323
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 6e-07
Identities = 26/107 (24%), Positives = 37/107 (34%), Gaps = 24/107 (22%)
Query: 73 RTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPT------------------- 113
R L L +L L QL + + LS+NR P
Sbjct: 1 RVLHLAHKDLTVL-CHLEQLLL--VTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN 57
Query: 114 -DAFDGMTSLRKLLLADNQFNG-PIPESLTRLSRLVELRLEGNKFEG 158
D + L++LLL +N+ + L RLV L L+GN
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 17/67 (25%), Positives = 28/67 (41%), Gaps = 10/67 (14%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKF 156
L + +SNN+ E+P L +L+ + N +PE L +L +E N
Sbjct: 286 LEELNVSNNKLI-ELP----ALPPRLERLIASFNHLAE-VPELPQNLK---QLHVEYNPL 336
Query: 157 EGQIPDF 163
+ PD
Sbjct: 337 R-EFPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 20/102 (19%), Positives = 35/102 (34%), Gaps = 7/102 (6%)
Query: 22 NWDDRTPPCNENGANWNGVLCHRGKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNN 81
P N N + LE++ + N I + + L N+
Sbjct: 256 FSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFNH 315
Query: 82 LEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLR 123
L +P+L N L+ +++ N E P D + + LR
Sbjct: 316 LAE-VPEL--PQN--LKQLHVEYNPLR-EFP-DIPESVEDLR 350
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 4e-05
Identities = 11/52 (21%), Positives = 19/52 (36%)
Query: 104 NNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNK 155
+N E+P D F G + L ++ + + L L +L K
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 26/141 (18%), Positives = 50/141 (35%), Gaps = 13/141 (9%)
Query: 78 MRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIP 137
N L+ P L + +NN E+P +G+ +L LLL +N IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLT--ELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 138 ESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSF--NVSNNALFGSISPALR--ELDPSS 193
+ L L GN + + + + + + + N ++ + +S
Sbjct: 189 KGFFGSHLLPFAFLHGNPW---LCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVAS 245
Query: 194 F---SGNRDLCGEPLGSPCPT 211
+ ++ + G CPT
Sbjct: 246 VQCDNSDKFPVYKYPGKGCPT 266
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 13/78 (16%), Positives = 25/78 (32%), Gaps = 4/78 (5%)
Query: 95 GALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGN 154
+ V + +P D L L++N +L +RL +L L+
Sbjct: 10 ASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 155 KFEGQIPDFQQKDLVSFN 172
+ D L + +
Sbjct: 66 ELTKLQVDGTLPVLGTLD 83
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 3e-04
Identities = 25/136 (18%), Positives = 39/136 (28%), Gaps = 7/136 (5%)
Query: 74 TLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFN 133
L R+ + L N +Y+ N + + G+ LR L + +
Sbjct: 12 GLRCTRDGALDSLHHLPGAENL--TELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 134 GPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQKDLVSFNVSNNALFGSIS----PALRE 188
P++ RL L L N E Q L +S N L S + E
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEE 129
Query: 189 LDPSSFSGNRDLCGEP 204
+ C
Sbjct: 130 EGLGGVPEQKLQCHGQ 145
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 25/144 (17%), Positives = 46/144 (31%), Gaps = 9/144 (6%)
Query: 60 NIDITILKELREMRTLSLMRNNLEGPMPDLRQLGN-GALRSVYLSNNRFSGEIPTDAFDG 118
+ ++ L +M + L N L+ + L + +++ + IP
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP-- 170
Query: 119 MTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQ--QKDLVSFNVSNN 176
SL +L L N+ SL L+ L +L L N L +++NN
Sbjct: 171 -PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229
Query: 177 ALFGSIS--PALRELDPSSFSGNR 198
L + + N
Sbjct: 230 KLVKVPGGLADHKYIQVVYLHNNN 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 25/134 (18%), Positives = 46/134 (34%), Gaps = 8/134 (5%)
Query: 70 REMRTLSLMRNNLEG-PMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLA 128
+ L L N + D + L N L ++ L NN+ S P AF + L +L L+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKN--LHTLILINNKISKISP-GAFAPLVKLERLYLS 87
Query: 129 DNQFNGPIPESLTRLSRLVELRLEGNKFE----GQIPDFQQKDLVSFNVSNNALFGSISP 184
NQ + L L E K + +L + + ++ +
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 185 ALRELDPSSFSGNR 198
+++L +
Sbjct: 148 GMKKLSYIRIADTN 161
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 13/56 (23%), Positives = 24/56 (42%), Gaps = 5/56 (8%)
Query: 97 LRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLE 152
L ++ +N+ S P + +L ++ L +NQ + P L S L + L
Sbjct: 175 LTTLKADDNKISDISP---LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 2/60 (3%)
Query: 116 FDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSN 175
++ L L DN+ + P L L L+E+ L+ N+ P +L ++N
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.001
Identities = 19/116 (16%), Positives = 37/116 (31%), Gaps = 9/116 (7%)
Query: 47 IWGLK-LEDMGLQGNIDITILKELR---EMRTLSLMRNNLEGPMPDLRQLGNGALRSVYL 102
GL L+ + L N + + N +P AL+ + L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEG 158
++N + + L+K + ++ +P+ L L L N +G
Sbjct: 233 NDNPWVCDCRARPL--WAWLQKFRGSSSEVPCSLPQRLAGRD-LKRLAA--NDLQG 283
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 678 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.66 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.57 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.52 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.46 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.45 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.41 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.37 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.37 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.29 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.26 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.24 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.19 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.18 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.18 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.13 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.08 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.05 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.03 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.02 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.98 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.94 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.92 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.9 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.63 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.62 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.36 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.24 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.23 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.21 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.12 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.89 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.89 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.87 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.7 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.6 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.04 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.26 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.02 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.36 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.31 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.26 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=417.37 Aligned_cols=246 Identities=22% Similarity=0.387 Sum_probs=197.3
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|..++..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 4579999999999999988889999998753 345678999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... .++|..++.|+.|||.||+|||+. +|+||||||+|||+|+++.+||+|||+++......
T Consensus 89 ~~l~~~~~----~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 89 DYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHhhcccc----CCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99876532 589999999999999999999976 79999999999999999999999999998765432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhC-CCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTG-KFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg-~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...+|..|+|||++.+..++.++|||||||++|||+|+ +.||. .....+.+....... . ...+.
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~--------~~~~~~~~~~i~~~~-~---~~~p~--- 225 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--------NRSNSEVVEDISTGF-R---LYKPR--- 225 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC--------SCCHHHHHHHHHHTC-C---CCCCT---
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC--------CCCHHHHHHHHHhcC-C---CCCcc---
Confidence 23457889999999999999999999999999999995 55543 123333333333221 1 11111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
....++.+++.+||+.||++||||+||++.|+++.+
T Consensus 226 -----~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 -----LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 123457788889999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=416.28 Aligned_cols=252 Identities=21% Similarity=0.353 Sum_probs=200.0
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||+||+|+++. .||||+++.. +....+.|++|+++|++++|||||+++|++. .+..++|||||++|+
T Consensus 13 ~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSS 89 (276)
T ss_dssp CSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEE
T ss_pred EEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCC
Confidence 4679999999999998643 5999998743 3456688999999999999999999999875 456899999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.++++.... .++|.+++.|+.|||+||+|||+. +||||||||+||||++++.+||+|||+++.....
T Consensus 90 L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 90 LYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp HHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred HHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999976532 599999999999999999999976 7999999999999999999999999999876532
Q ss_pred --ccccccceeeCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 528 --SAQELMIAYKSPEFLQL---GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~---~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
....+|+.|||||++.+ +.|+.++|||||||+||||+||+.||.. ......+......+...
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~--------~~~~~~~~~~~~~~~~~----- 228 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN--------INNRDQIIFMVGRGYLS----- 228 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT--------CCCHHHHHHHHHHTSCC-----
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC--------CChHHHHHHHHhcCCCC-----
Confidence 12346889999999864 4589999999999999999999999972 12222333333332211
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
+.+... .......+.+++.+||+.||++||||+||++.|+.+.+..+
T Consensus 229 p~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 229 PDLSKV--RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CCGGGS--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred Ccchhc--cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 111111 11223457788889999999999999999999999987544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-51 Score=418.50 Aligned_cols=247 Identities=21% Similarity=0.414 Sum_probs=194.8
Q ss_pred ccccCccCceeEEEEEecC-C---ceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLST-G---AMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+|+||+||+|.+.. + ..||||++... .....++|.+|+++|++++|||||+++|+|..++..++|||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 4689999999999998742 2 35888887653 44556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|.+++..... .++|.++++|+.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 111 ~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 111 NGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp TEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCcceeeeccccC----CCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999876432 599999999999999999999976 79999999999999999999999999998765432
Q ss_pred c---------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 529 A---------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 529 ~---------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
. ..+++.|||||++.++.++.++|||||||+||||+| |+.||.. ....+.+..... +...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~--------~~~~~~~~~i~~-~~~~- 252 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD--------MTNQDVINAIEQ-DYRL- 252 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHT-TCCC-
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC--------CCHHHHHHHHHc-CCCC-
Confidence 1 234678999999999999999999999999999998 8999862 222333332222 2111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
..+.+....+.+++.+||+.||++||||.||++.|+++..
T Consensus 253 ----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 253 ----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0111234457788889999999999999999999998865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-50 Score=411.60 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=204.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|++++|||||+++|+|.+++..++|||||++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 467999999999999875 5888999998754 34567899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc---
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA--- 529 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 529 (678)
.+++..... ..++|..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.......
T Consensus 101 ~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 101 LDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp HHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred HHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 999976532 3699999999999999999999976 799999999999999999999999999987754322
Q ss_pred --ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 530 --QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 530 --~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
..++..|+|||++.++.|+.|+|||||||++|||++|+.|+.. ..+.... ...+..+... .
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~-------~~~~~~~-~~~i~~~~~~-~-------- 236 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQV-YELLEKDYRM-E-------- 236 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST-------TCCHHHH-HHHHHTTCCC-C--------
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-------cchHHHH-HHHHhcCCCC-C--------
Confidence 2356789999999999999999999999999999998777641 1222222 2222222111 0
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.+......+.+++.+||+.||++||||.||++.|+.+...
T Consensus 237 --~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 237 --RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred --CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 0112234577888899999999999999999999988654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=410.23 Aligned_cols=247 Identities=22% Similarity=0.358 Sum_probs=200.0
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||+||+|.++++..||||+++.. ....+.|.+|+++|++++|||||+++|++. .+..++||||+++|+|.
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHH
Confidence 5679999999999999988889999999754 345678999999999999999999999875 45689999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... ..++|.++++|+.||++||.|||+. +|+||||||+||||++++.+||+|||+++.+....
T Consensus 96 ~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 96 DFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp HHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred HHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 98865432 2589999999999999999999976 79999999999999999999999999998775432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...+++.|||||++.++.++.++|||||||++|||+||+.|+.. .....+.+... ..+... ..+
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~-------~~~~~~~~~~i-~~~~~~---~~p----- 232 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP-------GMTNPEVIQNL-ERGYRM---VRP----- 232 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST-------TCCHHHHHHHH-HTTCCC---CCC-----
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC-------CCCHHHHHHHH-HhcCCC---CCc-----
Confidence 23456789999999988999999999999999999996665431 12222222222 222111 001
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
......+.+++.+||+.||++||||+||++.|+++-.
T Consensus 233 ---~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 233 ---DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1123357788889999999999999999999998643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=401.57 Aligned_cols=244 Identities=22% Similarity=0.366 Sum_probs=203.9
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
.+.||+|+||+||+|+++++..||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 4679999999999999988889999999864 345678999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-----
Q 044996 454 VNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES----- 528 (678)
Q Consensus 454 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 528 (678)
+++..... .+++..+.+|+.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 88 ~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 88 NYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp HHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred Hhhhcccc----CCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99876543 589999999999999999999976 89999999999999999999999999998765432
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++.+..++.|+|||||||++|||+| |+.||.. ....+... .+..+... ..+.
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~--------~~~~~~~~-~i~~~~~~---~~p~--- 224 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER--------FTNSETAE-HIAQGLRL---YRPH--- 224 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--------SCHHHHHH-HHHTTCCC---CCCT---
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC--------CCHHHHHH-HHHhCCCC---CCcc---
Confidence 2345788999999999999999999999999999998 8999972 22233332 23332211 1111
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.....+.+++.+||+.||++||||+||++.|.+|
T Consensus 225 -----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 -----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1224577888899999999999999999998653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=406.88 Aligned_cols=249 Identities=20% Similarity=0.398 Sum_probs=197.4
Q ss_pred ccccCccCceeEEEEEecCC-----ceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLSTG-----AMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.++||+|+||+||+|.++.. ..||||+++.. .....++|.+|++++++++|||||+++|+|.+.+..++|||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 46799999999999987543 36899998753 3445668999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
.+|++.+++..... .++|.++++|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+...
T Consensus 92 ~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 92 ENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp TTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ccCcchhhhhcccc----cccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999998876532 699999999999999999999976 7999999999999999999999999999876433
Q ss_pred c-------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 S-------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~-------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
. ...+|..|||||++.++.++.++|||||||++|||+||+.|+.. .....+.+.. +..+...
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~-------~~~~~~~~~~-i~~~~~~--- 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVMKA-INDGFRL--- 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT-------TCCHHHHHHH-HHTTCCC---
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc-------cCCHHHHHHH-HhccCCC---
Confidence 1 12357889999999999999999999999999999997666541 1222233322 2222111
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
..+......+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 233 --------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 --------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 01112334578888999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=400.06 Aligned_cols=239 Identities=22% Similarity=0.291 Sum_probs=199.2
Q ss_pred hccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
+.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++|||||++++++.+++..|+|||||+
T Consensus 10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4578999999999999874 6889999998642 23346778999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.+++.... .+++.++..|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 90 ~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 90 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred CCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999998653 589999999999999999999976 8999999999999999999999999999876543
Q ss_pred -ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 528 -SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
....+|+.|||||++.+..++.++|||||||+||||+||+.||.. .+..+............
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~--------~~~~~~~~~i~~~~~~~--------- 223 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--------NTYQETYKRISRVEFTF--------- 223 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHTTCCCC---------
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC--------CCHHHHHHHHHcCCCCC---------
Confidence 334578999999999999999999999999999999999999962 23333333333221111
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+......+.+++.+||+.||++|||++|+++
T Consensus 224 ----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 ----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0111234667788999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=406.31 Aligned_cols=244 Identities=21% Similarity=0.341 Sum_probs=198.7
Q ss_pred ccCccCceeEEEEEec---CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 376 ILGSGCFGSSYKASLS---TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 376 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.||+|+||+||+|.+. ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.. +..|||||||++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 3999999999999763 3457999999754 34556789999999999999999999999864 56899999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc---
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES--- 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 528 (678)
|.+++...+. .+++.++++|+.|||.||+|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 95 L~~~l~~~~~----~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 95 LHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp HHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred HHHHhhcccc----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999865432 599999999999999999999976 79999999999999999999999999998764321
Q ss_pred ----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 ----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
...+|+.|||||++.++.++.++|||||||++|||+| |+.||... ...+... .+..+... +.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~--------~~~~~~~-~i~~~~~~-~~--- 233 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEVMA-FIEQGKRM-EC--- 233 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CTHHHHH-HHHTTCCC-CC---
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC--------CHHHHHH-HHHcCCCC-CC---
Confidence 2235788999999998999999999999999999998 99999721 2222222 22232211 11
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
+......+.+++.+||+.||++||||.+|++.|+.+..
T Consensus 234 -------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 -------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223457788889999999999999999999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=404.17 Aligned_cols=242 Identities=21% Similarity=0.342 Sum_probs=195.7
Q ss_pred cccCccCceeEEEEEecC---CceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 375 EILGSGCFGSSYKASLST---GAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
+.||+|+||+||+|.+.. ++.||||+++.. +....++|.+|+++|++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999997643 467999998743 23446789999999999999999999999864 567899999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc-
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES- 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~- 528 (678)
|+|.++++... .++|.++++|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999998653 599999999999999999999976 79999999999999999999999999998764321
Q ss_pred ------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 529 ------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 529 ------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
...+|+.|||||++.+..++.++|||||||++|||+| |+.||.. ....+.. ..+..+... ..
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~--------~~~~~~~-~~i~~~~~~-~~- 231 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG--------MKGSEVT-AMLEKGERM-GC- 231 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT--------CCHHHHH-HHHHTTCCC-CC-
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC--------CCHHHHH-HHHHcCCCC-CC-
Confidence 2246788999999999999999999999999999998 8999972 2222222 222232211 10
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
+......+.+++.+||+.||++||||.+|++.|+..
T Consensus 232 ---------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 ---------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 112234577888899999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=401.84 Aligned_cols=240 Identities=22% Similarity=0.321 Sum_probs=199.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..|+|||||++|+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 45799999999999986 56899999999866556678899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.+++... .+++.++..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+... .
T Consensus 105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 9988653 489999999999999999999976 8999999999999999999999999999876433 2
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...+|+.|||||++.+..++.++|||||||++|||+||+.||.. .+..+.+......+... ...+
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~--------~~~~~~~~~~~~~~~~~--~~~~----- 239 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN--------ENPLRALYLIATNGTPE--LQNP----- 239 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHHCSCC--CSSG-----
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC--------CCHHHHHHHHHhCCCCC--CCCc-----
Confidence 33478999999999999999999999999999999999999962 22233333333322111 1000
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||+.||.+|||+.|+++
T Consensus 240 ---~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 ---EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111234677888999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=401.19 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=199.7
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
..+.||+|+||+||+|+++++..||||+++.. ....+.|.+|+.+|++++|||||+++|+|. .+..++||||+++|+|
T Consensus 21 i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l 98 (285)
T d1fmka3 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 98 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCch
Confidence 45789999999999999988888999998754 345678999999999999999999999985 4668999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc----
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES---- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 528 (678)
..++..... ..++|.+++.|+.||+.||+|||++ +|+||||||+|||||+++.+||+|||+++.+....
T Consensus 99 ~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 99 LDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp HHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred hhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 999876432 2599999999999999999999976 79999999999999999999999999998764332
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||++..+.++.++|||||||++|||+||+.|+.. .....+.+....... .. ..
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~-------~~~~~~~~~~i~~~~-~~-~~------- 235 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-------GMVNREVLDQVERGY-RM-PC------- 235 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST-------TCCHHHHHHHHHTTC-CC-CC-------
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC-------CCCHHHHHHHHHhcC-CC-CC-------
Confidence 23467889999999999999999999999999999997666541 123333333332221 11 10
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.......+.+++.+||+.||++||||++|+++|++.....
T Consensus 236 ---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 236 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1122345778888999999999999999999999866443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=401.68 Aligned_cols=242 Identities=20% Similarity=0.284 Sum_probs=198.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||+||+|+. .++..||||+++.......+.|.+|+++|++++|||||++++++.+.+..++|||||++|+|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence 46799999999999986 46889999999876666678899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----c
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE----S 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----~ 528 (678)
.+++..... .+++.++..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 97 ~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 97 DAVMLELER----PLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp HHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 999875432 599999999999999999999976 8999999999999999999999999999766432 2
Q ss_pred cccccceeeCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 529 AQELMIAYKSPEFLQ-----LGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~-----~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
...+|+.|||||++. ...|+.++|||||||++|||+||+.||... +..+.+.......... ...+
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~--------~~~~~~~~i~~~~~~~--~~~~ 238 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL--------NPMRVLLKIAKSEPPT--LAQP 238 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS--------CGGGHHHHHHHSCCCC--CSSG
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC--------CHHHHHHHHHcCCCCC--CCcc
Confidence 345788999999984 456899999999999999999999999721 2222222333222111 1000
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
......+.+++.+||+.||++|||+.|+++
T Consensus 239 --------~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 239 --------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111234677888999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=397.82 Aligned_cols=247 Identities=21% Similarity=0.260 Sum_probs=187.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEe--CCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR--KEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~Ey~~ 448 (678)
.+.||+|+||+||+|+. .+|+.||||.++.. +....+.|.+|+++|++++|||||++++++.+ .+..|+|||||+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 46799999999999976 46899999998753 34456779999999999999999999999975 456899999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhC-CCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYREL-PSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
+|+|.+++...... ...+++.++..++.||+.||+|||+.. ...+|+||||||+||||++++.+||+|||+++.+...
T Consensus 89 ~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 89 GGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 99999998753221 126999999999999999999999862 1234999999999999999999999999999876543
Q ss_pred c----cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 528 S----AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 528 ~----~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
. ...+|+.|||||++.+..|+.++|||||||++|||+||+.||.. .+..+......... .. .
T Consensus 168 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~--------~~~~~~~~~i~~~~-~~-~---- 233 (269)
T d2java1 168 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA--------FSQKELAGKIREGK-FR-R---- 233 (269)
T ss_dssp --------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHTC-CC-C----
T ss_pred CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC--------CCHHHHHHHHHcCC-CC-C----
Confidence 2 23568899999999999999999999999999999999999962 23333333332221 11 0
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+ +......+.+++.+||+.||.+|||+.|+++
T Consensus 234 -~-----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -I-----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -C-----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 0112234677888999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=401.11 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=204.6
Q ss_pred ccccCccCceeEEEEEecCC----ceEEEEEecc-cChhhHHHHHHHHHHHhccCCCCccceeEEEEeC-CceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLSTG----AMMVVKRFKQ-MNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-EEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~Ey~ 447 (678)
.++||+|+||+||+|.+..+ ..||||+++. ......++|.+|+++|++++|||||+++|+|... +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999987432 3589999975 3455668899999999999999999999998764 5789999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.++++.... .+++..+++++.|+|.||.|||+. +|+||||||+|||||+++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred ecCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999886533 578999999999999999999976 7999999999999999999999999999876433
Q ss_pred c--------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 528 S--------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 528 ~--------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
. ...++..|+|||.+..+.++.++||||||+++|||+||+.||... .+..++...... +...
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~-------~~~~~~~~~i~~-g~~~-- 253 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQ-GRRL-- 253 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHT-TCCC--
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC-------CCHHHHHHHHHc-CCCC--
Confidence 1 123578899999999999999999999999999999988887521 112222222222 2111
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCCCCcccc
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDGDEDFYS 657 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~~~~~~~ 657 (678)
.++ ......+.+++.+||+.||++||+|.||++.|+++...-..+.++.
T Consensus 254 -~~p--------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~~ 302 (311)
T d1r0pa_ 254 -LQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302 (311)
T ss_dssp -CCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCC
T ss_pred -CCc--------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhchh
Confidence 111 1123457788889999999999999999999999988766555443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=397.24 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=192.6
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEe-CCceEEEEeccCCCC
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR-KEEKLLVHEFVPKRS 451 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~Ey~~~gs 451 (678)
..+.||+|+||.||+|++ .|..||||+++.. ...+.|.+|++++++++|||||+++|+|.+ .+..++||||+++|+
T Consensus 11 ~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 356799999999999998 5788999999753 345789999999999999999999999965 456899999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-ccc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-SAQ 530 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~~~ 530 (678)
|.++|+.... ..++|..+++|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 88 L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~ 160 (262)
T d1byga_ 88 LVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160 (262)
T ss_dssp HHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence 9999976432 1489999999999999999999976 7999999999999999999999999999876543 233
Q ss_pred cccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhccc
Q 044996 531 ELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADER 609 (678)
Q Consensus 531 ~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 609 (678)
.++..|+|||++.++.++.++|||||||++|||+| |+.||.... ...+..++ ..+... +.
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----~~~~~~~i----~~~~~~-~~--------- 221 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRV----EKGYKM-DA--------- 221 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHHH----TTTCCC-CC---------
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHH----HcCCCC-CC---------
Confidence 45778999999999999999999999999999999 788876211 11222222 222111 11
Q ss_pred CCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 610 NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 610 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
+......+.+++.+||+.||.+||||.||+++|++++.
T Consensus 222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11122456788889999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=391.65 Aligned_cols=241 Identities=20% Similarity=0.322 Sum_probs=191.6
Q ss_pred cccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEe----CCceEEEEecc
Q 044996 375 EILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR----KEEKLLVHEFV 447 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~Ey~ 447 (678)
+.||+|+||+||+|... ++..||+|++... .....+.|.+|+++|++++|||||++++++.+ ....|+||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 46999999999999864 6788999998753 34456789999999999999999999999875 34579999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec-CCCceEEeecCCccccCc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN-ESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~ 526 (678)
++|+|.+++.... .+++.++..++.||++||+|||++ ..+|+||||||+||||+ +++.+||+|||+++....
T Consensus 95 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~--~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 95 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS--SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHC--CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999997653 589999999999999999999976 12399999999999996 589999999999987654
Q ss_pred c--ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 527 E--SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 527 ~--~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
. ....+|+.|||||++.+ +++.++|||||||++|||+||+.||... .+.....+. +..+... +.
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-------~~~~~~~~~-i~~~~~~-----~~ 233 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRR-VTSGVKP-----AS 233 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHH-HTTTCCC-----GG
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-------ccHHHHHHH-HHcCCCC-----cc
Confidence 3 23457899999999864 6999999999999999999999999621 222222222 2222111 11
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.. .. ..++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~-~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDK-VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGG-CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCc-cC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 11 223667888999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=407.34 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=197.0
Q ss_pred hccccCccCceeEEEEEecC-C-----ceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEE
Q 044996 373 SAEILGSGCFGSSYKASLST-G-----AMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 444 (678)
..++||+|+||+||+|++.. + ..||||++... .......|.+|+.+|.++ +|||||+++++|.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 46789999999999998643 2 25889988643 334456799999999998 8999999999999999999999
Q ss_pred eccCCCCHHHHhhccCCC------------------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEE
Q 044996 445 EFVPKRSLAVNLHGHQAL------------------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVL 506 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NIL 506 (678)
|||++|+|.++|+..... ....++|..++.|+.||++||+|||+. +||||||||+|||
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~IiHRDlKp~Nil 196 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVL 196 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCchhccc
Confidence 999999999999765321 113589999999999999999999976 7999999999999
Q ss_pred ecCCCceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCC
Q 044996 507 LNESLEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKA 579 (678)
Q Consensus 507 l~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~ 579 (678)
++.++.+||+|||+|+...... ...+|+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~------ 270 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI------ 270 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC------
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC------
Confidence 9999999999999998765432 2235788999999999999999999999999999998 89999621
Q ss_pred CCChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHH
Q 044996 580 DGDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIE 644 (678)
Q Consensus 580 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~ 644 (678)
...+-+...+..+... . .+......+.+++.+||+.||++||||+||++.|.
T Consensus 271 --~~~~~~~~~~~~~~~~-~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 --PVDANFYKLIQNGFKM-D----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp --CCSHHHHHHHHTTCCC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --CHHHHHHHHHhcCCCC-C----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1112223333333211 0 01112345778888999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=396.79 Aligned_cols=241 Identities=18% Similarity=0.236 Sum_probs=190.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+++..||||||+++|+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 46799999999999986 468999999987543 2334679999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
|.+++.... .+++.++..|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 90 L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 90 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred HHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999996542 599999999999999999999976 8999999999999999999999999999876432
Q ss_pred --ccccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 --SAQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....||+.|||||++.+..+ +.++|||||||++|||+||+.||.... ... ............. +.
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~------~~~-~~~~~~~~~~~~~-----~~ 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS------DSC-QEYSDWKEKKTYL-----NP 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS------TTS-HHHHHHHTTCTTS-----TT
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC------hHH-HHHHHHhcCCCCC-----Cc
Confidence 22347899999999988776 678999999999999999999996211 111 1111111111110 00
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. . .....+.+++.+||+.||++|||++|+++
T Consensus 229 ~--~----~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 W--K----KIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp G--G----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c--c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0 11234567778999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-48 Score=399.60 Aligned_cols=240 Identities=22% Similarity=0.308 Sum_probs=198.5
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||+||+|+. .+++.||||+++... ....+.|.+|+++|++++|||||++++++.+++..|+|||||++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 46799999999999976 568899999987543 23446789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcccc
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQESA 529 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 529 (678)
|+|..++.... .+++.++..|+.||+.||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 100 g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 100 SASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 99987765442 599999999999999999999976 899999999999999999999999999998887777
Q ss_pred ccccceeeCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhh
Q 044996 530 QELMIAYKSPEFLQL---GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMA 606 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~---~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 606 (678)
..||+.|||||++.+ +.|+.++|||||||++|||++|+.||.. ....+.+.......... +.
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~--------~~~~~~~~~i~~~~~~~-------~~ 235 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMSALYHIAQNESPA-------LQ 235 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT--------SCHHHHHHHHHHSCCCC-------CS
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHhCCCCC-------CC
Confidence 789999999999863 4689999999999999999999999962 22233333333322111 11
Q ss_pred cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 607 DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 607 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... ...+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111 234677788999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-48 Score=399.70 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=202.6
Q ss_pred ccccCccCceeEEEEEec------CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS------TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+++|++++||||++++++|...+..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~ 97 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 97 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence 567999999999999864 35789999987543 34467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCC-------------------CCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEe
Q 044996 447 VPKRSLAVNLHGHQA-------------------LGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLL 507 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl 507 (678)
+++|+|.++++.... .....++|.++++|+.|++.||+|||+. +||||||||+||||
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~ivHrDlKp~NILl 173 (301)
T d1lufa_ 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLV 173 (301)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEE
T ss_pred cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----CeEeeEEcccceEE
Confidence 999999999975321 1123589999999999999999999976 79999999999999
Q ss_pred cCCCceEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCC-CCccccccCCCCC
Q 044996 508 NESLEPVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGK-FPANFLQQGKKAD 580 (678)
Q Consensus 508 ~~~~~~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~-~P~~~~~~~~~~~ 580 (678)
|.++.+||+|||+++.+.... ...++..|+|||++.+..||.++|||||||++|||++|. .||..
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-------- 245 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-------- 245 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--------
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC--------
Confidence 999999999999997654331 234567899999999999999999999999999999986 46651
Q ss_pred CChHHHHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 581 GDLASWVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 581 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
.+..+....+ .++... .. +.....++.+++.+||+.||++||||.||++.|++|++
T Consensus 246 ~~~~e~~~~v-~~~~~~-~~----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 246 MAHEEVIYYV-RDGNIL-AC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp SCHHHHHHHH-HTTCCC-CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCHHHHHHHH-HcCCCC-CC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2233333332 222211 11 11223457889999999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=397.02 Aligned_cols=264 Identities=19% Similarity=0.246 Sum_probs=200.3
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC----ceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE----EKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~Ey~~~ 449 (678)
.+.||+|+||.||+|++ +|+.||||+++... .....++.|+..+.+++|||||+++++|.+.+ ..|+|||||++
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 46799999999999986 68899999986532 22223344555667889999999999998754 57899999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHh----CCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRE----LPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+|.++|+.. .++|.++++++.|+|.||+|||+. ++..+|+||||||+||||++++.+||+|||+++...
T Consensus 86 g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9999999864 489999999999999999999963 234589999999999999999999999999997654
Q ss_pred cc--------ccccccceeeCccccccC------CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCC------CChHH
Q 044996 526 QE--------SAQELMIAYKSPEFLQLG------RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKAD------GDLAS 585 (678)
Q Consensus 526 ~~--------~~~~~~~~y~aPE~~~~~------~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~------~~l~~ 585 (678)
.. ....+|..|||||++.+. .++.|+|||||||+||||+||..|+.......... ..-.+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 32 123468999999998754 25779999999999999999998875322111100 11223
Q ss_pred HHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 586 WVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.......... .++.+.......+....+.+++.+||+.||++||||.||++.|+++.+..
T Consensus 240 ~~~~~~~~~~-----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 240 EMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHTTSC-----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccc-----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 3333333221 12222222222345677889999999999999999999999999997643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=400.35 Aligned_cols=190 Identities=25% Similarity=0.351 Sum_probs=169.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|+++|++++|||||+++++|.+++..|+|||||++|+
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 46799999999999986 46899999998753 34446789999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--cc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--SA 529 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--~~ 529 (678)
|.+++.+.. .+++..+..++.|++.||.|||+.+ +|+||||||+||||++++.+||+|||+|+.+... ..
T Consensus 91 L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 162 (322)
T d1s9ja_ 91 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162 (322)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCcccc
Confidence 999998653 4899999999999999999999632 6999999999999999999999999999876443 23
Q ss_pred ccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 530 QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 530 ~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
..+|..|||||++.+..|+.++||||+||++|||+||+.||.
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 457899999999999999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-47 Score=393.73 Aligned_cols=242 Identities=20% Similarity=0.268 Sum_probs=183.5
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|||||||++|+
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~ 93 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 467999999999999864 68899999987533 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec---CCCceEEeecCCccccCccc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN---ESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~~~ 528 (678)
|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++......
T Consensus 94 L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 94 LFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp HHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred HHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999997643 599999999999999999999976 899999999999994 57899999999998765432
Q ss_pred ---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 529 ---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 529 ---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
...||+.|||||++.+..|+.++|||||||++|||+||+.||.. ....+............ +...
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--------~~~~~~~~~i~~~~~~~----~~~~ 232 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD--------ENDAKLFEQILKAEYEF----DSPY 232 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHTTCCCC----CTTT
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC--------CCHHHHHHHHhccCCCC----CCcc
Confidence 33578899999999999999999999999999999999999962 22233333333222111 1111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||++|||+.|+++
T Consensus 233 -----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 233 -----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0112234677888999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=389.02 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=191.6
Q ss_pred hccccCccCceeEEEEEecC----CceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 373 SAEILGSGCFGSSYKASLST----GAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
..+.||+|+||.||+|.+.. +..||||.++.. .....+.|.+|+++|++++|||||+++|++. .+..++||||+
T Consensus 11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence 35679999999999997642 356888888653 3445678999999999999999999999985 56789999999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
++|+|.+++..... .+++.+++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 90 ~~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 90 TLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp TTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cCCcHHhhhhccCC----CCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999998876532 589999999999999999999976 7999999999999999999999999999876533
Q ss_pred -----ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCcccccc
Q 044996 528 -----SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVF 601 (678)
Q Consensus 528 -----~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 601 (678)
....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+-..... .+... .
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~--------~~~~~~~i~-~~~~~-~-- 229 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------NNDVIGRIE-NGERL-P-- 229 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--------GGGHHHHHH-TTCCC-C--
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC--------HHHHHHHHH-cCCCC-C--
Confidence 22345788999999999999999999999999999998 899987321 111122222 22111 0
Q ss_pred chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc
Q 044996 602 DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER 649 (678)
Q Consensus 602 d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~ 649 (678)
.+......+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 230 --------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 230 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0112234577888899999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=390.73 Aligned_cols=240 Identities=22% Similarity=0.266 Sum_probs=197.4
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
..+.||+|+||+||+|+. .+++.||||+++.. .....+.+.+|+++|++++|||||++++++.+++..|+||||++
T Consensus 12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 356799999999999987 46899999998742 23345779999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 92 gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 92 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999988653 589999999999999999999976 89999999999999999999999999998765321
Q ss_pred ------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 529 ------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 529 ------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
...||+.|||||++.+..|+.++|||||||++|||+||+.||.. .+..+-...........
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--------~~~~~~~~~i~~~~~~~----- 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA--------GNEYLIFQKIIKLEYDF----- 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHTTCCCC-----
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC--------cCHHHHHHHHHcCCCCC-----
Confidence 23478999999999999999999999999999999999999962 22233333333221111
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
+......+.+++.+||+.||.+|||++|+++.
T Consensus 230 --------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 --------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 01112346778889999999999999997653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-47 Score=397.93 Aligned_cols=243 Identities=21% Similarity=0.310 Sum_probs=202.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|||||||++|+|
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 110 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 110 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCH
Confidence 56799999999999986 46899999999877666778899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec--CCCceEEeecCCccccCccc--
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN--ESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGla~~~~~~~-- 528 (678)
.+++..... .+++.++..|+.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++.+....
T Consensus 111 ~~~l~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 111 FEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp HHHHTCTTS----CBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999965432 599999999999999999999976 899999999999996 46889999999998765442
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...+|..|||||++.+..++.++|||||||++|||+||+.||. ..+..+.+........... .....
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~--------~~~~~~~~~~i~~~~~~~~---~~~~~- 250 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG--------GENDDETLRNVKSCDWNMD---DSAFS- 250 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC--------CSSHHHHHHHHHHTCCCSC---CGGGG-
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC--------CCCHHHHHHHHHhCCCCCC---ccccc-
Confidence 3457889999999999999999999999999999999999996 2233444444443322210 11110
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.....+.+++.+||+.||++|||+.|+++
T Consensus 251 -----~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 251 -----GISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp -----GCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11234677788999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=388.06 Aligned_cols=245 Identities=22% Similarity=0.334 Sum_probs=191.6
Q ss_pred ccccCccCceeEEEEEecC--C--ceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLST--G--AMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.+.||+|+||+||+|++.. + ..||||+++.. .....++|.+|+++|++++|||||+++|+|.+ +..++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 4679999999999997632 2 36899988743 23445789999999999999999999999965 567899999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
+++|++.+++..... .+++..++.++.|||.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 92 ~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 92 APLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp CTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred ecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999998876533 599999999999999999999976 799999999999999999999999999987644
Q ss_pred ccc-------ccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 527 ESA-------QELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 527 ~~~-------~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
... ..++..|+|||++.+..++.++|||||||++|||+| |+.||. +.+..+-+......+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~--------~~~~~~~~~~i~~~~~~~- 234 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--------GLNGSQILHKIDKEGERL- 234 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT--------TCCHHHHHHHHHTSCCCC-
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC--------CcCHHHHHHHHHhCCCCC-
Confidence 321 235678999999999999999999999999999998 899996 233334444444333221
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHh
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEV 646 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i 646 (678)
.. .......+.+++.+||+.||++||||.||++.|++.
T Consensus 235 ~~----------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 PR----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 111234577888899999999999999999999886
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.2e-47 Score=396.49 Aligned_cols=243 Identities=21% Similarity=0.304 Sum_probs=200.9
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||++|+|
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 113 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 113 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChH
Confidence 46799999999999986 57899999999876666677899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec--CCCceEEeecCCccccCccc--
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN--ESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGla~~~~~~~-- 528 (678)
.+++..... .+++.++..|+.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 114 ~~~~~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 114 FDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp HHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 988765432 599999999999999999999976 899999999999998 67899999999998876543
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|||||++.+..++.++|||||||++|||+||+.||.. .+..+.+.......... ....
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~i~~~~~~~----~~~~-- 251 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG--------EDDLETLQNVKRCDWEF----DEDA-- 251 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--------SSHHHHHHHHHHCCCCC----CSST--
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC----Cccc--
Confidence 23567899999999999999999999999999999999999962 23333333333322111 0100
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.......+.+++.+||+.||.+|||+.|+++
T Consensus 252 ---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 252 ---FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ---TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112234677888999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=394.27 Aligned_cols=246 Identities=21% Similarity=0.376 Sum_probs=195.6
Q ss_pred ccccCccCceeEEEEEec-CCc----eEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASLS-TGA----MMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~ 447 (678)
.++||+|+||+||+|.+. +|+ .||+|+++.. .....++|.+|++++++++|||||+++|+|.+ +..++++||+
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e~~ 92 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLM 92 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEEEec
Confidence 468999999999999864 343 5888888653 34457789999999999999999999999986 4678889999
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
.+|+|.+++..... .++|..+++|+.|||.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 93 ~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 93 PFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp TTCBHHHHHHHTSS----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred cCCccccccccccc----CCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999998876543 699999999999999999999976 7999999999999999999999999999876433
Q ss_pred c------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHHHHHHHHhcCCccccc
Q 044996 528 S------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLASWVNSVLANGDNRTEV 600 (678)
Q Consensus 528 ~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 600 (678)
. ...+|..|||||++.++.++.++|||||||++|||+| |+.||+.. ...+. ...+..+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~--------~~~~~-~~~i~~~~~~--- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEI-SSILEKGERL--- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--------CGGGH-HHHHHHTCCC---
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC--------CHHHH-HHHHHcCCCC---
Confidence 2 1235789999999999999999999999999999999 88898622 11111 1222222111
Q ss_pred cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 601 FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 601 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
..+......+.+++.+||+.||.+||||.||++.|+.+..
T Consensus 233 --------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 0111223457788889999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=384.87 Aligned_cols=243 Identities=22% Similarity=0.303 Sum_probs=197.8
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccC------hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMN------NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.|.+|+++|++++|||||++++++.+.+..|||||
T Consensus 14 ~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 356799999999999987 578999999986422 2246789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC----ceEEeecCCc
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL----EPVLADYGLI 521 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla 521 (678)
||++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 94 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred cCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999997653 599999999999999999999976 899999999999998776 4999999999
Q ss_pred cccCcc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 522 PVMNQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 522 ~~~~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
+..... ....++..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+............
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~--------~~~~~~~~~i~~~~~~~- 235 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG--------DTKQETLANVSAVNYEF- 235 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHTTCCCC-
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC--------CCHHHHHHHHHhcCCCC-
Confidence 876543 233567889999999998999999999999999999999999962 23333333333222111
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 236 ---~~~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 ---EDEYFS-----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---CHHHHT-----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CchhcC-----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 11234667888999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=392.71 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=199.9
Q ss_pred ccccCccCceeEEEEEecC-Cc--eEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLST-GA--MMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.++||+|+||+||+|.+.+ +. .||||+++.. .....++|.+|+++|+++ +|||||+++|+|.+++..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 5789999999999998754 43 4678887643 334566899999999999 79999999999999999999999999
Q ss_pred CCCHHHHhhccC-----------CCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEee
Q 044996 449 KRSLAVNLHGHQ-----------ALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLAD 517 (678)
Q Consensus 449 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~D 517 (678)
+|+|.++|+... ......++|.++++++.|||.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECC
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCCceEEcc
Confidence 999999997542 11123699999999999999999999976 799999999999999999999999
Q ss_pred cCCccccCccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCC-CccccccCCCCCCChHHHHHHHHhc
Q 044996 518 YGLIPVMNQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKF-PANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 518 fGla~~~~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~-P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
||+++...... ...+|..|+|||.+..+.++.++|||||||++|||++|.. ||. ..+..+.... +.+
T Consensus 171 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~--------~~~~~~~~~~-i~~ 241 (309)
T d1fvra_ 171 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--------GMTCAELYEK-LPQ 241 (309)
T ss_dssp TTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT--------TCCHHHHHHH-GGG
T ss_pred ccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC--------CCCHHHHHHH-HHh
Confidence 99998765442 2346788999999999999999999999999999999765 564 1233333322 222
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccCC
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERDG 651 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~~ 651 (678)
+... .. +......+.+++.+||+.||++||||.||++.|+++.+...
T Consensus 242 ~~~~------~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 242 GYRL------EK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp TCCC------CC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cCCC------CC-----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 2111 00 11123457788889999999999999999999999986543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=387.39 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=205.8
Q ss_pred hccccCccCceeEEEEEec------CCceEEEEEeccc-ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEe
Q 044996 373 SAEILGSGCFGSSYKASLS------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~E 445 (678)
..+.||+|+||+||+|.+. ++..||||+++.. .......|.+|++++++++|||||+++|+|...+..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4578999999999999763 3578999999753 34455679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhccC-----CCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCC
Q 044996 446 FVPKRSLAVNLHGHQ-----ALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGL 520 (678)
Q Consensus 446 y~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 520 (678)
||++|+|.++++... ......++|.++.+|+.|+|+||.|||+. +|+||||||+|||||+++++||+|||+
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecCCceEEEeeccc
Confidence 999999999987532 11223579999999999999999999976 799999999999999999999999999
Q ss_pred ccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCC-CCccccccCCCCCCChHHHHHHHHhc
Q 044996 521 IPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGK-FPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 521 a~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~-~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
++.+.... ...++..|+|||.+.++.++.++|||||||++|||+||+ .||. .....++...+...
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~--------~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--------GLSNEQVLRFVMEG 251 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT--------TSCHHHHHHHHHTT
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC--------CCCHHHHHHHHHhC
Confidence 98765432 224678899999999999999999999999999999985 6664 23445555444432
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
. .. .. +......+.+++.+||+.||++||||.||++.|++..++.
T Consensus 252 ~-~~-~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 252 G-LL-DK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp C-CC-CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred C-CC-CC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 2 11 11 1112345888888999999999999999999998876544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=386.92 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=192.1
Q ss_pred hccccCccCceeEEEEEec------CCceEEEEEeccc-ChhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCC-ceEEE
Q 044996 373 SAEILGSGCFGSSYKASLS------TGAMMVVKRFKQM-NNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKE-EKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-~~~lv 443 (678)
..+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|+..+.++ +|+|||.+++++...+ ..++|
T Consensus 17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv 96 (299)
T d1ywna1 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 96 (299)
T ss_dssp EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence 3578999999999999753 3468999998753 344566788888888777 6899999999987654 68999
Q ss_pred EeccCCCCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc
Q 044996 444 HEFVPKRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE 512 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~ 512 (678)
||||++|+|.++++..... ....++|.+++.++.||++||+|||+. +|+||||||+||||++++.
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGC
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCcCCccceeECCCCc
Confidence 9999999999999764321 123589999999999999999999976 7999999999999999999
Q ss_pred eEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCC-CCccccccCCCCCCChHH
Q 044996 513 PVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGK-FPANFLQQGKKADGDLAS 585 (678)
Q Consensus 513 ~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~-~P~~~~~~~~~~~~~l~~ 585 (678)
+||+|||+++...... ...+|..|||||++.++.++.++|||||||++|||+||. .||.. ....+
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~--------~~~~~ 244 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG--------VKIDE 244 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCCSH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC--------CCHHH
Confidence 9999999998654321 234678999999999999999999999999999999975 56752 12223
Q ss_pred HHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 586 WVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
.+...+..+... .. +.....++.+++.+||+.||++||||.||++.|+++.+
T Consensus 245 ~~~~~~~~~~~~-~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 245 EFCRRLKEGTRM-RA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHTCCC-CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCC-CC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 333334333221 11 11123357788889999999999999999999998864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=383.69 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=198.3
Q ss_pred ccccCccCceeEEEEEecC--------CceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEE
Q 044996 374 AEILGSGCFGSSYKASLST--------GAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv 443 (678)
.+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||+++++|.+++..++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 5679999999999997532 2478999997543 34567889999999888 899999999999999999999
Q ss_pred EeccCCCCHHHHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc
Q 044996 444 HEFVPKRSLAVNLHGHQAL-----------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE 512 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~ 512 (678)
||||++|+|.++|...... ....+++.++++++.||+.||+|||+. +||||||||+|||++.++.
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp~NiLl~~~~~ 173 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDNV 173 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCC
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeecccceeecCCCC
Confidence 9999999999999765421 123589999999999999999999977 7999999999999999999
Q ss_pred eEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHh-CCCCccccccCCCCCCChHH
Q 044996 513 PVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMT-GKFPANFLQQGKKADGDLAS 585 (678)
Q Consensus 513 ~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~t-g~~P~~~~~~~~~~~~~l~~ 585 (678)
+||+|||+++...... ...++..|+|||++.++.|+.++|||||||++|||+| |+.||.. ... .
T Consensus 174 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~--------~~~-~ 244 (299)
T d1fgka_ 174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------VPV-E 244 (299)
T ss_dssp EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT--------CCH-H
T ss_pred eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC--------CCH-H
Confidence 9999999998765432 2345788999999999999999999999999999998 7888762 222 2
Q ss_pred HHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhc
Q 044996 586 WVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKE 648 (678)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~ 648 (678)
.+...+..+... .. +......+.+++.+||+.||.+||||.||++.|+++..
T Consensus 245 ~~~~~i~~~~~~-~~----------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ELFKLLKEGHRM-DK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHTTCCC-CC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCC-CC----------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 233333333221 11 11123457888889999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=386.21 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=202.7
Q ss_pred ccccCccCceeEEEEEe------cCCceEEEEEecccC-hhhHHHHHHHHHHHhcc-CCCCccceeEEEEeCCceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL------STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRL-RHPNLLPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~E 445 (678)
.+.||+|+||.||+|++ .++..||||+++... .....+|.+|+.+++++ +|||||+++|+|.+.+..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 56899999999999975 345689999997543 44566799999999999 69999999999999999999999
Q ss_pred ccCCCCHHHHhhccCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCc
Q 044996 446 FVPKRSLAVNLHGHQAL-------------GQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLE 512 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~ 512 (678)
||++|+|.++++..... ....+++..+++|+.||++||+|||.+ ++|||||||+|||++.++.
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----~ivHrDLKp~NIl~~~~~~ 183 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGRI 183 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETTTE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccccccccccccCc
Confidence 99999999999865321 123589999999999999999999977 7999999999999999999
Q ss_pred eEEeecCCccccCccc------cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhC-CCCccccccCCCCCCChHH
Q 044996 513 PVLADYGLIPVMNQES------AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTG-KFPANFLQQGKKADGDLAS 585 (678)
Q Consensus 513 ~kl~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg-~~P~~~~~~~~~~~~~l~~ 585 (678)
+|++|||+++...... ...+++.|+|||++.++.++.++|||||||++|||+|+ +.||.. .+..+
T Consensus 184 ~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~--------~~~~~ 255 (311)
T d1t46a_ 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--------MPVDS 255 (311)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--------CCSSH
T ss_pred ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC--------CCHHH
Confidence 9999999998765432 23457889999999999999999999999999999995 554431 11112
Q ss_pred HHHHHHhcCCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 586 WVNSVLANGDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 586 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
-+...+..+... . .+......+.+++.+||+.||.+||||.||+++|+++..+.
T Consensus 256 ~~~~~i~~~~~~-~----------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 256 KFYKMIKEGFRM-L----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp HHHHHHHHTCCC-C----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHhcCCCC-C----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 222333332211 0 01112345788888999999999999999999999876653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.7e-46 Score=376.98 Aligned_cols=249 Identities=18% Similarity=0.227 Sum_probs=198.9
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC---hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCc----eEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN---NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEE----KLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----~~lv~E 445 (678)
.+.||+|+||+||+|+. .+++.||||+++... ....+.|.+|++++++++|||||++++++...+. .|||||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 46799999999999986 578999999997532 3345679999999999999999999999986543 789999
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+++|+|.+++.... .+++.++..|+.||+.||+|||+. +|+||||||+|||++.++..+|+|||.++...
T Consensus 92 ~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhhhhhc
Confidence 999999999887653 589999999999999999999976 89999999999999999999999999987553
Q ss_pred cc-------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc
Q 044996 526 QE-------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT 598 (678)
Q Consensus 526 ~~-------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 598 (678)
.. ....+|..|||||++.+..++.++|||||||++|||+||+.||. ..+..+.....+......
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~--------~~~~~~~~~~~~~~~~~~- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT--------GDSPVSVAYQHVREDPIP- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC--------CSSHHHHHHHHHHCCCCC-
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC--------CcCHHHHHHHHHhcCCCC-
Confidence 32 22346889999999999899999999999999999999999996 223334444444443222
Q ss_pred cccchhhhcccCCHHHHHHHHHHHhhcCccccccCC-CHHHHHHHHHHhhc
Q 044996 599 EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRL-DLKEAVEKIEEVKE 648 (678)
Q Consensus 599 ~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~ev~~~L~~i~~ 648 (678)
+...... ....+.+++.+||+.||.+|| |++++.+.|.++.+
T Consensus 234 ----~~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 ----PSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ----GGGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ----CchhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 1111111 123467788899999999999 89999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.5e-46 Score=384.26 Aligned_cols=239 Identities=18% Similarity=0.233 Sum_probs=199.0
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
+.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..|+|||||+
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence 356799999999999986 46899999998742 23346789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 88 gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 88 GGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp SCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred Cccccccccccc-----cccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 999999987654 478889999999999999999965 8999999999999999999999999999877544
Q ss_pred ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 528 SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
....||..|||||++.+..|+.++|||||||++|||+||+.||. ..+..+.............
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~--------~~~~~~~~~~i~~~~~~~p--------- 221 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAELRFP--------- 221 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC--------CSSHHHHHHHHHHCCCCCC---------
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC--------CcCHHHHHHHHHcCCCCCC---------
Confidence 33457899999999999899999999999999999999999996 2333444444443321110
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
......+.+++.+||+.||.+|+ |++|+++
T Consensus 222 ----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 ----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11123466778899999999996 8999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=380.72 Aligned_cols=238 Identities=21% Similarity=0.250 Sum_probs=197.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||+||+|+. .+++.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+..|+|||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 46799999999999986 57899999999743 233467789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc--
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-- 527 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-- 527 (678)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 90 g~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred Cchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999998754 488999999999999999999976 8999999999999999999999999999875432
Q ss_pred --ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhh
Q 044996 528 --SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEM 605 (678)
Q Consensus 528 --~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 605 (678)
....||+.|||||++.+..|+.++||||+||++|||++|+.||.. .+..+............
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~--------~~~~~~~~~i~~~~~~~-------- 224 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------QDHERLFELILMEEIRF-------- 224 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC--------
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC--------cCHHHHHHHHhcCCCCC--------
Confidence 234578999999999999999999999999999999999999972 23333333333322111
Q ss_pred hcccCCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 606 ADERNSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 606 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
+......+.+++.+||+.||.+||+ +.|+++
T Consensus 225 -----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 225 -----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1111234667788999999999995 788876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-45 Score=371.18 Aligned_cols=242 Identities=20% Similarity=0.246 Sum_probs=194.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh---------hhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN---------VGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l 442 (678)
.+.||+|+||+||+|+. .+++.+|||+++.... ...+.+.+|+.++++++ |||||++++++.+++..||
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 56799999999999986 5788999999875321 12356889999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
|||||++|+|.++|+... .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 88 vmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999997653 599999999999999999999976 89999999999999999999999999998
Q ss_pred ccCcc---ccccccceeeCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc
Q 044996 523 VMNQE---SAQELMIAYKSPEFLQL------GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN 593 (678)
Q Consensus 523 ~~~~~---~~~~~~~~y~aPE~~~~------~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~ 593 (678)
.+... ....+|..|+|||++.+ ..++.++||||+||++|||+||+.||.. .+...-.......
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~--------~~~~~~~~~i~~~ 230 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--------RKQMLMLRMIMSG 230 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC--------CCHHHHHHHHHhC
Confidence 76543 23346889999998853 3468899999999999999999999972 2222222333332
Q ss_pred CCccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 594 GDNRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 594 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... ..+.. . ....++.+++.+||+.||++|||+.||++
T Consensus 231 ~~~~---~~~~~--~----~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 NYQF---GSPEW--D----DYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCCC---CTTTG--G----GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCC---CCccc--c----cCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2111 11111 0 11234677888999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-45 Score=376.89 Aligned_cols=242 Identities=20% Similarity=0.266 Sum_probs=197.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCCH
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRSL 452 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gsL 452 (678)
.+.||+|+||+||+|... +++.||||.++... .....+.+|+++|++++|||||++++++.+.+..|||||||++|+|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 567999999999999864 68899999997643 3456788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC--CCceEEeecCCccccCccc--
Q 044996 453 AVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE--SLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 453 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~~-- 528 (678)
.+++..... .+++.++..|+.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++......
T Consensus 89 ~~~i~~~~~----~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 89 FERINTSAF----ELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp HHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 999976532 589999999999999999999976 8999999999999985 4589999999998765432
Q ss_pred -cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhc
Q 044996 529 -AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMAD 607 (678)
Q Consensus 529 -~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 607 (678)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.. .+..+.+.......... +.....
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~--------~~~~~~~~~i~~~~~~~----~~~~~~ 228 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA--------ETNQQIIENIMNAEYTF----DEEAFK 228 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC--------SSHHHHHHHHHHTCCCC----CHHHHT
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhCCCCC----Chhhcc
Confidence 23467889999999999999999999999999999999999962 23334444444332111 111100
Q ss_pred ccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 608 ERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 608 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. ....+.+++.+||..||.+|||+.|+++
T Consensus 229 -~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 -E----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -T----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -C----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1234677888999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-45 Score=380.70 Aligned_cols=238 Identities=17% Similarity=0.194 Sum_probs=198.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc---ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM---NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPK 449 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~ 449 (678)
.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+..++||||+.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 46799999999999986 47899999998642 223456789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-c
Q 044996 450 RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE-S 528 (678)
Q Consensus 450 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~-~ 528 (678)
|+|..++.... .+++.++..|+.||+.||.|||+. +||||||||+||||+.++.+||+|||+++.+... .
T Consensus 126 g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred cchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 99999997653 589999999999999999999976 8999999999999999999999999999877643 3
Q ss_pred cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchhhhcc
Q 044996 529 AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKEMADE 608 (678)
Q Consensus 529 ~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 608 (678)
...+|+.|||||++.+..++.++|||||||++|||+||+.||. ..+...............
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~--------~~~~~~~~~~i~~~~~~~----------- 257 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF--------ADQPIQIYEKIVSGKVRF----------- 257 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC--------CSSHHHHHHHHHHCCCCC-----------
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC--------CcCHHHHHHHHhcCCCCC-----------
Confidence 4457899999999999999999999999999999999999996 223334444433332111
Q ss_pred cCCHHHHHHHHHHHhhcCccccccCC-----CHHHHHH
Q 044996 609 RNSEGEMVKLLKIGLACCEEEVEKRL-----DLKEAVE 641 (678)
Q Consensus 609 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~ev~~ 641 (678)
+......+.+++.+||+.||.+|+ |+.|+++
T Consensus 258 --p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 --PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011123467788899999999994 8999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=375.20 Aligned_cols=238 Identities=22% Similarity=0.288 Sum_probs=193.2
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc---ChhhHHHHHHHHHHHh-ccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM---NNVGREEFQEHMRRLG-RLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
.+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|..++. .++|||||++++++.+++..|+|||||+
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 567999999999999864 6899999999742 2334556777777765 6899999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc-
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~- 527 (678)
+|+|.++++... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999998654 488999999999999999999977 7999999999999999999999999999865432
Q ss_pred ---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccchh
Q 044996 528 ---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDKE 604 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 604 (678)
....+|..|+|||++.+..++.++|||||||++|||+||+.||.. .+..+-...........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~--------~~~~~~~~~i~~~~~~~------- 222 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--------QDEEELFHSIRMDNPFY------- 222 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHCCCCC-------
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCCCCC-------
Confidence 233578899999999999999999999999999999999999962 23233333332221111
Q ss_pred hhcccCCHHHHHHHHHHHhhcCccccccCCCHH-HHHH
Q 044996 605 MADERNSEGEMVKLLKIGLACCEEEVEKRLDLK-EAVE 641 (678)
Q Consensus 605 l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-ev~~ 641 (678)
+......+.+++.+||+.||++||++. |+++
T Consensus 223 ------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 ------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111123467788899999999999995 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-44 Score=379.03 Aligned_cols=241 Identities=19% Similarity=0.253 Sum_probs=188.8
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccC---hhhHHHHHH---HHHHHhccCCCCccceeEEEEeCCceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMN---NVGREEFQE---HMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey 446 (678)
.++||+|+||.||+|+.. +|+.||||++.... ......+.+ |+++++.++|||||++++++.+.+..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 467999999999999864 68999999986421 122233444 46777888999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCc
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 526 (678)
|++|+|.++|.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 89 ~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 89 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred cCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999998653 488999999999999999999976 899999999999999999999999999987654
Q ss_pred c--ccccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccch
Q 044996 527 E--SAQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFDK 603 (678)
Q Consensus 527 ~--~~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 603 (678)
. ....+|..|||||++.. ..|+.++|||||||+||||+||+.||.... ........+.......
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~~~~~~~~~~-------- 226 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK-----TKDKHEIDRMTLTMAV-------- 226 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC-----SSCHHHHHHHSSSCCC--------
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcccCCC--------
Confidence 4 23457899999999875 468999999999999999999999997211 1122111111111100
Q ss_pred hhhcccCCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 604 EMADERNSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 604 ~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
.+ +......+.+++.+||+.||.+||| +.|+++
T Consensus 227 ~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 EL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC-----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC-----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 0111234677888999999999999 678764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=377.66 Aligned_cols=242 Identities=19% Similarity=0.260 Sum_probs=187.6
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhcc-CCCCccceeEEEEe----CCceEEEEeccC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRL-RHPNLLPLVAYYYR----KEEKLLVHEFVP 448 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~~~lv~Ey~~ 448 (678)
++||+|+||+||+|+. .+++.||||+++.. +.+.+|++++.++ +|||||+++++|.+ ....|+|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 5699999999999976 57899999998642 4577899987655 89999999999875 356899999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC---CCceEEeecCCccccC
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE---SLEPVLADYGLIPVMN 525 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~ 525 (678)
+|+|.++|..... ..+++.++..|+.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+++...
T Consensus 93 gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 93 GGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp SEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHHHc----CCccccccccccccccccccccccccccceeeecc
Confidence 9999999976432 3599999999999999999999976 8999999999999985 5679999999998765
Q ss_pred cc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccccccc
Q 044996 526 QE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTEVFD 602 (678)
Q Consensus 526 ~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 602 (678)
.. ....+|+.|||||++.+..|+.++|||||||+||||+||+.||..... ......+......+. . ..-.
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~-----~~~~~~~~~~i~~~~-~-~~~~ 238 (335)
T d2ozaa1 166 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQ-Y-EFPN 238 (335)
T ss_dssp CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC-----C--------CCCSCS-S-SCCT
T ss_pred CCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH-----HHHHHHHHHHHhcCC-C-CCCC
Confidence 43 234578999999999999999999999999999999999999973211 111111110000000 0 0000
Q ss_pred hhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 603 KEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 603 ~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.. .....++.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 239 PEW------SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp THH------HHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccc------ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 112345778888999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=372.22 Aligned_cols=250 Identities=21% Similarity=0.254 Sum_probs=186.8
Q ss_pred cccCccCceeEEEEEe-cCCceEEEEEecccChh-----hHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccC
Q 044996 375 EILGSGCFGSSYKASL-STGAMMVVKRFKQMNNV-----GREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVP 448 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~ 448 (678)
++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+++..|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999986 46899999998753221 12468899999999999999999999999999999999998
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES 528 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 528 (678)
++++..+.... ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 88777665433 2588999999999999999999976 89999999999999999999999999998765432
Q ss_pred ----cccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCccccccc
Q 044996 529 ----AQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTEVFD 602 (678)
Q Consensus 529 ----~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~d 602 (678)
...+|..|+|||++... .|+.++|||||||++|||+||+.||... +-.+-+...... +....+...
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~--------~~~~~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--------SDLDQLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCCCCTTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC--------CHHHHHHHHHHhcCCCChhhcc
Confidence 23467889999988654 5799999999999999999999998621 111111111110 000000000
Q ss_pred -----------hhhhccc---CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 603 -----------KEMADER---NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 603 -----------~~l~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
....... ........+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000 00011235778888999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=365.49 Aligned_cols=251 Identities=21% Similarity=0.283 Sum_probs=187.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||+|.. .+++.||||+++... ....+.+.+|+++|++++|||||++++++.+++..|+||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 46799999999999986 578999999996532 23357899999999999999999999999999999999999965
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc---
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE--- 527 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~--- 527 (678)
++.+++..... ..+++.++..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 86 DLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred chhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 45555543322 2599999999999999999999976 7999999999999999999999999999766432
Q ss_pred -ccccccceeeCccccccCC-CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh-cCCccccccchh
Q 044996 528 -SAQELMIAYKSPEFLQLGR-ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA-NGDNRTEVFDKE 604 (678)
Q Consensus 528 -~~~~~~~~y~aPE~~~~~~-~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~~d~~ 604 (678)
....++..|+|||.+.... ++.++|||||||++|||++|+.||... +-.+-+..... .+... +..-+.
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~--------~~~~~~~~i~~~~~~~~-~~~~~~ 229 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD--------SEIDQLFRIFRTLGTPD-EVVWPG 229 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCC-TTTSTT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC--------CHHHHHHHHHHhcCCCc-hhhccc
Confidence 2235678999999877655 589999999999999999999999621 11111111111 01000 000000
Q ss_pred h----------hc-ccCC-----HHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 605 M----------AD-ERNS-----EGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 605 l----------~~-~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
. .. .... ......+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 00 0000 011245677888999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=364.24 Aligned_cols=232 Identities=19% Similarity=0.277 Sum_probs=186.7
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccCh------hhHHHHHHHHHHHhccC--CCCccceeEEEEeCCceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNN------VGREEFQEHMRRLGRLR--HPNLLPLVAYYYRKEEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 444 (678)
.++||+|+||+||+|+. .+++.||||+++.... ....++.+|+.+|++++ |||||++++++.+.+..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 46799999999999986 4789999999874211 12234678999999996 899999999999999999999
Q ss_pred eccCC-CCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-CCceEEeecCCcc
Q 044996 445 EFVPK-RSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-SLEPVLADYGLIP 522 (678)
Q Consensus 445 Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~ 522 (678)
||+.+ +++.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 89 e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp ECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECccccce
Confidence 99975 68888887543 589999999999999999999976 8999999999999985 4799999999998
Q ss_pred ccCcc--ccccccceeeCccccccCCC-CCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcccc
Q 044996 523 VMNQE--SAQELMIAYKSPEFLQLGRI-TKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRTE 599 (678)
Q Consensus 523 ~~~~~--~~~~~~~~y~aPE~~~~~~~-t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 599 (678)
..... ....||..|+|||++.+..+ +.++|||||||++|||+||+.||.... ........
T Consensus 160 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~~~~~--- 222 (273)
T d1xwsa_ 160 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRGQVF--- 222 (273)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHCCCC---
T ss_pred ecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhhcccC---
Confidence 76543 23457899999999987765 577999999999999999999996210 11111111
Q ss_pred ccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 600 VFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 600 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.+ .. ..++.+++.+||+.||++|||++|+++
T Consensus 223 -~~~-----~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 -FRQ-----RV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CSS-----CC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCC-----CC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111 11 234667778999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.6e-43 Score=358.99 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=190.3
Q ss_pred ccccCccCceeEEEEEecCCceEEEEEecccC--hhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLSTGAMMVVKRFKQMN--NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||+||+|+..+++.||||+++... ....+.+.+|+.+|++++|||||++++++...+..+++|||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 46799999999999999999999999997543 3335789999999999999999999999999999999999998776
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc----
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE---- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~---- 527 (678)
+..+.... ..+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 87 KKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp HHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 66665433 2599999999999999999999976 7999999999999999999999999998765533
Q ss_pred ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh-cCCc----cccc-
Q 044996 528 SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA-NGDN----RTEV- 600 (678)
Q Consensus 528 ~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~-~~~~----~~~~- 600 (678)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||... +..+-...... .+.. ....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~--------~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV--------SEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC--------CHHHHHHHHHHhhCCCChhhccchh
Confidence 222356789999998754 5699999999999999999999999621 11111111110 0000 0000
Q ss_pred ----cchhhh------cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 601 ----FDKEMA------DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 601 ----~d~~l~------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.+.... ...........+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00001111245677888999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=357.80 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=185.0
Q ss_pred ccccCccCceeEEEEEe-cC-CceEEEEEecccC--hhhHHHHHHHHHHHhcc---CCCCccceeEEEEe-----CCceE
Q 044996 374 AEILGSGCFGSSYKASL-ST-GAMMVVKRFKQMN--NVGREEFQEHMRRLGRL---RHPNLLPLVAYYYR-----KEEKL 441 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~~~~ 441 (678)
.+.||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+|+.| +|||||+++++|.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 46799999999999986 34 5678999986432 22234566777776665 89999999999864 24678
Q ss_pred EEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCc
Q 044996 442 LVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLI 521 (678)
Q Consensus 442 lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 521 (678)
++|||+.++++........ ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 92 ~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred EEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecchhhh
Confidence 9999998877765544332 2589999999999999999999976 7999999999999999999999999999
Q ss_pred cccCcc---ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCcc
Q 044996 522 PVMNQE---SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNR 597 (678)
Q Consensus 522 ~~~~~~---~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~ 597 (678)
+..... ....+|+.|||||++.+..|+.++||||+||++|||+||+.||... +-.+-+...+.. +...
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS--------SDVDQLGKILDVIGLPG 235 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCC
T ss_pred hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHhhCCCc
Confidence 876543 3345789999999999999999999999999999999999999621 111212221110 0000
Q ss_pred cccc-------chhhh------cccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 598 TEVF-------DKEMA------DERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 598 ~~~~-------d~~l~------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.... ..... ...........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00000 00000111234667888999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-41 Score=349.41 Aligned_cols=262 Identities=14% Similarity=0.139 Sum_probs=192.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCcccee-EEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLV-AYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~-~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||+||+|+. .+++.||||.+.... ..+++..|++++++++|+|+|..+ +++.+.+..++||||+ +|+
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~ 88 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 88 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCc
Confidence 46799999999999986 568899999877532 234578899999999887766555 4456677889999999 567
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEec---CCCceEEeecCCccccCcc-
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLN---ESLEPVLADYGLIPVMNQE- 527 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~~- 527 (678)
|...+..... .+++..+..++.|++.||+|||+. +|+||||||+|||++ .+..+||+|||+++.+...
T Consensus 89 l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 89 LEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred hhhhhhhccC----CCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 7776654432 599999999999999999999976 899999999999976 4567999999999876432
Q ss_pred ----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc
Q 044996 528 ----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR 597 (678)
Q Consensus 528 ----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 597 (678)
....+|+.|||||++.+..++.++|||||||++|||+||+.||........ ......+.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~~---- 235 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMST---- 235 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHS----
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH-HHHHHHhhcccCCC----
Confidence 122478899999999999999999999999999999999999973221110 01111111111100
Q ss_pred ccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhcc--CCCCcccccc
Q 044996 598 TEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKER--DGDEDFYSSY 659 (678)
Q Consensus 598 ~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~--~~~~~~~~~~ 659 (678)
..+.+.. .....+.+++..||+.+|++||++.++.+.|+.+... ...++.++|.
T Consensus 236 ---~~~~~~~-----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 236 ---PIEVLCK-----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp ---CHHHHTT-----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred ---ChhHhcc-----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence 0011111 1224577788899999999999999999999987432 3334445543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=355.81 Aligned_cols=257 Identities=20% Similarity=0.266 Sum_probs=185.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEEEEec
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLLVHEF 446 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~Ey 446 (678)
.++||+|+||+||+|+.. +++.||||+++.... .+.+|+++|++++|||||+++++|... ...+|||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 367999999999999874 689999999975432 234799999999999999999998643 247899999
Q ss_pred cCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-ceEEeecCCccccC
Q 044996 447 VPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-EPVLADYGLIPVMN 525 (678)
Q Consensus 447 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~ 525 (678)
|+++.+..+.+.... ...+++.++..|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 101 ~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 101 VPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp CSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred cCCccHHHHHhhhhc--cCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 987644443332211 22699999999999999999999965 899999999999999775 89999999998765
Q ss_pred ccc---cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CC-----
Q 044996 526 QES---AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GD----- 595 (678)
Q Consensus 526 ~~~---~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~----- 595 (678)
... ...++..|+|||.+.+ ..++.++||||+||++|||++|+.||... +-.+.....+.. +.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~--------~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--------SGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS--------SHHHHHHHHHHHHCCCCHHH
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC--------CHHHHHHHHHHHhCCChHHh
Confidence 432 3346788999998765 56899999999999999999999999621 111111111100 00
Q ss_pred -----------ccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhcc
Q 044996 596 -----------NRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKER 649 (678)
Q Consensus 596 -----------~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~~ 649 (678)
............ .........+.+++.+||+.||++|||+.|+++ .++++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhhhccchhhccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 000000000000 000112234677788999999999999999986 36665443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=350.08 Aligned_cols=189 Identities=22% Similarity=0.319 Sum_probs=157.8
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEe--------CCceEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYR--------KEEKLL 442 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~~~~~l 442 (678)
.+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++.. .+..++
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence 46799999999999986 57899999998643 23345778999999999999999999999865 345899
Q ss_pred EEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 443 VHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 443 v~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
||||+.++.+..+.... ..++...+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 95 v~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 95 VFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp EEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeecceee
Confidence 99999887766554332 2588899999999999999999976 89999999999999999999999999997
Q ss_pred ccCcc--------ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 523 VMNQE--------SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 523 ~~~~~--------~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
.+... ....+|..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 65432 223468899999998754 68999999999999999999999996
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=353.70 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=186.2
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCC------ceEEEE
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE------EKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~lv~ 444 (678)
.+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ ..|+||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence 46799999999999986 46899999999753 3345678899999999999999999999997654 469999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+ +++|..+++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+++..
T Consensus 103 e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccceecc
Confidence 999 56788777543 599999999999999999999976 8999999999999999999999999999877
Q ss_pred Ccc-ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHh-cCCccc---
Q 044996 525 NQE-SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLA-NGDNRT--- 598 (678)
Q Consensus 525 ~~~-~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~--- 598 (678)
... ....++..|+|||++.+. .++.++||||+||++|||++|+.||.... .... ...... .+....
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~-------~~~~-~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-------HLDQ-LKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHH-HHHHHHHHCCCCHHHH
T ss_pred CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC-------hHHH-HHHHHhccCCCcHHHH
Confidence 654 334578899999998764 56999999999999999999999996211 1111 100000 000000
Q ss_pred ----------------cccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH--HHHhh
Q 044996 599 ----------------EVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK--IEEVK 647 (678)
Q Consensus 599 ----------------~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L~~i~ 647 (678)
+.....+.. ........+.+++.+||..||++|||+.|+++. ++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccchHH--hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000000000 000112346678889999999999999999973 55543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=349.70 Aligned_cols=243 Identities=22% Similarity=0.280 Sum_probs=190.2
Q ss_pred hccccCccCceeEEEEEe----cCCceEEEEEeccc----ChhhHHHHHHHHHHHhccCC-CCccceeEEEEeCCceEEE
Q 044996 373 SAEILGSGCFGSSYKASL----STGAMMVVKRFKQM----NNVGREEFQEHMRRLGRLRH-PNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv 443 (678)
..+.||+|+||+||+|+. .+|+.||||.++.. .....+.+.+|+++|++++| |||+++++++.+....++|
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeee
Confidence 457899999999999975 24789999998642 22345678899999999976 8999999999999999999
Q ss_pred EeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccc
Q 044996 444 HEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 444 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
|||+.+|+|.+++.... .+.......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999998764 367888999999999999999976 799999999999999999999999999986
Q ss_pred cCcc-----ccccccceeeCccccccC--CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCc
Q 044996 524 MNQE-----SAQELMIAYKSPEFLQLG--RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDN 596 (678)
Q Consensus 524 ~~~~-----~~~~~~~~y~aPE~~~~~--~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~ 596 (678)
+... ....++..|+|||.+.+. .++.++|||||||+||||+||+.||.... .........+........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~----~~~~~~~i~~~~~~~~~~ 254 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSEPP 254 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT----SCCCHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcccCCCC
Confidence 6432 223467789999998754 46889999999999999999999996321 112222222222211111
Q ss_pred cccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCC-----HHHHHH
Q 044996 597 RTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLD-----LKEAVE 641 (678)
Q Consensus 597 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~ev~~ 641 (678)
........+.+++.+||+.||.+||| ++|+++
T Consensus 255 -------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 255 -------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01122345677788999999999994 788875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=348.60 Aligned_cols=254 Identities=17% Similarity=0.253 Sum_probs=184.6
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccC-hhhHHHHHHHHHHHhccCCCCccceeEEEEeCC----ceEEEEecc
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMN-NVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKE----EKLLVHEFV 447 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv~Ey~ 447 (678)
.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.... ..++++||+
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 46799999999999975 578999999997543 445678999999999999999999999997643 234555667
Q ss_pred CCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCcc
Q 044996 448 PKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQE 527 (678)
Q Consensus 448 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 527 (678)
.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 93 ~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 93 MGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred cCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 799999999754 489999999999999999999976 8999999999999999999999999999766443
Q ss_pred c-------cccccceeeCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCccc-
Q 044996 528 S-------AQELMIAYKSPEFLQL-GRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNRT- 598 (678)
Q Consensus 528 ~-------~~~~~~~y~aPE~~~~-~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~~- 598 (678)
. ...++..|+|||++.. ..++.++||||+||++|||++|+.||..... .+................
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-----HHHHHHHhhhccCCChhhh
Confidence 2 2236788999999854 4678999999999999999999999962110 001111111110000000
Q ss_pred -cccc-------hhhhc-ccCCH-----HHHHHHHHHHhhcCccccccCCCHHHHHHH
Q 044996 599 -EVFD-------KEMAD-ERNSE-----GEMVKLLKIGLACCEEEVEKRLDLKEAVEK 642 (678)
Q Consensus 599 -~~~d-------~~l~~-~~~~~-----~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~ 642 (678)
.... ..+.. ..... ....++.+++.+|++.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000 00000 011346788889999999999999999873
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=342.17 Aligned_cols=252 Identities=19% Similarity=0.217 Sum_probs=194.0
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeCCceEEEEeccCCC
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRKEEKLLVHEFVPKR 450 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~Ey~~~g 450 (678)
.+.||+|+||+||+|+. .+++.||||+++.. .....+.+.+|+.+|++++|||||+++++|.+.+..++|+||+.++
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence 46799999999999986 57889999998643 2345678999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccCccc--
Q 044996 451 SLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMNQES-- 528 (678)
Q Consensus 451 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 528 (678)
+|..+++..+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++......
T Consensus 87 ~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 87 LKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred cccccccccc-----ccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9988876543 588999999999999999999976 89999999999999999999999999998765432
Q ss_pred --cccccceeeCccccccCC-CCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCCcc-c------
Q 044996 529 --AQELMIAYKSPEFLQLGR-ITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGDNR-T------ 598 (678)
Q Consensus 529 --~~~~~~~y~aPE~~~~~~-~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~------ 598 (678)
...++..|+|||.+.... ++.++|||||||++|||++|+.||.. ..+..+.+.......... .
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-------GNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC-------CSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC-------CCCHHHHHHHHHhhcCCCChhhhhhh
Confidence 223467799999887655 69999999999999999999999752 123333333322111000 0
Q ss_pred -ccc--------chhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 599 -EVF--------DKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 599 -~~~--------d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
+.. ................+.+++.+|++.||.+|||++||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000000111234677888999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.8e-41 Score=343.50 Aligned_cols=253 Identities=14% Similarity=0.124 Sum_probs=196.4
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEecccChhhHHHHHHHHHHHhccCC-CCccceeEEEEeCCceEEEEeccCCCC
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRH-PNLLPLVAYYYRKEEKLLVHEFVPKRS 451 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~Ey~~~gs 451 (678)
.+.||+|+||+||+|+.. +++.||||.+.... ..+.+.+|+++++.++| +||+.+++++......++||||+ +|+
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 467999999999999864 68899999886532 23457789999999975 89999999999999999999999 789
Q ss_pred HHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecC-----CCceEEeecCCccccCc
Q 044996 452 LAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNE-----SLEPVLADYGLIPVMNQ 526 (678)
Q Consensus 452 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~-----~~~~kl~DfGla~~~~~ 526 (678)
|.++++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 87 l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 87 LEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp HHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred HHHHHHhhcc----chhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999876532 589999999999999999999965 8999999999999974 57899999999987543
Q ss_pred c-----------ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhcCC
Q 044996 527 E-----------SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLANGD 595 (678)
Q Consensus 527 ~-----------~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~~~ 595 (678)
. ....||+.|||||++.+..++.++|||||||++|||+||+.||.... ................
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~-----~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-----AATNKQKYERIGEKKQ 233 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC-----SCCHHHHHHHHHHHHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc-----chhHHHHHHHHHhccC
Confidence 2 12247889999999999999999999999999999999999996321 1122222222111100
Q ss_pred ccccccchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHHHHHhhccC
Q 044996 596 NRTEVFDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEKIEEVKERD 650 (678)
Q Consensus 596 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~L~~i~~~~ 650 (678)
.. .-+.+.. ..+.++.+++..|++.+|++||+++.+.+.|+++.+..
T Consensus 234 ~~---~~~~l~~-----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 234 ST---PLRELCA-----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HS---CHHHHTT-----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CC---ChHHhcC-----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00 0011111 11234777778999999999999999999999875543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-40 Score=341.67 Aligned_cols=184 Identities=22% Similarity=0.302 Sum_probs=158.8
Q ss_pred hccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEeC--CceEEEEeccC
Q 044996 373 SAEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRK--EEKLLVHEFVP 448 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~Ey~~ 448 (678)
..++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++|||||.
T Consensus 39 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~ 115 (328)
T d3bqca1 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence 356899999999999986 57899999998753 3567899999999995 99999999999754 46899999999
Q ss_pred CCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC-ceEEeecCCccccCcc
Q 044996 449 KRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL-EPVLADYGLIPVMNQE 527 (678)
Q Consensus 449 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~ 527 (678)
+|+|..+.+ .+++.++..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 116 ~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 116 NTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp SCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred CCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999976532 489999999999999999999976 899999999999998654 6999999999876543
Q ss_pred ---ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCcc
Q 044996 528 ---SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPAN 571 (678)
Q Consensus 528 ---~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~ 571 (678)
....+|..|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 233467889999998765 47999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=341.49 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=188.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC-----CceEEEEe
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK-----EEKLLVHE 445 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv~E 445 (678)
.+.||+|+||+||+|+. .+|+.||||+++.. +....+.+.+|+++|++++|||||++++++... ...++++|
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 46799999999999985 57999999999753 334456789999999999999999999998643 33467778
Q ss_pred ccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCccccC
Q 044996 446 FVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVMN 525 (678)
Q Consensus 446 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 525 (678)
|+.+|+|.++++.. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 103 ~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 103 HLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp ECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchhcccC
Confidence 88899999998643 499999999999999999999976 89999999999999999999999999997765
Q ss_pred cc-ccccccceeeCccccccC-CCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHHHHHHHhc-CCccccc--
Q 044996 526 QE-SAQELMIAYKSPEFLQLG-RITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASWVNSVLAN-GDNRTEV-- 600 (678)
Q Consensus 526 ~~-~~~~~~~~y~aPE~~~~~-~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~-- 600 (678)
.. ....++..|+|||.+.+. .++.++|||||||++|||++|+.||... +-..-....+.. +....+.
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~--------~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT--------DHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHHHhcCCCChHHhh
Confidence 44 334567889999987665 4689999999999999999999999621 111111111110 0000000
Q ss_pred -----------------cchhhhcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHH--HHHHhhc
Q 044996 601 -----------------FDKEMADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE--KIEEVKE 648 (678)
Q Consensus 601 -----------------~d~~l~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~--~L~~i~~ 648 (678)
....+.... ......+.+++.+|++.||.+|||+.|+++ .+.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVF--IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHS--TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hccchhhhhhhhhcccCCCcchhhhc--CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 000000000 011234677888999999999999999997 4665543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=341.04 Aligned_cols=248 Identities=17% Similarity=0.230 Sum_probs=181.6
Q ss_pred ccccCccCceeEEEEEec-CCceEEEEEeccc--ChhhHHHHHHHHHHHhccCCCCccceeEEEEeC------CceEEEE
Q 044996 374 AEILGSGCFGSSYKASLS-TGAMMVVKRFKQM--NNVGREEFQEHMRRLGRLRHPNLLPLVAYYYRK------EEKLLVH 444 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~lv~ 444 (678)
.++||+|+||+||+|... +|+.||||++... +....+++.+|+.++++++|||||+++++|... ...|+||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 467999999999999864 6999999999753 344556789999999999999999999999643 5789999
Q ss_pred eccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceEEeecCCcccc
Q 044996 445 EFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPVLADYGLIPVM 524 (678)
Q Consensus 445 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 524 (678)
||+.++ +.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++..
T Consensus 102 Ey~~~~-l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 102 ELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp ECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eccchH-HHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhhhcc
Confidence 999654 5445432 489999999999999999999976 8999999999999999999999999998766
Q ss_pred Cccc---cccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCCCChHHH---------------
Q 044996 525 NQES---AQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKADGDLASW--------------- 586 (678)
Q Consensus 525 ~~~~---~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~~~l~~~--------------- 586 (678)
.... ...+|..|+|||++.+..++.++||||+||++|||++|+.||... +....
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~--------~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR--------DYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC--------CHHHHHHHHHHhccCCCHHH
Confidence 5432 234678899999999999999999999999999999999999521 11111
Q ss_pred -------HHHHHhcCCccccc-----cchhhhccc--CCHHHHHHHHHHHhhcCccccccCCCHHHHHH
Q 044996 587 -------VNSVLANGDNRTEV-----FDKEMADER--NSEGEMVKLLKIGLACCEEEVEKRLDLKEAVE 641 (678)
Q Consensus 587 -------~~~~~~~~~~~~~~-----~d~~l~~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~ 641 (678)
.............. +........ ........+.+++.+|++.||++|||++||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11111111111000 000000000 01123456788999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-35 Score=309.16 Aligned_cols=267 Identities=21% Similarity=0.248 Sum_probs=185.4
Q ss_pred ccccCccCceeEEEEEe-cCCceEEEEEecccChhhHHHHHHHHHHHhccC-----------CCCccceeEEEEeC--Cc
Q 044996 374 AEILGSGCFGSSYKASL-STGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-----------HPNLLPLVAYYYRK--EE 439 (678)
Q Consensus 374 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~~~--~~ 439 (678)
.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|++++++++ |+|||++++++... ..
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence 56799999999999986 57899999999754 334567888999888875 57899999988653 45
Q ss_pred eEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCC------ce
Q 044996 440 KLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESL------EP 513 (678)
Q Consensus 440 ~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~------~~ 513 (678)
.+++|+++..+.......... ....+++..+..++.||+.||+|||+.. +|+||||||+||||+.++ .+
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred eeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccccee
Confidence 667777665544333322221 1236888999999999999999999742 799999999999998665 39
Q ss_pred EEeecCCccccCcc-ccccccceeeCccccccCCCCCcchHHHHHHHHHHHHhCCCCccccccCCCCC--CChHHHHHHH
Q 044996 514 VLADYGLIPVMNQE-SAQELMIAYKSPEFLQLGRITKKTDVWSLGVLILEIMTGKFPANFLQQGKKAD--GDLASWVNSV 590 (678)
Q Consensus 514 kl~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~t~ksDvwS~Gvvl~el~tg~~P~~~~~~~~~~~--~~l~~~~~~~ 590 (678)
|++|||.++..... ....++..|+|||++....++.++||||+||+++||++|+.||.......... ..+...+...
T Consensus 172 kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~l 251 (362)
T d1q8ya_ 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251 (362)
T ss_dssp EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred eEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHh
Confidence 99999998765543 33457889999999999999999999999999999999999997322110000 0011111100
Q ss_pred -------HhcCCcccccc-----------------chhh-hcccCCHHHHHHHHHHHhhcCccccccCCCHHHHHHH--H
Q 044996 591 -------LANGDNRTEVF-----------------DKEM-ADERNSEGEMVKLLKIGLACCEEEVEKRLDLKEAVEK--I 643 (678)
Q Consensus 591 -------~~~~~~~~~~~-----------------d~~l-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev~~~--L 643 (678)
..........+ ...+ ............+.+++.+|++.||.+|||++|+++. +
T Consensus 252 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f 331 (362)
T d1q8ya_ 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331 (362)
T ss_dssp CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGG
T ss_pred CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 00000000000 0000 0111234566788999999999999999999999863 5
Q ss_pred HHh
Q 044996 644 EEV 646 (678)
Q Consensus 644 ~~i 646 (678)
++.
T Consensus 332 ~~~ 334 (362)
T d1q8ya_ 332 KDT 334 (362)
T ss_dssp TTC
T ss_pred CCC
Confidence 533
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=5.1e-30 Score=265.02 Aligned_cols=201 Identities=36% Similarity=0.605 Sum_probs=144.1
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCCCCcceEEecC----CcEEEEEeCCCCcee--ecChHHhhcCCCCCEE
Q 044996 2 TDSQTLLTLKQSLSNPTALANWDDRTPPCNENGANWNGVLCHR----GKIWGLKLEDMGLQG--NIDITILKELREMRTL 75 (678)
Q Consensus 2 ~~~~aLl~~k~~l~~~~~l~~W~~~~~~c~~~~~~w~gv~C~~----~~v~~l~l~~~~l~g--~~~~~~l~~l~~L~~L 75 (678)
+|++||++||+++.||..+++|..++|||. +.|.||+|+. +||++|+|+++++.| .+|+ .+++|++|++|
T Consensus 6 ~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~---~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~L 81 (313)
T d1ogqa_ 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFL 81 (313)
T ss_dssp HHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSEE
T ss_pred HHHHHHHHHHHHCCCCCcCCCCCCCCCCCC---CcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCcccccc
Confidence 589999999999999888999998899994 3699999973 379999999999988 5775 58999999999
Q ss_pred EccC-CcccccCC-cccccCCCCccEEEcccCccccccChh-----------------------hhcCCcccceeecccc
Q 044996 76 SLMR-NNLEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTD-----------------------AFDGMTSLRKLLLADN 130 (678)
Q Consensus 76 ~Ls~-N~l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~-----------------------~~~~l~~L~~l~l~~N 130 (678)
+|++ |+|+|.|| .+..+ ++|++|+|++|+|.|..|.. .|.+++.|+.+++++|
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L--~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKL--TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEETTEESCCCGGGGGC--TTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccc--cccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 9997 89999998 46666 66777777777776644432 1444555555555555
Q ss_pred ccccCCchhh----------------------------------------------------------------------
Q 044996 131 QFNGPIPESL---------------------------------------------------------------------- 140 (678)
Q Consensus 131 ~~~g~~p~~~---------------------------------------------------------------------- 140 (678)
.++|.+|..+
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~ 239 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5544444322
Q ss_pred -cCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchh--hhcCCCCCCCCCCCCCCCCCCCCC
Q 044996 141 -TRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA--LRELDPSSFSGNRDLCGEPLGSPC 209 (678)
Q Consensus 141 -~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~--~~~l~~~~~~gn~~lc~~~~~~~c 209 (678)
+.+++|++|+|++|+|+|.+|.. .+++|++|+|++|+|+|.||.. +.+|....+.||+.+||.|++ +|
T Consensus 240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 22345555555666666666553 4456667777777777766642 455666778888888887765 55
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.3e-23 Score=198.29 Aligned_cols=165 Identities=15% Similarity=0.188 Sum_probs=120.9
Q ss_pred hccccCccCceeEEEEEecCCceEEEEEecccCh------------------hhHHHHHHHHHHHhccCCCCccceeEEE
Q 044996 373 SAEILGSGCFGSSYKASLSTGAMMVVKRFKQMNN------------------VGREEFQEHMRRLGRLRHPNLLPLVAYY 434 (678)
Q Consensus 373 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~H~niv~l~~~~ 434 (678)
+++.||+|+||+||+|...+|+.||||+++.... .....+.+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4678999999999999988999999998753110 1123456788899999999999987653
Q ss_pred EeCCceEEEEeccCCCCHHHHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHHHhCCCCCCcccCCCCCCEEecCCCceE
Q 044996 435 YRKEEKLLVHEFVPKRSLAVNLHGHQALGQPSLDWPSRLKIVKGVAKGLQYLYRELPSLIAPHGHIKSSNVLLNESLEPV 514 (678)
Q Consensus 435 ~~~~~~~lv~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~~ivHrdlk~~NILl~~~~~~k 514 (678)
..+++|||++++.+. .++......++.|++.+|+|||+. +|+||||||+|||++++ .++
T Consensus 84 ----~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 84 ----GNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp ----TTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETT-EEE
T ss_pred ----CCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCC-CEE
Confidence 247999999875543 244455678999999999999976 89999999999999965 589
Q ss_pred EeecCCccccCcccccccc---ceeeCccccccCCCCCcchHHHHHHHH
Q 044996 515 LADYGLIPVMNQESAQELM---IAYKSPEFLQLGRITKKTDVWSLGVLI 560 (678)
Q Consensus 515 l~DfGla~~~~~~~~~~~~---~~y~aPE~~~~~~~t~ksDvwS~Gvvl 560 (678)
|+|||+|............ ...+ .|.+ .+.|+.++||||..--+
T Consensus 143 liDFG~a~~~~~~~~~~~l~rd~~~~-~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILERDVRNI-ITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHHHHHHHH-HHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHHHHHHHHHHH-HHHH-cCCCCCcccHHHHHHHH
Confidence 9999998766543221100 0000 1222 35678899999976443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.66 E-value=2.4e-17 Score=156.23 Aligned_cols=107 Identities=25% Similarity=0.365 Sum_probs=49.8
Q ss_pred CCCEEEccCCcccccCCc--ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCe
Q 044996 71 EMRTLSLMRNNLEGPMPD--LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVE 148 (678)
Q Consensus 71 ~L~~L~Ls~N~l~g~~p~--~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~ 148 (678)
+++.|+|++|+|++.++. +..+ ++|+.|+|++|++.+..+ +.|..+++|+.|+|++|++++..|..|.++++|++
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l--~~L~~L~L~~N~i~~~~~-~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~ 106 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRL--PHLVKLELKRNQLTGIEP-NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKT 106 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGC--TTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCE
T ss_pred CCCEEEeCCCCCcccccccccCCC--ceEeeeeccccccccccc-cccccccccceeeeccccccccCHHHHhCCCcccc
Confidence 444555555555443331 2222 345555555555553222 23445555555555555555444444555555555
Q ss_pred EeccCCcccccCCcc--CCCCCcEEEeecCcccc
Q 044996 149 LRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 149 l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g 180 (678)
|+|++|+|++..|.. .+.+|+.|+|++|.+..
T Consensus 107 L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 107 LNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp EECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cccCCccccccCHHHhcCCccccccccccccccc
Confidence 555555555433331 33445555555555443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=6e-15 Score=147.04 Aligned_cols=151 Identities=21% Similarity=0.247 Sum_probs=109.1
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCccccee
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l 125 (678)
.++.|+|++|.++ .+++..|.+|++|+.|+|++|+|+. +|.+..+ ++|++|+|++|+|++ +|.. +.++++|+.|
T Consensus 32 ~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l--~~L~~L~Ls~N~l~~-~~~~-~~~l~~L~~L 105 (266)
T d1p9ag_ 32 DTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTK-LQVDGTL--PVLGTLDLSHNQLQS-LPLL-GQTLPALTVL 105 (266)
T ss_dssp TCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCE-EECCSCC--TTCCEEECCSSCCSS-CCCC-TTTCTTCCEE
T ss_pred CCCEEECcCCcCC-CcCHHHhhccccccccccccccccc-ccccccc--ccccccccccccccc-cccc-cccccccccc
Confidence 5888999999988 4666678889999999999998874 4544444 567777887777774 3332 5555555555
Q ss_pred ecc------------------------ccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCccc
Q 044996 126 LLA------------------------DNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALF 179 (678)
Q Consensus 126 ~l~------------------------~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~ 179 (678)
+|+ +|.+++..+..+..+++|+.|++++|+|++..+.. .+.+|+.|+|++|+|+
T Consensus 106 ~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~ 185 (266)
T d1p9ag_ 106 DVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185 (266)
T ss_dssp ECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc
Confidence 555 45555444555667788888888888888665542 4678999999999998
Q ss_pred ccCchhhhcC---CCCCCCCCCCCCCC
Q 044996 180 GSISPALREL---DPSSFSGNRDLCGE 203 (678)
Q Consensus 180 g~ip~~~~~l---~~~~~~gn~~lc~~ 203 (678)
.||..+..+ ....+.||||.|.+
T Consensus 186 -~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 186 -TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp -CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred -ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 788776544 45579999999964
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.52 E-value=1.6e-14 Score=136.31 Aligned_cols=165 Identities=23% Similarity=0.282 Sum_probs=136.8
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEc
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~L 102 (678)
|.|..|.|++ ..++.|+|++|.|++.++...|..+++|+.|+|++|++.+.++. +..+ .+|++|+|
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~--~~L~~L~L 85 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA--SHIQELQL 85 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC--TTCCEEEC
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccc--cccceeee
Confidence 5799999962 25889999999999888777899999999999999999998874 3334 78999999
Q ss_pred ccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc-CCCCCcEEEeecCccccc
Q 044996 103 SNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 103 s~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ 181 (678)
++|+|+ .||+++|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.+..... ....+..+.+..|.++..
T Consensus 86 s~N~l~-~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 86 GENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CSCCCC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred cccccc-ccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeC
Confidence 999999 677777999999999999999999988999999999999999999998765432 122355566778888888
Q ss_pred CchhhhcCCCCCCCCCCCCCC
Q 044996 182 ISPALRELDPSSFSGNRDLCG 202 (678)
Q Consensus 182 ip~~~~~l~~~~~~gn~~lc~ 202 (678)
.|..+..+...++..|..-|.
T Consensus 165 ~p~~l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 165 APSKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp SSTTTTTSBGGGSCTTTCCCC
T ss_pred CChhhcCCEeeecCHhhCcCC
Confidence 888887777667777765563
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.46 E-value=4e-14 Score=144.47 Aligned_cols=119 Identities=27% Similarity=0.481 Sum_probs=107.5
Q ss_pred CCCCEEEccCCcccc--cCC-cccccCCCCccEEEccc-CccccccChhhhcCCcccceeeccccccccCCchhhcCCCC
Q 044996 70 REMRTLSLMRNNLEG--PMP-DLRQLGNGALRSVYLSN-NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSR 145 (678)
Q Consensus 70 ~~L~~L~Ls~N~l~g--~~p-~~~~~~~~~L~~L~Ls~-N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~ 145 (678)
.+++.|+|++|+++| .+| .+..+ ++|++|+|++ |+|+|.||++ |++|++|++|+|++|+|.|..|..+..+..
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L--~~L~~L~Ls~~N~l~g~iP~~-i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~ 126 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANL--PYLNFLYIGGINNLVGPIPPA-IAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGC--TTCSEEEEEEETTEESCCCGG-GGGCTTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcC--ccccccccccccccccccccc-cccccccchhhhccccccccccccccchhh
Confidence 367899999999998 466 57777 7899999997 8999999987 899999999999999999999999999999
Q ss_pred CCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhcCCC
Q 044996 146 LVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRELDP 191 (678)
Q Consensus 146 L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~l~~ 191 (678)
|+.+++++|.+.+.+|.. .++.|+.+++++|.++|.+|..+..+..
T Consensus 127 L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~ 174 (313)
T d1ogqa_ 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCT
T ss_pred hcccccccccccccCchhhccCcccceeeccccccccccccccccccc
Confidence 999999999999999974 6789999999999999999998876543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.1e-13 Score=138.97 Aligned_cols=141 Identities=26% Similarity=0.362 Sum_probs=119.4
Q ss_pred ecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCch
Q 044996 60 NIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPE 138 (678)
Q Consensus 60 ~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~ 138 (678)
.+++..+.++++|+.|+|++|.+.+..+. +... .+|+.+++++|+|+ .||+.+|..+++|+.|+|++|+|++..|.
T Consensus 95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~--~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL--AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC--TTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred cccchhhcccccCCEEecCCcccccccccccchh--cccchhhhcccccc-ccChhHhccccchhhcccccCcccccchh
Confidence 45556788999999999999999876553 2233 67999999999999 57767799999999999999999998899
Q ss_pred hhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchhhhc---CCCCCCCCCCCCCCC
Q 044996 139 SLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGNRDLCGE 203 (678)
Q Consensus 139 ~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn~~lc~~ 203 (678)
.|.++++|+.+++++|++++..|.. ...+|++|++++|.+++..|..+.. +....+.+|++-|.+
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence 9999999999999999999888864 5679999999999999887777765 445578899988854
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=3e-13 Score=134.49 Aligned_cols=130 Identities=17% Similarity=0.126 Sum_probs=102.7
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
....++.++++|+ .||.. + -++|+.|+|++|+|++..+. +..+ ++|++|+|++|+|+ .||. ++.+++|++
T Consensus 11 ~~~~v~C~~~~L~-~iP~~-l--p~~l~~L~Ls~N~i~~l~~~~f~~l--~~L~~L~L~~N~l~-~l~~--~~~l~~L~~ 81 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPD-L--PKDTTILHLSENLLYTFSLATLMPY--TRLTQLNLDRAELT-KLQV--DGTLPVLGT 81 (266)
T ss_dssp TCCEEECTTSCCS-SCCSC-C--CTTCCEEECTTSCCSEEEGGGGTTC--TTCCEEECTTSCCC-EEEC--CSCCTTCCE
T ss_pred CCeEEEccCCCCC-eeCcC-c--CcCCCEEECcCCcCCCcCHHHhhcc--cccccccccccccc-cccc--ccccccccc
Confidence 3455678888888 67754 2 15799999999999986553 5555 78999999999998 6874 688999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchh
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA 185 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~ 185 (678)
|+|++|++++ +|..+.++++|+.|++++|.+.+..+.. ...++..|++++|.+++..+..
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~ 143 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL 143 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred cccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceecccc
Confidence 9999999985 5677899999999999999988654442 5567888888888887544433
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.37 E-value=9.2e-13 Score=114.38 Aligned_cols=101 Identities=28% Similarity=0.406 Sum_probs=61.6
Q ss_pred CEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEecc
Q 044996 73 RTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLE 152 (678)
Q Consensus 73 ~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~ 152 (678)
|.|+|++|+++ .++.+..+ .+|++|||++|.|+ .||+. |+.+++|+.|+|++|.+++ +| .+.++++|+.|+++
T Consensus 1 R~L~Ls~n~l~-~l~~l~~l--~~L~~L~ls~N~l~-~lp~~-~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~ 73 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCHLEQL--LLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 73 (124)
T ss_dssp SEEECTTSCCS-SCCCGGGG--TTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CEEEcCCCCCC-CCcccccC--CCCCEEECCCCccC-cchhh-hhhhhcccccccccccccc-cC-ccccccccCeEECC
Confidence 45666666666 34555555 55677777777766 56654 6666677777777776663 34 36666777777777
Q ss_pred CCcccccCC--c-cCCCCCcEEEeecCcccc
Q 044996 153 GNKFEGQIP--D-FQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 153 ~N~l~g~~p--~-~~~~~l~~l~l~~N~l~g 180 (678)
+|+++.... . ..+.+|+.|++++|.++.
T Consensus 74 ~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 776663221 1 244566677777776653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.5e-12 Score=130.69 Aligned_cols=151 Identities=19% Similarity=0.233 Sum_probs=94.2
Q ss_pred CcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCccc-cc-----------
Q 044996 36 NWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLR-QL----------- 92 (678)
Q Consensus 36 ~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~-~~----------- 92 (678)
.|.-|.|++ ..++.|+|++|.++ .+|+..|.++++|+.|++++|++.+..+... .+
T Consensus 12 ~~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 12 PKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp SSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred CCeEEEcCCCCCCccCCCCCCCCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 355688863 24678999999998 7887789999999999999999987655211 11
Q ss_pred ------------CCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccC
Q 044996 93 ------------GNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQI 160 (678)
Q Consensus 93 ------------~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~ 160 (678)
..++|++|+|++|.+.+ ++...+..+.+|+.+++++|++++..+..|..+++|+.|+|++|+|++..
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred cccccccchhhcccccCCEEecCCccccc-ccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence 01345666666666553 33333555566666666666666544555556666666666666665443
Q ss_pred Ccc--CCCCCcEEEeecCcccccCchhhhc
Q 044996 161 PDF--QQKDLVSFNVSNNALFGSISPALRE 188 (678)
Q Consensus 161 p~~--~~~~l~~l~l~~N~l~g~ip~~~~~ 188 (678)
|.. ..++|+.+++++|++++..|..+..
T Consensus 170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~ 199 (284)
T d1ozna_ 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred hhhhccccccchhhhhhccccccChhHhhh
Confidence 332 3455666666666666555554443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.29 E-value=3.8e-12 Score=110.40 Aligned_cols=103 Identities=27% Similarity=0.372 Sum_probs=87.7
Q ss_pred EEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeecc
Q 044996 49 GLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLA 128 (678)
Q Consensus 49 ~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~ 128 (678)
.|+|++|+++ .++. +..|++|++|+|++|.|+...+.+..+ ++|+.|+|++|.|+ .+| . +..+++|+.|+++
T Consensus 2 ~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~~lp~~~~~l--~~L~~L~l~~N~i~-~l~-~-~~~l~~L~~L~l~ 73 (124)
T d1dcea3 2 VLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLRALPPALAAL--RCLEVLQASDNALE-NVD-G-VANLPRLQELLLC 73 (124)
T ss_dssp EEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCCCCCGGGGGC--TTCCEEECCSSCCC-CCG-G-GTTCSSCCEEECC
T ss_pred EEEcCCCCCC-CCcc--cccCCCCCEEECCCCccCcchhhhhhh--hccccccccccccc-ccC-c-cccccccCeEECC
Confidence 4899999998 6653 889999999999999998643356666 77999999999999 576 4 8999999999999
Q ss_pred ccccccCC-chhhcCCCCCCeEeccCCccccc
Q 044996 129 DNQFNGPI-PESLTRLSRLVELRLEGNKFEGQ 159 (678)
Q Consensus 129 ~N~~~g~~-p~~~~~l~~L~~l~l~~N~l~g~ 159 (678)
+|+++... ...+..+++|++|++++|.++..
T Consensus 74 ~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 99998543 35789999999999999999853
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.26 E-value=1.1e-11 Score=125.41 Aligned_cols=71 Identities=25% Similarity=0.368 Sum_probs=54.0
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc-ccccCCCCccEEEc
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYL 102 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~L 102 (678)
|.|.+|.|++ ..++.|+|++|.+. .+|+..|.+|++|+.|++++|.+....|. +..+ ..|++|+|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l--~~L~~L~l 86 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPL--VKLERLYL 86 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTC--TTCCEEEC
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCC--CccCEecc
Confidence 5899999963 34778999999987 67766688888899999988888876663 4444 55777777
Q ss_pred ccCccc
Q 044996 103 SNNRFS 108 (678)
Q Consensus 103 s~N~l~ 108 (678)
++|+++
T Consensus 87 ~~n~l~ 92 (305)
T d1xkua_ 87 SKNQLK 92 (305)
T ss_dssp CSSCCS
T ss_pred cCCccC
Confidence 777665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=4.8e-12 Score=115.33 Aligned_cols=106 Identities=21% Similarity=0.233 Sum_probs=51.3
Q ss_pred hcCCCCCEEEccCCcccccCCcc-cccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCC
Q 044996 67 KELREMRTLSLMRNNLEGPMPDL-RQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSR 145 (678)
Q Consensus 67 ~~l~~L~~L~Ls~N~l~g~~p~~-~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~ 145 (678)
.++..|+.|+|++|+++.. |.+ ..+ .+|++|||++|+++ .|+ . |..+++|+.|+|++|+++...+..+..+++
T Consensus 15 ~n~~~lr~L~L~~n~I~~i-~~~~~~l--~~L~~L~Ls~N~i~-~l~-~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPVI-ENLGATL--DQFDAIDFSDNEIR-KLD-G-FPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp ECTTSCEEEECTTSCCCSC-CCGGGGT--TCCSEEECCSSCCC-EEC-C-CCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred cCcCcCcEEECCCCCCCcc-Ccccccc--ccCCEEECCCCCCC-ccC-C-cccCcchhhhhcccccccCCCccccccccc
Confidence 3444555555555555432 322 122 44555555555555 443 2 455555555555555555433333444555
Q ss_pred CCeEeccCCcccccCCc----cCCCCCcEEEeecCccc
Q 044996 146 LVELRLEGNKFEGQIPD----FQQKDLVSFNVSNNALF 179 (678)
Q Consensus 146 L~~l~l~~N~l~g~~p~----~~~~~l~~l~l~~N~l~ 179 (678)
|+.|+|++|+++. ++. ..+++|+.|++++|.++
T Consensus 89 L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 89 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccceeccccccc-cccccccccccccchhhcCCCccc
Confidence 5555555555542 111 13345555555555553
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=2.5e-11 Score=115.71 Aligned_cols=123 Identities=27% Similarity=0.373 Sum_probs=59.0
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCccccee
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l 125 (678)
+++.|+|++|.+.+ +++ ++.|++|+.|+|++|++++ +|.+..+ ++|+.|++++|.+. .++ . +..++.|+.+
T Consensus 69 ~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~~-l~~l~~l--~~L~~L~l~~~~~~-~~~-~-l~~l~~l~~l 139 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LSSLKDL--KKLKSLSLEHNGIS-DIN-G-LVHLPQLESL 139 (210)
T ss_dssp TCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GGGGTTC--TTCCEEECTTSCCC-CCG-G-GGGCTTCCEE
T ss_pred CCCEEeCCCccccC-ccc--cccCccccccccccccccc-ccccccc--cccccccccccccc-ccc-c-cccccccccc
Confidence 34555555555543 221 3445555555555555543 2333333 44555555555544 232 1 4455555555
Q ss_pred eccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCccc
Q 044996 126 LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALF 179 (678)
Q Consensus 126 ~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~ 179 (678)
++++|.+++ +..+..+++|+.+++++|++++..+-..+++|+.|+|++|+++
T Consensus 140 ~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 140 YLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp ECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred ccccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC
Confidence 555555543 2234455555555555555553222234455555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.19 E-value=3e-11 Score=114.11 Aligned_cols=123 Identities=24% Similarity=0.400 Sum_probs=67.6
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCccccee
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l 125 (678)
+++.|+|.++++. .+. -+..|++|+.|+|++|++++.. .+..+ ++|++|++++|.+. .+|. +.+++.|+.|
T Consensus 41 ~l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~-~l~~l--~~L~~L~l~~n~~~-~~~~--l~~l~~L~~L 111 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDIT-PLKNL--TKLVDILMNNNQIA-DITP--LANLTNLTGL 111 (199)
T ss_dssp TCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCG-GGTTC--TTCCEEECCSSCCC-CCGG--GTTCTTCSEE
T ss_pred CCCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCcc-cccCC--cccccccccccccc-cccc--cccccccccc
Confidence 4556666666654 332 2555666666666666666533 24444 45666666666655 3442 5566666666
Q ss_pred eccccccccCCchhhcCCCCCCeEeccCCcccccCCc-cCCCCCcEEEeecCcccc
Q 044996 126 LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 126 ~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~~l~~l~l~~N~l~g 180 (678)
++++|.+... ..+..+++|+.|++++|.+.. ++. ....+|+.|++++|++++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhcc-cccccccccccccccccccccC
Confidence 6666655532 225556666666666666542 332 244556666666666554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.18 E-value=3.3e-11 Score=114.85 Aligned_cols=141 Identities=21% Similarity=0.301 Sum_probs=111.7
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCccccee
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l 125 (678)
.++.|+++++.+.. ++. +..|++|+.|+|++|++++ ++.+..+ ++|++|+|++|+++ .+| . +.++++|+.|
T Consensus 47 ~L~~L~l~~~~i~~-l~~--l~~l~~L~~L~L~~n~i~~-l~~~~~l--~~L~~L~l~~n~i~-~l~-~-l~~l~~L~~L 117 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQG--IQYLPNVTKLFLNGNKLTD-IKPLANL--KNLGWLFLDENKVK-DLS-S-LKDLKKLKSL 117 (210)
T ss_dssp TCCEEECTTSCCCC-CTT--GGGCTTCCEEECCSSCCCC-CGGGTTC--TTCCEEECCSSCCC-CGG-G-GTTCTTCCEE
T ss_pred CccEEECcCCCCCC-chh--HhhCCCCCEEeCCCccccC-ccccccC--cccccccccccccc-ccc-c-cccccccccc
Confidence 57889999998873 442 7889999999999999997 4445556 78999999999999 476 3 7899999999
Q ss_pred eccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCc-hhhhcCCCCCCCCC
Q 044996 126 LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSIS-PALRELDPSSFSGN 197 (678)
Q Consensus 126 ~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip-~~~~~l~~~~~~gn 197 (678)
++++|.+.. + ..+..++.|+.+++++|.+++..+...+++|+.+++++|++++..+ ..+.++....+.+|
T Consensus 118 ~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N 188 (210)
T d1h6ta2 118 SLEHNGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 188 (210)
T ss_dssp ECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred ccccccccc-c-ccccccccccccccccccccccccccccccccccccccccccccccccCCCCCCEEECCCC
Confidence 999999873 3 4588999999999999999865555577899999999999986332 12233444455555
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=1.4e-11 Score=112.17 Aligned_cols=121 Identities=17% Similarity=0.284 Sum_probs=99.1
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
-++..|+|++|.++ .|+ ..+..+++|+.|+|++|+++. ++.+..+ ++|++|+|++|+++ .+|+.++..+++|+.
T Consensus 18 ~~lr~L~L~~n~I~-~i~-~~~~~l~~L~~L~Ls~N~i~~-l~~~~~l--~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEIRK-LDGFPLL--RRLKTLLVNNNRIC-RIGEGLDQALPDLTE 91 (162)
T ss_dssp TSCEEEECTTSCCC-SCC-CGGGGTTCCSEEECCSSCCCE-ECCCCCC--SSCCEEECCSSCCC-EECSCHHHHCTTCCE
T ss_pred CcCcEEECCCCCCC-ccC-ccccccccCCEEECCCCCCCc-cCCcccC--cchhhhhccccccc-CCCcccccccccccc
Confidence 35788999999997 565 356789999999999999984 4666666 78999999999999 677776788999999
Q ss_pred eeccccccccCCc--hhhcCCCCCCeEeccCCcccccCCc------cCCCCCcEEEe
Q 044996 125 LLLADNQFNGPIP--ESLTRLSRLVELRLEGNKFEGQIPD------FQQKDLVSFNV 173 (678)
Q Consensus 125 l~l~~N~~~g~~p--~~~~~l~~L~~l~l~~N~l~g~~p~------~~~~~l~~l~l 173 (678)
|+|++|+++. ++ ..+..+++|++|++++|.++ ..|. ..+++|+.||-
T Consensus 92 L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 92 LILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp EECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred ceeccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeCC
Confidence 9999999985 33 46889999999999999997 3443 24577888763
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.13 E-value=1.3e-10 Score=109.58 Aligned_cols=125 Identities=22% Similarity=0.356 Sum_probs=105.4
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.+++ +++ ++.|++|+.|++++|.+.. ++.+..+ ..|+.|++++|.+.. ++ . +..+++|+.
T Consensus 62 ~nL~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~~-~~~l~~l--~~L~~L~l~~~~~~~-~~-~-~~~l~~L~~ 132 (199)
T d2omxa2 62 NNLTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIAD-ITPLANL--TNLTGLTLFNNQITD-ID-P-LKNLTNLNR 132 (199)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-CGGGTTC--TTCSEEECCSSCCCC-CG-G-GTTCTTCSE
T ss_pred CCcCcCccccccccC-ccc--ccCCccccccccccccccc-ccccccc--ccccccccccccccc-cc-c-cchhhhhHH
Confidence 579999999999985 432 8899999999999999875 4556655 779999999999984 43 2 789999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g 180 (678)
|++++|++.. +| .+..+++|+.|++.+|++++..+-..+++|+.|++++|+++.
T Consensus 133 L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 133 LELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp EECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred hhhhhhhhcc-cc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCCC
Confidence 9999999974 44 589999999999999999965444578899999999999976
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.08 E-value=2.1e-10 Score=103.46 Aligned_cols=87 Identities=26% Similarity=0.324 Sum_probs=40.8
Q ss_pred hhcCCCCCEEEccCCc-ccccCC-cccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCC
Q 044996 66 LKELREMRTLSLMRNN-LEGPMP-DLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRL 143 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N~-l~g~~p-~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l 143 (678)
+..+++|+.|+|++|+ ++..-+ .|..+ ++|+.|+|++|+|+ .|++.+|..+++|++|+|++|+|+ .+|..+...
T Consensus 27 l~~l~~l~~L~l~~n~~l~~i~~~~f~~l--~~L~~L~Ls~N~l~-~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~ 102 (156)
T d2ifga3 27 LPGAENLTELYIENQQHLQHLELRDLRGL--GELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQG 102 (156)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSC--CCCSEEECCSSCCC-EECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCS
T ss_pred ccCccccCeeecCCCccccccCchhhccc--cccCcceeeccccC-CcccccccccccccceeccCCCCc-ccChhhhcc
Confidence 4445555555555443 433222 23333 44555555555555 344444555555555555555555 333333223
Q ss_pred CCCCeEeccCCcc
Q 044996 144 SRLVELRLEGNKF 156 (678)
Q Consensus 144 ~~L~~l~l~~N~l 156 (678)
.+|+.|+|++|.|
T Consensus 103 ~~l~~L~L~~Np~ 115 (156)
T d2ifga3 103 LSLQELVLSGNPL 115 (156)
T ss_dssp CCCCEEECCSSCC
T ss_pred ccccccccCCCcc
Confidence 3455555555544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.05 E-value=3.9e-10 Score=113.68 Aligned_cols=148 Identities=20% Similarity=0.256 Sum_probs=106.8
Q ss_pred EEEEEeCCCCcee-ecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCccccee
Q 044996 47 IWGLKLEDMGLQG-NIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKL 125 (678)
Q Consensus 47 v~~l~l~~~~l~g-~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l 125 (678)
+..++...+.... ......+..+++|+.+++++|++.. +|.. .+ ++|+.|+|++|.+++.++.. |.+++.+++|
T Consensus 126 ~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~-~~--~~L~~L~l~~n~~~~~~~~~-~~~~~~l~~L 200 (305)
T d1xkua_ 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQG-LP--PSLTELHLDGNKITKVDAAS-LKGLNNLAKL 200 (305)
T ss_dssp CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSS-CC--TTCSEEECTTSCCCEECTGG-GTTCTTCCEE
T ss_pred ccccccccccccccCCCccccccccccCccccccCCccc-cCcc-cC--CccCEEECCCCcCCCCChhH-hhcccccccc
Confidence 4456665554321 1223457888999999999998874 4431 12 67899999999998777754 8888999999
Q ss_pred eccccccccCCchhhcCCCCCCeEeccCCcccccCCcc--CCCCCcEEEeecCcccccCchh-h---------hcCCCCC
Q 044996 126 LLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF--QQKDLVSFNVSNNALFGSISPA-L---------RELDPSS 193 (678)
Q Consensus 126 ~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~~l~~l~l~~N~l~g~ip~~-~---------~~l~~~~ 193 (678)
++++|.+++..|..+.++++|++|+|++|.|+ .+|.. .+++|+.|+|++|+|+. |+.. + ..+....
T Consensus 201 ~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~-i~~~~f~~~~~~~~~~~L~~L~ 278 (305)
T d1xkua_ 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKASYSGVS 278 (305)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC-CCTTSSSCSSCCTTSCCCSEEE
T ss_pred ccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCc-cChhhccCcchhcccCCCCEEE
Confidence 99999999888888899999999999999987 56653 56789999999999874 4321 1 1233345
Q ss_pred CCCCCCCC
Q 044996 194 FSGNRDLC 201 (678)
Q Consensus 194 ~~gn~~lc 201 (678)
+.||++-+
T Consensus 279 L~~N~~~~ 286 (305)
T d1xkua_ 279 LFSNPVQY 286 (305)
T ss_dssp CCSSSSCG
T ss_pred CCCCcCcc
Confidence 77777543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.03 E-value=8.3e-12 Score=117.77 Aligned_cols=113 Identities=23% Similarity=0.324 Sum_probs=91.0
Q ss_pred HHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCC
Q 044996 64 TILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRL 143 (678)
Q Consensus 64 ~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l 143 (678)
..+..|++|+.|+|++|+++ .++.+..+ .+|+.|+|++|+++ .||.. +..+++|+.|+|++|+++. + ..+..+
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~~l~~l--~~L~~L~Ls~N~i~-~i~~~-~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KISSLSGM--ENLRILSLGRNLIK-KIENL-DAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCCCHHHH--TTCCEEECCEEEEC-SCSSH-HHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hHHhcccccceeECcccCCC-CcccccCC--ccccChhhcccccc-ccccc-ccccccccccccccccccc-c-cccccc
Confidence 45888999999999999998 46767777 77999999999998 78753 5667789999999999985 3 358889
Q ss_pred CCCCeEeccCCccccc--CCc-cCCCCCcEEEeecCcccccCc
Q 044996 144 SRLVELRLEGNKFEGQ--IPD-FQQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 144 ~~L~~l~l~~N~l~g~--~p~-~~~~~l~~l~l~~N~l~g~ip 183 (678)
++|+.|+|++|+++.. +.. ..+++|+.|+|++|.++...+
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 9999999999998742 122 367889999999998865433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.02 E-value=2.4e-10 Score=118.88 Aligned_cols=127 Identities=20% Similarity=0.279 Sum_probs=94.0
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
..+..+++.++.+.+-.+ +..+++|+.|++++|.+.+..+ +..+ ..++.++++.|.+++ ++ . +..+++|+.
T Consensus 241 ~~L~~L~l~~n~l~~~~~---~~~~~~L~~L~l~~~~l~~~~~-~~~~--~~l~~l~~~~n~l~~-~~-~-~~~~~~l~~ 311 (384)
T d2omza2 241 TNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP-LAGL--TALTNLELNENQLED-IS-P-ISNLKNLTY 311 (384)
T ss_dssp TTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCCCCGG-GTTC--TTCSEEECCSSCCSC-CG-G-GGGCTTCSE
T ss_pred cccchhccccCccCCCCc---ccccccCCEeeccCcccCCCCc-cccc--ccccccccccccccc-cc-c-cchhcccCe
Confidence 357889999999886432 7889999999999999987543 4444 567888888888875 33 3 677788888
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCcc-CCCCCcEEEeecCcccccCc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGSIS 183 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ip 183 (678)
|+|++|++++.. .+..+++|+.|+|++|+|++ ++.. .+++|+.|++++|+|++-.|
T Consensus 312 L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 312 LTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp EECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG
T ss_pred EECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh
Confidence 888888887643 27778888888888888774 4432 56778888888888876544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.98 E-value=3.5e-10 Score=101.93 Aligned_cols=101 Identities=22% Similarity=0.307 Sum_probs=80.1
Q ss_pred EEccCCcccccCCcccccCCCCccEEEcccCc-cccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccC
Q 044996 75 LSLMRNNLEGPMPDLRQLGNGALRSVYLSNNR-FSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEG 153 (678)
Q Consensus 75 L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~-l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~ 153 (678)
++.++|++...+..+..+ ++|+.|+|++|+ |+ .|+...|.++++|+.|+|++|+++...|..|..+++|++|+|++
T Consensus 13 l~c~~~~~~~~p~~l~~l--~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 13 LRCTRDGALDSLHHLPGA--ENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp EECCSSCCCTTTTTSCSC--SCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEecCCCCccCcccccCc--cccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 333444443322233344 679999998765 77 78888899999999999999999988889999999999999999
Q ss_pred CcccccCCcc--CCCCCcEEEeecCccc
Q 044996 154 NKFEGQIPDF--QQKDLVSFNVSNNALF 179 (678)
Q Consensus 154 N~l~g~~p~~--~~~~l~~l~l~~N~l~ 179 (678)
|+|+ .+|.. ...+|+.|+|++|.|.
T Consensus 90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCc-ccChhhhccccccccccCCCccc
Confidence 9999 56653 4457999999999985
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.94 E-value=6.3e-10 Score=115.58 Aligned_cols=141 Identities=26% Similarity=0.330 Sum_probs=113.5
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|++++|.+.. ++ .+..+++|+.|++++|.+++..+ +..+ ++|+.|++++|++++ +++ +.+++.++.
T Consensus 219 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~-~~~~--~~L~~L~l~~~~l~~-~~~--~~~~~~l~~ 289 (384)
T d2omza2 219 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP-LSGL--TKLTELKLGANQISN-ISP--LAGLTALTN 289 (384)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG-GTTC--TTCSEEECCSSCCCC-CGG--GTTCTTCSE
T ss_pred CCCCEEECCCCCCCC-cc--hhhcccccchhccccCccCCCCc-cccc--ccCCEeeccCcccCC-CCc--ccccccccc
Confidence 468889999998874 43 47899999999999999998554 5555 779999999999995 442 788999999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccccCchhhhc---CCCCCCCCCC
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFGSISPALRE---LDPSSFSGNR 198 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g~ip~~~~~---l~~~~~~gn~ 198 (678)
++++.|.+++ +..+..+++|+.|++++|++++..|-..+++|+.|++++|+|++ +| .+.+ |...++.+|.
T Consensus 290 l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~ 362 (384)
T d2omza2 290 LELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQ 362 (384)
T ss_dssp EECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSC
T ss_pred cccccccccc--ccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCc
Confidence 9999999987 34588999999999999999986554578899999999999986 44 4554 3344565553
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.92 E-value=2.1e-09 Score=103.29 Aligned_cols=127 Identities=24% Similarity=0.411 Sum_probs=61.6
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccCh-----------
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPT----------- 113 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~----------- 113 (678)
.++..|+|++|.+.+..+ +..+++|+.|++++|.++ .++.+..+ ++|+.|++++|.+.+..+-
T Consensus 63 ~~L~~L~ls~n~i~~~~~---l~~l~~l~~l~~~~n~~~-~i~~l~~l--~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~ 136 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLAP---LKNLTKITELELSGNPLK-NVSAIAGL--QSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136 (227)
T ss_dssp TTCCEEECCSSCCCCCGG---GTTCCSCCEEECCSCCCS-CCGGGTTC--TTCCEEECTTSCCCCCGGGTTCTTCCEEEC
T ss_pred CCCcEeecCCceeecccc---cccccccccccccccccc-cccccccc--ccccccccccccccccchhccccchhhhhc
Confidence 345555555555543211 445555555555555444 23333333 3455555554444422110
Q ss_pred --------hhhcCCcccceeeccccccccCCchhhcCCCCCCeEeccCCcccccCCc-cCCCCCcEEEeecCcccc
Q 044996 114 --------DAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPD-FQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 114 --------~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~~l~~l~l~~N~l~g 180 (678)
..+.++++|+.|++++|.+++.. .++++++|+.|+|++|++++ +|. ..+++|+.|+|++|++++
T Consensus 137 ~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~ 209 (227)
T d1h6ua2 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISD 209 (227)
T ss_dssp CSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCB
T ss_pred hhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCC
Confidence 01334455566666666554322 25556666666666666653 333 244566666666666553
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.90 E-value=2.4e-09 Score=102.88 Aligned_cols=127 Identities=21% Similarity=0.324 Sum_probs=95.6
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
..++.|++.++++. .++ -+..|++|+.|+|++|++.+..| +..+ .+|++|++++|.++ .++ . +..+++|+.
T Consensus 41 ~~L~~L~l~~~~i~-~l~--~l~~l~~L~~L~ls~n~i~~~~~-l~~l--~~l~~l~~~~n~~~-~i~-~-l~~l~~L~~ 111 (227)
T d1h6ua2 41 DGITTLSAFGTGVT-TIE--GVQYLNNLIGLELKDNQITDLAP-LKNL--TKITELELSGNPLK-NVS-A-IAGLQSIKT 111 (227)
T ss_dssp HTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTC--CSCCEEECCSCCCS-CCG-G-GTTCTTCCE
T ss_pred CCcCEEECCCCCCC-cch--hHhcCCCCcEeecCCceeecccc-cccc--cccccccccccccc-ccc-c-ccccccccc
Confidence 46889999999998 564 28899999999999999987544 5666 77999999999998 676 3 789999999
Q ss_pred eeccccccccCCc--------------------hhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcccc
Q 044996 125 LLLADNQFNGPIP--------------------ESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNALFG 180 (678)
Q Consensus 125 l~l~~N~~~g~~p--------------------~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l~g 180 (678)
+++++|.+.+..+ ..+.++++|+.|++++|.+++..+-..+.+|+.|+|++|++++
T Consensus 112 l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 112 LDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187 (227)
T ss_dssp EECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred cccccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchhhcccccceecccCCCccCC
Confidence 9999888765322 1244556677777777766544333455677777777777765
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.81 E-value=7.4e-11 Score=111.08 Aligned_cols=110 Identities=23% Similarity=0.389 Sum_probs=89.7
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|+|++|.+. .++ .+..|++|+.|+|++|.++. +|.+... ..+|+.|+|++|+++ .++ . +..+++|+.
T Consensus 48 ~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~~-i~~~~~~-~~~L~~L~l~~N~i~-~l~-~-~~~l~~L~~ 119 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIKK-IENLDAV-ADTLEELWISYNQIA-SLS-G-IEKLVNLRV 119 (198)
T ss_dssp TTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEECS-CSSHHHH-HHHCCEEECSEEECC-CHH-H-HHHHHHSSE
T ss_pred cccceeECcccCCC-Ccc--cccCCccccChhhccccccc-ccccccc-ccccccccccccccc-ccc-c-ccccccccc
Confidence 56889999999987 675 38899999999999999974 5543322 146999999999999 465 3 788999999
Q ss_pred eeccccccccCCc-hhhcCCCCCCeEeccCCcccccCCc
Q 044996 125 LLLADNQFNGPIP-ESLTRLSRLVELRLEGNKFEGQIPD 162 (678)
Q Consensus 125 l~l~~N~~~g~~p-~~~~~l~~L~~l~l~~N~l~g~~p~ 162 (678)
|+|++|+++..-. ..+..+++|+.|+|++|.+....+.
T Consensus 120 L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred cccccchhccccccccccCCCccceeecCCCccccCccc
Confidence 9999999985322 4689999999999999999876554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=3.2e-08 Score=95.54 Aligned_cols=85 Identities=19% Similarity=0.270 Sum_probs=42.7
Q ss_pred CCCEEEccCCcccccCCc-ccccCCCCccEEEcccCccccccChhhhcCCcccceeecc-ccccccCCchhhcCCCCCCe
Q 044996 71 EMRTLSLMRNNLEGPMPD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLA-DNQFNGPIPESLTRLSRLVE 148 (678)
Q Consensus 71 ~L~~L~Ls~N~l~g~~p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~-~N~~~g~~p~~~~~l~~L~~ 148 (678)
++++|+|++|+++...+. +.++ ++|++|+|++|.+...+|...|.+++.++.|++. .|++....+..|.++++|+.
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l--~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~ 107 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGF--GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY 107 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTC--TTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCE
T ss_pred CCCEEECcCCcCCccChhHhhcc--chhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccc
Confidence 455555555555432221 2333 4455555555555544554445555555555543 24444444455555555555
Q ss_pred EeccCCccc
Q 044996 149 LRLEGNKFE 157 (678)
Q Consensus 149 l~l~~N~l~ 157 (678)
|++++|.+.
T Consensus 108 l~l~~~~l~ 116 (242)
T d1xwdc1 108 LLISNTGIK 116 (242)
T ss_dssp EEEESCCCC
T ss_pred cccchhhhc
Confidence 555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=3e-08 Score=95.82 Aligned_cols=142 Identities=13% Similarity=0.186 Sum_probs=105.7
Q ss_pred CCcceEEecC-----------CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCc--ccccCCCCccEEE
Q 044996 35 ANWNGVLCHR-----------GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPD--LRQLGNGALRSVY 101 (678)
Q Consensus 35 ~~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~~~~~L~~L~ 101 (678)
|.+..|.|.. ..++.|+|++|.+. .+|...|.++++|+.|+|++|.+...+|. +..+ ..++.|+
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l--~~l~~l~ 84 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL--PKLHEIR 84 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESC--TTCCEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccc--ccccccc
Confidence 4678899952 25889999999987 68777789999999999999999887664 3344 6789998
Q ss_pred ccc-CccccccChhhhcCCcccceeeccccccccCCch-hhcCCCCCCeEeccCCcccccCCcc---CCCCCcEEEeecC
Q 044996 102 LSN-NRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPE-SLTRLSRLVELRLEGNKFEGQIPDF---QQKDLVSFNVSNN 176 (678)
Q Consensus 102 Ls~-N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~-~~~~l~~L~~l~l~~N~l~g~~p~~---~~~~l~~l~l~~N 176 (678)
+.. |++. .+++..|.++++|+.|++++|.+....+. .+..+..|..+..+++.+...-+.. ....++.|++++|
T Consensus 85 ~~~~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n 163 (242)
T d1xwdc1 85 IEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 163 (242)
T ss_dssp EECCTTCC-EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred cccccccc-ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccc
Confidence 764 6777 45556689999999999999999754332 3445566666677777765332222 2347888999999
Q ss_pred cccc
Q 044996 177 ALFG 180 (678)
Q Consensus 177 ~l~g 180 (678)
+++.
T Consensus 164 ~l~~ 167 (242)
T d1xwdc1 164 GIQE 167 (242)
T ss_dssp CCCE
T ss_pred cccc
Confidence 9975
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.36 E-value=3.9e-07 Score=92.46 Aligned_cols=115 Identities=23% Similarity=0.340 Sum_probs=86.7
Q ss_pred CcEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccce
Q 044996 45 GKIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRK 124 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~ 124 (678)
.++..|||++++|+ .+|. .+++|+.|+|++|+|+ .+|.. + .+|+.|++++|+++ .|+. +. +.|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~--~--~~L~~L~l~~n~l~-~l~~--lp--~~L~~ 102 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPEL--P--QSLKSLLVDNNNLK-ALSD--LP--PLLEY 102 (353)
T ss_dssp HTCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCC--C--TTCCEEECCSSCCS-CCCS--CC--TTCCE
T ss_pred cCCCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCc-ccccc--h--hhhhhhhhhhcccc-hhhh--hc--ccccc
Confidence 35778999999997 6874 3678999999999998 67753 3 57999999999998 5652 21 46999
Q ss_pred eeccccccccCCchhhcCCCCCCeEeccCCcccccCCccCCCCCcEEEeecCcc
Q 044996 125 LLLADNQFNGPIPESLTRLSRLVELRLEGNKFEGQIPDFQQKDLVSFNVSNNAL 178 (678)
Q Consensus 125 l~l~~N~~~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~l~~l~l~~N~l 178 (678)
|+|++|.++ .+|. ++.+++|+.|++++|.+.+..+. ...+..+.+.++..
T Consensus 103 L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 103 LGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQL 152 (353)
T ss_dssp EECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCC
T ss_pred ccccccccc-cccc-hhhhccceeeccccccccccccc--cccccchhhccccc
Confidence 999999998 5675 68899999999999988754332 23455666655544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.24 E-value=1.5e-06 Score=87.87 Aligned_cols=97 Identities=29% Similarity=0.430 Sum_probs=78.2
Q ss_pred CCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchhhcCCCCCCeE
Q 044996 70 REMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPESLTRLSRLVEL 149 (678)
Q Consensus 70 ~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~~~~l~~L~~l 149 (678)
.+|+.|+|++|.++. +|++ + ++|++|+|++|+|+ .||.. +.+|+.|++++|+++ .++. + .+.|++|
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~--~--~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L 103 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL--P--PHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSD-L--PPLLEYL 103 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC--C--TTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCS-C--CTTCCEE
T ss_pred cCCCEEEeCCCCCCC-CCCC--C--CCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhh-h--ccccccc
Confidence 478999999999974 7753 3 67999999999999 89854 357999999999987 3442 1 2469999
Q ss_pred eccCCcccccCCcc-CCCCCcEEEeecCccccc
Q 044996 150 RLEGNKFEGQIPDF-QQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 150 ~l~~N~l~g~~p~~-~~~~l~~l~l~~N~l~g~ 181 (678)
+|++|.+. .+|.. ...+|+.|++++|.+++.
T Consensus 104 ~L~~n~l~-~lp~~~~l~~L~~L~l~~~~~~~~ 135 (353)
T d1jl5a_ 104 GVSNNQLE-KLPELQNSSFLKIIDVDNNSLKKL 135 (353)
T ss_dssp ECCSSCCS-SCCCCTTCTTCCEEECCSSCCSCC
T ss_pred cccccccc-cccchhhhccceeecccccccccc
Confidence 99999998 56654 678999999999998753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=2.1e-07 Score=92.16 Aligned_cols=139 Identities=18% Similarity=0.240 Sum_probs=77.5
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCC-cccccCCCCccEEEcccC-ccccc-cChhhhcCCccc
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMP-DLRQLGNGALRSVYLSNN-RFSGE-IPTDAFDGMTSL 122 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~~~~~L~~L~Ls~N-~l~G~-ip~~~~~~l~~L 122 (678)
++..|||+++.+.+.....++..+++|++|+|++|.++...+ .+..+ ++|++|+|+++ .++.. +. .++.++++|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~--~~L~~L~Ls~c~~itd~~l~-~l~~~~~~L 123 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKN--SNLVRLNLSGCSGFSEFALQ-TLLSSCSRL 123 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTC--TTCSEEECTTCBSCCHHHHH-HHHHHCTTC
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcC--CCCcCccccccccccccccc-hhhHHHHhc
Confidence 577888888777655434567778888888888888766443 23333 56888888773 55421 22 224567777
Q ss_pred ceeecccc-cccc-CCchhhcC-CCCCCeEeccCC--ccccc-CCc--cCCCCCcEEEeecC-cccccCchhhh
Q 044996 123 RKLLLADN-QFNG-PIPESLTR-LSRLVELRLEGN--KFEGQ-IPD--FQQKDLVSFNVSNN-ALFGSISPALR 187 (678)
Q Consensus 123 ~~l~l~~N-~~~g-~~p~~~~~-l~~L~~l~l~~N--~l~g~-~p~--~~~~~l~~l~l~~N-~l~g~ip~~~~ 187 (678)
++|+|+++ .++. .+...+.. .++|+.|++++. .++.. +.. ...++|+.|++++| .+++..+..+.
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~ 197 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 197 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhc
Confidence 77777763 3432 12222322 345666666543 22211 111 13355666666553 35544444443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.21 E-value=2.9e-06 Score=82.36 Aligned_cols=130 Identities=12% Similarity=0.060 Sum_probs=88.3
Q ss_pred ceeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccC-CCCccceeEEEEeCCceEEEEeccCCCCHHHHhhccC
Q 044996 382 FGSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLR-HPNLLPLVAYYYRKEEKLLVHEFVPKRSLAVNLHGHQ 460 (678)
Q Consensus 382 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~Ey~~~gsL~~~l~~~~ 460 (678)
...||+... ++..+++|+...........+.+|...+..+. +--+.++++++..++..++|||++++.++.+.....
T Consensus 27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~- 104 (263)
T d1j7la_ 27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE- 104 (263)
T ss_dssp SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-
T ss_pred CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-
Confidence 468998865 45567788776544444456778888877774 333567788888888899999999998876543211
Q ss_pred CCCCCCCChHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------
Q 044996 461 ALGQPSLDWPSRLKIVKGVAKGLQYLYREL-------------------------------------------------- 490 (678)
Q Consensus 461 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------------- 490 (678)
.....++.++++.|+.||+..
T Consensus 105 ---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 105 ---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp ---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred ---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 112234555555555555311
Q ss_pred -----CCCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 491 -----PSLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 491 -----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
....++|+|+.+.|||++++..+-|.||+.+.
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 12237899999999999987777899998764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=7.1e-07 Score=88.23 Aligned_cols=124 Identities=20% Similarity=0.244 Sum_probs=77.7
Q ss_pred EEEeCCCCceeecChHHhhcCCCCCEEEccCCcccccCCcccccCCCCccEEEcccCccccccChhhhcCCcccceeecc
Q 044996 49 GLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEGPMPDLRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLA 128 (678)
Q Consensus 49 ~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~ 128 (678)
.|||+++.+.+.+....+. ..+..+.++.......+...... .+|++|||++|.+++.....++..+++|++|+|+
T Consensus 4 ~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~~~~~~~--~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPLAEHFSP--FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCCCSCCCC--BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred EEECCCCCCCchHHHHHHh--ccceEeeccccccccchhhhccC--CCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 5788777765443322222 23456666666655444332222 5688888888877755444557778888888888
Q ss_pred ccccccCCchhhcCCCCCCeEeccCC-ccccc-CCc--cCCCCCcEEEeecC
Q 044996 129 DNQFNGPIPESLTRLSRLVELRLEGN-KFEGQ-IPD--FQQKDLVSFNVSNN 176 (678)
Q Consensus 129 ~N~~~g~~p~~~~~l~~L~~l~l~~N-~l~g~-~p~--~~~~~l~~l~l~~N 176 (678)
++.+++..+..++++++|+.|+|+++ .++.. +.. ...++|+.|+++++
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred ccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 88887777777888888888888774 44421 111 14567888888764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.96 E-value=1e-06 Score=92.51 Aligned_cols=110 Identities=22% Similarity=0.250 Sum_probs=67.5
Q ss_pred cEEEEEeCCCCceeecChHHhhcCCCCCEEEccCCcccc----cCCc-ccccCCCCccEEEcccCccccc----cChhhh
Q 044996 46 KIWGLKLEDMGLQGNIDITILKELREMRTLSLMRNNLEG----PMPD-LRQLGNGALRSVYLSNNRFSGE----IPTDAF 116 (678)
Q Consensus 46 ~v~~l~l~~~~l~g~~~~~~l~~l~~L~~L~Ls~N~l~g----~~p~-~~~~~~~~L~~L~Ls~N~l~G~----ip~~~~ 116 (678)
+|..||++.+++++.--...+..+++|+.|+|++|.++- .|.. +... ++|+.|||++|+|+.. +.....
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~--~~L~~LdLs~N~i~~~~~~~l~~~l~ 80 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVN--PALAELNLRSNELGDVGVHCVLQGLQ 80 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTC--TTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcC--CCCCEEECcCCcCChHHHHHHHHHHh
Confidence 477888888888753223456667888888888887652 1221 2223 5688888888877521 111101
Q ss_pred cCCcccceeeccccccccC----CchhhcCCCCCCeEeccCCccc
Q 044996 117 DGMTSLRKLLLADNQFNGP----IPESLTRLSRLVELRLEGNKFE 157 (678)
Q Consensus 117 ~~l~~L~~l~l~~N~~~g~----~p~~~~~l~~L~~l~l~~N~l~ 157 (678)
....+|+.|+|++|+++.. ++..+..+++|++|+|++|.++
T Consensus 81 ~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 81 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred cCCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 1234677777777777643 4555666777777777777665
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=2.8e-05 Score=74.67 Aligned_cols=142 Identities=19% Similarity=0.218 Sum_probs=84.8
Q ss_pred cCccCc-eeEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCC--CCccceeEEEEeCCceEEEEeccCCCCHH
Q 044996 377 LGSGCF-GSSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRH--PNLLPLVAYYYRKEEKLLVHEFVPKRSLA 453 (678)
Q Consensus 377 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~Ey~~~gsL~ 453 (678)
+..|.. +.||+.....+..+++|...... ...+..|++.++.+.. --+.+++++..+++..++||||+++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 67999988888888888765432 2346677777776643 33566788888888899999999875542
Q ss_pred H--------------H---hhccCCCCCCCCC--hHHHHHH--------------------HHHHHHHHHHHHHhCC---
Q 044996 454 V--------------N---LHGHQALGQPSLD--WPSRLKI--------------------VKGVAKGLQYLYRELP--- 491 (678)
Q Consensus 454 ~--------------~---l~~~~~~~~~~l~--~~~~~~i--------------------~~~ia~gL~yLH~~~~--- 491 (678)
+ . ||....... .+. +.....- .......+..+....+
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATC-PFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGC-CCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhC-CCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 1 1 111100000 011 1100000 0011222334433321
Q ss_pred CCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 492 ~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
+..++|+|+.+.|||++++..+-|+||+.+.
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 2347899999999999988778899998753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.89 E-value=1.9e-06 Score=77.31 Aligned_cols=82 Identities=20% Similarity=0.222 Sum_probs=43.8
Q ss_pred hhcCCCCCEEEccCCcccccC--Cc-ccccCCCCccEEEcccCccccccChhhhcCCcccceeeccccccccCCchh---
Q 044996 66 LKELREMRTLSLMRNNLEGPM--PD-LRQLGNGALRSVYLSNNRFSGEIPTDAFDGMTSLRKLLLADNQFNGPIPES--- 139 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N~l~g~~--p~-~~~~~~~~L~~L~Ls~N~l~G~ip~~~~~~l~~L~~l~l~~N~~~g~~p~~--- 139 (678)
...++.|+.|+|++|+++..- +. +..+ ++|+.|||++|+++ .+++-.+.....|+.|+|++|.++......
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l--~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKA--PNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHS--TTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhC--CcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 445666777777777665421 11 1223 45666666666666 444322333445666666666665544321
Q ss_pred ----hcCCCCCCeEe
Q 044996 140 ----LTRLSRLVELR 150 (678)
Q Consensus 140 ----~~~l~~L~~l~ 150 (678)
+..+++|+.||
T Consensus 138 ~~~i~~~~P~L~~LD 152 (162)
T d1koha1 138 ISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHTTSTTCCEET
T ss_pred HHHHHHHCCCCCEEC
Confidence 34556666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.89 E-value=3.5e-06 Score=85.47 Aligned_cols=38 Identities=21% Similarity=0.284 Sum_probs=25.5
Q ss_pred CcEEEEEeCCCCceee----cChHHhhcCCCCCEEEccCCccc
Q 044996 45 GKIWGLKLEDMGLQGN----IDITILKELREMRTLSLMRNNLE 83 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~----~~~~~l~~l~~L~~L~Ls~N~l~ 83 (678)
.++..|+|++|.++.. +. ..+..+++|+.|+|++|.|.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~-~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLI-DFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHH-HHHHHCTTCCEEECCSSCCH
T ss_pred CCcccccccccccccccccchh-hhhcccccchheeccccccc
Confidence 4577888888877542 21 23556778888888888763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=9.8e-07 Score=92.73 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=79.5
Q ss_pred CcEEEEEeCCCCceeecC---hHHhhcCCCCCEEEccCCcccccCC-cc---cccCCCCccEEEcccCccccccCh---h
Q 044996 45 GKIWGLKLEDMGLQGNID---ITILKELREMRTLSLMRNNLEGPMP-DL---RQLGNGALRSVYLSNNRFSGEIPT---D 114 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~~~---~~~l~~l~~L~~L~Ls~N~l~g~~p-~~---~~~~~~~L~~L~Ls~N~l~G~ip~---~ 114 (678)
..+..++|+++.+..... ...+..++.+..+++++|.+...-. .+ .......|+.+++++|.++..-.. .
T Consensus 255 ~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~ 334 (460)
T d1z7xw1 255 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 334 (460)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhccc
Confidence 357788888887763321 1235667788888888888764211 00 001124577777777777643211 1
Q ss_pred hhcCCcccceeeccccccccC----Cchhhc-CCCCCCeEeccCCccccc----CCcc--CCCCCcEEEeecCcccc
Q 044996 115 AFDGMTSLRKLLLADNQFNGP----IPESLT-RLSRLVELRLEGNKFEGQ----IPDF--QQKDLVSFNVSNNALFG 180 (678)
Q Consensus 115 ~~~~l~~L~~l~l~~N~~~g~----~p~~~~-~l~~L~~l~l~~N~l~g~----~p~~--~~~~l~~l~l~~N~l~g 180 (678)
.+....+|+.|+|++|+++.. ++..+. ..+.|++|+|++|.|+.. +... ..++|++|+|++|+|+.
T Consensus 335 ~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 335 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 233445677777777777642 333443 355677777777777642 2211 34677777777777764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.70 E-value=7.5e-06 Score=82.90 Aligned_cols=152 Identities=21% Similarity=0.240 Sum_probs=100.2
Q ss_pred CcEEEEEeCCCCceee----cCh--------HHhhcCCCCCEEEccCCccccc----CC-cccccCCCCccEEEcccCcc
Q 044996 45 GKIWGLKLEDMGLQGN----IDI--------TILKELREMRTLSLMRNNLEGP----MP-DLRQLGNGALRSVYLSNNRF 107 (678)
Q Consensus 45 ~~v~~l~l~~~~l~g~----~~~--------~~l~~l~~L~~L~Ls~N~l~g~----~p-~~~~~~~~~L~~L~Ls~N~l 107 (678)
.++..|+|++|.+... +.. ......+.|+.|++++|++.-. +. .+... ..|+.|+|++|++
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~--~~L~~L~L~~n~i 198 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH--RLLHTVKMVQNGI 198 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC--TTCCEEECCSSCC
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhh--hhhcccccccccc
Confidence 4688999999887421 100 1134577899999999987632 11 12223 5699999999998
Q ss_pred ccc----cChhhhcCCcccceeeccccccccC----CchhhcCCCCCCeEeccCCcccccCC--------ccCCCCCcEE
Q 044996 108 SGE----IPTDAFDGMTSLRKLLLADNQFNGP----IPESLTRLSRLVELRLEGNKFEGQIP--------DFQQKDLVSF 171 (678)
Q Consensus 108 ~G~----ip~~~~~~l~~L~~l~l~~N~~~g~----~p~~~~~l~~L~~l~l~~N~l~g~~p--------~~~~~~l~~l 171 (678)
+.. +-...+..+++|+.|+|++|.|+.. +...+..+++|++|+|++|.+++.-. ......|+.|
T Consensus 199 ~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L 278 (344)
T d2ca6a1 199 RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 278 (344)
T ss_dssp CHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEE
T ss_pred cccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEE
Confidence 632 1122366788999999999998643 45567788999999999999875411 1234678999
Q ss_pred EeecCccccc----Cchhh----hcCCCCCCCCCC
Q 044996 172 NVSNNALFGS----ISPAL----RELDPSSFSGNR 198 (678)
Q Consensus 172 ~l~~N~l~g~----ip~~~----~~l~~~~~~gn~ 198 (678)
++++|+++.. +...+ ..+....+.||.
T Consensus 279 ~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~ 313 (344)
T d2ca6a1 279 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 313 (344)
T ss_dssp ECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred ECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCc
Confidence 9999998642 22222 234445566665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.60 E-value=9.3e-06 Score=72.62 Aligned_cols=65 Identities=18% Similarity=0.276 Sum_probs=36.4
Q ss_pred hcCCcccceeeccccccccC--CchhhcCCCCCCeEeccCCcccccCCc---cCCCCCcEEEeecCccccc
Q 044996 116 FDGMTSLRKLLLADNQFNGP--IPESLTRLSRLVELRLEGNKFEGQIPD---FQQKDLVSFNVSNNALFGS 181 (678)
Q Consensus 116 ~~~l~~L~~l~l~~N~~~g~--~p~~~~~l~~L~~l~l~~N~l~g~~p~---~~~~~l~~l~l~~N~l~g~ 181 (678)
+..++.|++|+|++|+++.. ++..+..+++|+.|+|++|.++. ++. .....|+.|++++|.++..
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcC
Confidence 45566666666666666542 23445556666666666666652 222 1233556666666666543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.35 E-value=0.00044 Score=70.78 Aligned_cols=75 Identities=12% Similarity=0.070 Sum_probs=46.9
Q ss_pred cccCccCceeEEEEEecC-CceEEEEEeccc-------ChhhHHHHHHHHHHHhccC-C--CCccceeEEEEeCCceEEE
Q 044996 375 EILGSGCFGSSYKASLST-GAMMVVKRFKQM-------NNVGREEFQEHMRRLGRLR-H--PNLLPLVAYYYRKEEKLLV 443 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~~~~~lv 443 (678)
+.||.|....||+....+ ++.++||.-... -....++...|.+.|+.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 358999999999998754 567888864321 0112334556777776652 2 334555544 56677899
Q ss_pred EeccCCCC
Q 044996 444 HEFVPKRS 451 (678)
Q Consensus 444 ~Ey~~~gs 451 (678)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.04 E-value=0.0012 Score=65.61 Aligned_cols=137 Identities=14% Similarity=0.172 Sum_probs=79.5
Q ss_pred eEEEEEecCCceEEEEEecccChhhHHHHHHHHHHHhccCCCCc--ccee-----EEEEeCCceEEEEeccCCCCHH---
Q 044996 384 SSYKASLSTGAMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL--LPLV-----AYYYRKEEKLLVHEFVPKRSLA--- 453 (678)
Q Consensus 384 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~-----~~~~~~~~~~lv~Ey~~~gsL~--- 453 (678)
.||+++.++|..+++|..+.. ....+++..|.+.+..|....| +..+ ..+...+..+.+++|+++..+.
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred eeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 699999999999999987653 2345678888888877743222 1111 1223456678999998763321
Q ss_pred -----------HHhhc----cCCCCCCCCChH-------------------HHHHHHHHHHHHHHHHHHhC---CCCCCc
Q 044996 454 -----------VNLHG----HQALGQPSLDWP-------------------SRLKIVKGVAKGLQYLYREL---PSLIAP 496 (678)
Q Consensus 454 -----------~~l~~----~~~~~~~~l~~~-------------------~~~~i~~~ia~gL~yLH~~~---~~~~iv 496 (678)
..+|. ........+++. .+-.+...+.+.++.+.... .+.+++
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 11111 111011122221 11223333334444444432 245689
Q ss_pred ccCCCCCCEEecCCCceEEeecCCccc
Q 044996 497 HGHIKSSNVLLNESLEPVLADYGLIPV 523 (678)
Q Consensus 497 Hrdlk~~NILl~~~~~~kl~DfGla~~ 523 (678)
|+|+.+.|||++++ ..+.||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 45899988653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.64 E-value=0.00053 Score=61.00 Aligned_cols=111 Identities=12% Similarity=0.158 Sum_probs=61.4
Q ss_pred hhcCCCCCEEEccCC-ccccc-CC----cccccCCCCccEEEcccCccccccC---hhhhcCCcccceeeccccccccC-
Q 044996 66 LKELREMRTLSLMRN-NLEGP-MP----DLRQLGNGALRSVYLSNNRFSGEIP---TDAFDGMTSLRKLLLADNQFNGP- 135 (678)
Q Consensus 66 l~~l~~L~~L~Ls~N-~l~g~-~p----~~~~~~~~~L~~L~Ls~N~l~G~ip---~~~~~~l~~L~~l~l~~N~~~g~- 135 (678)
..+.+.|+.|+|+++ .++.. +. .+.. +..|+.|+|++|.+...-. .+.+...+.|+.|+|++|.++..
T Consensus 11 ~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~--n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g 88 (167)
T d1pgva_ 11 REDDTDLKEVNINNMKRVSKERIRSLIEAACN--SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 88 (167)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTT--CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhh--CCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHH
Confidence 344567777777763 34321 11 1111 2557777777777752111 11234556777778877777643
Q ss_pred ---CchhhcCCCCCCeEeccCCccccc-------CCc--cCCCCCcEEEeecCcc
Q 044996 136 ---IPESLTRLSRLVELRLEGNKFEGQ-------IPD--FQQKDLVSFNVSNNAL 178 (678)
Q Consensus 136 ---~p~~~~~l~~L~~l~l~~N~l~g~-------~p~--~~~~~l~~l~l~~N~l 178 (678)
+-..+...++|++|+|++|.+... +-. ...++|+.|+++.+..
T Consensus 89 ~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 89 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 223455667788888877765421 001 0346777888776654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.26 E-value=0.0049 Score=62.74 Aligned_cols=72 Identities=14% Similarity=0.178 Sum_probs=46.8
Q ss_pred cccCccCceeEEEEEecCC--------ceEEEEEecccChhhHHHHHHHHHHHhccCCCCc-cceeEEEEeCCceEEEEe
Q 044996 375 EILGSGCFGSSYKASLSTG--------AMMVVKRFKQMNNVGREEFQEHMRRLGRLRHPNL-LPLVAYYYRKEEKLLVHE 445 (678)
Q Consensus 375 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~E 445 (678)
+.|+-|-.=.+|++...++ ..|++++... . ....+..+|..+++.+.-.++ .++++++.+ .+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4577788889999986543 4566665542 2 223455678888888753344 467777632 68999
Q ss_pred ccCCCCH
Q 044996 446 FVPKRSL 452 (678)
Q Consensus 446 y~~~gsL 452 (678)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9986443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.02 E-value=0.0014 Score=58.19 Aligned_cols=84 Identities=21% Similarity=0.282 Sum_probs=60.9
Q ss_pred CCccEEEcccC-ccccc----cChhhhcCCcccceeeccccccccC----CchhhcCCCCCCeEeccCCcccccCCc---
Q 044996 95 GALRSVYLSNN-RFSGE----IPTDAFDGMTSLRKLLLADNQFNGP----IPESLTRLSRLVELRLEGNKFEGQIPD--- 162 (678)
Q Consensus 95 ~~L~~L~Ls~N-~l~G~----ip~~~~~~l~~L~~l~l~~N~~~g~----~p~~~~~l~~L~~l~l~~N~l~g~~p~--- 162 (678)
+.|+.|+|+++ .++.. +- ..+...+.|+.|+|++|.++.. +-..+...+.|+.|+|++|.++..--.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~-~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLI-EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHH-HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHH-HHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 67999999974 46522 21 1356778999999999998742 334456678999999999998753211
Q ss_pred ---cCCCCCcEEEeecCccc
Q 044996 163 ---FQQKDLVSFNVSNNALF 179 (678)
Q Consensus 163 ---~~~~~l~~l~l~~N~l~ 179 (678)
...++|+.|+|++|.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSC
T ss_pred HHHHhCCcCCEEECCCCcCC
Confidence 14578999999998654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.36 E-value=0.0058 Score=53.78 Aligned_cols=84 Identities=17% Similarity=0.295 Sum_probs=40.5
Q ss_pred CCccEEEcccCccccccCh---hhhcCCcccceeeccccccccC----CchhhcCCCCCCeEec--cCCccccc----CC
Q 044996 95 GALRSVYLSNNRFSGEIPT---DAFDGMTSLRKLLLADNQFNGP----IPESLTRLSRLVELRL--EGNKFEGQ----IP 161 (678)
Q Consensus 95 ~~L~~L~Ls~N~l~G~ip~---~~~~~l~~L~~l~l~~N~~~g~----~p~~~~~l~~L~~l~l--~~N~l~g~----~p 161 (678)
+.|+.|+|++|.++..--. ..+...++|+.|++++|.++.. +-..+...++|+.++| ++|.+... +-
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 4466666666665422110 1233455666666666665432 2234455566665443 34444321 11
Q ss_pred c--cCCCCCcEEEeecCcc
Q 044996 162 D--FQQKDLVSFNVSNNAL 178 (678)
Q Consensus 162 ~--~~~~~l~~l~l~~N~l 178 (678)
. ...++|+.|+++.|..
T Consensus 126 ~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeCcCCCC
Confidence 1 1345666777665544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.31 E-value=0.036 Score=53.95 Aligned_cols=31 Identities=16% Similarity=0.065 Sum_probs=27.3
Q ss_pred CCCCcccCCCCCCEEecCCCceEEeecCCcc
Q 044996 492 SLIAPHGHIKSSNVLLNESLEPVLADYGLIP 522 (678)
Q Consensus 492 ~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 522 (678)
+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4579999999999999998877899999863
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.26 E-value=0.0058 Score=53.75 Aligned_cols=112 Identities=19% Similarity=0.235 Sum_probs=74.3
Q ss_pred CCcEEEEEeCC-CCceeecC---hHHhhcCCCCCEEEccCCcccccCC----c-ccccCCCCccEEEcccCccccccCh-
Q 044996 44 RGKIWGLKLED-MGLQGNID---ITILKELREMRTLSLMRNNLEGPMP----D-LRQLGNGALRSVYLSNNRFSGEIPT- 113 (678)
Q Consensus 44 ~~~v~~l~l~~-~~l~g~~~---~~~l~~l~~L~~L~Ls~N~l~g~~p----~-~~~~~~~~L~~L~Ls~N~l~G~ip~- 113 (678)
...++.|+|++ +.++...- ...+...++|+.|+|++|.++..-- . +.. +..|+.|++++|.++..--.
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~--~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV--NNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHH--CSSCCEEECCSSCCCHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhh--cccchhhhhccccccchhHHH
Confidence 45788999987 44542210 1235678899999999998864311 1 122 26799999999998643211
Q ss_pred --hhhcCCcccceee--cccccccc----CCchhhcCCCCCCeEeccCCccc
Q 044996 114 --DAFDGMTSLRKLL--LADNQFNG----PIPESLTRLSRLVELRLEGNKFE 157 (678)
Q Consensus 114 --~~~~~l~~L~~l~--l~~N~~~g----~~p~~~~~l~~L~~l~l~~N~l~ 157 (678)
..+...++|+.++ +++|.+.. .+-..+...++|+.|+++.|...
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 2256678888644 46777753 35556778899999999887653
|